id,study_title,study_link,resultIA_no_fine_tunning,resultIA_fine_tunning,study_type,study_year,cannabinoids,organ_systems,study_conditions
2024001,Prenatal Cannabis Exposure and The Risk for Neuropsychiatric Anomalies in the Offspring: A Systematic Review and Meta-Analysis,https://pubmed.ncbi.nlm.nih.gov/38908654/,Inconclusive,,Meta-analysis,2024,,,Neonatal Cerebral Issues; Pregnancy; Psychosis
2024002,The potential of cannabinoids in managing cancer-related anorexia in older adults: a systematic review of the literature,https://www.sciencedirect.com/science/article/pii/S1279770724003865?via%3Dihub,Positive,,Clinical Meta-analysis,2024,,,Loss of Appetite; Quality of Life
2024003,Therapeutic potential of cannabidiol (CBD) in anxiety disorders: A systematic review and meta-analysis,https://www.sciencedirect.com/science/article/pii/S0165178124003342?via%3Dihub,Positive,,Clinical Meta-analysis,2024,,,PTSD
2024004,The prognostic significance of pro-BNP and heart failure in acute pulmonary embolism: A systematic review,https://www.sciencedirect.com/science/article/abs/pii/S0011502924001093?via%3Dihub,Positive,,Meta-analysis,2024,,,Cardiovascular Diseases (CVD)
2024005,Cannabis and anhedonia: A systematic review,https://www.sciencedirect.com/science/article/abs/pii/S0165178124003263?via%3Dihub,Negative,,Meta-analysis,2024,,,Cannabis Adverse Effects
2024006,Efficacy of cannabis-based medicine in the treatment of Tourette syndrome: a systematic review and meta-analysis,https://link.springer.com/article/10.1007/s00228-024-03710-9,Positive,,Clinical Meta-analysis,2024,,,Tics and Tourettes
2024007,Antiviral Potential of Spirulina in Individuals with Human Immunodeficiency Virus or Hepatis C Virus Infections: A Systematic Review and Meta-Analysis,https://pubmed.ncbi.nlm.nih.gov/39003731/,Positive,,Clinical Meta-analysis,2024,,,Hepatitis; HIV/AIDS
2024008,A systematic review of predictors of vaping cessation among young people,https://pubmed.ncbi.nlm.nih.gov/39031127/,Inconclusive,,Meta-analysis,2024,,,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2024009,Cannabinoids as alleviating treatment for core symptoms of autism spectrum disorder in children and adolescents: a systematic review,https://www.tandfonline.com/doi/full/10.1080/08039488.2024.2381541#d1e167,Inconclusive,,Clinical Meta-analysis,2024,,,Autism; Behavioral Disorders; Cognitive Dysfunction
2023001,CB1 Receptor Silencing Attenuates Ketamine-Induced Hyperlocomotion Without Compromising Its Antidepressant-Like Effects,https://pubmed.ncbi.nlm.nih.gov/36067014/,Positive,,Animal Study,2023,,,Depression
2019001,Ketamine-induced antidepressant like effects in mice: A possible involvement of cannabinoid system,https://www.sciencedirect.com/science/article/pii/S0753332218375309,Positive,,Animal Study,2019,,,Depression
2018001,The Involvement of the Endocannabinoid System in the Peripheral Antinociceptive Action of Ketamine,https://www.jpain.org/article/S1526-5900(17)30801-5/pdf,Positive,,Animal Study,2018,,,Pain; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral
2021001,P.0835 Synergistic effects of lysergic acid diethylamide (LSD) and cannabidiol (CBD),https://www.researchgate.net/publication/357426416_P0835_Synergistic_effects_of_lysergic_acid_diethylamide_LSD_and_cannabidiol_CBD,Positive,,Animal Study,2021,,,Depression
2023002,Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome,https://pubmed.ncbi.nlm.nih.gov/36316276/,Inconclusive,,Animal Study,2023,,,Microbiome Imbalance
2022001,Raising awareness: The implementation of medical cannabis and psychedelics used as an adjunct to standard therapy in the treatment of advanced metastatic breast cancer,https://journals.sagepub.com/doi/10.1177/20503245221114323,Positive,,Meta-analysis,2022,,,Cancer - Breast; Cancer - Metastatic; Cancer
2005001,Co-administration of THC and MDMA (‘Ecstasy’) Synergistically Disrupts Memory in Rats,https://www.nature.com/articles/1300692,Positive,,Animal Study,2005,,,Cannabis Adverse Effects; Cognitive Dysfunction
2024010,Sleep quality of adult recreational cannabis users: a systematic review of literature,https://pubmed.ncbi.nlm.nih.gov/38754072/,Negative,,Clinical Meta-analysis,2024,,,Cannabis Adverse Effects; Insomnia and Sleep Disorders
2024011,Cognitive-behavioral therapies in the management of adolescents with cannabis use disorder (CUD): A systematic review,https://www.sciencedirect.com/science/article/abs/pii/S0376871624002424?via%3Dihub,Positive,,Clinical Meta-analysis,2024,,,Addiction - Cannabis; Behavioral Disorders; Addiction; Cognitive Dysfunction
2024012,Patterns of drug use among people who inject drugs: A global systematic review and meta-analysis,https://www.sciencedirect.com/science/article/pii/S0955395924001403?via%3Dihub,Negative,,Meta-analysis,2024,,,Addiction; Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant
2024013,Association between history of cannabis use and outcomes after total hip or knee arthroplasty: a systematic review and meta-analysis,https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2024.1377688/full,Negative,,Meta-analysis,2024,,,Pain; Pain - Acute; Pain - Chronic; Wound Healing
2024014,Safety of medicinal and edible herbs from fruit sources for human consumption: A systematic review,https://www.sciencedirect.com/science/article/abs/pii/S0378874124007281?via%3Dihub,Negative,,Meta-analysis,2024,,,Cannabis Adverse Effects
2024015,Vasoactive and Antifibrotic Properties of Cannabinoids and Applications to Vasospastic/Vaso-Occlusive Disorders: A Systematic Review,https://pubmed.ncbi.nlm.nih.gov/38857012/,Positive,,Meta-analysis,2024,,,Cardiovascular Diseases (CVD); Reperfusion Injury; Stroke
2024016,Evidence for the use of cannabis-based medicines in osteoarthritis: a scoping review,https://pubmed.ncbi.nlm.nih.gov/38853226/,Positive,,Clinical Meta-analysis,2024,,Skeletal System,Arthritis
2024017,Recent Advanced Methods for Extracting and Analyzing Cannabinoids from Cannabis-Infused Edibles and Detecting Hemp-Derived Contaminants in Food (2013-2023): A Comprehensive Review,https://pubmed.ncbi.nlm.nih.gov/38857901/,Inconclusive,,Meta-analysis,2024,,Mental/Emotional System,Cannabis Adverse Effects
2024018,"Systematic review of drug-drug interactions of delta-9-tetrahydrocannabinol, cannabidiol, and Cannabis",https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1282831/full,Negative,,Meta-analysis,2024,,Mental/Emotional System,Cannabis Adverse Effects
2024019,Re-evaluation of the cardioprotective effects of cannabinoids against ischemia-reperfusion injury according to the IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria,https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1382995/full,Inconclusive,,Meta-analysis,2024,Endocannabinoid (unspecified),Cardiovascular System,Cardiovascular Diseases (CVD); Reperfusion Injury
2024020,Systematic review: the impact of maternal pre-and postnatal cannabis use on the behavioral and emotional regulation in early childhood,https://link.springer.com/article/10.1007/s00787-024-02494-8,Negative,,Meta-analysis,2024,Endocannabinoid (unspecified),Mental/Emotional System; Reproductive System,Behavioral Disorders; Pregnancy; Neonatal Cerebral Issues
2024021,Assessing effects of Cannabis on various neuropathologies: A systematic review,https://www.sciencedirect.com/science/article/pii/S0975947624000263?via%3Dihub#kwrds0010,Inconclusive,,Meta-analysis,2024,,Mental/Emotional System,Cannabis Adverse Effects
2024022,Understanding youth and young adult cannabis use in Canada post-legalization: a scoping review on a public health issue,https://substanceabusepolicy.biomedcentral.com/articles/10.1186/s13011-024-00615-9,Positive,,Meta-analysis,2024,,Mental/Emotional System,Cannabis Adverse Effects; Anxiety; Cannabis Hyperemesis Syndrome; Cognitive Dysfunction; Depression; Psychosis
2024023,Patent review of cannabinoid receptor type 2 (CB2R) modulators (2016-present),https://www.tandfonline.com/doi/full/10.1080/13543776.2024.2368745,Inconclusive,,Meta-analysis,2024,Endocannabinoid (unspecified); Tetrahydrocannabinol (THC),,Cancer; Cardiovascular Diseases (CVD); Fibrosis - Lung; Kidney Failure; Liver Failure; Pain; Neurodegenerative Issues; Osteoporosis; Psychosis; Skin Diseases
2024024,Endocannabinoid levels in female-sexed individuals with diagnosed depression: a systematic review,https://pubmed.ncbi.nlm.nih.gov/38886733/,Inconclusive,,Meta-analysis,2024,Endocannabinoid (unspecified),Mental/Emotional System,Depression; Anxiety; Psychosis
2024025,Meaningfully Characterizing Cannabis Use for Research and Clinical Settings: A Comprehensive Review of Existing Measures and Proposed Future Directions,https://pubmed.ncbi.nlm.nih.gov/38883882/,Inconclusive,,Meta-analysis,2024,,,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2024026,Endocannabinoid Hydrolase Inhibitors: Potential Novel Anxiolytic Drugs,https://www.dovepress.com/endocannabinoid-hydrolase-inhibitors-potential-novel-anxiolytic-drugs-peer-reviewed-fulltext-article-DDDT,Positive,,Meta-analysis,2024,Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); 2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),Mental/Emotional System,Anxiety
2024027,Seventeen years since rimonabant's downfall: reassessing its suicidality risk profile,https://onlinelibrary.wiley.com/doi/10.1002/oby.24019,Inconclusive,,Meta-analysis,2024,Synthetic Cannabinoid (unspecified),Endocrine System; Mental/Emotional System,Obesity; Suicide Attempt
2024028,Extended Treatment with Micron-Size Oral Palmitoylethanolamide (PEA) in Chronic Pain: A Systematic Review and Meta-Analysis,https://www.mdpi.com/2072-6643/16/11/1653,Positive,,Clinical Meta-analysis,2024,Palmitoylethanolamide (PEA),,Pain; Pain - Chronic
2024029,Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality,https://www.mdpi.com/1422-0067/25/11/6268,Inconclusive,,Meta-analysis,2024,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Cannabigerol (CBG); Cannabinol (CBN); Cannabitriol (CBT); Delta-8-THC; Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Tetrahydrocannabinol (THC),,Pain; Pain - Acute
2024030,"The Use of Compounds Derived from Cannabis sativa in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders",https://www.mdpi.com/1422-0067/25/11/5749,Positive,,Meta-analysis,2024,Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,Epilepsy; Pain; Neurodegenerative Issues; Psychosis; Inflammation; Quality of Life
2024031,Assessment of clinical outcomes in patients with inflammatory arthritis: analysis from the UK Medical Cannabis Registry,https://pubmed.ncbi.nlm.nih.gov/38976497/,Positive,,Meta-analysis,2024,,Nervous System; Skeletal System,Arthritis; Inflammation; Arthritis - Rheumatoid
2024032,Clinical and Family Implications of Cannabidiol (CBD)-Dominant Full-Spectrum Phytocannabinoid Extract in Children and Adolescents with Moderate to Severe Non-Syndromic Autism Spectrum Disorder (ASD): An Observational Study on Neurobehavioral Management,https://www.mdpi.com/1424-8247/17/6/686,Positive,,Clinical Trial,2024,,Mental/Emotional System; Nervous System,Autism; ADD and ADHD
2024033,Using Smartphone Technology to Track Real-Time Changes in Anxiety/Depression Symptomatology Among Florida Cannabis Users,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11225978/,Positive,,Meta-analysis,2024,,Mental/Emotional System; Nervous System,Anxiety; Depression
2024034,Examining the association between prenatal cannabis exposure and child autism traits: A multi-cohort investigation in the environmental influences on child health outcome program,https://pubmed.ncbi.nlm.nih.gov/38953698/,Inconclusive,,Meta-analysis,2024,,Mental/Emotional System; Nervous System,Autism; ADD and ADHD; Cannabis Adverse Effects
2024035,Update on cannabis in human sexuality,https://link.springer.com/article/10.1007/s00213-024-06643-4,Positive,,Meta-analysis,2024,,Endocrine System; Reproductive System,Libido; Erectile Dysfunction; Infertility (Female); Infertility (Male)
2015001,Cannabis use and mania symptoms: a systematic review and meta-analysis,https://pubmed.ncbi.nlm.nih.gov/25285897/,Negative,,Clinical Meta-analysis,2015,,Mental/Emotional System; Nervous System,Bipolar Disorder
2014001,Cannabis and schizophrenia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107010/,Inconclusive,,Clinical Meta-analysis,2014,,Mental/Emotional System; Nervous System,Schizophrenia
2015002,Assessment of cannabis use disorders: a systematic review of screening and diagnostic instruments,https://pubmed.ncbi.nlm.nih.gov/25366671/,Negative,,Clinical Meta-analysis,2015,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2014002,Prescribing smoked cannabis for chronic noncancer pain: preliminary recommendations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264803/,Positive,,Clinical Meta-analysis,2014,,Nervous System,Pain; Pain - Chronic; Pain - Neuropathy - Peripheral
2015003,Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases,https://pubmed.ncbi.nlm.nih.gov/25518050/,Negative,,Clinical Meta-analysis,2015,,Digestive System,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; IBD - Ulcerative Colitis
2015004,Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date,https://pubmed.ncbi.nlm.nih.gov/26068702/,Inconclusive,,Clinical Meta-analysis,2015,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Psychosis
2015005,Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444130/,Positive,,Meta-analysis,2015,,Mental/Emotional System; Nervous System,Addiction
2015006,Cannabis withdrawal and sleep: A systematic review of human studies,https://pubmed.ncbi.nlm.nih.gov/25893849/,Inconclusive,,Clinical Meta-analysis,2015,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Insomnia and Sleep Disorders
2015007,A systematic review of the antipsychotic properties of cannabidiol in humans,https://pubmed.ncbi.nlm.nih.gov/25667194/,Positive,,Clinical Meta-analysis,2015,,Mental/Emotional System; Nervous System,Schizophrenia
2014003,Pharmacotherapies for cannabis dependence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297244/,Negative,,Clinical Meta-analysis,2014,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2015008,The effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: a systematic review,https://pubmed.ncbi.nlm.nih.gov/25635955/,Inconclusive,,Clinical Meta-analysis,2015,,Nervous System,Pain; Pain - Chronic; Pain - Neuropathy - Peripheral
2024036,Anti-Cancer and Anti-Proliferative Potential of Cannabidiol: A Cellular and Molecular Perspective,https://www.mdpi.com/1422-0067/25/11/5659,Positive,,Meta-analysis,2024,,Nervous System,Cancer
2024037,Transdermal Delivery of Cannabidiol for the Management of Acute Inflammatory Pain: A Comprehensive Review of the Literature,https://www.mdpi.com/1422-0067/25/11/5858,Positive,,Meta-analysis,2024,Pharma CBD,Digestive System; Nervous System,Pain; Pain - Dental - Acute; Pain - Neuropathy - Inflammatory Polyneuropathy
2022002,Tina's ParTy line: Polysubstance use patterns in sexual minority men living with HIV who use methamphetamine,https://pubmed.ncbi.nlm.nih.gov/34806244/,Negative,,Clinical Trial,2022,,Immune System; Mental/Emotional System; Nervous System,Addiction - Stimulant; Addiction; HIV/AIDS; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Erectile Dysfunction
2024038,An intervention based on Well-Being Therapy to prevent alcohol use and other unhealthy lifestyle behaviors among students: a three-arm cluster randomized controlled trial,https://pubmed.ncbi.nlm.nih.gov/37467370/,Positive,,Clinical Trial,2024,Diet; Exercise,Mental/Emotional System,Addiction - Alcohol; Behavioral Disorders; Addiction; Addiction - Cannabis; Addiction - Nicotine; Addiction - Stimulant; Cannabis Adverse Effects; Insomnia and Sleep Disorders
2024039,Effect of a selective personality-targeted prevention program on 7-year illicit substance related outcomes: A secondary analysis of a cluster randomized controlled trial,https://www.sciencedirect.com/science/article/pii/S037687162400187X?via%3Dihub,Positive,,Clinical Trial,2024,,Mental/Emotional System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2024040,"Cannabidiol for behavior symptoms in Alzheimer’s disease (CANBiS-AD): a randomized, double-blind, placebo-controlled trial",https://www.cambridge.org/core/journals/international-psychogeriatrics/article/cannabidiol-for-behavior-symptoms-in-alzheimers-disease-canbisad-a-randomized-doubleblind-placebocontrolled-trial/7336D30201177E4B080785F055B11E8D,Positive,,Clinical Trial,2024,Pharma CBD,,Alzheimer's Disease; Behavioral Disorders; Anxiety; Dementia
2024041,"Cannabidiol Intervention for Muscular Tension, Pain, and Sleep Bruxism Intensity-A Randomized, Double-Blind Clinical Trial",https://www.mdpi.com/2077-0383/13/5/1417,Positive,,Double Blind Clinical Trial,2024,Pharma CBD,Muscular System,Insomnia and Sleep Disorders; Pain; Temporomandibular Disorders
2024042,The Impact of Cannabis Use on Cognition in People with HIV: Evidence of Function-Dependent Effects and Mechanisms from Clinical and Preclinical Studies,https://link.springer.com/article/10.1007/s11904-024-00698-w,Inconclusive,,Meta-analysis,2024,,Immune System,Cognitive Dysfunction; HIV/AIDS; Inflammation; Neurodegenerative Issues
2024043,Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder,https://www.tandfonline.com/doi/full/10.1080/14728214.2024.2342951,Positive,,Clinical Trial,2024,,Mental/Emotional System,Addiction - Alcohol; Addiction
2024044,Distinguishing Clinical Features of Cannabinoid Hyperemesis Syndrome and Cyclic Vomiting Syndrome: A Retrospective Cohort Study,https://pubmed.ncbi.nlm.nih.gov/38615942/,Inconclusive,,Meta-analysis,2024,,Digestive System; Nervous System,Cannabis Hyperemesis Syndrome; Nausea and Vomiting; Cannabis Adverse Effects
2024045,"Digital Interventions for Recreational Cannabis Use Among Young Adults: Systematic Review, Meta-Analysis, and Behavior Change Technique Analysis of Randomized Controlled Studies",https://www.jmir.org/2024/1/e55031,Positive,,Clinical Meta-analysis,2024,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2024046,The Clinical Translation of α-humulene - A Scoping Review,https://pubmed.ncbi.nlm.nih.gov/38626911/,Positive,,Meta-analysis,2024,Endocannabinoid (unspecified),,Cancer - Colon; Cancer - Breast; Cancer - Lung; Cancer - Ovarian; Cancer - Prostate; Cancer; Inflammation; Oxidative Stress
2024047,"Morphological and clinical findings in placentas and newborns with a history of tobacco, alcohol, and other substance abuse during pregnancy",https://pubmed.ncbi.nlm.nih.gov/38640173/,Negative,,Meta-analysis,2024,,Mental/Emotional System; Nervous System; Reproductive System,Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine; Addiction; Neonatal Cerebral Issues; Pregnancy
2024048,Dravet syndrome seizure frequency and clustering: Placebo-treated patients in clinical trials,https://www.epilepsybehavior.com/article/S1525-5050(24)00155-0/fulltext#secst115,Positive,,Clinical Meta-analysis,2024,,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy
2024049,"Problematic Consumption of Alcohol, Cannabis and Cigarettes—a German Nationwide Survey on Psychopathology, Stress, Mindfulness, and Quality of Life",https://pubmed.ncbi.nlm.nih.gov/38657177/,Negative,,Meta-analysis,2024,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine; Addiction; Psychosis; Quality of Life
2024050,Assessment of Clinical Outcomes in Patients With Osteoarthritis: Analysis From the UK Medical Cannabis Registry,https://www.tandfonline.com/doi/full/10.1080/15360288.2024.2340076,Positive,,Meta-analysis,2024,Pharma CBD; Pharma THC:CBD; Pharma THC,Skeletal System,Arthritis; Anxiety; Insomnia and Sleep Disorders; Pain
2024051,Placebo response in patients with Dravet syndrome: Post-hoc analysis of two clinical trials,https://www.epilepsybehavior.com/article/S1525-5050(24)00186-0/fulltext,Inconclusive,,Clinical Meta-analysis,2024,,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy
2008001,Peripheral endocannabinoid system activity in patients treated with sibutramine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527586/,Negative,,Double Blind Clinical Trial,2008,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Endocrine System,Obesity
2008002,Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial,https://pubmed.ncbi.nlm.nih.gov/18616861/,Negative,,Double Blind Clinical Trial,2008,,Mental/Emotional System,Addiction - Cannabis; Addiction; Schizophrenia
2008003,"SERENADE: the Study Evaluating Rimonabant Efficacy in Drug-naive Diabetic Patients: effects of monotherapy with rimonabant, the first selective CB1 receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabetes",https://pubmed.ncbi.nlm.nih.gov/18678611/,Inconclusive,,Double Blind Clinical Trial,2008,Synthetic Cannabinoid (unspecified),Endocrine System,Diabetes
2008004,"Influence of taranabant, an orally active, highly selective, potent cannabinoid-1 receptor (CB1R) inverse agonist, on ethinyl estradiol and norelgestromin plasma pharmacokinetics",https://pubmed.ncbi.nlm.nih.gov/18936284/,Positive,,Double Blind Clinical Trial,2008,Synthetic Cannabinoid (unspecified),Endocrine System,Obesity; Pregnancy
2011001,An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesity,https://pubmed.ncbi.nlm.nih.gov/21198716/,Inconclusive,,Clinical Meta-analysis,2011,Synthetic Cannabinoid (unspecified),Endocrine System,Obesity
2008005,"Effect of rimonabant on the high-triglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial",https://pubmed.ncbi.nlm.nih.gov/19112166/,Positive,,Double Blind Clinical Trial,2008,Synthetic Cannabinoid (unspecified),Endocrine System,Obesity
2024052,Opioid-positive urine drug screen during treatment with oral naltrexone and the clinical implications,https://meridian.allenpress.com/mhc/article/14/2/102/499684/Opioid-positive-urine-drug-screen-during-treatment,Negative,,Meta-analysis,2024,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction; Addiction - Cannabis
2005002,Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids,https://pubmed.ncbi.nlm.nih.gov/16148455/,Inconclusive,,Double Blind Clinical Trial,2005,Cannabichromene (CBC),,
2024053,Cannabinoids and healthy ageing: the potential for extending healthspan and lifespan in preclinical models with an emphasis on Caenorhabditis elegans,https://link.springer.com/article/10.1007/s11357-024-01162-8#Sec5,Positive,,Meta-analysis,2024,,Muscular System; Nervous System; Skeletal System,Geriatric Conditions; Quality of Life
2005003,Cannabis--psychosis pathway independent of other types of psychopathology,https://pubmed.ncbi.nlm.nih.gov/16125368/,Negative,,Clinical Trial,2005,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Psychosis
2005004,[Effect of the synthetic cannabinoid dronabinol on central pain in patients with multiple sclerosis--secondary publication],https://pubmed.ncbi.nlm.nih.gov/16014264/,Positive,,Double Blind Clinical Trial,2005,Pharma THC,Nervous System,Pain; Multiple Sclerosis; Pain - Central Pain Syndrome
2024054,Harmonization of clinical practice guidelines for primary prevention and screening: actionable recommendations and resources for primary care,https://bmcprimcare.biomedcentral.com/articles/10.1186/s12875-024-02388-3,Inconclusive,,Meta-analysis,2024,,Mental/Emotional System; Nervous System,Addiction; Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Nicotine; Addiction - Opioid; Allergic Contact Dermatitis; Cancer; Cardiovascular Diseases (CVD); COPD; Depression; Hepatitis; Obesity; Osteoporosis; Vaping injury (EVALI)
2005005,Cannabinoid influence on cytokine profile in multiple sclerosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1809378/,Inconclusive,,Double Blind Clinical Trial,2005,Tetrahydrocannabinol (THC),Nervous System,Multiple Sclerosis
2005006,Pain measurements and side effect profile of the novel cannabinoid ajulemic acid,https://pubmed.ncbi.nlm.nih.gov/15910892/,Positive,,Double Blind Clinical Trial,2005,Synthetic Cannabinoid (unspecified),Nervous System,Pain; Pain - Chronic; Pain - Neuropathy - Peripheral
2004001,The effect of cannabis on tremor in patients with multiple sclerosis,https://pubmed.ncbi.nlm.nih.gov/15079008/,Inconclusive,,Double Blind Clinical Trial,2004,,,Multiple Sclerosis
2024055,Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes,https://journals.sagepub.com/doi/10.1177/07067437241245384,Negative,,Meta-analysis,2024,,Mental/Emotional System; Nervous System,Anxiety; Depression; ADD and ADHD; Behavioral Disorders; Bipolar Disorder; Cognitive Dysfunction; Psychosis; Schizophrenia
2004002,Development and pharmacokinetic characterization of pulmonal and intravenous delta-9-tetrahydrocannabinol (THC) in humans,https://pubmed.ncbi.nlm.nih.gov/15067694/,Negative,,Double Blind Clinical Trial,2004,Pharma THC,,Pain
2024056,"Design of Mixed Medicinal Plants, Rich in Polyphenols, Vitamins B, and Palmitoylethanolamide-Based Supplement to Help Reduce Nerve Pain: A Preclinical Study",https://www.mdpi.com/1422-0067/25/9/4790,Positive,,Laboratory Study,2024,Palmitoylethanolamide (PEA),Nervous System,Pain; Pain - Neuropathy - Diabetic; Pain - Neuropathy - Drug-Ind. Polyneuropathy; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral; Inflammation; Oxidative Stress
2024057,"The Interplay of Sleep Quality, Mental Health, and Sociodemographic and Clinical Factors among Italian College Freshmen",https://www.mdpi.com/2077-0383/13/9/2626,Negative,,Clinical Trial,2024,,Nervous System,Insomnia and Sleep Disorders; Behavioral Disorders; Addiction; Anxiety; Depression; Psychosis
2024058,Clinical outcome analysis of patients with multiple sclerosis - Analysis from the UK Medical Cannabis Registry,https://www.msard-journal.com/article/S2211-0348(24)00242-6/fulltext,Positive,,Meta-analysis,2024,,Nervous System,Multiple Sclerosis; Quality of Life
2004003,First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol,https://pubmed.ncbi.nlm.nih.gov/15061244/,Negative,,Clinical Trial,2004,,Mental/Emotional System,Psychosis; Schizophrenia
2024059,"The Association between Oxaliplatin-Induced Peripheral Neuropathy, Sociodemographic, and Clinical Characteristics with Falls in Older Adults with Colorectal Cancer",https://pubmed.ncbi.nlm.nih.gov/38751324/,Negative,,Meta-analysis,2024,,Digestive System; Nervous System,Cancer - Colon; Cancer; Pain; Pain - Neuropathy - Drug-Ind. Polyneuropathy; Geriatric Conditions
2004004,Voluntary exercise augments acute effects of CB1-receptor inverse agonist on body weight loss in obese and lean mice,https://pubmed.ncbi.nlm.nih.gov/14724049/,Positive,,Animal Study,2004,AM-x Synthetic Cannabinoids,Endocrine System,Obesity
2024060,Process evaluation of a pragmatic feasibility trial on smokeless tobacco cessation intervention delivered in dental hospitals,https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-024-18821-2,Negative,,Clinical Trial,2024,,Mental/Emotional System; Nervous System,Addiction - Nicotine; Addiction; Cannabis Adverse Effects; Periodontal Disease
2003001,Characteristics of subgroups of individuals with psychotic illness and a comorbid substance use disorder,https://pubmed.ncbi.nlm.nih.gov/12663845/,Negative,,Clinical Trial,2003,,Mental/Emotional System; Nervous System,Addiction; Psychosis
2002001,"Dexanabinol (HU-211) in the treatment of severe closed head injury: a randomized, placebo-controlled, phase II clinical trial",https://pubmed.ncbi.nlm.nih.gov/11990913/,Positive,,Double Blind Clinical Trial,2002,HU-x Synthetic Cannabinoids,Nervous System,Traumatic Brain Injury
2002002,Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer,https://pubmed.ncbi.nlm.nih.gov/11818522/,Negative,,Clinical Trial,2002,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Reproductive System,Pregnancy
2024061,Evaluating possible 'next day' impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trial,https://link.springer.com/article/10.1007/s00213-024-06595-9,Inconclusive,,Clinical Trial,2024,,Nervous System,Cognitive Dysfunction; Insomnia and Sleep Disorders; Cannabis Adverse Effects
2024062,Anticancer effect of minor phytocannabinoids in preclinical models of multiple myeloma,https://iubmb.onlinelibrary.wiley.com/doi/10.1002/biof.2078,Positive,,Animal Study,2024,Cannabichromene (CBC); Cannabidivarin (CBDV); Cannabigerol (CBG); Cannabinol (CBN),Cardiovascular System,Cancer - Myeloma
2024063,Perioperative Cannabis Use in Bariatric Patients: A Review of Outcomes and Proposed Clinical Pathway for Management,https://link.springer.com/article/10.1007/s11695-024-07281-7,Negative,,Meta-analysis,2024,,Endocrine System,Obesity; Addiction - Alcohol; Addiction - Cannabis; Addiction - Opioid; Addiction; Anorexia Nervosa; Anorexia; Anxiety; Cannabis Adverse Effects; Depression; Pain; Psychosis; Schizophrenia
2024064,Clinical factors associated with smoking cessation among smokers with Chronic Obstructive Pulmonary Disease by sex: Longitudinal analyses from French smoking cessation services,https://www.cell.com/heliyon/fulltext/S2405-8440(24)06951-2?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2405844024069512%3Fshowall%3Dtrue,Negative,,Clinical Trial,2024,,Mental/Emotional System; Nervous System; Respiratory System,Addiction - Nicotine; Addiction; COPD
2024065,Absence of Evidence for Sustained Effects of Daily Cannabidiol Administration on Anandamide Plasma Concentration in Individuals with Cocaine Use Disorder: Exploratory Findings from a Randomized Controlled Trial,https://pubmed.ncbi.nlm.nih.gov/38770686/,Inconclusive,,Double Blind Clinical Trial,2024,Anandamide (AEA),Mental/Emotional System; Nervous System,Addiction - Cocaine; Addiction; Cannabis Adverse Effects
2013001,Acute Effects of THC on Time Perception in Frequent and Infrequent Cannabis Users,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581701/,Inconclusive,,Double Blind Clinical Trial,2013,,,Erectile Dysfunction; Cognitive Dysfunction; Libido
2001001,Progesterone receptor and dopamine receptors are required in Δ9-tetrahydrocannabinol modulation of sexual receptivity in female rats,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC14740/,Positive,,Animal Study,2001,Tetrahydrocannabinol (THC),Endocrine System; Reproductive System,Libido; Erectile Dysfunction
2013002,Anandamide transforms noncopulating rats into sexually active animals,https://pubmed.ncbi.nlm.nih.gov/22906359/,Positive,,Animal Study,2013,Anandamide (AEA),,Erectile Dysfunction; Libido
2011002,Impact of cannabis use on male sexual health,https://pubmed.ncbi.nlm.nih.gov/21269404/,Inconclusive,,Meta-analysis,2011,,,Erectile Dysfunction; Libido
2019002,How Cannabis Alters Sexual Experience: A Survey of Men and Women,https://pubmed.ncbi.nlm.nih.gov/31447385/,Positive,,Meta-analysis,2019,,Endocrine System; Reproductive System,Libido; Erectile Dysfunction
2010001,Cannabis use and sexual health,https://pubmed.ncbi.nlm.nih.gov/19694929/,Inconclusive,,Meta-analysis,2010,,,Erectile Dysfunction; Libido
2024066,Is marijuana a foe of male sexuality? Data from a large cohort of men with sexual dysfunction,https://pubmed.ncbi.nlm.nih.gov/36617843/,Positive,,Meta-analysis,2024,,Endocrine System; Reproductive System,Erectile Dysfunction; Libido
2020001,A Survey Exploring the Relationship Between Cannabis Use Characteristics and Sexual Function in Men,https://pubmed.ncbi.nlm.nih.gov/32561331/,Positive,,Meta-analysis,2020,,Endocrine System; Reproductive System,Erectile Dysfunction; Libido
2024067,Psychosexual dysfunction in male patients with cannabis dependence and synthetic cannabinoid dependence,https://pubmed.ncbi.nlm.nih.gov/38282460/,Negative,,Meta-analysis,2024,Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System; Reproductive System,Addiction - Cannabis; Addiction; Erectile Dysfunction; Libido
2008006,Early endothelial dysfunction as a marker of vasculogenic erectile dysfunction in young habitual cannabis users,https://pubmed.ncbi.nlm.nih.gov/18997809/,Negative,,Meta-analysis,2008,,Reproductive System,Erectile Dysfunction; Libido
2024068,Relationship Between Cannabis Use and Erectile Dysfunction: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893937/#,Negative,,Meta-analysis,2024,,Reproductive System,Erectile Dysfunction; Libido
2024069,The impact of cannabis use on erectile dysfunction and sex hormones: a Mendelian randomization analysis,https://pubmed.ncbi.nlm.nih.gov/38834872/,Inconclusive,,Meta-analysis,2024,,Reproductive System,Erectile Dysfunction; Infertility (Female); Infertility (Male); Libido
2024070,Association of Cannabis Use With Cardiovascular Outcomes Among US Adults,https://www.ahajournals.org/doi/10.1161/JAHA.123.030178,Negative,,Meta-analysis,2024,,Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack; Stroke
2024071,The Impact of Recreational Marijuana Legalization on Intimate Partner Violence,https://repository.library.georgetown.edu/bitstream/handle/10822/1088803/Baldwin_georgetown_0076M_15972.pdf?sequence=1&isAllowed=y,Positive,,Meta-analysis,2024,,Mental/Emotional System,Domestic Abuse; Intermittent Explosive Disorder
2024072,Cyclic vomiting syndrome: Future clinical and research priorities for: Special supplement/proceedings of 3rd international symposium,https://pubmed.ncbi.nlm.nih.gov/38775195/,Negative,,Meta-analysis,2024,Endocannabinoid (unspecified),Digestive System,Nausea and Vomiting; Cannabis Hyperemesis Syndrome
2024073,"Clinical, sociodemographic and environmental predicting factors for relapse in bipolar disorder: A systematic review",https://www.sciencedirect.com/science/article/abs/pii/S0165032724008000?via%3Dihub,Negative,,Meta-analysis,2024,,Mental/Emotional System; Nervous System,Bipolar Disorder; Depression
2022003,Marijuana and thromboembolic events in geriatric trauma patients: The cannabinoids clots correlation!,https://pubmed.ncbi.nlm.nih.gov/34334193/,Negative,,Meta-analysis,2022,Tetrahydrocannabinol (THC),,Bleeding Disorders; Cardiovascular Diseases (CVD); Heart Attack; Stroke; Wound Healing
2020002,Impact of marijuana on venous thromboembolic events: Cannabinoids cause clots in trauma patients,https://pubmed.ncbi.nlm.nih.gov/32209959/,Negative,,Meta-analysis,2020,,Immune System; Integumentary System; Nervous System,Wound Healing; Bleeding Disorders; Cardiovascular Diseases (CVD); Heart Attack; Stroke
2014004,"Ischemic stroke after use of the synthetic marijuana ""spice""",https://pubmed.ncbi.nlm.nih.gov/25135913/,Negative,,Meta-analysis,2014,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis; Bleeding Disorders
2014005,Endocannabinoids Control Platelet Activation and Limit Aggregate Formation under Flow,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180465/,Positive,,Laboratory Study,2014,Anandamide (AEA),,Bleeding Disorders
2024074,"The inhibitory effects of cannabinoids, the active constituents of Cannabis sativa L. on human and rabbit platelet aggregation",https://pubmed.ncbi.nlm.nih.gov/2575149/,Inconclusive,,Laboratory Study,2024,Cannabigerol (CBG); Cannabinol (CBN); Tetrahydrocannabinol (THC),,Bleeding Disorders
2007001,Anticoagulant effects of a Cannabis extract in an obese rat model,https://pubmed.ncbi.nlm.nih.gov/16644197/,Positive,,Animal Study,2007,Cannabinol (CBN),,Bleeding Disorders
2024075,"In vivo effects of Cannabis sativa L. extract on blood coagulation, fat and glucose metabolism in normal and streptozocin-induced diabetic rats",https://www.researchgate.net/publication/279696665_In_vivo_effects_of_Cannabis_sativa_L_extract_on_blood_coagulation_fat_and_glucose_metabolism_in_normal_and_streptozocin-induced_diabetic_rats,Positive,,Animal Study,2024,,,Bleeding Disorders; Diabetes; Metabolic Syndrome
2019003,Interaction between warfarin and cannabis,https://pubmed.ncbi.nlm.nih.gov/30326170/,Inconclusive,,Meta-analysis,2019,,,Bleeding Disorders
2020003,Warfarin dose adjustment required after cannabidiol initiation and titration,https://pubmed.ncbi.nlm.nih.gov/33016308/,Inconclusive,,Meta-analysis,2020,,,Bleeding Disorders
2024076,The Endocannabinoid System: A Potential Therapeutic Target for Coagulopathies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228226/,Inconclusive,,Meta-analysis,2024,,Cardiovascular System,Bleeding Disorders
2016001,"Differential effects of endogenous, phyto and synthetic cannabinoids on thrombogenesis and platelet activity",https://pubmed.ncbi.nlm.nih.gov/27151562/,Positive,,Animal Study,2016,Anandamide (AEA); WIN-x Synthetic Cannabinoids,Cardiovascular System,Bleeding Disorders
2024077,"Spirulina Unveiled: A Comprehensive Review on Biotechnological Innovations, Nutritional Proficiency, and Clinical Implications",https://pubmed.ncbi.nlm.nih.gov/38803172/,Positive,,Meta-analysis,2024,Phycocyanin,,
2024078,Cannabidiol-enriched oil for adult patients with drug-resistant epilepsy: Prospective clinical and electrophysiological study,https://onlinelibrary.wiley.com/doi/10.1111/epi.18025,Positive,,Clinical Trial,2024,Tetrahydrocannabinol (THC),Nervous System,Epilepsy
2024079,A systematic review of novel cannabinoids and their targets: Insights into the significance of structure in activity,https://www.sciencedirect.com/science/article/abs/pii/S0014299924003674?via%3Dihub#preview-section-snippets,Inconclusive,,Meta-analysis,2024,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Cannabichromene (CBC); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),,
2021002,"Endocannabinoid system: Role in blood cell development, neuroimmune interactions and associated disorders",https://pubmed.ncbi.nlm.nih.gov/33571815/,Negative,,Meta-analysis,2021,Endocannabinoid (unspecified),,Bleeding Disorders
2024080,Probable interaction between warfarin and marijuana smoking,https://pubmed.ncbi.nlm.nih.gov/19531696/,Negative,,Meta-analysis,2024,,,Bleeding Disorders; Cardiovascular Diseases (CVD)
2018002,"An interaction between warfarin and cannabidiol, a case report",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789126/,Positive,,Meta-analysis,2018,Pharma CBD,,Bleeding Disorders; Epilepsy; Stroke
2014006,Increase in the Number of CB1 Immunopositive Neurons in the Amygdaloid Body after Acute Cold Stress Exposure,https://www.researchgate.net/publication/272355424_INCREASE_IN_THE_NUMBER_OF_CB1_IMMUNOPOSITIVE_NEURONS_IN_THE_AMYGDALOID_BODY_AFTER_ACUTE_COLD_STRESS_EXPOSURE,Negative,,Animal Study,2014,Cold Exposure,,
2024081,Cold-induced changes in plasma signaling lipids are associated with a healthier cardiometabolic profile independently of brown adipose tissue,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10897514/,Positive,,Clinical Trial,2024,Cold Exposure; Endocannabinoid (unspecified),Endocrine System,Obesity; Diabetes; Metabolic Syndrome
2006001,Cold exposure stimulates synthesis of the bioactive lipid oleoylethanolamide in rat adipose tissue,https://pubmed.ncbi.nlm.nih.gov/16785227/,Positive,,Animal Study,2006,Cold Exposure; Oleoylethanolamide (OEA),,Diabetes; Metabolic Syndrome; Obesity
2024082,The role of cannabinoids in chronic pain management: clinical insights and challenges,https://www.sciencedirect.com/science/article/pii/S0104001424000459?via%3Dihub,Inconclusive,,Meta-analysis,2024,,Nervous System,Pain; Pain - Chronic; Inflammation; Pain - Cancer; Pain - Neuropathy - Diabetic; Pain - Neuropathy - Drug-Ind. Polyneuropathy; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral
2024083,Medical cannabis and its efficacy/effectiveness on the management of osteoarthritis pain and function,https://pubmed.ncbi.nlm.nih.gov/38832841/,Inconclusive,,Clinical Meta-analysis,2024,,Skeletal System,Arthritis
2024084,TRPV1 channel in the pathophysiology of epilepsy and its potential as a molecular target for the development of new antiseizure drug candidates,https://www.sciencedirect.com/science/article/pii/S0301008224000704?via%3Dihub,Positive,,Meta-analysis,2024,,Nervous System,Epilepsy
2024085,The circulating and central endocannabinoid system in obesity and weight loss,https://pubmed.ncbi.nlm.nih.gov/38834796/,Inconclusive,,Meta-analysis,2024,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified),Endocrine System,Obesity
2024086,Neurolipidomic insights into anxiety disorders: Uncovering lipid dynamics for potential therapeutic advances,https://www.sciencedirect.com/science/article/pii/S0149763424002100?via%3Dihub,Positive,,Meta-analysis,2024,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Omega-3; Diet; Fatty Acid Amide Hydrolase (FAAH); Omega-6; Monoacylglycerol Lipase (MAGL),Mental/Emotional System; Nervous System,Anxiety; Oxidative Stress
2024087,"The Effect of Palmitoylethanolamide (PEA) on Skeletal Muscle Hypertrophy, Strength, and Power in Response to Resistance Training in Healthy Active Adults: A Double-Blind Randomized Control Trial",https://sportsmedicine-open.springeropen.com/articles/10.1186/s40798-024-00732-6,Positive,,Double Blind Clinical Trial,2024,Palmitoylethanolamide (PEA),,Insomnia and Sleep Disorders; Pain; Quality of Life
2024088,Palmitoylethanolamide and Luteolin for postinfectious olfactory disorders: How clinically meaningful is its effect?,https://karger.com/orl/article-pdf/doi/10.1159/000539651/4240689/000539651.pdf,Positive,,Clinical Trial,2024,Palmitoylethanolamide (PEA),Respiratory System,COVID-19; Acute Respiratory Distress Syndrome; Respiratory Syncytial Virus; Stress
2024089,Therapeutic potential of Phycocyanin in gastrointestinal cancers and related disorders,https://pubmed.ncbi.nlm.nih.gov/38874869/,Positive,,Meta-analysis,2024,Phycocyanin,Digestive System; Nervous System,Cancer - Stomach; Cancer
2024090,Editorial: Insights on cannabinoid translational science and medicine: the endocannabinoidome as a target for clinical practice,https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2024.1432892/full,Positive,,Meta-analysis,2024,Microbiome; 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Cannabidivarin (CBDV); Cannabigerol (CBG); Delta-8-THC; Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Other Related Compounds; Tetrahydrocannabivarin (THCV); Tetrahydrocannabinol (THC),,
2024091,"Evaluating the Impact of Probiotic Therapy on the Endocannabinoid System, Pain, Sleep and Fatigue: A Randomized, Double-Blind, Placebo-Controlled Trial in Dancers",https://www.mdpi.com/1422-0067/25/11/5611,Positive,,Double Blind Clinical Trial,2024,Endocannabinoid (unspecified); Fatty Acid-Binding Protein (FABP); Microbiome; Diet; Exercise,Nervous System,Insomnia and Sleep Disorders; Pain
2024092,"Chemical compounds, anti-tumor and anti-neuropathic pain effect of hemp essential oil in vivo",https://pubmed.ncbi.nlm.nih.gov/38914272/,Positive,,Animal Study,2024,,Nervous System; Respiratory System,Cancer - Lung; Cancer; Pain; Pain - Neuropathy - Drug-Ind. Polyneuropathy; Inflammation
2024093,"Evaluation of the efficacy, safety, and pharmacokinetics of nanodispersible cannabidiol oral solution (150 mg/mL) versus placebo in mild to moderate anxiety subjects: A double blind multicenter randomized clinical trial",https://www.sciencedirect.com/science/article/pii/S1876201824001667,Positive,,Double Blind Clinical Trial,2024,,Mental/Emotional System; Nervous System,Anxiety; Depression; Grief and Bereavement; Insomnia and Sleep Disorders; OCD; PTSD
2024094,Continuous spike-wave of slow sleep in a patient with KCNB1-related epilepsy responsive to highly purified cannabidiol: a case report and comparison with literature,https://pubmed.ncbi.nlm.nih.gov/38769754/,Positive,,Meta-analysis,2024,,Nervous System,Epilepsy; Autism
2024095,Acute and Long-Term Effects of App-Delivered Heartfulness Meditation on Psychological Outcomes and the Endocannabinoid Signaling System in Cyclic Vomiting Syndrome,https://pubmed.ncbi.nlm.nih.gov/38713142/,Positive,,Clinical Trial,2024,Anandamide (AEA); Oleoylethanolamide (OEA); Palmitoylethanolamide (PEA),Digestive System,Nausea and Vomiting; Cannabis Hyperemesis Syndrome
2024096,"Examining the oleoylethanolamide supplement effects on glycemic status, oxidative stress, inflammation, and anti-mullerian hormone in polycystic ovary syndrome",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11110282/,Positive,,Double Blind Clinical Trial,2024,Oleoylethanolamide (OEA),Endocrine System,Polycystic Ovary Disease
2024097,Cannabidiol-Only Product Use in Pregnancy in the United States and Canada: Findings From the International Cannabis Policy Study,https://pubmed.ncbi.nlm.nih.gov/38723262/,Negative,,Meta-analysis,2024,,Reproductive System,Pregnancy
2024098,Effects of Chronic Cannabidiol Dosing on Brain Blood Flow: Insights from the Hyper-H21-4 Trial,https://journals.lww.com/jhypertension/abstract/2024/05001/effects_of_chronic_cannabidiol_dosing_on_brain.593.aspx?utm_source=substack&utm_medium=email,Inconclusive,,Double Blind Clinical Trial,2024,,Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2024099,An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11116491/,Positive,,Clinical Trial,2024,,Skeletal System,Arthritis; Anxiety; Pain; Pain - Chronic
2024100,The Intoxication Equivalency of 11-Hydroxy-Δ9-tetrahydrocannabinol (11-OH-THC) Relative to Δ9-tetrahydrocannabinol (THC),https://pubmed.ncbi.nlm.nih.gov/38858091/,Inconclusive,,Animal Study,2024,Tetrahydrocannabinol (THC),,
2024101,Cannabidiol Therapy for Comorbid Schizophrenia and Addiction: A Guide for Clinical Practice,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4857098,Positive,,Clinical Meta-analysis,2024,,Mental/Emotional System; Nervous System,Addiction; Schizophrenia; Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant; Psychosis
2008007,CB2 receptors in reproduction,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219526/,Positive,,Meta-analysis,2008,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Reproductive System,Infertility (Female); Infertility (Male); Pregnancy
2024102,Moving to Improve Mental Health - The Role of Exercise in Cognitive Function: A Narrative Review,https://pubmed.ncbi.nlm.nih.gov/38595617/,Positive,,Meta-analysis,2024,Endocannabinoid (unspecified); Exercise,Nervous System,Cognitive Dysfunction; Anxiety; Depression
2020004,Role of endocannabinoid signaling in a septohabenular pathway in the regulation of anxiety- and depressive-like behavior,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060365/,Positive,,Animal Study,2020,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Monoacylglycerol Lipase (MAGL),Mental/Emotional System; Nervous System,Anxiety; Depression
2024103,Clinical application of hempseed or flaxseed oil-based lyotropic liquid crystals: Evaluation of their impact on skin barrier function,https://pubmed.ncbi.nlm.nih.gov/38815204/,Positive,,Double Blind Clinical Trial,2024,,Integumentary System,Skin Diseases; Allergic Contact Dermatitis; Inflammation
2004005,Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial,https://pubmed.ncbi.nlm.nih.gov/15258006/,Positive,,Double Blind Clinical Trial,2004,Pharma THC,,Multiple Sclerosis
2004006,"Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study",https://pubmed.ncbi.nlm.nih.gov/15327040/,Inconclusive,,Double Blind Clinical Trial,2004,Tetrahydrocannabinol (THC),,Multiple Sclerosis
2004007,Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study,https://pubmed.ncbi.nlm.nih.gov/15477546/,Negative,,Double Blind Clinical Trial,2004,Tetrahydrocannabinol (THC),,Parkinson's Disease
2005007,Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood,https://pubmed.ncbi.nlm.nih.gov/15778874/,Positive,,Clinical Trial,2005,Pharma THC,Immune System,HIV/AIDS
2005008,"Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction",https://pubmed.ncbi.nlm.nih.gov/15780846/,Negative,,Double Blind Clinical Trial,2005,Pharma THC,Mental/Emotional System,Schizophrenia
2002003,Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study,https://pubmed.ncbi.nlm.nih.gov/11786587/,Inconclusive,,Clinical Trial,2002,Pharma THC,Digestive System,Nausea and Vomiting
2004008,"Neurokinin B, neurotensin, and cannabinoid receptor antagonists and Parkinson disease",https://pubmed.ncbi.nlm.nih.gov/15190231/,Negative,,Double Blind Clinical Trial,2004,SR-x Synthetic Cannabinoids,,Parkinson's Disease
2004009,The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis,https://pubmed.ncbi.nlm.nih.gov/15173844/,Inconclusive,,Double Blind Clinical Trial,2004,Pharma THC,Mental/Emotional System,Psychosis; Schizophrenia
2008008,"Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213874/,Inconclusive,,Double Blind Clinical Trial,2008,Pharma THC,,Pain; Pain - Neuropathy - Peripheral
2008009,"Safety, tolerability, pharmacokinetics, and pharmacodynamic properties of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, for the treatment of obesity: results from a double-blind, placebo-controlled, single oral dose study in healthy volunteers",https://pubmed.ncbi.nlm.nih.gov/18258750/,Inconclusive,,Double Blind Clinical Trial,2008,,Endocrine System,Obesity
2008010,Analgesic and antihyperalgesic effects of nabilone on experimental heat pain,https://pubmed.ncbi.nlm.nih.gov/18302810/,Inconclusive,,Double Blind Clinical Trial,2008,Pharma THC,,Pain
2008011,Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study,https://pubmed.ncbi.nlm.nih.gov/18417461/,Positive,,Double Blind Clinical Trial,2008,,Endocrine System,Obesity
2023003,"Cannabidiol (CBD) Products for Pain: Ineffective, Expensive, and With Potential Harms",https://www.jpain.org/article/S1526-5900(23)00582-5/fulltext,Negative,,Clinical Meta-analysis,2023,,,Pain - Acute; Pain - Cancer; Pain - Central Pain Syndrome; Pain - Chronic; Pain - Dental - Acute; Pain - Eye; Pain - Neuropathy - Diabetic; Pain - Neuropathy - Drug-Ind. Polyneuropathy; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral
2005009,Reinforcing effects of oral Delta9-THC in male marijuana smokers in a laboratory choice procedure,https://pubmed.ncbi.nlm.nih.gov/15830233/,Inconclusive,,Clinical Trial,2005,Pharma THC,,
2005010,The effect of nabilone on neuropsychological functions related to driving ability: an extended case series,https://pubmed.ncbi.nlm.nih.gov/15834843/,Positive,,Double Blind Clinical Trial,2005,Pharma THC,,Multiple Sclerosis
2005011,Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study,https://pubmed.ncbi.nlm.nih.gov/15836887/,Negative,,Double Blind Clinical Trial,2005,Synthetic Cannabinoid (unspecified),Cardiovascular System; Endocrine System,Cardiovascular Diseases (CVD); Obesity
2014007,Do withdrawal-like symptoms mediate increased marijuana smoking in individuals treated with venlafaxine-XR?,https://www.sciencedirect.com/science/article/abs/pii/S0376871614009673?via%3Dihub,Negative,,Meta-analysis,2014,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2015009,The association between impulsivity and alcohol/drug use among prison inmates,https://www.sciencedirect.com/science/article/abs/pii/S0306460314003979?via%3Dihub,Negative,,Clinical Trial,2015,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Behavioral Disorders; Addiction - Stimulant
2015010,"Activity of liver enzymes in multiple sclerosis patients with Hot-nature diet and co-supplemented hemp seed, evening primrose oils intervention",https://www.sciencedirect.com/science/article/abs/pii/S0965229914001575?via%3Dihub#preview-section-snippets,Positive,,Double Blind Clinical Trial,2015,,Nervous System,Multiple Sclerosis
2014008,Placebo effects in a multiple sclerosis spasticity enriched clinical trial with the oromucosal cannabinoid spray (THC/CBD): dimension and possible causes,https://onlinelibrary.wiley.com/doi/10.1111/cns.12358,Positive,,Clinical Meta-analysis,2014,Pharma THC:CBD; Tetrahydrocannabinol (THC),Nervous System,Multiple Sclerosis
2015011,Cognitive Enhancement Therapy in substance misusing schizophrenia: results of an 18-month feasibility trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308498/,Positive,,Clinical Trial,2015,,Mental/Emotional System; Nervous System,Cognitive Dysfunction; Schizophrenia; Addiction - Alcohol; Addiction - Cannabis; Addiction; Psychosis
2015012,"Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users",https://www.sciencedirect.com/science/article/pii/S0924977X14003253?via%3Dihub#s0010,Positive,,Double Blind Clinical Trial,2015,Tetrahydrocannabinol (THC),Nervous System,Cognitive Dysfunction; Addiction - Cannabis; Addiction; Psychosis; Schizophrenia
2015013,Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials,https://pubmed.ncbi.nlm.nih.gov/25796592/,Positive,,Clinical Meta-analysis,2015,,Nervous System,Pain; Pain - Chronic
2009001,Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing,https://pubmed.ncbi.nlm.nih.gov/19124693/,Inconclusive,,Double Blind Clinical Trial,2009,Tetrahydrocannabinol (THC),,Anxiety
2024104,Association between cannabis use disorder and schizophrenia stronger in young males than in females,http://www.ncbi.nlm.nih.gov/pmc/articles/pmc10719679/,Inconclusive,,Meta-analysis,2024,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Schizophrenia; Psychosis
2009002,Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815025/,Negative,,Double Blind Clinical Trial,2009,Tetrahydrocannabivarin (THCV); Pharma THC; Tetrahydrocannabinol (THC),,Addiction - Cannabis; Addiction
2010002,"Development of a population pharmacokinetic model for taranabant, a cannibinoid-1 receptor inverse agonist",https://pubmed.ncbi.nlm.nih.gov/20582578/,Negative,,Clinical Meta-analysis,2010,Synthetic Cannabinoid (unspecified),,Obesity
2010003,"Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease",https://pubmed.ncbi.nlm.nih.gov/20600015/,Negative,,Clinical Trial,2010,2-Arachidonoyl Glycerol (2-AG); Fatty Acid-Binding Protein (FABP),Digestive System,Liver Failure
2015014,Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers,https://www.nature.com/articles/npp2015108,Positive,,Clinical Trial,2015,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2015015,Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review,https://www.sciencedirect.com/science/article/pii/S0149763415001190?via%3Dihub,Positive,,Meta-analysis,2015,,Mental/Emotional System; Nervous System,Neurodegenerative Issues; Psychosis; ADD and ADHD; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Stimulant; Addiction; Alzheimer's Disease; Amyotrophic Lateral Sclerosis (ALS); Anxiety; Autism; Bipolar Disorder; Depression; Epilepsy; Tics and Tourettes; Pain; OCD; Pain - Neuropathy - Drug-Ind. Polyneuropathy; Schizophrenia
2015016,Motivational interviewing and interaction skills training for parents of young adults with recent-onset schizophrenia and co-occurring cannabis use: 15-month follow-up,https://pubmed.ncbi.nlm.nih.gov/25959502/,Positive,,Clinical Trial,2015,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Schizophrenia; Psychosis
2015017,The fatty acid amide hydrolase C385A variant affects brain binding of the positron emission tomography tracer [11C]CURB,https://journals.sagepub.com/doi/10.1038/jcbfm.2015.119,Positive,,Laboratory Study,2015,Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH),,Addiction; Anxiety
2015018,Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541447/,Positive,,Clinical Meta-analysis,2015,Tetrahydrocannabinol (THC),Nervous System,Pain; Pain - Chronic; HIV/AIDS; Multiple Sclerosis; Pain - Neuropathy - Diabetic; Pain - Neuropathy - Drug-Ind. Polyneuropathy; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral; PTSD
2016002,"Efficacy, Tolerability, and Safety of Cannabinoid Treatments in the Rheumatic Diseases: A Systematic Review of Randomized Controlled Trials",https://acrjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/acr.22727,Positive,,Clinical Meta-analysis,2016,Pharma THC; Synthetic Cannabinoid (unspecified),Skeletal System,Arthritis - Rheumatoid; Arthritis; Fibromyalgia; Insomnia and Sleep Disorders; Pain; Quality of Life
2009003,Drug reimbursement and GPs' prescribing decisions: a randomized case-vignette study about the pharmacotherapy of obesity associated with type 2 diabetes: how GPs react to drug reimbursement,https://pubmed.ncbi.nlm.nih.gov/19840120/,Negative,,Clinical Trial,2009,,Endocrine System,Diabetes; Obesity
2009004,Impact of substance use on the physical health of patients with bipolar disorder,https://pubmed.ncbi.nlm.nih.gov/19895620/,Negative,,Clinical Trial,2009,,Cardiovascular System; Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine; Addiction; Bipolar Disorder; Cardiovascular Diseases (CVD)
2009005,Rimonabant (SR141716) has no effect on alcohol self-administration or endocrine measures in nontreatment-seeking heavy alcohol drinkers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963590/,Negative,,Double Blind Clinical Trial,2009,Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction
2010004,"A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study",https://pubmed.ncbi.nlm.nih.gov/20157323/,Negative,,Double Blind Clinical Trial,2010,Synthetic Cannabinoid (unspecified),Endocrine System,Obesity
2010005,"Randomized, controlled, double-blind trial of taranabant for smoking cessation",https://pubmed.ncbi.nlm.nih.gov/20191360/,Negative,,Double Blind Clinical Trial,2010,Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Addiction - Nicotine; Addiction
2010006,A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study,https://pubmed.ncbi.nlm.nih.gov/20212496/,Inconclusive,,Double Blind Clinical Trial,2010,,Endocrine System,Obesity
2010007,"A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis",https://pubmed.ncbi.nlm.nih.gov/20307378/,Positive,,Double Blind Clinical Trial,2010,Pharma THC:CBD,Nervous System,Multiple Sclerosis
2010008,A randomized trial of lifestyle modification and taranabant for maintaining weight loss achieved with a low-calorie diet,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708144/,Inconclusive,,Double Blind Clinical Trial,2010,,Endocrine System,Obesity
2010009,Reduced neural response to reward following 7 days treatment with the cannabinoid CB1 antagonist rimonabant in healthy volunteers,https://pubmed.ncbi.nlm.nih.gov/20426883/,Negative,,Double Blind Clinical Trial,2010,,Mental/Emotional System; Nervous System,Depression
2010010,A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes,https://pubmed.ncbi.nlm.nih.gov/20518807/,Negative,,Double Blind Clinical Trial,2010,,Endocrine System,Diabetes; Obesity
2015019,Marijuana's acute effects on cognitive bias for affective and marijuana cues,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578985/,Inconclusive,,Clinical Trial,2015,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cognitive Dysfunction
2015020,Mismatch negativity in tobacco-naïve cannabis users and its alteration with acute nicotine administration,https://www.sciencedirect.com/science/article/abs/pii/S0091305715300253?via%3Dihub#preview-section-snippets,Negative,,Clinical Trial,2015,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction - Nicotine; Addiction; Cannabis Adverse Effects
2015021,An Overview of Translationally Informed Treatments for Posttraumatic Stress Disorder: Animal Models of Pavlovian Fear Conditioning to Human Clinical Trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527085/,Positive,,Meta-analysis,2015,Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System; Nervous System,PTSD; Anxiety
2015022,Neurocognitive and social cognitive predictors of cannabis use in first-episode psychosis,https://www.sciencedirect.com/science/article/abs/pii/S092099641500417X?via%3Dihub,Inconclusive,,Meta-analysis,2015,,Mental/Emotional System; Nervous System,Cognitive Dysfunction; Psychosis; Addiction - Cannabis; Addiction; Cannabis Adverse Effects; Neurodegenerative Issues
2015023,The Effects of Lithium Carbonate Supplemented with Nitrazepam on Sleep Disturbance during Cannabis Abstinence,https://jcsm.aasm.org/doi/10.5664/jcsm.5090#d1e475,Positive,,Double Blind Clinical Trial,2015,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Insomnia and Sleep Disorders; Cannabis Adverse Effects
2015024,Dose-dependent effects of cannabis on the neural correlates of error monitoring in frequent cannabis users,https://www.sciencedirect.com/science/article/abs/pii/S0924977X15002461?via%3Dihub#preview-section-abstract,Negative,,Double Blind Clinical Trial,2015,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cancer; Cannabis Adverse Effects; Cognitive Dysfunction
2015025,"Alteration of delta-6-desaturase (FADS2), secretory phospholipase-A2 (sPLA2) enzymes by Hot-nature diet with co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients",https://www.sciencedirect.com/science/article/abs/pii/S0965229915001090?via%3Dihub#preview-section-abstract,Positive,,Double Blind Clinical Trial,2015,Diet,Nervous System,Multiple Sclerosis
2015026,"Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial",https://www.sciencedirect.com/science/article/abs/pii/S0376871615016063?via%3Dihub,Negative,,Clinical Trial,2015,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2015027,"Chronic pelvic pain, quality of life and sexual health of women treated with palmitoylethanolamide and α-lipoic acid",https://pubmed.ncbi.nlm.nih.gov/26491823/,Positive,,Clinical Trial,2015,Palmitoylethanolamide (PEA),Nervous System,Pain; Pain - Chronic; Quality of Life
2015028,Substance Use in Patients With First-Episode Psychosis: Is Gender Relevant?,https://pubmed.ncbi.nlm.nih.gov/26513726/,Negative,,Meta-analysis,2015,,Mental/Emotional System; Nervous System,Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine
2016003,REDUCTIONS IN CANNABIS USE ARE ASSOCIATED WITH MOOD IMPROVEMENT IN FEMALE EMERGING ADULTS,https://pubmed.ncbi.nlm.nih.gov/26636547/,Negative,,Meta-analysis,2016,,Mental/Emotional System,Addiction - Cannabis; Addiction; Depression; Addiction - Alcohol; Cannabis Adverse Effects
2016004,"Vilazodone for Cannabis Dependence: A Randomized, Controlled Pilot Trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937726/,Negative,,Clinical Trial,2016,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2016005,"Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial",https://www.sciencedirect.com/science/article/abs/pii/S0376871615017780?via%3Dihub#preview-section-abstract,Inconclusive,,Double Blind Clinical Trial,2016,Pharma THC,Mental/Emotional System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2016006,Prevalence and correlates of a lifetime cannabis use disorder among pregnant former tobacco smokers,https://www.sciencedirect.com/science/article/abs/pii/S0306460315300745?via%3Dihub,Positive,,Meta-analysis,2016,,Mental/Emotional System; Nervous System; Reproductive System,Addiction - Cannabis; Addiction; Pregnancy; Cannabis Adverse Effects
2016007,Topiramate and motivational enhancement therapy for cannabis use among youth: a randomized placebo-controlled pilot study,https://pubmed.ncbi.nlm.nih.gov/26752416/,Positive,,Clinical Trial,2016,,Mental/Emotional System,Addiction - Cannabis; Addiction
2016008,A randomized clinical trial of Motivational Interviewing to reduce alcohol and drug use among patients with depression,https://pubmed.ncbi.nlm.nih.gov/26985728/,Positive,,Clinical Trial,2016,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction; Addiction - Benzodiazepine; Addiction - Opioid; Addiction - Stimulant; Depression
2016009,Feasibility and success of cell-phone assisted remote observation of medication adherence (CAROMA) in clinical trials,https://www.sciencedirect.com/science/article/abs/pii/S0376871616001484?via%3Dihub,Positive,,Double Blind Clinical Trial,2016,,Mental/Emotional System,Addiction; Addiction - Cannabis; Cannabis Adverse Effects
2016010,Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users,https://pubmed.ncbi.nlm.nih.gov/27085870/,Positive,,Clinical Trial,2016,Pharma THC,Mental/Emotional System,Addiction - Cannabis; Addiction; Behavioral Disorders; Cannabis Adverse Effects; Cognitive Dysfunction; Insomnia and Sleep Disorders
2016011,Maximizing retention in long-term clinical trials of a weight loss agent: use of a dietitian support team,https://onlinelibrary.wiley.com/doi/10.1002/osp4.57,Positive,,Clinical Trial,2016,Diet; Endocannabinoid (unspecified),Endocrine System,Obesity
2016012,Acute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase,https://www.nejm.org/doi/10.1056/NEJMoa1604221,Negative,,Clinical Trial,2016,Fatty Acid Amide Hydrolase (FAAH),,Cognitive Dysfunction; Inflammation; Pain
2023004,"Cannabidiol (CBD) Upregulates Vitamin D3 Receptors (VDRs) Expression That Modulates Cytokines (TNF-α, IL-6), Tissue Elasticity, Cellular Senescence, and Mitochondrial ATP Generation in Human and Rodent Cell Lines.",https://www.tandfonline.com/doi/full/10.2147/NDS.S435447,Positive,,Laboratory Study,2023,Vitamin D,Nervous System,Inflammation
2021003,Vitamin D deficiency promotes accumulation of bioactive lipids and increased endocannabinoid tone in zebrafish,http://www.ncbi.nlm.nih.gov/pmc/articles/pmc8604674/,Inconclusive,,Animal Study,2021,Vitamin D,,
2016013,"Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: a survey of preferences, attitudes and beliefs among patients willing to consider participation",https://pubmed.ncbi.nlm.nih.gov/27530738/,Positive,,Meta-analysis,2016,,Mental/Emotional System,Cancer; Loss of Appetite; Anorexia
2020005,Cannabidiol and Vitamin D3 Impact on Osteogenic Differentiation of Human Dental Mesenchymal Stem Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697067/,Positive,,Laboratory Study,2020,Vitamin D,,Cavities; Osteoporosis
2017001,"Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies",https://journals.sagepub.com/doi/10.1177/2049463717710042,Inconclusive,,Clinical Meta-analysis,2017,Pharma THC:CBD; Tetrahydrocannabinol (THC),,Pain; Pain - Cancer
2018003,Therapeutic Benefit of Smoked Cannabis in Randomized Placebo-Controlled Studies,https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2064,Inconclusive,,Clinical Meta-analysis,2018,Pharma THC; Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Anorexia; Cachexia; Cardiovascular Diseases (CVD); Glaucoma; HIV/AIDS; Hypertension (High Blood Pressure); Pain; Multiple Sclerosis; Pain - Eye; Pain - Neuropathy - Peripheral; Quality of Life
2018004,Therapeutic Effects of Prolonged Cannabidiol Treatment on Psychological Symptoms and Cognitive Function in Regular Cannabis Users: A Pragmatic Open-Label Clinical Trial,https://www.liebertpub.com/doi/10.1089/can.2017.0043,Positive,,Clinical Trial,2018,Tetrahydrocannabinol (THC),Mental/Emotional System,Cannabis Adverse Effects; Cognitive Dysfunction; Psychosis; Addiction - Cannabis; Addiction
2018005,Systemic sclerosis phase III clinical trials: Hope on the horizon?,https://pubmed.ncbi.nlm.nih.gov/35382012/,Positive,,Meta-analysis,2018,Endocannabinoid (unspecified),,Inflammation
2018006,Investigational small molecules in phase II clinical trials for the treatment of epilepsy,https://www.tandfonline.com/doi/full/10.1080/13543784.2018.1543398,Positive,,Meta-analysis,2018,Cannabidivarin (CBDV),Nervous System,Epilepsy
2022004,Chemical Analysis by LC-MS of Cannabis sativa Root Samples from Northeast Brazil and Evaluation of Antitussive and Expectorant Activities,https://pubmed.ncbi.nlm.nih.gov/34715694/,Positive,,Animal Study,2022,Tetrahydrocannabinol (THC),Respiratory System,Cough
2020006,Therapeutic Applications of Cannabinoids in Cardiomyopathy and Heart Failure,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641267/,Positive,,Meta-analysis,2020,,Cardiovascular System,Cardiovascular Diseases (CVD); Cardiac Arrhythmias; Fibrosis - Cardiac; Heart Attack; Hypertension (High Blood Pressure); Myocarditis; Reperfusion Injury
2018007,Herbs and Spices in the Treatment of Functional Gastrointestinal Disorders: A Review of Clinical Trials,https://www.mdpi.com/2072-6643/10/11/1715,Inconclusive,,Meta-analysis,2018,,Digestive System,Irritable Bowel Syndrome; Pain
2019004,Newest evidence for tetrahydrocannabinol:cannabidiol oromucosal spray from randomized clinical trials,https://pubmed.ncbi.nlm.nih.gov/30657024/,Positive,,Meta-analysis,2019,Pharma THC:CBD; Tetrahydrocannabinol (THC),,Multiple Sclerosis
2019005,Effect of a Multistrain Probiotic on Cognitive Function and Risk of Falls in Patients With Cirrhosis: A Randomized Trial,https://journals.lww.com/hepcomm/fulltext/2019/05000/effect_of_a_multistrain_probiotic_on_cognitive.6.aspx,Positive,,Clinical Trial,2019,Fatty Acid-Binding Protein (FABP); Microbiome,Digestive System,Cognitive Dysfunction; Fibrosis - Liver (Cirrhosis); Inflammation; Liver Failure; Oxidative Stress
2019006,The use of cannabinoids for sleep: A critical review on clinical trials,https://psycnet.apa.org/doiLanding?doi=10.1037%2Fpha0000285,Positive,,Meta-analysis,2019,Tetrahydrocannabinol (THC),,Insomnia and Sleep Disorders; Pain; Multiple Sclerosis; Pain - Chronic; PTSD
2019007,Facilitators and Barriers to Participating in a Randomized Controlled Trial of a Psychological Therapy for Substance Use,https://pubmed.ncbi.nlm.nih.gov/31158110/,Inconclusive,,Clinical Trial,2019,,Mental/Emotional System,Addiction - Cannabis; Addiction; Psychosis; Schizophrenia
2019008,24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderate-to-Severe Alzheimer's Disease: Analyses from a Clinical Trial with Nabilone,https://content.iospress.com/articles/journal-of-alzheimers-disease/jad190202,Inconclusive,,Meta-analysis,2019,Endocannabinoid (unspecified); Pharma THC,,Alzheimer's Disease; Cognitive Dysfunction; Dementia; Neurodegenerative Issues
2019009,Investigational drugs for the treatment of cancer cachexia: a focus on phase I and phase II clinical trials,https://www.tandfonline.com/doi/full/10.1080/13543784.2019.1646727,Positive,,Meta-analysis,2019,Omega-3,Digestive System; Muscular System,Cachexia; Cancer; Anorexia; Inflammation; Loss of Appetite; Palliative Care; Quality of Life
2024105,The association between prenatal cannabis use and congenital birth defects in offspring: A cumulative meta-analysis,https://www.sciencedirect.com/science/article/pii/S0892036224000229?via%3Dihub,Negative,,Meta-analysis,2024,,Nervous System; Reproductive System,Neonatal Cerebral Issues; Pregnancy
2019010,"Cannabis users: Screen systematically, treat individually. A descriptive study of participants in a randomized trial in primary care",https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0224867,Inconclusive,,Meta-analysis,2019,,Mental/Emotional System,Cannabis Adverse Effects
2019011,Anandamide Is Related to Clinical and Cardiorespiratory Benefits of Aerobic Exercise Training in Migraine Patients: A Randomized Controlled Clinical Trial,https://pubmed.ncbi.nlm.nih.gov/31872062/,Positive,,Clinical Trial,2019,Anandamide (AEA); Exercise,,Migraine
2020007,Brief Interventions for Cannabis Use in Healthcare Settings: Systematic Review and Meta-analyses of Randomized Trials,https://pubmed.ncbi.nlm.nih.gov/32012140/,Inconclusive,,Clinical Meta-analysis,2020,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2020008,Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials,https://www.nature.com/articles/s41375-020-0756-6,Positive,,Meta-analysis,2020,Pharma THC; Tetrahydrocannabinol (THC),Cardiovascular System,Cancer - Myeloma; Anorexia; Cachexia; Cancer - Leukemia; Cancer; Loss of Appetite
2020009,Cannabis and Radiation Therapy: A Scoping Review of Human Clinical Trials,https://www.jmirs.org/article/S1939-8654(20)30007-2/abstract,Positive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2020010,The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda,https://www.sciencedirect.com/science/article/abs/pii/S0376871620301587?via%3Dihub,Inconclusive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2010011,Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia,https://pubmed.ncbi.nlm.nih.gov/20471224/,Inconclusive,,Clinical Trial,2010,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Psychosis; Schizophrenia
2010012,Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946416/,Negative,,Double Blind Clinical Trial,2010,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Depression
2010013,Polymorphisms in the endocannabinoid receptor 1 in relation to fat mass distribution,https://pubmed.ncbi.nlm.nih.gov/20587580/,Negative,,Clinical Trial,2010,,Endocrine System,Obesity; Diabetes
2010014,Modulation of risk-taking in marijuana users by transcranial direct current stimulation (tDCS) of the dorsolateral prefrontal cortex (DLPFC),https://pubmed.ncbi.nlm.nih.gov/20729009/,Negative,,Clinical Trial,2010,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cognitive Dysfunction
2010015,Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis,https://pubmed.ncbi.nlm.nih.gov/20829244/,Inconclusive,,Double Blind Clinical Trial,2010,Pharma THC:CBD,Nervous System,Multiple Sclerosis
2010016,Smoked cannabis for chronic neuropathic pain: a randomized controlled trial,https://pubmed.ncbi.nlm.nih.gov/20805210/,Positive,,Double Blind Clinical Trial,2010,Tetrahydrocannabinol (THC),Nervous System,Pain; Pain - Chronic; Pain - Neuropathy - Peripheral
2010017,Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study,https://pubmed.ncbi.nlm.nih.gov/20851843/,Negative,,Double Blind Clinical Trial,2010,Pharma THC,,Psychosis; Schizophrenia
2010018,Psychiatric adverse effects of rimonobant in adults with Prader Willi syndrome,https://pubmed.ncbi.nlm.nih.gov/20965292/,Negative,,Double Blind Clinical Trial,2010,Synthetic Cannabinoid (unspecified),Endocrine System,Obesity
2010019,The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects,https://pubmed.ncbi.nlm.nih.gov/21062637/,Negative,,Clinical Trial,2010,Pharma CBD,,Schizophrenia
2010020,Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration,https://pubmed.ncbi.nlm.nih.gov/21078841/,Negative,,Double Blind Clinical Trial,2010,Pharma THC:CBD; Pharma THC,,
2010021,Disruption of frontal θ coherence by Δ9-tetrahydrocannabinol is associated with positive psychotic symptoms,https://pubmed.ncbi.nlm.nih.gov/21150914/,Negative,,Double Blind Clinical Trial,2010,Pharma THC,Mental/Emotional System,Psychosis
2010022,The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humans,https://pubmed.ncbi.nlm.nih.gov/21176784/,Inconclusive,,Double Blind Clinical Trial,2010,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2020011,Effect of flaxseed oil supplementation on the erythrocyte membrane fatty acid composition and endocannabinoid system modulation in patients with coronary artery disease: a double-blind randomized controlled trial,https://genesandnutrition.biomedcentral.com/articles/10.1186/s12263-020-00665-1,Positive,,Clinical Trial,2020,Anandamide (AEA); Diet; Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH),,Atherosclerosis; Cardiovascular Diseases (CVD); Inflammation
2020012,Does cannabidiol have antiseizure activity independent of its interactions with clobazam? An appraisal of the evidence from randomized controlled trials,https://pubmed.ncbi.nlm.nih.gov/32452568/,Positive,,Clinical Meta-analysis,2020,Pharma CBD,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2020013,A Scoping Review on Clinical Trials of Pain Reduction With Cannabis Administration in Adults,https://www.jocmr.org/index.php/JOCMR/article/view/4210/25893152,Inconclusive,,Clinical Meta-analysis,2020,,Nervous System,Pain; Arthritis - Rheumatoid; Arthritis; Multiple Sclerosis; Pain - Acute; Pain - Cancer; Pain - Chronic
2020014,Cannabidiol efficacy independent of clobazam: Meta-analysis of four randomized controlled trials,https://onlinelibrary.wiley.com/doi/10.1111/ane.13305,Positive,,Clinical Meta-analysis,2020,Pharma CBD,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2020015,"Preparation and Characterization of Liposomal β-Caryophyllene (Rephyll) by Nanofiber Weaving Technology and Its Effects on Delayed Onset Muscle Soreness (DOMS) in Humans: A Randomized, Double-Blinded, Crossover-Designed, and Placebo-Controlled Study",https://pubs.acs.org/doi/10.1021/acsomega.0c03456,Positive,,Laboratory Study,2020,,Nervous System,Pain; Inflammation
2021004,"The Safety of Medications used to Treat Peripheral Neuropathic Pain, Part 2 (Opioids, Cannabinoids and Other Drugs): review of Double-Blind, Placebo-Controlled, Randomized Clinical Trials",https://www.tandfonline.com/doi/full/10.1080/14740338.2021.1842871,Negative,,Clinical Meta-analysis,2021,,,Pain; Pain - Neuropathy - Peripheral
2021005,"An overview of ongoing clinical trials assessing pharmacological therapeutic strategies to manage chemotherapy-induced peripheral neuropathy, based on preclinical studies in rodent models",https://pubmed.ncbi.nlm.nih.gov/33107619/,Inconclusive,,Meta-analysis,2021,Endocannabinoid (unspecified),Nervous System,Cancer; Pain; Pain - Cancer; Pain - Neuropathy - Drug-Ind. Polyneuropathy; Pain - Neuropathy - Peripheral; Oxidative Stress
2020016,"Clinical trials with cannabis medicines-guidance for ethics committees, governance officers and researchers to streamline ethics applications and ensuring patient safety: considerations from the Australian experience",https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-020-04862-6#Sec3,Inconclusive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2006002,Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis,https://pubmed.ncbi.nlm.nih.gov/16836598/,Negative,,Clinical Trial,2006,,Mental/Emotional System; Nervous System,Psychosis
2007002,Nonreporting of cannabis use: Predictors and relationship to treatment outcome in methadone maintained patients,https://pubmed.ncbi.nlm.nih.gov/16887281/,Negative,,Clinical Trial,2007,,Mental/Emotional System,Addiction - Opioid; Addiction
2007003,The effects of low doses of delta-9 tetrahydrocannabinol on reinforcement processing in the risky decision-making of young healthy adults,https://pubmed.ncbi.nlm.nih.gov/17006433/,Negative,,Double Blind Clinical Trial,2007,,,Behavioral Disorders; Cognitive Dysfunction
2006003,Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis,https://pubmed.ncbi.nlm.nih.gov/17086911/,Inconclusive,,Clinical Trial,2006,Pharma THC:CBD,Nervous System,Multiple Sclerosis
2007004,Does occasional cannabis use impact anxiety and depression treatment outcomes?: Results from a randomized effectiveness trial,https://pubmed.ncbi.nlm.nih.gov/17096386/,Negative,,Clinical Trial,2007,Tetrahydrocannabinol (THC),Mental/Emotional System,Anxiety; Depression
2006004,Evaluation of herbal cannabis characteristics by medical users: a randomized trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1654142/,Negative,,Double Blind Clinical Trial,2006,,,Pain; Pain - Chronic
2006005,Endocannabinoid blockade for improving glycemic control and lipids in patients with type 2 diabetes mellitus,https://pubmed.ncbi.nlm.nih.gov/17296341/,Positive,,Double Blind Clinical Trial,2006,Synthetic Cannabinoid (unspecified),Endocrine System,Diabetes
2008012,Cannabinoid modulation of amygdala reactivity to social signals of threat in humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2657360/,Positive,,Double Blind Clinical Trial,2008,,Mental/Emotional System; Nervous System,Anxiety; PTSD
2008013,Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users,https://pubmed.ncbi.nlm.nih.gov/18719045/,Negative,,Double Blind Clinical Trial,2008,,Nervous System,Cognitive Dysfunction
2008014,Inhibition of THC-induced effects on the central nervous system and heart rate by a novel CB1 receptor antagonist AVE1625,https://pubmed.ncbi.nlm.nih.gov/18801827/,Negative,,Clinical Trial,2008,Synthetic Cannabinoid (unspecified),,Addiction - Nicotine; Behavioral Disorders; Addiction; Cardiovascular Diseases (CVD); Cognitive Dysfunction; Obesity
2009006,Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791800/,Negative,,Double Blind Clinical Trial,2009,Tetrahydrocannabinol (THC),,Cognitive Dysfunction; Schizophrenia
2009007,"A randomized controlled trial of adding the nicotine patch to rimonabant for smoking cessation: efficacy, safety and weight gain",https://pubmed.ncbi.nlm.nih.gov/19149823/,Positive,,Double Blind Clinical Trial,2009,Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Addiction - Nicotine; Addiction
2009008,A placebo-controlled trial of buspirone for the treatment of marijuana dependence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2789590/,Inconclusive,,Double Blind Clinical Trial,2009,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2009009,Effect of rimonabant on glycemic control in insulin-treated type 2 diabetes: the ARPEGGIO trial,https://pubmed.ncbi.nlm.nih.gov/20009090/,Inconclusive,,Double Blind Clinical Trial,2009,Synthetic Cannabinoid (unspecified),Endocrine System,Diabetes
2020017,Therapeutic Efficacy of Cannabidiol (CBD): A Review of the Evidence from Clinical Trials and Human Laboratory Studies,https://pubmed.ncbi.nlm.nih.gov/33585159/,Inconclusive,,Meta-analysis,2020,,Nervous System; Respiratory System,COVID-19; Tics and Tourettes; Addiction; Anxiety; Epilepsy; Inflammation; Pain; Psychosis; PTSD; Schizophrenia
2021006,"Palmitoylethanolamide for sleep disturbance. A double-blind, randomised, placebo-controlled interventional study",https://sleep.biomedcentral.com/articles/10.1186/s41606-021-00065-3#Sec6,Positive,,Double Blind Clinical Trial,2021,Palmitoylethanolamide (PEA),Nervous System,Insomnia and Sleep Disorders
2022005,Interpreting Clinical Trials With Omega-3 Supplements in the Context of Ancestry and FADS Genetic Variation,https://www.frontiersin.org/articles/10.3389/fnut.2021.808054/full,Positive,,Meta-analysis,2022,Omega-3; Diet; Omega-6; Endocannabinoid (unspecified),,Cardiovascular Diseases (CVD); Inflammation; Metabolic Syndrome; Obesity
2022006,Cannabinoid Use for Pain Reduction in Spinal Cord Injuries: A Meta-Analysis of Randomized Controlled Trials,https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.866235/full,Negative,,Clinical Meta-analysis,2022,,Nervous System; Skeletal System,Pain; Spinal Cord Injuries
2022007,"Eye Tracking in Patients with Parkinson's Disease Treated with Nabilone-Results of a Phase II, Placebo-Controlled, Double-Blind, Parallel-Group Pilot Study",https://www.mdpi.com/2076-3425/12/5/661,Positive,,Clinical Trial,2022,Pharma THC; Tetrahydrocannabinol (THC),Nervous System,Parkinson's Disease; Cognitive Dysfunction
2007005,"Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine",https://pubmed.ncbi.nlm.nih.gov/17712817/,Positive,,Clinical Trial,2007,Pharma THC:CBD,Skeletal System,Arthritis - Rheumatoid; Arthritis; Insomnia and Sleep Disorders; Pain; Multiple Sclerosis; Pain - Cancer; Pain - Neuropathy - Peripheral
2007006,"Exposure to terrorism and Israeli youths' cigarette, alcohol, and cannabis use",https://pubmed.ncbi.nlm.nih.gov/17761574/,Negative,,Clinical Trial,2007,,Mental/Emotional System,Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine; Addiction; PTSD
2007007,Acute effects of Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity,https://pubmed.ncbi.nlm.nih.gov/17884351/,Positive,,Clinical Trial,2007,Tetrahydrocannabinol (THC),,
2007008,Role of osteopathic manipulative treatment in altering pain biomarkers: a pilot study,https://pubmed.ncbi.nlm.nih.gov/17908831/,Positive,,Clinical Trial,2007,Anandamide (AEA); Palmitoylethanolamide (PEA),,Pain
2007009,Insulin differentially modulates the peripheral endocannabinoid system in human subcutaneous abdominal adipose tissue from lean and obese individuals,https://pubmed.ncbi.nlm.nih.gov/17923791/,Negative,,Double Blind Clinical Trial,2007,Fatty Acid Amide Hydrolase (FAAH),Endocrine System,Obesity
2007010,"Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial",https://pubmed.ncbi.nlm.nih.gov/17997224/,Positive,,Double Blind Clinical Trial,2007,Pharma THC:CBD,Nervous System,Pain; Pain - Neuropathy - Peripheral
2008015,Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy,https://pubmed.ncbi.nlm.nih.gov/18088560/,Positive,,Double Blind Clinical Trial,2008,Pharma THC,Nervous System,Pain; Pain - Chronic
2008016,Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372576/,Negative,,Clinical Trial,2008,Pharma THC,Mental/Emotional System,Addiction - Cannabis; Addiction
2008017,Patients with chronic pain on opioid therapy taking dronabinol: incidence of false negatives using radioimmunoassay,https://pubmed.ncbi.nlm.nih.gov/18444444/,Negative,,Clinical Trial,2008,Pharma THC,,Pain; Pain - Chronic
2008018,"Multiple-dose pharmacokinetics, pharmacodynamics, and safety of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, in healthy male volunteers",https://pubmed.ncbi.nlm.nih.gov/18508950/,Negative,,Clinical Trial,2008,Synthetic Cannabinoid (unspecified),Endocrine System,Obesity
2008019,Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers,https://pubmed.ncbi.nlm.nih.gov/18544469/,Negative,,Clinical Trial,2008,Tetrahydrocannabinol (THC),,Schizophrenia
2009010,Computer-based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use: a randomized controlled trial of clinical efficacy,https://pubmed.ncbi.nlm.nih.gov/19207345/,Negative,,Clinical Trial,2009,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction; Depression
2009011,"A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2759381/,Negative,,Double Blind Clinical Trial,2009,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2009012,Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects,https://pubmed.ncbi.nlm.nih.gov/19224107/,Positive,,Double Blind Clinical Trial,2009,Pharma THC,,Schizophrenia
2009013,The long and the short of treatments for alcohol or cannabis misuse among people with severe mental disorders,https://pubmed.ncbi.nlm.nih.gov/19299087/,Negative,,Clinical Meta-analysis,2009,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction; Depression; Psychosis
2009014,The short-term safety and efficacy of fluoxetine in depressed adolescents with alcohol and cannabis use disorders: a pilot randomized placebo-controlled trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2666637/,Negative,,Double Blind Clinical Trial,2009,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction; Depression
2009015,Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis,https://pubmed.ncbi.nlm.nih.gov/19349314/,Inconclusive,,Clinical Trial,2009,,Nervous System,Cognitive Dysfunction
2009016,Synthetic delta-9-tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia,https://pubmed.ncbi.nlm.nih.gov/19440079/,Positive,,Clinical Trial,2009,Pharma THC,Mental/Emotional System; Nervous System,Schizophrenia
2009017,Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis,https://pubmed.ncbi.nlm.nih.gov/19768368/,Negative,,Clinical Trial,2009,Pharma THC:CBD,Nervous System,Multiple Sclerosis
2004010,Endogenous cannabinoids are candidates for lipid mediators of bone cement implantation syndrome,https://pubmed.ncbi.nlm.nih.gov/14676677/,Negative,,Clinical Trial,2004,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Mental/Emotional System,Harm Reduction
2003002,Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial,https://pubmed.ncbi.nlm.nih.gov/14615106/,Inconclusive,,Double Blind Clinical Trial,2003,,Nervous System,Multiple Sclerosis; Neurodegenerative Issues
2004011,Marijuana withdrawal in humans: effects of oral THC or divalproex,https://pubmed.ncbi.nlm.nih.gov/14560320/,Positive,,Clinical Trial,2004,,Mental/Emotional System,Addiction - Cannabis; Addiction
2003003,Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin,https://pubmed.ncbi.nlm.nih.gov/12835895/,Negative,,Clinical Trial,2003,HU-x Synthetic Cannabinoids,Integumentary System,Allergic Contact Dermatitis
2003004,Behavioral and subjective effects of marijuana following partial sleep deprivation,https://pubmed.ncbi.nlm.nih.gov/12757961/,Inconclusive,,Clinical Trial,2003,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Insomnia and Sleep Disorders
2022008,"Improved glycemic status, insulin resistance and inflammation after receiving oral oleoylethanolamide supplement in people with prediabetes: a randomized controlled trial",https://dmsjournal.biomedcentral.com/articles/10.1186/s13098-022-00848-3#Sec2,Positive,,Double Blind Clinical Trial,2022,Oleoylethanolamide (OEA),Endocrine System,Inflammation; Metabolic Syndrome; Diabetes
2002004,Nefazodone decreases anxiety during marijuana withdrawal in humans,https://pubmed.ncbi.nlm.nih.gov/12439626/,Negative,,Clinical Trial,2002,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Anxiety
2002005,Motivational interviewing among psychiatric in-patients with substance use disorder,https://pubmed.ncbi.nlm.nih.gov/12197863/,Negative,,Clinical Trial,2002,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction - Stimulant; Addiction
2022009,Systematic reviews of randomized controlled trials of cannabinoid products in chronic pain conditions and for symptoms associated with multiple sclerosis: what do they tell us?,https://www.tandfonline.com/doi/full/10.1080/17512433.2022.2088501,Inconclusive,,Clinical Meta-analysis,2022,,Nervous System,Pain; Multiple Sclerosis; Pain - Chronic; Pain - Cancer; Pain - Neuropathy - Peripheral
2002006,"Safety, tolerability, and efficacy of orally administered cannabinoids in MS",https://pubmed.ncbi.nlm.nih.gov/12011290/,Negative,,Double Blind Clinical Trial,2002,,Nervous System,Multiple Sclerosis
2001002,Marijuana abstinence effects in marijuana smokers maintained in their home environment,https://pubmed.ncbi.nlm.nih.gov/11576029/,Negative,,Clinical Trial,2001,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2001003,Delta9-tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol: results of a clinical study,https://pubmed.ncbi.nlm.nih.gov/11599601/,Negative,,Clinical Trial,2001,Tetrahydrocannabivarin (THCV); Pharma THC; Tetrahydrocannabinol (THC),,
2022010,Cannabinoid Effect and Safety in Spasticity Following Stroke: A Double-Blind Randomized Placebo-Controlled Study,https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2022.892165/full,Inconclusive,,Double Blind Clinical Trial,2022,Pharma THC:CBD; Tetrahydrocannabinol (THC),Nervous System,Stroke
2023005,"A Double-Blind, Randomized, Placebo-Controlled Test of the Effects of Cannabidiol on Experiences of Test Anxiety Among College Students",https://pubmed.ncbi.nlm.nih.gov/35861792/,Inconclusive,,Double Blind Clinical Trial,2023,,Mental/Emotional System; Nervous System,Anxiety; Cannabis Adverse Effects
2022011,"No protective benefits of low dose acute L-glutamine supplementation on small intestinal permeability, epithelial injury and bacterial translocation biomarkers in response to subclinical exertional-heat stress: A randomized cross-over trial",https://www.tandfonline.com/doi/full/10.1080/23328940.2021.2015227,Inconclusive,,Clinical Trial,2022,Fatty Acid-Binding Protein (FABP),Mental/Emotional System,
2022012,Implications for blinding in clinical trials with THC-containing cannabinoids based on the CANNA-TICS trial,https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2022.793703/full,Inconclusive,,Meta-analysis,2022,Tetrahydrocannabinol (THC),,
2024106,"A Single-Blind, Randomized, Placebo Controlled Study to Evaluate the Benefits and Safety of Endourage Targeted Wellness Formula C Sublingual +Drops in People with Post-Acute Coronavirus Disease 2019 Syndrome",https://pubmed.ncbi.nlm.nih.gov/36252151/,Positive,,Clinical Trial,2024,Omega-3; Omega-6,Respiratory System,COVID-19
2022013,"Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial",https://www.nature.com/articles/s43856-022-00202-8,Positive,,Clinical Trial,2022,,Mental/Emotional System; Nervous System,Anxiety; Cognitive Dysfunction; Insomnia and Sleep Disorders; Quality of Life
2024107,Screening and Brief Intervention for Cannabis Misuse in Individuals on Buprenorphine Treatment for Opioid Use Disorder: Double-Blind Randomized Clinical Trial,https://pubmed.ncbi.nlm.nih.gov/36352558/,Positive,,Double Blind Clinical Trial,2024,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction - Opioid; Addiction; Cannabis Adverse Effects
2022014,"Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios",https://www.nature.com/articles/s41386-022-01478-z,Inconclusive,,Double Blind Clinical Trial,2022,,Mental/Emotional System,Cannabis Adverse Effects; Psychosis
2022015,Nabiximols effect on blood pressure and heart rate in post-stroke patients of a randomized controlled study,https://www.frontiersin.org/articles/10.3389/fcvm.2022.990188/full,Inconclusive,,Double Blind Clinical Trial,2022,Pharma THC:CBD; Tetrahydrocannabinol (THC),Cardiovascular System; Nervous System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Stroke; Cardiac Arrhythmias
2023006,Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review,https://pubmed.ncbi.nlm.nih.gov/36449315/,Positive,,Meta-analysis,2023,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
2023007,Peer Network Counseling Effects on Substance Use: an Individual Participant Data Meta-Analysis Integrating Three Randomized Controlled Trials,https://pubmed.ncbi.nlm.nih.gov/36478336/,Positive,,Clinical Meta-analysis,2023,,Mental/Emotional System; Nervous System,Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine
2024108,Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Plasma Endocannabinoid Levels in Healthy Volunteers: A Randomized Double-Blind Four-Arm Crossover Study,https://www.liebertpub.com/doi/10.1089/can.2022.0174,Inconclusive,,Double Blind Clinical Trial,2024,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Tetrahydrocannabinol (THC); Oleoylethanolamide (OEA),,Cannabis Adverse Effects
2022016,Medicinal cannabis improves sleep in adults with insomnia: a randomised double-blind placebo-controlled crossover study,https://onlinelibrary.wiley.com/doi/10.1111/jsr.13793,Positive,,Double Blind Clinical Trial,2022,Pharma THC:CBD; Tetrahydrocannabinol (THC),,Insomnia and Sleep Disorders
2022017,"Safety and Tolerability of Oral Cannabinoids in People Living with HIV on Long-Term ART: A Randomized, Open-Label, Interventional Pilot Clinical Trial (CTNPT 028)",https://www.mdpi.com/2227-9059/10/12/3168,Positive,,Clinical Trial,2022,Pharma CBD; Pharma THC:CBD; Tetrahydrocannabinol (THC),Immune System,HIV/AIDS; Hepatitis; Inflammation
2022018,Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020-2022),https://www.mdpi.com/1999-4923/14/12/2598,Positive,,Clinical Meta-analysis,2022,Pharma CBD,Mental/Emotional System,Cannabis Adverse Effects
2022019,Efficacy of overactive neurogenic bladder treatment: A systematic review of randomized controlled trials,https://pubmed.ncbi.nlm.nih.gov/36576454/,Positive,,Clinical Meta-analysis,2022,,Urinary System,Urinary Incontinence; Multiple Sclerosis; Parkinson's Disease; Spinal Cord Injuries; Stroke
2023008,"The effects of cannabidiol on subjective states, cognition, and psychomotor function in healthy adults: A randomized clinical trial",https://pubmed.ncbi.nlm.nih.gov/36625844/,Negative,,Double Blind Clinical Trial,2023,,Nervous System,Cognitive Dysfunction; Cannabis Adverse Effects
2023009,"Efficacy and safety of olorinab, a full agonist of the cannabinoid receptor 2, for the treatment of abdominal pain in patients with irritable bowel syndrome: Results from a phase 2b randomized placebo-controlled trial (CAPTIVATE)",https://onlinelibrary.wiley.com/doi/10.1111/nmo.14539,Positive,,Double Blind Clinical Trial,2023,Endocannabinoid (unspecified),Digestive System; Nervous System,Irritable Bowel Syndrome; Pain; Pain - Chronic; Constipation
2023010,"Cannabidiol-enriched cannabis extraction product in Parkinson's disease: A randomized, double-blind, and placebo-controlled trial in Buriram Hospital",https://ruralneuropractice.com/cannabidiol-enriched-cannabis-extraction-product-in-parkinsons-disease-a-randomized-double-blind-and-placebo-controlled-trial-in-buriram-hospital/,Positive,,Double Blind Clinical Trial,2023,Pharma CBD,Nervous System,Parkinson's Disease; Anxiety; Depression; Kidney Failure; Quality of Life
2023011,"The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double-blind, placebo-controlled, crossover experiment",https://onlinelibrary.wiley.com/doi/10.1111/add.16154,Inconclusive,,Double Blind Clinical Trial,2023,,Mental/Emotional System,Cannabis Adverse Effects; Behavioral Disorders; Cognitive Dysfunction; Psychosis
2023012,"CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders - Results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study",https://www.sciencedirect.com/science/article/pii/S0165178123000860?via%3Dihub#sec0012,Positive,,Double Blind Clinical Trial,2023,Pharma THC:CBD,,Tics and Tourettes; ADD and ADHD; Depression; Quality of Life
2023013,"A Phase I Randomized, Double-blind, Placebo-controlled Study on Efficacy and Safety Profile of a Sublingually Administered Cannabidiol /Delta 9-tetrahydrocannabidiol (10: 1) Regimen in Diabetes Type 2 Patients",https://brieflands.com/articles/ijpr-132647,Positive,,Double Blind Clinical Trial,2023,,Endocrine System,Diabetes; Metabolic Syndrome
2023014,Development of cannabis use disorder in medical cannabis users: A 9-month follow-up of a randomized clinical trial testing effects of medical cannabis card ownership,https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2023.1083334/full,Negative,,Clinical Trial,2023,,Mental/Emotional System,Addiction - Cannabis; Addiction; Anxiety; Cannabis Adverse Effects; Depression; Insomnia and Sleep Disorders; Pain
2022020,"Medical cannabis for pain management in patients undergoing chronic hemodialysis: randomized, double-blind, cross-over, feasibility study",https://academic.oup.com/ckj/article/16/4/701/6958829?login=false,Positive,,Double Blind Clinical Trial,2022,Tetrahydrocannabinol (THC),,Pain; Pain - Chronic; Kidney Failure
2023015,Seizure-free days as a novel outcome in patients with Lennox-Gastaut syndrome: Post hoc analysis of patients receiving cannabidiol in two randomized controlled trials,https://onlinelibrary.wiley.com/doi/10.1111/epi.17618,Positive,,Clinical Meta-analysis,2023,Pharma CBD,,Epilepsy; Epilepsy - Lennox-Gastaut
2023016,"Impact of cannabidiol on reward- and stress-related neurocognitive processes among individuals with opioid use disorder: A pilot, double-blind, placebo-controlled, randomized cross-over trial",https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2023.1155984/full,Positive,,Double Blind Clinical Trial,2023,Pharma CBD,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction; Cognitive Dysfunction; Neurodegenerative Issues
2023017,"Chronic Effects of Oral Cannabidiol Delivery on 24-h Ambulatory Blood Pressure in Patients with Hypertension (HYPER-H21-4): A Randomized, Placebo-Controlled, and Crossover Study",https://pubmed.ncbi.nlm.nih.gov/37093160/,Positive,,Clinical Trial,2023,,Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Cannabis Adverse Effects
2023018,Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder,https://www.nature.com/articles/s41398-023-02410-9#Sec6,Positive,,Double Blind Clinical Trial,2023,Anandamide (AEA),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2023019,"Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis",https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/art.42510,Inconclusive,,Clinical Trial,2023,,Integumentary System,Skin Diseases; Systemic Sclerosis
2023020,Prevalence of cannabis use among young adults in Sweden comparing randomized response technique with a traditional survey,https://onlinelibrary.wiley.com/doi/10.1111/add.16219,Inconclusive,,Clinical Trial,2023,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2023021,Therapeutic targeting of the tumor microenvironments with cannabinoids and their analogs: Update on clinical trials,https://pubmed.ncbi.nlm.nih.gov/37146933/,Positive,,Meta-analysis,2023,,Nervous System,Cancer; Cancer - Metastatic
2024109,Perceived Effectiveness of Cigar Warnings in Discouraging Blunt Use,https://pubmed.ncbi.nlm.nih.gov/37819722/,Positive,,Clinical Trial,2024,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Addiction - Cannabis; Addiction - Nicotine; Addiction
2024110,"Results of a randomized controlled trial of the cannabis eCHECKUP TO GO personalized normative feedback intervention on reducing cannabis use, cannabis consequences, and descriptive norms",https://pubmed.ncbi.nlm.nih.gov/38103837/,Positive,,Double Blind Clinical Trial,2024,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2023022,An on-line school-based substance use harm reduction programme: The Illicit Project randomized controlled trial results,https://onlinelibrary.wiley.com/doi/10.1111/add.16403,Positive,,Clinical Trial,2023,,Mental/Emotional System; Nervous System,Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Cannabis Adverse Effects; MDMA Adverse Effects
2024111,[Effectiveness of a cannabis prevention program in school: results of a randomized prospective study],https://pubmed.ncbi.nlm.nih.gov/38172374/,Positive,,Clinical Trial,2024,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2024112,Contingency management is associated with positive changes in attitudes and reductions in cannabis use even after discontinuation of incentives among non-treatment seeking youth,https://www.sciencedirect.com/science/article/abs/pii/S0376871624000176?via%3Dihub,Positive,,Clinical Trial,2024,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2024113,Prior acute exercise restores postprandial fat oxidation in active cannabis users,https://physoc.onlinelibrary.wiley.com/doi/10.14814/phy2.15968,Positive,,Clinical Trial,2024,Diet; Exercise,Nervous System,Oxidative Stress; Atherosclerosis; Cardiovascular Diseases (CVD)
2024114,The prevalence of cannabis use disorder in attention-deficit hyperactivity disorder: A clinical epidemiological meta-analysis,https://www.sciencedirect.com/science/article/abs/pii/S0022395624001249?via%3Dihub,Negative,,Clinical Meta-analysis,2024,,Mental/Emotional System; Nervous System,ADD and ADHD; Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2024115,AGA Clinical Practice Update on Diagnosis and Management of Cannabinoid Hyperemesis Syndrome: Commentary,https://www.gastrojournal.org/article/S0016-5085(24)00127-6/fulltext?referrer=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F#secsectitle0060,Inconclusive,,Meta-analysis,2024,,Nervous System,Cannabis Hyperemesis Syndrome; Cannabis Adverse Effects; Pain; Nausea and Vomiting
2024116,Oral Cannabidiol for Seborrheic Dermatitis in Patients With Parkinson Disease: Randomized Clinical Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10964137/,Inconclusive,,Double Blind Clinical Trial,2024,Tetrahydrocannabinol (THC),Nervous System,Parkinson's Disease; Skin Diseases
2024117,Cannabidiol: metabolism and clinical efficacy in epileptic patients,https://pubmed.ncbi.nlm.nih.gov/38465404/,Positive,,Meta-analysis,2024,Pharma CBD,Nervous System,Epilepsy
2024118,Palmitoylethanolamide and polydatin in pediatric irritable bowel syndrome: A multicentric randomized controlled trial,https://www.sciencedirect.com/science/article/pii/S0899900724000479?via%3Dihub,Positive,,Double Blind Clinical Trial,2024,Palmitoylethanolamide (PEA),Digestive System,Irritable Bowel Syndrome; Pain
2024119,Short-Term Cannabidiol with Δ-9-Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial,https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.29768,Negative,,Double Blind Clinical Trial,2024,,Nervous System,Parkinson's Disease; Cannabis Adverse Effects; Cognitive Dysfunction; Insomnia and Sleep Disorders; Neurodegenerative Issues
2024120,"A randomised, placebo-controlled, double blind, crossover trial on the effect of a 20:1 cannabidiol: Δ9-tetrahydrocannabinol medical cannabis product on neurocognition, attention, and mood",https://www.sciencedirect.com/science/article/pii/S0924977X24000373?via%3Dihub#sec0019,Negative,,Double Blind Clinical Trial,2024,,Nervous System,Cognitive Dysfunction; Cannabis Adverse Effects; Neurodegenerative Issues
2024121,A national study of clinical discussions about cannabis use among Veteran patients prescribed opioids,https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-024-00221-3#Sec15,Negative,,Meta-analysis,2024,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction; Addiction - Cannabis; Cannabis Adverse Effects
2024122,The efficacy and safety of cannabidiol (CBD) in pediatric patients with Dravet Syndrome: a narrative review of clinical trials,https://eurjmedres.biomedcentral.com/articles/10.1186/s40001-024-01788-6,Positive,,Clinical Meta-analysis,2024,Pharma CBD,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy
2024123,Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial,https://www.jmir.org/2024/1/e54287,Positive,,Clinical Trial,2024,,Mental/Emotional System; Nervous System,Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Opioid; Addiction - Stimulant; Anxiety; Depression
2024124,"Clinical Variables and Peripheral Biomarkers Associated with Substance-Induced Psychotic Disorder: Differences Related to Alcohol, Cannabis, and Psychostimulant Abuse",https://www.mdpi.com/2075-4426/14/3/325,Negative,,Meta-analysis,2024,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction - Stimulant; Addiction; Cannabis Adverse Effects; Psychosis
2024125,Δ9-Tetrahydrocannabinol (THC): A Critical Overview of Recent Clinical Trials and Suggested Guidelines for Future Research,https://www.mdpi.com/2077-0383/13/6/1540,Positive,,Clinical Meta-analysis,2024,Pharma THC; Tetrahydrocannabinol (THC),,Addiction - Cannabis; Addiction - Opioid; Addiction; Alzheimer's Disease; Anxiety; Dementia; Depression; Gastroparesis; Insomnia and Sleep Disorders; Tics and Tourettes; Pain; Multiple Sclerosis; Pain - Chronic; Pain - Neuropathy - Diabetic; Pain - Neuropathy - Peripheral; Quality of Life; Sleep Apnea
2024126,Influence of short-term chronic oral cannabidiol application on muscle recovery and performance after an intensive training protocol - a randomized double-blind crossover study,https://www.tandfonline.com/doi/full/10.1080/15502783.2024.2337252,Negative,,Double Blind Clinical Trial,2024,,,Inflammation; Oxidative Stress
2024127,Substance use and self-poisoning in schizophrenia: 11-year findings from a national clinical survey of suicide in mental health patients in England,https://www.sciencedirect.com/science/article/pii/S0920996424001488?via%3Dihub,Inconclusive,,Meta-analysis,2024,,Mental/Emotional System; Nervous System,Addiction; Schizophrenia; Suicide Attempt; Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Opioid; Addiction - Stimulant; Psychosis
2023023,"The Safety and Comparative Effectiveness of Non-Psychoactive Cannabinoid Formulations for the Improvement of Sleep: A Double-Blinded, Randomized Controlled Trial",https://www.tandfonline.com/doi/full/10.1080/27697061.2023.2203221,Positive,,Double Blind Clinical Trial,2023,Cannabichromene (CBC); Cannabinol (CBN),Mental/Emotional System; Nervous System,Insomnia and Sleep Disorders; Psychosis; Cannabis Adverse Effects
2023024,Parosmia COVID-19 Related Treated by a Combination of Olfactory Training and Ultramicronized PEA-LUT: A Prospective Randomized Controlled Trial,https://www.mdpi.com/2227-9059/11/4/1109,Positive,,Clinical Trial,2023,Palmitoylethanolamide (PEA),Respiratory System,COVID-19; Inflammation; Pain; Pain - Neuropathy - Peripheral
2023025,"Within-subject, double-blind, randomized, placebo-controlled evaluation of combining the cannabinoid dronabinol and the opioid hydromorphone in adults with chronic pain",https://www.nature.com/articles/s41386-023-01597-1,Inconclusive,,Double Blind Clinical Trial,2023,Pharma THC,Nervous System,Pain - Chronic; Addiction - Opioid; Arthritis; Cognitive Dysfunction
2023026,"Efficacy of nabiximols oromucosal spray on spasticity in people with multiple sclerosis: Treatment effects on Spasticity Numeric Rating Scale, muscle spasm count, and spastic muscle tone in two randomized clinical trials",https://www.msard-journal.com/article/S2211-0348(23)00249-3/fulltext#seccesectitle0024,Positive,,Clinical Meta-analysis,2023,Pharma THC:CBD,,Multiple Sclerosis
2023027,"Cognitive Safety Data from a Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase IIb Study of the Effects of a Cannabidiol and Δ9-Tetrahydrocannabinol Drug on Parkinson's Disease-Related Motor Symptoms",https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.29447,Negative,,Double Blind Clinical Trial,2023,,,Cognitive Dysfunction; Parkinson's Disease; Neurodegenerative Issues
1998001,"Laboratory validation study of drug evaluation and classification program: alprazolam, d-amphetamine, codeine, and marijuana",https://pubmed.ncbi.nlm.nih.gov/9788526/,Inconclusive,,Clinical Trial,1998,,Nervous System,Cognitive Dysfunction
1999001,"Delta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study",https://pubmed.ncbi.nlm.nih.gov/9892882/,Inconclusive,,Clinical Trial,1999,Delta-8-THC,Digestive System,Gastroparesis
1999002,Effect of cannabis use on cognitive functions and driving ability,https://www.psychiatrist.com/jcp/effect-cannabis-cognitive-functions-driving-ability/,Negative,,Clinical Trial,1999,,,Cognitive Dysfunction
1999003,A comparison of olanzapine with haloperidol in cannabis-induced psychotic disorder: a double-blind randomized controlled trial,https://pubmed.ncbi.nlm.nih.gov/10435771/,Inconclusive,,Clinical Trial,1999,,Mental/Emotional System,Psychosis
1999004,[Cannabis and pregnancy],https://ncbi.nlm.nih.gov/pubmed/10489797,Positive,,Clinical Trial,1999,,Reproductive System,Pregnancy
2023028,"Trial of a Novel Oral Cannabinoid Formulation in Patients with Hypertension: A Double-Blind, Placebo-Controlled Pharmacogenetic Study",https://www.mdpi.com/1424-8247/16/5/645,Positive,,Double Blind Clinical Trial,2023,Pharma CBD; Synthetic Cannabinoid (unspecified),Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Cancer
2023029,"The Effects of β-myrcene on Simulated Driving and Divided Attention: A Double-Blind, Placebo-Controlled, Crossover Pilot Study",https://pubmed.ncbi.nlm.nih.gov/37287732/,Negative,,Double Blind Clinical Trial,2023,,Mental/Emotional System,Cannabis Adverse Effects; Cognitive Dysfunction
2023030,"The Influence of Oral Cannabidiol on 24-h Ambulatory Blood Pressure and Arterial Stiffness in Untreated Hypertension: A Double-Blind, Placebo-Controlled, Cross-Over Pilot Study",https://pubmed.ncbi.nlm.nih.gov/37291376/,Positive,,Double Blind Clinical Trial,2023,,Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Insomnia and Sleep Disorders
2023031,Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials,https://www.nature.com/articles/s41591-023-02381-w#Sec16,Positive,,Double Blind Clinical Trial,2023,Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2023032,Examining the use of cannabidiol and delta-9-tetrahydrocannabinol-based medicine among individuals diagnosed with dementia living within residential aged care facilities: Results of a double-blind randomised crossover trial,https://onlinelibrary.wiley.com/doi/10.1111/ajag.13224,Positive,,Double Blind Clinical Trial,2023,,Nervous System,Dementia; Alzheimer's Disease; Quality of Life
2023033,"Interactive Effects of Ayahuasca and Cannabidiol in Social Cognition in Healthy Volunteers: A Pilot, Proof-of-Concept, Feasibility, Randomized-Controlled Trial",https://pubmed.ncbi.nlm.nih.gov/37335211/,Inconclusive,,Clinical Trial,2023,Ayahuasca,Nervous System,Cognitive Dysfunction; Anxiety; Cannabis Adverse Effects
2023034,Associations between Plasma Lipid Mediators and Chronic Daily Headache Outcomes in Patients Randomized to a Low Linoleic Acid Diet with or without Added Omega-3 Fatty Acids,https://www.mdpi.com/2218-1989/13/6/690,Positive,,Clinical Trial,2023,Omega-3; Diet; Omega-6,Nervous System,Migraine; Pain; Pain - Chronic; Quality of Life
2001004,Antiemetic efficacy of smoked marijuana: subjective and behavioral effects on nausea induced by syrup of ipecac,https://pubmed.ncbi.nlm.nih.gov/11509190/,Inconclusive,,Clinical Trial,2001,,Digestive System,Nausea and Vomiting
2001005,Treating the substance-abusing suicidal patient,https://pubmed.ncbi.nlm.nih.gov/11411192/,Negative,,Clinical Meta-analysis,2001,,Mental/Emotional System,Suicide Attempt
2001006,Bupropion SR worsens mood during marijuana withdrawal in humans,https://pubmed.ncbi.nlm.nih.gov/11401006/,Negative,,Clinical Trial,2001,,Mental/Emotional System,Addiction - Cannabis; Addiction
2001007,Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716,https://pubmed.ncbi.nlm.nih.gov/11296091/,Positive,,Clinical Trial,2001,SR-x Synthetic Cannabinoids,,
2001008,The synthetic cannabinoid WIN55212-2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies,https://pubmed.ncbi.nlm.nih.gov/11168547/,Positive,,Clinical Trial,2001,WIN-x Synthetic Cannabinoids,,Glaucoma
2000001,Standardized stimuli to assess drug craving and drug memory in addicts,https://pubmed.ncbi.nlm.nih.gov/10943911/,Negative,,Clinical Trial,2000,,Mental/Emotional System; Nervous System,Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine; Addiction - Opioid
2000002,Risperidone compared to haloperidol in cannabis-induced psychotic disorder: A double blind randomized controlled trial,https://pubmed.ncbi.nlm.nih.gov/24921450/,Negative,,Clinical Trial,2000,,Mental/Emotional System; Nervous System,Psychosis; Cannabis Adverse Effects
1999005,A validity study of the SSAGA--a comparison with the SCAN,https://pubmed.ncbi.nlm.nih.gov/10615721/,Negative,,Clinical Meta-analysis,1999,,Mental/Emotional System,Addiction - Alcohol; Addiction; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Cocaine; Addiction - Stimulant
2023035,Co-use of cigarettes and cannabis among people with HIV: Results from a randomized controlled smoking cessation trial,https://www.sciencedirect.com/science/article/pii/S2772724623000422?via%3Dihub#sec0015,Positive,,Clinical Trial,2023,,Immune System; Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction - Nicotine; Addiction; HIV/AIDS
2023036,"Alleviation of Pain, PAIN Interference, and Oxidative Stress by a Novel Combination of Hemp Oil, Calamari Oil, and Broccoli: A Randomized, Double-Blind, Placebo-Controlled Trial",https://www.mdpi.com/2072-6643/15/12/2654,Positive,,Double Blind Clinical Trial,2023,Omega-3,Mental/Emotional System; Nervous System,Pain; Oxidative Stress; Addiction - Opioid; Addiction; Inflammation; Insomnia and Sleep Disorders
2012001,Patient's perceptions of the cannabis-psychosis link--a systematic review,https://pubmed.ncbi.nlm.nih.gov/22716137/,Negative,,Clinical Meta-analysis,2012,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2013003,The pathophysiology and pharmacological treatment of Huntington disease,https://pubmed.ncbi.nlm.nih.gov/22713409/,Negative,,Clinical Meta-analysis,2013,,Cardiovascular System; Nervous System,Cardiovascular Diseases (CVD); Huntington's Disease
2012002,Cannabinoids for epilepsy,https://pubmed.ncbi.nlm.nih.gov/22696383/,Inconclusive,,Clinical Meta-analysis,2012,,Nervous System,Epilepsy
2012003,Attitudes and perceptions towards substances among people with mental disorders: a systematic review,https://pubmed.ncbi.nlm.nih.gov/22486607/,Negative,,Clinical Meta-analysis,2012,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction
2012004,Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy,https://pubmed.ncbi.nlm.nih.gov/22397999/,Negative,,Clinical Meta-analysis,2012,,Nervous System,Tics and Tourettes
2012005,Clinical correlates of co-occurring cannabis and tobacco use: a systematic review,https://pubmed.ncbi.nlm.nih.gov/22340422/,Negative,,Clinical Meta-analysis,2012,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction - Nicotine; Addiction
2012006,Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis,https://pubmed.ncbi.nlm.nih.gov/22323502/,Negative,,Clinical Meta-analysis,2012,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2012007,A systematic review and mixed treatment comparison of pharmacological interventions for the treatment of obesity,https://pubmed.ncbi.nlm.nih.gov/22288431/,Negative,,Clinical Meta-analysis,2012,SR-x Synthetic Cannabinoids,Endocrine System,Obesity
2012008,Pharmacological interventions in the treatment of the acute effects of cannabis: a systematic review of literature,https://pubmed.ncbi.nlm.nih.gov/22273390/,Positive,,Clinical Meta-analysis,2012,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2012009,Increasing delta-9-tetrahydrocannabinol (Δ-9-THC) content in herbal cannabis over time: systematic review and meta-analysis,https://pubmed.ncbi.nlm.nih.gov/22150622/,Negative,,Clinical Meta-analysis,2012,Tetrahydrocannabinol (THC),,
2011003,A systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia,https://pubmed.ncbi.nlm.nih.gov/21999904/,Negative,,Clinical Meta-analysis,2011,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Schizophrenia
2011004,Substance use disorder among people with first-episode psychosis: a systematic review of course and treatment,https://pubmed.ncbi.nlm.nih.gov/21885577/,Negative,,Clinical Meta-analysis,2011,,Mental/Emotional System; Nervous System,Addiction; Psychosis
2011005,Cannabinoid type 1 receptor antagonists for smoking cessation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486173/,Negative,,Clinical Meta-analysis,2011,SR-x Synthetic Cannabinoids,Mental/Emotional System,Addiction - Nicotine; Addiction
2010023,Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010990/,Positive,,Clinical Meta-analysis,2010,,Immune System; Nervous System,HIV/AIDS; Pain; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral
2010024,Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood,https://pubmed.ncbi.nlm.nih.gov/20824866/,Positive,,Clinical Meta-analysis,2010,,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
2010025,Structural MRI findings in long-term cannabis users: what do we know?,https://pubmed.ncbi.nlm.nih.gov/20590400/,Negative,,Clinical Meta-analysis,2010,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2010026,Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use,https://pubmed.ncbi.nlm.nih.gov/20565525/,Negative,,Clinical Meta-analysis,2010,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2019012,Cannabinoids Reduce Inflammation but Inhibit Lymphocyte Recovery in Murine Models of Bone Marrow Transplantation,https://pubmed.ncbi.nlm.nih.gov/30720730/,Positive,,Animal Study,2019,,,Inflammation; Organ Transplant Failure
2010027,"Systematic review of prospective studies investigating ""remission"" from amphetamine, cannabis, cocaine or opioid dependence",https://pubmed.ncbi.nlm.nih.gov/20444552/,Negative,,Clinical Meta-analysis,2010,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction - Cocaine; Addiction - Opioid; Addiction - Stimulant; Addiction
2021007,Signaling through the type 2 cannabinoid receptor regulates the severity of acute and chronic graft-versus-host disease,https://pubmed.ncbi.nlm.nih.gov/33027805/,Positive,,Animal Study,2021,JWH-x Synthetic Cannabinoids,Immune System,Graft-versus-Host-Disease; Organ Transplant Failure
2010028,Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review,https://pubmed.ncbi.nlm.nih.gov/20331929/,Negative,,Clinical Meta-analysis,2010,,Mental/Emotional System; Nervous System,Depression; Psychosis
2010029,Cannabis-associated arteritis,https://pubmed.ncbi.nlm.nih.gov/20186675/,Positive,,Clinical Meta-analysis,2010,Pharma THC,Cardiovascular System; Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cardiovascular Diseases (CVD)
2009018,Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review,https://pubmed.ncbi.nlm.nih.gov/19961570/,Positive,,Clinical Meta-analysis,2009,,Nervous System,Multiple Sclerosis
2009019,"Chronic neuropathic pain management in spinal cord injury patients. What is the efficacy of pharmacological treatments with a general mode of administration? (oral, transdermal, intravenous)",https://pubmed.ncbi.nlm.nih.gov/19909703/,Negative,,Clinical Meta-analysis,2009,,,Pain; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral
2009020,Systematic review and meta-analysis on the adverse events of rimonabant treatment: considerations for its potential use in hepatology,https://pubmed.ncbi.nlm.nih.gov/19818116/,Negative,,Clinical Meta-analysis,2009,SR-x Synthetic Cannabinoids,Digestive System,Hepatitis; Cannabis Adverse Effects; Obesity
2009021,Cannabis and psychosis: search of a causal link through a critical and systematic review,https://pubmed.ncbi.nlm.nih.gov/19748375/,Negative,,Clinical Meta-analysis,2009,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Psychosis
2009022,Systematic review and meta-analysis of cannabis treatment for chronic pain,https://pubmed.ncbi.nlm.nih.gov/19732371/,Positive,,Clinical Meta-analysis,2009,Tetrahydrocannabinol (THC),Nervous System,Pain; Pain - Chronic
2009023,Cannabis and anxiety: a critical review of the evidence,https://pubmed.ncbi.nlm.nih.gov/19693792/,Inconclusive,,Clinical Meta-analysis,2009,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Anxiety
2009024,Neuroimaging in cannabis use: a systematic review of the literature,https://pubmed.ncbi.nlm.nih.gov/19627647/,Positive,,Clinical Meta-analysis,2009,Tetrahydrocannabinol (THC),Nervous System,Cognitive Dysfunction
2009025,Chronic toxicology of cannabis,https://pubmed.ncbi.nlm.nih.gov/19586351/,Negative,,Clinical Meta-analysis,2009,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2009026,Nausea and vomiting in people with cancer and other chronic diseases,https://pubmed.ncbi.nlm.nih.gov/19445763/,Negative,,Clinical Meta-analysis,2009,,Digestive System; Nervous System,Cancer; Chemotherapy-induced Nausea & Vomiting; IBD - Inflammatory Bowel Disease; Hepatitis
2009027,Treatment of cannabis use disorders in people with schizophrenia spectrum disorders - a systematic review,https://pubmed.ncbi.nlm.nih.gov/19268481/,Inconclusive,,Clinical Meta-analysis,2009,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Schizophrenia
2008020,Cost-effectiveness of pharmacological anti-obesity treatments: a systematic review,https://pubmed.ncbi.nlm.nih.gov/18982009/,Negative,,Clinical Meta-analysis,2008,SR-x Synthetic Cannabinoids,Endocrine System,Obesity
2008021,Effects of cannabis use on outcomes of psychotic disorders: systematic review,https://pubmed.ncbi.nlm.nih.gov/18978312/,Negative,,Clinical Meta-analysis,2008,,Mental/Emotional System,Psychosis
2008022,Complementary therapies for neuropathic and neuralgic pain: systematic review,https://pubmed.ncbi.nlm.nih.gov/18806539/,Negative,,Clinical Meta-analysis,2008,,,Pain; Pain - Neuropathy - Diabetic; Pain - Neuropathy - Drug-Ind. Polyneuropathy; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral
2008023,Cannabis and schizophrenia,https://pubmed.ncbi.nlm.nih.gov/18646115/,Inconclusive,,Clinical Meta-analysis,2008,,Mental/Emotional System,Schizophrenia
2008024,Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis,https://pubmed.ncbi.nlm.nih.gov/18625004/,Positive,,Clinical Meta-analysis,2008,Pharma THC,Digestive System,Chemotherapy-induced Nausea & Vomiting
2008025,Adverse effects of medical cannabinoids: a systematic review,https://pubmed.ncbi.nlm.nih.gov/18559804/,Negative,,Clinical Meta-analysis,2008,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2008026,Psychosocial interventions for people with both severe mental illness and substance misuse,https://pubmed.ncbi.nlm.nih.gov/18253984/,Negative,,Clinical Meta-analysis,2008,,Mental/Emotional System; Nervous System,Addiction
2008027,Obesity in adults,https://pubmed.ncbi.nlm.nih.gov/19450339/,Negative,,Clinical Meta-analysis,2008,SR-x Synthetic Cannabinoids,Endocrine System,Obesity
2008028,Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain,https://pubmed.ncbi.nlm.nih.gov/18095921/,Positive,,Clinical Meta-analysis,2008,Pharma THC,Digestive System; Nervous System,Chemotherapy-induced Nausea & Vomiting; Pain; Pain - Cancer
2007011,Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation,https://pubmed.ncbi.nlm.nih.gov/17943852/,Negative,,Clinical Meta-analysis,2007,SR-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Addiction - Nicotine; Addiction
2007012,Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review,https://pubmed.ncbi.nlm.nih.gov/17662880/,Negative,,Clinical Meta-analysis,2007,,Mental/Emotional System; Nervous System,Psychosis
2007013,Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation,https://pubmed.ncbi.nlm.nih.gov/17636794/,Negative,,Clinical Meta-analysis,2007,SR-x Synthetic Cannabinoids,Mental/Emotional System,Addiction - Nicotine; Addiction
2007014,Prevalence of alcohol and illicit drugs in blood specimens from drivers involved in traffic law offenses. Systematic review of cross-sectional studies,https://pubmed.ncbi.nlm.nih.gov/17497523/,Negative,,Clinical Meta-analysis,2007,Tetrahydrocannabinol (THC),,
2006006,Rimonabant for overweight or obesity,https://pubmed.ncbi.nlm.nih.gov/17054276/,Positive,,Clinical Meta-analysis,2006,SR-x Synthetic Cannabinoids,Endocrine System,Obesity
2006007,A meta-analysis of negative symptoms in dual diagnosis schizophrenia,https://pubmed.ncbi.nlm.nih.gov/16536885/,Positive,,Clinical Meta-analysis,2006,,Mental/Emotional System; Nervous System,Schizophrenia; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Opioid; Addiction - Stimulant; Addiction
2005012,Cannabis as a risk factor for psychosis: systematic review,https://pubmed.ncbi.nlm.nih.gov/15871146/,Negative,,Clinical Meta-analysis,2005,,Mental/Emotional System,Psychosis; Schizophrenia
2001009,Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC34324/,Negative,,Clinical Meta-analysis,2001,,,Pain - Acute; Pain - Cancer; Pain - Chronic
2023037,Effects of Oral Cannabidiol on Health and Fitness in Healthy Adults: An 8-Week Randomized Trial,https://www.mdpi.com/2072-6643/15/12/2664,Positive,,Clinical Trial,2023,,,Cannabis Adverse Effects; Cognitive Dysfunction
2023038,"Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: a blinded controlled multicenter randomized trial",https://link.springer.com/article/10.1007/s00405-023-08085-8#Sec14,Positive,,Double Blind Clinical Trial,2023,Palmitoylethanolamide (PEA),Respiratory System,COVID-19; Neurodegenerative Issues
2023039,"A Phase Ib, Double Blind, Randomized Study of Cannabis Oil for Pain in Parkinson's Disease",https://pubmed.ncbi.nlm.nih.gov/37476317/,Positive,,Double Blind Clinical Trial,2023,,Nervous System,Pain; Parkinson's Disease; Pain - Chronic
2023040,"A Randomized, Controlled Trial of Efficacy and Safety of Cannabidiol in Idiopathic and Diabetic Gastroparesis",https://pubmed.ncbi.nlm.nih.gov/37482172/,Positive,,Double Blind Clinical Trial,2023,Fatty Acid Amide Hydrolase (FAAH); Pharma CBD,Digestive System; Endocrine System,Diabetes; Gastroparesis
2023041,Effects of Oral Cannabinoids on Systemic Inflammation and Viral Reservoir Markers in People with HIV on Antiretroviral Therapy: Results of the CTN PT028 Pilot Clinical Trial,https://www.mdpi.com/2073-4409/12/14/1811,Positive,,Clinical Trial,2023,,Immune System,HIV/AIDS; Inflammation
2023042,Nabiximols is Efficient as Add-On Treatment for Patients with Multiple Sclerosis Spasticity Refractory to Standard Treatment: A Systematic Review and Meta-Analysis of Randomised Clinical Trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616923/,Positive,,Meta-analysis,2023,Pharma THC:CBD,,Multiple Sclerosis
2023043,"The effects of cannabidiol on worry and anxiety among high trait worriers: a double-blind, randomized placebo controlled trial",https://pubmed.ncbi.nlm.nih.gov/37552290/,Positive,,Clinical Trial,2023,,Mental/Emotional System,Anxiety; Behavioral Disorders; Cognitive Dysfunction
2023044,"Oral Tetrahydrocannabinol (THC):Cannabinoid (CBD) Cannabis Extract Adjuvant for Reducing Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial",https://www.dovepress.com/oral-tetrahydrocannabinol-thccannabinoid-cbd-cannabis-extract-adjuvant-peer-reviewed-fulltext-article-IJWH,Positive,,Double Blind Clinical Trial,2023,,Digestive System,Chemotherapy-induced Nausea & Vomiting; Cancer - Cervical; Cancer - Ovarian; Cancer - Uterine; Cancer; Nausea and Vomiting
2023045,Effect of vaporizing cannabis rich in cannabidiol on cannabinoid levels in blood and on driving ability - a randomized clinical trial,https://link.springer.com/article/10.1007/s00414-023-03076-0,Inconclusive,,Double Blind Clinical Trial,2023,,,Cognitive Dysfunction; Cannabis Adverse Effects
2023046,"Cannabis-Based Medicine for Neuropathic Pain and Spasticity-A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial",https://www.mdpi.com/1424-8247/16/8/1079,Inconclusive,,Double Blind Clinical Trial,2023,Synthetic Cannabinoid (unspecified),,Pain; Pain - Chronic; Multiple Sclerosis; Pain - Neuropathy - Peripheral; Quality of Life; Spinal Cord Injuries
2023047,"Delta-9-tetrahydrocannabinol modulates pain sensitivity among persons receiving opioid agonist therapy for opioid use disorder: A within-subject, randomized, placebo-controlled laboratory study",https://pubmed.ncbi.nlm.nih.gov/37644897/,Positive,,Clinical Trial,2023,Pharma THC,Mental/Emotional System,Addiction - Opioid; Addiction; Pain; Cognitive Dysfunction
2023048,"A Randomized, Double-Blind, Placebo-Controlled Decentralized Trial to Assess Sleep, Health Outcomes, and Overall Well-Being in Healthy Adults Reporting Disturbed Sleep, Taking a Melatonin-Free Supplement",https://www.mdpi.com/2072-6643/15/17/3788,Positive,,Clinical Trial,2023,Tetrahydrocannabinol (THC); Cannabinol (CBN),,Insomnia and Sleep Disorders; Anxiety; Pain
2023049,A small clinical trial of vaporized cannabis for PTSD: suggestive results and directions for future study,https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-023-07543-2,Positive,,Double Blind Clinical Trial,2023,,Mental/Emotional System,PTSD
2023050,Effects of sub-chronic nabiximols on biological markers of individuals undergoing a clinical trial for the treatment of cannabis use disorder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492088/,Positive,,Meta-analysis,2023,Pharma THC:CBD,Mental/Emotional System,Addiction - Cannabis; Addiction
2024128,Randomized controlled trial of zolpidem as a pharmacotherapy for cannabis use disorder,https://www.jsatjournal.com/article/S2949-8759(23)00231-X/abstract#secst0030,Positive,,Clinical Trial,2024,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2024129,10.1016/j.addbeh.2023.107877,https://www.sciencedirect.com/science/article/abs/pii/S0306460323002721?via%3Dihub#preview-section-snippets,Inconclusive,,Meta-analysis,2024,Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction - Nicotine; Addiction
2023051,"Cannabidiol does not attenuate acute delta-9-tetrahydrocannabinol-induced attentional bias in healthy volunteers: A randomised, double-blind, cross-over study",https://onlinelibrary.wiley.com/doi/10.1111/add.16353,Negative,,Double Blind Clinical Trial,2023,,Mental/Emotional System; Nervous System,Behavioral Disorders; Cannabis Adverse Effects; Addiction - Cannabis; Addiction
2023052,Functional brain changes after alternative pharmacological interventions in posttraumatic stress disorder: A systematic review of clinical trials,https://onlinelibrary.wiley.com/doi/10.1002/brb3.3292,Negative,,Meta-analysis,2023,,Mental/Emotional System; Nervous System,PTSD
2023053,Risk of relapse to non-opioid addictive substances among opioid dependent patients treated with an opioid receptor antagonist or a partial agonist: A randomized clinical trial,https://www.sciencedirect.com/science/article/pii/S1551714423002835?via%3Dihub,Inconclusive,,Clinical Trial,2023,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction; Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Stimulant
2023054,"The Efficacy of Palmitoylethanolamide (Levagen+) on the Incidence and Symptoms of Upper Respiratory Tract Infection-A Double Blind, Randomised, Placebo-Controlled Trial",https://www.mdpi.com/2072-6643/15/20/4453,Positive,,Double Blind Clinical Trial,2023,Palmitoylethanolamide (PEA),Immune System,Bacterial Infections; Acute Respiratory Distress Syndrome; Flu; Respiratory Syncytial Virus; Stress
2023055,"Effects of CB1R inverse agonist, INV-202, in patients with features of metabolic syndrome. A randomized, placebo-controlled, double-blind phase 1b study",https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.15353,Positive,,Double Blind Clinical Trial,2023,Endocannabinoid (unspecified),Endocrine System,Metabolic Syndrome; Obesity
2023056,"A randomized, double-blind, placebo-controlled, repeated-dose pilot study of the safety, tolerability, and preliminary effects of a cannabidiol (CBD)- and cannabigerol (CBG)-based beverage powder to support recovery from delayed onset muscle soreness (DOMS)",https://www.tandfonline.com/doi/full/10.1080/15502783.2023.2280113,Positive,,Double Blind Clinical Trial,2023,Cannabigerol (CBG); Endocannabinoid (unspecified),Nervous System,Pain; Pain - Acute
2023057,"Oral cannabidiol (CBD) as add-on to paracetamol for painful chronic osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial",https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(23)00196-5/fulltext#secsectitle0145,Inconclusive,,Double Blind Clinical Trial,2023,,Nervous System; Skeletal System,Arthritis; Pain; Pain - Chronic; Inflammation
2024130,"Experimental Effects of Substance Use Legality (Sober, Alcohol, Marijuana, Cocaine) and Sexual Crime (Indecent Exposure, Rape) on Attributions of Perpetrator Responsibility, Blame, and Punishment",https://pubmed.ncbi.nlm.nih.gov/38044493/,Inconclusive,,Clinical Trial,2024,Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction; Domestic Abuse
2024131,A preliminary randomized controlled trial of repetitive transcranial magnetic stimulation applied to the left dorsolateral prefrontal cortex in treatment seeking participants with cannabis use disorder,https://www.sciencedirect.com/science/article/abs/pii/S0376871623012735?via%3Dihub,Inconclusive,,Double Blind Clinical Trial,2024,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2024132,"Pharmacokinetics and pharmacodynamics of cannabis-based medicine in a patient population included in a randomized, placebo-controlled, clinical trial",https://ascpt.onlinelibrary.wiley.com/doi/10.1111/cts.13685,Inconclusive,,Clinical Trial,2024,Cannabidiol (CBD); Synthetic Cannabinoid (unspecified); Tetrahydrocannabinol (THC),,Pain; Multiple Sclerosis; Neurodegenerative Issues; Pain - Chronic; Pain - Neuropathy - Peripheral
2024133,Positive psychological interventions on alcohol use and consequences: Pilot randomized trial in a young adult cannabis-using sample,https://pubmed.ncbi.nlm.nih.gov/38056630/,Inconclusive,,Clinical Trial,2024,Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction
2023058,The Effect of Levagen+ (Palmitoylethanolamide) Supplementation on Symptoms of Allergic Rhinitis-A Double-Blind Placebo-Controlled Trial,https://www.mdpi.com/2072-6643/15/23/4940,Positive,,Double Blind Clinical Trial,2023,Palmitoylethanolamide (PEA),Nervous System,Inflammation; Allergic Contact Dermatitis
2023059,Can inhaled cannabis users accurately evaluate impaired driving ability? A randomized controlled trial,https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2023.1234765/full,Negative,,Clinical Trial,2023,,Nervous System,Cognitive Dysfunction
2023060,"Effects of eight-week regular high-intensity interval training and hemp (Cannabis sativa L.) seed on total testosterone level among sedentary young males: double-blind, randomized, controlled clinical trial",https://pubmed.ncbi.nlm.nih.gov/38085421/,Positive,,Double Blind Clinical Trial,2023,,,Metabolic Syndrome; Obesity; Oxidative Stress
2024134,"Dietary linoleic acid lowering alone does not lower arachidonic acid or endocannabinoids among women with overweight and obesity: A randomized, controlled trial",https://pubmed.ncbi.nlm.nih.gov/38100748/,Inconclusive,,Clinical Trial,2024,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Omega-3; Fatty Acid Amide Hydrolase (FAAH); Fatty Acid-Binding Protein (FABP); N-Arachidonoyl Dopamine (NADA); Other Related Compounds,Endocrine System,Obesity; Inflammation; Metabolic Syndrome
2024135,Patterns of Polysubstance Use in Young Black and Latinx Sexual Minority Men and Transgender Women and Its Association with Sexual Partnership Factors: The PUSH Study,https://www.tandfonline.com/doi/full/10.1080/10826084.2023.2267655,Negative,,Clinical Trial,2024,Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Opioid; Addiction - Stimulant; HIV/AIDS
2024136,Cannabis for medical use versus opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised clinical trials,https://bmjopen.bmj.com/content/14/1/e068182,Positive,,Clinical Meta-analysis,2024,,Nervous System,Pain; Pain - Chronic; Addiction - Cannabis; Addiction - Opioid; Addiction
2024137,Low vitamin D levels are linked with increased cardiovascular disease risk in young adults: a sub-study and secondary analyses from the ACTIBATE randomized controlled trial,https://pubmed.ncbi.nlm.nih.gov/38172418/,Positive,,Clinical Trial,2024,Endocannabinoid (unspecified),Cardiovascular System,Cardiovascular Diseases (CVD); Atherosclerosis; Inflammation; Metabolic Syndrome
2024138,Cannabidiol for moderate-severe insomnia: a randomized controlled pilot trial of 150 mg of nightly dosing,https://pubmed.ncbi.nlm.nih.gov/38174873/,Inconclusive,,Clinical Trial,2024,Cannabidiol (CBD),Nervous System,Insomnia and Sleep Disorders
2024139,"The Effect of Nabiximols on Driving Ability in Adults with Chronic Tic Disorders: Results of a Substudy Analysis of the Double-Blind, Randomized, Placebo-Controlled CANNA-TICS Trial",https://pubmed.ncbi.nlm.nih.gov/38265476/,Positive,,Double Blind Clinical Trial,2024,Pharma THC:CBD,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cognitive Dysfunction; Tics and Tourettes
2024140,Application of the Bayesian network theory in clinical trial data: Severity shift in spasticity numeric rating scale in patients with multiple sclerosis,https://www.msard-journal.com/article/S2211-0348(24)00045-2/fulltext,Positive,,Clinical Meta-analysis,2024,Pharma THC:CBD,Nervous System,Multiple Sclerosis
2024141,Phytocannabinoids and gingival inflammation: Preclinical findings and a placebo-controlled double-blind randomized clinical trial with cannabidiol,https://onlinelibrary.wiley.com/doi/10.1111/jre.13234,Positive,,Clinical Trial,2024,,Digestive System; Nervous System,Inflammation; Periodontal Disease; Bacterial Infections
2024142,Cannabidiol for Postoperative Pain Control After Arthroscopic Rotator Cuff Repair Demonstrates No Deficits in Patient-Reported Outcomes Versus Placebo: 1-Year Follow-up of a Randomized Controlled Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10846110/,Inconclusive,,Clinical Trial,2024,,Nervous System,Pain
2024143,A social media intervention for high-intensity drinking among emerging adults: a pilot randomized controlled trial,https://pubmed.ncbi.nlm.nih.gov/38364317/,Positive,,Clinical Trial,2024,Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction; Addiction - Cannabis
2024144,Bovine Colostrum Increases Intestinal Permeability in Healthy Athletes and Patients: A Meta-Analysis of Randomized Clinical Trials,https://pubmed.ncbi.nlm.nih.gov/38361147/,Negative,,Meta-analysis,2024,Fatty Acid Amide Hydrolase (FAAH),,IBD - Inflammatory Bowel Disease; Inflammation
2023061,"Prebiotics Plus Probiotics May Favorably Impact on Gut Permeability, Endocannabinoid Receptors, and Inflammatory Biomarkers in Patients with Coronary Artery Diseases: A Clinical Trial",https://onlinelibrary.wiley.com/doi/10.1002/fsn3.3835,Positive,,Clinical Trial,2023,Endocannabinoid (unspecified); Microbiome,Cardiovascular System,Atherosclerosis; Cardiovascular Diseases (CVD); Inflammation; Microbiome Imbalance; Oxidative Stress
2024145,"Effectiveness of Palmitoylethanolamide (Levagen+) Compared to a Placebo for Reducing Pain, Duration, and Medication Use during Migraines in Otherwise Healthy Participants-A Double-Blind Randomised Controlled Study",https://www.mdpi.com/1424-8247/17/2/145,Positive,,Clinical Trial,2024,Palmitoylethanolamide (PEA),Nervous System,Migraine; Pain; Pain - Chronic
2024146,Nutrient composition of different energy-restricted diets determines plasma endocannabinoid profiles and adipose tissue DAGL-α expression; a 12-week randomized controlled trial in subjects with abdominal obesity,https://www.sciencedirect.com/science/article/pii/S095528632400038X?via%3Dihub,Inconclusive,,Clinical Trial,2024,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH),Endocrine System,Obesity; Metabolic Syndrome
2024147,Vaporized Cannabis versus Placebo for Acute Migraine: A Randomized Controlled Trial,https://pubmed.ncbi.nlm.nih.gov/38405890/,Positive,,Double Blind Clinical Trial,2024,Cannabidiol (CBD); Tetrahydrocannabinol (THC),Nervous System,Migraine; Pain
2024148,"The acute effects of cannabis, with and without cannabidiol, on attentional bias to cannabis related cues: a randomised, double-blind, placebo-controlled, cross-over study",https://link.springer.com/article/10.1007/s00213-024-06543-7,Inconclusive,,Clinical Trial,2024,Cannabidiol (CBD); Tetrahydrocannabinol (THC),,Behavioral Disorders; Cannabis Adverse Effects; Cognitive Dysfunction
2023062,The Effect of Cannabis Plant Extracts on Head and Neck Squamous Cell Carcinoma and the Quest for Cannabis-Based Personalized Therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856564/,Positive,,Laboratory Study,2023,Cannabichromene (CBC),Integumentary System,Cancer - Squamous Head/Neck; Cancer
2023063,Mixed Methods Evaluation of Satisfaction with Two Culturally Tailored Substance use Prevention Programs for American Indian/Alaska Native Emerging Adults,https://link.springer.com/article/10.1007/s11121-023-01612-3,Positive,,Clinical Trial,2023,,Mental/Emotional System,Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Opioid; Cannabis Adverse Effects
2024149,Initial Results from a New College Substance Use Prevention Program Targeting Externalizing and Internalizing Traits,https://pubmed.ncbi.nlm.nih.gov/37897057/,Positive,,Clinical Trial,2024,,Mental/Emotional System; Nervous System,Addiction; Addiction - Alcohol
2023064,Long-term Effects of the Raising Healthy Children Intervention on Family Functioning in Adulthood: A Nonrandomized Controlled Trial,https://pubmed.ncbi.nlm.nih.gov/37973659/,Inconclusive,,Clinical Trial,2023,,,Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine; Addiction; Cannabis Adverse Effects
2024150,"Narrative bias (""spin"") is common in randomised trials and systematic reviews of cannabinoids for pain",https://pubmed.ncbi.nlm.nih.gov/38227560/,Negative,,Meta-analysis,2024,Cannabinoid (unspecified),Nervous System,Pain
2024151,The Association Between Intraoperative Compromised Intestinal Integrity and Postoperative Complications in Cancer Patients,https://link.springer.com/article/10.1245/s10434-023-14857-7,Negative,,Clinical Trial,2024,Fatty Acid-Binding Protein (FABP),Nervous System,Cancer
2024152,Hepatoprotective Effect Assessment of C-Phycocyanin on Hepatocellular Carcinoma Rat Model by Using Photoacoustic Spectroscopy,https://pubmed.ncbi.nlm.nih.gov/38224996/,Positive,,Animal Study,2024,Phycocyanin,Digestive System; Nervous System,Cancer - Liver; Cancer; Fibrosis - Liver (Cirrhosis); Liver Failure; Oxidative Stress
2024153,Oxytocin alleviates periodontitis in adult rats,https://onlinelibrary.wiley.com/doi/10.1111/jre.13212,Positive,,Animal Study,2024,Endocannabinoid (unspecified),Digestive System; Nervous System,Inflammation; Periodontal Disease
2024154,The impact of cannabis on non-medical opioid use among individuals receiving pharmacotherapies for opioid use disorder: a systematic review and meta-analysis of longitudinal studies,https://www.tandfonline.com/doi/full/10.1080/00952990.2023.2287406,Inconclusive,,Meta-analysis,2024,Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction - Opioid; Addiction; Cannabis Adverse Effects
2023065,Twice-daily oral administration of a cannabidiol and cannabidiolic acid-rich hemp extract was well tolerated in orange-winged Amazon parrots (Amazona amazonica) and has a favorable pharmacokinetic profile,https://pubmed.ncbi.nlm.nih.gov/36795552/,Negative,,Animal Study -,2023,Cannabidiolic Acid (CBD-a),,Veterinary Applications
2023066,The clinical use of cannabidiol and cannabidiolic acid-rich hemp in veterinary medicine and lessons from human medicine,https://pubmed.ncbi.nlm.nih.gov/36965472/,Positive,,Meta-analysis -,2023,Cannabidiolic Acid (CBD-a),,Veterinary Applications
2023067,Combining cannabis and melatonin treatment with a rehabilitation program improved symptoms in a dog with compulsive disorder: A case report,https://pubmed.ncbi.nlm.nih.gov/37245289/,Positive,,Animal Study - Veterinary Clinical Trial,2023,Cannabigerol (CBG),,Veterinary Applications
2023068,Endocannabinoid System Receptors at the Hip and Stifle Joints of Middle-Aged Dogs: A Novel Target for the Therapeutic Use of Cannabis sativa Extract in Canine Arthropathies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525782/,Inconclusive,,Animal Study -,2023,,,Veterinary Applications
2023069,The efficacy and safety of cannabidiol as adjunct treatment for drug‐resistant idiopathic epilepsy in 51 dogs: A double‐blinded crossover study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658598/,Positive,,Animal Study - Veterinary Clinical Trial,2023,,,Veterinary Applications
2023070,Canine immune cells express high levels of CB1 and CB2 cannabinoid receptors and cannabinoid-mediated alteration of canine cytokine production is vehicle-dependent,https://pubmed.ncbi.nlm.nih.gov/37931433/,Positive,,Laboratory Study -,2023,,,Veterinary Applications
2024155,Cannabis and pathologies in dogs and cats: first survey of phytocannabinoid use in veterinary medicine in Argentina,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685507/,Positive,,Meta-analysis -,2024,Cannabinoid (unspecified),,Veterinary Applications
2024156,The Therapeutic Potential of Cannabidiol in Revolutionising Opioid Use Disorder Management,https://www.cureus.com/articles/214898-the-therapeutic-potential-of-cannabidiol-in-revolutionising-opioid-use-disorder-management#!/#review,Positive,,Meta-analysis,2024,Cannabidiol (CBD); Endocannabinoid (unspecified); Pharma CBD,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
2024157,Cannabinoid treatment for the symptoms of autism spectrum disorder,https://pubmed.ncbi.nlm.nih.gov/38226593/,Inconclusive,,Meta-analysis,2024,Cannabidiol (CBD); Pharma CBD,Mental/Emotional System; Nervous System,Autism; Fragile X Syndrome
2024158,"Alzheimer's disease, aging, and cannabidiol treatment: a promising path to promote brain health and delay aging",https://pubmed.ncbi.nlm.nih.gov/38227160/,Positive,,Meta-analysis,2024,Pharma CBD,Nervous System,Alzheimer's Disease; Dementia; Geriatric Conditions; Inflammation; Neurodegenerative Issues; Oxidative Stress
2020018,"The urothelium, the urinary microbioma and men LUTS: a systematic review",https://pubmed.ncbi.nlm.nih.gov/32550631/,Positive,,Meta-analysis,2020,Endocannabinoid (unspecified),Urinary System,Urinary Tract Infection
2020019,Cutaneous Adverse Events in Newly Approved FDA Non-cancer Drugs: A Systematic Review,https://link.springer.com/article/10.1007/s40268-020-00311-6,Negative,,Meta-analysis,2020,Pharma CBD,Integumentary System,Skin Diseases; Cannabis Adverse Effects
2020020,A systematic integrative review of the literature on midwives and student midwives engaged in problematic substance use,https://www.sciencedirect.com/science/article/abs/pii/S0266613820301571?via%3Dihub,Inconclusive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine; Cannabis Adverse Effects
2020021,Does cannabis complement or substitute alcohol consumption? A systematic review of human and animal studies,https://pubmed.ncbi.nlm.nih.gov/32648806/,Inconclusive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction
2020022,"Cannabis, nicotine and the negative symptoms of schizophrenia: Systematic review and meta-analysis of observational studies",https://www.sciencedirect.com/science/article/pii/S0149763420304681?via%3Dihub,Positive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction - Nicotine; Addiction; Schizophrenia; Psychosis
2020023,A systematic review of cigarette smoking trajectories in adolescents,https://www.sciencedirect.com/science/article/abs/pii/S0955395920301791?via%3Dihub#preview-section-snippets,Negative,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Addiction - Nicotine; Addiction; Addiction - Alcohol; Addiction - Cannabis; Behavioral Disorders; Depression
2020024,Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: a systematic review,https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-020-01425-3,Positive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction; Pain; Pain - Chronic
2020025,Cannabis and Inflammatory Mediators,https://pubmed.ncbi.nlm.nih.gov/32726782/,Negative,,Meta-analysis,2020,,Nervous System,Inflammation; Cannabis Adverse Effects; Multiple Sclerosis
2020026,Acute effects of cannabis consumption on exercise performance: a systematic and umbrella review,https://pubmed.ncbi.nlm.nih.gov/32734752/,Negative,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2020027,Changes in Novel AKI Biomarkers after Exercise. A Systematic Review,https://www.mdpi.com/1422-0067/21/16/5673,Positive,,Meta-analysis,2020,Fatty Acid-Binding Protein (FABP),Urinary System,Kidney Failure
2020028,Roles of Cannabinoids in Melanoma: Evidence from In Vivo Studies,https://www.mdpi.com/1422-0067/21/17/6040,Positive,,Meta-analysis,2020,Palmitoylethanolamide (PEA); Pharma THC:CBD; Pharma THC; WIN-x Synthetic Cannabinoids,Integumentary System; Nervous System,Cancer - Melanoma; Cancer
2020029,Cannabinoids and Prostate Cancer: A Systematic Review of Animal Studies,https://www.mdpi.com/1422-0067/21/17/6265,Positive,,Meta-analysis,2020,WIN-x Synthetic Cannabinoids,Nervous System; Reproductive System,Cancer - Prostate; Cancer
2020030,Brief Behavioral Interventions for Substance Use in Adolescents: A Meta-analysis,https://publications.aap.org/pediatrics/article/146/4/e20200351/79693/Brief-Behavioral-Interventions-for-Substance-Use?autologincheck=redirected,Negative,,Clinical Meta-analysis,2020,,Mental/Emotional System; Nervous System,Behavioral Disorders; Addiction - Alcohol; Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2020031,"Impact evaluations of drug decriminalisation and legal regulation on drug use, health and social harms: a systematic review",https://bmjopen.bmj.com/content/10/9/e035148,Inconclusive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine
2020032,Effects of Perioperative Cannabis Use on Bariatric Surgical Outcomes: a Systematic Review,https://pubmed.ncbi.nlm.nih.gov/32970257/,Positive,,Meta-analysis,2020,,Endocrine System,Obesity; Cannabis Adverse Effects
2020033,Patterns of substance use among adolescents: A systematic review,https://www.sciencedirect.com/science/article/abs/pii/S0376871620303872?via%3Dihub#preview-section-snippets,Negative,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Addiction
2020034,Prevalence of Common Mental Disorders in South Asia: A Systematic Review and Meta-Regression Analysis,https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2020.573150/full,Negative,,Meta-analysis,2020,,,Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant; Addiction; Anxiety; Bipolar Disorder; Cannabis Adverse Effects; Depression; OCD; PTSD; Suicide Attempt
2020035,Treatment Outcomes in Patients With Opioid Use Disorder Who Were First Introduced to Opioids by Prescription: A Systematic Review and Meta-Analysis,https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2020.00812/full,Positive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Cannabis Adverse Effects
2020036,Biological effects of Cannabidiol on normal human healthy cell populations: Systematic review of the literature,https://www.sciencedirect.com/science/article/pii/S0753332220309215?via%3Dihub#sec0110,Positive,,Meta-analysis,2020,,,Inflammation; Oxidative Stress
2020037,"A systematic review of physical activity, sedentary behavior, and substance use in adolescents and emerging adults",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549408/,Inconclusive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Behavioral Disorders; Addiction; Addiction - Alcohol; Addiction - Cannabis; Cannabis Adverse Effects
2020038,The relationship between cannabis use and patient outcomes in medication-based treatment of opioid use disorder: A systematic review,https://www.sciencedirect.com/science/article/abs/pii/S0272735820301276?via%3Dihub#preview-section-snippets,Inconclusive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction - Opioid; Addiction; Cannabis Adverse Effects
2021008,Cannabinoids in Urology. Which Benign Conditions Might They Be Appropriate to Treat: A Systematic Review,https://pubmed.ncbi.nlm.nih.gov/33129871/,Inconclusive,,Meta-analysis,2021,,Urinary System,Cystitis; Urinary Incontinence
2020039,Risk Management in First Aid for Acute Drug Intoxication,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7663746/,Positive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Addiction; Addiction - Cannabis; Addiction - Cocaine; Addiction - Opioid; Addiction - Stimulant
2020040,10.1097/JTN.0000000000000544,https://pubmed.ncbi.nlm.nih.gov/33156253/,Inconclusive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Traumatic Brain Injury
2021009,Antipsychotic Treatment Failure: A Systematic Review on Risk Factors and Interventions for Treatment Adherence in Psychosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584050/,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Psychosis; Addiction - Cannabis; Addiction; Cannabis Adverse Effects; Schizophrenia
2021010,A systematic review of the label accuracy of cannabinoid-based products in regulated markets: is what's on the label what's in the product?,https://journals.sagepub.com/doi/10.1177/1039856220965334,Inconclusive,,Meta-analysis,2021,AB-x Synthetic Cannabinoids,,Cannabis Adverse Effects; Poisoning by Synthetic Cannabis
2021011,Preventive interventions targeting cannabis use and related harms in people with psychosis: A systematic review,https://pubmed.ncbi.nlm.nih.gov/33283448/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Psychosis
2020041,Pharmacological treatment of central neuropathic pain: consensus of the Brazilian Academy of Neurology,https://www.scielo.br/j/anp/a/FSp83hN3hwX8ydRczvwLBPS/?lang=en,Positive,,Meta-analysis,2020,Pharma THC; Tetrahydrocannabinol (THC),Nervous System,Pain; Pain - Central Pain Syndrome; Depression; Multiple Sclerosis; Pain - Neuropathy - Diabetic; Pain - Neuropathy - Drug-Ind. Polyneuropathy; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral; Spinal Cord Injuries; Stroke
2021012,Endogenous antagonists of N-methyl-d-aspartate receptor in schizophrenia,https://pubmed.ncbi.nlm.nih.gov/33336545/,Inconclusive,,Meta-analysis,2021,Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,Schizophrenia; Psychosis
2021013,Addictive behaviors across the menstrual cycle: a systematic review,https://pubmed.ncbi.nlm.nih.gov/33404701/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System; Reproductive System,Behavioral Disorders; Addiction; Menstrual Disorders
2021014,Young and under the influence: A systematic literature review of the impact of cannabis on the driving performance of youth,https://www.sciencedirect.com/science/article/abs/pii/S0001457520317814?via%3Dihub#preview-section-snippets,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cognitive Dysfunction
2021015,Systematic review and meta-analysis of socio-cognitive and socio-affective processes association with adolescent substance use.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943258/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction; Cognitive Dysfunction; Addiction - Alcohol; Addiction - Cannabis
2024159,Tolerability of long‐term cannabidiol supplementation to healthy adult dogs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10800185/,Positive,,Animal Study,2024,Cannabidiol (CBD),,
2021016,"Topical capsaicin for the treatment of cannabinoid hyperemesis syndrome, a systematic review and meta-analysis",https://www.sciencedirect.com/science/article/abs/pii/S073567572100005X?via%3Dihub,Positive,,Meta-analysis,2021,Capsaicin (CAPS),Nervous System,Cannabis Hyperemesis Syndrome; Cannabis Adverse Effects
2021017,Intelligence quotient decline following frequent or dependent cannabis use in youth: a systematic review and meta-analysis of longitudinal studies,https://www.cambridge.org/core/journals/psychological-medicine/article/intelligence-quotient-decline-following-frequent-or-dependent-cannabis-use-in-youth-a-systematic-review-and-metaanalysis-of-longitudinal-studies/26BEC9CBD2A39010C26100278F8CA813,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cognitive Dysfunction; Cannabis Adverse Effects
2021018,Assessments and Interventions for Sleep Disorders in Infants With or at High Risk for Cerebral Palsy: A Systematic Review,https://www.pedneur.com/article/S0887-8994(20)30348-9/fulltext,Inconclusive,,Meta-analysis,2021,Pharma CBD; Pharma THC,Nervous System,Cerebral Palsy; Insomnia and Sleep Disorders
2021019,The relationship between cannabis use and cognition in people with bipolar disorder: A systematic scoping review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914198/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Bipolar Disorder; Cognitive Dysfunction; Cannabis Adverse Effects
2021020,A Systematic Review of Assessments and Interventions for Chronic Pain in Young Children With or at High Risk for Cerebral Palsy,https://pubmed.ncbi.nlm.nih.gov/33719661/,Inconclusive,,Meta-analysis,2021,,Nervous System,Cerebral Palsy; Pain; Pain - Chronic; Cannabis Adverse Effects
2022021,Clinician responses to cannabis use during pregnancy and lactation: a systematic review and integrative mixed-methods research synthesis,https://academic.oup.com/fampra/article/39/3/504/6429125?login=false,Inconclusive,,Meta-analysis,2022,,Reproductive System,Pregnancy; Cannabis Adverse Effects
2024160,Cannabis induced gastrointestinal tract symptoms in the adult population: a systematic review,https://karger.com/mpp/article/doi/10.1159/000536161/894160/Cannabis-Induced-Gastrointestinal-Tract-Symptoms,Negative,,Meta-analysis,2024,Cannabidiol (CBD); Cannabinoid (unspecified); Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cannabis Hyperemesis Syndrome; Diarrhea; Pain; Nausea and Vomiting
2016014,Patterns of Substance Use During Cognitive Enhancement Therapy: An 18-Month Randomized Feasibility Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837677/,Positive,,Double Blind Clinical Trial,2016,,,Cognitive Dysfunction; Addiction - Cannabis; Addiction; Psychosis; Schizophrenia
2016015,Therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis,https://www.sciencedirect.com/science/article/abs/pii/S0010440X15300997?via%3Dihub,Positive,,Clinical Trial,2016,,Mental/Emotional System,Addiction - Cannabis; Addiction; Psychosis; Cannabis Adverse Effects
2016016,Opposite effects of cannabis and cocaine on performance monitoring,https://www.sciencedirect.com/science/article/abs/pii/S0924977X1630013X?via%3Dihub,Inconclusive,,Clinical Trial,2016,,Mental/Emotional System,Addiction - Cannabis; Addiction - Cocaine; Addiction; Cognitive Dysfunction
2016017,Does cannabis use moderate smoking cessation outcomes in treatment-seeking tobacco smokers? Analysis from a large multi-center trial,https://pubmed.ncbi.nlm.nih.gov/27187893/,Inconclusive,,Double Blind Clinical Trial,2016,,Mental/Emotional System,Addiction - Cannabis; Addiction - Nicotine; Addiction; Cannabis Adverse Effects
2016018,Opioid withdrawal suppression efficacy of oral dronabinol in opioid dependent humans,https://www.sciencedirect.com/science/article/abs/pii/S0376871616301065?via%3Dihub,Positive,,Double Blind Clinical Trial,2016,Pharma THC; Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction - Opioid; Addiction
2016019,"Anxiety, depression and risk of cannabis use: Examining the internalising pathway to use among Chilean adolescents",https://www.sciencedirect.com/science/article/abs/pii/S0376871616301806?via%3Dihub,Negative,,Clinical Trial,2016,,Mental/Emotional System,Addiction - Cannabis; Addiction; Anxiety; Cannabis Adverse Effects; Depression
2016020,A preliminary evaluation of synthetic cannabinoid use among adolescent cannabis users: Characteristics and treatment outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993666/,Inconclusive,,Clinical Trial,2016,Synthetic Cannabinoid (unspecified),,Poisoning by Synthetic Cannabis; Addiction - Alcohol; Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2016021,Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation,https://linkinghub.elsevier.com/retrieve/pii/S0306460316302726,Positive,,Clinical Trial,2016,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction; Cannabis Adverse Effects; Oxidative Stress
2016022,Hair analysis and its concordance with self-report for drug users presenting in emergency department,https://www.sciencedirect.com/science/article/abs/pii/S0376871616302447?via%3Dihub,Inconclusive,,Clinical Trial,2016,,Mental/Emotional System; Nervous System,Addiction; Addiction - Cannabis; Addiction - Cocaine; Addiction - Opioid
2017002,Risk of neonatal and childhood morbidity among preterm infants exposed to marijuana,https://pubmed.ncbi.nlm.nih.gov/27921445/,Inconclusive,,Clinical Trial,2017,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cerebral Palsy; Hemorrhagic Shock; Neonatal Cerebral Issues; Neurodegenerative Issues; Pregnancy
2016023,Mixed-amphetamine salts increase abstinence from marijuana in patients with co-occurring attention-deficit/hyperactivity disorder and cocaine dependence,https://pubmed.ncbi.nlm.nih.gov/28051838/,Positive,,Clinical Trial,2016,,Mental/Emotional System; Nervous System,ADD and ADHD; Addiction - Cannabis; Addiction - Cocaine; Addiction - Stimulant; Addiction; Cannabis Adverse Effects; Cognitive Dysfunction
2017003,Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study,https://pubmed.ncbi.nlm.nih.gov/28152236/,Inconclusive,,Clinical Trial,2017,,Mental/Emotional System,Addiction - Cannabis; Addiction
2017004,Newborn birth-weight of pregnant women on methadone or buprenorphine maintenance treatment: A national contingency management approach trial,https://pubmed.ncbi.nlm.nih.gov/28191917/,Inconclusive,,Clinical Trial,2017,,Mental/Emotional System; Nervous System; Reproductive System,Addiction; Neonatal Cerebral Issues; Pregnancy; Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Nicotine; Addiction - Opioid; Depression
2018008,Comparing the effect of clozapine and risperidone on cue reactivity in male patients with schizophrenia and a cannabis use disorder: A randomized fMRI study,https://www.sciencedirect.com/science/article/abs/pii/S0920996417301688?via%3Dihub#preview-section-snippets,Positive,,Clinical Trial,2018,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Schizophrenia; Psychosis
2017005,The social exigencies of the gateway progression to the use of illicit drugs from adolescence into adulthood,https://www.sciencedirect.com/science/article/abs/pii/S0306460317301806?via%3Dihub,Negative,,Meta-analysis,2017,,Mental/Emotional System; Nervous System,Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant
2017006,A placebo controlled study of quetiapine-XR in bipolar depression accompanied by generalized anxiety with and without a recent history of alcohol and cannabis use,https://pubmed.ncbi.nlm.nih.gov/28536866/,Inconclusive,,Double Blind Clinical Trial,2017,,Mental/Emotional System,Addiction - Alcohol; Addiction - Cannabis; Addiction; Anxiety; Bipolar Disorder; Depression; Cannabis Adverse Effects
2017007,A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults,https://www.sciencedirect.com/science/article/abs/pii/S0376871617302624?via%3Dihub,Inconclusive,,Double Blind Clinical Trial,2017,,Mental/Emotional System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2017008,Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal information,https://www.sciencedirect.com/science/article/abs/pii/S0278584617300404?via%3Dihub,Inconclusive,,Clinical Trial,2017,Tetrahydrocannabinol (THC),Nervous System,Cognitive Dysfunction; Cannabis Adverse Effects
2017009,Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot Study,https://neuro.psychiatryonline.org/doi/10.1176/appi.neuropsych.16120328,Positive,,Double Blind Clinical Trial,2017,Pharma THC,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cognitive Dysfunction
2017010,Influence of childhood trauma on diagnosis and substance use in first-episode psychosis,https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/influence-of-childhood-trauma-on-diagnosis-and-substance-use-in-firstepisode-psychosis/A8E4E2504A296877521C76E4421B88C9,Negative,,Meta-analysis,2017,,Mental/Emotional System; Nervous System,Addiction; Psychosis; PTSD; Addiction - Cannabis; Addiction - Cocaine; Addiction - Opioid; Behavioral Disorders; Anxiety; Depression; Domestic Abuse; Suicide Attempt
2018009,Repetitive transcranial magnetic stimulation (rTMS) administration to heavy cannabis users,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5962012/,Positive,,Clinical Trial,2018,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2018010,Cannabis Use is Associated with Lower Odds of Prescription Opioid Analgesic Use Among HIV-Infected Individuals with Chronic Pain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037547/,Positive,,Meta-analysis,2018,,Immune System; Nervous System,HIV/AIDS; Pain; Pain - Chronic; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Addiction
2018011,Attachment and therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis,https://pubmed.ncbi.nlm.nih.gov/29446195/,Inconclusive,,Clinical Trial,2018,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Psychosis; Behavioral Disorders; Anxiety; Cannabis Adverse Effects; Cognitive Dysfunction
2018012,Electroacupuncture Improves Intestinal Dysfunction in Septic Patients: A Randomised Controlled Trial,https://www.hindawi.com/journals/bmri/2018/8293594/,Positive,,Clinical Trial,2018,Fatty Acid-Binding Protein (FABP),Immune System,Sepsis; Bacterial Infections; Constipation; Inflammation
2018013,Impact of comprehensive treatment for first episode psychosis on substance use outcomes: A randomized controlled trial,https://www.sciencedirect.com/science/article/abs/pii/S0165178118302361?via%3Dihub#preview-section-snippets,Inconclusive,,Clinical Meta-analysis,2018,,Mental/Emotional System; Nervous System,Addiction; Psychosis; Addiction - Alcohol; Addiction - Cannabis; Schizophrenia
2023071,Enhancing Psychological Interventions for Post-Traumatic Stress Disorder (PTSD) Treatment with Memory Influencing Drugs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207915/,Positive,,Meta-analysis,2023,,Mental/Emotional System,PTSD
2018014,Posttraumatic Stress Symptoms and Emerging Adult Sexual Minority Men: Implications for Assessment and Treatment of Childhood Sexual Abuse,https://pubmed.ncbi.nlm.nih.gov/30338584/,Positive,,Meta-analysis,2018,,Mental/Emotional System; Nervous System,PTSD; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Behavioral Disorders; Addiction; Anxiety; Domestic Abuse; HIV/AIDS; Psychosis
2019013,The Role of Acculturation and Alcohol Problems on Frequency of Cannabis Use Among Latinas at Risk of an Alcohol-Exposed Pregnancy,https://pubmed.ncbi.nlm.nih.gov/31220980/,Negative,,Clinical Trial,2019,,Mental/Emotional System; Reproductive System,Addiction - Alcohol; Addiction - Cannabis; Addiction; Pregnancy; Cannabis Adverse Effects
2019014,Perceptions of effectiveness and believability of pictorial and text-only health warning labels for cannabis products among Canadian youth,https://www.sciencedirect.com/science/article/abs/pii/S0955395919301793?via%3Dihub,Positive,,Meta-analysis,2019,,Mental/Emotional System,Cannabis Adverse Effects
2019015,Clinical and cost-effectiveness of contingency management for cannabis use in early psychosis: the CIRCLE randomised clinical trial,https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-019-1395-5,Inconclusive,,Meta-analysis,2019,,Mental/Emotional System,Addiction - Cannabis; Addiction; Psychosis; Cannabis Adverse Effects
2020042,A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCT,https://pubmed.ncbi.nlm.nih.gov/31460865/,Inconclusive,,Double Blind Clinical Trial,2020,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Psychosis; Cannabis Adverse Effects
2022022,Tobacco cessation among smokers under substance use treatment for alcohol and/or cannabis: study protocol and pilot study,https://pubmed.ncbi.nlm.nih.gov/36451226/,Negative,,Clinical Trial,2022,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine; Addiction
2023072,Cannabis and Psychosis.,https://pubmed.ncbi.nlm.nih.gov/36410907/,Negative,,Meta-analysis,2023,,Mental/Emotional System,Psychosis
2022023,"Substance Use Screening, Brief Intervention, and Referral to Treatment in Pediatric Primary Care, School-Based Health Clinics, and Mental Health Clinics",https://pubmed.ncbi.nlm.nih.gov/36410898/,Negative,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2022024,Does cannabis use impact cognitive behavioural therapy outcomes for anxiety and related disorders? A preliminary examination,https://pubmed.ncbi.nlm.nih.gov/36401953/,Inconclusive,,Clinical Trial,2022,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2022025,Cannabis use and related clinical variables in patients with obsessive-compulsive disorder,https://pubmed.ncbi.nlm.nih.gov/36148826/,Inconclusive,,Clinical Trial,2022,,Mental/Emotional System; Nervous System,OCD
2010030,Assessment of medication adherence in a cohort of patients with bipolar disorder,https://pubmed.ncbi.nlm.nih.gov/20842617/,Negative,,Clinical Trial,2010,,Mental/Emotional System; Nervous System,Bipolar Disorder; Cannabis Adverse Effects; Psychosis
2011006,Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users,https://link.springer.com/article/10.1007/s00213-010-2042-1#Abs1,Inconclusive,,Double Blind Clinical Trial,2011,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cognitive Dysfunction; Addiction - Alcohol; Addiction - Cannabis; Addiction
2011007,Olmesartan reduces arterial stiffness and serum adipocyte fatty acid-binding protein in hypertensive patients,https://pubmed.ncbi.nlm.nih.gov/21063874/,Positive,,Clinical Trial,2011,Fatty Acid-Binding Protein (FABP),Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Atherosclerosis; Diabetes; Metabolic Syndrome
2011008,Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study,https://pubmed.ncbi.nlm.nih.gov/21538146/,Inconclusive,,Clinical Trial,2011,,Mental/Emotional System; Reproductive System,Addiction - Opioid; Addiction; Pregnancy; Addiction - Cannabis; Addiction - Cocaine; Cannabis Adverse Effects; Neonatal Cerebral Issues
2012010,"A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults",https://www.nature.com/articles/npp201214#Sec18,Positive,,Double Blind Clinical Trial,2012,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2012011,A placebo-controlled study to assess Standardized Field Sobriety Tests performance during alcohol and cannabis intoxication in heavy cannabis users and accuracy of point of collection testing devices for detecting THC in oral fluid,https://link.springer.com/article/10.1007/s00213-012-2732-y,Inconclusive,,Double Blind Clinical Trial,2012,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction; Cannabis Adverse Effects; Cognitive Dysfunction; Psychosis
2012012,"Early survival of comatose patients after severe traumatic brain injury with the dual cannabinoid CB1/CB2 receptor agonist KN38-7271: a randomized, double-blind, placebo-controlled phase II trial",https://pubmed.ncbi.nlm.nih.gov/22696266/,Positive,,Double Blind Clinical Trial,2012,Synthetic Cannabinoid (unspecified),Nervous System,Traumatic Brain Injury
2012013,Detecting impairment associated with cannabis with and without alcohol on the Standardized Field Sobriety Tests.,https://pubmed.ncbi.nlm.nih.gov/22763669/,Negative,,Clinical Trial,2012,,Mental/Emotional System,Addiction - Alcohol; Addiction - Cannabis; Addiction
2013004,Evaluating brief screeners to discriminate between drug use disorders in a sample of treatment-seeking adults,https://www.sciencedirect.com/science/article/abs/pii/S0163834312002058?via%3Dihub,Positive,,Clinical Trial,2013,,Mental/Emotional System; Nervous System,Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Opioid; Addiction - Stimulant
2013005,Illicit drug use among pregnant women enrolled in treatment for cigarette smoking cessation,https://pubmed.ncbi.nlm.nih.gov/23072871/,Negative,,Clinical Trial,2013,,Mental/Emotional System; Nervous System; Reproductive System,Addiction - Nicotine; Addiction; Pregnancy; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Cocaine; Addiction - Opioid; Addiction - Stimulant
2013006,Influence of ethanol on the pharmacokinetic properties of Δ9-tetrahydrocannabinol in oral fluid,https://academic.oup.com/jat/article/37/3/152/819661?login=false,Inconclusive,,Clinical Trial,2013,,,Addiction - Alcohol; Addiction; Cannabis Adverse Effects
2022026,Altered White Matter Integrity at Illness Onset in Adolescents With a First Episode of Psychosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127302/,Inconclusive,,Clinical Trial,2022,,Mental/Emotional System; Nervous System,Psychosis
2022027,Preventive Medication Patterns in Bipolar Disorder and Their Relationship With Comorbid Substance Use Disorders in a Cross-National Observational Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110763/,Inconclusive,,Clinical Trial,2022,,Mental/Emotional System; Nervous System,Addiction; Bipolar Disorder; Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine
2022028,"Multimodal Correlates of Cannabis Use among U.S. Veterans with Bipolar Disorder: An Integrated Study of Clinical, Cognitive, and Functional Outcomes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794455/,Inconclusive,,Clinical Trial,2022,,Mental/Emotional System; Nervous System,Bipolar Disorder; PTSD
2022029,Premorbid characteristics of patients with DSM-IV psychotic disorders,https://pubmed.ncbi.nlm.nih.gov/35385814/,Negative,,Clinical Trial,2022,,Mental/Emotional System; Nervous System,Bipolar Disorder; Psychosis; Schizophrenia
2022030,Nonpharmacologic management of chronic pain in the United States’ Medicare population: a scoping review protocol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594142/,Negative,,Meta-analysis,2022,,Nervous System,Pain; Pain - Chronic
2023073,"Anti-proliferative effect of Cannabidiol in Prostate cancer cell PC3 is mediated by apoptotic cell death, NFκB activation, increased oxidative stress, and lower reduced glutathione status",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553363/,Positive,,Laboratory Study,2023,,Nervous System; Reproductive System,Cancer - Prostate; Cancer
2023074,"Effects of Chronic, Low-Dose Cannabinoids, Cannabidiol, Delta-9-Tetrahydrocannabinol and a Combination of Both, on Amyloid Pathology in the 5xFAD Mouse Model of Alzheimer's Disease",https://pubmed.ncbi.nlm.nih.gov/37862567/,Inconclusive,,Animal Study,2023,Pharma CBD; Pharma THC:CBD; Pharma THC,Nervous System,Alzheimer's Disease
2023075,Interplay Between Astroglial Endocannabinoid System and the Cognitive Dysfunction in Alzheimer's Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10751057/,Inconclusive,,Laboratory Study,2023,,Nervous System,Alzheimer's Disease
2013007,"H-FABP, cardiovascular risk factors, and functional status in asymptomatic spinal cord injury patients",https://pubmed.ncbi.nlm.nih.gov/23483223/,Negative,,Clinical Trial,2013,Fatty Acid-Binding Protein (FABP),Skeletal System,Spinal Cord Injuries; Atherosclerosis; Cardiovascular Diseases (CVD)
2023076,"Phytocannabinoids: Pharmacological effects, biomedical applications, and worldwide prospection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658372/,Inconclusive,,Clinical Meta-analysis,2023,Cannabigerol (CBG); Pharma CBD; Pharma THC:CBD; Pharma THC,Digestive System; Immune System; Integumentary System; Mental/Emotional System; Nervous System,Alzheimer's Disease; Anxiety; Cancer; Chemotherapy-induced Nausea & Vomiting; Depression; Epilepsy; HIV/AIDS; Pain; Nausea and Vomiting; Neurodegenerative Issues; Wound Healing
2013008,Metabolic effects of chronic cannabis smoking,https://diabetesjournals.org/care/article/36/8/2415/33224/Metabolic-Effects-of-Chronic-Cannabis-Smoking,Negative,,Clinical Trial,2013,,Endocrine System,Metabolic Syndrome; Atherosclerosis; Cannabis Adverse Effects; Cardiovascular Diseases (CVD); Diabetes; Liver Failure
2023077,Cannabis use disorders and outcome of admission to intensive care: A retrospective multi-centre cohort study,https://pubmed.ncbi.nlm.nih.gov/38128218/,Inconclusive,,Clinical Trial,2023,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2014009,Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence,https://pubmed.ncbi.nlm.nih.gov/24067260/,Inconclusive,,Clinical Trial,2014,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2015029,Association of substance dependence phenotypes in the COGA sample,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233207/,Negative,,Meta-analysis,2015,,Mental/Emotional System; Nervous System,Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Opioid
2015030,Rivastigmine but not vardenafil reverses cannabis-induced impairment of verbal memory in healthy humans,https://pubmed.ncbi.nlm.nih.gov/24998257/,Positive,,Double Blind Clinical Trial,2015,,Nervous System,Cognitive Dysfunction; Cannabis Adverse Effects
2015031,"Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9-tetrahydrocannabinol in older persons with dementia",https://link.springer.com/article/10.1007/s00213-015-3889-y,Positive,,Double Blind Clinical Trial,2015,Pharma THC; Tetrahydrocannabinol (THC),,Dementia; Alzheimer's Disease; Cognitive Dysfunction
2015032,"Comparison of shock wave therapy and nutraceutical composed of Echinacea angustifolia, alpha lipoic acid, conjugated linoleic acid and quercetin (perinerv) in patients with carpal tunnel syndrome",https://journals.sagepub.com/doi/10.1177/0394632015584501,Positive,,Clinical Trial,2015,Echinacea,,Inflammation; Pain; Oxidative Stress
2015033,"A Preliminary Investigation of Individual Differences in Subjective Responses to D-Amphetamine, Alcohol, and Delta-9-Tetrahydrocannabinol Using a Within-Subjects Randomized Trial",https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0140501,Inconclusive,,Clinical Trial,2015,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction - Stimulant; Addiction
2016024,Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative Colitis,https://www.tandfonline.com/doi/full/10.1080/15284336.2015.1125077,Inconclusive,,Clinical Trial,2016,Fatty Acid-Binding Protein (FABP),Digestive System; Immune System,IBD - Inflammatory Bowel Disease; HIV/AIDS; IBD - Ulcerative Colitis; Inflammation
2019016,"The influence of substance use on the effectiveness of antipsychotic medication: a prospective, pragmatic study",https://pubmed.ncbi.nlm.nih.gov/31140342/,Inconclusive,,Clinical Trial,2019,,Mental/Emotional System,Addiction; Psychosis; Addiction - Cannabis; Addiction - Stimulant
2020043,The Prognostic Value of Endotoxemia and Intestinal Barrier Biomarker ZO-1 in Bacteremic Sepsis,https://pubmed.ncbi.nlm.nih.gov/31812215/,Inconclusive,,Clinical Trial,2020,Fatty Acid-Binding Protein (FABP),,Sepsis
2021021,Hemp Seeds in Post-Arthroplasty Rehabilitation: A Pilot Clinical Study and an In Vitro Investigation,https://www.mdpi.com/2072-6643/13/12/4330,Positive,,Clinical Trial,2021,,Skeletal System,Arthritis; Pain
2016025,Psychiatric comorbidities in a young man with subacute myelopathy induced by abusive nitrous oxide consumption: a case report,https://pubmed.ncbi.nlm.nih.gov/27729826/,Negative,,Meta-analysis,2016,,Mental/Emotional System,Addiction
2008029,Use of dronabinol for cannabis dependence: two case reports and review,https://pubmed.ncbi.nlm.nih.gov/18393061/,Positive,,Meta-analysis,2008,Pharma THC,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2019017,Add-on administration of ultramicronized palmitoylethanolamide in the treatment of new-onset burning mouth syndrome,https://pubmed.ncbi.nlm.nih.gov/30858732/,Positive,,Meta-analysis,2019,Fatty Acid Amide Hydrolase (FAAH),Digestive System,Burning Mouth Syndrome
2015034,Light microscopy can reveal the consumption of a mixture of psychotropic plant and fungal material in suspicious death,https://pubmed.ncbi.nlm.nih.gov/26165663/,Negative,,Meta-analysis,2015,Ayahuasca,,
2020044,Oral Supplementation with Ultramicronized Palmitoylethanolamide for Joint Disease and Lameness Management in Four Jumping Horses: A Case Report,https://pubmed.ncbi.nlm.nih.gov/32825646/,Positive,,Animal Study,2020,Fatty Acid Amide Hydrolase (FAAH),,
2020045,Cannabis extract for the treatment of painful tonic spasms in a patient with neuromyelitis optica spectrum disorder: A case report,https://pubmed.ncbi.nlm.nih.gov/32559701/,Positive,,Meta-analysis,2020,Tetrahydrocannabinol (THC),Nervous System,Pain; Pain - Eye
2012014,"""Spice"" and ""K2"" herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans",https://pubmed.ncbi.nlm.nih.gov/22691010/,Positive,,Meta-analysis,2012,CP-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,,Addiction - Cannabis; Addiction
2010031,An open-label comparison of nabilone and gabapentin as adjuvant therapy or monotherapy in the management of neuropathic pain in patients with peripheral neuropathy,https://pubmed.ncbi.nlm.nih.gov/21087411/,Positive,,Clinical Trial,2010,Pharma THC,Nervous System,Pain; Pain - Neuropathy - Peripheral
2006008,"Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls",https://pubmed.ncbi.nlm.nih.gov/16510488/,Inconclusive,,Clinical Trial,2006,Delta-8-THC,Mental/Emotional System; Nervous System,Anxiety; Cognitive Dysfunction; Depression
1986001,"Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjects",https://pubmed.ncbi.nlm.nih.gov/3016764/,Negative,,Double Blind Clinical Trial,1986,Delta-8-THC,Reproductive System,Infertility (Male)
1986002,Marihuana smoking suppresses luteinizing hormone in women,https://pubmed.ncbi.nlm.nih.gov/3012072/,Negative,,Clinical Trial,1986,,Reproductive System,Infertility (Female)
2009028,Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers,https://pubmed.ncbi.nlm.nih.gov/19337726/,Inconclusive,,Double Blind Clinical Trial,2009,Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Depression
2008030,"Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependence: results from a placebo-controlled, double-blind trial",https://pubmed.ncbi.nlm.nih.gov/18480689/,Inconclusive,,Double Blind Clinical Trial,2008,Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction
2007015,Rimonabant: the role of endocannabinoid type 1 receptor antagonism in modulating the weight and lipid profile of obese patients,https://pubmed.ncbi.nlm.nih.gov/18001618/,Positive,,Clinical Meta-analysis,2007,Synthetic Cannabinoid (unspecified),Endocrine System,Obesity; Diabetes
2016026,Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study,https://pubmed.ncbi.nlm.nih.gov/26650973/,Positive,,Clinical Trial,2016,Ayahuasca,Mental/Emotional System,Depression
2017011,"Therapeutic Alliance, Client Need for Approval, and Perfectionism as Differential Moderators of Response to eHealth and Traditionally Delivered Treatments for Comorbid Depression and Substance Use Problems",https://pubmed.ncbi.nlm.nih.gov/28819922/,Positive,,Clinical Trial,2017,,Mental/Emotional System,Addiction; Depression; Addiction - Alcohol; Addiction - Cannabis; Behavioral Disorders; Cognitive Dysfunction
2017012,"Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life",https://www.jsatjournal.com/article/S0740-5472(17)30193-9/fulltext,Positive,,Clinical Meta-analysis,2017,,Mental/Emotional System,Addiction - Cannabis; Addiction; Anxiety; Depression; Insomnia and Sleep Disorders; Quality of Life; Cannabis Adverse Effects
2017013,"Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5699926/,Positive,,Clinical Trial,2017,Pharma THC,Mental/Emotional System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2018015,The efficacy of a working memory training in substance use patients: A randomized double-blind placebo-controlled clinical trial,https://pubmed.ncbi.nlm.nih.gov/28933254/,Inconclusive,,Double Blind Clinical Trial,2018,,Mental/Emotional System; Nervous System,Addiction; Cognitive Dysfunction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Cannabis Adverse Effects; Psychosis
2018016,Pharmacokinetic Characterization of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Following Acute Oral Cannabis Ingestion in Healthy Adults,https://academic.oup.com/jat/article/42/4/232/4780784?login=false,Inconclusive,,Clinical Trial,2018,Tetrahydrocannabinol (THC),,
2018017,The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial,https://www.sciencedirect.com/science/article/abs/pii/S0376871618300267?via%3Dihub#preview-section-snippets,Positive,,Double Blind Clinical Trial,2018,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2018018,"Predictors of Topiramate Tolerability in Heavy Cannabis-Using Adolescents and Young Adults: A Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial",https://pubmed.ncbi.nlm.nih.gov/29424802/,Positive,,Double Blind Clinical Trial,2018,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2018019,Effect of Including Alcohol and Cannabis Content in a Sexual Risk-Reduction Intervention on the Incidence of Sexually Transmitted Infections in Adolescents: A Cluster Randomized Clinical Trial,https://pubmed.ncbi.nlm.nih.gov/29435591/,Positive,,Clinical Trial,2018,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2018020,Abstinence and reduced frequency of use are associated with improvements in quality of life among treatment-seekers with cannabis use disorder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846101/,Negative,,Double Blind Clinical Trial,2018,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects; Quality of Life
2018021,Approach bias modification for cannabis use disorder: A proof-of-principle study,https://www.jsatjournal.com/article/S0740-5472(17)30372-0/fulltext,Positive,,Double Blind Clinical Trial,2018,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Behavioral Disorders; Cannabis Adverse Effects; Cognitive Dysfunction
2018022,Testing the role of the posterior cingulate cortex in processing salient stimuli in cannabis users: an rTMS study,https://onlinelibrary.wiley.com/doi/10.1111/ejn.14194,Inconclusive,,Clinical Trial,2018,,,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2018023,Effects of acute Δ9-tetrahydrocannabinol on next-day extinction recall is mediated by post-extinction resting-state brain dynamics,https://www.sciencedirect.com/science/article/abs/pii/S0028390818307470?via%3Dihub#preview-section-snippets,Inconclusive,,Double Blind Clinical Trial,2018,Tetrahydrocannabinol (THC),Nervous System,Cognitive Dysfunction; Cannabis Adverse Effects
2021022,"Use of Topiramate in the Spectrum of Addictive and Eating Disorders: A Systematic Review Comparing Treatment Schemes, Efficacy, and Safety Features",https://pubmed.ncbi.nlm.nih.gov/33591567/,Inconclusive,,Clinical Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant; Alcoholic Liver Disease; Anorexia; Cannabis Adverse Effects; MDMA Adverse Effects; Night Blindness
2021023,A systematic review of possible interactions for herbal medicines and dietary supplements used concomitantly with disease-modifying or symptom-alleviating multiple sclerosis drugs,https://pubmed.ncbi.nlm.nih.gov/33624893/,Inconclusive,,Meta-analysis,2021,,Nervous System,Multiple Sclerosis; Cannabis Adverse Effects
2021024,Cannabis use in adolescence and risk of psychosis: Are there factors that moderate this relationship? A systematic review and meta-analysis,https://pubmed.ncbi.nlm.nih.gov/33617756/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Psychosis
2021025,Public health impact of daily life triggers of sudden cardiac death: A systematic review and comparative risk assessment,https://pubmed.ncbi.nlm.nih.gov/33662523/,Negative,,Meta-analysis,2021,,Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Stimulant; Addiction; Cannabis Adverse Effects
2021026,Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis,https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003524,Inconclusive,,Clinical Meta-analysis,2021,Pharma THC; Synthetic Cannabinoid (unspecified),Mental/Emotional System; Muscular System; Nervous System; Skeletal System,Cannabis Adverse Effects; Geriatric Conditions; Poisoning by Synthetic Cannabis; Nausea and Vomiting
2021027,Impact of COVID-19 on Mental Health in Adolescents: A Systematic Review,https://www.mdpi.com/1660-4601/18/5/2470,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Anxiety; Depression; Addiction - Alcohol; Addiction - Cannabis; Addiction
2019018,Short-Term Treatment Effects of a Substance Use Disorder Therapy Involving Traditional Amazonian Medicine,https://pubmed.ncbi.nlm.nih.gov/31043116/,Positive,,Clinical Trial,2019,Ayahuasca,Mental/Emotional System,Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction
2011009,"Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717343/,Negative,,Double Blind Clinical Trial,2011,Pharma THC,Endocrine System; Mental/Emotional System; Nervous System,Obesity; Schizophrenia
2021028,Anti-seizure medications for Lennox-Gastaut syndrome,https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003277.pub4/full,Inconclusive,,Meta-analysis,2021,Pharma CBD,Nervous System,Epilepsy - Lennox-Gastaut; Epilepsy
2021029,"The Efficacy, Adverse Events, and Withdrawal Rates of the Pharmacological Management of Chronic Spinal Cord Injury Pain: A Systematic Review and Meta-Analysis",https://academic.oup.com/painmedicine/article/23/2/375/6222194?login=falsemg,Negative,,Meta-analysis,2021,,Nervous System; Skeletal System,Pain; Pain - Chronic; Spinal Cord Injuries; Pain - Neuropathy - Peripheral
2021030,Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185792/,Negative,,Meta-analysis,2021,Synthetic Cannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); 5F-x Synthetic Cannabinoids; AB-x Synthetic Cannabinoids; AM-x Synthetic Cannabinoids; Anandamide (AEA); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Lysophosphatidylinositol (LPI); Palmitoylethanolamide (PEA); Pharma THC; WIN-x Synthetic Cannabinoids,Nervous System,Poisoning by Synthetic Cannabis; Addiction - Cannabis; Addiction - Cocaine; Addiction - Stimulant; Addiction; Atherosclerosis; Atrial Fibrillation; Cannabis Adverse Effects; Cannabis Hyperemesis Syndrome; Cardiac Arrhythmias; Cardiac Toxicity; Cardiovascular Diseases (CVD); Chronic Heart Disease; Heart Attack; Heart Disease; Inflammation; Kidney Failure; MDMA Adverse Effects; Myocarditis; Oxidative Stress
2021031,"Prevalence, sociodemographic variables, mental health condition, and type of drug use associated with suicide behaviors among people with substance use disorders: a systematic review and meta-analysis",https://pubmed.ncbi.nlm.nih.gov/33896407/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction; Suicide Attempt; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Behavioral Disorders; Addiction - Stimulant; Depression
2021032,Motivational Interviewing for Cannabis Use Disorders: A Systematic Review and Meta-Analysis,https://pubmed.ncbi.nlm.nih.gov/33965941/,Positive,,Double Blind Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2021033,Universal and Selective Interventions to Prevent Poor Mental Health Outcomes in Young People: Systematic Review and Meta-analysis,https://pubmed.ncbi.nlm.nih.gov/33979106/,Positive,,Meta-analysis,2021,,,ADD and ADHD; Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine; Behavioral Disorders; Addiction; Anxiety; Domestic Abuse; Insomnia and Sleep Disorders; Psychosis; PTSD
2021034,Using Mendelian randomization analysis to better understand the relationship between mental health and substance use: a systematic review,https://www.cambridge.org/core/journals/psychological-medicine/article/using-mendelian-randomization-analysis-to-better-understand-the-relationship-between-mental-health-and-substance-use-a-systematic-review/189270C8258FDCEC35B4B7BAE7975CC9,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine; Cognitive Dysfunction
2021035,Effectiveness of complementary therapies for the management of symptom clusters in palliative care in pediatric oncology: a systematic review,https://www.scielo.br/j/reeusp/a/rCRgxxQpmcfnFhDwxHxpH5K/?lang=en,Positive,,Meta-analysis,2021,,Nervous System,Cancer; Palliative Care; Anxiety; Pain; Pain - Cancer
2021036,Investigating interventions that lead to the highest treatment retention for emerging adults with substance use disorder: A systematic review,https://www.sciencedirect.com/science/article/abs/pii/S0306460321001908?via%3Dihub,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Opioid
2021037,Cannabis Use and Car Crashes: A Review,https://www.frontiersin.org/articles/10.3389/fpsyt.2021.643315/full,Negative,,Meta-analysis,2021,Pharma THC:CBD,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2021038,A systematic review of longitudinal studies investigating the impact of cannabis use in patients with psychotic disorders,https://pubmed.ncbi.nlm.nih.gov/34120548/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Psychosis; Cannabis Adverse Effects
2021039,The Relationship Between Childhood Physical and Sexual Abuse and Adolescent Cannabis Use: A Systematic Review,https://www.frontiersin.org/articles/10.3389/fpsyt.2021.631245/full,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Addiction - Cannabis; Addiction
2021040,New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature,https://www.mdpi.com/1648-9144/57/6/580,Negative,,Meta-analysis,2021,Synthetic Cannabinoid (unspecified),Mental/Emotional System,Suicide Attempt; Addiction - Cannabis; Addiction - Opioid; Behavioral Disorders; Addiction; Cannabis Adverse Effects; Poisoning by Synthetic Cannabis; Psychosis
2021041,New Pharmacological Targets for the Treatment of Schizophrenia: A Literature Review,https://pubmed.ncbi.nlm.nih.gov/34218785/,Positive,,Meta-analysis,2021,Pharma CBD,Mental/Emotional System; Nervous System,Schizophrenia; Psychosis
2021042,Cannabinoid Activity-Is There a Causal Connection to Spasmolysis in Clinical Studies?,https://www.mdpi.com/2218-273X/11/6/826,Inconclusive,,Clinical Meta-analysis,2021,,,Pain
2018024,"Medical and non-medical marijuana use in depression: Longitudinal associations with suicidal ideation, everyday functioning, and psychiatry service utilization",https://www.sciencedirect.com/science/article/abs/pii/S0165032717325478?via%3Dihub,Negative,,Clinical Trial,2018,,Mental/Emotional System; Nervous System,Depression; Suicide Attempt; Addiction - Alcohol; Addiction - Cannabis; Addiction; Anxiety; Cannabis Adverse Effects
2018025,The dose-dependent psychomotor effects of intravenous delta-9-tetrahydrocannabinol (Δ9-THC) in humans,https://journals.sagepub.com/doi/10.1177/0269881118799953,Negative,,Double Blind Clinical Trial,2018,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2018026,One Month of Cannabis Abstinence in Adolescents and Young Adults Is Associated With Improved Memory,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587572/,Positive,,Clinical Trial,2018,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects; Cognitive Dysfunction
2018027,Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis: A Crossover Trial,https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2716990,Inconclusive,,Double Blind Clinical Trial,2018,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cognitive Dysfunction
2019019,Effect of Smoked Cannabis on Vigilance and Accident Risk Using Simulated Driving in Occasional and Chronic Users and the Pharmacokinetic-Pharmacodynamic Relationship,https://academic.oup.com/clinchem/article/65/5/684/5608034?login=false,Negative,,Clinical Trial,2019,,Mental/Emotional System,Cannabis Adverse Effects; Cognitive Dysfunction
2019020,Blunts versus joints: Cannabis use characteristics and consequences among treatment-seeking adults,https://www.sciencedirect.com/science/article/abs/pii/S0376871619300730?via%3Dihub,Positive,,Clinical Trial,2019,,Mental/Emotional System,Addiction - Cannabis; Addiction
2019021,"Effect of acute Δ9-tetrahydrocannabinol administration on subjective and metabolic hormone responses to food stimuli and food intake in healthy humans: a randomized, placebo-controlled study",https://www.sciencedirect.com/science/article/pii/S0002916522031690?via%3Dihub#s0100,Positive,,Clinical Trial,2019,Pharma THC; Tetrahydrocannabinol (THC),Endocrine System,Metabolic Syndrome; Anorexia; Loss of Appetite
2019022,Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition,https://link.springer.com/article/10.1007/s00213-019-05246-8,Negative,,Double Blind Clinical Trial,2019,Tetrahydrocannabinol (THC),Mental/Emotional System,Cognitive Dysfunction; Psychosis
2019023,Influence of Δ9-tetrahydrocannabinol on long-term neural correlates of threat extinction memory retention in humans,https://www.nature.com/articles/s41386-019-0416-6#Sec2,Negative,,Clinical Trial,2019,Pharma THC; Tetrahydrocannabinol (THC),,Cognitive Dysfunction; Anxiety; Cannabis Adverse Effects; PTSD
2019024,Cannabis-induced altered states of consciousness are associated with specific dynamic brain connectivity states,https://journals.sagepub.com/doi/10.1177/0269881119849814,Inconclusive,,Clinical Trial,2019,,Mental/Emotional System,Behavioral Disorders; Cognitive Dysfunction; Psychosis
2019025,Highs and lows of cannabinoid-dopamine interactions: effects of genetic variability and pharmacological modulation of catechol-O-methyl transferase on the acute response to delta-9-tetrahydrocannabinol in humans,https://pubmed.ncbi.nlm.nih.gov/31187152/,Inconclusive,,Clinical Trial,2019,Tetrahydrocannabinol (THC),,Cannabis Adverse Effects; Cognitive Dysfunction; Psychosis
2019026,Cannabinoid modulation of opioid analgesia and subjective drug effects in healthy humans,https://pubmed.ncbi.nlm.nih.gov/31201479/,Negative,,Double Blind Clinical Trial,2019,Pharma THC; Tetrahydrocannabinol (THC),,Addiction - Cannabis; Addiction - Opioid; Addiction; Pain
2019027,The effectiveness of chair work intervention on anxiety and depression in divorced women using Cannabis,https://www.sciencedirect.com/science/article/abs/pii/S1876201819300024?via%3Dihub,Positive,,Clinical Trial,2019,,Mental/Emotional System,Anxiety; Cannabis Adverse Effects; Depression
2019028,Detection of Δ9 THC in oral fluid following vaporized cannabis with varied cannabidiol (CBD) content: An evaluation of two point-of-collection testing devices,https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/dta.2687,Negative,,Laboratory Study,2019,Pharma THC:CBD; Pharma THC,,
2019029,"Examination of a New Delivery Approach for Oral Cannabidiol in Healthy Subjects: A Randomized, Double-Blinded, Placebo-Controlled Pharmacokinetics Study",https://pubmed.ncbi.nlm.nih.gov/31512143/,Positive,,Double Blind Clinical Trial,2019,Pharma CBD,,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2020046,Sex differences in the acute effects of smoked cannabis: evidence from a human laboratory study of young adults,https://pubmed.ncbi.nlm.nih.gov/31637452/,Inconclusive,,Clinical Trial,2020,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cognitive Dysfunction
2021043,Safety and Tolerability of Natural and Synthetic Cannabinoids in Older Adults: A Systematic Review and Meta-Analysis of Open-Label Trials and Observational Studies,https://pubmed.ncbi.nlm.nih.gov/34235645/,Positive,,Clinical Trial,2021,,Mental/Emotional System; Muscular System; Nervous System; Skeletal System,Cannabis Adverse Effects; Geriatric Conditions; Poisoning by Synthetic Cannabis
2021044,A systematic review and meta-analysis of sex differences in cannabis use disorder amongst people with comorbid mental illness,https://pubmed.ncbi.nlm.nih.gov/34280058/,Negative,,Clinical Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Bipolar Disorder; Depression; Psychosis; Schizophrenia
2019030,"Acute and residual effects of smoked cannabis: Impact on driving speed and lateral control, heart rate, and self-reported drug effects",https://www.sciencedirect.com/science/article/abs/pii/S0376871619304181?via%3Dihub,Inconclusive,,Double Blind Clinical Trial,2019,,Mental/Emotional System,Cannabis Adverse Effects; Cognitive Dysfunction
2019031,"The Acute and Chronic Cognitive and Cerebral Blood-Flow Effects of Nepalese Pepper ( Zanthoxylum armatum DC.) Extract-A Randomized, Double-Blind, Placebo-Controlled Study in Healthy Humans",https://www.mdpi.com/2072-6643/11/12/3022,Positive,,Double Blind Clinical Trial,2019,Endocannabinoid (unspecified),,Cognitive Dysfunction
2020047,A web-based episodic specificity and future thinking session modulates delay discounting in cannabis users,https://pubmed.ncbi.nlm.nih.gov/31999170/,Positive,,Clinical Trial,2020,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Addiction - Alcohol; Addiction - Nicotine
2020048,Randomized Trial of Screening and Brief Intervention to Reduce Injury and Substance Abuse in an urban Level I Trauma Center,https://www.sciencedirect.com/science/article/abs/pii/S0376871619305691?via%3Dihub,Inconclusive,,Clinical Trial,2020,,Mental/Emotional System; Nervous System,Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine
2020049,Guided web-based treatment program for reducing cannabis use: a randomized controlled trial,https://ascpjournal.biomedcentral.com/articles/10.1186/s13722-020-00185-8#Sec26,Inconclusive,,Double Blind Clinical Trial,2020,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2020050,"Effects of oral, smoked, and vaporized cannabis on endocrine pathways related to appetite and metabolism: a randomized, double-blind, placebo-controlled, human laboratory study",https://www.nature.com/articles/s41398-020-0756-3#Sec2,Inconclusive,,Clinical Trial,2020,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2020051,The effects of acute and sustained cannabidiol dosing for seven days on the haemodynamics in healthy men: A randomised controlled trial,https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.14225,Positive,,Double Blind Clinical Trial,2020,,Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2020052,Evaluation of pharmacokinetics and acute anti-inflammatory potential of two oral cannabidiol preparations in healthy adults,https://pubmed.ncbi.nlm.nih.gov/32147925/,Inconclusive,,Double Blind Clinical Trial,2020,,Nervous System,Inflammation
2020053,Factors Associated With Cannabis Use Among African American Nondaily Smokers,https://pubmed.ncbi.nlm.nih.gov/32187115/,Negative,,Clinical Trial,2020,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Addiction - Nicotine; Cannabis Adverse Effects
2021045,"Effect of screening, brief intervention and referral to treatment for unhealthy alcohol and other drug use in mental health treatment settings: a randomized controlled trial",https://pubmed.ncbi.nlm.nih.gov/32415721/,Positive,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction; Addiction - Cannabis; Addiction - Stimulant
2021046,"Impact of smoked cannabis on tobacco cigarette smoking intensity and subjective effects: A placebo-controlled, double-blind, within-subjects human laboratory study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457526/,Inconclusive,,Double Blind Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction
2022031,A national effectiveness trial of an eHealth program to prevent alcohol and cannabis misuse: responding to the replication crisis,https://pubmed.ncbi.nlm.nih.gov/32613919/,Positive,,Clinical Trial,2022,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction
2020054,Sales to apparently alcohol-intoxicated customers and online responsible vendor training in recreational cannabis stores in a randomized trial,https://www.sciencedirect.com/science/article/abs/pii/S0955395920302000?via%3Dihub,Negative,,Clinical Trial,2020,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction; Behavioral Disorders; Cannabis Adverse Effects
2020055,The acute effects of cannabidiol on the neural correlates of reward anticipation and feedback in healthy volunteers,https://journals.sagepub.com/doi/10.1177/0269881120944148,Inconclusive,,Double Blind Clinical Trial,2020,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cognitive Dysfunction
2020056,Treating cannabis use disorder: Exploring a treatment as needed model with 34-month follow-up,https://www.jsatjournal.com/article/S0740-5472(20)30344-5/fulltext#secst0085,Positive,,Clinical Trial,2020,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2020057,Temporal dynamics of the relationship between change in depressive symptoms and cannabis use in adolescents receiving psychosocial treatment for cannabis use disorder,https://www.jsatjournal.com/article/S0740-5472(20)30343-3/fulltext#secst0080,Positive,,Clinical Trial,2020,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Depression; Cannabis Adverse Effects
2020058,Promoting a Healthy Lifestyle through Mindfulness in University Students: A Randomized Controlled Trial,https://www.mdpi.com/2072-6643/12/8/2450,Positive,,Clinical Trial,2020,,,Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine
2021047,Nurse home visiting and prenatal substance use in a socioeconomically disadvantaged population in British Columbia: analysis of prenatal secondary outcomes in an ongoing randomized controlled trial,https://www.cmajopen.ca/content/8/4/E667,Positive,,Double Blind Clinical Trial,2021,,Nervous System; Reproductive System,Neonatal Cerebral Issues; Pregnancy
2021048,Substance Use Disorder Detection Rates Among Providers of General Medical Inpatients,https://link.springer.com/article/10.1007/s11606-020-06319-7,Negative,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid
2021049,Quetiapine treatment for cannabis use disorder,https://www.sciencedirect.com/science/article/abs/pii/S0376871620305317?via%3Dihub,Positive,,Double Blind Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2021050,"Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial",https://pubmed.ncbi.nlm.nih.gov/33160719/,Positive,,Double Blind Clinical Trial,2021,,Nervous System,Cannabis Hyperemesis Syndrome; Addiction - Cannabis; Addiction; Cannabis Adverse Effects; Pain; Nausea and Vomiting
2021051,Latency to cannabis dependence mediates the relationship between age at cannabis use initiation and cannabis use outcomes during treatment in men but not women,https://www.sciencedirect.com/science/article/abs/pii/S0376871620305482?via%3Dihub,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2021052,Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial,https://jamanetwork.com/journals/jama/fullarticle/2773562,Negative,,Double Blind Clinical Trial,2021,,Mental/Emotional System,Cannabis Adverse Effects; Cognitive Dysfunction
2021053,Predictors of substance use in a clinical sample of youth seeking treatment for Trauma-related mental health problems,https://www.sciencedirect.com/science/article/abs/pii/S0306460320308716?via%3Dihub#preview-section-snippets,Inconclusive,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction; PTSD; Addiction - Alcohol; Addiction - Cannabis
2021054,"Computer- vs. nurse practitioner-delivered brief intervention for adolescent marijuana, alcohol, and sex risk behaviors in school-based health centers",https://www.sciencedirect.com/science/article/abs/pii/S0376871620305883?via%3Dihub,Inconclusive,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2021055,Alcohol substitution during one month of cannabis abstinence among non-treatment seeking youth,https://www.sciencedirect.com/science/article/abs/pii/S0278584620305212?via%3Dihub,Negative,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2020059,"Combined prevention for substance use, depression, and anxiety in adolescence: a cluster-randomised controlled trial of a digital online intervention",https://www.thelancet.com/journals/landig/article/PIIS2589-7500(19)30213-4/fulltext,Positive,,Clinical Trial,2020,,Mental/Emotional System; Nervous System,Addiction; Anxiety; Depression; Addiction - Alcohol; Addiction - Cannabis; Cannabis Adverse Effects
2021056,Impact of a computerized intervention for high distress intolerance on cannabis use outcomes: A randomized controlled trial,https://www.jsatjournal.com/article/S0740-5472(20)30451-7/fulltext,Positive,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Anxiety; Depression
2021057,"Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial",https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0241708#sec004,Negative,,Clinical Meta-analysis,2021,,Immune System,HIV/AIDS; Cannabis Adverse Effects
2023078,Impact of Harm Reduction Treatment with or without Pharmacotherapy on Polysubstance Use among People Experiencing Homelessness and Alcohol Use Disorder,https://pubmed.ncbi.nlm.nih.gov/37788612/,Positive,,Clinical Trial,2023,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction; Addiction - Cannabis; Addiction - Cocaine; Addiction - Stimulant
2023079,A - 93 The Impact of Motivation on Neuropsychological Performance in Chronic Cannabis Users,https://academic.oup.com/acn/article-abstract/38/7/1259/7299715?redirectedFrom=fulltext,Positive,,Clinical Trial,2023,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cognitive Dysfunction
2021058,Piloting a brief intervention plus mobile boosters for drug use among emerging adults receiving emergency department care,https://www.sciencedirect.com/science/article/abs/pii/S0376871621001204?via%3Dihub,Positive,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction; Addiction - Cannabis
2022032,Randomized controlled trial of motivational interviewing for alcohol and cannabis use within a predominantly Hispanic adolescent sample,https://pubmed.ncbi.nlm.nih.gov/33749294/,Positive,,Clinical Trial,2022,,Mental/Emotional System,Addiction - Alcohol; Addiction - Cannabis; Addiction
2022033,Correlates of the nicotine metabolite ratio in Alaska Native people who smoke cigarettes,https://pubmed.ncbi.nlm.nih.gov/33856821/,Negative,,Clinical Trial,2022,,Mental/Emotional System,Addiction - Nicotine; Addiction; Addiction - Alcohol; Addiction - Cannabis
2021059,CANreduce 2.0 Adherence-Focused Guidance for Internet Self-Help Among Cannabis Users: Three-Arm Randomized Controlled Trial,https://www.jmir.org/2021/4/e27463,Positive,,Double Blind Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2021060,Telephone veteran peer coaching for mental health treatment engagement among rural veterans: The importance of secondary outcomes and qualitative data in a randomized controlled trial,https://onlinelibrary.wiley.com/doi/10.1111/jrh.12582,Positive,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Depression; PTSD; Quality of Life
2021061,The Effect of Orally Administered Low-Dose Dronabinol on Retinal Blood Flow and Oxygen Metabolism in Healthy Subjects,https://pubmed.ncbi.nlm.nih.gov/33999707/,Positive,,Double Blind Clinical Trial,2021,Pharma THC,,Cardiovascular Diseases (CVD); Glaucoma; Hypertension (High Blood Pressure); Pain; Pain - Eye
2021062,Day-level shifts in social contexts during youth cannabis use treatment,https://pubmed.ncbi.nlm.nih.gov/34014688/,Positive,,Double Blind Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2021063,Momentary coping and marijuana use in treated adults: Exploring mechanisms of treatment,https://pubmed.ncbi.nlm.nih.gov/34014689/,Positive,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2021064,Reaching nontreatment-seeking cannabis users: Testing an extended marijuana check-up intervention,https://www.jsatjournal.com/action/showPdf?pii=S0740-5472%2820%2930526-2,Positive,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2021065,Combined pharmacotherapy and evidence-based psychosocial Cannabis treatment for youth and selection of cannabis-using friends,https://www.sciencedirect.com/science/article/abs/pii/S0376871621002428?via%3Dihub,Positive,,Double Blind Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2023080,An observational study of clinical outcome measures in patients treated with cannabis-based medicinal products on the UK Medical Cannabis Registry,https://pubmed.ncbi.nlm.nih.gov/38057993/,Positive,,Meta-analysis,2023,,,Quality of Life; Addiction - Opioid; Addiction; Anxiety; Insomnia and Sleep Disorders
2021066,Medical cannabinoids for treatment of neuropsychiatric symptoms in dementia: a systematic review,https://www.scielo.br/j/trends/a/q5dqGnx8GCLxHFnnwnbBjkP/?lang=en#,Positive,,Meta-analysis,2021,Pharma CBD; Pharma THC:CBD; Pharma THC,Nervous System,Dementia; Behavioral Disorders; Alzheimer's Disease; Anorexia; Cognitive Dysfunction; Insomnia and Sleep Disorders; Loss of Appetite; Neurodegenerative Issues
2021067,The Impact of THC and CBD in Schizophrenia: A Systematic Review,https://www.frontiersin.org/articles/10.3389/fpsyt.2021.694394/full,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Schizophrenia; Addiction - Cannabis; Addiction; Cognitive Dysfunction; Psychosis
2021068,Systematic review of the impact of cannabinoids on neurobehavioral outcomes in preclinical models of traumatic and nontraumatic spinal cord injury,https://www.nature.com/articles/s41393-021-00680-y#Sec13,Positive,,Meta-analysis,2021,AM-x Synthetic Cannabinoids; CP-x Synthetic Cannabinoids; Endocannabinoid (unspecified); JWH-x Synthetic Cannabinoids; Palmitoylethanolamide (PEA); SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Mental/Emotional System; Skeletal System,Behavioral Disorders; Spinal Cord Injuries; Cannabis Adverse Effects; Cardiovascular Diseases (CVD); Neurodegenerative Issues; Reperfusion Injury
2021069,"Natural and Synthetic Cannabinoids: Pharmacology, Uses, Adverse Drug Events, and Drug Interactions",https://accp1.onlinelibrary.wiley.com/doi/10.1002/jcph.1871,Negative,,Meta-analysis,2021,Cannabigerolic Acid (CBG-a); Pharma CBD; Pharma THC:CBD; Pharma THC; Synthetic Cannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); 5F-x Synthetic Cannabinoids; AM-x Synthetic Cannabinoids; CP-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH); JWH-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL),Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Poisoning by Synthetic Cannabis; Addiction - Cannabis; Addiction - Nicotine; Addiction; Allergic Contact Dermatitis; Anorexia; Chemotherapy-induced Nausea & Vomiting; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; HIV/AIDS; Pain; Multiple Sclerosis; Obesity; Pain - Cancer; Pain - Chronic; Pregnancy
2021070,Evidence for an increase in cannabis use in Iran - A systematic review and trend analysis,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0256563#sec026,Negative,,Meta-analysis,2021,,Nervous System,Cannabis Adverse Effects; Addiction - Cannabis; Addiction; Epilepsy
2022034,Biomarkers for the early prediction of contrast-induced nephropathy after percutaneous coronary intervention in adults: A systematic review and meta-analysis,https://pubmed.ncbi.nlm.nih.gov/34461746/,Negative,,Meta-analysis,2022,Fatty Acid-Binding Protein (FABP),Urinary System,Kidney Failure; Atherosclerosis; Cardiovascular Diseases (CVD); Chronic Kidney Disease
2021071,Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials,https://www.bmj.com/content/374/bmj.n1034,Inconclusive,,Clinical Meta-analysis,2021,,Nervous System,Pain; Pain - Cancer; Pain - Chronic; Insomnia and Sleep Disorders
2021072,Patterns of brain function associated with cannabis cue-reactivity in regular cannabis users: a systematic review of fMRI studies,https://link.springer.com/article/10.1007/s00213-021-05973-x#Sec26,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2021073,The acute and non-acute effects of cannabis on reward processing: A systematic review,https://www.sciencedirect.com/science/article/abs/pii/S0149763421003912?via%3Dihub,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2021074,Mechanisms of cannabis impairment: Implications for modeling driving performance,https://www.sciencedirect.com/science/article/abs/pii/S037907382100222X?via%3Dihub,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2022035,Technology-mediated just-in-time adaptive interventions (JITAIs) to reduce harmful substance use: a systematic review,https://onlinelibrary.wiley.com/doi/10.1111/add.15687,Inconclusive,,Meta-analysis,2022,,Mental/Emotional System,Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine
2022036,Efficacy and safety of antiseizure medication for Lennox-Gastaut syndrome: a systematic review and network meta-analysis,https://onlinelibrary.wiley.com/doi/10.1111/dmcn.15072,Positive,,Clinical Meta-analysis,2022,,,Epilepsy - Lennox-Gastaut; Epilepsy
2021075,A systematic review of addiction substitution in recovery: Clinical lore or empirically-based?,https://www.sciencedirect.com/science/article/abs/pii/S0272735821001264?via%3Dihub,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid
2021076,Treatment options for progression or recurrence of glioblastoma: a network meta-analysis,https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013579.pub2/full,Inconclusive,,Clinical Meta-analysis,2021,,Nervous System,Cancer; Cancer - Brain
2021077,Cannabis related side effects in otolaryngology: a scoping review,https://journalotohns.biomedcentral.com/articles/10.1186/s40463-021-00538-6,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Bacterial Infections; Hearing Loss; Tinnitus
2021078,Bioactive Compounds of Arthrospira spp. (Spirulina) with Potential Anticancer Activities: A Systematic Review,https://pubmed.ncbi.nlm.nih.gov/34597512/,Positive,,Meta-analysis,2021,Phycocyanin,Nervous System,Cancer; Cancer - Colon
2022037,"Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies",https://link.springer.com/article/10.1007/s00213-021-05960-2,Positive,,Meta-analysis,2022,Tetrahydrocannabinol (THC),Mental/Emotional System,Addiction - Cannabis; Behavioral Disorders; Addiction - Stimulant; Addiction
2021079,eHealth Interventions to Treat Substance Use in Pregnancy: A Systematic Review and Meta-Analysis,https://www.mdpi.com/1660-4601/18/19/9952,Positive,,Clinical Meta-analysis,2021,,Mental/Emotional System; Nervous System; Reproductive System,Addiction; Pregnancy; Addiction - Alcohol; Addiction - Cannabis; Cannabis Adverse Effects; Neonatal Cerebral Issues
2022038,Effects of brief substance use interventions delivered in general medical settings: a systematic review and meta-analysis,https://pubmed.ncbi.nlm.nih.gov/34647649/,Positive,,Clinical Meta-analysis,2022,,Mental/Emotional System,Addiction; Addiction - Alcohol; Addiction - Cannabis
2021080,A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019,https://karger.com/mca/article/4/1/21/188923/A-Mapping-Literature-Review-of-Medical-Cannabis,Inconclusive,,Meta-analysis,2021,Pharma CBD; Pharma THC,,Amyotrophic Lateral Sclerosis (ALS); Autism; Cancer; Epilepsy; Glaucoma; IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; HIV/AIDS; Pain; Multiple Sclerosis; Pain - Chronic; Parkinson's Disease; PTSD
2023081,Circulating Endocannabinoid Levels as Potential Biomarkers for Mortality in Hemodialysis Patients,https://karger.com/ajn/article/51/2/83/32999/Circulating-Endocannabinoid-Levels-as-Potential,Positive,,Meta-analysis,2023,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Urinary System,Hemodialysis
2023082,Electroacupuncture Exerts Analgesic Effects by Restoring Hyperactivity via Cannabinoid Type 1 Receptors in the Anterior Cingulate Cortex in Chronic Inflammatory Pain,https://pubmed.ncbi.nlm.nih.gov/37957422/,Positive,,Clinical Trial,2023,Acupuncture (TCM); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),,Pain; Pain - Chronic
2022039,Prevalence of Adolescent Cannabis Vaping: A Systematic Review and Meta-analysis of US and Canadian Studies,https://jamanetwork.com/journals/jamapediatrics/fullarticle/2785376,Negative,,Meta-analysis,2022,,Respiratory System,Vaping injury (EVALI)
2022040,Comorbidity between mood and substance-related disorders: A systematic review and meta-analysis,https://pubmed.ncbi.nlm.nih.gov/34708662/,Negative,,Meta-analysis,2022,,Mental/Emotional System,Addiction; Cannabis Adverse Effects
2021081,Substance use as a risk factor for bipolar disorder: A systematic review,https://www.sciencedirect.com/science/article/abs/pii/S0022395621006099?via%3Dihub#preview-section-snippets,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Bipolar Disorder; Addiction - Cannabis; Addiction - Cocaine; Addiction
2021082,"Treatment Guidelines for Rare, Early-Onset, Treatment-Resistant Epileptic Conditions: A Literature Review on Dravet Syndrome, Lennox-Gastaut Syndrome and CDKL5 Deficiency Disorder",https://www.frontiersin.org/articles/10.3389/fneur.2021.734612/full,Inconclusive,,Clinical Meta-analysis,2021,,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2022041,Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a 'moral hazard' associated with naloxone supply,https://www.sciencedirect.com/science/article/abs/pii/S095539592100431X?via%3Dihub,Negative,,Meta-analysis,2022,,Mental/Emotional System,Addiction - Opioid; Addiction - Opioid; Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Stimulant
2022042,"Association of cannabinoid receptor modulation with normal and abnormal skeletal remodelling: A systematic review and meta-analysis of in vitro, in vivo and human studies",https://www.sciencedirect.com/science/article/abs/pii/S1043661821005120?via%3Dihub#preview-section-snippets,Negative,,Meta-analysis,2022,AM-x Synthetic Cannabinoids; Endocannabinoid (unspecified); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,,Arthritis; Bone Fractures; Osteoporosis
2022043,Alcohol-medication interactions: A systematic review and meta-analysis of placebo-controlled trials,https://www.sciencedirect.com/science/article/abs/pii/S0149763421005121?via%3Dihub,Negative,,Clinical Meta-analysis,2022,,,Addiction - Alcohol; Addiction - Cannabis; Addiction - Opioid; Addiction; Cannabis Adverse Effects
2021083,Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis,https://www.nature.com/articles/s41598-021-02770-6#Sec8,Positive,,Meta-analysis,2021,Pharma CBD; Pharma THC:CBD; Tetrahydrocannabivarin (THCV); Pharma THC,Nervous System,Epilepsy; Cannabis Adverse Effects; Epilepsy - Dravet Syndrome; Loss of Appetite
2021084,Age- and Sex-Related Cortical Gray Matter Volume Differences in Adolescent Cannabis Users: A Systematic Review and Meta-Analysis of Voxel-Based Morphometry Studies,https://www.frontiersin.org/articles/10.3389/fpsyt.2021.745193/full,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2022044,"The mental health of young people who are not in education, employment, or training: a systematic review and meta-analysis",https://link.springer.com/article/10.1007/s00127-021-02212-8,Positive,,Meta-analysis,2022,,,Addiction - Alcohol; Addiction - Cannabis; Behavioral Disorders; Addiction; Anxiety; Psychosis; Suicide Attempt
2021085,The Impact of Co-occurring Post-traumatic Stress Disorder and Substance Use Disorders on Craving: A Systematic Review of the Literature,https://www.frontiersin.org/articles/10.3389/fpsyt.2021.786664/full,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System,Addiction; PTSD; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant
2022045,Substance-induced psychosis and cognitive functioning: A systematic review,https://www.sciencedirect.com/science/article/abs/pii/S0165178121006557?via%3Dihub,Negative,,Meta-analysis,2022,,Mental/Emotional System,Addiction; Cognitive Dysfunction; Psychosis; Schizophrenia
2021086,Long-Acting Injectable Antipsychotic Treatment in Schizophrenia and Co-occurring Substance Use Disorders: A Systematic Review,https://www.frontiersin.org/articles/10.3389/fpsyt.2021.808002/full,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction; Psychosis; Schizophrenia; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Opioid; Addiction - Stimulant
2022046,"Status and Impacts of Recreational and Medicinal Cannabis Policies in Africa: A Systematic Review and Thematic Analysis of Published and ""Gray"" Literature",https://pubmed.ncbi.nlm.nih.gov/34986005/,Inconclusive,,Meta-analysis,2022,,,Cannabis Adverse Effects
2022047,Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry,https://pubmed.ncbi.nlm.nih.gov/35045580/,Positive,,Meta-analysis,2022,Ayahuasca,Mental/Emotional System,Depression
2022048,Evidence on the acute and residual neurocognitive effects of cannabis use in adolescents and adults: a systematic meta-review of meta-analyses,https://pubmed.ncbi.nlm.nih.gov/35048456/,Negative,,Meta-analysis,2022,,Mental/Emotional System,Cannabis Adverse Effects; Cognitive Dysfunction
2022049,"Harm Reduction Strategies among University Students Who Use Alcohol and Cannabis, and Related Psychological Variables: A Systematic Review",https://pubmed.ncbi.nlm.nih.gov/35060424/,Positive,,Meta-analysis,2022,,Mental/Emotional System,Addiction - Alcohol; Addiction - Cannabis; Addiction; Cannabis Adverse Effects; Psychosis; Anxiety; Cognitive Dysfunction; Depression
2022050,Adolescent cannabis use and later development of schizophrenia: An updated systematic review of longitudinal studies,https://pubmed.ncbi.nlm.nih.gov/35018649/,Negative,,Meta-analysis,2022,,Mental/Emotional System,Cannabis Adverse Effects; Schizophrenia; Psychosis
2022051,Societal Costs and Outcomes of Medical and Recreational Marijuana Policies in the United States: A Systematic Review,https://pubmed.ncbi.nlm.nih.gov/35068253/,Inconclusive,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Addiction - Alcohol; Addiction - Nicotine; Addiction - Opioid; Addiction
2022052,"Causal effects of cannabis legalization on parents, parenting, and children: A systematic review",https://www.sciencedirect.com/science/article/abs/pii/S0091743522000044?via%3Dihub,Negative,,Meta-analysis,2022,,Mental/Emotional System,Cannabis Adverse Effects
2022053,The effects of cannabis and alcohol on driving performance and driver behaviour: a systematic review and meta-analysis,https://pubmed.ncbi.nlm.nih.gov/35083810/,Negative,,Clinical Meta-analysis,2022,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction; Cannabis Adverse Effects; Cognitive Dysfunction
2022054,Prevalence and use of cannabis products and routes of administration among youth and young adults in Canada and the United States: A systematic review,https://www.sciencedirect.com/science/article/abs/pii/S0306460322000247?via%3Dihub,Inconclusive,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2022055,"Resting-state EEG, Substance use and Abstinence After Chronic use: A Systematic Review",https://pubmed.ncbi.nlm.nih.gov/35142589/,Positive,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Addiction; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant
2022056,Cys-loop receptors on cannabinoids: All high?,https://www.frontiersin.org/articles/10.3389/fphys.2022.1044575/full,Positive,,Meta-analysis,2022,,,Epilepsy; Pain; Pain - Chronic
2023083,Role of bone marrow adipocytes in bone metastasis development and progression: a systematic review,https://www.frontiersin.org/articles/10.3389/fendo.2023.1207416/full,Negative,,Meta-analysis,2023,Fatty Acid-Binding Protein (FABP),Nervous System; Skeletal System,Cancer - Bone; Cancer - Metastatic; Cancer; Oxidative Stress
2023084,Efficacy and safety of cannabidiol for the treatment of canine osteoarthritis: a systematic review and meta-analysis of animal intervention studies,https://www.frontiersin.org/articles/10.3389/fvets.2023.1248417/full,Positive,,Meta-analysis,2023,,Skeletal System,Arthritis; Pain; Pain - Chronic; Quality of Life
2023085,Associations of the P300 Event-Related Potentials and Self-Reported Craving in Substance Use Disorders: A Systematic Review,https://karger.com/ear/article/doi/10.1159/000533147/864332/Associations-of-the-P300-Event-Related-Potentials,Inconclusive,,Meta-analysis,2023,,Mental/Emotional System; Nervous System,Addiction; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid
2015035,Tetrahydrocannabinol in Behavioral Disturbances in Dementia: A Crossover Randomized Controlled Trial,https://pubmed.ncbi.nlm.nih.gov/26560511/,Inconclusive,,Double Blind Clinical Trial,2015,Tetrahydrocannabinol (THC),Mental/Emotional System,Behavioral Disorders; Dementia; Alzheimer's Disease
2018028,Biological correlates of self-reported new and continued abstinence in cannabis cessation treatment clinical trials,https://www.sciencedirect.com/science/article/abs/pii/S037687161830214X?via%3Dihub#preview-section-snippets,Positive,,Meta-analysis,2018,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2018029,Influence of tiagabine maintenance on cannabis effects and related behaviors in daily cannabis users,https://pubmed.ncbi.nlm.nih.gov/29863387/,Negative,,Double Blind Clinical Trial,2018,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2020060,"A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065230/,Inconclusive,,Clinical Trial,2020,,Cardiovascular System; Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2020061,Adult attention-deficit hyperactivity disorder and clinical correlates of delayed sleep phase disorder,https://www.sciencedirect.com/science/article/abs/pii/S0165178119324564?via%3Dihub,Negative,,Clinical Trial,2020,,Mental/Emotional System; Nervous System,ADD and ADHD; Insomnia and Sleep Disorders; Behavioral Disorders
2023086,Neuronal Cannabinoid CB1 Receptors Suppress the Growth of Melanoma Brain Metastases by Inhibiting Glutamatergic Signalling,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177062/,Positive,,Meta-analysis,2023,,Integumentary System; Nervous System,Cancer - Melanoma; Cancer - Metastatic; Cancer
2021087,Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial,https://pubmed.ncbi.nlm.nih.gov/34075644/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction - Opioid; Addiction; Addiction - Cannabis; Addiction - Nicotine; Anxiety; Depression
2021088,Effectiveness of attentional bias modification training as add-on to regular treatment in alcohol and cannabis use disorder: A multicenter randomized control trial,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0252494#sec028,Inconclusive,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction; Cannabis Adverse Effects
2022057,Mindfulness-based relapse prevention for cannabis regular users: Preliminary outcomes of a randomized clinical trial,https://www.sciencedirect.com/science/article/abs/pii/S0013700621001159?via%3Dihub#preview-section-snippets,Positive,,Clinical Trial,2022,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2021089,Effects of a cannabis use disorder text message-delivered treatment on young adult alcohol misuse: Differential effects by gender,https://www.jsatjournal.com/article/S0740-5472(21)00192-6/fulltext,Inconclusive,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2021090,Experimentally exploring the potential behavioral effects of personalized genetic information about marijuana and schizophrenia risk,https://www.sciencedirect.com/science/article/abs/pii/S0022395621003368?via%3Dihub#preview-section-snippets,Positive,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Behavioral Disorders; Addiction; Psychosis; Schizophrenia
2021091,Parent SMART (Substance Misuse in Adolescents in Residential Treatment): Pilot randomized trial of a technology-assisted parenting intervention,https://www.jsatjournal.com/article/S0740-5472(21)00183-5/fulltext#secst0030,Positive,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction; Addiction - Alcohol; Addiction - Cannabis
2021092,A pilot randomized clinical trial of Brief Behavioral Treatment for Insomnia to reduce problematic cannabis use among trauma-exposed young adults,https://www.jsatjournal.com/article/S0740-5472(21)00263-4/fulltext,Positive,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Insomnia and Sleep Disorders; PTSD
2023087,Cannabidiol as an Adjunctive Treatment for Acute Bipolar Depression: A Pilot Study,https://pubmed.ncbi.nlm.nih.gov/37920963/,Positive,,Double Blind Clinical Trial,2023,,Mental/Emotional System; Nervous System,Depression
2021093,The Partners for Change Outcome Management System in the psychotherapeutic treatment of cannabis use: a pilot effectiveness randomized clinical trial,https://pubmed.ncbi.nlm.nih.gov/34154520/,Inconclusive,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2021094,Predictors and moderators of marijuana and heavy alcohol use outcomes in adolescents treated for co-occurring substance use and psychiatric disorders in a randomized controlled trial,https://www.jsatjournal.com/article/S0740-5472(21)00262-2/fulltext#secst0055,Negative,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction; Psychosis
2021095,A Mobile Phone-Based Life-Skills Training Program for Substance Use Prevention Among Adolescents: Cluster-Randomized Controlled Trial,https://mhealth.jmir.org/2021/7/e26951,Positive,,Double Blind Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine
2023088,Cannabidiol as an Alternative Analgesic for Acute Dental Pain,https://journals.sagepub.com/doi/full/10.1177/00220345231200814?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org,Positive,,Double Blind Clinical Trial,2023,Pharma CBD,Digestive System; Nervous System,Pain; Pain - Acute; Pain - Dental - Acute; Cavities; Periodontal Disease
2021096,"Race, psychosocial characteristics, and treatment outcomes among individuals undergoing treatment for cannabis use disorder: A latent profile analysis based on preferred method of using cannabis",https://www.jsatjournal.com/article/S0740-5472(21)00287-7/fulltext,Negative,,Clinical Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2021097,Be under your own influence: Effectiveness of a Culturally-Adapted drug prevention campaign targeting Reservation-Dwelling American Indian youth,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380716/,Positive,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction; Addiction - Cannabis
2022058,Engaging the Endocannabinoid System in Neuroendocrine Neoplasms (NENs) potentiates treatment outcomes and null drug resistance,https://www.endocrine-abstracts.org/ea/0081/ea0081oc14.6,Positive,,Laboratory Study,2022,,Endocrine System,Cancer - Neuroendocrine
2019032,Gastrointestinal Adverse Events of Cannabinoid 1 Receptor Inverse Agonists suggest their Potential Use in Irritable Bowel Syndrome with Constipation: A Systematic Review and Meta-Analysis,https://pubmed.ncbi.nlm.nih.gov/31826058/,Negative,,Meta-analysis,2019,Synthetic Cannabinoid (unspecified),Digestive System; Mental/Emotional System,Cannabis Adverse Effects; Constipation; Irritable Bowel Syndrome; Diarrhea; Pain
2012015,Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease,https://pubmed.ncbi.nlm.nih.gov/22513921/,Inconclusive,,Clinical Meta-analysis,2012,Tetrahydrocannabinol (THC),Nervous System,Amyotrophic Lateral Sclerosis (ALS); Pain; Neurodegenerative Issues
2017014,Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease,https://pubmed.ncbi.nlm.nih.gov/28072907/,Inconclusive,,Meta-analysis,2017,Tetrahydrocannabinol (THC),,Amyotrophic Lateral Sclerosis (ALS); Menstrual Disorders; Pain; Neurodegenerative Issues
2015036,Cannabinoids in experimental stroke: a systematic review and meta-analysis,https://journals.sagepub.com/doi/10.1038/jcbfm.2014.218,Positive,,Animal Study,2015,Tetrahydrocannabinol (THC); Abnormal Cannabidiol (Abn-CBD); Anandamide (AEA); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Palmitoylethanolamide (PEA); Pharma THC:CBD; SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Nervous System,Stroke
2009029,Cannabinoids for the treatment of dementia,https://pubmed.ncbi.nlm.nih.gov/19370677/,Inconclusive,,Clinical Meta-analysis,2009,,Nervous System,Dementia; Neurodegenerative Issues
2017015,A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia,https://www.sciencedirect.com/science/article/abs/pii/S0149763416304390?via%3Dihub,Positive,,Meta-analysis,2017,,Mental/Emotional System,Cognitive Dysfunction; Psychosis; Schizophrenia; Bacterial Meningitis; Alzheimer's Disease; Inflammation; Neurodegenerative Issues; Sepsis; Stroke
2019033,Beyond stimulants: a systematic review of randomised controlled trials assessing novel compounds for ADHD,https://www.tandfonline.com/doi/abs/10.1080/14737175.2019.1628640,Positive,,Clinical Meta-analysis,2019,Pharma THC:CBD,Mental/Emotional System,ADD and ADHD; Addiction - Stimulant; Addiction
2019034,"The effects of oleoylethanolamide, an endogenous PPAR-α agonist, on risk factors for NAFLD: A systematic review",https://pubmed.ncbi.nlm.nih.gov/31111657/,Positive,,Meta-analysis,2019,Oleoylethanolamide (OEA),Digestive System,Fatty Liver Disease; Fibrosis - Liver (Cirrhosis)
2022059,Cannabis-Based Medicinal Products in the Management of Emotionally Unstable Personality Disorder (EUPD): A Narrative Review and Case Series,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688780/,Positive,,Meta-analysis,2022,Tetrahydrocannabinol (THC),Mental/Emotional System,Emotionally Unstable Personality Disorder (EUPD)
2023089,"Pentadecanoic Acid (C15:0), an Essential Fatty Acid, Shares Clinically Relevant Cell-Based Activities with Leading Longevity-Enhancing Compounds",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649853/,Positive,,Laboratory Study,2023,Pentadecanoic acid (C15:0); Pentadecanoylcarnitine (PDC),Integumentary System,Longevity
2023090,"Rabies: Presentation, case management and therapy",https://pubmed.ncbi.nlm.nih.gov/33812240/,Positive,,Meta-analysis,2023,Endocannabinoid (unspecified),Nervous System,Rabies
2019035,Evidence for the involvement of opioid and cannabinoid systems in the peripheral antinociception mediated by resveratrol,https://pubmed.ncbi.nlm.nih.gov/30763598/,Positive,,Animal Study,2019,Endocannabinoid (unspecified); Resveratrol,,Pain; Pain - Neuropathy - Peripheral
2023091,The endocannabinoid system and NGF are involved in the mechanism of action of resveratrol: a multi-target nutraceutical with therapeutic potential in neuropsychiatric disorders,https://pubmed.ncbi.nlm.nih.gov/26780936/,Positive,,Animal Study,2023,Resveratrol,Mental/Emotional System; Nervous System,Depression
2020062,Resveratrol attenuates high-fat diet-induced non-alcoholic steatohepatitis by maintaining gut barrier integrity and inhibiting gut inflammation through regulation of the endocannabinoid system,https://pubmed.ncbi.nlm.nih.gov/31189495/,Positive,,Animal Study,2020,Resveratrol,Digestive System,IBD - Inflammatory Bowel Disease; Fatty Liver Disease; IBD - Crohn's Disease; IBD - Ulcerative Colitis; Inflammation
2018030,Preventive Effects of Resveratrol on Endocannabinoid System and Synaptic Protein Modifications in Rat Cerebral Cortex Challenged by Bilateral Common Carotid Artery Occlusion and Reperfusion,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855648/,Positive,,Animal Study,2018,Resveratrol,Cardiovascular System,Cardiovascular Diseases (CVD); Reperfusion Injury; Stroke
2020063,"Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) for chronic insomnia disorder ('CANSLEEP' trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239553/,Negative,,Double Blind Clinical Trial,2020,,Nervous System,Insomnia and Sleep Disorders
2013009,Two novel mutations in ABHD12: expansion of the mutation spectrum in PHARC and assessment of their functional effects.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855015/,Negative,,Meta-analysis,2013,Endocannabinoid (unspecified),Nervous System,Neurodegenerative Issues; Cataract; Hearing Loss; Pain; Pain - Neuropathy - Inflammatory Polyneuropathy; Retinal Disorders
2016027,Functional validation of ABHD12 mutations in the neurodegenerative disease PHARC.,https://pubmed.ncbi.nlm.nih.gov/27890673/,Negative,,Animal Study,2016,,Nervous System,Neurodegenerative Issues; Cataract; Hearing Loss; Pain; Pain - Neuropathy - Inflammatory Polyneuropathy; Retinal Disorders
2018031,Ischaemic cardiomyopathy and embolic stroke in a young adult with suspected synthetic cannabinoid use.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040562/,Negative,,Meta-analysis,2018,Synthetic Cannabinoid (unspecified),Cardiovascular System; Nervous System,Cardiac Toxicity; Cardiovascular Diseases (CVD); Poisoning by Synthetic Cannabis; Stroke
2022060,Influence of personality on acute smoked cannabis effects on simulated driving,https://pubmed.ncbi.nlm.nih.gov/34291988/,Negative,,Clinical Trial,2022,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Behavioral Disorders
2021098,"Effects of topiramate on the association between affect, cannabis craving, and cannabis use in the daily life of youth during a randomized clinical trial",https://pubmed.ncbi.nlm.nih.gov/34331080/,Positive,,Double Blind Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2021099,Engagement patterns with a digital therapeutic for substance use disorders: Correlations with abstinence outcomes,https://www.jsatjournal.com/article/S0740-5472(21)00311-1/fulltext,Positive,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction; Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Stimulant
2022061,Adaptive Treatment for Youth With Substance Use and Depression: Early Depression Response and Short-term Outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818057/,Positive,,Clinical Trial,2022,,Mental/Emotional System; Nervous System,Addiction; Depression; Addiction - Alcohol; Addiction - Cannabis
2021100,Orally administered cannabidiol does not produce false-positive tests for Δ9 -tetrahydrocannabinol on the Securetec DrugWipe® 5S or Dräger DrugTest® 5000,https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/dta.3153,Inconclusive,,Double Blind Clinical Trial,2021,Cannabigerol (CBG); Cannabinol (CBN),,Cannabis Adverse Effects
2021101,"Influence of package colour, branding and health warnings on appeal and perceived harm of cannabis products among respondents in Canada and the US",https://www.sciencedirect.com/science/article/abs/pii/S0091743521003571?via%3Dihub#preview-section-snippets,Negative,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2021102,Moderator effects in a randomized controlled trial of the Common Elements Treatment Approach (CETA) for intimate partner violence and hazardous alcohol use in Zambia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808821/,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction; Addiction; Domestic Abuse; Addiction - Cannabis; Depression; HIV/AIDS; PTSD
2021103,A randomized controlled trial of a therapeutic relational agent for reducing substance misuse during the COVID-19 pandemic,https://www.sciencedirect.com/science/article/pii/S0376871621004816?via%3Dihub#sec0075,Positive,,Clinical Trial,2021,,Respiratory System,COVID-19; Addiction - Alcohol; Addiction - Cannabis; Addiction; Anxiety; Depression
2021104,"VOICES: An efficacious trauma-informed, gender-responsive cannabis use intervention for justice and school-referred girls with lifetime substance use history",https://www.sciencedirect.com/science/article/abs/pii/S0376871621004294?via%3Dihub,Positive,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Addiction - Alcohol; HIV/AIDS; PTSD
2021105,Varenicline as a treatment for cannabis use disorder: A placebo-controlled pilot trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665036/,Positive,,Double Blind Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Addiction - Alcohol; Anxiety; Depression
2022062,Longitudinal study of impact of medication for opioid use disorder on Hamilton Depression Rating Scale,https://www.sciencedirect.com/science/article/abs/pii/S0165032721010922?via%3Dihub#preview-section-snippets,Negative,,Clinical Meta-analysis,2022,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction; Depression; Addiction - Cannabis; Addiction - Cocaine; Addiction - Stimulant; Anxiety
2023092,Financial incentives for smoking cessation in pregnancy: multicentre randomised controlled trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634365/,Positive,,Clinical Trial,2023,,Mental/Emotional System; Reproductive System,Addiction - Nicotine; Addiction; Addiction; Pregnancy; Addiction - Alcohol; Addiction - Cannabis; Cannabis Adverse Effects
2022063,"Sex differences in acute cannabis effects revisited: Results from two randomized, controlled trials",https://onlinelibrary.wiley.com/doi/10.1111/adb.13125,Inconclusive,,Clinical Meta-analysis,2022,,,Cannabis Adverse Effects
2023093,Assessing changes in sleep across four weeks among adolescents randomized to incentivized cannabis abstinence,https://www.sciencedirect.com/science/article/abs/pii/S0376871623012279?via%3Dihub#preview-section-snippets,Negative,,Clinical Trial,2023,,Mental/Emotional System,Addiction - Cannabis; Addiction; Insomnia and Sleep Disorders
2020064,Parsing impulsivity in individuals with anxiety and depression who use Cannabis,https://www.sciencedirect.com/science/article/abs/pii/S0376871620304543?via%3Dihub,Negative,,Clinical Trial,2020,,Mental/Emotional System; Nervous System,Anxiety; Cannabis Adverse Effects; Depression
2021106,"Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosis",https://www.cysticfibrosisjournal.com/article/S1569-1993(20)30873-0/fulltext#seccesectitle0015,Positive,,Double Blind Clinical Trial,2021,Endocannabinoid (unspecified),,Inflammation
2021107,The concomitant use of cannabis and cocaine coexists with increased LPS levels and systemic inflammation in male drug users,https://www.sciencedirect.com/science/article/abs/pii/S1043466621000521?via%3Dihub#preview-section-snippets,Negative,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction - Cocaine; Addiction; Inflammation; Oxidative Stress
2021108,Correlates of High HIV Viral Load and Antiretroviral Therapy Adherence Among Viremic Youth in the United States Enrolled in an Adherence Improvement Intervention,https://pubmed.ncbi.nlm.nih.gov/33960843/,Negative,,Clinical Trial,2021,,Immune System,HIV/AIDS; Addiction - Cannabis; Addiction; Depression
2022064,Naloxone Co-Dispensing with Opioids: a Cluster Randomized Pragmatic Trial,https://link.springer.com/article/10.1007/s11606-021-07356-6,Positive,,Clinical Trial,2022,,,Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine; Addiction - Opioid; Addiction
2022065,Identification of ∆9-tetrahydrocannabinol (THC) impairment using functional brain imaging,https://www.nature.com/articles/s41386-021-01259-0#Sec2,Negative,,Double Blind Clinical Trial,2022,Pharma THC,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cognitive Dysfunction
2022066,Targeting maladaptive reactivity to negative affect in emerging adults with cannabis use disorder: A preliminary test and proof of concept,https://www.sciencedirect.com/science/article/abs/pii/S0005796722000031?via%3Dihub,Positive,,Clinical Trial,2022,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2022067,Driving Performance and Cannabis Users' Perception of Safety: A Randomized Clinical Trial,https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2788264,Negative,,Double Blind Clinical Trial,2022,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2022068,Sexually Transmitted Infection Testing After Brief Intervention for Risk Behaviors in School-Based Health Centers,https://pubmed.ncbi.nlm.nih.gov/35078735/,Positive,,Meta-analysis,2022,,Mental/Emotional System,Addiction; Addiction; Addiction - Alcohol; Addiction - Cannabis
2022069,Responsiveness to mHealth Intervention for Cannabis Use in Young Adults Predicts Improved Outcomes,https://pubmed.ncbi.nlm.nih.gov/35080713/,Positive,,Clinical Trial,2022,,Mental/Emotional System,Addiction - Cannabis; Addiction
2022070,Delta-9-tetrahydrocannabinol reduces willingness to exert effort in women,https://link.springer.com/article/10.1007/s00213-021-06032-1#Sec17,Negative,,Double Blind Clinical Trial,2022,Tetrahydrocannabinol (THC),Mental/Emotional System,Behavioral Disorders
2022071,Impact of a computerized distress intolerance intervention on electrocortical reactivity to cannabis and threat cues: A randomized controlled trial,https://pubmed.ncbi.nlm.nih.gov/35129994/,Inconclusive,,Clinical Trial,2022,,Mental/Emotional System,Cannabis Adverse Effects; Addiction - Cannabis; Addiction
2022072,A social media intervention for cannabis use among emerging adults: Randomized controlled trial,https://www.sciencedirect.com/science/article/abs/pii/S0376871622000825?via%3Dihub,Positive,,Clinical Trial,2022,,Mental/Emotional System,Addiction - Cannabis; Addiction
2022073,Effectiveness of the Strengthening Families Programme in the UK at preventing substance misuse in 10-14 year-olds: a pragmatic randomised controlled trial,https://pubmed.ncbi.nlm.nih.gov/35190414/,Inconclusive,,Clinical Trial,2022,,Mental/Emotional System,Addiction; Addiction; Addiction - Alcohol; Addiction - Cannabis; Cannabis Adverse Effects
2022074,Central stress response among deprived and continuing marijuana users and nonusers,https://pubmed.ncbi.nlm.nih.gov/35201806/,Inconclusive,,Clinical Trial,2022,,Mental/Emotional System,
2022075,The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD,https://www.sciencedirect.com/science/article/pii/S037687162200093X?via%3Dihub#sec0055,Positive,,Double Blind Clinical Trial,2022,,Mental/Emotional System,Addiction - Alcohol; Addiction; Addiction; MDMA Adverse Effects; PTSD; Addiction - Cannabis; Cannabis Adverse Effects
2022076,A systematic review of factors associated with illegal drug driving,https://www.sciencedirect.com/science/article/abs/pii/S0001457522000100?via%3Dihub,Negative,,Meta-analysis,2022,,,Cannabis Adverse Effects
2022077,A systematic review of the effects of cannabis on cognition in people with multiple sclerosis,https://pubmed.ncbi.nlm.nih.gov/35158449/,Inconclusive,,Meta-analysis,2022,,,Multiple Sclerosis; Cognitive Dysfunction
2022078,Latent Classes of Substance Use in Young Adults - A Systematic Review,https://pubmed.ncbi.nlm.nih.gov/35188870/,Negative,,Meta-analysis,2022,,Mental/Emotional System,Addiction; Addiction; Addiction - Alcohol; Addiction - Cannabis
2022079,Diagnostic significance of heart-type fatty acid-binding protein as a potential biomarker to predict the mortality rate of patients with sepsis: a systematic review and meta-analysis,https://pubmed.ncbi.nlm.nih.gov/35196937/,Positive,,Meta-analysis,2022,Fatty Acid-Binding Protein (FABP),Immune System,Sepsis
2022080,Biomarkers for the early detection of pressure injury: A systematic review and meta-analysis,https://www.sciencedirect.com/science/article/pii/S0965206X22000250?via%3Dihub#sec3,Positive,,Meta-analysis,2022,Fatty Acid-Binding Protein (FABP),Immune System; Integumentary System; Nervous System,Wound Healing; Inflammation
2022081,Neuromodulation to Treat Substance Use Disorders in People With Schizophrenia and Other Psychoses: A Systematic Review,https://www.frontiersin.org/articles/10.3389/fpsyt.2022.793938/full,Positive,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Addiction; Addiction; Psychosis; Schizophrenia; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; MDMA Adverse Effects
2022082,A Systematic Review and Narrative Synthesis of the Evolution of Adolescent and Young Adult Cannabis Consumption Before and After Legalization,https://pubmed.ncbi.nlm.nih.gov/35246363/,Negative,,Meta-analysis,2022,,,Cannabis Adverse Effects
2022083,Post-Harvest Operations to Generate High-Quality Medicinal Cannabis Products: A Systemic Review,https://www.mdpi.com/1420-3049/27/5/1719,Inconclusive,,Meta-analysis,2022,Cannabichromene (CBC); Cannabigerol (CBG); Cannabinol (CBN); Delta-8-THC; Tetrahydrocannabinolic Acid (THC-a),,
2022084,Gender differences in the association between environment and psychosis,https://www.sciencedirect.com/science/article/pii/S0920996422001177?via%3Dihub#s0025,Negative,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Psychosis; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant; Addiction; Anxiety; Bipolar Disorder; Cannabis Adverse Effects; Schizophrenia
2023094,Tai Chi exercise reduces circulating levels of inflammatory oxylipins in postmenopausal women with knee osteoarthritis: results from a pilot study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466388/,Positive,,Clinical Trial,2023,Omega-3; Other Related Compounds,Skeletal System,Arthritis
2022085,Cannabis and orofacial pain: a systematic review,https://pubmed.ncbi.nlm.nih.gov/35305839/,Positive,,Meta-analysis,2022,Synthetic Cannabinoid (unspecified),Nervous System,Pain; Pain; Inflammation; Pain - Chronic; Pain - Neuropathy - Peripheral; Poisoning by Synthetic Cannabis
2022086,Road traffic injuries and substance use in Latin America: A systematic review,https://pubmed.ncbi.nlm.nih.gov/35333682/,Negative,,Meta-analysis,2022,,,Addiction - Alcohol; Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2022087,Pharmacological treatment of tremor in multiple sclerosis; a systematic review,https://pubmed.ncbi.nlm.nih.gov/35339007/,Inconclusive,,Clinical Meta-analysis,2022,,Nervous System,Multiple Sclerosis; Neurodegenerative Issues
2022088,Dopaminergic alterations in populations at increased risk for psychosis: A systematic review of imaging findings,https://www.sciencedirect.com/science/article/pii/S030100822200051X?via%3Dihub#sec0010,Positive,,Clinical Meta-analysis,2022,,Mental/Emotional System; Nervous System,Psychosis
2022089,"NPS detection in prison: A systematic literature review of use, drug form, and analytical approaches",https://pubmed.ncbi.nlm.nih.gov/35355411/,Negative,,Meta-analysis,2022,5F-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Opioid; Addiction - Stimulant; Addiction; Cannabis Adverse Effects
2022090,Comparative Efficacy and Safety of 11 Drugs as Therapies for Adults With Neuropathic Pain After Spinal Cord Injury: A Bayesian Network Analysis Based on 20 Randomized Controlled Trials,https://www.frontiersin.org/articles/10.3389/fneur.2022.818522/full,Inconclusive,,Clinical Meta-analysis,2022,,Skeletal System,Pain; Spinal Cord Injuries; Insomnia and Sleep Disorders; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral
2022091,Movement Disorders Secondary to Novel Antiseizure Medications in Pediatric Populations: A Systematic Review and Meta-analysis of Risk,https://journals.sagepub.com/doi/10.1177/08830738221089742,Inconclusive,,Clinical Meta-analysis,2022,Pharma CBD,,Epilepsy; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut
2022092,Pregnant People's Perspectives On Cannabis Use During Pregnancy: A Systematic Review and Integrative Mixed-Methods Research Synthesis,https://onlinelibrary.wiley.com/doi/10.1111/jmwh.13363,Positive,,Meta-analysis,2022,,Reproductive System,Pregnancy; Addiction; Anxiety; Arthritis; Bipolar Disorder; Cannabis Adverse Effects; Insomnia and Sleep Disorders; Pain; Nausea and Vomiting; Pain - Chronic; PTSD
2022093,Validity of self-report measures of cannabis use compared to biological samples among women of reproductive age: a scoping review,https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-022-04677-0#Sec23,Positive,,Meta-analysis,2022,,Mental/Emotional System,Cannabis Adverse Effects; Addiction - Cannabis; Addiction; Pregnancy
2022094,Association between cannabis use and suicidal behavior: A systematic review of cohort studies,https://www.sciencedirect.com/science/article/abs/pii/S0165178122001652?via%3Dihub#preview-section-snippets,Inconclusive,,Meta-analysis,2022,,Mental/Emotional System,Behavioral Disorders; Suicide Attempt; Cardiac Arrhythmias; Cardiovascular Diseases (CVD)
2022095,"CB1R, CB2R and TRPV1 expression and modulation in in vivo, animal glaucoma models: A systematic review",https://www.sciencedirect.com/science/article/pii/S0753332222003705?via%3Dihub#sec0070,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified),,Glaucoma; Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2022096,Global population attributable fraction of potentially modifiable risk factors for mental disorders: a meta-umbrella systematic review,https://www.nature.com/articles/s41380-022-01586-8#Sec6,Positive,,Clinical Meta-analysis,2022,,,Addiction - Cannabis; Addiction - Nicotine; Addiction - Opioid; Addiction; Alzheimer's Disease; Anxiety; Depression; Psychosis; Schizophrenia
2022097,Common and distinguishing genetic factors for substance use behavior and disorder: an integrated analysis of genomic and transcriptomic studies from both human and animal studies,https://pubmed.ncbi.nlm.nih.gov/35491750/,Positive,,Clinical Meta-analysis,2022,,Mental/Emotional System,Addiction; Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; MDMA Adverse Effects
2022098,Safety and efficacy of a digital therapeutic for substance use disorder: Secondary analysis of data from a NIDA clinical trials network study,https://journals.sagepub.com/doi/10.1080/08897077.2022.2060425,Positive,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Addiction; Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Stimulant
2022099,"Pharmacokinetic Profile of ∆9-Tetrahydrocannabinol, Cannabidiol and Metabolites in Blood following Vaporization and Oral Ingestion of Cannabidiol Products",https://academic.oup.com/jat/article/46/6/583/6529814?login=false,Inconclusive,,Double Blind Clinical Trial,2022,Pharma CBD,,
2022100,"Separate and combined effects of alcohol and cannabis on mood, subjective experience, cognition and psychomotor performance: A randomized trial",https://www.sciencedirect.com/science/article/abs/pii/S0278584622000628?via%3Dihub#preview-section-snippets,Negative,,Double Blind Clinical Trial,2022,,Nervous System,Cognitive Dysfunction; Behavioral Disorders; Anxiety; Cannabis Adverse Effects
2022101,"Cannabidiol and Cannabidiol Metabolites: Pharmacokinetics, Interaction with Food, and Influence on Liver Function",https://www.mdpi.com/2072-6643/14/10/2152,Inconclusive,,Clinical Trial,2022,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2022102,Examining the influence of rurality on frequency of cannabis use and severity of consequences as moderated by age and gender,https://www.sciencedirect.com/science/article/pii/S0306460322001514?via%3Dihub#s0035,Negative,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2022103,Intergenerational effects of the Fast Track intervention on the home environment: A randomized control trial,https://pubmed.ncbi.nlm.nih.gov/35705512/,Negative,,Clinical Trial,2022,,,Cannabis Adverse Effects; Domestic Abuse
2022104,Correlates of high phosphatidylethanol (PEth) levels and their concordance with self-reported heavy alcohol consumption among men who have sex with men who binge drink alcohol,https://pubmed.ncbi.nlm.nih.gov/35722862/,Negative,,Clinical Trial,2022,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction
2022105,"The Impact of Juvenile Drug Treatment Courts on Substance Use, Mental Health, and Recidivism: Results from a Multisite Experimental Evaluation",https://link.springer.com/article/10.1007/s11414-022-09805-4#Sec16,Positive,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Addiction; Addiction - Cannabis
2022106,Cognitive Behavioral Therapy Program for Cannabis Use Cessation in First-Episode Psychosis Patients: A 1-Year Randomized Controlled Trial,https://www.mdpi.com/1660-4601/19/12/7325,Positive,,Clinical Trial,2022,,Mental/Emotional System; Nervous System,Psychosis; Cannabis Adverse Effects
2022107,A randomized controlled trial of social media interventions for risky drinking among adolescents and emerging adults,https://pubmed.ncbi.nlm.nih.gov/35759874/,Inconclusive,,Clinical Trial,2022,,Mental/Emotional System,Addiction - Alcohol; Addiction; Addiction; Addiction - Cannabis; Cannabis Adverse Effects
2022108,A Student Walks into Class … Vignettes to Identify Substance Use Disorder Models of Illness among College Students,https://pubmed.ncbi.nlm.nih.gov/35787230/,Negative,,Clinical Trial,2022,,Mental/Emotional System,Addiction; Addiction; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant
2022109,"Adolescent Sibling Associations among Alcohol, Cannabis, and Sexual Risk Behavior: A Test of Interdependence",https://pubmed.ncbi.nlm.nih.gov/35791906/,Negative,,Meta-analysis,2022,,Mental/Emotional System,Addiction - Alcohol; Addiction - Cannabis; Addiction
2023095,Cannabis use does not increase actual creativity but biases evaluations of creativity,https://pubmed.ncbi.nlm.nih.gov/35901408/,Inconclusive,,Clinical Trial,2023,,,Cognitive Dysfunction
2023096,Relationship between patterns of cannabis use and functional and symptomatic trajectories in first-episode psychosis,https://pubmed.ncbi.nlm.nih.gov/35900474/,Negative,,Clinical Trial,2023,,Mental/Emotional System,Psychosis; Depression; Schizophrenia
2022110,"Buccally Absorbed Cannabidiol Shows Significantly Superior Pain Control and Improved Satisfaction Immediately After Arthroscopic Rotator Cuff Repair: A Placebo-Controlled, Double-Blinded, Randomized Trial",https://pubmed.ncbi.nlm.nih.gov/35905305/,Positive,,Double Blind Clinical Trial,2022,,,Pain
2022111,A randomized pilot trial of a mobile phone-based brief intervention with personalized feedback and interactive text messaging to reduce driving after cannabis use and riding with a cannabis impaired driver,https://pubmed.ncbi.nlm.nih.gov/36007434/,Positive,,Clinical Trial,2022,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2023097,"Long-term effects of a diet supplement containing Cannabis sativa oil and Boswellia serrata in dogs with osteoarthritis following physiotherapy treatments: a randomised, placebo-controlled and double-blind clinical trial",https://www.tandfonline.com/doi/abs/10.1080/14786419.2022.2119967,Positive,,Double Blind Clinical Trial,2023,,Skeletal System,Arthritis; Inflammation; Pain; Oxidative Stress; Pain - Chronic
2022112,Can Intersectoral Interventions Reduce Substance Use in Adolescence? Evidence From a Multicentre Randomized Controlled Study,https://www.ssph-journal.org/articles/10.3389/ijph.2022.1604677/full,Positive,,Clinical Trial,2022,,Mental/Emotional System; Nervous System,Addiction; Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine
2022113,"Effects of hemp seed alone and combined with aerobic exercise on metabolic parameters, oxidative stress, and neurotrophic factors in young sedentary men",https://pubmed.ncbi.nlm.nih.gov/36114824/,Positive,,Double Blind Clinical Trial,2022,Exercise,Endocrine System; Nervous System,Metabolic Syndrome; Oxidative Stress
2022114,Cost-Effectiveness of Motivational Interviewing to Reduce Alcohol and Cannabis Use Among Patients With Depression,https://pubmed.ncbi.nlm.nih.gov/36136436/,Positive,,Clinical Trial,2022,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction; Depression
2022115,Substance Use Among Youth During the COVID-19 Pandemic: a Systematic Review,https://link.springer.com/article/10.1007/s11920-022-01338-z#Sec18,Positive,,Meta-analysis,2022,,Respiratory System,COVID-19; Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine; Addiction
2022116,Effects of endocannabinoid system modulation on social behaviour: A systematic review of animal studies,https://www.sciencedirect.com/science/article/abs/pii/S0149763422001695?via%3Dihub#preview-section-snippets,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System; Nervous System,Behavioral Disorders
2023098,Poster 186: Cannabidiol for Post-Operative Pain Control after Arthroscopic Rotator Cuff Repair Demonstrates No Functional Deficits at 1-Year,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392481/,Positive,,Double Blind Clinical Trial,2023,Pharma CBD,,Pain; Pain - Acute
2022117,"Immigrants, refugees and cannabis use",https://pubmed.ncbi.nlm.nih.gov/35584015/,Inconclusive,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2022118,Cannabis induced psychosis: A systematic review on the role of genetic polymorphisms,https://www.sciencedirect.com/science/article/pii/S1043661822002031?via%3Dihub#sec0050,Negative,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Psychosis
2022119,Addiction and human male fertility: A systematic review and a critical appraisal,https://onlinelibrary.wiley.com/doi/10.1111/andr.13196,Negative,,Meta-analysis,2022,,Mental/Emotional System; Reproductive System,Addiction; Addiction; Infertility (Male); Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid
2022120,Impact of Antiseizure Medications on Appetite and Weight in Children,https://pubmed.ncbi.nlm.nih.gov/35596110/,Inconclusive,,Clinical Meta-analysis,2022,,Mental/Emotional System,Epilepsy; Loss of Appetite
2023099,Using recovery management checkups for primary care to improve linkage to alcohol and other drug use treatment: a randomized controlled trial three month findings,https://onlinelibrary.wiley.com/doi/10.1111/add.16064,Positive,,Clinical Trial,2023,,Mental/Emotional System,Addiction - Alcohol; Addiction; Addiction; Addiction - Cannabis; Addiction - Cocaine; Addiction - Opioid; Addiction - Stimulant; Cannabis Adverse Effects; MDMA Adverse Effects
2023100,Associations of Momentary Mindfulness With Affect and Cannabis Desire in a Trial of Cannabis Use Interventions With and Without Momentary Assessment,https://pubmed.ncbi.nlm.nih.gov/36272891/,Positive,,Clinical Trial,2023,,Mental/Emotional System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2022121,Controlled Trial Examining the Strength-Based Grit Wellbeing and Self-Regulation Program for Young People in Residential Settings for Substance Use,https://www.mdpi.com/1660-4601/19/21/13835,Positive,,Clinical Trial,2022,,Mental/Emotional System,Addiction; Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Stimulant; Anxiety; Depression; MDMA Adverse Effects
2023101,Social media interventions addressing physical activity among emerging adults who use cannabis: A pilot trial of feasibility and acceptability,https://www.sciencedirect.com/science/article/abs/pii/S0376871622004306?via%3Dihub#preview-section-snippets,Positive,,Clinical Trial,2023,Exercise,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2023102,Emerging Adult Perceptions of Cannabis Consumption Post-Legalization: Considering Age and Sex Differences,https://pubmed.ncbi.nlm.nih.gov/36476394/,Inconclusive,,Clinical Trial,2023,,,Addiction - Cannabis; Addiction
2022122,Efficacy of a Mobile App-Based Coaching Program for Addiction Prevention among Apprentices: A Cluster-Randomized Controlled Trial,https://www.mdpi.com/1660-4601/19/23/15730,Positive,,Clinical Trial,2022,,Mental/Emotional System,Addiction; Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine
2023103,Cross-substance primed and cue-induced craving among alcohol and cannabis co-users: An experimental psychopharmacology approach,https://pubmed.ncbi.nlm.nih.gov/36534416/,Negative,,Clinical Trial,2023,Tetrahydrocannabivarin (THCV),Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction
2023104,"Digital screening and brief intervention for illicit drug misuse in college students: A mixed methods, pilot, cluster, randomized trial from India",https://www.sciencedirect.com/science/article/abs/pii/S1876201822004300?via%3Dihub,Positive,,Clinical Trial,2023,,Mental/Emotional System; Nervous System,Addiction; Addiction; Addiction - Alcohol; Addiction - Cannabis
2023105,Gender differences in outcomes of early intervention services for first episode psychosis,https://pubmed.ncbi.nlm.nih.gov/36623822/,Inconclusive,,Clinical Trial,2023,,Mental/Emotional System; Nervous System,Psychosis; Behavioral Disorders; Bipolar Disorder; Quality of Life; Schizophrenia
2023106,Cannabis use and sleep quality in daily life: An electronic daily diary study of adults starting cannabis for health concerns,https://www.sciencedirect.com/science/article/abs/pii/S0376871622004975?via%3Dihub#preview-section-snippets,Positive,,Clinical Trial,2023,,Nervous System,Insomnia and Sleep Disorders; Depression; Pain
2023107,"Effects of an App-Based Intervention Program to Reduce Substance Use, Gambling, and Digital Media Use in Adolescents and Young Adults: A Multicenter, Cluster-Randomized Controlled Trial in Vocational Schools in Germany",https://www.mdpi.com/1660-4601/20/3/1970,Positive,,Clinical Trial,2023,,Mental/Emotional System; Nervous System,Addiction; Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine
2023108,"Induced negative affect's impact on self-reported cannabis use, expectancies, and problems",https://www.sciencedirect.com/science/article/abs/pii/S0306460323000473?via%3Dihub,Negative,,Clinical Trial,2023,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2023109,"Moderating the impact of the COVID-19 pandemic on children's and adolescents' substance use, digital media use, and mental health: A randomized positive psychology addiction prevention program",https://www.sciencedirect.com/science/article/pii/S0306460323000552?via%3Dihub#s0020,Positive,,Clinical Trial,2023,,Mental/Emotional System; Respiratory System,Addiction; COVID-19
2023110,"""Letting Go and Staying Connected"": Substance Use Outcomes from a Developmentally Targeted Intervention for Parents of College Students",https://link.springer.com/article/10.1007/s11121-023-01520-6#Sec11,Positive,,Clinical Trial,2023,,Mental/Emotional System,Addiction; Addiction; Addiction - Alcohol; Addiction - Cannabis
2023111,Cognitive behavioral therapy for insomnia to reduce cannabis use: Results from a pilot randomized controlled trial,https://www.sciencedirect.com/science/article/abs/pii/S037687162300073X?via%3Dihub#preview-section-snippets,Positive,,Clinical Trial,2023,,,Insomnia and Sleep Disorders; Addiction - Cannabis; Addiction
2023112,Comparing the Efficacy of Mindfulness-Based Relapse Prevention Versus Relapse Prevention for Alcohol Use Disorder: A Randomized Control Trial,https://pubmed.ncbi.nlm.nih.gov/36971735/,Positive,,Clinical Trial,2023,,Mental/Emotional System,Addiction - Alcohol; Addiction; Addiction; Addiction - Cannabis; Cannabis Adverse Effects
2023113,"Effectiveness of Raw, Natural Medical Cannabis Flower for Treating Insomnia under Naturalistic Conditions",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164964/,Positive,,Meta-analysis,2023,,,Insomnia and Sleep Disorders
2023114,"A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality",https://psycnet.apa.org/fulltext/2024-14146-001.html,Positive,,Double Blind Clinical Trial,2023,Cannabinol (CBN),,Insomnia and Sleep Disorders
2023115,Comparison of the influence of alcohol and cannabis on the dynamics of the accommodative response,https://pubmed.ncbi.nlm.nih.gov/36976357/,Inconclusive,,Clinical Trial,2023,,Mental/Emotional System,Addiction - Alcohol; Addiction - Cannabis; Addiction
2023116,Cannabis use for medical symptoms: Patterns over the first year of use,https://www.sciencedirect.com/science/article/abs/pii/S0306460323001144?via%3Dihub,Positive,,Meta-analysis,2023,,,Addiction - Cannabis; Addiction; Anxiety; Depression; Insomnia and Sleep Disorders; Pain
2023117,Long-Term RCT outcomes for adolescent alcohol and cannabis use within a predominantly Hispanic sample,https://pubmed.ncbi.nlm.nih.gov/37127932/,Positive,,Clinical Trial,2023,,Mental/Emotional System,Addiction - Alcohol; Addiction - Cannabis; Addiction
2023118,A guided digital intervention to reduce cannabis use: The ICan randomized controlled trial,https://onlinelibrary.wiley.com/doi/10.1111/add.16217,Positive,,Clinical Trial,2023,,Mental/Emotional System,Addiction - Cannabis; Addiction
2023119,"Measuring Readiness to Change Substance Use, Alcohol Use, and Cannabis Use: An Experimental Manipulation of Cognitive Effort",https://pubmed.ncbi.nlm.nih.gov/37139932/,Positive,,Clinical Trial,2023,,Mental/Emotional System,Addiction - Alcohol; Addiction - Cannabis; Addiction
2023120,Assessment of Screening Tools to Identify Substance Use Disorders Among Adolescents,https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2805055,Positive,,Meta-analysis,2023,,Mental/Emotional System; Nervous System,Addiction; Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine
2023121,Results of a pilot study examining the effect of positive psychology interventions on cannabis use and related consequences,https://www.sciencedirect.com/science/article/abs/pii/S1551714423001702?via%3Dihub,Positive,,Clinical Trial,2023,,Mental/Emotional System,Addiction - Cannabis; Addiction
2023122,"Does drug use affect the efficacy of amisulpride, aripiprazole and olanzapine in patients with schizophrenia spectrum disorders? Results from a pragmatic, randomised study",https://www.sciencedirect.com/science/article/pii/S0163834323000786?via%3Dihub#s0075,Inconclusive,,Double Blind Clinical Trial,2023,,Mental/Emotional System; Nervous System,Schizophrenia; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Cocaine; Addiction - Opioid; Addiction - Stimulant; Addiction; Psychosis
2023123,"Effects of hypnosis, mindfulness meditation, and education for chronic pain on substance use in veterans: A supplementary analysis of a randomized clinical trial",https://pubmed.ncbi.nlm.nih.gov/37289535/,Positive,,Clinical Trial,2023,,Mental/Emotional System; Nervous System,Addiction; Addiction; Pain; Pain - Chronic; Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine
2023124,"Intervention for marijuana using, court-involved non-incarcerated youth",https://www.sciencedirect.com/science/article/abs/pii/S2949875923001510?via%3Dihub,Inconclusive,,Clinical Trial,2023,,Mental/Emotional System; Nervous System,Addiction; Cannabis Adverse Effects
2023125,Bridging the gap between genetic epidemiological research and prevention: A randomized control trial of a novel personalized feedback program for alcohol and cannabis use,https://www.sciencedirect.com/science/article/abs/pii/S0376871623010566?via%3Dihub,Positive,,Clinical Trial,2023,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction
2023126,Keepin' It REAL-Mantente REAL in Mexico: Longitudinal Examination of Youth Drug Resistance Strategies and Substance Use Among Early Adolescents,https://pubmed.ncbi.nlm.nih.gov/37422739/,Positive,,Clinical Trial,2023,,Mental/Emotional System; Nervous System,Addiction; Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine
2023127,Young Adults' Perceptions of and Intentions to Use Nicotine and Cannabis Vaporizers in Response to e-Cigarette or Vaping-Associated Lung Injury Instagram Posts: Experimental Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540020/,Positive,,Clinical Trial,2023,,Respiratory System,Vaping injury (EVALI); Cannabis Adverse Effects
2022123,Correlation between oral fluid and blood THC concentration: A systematic review and discussion of policy implications,https://www.sciencedirect.com/science/article/pii/S0001457522001300?via%3Dihub#s0080,Negative,,Meta-analysis,2022,Tetrahydrocannabinol (THC),,
2022124,Dropout Rates in Psychosocial Interventions for People With Both Severe Mental Illness and Substance Misuse: A Systematic Review and Meta-Analysis,https://www.frontiersin.org/articles/10.3389/fpsyt.2022.842329/full,Positive,,Meta-analysis,2022,,Mental/Emotional System,Addiction; Psychosis; Schizophrenia
2022125,The antidepressant and anxiolytic effects of cannabinoids in chronic unpredictable stress: a preclinical systematic review and meta-analysis,https://www.nature.com/articles/s41398-022-01967-1#Sec2,Positive,,Meta-analysis,2022,,Mental/Emotional System,Anxiety; Depression
2022126,"Individual-, family- and school-based interventions to prevent multiple risk behaviours relating to alcohol, tobacco and drug use in young people aged 8-25 years: a systematic review and meta-analysis",https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-022-13072-5,Negative,,Meta-analysis,2022,,Mental/Emotional System,Addiction - Alcohol; Addiction - Nicotine; Addiction; Addiction; Addiction - Cannabis
2022127,A systematic review of substance use and substance use disorder research in Kenya,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0269340#sec016,Positive,,Meta-analysis,2022,,Mental/Emotional System,Addiction; Addiction; Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant; MDMA Adverse Effects
2022128,Regulating for Safety: Cannabidiol Dose in Food: A Review,https://www.sciencedirect.com/science/article/pii/S0362028X22056204?via%3Dihub#s0015,Negative,,Meta-analysis,2022,Cannabichromene (CBC); Cannabichromenic Acid (CBC-a); Cannabidiolic Acid (CBD-a); Cannabigerol (CBG); Cannabigerolic Acid (CBG-a); Cannabinol (CBN); Diet; Tetrahydrocannabinolic Acid (THC-a),,
2022129,Cannabis in Palliative Care: A Systematic Review of Current Evidence,https://pubmed.ncbi.nlm.nih.gov/35705116/,Inconclusive,,Meta-analysis,2022,,,Palliative Care; Cancer; Dementia; Epilepsy; HIV/AIDS; Insomnia and Sleep Disorders; Loss of Appetite; Nausea and Vomiting; Night Sweats and Excessive Sweating; Quality of Life
2022130,"Racial and ethnic differences in alcohol, cannabis, and illicit substance use treatment: a systematic review and narrative synthesis of studies done in the USA",https://pubmed.ncbi.nlm.nih.gov/35752192/,Positive,,Meta-analysis,2022,,Mental/Emotional System,Addiction - Alcohol; Addiction - Cannabis; Addiction; Addiction; Addiction - Cocaine; Addiction - Stimulant
2023128,Substance-related cross-commodity purchase tasks: A systematic review,https://pubmed.ncbi.nlm.nih.gov/35787100/,Negative,,Meta-analysis,2023,,Mental/Emotional System; Nervous System,Addiction; Addiction; Addiction - Cannabis; Addiction - Nicotine
2022131,Cannabis smoking increases the risk of suicide ideation and suicide attempt in young individuals of 11-21 years: A systematic review and meta-analysis,https://pubmed.ncbi.nlm.nih.gov/35810604/,Negative,,Meta-analysis,2022,,Mental/Emotional System,Cannabis Adverse Effects; Suicide Attempt
2022132,Kidney Damage and Stress Biomarkers for Early Identification of Drug-Induced Kidney Injury: A Systematic Review,https://pubmed.ncbi.nlm.nih.gov/35831683/,Positive,,Meta-analysis,2022,Fatty Acid-Binding Protein (FABP),Urinary System,Drug-Induced Nephropathy; Chronic Kidney Disease; Kidney Failure
2022133,"Brain morphology predictors of alcohol, tobacco, and cannabis use in adolescence: A systematic review",https://www.sciencedirect.com/science/article/pii/S000689932200244X?via%3Dihub#s0015,Negative,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine; Addiction; Behavioral Disorders; Cannabis Adverse Effects; Cognitive Dysfunction
2023129,A Systematic Review of Risk Factors and Consequences of Nyaope Usage: The Illicit Street Drug Containing HIV Antiretrovirals,https://link.springer.com/article/10.1007/s10461-022-03791-6,Negative,,Meta-analysis,2023,,Immune System,HIV/AIDS; Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine; Addiction
2022134,Nutritional Interventions to Improve Cachexia Outcomes in Cancer-A Systematic Review,https://www.mdpi.com/1648-9144/58/7/966,Inconclusive,,Clinical Meta-analysis,2022,Omega-3; Diet,Digestive System; Muscular System; Nervous System,Cachexia; Cancer; Anorexia
2022135,MicroRNA Regulation of the Environmental Impact on Adolescent Neurobehavioral Development: A Systematic Review,https://www.frontiersin.org/articles/10.3389/fncel.2022.956609/full,Negative,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Behavioral Disorders; Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant; Addiction; Cannabis Adverse Effects
2022136,United States Emergency Department Screening for Drug Use Among Assault-Injured Individuals: A Systematic Review,https://escholarship.org/uc/item/6kh7q5qg,Negative,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Domestic Abuse
2022137,#TurntTrending: a systematic review of substance use portrayals on social media platforms,https://onlinelibrary.wiley.com/doi/10.1111/add.16020,Negative,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Addiction; Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant; MDMA Adverse Effects
2022138,Behavioral effects on the offspring of rodent mothers exposed to Tetrahydrocannabinol (THC): A meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462465/,Inconclusive,,Clinical Meta-analysis,2022,Tetrahydrocannabinol (THC); WIN-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Behavioral Disorders; Anxiety; Cannabis Adverse Effects; Cognitive Dysfunction
2022139,Performance of urinary liver-type fatty acid-binding protein in diabetic nephropathy: A meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479543/,Positive,,Clinical Meta-analysis,2022,Fatty Acid-Binding Protein (FABP),Endocrine System; Urinary System,Diabetic Kidney Disease; Chronic Kidney Disease; Diabetes; Kidney Failure
2022140,Efficacy and safety of adjunctive antiseizure medications for dravet syndrome: A systematic review and network meta-analysis,https://www.frontiersin.org/articles/10.3389/fphar.2022.980937/full,Positive,,Clinical Meta-analysis,2022,,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy
2022141,Digital Help for Substance Users (SU): A Systematic Review,https://www.mdpi.com/1660-4601/19/18/11309,Inconclusive,,Clinical Meta-analysis,2022,,Mental/Emotional System; Nervous System,Addiction; Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant
2022142,A 2022 Systematic Review and Meta-Analysis of Enriched Therapeutic Diets and Nutraceuticals in Canine and Feline Osteoarthritis,https://www.mdpi.com/1422-0067/23/18/10384,Positive,,Meta-analysis,2022,Omega-3; Diet,Skeletal System,Arthritis; Pain
2022143,Neuropsychological functioning and suicidal behaviours in patients with first-episode psychosis: A systematic review,https://pubmed.ncbi.nlm.nih.gov/36153777/,Negative,,Meta-analysis,2022,,Mental/Emotional System,Psychosis; Addiction - Cannabis; Addiction; Anxiety; Cannabis Adverse Effects; Depression; Suicide Attempt
2022144,The Impact of Cannabis Decriminalization and Legalization on Road Safety Outcomes: A Systematic Review,https://pubmed.ncbi.nlm.nih.gov/36167602/,Negative,,Meta-analysis,2022,,Mental/Emotional System,Cannabis Adverse Effects; Cognitive Dysfunction
2022145,Effects of Cannabidiol on Appetite and Body Weight: A Systematic Review,https://link.springer.com/article/10.1007/s40261-022-01205-y#Sec7,Positive,,Meta-analysis,2022,Tetrahydrocannabinol (THC),Mental/Emotional System,Loss of Appetite; Anorexia; Anxiety; Diabetes; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Metabolic Syndrome; Obesity
2022146,Breastfeeding while on treatment with antiseizure medications: a systematic review from the ILAE Women Task Force,https://onlinelibrary.wiley.com/doi/10.1684/epd.2022.1492,Positive,,Clinical Meta-analysis,2022,,Reproductive System,Epilepsy; Pregnancy; Cannabis Adverse Effects
2023130,Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis,https://www.sciencedirect.com/science/article/pii/S0014488622002631?via%3Dihub#s0010,Positive,,Clinical Meta-analysis,2023,Pharma CBD,,Epilepsy; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut
2022147,Cannabidiol in clinical and preclinical anxiety research. A systematic review into concentration-effect relations using the IB-de-risk tool,https://journals.sagepub.com/doi/10.1177/02698811221124792,Inconclusive,,Meta-analysis,2022,,Mental/Emotional System,Anxiety
2022148,Variations of cannabis-related adverse mental health and addiction outcomes across adolescence and adulthood: A scoping review,https://www.frontiersin.org/articles/10.3389/fpsyt.2022.973988/full,Negative,,Meta-analysis,2022,,Mental/Emotional System,Addiction - Cannabis; Addiction; Addiction; Cannabis Adverse Effects; Addiction - Nicotine; Anxiety; Depression; Psychosis; Suicide Attempt
2022149,[Effects of cannabis use on attention and memory in adolescent population: a systematic review],https://pubmed.ncbi.nlm.nih.gov/36300331/,Negative,,Meta-analysis,2022,,Mental/Emotional System,Cannabis Adverse Effects; Cognitive Dysfunction; Addiction - Cannabis; Addiction - Nicotine; Addiction
2023131,Fenfluramine for Treating Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal,https://link.springer.com/article/10.1007/s40273-022-01209-8#Sec1,Positive,,Meta-analysis,2023,,,Epilepsy - Dravet Syndrome; Epilepsy; Quality of Life
2023132,"Systematic review of the efficacy, effectiveness, and cost-effectiveness of stepped-care interventions for the prevention and treatment of problematic substance use",https://www.jsatjournal.com/article/S0740-5472(22)00210-0/fulltext#secst0205,Positive,,Meta-analysis,2023,,Mental/Emotional System,Addiction; Addiction; Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Opioid; Addiction - Stimulant; MDMA Adverse Effects
2022150,Comparative accuracy of biomarkers for the prediction of hospital-acquired acute kidney injury: a systematic review and meta-analysis,https://ccforum.biomedcentral.com/articles/10.1186/s13054-022-04223-6#Sec18,Inconclusive,,Meta-analysis,2022,Fatty Acid-Binding Protein (FABP),Urinary System,Kidney Failure; Inflammation
2023133,Substance use and psychotic-like experiences in young people: a systematic review and meta-analysis,https://www.cambridge.org/core/journals/psychological-medicine/article/substance-use-and-psychoticlike-experiences-in-young-people-a-systematic-review-and-metaanalysis/92B6A688FA8268F3C1CB244EA6373F3B,Negative,,Meta-analysis,2023,,Mental/Emotional System,Addiction; Addiction; Psychosis; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Stimulant; Anxiety; Depression; Schizophrenia
2022151,Impact of cannabis use and its cessation on the dosage and the efficacy of antipsychotic drugs in in- and outpatients with schizophrenia taking medication: A systematic review and meta-analysis,https://www.sciencedirect.com/science/article/pii/S0022395622006367?via%3Dihub#sec2,Inconclusive,,Clinical Meta-analysis,2022,,Mental/Emotional System; Nervous System,Schizophrenia; Cannabis Adverse Effects; Psychosis
2022152,"Use of cannabidiol in the treatment of epilepsy: Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex",https://www.scielo.br/j/ramb/a/vh3QpdBkQfXVrdw7nT63bdd/?lang=en,Positive,,Clinical Meta-analysis,2022,Pharma CBD,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2022153,"A systematic review of the efficacy, effectiveness and cost-effectiveness of workplace-based interventions for the prevention and treatment of problematic substance use",https://www.frontiersin.org/articles/10.3389/fpubh.2022.1051119/full,Positive,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Addiction; Addiction; Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Opioid; Addiction - Stimulant
2023134,County-level predictors of US drug overdose mortality: A systematic review,https://www.sciencedirect.com/science/article/pii/S0376871622004513?via%3Dihub,Inconclusive,,Meta-analysis,2023,,Mental/Emotional System; Nervous System,Addiction; Addiction; Addiction - Opioid
2022154,Why Do Some People Become More Involved in Cannabis Use Than Others? A Systematic Narrative Review on Cannabis Use Transition Predictors,https://pubmed.ncbi.nlm.nih.gov/36484575/,Inconclusive,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2023135,Pharmacotherapy for Dravet Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials,https://link.springer.com/article/10.1007/s40265-023-01936-y#Sec9,Positive,,Clinical Meta-analysis,2023,Pharma CBD,,Epilepsy - Dravet Syndrome; Epilepsy
2023136,Early Administration of the Phytocannabinoid Cannabidivarin Prevents the Neurobehavioral Abnormalities Associated with the Fmr1-KO Mouse Model of Fragile X Syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416983/,Positive,,Animal Study,2023,Cannabidivarin (CBDV),Nervous System,Fragile X Syndrome
2023137,Impact of a brief distress intolerance intervention on acute stress modulation of response inhibition neurophysiology in cannabis use disorder,https://www.sciencedirect.com/science/article/abs/pii/S030646032300206X?via%3Dihub#preview-section-snippets,Positive,,Clinical Trial,2023,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2023138,A remote brief intervention plus social media messaging for cannabis use among emerging adults: A pilot randomized controlled trial in emergency department patients,https://www.sciencedirect.com/science/article/abs/pii/S0306460323002241?via%3Dihub,Positive,,Clinical Trial,2023,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Addiction - Cannabis; Addiction
2023139,Emerging adult perceptions of higher-risk cannabis consumption behaviours,https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-023-00860-4#Sec9,Inconclusive,,Meta-analysis,2023,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Addiction; Addiction - Alcohol; Addiction - Nicotine; Cannabis Adverse Effects; Psychosis
2022155,Effects of 28 days of cannabis abstinence on cognition in major depressive disorder: A pilot study,https://pubmed.ncbi.nlm.nih.gov/35690891/,Positive,,Clinical Trial,2022,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Depression; Cognitive Dysfunction
2023140,Self-report and urine drug screen concordance among women with co-occurring PTSD and substance use disorders participating in a clinical trial: Impact of drug type and participant characteristics,https://www.sciencedirect.com/science/article/abs/pii/S0376871623000078?via%3Dihub,Inconclusive,,Meta-analysis,2023,,Mental/Emotional System; Nervous System,Addiction; Addiction; PTSD; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Cocaine; Addiction - Opioid
2023141,Mental health and substance use screening in HIV primary care before and during the early COVID-19 pandemic,https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-023-09477-6#Sec9,Inconclusive,,Meta-analysis,2023,,Immune System; Mental/Emotional System; Nervous System; Respiratory System,Addiction; Addiction; COVID-19; HIV/AIDS; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Anxiety; Depression; Suicide Attempt
2023142,Amphetamine use and its associations with antiretroviral adherence and viral load among sexual minority men and transgender women living with HIV,https://pubmed.ncbi.nlm.nih.gov/37139536/,Negative,,Clinical Trial,2023,,Immune System; Mental/Emotional System,Addiction - Stimulant; Addiction; Addiction; HIV/AIDS; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine
2016028,Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper,https://pubmed.ncbi.nlm.nih.gov/27207462/,Positive,,Meta-analysis,2016,Pharma THC:CBD,Nervous System,Multiple Sclerosis
2017016,Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis,https://journals.lww.com/anesthesia-analgesia/fulltext/2017/11000/selective_cannabinoids_for_chronic_neuropathic.32.aspx,Positive,,Clinical Meta-analysis,2017,Pharma THC:CBD; Pharma THC,Nervous System,Pain; Pain; Pain - Chronic; Pain - Central Pain Syndrome; Pain - Neuropathy - Diabetic; Pain - Neuropathy - Drug-Ind. Polyneuropathy; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral
2022156,Dexmedetomidine in the treatment of toxicologic conditions: a systematic review and review of the toxicology investigators consortium database,https://pubmed.ncbi.nlm.nih.gov/36346349/,Inconclusive,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Addiction; Addiction; Addiction - Cannabis; Addiction - Opioid; Addiction - Stimulant
2017017,Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,https://pubmed.ncbi.nlm.nih.gov/28934780/,Positive,,Clinical Meta-analysis,2017,,Nervous System,Pain; Pain; Pain - Chronic; Pain - Neuropathy - Diabetic; Pain - Neuropathy - Drug-Ind. Polyneuropathy; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral
2023143,"A systematic review of brief, freely accessible, and valid self-report measures for substance use disorders and treatment",https://www.sciencedirect.com/science/article/abs/pii/S0376871622004665?via%3Dihub,Negative,,Meta-analysis,2023,,Mental/Emotional System,Addiction; Addiction; Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant
2022157,Effects of substance use disorder on oxidative and antioxidative stress markers: A systematic review and meta-analysis,https://onlinelibrary.wiley.com/doi/10.1111/adb.13254,Negative,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Addiction; Oxidative Stress; Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine; Addiction - Opioid; Inflammation
2023144,How are young people’s mental health related to their sexual health and substance use? A systematic review of UK literature,https://pubmed.ncbi.nlm.nih.gov/36636992/,Negative,,Meta-analysis,2023,,Mental/Emotional System,Addiction; Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Stimulant; Anorexia; Anxiety; Depression; Psychosis
2023145,The clouded debate: A systematic review of comparative longitudinal studies examining the impact of recreational cannabis legalization on key public health outcomes,https://www.frontiersin.org/articles/10.3389/fpsyt.2022.1060656/full,Negative,,Meta-analysis,2023,,,Addiction - Alcohol; Addiction - Nicotine; Addiction - Opioid; Addiction; Cannabis Adverse Effects; Domestic Abuse; Suicide Attempt
2023146,Interventions Addressing Cannabis Use During Pregnancy: A Systematic Review,https://pubmed.ncbi.nlm.nih.gov/36731108/,Positive,,Meta-analysis,2023,,Reproductive System,Pregnancy; Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2023147,"Systematic Review: Polysubstance Prevalence Estimates Reported during Pregnancy, US, 2009-2020",https://pubmed.ncbi.nlm.nih.gov/36752906/,Inconclusive,,Meta-analysis,2023,,Mental/Emotional System; Reproductive System,Addiction; Addiction; Pregnancy; Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine
2023148,Negative experiences of patients using medicinal cannabis: A systematic review of qualitative studies,https://pubmed.ncbi.nlm.nih.gov/36807590/,Negative,,Meta-analysis,2023,,Mental/Emotional System,Cannabis Adverse Effects
2023149,Cannabis use in sub-Saharan Africa: A systematic review and meta-analysis,https://onlinelibrary.wiley.com/doi/10.1111/add.16170,Inconclusive,,Meta-analysis,2023,,Mental/Emotional System,Addiction - Cannabis; Addiction
2023150,"Multinational Association of Supportive Care in Cancer (MASCC) guidelines: cannabis for psychological symptoms including insomnia, anxiety, and depression",https://pubmed.ncbi.nlm.nih.gov/36809575/,Inconclusive,,Clinical Meta-analysis,2023,,Mental/Emotional System,Anxiety; Cancer; Depression; Insomnia and Sleep Disorders; Psychosis
2023151,"Drug use, drug use disorders, and treatment services in the Eastern Mediterranean region: a systematic review",https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(22)00435-7/fulltext,Negative,,Meta-analysis,2023,,Mental/Emotional System,Addiction; Addiction; Addiction - Cannabis; Addiction - Opioid
2023152,Effects of Cannabis Legalization on Road Safety: A Literature Review,https://www.mdpi.com/1660-4601/20/5/4655,Negative,,Meta-analysis,2023,,,Cannabis Adverse Effects
2023153,Paternal preconception modifiable risk factors for adverse pregnancy and offspring outcomes: a review of contemporary evidence from observational studies,https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-023-15335-1#Sec8,Negative,,Meta-analysis,2023,,Reproductive System,Pregnancy; Addiction - Alcohol; Addiction - Nicotine; Addiction; Cannabis Adverse Effects
2023154,Evidence-Based Treatment of Pain in Chemotherapy-Induced Peripheral Neuropathy,https://pubmed.ncbi.nlm.nih.gov/37058254/,Positive,,Meta-analysis,2023,,,Pain; Pain - Cancer; Pain - Neuropathy - Peripheral
2023155,Scoping review of guidance on cessation interventions for electronic cigarettes and dual electronic and combustible cigarettes use,https://www.cmajopen.ca/content/11/2/E336,Negative,,Meta-analysis,2023,,Respiratory System,Vaping injury (EVALI); Cannabis Adverse Effects
2023156,[Diffuse alveolar hemorrhage in cannabis smokers. A systematic literature review],https://www.sciencedirect.com/science/article/abs/pii/S0761842523001407?via%3Dihub,Negative,,Meta-analysis,2023,,Mental/Emotional System,Cannabis Adverse Effects
2023157,The effectiveness of oxytocin for treating substance use disorders:A systematic review of randomized placebo-controlled trials,https://www.sciencedirect.com/science/article/pii/S0149763423001549?via%3Dihub,Inconclusive,,Clinical Meta-analysis,2023,,Mental/Emotional System; Nervous System,Addiction; Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant; Anxiety; Depression
2023158,The impact of legal cannabis availability on cannabis use and health outcomes: A systematic review,https://www.sciencedirect.com/science/article/abs/pii/S0955395923000804?via%3Dihub,Negative,,Meta-analysis,2023,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Nausea and Vomiting; Pregnancy; Psychosis
2023159,Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies,https://pubmed.ncbi.nlm.nih.gov/37167985/,Positive,,Meta-analysis,2023,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction; Addiction; Addiction - Alcohol; Addiction - Cocaine; Addiction - Nicotine; Insomnia and Sleep Disorders; Pain
2023160,Substance abuse and susceptibility to false memory formation: a systematic review and meta-analysis,https://www.frontiersin.org/articles/10.3389/fpsyg.2023.1176564/full#h4,Negative,,Meta-analysis,2023,,Mental/Emotional System; Nervous System,Addiction; Addiction; Cognitive Dysfunction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Stimulant
2023161,"A systematic review and meta-analysis of the association between young adults' sleep habits and substance use, with a focus on self-medication behaviours",https://pubmed.ncbi.nlm.nih.gov/37269785/,Negative,,Meta-analysis,2023,,Mental/Emotional System; Nervous System,Addiction; Addiction; Insomnia and Sleep Disorders; Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine
2023162,Factors associated with suicide in people who use drugs: a scoping review,https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-023-05131-x#Sec10,Negative,,Meta-analysis,2023,,Mental/Emotional System,Suicide Attempt; Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Cocaine; Addiction - Opioid; Addiction - Stimulant; Addiction; Anxiety; Depression; MDMA Adverse Effects; Psychosis; PTSD; Schizophrenia
2020065,Adherence to Consolidated Standards of Reporting Trials (CONSORT) Guidelines for Reporting Safety Outcomes in Trials of Medical Cannabis and Cannabis-based Medicines for Chronic Noncancer Pain: A Systematic Review,https://pubmed.ncbi.nlm.nih.gov/31977375/,Negative,,Clinical Meta-analysis,2020,Pharma THC:CBD; Pharma THC; Synthetic Cannabinoid (unspecified),Nervous System,Pain
2022158,A systematic review of European regional and national guidelines: a focus on the recommended use of nabiximols in the management of spasticity in multiple sclerosis,https://www.tandfonline.com/doi/full/10.1080/14737175.2022.2075263,Negative,,Clinical Meta-analysis,2022,Pharma THC:CBD,,Multiple Sclerosis
2020066,Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids: A Systematic Review and Meta-analysis,https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2764234,Negative,,Clinical Meta-analysis,2020,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Addiction - Nicotine; Cannabis Adverse Effects
2023163,Effects of Δ9-THC and Type-1 Cannabinoid Receptor Agonists in the Elevated Plus Maze Test of Anxiety: A Systematic Review and Meta-Analysis,https://pubmed.ncbi.nlm.nih.gov/35984927/,Negative,,Meta-analysis,2023,,Mental/Emotional System; Nervous System,Anxiety
2022159,Effects of psychotropic drugs on ocular parameters relevant to traffic safety: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067018/,Negative,,Clinical Meta-analysis,2022,,,Cannabis Adverse Effects; Psychosis
2006009,Comorbidity between substance use disorders and psychiatric conditions,https://pubmed.ncbi.nlm.nih.gov/16930163/,Negative,,Meta-analysis,2006,,Mental/Emotional System,Addiction; Psychosis; Anxiety; Depression
2022160,Effects of SativexⓇ on cognitive function in patients with multiple sclerosis: A systematic review and meta-analysis,https://www.msard-journal.com/article/S2211-0348(22)00678-2/fulltext#seccesectitle0017,Positive,,Clinical Meta-analysis,2022,Pharma THC:CBD,,Cognitive Dysfunction; Multiple Sclerosis
2023164,The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841308/,Positive,,Clinical Meta-analysis,2023,,,Addiction; Anxiety; Insomnia and Sleep Disorders; Pain; Neurodegenerative Issues; Pain - Chronic
2023165,"Perturbation of 3D nuclear architecture, epigenomic dysregulation and aging, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 1-aging and epigenomics",https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1182535/full?utm_source=substack&utm_medium=email,Negative,,Meta-analysis,2023,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Addiction - Cannabis; Addiction
2022161,The effect of medical cannabis on cognitive functions: a systematic review,https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-022-02073-5#Sec13,Negative,,Clinical Meta-analysis,2022,Cannabinol (CBN); Pharma CBD; Pharma THC:CBD,,Cognitive Dysfunction; ADD and ADHD; Brachial Plexus Disorders; Cancer; Cannabis Adverse Effects; COPD; Epilepsy; Tics and Tourettes; Pain; Multiple Sclerosis; Pain - Chronic; Pain - Neuropathy - Diabetic; Pain - Neuropathy - Peripheral; Spinal Cord Injuries
2020067,Pharmacotherapeutic Considerations for Use of Cannabinoids to Relieve Symptoms of Nausea and Vomiting Induced by Chemotherapy,https://foliamedica.bg/article/51478/,Positive,,Clinical Meta-analysis,2020,Delta-8-THC; Pharma CBD; Pharma THC:CBD; Pharma THC; Tetrahydrocannabinol (THC),Nervous System,Cannabis Hyperemesis Syndrome; Nausea and Vomiting
2021109,"[Efficacy of psychedelics in psychiatry, a systematic review of the literature]",https://www.sciencedirect.com/science/article/abs/pii/S0013700621000592?via%3Dihub#preview-section-snippets,Positive,,Clinical Meta-analysis,2021,Ayahuasca,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant; Addiction; Anxiety; Depression; OCD; Psychosis; Schizophrenia
2022162,Therapeutic effect of palmitoylethanolamide in cognitive decline: A systematic review and preliminary meta-analysis of preclinical and clinical evidence,https://www.frontiersin.org/articles/10.3389/fpsyt.2022.1038122/full#h3,Positive,,Clinical Meta-analysis,2022,Palmitoylethanolamide (PEA),,Cognitive Dysfunction; Alzheimer's Disease; Dementia; Inflammation; Pain; Neurodegenerative Issues; Obesity; Oxidative Stress; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral; Parkinson's Disease; Traumatic Brain Injury
2016029,Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence,https://www.sciencedirect.com/science/article/abs/pii/S014976341630029X?via%3Dihub#preview-section-abstract,Negative,,Meta-analysis,2016,,,Psychosis
2019036,The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species,https://link.springer.com/article/10.1007/s00213-019-05283-3,Negative,,Meta-analysis,2019,Anandamide (AEA); CP-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,,Cognitive Dysfunction; Cannabis Adverse Effects
2022163,"Effects of synthetic cannabinoids on psychomotor, sensory and cognitive functions relevant for safe driving",https://www.frontiersin.org/articles/10.3389/fpsyt.2022.998828/full#h3,Negative,,Meta-analysis,2022,JWH-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),,Cognitive Dysfunction; Poisoning by Synthetic Cannabis; Cannabis Adverse Effects
2022164,Randomized controlled trials on the use of cannabis-based medicines in movement disorders: a systematic review,https://pubmed.ncbi.nlm.nih.gov/35859051/,Positive,,Clinical Meta-analysis,2022,Pharma CBD; Pharma THC,,ADD and ADHD; Anxiety; Chorea; Essential Tremor; Huntington's Disease; Insomnia and Sleep Disorders; Tics and Tourettes; Parkinson's Disease; Restless Leg Syndrome
2014010,Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology,https://n.neurology.org/content/82/17/1556,Positive,,Clinical Meta-analysis,2014,Pharma CBD; Pharma THC:CBD; Pharma THC,,Epilepsy; Huntington's Disease; Tics and Tourettes; Pain; Multiple Sclerosis; Pain - Central Pain Syndrome; Parkinson's Disease; Urinary Incontinence
2015037,Is There a Place for Off-Label Pharmacotherapy in Cannabis Use Disorder? A Review on Efficacy and Safety,https://pubmed.ncbi.nlm.nih.gov/26088109/,Inconclusive,,Clinical Meta-analysis,2015,Pharma THC:CBD; Pharma THC,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2016030,Psychosocial interventions for cannabis use disorder,https://pubmed.ncbi.nlm.nih.gov/27149547/,Positive,,Clinical Meta-analysis,2016,,Mental/Emotional System,Addiction - Cannabis; Addiction
2021110,Cost-Effectiveness of Medicinal Cannabis for Management of Refractory Symptoms Associated With Chronic Conditions: A Systematic Review of Economic Evaluations,https://www.valueinhealthjournal.com/article/S1098-3015(21)01522-9/fulltext?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1098301521015229%3Fshowall%3Dtrue,Positive,,Meta-analysis,2021,Pharma CBD; Pharma THC:CBD; Pharma THC,,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Pain; Multiple Sclerosis; Pain - Chronic; Pain - Neuropathy - Diabetic; Pain - Neuropathy - Drug-Ind. Polyneuropathy; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral
2018032,Systematic Review of the Costs and Benefits of Prescribed Cannabis-Based Medicines for the Management of Chronic Illness: Lessons from Multiple Sclerosis,https://pubmed.ncbi.nlm.nih.gov/28866778/,Positive,,Meta-analysis,2018,Pharma THC:CBD,Nervous System,Multiple Sclerosis
2020068,"""Residual blood THC levels in frequent cannabis users after over four hours of abstinence: A systematic review.""",https://www.sciencedirect.com/science/article/abs/pii/S0376871620303422?via%3Dihub#preview-section-snippets,Inconclusive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2020069,Endocannabinoid system and cardiometabolic risk factors: A comprehensive systematic review insight into the mechanistic effects of omega-3 fatty acids,https://pubmed.ncbi.nlm.nih.gov/32184122/,Positive,,Meta-analysis,2020,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Omega-3; Endocannabinoid (unspecified); Omega-6,Cardiovascular System; Endocrine System,Cardiovascular Diseases (CVD); Metabolic Syndrome; Obesity
2021111,Genetics of methamphetamine use disorder: A systematic review and meta-analyses of gene association studies,https://www.sciencedirect.com/science/article/abs/pii/S0149763420306333?via%3Dihub#preview-section-snippets,Positive,,Meta-analysis,2021,Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System; Nervous System,Addiction - Stimulant; Addiction
2021112,"A systematic, integrative review of the effects of the endocannabinoid system on inflammation and neurogenesis in animal models of affective disorders",https://www.sciencedirect.com/science/article/abs/pii/S088915912032482X?via%3Dihub#preview-section-snippets,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH),Nervous System,Inflammation; Neurodegenerative Issues; Behavioral Disorders; Depression
2021113,Cannabinoids Drugs and Oral Health-From Recreational Side-Effects to Medicinal Purposes: A Systematic Review,https://www.mdpi.com/1422-0067/22/15/8329,Inconclusive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); HU-x Synthetic Cannabinoids,Digestive System,Periodontal Disease; Bacterial Infections; Cancer - Oral; Cancer - Squamous Head/Neck; Cancer; Cannabis Adverse Effects; Fungal Infections; Inflammation; Pain
1981001,"Biological activity of cannabichromene, its homologs and isomers",https://pubmed.ncbi.nlm.nih.gov/7298870/,Positive,,Animal Study,1981,Cannabichromene (CBC),,Bacterial Infections; Fungal Infections; Pain
1981002,Perinatal exposure to cannabichromene and delta 9-tetrahydrocannabinol: separate and combined effects on viability of pups and on male reproductive system at maturity,https://pubmed.ncbi.nlm.nih.gov/6264652/,Inconclusive,,Animal Study,1981,Cannabichromene (CBC); Tetrahydrocannabinol (THC),Reproductive System,Infertility (Male); Pregnancy
2018033,A Systematic Review of the Efficacy of Cannabinoid Agonist Replacement Therapy for Cannabis Withdrawal Symptoms,https://pubmed.ncbi.nlm.nih.gov/30361897/,Positive,,Clinical Meta-analysis,2018,Pharma THC:CBD; Pharma THC; Synthetic Cannabinoid (unspecified); Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Anxiety; Depression; Insomnia and Sleep Disorders; Loss of Appetite
2014011,Mid-ventricular variant takotsubo cardiomyopathy associated with Cannabinoid Hyperemesis Syndrome: a case report,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998230/,Negative,,Meta-analysis,2014,,Cardiovascular System; Nervous System,Cannabis Hyperemesis Syndrome; Cardiovascular Diseases (CVD)
2014012,Synthetic cannabinoid leading to cannabinoid hyperemesis syndrome,https://pubmed.ncbi.nlm.nih.gov/25092369/,Positive,,Meta-analysis,2014,Synthetic Cannabinoid (unspecified),Nervous System,Cannabis Hyperemesis Syndrome; Poisoning by Synthetic Cannabis
2015038,A Common Source Outbreak of Severe Delirium Associated with Exposure to the Novel Synthetic Cannabinoid ADB-PINACA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049074/,Positive,,Meta-analysis,2015,AB-x Synthetic Cannabinoids,,Poisoning by Synthetic Cannabis; Psychosis
2017018,Propranolol Treatment of Cannabinoid Hyperemesis Syndrome: A Case Report,https://pubmed.ncbi.nlm.nih.gov/28604421/,Positive,,Meta-analysis,2017,,,Cannabis Hyperemesis Syndrome; Cannabis Adverse Effects
2018034,Cannabinoid hyperemesis syndrome,https://pubmed.ncbi.nlm.nih.gov/29745720/,Negative,,Meta-analysis,2018,Tetrahydrocannabinol (THC),Nervous System,Cannabis Hyperemesis Syndrome
2019037,Erythema ab igne as a complication of cannabinoid hyperemesis syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352823/,Negative,,Meta-analysis,2019,,,Cannabis Hyperemesis Syndrome; Cannabis Adverse Effects
2020070,Asymptomatic pneumopericardium in a young male cannabis smoker,https://pubmed.ncbi.nlm.nih.gov/32285772/,Negative,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cannabis Hyperemesis Syndrome
2019038,Cerebellar alterations in cannabis users: A systematic review,https://pubmed.ncbi.nlm.nih.gov/30811097/,Negative,,Clinical Meta-analysis,2019,,Mental/Emotional System,Behavioral Disorders; Addiction; Addiction; Cognitive Dysfunction; Addiction - Cannabis; Addiction - Nicotine; Cannabis Adverse Effects
2020071,Marijuana use and acute myocardial infarction: A systematic review of published cases in the literature,https://www.sciencedirect.com/science/article/abs/pii/S1050173819301124?via%3Dihub#preview-section-snippets,Negative,,Meta-analysis,2020,Synthetic Cannabinoid (unspecified),Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack; Diabetes; Hypertension (High Blood Pressure); Metabolic Syndrome; Stroke
2022165,Cannabinoid therapeutics in orofacial pain management: a systematic review,https://onlinelibrary.wiley.com/doi/10.1111/adj.12934,Inconclusive,,Meta-analysis,2022,Pharma THC; Synthetic Cannabinoid (unspecified); Palmitoylethanolamide (PEA),,Pain; Pain; Cancer - Squamous Head/Neck; Cancer; Pain - Chronic; Periodontal Disease; Temporomandibular Disorders
2022166,Does cannabis use predict aggressive or violent behavior in psychiatric populations? A systematic review,https://pubmed.ncbi.nlm.nih.gov/36137273/,Inconclusive,,Meta-analysis,2022,,Mental/Emotional System,Domestic Abuse; Behavioral Disorders; Anxiety; Cognitive Dysfunction; Depression; Psychosis; PTSD; Schizophrenia
2022167,Therapeutic Effects of Medicinal Cannabinoids on the Gastrointestinal System in Pediatric Patients: A Systematic Review,https://pubmed.ncbi.nlm.nih.gov/36219741/,Positive,,Meta-analysis,2022,,,Chemotherapy-induced Nausea & Vomiting; IBD - Inflammatory Bowel Disease
2020072,Cannabinoid Hyperemesis Syndrome: An Unexpected Problem in an Unusual Setting-A Case Report,https://pubmed.ncbi.nlm.nih.gov/32472123/,Negative,,Meta-analysis,2020,,Nervous System,Cannabis Hyperemesis Syndrome
2022168,Placebo Response and Media Attention in Randomized Clinical Trials Assessing Cannabis-Based Therapies for Pain: A Systematic Review and Meta-analysis,https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2799017,Inconclusive,,Clinical Meta-analysis,2022,Pharma THC:CBD; Pharma THC; Tetrahydrocannabinol (THC),,Pain; Pain; Multiple Sclerosis; Pain - Neuropathy - Peripheral
1989001,Nabilone as effective therapy for intractable nausea and vomiting in AIDS,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1380003/,Positive,,Meta-analysis,1989,Pharma THC,Digestive System; Immune System,HIV/AIDS; Nausea and Vomiting
2001010,Tetrahydrocannabinol for treatment of chronic pain,https://pubmed.ncbi.nlm.nih.gov/11810357/,Inconclusive,,Clinical Meta-analysis,2001,Tetrahydrocannabinol (THC),,Pain; Pain - Chronic
2014013,Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0089566#s3,Positive,,Meta-analysis,2014,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); CP-x Synthetic Cannabinoids; Diet; Exercise; Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,,Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant; Addiction; Anxiety; Depression; Fibromyalgia; Inflammation; Irritable Bowel Syndrome; Migraine
2021114,Pharmacotherapies for cannabis use disorder: A systematic review and network meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881089/,Positive,,Clinical Meta-analysis,2021,Fatty Acid Amide Hydrolase (FAAH); Pharma THC,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2022169,The Potential Proconvulsant Effects of Cannabis: a Scoping Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198115/,Negative,,Meta-analysis,2022,Tetrahydrocannabinol (THC),,Epilepsy; Cannabis Adverse Effects
2013010,Dronabinol treatment of refractory nausea and vomiting related to peritoneal carcinomatosis,https://pubmed.ncbi.nlm.nih.gov/24052427/,Positive,,Meta-analysis,2013,Pharma THC,Digestive System,Nausea and Vomiting; Cancer - Uterine; Cancer
2014014,Nabilone therapy for cannabis withdrawal presenting as protracted nausea and vomiting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4173142/,Positive,,Meta-analysis,2014,Pharma THC,Digestive System,Nausea and Vomiting; Cannabis Hyperemesis Syndrome
2015039,Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review,https://pubmed.ncbi.nlm.nih.gov/26103031/,Positive,,Clinical Meta-analysis,2015,,,Pain; Pain; Pain - Chronic; Multiple Sclerosis; Pain - Neuropathy - Peripheral
2017019,Unintentional Marijuana Exposure Presenting as Altered Mental Status in the Pediatric Emergency Department: A Case Series,https://pubmed.ncbi.nlm.nih.gov/28987305/,Negative,,Meta-analysis,2017,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2022170,Cannabinoids in the Treatment of Cannabis Use Disorder: Systematic Review of Randomized Controlled Trials,https://www.frontiersin.org/articles/10.3389/fpsyt.2022.867878/full,Positive,,Clinical Meta-analysis,2022,Fatty Acid Amide Hydrolase (FAAH); Pharma THC:CBD; Pharma THC,Mental/Emotional System,Addiction - Cannabis; Addiction
2022171,Association of cannabis potency with mental ill health and addiction: a systematic review,https://pubmed.ncbi.nlm.nih.gov/35901795/,Negative,,Clinical Meta-analysis,2022,Tetrahydrocannabinol (THC),Mental/Emotional System,Addiction - Cannabis; Addiction; Anxiety; Depression; Psychosis
2022172,Alleviation of opioid withdrawal by cannabis and delta-9-tetrahydrocannabinol: A systematic review of observational and experimental human studies,https://www.sciencedirect.com/science/article/abs/pii/S0376871622004392?via%3Dihub,Positive,,Clinical Meta-analysis,2022,,Mental/Emotional System,Addiction - Opioid; Addiction
2022173,"The ""Next Day"" Effects of Cannabis Use: A Systematic Review",https://www.liebertpub.com/doi/10.1089/can.2022.0185,Inconclusive,,Clinical Meta-analysis,2022,Tetrahydrocannabinol (THC),Mental/Emotional System,Cannabis Adverse Effects
2013011,Cannabis derivatives therapy for a seronegative stiff-person syndrome: a case report,https://pubmed.ncbi.nlm.nih.gov/22726074/,Positive,,Meta-analysis,2013,Pharma THC:CBD,,
2023166,Cannabidiol as a Harm Reduction Strategy for People Who Use Drugs: A Rapid Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411365/,Positive,,Clinical Meta-analysis,2023,,Mental/Emotional System,Harm Reduction; Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant; Addiction; Anxiety
2023167,An observational study of safety and clinical outcome measures across patient groups in the United Kingdom Medical Cannabis Registry,https://www.tandfonline.com/doi/full/10.1080/17512433.2023.2183841,Positive,,Meta-analysis,2023,,,Quality of Life; Anxiety; Depression; Insomnia and Sleep Disorders; Pain
2023168,Health-related quality of life in patients accessing medicinal cannabis in Australia: The QUEST initiative results of a 3-month follow-up observational study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482296/,Positive,,Meta-analysis,2023,,,Quality of Life; Anxiety; Depression; Insomnia and Sleep Disorders; Pain; Pain - Chronic
2023169,The association between callous-unemotional traits and substance use in childhood and adolescence: A systematic review and meta-analysis,https://www.sciencedirect.com/science/article/pii/S0165032723008170?via%3Dihub#s0080,Negative,,Clinical Meta-analysis,2023,,Mental/Emotional System,Addiction
2023170,Incidence and Persistence of Psychotic Experiences in the General Population: Systematic Review and Meta-Analysis,https://academic.oup.com/schizophreniabulletin/article/49/4/1007/7126992?login=true,Negative,,Clinical Meta-analysis,2023,,Mental/Emotional System; Nervous System,Psychosis; Addiction; Cannabis Adverse Effects
2023171,"The effect of recreational cannabis legalization and commercialization on substance use, mental health, and injury: a systematic review",https://www.sciencedirect.com/science/article/pii/S0033350623002019?via%3Dihub,Negative,,Clinical Meta-analysis,2023,,Mental/Emotional System; Nervous System,Addiction; Addiction; Cannabis Adverse Effects; Addiction - Opioid; Anxiety; Depression
2023172,Psychological Interventions for Cannabis Use among Adolescents and Young Adults: A Systematic Review,https://www.mdpi.com/1660-4601/20/14/6346,Positive,,Clinical Meta-analysis,2023,,,Addiction - Cannabis; Addiction; Cannabis Adverse Effects; Cognitive Dysfunction; Psychosis
2022174,Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer,https://pubmed.ncbi.nlm.nih.gov/36525085/,Inconclusive,,Clinical Meta-analysis,2022,Pharma THC:CBD; Pharma THC,Nervous System,Cancer; Anorexia; Cachexia; Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting; Palliative Care
2021115,Cannabinoids for the treatment of dementia,https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012820.pub2/full#CD012820-sec-0039,Inconclusive,,Clinical Meta-analysis,2021,Pharma THC; Synthetic Cannabinoid (unspecified); JWH-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Nervous System,Dementia; Alzheimer's Disease; Cognitive Dysfunction; Insomnia and Sleep Disorders
2023173,Effects of cannabinoids on resting state functional brain connectivity: A systematic review,https://www.sciencedirect.com/science/article/pii/S0149763422005036?via%3Dihub#sec0035,Inconclusive,,Clinical Meta-analysis,2023,Cannabidivarin (CBDV); Tetrahydrocannabivarin (THCV),,
2022175,Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis,https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013444.pub2/full,Inconclusive,,Clinical Meta-analysis,2022,Pharma CBD; Pharma THC:CBD; Pharma THC,Nervous System,Multiple Sclerosis; Pain; Pain - Chronic; Psychosis
2022176,Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids,https://pubmed.ncbi.nlm.nih.gov/36042166/,Inconclusive,,Meta-analysis,2022,Tetrahydrocannabinol (THC),,
2022177,Cannabis dosing and administration for sleep: a systematic review,https://pubmed.ncbi.nlm.nih.gov/36107800/,Inconclusive,,Clinical Meta-analysis,2022,Tetrahydrocannabinol (THC),Nervous System,Insomnia and Sleep Disorders
2022178,The Effectiveness and Safety of Cannabidiol in Non-seizure-related Indications: A Systematic Review of Published Randomized Clinical Trials,https://pubmed.ncbi.nlm.nih.gov/36271316/,Inconclusive,,Clinical Meta-analysis,2022,Pharma CBD; Tetrahydrocannabinol (THC),Nervous System,Epilepsy; Addiction; Anxiety; Psychosis; Schizophrenia
2022179,The Characteristics of Clinical Trials on Cannabis and Cannabinoids: A Review of Trials for Therapeutic or Drug Development Purposes,https://pubmed.ncbi.nlm.nih.gov/36357543/,Positive,,Clinical Meta-analysis,2022,,,Behavioral Disorders; Anxiety; Cancer; Depression; Diabetes; Metabolic Syndrome; Pain; Neurodegenerative Issues; Pain - Chronic
2022180,Cannabinoid treatments for anxiety: A systematic review and consideration of the impact of sleep disturbance,https://www.sciencedirect.com/science/article/abs/pii/S0149763422004304?via%3Dihub,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,Anxiety; Insomnia and Sleep Disorders
2023174,Cannabis use in Attention - Deficit/Hyperactivity Disorder (ADHD): A scoping review,https://pubmed.ncbi.nlm.nih.gov/36508935/,Inconclusive,,Meta-analysis,2023,,Mental/Emotional System; Nervous System,ADD and ADHD; Psychosis
2019039,A case report positive for synthetic cannabinoids: are cardiovascular effects related to their protracted use?,https://pubmed.ncbi.nlm.nih.gov/31683096/,Negative,,Meta-analysis,2019,Synthetic Cannabinoid (unspecified),,Poisoning by Synthetic Cannabis
2020073,"A Case of Vaping TCH Oil Leading to Vaping Associated Pulmonary Injury: Our Approach to Its Diagnosis, Management, and Recommendations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968930/,Negative,,Meta-analysis,2020,,Respiratory System,Vaping injury (EVALI)
1986003,Marijuana smoking--possible cause of head and neck carcinoma in young patients,https://pubmed.ncbi.nlm.nih.gov/3012440/,Negative,,Meta-analysis,1986,,Nervous System,Cancer
2013012,The use of cannabinoids in chronic pain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736518/,Positive,,Meta-analysis,2013,Pharma THC,Nervous System,Pain; Pain - Chronic; Cancer
2020074,Clinically Significant Drug-Drug Interaction Between Methadone and Cannabidiol,https://pubmed.ncbi.nlm.nih.gov/32444381/,Negative,,Meta-analysis,2020,,Nervous System,Pain; Pain - Cancer; Cancer - Metastatic; Cancer
2020075,"New Perspectives for Mucolytic, Anti-inflammatory and Adjunctive Therapy with 1,8-Cineole in COPD and Asthma: Review on the New Therapeutic Approach",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467491/,Positive,,Meta-analysis,2020,,Respiratory System,Asthma; COPD
2023175,"Sabinene suppresses growth, biofilm formation, and adhesion of Streptococcus mutans by inhibiting cariogenic virulence factors",https://www.tandfonline.com/doi/full/10.1080/20002297.2019.1632101,Positive,,Laboratory Study,2023,,Integumentary System,Cavities
2023176,Sabinene Prevents Skeletal Muscle Atrophy by Inhibiting the MAPK–MuRF-1 Pathway in Rats,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801606/,Positive,,Animal Study,2023,,,Sarcopenia
2016031,Chemical characterization of essential oil from seeds of wild and cultivated carrots from Serbia,"https://cer.ihtm.bg.ac.rs/bitstream/handle/123456789/3197/BS_40_1_07.pdf?sequence=1&isAllowed=y#:~:text=The%20major%20constituents%20of%20essential,of%20myrcene%20amounts%20to%204.7%25.",Positive,,Laboratory Study,2016,,,Cancer; Diabetes; Inflammation; Pain - Nociceptive; Pain
2022181,Evaluating the impact of cannabinoids on sleep health and pain in patients with chronic neuropathic pain: a systematic review and meta-analysis of randomized controlled trials,https://pubmed.ncbi.nlm.nih.gov/36598058/,Positive,,Clinical Meta-analysis,2022,,Nervous System,Insomnia and Sleep Disorders; Pain; Pain - Chronic
2023177,The effect of tetrahydrocannabinol:cannabidiol oromucosal spray on cognition: a systematic review,https://pubmed.ncbi.nlm.nih.gov/36700997/,Inconclusive,,Meta-analysis,2023,Pharma THC:CBD,Nervous System,Cognitive Dysfunction; Cannabis Adverse Effects
2023178,"The Effects of Pharmacological Treatment of Nightmares: A Systematic Literature Review and Meta-Analysis of Placebo-Controlled, Randomized Clinical Trials",https://www.mdpi.com/1660-4601/20/1/777,Positive,,Clinical Meta-analysis,2023,Pharma CBD; Tetrahydrocannabinol (THC),Nervous System,Insomnia and Sleep Disorders; Anxiety; Depression; PTSD
2022182,Interventions for generalized anxiety disorder,https://pubmed.ncbi.nlm.nih.gov/36705012/,Inconclusive,,Meta-analysis,2022,Exercise,Mental/Emotional System; Nervous System,Anxiety
2019040,Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice,https://pubmed.ncbi.nlm.nih.gov/31084246/,Positive,,Animal Study,2019,Cannabidivarin (CBDV),,Cognitive Dysfunction; Neurodegenerative Issues; Rett Syndrome
2023179,Anticancer effect of terpenes: focus on malignant melanoma,https://pubmed.ncbi.nlm.nih.gov/37515699/,Positive,,Meta-analysis,2023,,Integumentary System; Nervous System,Cancer - Melanoma; Cancer
2023180,Efficacy and tolerance of cannabidiol in the treatment of epilepsy in patients with Rett syndrome,https://pubmed.ncbi.nlm.nih.gov/37485779/,Positive,,Clinical Trial,2023,,,Epilepsy; Rett Syndrome; Anxiety
2023181,Cannabinoids versus placebo for pain: A systematic review with meta-analysis and Trial Sequential Analysis,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0267420,Inconclusive,,Clinical Meta-analysis,2023,,Nervous System,Pain; Pain; Addiction - Cannabis; Addiction; Anorexia; Cancer - Metastatic; Cancer; Cannabis Adverse Effects; Chemotherapy-induced Nausea & Vomiting; Cognitive Dysfunction; Depression; Inflammation; Insomnia and Sleep Disorders; Loss of Appetite; Nausea and Vomiting; Pain - Acute; Pain - Cancer; Pain - Chronic; Pain - Neuropathy - Diabetic; Pain - Neuropathy - Drug-Ind. Polyneuropathy
2023182,MASCC guideline: cannabis for cancer-related pain and risk of harms and adverse events,https://link.springer.com/article/10.1007/s00520-023-07662-1,Negative,,Meta-analysis,2023,,Mental/Emotional System,Cannabis Adverse Effects; Pain; Pain - Cancer
2023183,"Screening, brief intervention, and referral to treatment (SBIRT) for cannabis: A scoping review",https://pubmed.ncbi.nlm.nih.gov/36880902/,Inconclusive,,Meta-analysis,2023,,Mental/Emotional System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
1992001,Clinical management of anorexia and cachexia in patients with advanced cancer,https://karger.com/ocl/article-abstract/49/Suppl.%202/35/236201/Clinical-Management-of-Anorexia-and-Cachexia-in?redirectedFrom=fulltext,Positive,,Meta-analysis,1992,,,Anorexia Nervosa; Parkinson's Disease
1999006,Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's disease,https://link.springer.com/article/10.1007/s002130051102,Positive,,Double Blind Clinical Trial,1999,,,Parkinson's Disease
2004012,Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers,https://link.springer.com/article/10.1007/s00213-004-1899-2,Positive,,Double Blind Clinical Trial,2004,,,Parkinson's Disease
2019041,"Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease: the EMERALD trial",https://bmjopen.bmj.com/content/9/11/e029449,Inconclusive,,Double Blind Clinical Trial,2019,Tetrahydrocannabinol (THC),,Amyotrophic Lateral Sclerosis (ALS)
2019042,Assay of plasma cannabidiol by capillary gas chromatography/ion trap mass spectroscopy following high-dose repeated daily oral administration in humans,https://www.sciencedirect.com/science/article/abs/pii/0091305791903578?via%3Dihub,Positive,,Double Blind Clinical Trial,2019,Pharma CBD,Muscular System,Muscular Dystrophy & Myotonic Disorders
2020076,Use of cannabinoid-based medicine among older residential care recipients diagnosed with dementia: study protocol for a double-blind randomised crossover trial,https://pubmed.ncbi.nlm.nih.gov/32059690/,Positive,,Double Blind Clinical Trial,2020,,Nervous System,Dementia
2019043,Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease,https://www.ajgponline.org/article/S1064-7481(19)30355-0/fulltext,Positive,,Double Blind Clinical Trial,2019,Pharma THC,,Alzheimer's Disease
2023184,Use of non-medical cannabis in epilepsy: A scoping review,https://www.frontiersin.org/articles/10.3389/fneur.2023.1132106/full,Inconclusive,,Meta-analysis,2023,Pharma CBD,,Epilepsy; Epilepsy; Alzheimer's Disease; Amyotrophic Lateral Sclerosis (ALS); Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Multiple Sclerosis
2023185,Regulatory role of the endocannabinoid system on glial cells toward cognitive function in Alzheimer's disease: A systematic review and meta-analysis of animal studies,https://www.frontiersin.org/articles/10.3389/fphar.2023.1053680/full#h4,Positive,,Meta-analysis,2023,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); JWH-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); N-Arachidonoyl Dopamine (NADA); Palmitoylethanolamide (PEA); Tetrahydrocannabinol (THC),,Alzheimer's Disease; Cognitive Dysfunction; Dementia; Inflammation; Neurodegenerative Issues; Oxidative Stress
2023186,Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials,https://www.mdpi.com/2072-6643/15/6/1350,Positive,,Clinical Meta-analysis,2023,Palmitoylethanolamide (PEA); Anandamide (AEA),,Pain; Pain; Pain - Chronic; Bacterial Infections; Inflammation; Pain - Nociceptive; Pain - Neuropathy - Peripheral
2023187,Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder,https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1144276/full,Inconclusive,,Meta-analysis,2023,Tetrahydrocannabinol (THC); Endocannabinoid (unspecified),Mental/Emotional System,Addiction - Cannabis; Addiction; Addiction; Addiction - Alcohol; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Anorexia; Cannabis Adverse Effects; Cannabis Hyperemesis Syndrome; Cardiac Arrhythmias; Cardiac Toxicity; Cardiovascular Diseases (CVD); Cognitive Dysfunction; Depression; Heart Attack; MDMA Adverse Effects; Pain; Nausea and Vomiting; Psychosis
2023188,"Measuring white matter microstructure in 1,457 cannabis users and 1,441 controls: A systematic review of diffusion-weighted MRI studies",https://www.frontiersin.org/articles/10.3389/fnimg.2023.1129587/full,Inconclusive,,Meta-analysis,2023,Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Addiction - Cannabis; Behavioral Disorders; Addiction; Anxiety; Cognitive Dysfunction; Depression; Psychosis
2023189,Toxic Tetrahydrocannabinol (THC) Dose in Pediatric Cannabis Edible Ingestions,https://publications.aap.org/pediatrics/article/152/3/e2023061374/193757/Toxic-Tetrahydrocannabinol-THC-Dose-in-Pediatric?autologincheck=redirected,Negative,,Meta-analysis,2023,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Epilepsy
2023190,Cannabidiol safety considerations: Development of a potential acceptable daily intake value and recommended upper intake limits for dietary supplement use,https://www.sciencedirect.com/science/article/pii/S0273230023001502?via%3Dihub,Positive,,Clinical Trial,2023,Diet; Pharma CBD; Pharma THC:CBD; Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Anxiety; Cancer; Depression; Epilepsy; IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Huntington's Disease; IBD - Ulcerative Colitis; Insomnia and Sleep Disorders; Pain; Parkinson's Disease
2023191,Structural organisation of perisomatic inhibition in the mouse medial prefrontal cortex,https://www.jneurosci.org/content/early/2023/08/25/JNEUROSCI.0432-23.2023,Inconclusive,,Animal Study,2023,Endocannabinoid (unspecified),,Cognitive Dysfunction; Neurodegenerative Issues
2023192,Cannabinoids for symptom management in children with cancer: It's complicated,https://acsjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/cncr.34962,Inconclusive,,Meta-analysis,2023,,Nervous System,Cancer; Chemotherapy-induced Nausea & Vomiting; Pain; Pain - Cancer
2023193,COMPARING DEHULLED HEMP MEAL AND CANOLA MEAL AS A PROTEIN SUPPLEMENT FOR LACTATING DAIRY COWS,https://www.journalofdairyscience.org/article/S0022-0302(23)00538-6/fulltext#seccestitle40,Positive,,Animal Study -,2023,Cannabidiolic Acid (CBD-a); Tetrahydrocannabinol (THC); Tetrahydrocannabinolic Acid (THC-a),,Veterinary Applications
2023194,"Quantitative Analysis of Three Synthetic Cannabinoids MDMB-4en-PINACA, ADB-BUTINACA, and ADB-4en-PINACA by Thermal-Assisted Carbon Fiber Ionization Mass Spectrometry",https://pubmed.ncbi.nlm.nih.gov/37641897/,Positive,,Laboratory Study,2023,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis; Cannabis Adverse Effects; Psychosis
2023195,"Instant Detection of Synthetic Cannabinoids on Physical Matrices, Implemented on a Low-Cost, Ultraportable Device",https://pubs.acs.org/doi/10.1021/acs.analchem.3c01844,Positive,,Clinical Trial,2023,Synthetic Cannabinoid (unspecified); 5F-x Synthetic Cannabinoids,Nervous System,Poisoning by Synthetic Cannabis; Addiction - Benzodiazepine; Addiction - Opioid; Behavioral Disorders; Addiction; Cannabis Adverse Effects; Epilepsy; Psychosis; Stroke
2023196,Associations of psychoactive substances and steroid hormones in hair: Findings relevant to stress research from a large cohort of young adults,https://www.sciencedirect.com/science/article/pii/S0306453023003475?via%3Dihub#keys0005,Negative,,Meta-analysis,2023,,Mental/Emotional System; Nervous System,Psychosis; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant; Addiction; Cannabis Adverse Effects; MDMA Adverse Effects
2011010,Subjective and physiological effects after controlled Sativex and oral THC administration,https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1038/clpt.2010.318,Inconclusive,,Clinical Trial,2011,Pharma THC:CBD; Pharma THC; Tetrahydrocannabinol (THC),,Anxiety; Psychosis
2011011,Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study,https://www.nature.com/articles/npp201117#Sec2,Positive,,Double Blind Clinical Trial,2011,Tetrahydrocannabinol (THC),,Anxiety; Cognitive Dysfunction; Psychosis
2023197,Quality and safety of hemp meal as a protein supplement for nonlactating dairy cows,https://www.journalofdairyscience.org/action/showPdf?pii=S0022-0302%2823%2900482-4,Positive,,Animal Study -,2023,Cannabidiolic Acid (CBD-a); Diet; Tetrahydrocannabinolic Acid (THC-a),,Veterinary Applications
2020077,A Case Series of Vaping-Induced Lung Injury in a Community Hospital Setting,https://www.hindawi.com/journals/cripu/2020/9631916/,Negative,,Meta-analysis,2020,,Respiratory System,Vaping injury (EVALI); Addiction - Nicotine
2011012,Recent advances in the understanding of the role of the endocannabinoid system in liver diseases,https://www.dldjournalonline.com/article/S1590-8658(10)00289-6/fulltext,Positive,,Laboratory Study,2011,WIN-x Synthetic Cannabinoids,Digestive System,Liver Failure; Fatty Liver Disease; Fibrosis - Liver (Cirrhosis); Fibrosis
2018035,Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic Cannabidiol,https://ar.iiarjournals.org/content/38/10/5831,Positive,,Meta-analysis,2018,Pharma CBD; Pharma THC:CBD,Nervous System,Cancer; Cancer - Brain; Cancer - Breast; Cancer - Lymphoma; Cancer - Metastatic; Cancer - Oral; Cancer - Prostate; Multiple Sclerosis
2012016,Cannabinoid Hyperemesis,https://emj.bmj.com/content/29/1/67,Negative,,Meta-analysis,2012,,Nervous System,Cannabis Hyperemesis Syndrome
2013013,The synthetic cannabinoid withdrawal syndrome,https://journals.lww.com/journaladdictionmedicine/abstract/2013/07000/the_synthetic_cannabinoid_withdrawal_syndrome.12.aspx,Negative,,Meta-analysis,2013,Synthetic Cannabinoid (unspecified),,
1990001,Case report: the effect of tetrahydrocannabinol on food intake during chemotherapy,https://pubmed.ncbi.nlm.nih.gov/2177068/,Positive,,Meta-analysis,1990,Pharma THC,Digestive System,Chemotherapy-induced Nausea & Vomiting; Anorexia; Cancer - Lymphoma; Cancer; Nausea and Vomiting
2010032,[Cannabis and the lung - chill or kill?].,https://pubmed.ncbi.nlm.nih.gov/20687046/,Positive,,Clinical Meta-analysis,2010,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2020078,Cannabis Vaping-Induced Acute Pulmonary Toxicity: Case Series and Review of Literature.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543135/,Positive,,Meta-analysis,2020,,Respiratory System,Vaping injury (EVALI)
2023198,Clinical Research Evidence Supporting Administration and Dosing Recommendations of Medicinal Cannabis as Analgesic in Cancer Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821014/,Positive,,Clinical Meta-analysis,2023,Pharma THC:CBD,,Pain; Pain - Cancer
1995001,3 different malignancies of the aerodigestive tract after chronic abuse of cannabis products,https://pubmed.ncbi.nlm.nih.gov/8582833/,Positive,,Meta-analysis,1995,,,Cancer - Metastatic; Cancer
2023199,Exploring the Neuroprotective Effects of Spirulina platensis: Insights Into Hemorrhagic Volume and Histological Outcomes,https://www.cureus.com/articles/168983-exploring-the-neuroprotective-effects-of-spirulina-platensis-insights-into-hemorrhagic-volume-and-histological-outcomes#!/,Positive,,Animal Study,2023,Phycocyanin,,Stroke; Cardiovascular Diseases (CVD); Geriatric Conditions; Hypertension (High Blood Pressure); Inflammation; Neurodegenerative Issues; Oxidative Stress
1997001,Intractable nausea and vomiting due to gastrointestinal mucosal metastases relieved by tetrahydrocannabinol (dronabinol).,https://pubmed.ncbi.nlm.nih.gov/9392925/,Positive,,Meta-analysis,1997,Pharma THC,Digestive System; Integumentary System; Nervous System,Cancer - Melanoma; Cancer - Metastatic; Cancer; Cancer; Nausea and Vomiting; Cancer - Colon; Cancer - Bone; Cancer - Brain; Cancer - Liver; Cancer - Lung; Chemotherapy-induced Nausea & Vomiting; Pain; Pain - Cancer
2023200,Palmitoylethanolamide counteracts high-fat diet-induced gut dysfunction by reprogramming microbiota composition and affecting tryptophan metabolism,https://www.frontiersin.org/articles/10.3389/fnut.2023.1143004/full,Positive,,Animal Study,2023,Diet; Microbiome; Palmitoylethanolamide (PEA),,Cardiovascular Diseases (CVD); Gastro-Esophageal Reflux; Gastroparesis; Inflammation; Metabolic Syndrome; Obesity; Reperfusion Injury
2019044,Potential role of cannabidiol for seizure control in a patient with recurrent glioma.,https://pubmed.ncbi.nlm.nih.gov/31848037/,Positive,,Meta-analysis,2019,,,Cancer - Brain; Cancer; Epilepsy
2023201,Molecular Insights into GPCR Mechanisms for Drugs of Abuse,https://www.jbc.org/article/S0021-9258(23)02204-4/fulltext,Inconclusive,,Meta-analysis,2023,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Mental/Emotional System,Addiction - Cannabis; Addiction - Opioid; Addiction - Stimulant; Addiction; Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Cocaine; Addiction - Nicotine; Anxiety; Cannabis Adverse Effects; Cannabis Hyperemesis Syndrome; MDMA Adverse Effects; Pain; Psychosis
2014015,"Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22",https://academic.oup.com/jat/article/38/8/559/2797995?login=false,Negative,,Meta-analysis,2014,5F-x Synthetic Cannabinoids; AM-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,Nervous System,Poisoning by Synthetic Cannabis; Acute Respiratory Distress Syndrome; Kidney Failure; Liver Failure; Metabolic Syndrome; Stress
2008031,Management of bone metastases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2294085/,Positive,,Meta-analysis,2008,Pharma THC:CBD,,Cancer - Metastatic; Cancer; Pain - Cancer; Cancer - Kidney; Cancer - Colon; Cancer - Bladder; Cancer - Breast; Cancer - Lung; Cancer - Prostate; Cancer - Stomach; Cancer - Uterine; Pain
2016032,"Suicide attempt with a mix of synthetic cannabinoids and synthetic cathinones: Case report of non-fatal intoxication with AB-CHMINACA, AB-FUBINACA, alpha-PHP, alpha-PVP and 4-CMC",https://www.sciencedirect.com/science/article/abs/pii/S0379073816000372?via%3Dihub,Negative,,Meta-analysis,2016,AB-x Synthetic Cannabinoids,Mental/Emotional System,Poisoning by Synthetic Cannabis; Suicide Attempt
2016033,Hypotension associated with ingestion of cannabinoids in two children with cancer.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868608/,Inconclusive,,Meta-analysis,2016,Tetrahydrocannabinol (THC),,Cancer; Cannabis Adverse Effects; Chemotherapy-induced Nausea & Vomiting
2017020,Supraventricular tachycardia and acute confusion following ingestion of e-cigarette fluid containing AB-FUBINACA and ADB-FUBINACA: a case report with quantitative analysis of serum drug concentrations,https://www.tandfonline.com/doi/abs/10.1080/15563650.2017.1307385?journalCode=ictx20,Negative,,Meta-analysis,2017,AB-x Synthetic Cannabinoids,Cardiovascular System; Nervous System,Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Cognitive Dysfunction; Poisoning by Synthetic Cannabis
2006010,The emerging role of cannabinoid neuromodulators in symptom management.,https://pubmed.ncbi.nlm.nih.gov/17139494/,Positive,,Clinical Meta-analysis,2006,Pharma THC,Digestive System,Chemotherapy-induced Nausea & Vomiting; Cancer; Pain; Nausea and Vomiting; Pain - Cancer
2023202,Preventing Neurocognitive Decline in Adults Aging with HIV: Implications for Practice and Research,https://pubmed.ncbi.nlm.nih.gov/37599532/,Positive,,Meta-analysis,2023,,Immune System,Cognitive Dysfunction; HIV/AIDS; Alzheimer's Disease; Geriatric Conditions; Inflammation; Longevity; Neurodegenerative Issues
2023203,Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm - A Randomized Pilot Study,https://tvst.arvojournals.org/article.aspx?articleid=2791424#247585750,Positive,,Double Blind Clinical Trial,2023,Pharma CBD; Pharma THC:CBD; Pharma THC,,Blepharospasm; Cancer; Chemotherapy-induced Nausea & Vomiting; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Gastro-Esophageal Reflux; Pain; Pain - Chronic; Pain - Eye; Psychosis
2020079,AB-CHMINACA-induced sudden death from non-cardiogenic pulmonary edema,https://www.tandfonline.com/doi/abs/10.1080/15563650.2017.1340648?journalCode=ictx20,Inconclusive,,Meta-analysis,2020,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis
2013014,An accidental fatal intoxication with methoxetamine,https://academic.oup.com/jat/article/37/1/43/747496?login=false,Positive,,Meta-analysis,2013,AM-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,Nervous System,Poisoning by Synthetic Cannabis
2016034,Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism,https://pubmed.ncbi.nlm.nih.gov/27701827/,Positive,,Meta-analysis,2016,Palmitoylethanolamide (PEA),Mental/Emotional System,Autism; Behavioral Disorders; Cognitive Dysfunction; Inflammation
2018036,Cannabinoid Disposition After Human Intraperitoneal Use: AnInsight Into Intraperitoneal Pharmacokinetic Properties in Metastatic Cancer,https://www.clinicaltherapeutics.com/article/S0149-2918(17)31114-1/fulltext,Negative,,Meta-analysis,2018,,Nervous System,Cancer - Metastatic; Cancer; Cancer; Cancer - Ovarian
2011013,Molecular allergology in practice: an unusual case of LTP allergy.,https://ncbi.nlm.nih.gov/pubmed/22360137,Positive,,Meta-analysis,2011,,Integumentary System,Allergic Contact Dermatitis; Inflammation
2019045,"A case of intoxication with a mixture of synthetic cannabinoids EAM-2201, AB-PINACA and AB-FUBINACA, and a synthetic cathinone α-PVP",https://www.sciencedirect.com/science/article/abs/pii/S1344622318301482?via%3Dihub,Positive,,Meta-analysis,2019,AB-x Synthetic Cannabinoids,,Poisoning by Synthetic Cannabis
2019046,Fatal intoxication of a regular drug user following N-ethyl-hexedrone and ADB-FUBINACA consumption,https://www.sciencedirect.com/science/article/abs/pii/S1752928X18306681?via%3Dihub,Negative,,Meta-analysis,2019,Synthetic Cannabinoid (unspecified),,Poisoning by Synthetic Cannabis; Cardiac Toxicity; Cardiovascular Diseases (CVD)
2015040,K2--not the spice of life; synthetic cannabinoids and ST elevation myocardial infarction: a case report.,https://ncbi.nlm.nih.gov/pubmed/25154434,Positive,,Meta-analysis,2015,Synthetic Cannabinoid (unspecified),,Poisoning by Synthetic Cannabis; Cardiac Toxicity; Cardiovascular Diseases (CVD)
2016035,Adverse Structural and Functional Effects of Marijuana on the Brain: Evidence Reviewed.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954727/,Negative,,Meta-analysis,2016,,Mental/Emotional System,Cannabis Adverse Effects; Addiction - Cannabis; Psychosis; Schizophrenia
2004013,[Experiences with dronabinol (delta-tetrahydrocannabinol) in oncological patients with anorexia-cachexia syndrome. Illustration of clinical problems and therapy based on 2 case reports],https://pubmed.ncbi.nlm.nih.gov/23570088/,Positive,,Meta-analysis,2004,Pharma THC,Digestive System; Mental/Emotional System; Muscular System,Anorexia Nervosa; Cachexia
2023204,An electrochemical approach for the prediction of Δ9-tetrahydrocannabinolic acid and total cannabinoid content in Cannabis sativa L,https://pubmed.ncbi.nlm.nih.gov/37602722/,Inconclusive,,Laboratory Study,2023,Tetrahydrocannabinolic Acid (THC-a),,
2023205,"Use of psychoactive substances by goods carriage drivers associated with Kerala, India",https://pubmed.ncbi.nlm.nih.gov/37603111/,Negative,,Clinical Trial,2023,,Mental/Emotional System,Psychosis; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Opioid; Addiction - Stimulant; Cannabis Adverse Effects; MDMA Adverse Effects; Poisoning by Synthetic Cannabis
2023206,Identifying a suspect powder as a cannabis concentrate through chemical analysis and DNA testing,https://pubmed.ncbi.nlm.nih.gov/37603166/,Inconclusive,,Laboratory Study,2023,,,
2023207,Retrospective chart review of substance abuse in patients with psychiatric emergencies in an emerging urban county,https://onlinelibrary.wiley.com/doi/10.1002/emp2.13028,Negative,,Meta-analysis,2023,,Mental/Emotional System,Psychosis; ADD and ADHD; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Stimulant; Anxiety; Bipolar Disorder; Cannabis Adverse Effects; Depression; Schizophrenia; Suicide Attempt
2023208,A daily diary investigation of cannabis use and its diet and exercise correlates,https://www.frontiersin.org/articles/10.3389/fpsyg.2023.1217144/full,Inconclusive,,Clinical Trial,2023,Diet; Exercise,,Cancer; Cannabis Adverse Effects; Cardiovascular Diseases (CVD); Diabetes; Metabolic Syndrome; Obesity
2023209,Synergetic effect of β-asarone and cannabidiol against Aβ aggregation in vitro and in vivo,https://www.csbj.org/article/S2001-0370(23)00262-3/fulltext#secsect0005,Positive,,Laboratory Study,2023,Endocannabinoid (unspecified),,Alzheimer's Disease; Dementia; Inflammation; Neurodegenerative Issues; Oxidative Stress
2023210,"The Cross Reactivity of Cannabinoid Analogs (Delta-8-THC, Delta-10-THC and CBD), their metabolites, and Chiral Carboxy HHC metabolites in Urine of Six Commercially Available Homogeneous Immunoassays",https://pubmed.ncbi.nlm.nih.gov/37602947/,Inconclusive,,Laboratory Study,2023,Cannabidiolic Acid (CBD-a); Delta-8-THC; Tetrahydrocannabinol (THC),,
2023211,Daily Cannabidiol Administration for 10 Weeks Modulates Hippocampal and Amygdalar Resting-State Functional Connectivity in Cannabis Users: A Functional Magnetic Resonance Imaging Open-Label Clinical Trial,https://www.liebertpub.com/doi/10.1089/can.2022.0336,Positive,,Clinical Trial,2023,Tetrahydrocannabinol (THC),Mental/Emotional System,Cannabis Adverse Effects; Addiction - Cannabis; Anxiety; Depression; Psychosis
2023212,Resolvin E1 heals injured cardiomyocytes: Therapeutic implications and H-FABP as a readout for cardiovascular disease & systemic inflammation,https://pubmed.ncbi.nlm.nih.gov/37604082/,Positive,,Laboratory Study,2023,Fatty Acid-Binding Protein (FABP),Cardiovascular System,Cardiovascular Diseases (CVD); Inflammation; Chronic Heart Disease; Chronic Kidney Disease; Diabetes; Diabetic Kidney Disease; Heart Disease; Kidney Failure
2023213,"Recreational Cannabis Use Over Time in Individuals at Clinical High Risk for Psychosis: Lack of Associations with Symptom, Neurocognitive, Functioning, and Treatment Patterns",https://www.sciencedirect.com/science/article/abs/pii/S0165178123003700,Inconclusive,,Meta-analysis,2023,,Mental/Emotional System,Psychosis; Schizophrenia
2023214,Cannabis Improves Clinical Outcomes and Quality of Life in Patients With Chronic Pouchitis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435015/,Positive,,Meta-analysis,2023,,Digestive System,Pouchitis
2023215,Chitosan Sponges for Efficient Accumulation and Controlled Release of C-Phycocyanin,https://www.mdpi.com/2673-6284/12/3/55,Positive,,Laboratory Study,2023,Phycocyanin,,Bacterial Infections; Fungal Infections; Inflammation; Oxidative Stress; Wound Healing
2023216,Turning down the spice: tackling the problems of synthetic cannabinoids,https://www.bmj.com/content/382/bmj-2023-076611.full,Inconclusive,,Meta-analysis,2023,Synthetic Cannabinoid (unspecified); Tetrahydrocannabinol (THC),,Poisoning by Synthetic Cannabis; Cannabis Adverse Effects; Cardiovascular Diseases (CVD); Epilepsy; Psychosis
2005013,The Efficacy and Tolerability of Long-Term Use of Dronabinol in Cancer-Related Anorexia: A Case Series,https://www.jpsmjournal.com/article/S0885-3924(05)00559-2/fulltext,Positive,,Clinical Trial,2005,Pharma THC,Digestive System,Anorexia; Cancer
2012017,An accidental fatal intoxication with methoxetamine,https://academic.oup.com/jat/article/37/1/43/747496?login=false,Negative,,Meta-analysis,2012,AM-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,,Poisoning by Synthetic Cannabis
2019047,Severe hyponatremia secondary to Phyllomedusa bicolor (Kambó frog) poisoning. Report of one case,https://pubmed.ncbi.nlm.nih.gov/31859994/,Inconclusive,,Meta-analysis,2019,Ayahuasca,,Nausea and Vomiting
2013015,"Driving under the influence of synthetic cannabinoids (""Spice""): a case series",https://link.springer.com/article/10.1007/s00414-013-0864-1,Positive,,Meta-analysis,2013,AM-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,Nervous System,Poisoning by Synthetic Cannabis
2020080,"Ayahuasca - religion, life-style or drug?",https://pubmed.ncbi.nlm.nih.gov/32544955/,Inconclusive,,Meta-analysis,2020,Ayahuasca,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2013016,K2 Toxicity: Fatal Case of Psychiatric Complications Following AM2201 Exposure†,https://onlinelibrary.wiley.com/doi/full/10.1111/1556-4029.12216,Negative,,Meta-analysis,2013,AM-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,Nervous System,Poisoning by Synthetic Cannabis; Psychosis
2014016,Synthetic Cannabis Substances (SPS) Use and Hallucinogen Persisting Perception Disorder (HPPD): Two Case Reports,https://pubmed.ncbi.nlm.nih.gov/25841224/,Positive,,Meta-analysis,2014,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis; Anxiety
2011014,Antitumor effects of α-bisabolol against pancreatic cancer,https://pubmed.ncbi.nlm.nih.gov/21883695/,Positive,,Animal Study,2011,,Endocrine System; Nervous System,Cancer - Pancreatic; Cancer
2017021,The Anticancer Effects of Novel α-Bisabolol Derivatives Against Pancreatic Cancer,https://pubmed.ncbi.nlm.nih.gov/28179305/,Positive,,Laboratory Study,2017,,Endocrine System,Cancer - Pancreatic; Cancer
2023217,Cyclodextrin Conjugated α-Bisabolol Suppresses FAK Phosphorylation and Induces Apoptosis in Pancreatic Cancer,https://pubmed.ncbi.nlm.nih.gov/36854520/,Positive,,Animal Study,2023,,Endocrine System,Cancer - Pancreatic; Cancer
2016036,α-Bisabolol Inhibits Invasiveness and Motility in Pancreatic Cancer Through KISS1R Activation,https://pubmed.ncbi.nlm.nih.gov/26851012/,Positive,,Laboratory Study,2016,,Endocrine System,Cancer - Pancreatic; Cancer
2017022,"A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial",https://pubmed.ncbi.nlm.nih.gov/29181960/,Positive,,Double Blind Clinical Trial,2017,,Integumentary System,Allergic Contact Dermatitis; Eczema; Inflammation
2023218,"Clinical efficacy of new α-bisabolol mouthwashes in postoperative complications of maxillofacial surgeries: a randomized, controlled, triple-blind clinical trial",https://pubmed.ncbi.nlm.nih.gov/29725846/,Positive,,Double Blind Clinical Trial,2023,,Immune System; Integumentary System; Nervous System,Wound Healing; Bacterial Infections; Inflammation; Pain; Pain - Acute; Pain - Inflammatory
2023219,Effectiveness of the sesquiterpene (-)-α-bisabolol in dogs with naturally acquired canine leishmaniosis: an exploratory clinical trial,https://pubmed.ncbi.nlm.nih.gov/29453596/,Positive,,Animal Study -,2023,,Integumentary System,Leishmaniasis; Veterinary Applications; Parasitic Worms
2010033,Whitening effect of alpha-bisabolol in Asian women subjects,https://pubmed.ncbi.nlm.nih.gov/20642768/,Positive,,Clinical Trial,2010,,,Allergic Contact Dermatitis; Cancer - Melanoma; Cancer; Longevity; Skin Diseases; Sunburn
2022183,Is There a Place for Medicinal Cannabis in Treating Patients with Sleep Disorders? What We Know so Far,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124464/,Positive,,Clinical Meta-analysis,2022,Cannabinol (CBN); Pharma CBD; Pharma THC:CBD; Pharma THC; Tetrahydrocannabinol (THC),,Insomnia and Sleep Disorders; REM Sleep Behavior Disorder; Restless Leg Syndrome; Sleep Apnea
2023220,"The Cannabinoids, CBDA and THCA, Rescue Memory Deficits and Reduce Amyloid-Beta and Tau Pathology in an Alzheimer’s Disease-like Mouse Model",https://www.mdpi.com/1422-0067/24/7/6827,Positive,,Animal Study,2023,Cannabidiolic Acid (CBD-a); Tetrahydrocannabinolic Acid (THC-a),Nervous System,Alzheimer's Disease
2023221,Daily Δ9-Tetrahydrocannabinol and Withdrawal Increase Dopamine D1-D2 Receptor Heteromer to Mediate Anhedonia- and Anxiogenic-like Behavior Through a Dynorphin and Kappa Opioid Receptor Mechanism,https://www.sciencedirect.com/science/article/pii/S266717432200088X?via%3Dihub,Negative,,Animal Study,2023,,Mental/Emotional System,Anxiety; Cannabis Adverse Effects; Addiction - Cannabis
2023222,Hepatotoxicity assessment investigations on PFASs targeting L-FABP using binding affinity data and machine learning-based QSAR model,https://www.sciencedirect.com/science/article/pii/S014765132300814X?via%3Dihub,Negative,,Laboratory Study,2023,Fatty Acid-Binding Protein (FABP),Digestive System,Liver Failure
2023223,Disclosing Environmental Ligands of L-FABP and PPARγ: Should We Re-evaluate the Chemical Safety of Hydrocarbon Surfactants?,https://pubs.acs.org/doi/10.1021/acs.est.3c02898,Inconclusive,,Laboratory Study,2023,Fatty Acid-Binding Protein (FABP),,
2023224,Screening of Spirulina Components for Anti-Parkinson's and Anti-Alzheimer's Activity by in Silico Methods and Docking Studies,https://link.springer.com/chapter/10.1007/978-3-031-31978-5_13,Positive,,Laboratory Study,2023,Phycocyanin,Nervous System,Alzheimer's Disease; Parkinson's Disease; Cancer; Diabetes; Neurodegenerative Issues; Oxidative Stress
2023225,N-oleoyl glycine and N-oleoyl alanine attenuate alcohol self-administration and preference in mice,https://www.nature.com/articles/s41398-023-02574-4,Inconclusive,,Animal Study,2023,Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction; Addiction - Cocaine; Behavioral Disorders; Pain
2013017,"""Spiceophrenia"": a systematic overview of ""spice""-related psychopathological issues and a case report",https://ncbi.nlm.nih.gov/pubmed/23881886,Negative,,Meta-analysis,2013,JWH-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Psychosis; Poisoning by Synthetic Cannabis; Schizophrenia
2013018,A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids,https://ncbi.nlm.nih.gov/pubmed/23890687,Negative,,Meta-analysis,2013,JWH-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Nervous System,Cannabis Hyperemesis Syndrome; Nausea and Vomiting
2013019,Ischemic stroke after use of the synthetic marijuana “spice”,https://ncbi.nlm.nih.gov/pubmed/24212384,Negative,,Meta-analysis,2013,JWH-x Synthetic Cannabinoids,Nervous System,Stroke; Cardiovascular Diseases (CVD); Heart Attack
2023226,Induction of Anxiety-Like Phenotypes by Knockdown of Cannabinoid Type-1 Receptors in the Amygdala of Marmosets,https://link.springer.com/epdf/10.1007/s12264-023-01081-2?sharing_token=3aHZO0EinBV4P0wQn-z8i_e4RwlQNchNByi7wbcMAY6WMORDeRzlSBk881rWkZC3Jx_wLAHVwCf69S2dhfPhJNJJ4umFQvj0gxctvOzhueaG4KeBLfoRlNe7pLftwhJgdjVKwnbZwe0Tg5DQvc5a5ruEGg5XrZe_IYi4Ea2hBxk%3D,Negative,,Animal Study,2023,Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,Anxiety; Behavioral Disorders; Cognitive Dysfunction; Depression; Insomnia and Sleep Disorders
2014017,A case of acute cerebral ischemia following inhalation of a synthetic cannabinoid,https://www.tandfonline.com/doi/abs/10.3109/15563650.2014.958614?journalCode=ictx20,Negative,,Meta-analysis,2014,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis; Stroke
2023227,Implementation of the First Comprehensive State Oral Fluid Drug Testing Program for Roadside Screening and Laboratory Testing in DUID Cases - A Five-Year Review,https://pubmed.ncbi.nlm.nih.gov/37526020/,Positive,,Clinical Trial,2023,,,Addiction - Opioid; Cannabis Adverse Effects
2023228,Could cannabinoids provide a new hope for ovarian cancer patients?,https://bpspubs.onlinelibrary.wiley.com/doi/10.1002/prp2.1122,Positive,,Meta-analysis,2023,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Cannabichromene (CBC); Cannabidivarin (CBDV); Fatty Acid Amide Hydrolase (FAAH); JWH-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); N-Arachidonoyl Dopamine (NADA); Pharma THC:CBD; Virodhamine (O-AEA); WIN-x Synthetic Cannabinoids,Nervous System; Reproductive System,Cancer - Ovarian; Cancer; Cancer; Acne; Anorexia; Arthritis - Rheumatoid; Arthritis; Cancer - Brain; Cancer - Breast; Cancer - Lung; Cancer - Metastatic; Chemotherapy-induced Nausea & Vomiting; Cognitive Dysfunction; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Inflammation; Tetanus; Loss of Appetite; Pain
2023229,"Prenatal THC exposure induces long-term, sex-dependent cognitive dysfunction associated with lipidomic and neuronal pathology in the prefrontal cortex-hippocampal network",https://www.nature.com/articles/s41380-023-02190-0,Negative,,Animal Study,2023,Tetrahydrocannabinol (THC); Endocannabinoid (unspecified),Nervous System; Reproductive System,Cognitive Dysfunction; Neonatal Cerebral Issues; Pregnancy; Cannabis Adverse Effects; Psychosis
2023230,Cannabidiol tempers alcohol intake and neuroendocrine and behavioural correlates in alcohol binge drinking adolescent rats. Focus on calcitonin gene-related peptide's brain levels,https://onlinelibrary.wiley.com/doi/10.1002/ptr.7972,Positive,,Animal Study,2023,,Mental/Emotional System,Addiction - Alcohol; Addiction; Behavioral Disorders; Anxiety
2023231,"Cannabidiol (CBD) with 4',7-Isoflavandiol (Equol) Efficacy is Greater than CBD or Equol Treatment Alone via Human Skin Gene Expression Analysis",https://www.imrpress.com/journal/FBL/28/7/10.31083/j.fbl2807154/htm#S2,Positive,,Laboratory Study,2023,Cannabigerol (CBG),Integumentary System,Skin Diseases; Acne; Geriatric Conditions; Inflammation; Oxidative Stress; Wound Healing
2023232,Cannabidiol Analogue CIAC001 for the Treatment of Morphine-Induced Addiction by Targeting PKM2,https://pubmed.ncbi.nlm.nih.gov/37531582/,Positive,,Laboratory Study,2023,,Mental/Emotional System,Addiction - Opioid; Addiction; Inflammation
2023233,Effect of any form of steroids in comparison with that of other medications on the duration of olfactory dysfunction in patients with COVID-19: A systematic review of randomized trials and quasi-experimental studies,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0288285#sec020,Positive,,Meta-analysis,2023,Palmitoylethanolamide (PEA),Respiratory System,COVID-19; Depression; Inflammation
2020081,The potential of Allium sativum and Cannabis sativa extracts for anti-tick activities against Rhipicephalus (Boophilus) microplus,https://pubmed.ncbi.nlm.nih.gov/32886258/,Positive,,Animal Study,2020,,,Chagas Disease; Leishmaniasis; Malaria; Parasitic Worms
2023234,"In Vitro and In Vivo Safety of Hyaluronic Acid-Decorated Microparticles for Intravitreal Injection of Palmitoylethanolamide, Citicoline, or Glial-Cell-Derived Neurotrophic Factor",https://pubmed.ncbi.nlm.nih.gov/37531486/,Positive,,Laboratory Study,2023,Palmitoylethanolamide (PEA),,Glaucoma; Inflammation; Pain; Pain - Eye
2023235,Saffron (Crocus sativus) and its constituents for pain management: A review of current evidence,https://pubmed.ncbi.nlm.nih.gov/37528638/,Positive,,Meta-analysis,2023,Endocannabinoid (unspecified),,Pain; Arthritis - Rheumatoid; Arthritis; Fibromyalgia; Menstrual Disorders; Oxidative Stress; Pregnancy
2023236,Exploring the therapeutic potential of an antinociceptive and anti-inflammatory peptide from wasp venom,https://www.nature.com/articles/s41598-023-38828-w#Sec15,Positive,,Animal Study,2023,AM-x Synthetic Cannabinoids; Endocannabinoid (unspecified),Nervous System,Inflammation; Pain; Pain; Addiction - Opioid; Constipation; Epilepsy; Pain - Nociceptive; Pain - Chronic
2023237,Striatonigral direct pathway 2-arachidonoylglycerol contributes to ethanol effects on synaptic transmission and behavior,https://www.nature.com/articles/s41386-023-01671-8#Sec20,Positive,,Animal Study,2023,2-Arachidonoyl Glycerol (2-AG); Endocannabinoid (unspecified); Anandamide (AEA),Mental/Emotional System; Nervous System,Addiction - Alcohol; Behavioral Disorders; Addiction
2023238,Evaluation of Field Sobriety Tests for Identifying Drivers Under the Influence of Cannabis: A Randomized Clinical Trial,https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2807719,Negative,,Double Blind Clinical Trial,2023,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2023239,The Effectiveness and Adverse Events of Cannabidiol and Tetrahydrocannabinol Used in the Treatment of Anxiety Disorders in a PTSD Subpopulation: An Interim Analysis of an Observational Study,https://journals.sagepub.com/doi/10.1177/87551225231180796,Positive,,Meta-analysis,2023,,Mental/Emotional System,Anxiety; PTSD; Depression; Nausea and Vomiting; Quality of Life
2016037,Effect of marijuana on Essential Tremor: A case report,https://www.mdsabstracts.org/abstract/effect-of-marijuana-on-essential-tremor-a-case-report/,Positive,,Meta-analysis,2016,Tetrahydrocannabinol (THC),,Essential Tremor
2023240,[Regulative effects of endogenous sulfur dioxide on oxidant stress in myocardium of rat with sepsis],https://pubmed.ncbi.nlm.nih.gov/37534635/,Positive,,Animal Study,2023,Fatty Acid-Binding Protein (FABP),Immune System; Nervous System,Oxidative Stress; Sepsis; Cardiovascular Diseases (CVD); Heart Attack; Inflammation
2023241,"Does the ""Entourage Effect"" in Cannabinoids Exist? A Narrative Scoping Review",https://pubmed.ncbi.nlm.nih.gov/37535820/,Positive,,Laboratory Study,2023,Endocannabinoid (unspecified); Tetrahydrocannabinol (THC),,
2021116,Spinal astroglial cannabinoid receptors control pathological tremor,https://www.researchgate.net/publication/350158265_Spinal_astroglial_cannabinoid_receptors_control_pathological_tremor,Positive,,Animal Study,2021,WIN-x Synthetic Cannabinoids,Nervous System,Essential Tremor
2023242,Questioning the role of palmitoylethanolamide in psychosis: a systematic review of clinical and preclinical evidence,https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1231710/full,Positive,,Meta-analysis,2023,Palmitoylethanolamide (PEA); 2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Psychosis; Addiction - Cannabis; Anxiety; Bipolar Disorder; Depression; Inflammation; Pain; Neurodegenerative Issues; Oxidative Stress; Parkinson's Disease; PTSD; Schizophrenia
2023243,Cannabinoid receptor type 1 (CB1R) inhibits hypothalamic leptin signaling via β-arrestin1 in complex with TC-PTP and STAT3,https://www.cell.com/action/showPdf?pii=S2589-0042%2823%2901284-1,Positive,,Animal Study,2023,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); CP-x Synthetic Cannabinoids; Diet; Fatty Acid Amide Hydrolase (FAAH); Synthetic Cannabinoid (unspecified),,Anorexia; Loss of Appetite; Obesity
2023244,Molecular pathway and structural mechanism of human oncochannel TRPV6 inhibition by the phytocannabinoid tetrahydrocannabivarin,https://www.nature.com/articles/s41467-023-40362-2#Sec12,Positive,,Laboratory Study,2023,Tetrahydrocannabivarin (THCV),Nervous System,Cancer
2023245,Biobehavioral Interactions between Endocannabinoid and Hypothalamic-pituitary-adrenal Systems in Psychosis: A Systematic Review,https://pubmed.ncbi.nlm.nih.gov/37533248/,Inconclusive,,Meta-analysis,2023,Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,Behavioral Disorders; Psychosis; Addiction - Cannabis; PTSD
2023246,Hippocampal differential expression underlying the neuroprotective effect of delta-9-tetrahydrocannabinol microdose on old mice,https://www.frontiersin.org/articles/10.3389/fnins.2023.1182932/full,Positive,,Animal Study,2023,,,Neurodegenerative Issues; Cognitive Dysfunction; Inflammation
2023247,Dramatic efficacy of cannabidiol on refractory chronic pain in an adolescent with sickle cell disease,https://onlinelibrary.wiley.com/doi/10.1002/ajh.27049,Positive,,Meta-analysis,2023,Pharma CBD; Synthetic Cannabinoid (unspecified),Cardiovascular System,Pain; Pain - Chronic; Sickle Cell Disorders; Anxiety; Constipation; Depression; Pain - Acute
2023248,Role of Algal-derived Bioactive Compounds in Human Health,https://pubmed.ncbi.nlm.nih.gov/37537776/,Positive,,Meta-analysis,2023,Diet; Phycocyanin,,Bacterial Infections; Cancer; Inflammation; Oxidative Stress
2023249,"Anandamide reduces the migration of lymphocytes to the intestine by CB2 activation and reduces TNF-α in the target organs, protecting mice from graft-versus-host disease",https://www.sciencedirect.com/science/article/abs/pii/S0014299923004442?via%3Dihub,Positive,,Animal Study,2023,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); JWH-x Synthetic Cannabinoids,Immune System,Graft-versus-Host-Disease; Inflammation; Organ Transplant Failure
2023250,"Medical Cannabis Received by Patients According to Qualifying Condition in a US State Cannabis Program: Product Choice, Dosing, and Age-Related Trends",https://www.sciencedirect.com/science/article/pii/S0011393X23000188?via%3Dihub,Positive,,Meta-analysis,2023,Pharma CBD; Pharma THC,,Anorexia; Autism; Cachexia; Cancer; Chemotherapy-induced Nausea & Vomiting; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Glaucoma; IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; HIV/AIDS; Insomnia and Sleep Disorders; Tics and Tourettes; Pain; Multiple Sclerosis; Nausea and Vomiting; Pain - Cancer; Pain - Chronic; PTSD
2023251,Confirmation of cannabinoids in forensic toxicology casework by isomer-selective UPLC-MS-MS analysis in urine,https://pubmed.ncbi.nlm.nih.gov/37540526/,Inconclusive,,Laboratory Study,2023,Delta-8-THC; Tetrahydrocannabinol (THC),,
2023252,Involvement of cannabinoid receptors and neuroinflammation in early sepsis: Implications for posttraumatic stress disorder,https://www.sciencedirect.com/science/article/abs/pii/S1567576923010706?via%3Dihub,Positive,,Clinical Trial,2023,AM-x Synthetic Cannabinoids; 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified); Tetrahydrocannabinol (THC); WIN-x Synthetic Cannabinoids,Immune System; Mental/Emotional System,Inflammation; PTSD; Sepsis; Acute Respiratory Distress Syndrome; Anxiety; Bacterial Infections; Cardiovascular Diseases (CVD); COVID-19; Depression; Kidney Failure; Liver Failure; Stress
2023253,CB1 receptor expression and signaling are required for dexamethasone-induced aversive memory consolidation,https://www.sciencedirect.com/science/article/abs/pii/S0028390823002642?via%3Dihub,Positive,,Animal Study,2023,Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); AM-x Synthetic Cannabinoids; Anandamide (AEA); Delta-8-THC; HU-x Synthetic Cannabinoids,,Cognitive Dysfunction; Anxiety; Poisoning by Synthetic Cannabis
2023254,Therapeutic effect of cannabidiol on myocardial arachidonic acid content in various lipid fractions in a rat model of obesity,https://www.sciencedirect.com/science/article/abs/pii/S1098882323000643?via%3Dihub,Positive,,Animal Study,2023,Endocannabinoid (unspecified),Endocrine System,Obesity; Cardiovascular Diseases (CVD); Inflammation; Metabolic Syndrome; Multiple Sclerosis; Neurodegenerative Issues; Oxidative Stress
2023255,Cannabidiol's impact on drug-metabolization,https://pubmed.ncbi.nlm.nih.gov/37541924/,Inconclusive,,Laboratory Study,2023,,,Cannabis Adverse Effects
2023256,Endocannabinoid system components as potential neuroimmune therapeutic targets in tinnitus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248455/,Positive,,Meta-analysis,2023,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),,Tinnitus
2023257,The endogenous cannabinoid system modulates male sexual behavior expression,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264596/,Positive,,Meta-analysis,2023,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),Endocrine System; Reproductive System,Libido; Erectile Dysfunction; Infertility (Male)
2023258,The role of cannabidiol in aging,https://www.sciencedirect.com/science/article/pii/S075333222300865X?via%3Dihub,Positive,,Meta-analysis,2023,,Integumentary System,Longevity; Sarcopenia
2023259,Cannabidiol-induced crosstalk of apoptosis and macroautophagy in colorectal cancer cells involves p53 and Hsp70,https://www.nature.com/articles/s41420-023-01578-9,Positive,,Laboratory Study,2023,,Digestive System,Cancer - Colon; Cancer; Cancer; Cancer - Brain; Cancer - Lung; Cancer - Metastatic; Oxidative Stress
2023260,Cannabis use for exercise recovery in trained individuals: a survey study,https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-023-00198-5,Positive,,Meta-analysis,2023,Exercise,,Cannabis Adverse Effects; Inflammation; Insomnia and Sleep Disorders; Pain; Pain - Chronic
2023261,"Discovery of 1,3-disubstituted pyrazole peripheral cannabinoid receptor partial agonists",https://www.sciencedirect.com/science/article/abs/pii/S0960894X23003086?via%3Dihub#preview-section-abstract,Positive,,Laboratory Study,2023,Tetrahydrocannabinol (THC),,
2023262,A systematic review of cannabidiol trials in neurodevelopmental disorders,https://www.sciencedirect.com/science/article/pii/S0091305723000941?via%3Dihub#s0115,Positive,,Clinical Meta-analysis,2023,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Cannabidivarin (CBDV); Fatty Acid Amide Hydrolase (FAAH),,ADD and ADHD; Behavioral Disorders; Anxiety; Autism; Cognitive Dysfunction; Depression; Epilepsy; Inflammation; Tics and Tourettes; Loss of Appetite; Pain; Psychosis
2023263,CBD-oil as a potential solution in case of severe tamoxifen-related side effects,https://www.nature.com/articles/s41523-023-00570-x#Sec1,Positive,,Clinical Trial,2023,,Reproductive System,Cancer - Breast; Cancer; Insomnia and Sleep Disorders; Pain; Night Sweats and Excessive Sweating; Quality of Life
2011015,"A randomized, double-blind, placebo-controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use",https://pubmed.ncbi.nlm.nih.gov/21671456/,Negative,,Double Blind Clinical Trial,2011,Pharma THC:CBD; Pharma THC,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cognitive Dysfunction; Addiction - Cannabis; Poisoning by Synthetic Cannabis
2011016,Ocular hypotensive effect of oral palmitoyl-ethanolamide: a clinical trial,https://iovs.arvojournals.org/article.aspx?articleid=2187063,Positive,,Double Blind Clinical Trial,2011,Palmitoylethanolamide (PEA); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Nervous System,Glaucoma; Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Inflammation; Pain; Oxidative Stress; Pain - Chronic
2011017,Myocardial protective effect of human atrial natriuretic Peptide in cardiac surgery. -hANP Shot” in clinical safety trial-,https://www.jstage.jst.go.jp/article/circj/75/9/75_CJ-11-0185/_pdf/-char/en,Positive,,Clinical Trial,2011,Fatty Acid-Binding Protein (FABP),Cardiovascular System,Cardiovascular Diseases (CVD); Atherosclerosis; Cardiac Arrhythmias; Heart Attack; Inflammation; Kidney Failure
2011018,CB1 - cannabinoid receptor antagonist effects on cortisol in cannabis-dependent men,https://pubmed.ncbi.nlm.nih.gov/21797816/,Inconclusive,,Double Blind Clinical Trial,2011,SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects; Poisoning by Synthetic Cannabis
2011019,Pharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndrome,https://www.gastrojournal.org/action/showPdf?pii=S0016-5085%2811%2901069-9,Positive,,Double Blind Clinical Trial,2011,Pharma THC; 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Digestive System,Irritable Bowel Syndrome; Diarrhea; IBD - Inflammatory Bowel Disease
2011020,Involvement of the endocannabinoid system in reward processing in the human brain,https://link.springer.com/article/10.1007/s00213-011-2428-8,Positive,,Clinical Trial,2011,Endocannabinoid (unspecified); Tetrahydrocannabinol (THC); SR-x Synthetic Cannabinoids,,ADD and ADHD; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant; Anxiety; Cannabis Adverse Effects; Cognitive Dysfunction; Depression; Psychosis
2011021,Palmitoylethanolamide effects on intraocular pressure after Nd:YAG laser iridotomy: an experimental clinical study,https://pubmed.ncbi.nlm.nih.gov/21830944/,Positive,,Clinical Trial,2011,Palmitoylethanolamide (PEA),,Glaucoma; Inflammation; Pain; Pain - Eye
2011022,Antagonist-elicited cannabis withdrawal in humans,https://pubmed.ncbi.nlm.nih.gov/21869692/,Inconclusive,,Double Blind Clinical Trial,2011,SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2011023,"A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)",https://journals.sagepub.com/doi/10.1177/1352458511419700,Positive,,Clinical Trial,2011,Pharma THC:CBD; 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified),Nervous System,Multiple Sclerosis; Anxiety; Epilepsy; Insomnia and Sleep Disorders; Loss of Appetite; Pain; Nausea and Vomiting; Oxidative Stress; Pain - Chronic; Psychosis
2011024,Effects of lipid-lowering therapy with rosuvastatin on kidney function and oxidative stress in patients with diabetic nephropathy,https://www.jstage.jst.go.jp/article/jat/18/11/18_9084/_pdf/-char/en,Positive,,Clinical Trial,2011,Fatty Acid-Binding Protein (FABP),Endocrine System; Urinary System,Diabetic Kidney Disease; Kidney Failure; Oxidative Stress; Arthritis; Atherosclerosis; Cardiovascular Diseases (CVD); Chronic Kidney Disease; Diabetes; Inflammation
2011025,Addition of aliskiren to olmesartan ameliorates tubular injury in chronic kidney disease patients partly by reducing proteinuria,https://journals.sagepub.com/doi/10.1177/1470320311422580,Positive,,Clinical Trial,2011,Fatty Acid-Binding Protein (FABP),Urinary System,Chronic Kidney Disease; Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2011026,ANKK1/DRD2 locus variants are associated with rimonabant efficacy in aiding smoking cessation: pilot data,https://pubmed.ncbi.nlm.nih.gov/21997315/,Positive,,Double Blind Clinical Trial,2011,SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Addiction - Nicotine; Addiction; Poisoning by Synthetic Cannabis
2011027,Does change in cannabis use in established psychosis affect clinical outcome?,https://academic.oup.com/schizophreniabulletin/article/39/2/339/1824440?login=false#google_vignette,Inconclusive,,Clinical Trial,2011,,Mental/Emotional System; Nervous System,Psychosis; Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Opioid; Addiction - Stimulant; Cannabis Adverse Effects; Schizophrenia
2011028,Adipose tissue endocannabinoid system gene expression: depot differences and effects of diet and exercise,https://lipidworld.biomedcentral.com/articles/10.1186/1476-511X-10-194#Sec16,Positive,,Clinical Trial,2011,Diet; Endocannabinoid (unspecified); Exercise; Fatty Acid Amide Hydrolase (FAAH); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Endocrine System,Obesity; Cardiovascular Diseases (CVD); Diabetes; Metabolic Syndrome
2011029,Rimonabant for neurocognition in schizophrenia: a 16-week double blind randomized placebo controlled trial,https://www.sciencedirect.com/science/article/abs/pii/S0920996411006037?via%3Dihub,Negative,,Double Blind Clinical Trial,2011,SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Mental/Emotional System,Cognitive Dysfunction; Schizophrenia; Poisoning by Synthetic Cannabis
2012018,Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial,https://pubmed.ncbi.nlm.nih.gov/22151583/,Positive,,Clinical Trial,2012,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Psychosis; Cannabis Adverse Effects
2012019,Does rimonabant independently affect free fatty acid and glucose metabolism?,https://academic.oup.com/jcem/article/97/3/819/2536339?login=false#59670953,Negative,,Double Blind Clinical Trial,2012,SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); Endocannabinoid (unspecified),,Diabetes; Inflammation; Metabolic Syndrome; Obesity; Poisoning by Synthetic Cannabis
2012020,Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans,https://academic.oup.com/ijnp/article/15/9/1251/670746?login=false#11727103,Inconclusive,,Double Blind Clinical Trial,2012,Anandamide (AEA),Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Addiction - Cannabis; Addiction - Opioid; Behavioral Disorders; Anxiety; Cognitive Dysfunction; Pain; Psychosis
2012021,Total intermittent Pringle maneuver during liver resection can induce intestinal epithelial cell damage and endotoxemia,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0030539#s4,Negative,,Clinical Trial,2012,Fatty Acid-Binding Protein (FABP),Digestive System,Toxic Liver Disease; Bacterial Infections; Inflammation; Liver Failure; Sepsis
2012022,Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea,https://pubmed.ncbi.nlm.nih.gov/22288893/,Inconclusive,,Double Blind Clinical Trial,2012,Fatty Acid Amide Hydrolase (FAAH); Tetrahydrocannabinol (THC),Digestive System,Diarrhea; Irritable Bowel Syndrome
2012023,Effects of δ9-tetrahydrocannabinol on human working memory function,https://pubmed.ncbi.nlm.nih.gov/22341370/,Negative,,Clinical Trial,2012,Endocannabinoid (unspecified); Tetrahydrocannabinol (THC),Nervous System,Cognitive Dysfunction; Psychosis; Schizophrenia
2023264,"CBD: A Potential Lead against Hair Loss, Alopecia, and its Potential Mechanisms",https://europepmc.org/article/med/37475557?link_id=42&can_id=a903211256bc196929fb9c03ae400769&source=email-download-new-cal-norml-white-paper-and-literature-your-weekly-news-action-items-and-events&email_referrer=email_2002413&email_subject=your-weekly-news-action-items-and-events-from-cal-norml,Positive,,Meta-analysis,2023,,Integumentary System,Hair Loss
2012024,[Six-month follow-up study of drug treatment for cannabis addiction: comparison study of four drugs],https://pubmed.ncbi.nlm.nih.gov/22352278/,Positive,,Clinical Trial,2012,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Anxiety; Cannabis Adverse Effects; Depression
2012025,Fatty acid flux and oxidation are increased by rimonabant in obese women,https://pubmed.ncbi.nlm.nih.gov/22445512/,Positive,,Clinical Trial,2012,SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Endocrine System,Obesity; Oxidative Stress; Poisoning by Synthetic Cannabis
2012026,"Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial",https://pubmed.ncbi.nlm.nih.gov/22483680/,Positive,,Double Blind Clinical Trial,2012,Pharma THC:CBD,Nervous System,Pain; Pain - Cancer; Pain - Chronic; Addiction - Opioid; Cancer; Insomnia and Sleep Disorders
2012027,Palmitoylethanolamide versus a nonsteroidal anti-inflammatory drug in the treatment of temporomandibular joint inflammatory pain,https://pubmed.ncbi.nlm.nih.gov/22558609/,Positive,,Clinical Trial,2012,Palmitoylethanolamide (PEA),Nervous System; Skeletal System,Arthritis; Inflammation; Pain
2012028,Additive renoprotective effects of aliskiren on angiotensin receptor blocker and calcium channel blocker treatments for type 2 diabetic patients with albuminuria,https://www.nature.com/articles/hr201245,Positive,,Clinical Trial,2012,Fatty Acid-Binding Protein (FABP),Endocrine System; Urinary System,Diabetes; Diabetic Kidney Disease; Cardiovascular Diseases (CVD); Chronic Kidney Disease; Hypertension (High Blood Pressure); Oxidative Stress
2012029,Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects,https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.2012.04164.x,Positive,,Double Blind Clinical Trial,2012,Pharma THC,,Anorexia; Cancer; Cannabis Hyperemesis Syndrome; HIV/AIDS; Pain; Multiple Sclerosis; Nausea and Vomiting
2012030,"Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers",https://pubmed.ncbi.nlm.nih.gov/22716148/,Negative,,Double Blind Clinical Trial,2012,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Anxiety; Psychosis
2012031,"Human abuse potential and cognitive effects of taranabant, a cannabinoid 1 receptor inverse agonist: a randomized, double-blind, placebo- and active-controlled, crossover study in recreational polydrug users",https://pubmed.ncbi.nlm.nih.gov/22722508/,Positive,,Double Blind Clinical Trial,2012,Pharma THC; Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cognitive Dysfunction
2012032,"An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee",https://pubmed.ncbi.nlm.nih.gov/22727500/,Inconclusive,,Double Blind Clinical Trial,2012,Fatty Acid-Binding Protein (FABP),Nervous System; Skeletal System,Arthritis - Osteoarthritis; Arthritis; Pain; Pain; Pain - Chronic
2012033,A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers,https://pubmed.ncbi.nlm.nih.gov/22741619/,Negative,,Double Blind Clinical Trial,2012,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Anorexia; Cannabis Adverse Effects; Insomnia and Sleep Disorders
2012034,Renoprotective and antioxidant effects of cilnidipine in hypertensive patients,https://www.nature.com/articles/hr201296,Positive,,Clinical Trial,2012,Fatty Acid-Binding Protein (FABP),Cardiovascular System; Nervous System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Oxidative Stress; Chronic Kidney Disease; Kidney Failure
2012035,Acute stress increases circulating anandamide and other N-acylethanolamines in healthy humans,https://www.nature.com/articles/npp2012100,Negative,,Clinical Trial,2012,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Palmitoylethanolamide (PEA),Mental/Emotional System,Anxiety; Cardiovascular Diseases (CVD); Depression; Hypertension (High Blood Pressure); Menstrual Disorders; Metabolic Syndrome; Psychosis
2012036,CB(1) blockade-induced weight loss over 48 weeks decreases liver fat in proportion to weight loss in humans,https://pubmed.ncbi.nlm.nih.gov/22828945/,Positive,,Clinical Trial,2012,Synthetic Cannabinoid (unspecified); Endocannabinoid (unspecified),Digestive System; Endocrine System,Fatty Liver Disease; Obesity; Liver Failure
2012037,Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis,https://pubmed.ncbi.nlm.nih.gov/22878432/,Positive,,Clinical Trial,2012,Pharma THC:CBD,Nervous System,Multiple Sclerosis; Psychosis
2012038,"L/N-type calcium channel blocker cilnidipine reduces plasma aldosterone, albuminuria, and urinary liver-type fatty acid binding protein in patients with chronic kidney disease",https://pubmed.ncbi.nlm.nih.gov/22914905/,Positive,,Clinical Trial,2012,Fatty Acid-Binding Protein (FABP),Urinary System,Chronic Kidney Disease; Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Kidney Failure
2012039,"An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain",https://pubmed.ncbi.nlm.nih.gov/22921260/,Positive,,Double Blind Clinical Trial,2012,Pharma THC,Nervous System,Pain; Pain; Pain - Neuropathy - Diabetic; Anxiety; Depression; Diabetes; Pain - Chronic; Pain - Neuropathy - Peripheral
2012040,Glucocorticoid-endocannabinoid interaction in cardiac surgical patients: relationship to early cognitive dysfunction and late depression,https://pubmed.ncbi.nlm.nih.gov/23006898/,Negative,,Clinical Trial,2012,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,Cognitive Dysfunction; Depression
2012041,Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers,https://pubmed.ncbi.nlm.nih.gov/23020923/,Inconclusive,,Double Blind Clinical Trial,2012,,Mental/Emotional System; Nervous System,Psychosis
2012042,Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment,https://pubmed.ncbi.nlm.nih.gov/23042808/,Negative,,Clinical Trial,2012,,Nervous System,Cognitive Dysfunction; Psychosis
2012043,Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes,https://academic.oup.com/jcem/article/97/12/4701/2536631?login=false,Negative,,Double Blind Clinical Trial,2012,Endocannabinoid (unspecified); Fatty Acid-Binding Protein (FABP),Endocrine System,Diabetes; Cardiovascular Diseases (CVD); Inflammation; Metabolic Syndrome; Obesity
2012044,An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics,https://www.jpsmjournal.com/article/S0885-3924(12)00439-3/fulltext#secd33833369e980,Positive,,Clinical Trial,2012,Pharma THC:CBD; Pharma THC; Endocannabinoid (unspecified),Nervous System,Pain; Pain; Pain - Cancer; Addiction - Opioid; Anxiety; Cancer; Epilepsy; Insomnia and Sleep Disorders; Loss of Appetite; Multiple Sclerosis; Nausea and Vomiting; Pain - Chronic; Pain - Neuropathy - Peripheral; Psychosis
2012045,Efficacy of rimonabant in obese patients with binge eating disorder,https://pubmed.ncbi.nlm.nih.gov/23147209/,Positive,,Double Blind Clinical Trial,2012,SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); Endocannabinoid (unspecified),Endocrine System,Obesity; Metabolic Syndrome; Poisoning by Synthetic Cannabis
2012046,Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?,https://www.sciencedirect.com/science/article/abs/pii/S0376871612004115?via%3Dihub,Positive,,Clinical Trial,2012,Cannabinol (CBN); Pharma THC:CBD,,Addiction - Cannabis; Anorexia; Arthritis - Rheumatoid; Arthritis; Cannabis Adverse Effects; Chemotherapy-induced Nausea & Vomiting; Epilepsy; Glaucoma; HIV/AIDS; Insomnia and Sleep Disorders; Pain; Pain - Cancer; Poisoning by Synthetic Cannabis
2012047,"A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis",https://pubmed.ncbi.nlm.nih.gov/23180178/,Inconclusive,,Double Blind Clinical Trial,2012,Pharma THC:CBD,Nervous System,Pain; Pain; Multiple Sclerosis; Pain - Central Pain Syndrome; Pain - Chronic; Pain - Neuropathy - Peripheral
2012048,Pain as a reward: changing the meaning of pain from negative to positive co-activates opioid and cannabinoid systems,https://pubmed.ncbi.nlm.nih.gov/23265686/,Positive,,Clinical Trial,2012,Endocannabinoid (unspecified),Nervous System,Pain; Pain; Pain - Acute; Addiction - Opioid; Pain - Cancer
2013020,Effects of the Cannabinoid-1 Receptor Antagonist/Inverse Agonist Rimonabant on Satiety Signaling in Overweight People with Schizophrenia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836264/,Negative,,Double Blind Clinical Trial,2013,SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Schizophrenia; Loss of Appetite; Obesity; Poisoning by Synthetic Cannabis; Psychosis
2013021,"Surinabant, a selective cannabinoid receptor type 1 antagonist, inhibits Δ9-tetrahydrocannabinol-induced central nervous system and heart rate effects in humans",https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.12071,Inconclusive,,Double Blind Clinical Trial,2013,,,Addiction - Nicotine; Behavioral Disorders; Anxiety; Cannabis Adverse Effects; Cardiovascular Diseases (CVD); Cognitive Dysfunction; Depression; Diabetes; Obesity; Psychosis; Suicide Attempt
2013022,"A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders",https://pubmed.ncbi.nlm.nih.gov/23297841/,Negative,,Double Blind Clinical Trial,2013,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Depression
2013023,"Effectiveness of palmitoylethanolamide on endothelial dysfunction in ocular hypertensive patients: a randomized, placebo-controlled cross-over study",https://iovs.arvojournals.org/article.aspx?articleid=2128967,Positive,,Double Blind Clinical Trial,2013,Palmitoylethanolamide (PEA); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH),Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Glaucoma; Heart Attack; Inflammation; Oxidative Stress
2013024,Effects of a topically applied 2% delta-9-tetrahydrocannabinol ophthalmic solution on intraocular pressure and aqueous humor flow rate in clinically normal dogs,https://avmajournals.avma.org/view/journals/ajvr/74/2/ajvr.74.2.275.xml,Positive,,Animal Study -,2013,Pharma THC,,Veterinary Applications; Anorexia; Cachexia; Cancer; Glaucoma; HIV/AIDS; Loss of Appetite; Pain; Nausea and Vomiting; Neurodegenerative Issues; Oxidative Stress; Pain - Cancer; Pain - Eye; Psychosis
2013025,Addition of capsaicin and exchange of carbohydrate with protein counteract energy intake restriction effects on fullness and energy expenditure,https://www.sciencedirect.com/science/article/pii/S0022316622011440?via%3Dihub#s0010,Positive,,Clinical Trial,2013,Capsaicin (CAPS),,Anorexia; Atherosclerosis; Cancer; Cardiovascular Diseases (CVD); Diabetes; Hypertension (High Blood Pressure); Loss of Appetite; Metabolic Syndrome; Obesity; Oxidative Stress
2013026,Randomised Assessment of Treatment using Panel Assay of Cardiac markers--Contemporary Biomarker Evaluation (RATPAC CBE),https://pubmed.ncbi.nlm.nih.gov/23597479/,Negative,,Clinical Trial,2013,Fatty Acid-Binding Protein (FABP),Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack; Pain; Pain - Acute
2013027,Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia,https://www.sciencedirect.com/science/article/abs/pii/S1053811913003996?via%3Dihub#preview-section-snippets,Negative,,Clinical Trial,2013,Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,Schizophrenia; Depression; Psychosis
2013028,"A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain",https://www.jpsmjournal.com/article/S0885-3924(13)00238-8/fulltext#secd54940049e992,Positive,,Clinical Trial,2013,Pharma THC:CBD,Nervous System,Pain; Pain; Pain - Cancer; Pain - Neuropathy - Peripheral; Anxiety; Cancer; Depression; Loss of Appetite; Nausea and Vomiting; Pain - Neuropathy - Drug-Ind. Polyneuropathy
2013029,Acute effects of capsaicin on energy expenditure and fat oxidation in negative energy balance,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0067786#s2,Positive,,Clinical Trial,2013,Capsaicin (CAPS); Diet,Nervous System,Oxidative Stress; Obesity
2013030,"Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial",https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(13)70159-5/fulltext#seccestitle150,Inconclusive,,Double Blind Clinical Trial,2013,Pharma THC,Nervous System,Multiple Sclerosis; Inflammation; Pain; Neurodegenerative Issues; Oxidative Stress; Pain - Chronic
2013031,Th1 and Th2 cytokine gene expression in primary infection and vaccination against Fasciola gigantica in buffaloes by real-time PCR,https://pubmed.ncbi.nlm.nih.gov/23873619/,Inconclusive,,Animal Study -,2013,Fatty Acid-Binding Protein (FABP),Digestive System,Parasitic Worms; Veterinary Applications
2013032,Default mode network in the effects of Δ9-Tetrahydrocannabinol (THC) on human executive function,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0070074#s2,Negative,,Double Blind Clinical Trial,2013,Tetrahydrocannabinol (THC),Nervous System,Cognitive Dysfunction; ADD and ADHD; Alzheimer's Disease; Cannabis Adverse Effects; Psychosis; Schizophrenia
2013033,Remote ischemic pre-conditioning alleviates contrast-induced acute kidney injury in patients with moderate chronic kidney disease,https://pubmed.ncbi.nlm.nih.gov/23986081/,Positive,,Clinical Trial,2013,Fatty Acid-Binding Protein (FABP),Urinary System,Chronic Kidney Disease; Kidney Failure
2014018,"The subjective psychoactive effects of oral dronabinol studied in a randomized, controlled crossover clinical trial for pain",https://pubmed.ncbi.nlm.nih.gov/24281276/,Negative,,Clinical Trial,2014,Pharma THC,Mental/Emotional System; Nervous System,Pain; Pain; Psychosis; Addiction - Opioid; Pain - Chronic
2014019,Treatment of cannabis dependence using escitalopram in combination with cognitive-behavior therapy: a double-blind placebo-controlled study,https://pubmed.ncbi.nlm.nih.gov/24359507/,Inconclusive,,Double Blind Clinical Trial,2014,Mind-Body Medicine; Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Behavioral Disorders; Anxiety; Cognitive Dysfunction; Depression
2014020,"A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment",https://pubmed.ncbi.nlm.nih.gov/24420962/,Positive,,Double Blind Clinical Trial,2014,Tetrahydrocannabinol (THC); Pharma THC:CBD,Nervous System,Pain; Pain - Neuropathy - Peripheral; Insomnia and Sleep Disorders
2014021,Xylanase supplementation of a wheat-based diet improved nutrient digestion and mRNA expression of intestinal nutrient transporters in broiler chickens infected with Clostridium perfringens,https://www.sciencedirect.com/science/article/pii/S0032579119359875?via%3Dihub,Negative,,Animal Study,2014,Fatty Acid-Binding Protein (FABP),Immune System,Bacterial Infections
2014022,Influence of dietary fat intake on the endocannabinoid system in lean and obese subjects,https://onlinelibrary.wiley.com/doi/10.1002/oby.20728,Positive,,Clinical Trial,2014,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Diet; Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Endocrine System,Obesity; Inflammation; Metabolic Syndrome
2014023,"Capsaicin increases sensation of fullness in energy balance, and decreases desire to eat after dinner in negative energy balance",https://pubmed.ncbi.nlm.nih.gov/24630935/,Positive,,Clinical Trial,2014,Capsaicin (CAPS),,Metabolic Syndrome; Obesity
2014024,Effects of 20 mg oral Δ(9) -tetrahydrocannabinol on the olfactory function of healthy volunteers,https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.12415,Negative,,Double Blind Clinical Trial,2014,Tetrahydrocannabinol (THC); Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cognitive Dysfunction
2014025,Effect of palmitoylethanolamide on visual field damage progression in normal tension glaucoma patients: results of an open-label six-month follow-up,https://pubmed.ncbi.nlm.nih.gov/24827384/,Positive,,Clinical Trial,2014,Palmitoylethanolamide (PEA),Nervous System,Glaucoma
2014026,Effects of two different specific neck exercise interventions on palmitoylethanolamide and stearoylethanolamide concentrations in the interstitium of the trapezius muscle in women with chronic neck shoulder pain,https://academic.oup.com/painmedicine/article/15/8/1379/1877614?login=false,Positive,,Clinical Trial,2014,Palmitoylethanolamide (PEA); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Nervous System,Pain; Pain; Pain - Chronic; Arthritis - Osteoarthritis; Arthritis; Herpes; Pain - Nociceptive; Pain - Neuropathy - Diabetic; Temporomandibular Disorders
2014027,How cannabis causes paranoia: using the intravenous administration of ∆9-tetrahydrocannabinol (THC) to identify key cognitive mechanisms leading to paranoia,https://academic.oup.com/schizophreniabulletin/article/41/2/391/2526091,Negative,,Double Blind Clinical Trial,2014,Pharma THC,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cognitive Dysfunction; Psychosis; Addiction - Cannabis; Anxiety; Depression; Insomnia and Sleep Disorders; Schizophrenia
2014028,"N-palmitoylethanolamine and N-acetylethanolamine are effective in asteatotic eczema: results of a randomized, double-blind, controlled study in 60 patients",https://www.dovepress.com/n-palmitoylethanolamine-and-n-acetylethanolamine-are-effective-in-aste-peer-reviewed-fulltext-article-CIA,Positive,,Double Blind Clinical Trial,2014,Anandamide (AEA); Palmitoylethanolamide (PEA),Integumentary System,Eczema; Inflammation; Pruritis; Skin Diseases
2014029,"A multicentre, open-label, follow-on study to assess the long-term maintenance of effect, tolerance and safety of THC/CBD oromucosal spray in the management of neuropathic pain",https://pubmed.ncbi.nlm.nih.gov/25270679/,Positive,,Clinical Trial,2014,Tetrahydrocannabinol (THC); Pharma THC:CBD,Nervous System,Pain; Pain - Neuropathy - Peripheral; Pain - Neuropathy - Diabetic
2014030,Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial,https://academic.oup.com/painmedicine/article/16/1/149/2460271?login=false,Positive,,Double Blind Clinical Trial,2014,Pharma THC; Tetrahydrocannabinol (THC),,Pain; Multiple Sclerosis; Pain - Chronic; Pain - Neuropathy - Peripheral
2014031,Molecular basis for the improvement in muscle metaboreflex and mechanoreflex control in exercise-trained humans with chronic heart failure,https://journals.physiology.org/doi/full/10.1152/ajpheart.00136.2014,Positive,,Clinical Trial,2014,Endocannabinoid (unspecified),Cardiovascular System,Cardiovascular Diseases (CVD); Chronic Heart Disease; Heart Disease; Inflammation
2014032,Curcuminoids Target Decreasing Serum Adipocyte-fatty Acid Binding Protein Levels in Their Glucose-lowering Effect in Patients with Type 2 Diabetes,https://www.besjournal.com/en/article/doi/10.3967/bes2014.127,Positive,,Clinical Trial,2014,Turmeric,Endocrine System,Diabetes; Inflammation; Metabolic Syndrome; Obesity; Oxidative Stress
2011030,"Efficacy and safety of CP-945,598, a selective cannabinoid CB1 receptor antagonist, on weight loss and maintenance",https://onlinelibrary.wiley.com/doi/full/10.1038/oby.2010.352,Positive,,Double Blind Clinical Trial,2011,CP-x Synthetic Cannabinoids,,Anxiety; Diabetes; Diarrhea; Metabolic Syndrome; Pain; Nausea and Vomiting; Obesity; Suicide Attempt
2011031,Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal,https://www.sciencedirect.com/science/article/abs/pii/S0376871611000536?via%3Dihub,Negative,,Clinical Trial,2011,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Insomnia and Sleep Disorders; Addiction - Cannabis; Addiction - Nicotine
2011032,"Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial",https://www.annalsofoncology.org/action/showPdf?pii=S0923-7534%2819%2938360-7,Positive,,Double Blind Clinical Trial,2011,Pharma THC,Nervous System,Cancer; Palliative Care; Anorexia; Anxiety; Chemotherapy-induced Nausea & Vomiting; Depression; HIV/AIDS; Inflammation; Insomnia and Sleep Disorders; Loss of Appetite; Pain; Nausea and Vomiting; Pain - Cancer
2011033,Increased blood pressure after abrupt cessation of daily cannabis use,https://pubmed.ncbi.nlm.nih.gov/21359104/,Negative,,Clinical Trial,2011,,Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Cannabis Adverse Effects
2011034,Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential,https://pubmed.ncbi.nlm.nih.gov/21513772/,Inconclusive,,Clinical Trial,2011,Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Psychosis; Schizophrenia
2011035,Biomarkers for early detection of sickle nephropathy,https://onlinelibrary.wiley.com/doi/10.1002/ajh.22045,Positive,,Clinical Trial,2011,Fatty Acid-Binding Protein (FABP),Cardiovascular System; Urinary System,Chronic Kidney Disease; Sickle Cell Disorders; Kidney Failure; Oxidative Stress
2011036,Potential benefit of statin therapy for dyslipidemia with chronic kidney disease: Fluvastatin Renal Evaluation Trial (FRET),https://www.jstage.jst.go.jp/article/internalmedicine/50/12/50_12_1273/_pdf/-char/en,Positive,,Clinical Trial,2011,Fatty Acid-Binding Protein (FABP),Urinary System,Chronic Kidney Disease; Atherosclerosis; Cardiovascular Diseases (CVD); Chronic Heart Disease; Heart Disease; Metabolic Syndrome; Oxidative Stress
2011037,Renovascular protective effects of erythropoietin in patients with chronic kidney disease,https://pubmed.ncbi.nlm.nih.gov/21921371/,Positive,,Clinical Trial,2011,Fatty Acid-Binding Protein (FABP),Urinary System,Chronic Kidney Disease; Hemodialysis; Kidney Failure; Oxidative Stress
2011038,Heart fatty acid-binding protein offers similar diagnostic performance to high-sensitivity troponin T in emergency room patients presenting with chest pain,https://www.jstage.jst.go.jp/article/circj/75/12/75_CJ-11-0598/_pdf/-char/en,Positive,,Clinical Trial,2011,Fatty Acid-Binding Protein (FABP),Nervous System,Pain; Pain - Acute; Atherosclerosis; Cardiovascular Diseases (CVD); Inflammation
2011039,Serum A-FABP is increased and closely associated with elevated NT-proBNP levels in type 2 diabetic patients treated with rosiglitazone,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0027032,Negative,,Clinical Trial,2011,Fatty Acid-Binding Protein (FABP),Endocrine System,Diabetes; Cardiovascular Diseases (CVD); Metabolic Syndrome
2011040,The fatty acid amide hydrolase (FAAH) gene variant rs324420 AA/AC is not associated with weight loss in a 1-year lifestyle intervention for obese children and adolescents,https://pubmed.ncbi.nlm.nih.gov/22068813/,Inconclusive,,Clinical Trial,2011,Fatty Acid Amide Hydrolase (FAAH),Endocrine System,Obesity
2012049,Rimonabant improves obesity but not the overall cardiovascular risk and quality of life; results from CARDIO-REDUSE (CArdiometabolic Risk reDuctIOn by Rimonabant: the Effectiveness in Daily practice and its USE),https://pubmed.ncbi.nlm.nih.gov/22389428/,Positive,,Clinical Trial,2012,SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Cardiovascular System; Endocrine System; Nervous System,Cardiovascular Diseases (CVD); Obesity; Poisoning by Synthetic Cannabis; Diabetes; Metabolic Syndrome
2012050,Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of δ-9-tetrahydrocannabinol on midbrain and striatal function,https://www.nature.com/articles/mp2011187#relevant-content-header,Inconclusive,,Clinical Trial,2012,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2012051,Combination of two urinary biomarkers predicts acute kidney injury after adult cardiac surgery,https://www.annalsthoracicsurgery.org/article/S0003-4975(11)02538-0/fulltext,Positive,,Clinical Trial,2012,Fatty Acid-Binding Protein (FABP),Cardiovascular System; Urinary System,Cardiovascular Diseases (CVD); Kidney Failure
2011041,Palmitoylethanolamide restores myelinated-fibre function in patients with chemotherapy-induced painful neuropathy,https://pubmed.ncbi.nlm.nih.gov/22229320/,Positive,,Double Blind Clinical Trial,2011,Palmitoylethanolamide (PEA),Nervous System,Pain; Pain - Cancer; Pain - Neuropathy - Peripheral; Cancer - Myeloma
2011042,Heart-type fatty acid binding protein and the diagnosis of acute coronary syndrome in the ED,https://www.sciencedirect.com/science/article/abs/pii/S0735675711005006?via%3Dihub,Negative,,Clinical Trial,2011,Fatty Acid-Binding Protein (FABP),Cardiovascular System,Cardiovascular Diseases (CVD); Atherosclerosis; Heart Attack
2012052,Does olanzapine inhibit the psychomimetic effects of Δ⁹-tetrahydrocannabinol?,https://pubmed.ncbi.nlm.nih.gov/22596206/,Positive,,Double Blind Clinical Trial,2012,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Psychosis
2012053,Single-dose Pharmacokinetics and Tolerability of Oral Delta-9- Tetrahydrocannabinol in Patients with Amyotrophic Lateral Sclerosis,http://www.eurekaselect.com/article/47431,Negative,,Clinical Trial,2012,,,Neurodegenerative Issues
2012054,Multiple sclerosis and extract of cannabis: results of the MUSEC trial,https://jnnp.bmj.com/content/83/11/1125,Positive,,Double Blind Clinical Trial,2012,,Nervous System,Multiple Sclerosis; Insomnia and Sleep Disorders; Pain
2012055,Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis,https://academic.oup.com/painmedicine/article/13/9/1121/1864240?login=false,Positive,,Clinical Trial,2012,Palmitoylethanolamide (PEA),Nervous System,Pain; Pain - Chronic; Arthritis; Diabetes; Herpes; Pain - Cancer; Pain - Neuropathy - Diabetic; Pain - Neuropathy - Peripheral
2012056,Periodontal therapy decreases serum levels of adipocyte fatty acid-binding protein in systemically healthy subjects: a pilot clinical trial,https://pubmed.ncbi.nlm.nih.gov/23057990/,Positive,,Clinical Trial,2012,Fatty Acid-Binding Protein (FABP),Digestive System,Periodontal Disease; Atherosclerosis; Cardiovascular Diseases (CVD); Inflammation; Metabolic Syndrome
2013034,Evaluation of the diagnostic performance of heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study,https://pubmed.ncbi.nlm.nih.gov/23328883/,Positive,,Clinical Trial,2013,Fatty Acid-Binding Protein (FABP),Nervous System,Pain; Pain - Acute; Cardiovascular Diseases (CVD); Heart Attack
2013035,Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy,https://journals.lww.com/aidsonline/Fulltext/2013/09100/Oral_serum_derived_bovine_immunoglobulin_improves.7.aspx,Positive,,Clinical Trial,2013,Fatty Acid-Binding Protein (FABP),Immune System,HIV/AIDS; Diarrhea; Inflammation
2013036,Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085073#s4,Negative,,Clinical Trial,2013,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Fatty Acid-Binding Protein (FABP); Palmitoylethanolamide (PEA),Digestive System,Irritable Bowel Syndrome; Pain
2014033,"The detection of THC, CBD and CBN in the oral fluid of Sativex® patients using two on-site screening tests and LC–MS/MS",https://www.sciencedirect.com/science/article/abs/pii/S0379073814000978?via%3Dihub#preview-section-abstract,Negative,,Double Blind Clinical Trial,2014,Pharma THC:CBD; Cannabinol (CBN),,MDMA Adverse Effects; Multiple Sclerosis
2014034,Potential first trimester metabolomic biomarkers of abnormal birth weight in healthy pregnancies,https://pubmed.ncbi.nlm.nih.gov/24733416/,Positive,,Clinical Trial,2014,Fatty Acid-Binding Protein (FABP),Endocrine System; Reproductive System,Metabolic Syndrome; Pregnancy; Diabetes
2014035,"Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C",https://bmcgastroenterol.biomedcentral.com/articles/10.1186/1471-230X-14-131,Positive,,Clinical Trial,2014,Endocannabinoid (unspecified),Digestive System,Hepatitis; Fibrosis - Liver (Cirrhosis); Fibrosis; Inflammation; Liver Failure
2014036,Moderate-vigorous physical activity across body mass index in females: moderating effect of endocannabinoids and temperament,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125187/,Positive,,Clinical Trial,2014,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Palmitoylethanolamide (PEA),Endocrine System,Obesity; Cardiovascular Diseases (CVD); Cognitive Dysfunction; Diabetes; Osteoporosis
2014037,Impairment of inhibitory control processing related to acute psychotomimetic effects of cannabis,https://www.sciencedirect.com/science/article/abs/pii/S0924977X14003290?via%3Dihub,Negative,,Double Blind Clinical Trial,2014,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Psychosis; Anxiety; Cannabis Adverse Effects; Cognitive Dysfunction; Schizophrenia
2015041,The effect of acute alcohol intoxication on gut wall integrity in healthy male volunteers; a randomized controlled trial,https://www.sciencedirect.com/science/article/abs/pii/S0741832914201649?via%3Dihub,Negative,,Clinical Trial,2015,Fatty Acid-Binding Protein (FABP),Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction; Fibrosis - Liver (Cirrhosis); Fibrosis; Inflammation; Liver Failure; Toxic Liver Disease
2015042,Psychedelic symptoms of cannabis and cocaine use as a function of trait impulsivity,https://pubmed.ncbi.nlm.nih.gov/25572345/,Inconclusive,,Clinical Trial,2015,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Addiction - Cocaine; Anxiety; Depression; Psychosis
2015043,Combination of biomarkers for diagnosis of acute kidney injury after cardiopulmonary bypass,https://www.tandfonline.com/doi/full/10.3109/0886022X.2014.1001303,Negative,,Clinical Trial,2015,Fatty Acid-Binding Protein (FABP),Cardiovascular System; Urinary System,Cardiovascular Diseases (CVD); Chronic Heart Disease; Heart Disease; Kidney Failure; Inflammation
2015044,"Renoprotective effects of febuxostat in hyperuricemic patients with chronic kidney disease: a parallel-group, randomized, controlled trial",https://pubmed.ncbi.nlm.nih.gov/25676011/,Positive,,Clinical Trial,2015,Fatty Acid-Binding Protein (FABP),Urinary System,Chronic Kidney Disease
2015045,The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis,https://www.journalslibrary.nihr.ac.uk/hta/hta19120/#/abstract,Negative,,Double Blind Clinical Trial,2015,Pharma THC; 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Nervous System,Inflammation; Multiple Sclerosis; Neurodegenerative Issues; Oxidative Stress
2015046,Δ9-THC Disrupts Gamma (γ)-Band Neural Oscillations in Humans,https://www.nature.com/articles/npp201553,Negative,,Double Blind Clinical Trial,2015,Tetrahydrocannabinol (THC); CP-x Synthetic Cannabinoids,,Anxiety; Cannabis Adverse Effects; Cognitive Dysfunction; Psychosis; Schizophrenia
2015047,GABA Deficits Enhance the Psychotomimetic Effects of Δ9-THC,https://www.nature.com/articles/npp201558#Sec23,Negative,,Double Blind Clinical Trial,2015,Tetrahydrocannabinol (THC); Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2015048,Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum,https://pubmed.ncbi.nlm.nih.gov/25801289/,Positive,,Meta-analysis,2015,Endocannabinoid (unspecified),,Cannabis Adverse Effects; Psychosis; Schizophrenia
2015049,No evidence for reduction of opioid-withdrawal symptoms by cannabis smoking during a methadone dose taper,https://pubmed.ncbi.nlm.nih.gov/25846329/,Negative,,Meta-analysis,2015,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction; Addiction - Cocaine
2015050,Effects of administration of omega-3 fatty acids with or without vitamin E supplementation on adiponectin gene expression in PBMCs and serum adiponectin and adipocyte fatty acid-binding protein levels in male patients with CAD,https://pubmed.ncbi.nlm.nih.gov/25880054/,Positive,,Double Blind Clinical Trial,2015,Omega-3; Fatty Acid-Binding Protein (FABP); Diet,Cardiovascular System,Atherosclerosis; Cardiovascular Diseases (CVD)
2015051,The psychosis-like effects of Δ(9)-tetrahydrocannabinol are associated with increased cortical noise in healthy humans,https://pubmed.ncbi.nlm.nih.gov/25913109/,Negative,,Double Blind Clinical Trial,2015,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Psychosis; Cannabis Adverse Effects
2015052,"Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure",https://pubmed.ncbi.nlm.nih.gov/25945865/,Negative,,Clinical Trial,2015,Fatty Acid-Binding Protein (FABP),Cardiovascular System,Cardiovascular Diseases (CVD); Chronic Heart Disease; Heart Disease
2015053,"MDMA, cannabis, and cocaine produce acute dissociative symptoms",https://www.sciencedirect.com/science/article/abs/pii/S0165178115002310?via%3Dihub,Negative,,Clinical Trial,2015,,Mental/Emotional System; Nervous System,Addiction - Cocaine; Addiction; Cannabis Adverse Effects; MDMA Adverse Effects; Addiction - Stimulant; Anxiety; Depression; Insomnia and Sleep Disorders; Loss of Appetite; Psychosis; Schizophrenia
2014038,Gluten and casein supplementation does not increase symptoms in children with autism spectrum disorder,https://pubmed.ncbi.nlm.nih.gov/26148018/,Inconclusive,,Double Blind Clinical Trial,2014,Fatty Acid-Binding Protein (FABP),Mental/Emotional System; Nervous System,Autism; Behavioral Disorders
2015054,Food Liking Enhances the Plasma Response of 2-Arachidonoylglycerol and of Pancreatic Polypeptide upon Modified Sham Feeding in Humans,https://www.sciencedirect.com/science/article/pii/S0022316622088745?via%3Dihub,Positive,,Clinical Trial,2015,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Other Related Compounds; Palmitoylethanolamide (PEA),,Pancreatitis
2014039,Effectiveness of the Association N-Palmitoylethanolamine and Transpolydatin in the Treatment of Primary Dysmenorrhea,https://pubmed.ncbi.nlm.nih.gov/26233289/,Positive,,Clinical Trial,2014,Palmitoylethanolamide (PEA),Reproductive System,Menstrual Disorders; Pain - Acute; Pain - Cancer; Pregnancy
2015055,A 4-week pilot study with the cannabinoid receptor agonist dronabinol and its effect on metabolic parameters in a randomized trial,https://pubmed.ncbi.nlm.nih.gov/26283236/,Positive,,Double Blind Clinical Trial,2015,Pharma THC,Endocrine System,Metabolic Syndrome; Cardiovascular Diseases (CVD); Chemotherapy-induced Nausea & Vomiting; HIV/AIDS; Loss of Appetite; Pain; Pain - Acute
2015056,Sativex(®) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis,https://pubmed.ncbi.nlm.nih.gov/26289497/,Positive,,Double Blind Clinical Trial,2015,Pharma THC:CBD,Nervous System,Multiple Sclerosis
2015057,Intravenous Delta-9-Tetrahydrocannabinol to Prevent Postoperative Nausea and Vomiting: A Randomized Controlled Trial,https://journals.lww.com/anesthesia-analgesia/Fulltext/2015/11000/Intravenous_Delta_9_Tetrahydrocannabinol_to.10.aspx,Negative,,Double Blind Clinical Trial,2015,Tetrahydrocannabinol (THC),Digestive System,Nausea and Vomiting; Cannabis Adverse Effects
2015058,Genetic moderation of the effects of cannabis: catechol-O-methyltransferase (COMT) affects the impact of Δ9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences,https://pubmed.ncbi.nlm.nih.gov/26464454/,Inconclusive,,Double Blind Clinical Trial,2015,,Mental/Emotional System; Nervous System,Psychosis; Cognitive Dysfunction
2015059,Safety of oral dronabinol during opioid withdrawal in humans,https://www.sciencedirect.com/science/article/abs/pii/S037687161501683X?via%3Dihub,Negative,,Double Blind Clinical Trial,2015,Pharma THC; SR-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction; Anxiety; Cannabis Adverse Effects; Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Chemotherapy-induced Nausea & Vomiting; HIV/AIDS
2015060,"Single dose delta-9-tetrahydrocannabinol in chronic pancreatitis patients: analgesic efficacy, pharmacokinetics and tolerability",https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.12811,Inconclusive,,Double Blind Clinical Trial,2015,Pharma THC; Synthetic Cannabinoid (unspecified),Digestive System; Endocrine System,Pain; Pain; Pain - Chronic; Pancreatitis; Addiction - Benzodiazepine; Addiction - Opioid; Pain - Nociceptive; Pain - Neuropathy - Peripheral
2015061,Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial,https://pubmed.ncbi.nlm.nih.gov/26503964/,Inconclusive,,Double Blind Clinical Trial,2015,Pharma THC,Integumentary System,Cancer - Squamous Head/Neck; Cancer; Anorexia; Chemotherapy-induced Nausea & Vomiting; Insomnia and Sleep Disorders; Loss of Appetite; Pain; Nausea and Vomiting; Pain - Cancer
2023265,The antinociceptive activity and mechanism of action of cannabigerol,https://www.sciencedirect.com/science/article/pii/S0753332222015529?via%3Dihub#sec0010,Positive,,Animal Study,2023,Cannabigerol (CBG); AM-x Synthetic Cannabinoids; Cannabichromene (CBC),Nervous System,Pain - Nociceptive; Pain; Pain; Arthritis - Gout; Arthritis - Osteoarthritis; Arthritis - Rheumatoid; Arthritis; Inflammation; Pain - Chronic
2023266,Cannabichromene Induces Neuronal Differentiation in NSC-34 Cells: Insights from Transcriptomic Analysis,https://www.mdpi.com/2075-1729/13/3/742,Positive,,Laboratory Study,2023,Cannabichromene (CBC); Cannabichromenic Acid (CBC-a); Tetrahydrocannabinol (THC),,Alzheimer's Disease
2020082,Drug-Drug Interactions Between Cannabidiol and Lithium,https://journals.sagepub.com/doi/10.1177/2329048X20947896,Positive,,Meta-analysis,2020,,,Autism; Diarrhea; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2020083,[Ayahuasca in the Netherlands: what the doctor should know about its side effects],https://pubmed.ncbi.nlm.nih.gov/32940978/,Negative,,Meta-analysis,2020,Ayahuasca,,
2020084,"19-Year-Old Man With Fevers, Abdominal Pain, and Cough",https://www.mayoclinicproceedings.org/article/S0025-6196(20)30714-X/fulltext#secsectitle0010,Negative,,Meta-analysis,2020,,Immune System; Nervous System; Respiratory System,Cough; Pain; Pain - Acute; Cannabis Adverse Effects; Nausea and Vomiting; Vaping injury (EVALI)
2020085,Small bowel intussusception in marijuana users,https://academic.oup.com/jscr/article/2020/9/rjaa335/5912996?login=false,Negative,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cannabis Hyperemesis Syndrome; Celiac Disease; Chemotherapy-induced Nausea & Vomiting; IBD - Crohn's Disease; Insomnia and Sleep Disorders; Pain; Nausea and Vomiting; Pain - Acute; Pain - Chronic
2020086,Synthetic Cannabinoids and Its Association With Persistent Negative Symptoms of Schizophrenia,https://www.cureus.com/articles/39183-synthetic-cannabinoids-and-its-association-with-persistent-negative-symptoms-of-schizophrenia#!/,Negative,,Meta-analysis,2020,Synthetic Cannabinoid (unspecified); Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Poisoning by Synthetic Cannabis; Schizophrenia; Cannabis Adverse Effects; Cognitive Dysfunction; Psychosis
2020087,A Little Dab Will Do: A Case of Cannabis-Induced Psychosis,https://www.cureus.com/articles/36987-a-little-dab-will-do-a-case-of-cannabis-induced-psychosis#!/,Negative,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Psychosis; Addiction - Cannabis; Anxiety; Bipolar Disorder; Depression; Insomnia and Sleep Disorders; Schizophrenia
2021117,The Effects of Intermittent Hypoxic-Hyperoxic Exposures on Lipid Profile and Inflammation in Patients With Metabolic Syndrome,https://www.frontiersin.org/articles/10.3389/fcvm.2021.700826/full,Positive,,Clinical Trial,2021,Fatty Acid Amide Hydrolase (FAAH),Endocrine System; Nervous System,Inflammation; Metabolic Syndrome; Cardiovascular Diseases (CVD); Diabetes; Hypertension (High Blood Pressure); Obesity
2023267,Urinary liver-type fatty acid-binding protein: A hemodynamic index during extracorporeal membrane oxygenation,https://onlinelibrary.wiley.com/doi/10.1002/ccr3.6531,Positive,,Meta-analysis,2023,Fatty Acid-Binding Protein (FABP),Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack; Chronic Kidney Disease; Hemodialysis; Kidney Failure; Reperfusion Injury
2023268,Urinary liver-type fatty acid-binding protein in two dogs with acquired Fanconi syndrome: A case report,https://www.ejmanager.com/mnstemps/100/100-1657281049.pdf?t=1688569033,Inconclusive,,Animal Study -,2023,Fatty Acid-Binding Protein (FABP),,Veterinary Applications; Chronic Kidney Disease; Kidney Failure; Metabolic Syndrome; Oxidative Stress
2023269,Cannabis-Induced Acute Encephalopathy in a 94-Year-Old Woman Due to Family Administration of Cannabidiol (CBD) Products: A Case Report,https://www.cureus.com/articles/152003-cannabis-induced-acute-encephalopathy-in-a-94-year-old-woman-due-to-family-administration-of-cannabidiol-cbd-products-case-report#!/,Negative,,Meta-analysis,2023,Tetrahydrocannabinol (THC); Pharma THC; Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cognitive Dysfunction; Anorexia; Chemotherapy-induced Nausea & Vomiting; Dementia; Geriatric Conditions; HIV/AIDS; Kidney Failure; Liver Failure; Loss of Appetite; Pain; Pain - Cancer
2023270,Marijuana as a Cause of Diffuse Coronary Vasospasm Leading to Cardiac Arrest,https://www.cureus.com/articles/64574-marijuana-as-a-cause-of-diffuse-coronary-vasospasm-leading-to-cardiac-arrest#!/,Negative,,Meta-analysis,2023,Synthetic Cannabinoid (unspecified); JWH-x Synthetic Cannabinoids,Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack; Anxiety; Cannabis Adverse Effects; Cardiac Arrhythmias; COPD; Hypertension (High Blood Pressure); Pain; Nausea and Vomiting; Pain - Acute; Poisoning by Synthetic Cannabis; Psychosis
2023271,Sudden Cardiac Arrest in Patient With Ventricular Septal Defect and Marijuana Consumption: A Case Report and Review of Literature,https://www.cureus.com/articles/152031-sudden-cardiac-arrest-in-patient-with-ventricular-septal-defect-and-marijuana-consumption-a-case-report-and-review-of-literature#!/,Negative,,Meta-analysis,2023,Endocannabinoid (unspecified); Tetrahydrocannabinol (THC),Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack; Atherosclerosis; Cannabis Adverse Effects; Cardiac Arrhythmias; Chronic Heart Disease; Heart Disease; Inflammation; Pain; Pain - Acute
2023272,Synthetic Cannabinoids and ST-Elevated Myocardial Infarction: A Case Report and Literature Review,https://www.cureus.com/articles/154782-synthetic-cannabinoids-and-st-elevated-myocardial-infarction-a-case-report-and-literature-review#!/,Negative,,Meta-analysis,2023,Synthetic Cannabinoid (unspecified),Cardiovascular System; Nervous System,Cardiovascular Diseases (CVD); Heart Attack; Poisoning by Synthetic Cannabis; Cannabis Adverse Effects; Depression; Pain; Pain - Acute
2023273,Weeding Out the Culprit: Cannabinoid-Associated Stevens-Johnson Syndrome,https://www.cureus.com/articles/155251-weeding-out-the-culprit-cannabinoid-associated-stevens-johnson-syndrome#!/,Negative,,Meta-analysis,2023,,Integumentary System,Skin Diseases; Anxiety; Cannabis Adverse Effects; Eczema; Herpes; HIV/AIDS; Pain; Pain - Acute
2023274,Cannabis-Induced ST-Segment Elevation Myocardial Infarction With Possible Coronary Artery Dissection: A Case Report,https://www.cureus.com/articles/159684-cannabis-induced-st-segment-elevation-myocardial-infarction-with-possible-coronary-artery-dissection-a-case-report#!/,Negative,,Meta-analysis,2023,,Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack; Atherosclerosis; Cannabis Adverse Effects; Cardiac Arrhythmias; Ehlers-Danlos Syndrome; Pain; Nausea and Vomiting; Oxidative Stress; Pain - Acute; Stroke
2023275,Cannabidiol (CBD) for the treatment of subcutaneous treprostinil (Remodulin®) site pain: a case report,https://www.frontiersin.org/articles/10.3389/fmed.2023.1188083/full,Positive,,Meta-analysis,2023,,,Pain; Pain - Acute; Anxiety; Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Inflammation; Palliative Care
2015062,Brain Mapping-Based Model of Δ(9)-Tetrahydrocannabinol Effects on Connectivity in the Pain Matrix,https://www.nature.com/articles/npp2015336#Sec2,Positive,,Double Blind Clinical Trial,2015,Tetrahydrocannabinol (THC),Nervous System,Pain; Pain - Acute
2015063,Urine Injury Biomarkers and Risk of Adverse Outcomes in Recipients of Prevalent Kidney Transplants: The Folic Acid for Vascular Outcome Reduction in Transplantation Trial,https://journals.lww.com/jasn/Fulltext/2016/07000/Urine_Injury_Biomarkers_and_Risk_of_Adverse.26.aspx,Inconclusive,,Clinical Trial,2015,Fatty Acid-Binding Protein (FABP),Immune System,Organ Transplant Failure; Chronic Kidney Disease; Inflammation; Kidney Failure; Oxidative Stress
2015064,The Use of Release-Active Antibody-Based Preparations for Vertigo Prevention in Adults,https://pubmed.ncbi.nlm.nih.gov/26608378/,Positive,,Clinical Trial,2015,Endocannabinoid (unspecified),,Motion Sickness
2017023,Substance Use Among Homeless Individuals With Schizophrenia and Bipolar Disorder,https://pubmed.ncbi.nlm.nih.gov/26785056/,Negative,,Meta-analysis,2017,,Mental/Emotional System; Nervous System,Bipolar Disorder; Schizophrenia; Addiction - Cannabis; Addiction - Cocaine; Addiction - Opioid; Addiction - Stimulant; MDMA Adverse Effects; Psychosis
2016038,Dronabinol increases pain threshold in patients with functional chest pain: a pilot double-blind placebo-controlled trial,https://academic.oup.com/dote/article/30/2/1/2725531?login=false,Positive,,Double Blind Clinical Trial,2016,Pharma THC; Tetrahydrocannabinol (THC),,Pain; Pain - Acute; Anxiety; Depression; Gastro-Esophageal Reflux; Gastroparesis
2016039,Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis,https://link.springer.com/article/10.1007/s13311-016-0420-z#Sec2,Positive,,Double Blind Clinical Trial,2016,Anandamide (AEA); Palmitoylethanolamide (PEA),,Inflammation; Multiple Sclerosis; Pain; Neurodegenerative Issues; Pain - Chronic; Skin Diseases
2016040,Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy,https://www.pnas.org/doi/full/10.1073/pnas.1600251113#sec-4,Positive,,Clinical Trial,2016,Palmitoylethanolamide (PEA),,Neurodegenerative Issues; Amyotrophic Lateral Sclerosis (ALS)
2016041,Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings,https://www.sciencedirect.com/science/article/abs/pii/S0376871616000958?via%3Dihub,Positive,,Double Blind Clinical Trial,2016,Pharma THC:CBD,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Anxiety; Cannabis Adverse Effects; Psychosis
2016042,A Randomized Placebo Controlled Trial of Ibuprofen for Respiratory Syncytial Virus Infection in a Bovine Model,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0152913,Inconclusive,,Animal Study -,2016,Endocannabinoid (unspecified); Anandamide (AEA),Respiratory System,Respiratory Syncytial Virus; Veterinary Applications; Anorexia; Bronchitis; Depression
2016043,"A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease",https://pubmed.ncbi.nlm.nih.gov/27159993/,Positive,,Double Blind Clinical Trial,2016,Pharma THC:CBD,,Huntington's Disease; Behavioral Disorders; Cognitive Dysfunction; Neurodegenerative Issues
2016044,Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity,https://pubmed.ncbi.nlm.nih.gov/27160412/,Positive,,Clinical Trial,2016,Pharma THC:CBD,,Multiple Sclerosis; Insomnia and Sleep Disorders
2016045,Impact of teneligliptin on oxidative stress and endothelial function in type 2 diabetes patients with chronic kidney disease: a case-control study,https://cardiab.biomedcentral.com/articles/10.1186/s12933-016-0396-3#Sec11,Positive,,Clinical Trial,2016,Fatty Acid-Binding Protein (FABP),Endocrine System; Urinary System,Chronic Kidney Disease; Diabetes; Oxidative Stress; Atherosclerosis; Cardiovascular Diseases (CVD); Diabetic Kidney Disease
2016046,Endocannabinoid receptor blockade increases hepatocyte growth factor and reduces insulin levels in obese women with polycystic ovary syndrome,https://hull-repository.worktribe.com/output/439454,Positive,,Meta-analysis,2016,Endocannabinoid (unspecified); Pharma THC,Endocrine System,Obesity; Polycystic Ovary Disease; Cancer - Liver; Cancer; Fibrosis - Liver (Cirrhosis); Fibrosis; Inflammation; Liver Failure
2015065,"Clinical Safety of a High Dose of Phycocyanin-Enriched Aqueous Extract from Arthrospira (Spirulina) platensis: Results from a Randomized, Double-Blind, Placebo-Controlled Study with a Focus on Anticoagulant Activity and Platelet Activation",https://www.liebertpub.com/doi/10.1089/jmf.2015.0143,Positive,,Double Blind Clinical Trial,2015,Phycocyanin,,Atherosclerosis; Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Inflammation; Kidney Failure; Pain; Oxidative Stress; Pain - Chronic
2016047,"Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease",https://bmccomplementmedtherapies.biomedcentral.com/articles/10.1186/s12906-016-1228-4#Sec1,Negative,,Meta-analysis,2016,Fatty Acid-Binding Protein (FABP),Endocrine System; Urinary System,Diabetes; Diabetic Kidney Disease; Inflammation; Kidney Failure
2016048,Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses,https://link.springer.com/article/10.1007/s00213-016-4383-x#Sec42,Negative,,Clinical Trial,2016,Tetrahydrocannabinol (THC); Anandamide (AEA),,Addiction - Cannabis; Behavioral Disorders; Anxiety; Depression; Psychosis
2016049,The protective effect of human atrial natriuretic peptide on renal damage during cardiac surgery,https://link.springer.com/article/10.1007/s00540-016-2284-0,Positive,,Clinical Trial,2016,Fatty Acid-Binding Protein (FABP),Cardiovascular System,Cardiovascular Diseases (CVD); Inflammation; Kidney Failure; Oxidative Stress; Reperfusion Injury
2016050,"Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake",https://academic.oup.com/clinchem/article/62/12/1579/5612073?login=false,Inconclusive,,Double Blind Clinical Trial,2016,Cannabigerol (CBG); Cannabinol (CBN); Tetrahydrocannabivarin (THCV),,
2016051,Relation between postoperative ileus and anastomotic leakage after colorectal resection: a post hoc analysis of a prospective randomized controlled trial,https://onlinelibrary.wiley.com/doi/10.1111/codi.13582,Negative,,Meta-analysis,2016,Fatty Acid-Binding Protein (FABP),,Diabetes; Gastroparesis; Inflammation; Obesity
2016052,Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers,https://www.sciencedirect.com/science/article/abs/pii/S0376871616310456?via%3Dihub,Positive,,Clinical Trial,2016,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Pharma CBD; Pharma THC:CBD,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Opioid; Addiction - Stimulant; Cancer - Oral; Cancer; Epilepsy - Dravet Syndrome; Epilepsy; Inflammation; Pain; Oxidative Stress; Pain - Acute; Pain - Chronic
2017024,Propofol-based anaesthesia versus sevoflurane-based anaesthesia for living donor kidney transplantation: results of the VAPOR-1 randomized controlled trial,https://www.bjanaesthesia.org/article/S0007-0912(17)31332-6/fulltext#seccestitle290,Positive,,Clinical Trial,2017,Fatty Acid-Binding Protein (FABP),,Cardiovascular Diseases (CVD); Inflammation; Kidney Failure; Reperfusion Injury
2014040,Acute kidney injury after using contrast during cardiac catheterization in children with heart disease,https://jkms.org/DOIx.php?id=10.3346/jkms.2014.29.8.1102,Positive,,Clinical Trial,2014,Fatty Acid-Binding Protein (FABP),Cardiovascular System; Urinary System,Cardiovascular Diseases (CVD); Kidney Failure; Oxidative Stress; Reperfusion Injury
2014041,Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking,https://pubmed.ncbi.nlm.nih.gov/25220020/,Negative,,Clinical Trial,2014,Cannabinol (CBN),,Addiction - Cannabis
2015066,Novel associations between FAAH genetic variants and postoperative central opioid-related adverse effects,https://pubmed.ncbi.nlm.nih.gov/25558980/,Negative,,Clinical Trial,2015,Fatty Acid Amide Hydrolase (FAAH); Anandamide (AEA); Endocannabinoid (unspecified),,Nausea and Vomiting
2015067,[Assessment of the effectiveness and safety of Sativex® in compassionate use],https://pubmed.ncbi.nlm.nih.gov/25710689/,Positive,,Clinical Trial,2015,Pharma THC:CBD,,Pain; Pain - Chronic; Pain - Neuropathy - Peripheral
2014042,Intestinal Fatty Acid Binding Protein (I-FABP) as a Promising Test for Crohn's Disease: A Preliminary Study,https://pubmed.ncbi.nlm.nih.gov/25807642/,Positive,,Clinical Trial,2014,Fatty Acid-Binding Protein (FABP),Digestive System,IBD - Crohn's Disease; Inflammation
2015068,Efficacy of ultra-micronized palmitoylethanolamide in canine atopic dermatitis: an open-label multi-centre study,https://onlinelibrary.wiley.com/doi/10.1111/vde.12250,Positive,,Animal Study -,2015,Palmitoylethanolamide (PEA),Integumentary System,Eczema; Veterinary Applications; Allergic Contact Dermatitis; Inflammation; Pain; Pain - Acute; Pruritis; Skin Diseases
2015069,Urine Biomarkers and Perioperative Acute Kidney Injury: The Impact of Preoperative Estimated GFR,https://pubmed.ncbi.nlm.nih.gov/26386737/,Negative,,Meta-analysis,2015,Fatty Acid-Binding Protein (FABP),Urinary System,Kidney Failure; Cardiovascular Diseases (CVD); Liver Failure
2015070,"Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus",https://www.jlr.org/article/S0022-2275(20)30955-X/fulltext#seccestitle20,Positive,,Clinical Trial,2015,Fatty Acid-Binding Protein (FABP),Endocrine System,Diabetes; Atherosclerosis; Cardiovascular Diseases (CVD); Metabolic Syndrome; Obesity
2015071,"Schistosomiasis vaccine candidate Sm14/GLA-SE: Phase 1 safety and immunogenicity clinical trial in healthy, male adults",https://www.sciencedirect.com/science/article/abs/pii/S0264410X15014425?via%3Dihub,Positive,,Clinical Trial,2015,Fatty Acid-Binding Protein (FABP),Digestive System,Parasitic Worms
2016053,Cannabis and cocaine decrease cognitive impulse control and functional corticostriatal connectivity in drug users with low activity DBH genotypes,https://link.springer.com/article/10.1007/s11682-015-9488-z#Sec2,Negative,,Clinical Trial,2016,Tetrahydrocannabinol (THC),Mental/Emotional System,Addiction - Cocaine; Addiction; Cognitive Dysfunction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Stimulant; Cannabis Adverse Effects; Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); MDMA Adverse Effects
2016054,Reduction of circulating FABP4 level by treatment with omega-3 fatty acid ethyl esters,https://lipidworld.biomedcentral.com/articles/10.1186/s12944-016-0177-8,Positive,,Clinical Trial,2016,Fatty Acid-Binding Protein (FABP),,Atherosclerosis; Cardiovascular Diseases (CVD); Diabetes; Hypertension (High Blood Pressure); Obesity
2016055,Evaluating Sativex® in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis,https://academic.oup.com/painmedicine/article/17/6/1145/1752844?login=false,Positive,,Clinical Trial,2016,Pharma THC:CBD,,Pain; Multiple Sclerosis; Pain - Neuropathy - Peripheral; Inflammation; Neurodegenerative Issues; Pain - Chronic; Quality of Life; Urinary Tract Infection
2016056,Interactions between dietary oil treatments and genetic variants modulate fatty acid ethanolamides in plasma and body weight composition,https://www.cambridge.org/core/journals/british-journal-of-nutrition/article/interactions-between-dietary-oil-treatments-and-genetic-variants-modulate-fatty-acid-ethanolamides-in-plasma-and-body-weight-composition/FCE6585C571E644CF40DBA0F76AF7315,Positive,,Double Blind Clinical Trial,2016,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Diet; Endocannabinoid (unspecified); Pharma THC,,Metabolic Syndrome; Obesity
2016057,A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0148734,Negative,,Clinical Trial,2016,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Palmitoylethanolamide (PEA),,Anorexia; Cachexia; Inflammation; Obesity
2016058,"Possible Increase in Serum FABP4 Level Despite Adiposity Reduction by Canagliflozin, an SGLT2 Inhibitor",https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0154482,Negative,,Clinical Trial,2016,Fatty Acid-Binding Protein (FABP),,Atherosclerosis; Cardiovascular Diseases (CVD); Diabetes; Kidney Failure; Metabolic Syndrome; Obesity
2016059,Sativex Associated With Behavioral-Relapse Prevention Strategy as Treatment for Cannabis Dependence: A Case Series,https://pubmed.ncbi.nlm.nih.gov/27261670/,Positive,,Clinical Trial,2016,Pharma THC:CBD; Mind-Body Medicine,Mental/Emotional System,Addiction - Cannabis; Behavioral Disorders; Addiction; Cannabis Adverse Effects
2016060,Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials,https://academic.oup.com/cid/article/63/11/1405/2526223?login=false,Inconclusive,,Meta-analysis,2016,,Digestive System,Hepatitis; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Opioid; Addiction - Stimulant
2016061,Effects of tetrahydrocannabinol on balance and gait in patients with dementia: A randomised controlled crossover trial,https://pubmed.ncbi.nlm.nih.gov/27624148/,Positive,,Double Blind Clinical Trial,2016,,,Dementia; Geriatric Conditions
2016062,Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo-controlled Study,https://www.cghjournal.org/article/S1542-3565(16)30858-8/fulltext,Inconclusive,,Clinical Trial,2016,Pharma THC; Tetrahydrocannabinol (THC),Nervous System,Pain; Pain - Chronic
2016063,Upper motor neuron evaluation in multiple sclerosis patients treated with Sativex®,https://pubmed.ncbi.nlm.nih.gov/27500463/,Positive,,Clinical Trial,2016,Pharma THC:CBD,,Multiple Sclerosis; Neurodegenerative Issues
2016064,Transition of intestinal fatty acid-binding protein on hypothermic circulatory arrest with cardiopulmonary bypass,https://pubmed.ncbi.nlm.nih.gov/27765895/,Negative,,Clinical Trial,2016,Fatty Acid-Binding Protein (FABP),Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack
2016065,Prolonged Cardiopulmonary Bypass is a Risk Factor for Intestinal Ischaemic Damage and Endotoxaemia,https://pubmed.ncbi.nlm.nih.gov/27956161/,Negative,,Clinical Trial,2016,Fatty Acid-Binding Protein (FABP),,Atherosclerosis; Cardiovascular Diseases (CVD); Inflammation
2017025,Circulating intestinal fatty acid-binding protein (I-FABP) levels in acute decompensated heart failure,https://www.sciencedirect.com/science/article/abs/pii/S0009912017300115?via%3Dihub,Negative,,Clinical Trial,2017,Fatty Acid-Binding Protein (FABP),Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Inflammation; Kidney Failure
2017026,Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patients,https://pubmed.ncbi.nlm.nih.gov/28716266/,Positive,,Clinical Trial,2017,Pharma THC:CBD,,Multiple Sclerosis; Inflammation; Pain; Neurodegenerative Issues; Pain - Chronic
2017027,iperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: Pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration,https://www.sciencedirect.com/science/article/abs/pii/S016836591730843X?via%3Dihub,Positive,,Clinical Trial,2017,Pharma THC:CBD,,Anxiety; Multiple Sclerosis; Oxidative Stress
2017028,Circulating adipocyte fatty acid-binding protein is a predictor of cardiovascular events in patients with stable angina undergoing percutaneous coronary intervention,https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-017-0691-2#Sec11,Negative,,Clinical Trial,2017,Fatty Acid-Binding Protein (FABP),Cardiovascular System,Atherosclerosis; Cardiovascular Diseases (CVD); Heart Attack; Obesity; Stroke
2017029,Use of Topical Cannabinomimetic Palmitoylethanolamide in Ocular Surface Disease Associated with Antiglaucoma Medications,https://pubmed.ncbi.nlm.nih.gov/29045169/,Positive,,Clinical Trial,2017,Palmitoylethanolamide (PEA),Nervous System,Glaucoma; Inflammation
2017030,Peripheral endocannabinoid concentrations are not associated with verbal memory impairment during MDMA intoxication,https://link.springer.com/article/10.1007/s00213-017-4787-2#Sec19,Inconclusive,,Double Blind Clinical Trial,2017,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified),Nervous System,MDMA Adverse Effects; Cannabis Adverse Effects; Cognitive Dysfunction
2018037,Excretion of metabolites of the synthetic cannabinoid JWH-018 in urine after controlled inhalation,https://www.sciencedirect.com/science/article/abs/pii/S0731708517322410?via%3Dihub#preview-section-abstract,Inconclusive,,Clinical Trial,2018,JWH-x Synthetic Cannabinoids,Nervous System,Poisoning by Synthetic Cannabis; Cannabis Adverse Effects
2018038,Association of vascular indices with novel circulating biomarkers as prognostic factors for cardiovascular complications in patients with type 2 diabetes mellitus,https://www.sciencedirect.com/science/article/abs/pii/S0009912017311293?via%3Dihub,Negative,,Clinical Trial,2018,Fatty Acid-Binding Protein (FABP),Cardiovascular System; Endocrine System,Cardiovascular Diseases (CVD); Diabetes; Atherosclerosis; Heart Attack; Inflammation; Metabolic Syndrome; Stroke
2017031,A randomized-controlled trial of nabilone for the prevention of acute postoperative nausea and vomiting in elective surgery,https://link.springer.com/article/10.1007/s12630-017-0814-3#Sec1,Inconclusive,,Clinical Trial,2017,Pharma THC; Synthetic Cannabinoid (unspecified),Digestive System,Nausea and Vomiting; Chemotherapy-induced Nausea & Vomiting; Pain; Pain - Acute
2017032,Effects on Spasticity and Neuropathic Pain of an Oral Formulation of Δ9-tetrahydrocannabinol in Patients WithProgressive Multiple Sclerosis,https://www.clinicaltherapeutics.com/article/S0149-2918(17)30054-1/fulltext#secsect0035,Positive,,Double Blind Clinical Trial,2017,Tetrahydrocannabinol (THC); Synthetic Cannabinoid (unspecified),Nervous System,Pain; Multiple Sclerosis; Pain - Neuropathy - Peripheral; Inflammation
2017033,"Fatty Acid Amide Hydrolase Inhibitor Treatment in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: An Adaptive Double-blind, Randomized Controlled Trial",https://pubmed.ncbi.nlm.nih.gov/28254462/,Inconclusive,,Double Blind Clinical Trial,2017,Fatty Acid Amide Hydrolase (FAAH),Urinary System,Urinary Tract Infection
2017034,RECAST (Remote Ischemic Conditioning After Stroke Trial): A Pilot Randomized Placebo Controlled Phase II Trial in Acute Ischemic Stroke,https://www.ahajournals.org/doi/10.1161/STROKEAHA.116.016429#d1e297,Positive,,Clinical Trial,2017,Endocannabinoid (unspecified),Nervous System,Stroke; Cardiovascular Diseases (CVD); Heart Attack; Inflammation
2017035,Use of palmitoylethanolamide in carpal tunnel syndrome: a prospective randomized study,https://jorthoptraumatol.springeropen.com/articles/10.1007/s10195-017-0453-z,Inconclusive,,Double Blind Clinical Trial,2017,Palmitoylethanolamide (PEA),,Arthritis - Osteoarthritis; Diabetes; Inflammation; Pain; Pain - Acute; Pain - Chronic; Pain - Neuropathy - Diabetic; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral
2017036,The effect of desflurane and propofol protocols on preconditioning,https://advances.umw.edu.pl/en/article/2017/26/5/817/,Positive,,Clinical Trial,2017,Fatty Acid-Binding Protein (FABP),,Atherosclerosis; Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Inflammation; Oxidative Stress
2017037,"The impact of exertional-heat stress on gastrointestinal integrity, gastrointestinal symptoms, systemic endotoxin and cytokine profile",https://link.springer.com/article/10.1007/s00421-017-3781-z,Positive,,Clinical Trial,2017,Exercise; Fatty Acid-Binding Protein (FABP),Mental/Emotional System,IBD - Inflammatory Bowel Disease; Inflammation
2017038,Effect of Remote Ischemic Preconditioning on Intestinal Ischemia-Reperfusion Injury in Adults Undergoing On-Pump CABG Surgery: A Randomized Controlled Pilot Trial,https://www.jcvaonline.com/article/S1053-0770(17)30674-2/fulltext,Positive,,Double Blind Clinical Trial,2017,Fatty Acid-Binding Protein (FABP),Cardiovascular System,Atherosclerosis; Cardiovascular Diseases (CVD)
2019048,"Effect of a short-term low fermentable oligiosaccharide, disaccharide, monosaccharide and polyol (FODMAP) diet on exercise-related gastrointestinal symptoms",https://www.tandfonline.com/doi/full/10.1186/s12970-019-0268-9,Positive,,Clinical Trial,2019,Fatty Acid-Binding Protein (FABP),,Irritable Bowel Syndrome; Oxidative Stress
2020088,P-NGAL Day 1 predicts early but not one year graft function following deceased donor kidney transplantation - The CONTEXT study,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0212676,Positive,,Clinical Trial,2020,Fatty Acid-Binding Protein (FABP),Immune System,Organ Transplant Failure; Kidney Failure
2020089,Validation of the Micronutrient and Environmental Enteric Dysfunction Assessment Tool and evaluation of biomarker risk factors for growth faltering and vaccine failure in young Malian children,https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0008711#sec002,Inconclusive,,Clinical Trial,2020,Fatty Acid-Binding Protein (FABP),,Cognitive Dysfunction; Inflammation
2020090,"Impact of exercise-induced hypohydration on gastrointestinal integrity, function, symptoms, and systemic endotoxin and inflammatory profile",https://journals.physiology.org/doi/full/10.1152/japplphysiol.01032.2018,Negative,,Clinical Trial,2020,Exercise; Fatty Acid-Binding Protein (FABP),Nervous System,Inflammation
2019049,"The effect of crocetin supplementation on markers of atherogenic risk in patients with coronary artery disease: a pilot, randomized, double-blind, placebo-controlled clinical trial",https://pubmed.ncbi.nlm.nih.gov/31667483/,Positive,,Double Blind Clinical Trial,2019,Fatty Acid-Binding Protein (FABP),Cardiovascular System,Atherosclerosis; Cardiovascular Diseases (CVD); Oxidative Stress
2020091,Effects of exercise on residual renal function in patients undergoing peritoneal dialysis: A post-hoc analysis of a randomized controlled trial,https://pubmed.ncbi.nlm.nih.gov/31997526/,Positive,,Clinical Trial,2020,Exercise; Fatty Acid-Binding Protein (FABP),Urinary System,Chronic Kidney Disease
2020092,Evaluation of the cardioprotective effects of crystalloid del Nido cardioplegia solution via a rapid and accurate cardiac marker: heart-type fatty acid-binding protein,https://pubmed.ncbi.nlm.nih.gov/32394686/,Positive,,Clinical Trial,2020,Fatty Acid-Binding Protein (FABP),,Atherosclerosis; Cardiovascular Diseases (CVD)
2021118,The influence of exercise intensity and exercise mode on gastrointestinal damage,https://pubmed.ncbi.nlm.nih.gov/33725465/,Positive,,Clinical Trial,2021,Exercise; Exercise; Fatty Acid-Binding Protein (FABP),,Inflammation
2021119,Effect of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Biomarkers of Kidney Injury and Vascular Calcification in Diabetic Kidney Disease: A Randomized Controlled Trial,https://www.hindawi.com/journals/jdr/2021/7382620/,Positive,,Clinical Trial,2021,Fatty Acid-Binding Protein (FABP),Endocrine System; Urinary System,Diabetes; Diabetic Kidney Disease; Inflammation
2022184,Clinical Utility of a Biomarker to Detect Contrast-Induced Acute Kidney Injury during Percutaneous Cardiovascular Proceduresv,https://karger.com/crm/article/12/1/11/822411/Clinical-Utility-of-a-Biomarker-to-Detect-Contrast,Positive,,Clinical Trial,2022,Fatty Acid-Binding Protein (FABP),Urinary System,Drug-Induced Nephropathy; Kidney Failure
2022185,Effects of oral cystine and glutamine on exercise-induced changes in gastrointestinal permeability and damage markers in young men,https://link.springer.com/article/10.1007/s00394-022-02806-1,Positive,,Double Blind Clinical Trial,2022,Fatty Acid-Binding Protein (FABP); Exercise,,Inflammation
2021120,A New Clinical Utility for Tubular Markers to Identify Kidney Responders to Saxagliptin Treatment in Adults With Diabetic Nephropathy,https://pubmed.ncbi.nlm.nih.gov/35181219/,Inconclusive,,Clinical Trial,2021,Fatty Acid-Binding Protein (FABP),Endocrine System; Nervous System; Urinary System,Diabetes; Diabetic Kidney Disease; Pain; Pain - Neuropathy - Diabetic; Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2022186,Simvastatin Combined with Resistance Training Improves Outcomes in Patients with Chronic Heart Failure by Modulating Mitochondrial Membrane Potential and the Janus Kinase/Signal Transducer and Activator of Transcription 3 Signaling Pathways,https://www.hindawi.com/journals/cdtp/2022/8430733/,Inconclusive,,Clinical Trial,2022,Fatty Acid-Binding Protein (FABP),Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack; Inflammation
2022187,Transcutaneous vagal nerve stimulation protects against stress-induced intestinal barrier dysfunction in healthy adults,https://onlinelibrary.wiley.com/doi/10.1111/nmo.14382,Negative,,Clinical Trial,2022,Fatty Acid-Binding Protein (FABP),Mental/Emotional System,Inflammation
2022188,"Safety of Bifidobacterium breve, Bif195, employing a human exercise-induced intestinal permeability model: a randomised, double-blinded, placebo-controlled, parallel group trial",https://pubmed.ncbi.nlm.nih.gov/35866597/,Inconclusive,,Double Blind Clinical Trial,2022,Fatty Acid-Binding Protein (FABP); Exercise,,Inflammation
2022189,Ibuprofen Increases Markers of Intestinal Barrier Injury But Suppresses Inflammation at Rest and After Exercise in Hypoxia,https://pubmed.ncbi.nlm.nih.gov/36069803/,Negative,,Double Blind Clinical Trial,2022,Exercise; Fatty Acid-Binding Protein (FABP),,Inflammation
2023276,[Changes of myocardial calcium currents in rats with myocardial injury induced by running exercise during acute hypoxia],https://pubmed.ncbi.nlm.nih.gov/36210709/,Negative,,Animal Study,2023,Fatty Acid-Binding Protein (FABP); Exercise,Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack; Oxidative Stress
2022190,"The effects of collagen peptides on exercise-induced gastrointestinal stress: a randomized, controlled trial",https://link.springer.com/article/10.1007/s00394-022-03051-2,Positive,,Double Blind Clinical Trial,2022,Fatty Acid-Binding Protein (FABP); Exercise,Mental/Emotional System,Celiac Disease; Diarrhea; Inflammation; Irritable Bowel Syndrome; Pain; Nausea and Vomiting; Pain - Acute
2022191,"Gut microbiota alterations after switching from a protease inhibitor or efavirenz to raltegravir in a randomized, controlled study",https://pubmed.ncbi.nlm.nih.gov/36541643/,Inconclusive,,Laboratory Study,2022,Fatty Acid-Binding Protein (FABP); Microbiome,Immune System,HIV/AIDS
2023277,The effect of tilmicosin and diclofenac sodium combination on cardiac biomarkers in sheep,https://pubmed.ncbi.nlm.nih.gov/36961261/,Positive,,Animal Study -,2023,Fatty Acid-Binding Protein (FABP),,Veterinary Applications; Cardiac Toxicity; Cardiovascular Diseases (CVD); Heart Attack
2018039,N-Palmitoyl Ethanol Amide Pharmacological Treatment in Patients With Nonsurgical Lumbar Radiculopathy,https://pubmed.ncbi.nlm.nih.gov/29364513/,Positive,,Clinical Trial,2018,Palmitoylethanolamide (PEA),Nervous System,Pain; Pain - Chronic
2020093,Analysis of Novel Cardiovascular Biomarkers in Patients With Pulmonary Hypertension (PH),https://pubmed.ncbi.nlm.nih.gov/31327702/,Negative,,Meta-analysis,2020,Fatty Acid-Binding Protein (FABP),Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2022192,Different circulating biomarkers in women and men with paroxysmal atrial fibrillation: results from the AF-RISK and RACE V studies,https://academic.oup.com/europace/article/24/2/193/6331356?login=false,Inconclusive,,Clinical Trial,2022,Fatty Acid-Binding Protein (FABP),Cardiovascular System,Atrial Fibrillation; Cardiovascular Diseases (CVD); Cardiac Arrhythmias; Inflammation
2022193,Short-Term Very High Carbohydrate Diet and Gut-Training Have Minor Effects on Gastrointestinal Status and Performance in Highly Trained Endurance Athletes,https://www.mdpi.com/2072-6643/14/9/1929,Inconclusive,,Clinical Trial,2022,Fatty Acid-Binding Protein (FABP),,Metabolic Syndrome
2022194,The impact of exercise modality on exercise-induced gastrointestinal syndrome and associated gastrointestinal symptoms,https://www.jsams.org/article/S1440-2440(22)00203-1/fulltext,Positive,,Clinical Trial,2022,Exercise; Fatty Acid-Binding Protein (FABP),,
2023278,Biomarkers in the cerebrospinal fluid of patients with psychotic disorders compared to healthy controls: a systematic review and meta-analysis,https://pubmed.ncbi.nlm.nih.gov/37169812/,Positive,,Clinical Meta-analysis,2023,Anandamide (AEA),Mental/Emotional System,Psychosis; Inflammation
2020094,Myocardial ischaemia associated with tetrahydrocannabinol intake in a teenage boy: A case report,https://onlinelibrary.wiley.com/doi/10.1111/jpc.15227,Negative,,Meta-analysis,2020,Tetrahydrocannabinol (THC),Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack; Cardiac Arrhythmias; Cardiac Toxicity; Pain; Nausea and Vomiting; Pain - Acute
2020095,Cannabidiol Oil-Associated Microscopic Colitis,https://www.cureus.com/articles/39171-cannabidiol-oil-associated-microscopic-colitis#!/,Negative,,Meta-analysis,2020,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Digestive System,IBD - Inflammatory Bowel Disease; Cannabis Adverse Effects; Diarrhea; Inflammation; Pain; Pain - Cancer
2020096,Brodifacoum-Laced Synthetic Marijuana Toxicity: A Fight Against Time,https://amjcaserep.com/abstract/full/idArt/927111,Negative,,Meta-analysis,2020,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis; Addiction - Cannabis; Cannabis Adverse Effects; Nausea and Vomiting
2005014,Cannabis use in HIV for pain and other medical symptoms,https://www.jpsmjournal.com/article/S0885-3924(05)00063-1/fulltext,Positive,,Meta-analysis,2005,,Immune System; Nervous System,HIV/AIDS; Pain; Pain - Neuropathy - Peripheral
2017039,The efficacy of an association of palmitoylethanolamide and alpha-lipoic acid in patients with chronic prostatitis/chronic pelvic pain syndrome: A randomized clinical trial,https://pubmed.ncbi.nlm.nih.gov/28403589/,Positive,,Clinical Trial,2017,Palmitoylethanolamide (PEA),Urinary System,Pain; Pain - Chronic; Urinary Tract Infection; Bacterial Infections; Inflammation
2017040,"Pooled analysis of three randomized, double-blind, placebo controlled trials with rimonabant for smoking cessation",https://pubmed.ncbi.nlm.nih.gov/28429843/,Positive,,Clinical Meta-analysis,2017,SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); Pharma THC,Mental/Emotional System; Nervous System,Addiction - Nicotine; Addiction; Anorexia; Cannabis Adverse Effects
2017041,Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome,https://www.nejm.org/doi/10.1056/NEJMoa1611618,Positive,,Double Blind Clinical Trial,2017,Pharma CBD,,Epilepsy - Dravet Syndrome; Epilepsy; Diarrhea; Nausea and Vomiting
2017042,Neurosteroid Levels in Patients With Bipolar Disorder and a History of Cannabis Use Disorders,https://pubmed.ncbi.nlm.nih.gov/29045302/,Negative,,Clinical Trial,2017,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Bipolar Disorder; Cannabis Adverse Effects; Depression
2017043,The effects of cannabidiol on persecutory ideation and anxiety in a high trait paranoid group,https://pubmed.ncbi.nlm.nih.gov/29086614/,Negative,,Clinical Trial,2017,,Mental/Emotional System,Anxiety; Psychosis
2017044,Single-Dose Pharmacokinetics of Oral Cannabidiol Following Administration of PTL101: A New Formulation Based on Gelatin Matrix Pellets Technology,https://pubmed.ncbi.nlm.nih.gov/29125702/,Positive,,Clinical Trial,2017,Pharma THC:CBD,,Anxiety; Depression; Epilepsy; Inflammation; Neurodegenerative Issues; Oxidative Stress; Psychosis
2023279,Climbing the Evidence Pyramid: Dosing Considerations for Medical Cannabis in the Management of Chronic Pain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134049/,Positive,,Meta-analysis,2023,Pharma CBD; Pharma THC:CBD; Pharma THC; Tetrahydrocannabinol (THC),,Pain; Pain - Chronic
2022195,"Efficacy, Safety, and Regulation of Cannabidiol on Chronic Pain: A Systematic Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288157/,Positive,,Clinical Meta-analysis,2022,,,Pain; Pain - Chronic
2017045,Low-fat yogurt consumption reduces biomarkers of chronic inflammation and inhibits markers of endotoxin exposure in healthy premenopausal women: a randomised controlled trial,https://www.cambridge.org/core/journals/british-journal-of-nutrition/article/lowfat-yogurt-consumption-reduces-biomarkers-of-chronic-inflammation-and-inhibits-markers-of-endotoxin-exposure-in-healthy-premenopausal-women-a-randomised-controlled-trial/B7ED318F1F80DCC04DBC348700C071C1,Positive,,Clinical Trial,2017,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Nervous System,Inflammation; Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Menopause; Obesity
2018040,N-of-1 Randomized Trials of Ultra-Micronized Palmitoylethanolamide in Older Patients with Chronic Pain,https://pubmed.ncbi.nlm.nih.gov/29210011/,Positive,,Clinical Trial,2018,Palmitoylethanolamide (PEA),Nervous System,Pain - Chronic; Pain
2018041,Potent Anti-Inflammatory and Pro-Resolving Effects of Anabasum in a Human Model of Self-Resolving Acute Inflammation,https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.980,Positive,,Clinical Trial,2018,Delta-8-THC; Synthetic Cannabinoid (unspecified),Nervous System,Inflammation; Fibrosis; Lupus; Systemic Sclerosis
2018042,Cannabidiol for drug-resistant seizures in the Dravet syndrome,https://onlinelibrary.wiley.com/doi/10.1111/jpc.13803,Positive,,Clinical Trial,2018,,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy; Anorexia; Diarrhea; Nausea and Vomiting
2018043,Cannabis for paediatric epilepsy: challenges and conundrums,https://onlinelibrary.wiley.com/doi/full/10.5694/mja17.00699,Positive,,Meta-analysis,2018,,Nervous System,Epilepsy; Epilepsy - Dravet Syndrome
2018044,Increased hippocampal engagement during learning as a marker of sensitivity to psychotomimetic effects of δ-9-THC,https://pubmed.ncbi.nlm.nih.gov/29502548/,Positive,,Double Blind Clinical Trial,2018,,,Cannabis Adverse Effects; Psychosis
2018045,Effects of polymorphism rs3123554 in the cannabinoid receptor gene type 2 (CB2R) on metabolic and adiposity parameters after weight loss with two hypocaloric diets,https://pubmed.ncbi.nlm.nih.gov/29518488/,Positive,,Double Blind Clinical Trial,2018,Endocannabinoid (unspecified),Endocrine System,Metabolic Syndrome; Cardiovascular Diseases (CVD); Diabetes; Hypertension (High Blood Pressure); Obesity
2020097,Cannabinoid Hyperemesis Syndrome: A Case Report and Discussion Regarding Patients with Concurrent Disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556397/,Negative,,Meta-analysis,2020,,Digestive System; Nervous System,Cannabis Hyperemesis Syndrome; Nausea and Vomiting; Addiction - Alcohol; Addiction - Nicotine; Addiction - Opioid; Cannabis Adverse Effects; Depression; Diarrhea; Pain; Night Sweats and Excessive Sweating; Psychosis; PTSD; Schizophrenia
2020098,Effect of Cannabinoids on Electroencephalography of a Child with Lennox-Gastaut Syndrome,https://ruralneuropractice.com/effect-of-cannabinoids-on-electroencephalography-of-a-child-with-lennox-gastaut-syndrome/#,Positive,,Meta-analysis,2020,Pharma CBD,Nervous System,Epilepsy - Lennox-Gastaut; Epilepsy; Epilepsy - Dravet Syndrome
2023280,Cytosolic Enzymes Generate Cannabinoid Metabolites 7-Carboxycannabidiol and 11-Nor-9-carboxytetrahydrocannabinol,https://pubs.acs.org/doi/10.1021/acsmedchemlett.3c00017,Positive,,Laboratory Study,2023,WIN-x Synthetic Cannabinoids,,Oxidative Stress
2023281,"Effervescent cannabidiol solid dispersion-doped dissolving microneedles for boosted melanoma therapy via the ""TRPV1-NFATc1-ATF3"" pathway and tumor microenvironment engineering",https://biomaterialsres.biomedcentral.com/articles/10.1186/s40824-023-00390-x,Positive,,Animal Study,2023,,Integumentary System; Nervous System,Cancer - Melanoma; Cancer
2023282,Cannabidiol sensitizes TRPV2 channels to activation by 2-APB,https://elifesciences.org/articles/86166#s4,Positive,,Animal Study,2023,Capsaicin (CAPS),,Oxidative Stress
2022196,Cannabinoids for Symptom Management in Patients with Kidney Failure: A Narrative Review,https://pubmed.ncbi.nlm.nih.gov/34987023/,Negative,,Meta-analysis,2022,,Urinary System,Kidney Failure; Anorexia; Anxiety; Inflammation; Insomnia and Sleep Disorders; Pain; Nausea and Vomiting; Pain - Chronic; Pain - Neuropathy - Diabetic; Pain - Neuropathy - Drug-Ind. Polyneuropathy; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral; Pruritis; Restless Leg Syndrome
2022197,Cannabis in Parkinson's Disease - the patient's perspective versus clinical trials: a systematic literature review,https://journals.viamedica.pl/neurologia_neurochirurgia_polska/article/view/PJNNS.a2022.0004/65365,Negative,,Clinical Meta-analysis,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Pharma CBD; Pharma THC:CBD; Pharma THC,Nervous System,Parkinson's Disease; Anxiety; Inflammation; Insomnia and Sleep Disorders; Pain
2022198,Effects of short-term environmental stresses on the onset of cannabinoid production in young immature flowers of industrial hemp (Cannabis sativa L.),https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-021-00111-y#Sec2,Positive,,Laboratory Study,2022,Cannabidiolic Acid (CBD-a); Cannabigerol (CBG); Cannabigerolic Acid (CBG-a); Cannabinol (CBN); Tetrahydrocannabinolic Acid (THC-a),Mental/Emotional System,Cancer; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Parkinson's Disease
2022199,Cannabis Use and the Endocannabinoid System: A Clinical Perspective,https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2021.21111138,Inconclusive,,Meta-analysis,2022,Endocannabinoid (unspecified); Tetrahydrocannabinol (THC); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Cannabichromene (CBC); Cannabigerol (CBG); Cannabinol (CBN); Delta-8-THC; Fatty Acid Amide Hydrolase (FAAH); Tetrahydrocannabivarin (THCV); Pharma THC; Synthetic Cannabinoid (unspecified),,Addiction - Cannabis; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant; Anorexia; Anxiety; Cannabis Adverse Effects; Epilepsy; Insomnia and Sleep Disorders; Pain; Nausea and Vomiting; Pain - Cancer; Suicide Attempt
2021121,Early-life stress induces emotional and molecular alterations in female mice that are partially reversed by cannabidiol,https://www.sciencedirect.com/science/article/abs/pii/S0278584621002670?via%3Dihub,Positive,,Animal Study,2021,Endocannabinoid (unspecified),Mental/Emotional System,Anxiety; Depression; Domestic Abuse; Inflammation; Metabolic Syndrome; Oxidative Stress; Pregnancy
2020099,Reduction in Tamoxifen Metabolites Endoxifen and N-desmethyltamoxifen With Chronic Administration of Low Dose Cannabidiol: A CYP3A4 and CYP2D6 Drug Interaction,https://pubmed.ncbi.nlm.nih.gov/33191836/,Negative,,Meta-analysis,2020,,,Cancer - Breast; Cancer; Pain; Pain - Cancer
2020100,A new treatment paradigm for sickle cell disease leg ulcers: Topical cannabis-based medicines,https://onlinelibrary.wiley.com/doi/10.1111/exd.14256,Positive,,Clinical Trial,2020,Tetrahydrocannabinolic Acid (THC-a),Cardiovascular System; Immune System; Integumentary System; Nervous System,Sickle Cell Disorders; Wound Healing; Epidermolysis bullosa; Inflammation; Pain; Palliative Care
2020101,"Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers",https://www.frontiersin.org/articles/10.3389/fpsyt.2020.576877/full,Inconclusive,,Double Blind Clinical Trial,2020,Pharma THC,,Cognitive Dysfunction; Psychosis; Schizophrenia
2020102,An Unusual Case of Ventricular Tachycardia in a Young Patient Associated with Cannabis Use,https://www.hindawi.com/journals/cric/2020/8813930/,Negative,,Meta-analysis,2020,,Cardiovascular System,Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Addiction - Cannabis; Cannabis Adverse Effects; Pain; Obesity; Sleep Apnea
2020103,"Do Not Huff, Puff, or Vape That Stuff: Interstitial Airspace Disease in a Teenager",https://www.hindawi.com/journals/cripe/2020/8822362/,Negative,,Meta-analysis,2020,,Respiratory System,Vaping injury (EVALI); Acute Respiratory Distress Syndrome; Addiction - Nicotine; Cannabis Adverse Effects; Cough; Diarrhea; Inflammation; Pain; Nausea and Vomiting; Stress
2020104,Cannabis-induced basal-mid-left ventricular stress cardiomyopathy: A case report,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759071/,Negative,,Meta-analysis,2020,Tetrahydrocannabinol (THC),Mental/Emotional System,Cannabis Adverse Effects; Cardiac Arrhythmias; Cardiac Toxicity; Cardiovascular Diseases (CVD); Heart Attack; Stroke
2021122,The antipsychotic potential of cannabidiol: clinical implications for patients with psychosis and comorbid cannabis use disorder,https://www.jpn.ca/content/46/1/E164,Negative,,Meta-analysis,2021,,Mental/Emotional System,Addiction - Cannabis; Addiction; Psychosis; Anxiety; Cannabis Adverse Effects; Schizophrenia
2021123,"A 41-Year-Old Man Presenting With Shortness of Breath, Nausea, Vomiting, and Diarrhea",https://journal.chestnet.org/article/S0012-3692(20)34518-9/fulltext,Negative,,Meta-analysis,2021,,Digestive System,Diarrhea; Nausea and Vomiting; Anxiety; Cannabis Adverse Effects; Gastro-Esophageal Reflux; Migraine
2021124,A 23-year-old man with acute lung injury after using a tetrahydrocannabinol-containing vaping device: a case report,https://jmedicalcasereports.biomedcentral.com/articles/10.1186/s13256-020-02549-9,Negative,,Meta-analysis,2021,,Respiratory System,Vaping injury (EVALI); Acute Respiratory Distress Syndrome; Addiction - Benzodiazepine; Addiction - Stimulant; Cannabis Adverse Effects; Cough; Inflammation; Nausea and Vomiting; Stress
2023283,A Case of a Patient With Cannabis Hyperemesis Syndrome Along With Recurrent Nephrolithiasis,https://www.cureus.com/articles/142401-a-case-of-a-patient-with-cannabis-hyperemesis-syndrome-along-with-recurrent-nephrolithiasis#!/,Negative,,Meta-analysis,2023,,Digestive System; Nervous System,Cannabis Hyperemesis Syndrome; Nausea and Vomiting; Cannabis Adverse Effects; Cardiovascular Diseases (CVD); Chronic Kidney Disease; Diabetes; Hypertension (High Blood Pressure); Inflammation; Pain; Obesity; Pain - Acute
2022200,Persistent Diarrhea and Eosinophilic Esophagitis Resulting From Chronic Cannabidiol Usage for Refractory Epilepsy,https://journals.lww.com/jpgnr/Fulltext/2022/11000/Persistent_Diarrhea_and_Eosinophilic_Esophagitis.7.aspx,Negative,,Meta-analysis,2022,,Digestive System,Diarrhea; Epilepsy; Cachexia; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; IBD - Inflammatory Bowel Disease; Pain
2023284,A Rare Case of Cannabinoid Hyperemesis Syndrome Secondary to Cannabidiol for Refractory Epilepsy,https://journals.lww.com/jpgnr/Fulltext/2023/02000/A_Rare_Case_of_Cannabinoid_Hyperemesis_Syndrome.15.aspx,Negative,,Meta-analysis,2023,,Digestive System; Nervous System,Cannabis Hyperemesis Syndrome; Epilepsy; Nausea and Vomiting; Cannabis Adverse Effects; Constipation; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut
2023285,A Case of Near-Fatal Bradycardia Caused by Accidental Cannabis Intoxication,https://www.cureus.com/articles/144816-a-case-of-near-fatal-bradycardia-caused-by-accidental-cannabis-intoxication#!/,Negative,,Meta-analysis,2023,Tetrahydrocannabinol (THC),Cardiovascular System,Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Cannabis Adverse Effects
2023286,Late Onset Diaphragmatic Hernia: A Forgotten Etiology of Recurrent Vomiting in the Adolescent Population,https://www.dovepress.com/late-onset-diaphragmatic-hernia-a-forgotten-etiology-of-recurrent-vomi-peer-reviewed-fulltext-article-PHMT,Negative,,Meta-analysis,2023,,Digestive System,Nausea and Vomiting; Cannabis Hyperemesis Syndrome; Diabetes; Pain
2017046,Synthetic Cannabis Analogues and Suicidal Behavior: Case Report,https://pubmed.ncbi.nlm.nih.gov/28796120/,Negative,,Meta-analysis,2017,Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Poisoning by Synthetic Cannabis; Suicide Attempt; Anxiety; Cannabis Adverse Effects; Psychosis; Schizophrenia
2019050,Clinical Challenges in Patients with First Episode Psychosis and Cannabis Use: Mini-Review and a Case Study,https://www.psychiatria-danubina.com/UserDocsImages/pdf/dnb_vol31_noSuppl%202/dnb_vol31_noSuppl%202_162.pdf,Negative,,Meta-analysis,2019,Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Psychosis; Addiction - Cannabis; Behavioral Disorders; Anxiety; Cannabis Adverse Effects; Cognitive Dysfunction; Depression; Domestic Abuse; Insomnia and Sleep Disorders; Poisoning by Synthetic Cannabis; Schizophrenia
2020105,Emergence of Cumyl-PEGACLONE-related fatalities in the Northern Territory of Australia,https://pubmed.ncbi.nlm.nih.gov/33185835/,Negative,,Meta-analysis,2020,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis; Addiction - Alcohol; Cannabis Adverse Effects; Cardiovascular Diseases (CVD)
2018046,"Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome",https://n.neurology.org/content/90/14/e1204,Positive,,Double Blind Clinical Trial,2018,,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy; Loss of Appetite; Nausea and Vomiting
2018047,"The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial",https://pubmed.ncbi.nlm.nih.gov/29550881/,Positive,,Double Blind Clinical Trial,2018,Pharma THC,Mental/Emotional System; Respiratory System,Cancer - Lung; Loss of Appetite; Anorexia; Cachexia; Chemotherapy-induced Nausea & Vomiting; Insomnia and Sleep Disorders; Pain; Pain - Cancer
2018048,[EFFECTS OF CANNABIS EXTRACT PREMEDICATION ON ANESTHETIC DEPTH],https://pubmed.ncbi.nlm.nih.gov/29582946/,Negative,,Double Blind Clinical Trial,2018,Pharma THC:CBD; Tetrahydrocannabinol (THC),,Pain
2023287,Assessment of Medical Cannabis and Health-Related Quality of Life,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170337/,Positive,,Meta-analysis,2023,,,Pain; Pain - Chronic
2018049,Cannabinoid receptor-mediated disruption of sensory gating and neural oscillations: A translational study in rats and humans,https://www.sciencedirect.com/science/article/abs/pii/S0028390818301485?via%3Dihub,Negative,,Double Blind Clinical Trial,2018,CP-x Synthetic Cannabinoids; AM-x Synthetic Cannabinoids,,Cognitive Dysfunction
2018050,Palatability and oral cavity tolerability of THC:CBD oromucosal spray and possible improvement measures in multiple sclerosis patients with resistant spasticity: a pilot study,https://pubmed.ncbi.nlm.nih.gov/29683408/,Positive,,Clinical Trial,2018,Pharma THC:CBD; Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Multiple Sclerosis
2018051,"Sativex® as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial",https://pubmed.ncbi.nlm.nih.gov/29792372/,Positive,,Double Blind Clinical Trial,2018,Pharma THC:CBD; Tetrahydrocannabinol (THC),Nervous System,Multiple Sclerosis
2018052,The Relationship of Endocannabinoidome Lipid Mediators With Pain and Psychological Stress in Women With Fibromyalgia: A Case-Control Study,https://pubmed.ncbi.nlm.nih.gov/29885369/,Positive,,Double Blind Clinical Trial,2018,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Palmitoylethanolamide (PEA),Mental/Emotional System; Muscular System; Nervous System,Fibromyalgia; Pain; Anxiety; Depression; Inflammation; Pain - Chronic
2018053,Probing the endocannabinoid system in healthy volunteers: Cannabidiol alters fronto-striatal resting-state connectivity,https://www.sciencedirect.com/science/article/abs/pii/S0924977X18301135?via%3Dihub,Positive,,Double Blind Clinical Trial,2018,Tetrahydrocannabinol (THC),,Anxiety; Psychosis; Schizophrenia
2022201,"Enhanced Oral Bioavailability of β-Caryophyllene in Healthy Subjects Using the VESIsorb® Formulation Technology, a Novel Self-Emulsifying Drug Delivery System (SEDDS)",https://www.mdpi.com/1420-3049/27/9/2860,Positive,,Double Blind Clinical Trial,2022,,,Anxiety; Depression; Inflammation; Oxidative Stress
2020106,"Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial",https://pubmed.ncbi.nlm.nih.gov/33843820/,Inconclusive,,Double Blind Clinical Trial,2020,Ayahuasca,,
2020107,Subacute effects of the psychedelic ayahuasca on the salience and default mode networks,https://pubmed.ncbi.nlm.nih.gov/32255395/,Positive,,Double Blind Clinical Trial,2020,Ayahuasca,,
2018054,Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial,https://www.cambridge.org/core/journals/psychological-medicine/article/rapid-antidepressant-effects-of-the-psychedelic-ayahuasca-in-treatmentresistant-depression-a-randomized-placebocontrolled-trial/E67A8A4BBE4F5F14DE8552DB9A0CBC97,Positive,,Double Blind Clinical Trial,2018,Ayahuasca,Mental/Emotional System; Nervous System,Addiction - Alcohol; Depression; Diarrhea; Nausea and Vomiting; OCD
2016066,A Personal Retrospective: Elevating Anandamide (AEA) by Targeting Fatty Acid Amide Hydrolase (FAAH) and the Fatty Acid Binding Proteins (FABPs),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062061/,Positive,,Meta-analysis,2016,Anandamide (AEA); Fatty Acid-Binding Protein (FABP),,Epilepsy - Dravet Syndrome; Epilepsy - FIRES; Epilepsy - Lennox-Gastaut; Epilepsy
2018055,"Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis: A Randomized Clinical Trial",https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2697762,Positive,,Double Blind Clinical Trial,2018,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Palmitoylethanolamide (PEA),Mental/Emotional System; Nervous System,Psychosis; Anxiety; Cognitive Dysfunction; Schizophrenia
2018056,Common polymorphism in the cannabinoid receptor gene type 2 (CB2R) rs3123554 are associated with metabolic changes after two different hypocaloric diets with different dietary fatty profiles,https://pubmed.ncbi.nlm.nih.gov/30528951/,Positive,,Clinical Trial,2018,,Endocrine System,Metabolic Syndrome; Obesity
2019051,The association between endogenous opioid function and morphine responsiveness: a moderating role for endocannabinoids,https://pubmed.ncbi.nlm.nih.gov/30562268/,Positive,,Clinical Trial,2019,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified),,Pain; Pain - Chronic
2019052,Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial,https://onlinelibrary.wiley.com/doi/10.1111/epi.14628,Positive,,Clinical Trial,2019,Pharma CBD,,Epilepsy - Dravet Syndrome; Epilepsy; Diarrhea; Epilepsy - FIRES; Loss of Appetite
2019053,Cannabidiol in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study,https://onlinelibrary.wiley.com/doi/10.1111/epi.14670,Positive,,Double Blind Clinical Trial,2019,Pharma CBD,,Epilepsy - Lennox-Gastaut; Epilepsy; Epilepsy - Dravet Syndrome
2019054,"A double-blind randomized placebo controlled study assessing safety, tolerability and efficacy of palmitoylethanolamide for symptoms of knee osteoarthritis",https://pubmed.ncbi.nlm.nih.gov/30927159/,Positive,,Double Blind Clinical Trial,2019,Palmitoylethanolamide (PEA),Mental/Emotional System,Anxiety; Depression; Insomnia and Sleep Disorders
2019055,Acute effects of ∆9-tetrahydrocannabinol (THC) on resting state brain function and their modulation by COMT genotype,https://www.sciencedirect.com/science/article/abs/pii/S0924977X19301981?via%3Dihub,Inconclusive,,Double Blind Clinical Trial,2019,,,Cannabis Adverse Effects; Cognitive Dysfunction; Schizophrenia
2019056,Delta-9-tetrahydrocannabinol intoxication is associated with increased prefrontal activation as assessed with functional near-infrared spectroscopy: A report of a potential biomarker of intoxication,https://www.sciencedirect.com/science/article/abs/pii/S1053811919303957?via%3Dihub,Positive,,Clinical Trial,2019,Pharma THC,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Behavioral Disorders; Cognitive Dysfunction
2018057,Chronic Pain Treatment With Cannabidiol in Kidney Transplant Patients in Uruguay,https://www.sciencedirect.com/science/article/abs/pii/S0041134517309624?via%3Dihub,Positive,,Clinical Trial,2018,,Nervous System; Urinary System,Chronic Kidney Disease; Pain - Chronic; Inflammation; Kidney Failure; Pain
2018058,METABOLISM| APRIL 12 2018 Cannabinoid Type 1 Receptors Are Upregulated During Acute Activation of Brown Adipose Tissue,https://diabetesjournals.org/diabetes/article/67/7/1226/35336/Cannabinoid-Type-1-Receptors-Are-Upregulated,Positive,,Clinical Trial,2018,Endocannabinoid (unspecified); Pharma THC,,Cardiovascular Diseases (CVD); Diabetes; Metabolic Syndrome; Obesity
2021125,Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial,https://pubmed.ncbi.nlm.nih.gov/33118052/,Positive,,Clinical Trial,2021,Ayahuasca,Mental/Emotional System,Depression; Suicide Attempt
2021126,"A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats",https://link.springer.com/article/10.1007/s00213-021-05817-8,Inconclusive,,Clinical Trial,2021,Ayahuasca,,Anxiety; Depression
2023288,Perfluorooctane sulfonate-induced apoptosis in kidney cells by triggering the NOX4/ROS/JNK axis and antagonism of cannabidiol,https://onlinelibrary.wiley.com/doi/10.1002/tox.23794,Positive,,Laboratory Study,2023,,,Inflammation; Kidney Failure; Oxidative Stress
2019057,CNR1 and FAAH variation and affective states induced by marijuana smoking,https://pubmed.ncbi.nlm.nih.gov/31184938/,Inconclusive,,Clinical Trial,2019,,,Addiction - Cannabis; Behavioral Disorders; Anxiety
2019058,Repetitive high-frequency transcranial magnetic stimulation reverses depressive-like behaviors and protein expression at hippocampal synapses in chronic unpredictable stress-treated rats by enhancing endocannabinoid signaling,https://www.sciencedirect.com/science/article/abs/pii/S0091305719301376?via%3Dihub,Positive,,Animal Study,2019,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Other Related Compounds,Mental/Emotional System; Nervous System,Depression
2019059,"Effect of dietary supplementation with ultramicronized palmitoylethanolamide in maintaining remission in cats with nonflea hypersensitivity dermatitis: a double-blind, multicentre, randomized, placebo-controlled study",https://onlinelibrary.wiley.com/doi/10.1111/vde.12764,Positive,,Animal Study -,2019,Palmitoylethanolamide (PEA),,Veterinary Applications; Allergic Contact Dermatitis; Pruritis
2023289,A case of panic attack developing after THC-O acetate inhalation using an e-cigarette device,https://onlinelibrary.wiley.com/doi/10.1002/npr2.12345,Negative,,Meta-analysis,2023,,Mental/Emotional System,Anxiety; Cannabis Adverse Effects; Cognitive Dysfunction; Depression; Nausea and Vomiting; Psychosis; Schizophrenia; Vaping injury (EVALI)
2023290,Ulceration and a White Lesion of the Tongue in a Male HIV Positive Patient: A Journey on the Avenue of Differential Diagnoses in Search of a Solution,https://www.mdpi.com/2075-1729/13/4/901,Negative,,Meta-analysis,2023,Microbiome,Immune System,HIV/AIDS; Cancer - Lymphoma; Cancer - Squamous Head/Neck; Cannabis Adverse Effects; Herpes; Inflammation; Loss of Appetite; Pain; Stomach Ulcers; Wound Healing
2021127,Cannabinoid Hyperemesis Syndrome: A Case Study in a Tunisian Young Man,https://www.hindawi.com/journals/crim/2021/6617148/,Negative,,Meta-analysis,2021,,Digestive System; Nervous System,Cannabis Hyperemesis Syndrome; Nausea and Vomiting; Cannabis Adverse Effects; Pain
2021128,Psychosis induced by abuse of ayahuasca: a case report,https://www.sciencedirect.com/science/article/abs/pii/S0034745019300794?via%3Dihub,Negative,,Meta-analysis,2021,Ayahuasca,Mental/Emotional System; Nervous System,Addiction - Cocaine; Anxiety; Depression; Psychosis; Schizophrenia
2021129,Cannabis-Induced Mania Following COVID-19 Self-Medication: A Wake-Up Call to Improve Community Awareness,https://www.dovepress.com/cannabis-induced-mania-following-covid-19-self-medication-a-wake-up-ca-peer-reviewed-fulltext-article-IMCRJ,Negative,,Meta-analysis,2021,,Respiratory System,COVID-19; Bipolar Disorder; Cannabis Adverse Effects; Psychosis
2022202,Ayahuasca-Induced Psychosis: A Case Report,https://www.sciencedirect.com/science/article/abs/pii/S0034745020301293?via%3Dihub,Negative,,Meta-analysis,2022,Ayahuasca,Mental/Emotional System,Insomnia and Sleep Disorders; Psychosis
2021130,"Vape-Associated Pulmonary Injury (VAPI) Presenting With a ""Miliary"" Pattern on Imaging",https://www.cureus.com/articles/52030-vape-associated-pulmonary-injury-vapi-presenting-with-a-miliary-pattern-on-imaging#!/,Negative,,Meta-analysis,2021,,Respiratory System,Vaping injury (EVALI); Cannabis Adverse Effects; Cough; Diarrhea; Inflammation; Loss of Appetite; Nausea and Vomiting
2021131,EVALI - E-Cigarette or Vaping Product Use-Associated Lung Injury: A Case Report,https://www.cureus.com/articles/51365-evali---e-cigarette-or-vaping-product-use-associated-lung-injury-case-report#!/,Negative,,Meta-analysis,2021,Tetrahydrocannabinol (THC),Respiratory System,Vaping injury (EVALI); Cannabis Adverse Effects
2021132,Cannabinoid hyperemesis syndrome can be relieved by warm baths,https://ugeskriftet.dk/videnskab/cannabinoid-hyperemesis-syndrom-kan-lindres-af-varme-bade,Negative,,Meta-analysis,2021,,Digestive System; Nervous System,Cannabis Hyperemesis Syndrome; Nausea and Vomiting; Addiction - Cannabis; Cannabis Adverse Effects; Epilepsy; Pain
2021133,Change in Refractive Error Associated With the Use of Cannabidiol Oil,https://www.cureus.com/articles/53149-change-in-refractive-error-associated-with-the-use-of-cannabidiol-oil#!/,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Diabetes; Metabolic Syndrome; Oxidative Stress; Sleep Apnea
2021134,A Change in Blood Carbamazepine Levels Associated With Cannabis Use: Implications for Clinical Practice,https://www.psychiatrist.com/jcp/bipolar/change-in-blood-carbamazepine-levels-with-cannabis-use-implications-for-clinical-practice/,Negative,,Meta-analysis,2021,Cannabichromene (CBC); Cannabinol (CBN),Mental/Emotional System; Nervous System,Bipolar Disorder; Cannabis Adverse Effects; Addiction - Cannabis
2021135,Cannabis induced thermal epiglottitis in a pediatric patient,https://www.sciencedirect.com/science/article/abs/pii/S0735675721004125?via%3Dihub,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Inflammation; Addiction - Benzodiazepine; Addiction - Opioid
2021136,Potential Benefit of Add-on Δ9-Tetrahydrocannabinol in Pediatric Drug-Resistant Epilepsy: A Case Series,https://pubmed.ncbi.nlm.nih.gov/34183079/,Positive,,Meta-analysis,2021,,Nervous System,Epilepsy
2021137,Near-Fatal Spice Intoxication of a Toddler,https://publications.aap.org/pediatrics/article/148/2/e2021050888/179803/Near-Fatal-Spice-Intoxication-of-a-Toddler?autologincheck=redirected,Negative,,Meta-analysis,2021,5F-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Poisoning by Synthetic Cannabis; Addiction - Stimulant
2021138,Palmitoylethanolamide (PEA) in the treatment of neuropathic pain: a case study,https://pubmed.ncbi.nlm.nih.gov/34289728/,Positive,,Meta-analysis,2021,Palmitoylethanolamide (PEA),,Pain; Herpes; Pain - Neuropathy - Peripheral; Shingles (Herpes Zoster)
2021139,Cannabinoid Hyperemesis Syndrome Secondary to Delta-8 THC Use,https://www.amjmed.com/article/S0002-9343(21)00486-1/fulltext,Negative,,Meta-analysis,2021,Delta-8-THC,Digestive System; Nervous System,Cannabis Hyperemesis Syndrome; Nausea and Vomiting; Addiction - Opioid; Cannabis Adverse Effects
2021140,Kaposi-Juliusberg Varicelliform Eruption complicating Darier disease: May cannabinoid abuse be an underestimated risk factor?,https://onlinelibrary.wiley.com/doi/10.1002/ccr3.4589,Negative,,Meta-analysis,2021,,Integumentary System; Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Herpes; Eczema; Wound Healing
2021141,Cardiac sudden death in a young cannabis user,https://www.sciencedirect.com/science/article/abs/pii/S134462232100119X?via%3Dihub,Negative,,Meta-analysis,2021,,Cardiovascular System; Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cardiovascular Diseases (CVD); Heart Attack; Atherosclerosis; Cannabis Adverse Effects; Pain
2021142,E-Cigarette or Vaping Associated Lung Injury: Evolving Threat to Healthy Teens,https://pubmed.ncbi.nlm.nih.gov/34449994/,Negative,,Meta-analysis,2021,,Respiratory System,Vaping injury (EVALI); Cannabis Adverse Effects
2021143,A Rare Case of Vaping-Induced Spontaneous Pneumomediastinum,https://www.cureus.com/articles/64162-a-rare-case-of-vaping-induced-spontaneous-pneumomediastinum#!/,Negative,,Meta-analysis,2021,,Respiratory System,Vaping injury (EVALI); Addiction - Opioid; Asthma; Cannabis Adverse Effects; Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Pain
2021144,Suicide by vaping the synthetic cannabinoid 4F-MDMB-BINACA: cannabinoid receptors and fluoride at the crossroads of toxicity?,https://pubmed.ncbi.nlm.nih.gov/34542803/,Negative,,Meta-analysis,2021,Synthetic Cannabinoid (unspecified),Mental/Emotional System,Poisoning by Synthetic Cannabis; Suicide Attempt; Acute Respiratory Distress Syndrome; Addiction - Cannabis; Cannabis Adverse Effects; Kidney Failure; Pancreatitis; Stress; Vaping injury (EVALI)
2021145,[Droghe d'abuso e rene] Drugs of Abuse and the Kidney,https://pubmed.ncbi.nlm.nih.gov/34669304/,Positive,,Meta-analysis,2021,Synthetic Cannabinoid (unspecified),Urinary System,Kidney Failure; Addiction - Cannabis; Addiction - Cocaine; Addiction - Opioid; Addiction - Stimulant; Cannabis Adverse Effects
2021146,Cannabis Dopaminergic Effects Induce Hallucinations in a Patient with Parkinson's Disease,https://www.mdpi.com/1648-9144/57/10/1107,Negative,,Meta-analysis,2021,Pharma THC,Mental/Emotional System,Cannabis Adverse Effects; Cognitive Dysfunction; Parkinson's Disease; Addiction - Alcohol; Addiction - Nicotine; Pain; Neurodegenerative Issues; Pain - Chronic
2021147,Death of a young woman with cyclic vomiting: a case report,https://pubmed.ncbi.nlm.nih.gov/34735682/,Negative,,Meta-analysis,2021,,Digestive System,Nausea and Vomiting; Cannabis Adverse Effects; Cannabis Hyperemesis Syndrome; Cardiac Arrhythmias; Cardiovascular Diseases (CVD)
2021148,A Reason to Rethink Fasting Guidelines? Marijuana-Induced Gastroparesis and the Implications for Aspiration Risk in the Nil Per Os (NPO) Patient: A Case Report,https://amjcaserep.com/abstract/full/idArt/934187,Negative,,Meta-analysis,2021,,Digestive System,Gastroparesis; Cannabis Adverse Effects; Cannabis Hyperemesis Syndrome; Pain; Nausea and Vomiting
2021149,Brugada Electrocardiogram Pattern Induced by Recreational Delta-8-Tetrahydrocannabinol (THC): A Case Report,https://www.cureus.com/articles/74808-brugada-electrocardiogram-pattern-induced-by-recreational-delta-8-tetrahydrocannabinol-thc-a-case-report#!/,Negative,,Meta-analysis,2021,Delta-8-THC,Cardiovascular System,Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Cannabis Adverse Effects; Hypertension (High Blood Pressure)
2021150,[Electronic cigarette use-associated lung injury: a case report and literature review],https://pubmed.ncbi.nlm.nih.gov/34865370/,Negative,,Meta-analysis,2021,,Respiratory System,Vaping injury (EVALI); Cannabis Adverse Effects
2020108,Cannabinoid Hyperemesis Syndrome: A Case Report of an Underdiagnosed Condition,https://karger.com/pjg/article/28/6/420/829041/Cannabinoid-Hyperemesis-Syndrome-A-Case-Report-of,Negative,,Meta-analysis,2020,,Digestive System; Nervous System,Cannabis Hyperemesis Syndrome; Nausea and Vomiting; Cannabis Adverse Effects; Pain
2021151,Case Report: Lennox-Gastaut Epileptic Encephalopathy Responsive to Cannabidiol Treatment Associated With a Novel de novo Mosaic SHANK1 Variant,https://www.frontiersin.org/articles/10.3389/fgene.2021.735292/full,Positive,,Meta-analysis,2021,,Nervous System,Epilepsy - Lennox-Gastaut; Epilepsy; Autism; Epilepsy - Dravet Syndrome
2021152,Lethal case of myocardial ischemia following overdose of the synthetic cannabinoid ADB-FUBINACA,https://www.sciencedirect.com/science/article/pii/S1344622321001681?via%3Dihub,Negative,,Meta-analysis,2021,Synthetic Cannabinoid (unspecified),Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack; Poisoning by Synthetic Cannabis; Addiction - Stimulant; Atrial Fibrillation; Cannabis Adverse Effects; Cardiac Arrhythmias; Epilepsy; Hypertension (High Blood Pressure); Inflammation; Kidney Failure; Liver Failure; Nausea and Vomiting; Psychosis; Stroke; Wound Healing
2018059,"Safety and efficacy of nabilone for acute chemotherapy-induced vomiting prophylaxis in pediatric patients: A multicenter, retrospective review",https://pubmed.ncbi.nlm.nih.gov/30051617/,Negative,,Meta-analysis,2018,Pharma THC,Digestive System; Nervous System,Cancer; Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
2018060,"Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial",https://www.epilepsybehavior.com/article/S1525-5050(18)30483-9/fulltext,Positive,,Double Blind Clinical Trial,2018,Pharma CBD; Pharma THC,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Addiction - Benzodiazepine; Bipolar Disorder; Cognitive Dysfunction; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Insomnia and Sleep Disorders; Poisoning by Synthetic Cannabis
2019060,Suspected synthetic cannabinoid receptor agonist intoxication: Does analysis of samples reflect the presence of suspected agents?,https://www.sciencedirect.com/science/article/abs/pii/S0735675718310064?via%3Dihub,Negative,,Laboratory Study,2019,5F-x Synthetic Cannabinoids; AB-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); CP-x Synthetic Cannabinoids; HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,Nervous System,Poisoning by Synthetic Cannabis; Cannabis Adverse Effects; Cardiovascular Diseases (CVD); Epilepsy; Heart Attack; Kidney Failure
2019061,Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results,https://www.sciencedirect.com/science/article/pii/S0920121118305837?via%3Dihub,Positive,,Clinical Trial,2019,Pharma CBD,,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Diarrhea
2019062,Application device for THC:CBD oromucosal spray in the management of resistant spasticity: pre-production testing,https://www.tandfonline.com/doi/abs/10.1080/17434440.2019.1653182?journalCode=ierd20,Positive,,Clinical Trial,2019,Pharma THC:CBD,Nervous System,Multiple Sclerosis
2020109,Synthetic pharmaceutical grade cannabidiol for treatment of refractory infantile spasms: A multicenter phase-2 study,https://pubmed.ncbi.nlm.nih.gov/31816477/,Negative,,Clinical Trial,2020,Synthetic Cannabinoid (unspecified),Nervous System,Epilepsy
2021153,A Systematic Review With Meta-Analysis of the Efficacy of Cannabis and Cannabinoids for Inflammatory Bowel Disease: What Can We Learn From Randomized and Nonrandomized Studies?,https://pubmed.ncbi.nlm.nih.gov/32675631/,Negative,,Meta-analysis,2021,,,Diarrhea; Loss of Appetite; Pain; Nausea and Vomiting
2019063,Co-ultraPEALut: Role in Preclinical and Clinical Delirium Manifestations,https://www.eurekaselect.com/article/98891,Positive,,Clinical Trial,2019,Palmitoylethanolamide (PEA),Nervous System,Cognitive Dysfunction; Inflammation; Oxidative Stress
2019064,Acute separate and combined effects of cannabinoid and nicotinic receptor agonists on MMN-indexed auditory deviance detection in healthy humans,https://www.sciencedirect.com/science/article/abs/pii/S0091305718305926?via%3Dihub,Positive,,Double Blind Clinical Trial,2019,Pharma THC,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction - Nicotine; Addiction; Cognitive Dysfunction
2019065,Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis,https://www.nature.com/articles/s41398-019-0534-2,Positive,,Double Blind Clinical Trial,2019,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2020110,"Double blinded, vehicle controlled, crossover study on the efficacy of a topical endocannabinoid membrane transporter inhibitor in atopic Beagles",https://pubmed.ncbi.nlm.nih.gov/31446453/,Positive,,Animal Study -,2020,Endocannabinoid (unspecified),Integumentary System,Pruritis; Skin Diseases; Veterinary Applications; Allergic Contact Dermatitis; Inflammation
2020111,"Effects of a high protein/low carbohydrate low-calorie diet versus a standard low-calorie diet on anthropometric parameters and cardiovascular risk factors, role of polymorphism rs3123554 in the cannabinoid receptor gene type 2 (CB2R)",https://pubmed.ncbi.nlm.nih.gov/31839571/,Positive,,Clinical Trial,2020,Endocannabinoid (unspecified),Cardiovascular System; Endocrine System,Atherosclerosis; Cardiovascular Diseases (CVD); Metabolic Syndrome; Inflammation; Obesity
2020112,Depressive symptoms moderate cannabis use for young adults in a Text-Delivered randomized clinical trial for cannabis use disorder,https://www.sciencedirect.com/science/article/abs/pii/S0306460319313279?via%3Dihub,Negative,,Clinical Trial,2020,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Depression; Cannabis Adverse Effects
2020113,Nicotine patch for cannabis withdrawal symptom relief: a randomized controlled trial,https://pubmed.ncbi.nlm.nih.gov/32034447/,Positive,,Clinical Trial,2020,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Addiction - Nicotine
2020114,Tetrahydrocannabinol and cannabidiol oromucosal spray in resistant multiple sclerosis spasticity: consistency of response across subgroups from the SAVANT randomized clinical trial,https://pubmed.ncbi.nlm.nih.gov/32065006/,Positive,,Double Blind Clinical Trial,2020,Pharma THC:CBD,Nervous System,Pain; Multiple Sclerosis; Pain - Cancer
2020115,Prefrontal Cortex Neuromodulation Enhances Frontal Asymmetry and Reduces Caloric Intake in Patients with Morbid Obesity,https://pubmed.ncbi.nlm.nih.gov/32144883/,Positive,,Double Blind Clinical Trial,2020,Endocannabinoid (unspecified),Endocrine System,Obesity
2020116,"Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: Effects on metabolic parameters, anthropometric indices, and expression of PPAR-α, UCP1, and UCP2 genes",https://www.sciencedirect.com/science/article/abs/pii/S1043661820302917?via%3Dihub,Positive,,Double Blind Clinical Trial,2020,Oleoylethanolamide (OEA); Anandamide (AEA),Digestive System; Endocrine System,Fatty Liver Disease; Metabolic Syndrome; Obesity; Atherosclerosis; Cardiovascular Diseases (CVD); Diabetes; Inflammation; Liver Failure; Oxidative Stress
2021154,Acute effects of cannabis on speech illusions and psychotic-like symptoms: two studies testing the moderating effects of cannabidiol and adolescence,https://pubmed.ncbi.nlm.nih.gov/32340632/,Negative,,Clinical Meta-analysis,2021,,Mental/Emotional System,Cannabis Adverse Effects; Psychosis
2020117,Cognitive function and adaptive skills after a one-year trial of cannabidiol (CBD) in a pediatric sample with treatment-resistant epilepsy,https://pubmed.ncbi.nlm.nih.gov/32759071/,Positive,,Clinical Trial,2020,Pharma CBD,Nervous System,Cognitive Dysfunction; Epilepsy; Behavioral Disorders
2020118,Dietary fatty acid intake and gut microbiota determine circulating endocannabinoidome signaling beyond the effect of body fat,https://www.nature.com/articles/s41598-020-72861-3,Inconclusive,,Clinical Trial,2020,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Oleoylethanolamide (OEA); Other Related Compounds; Palmitoylethanolamide (PEA),Endocrine System,Obesity; Metabolic Syndrome
2021155,"A validated method for the simultaneous quantification of cannabidiol, Δ9 -tetrahydrocannabinol, and their metabolites in human plasma and application to plasma samples from an oral cannabidiol open-label trial",https://pubmed.ncbi.nlm.nih.gov/33095968/,Positive,,Laboratory Study,2021,Cannabichromene (CBC),,Anxiety; Epilepsy; Pain - Chronic
2021156,High levels of eicosanoids and docosanoids in the lungs of intubated COVID-19 patients,https://faseb.onlinelibrary.wiley.com/doi/epdf/10.1096/fj.202100540R,Positive,,Laboratory Study,2021,2-Arachidonoyl Glycerol (2-AG); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Microbiome,Respiratory System,Acute Respiratory Distress Syndrome; COVID-19; Inflammation; Stress; Bacterial Infections
2021157,Cannabinoid Receptor 2 Agonism is Capable of Preventing Lipopolysaccharide Induced Decreases of Cochlear Microcirculation - A Potential Approach for Inner Ear Pathologies,https://pubmed.ncbi.nlm.nih.gov/34267099/,Positive,,Animal Study,2021,JWH-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),,Inflammation; Middle Ear Infection
2022203,United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020,https://www.sciencedirect.com/science/article/abs/pii/S0955395921003789?via%3Dihub,Inconclusive,,Meta-analysis,2022,Ayahuasca,,Anxiety; Bipolar Disorder; Cancer; Depression; MDMA Adverse Effects; PTSD
2020119,"Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic Sclerosis",https://onlinelibrary.wiley.com/doi/10.1002/art.41294,Positive,,Double Blind Clinical Trial,2020,Endocannabinoid (unspecified),Integumentary System,Systemic Sclerosis; Inflammation
2020120,N-Acylphosphatidylethanolamines and N-acylethanolamines increase in saliva upon food mastication: the influence of the individual nutritional status and fat type in food,https://pubmed.ncbi.nlm.nih.gov/32232261/,Positive,,Clinical Trial,2020,Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Palmitoylethanolamide (PEA),,Obesity
2020121,Cannabinoids for Pain Control During Medical Abortion: A Randomized Controlled Trial,https://pubmed.ncbi.nlm.nih.gov/32459420/,Negative,,Double Blind Clinical Trial,2020,Pharma THC,Nervous System,Pain; Anxiety; Nausea and Vomiting; Pain - Acute; Pregnancy
2020122,"Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP3652, a Reversible Fatty Acid Amide Hydrolase Inhibitor, in Healthy, Nonelderly, Japanese Men and Elderly, Japanese Men and Women: A Randomized, Double-blind, Placebo-controlled, Single and Multiple Oral Dose, Phase I Study",https://pubmed.ncbi.nlm.nih.gov/32456804/,Positive,,Double Blind Clinical Trial,2020,Fatty Acid Amide Hydrolase (FAAH),,
2020123,A Pilot Trial of Topical Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome,https://onlinelibrary.wiley.com/doi/10.1111/acem.14062,Positive,,Double Blind Clinical Trial,2020,Capsaicin (CAPS),Nervous System,Cannabis Hyperemesis Syndrome; Arthritis - Osteoarthritis; Pain; Nausea and Vomiting; Pain - Acute
2021158,"Expression of NF-κB, IL-6, and IL-10 genes, body composition, and hepatic fibrosis in obese patients with NAFLD-Combined effects of oleoylethanolamide supplementation and calorie restriction: A triple-blind randomized controlled clinical trial",https://pubmed.ncbi.nlm.nih.gov/32572955/,Positive,,Double Blind Clinical Trial,2021,Oleoylethanolamide (OEA),Digestive System; Endocrine System,Fatty Liver Disease; Obesity; Liver Failure
2018061,"Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial.",https://ncbi.nlm.nih.gov/pubmed/30528676,Positive,,Double Blind Clinical Trial,2018,Fatty Acid Amide Hydrolase (FAAH); Anandamide (AEA),Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Addiction - Cannabis
2011043,Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872061/,Positive,,Animal Study,2011,Anandamide (AEA),Digestive System,Cancer - Liver; Cancer
2020124,Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca,https://pubmed.ncbi.nlm.nih.gov/32648790/,Positive,,Clinical Trial,2020,Ayahuasca,Mental/Emotional System; Nervous System,Depression; Inflammation
2020125,Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial,https://www.sciencedirect.com/science/article/abs/pii/S0376871620303859?via%3Dihub,Positive,,Double Blind Clinical Trial,2020,Pharma THC:CBD; Pharma THC,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects; Multiple Sclerosis
2021159,"The effect of oral Δ-9-tetrahydrocannabinol on the minimal alveolar concentration of sevoflurane A randomised, controlled, observer-blinded experimental study",https://pubmed.ncbi.nlm.nih.gov/32833854/,Negative,,Animal Study,2021,,Nervous System,Pain - Acute; Anxiety; Pain
2010034,Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling,https://www.sciencedirect.com/science/article/abs/pii/S0014482710001242?via%3Dihub,Positive,,Laboratory Study,2010,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Digestive System; Nervous System,Cancer - Liver; Cancer
2021160,Dysregulation of endocannabinoid concentrations in human subcutaneous adipose tissue in obesity and modulation by omega-3 polyunsaturated fatty acids,https://pubmed.ncbi.nlm.nih.gov/33393630/,Positive,,Laboratory Study,2021,Anandamide (AEA); Endocannabinoid (unspecified),Endocrine System,Inflammation; Obesity; Metabolic Syndrome
2021161,Combined effect of alcohol and cannabis on simulated driving,https://pubmed.ncbi.nlm.nih.gov/33544195/,Negative,,Double Blind Clinical Trial,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2021162,Impact of saffron (Crocus Sativus Linn) supplementation and resistance training on markers implicated in depression and happiness levels in untrained young males,https://www.sciencedirect.com/science/article/abs/pii/S0031938421000445?via%3Dihub,Positive,,Double Blind Clinical Trial,2021,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System; Nervous System,Depression; Anxiety
2021163,Sensory gating in tobacco-naïve cannabis users is unaffected by acute nicotine administration,https://pubmed.ncbi.nlm.nih.gov/33932162/,Inconclusive,,Double Blind Clinical Trial,2021,,Mental/Emotional System; Nervous System,Cognitive Dysfunction; Psychosis; Schizophrenia; Addiction - Nicotine; Cannabis Adverse Effects
2021164,"Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A 12-Week, Randomized, Controlled Study",https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.28681,Negative,,Double Blind Clinical Trial,2021,Monoacylglycerol Lipase (MAGL); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Tetrahydrocannabinol (THC),Nervous System,Tics and Tourettes; ADD and ADHD; OCD
2021165,"Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder: A Pilot, Proof-of-Concept, Randomized, Placebo-Controlled Trial",https://pubmed.ncbi.nlm.nih.gov/34166299/,Positive,,Double Blind Clinical Trial,2021,Ayahuasca,Mental/Emotional System; Nervous System,Anxiety; Cognitive Dysfunction; Depression
2021166,Detectability of cannabinoids in the serum samples of cannabis users: Indicators of recent cannabis use? A follow-up study,https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/dta.3110,Positive,,Clinical Trial,2021,Cannabichromene (CBC); Cannabichromenic Acid (CBC-a); Cannabidiolic Acid (CBD-a); Cannabidivarin (CBDV); Cannabigerol (CBG); Cannabigerolic Acid (CBG-a); Cannabinol (CBN); Delta-8-THC; Tetrahydrocannabivarin (THCV); Tetrahydrocannabinolic Acid (THC-a),,
2010035,The dual effects of delta(9)-tetrahydrocannabinol on cholangiocarcinoma cells: anti-invasion activity at low concentration and apoptosis induction at high concentration,https://pubmed.ncbi.nlm.nih.gov/19916793/,Positive,,Laboratory Study,2010,Tetrahydrocannabinol (THC),Digestive System,Cancer - Liver; Cancer
2020126,Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608221/,Positive,,Clinical Meta-analysis,2020,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2021167,"Biomarkers of Recent Cannabis Use in Blood, Oral Fluid and Breath",https://academic.oup.com/jat/article/45/8/820/6311388?login=false,Positive,,Double Blind Clinical Trial,2021,Cannabigerol (CBG); Cannabinol (CBN); Tetrahydrocannabivarin (THCV); Tetrahydrocannabinolic Acid (THC-a),,
2021168,The use of drug based on technologically processed antibodies to endocannabinoid receptor type 1 in the treatment of obesity in adults: results of a multicenter double blind placebo controlled randomized clinical trial,https://ter-arkhiv.ru/0040-3660/article/view/79513,Positive,,Double Blind Clinical Trial,2021,Endocannabinoid (unspecified),Endocrine System,Obesity
2022204,Acute effects of Δ9-tetrahydrocannabinol and cannabidiol on auditory mismatch negativity,https://pubmed.ncbi.nlm.nih.gov/34719731/,Negative,,Double Blind Clinical Trial,2022,,Mental/Emotional System,Schizophrenia
2022205,Severe liver dysfunction in a toddler receiving nonprescription phytocannabinoid,https://pubmed.ncbi.nlm.nih.gov/35422394/,Negative,,Meta-analysis,2022,,Digestive System; Mental/Emotional System,Cannabis Adverse Effects; Liver Failure
2022206,Synthetic cannabinoids and ST elevation myocardial infarction,https://pubmed.ncbi.nlm.nih.gov/35545143/,Negative,,Meta-analysis,2022,Synthetic Cannabinoid (unspecified),Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack; Poisoning by Synthetic Cannabis; Cannabis Adverse Effects
2022207,A case report of clozapine-treatment-resistant schizophrenia successfully managed with brexpiprazole combination therapy,https://www.sciencedirect.com/science/article/abs/pii/S1876201822001198?via%3Dihub,Negative,,Meta-analysis,2022,,Mental/Emotional System,Schizophrenia; Addiction - Benzodiazepine; Addiction - Cannabis; Psychosis
2022208,Ayahuasca-induced psychosis: A case report,https://www.sciencedirect.com/science/article/abs/pii/S2530312022000510?via%3Dihub,Negative,,Meta-analysis,2022,Ayahuasca,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2022209,Cannabinoids in hyperhidrosis,https://www.tandfonline.com/doi/full/10.1080/09546634.2022.2127308,Positive,,Meta-analysis,2022,Pharma THC; Tetrahydrocannabinol (THC),Integumentary System,Night Sweats and Excessive Sweating
2021169,Healing of a Chronic Pressure Injury in a Patient Treated With Medical Cannabis for Pain and Sleep Improvement: A Case Report,https://www.hmpgloballearningnetwork.com/site/wmp/case-report/healing-chronic-pressure-injury-patient-treated-medical-cannabis-pain-and,Positive,,Meta-analysis,2021,,Immune System; Integumentary System; Nervous System,Insomnia and Sleep Disorders; Pain; Pain - Chronic; Wound Healing; Allergic Contact Dermatitis
2022210,Factor-guided diagnosis of coagulopathy associated with coumarin-contaminated synthetic cannabinoids,https://www.sciencedirect.com/science/article/abs/pii/S0735675722003047?via%3Dihub,Negative,,Meta-analysis,2022,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis; Cannabis Adverse Effects
2022211,Case report of a phencyclidine false positive due to lamotrigine use with confirmatory testing,https://www.sciencedirect.com/science/article/abs/pii/S0735675722005137?via%3Dihub,Inconclusive,,Meta-analysis,2022,,,Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Opioid; Bipolar Disorder; Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); PTSD; Schizophrenia
2023291,Medical Cannabinoids as Treatment for Hypophosphatasia-Related Symptoms,https://pubmed.ncbi.nlm.nih.gov/36380652/,Positive,,Meta-analysis,2023,,,Inflammation; Metabolic Syndrome; Pain; Pain - Chronic
2022212,A Systematic Review of Medical Cannabinoids Dosing in Human,https://pubmed.ncbi.nlm.nih.gov/36411116/,Positive,,Clinical Meta-analysis,2022,Tetrahydrocannabivarin (THCV); Tetrahydrocannabinol (THC),,
2023292,'Flying high?'-Jump from a height in a 'Spice' high?: A case report on the synthetic cannabinoid 5F-MDMB-P7AICA,https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/dta.3401,Negative,,Meta-analysis,2023,5F-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC),Nervous System,Poisoning by Synthetic Cannabis; Cannabis Adverse Effects
2023293,A Fatal Case Report Resulting from the Abuse of the Designer Benzodiazepines Clonazolam and Flualprazolam in Conjunction with Dried Opium Poppy Pods,https://pubmed.ncbi.nlm.nih.gov/36516236/,Negative,,Meta-analysis,2023,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis; Addiction - Benzodiazepine; Addiction - Opioid; Addiction - Stimulant
2023294,E-cigarette or vaping-associated lung injury (EVALI): a review of international case reports from outside the United States of America,https://www.tandfonline.com/doi/epdf/10.1080/15563650.2022.2160342?needAccess=true&role=button,Negative,,Meta-analysis,2023,,Respiratory System,Vaping injury (EVALI); Addiction - Nicotine; Cannabis Adverse Effects
2023295,"Methyl (S)-2-(1-7 (5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (5F-MDMB-PICA) intoxication in a child with identification of two new metabolites (ultra-high-performance liquid chromatography-tandem mass spectrometry)",https://pubmed.ncbi.nlm.nih.gov/36652054/,Negative,,Meta-analysis,2023,5F-x Synthetic Cannabinoids,Nervous System,Poisoning by Synthetic Cannabis
2023296,Myoclonic super-refractory status epilepticus with favourable evolution in a teenager with FIRES: Is the association of vagus nerve stimulation and cannabidiol effective?,https://pubmed.ncbi.nlm.nih.gov/36725381/,Positive,,Meta-analysis,2023,,,Epilepsy - FIRES; Epilepsy
2023297,A Case of Panic Attacks Developing After 10 Years of Chronic Cannabis Use in a Patient With No Prior Psychiatric History,https://www.cureus.com/articles/128403-a-case-of-panic-attacks-developing-after-10-years-of-chronic-cannabis-use-in-a-patient-with-no-prior-psychiatric-history#!/,Negative,,Meta-analysis,2023,Cannabigerol (CBG); Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Anxiety; Cannabis Adverse Effects; Cancer; Epilepsy; Glaucoma; IBD - Crohn's Disease; HIV/AIDS; Inflammation; Pain; Nausea and Vomiting; Neurodegenerative Issues; Palliative Care; Pain - Cancer; Pain - Chronic; Parkinson's Disease; PTSD; Systemic Sclerosis
2023298,A Case of Cannabinoid Hyperemesis Syndrome and Acute Kidney Injury: A Review of the Literature,https://www.cureus.com/articles/135836-a-case-of-cannabinoid-hyperemesis-syndrome-and-acute-kidney-injury-a-review-of-the-literature#!/,Negative,,Meta-analysis,2023,,Digestive System; Nervous System,Cannabis Hyperemesis Syndrome; Nausea and Vomiting; Cannabis Adverse Effects
2023299,Recurrent Severe Burns Due to Cannabinoid Hyperemesis Syndrome,https://www.cureus.com/articles/133674-recurrent-severe-burns-due-to-cannabinoid-hyperemesis-syndrome#!/,Negative,,Meta-analysis,2023,Tetrahydrocannabinol (THC),Digestive System,Cannabis Hyperemesis Syndrome; Nausea and Vomiting; Addiction - Cannabis; Addiction - Cocaine; Anxiety; Bipolar Disorder; Cannabis Adverse Effects; Epilepsy; IBD - Inflammatory Bowel Disease; Irritable Bowel Syndrome; Wound Healing
2023300,Delta-8-THC association with psychosis: A case report with literature review,https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1103123/full,Negative,,Meta-analysis,2023,Delta-8-THC; Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Psychosis; Behavioral Disorders; Bipolar Disorder; Cognitive Dysfunction; Domestic Abuse; Inflammation; Schizophrenia; Suicide Attempt; Traumatic Brain Injury
2023301,Cannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: A case report in a clinically high-risk mental state,https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1088459/full#h3,Positive,,Meta-analysis,2023,Anandamide (AEA),Mental/Emotional System; Nervous System,Cognitive Dysfunction; Psychosis; Behavioral Disorders; Schizophrenia
2013037,"Fat to treat fat: Emerging relationship between dietary PUFA, endocannabinoids, and obesity",https://www.sciencedirect.com/science/article/abs/pii/S1098882312001372,Positive,,Meta-analysis,2013,Diet,Endocrine System,Obesity; Metabolic Syndrome
2008032,"Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine",https://www.sciencedirect.com/science/article/abs/pii/S1388198108000358,Positive,,Animal Study,2008,Diet,,
2010036,"Effect of dietary fat on endocannabinoids and related mediators: Consequences on energy homeostasis, inflammation and mood",https://onlinelibrary.wiley.com/doi/abs/10.1002/mnfr.200900516,Positive,,Meta-analysis,2010,2-Arachidonoyl Glycerol (2-AG); Diet; Other Related Compounds,Nervous System,Inflammation; Anxiety; Depression; Diabetes; Metabolic Syndrome; Obesity
2019066,"Food database of N-acyl-phosphatidylethanolamines, N-acylethanolamines and endocannabinoids and daily intake from a Western, a Mediterranean and a vegetarian diet",https://www.sciencedirect.com/science/article/abs/pii/S0308814619313263,Inconclusive,,Laboratory Study,2019,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Diet; Other Related Compounds,,
2022213,The Mediterranean Diet as a Source of Bioactive Molecules with Cannabinomimetic Activity in Prevention and Therapy Strategy,https://www.mdpi.com/2072-6643/14/3/468,Positive,,Meta-analysis,2022,Diet,,Metabolic Syndrome; Obesity
2022214,Sex differences in endocannabinoids during 3 years of Mediterranean diet intervention: Association with insulin resistance and weight loss in a population with metabolic syndrome,https://www.frontiersin.org/articles/10.3389/fnut.2022.1076677/full,Positive,,Clinical Trial,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Diet; Other Related Compounds; Palmitoylethanolamide (PEA),Endocrine System,Diabetes; Metabolic Syndrome; Obesity
2021170,Mediterranean Diet and Neurodegenerative Diseases: The Neglected Role of Nutrition in the Modulation of the Endocannabinoid System,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999285/,Positive,,Meta-analysis,2021,Diet,Nervous System,Neurodegenerative Issues; Inflammation
2023302,Geriatric Pharmacotherapy Case Series: Potential Drug Interactions With Antiplatelet Medications and Cannabidiol-A Focus on P2Y12 Inhibitors,https://pubmed.ncbi.nlm.nih.gov/36949558/,Negative,,Meta-analysis,2023,,Cardiovascular System; Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cardiovascular Diseases (CVD); Heart Attack; Hypertension (High Blood Pressure); Pain; Stroke
2023303,A case report of CBD and THC as analgesic therapy in a cat with chronic osteoarthritic pain,https://onlinelibrary.wiley.com/doi/10.1002/vms3.1057,Positive,,Animal Study -,2023,,,Veterinary Applications; Arthritis - Osteoarthritis; Pain
2023304,Persistent Coagulopathy After Synthetic Cannabinoid Use,https://www.cureus.com/articles/136350-persistent-coagulopathy-after-synthetic-cannabinoid-use#!/,Negative,,Meta-analysis,2023,Synthetic Cannabinoid (unspecified),,Poisoning by Synthetic Cannabis
2022215,"LSD, afterglow and hangover: Increased episodic memory and verbal fluency, decreased cognitive flexibility",https://www.sciencedirect.com/science/article/abs/pii/S0924977X22001249?via%3Dihub#preview-section-introduction,Positive,,Double Blind Clinical Trial,2022,Ayahuasca,,Alzheimer's Disease; Anxiety; Cognitive Dysfunction; Dementia; Inflammation; Pain; OCD; PTSD; Stroke; Traumatic Brain Injury
2022216,Effect of antimicrobial photodynamic therapy with different photosensitizers and adhesion protocol on the bond strength of resin composite to sound dentin,https://pubmed.ncbi.nlm.nih.gov/35029748/,Positive,,Laboratory Study,2022,Phycocyanin,,Bacterial Infections
2022217,"Pain response to cannabidiol in opioid-induced hyperalgesia, acute nociceptive pain, and allodynia using a model mimicking acute pain in healthy adults in a randomized trial (CANAB II)",https://journals.lww.com/pain/Fulltext/2022/10000/Pain_response_to_cannabidiol_in_opioid_induced.7.aspx,Negative,,Double Blind Clinical Trial,2022,Pharma CBD,Nervous System,Pain; Addiction - Opioid; Epilepsy; Inflammation
2022218,Cannabinoid receptor availability modulates the magnitude of dopamine release in vivo in the human reward system: A preliminary multitracer positron emission tomography study,https://pubmed.ncbi.nlm.nih.gov/35470551/,Positive,,Clinical Trial,2022,Endocannabinoid (unspecified),,Addiction - Stimulant; Schizophrenia
2022219,Cannabinoids and Pain for the Plastic Surgeon: What Is the Evidence?,https://pubmed.ncbi.nlm.nih.gov/35502947/,Inconclusive,,Meta-analysis,2022,,Nervous System,Pain; Addiction - Opioid; Arthritis; Inflammation; Pain - Neuropathy - Peripheral
2022220,Comparison of bacterial disinfection efficacy using blue and red lights on dental implants contaminated with Aggregatibacter actinomycetemcomitans,https://www.sciencedirect.com/science/article/abs/pii/S1572100022004653?via%3Dihub,Positive,,Laboratory Study,2022,Phycocyanin,Immune System,Bacterial Infections; Periodontal Disease
2022221,Palmitoylethanolamide-based nutraceutical Calmux® in preventive treatment of migraine,https://www.sciencedirect.com/science/article/abs/pii/S0303846722001639?via%3Dihub,Positive,,Clinical Trial,2022,Palmitoylethanolamide (PEA),Nervous System,Migraine; Inflammation; Pain
2022222,Cannabis-based magistral formulation is highly effective as an adjuvant treatment in drug-resistant focal epilepsy in adult patients: an open-label prospective cohort study,https://pubmed.ncbi.nlm.nih.gov/36129615/,Positive,,Double Blind Clinical Trial,2022,Tetrahydrocannabinol (THC),,Epilepsy
2022223,"Rice Bran Lipidome Identifies Novel Phospholipids, Glycolipids, and Oxylipins with Roles in Lipid Metabolism of Hypercholesterolemic Children",https://onlinelibrary.wiley.com/doi/10.1002/mnfr.202200111,Positive,,Clinical Trial,2022,Endocannabinoid (unspecified),Cardiovascular System; Endocrine System,Cardiovascular Diseases (CVD); Metabolic Syndrome; Atherosclerosis
2023305,Establishment of a point of departure for CBD hepatotoxicity employing human HepaRG spheroids,https://www.sciencedirect.com/science/article/abs/pii/S0300483X23000550?via%3Dihub#preview-section-abstract,Inconclusive,,Laboratory Study,2023,Pharma CBD; Tetrahydrocannabinol (THC),,Cancer; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Hepatitis; Inflammation; Psychosis
2022224,Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder,https://pubmed.ncbi.nlm.nih.gov/35029706/,Positive,,Double Blind Clinical Trial,2022,,Mental/Emotional System; Nervous System,PTSD; Anxiety
2023306,"Cannabidiol Treatment for Neurological, Cognitive, and Psychiatric Symptoms in Sturge-Weber Syndrome",https://pubmed.ncbi.nlm.nih.gov/36508880/,Positive,,Clinical Trial,2023,Pharma CBD,,Sturge-Weber Syndrome; Anxiety
2022225,Advanced Meditation and Vegan Diet Increased Acylglycines and Reduced Lipids Associated with Improved Health: A Prospective Longitudinal Study,https://pubmed.ncbi.nlm.nih.gov/35532984/,Positive,,Clinical Trial,2022,Anandamide (AEA); Exercise; Mind-Body Medicine,,Atherosclerosis; Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Inflammation; Pain; Pain - Inflammatory; Pain - Neuropathy - Inflammatory Polyneuropathy
2022226,Involvement of spinal G-protein inwardly rectifying potassium (GIRK) channels in the enhanced antinociceptive effects of the activation of both μ-opioid and cannabinoid CB1 receptors,https://www.sciencedirect.com/science/article/pii/S1347861322000287?via%3Dihub,Positive,,Animal Study,2022,CP-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Nervous System,Pain - Nociceptive; Pain; Pain - Neuropathy - Peripheral
2022227,Cannabidiol Effect on Anxiety Symptoms and Stress Response in Individuals With Cocaine Use Disorder: Exploratory Results From a Randomized Controlled Trial,https://pubmed.ncbi.nlm.nih.gov/35135986/,Negative,,Double Blind Clinical Trial,2022,,Mental/Emotional System,Addiction - Cocaine; Addiction; Anxiety
2023307,"Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD)",https://pubmed.ncbi.nlm.nih.gov/36409969/,Negative,,Double Blind Clinical Trial,2023,,,Cancer; Palliative Care; Anxiety; Depression
2022228,"Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial",https://www.jidonline.org/article/S0022-202X(22)00295-0/fulltext,Positive,,Double Blind Clinical Trial,2022,,Integumentary System,Inflammation; Skin Diseases; Pruritis
2022229,"The effect of β-caryophyllene on food addiction and its related behaviors: A randomized, double-blind, placebo-controlled trial",https://pubmed.ncbi.nlm.nih.gov/35809704/,Positive,,Double Blind Clinical Trial,2022,Endocannabinoid (unspecified),Endocrine System; Mental/Emotional System; Nervous System,Behavioral Disorders; Obesity; Anxiety; Depression
2022230,Cannabinoid modulation of brain activation during volitional regulation of negative affect in trauma-exposed adults,https://www.sciencedirect.com/science/article/abs/pii/S0028390822002817?via%3Dihub,Positive,,Double Blind Clinical Trial,2022,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,PTSD
2022231,Potential effects of nicotine content in cigarettes on use of other substances,https://www.sciencedirect.com/science/article/pii/S0091743522003395?via%3Dihub,Negative,,Double Blind Clinical Trial,2022,,Mental/Emotional System,Addiction - Nicotine; Addiction; Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Cocaine; Addiction - Stimulant
2022232,Cannabidiol effects on cognition in individuals with cocaine use disorder: Exploratory results from a randomized controlled trial,https://www.sciencedirect.com/science/article/pii/S0091305722000557?via%3Dihub,Negative,,Double Blind Clinical Trial,2022,,Mental/Emotional System,Addiction - Cocaine; Addiction; Cognitive Dysfunction
2022233,"Adjuvant palmitoylethanolamide therapy with risperidone improves negative symptoms in patients with schizophrenia: A randomized, double-blinded, placebo-controlled trial",https://www.sciencedirect.com/science/article/abs/pii/S0165178122003328?via%3Dihub#preview-section-abstract,Positive,,Double Blind Clinical Trial,2022,Palmitoylethanolamide (PEA); Anandamide (AEA),Mental/Emotional System,Schizophrenia; Behavioral Disorders; Alzheimer's Disease; Autism; Cognitive Dysfunction; Depression; Psychosis
2023308,"Effect of Cannabidiol Oil on Post-ureteroscopy Pain for Urinary Calculi: A Randomized, Double-blind, Placebo-controlled Trial",https://www.auajournals.org/doi/10.1097/JU.0000000000003139,Inconclusive,,Double Blind Clinical Trial,2023,Pharma CBD,Urinary System,Kidney Stones; Pain; Pain - Acute; Inflammation
2022234,Urinary Excretion Profile of Cannabinoid Analytes Following Acute Administration of Oral and Vaporized Cannabis in Infrequent Cannabis Users,https://academic.oup.com/jat/article/46/8/882/6621941?login=false,Inconclusive,,Double Blind Clinical Trial,2022,Cannabinol (CBN); Delta-8-THC; Tetrahydrocannabivarin (THCV),,
2023309,Smoked cannabis reduces peak cocaine plasma levels and subjective effects in a controlled drug administration study of polysubstance use in men,https://www.sciencedirect.com/science/article/abs/pii/S037687162200494X?via%3Dihub,Positive,,Double Blind Clinical Trial,2023,,Mental/Emotional System,Addiction - Cocaine; Addiction; Cannabis Adverse Effects; Addiction - Cannabis
2023310,Inhaled Δ9-tetrahydrocannabinol does not enhance oxycodone-induced respiratory depression: randomised controlled trial in healthy volunteers,https://www.bjanaesthesia.org/article/S0007-0912(22)00743-7/fulltext#secsectitle0045,Inconclusive,,Double Blind Clinical Trial,2023,Pharma THC; Tetrahydrocannabinol (THC),Mental/Emotional System,Cannabis Adverse Effects; Addiction - Opioid
2022235,"Oral capsules of tetra-hydro-cannabinol (THC), cannabidiol (CBD) and their combination in peripheral neuropathic pain treatment",https://onlinelibrary.wiley.com/doi/10.1002/ejp.2072,Negative,,Double Blind Clinical Trial,2022,,,Pain - Neuropathy - Drug-Ind. Polyneuropathy; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral; Herpes; Pain; Pain - Chronic; Psychosis
2022236,Topical Cannabidiol (CBD) After Total Knee Arthroplasty Does Not Decrease Pain or Opioid Use: A Prospective Randomized Double-Blinded Placebo-Controlled Trial,https://www.arthroplastyjournal.org/article/S0883-5403(22)00383-7/fulltext,Negative,,Double Blind Clinical Trial,2022,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction; Pain - Acute; Insomnia and Sleep Disorders; Pain
2023311,The Effects of Acute Cannabis With and Without Cannabidiol on Neural Reward Anticipation in Adults and Adolescents,https://www.sciencedirect.com/science/article/pii/S2451902222002506?via%3Dihub,Negative,,Double Blind Clinical Trial,2023,,Mental/Emotional System,Cannabis Adverse Effects
2023312,CBD supplementation reduces arterial blood pressure via modulation of the sympatho-chromaffin system: A substudy from the HYPER-H21-4 trial,https://www.sciencedirect.com/science/article/pii/S0753332223001750?via%3Dihub,Positive,,Double Blind Clinical Trial,2023,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2023313,Biotechnological Fungal Platforms for the Production of Biosynthetic Cannabinoids,https://www.mdpi.com/2309-608X/9/2/234,Positive,,Laboratory Study,2023,Cannabichromene (CBC); Cannabichromenic Acid (CBC-a); Cannabidiolic Acid (CBD-a); Cannabigerol (CBG); Cannabigerolic Acid (CBG-a); Cannabinol (CBN); Cannabitriol (CBT); Pharma CBD; Pharma THC; Tetrahydrocannabinol (THC); Tetrahydrocannabinolic Acid (THC-a),,Alzheimer's Disease; Anorexia; Anxiety; Arthritis - Rheumatoid; Bacterial Infections; Cancer; Cardiovascular Diseases (CVD); Chemotherapy-induced Nausea & Vomiting; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Fungal Infections; IBD - Crohn's Disease; HIV/AIDS; Inflammation; Insomnia and Sleep Disorders; Pain; Nausea and Vomiting; Obesity; Oxidative Stress
2023314,Monitoring Perfusion Index in Patients Presenting to the Emergency Department Due to Drug Use,https://www.mdpi.com/2075-4426/13/2/372,Negative,,Clinical Trial,2023,Synthetic Cannabinoid (unspecified); Tetrahydrocannabinol (THC),Nervous System,Poisoning by Synthetic Cannabis; Cannabis Adverse Effects
2023315,Structure-Based Virtual Screening and Molecular Dynamics Simulation Assessments of Depsidones as Possible Selective Cannabinoid Receptor Type 2 Agonists,https://www.mdpi.com/1420-3049/28/4/1761,Positive,,Laboratory Study,2023,Endocannabinoid (unspecified),,Bacterial Infections; Fungal Infections; Inflammation; Malaria; Pain; Pain - Neuropathy - Inflammatory Polyneuropathy; Tuberculosis
2023316,Endocannabinoid 2-Arachidonoylglycerol Synthesis and Metabolism at Neuronal Nuclear Matrix Fractions Derived from Adult Rat Brain Cortex,https://www.mdpi.com/1422-0067/24/4/3165,Positive,,Laboratory Study,2023,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Palmitoylethanolamide (PEA),,Oxidative Stress
2023317,Cannabinoid Receptor 2 Blockade Prevents Anti-Depressive-like Effect of Cannabidiol Acid Methyl Ester in Female WKY Rats,https://www.mdpi.com/1422-0067/24/4/3828,Positive,,Animal Study,2023,AM-x Synthetic Cannabinoids; Cannabidiolic Acid (CBD-a); Synthetic Cannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Mental/Emotional System; Nervous System,Depression
2023318,Systemic Changes in Endocannabinoids and Endocannabinoid-like Molecules in Response to Partial Nephrectomy-Induced Ischemia in Humans,https://www.mdpi.com/1422-0067/24/4/4216,Positive,,Clinical Trial,2023,Anandamide (AEA); Other Related Compounds; Palmitoylethanolamide (PEA); Endocannabinoid (unspecified),Urinary System,Kidney Failure
2023319,Multi-Targeting Intranasal Nanoformulation as a Therapeutic for Alzheimer's Disease,https://www.mdpi.com/2218-273X/13/2/232,Positive,,Animal Study,2023,,,Alzheimer's Disease; Cognitive Dysfunction; Dementia; Neurodegenerative Issues
2023320,The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology,https://www.mdpi.com/1422-0067/24/4/3907,Negative,,Animal Study,2023,Tetrahydrocannabinol (THC); CP-x Synthetic Cannabinoids; Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Psychosis; Behavioral Disorders; Autism; Cognitive Dysfunction; Neonatal Cerebral Issues; OCD; Pregnancy; Schizophrenia
2023321,Prenatal Exposure to Δ9-Tetrahydrocannabinol Affects Hippocampus-Related Cognitive Functions in the Adolescent Rat Offspring: Focus on Specific Markers of Neuroplasticity,https://www.mdpi.com/1999-4923/15/2/692,Negative,,Animal Study,2023,Tetrahydrocannabinol (THC); 2-Arachidonoyl Glycerol (2-AG); Endocannabinoid (unspecified),Nervous System; Reproductive System,Neonatal Cerebral Issues; Pregnancy; Behavioral Disorders; Cognitive Dysfunction
2019067,Prevention of Alcohol and Other Drug Overuse Among Nightclub Patrons: A Randomized Trial of a Group-Based Mobile Intervention at Nightclubs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739647/,Positive,,Clinical Trial,2019,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction; Addiction - Opioid; Addiction - Stimulant; Cannabis Adverse Effects
2021171,Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024037/,Inconclusive,,Clinical Trial,2021,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Depression; Cannabis Adverse Effects
2021172,Psychological and endocannabinoid responses to aerobic exercise in substance use disorder patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225058/,Positive,,Clinical Trial,2021,Anandamide (AEA); Exercise; 2-Arachidonoyl Glycerol (2-AG); Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cannabis; Addiction - Opioid; Addiction - Stimulant; Addiction; Addiction - Nicotine; Anxiety; Depression
2020127,Reduced responsiveness of the reward system is associated with tolerance to cannabis impairment in chronic users,https://onlinelibrary.wiley.com/doi/10.1111/adb.12870,Negative,,Double Blind Clinical Trial,2020,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Addiction - Cannabis
2020128,Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis,https://link.springer.com/article/10.1007/s00213-019-05442-6#Sec2,Negative,,Double Blind Clinical Trial,2020,,Mental/Emotional System; Nervous System,Psychosis; Anxiety
2020129,The Effect of Orally Administered Dronabinol on Optic Nerve Head Blood Flow in Healthy Subjects—A Randomized Clinical Trial,https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.1797,Positive,,Double Blind Clinical Trial,2020,Pharma THC; Synthetic Cannabinoid (unspecified),Nervous System,Glaucoma; Anorexia; Chemotherapy-induced Nausea & Vomiting; HIV/AIDS; Inflammation; Pain; Pain - Eye
2020130,Measuring the placebo effect in carpal tunnel syndrome,https://jorthoptraumatol.springeropen.com/articles/10.1186/s10195-019-0540-4#Sec2,Positive,,Double Blind Clinical Trial,2020,Palmitoylethanolamide (PEA),Nervous System,Pain; Arthritis - Osteoarthritis; Arthritis; Pain - Chronic; Pain - Neuropathy - Peripheral
2020131,Cannabis increases susceptibility to false memory,https://www.pnas.org/doi/full/10.1073/pnas.1920162117#sec-3,Negative,,Double Blind Clinical Trial,2020,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cognitive Dysfunction
2020132,Cannabinoid Augmentation of Exposure-Based Psychotherapy for Obsessive-Compulsive Disorder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206660/,Positive,,Clinical Trial,2020,Pharma THC; Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,OCD
2020133,Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome: A Randomized Clinical Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052786/,Positive,,Double Blind Clinical Trial,2020,Pharma CBD,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy; Epilepsy - Lennox-Gastaut
2020134,Cannabinoid modulation of corticolimbic activation to threat in trauma-exposed adults: a preliminary study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244361/,Positive,,Double Blind Clinical Trial,2020,Pharma THC; Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,PTSD; Anxiety
2018062,"Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH-018: a phase 1, placebo-controlled, pilot study",https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.14066,Positive,,Clinical Trial,2018,JWH-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); Tetrahydrocannabinol (THC),,Cognitive Dysfunction; Poisoning by Synthetic Cannabis; Cannabis Adverse Effects; Epilepsy
2018063,Peripheral Endocannabinoids Associated With Energy Expenditure in Native Americans of Southwestern Heritage,https://academic.oup.com/jcem/article/103/3/1077/4780813?login=false,Positive,,Clinical Trial,2018,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Other Related Compounds; Endocannabinoid (unspecified),Endocrine System,Metabolic Syndrome; Cardiovascular Diseases (CVD); Chronic Heart Disease; Diabetes; Heart Disease; Obesity; Oxidative Stress
2018064,"Effects of a Weight Loss Program on Metabolic Syndrome, Eating Disorders and Psychological Outcomes: Mediation by Endocannabinoids?",https://www.karger.com/Article/FullText/487890,Positive,,Clinical Trial,2018,Palmitoylethanolamide (PEA); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Endocrine System,Metabolic Syndrome; Cardiovascular Diseases (CVD); Depression; Inflammation; Obesity
2020135,"A Phase I, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics, Safety, and Tolerability of Cannabidiol in Subjects with Mild to Severe Renal Impairment",https://link.springer.com/article/10.1007/s40262-019-00841-6,Positive,,Clinical Trial,2020,Pharma CBD,Urinary System,Kidney Failure; Cannabis Adverse Effects; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2020136,"Therapeutic potential of ayahuasca in grief: a prospective, observational study",https://link.springer.com/article/10.1007/s00213-019-05446-2,Positive,,Clinical Trial,2020,Ayahuasca,Mental/Emotional System; Nervous System,Anxiety; Cognitive Dysfunction; Depression; Psychosis; PTSD
2020137,Effects of the monoacylglycerol lipase inhibitor JZL184 on chickens infected with avian pathogenic Escherichia coli O78: A preliminary pharmacokinetic and infection study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301670/,Negative,,Animal Study -,2020,Monoacylglycerol Lipase (MAGL); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),,Veterinary Applications; Bacterial Infections; Inflammation
2020138,"Impact of a weight loss and fitness intervention on exercise-associated plasma oxylipin patterns in obese, insulin-resistant, sedentary women",https://physoc.onlinelibrary.wiley.com/doi/10.14814/phy2.14547,Positive,,Clinical Trial,2020,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Other Related Compounds; Palmitoylethanolamide (PEA),Endocrine System,Diabetes; Metabolic Syndrome; Obesity; Oxidative Stress
2020139,Assessment of boron-containing compounds and oleoylethanolamide supplementation on the recovery trend in patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588946/,Positive,,Clinical Trial,2020,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Omega-3; Omega-6; Microbiome; Monoacylglycerol Lipase (MAGL); Oleoylethanolamide (OEA); Other Related Compounds; Fatty Acid Amide Hydrolase (FAAH),,Bacterial Infections; Metabolic Syndrome; Obesity
2020140,"Associating Emergency Medical Services personnel's workload, trauma exposure, and health with the cortisol, endocannabinoid, and N-acylethanolamine concentrations in their hair",https://www.nature.com/articles/s41598-020-79859-x,Negative,,Clinical Trial,2020,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Other Related Compounds; Palmitoylethanolamide (PEA),Mental/Emotional System,Anxiety; Depression; Pain; Oxidative Stress; Pain - Neuropathy - Peripheral; PTSD
2023322,Use of Cannabidiol in the Management of Insomnia: A Systematic Review,https://www.liebertpub.com/doi/10.1089/can.2022.0122,Positive,,Clinical Meta-analysis,2023,Pharma THC:CBD; Tetrahydrocannabinol (THC),Nervous System,Insomnia and Sleep Disorders
2023323,A Survey of Cannabis Use among Patients with Inflammatory Bowel Disease (IBD),https://www.mdpi.com/1660-4601/20/6/5129,Positive,,Meta-analysis,2023,,Digestive System,IBD - Inflammatory Bowel Disease
2023324,"The Effects of Long-Term Self-Dosing of Cannabidiol on Drowsiness, Testosterone Levels, and Liver Function",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036916/,Positive,,Meta-analysis,2023,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Fatty Liver Disease; Infertility (Male)
2021173,Linking the Endocannabinoidome with Specific Metabolic Parameters in an Overweight and Insulin-Resistant Population: From Multivariate Exploratory Analysis to Univariate Analysis and Construction of Predictive Models,https://www.mdpi.com/2073-4409/10/1/71,Positive,,Laboratory Study,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); N-Arachidonoyl Dopamine (NADA); Palmitoylethanolamide (PEA),Endocrine System,Diabetes; Metabolic Syndrome; Cardiovascular Diseases (CVD); Hepatitis; Inflammation; Liver Failure; Obesity
2021174,Brain imaging of cannabinoid type I (CB1 ) receptors in women with cannabis use disorder and male and female healthy controls,https://onlinelibrary.wiley.com/doi/10.1111/adb.13061,Negative,,Double Blind Clinical Trial,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Cannabinol (CBN),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2023325,Structural Optimization of Cannabidiol as Multifunctional Cosmetic Raw Materials,https://www.mdpi.com/2076-3921/12/2/314,Positive,,Laboratory Study,2023,,Muscular System; Nervous System; Skeletal System,Geriatric Conditions; Inflammation; Oxidative Stress; Skin Diseases
2023326,"Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance",https://www.mdpi.com/2076-3921/12/2/485,Positive,,Meta-analysis,2023,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Cannabichromene (CBC); Cannabigerol (CBG); Cannabinol (CBN); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Pharma CBD,,Cognitive Dysfunction; Oxidative Stress; Addiction - Stimulant; Alzheimer's Disease; Anxiety; Bacterial Infections; Constipation; Depression; Encephalitis and Myelitis; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Huntington's Disease; Inflammation; Malaria; Pain; Neurodegenerative Issues; Parkinson's Disease; Schizophrenia; Sepsis
2023327,Improved Anti-Biofilm Effect against the Oral Cariogenic Streptococcus mutans by Combined Triclosan/CBD Treatment,https://www.mdpi.com/2227-9059/11/2/521,Positive,,Laboratory Study,2023,Anandamide (AEA),Digestive System; Immune System,Bacterial Infections; Periodontal Disease; Cavities; Fungal Infections; Inflammation
2023328,Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review,https://www.mdpi.com/2076-3425/13/2/325,Inconclusive,,Meta-analysis,2023,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); Pharma CBD; Pharma THC:CBD; Pharma THC; Synthetic Cannabinoid (unspecified); WIN-x Synthetic Cannabinoids,Mental/Emotional System,Anxiety; Depression; Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Opioid; Behavioral Disorders; Bipolar Disorder; Cancer; Cannabis Adverse Effects; Cardiovascular Diseases (CVD); Cognitive Dysfunction; Diabetes; Epilepsy; HIV/AIDS; Inflammation; Insomnia and Sleep Disorders; Pain; Multiple Sclerosis; Nausea and Vomiting
2023329,Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance,https://www.mdpi.com/1422-0067/24/4/3125,Positive,,Meta-analysis,2023,Cannabichromene (CBC); Cannabidiolic Acid (CBD-a); Cannabidivarin (CBDV); Cannabigerol (CBG); Cannabinol (CBN); Tetrahydrocannabinolic Acid (THC-a),,Inflammation; Alzheimer's Disease; Anxiety; Arthritis - Osteoarthritis; Arthritis - Rheumatoid; Asthma; Atherosclerosis; Bacterial Infections; Bipolar Disorder; Cancer; Cardiovascular Diseases (CVD); Cognitive Dysfunction; COVID-19; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Fibromyalgia; IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Heart Attack
2023330,Characterization of the Antitumor Potential of Extracts of Cannabis sativa Strains with High CBD Content in Human Neuroblastoma,https://www.mdpi.com/1422-0067/24/4/3837,Positive,,Laboratory Study,2023,AM-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,,Cancer - Brain; Cancer; Oxidative Stress; Chemotherapy-induced Nausea & Vomiting; Pain; Palliative Care; Pain - Cancer
2023331,Hemp Waste as a Substrate for Hermetia illucens (L.) (Diptera: Stratiomyidae) and Tenebrio molitor L. (Coleoptera: Tenebrionidae) Rearing,https://www.mdpi.com/2075-4450/14/2/183,Positive,,Animal Study -,2023,Cannabidiolic Acid (CBD-a); Cannabigerolic Acid (CBG-a),,Veterinary Applications
2023332,The Fundamental Role of Lipids in Polymeric Nanoparticles: Dermal Delivery and Anti-Inflammatory Activity of Cannabidiol,https://www.mdpi.com/1420-3049/28/4/1774,Positive,,Laboratory Study,2023,,Integumentary System,Inflammation; Skin Diseases; Acne; Bacterial Infections; Psoriasis
2023333,Film Forming Systems for Delivery of Active Molecules into and across the Skin,https://www.mdpi.com/1999-4923/15/2/397,Positive,,Laboratory Study,2023,Cannabigerol (CBG),Integumentary System,Pain; Skin Diseases
2023334,"Cannabidiol-Loaded Nanostructured Lipid Carriers (NLCs) for Dermal Delivery: Enhancement of Photostability, Cell Viability, and Anti-Inflammatory Activity",https://www.mdpi.com/1999-4923/15/2/537,Positive,,Laboratory Study,2023,,Integumentary System,Inflammation; Skin Diseases; Acne; Epidermolysis bullosa; Geriatric Conditions; Oxidative Stress; Psoriasis
2023335,Cannabidiol-Loaded Extracellular Vesicles from Human Umbilical Cord Mesenchymal Stem Cells Alleviate Paclitaxel-Induced Peripheral Neuropathy,https://www.mdpi.com/1999-4923/15/2/554,Positive,,Laboratory Study,2023,Pharma THC,,Pain - Neuropathy - Drug-Ind. Polyneuropathy; Pain - Neuropathy - Peripheral; Alzheimer's Disease; Cancer - Colon; Cancer - Breast; Cancer - Skin (Non-melanoma); Cancer; Diabetes; Glaucoma; IBD - Inflammatory Bowel Disease; Huntington's Disease; Inflammation; Oxidative Stress; Pain - Cancer; Parkinson's Disease; Psoriasis
2015072,Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464746/,Positive,,Double Blind Clinical Trial,2015,Pharma THC,,Dementia; Behavioral Disorders; Alzheimer's Disease; Cognitive Dysfunction; Geriatric Conditions; Inflammation; Pain
2017047,Big conductance calcium-activated potassium channel openers control spasticity without sedation,https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.13889,Positive,,Animal Study,2017,Anandamide (AEA); Endocannabinoid (unspecified); Pharma THC:CBD,,Encephalitis and Myelitis; Multiple Sclerosis
2017048,Dronabinol Is a Safe Long-Term Treatment Option for Neuropathic Pain Patients,https://www.karger.com/Article/FullText/481089,Positive,,Double Blind Clinical Trial,2017,Pharma THC,Nervous System,Pain; Pain - Neuropathy - Peripheral; Anxiety; Inflammation; Pain - Nociceptive; Multiple Sclerosis; Pain - Inflammatory; Pain - Neuropathy - Inflammatory Polyneuropathy
2018065,"A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects",https://link.springer.com/content/pdf/10.1007/s40263-018-0578-5.pdf?pdf=button,Positive,,Clinical Trial,2018,Pharma CBD; Tetrahydrocannabinol (THC),,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2019068,The Endocannabinoid System as a Potential Mechanism through which Exercise Influences Episodic Memory Function,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562547/,Positive,,Meta-analysis,2019,Exercise,,Cognitive Dysfunction
2018066,Endocannabinoid and Opioid System Interactions in Exercise-Induced Hypoalgesia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454785/,Positive,,Double Blind Clinical Trial,2018,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Exercise,,Pain; Pain - Acute
2014043,A role for the endocannabinoid system in exercise-induced spatial memory enhancement in mice,https://pubmed.ncbi.nlm.nih.gov/24115292/,Positive,,Animal Study,2014,AM-x Synthetic Cannabinoids; Exercise,,Cognitive Dysfunction
2017049,Exercise as an adjunctive treatment for cannabis use disorder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055462/,Inconclusive,,Meta-analysis,2017,Exercise,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2019069,Serum Endocannabinoid and Mood Changes after Exercise in Major Depressive Disorder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727944/,Positive,,Clinical Trial,2019,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Mental/Emotional System; Nervous System,Depression; Anxiety
2018067,"Endocannabinoids, exercise, pain, and a path to health with aging",https://pubmed.ncbi.nlm.nih.gov/30290200/,Positive,,Meta-analysis,2018,Omega-3; Exercise; Omega-6,,Pain; Pain - Inflammatory
2020141,Increased Anandamide and Decreased Pain and Depression after Exercise in Fibromyalgia,https://pubmed.ncbi.nlm.nih.gov/32168104/,Positive,,Clinical Trial,2020,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Exercise,Mental/Emotional System; Muscular System; Nervous System,Depression; Fibromyalgia; Pain; Pain - Chronic
2017050,"Circulating levels of endocannabinoids respond acutely to voluntary exercise, are altered in mice selectively bred for high voluntary wheel running, and differ between the sexes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5305303/,Positive,,Animal Study,2017,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),,
2017051,Endocannabinoid and Mood Responses to Exercise in Adults with Varying Activity Levels,https://pubmed.ncbi.nlm.nih.gov/28319590/,Positive,,Clinical Trial,2017,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Exercise,,Anxiety; Depression
2012057,The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity,https://pubmed.ncbi.nlm.nih.gov/22943701/,Positive,,Meta-analysis,2012,Anandamide (AEA); Exercise,Endocrine System,Obesity; Metabolic Syndrome
2012058,Intense exercise increases circulating endocannabinoid and BDNF levels in humans--possible implications for reward and depression,https://pubmed.ncbi.nlm.nih.gov/22029953/,Positive,,Clinical Trial,2012,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Mental/Emotional System; Nervous System,Depression
2014044,Physical activity and the endocannabinoid system: an overview,https://pubmed.ncbi.nlm.nih.gov/24526057/,Positive,,Meta-analysis,2014,Exercise,,
2022237,How and why adults use cannabis during physical activity,https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-022-00134-z,Positive,,Meta-analysis,2022,Exercise,,
2021175,Exercise in Treatment of Migraine Including Chronic Migraine,https://pubmed.ncbi.nlm.nih.gov/33630184/,Positive,,Meta-analysis,2021,Exercise,,Migraine; Pain; Pain - Chronic
2021176,Lack of Association Between Recent Cannabis Use and Advanced Liver Fibrosis Among HIV-positive Heavy Drinkers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597417/,Inconclusive,,Meta-analysis,2021,,Digestive System; Immune System; Mental/Emotional System,Addiction - Alcohol; Addiction; Hepatitis; HIV/AIDS; Liver Failure; Inflammation
2020142,Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment-Resistant Epilepsy,https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.2408,Positive,,Clinical Trial,2020,Pharma CBD,Nervous System,Epilepsy; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut
2020143,A Phase II Randomized Trial to Explore the Potential for Pharmacokinetic Drug-Drug Interactions with Stiripentol or Valproate when Combined with Cannabidiol in Patients with Epilepsy,https://link.springer.com/article/10.1007/s40263-020-00726-4,Positive,,Double Blind Clinical Trial,2020,Pharma CBD,Nervous System,Epilepsy; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut
2020144,Acute effects of cannabinoids on symptoms of obsessive-compulsive disorder: A human laboratory study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423713/,Negative,,Double Blind Clinical Trial,2020,Tetrahydrocannabinol (THC); Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,OCD; Anxiety; Depression; Insomnia and Sleep Disorders
2020145,"A Phase 1, Randomised, Placebo-Controlled, Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Cannabidiol in Fed Healthy Volunteers",https://link.springer.com/article/10.1007/s13318-020-00624-6,Positive,,Double Blind Clinical Trial,2020,,,Anxiety; Epilepsy; Inflammation; Nausea and Vomiting
2020146,Association of Naturalistic Administration of Cannabis Flower and Concentrates With Intoxication and Impairment,https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2767219,Inconclusive,,Clinical Trial,2020,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cognitive Dysfunction; Behavioral Disorders
2020147,"A Phase 2, Double-Blind, Placebo-Controlled Trial to Investigate Potential Drug-Drug Interactions Between Cannabidiol and Clobazam",https://accp1.onlinelibrary.wiley.com/doi/10.1002/jcph.1634,Positive,,Double Blind Clinical Trial,2020,Pharma CBD,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2020148,Whey protein supplementation reducing fasting levels of anandamide and 2-AG without weight loss in pre-menopausal women with obesity on a weight-loss diet,https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-020-04586-7#Sec1,Positive,,Double Blind Clinical Trial,2020,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Endocrine System,Metabolic Syndrome; Obesity; Arthritis - Gout; Asthma; Atherosclerosis; Cancer; Cardiovascular Diseases (CVD); Depression; Diabetes; Heart Attack; Inflammation
2020149,Non-Motor Symptoms in Parkinson's Disease are Reduced by Nabilone,https://onlinelibrary.wiley.com/doi/10.1002/ana.25864,Positive,,Double Blind Clinical Trial,2020,Pharma THC; Endocannabinoid (unspecified),Nervous System,Parkinson's Disease; Behavioral Disorders; Insomnia and Sleep Disorders; Neurodegenerative Issues
2020150,A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis,https://www.nature.com/articles/s41398-020-0862-2,Positive,,Double Blind Clinical Trial,2020,Anandamide (AEA),Mental/Emotional System; Nervous System,Psychosis; Schizophrenia; Anxiety; Cognitive Dysfunction
2020151,"The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study",https://www.nature.com/articles/s41386-020-00888-1,Positive,,Double Blind Clinical Trial,2020,Fatty Acid Amide Hydrolase (FAAH); Anandamide (AEA); Palmitoylethanolamide (PEA),Mental/Emotional System; Nervous System,Anxiety; Addiction - Benzodiazepine; Behavioral Disorders; Cognitive Dysfunction; Depression
2021177,Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study,https://www.scielo.br/j/rbp/a/HKHbSCdrDZhH6FXQbWkfBkp/?lang=en,Inconclusive,,Double Blind Clinical Trial,2021,Anandamide (AEA),Mental/Emotional System,Addiction - Cocaine; Addiction; Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine; Addiction - Opioid; Anxiety; Depression; Inflammation; Insomnia and Sleep Disorders; Oxidative Stress; Parkinson's Disease
2021178,The effects of FAAH inhibition on the neural basis of anxiety-related processing in healthy male subjects: a randomized clinical trial,https://www.nature.com/articles/s41386-020-00936-w#Sec2,Positive,,Double Blind Clinical Trial,2021,Fatty Acid Amide Hydrolase (FAAH); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Mental/Emotional System; Nervous System,Anxiety; PTSD
2021179,ACPA decreases non-small cell lung cancer line growth through Akt/PI3K and JNK pathways in vitro,https://www.nature.com/articles/s41419-020-03274-3#Sec21,Positive,,Laboratory Study,2021,AM-x Synthetic Cannabinoids; Endocannabinoid (unspecified),Respiratory System,Cancer - Lung; Cancer - Colon; Cancer - Breast; Cancer - Leukemia; Cancer - Uterine
2022238,Sleep time differs among people who co-use cocaine and cannabis compared to people who only use cocaine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856213/,Negative,,Clinical Trial,2022,,Mental/Emotional System,Addiction - Cocaine; Addiction; Cannabis Adverse Effects; Insomnia and Sleep Disorders
2021180,Beneficial Effects of Akkermansia muciniphila Are Not Associated with Major Changes in the Circulating Endocannabinoidome but Linked to Higher Mono-Palmitoyl-Glycerol Levels as New PPARα Agonists,https://www.mdpi.com/2073-4409/10/1/185,Inconclusive,,Clinical Trial,2021,Endocannabinoid (unspecified); Microbiome,Endocrine System,Metabolic Syndrome; Cardiovascular Diseases (CVD); Microbiome Imbalance; Obesity
2021181,Safety and tolerability of escalating cannabinoid doses in healthy cats,https://journals.sagepub.com/doi/10.1177/1098612X211004215,Positive,,Animal Study -,2021,Cannabidiolic Acid (CBD-a),,Veterinary Applications; Arthritis - Osteoarthritis; Arthritis; Cannabis Adverse Effects; Epilepsy; Pain; Pain - Chronic
2022239,"Safety, Pharmacokinetics and Pharmacodynamics of Spectrum Yellow Oil in Healthy Participants",https://academic.oup.com/jat/article/46/4/393/6168725?login=false,Positive,,Clinical Trial,2022,Pharma CBD; Pharma THC:CBD; Tetrahydrocannabinol (THC),,Cannabis Adverse Effects; Diarrhea; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Loss of Appetite
2007016,High-cholesterol feeding aggravates cerebral infarction via decreasing the CB1 receptor,https://pubmed.ncbi.nlm.nih.gov/17208374/,Positive,,Animal Study,2007,,Nervous System,Stroke; Diabetes; Longevity; Metabolic Syndrome; Obesity
2022240,"Safety, Pharmacokinetics and Pharmacodynamics of Spectrum Red Softgels in Healthy Participants",https://academic.oup.com/jat/article/46/5/528/6225091?login=false#355281723,Positive,,Double Blind Clinical Trial,2022,Pharma THC; Tetrahydrocannabinol (THC),,
2021182,Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827362/,Inconclusive,,Double Blind Clinical Trial,2021,,,Anxiety; Cognitive Dysfunction
2021183,Exploring cannabidiol effects on inflammatory markers in individuals with cocaine use disorder: a randomized controlled trial,https://www.nature.com/articles/s41386-021-01098-z,Positive,,Double Blind Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Cocaine; Addiction; Inflammation; Oxidative Stress
2021184,Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary report,https://link.springer.com/article/10.1007/s00406-021-01318-z#Sec2,Positive,,Double Blind Clinical Trial,2021,,Mental/Emotional System; Nervous System,Psychosis; Anxiety
2021185,Gut barrier and microbiota changes with glycine and branched-chain amino acid supplementation in chronic haemodialysis patients,https://onlinelibrary.wiley.com/doi/10.1002/jcsm.12781,Negative,,Double Blind Clinical Trial,2021,Endocannabinoid (unspecified); Microbiome; 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Other Related Compounds; Palmitoylethanolamide (PEA),Urinary System,Kidney Failure; Inflammation
2021186,"Endocannabinoid Modulation Using Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A Phase 1 Randomized, Placebo-Controlled Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110099/,Positive,,Double Blind Clinical Trial,2021,Monoacylglycerol Lipase (MAGL); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),,Tics and Tourettes; ADD and ADHD; Anxiety; Depression; Neurodegenerative Issues; OCD
2022241,Prenatal Nicotine or Cannabis Exposure and Offspring Neurobehavioral Outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715943/,Inconclusive,,Meta-analysis,2022,,Mental/Emotional System; Reproductive System,Addiction - Nicotine; Addiction; Neonatal Cerebral Issues; Pregnancy; Behavioral Disorders; Cognitive Dysfunction; Metabolic Syndrome
2021187,Long-term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open-label extension trial,https://onlinelibrary.wiley.com/doi/10.1111/epi.17150,Positive,,Clinical Trial,2021,Pharma CBD,Nervous System,Epilepsy; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut
2021188,Influence of pregabalin maintenance on cannabis effects and related behaviors in daily cannabis users,https://pubmed.ncbi.nlm.nih.gov/33983765/,Negative,,Clinical Meta-analysis,2021,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2021189,Contingency management for alcohol use disorder reduces cannabis use among American Indian and Alaska Native adults,https://www.jsatjournal.com/article/S0740-5472(21)00419-0/fulltext#secst0090,Positive,,Clinical Trial,2021,,Mental/Emotional System,Addiction - Alcohol; Addiction - Cannabis; Addiction; Addiction - Cocaine; Addiction - Nicotine; Addiction - Stimulant
2022242,"Influence of diet on acute endocannabinoidome mediator levels post exercise in active women, a crossover randomized study",https://www.nature.com/articles/s41598-022-10757-0#Sec2,Positive,,Clinical Trial,2022,Diet; Exercise; Microbiome; 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Palmitoylethanolamide (PEA),,Anxiety; Inflammation; Loss of Appetite
2023336,"Cannabis-opioid interaction in the treatment of fibromyalgia pain: an open-label, proof of concept study with randomization between treatment groups: cannabis, oxycodone or cannabis/oxycodone combination-the SPIRAL study",https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-023-07078-6,Inconclusive,,Meta-analysis,2023,Pharma CBD; Pharma THC:CBD; Pharma THC,Mental/Emotional System; Muscular System; Nervous System,Addiction - Opioid; Addiction; Fibromyalgia; Pain - Chronic
2023337,Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial,https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2801352,Negative,,Double Blind Clinical Trial,2023,Tetrahydrocannabinol (THC),Mental/Emotional System,Cannabis Adverse Effects; Anxiety; Cognitive Dysfunction
2022243,"Assessment of spent hemp biomass as a potential ingredient in ruminant diet: nutritional quality and effect on performance, meat and carcass quality, and hematological parameters in finishing lambs",https://academic.oup.com/jas/article-abstract/100/10/skac263/6661414?redirectedFrom=fulltext&login=false,Positive,,Animal Study -,2022,Diet,,Veterinary Applications; Inflammation
2023338,Almond Consumption for 8 Weeks Altered Host and Microbial Metabolism in Comparison to a Control Snack in Young Adults,https://www.tandfonline.com/doi/full/10.1080/07315724.2021.2025168,Positive,,Meta-analysis,2023,Microbiome; Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH),Endocrine System; Nervous System,Inflammation; Metabolic Syndrome
2022244,"The Effect of Oleoylethanolamide (OEA) Add-On Treatment on Inflammatory, Oxidative Stress, Lipid, and Biochemical Parameters in the Acute Ischemic Stroke Patients: Randomized Double-Blind Placebo-Controlled Study",https://www.hindawi.com/journals/omcl/2022/5721167/#conclusion,Positive,,Double Blind Clinical Trial,2022,Oleoylethanolamide (OEA); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),,Inflammation; Oxidative Stress; Stroke; Alzheimer's Disease; Anxiety; Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Insomnia and Sleep Disorders; Pain; Parkinson's Disease
2022245,The effects of acute alcohol administration on circulating endocannabinoid levels in humans,https://pubmed.ncbi.nlm.nih.gov/36001429/,Positive,,Double Blind Clinical Trial,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified),Mental/Emotional System,Addiction - Alcohol; Behavioral Disorders; Addiction
2022246,The anxiolytic effect of cannabidiol depends on the nature of the trauma when patients with post-traumatic stress disorder recall their trigger event,https://www.scielo.br/j/rbp/a/y4LLjMvtPTVcxn4Z9xzYBJc/?lang=en,Positive,,Double Blind Clinical Trial,2022,,Mental/Emotional System,Anxiety; PTSD; Behavioral Disorders; Cognitive Dysfunction
2022247,The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study,https://link.springer.com/article/10.1007/s00213-022-06070-3,Inconclusive,,Double Blind Clinical Trial,2022,Synthetic Cannabinoid (unspecified); Endocannabinoid (unspecified); SR-x Synthetic Cannabinoids,Mental/Emotional System,Behavioral Disorders; Anxiety; Addiction - Opioid; Cognitive Dysfunction; Parkinson's Disease; Psychosis
2022248,Characterizing cannabis use reduction and change in functioning during treatment: Initial steps on the path to new clinical endpoints,https://pubmed.ncbi.nlm.nih.gov/35084903/#affiliation-1,Positive,,Meta-analysis,2022,,Mental/Emotional System,Addiction - Cannabis; Addiction; Anxiety; Depression
2022249,Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial,https://journals.sagepub.com/doi/10.1177/02698811221095356,Positive,,Double Blind Clinical Trial,2022,Tetrahydrocannabinol (THC),Mental/Emotional System,Cannabis Adverse Effects; Cognitive Dysfunction; Anxiety; Epilepsy; Psychosis
2022250,Effect Compartment Model for the Evaluation of Tolerance to Psychological Highness Following Smoking Marijuana,https://accp1.onlinelibrary.wiley.com/doi/10.1002/jcph.2109,Negative,,Double Blind Clinical Trial,2022,,Mental/Emotional System,Cannabis Adverse Effects
2022251,"A Randomized, Triple-Blind, Comparator-Controlled Parallel Study Investigating the Pharmacokinetics of Cannabidiol and Tetrahydrocannabinol in a Novel Delivery System, Solutech, in Association with Cannabis Use History",https://www.liebertpub.com/doi/10.1089/can.2021.0176,Positive,,Clinical Trial,2022,Pharma THC:CBD,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2022252,Effect of Ultra-Micronized Palmitoylethanolamide and Luteolin on Olfaction and Memory in Patients with Long COVID: Results of a Longitudinal Study,https://www.mdpi.com/2073-4409/11/16/2552,Positive,,Clinical Trial,2022,Palmitoylethanolamide (PEA); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Respiratory System,COVID-19; Inflammation
2022253,A randomized controlled trial assessing the safety and efficacy of palmitoylethanolamide for treating diabetic-related peripheral neuropathic pain,https://link.springer.com/article/10.1007/s10787-022-01033-8#Sec2,Positive,,Double Blind Clinical Trial,2022,Palmitoylethanolamide (PEA); Anandamide (AEA),Endocrine System; Nervous System,Diabetes; Pain - Neuropathy - Diabetic; Pain - Neuropathy - Peripheral; Anxiety; Depression; Epilepsy; Inflammation; Insomnia and Sleep Disorders; Pain
2022254,Palmitoylethanolamide Reduces Proinflammatory Markers in Unvaccinated Adults Recently Diagnosed with COVID-19: A Randomized Controlled Trial,https://www.sciencedirect.com/science/article/pii/S002231662308598X?via%3Dihub,Positive,,Double Blind Clinical Trial,2022,Palmitoylethanolamide (PEA); 2-Arachidonoyl Glycerol (2-AG),Respiratory System,COVID-19; Inflammation; Asthma; Atherosclerosis; Cancer; Cardiovascular Diseases (CVD); Heart Attack; Hypertension (High Blood Pressure); Obesity
2022255,"The Effect of Palmitoylethanolamide on Pain Intensity, Central and Peripheral Sensitization, and Pain Modulation in Healthy Volunteers-A Randomized, Double-Blinded, Placebo-Controlled Crossover Trial",https://www.mdpi.com/2072-6643/14/19/4084,Positive,,Double Blind Clinical Trial,2022,Palmitoylethanolamide (PEA); Anandamide (AEA),,Inflammation; Pain; Pain - Acute
2022256,"Acute and long-term exercise differently modulate plasma levels of oxylipins, endocannabinoids, and their analogues in young sedentary adults: A sub-study and secondary analyses from the ACTIBATE randomized controlled-trial",https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(22)00495-9/fulltext#%20,Positive,,Clinical Trial,2022,Anandamide (AEA); Endocannabinoid (unspecified); Exercise; Fatty Acid Amide Hydrolase (FAAH); 2-Arachidonoyl Glycerol (2-AG); Palmitoylethanolamide (PEA),Mental/Emotional System; Nervous System,Inflammation; Oxidative Stress
2023339,Co-ultramicronized palmitoylethanolamide/luteolin normalizes GABAB-ergic activity and cortical plasticity in long COVID-19 syndrome,https://www.sciencedirect.com/science/article/pii/S1388245722009385?via%3Dihub,Positive,,Double Blind Clinical Trial,2023,Palmitoylethanolamide (PEA); 2-Arachidonoyl Glycerol (2-AG),Respiratory System,Cognitive Dysfunction; COVID-19; Inflammation; Oxidative Stress
2023340,Additive or synergistic analgesic effect of metamizole on standard pain treatment at home after arthroscopic shoulder surgery: A randomised controlled superiority trial,https://journals.lww.com/ejanaesthesiology/Fulltext/2023/03000/Additive_or_synergistic_analgesic_effect_of.4.aspx,Inconclusive,,Double Blind Clinical Trial,2023,Endocannabinoid (unspecified),Nervous System,Pain; Pain - Acute; Addiction - Opioid; Inflammation
2022257,Adjunctive Transdermal Cannabidiol for Adults With Focal Epilepsy: A Randomized Clinical Trial,https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2794028,Inconclusive,,Double Blind Clinical Trial,2022,,,Epilepsy; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut
2022258,Enhancing exposure therapy for posttraumatic stress disorder (PTSD): a randomized clinical trial of virtual reality and imaginal exposure with a cognitive enhancer,https://www.nature.com/articles/s41398-022-02066-x,Positive,,Double Blind Clinical Trial,2022,Fatty Acid Amide Hydrolase (FAAH),,Depression; PTSD
2022259,Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis,https://link.springer.com/article/10.1007/s00213-022-06248-9#Sec2,Positive,,Double Blind Clinical Trial,2022,,Mental/Emotional System,Anxiety; Cannabis Adverse Effects
2022260,"Treatment of Ovarian Hyperstimulation Syndrome in a Mouse Model by Cannabidiol, an Angiogenesis Pathway Inhibitor",https://www.hindawi.com/journals/bmri/2022/1111777/#materials-and-methods,Positive,,Animal Study,2022,,Endocrine System,Ovarian Dysfunction; Alzheimer's Disease; Anxiety; Arthritis - Osteoarthritis; Arthritis - Rheumatoid; Arthritis; Autism; Cancer; Cardiovascular Diseases (CVD); Depression; Endometriosis; Epilepsy; IBD - Inflammatory Bowel Disease; Huntington's Disease; Hypertension (High Blood Pressure); Infertility (Female); Inflammation; Irritable Bowel Syndrome; Pain; Multiple Sclerosis
2023341,Effect of four-week cannabidiol treatment on cognitive function: secondary outcomes from a randomised clinical trial for the treatment of cannabis use disorder,https://link.springer.com/article/10.1007/s00213-022-06303-5,Inconclusive,,Double Blind Clinical Trial,2023,Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cognitive Dysfunction; Cannabis Adverse Effects
2022261,Laser Treatment Increases the Antimicrobial Efficacy of Cyanobacterial Extracts against Staphylococcusaureus (SA) and Methicillin-resistantStaphylococcus aureus (MRSA),https://www.mdpi.com/1660-4601/19/20/13305,Positive,,Laboratory Study,2022,Phycocyanin,Immune System,Staph Infection
2022262,Syndrome of Inappropriate Antidiuretic Hormone Secretion Following Ayahuasca Use in a Satanic Ritual: A Case Report,https://www.cureus.com/articles/92037-syndrome-of-inappropriate-antidiuretic-hormone-secretion-following-ayahuasca-use-in-a-satanic-ritual-a-case-report#!/,Negative,,Meta-analysis,2022,Ayahuasca,,Addiction - Benzodiazepine; Addiction - Opioid; Cardiovascular Diseases (CVD); Diabetes; Epilepsy; Hypertension (High Blood Pressure); MDMA Adverse Effects; Nausea and Vomiting; Psychosis; Suicide Attempt
2023342,Cocaine-Induced Raynaud's Phenomenon: A Case Report,https://www.cureus.com/articles/127827-cocaine-induced-raynauds-phenomenon-a-case-report#!/,Negative,,Meta-analysis,2023,Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Addiction - Cocaine; Addiction; Addiction - Nicotine; Addiction - Stimulant; Anxiety; Atherosclerosis; Cannabis Adverse Effects; Cardiovascular Diseases (CVD); COPD; Depression; Heart Attack; Hypertension (High Blood Pressure); MDMA Adverse Effects; Suicide Attempt
2023343,Cannabinoid Hyperemesis Syndrome in a 23-Year-Old Woman with Uncontrolled Type 1 Diabetes Mellitus,https://amjcaserep.com/abstract/full/idArt/938418,Negative,,Meta-analysis,2023,Endocannabinoid (unspecified),Digestive System; Endocrine System,Cannabis Hyperemesis Syndrome; Diabetes; Nausea and Vomiting; Cannabis Adverse Effects; Gastroparesis; Pain; Pain - Acute; Pain - Chronic
2023344,The use of cannabidiol as a novel treatment for oral stereotypic behaviour (crib-biting) in a horse,https://www.sciencedirect.com/science/article/pii/S2451943X23000066?via%3Dihub,Positive,,Animal Study -,2023,Endocannabinoid (unspecified),,Veterinary Applications; Alzheimer's Disease; Anxiety; Autism; Depression; Epilepsy; Huntington's Disease; Inflammation; Pain; Pain - Chronic; Pain - Neuropathy - Peripheral; Parkinson's Disease; Periodontal Disease; Psychosis; Schizophrenia; Stroke
2022263,The Effectiveness and Safety of Pharmaceutical-Grade Cannabidiol in the Treatment of Mastocytosis-Associated Pain: A Pilot Study,https://www.mdpi.com/2227-9059/11/2/520,Positive,,Clinical Trial,2022,,,Pain; Pain - Chronic; Anxiety; Depression; Insomnia and Sleep Disorders; Liver Failure; MDMA Adverse Effects
2022264,Transient Neurogenic Bowel Dysfunction in a Case of Cocaine-Induced Spinal Cord Infarction,https://www.cureus.com/articles/91851-transient-neurogenic-bowel-dysfunction-in-a-case-of-cocaine-induced-spinal-cord-infarction#!/,Negative,,Meta-analysis,2022,Tetrahydrocannabinol (THC),Digestive System; Mental/Emotional System; Skeletal System,Addiction - Cocaine; Addiction; Constipation; Spinal Cord Injuries; Cannabis Adverse Effects
2022265,Succinylcholine Induced Rhabdomyolysis in a Heavy Marijuana Smoker: A Case Report,https://ima-files.s3.amazonaws.com/417345_c3c91f13-2d59-4fe4-bc22-e7f10f095536.pdf,Negative,,Meta-analysis,2022,,,Kidney Failure
2022266,Malignant Syphilis in a Female Patient: A Case Report and Mini-Review,https://www.mdpi.com/2414-6366/7/3/47,Negative,,Meta-analysis,2022,,Immune System,Bacterial Infections; Addiction - Alcohol; Cancer - Lymphoma; Cancer; Cannabis Adverse Effects; Diabetes; Hair Loss; Hepatitis; HIV/AIDS; Inflammation; Nausea and Vomiting; Pregnancy; Periodontal Disease; Staph Infection; Suicide Attempt
2022267,Capgras Syndrome Due to Cannabinoids Use: A Case Report With Radiological Findings,https://www.cureus.com/articles/83724-capgras-syndrome-due-to-cannabinoids-use-a-case-report-with-radiological-findings#!/,Negative,,Meta-analysis,2022,,Mental/Emotional System,Cannabis Adverse Effects; Psychosis; Anorexia; Anxiety; Insomnia and Sleep Disorders
2022268,"Pneumopericardium, Epidural Pneumatosis, and Muscular Emphysema: Rare Complications of Spontaneous Pneumomediastinum Due to Refractory Hyperemesis Gravidarum",https://www.cureus.com/articles/83180-pneumopericardium-epidural-pneumatosis-and-muscular-emphysema-rare-complications-of-spontaneous-pneumomediastinum-due-to-refractory-hyperemesis-gravidarum#!/,Negative,,Meta-analysis,2022,,Digestive System; Reproductive System,Nausea and Vomiting; Pregnancy; Cannabis Adverse Effects; Cannabis Hyperemesis Syndrome; Morning sickness
2022269,Hypokalemic Paresis in a 26-Year-Old Man After Recreational Cannabis Use,https://amjcaserep.com/abstract/full/idArt/936008,Negative,,Meta-analysis,2022,,Mental/Emotional System,Cannabis Adverse Effects
2022270,Unexpected improvement of hyperhidrosis with cannabidiol,https://pubmed.ncbi.nlm.nih.gov/35170710/,Positive,,Meta-analysis,2022,,Integumentary System,Night Sweats and Excessive Sweating; Autism; Cancer - Lung; Cancer
2022271,A Case of Synthetic Cannabinoid (K2)-Induced Posterior Reversible Encephalopathy Syndrome (PRES),https://amjcaserep.com/abstract/full/idArt/936209,Negative,,Meta-analysis,2022,Synthetic Cannabinoid (unspecified); Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Poisoning by Synthetic Cannabis; Anxiety; Cardiovascular Diseases (CVD); Epilepsy; Hypertension (High Blood Pressure); Nausea and Vomiting; Stroke
2022272,Case report: A case of undiagnosed cannabinoid hyperemesis syndrome in rural part of Nepal,https://journals.lww.com/annals-of-medicine-and-surgery/Fulltext/2022/12000/Case_report__A_case_of_undiagnosed_cannabinoid.93.aspx,Negative,,Meta-analysis,2022,,Digestive System; Nervous System,Cannabis Hyperemesis Syndrome; Nausea and Vomiting; Cannabis Adverse Effects
2023345,Reversible cerebral vasoconstriction syndrome associated with probable drug poisoning,https://www.sciencedirect.com/science/article/pii/S1930043322010287?via%3Dihub,Negative,,Meta-analysis,2023,Endocannabinoid (unspecified),,Addiction - Opioid; Cannabis Adverse Effects; Depression; Epilepsy; Oxidative Stress; Stroke
2022273,Pneumomediastinum and Pneumorrhachis Associated With Cannabinoid Hyperemesis Syndrome,https://www.cureus.com/articles/125647-pneumomediastinum-and-pneumorrhachis-associated-with-cannabinoid-hyperemesis-syndrome#!/#case_presentation,Negative,,Meta-analysis,2022,,Digestive System; Nervous System,Cannabis Hyperemesis Syndrome; Nausea and Vomiting; Addiction - Nicotine; Cannabis Adverse Effects
2022274,Circulating endocannabinoid levels in pregnant women with gestational diabetes mellitus: a case-control study,https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-022-01182-5,Negative,,Meta-analysis,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Endocrine System; Reproductive System,Diabetes; Pregnancy
2022275,Integration of Cannabis Extract Tetrahydrocannabinol:Cannabidiol in an Interdisciplinary Therapy Setting: A Case of Chronic Multilocular Pain Disorder,https://www.karger.com/Article/FullText/527521,Positive,,Meta-analysis,2022,Tetrahydrocannabinol (THC),,Pain; Pain - Chronic; Anxiety; Cancer; Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Depression; Fibromyalgia; Inflammation; Insomnia and Sleep Disorders; Tics and Tourettes; Tinnitus; Multiple Sclerosis; Restless Leg Syndrome
2022276,Cannabinoids-Perspectives for Individual Treatment in Selected Patients: Analysis of the Case Series,https://www.mdpi.com/2227-9059/10/8/1862,Positive,,Meta-analysis,2022,Cannabigerol (CBG); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),,Addiction - Alcohol; Addiction - Opioid; Anxiety; Bipolar Disorder; Cancer - Lymphoma; Cancer; Depression; Inflammation; Insomnia and Sleep Disorders; Migraine; Pain; Palliative Care; Pain - Chronic; Pruritis; Psychosis; Wound Healing
2022277,Cannabidiol as a personalized treatment for anxiety: clinical cases in Mexico,https://www.drugsincontext.com/cannabidiol-as-a-personalized-treatment-for-anxiety-clinical-cases-in-mexico/,Positive,,Meta-analysis,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Mental/Emotional System,Anxiety; Depression; Fragile X Syndrome; IBD - Crohn's Disease; Insomnia and Sleep Disorders; OCD; PTSD
2022278,Terpene-Enriched CBD oil for treating autism-derived symptoms unresponsive to pure CBD: Case report,https://www.frontiersin.org/articles/10.3389/fphar.2022.979403/full,Positive,,Meta-analysis,2022,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System; Nervous System,Autism; Behavioral Disorders; Anxiety; Cognitive Dysfunction; Depression; Epilepsy; Inflammation; Insomnia and Sleep Disorders; Psychosis
2023346,A case of clinical worsening after stereo-electroencephalographic-guided radiofrequency thermocoagulation in a patient with polymicrogyria,https://www.sciencedirect.com/science/article/pii/S2589986422000569?via%3Dihub,Positive,,Meta-analysis,2023,,,Epilepsy; Psychosis
2022279,FABP5 deletion in nociceptors augments endocannabinoid signaling and suppresses TRPV1 sensitization and inflammatory pain,https://www.nature.com/articles/s41598-022-13284-0,Positive,,Animal Study,2022,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); 2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Capsaicin (CAPS); Monoacylglycerol Lipase (MAGL); Palmitoylethanolamide (PEA),Nervous System,Pain
2022280,Impact of cyclooxygenase-2 inhibition on cannabis withdrawal and circulating endocannabinoids in daily cannabis smokers,https://pubmed.ncbi.nlm.nih.gov/35754107/,Positive,,Clinical Trial,2022,Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2022281,"The C4EB study-Transvamix (10% THC / 5% CBD) to treat chronic pain in epidermolysis bullosa: A protocol for an explorative randomized, placebo controlled, and double blind intervention crossover study",https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0277512,Inconclusive,,Meta-analysis,2022,Pharma THC:CBD,Integumentary System,Epidermolysis bullosa; Pain; Pain - Chronic
2022282,Change in upper limb function in people with multiple sclerosis treated with nabiximols: a quantitative kinematic pilot study,https://link.springer.com/article/10.1007/s10072-022-06456-3,Positive,,Clinical Trial,2022,Pharma THC:CBD,,Multiple Sclerosis; Cognitive Dysfunction; Inflammation; Neurodegenerative Issues
2022283,Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo- Controlled Clinical Trial,https://pubmed.ncbi.nlm.nih.gov/35450527/,Positive,,Double Blind Clinical Trial,2022,Palmitoylethanolamide (PEA),Respiratory System,COVID-19; Inflammation
2022284,"A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)",https://jneurodevdisorders.biomedcentral.com/articles/10.1186/s11689-022-09466-6,Positive,,Double Blind Clinical Trial,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Nervous System,Fragile X Syndrome; ADD and ADHD; Behavioral Disorders; Anxiety; Autism
2022285,Assessment of Delta-9-Tetrahydrocannabinol (THC) in Saliva and Blood After Oral Administration of Medical Cannabis With Respect to its Effect on Driving Abilities,https://www.biomed.cas.cz/physiolres/pdf/2022/71_703.pdf,Negative,,Clinical Trial,2022,Tetrahydrocannabinol (THC); Cannabidiolic Acid (CBD-a); Tetrahydrocannabinolic Acid (THC-a),Mental/Emotional System,Cannabis Adverse Effects; Pain; Pain - Chronic
2023347,Oral THC: CBD cannabis extract in main symptoms of Alzheimer disease: agitation and weight loss,https://pubmed.ncbi.nlm.nih.gov/36655645/,Positive,,Clinical Trial,2023,,Nervous System,Alzheimer's Disease
2023348,Efficacy and safety of topical 0.1% cannabidiol for managing recurrent aphthous ulcers: a randomized controlled trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940329/,Positive,,Double Blind Clinical Trial,2023,,,Canker Sore
2022286,Adulteration of low-delta-9-tetrahydrocannabinol products with synthetic cannabinoids: Results from drug checking services,https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/dta.3220,Negative,,Clinical Trial,2022,Synthetic Cannabinoid (unspecified); Cannabidiolic Acid (CBD-a); Tetrahydrocannabinolic Acid (THC-a),Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Anxiety; Cardiovascular Diseases (CVD); Epilepsy; Heart Attack; Nausea and Vomiting
2022287,Implications of Electronic Cigarettes on the Safe Administration of Sedation and General Anesthesia in the Outpatient Dental Setting,https://pubmed.ncbi.nlm.nih.gov/35849811/,Negative,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Addiction - Nicotine; Periodontal Disease; Vaping injury (EVALI)
2023349,Inhibition of Nicotine Metabolism by Cannabidiol (CBD) and 7-Hydroxycannabidiol (7-OH-CBD),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945182/,Positive,,Laboratory Study,2023,,Mental/Emotional System; Nervous System,Addiction - Nicotine; Addiction
2023350,Comparing the effects of medical cannabis for chronic pain patients with and without co-morbid anxiety: A cohort study,https://pubmed.ncbi.nlm.nih.gov/36803620/,Positive,,Meta-analysis,2023,,Mental/Emotional System,Anxiety; Pain; Pain - Chronic
2023351,Cannabis use amongst tinnitus patients: consumption patterns and attitudes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951523/,Positive,,Meta-analysis,2023,,,Tinnitus
2022288,Modulation of type 1 cannabinoid receptor activity by cannabinoid by-products from Cannabis sativa and non-cannabis phytomolecules,https://www.frontiersin.org/articles/10.3389/fphar.2022.956030/full,Inconclusive,,Animal Study,2022,Cannabinol (CBN); Palmitoylethanolamide (PEA); Tetrahydrocannabinolic Acid (THC-a),Nervous System,Pain
2022289,Time Trends of Tetrahydrocannabinol (THC) in a 2008-2021 German National Survey of Hemp Food Products,https://www.mdpi.com/2304-8158/11/3/486,Negative,,Laboratory Study,2022,Tetrahydrocannabinolic Acid (THC-a),Mental/Emotional System,Cannabis Adverse Effects
2022290,Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer?,https://link.springer.com/article/10.1007/s11864-021-00934-0,Positive,,Meta-analysis,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Pharma CBD; Pharma THC:CBD,Mental/Emotional System,Cancer; Cannabis Adverse Effects; Anorexia; Anxiety; Cachexia; Cancer - Metastatic; Chemotherapy-induced Nausea & Vomiting; Cognitive Dysfunction; Diarrhea; Epilepsy; HIV/AIDS; Insomnia and Sleep Disorders; Pain; Multiple Sclerosis; Nausea and Vomiting; Palliative Care; Pain - Cancer; Pain - Neuropathy - Peripheral; Psychosis; Schizophrenia
2022291,Cannabis for Medical Use: Versatile Plant Rather Than a Single Drug,https://www.frontiersin.org/articles/10.3389/fphar.2022.894960/full,Positive,,Meta-analysis,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Cannabichromene (CBC); Cannabichromenic Acid (CBC-a); Cannabidiolic Acid (CBD-a); Cannabidivarin (CBDV); Cannabigerol (CBG); Cannabigerolic Acid (CBG-a); Cannabinol (CBN); Cannabitriol (CBT); Tetrahydrocannabivarin (THCV); Tetrahydrocannabinolic Acid (THC-a),,Cancer - Breast; Cancer; Cannabis Adverse Effects; Cardiovascular Diseases (CVD); Cognitive Dysfunction; Epilepsy; Inflammation; Migraine; Pain; Multiple Sclerosis; Nausea and Vomiting; Pain - Chronic
2020152,Cannabinoid as Potential Aromatase Inhibitor Through Molecular Modeling and Screening for Anti-Cancer Activity,https://www.researchgate.net/publication/342583417_Cannabinoid_as_Potential_Aromatase_Inhibitor_Through_Molecular_Modeling_and_Screening_for_Anti-Cancer_Activity,Positive,,Laboratory Study,2020,Cannabitriol (CBT),Nervous System; Reproductive System,Cancer - Breast; Cancer
1977001,Isolation and characterization of (+)-cannabitriol and (-)-10-ethoxy-9-hydroxy-delta 6a[10a]-tetrahydrocannabinol: two new cannabinoids from Cannabis sativa L. extract,https://pubmed.ncbi.nlm.nih.gov/895385/,Inconclusive,,Laboratory Study,1977,Cannabitriol (CBT),,Cancer - Breast; Cancer
2023352,Cannabidiol repairs behavioral and brain disturbances in a model of fetal alcohol spectrum disorder,https://www.sciencedirect.com/science/article/pii/S1043661823000117?via%3Dihub,Positive,,Animal Study,2023,Cannabichromene (CBC),,Neonatal Cerebral Issues; Addiction - Alcohol; Behavioral Disorders; Anxiety; Cognitive Dysfunction; Depression; Oxidative Stress; Pregnancy
2023353,THC and CBD: Similarities and differences between siblings,https://pubmed.ncbi.nlm.nih.gov/36638804/,Positive,,Meta-analysis,2023,,,Anxiety; Cannabis Adverse Effects; Depression
2006011,The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells,https://www.cell.com/cancer-cell/fulltext/S1535-6108(06)00085-7#secd49814185e1186,Positive,,Laboratory Study,2006,SR-x Synthetic Cannabinoids; 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Mental/Emotional System,Cancer; Cancer - Brain; Cancer - Metastatic; Cancer - Pancreatic; Cancer - Prostate
2022292,Interaction of Glia Cells with Glioblastoma and Melanoma Cells under the Influence of Phytocannabinoids,https://www.mdpi.com/2073-4409/11/1/147,Negative,,Laboratory Study,2022,HU-x Synthetic Cannabinoids,Integumentary System,Cancer - Brain; Cancer - Melanoma; Cancer; Cancer - Metastatic
2022293,Cannabinoids orchestrate cross-talk between cancer cells and endothelial cells in colorectal cancer,https://pubmed.ncbi.nlm.nih.gov/34007062/,Negative,,Animal Study,2022,,Digestive System,Cancer - Colon; Cancer - Metastatic; Cancer; Chemotherapy-induced Nausea & Vomiting
2018068,Antitumorigenic Properties of Omega-3 Endocannabinoid Epoxides,https://pubmed.ncbi.nlm.nih.gov/29856219/,Positive,,Animal Study,2018,Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH),Nervous System; Skeletal System,Cancer - Bone; Cancer - Metastatic; Cancer; Inflammation
2012059,"Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice",https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.01879.x,Positive,,Animal Study,2012,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Cannabichromene (CBC); Palmitoylethanolamide (PEA); Monoacylglycerol Lipase (MAGL),Digestive System; Nervous System,IBD - Inflammatory Bowel Disease; Inflammation
2013038,"Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profile",https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0070052#s1,Positive,,Laboratory Study,2013,Cannabichromene (CBC); Cannabidiolic Acid (CBD-a); Cannabigerol (CBG); Cannabigerolic Acid (CBG-a); Cannabinol (CBN); Tetrahydrocannabivarin (THCV); Tetrahydrocannabinol (THC); Tetrahydrocannabinolic Acid (THC-a); CP-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,,Addiction - Cannabis; Cannabis Adverse Effects; Depression; Inflammation; Pain; Pain - Acute; Psychosis
2011044,Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action,https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2010.01063.x,Positive,,Animal Study,2011,Cannabichromene (CBC); 2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Nervous System,Pain - Nociceptive; Pain
2010037,"Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol",https://www.sciencedirect.com/science/article/abs/pii/S0376871610002073?via%3Dihub,Positive,,Animal Study,2010,Cannabichromene (CBC); Tetrahydrocannabinol (THC); Pharma THC; SR-x Synthetic Cannabinoids,,Inflammation; Pain - Nociceptive
2010038,"Disposition of cannabichromene, cannabidiol, and Δ⁹-tetrahydrocannabinol and its metabolites in mouse brain following marijuana inhalation determined by high-performance liquid chromatography-tandem mass spectrometry",https://watermark.silverchair.com/34-8-516.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAsEwggK9BgkqhkiG9w0BBwagggKuMIICqgIBADCCAqMGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMZUi0a5UjO3ZaRP8uAgEQgIICdH4-vL52lXCyDEI49m1t2VNnZOL_pSUI1SDVihdD20b0EcmEezJF6sTCRo6JaWpTyciZpp-QjWYnx9XAEGSnmdGNb4OUGaaOQUSXJpPth7Rr1EgKHwEzFwd_vqkNQf9n-3YWILMQLVu19Nj-CltXL95vIWq4IAYvDj5QQ6qqV72m6txlGYuzqD7xvLv6RanKbe_p5mx12ESwzLyr90GSEtcC1EpJLFHduO_ZoK45blHOPhqGoUqGjP0t8r_coie5PspPFZvRxjCANqbFudID3Bshahtxs1TiNoi_yXcoR21SNlD6YEI3gKudPDXzA__p_AopIZoP_neJmEikx4BY5KBapkCdF2-z3qDTup_0BS_8-ixXsMDlTMFsW6UWGum8LtdfUVchVSFf6FcJqMZIbBvO4ff4wgrizyIckOPCLoYBGd3JhNgyoWREa5fnVGxn2IwlNA24wpQuc_qnWEgcz9fUPMg-v6jBGICUFfZfipTAxON-3rN2UtumcTLaAq8rqH3GmCXA-NFjfcURIVKhfsxtQHhFH6mezk1hi8GEeutuLhPP--T2ulXZ1UOVtev6LBRjooWNT39BMHiq-LwbU0xgNH6PNnRoI9bBogqIMqABqXccWIn61fyDkc3jwqBE5XcsqvSBI7_JbyVZL5Fbns8El_ORwY-MI6gebBYafH1ozMsbiQdAj5AphjZOWofXlrC9xGr4lx0NQIJqyaesWQoY0Gs1HOrl5nwwybJ_O4NX-gfqDmnT4GEvkWILpTqyU7aIKEDQa_ldR72qjz_uEM0gGOG5-7MY5VLmdsUKxK3vyJB_yO5mqL8CNGHSGhNCRH415Dg,Positive,,Animal Study,2010,Cannabichromene (CBC),,
2012060,Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation,https://pubmed.ncbi.nlm.nih.gov/21726418/,Positive,,Laboratory Study,2012,Cannabigerolic Acid (CBG-a); Tetrahydrocannabinol (THC); Cannabigerol (CBG),Digestive System,IBD - Inflammatory Bowel Disease; Inflammation
2022294,"Characterizing and Quantifying Extrahepatic Metabolism of (-)-Δ9-Tetrahydrocannabinol (THC) and Its Psychoactive Metabolite, (±)-11-Hydroxy-Δ9-THC (11-OH-THC)",https://pubmed.ncbi.nlm.nih.gov/35370140/,Positive,,Laboratory Study,2022,,,Pregnancy
1984001,Early cannabinoid exposure influences neuroendocrine and reproductive functions in mice: II. Postnatal effects,https://www.sciencedirect.com/science/article/abs/pii/0091305784901114?via%3Dihub,Negative,,Animal Study,1984,Cannabinol (CBN),Reproductive System,Pregnancy; Infertility (Female); Infertility (Male); Metabolic Syndrome; Neonatal Cerebral Issues
1984002,Early cannabinoid exposure influences neuroendocrine and reproductive functions in male mice: I. Prenatal exposure,https://pubmed.ncbi.nlm.nih.gov/6320227/,Negative,,Animal Study,1984,Cannabinol (CBN),Mental/Emotional System; Reproductive System,Cannabis Adverse Effects; Pregnancy; Infertility (Male); Libido
1995002,The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling,https://pubmed.ncbi.nlm.nih.gov/7568154/,Negative,,Laboratory Study,1995,Anandamide (AEA); CP-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC),Reproductive System,Pregnancy; Cannabis Adverse Effects
2017052,Pediatric Concerns Due to Expanded Cannabis Use: Unintended Consequences of Legalization,https://pubmed.ncbi.nlm.nih.gov/27139708/,Negative,,Meta-analysis,2017,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Epilepsy; Neonatal Cerebral Issues; Pregnancy
2018069,Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model,https://www.scielo.br/j/bjmbr/a/NBVt63PKDbLSLzYpDfwTKBv/?lang=en,Positive,,Animal Study,2018,,Nervous System; Reproductive System,Inflammation; Pregnancy; Alzheimer's Disease; Arthritis - Rheumatoid; Arthritis; Cancer; Diabetes; IBD - Inflammatory Bowel Disease; Nausea and Vomiting; Oxidative Stress; Parkinson's Disease; Stroke
2019070,"A Phase 1, Open-Label, Pharmacokinetic Trial to Investigate Possible Drug-Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects",https://accp1.onlinelibrary.wiley.com/doi/10.1002/cpdd.665,Positive,,Clinical Trial,2019,Pharma CBD,,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2021190,The Use of Cannabis and Cannabinoid-based Products by Pregnant Women: A Patent Review,https://pubmed.ncbi.nlm.nih.gov/34825644/,Positive,,Meta-analysis,2021,,Reproductive System,Pregnancy; Inflammation; Pain; Nausea and Vomiting; Pain - Acute
2019071,"A Review on Studies of Marijuana for Alzheimer's Disease - Focusing on CBD, THC",https://www.journal-jop.org/journal/view.html?doi=10.3831/KPI.2019.22.030,Positive,,Meta-analysis,2019,Cannabigerol (CBG); Cannabinol (CBN),,Alzheimer's Disease; Behavioral Disorders; Cancer; Cognitive Dysfunction; Dementia; Inflammation; Insomnia and Sleep Disorders; Neurodegenerative Issues
2020153,Chronic Treatment with 50 mg/kg Cannabidiol Improves Cognition and Moderately Reduces Aβ40 Levels in 12-Month-Old Male AβPPswe/PS1ΔE9 Transgenic Mice,https://pubmed.ncbi.nlm.nih.gov/32116258/,Positive,,Animal Study,2020,,Nervous System,Cognitive Dysfunction; Behavioral Disorders; Dementia; Inflammation; Neurodegenerative Issues
2020154,Debunking Cannabidiol as a Treatment for COVID-19: Time for the FDA to Adopt a Focused Deterrence Model?,https://www.cureus.com/articles/33916-debunking-cannabidiol-as-a-treatment-for-covid-19-time-for-the-fda-to-adopt-a-focused-deterrence-model#!/,Negative,,Meta-analysis,2020,,Respiratory System,COVID-19; Alzheimer's Disease; Cancer; Depression; Diabetes
2020155,The effects of acute cannabidiol on cerebral blood flow and its relationship to memory: An arterial spin labelling magnetic resonance imaging study,https://journals.sagepub.com/doi/10.1177/0269881120936419,Positive,,Double Blind Clinical Trial,2020,Synthetic Cannabinoid (unspecified),,Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine; Alzheimer's Disease; Anxiety; Dementia; Psychosis; PTSD; Schizophrenia
2020156,Isomeric O-methyl cannabidiolquinones with dual BACH1/NRF2 activity,https://www.sciencedirect.com/science/article/pii/S2213231720308946?via%3Dihub,Positive,,Laboratory Study,2020,,Nervous System,Huntington's Disease; Huntington's Disease; Neurodegenerative Issues; Alzheimer's Disease; Dementia; Inflammation; Oxidative Stress; Parkinson's Disease
2020157,Attenuation of Oxidative Stress by Cannabinoids and Cannabis Extracts in Differentiated Neuronal Cells,https://www.mdpi.com/1424-8247/13/11/328,Positive,,Laboratory Study,2020,Cannabichromene (CBC); Cannabigerol (CBG); Cannabinol (CBN); Pharma THC,Nervous System,Oxidative Stress; Alzheimer's Disease; Amyotrophic Lateral Sclerosis (ALS); Cognitive Dysfunction; HIV/AIDS; Inflammation; Parkinson's Disease
2020158,Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease,https://www.mdpi.com/1420-3049/25/21/5186,Positive,,Meta-analysis,2020,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Nervous System,Neurodegenerative Issues; Alzheimer's Disease; Anxiety; Dementia; Depression; Epilepsy; Inflammation; Multiple Sclerosis; Oxidative Stress; Parkinson's Disease
2022295,Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of APP Swe /PS1ΔE9 Transgenic Female Mice,https://www.frontiersin.org/articles/10.3389/fphar.2020.587604/full,Positive,,Animal Study,2022,,Nervous System,Alzheimer's Disease; Behavioral Disorders; Anxiety; Cognitive Dysfunction; Dementia; Inflammation; Neurodegenerative Issues; Oxidative Stress
2022296,"The Effect of Cannabidiol Coated by Nano-Chitosan on Learning and Memory, Hippocampal CB1 and CB2 Levels, and Amyloid Plaques in an Alzheimer's Disease Rat Model",https://pubmed.ncbi.nlm.nih.gov/34727550/,Positive,,Animal Study,2022,,Nervous System,Alzheimer's Disease; Dementia; Neurodegenerative Issues
2003005,CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?,https://www.sciencedirect.com/science/article/abs/pii/S1471489202000048?via%3Dihub,Positive,,Meta-analysis,2003,Endocannabinoid (unspecified); AM-x Synthetic Cannabinoids; HU-x Synthetic Cannabinoids; Palmitoylethanolamide (PEA); SR-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC),,Inflammation; Pain - Acute; Pain - Chronic; Pain; Pain - Neuropathy - Peripheral
1999007,Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice,https://pubmed.ncbi.nlm.nih.gov/9888857/,Positive,,Animal Study,1999,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction; Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Pain; Pain - Acute
2000003,"Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide",https://www.sciencedirect.com/science/article/abs/pii/S0006899300019818?via%3Dihub,Positive,,Animal Study,2000,Anandamide (AEA); CP-x Synthetic Cannabinoids,Nervous System,Pain; Pain - Acute
2000004,Activation of spinal cannabinoid 1 receptors inhibits C-fibre driven hyperexcitable neuronal responses and increases [35S]GTPgammaS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats,https://pubmed.ncbi.nlm.nih.gov/10886347/,Positive,,Animal Study,2000,HU-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,,Inflammation; Pain - Chronic; Pain; Pain - Acute; Spinal Cord Injuries
2001011,Absence of delta -9-tetrahydrocannabinol dysphoric effects in dynorphin-deficient mice,https://www.jneurosci.org/content/21/23/9499#abstract-1,Positive,,Animal Study,2001,Tetrahydrocannabinol (THC); SR-x Synthetic Cannabinoids,,Pain; Pain - Acute; Addiction - Opioid
2002007,Dose-dependent effects of Delta9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat,https://onlinelibrary.wiley.com/doi/10.1002/syn.10089,Negative,,Animal Study,2002,SR-x Synthetic Cannabinoids,,Behavioral Disorders; Cognitive Dysfunction; Metabolic Syndrome
2002008,Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta(9)-tetrahydrocannabinol administration,https://pubmed.ncbi.nlm.nih.gov/12235269/,Negative,,Animal Study,2002,Tetrahydrocannabinol (THC); Anandamide (AEA); JWH-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,,Pain; Pain - Acute
2022297,"Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687782/,Positive,,Meta-analysis,2022,Ayahuasca; Endocannabinoid (unspecified),Mental/Emotional System,Depression
2022298,Metabolomics and integrated network analysis reveal roles of endocannabinoids and large neutral amino acid balance in the ayahuasca experience,https://pubmed.ncbi.nlm.nih.gov/35339828/,Inconclusive,,Clinical Trial,2022,Ayahuasca,,Depression
2018070,Possible Interactions Between 5-HT2A Receptors and the Endocannabinoid System in Humans: Preliminary Evidence of Interactive Effects of Ayahuasca and Endocannabinoids in a Healthy Human Subject,https://pubmed.ncbi.nlm.nih.gov/30339603/,Inconclusive,,Clinical Trial,2018,Ayahuasca,,Depression
2022299,C-phycocyanin alleviated cisplatin-induced oxidative stress and inflammation via gut microbiota—metabolites axis in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549462/,Positive,,Animal Study,2022,Phycocyanin,,Inflammation; Oxidative Stress; Cardiac Toxicity; Cardiovascular Diseases (CVD); Chemotherapy-induced Nausea & Vomiting; Drug-Induced Bone Loss; Drug-Induced Nephropathy; Pain; Pain - Neuropathy - Drug-Ind. Polyneuropathy
2022300,Phycocyanin improved alcohol-induced hepatorenal toxicity and behavior impairment in Wistar rats,https://pubmed.ncbi.nlm.nih.gov/36342230/,Positive,,Animal Study,2022,Phycocyanin,Digestive System,Alcoholic Liver Disease; Liver Failure
2020159,Therapeutic effect of phycocyanin on acute liver oxidative damage caused by X-ray,https://pubmed.ncbi.nlm.nih.gov/32739742/,Positive,,Animal Study,2020,Phycocyanin,,Radiation sickness; Oxidative Stress
2022301,The Nutraceutical Antihypertensive Action of C-Phycocyanin in Chronic Kidney Disease Is Related to the Prevention of Endothelial Dysfunction,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002637/,Positive,,Animal Study,2022,Phycocyanin,Urinary System,Chronic Kidney Disease; Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2021191,Phycocyanobilin is the molecule responsible for the nephroprotective action of phycocyanin in acute kidney injury caused by mercury,https://pubmed.ncbi.nlm.nih.gov/33704296/,Positive,,Animal Study,2021,Phycocyanin,Urinary System,Kidney Failure
2015073,Molecular mechanism of anti-cancer activity of phycocyanin in triple-negative breast cancer cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619068/,Positive,,Laboratory Study,2015,Phycocyanin,Nervous System; Reproductive System,Cancer - Breast; Cancer
2022302,The protective effect of C-phycocyanin in male mouse reproductive system,https://pubmed.ncbi.nlm.nih.gov/35167640/,Positive,,Animal Study,2022,Phycocyanin,Reproductive System,Infertility (Male)
2018071,Spirulina maxima Extract Reduces Obesity through Suppression of Adipogenesis and Activation of Browning in 3T3-L1 Cells and High-Fat Diet-Induced Obese Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024816/,Positive,,Animal Study,2018,Phycocyanin,Endocrine System,Obesity; Diabetes; Metabolic Syndrome
2022303,Spirulina phycocyanin extract and its active components suppress epithelial-mesenchymal transition process in endometrial cancer via targeting TGF-beta1/SMAD4 signaling pathway,https://pubmed.ncbi.nlm.nih.gov/35691155/,Positive,,Animal Study,2022,Phycocyanin,Nervous System; Reproductive System,Cancer - Uterine; Cancer
2021192,Insulin Receptor Substrate 1 Is Involved in the Phycocyanin-Mediated Antineoplastic Function of Non-Small Cell Lung Cancer Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401963/,Positive,,Laboratory Study,2021,Phycocyanin,Nervous System; Respiratory System,Cancer - Lung; Cancer
2016067,Phycocyanin Inhibits Tumorigenic Potential of Pancreatic Cancer Cells: Role of Apoptosis and Autophagy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5046139/,Positive,,Animal Study,2016,Phycocyanin,Endocrine System; Nervous System,Cancer - Pancreatic; Cancer
2022304,Phycocyanin Ameliorates Colitis-Associated Colorectal Cancer by Regulating the Gut Microbiota and the IL-17 Signaling Pathway,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030732/,Positive,,Animal Study,2022,Phycocyanin,Digestive System,Cancer - Colon; Cancer; IBD - Inflammatory Bowel Disease
2018072,C-Phycocyanin exerts anti-cancer effects via the MAPK signaling pathway in MDA-MB-231 cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785878/,Positive,,Laboratory Study,2018,Phycocyanin,Reproductive System,Cancer - Breast; Cancer
2021193,Phycocyanin inhibits pancreatic cancer metastasis via suppressing epithelial-mesenchymal transition and targeting Akt/β-catenin pathway,https://pubmed.ncbi.nlm.nih.gov/34648301/,Positive,,Animal Study,2021,Phycocyanin,Endocrine System; Nervous System,Cancer - Metastatic; Cancer - Pancreatic; Cancer
2017053,Phycocyanin: A Potential Drug for Cancer Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687155/,Positive,,Meta-analysis,2017,Phycocyanin,Nervous System,Cancer; Inflammation; Oxidative Stress
2021194,Phycocyanin from Arthrospira platensis as Potential Anti-Cancer Drug: Review of In Vitro and In Vivo Studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911896/,Positive,,Meta-analysis,2021,Phycocyanin,Nervous System,Cancer; Inflammation; Oxidative Stress
2004014,Synergistic interactions between cannabinoid and opioid analgesics,https://www.sciencedirect.com/science/article/abs/pii/S0024320503010129?via%3Dihub,Positive,,Meta-analysis,2004,Tetrahydrocannabinol (THC),Mental/Emotional System,Addiction - Opioid; Addiction; Pain - Chronic; Pain; Pain - Acute
2004015,Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC,https://pubmed.ncbi.nlm.nih.gov/15450100/,Negative,,Animal Study,2004,Tetrahydrocannabinol (THC),Mental/Emotional System,Cannabis Adverse Effects; Pain; Pain - Acute
2005015,Antihyperalgesic properties of the cannabinoid CT-3 in chronic neuropathic and inflammatory pain states in the rat,https://pubmed.ncbi.nlm.nih.gov/15936883/,Positive,,Laboratory Study,2005,SR-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC); WIN-x Synthetic Cannabinoids,Nervous System,Inflammation; Pain; Pain - Chronic; Pain - Inflammatory; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral
2008033,Cross-sensitization and cross-tolerance between exogenous cannabinoid antinociception and endocannabinoid-mediated stress-induced analgesia,https://pubmed.ncbi.nlm.nih.gov/17714742/,Positive,,Animal Study,2008,Tetrahydrocannabinol (THC); WIN-x Synthetic Cannabinoids,Nervous System,Pain; Pain - Acute
2009030,Nabilone produces marked impairments to cognitive function and changes in subjective state in healthy volunteers,https://pubmed.ncbi.nlm.nih.gov/19525335/,Positive,,Double Blind Clinical Trial,2009,Pharma THC,,Cannabis Adverse Effects; Cognitive Dysfunction
2010039,Acute psychotropic effects of oral cannabis extract with a defined content of Delta9-tetrahydrocannabinol (THC) in healthy volunteers,https://pubmed.ncbi.nlm.nih.gov/20178093/,Negative,,Double Blind Clinical Trial,2010,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Addiction - Benzodiazepine
2010040,"Disruption of thermal nociceptive behaviour in mice mutant for the schizophrenia-associated genes NRG1, COMT and DISC1",https://www.sciencedirect.com/science/article/abs/pii/S0006899310013624?via%3Dihub,Positive,,Animal Study,2010,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Pain - Nociceptive; Schizophrenia
2011045,"THC-methadone and THC-naltrexone interactions on discrimination, antinociception, and locomotion in rats",https://pubmed.ncbi.nlm.nih.gov/21716095/,Positive,,Animal Study,2011,,Nervous System,Pain - Nociceptive; Pain; Addiction - Opioid; Pain - Chronic
2013039,"Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Δ(9)-tetrahydrocannabinol in the rat",https://pubmed.ncbi.nlm.nih.gov/23707295/,Positive,,Animal Study,2013,SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Cardiovascular System; Immune System; Integumentary System; Nervous System; Respiratory System,Edema; Inflammation; Pain
2014045,In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects,https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.12298,Positive,,Animal Study,2014,Monoacylglycerol Lipase (MAGL); Synthetic Cannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Palmitoylethanolamide (PEA); SR-x Synthetic Cannabinoids,Nervous System,Pain - Nociceptive; Pain; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral; IBD - Inflammatory Bowel Disease; Inflammation; Pain - Inflammatory; Stomach Ulcers
2015074,Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal,https://pubmed.ncbi.nlm.nih.gov/24853387/,Positive,,Animal Study,2015,AM-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC),,Pain; Pain - Neuropathy - Drug-Ind. Polyneuropathy; Cancer; Cannabis Adverse Effects; Pain - Acute; Pain - Chronic; Pain - Neuropathy - Peripheral
2014046,Sex differences in antinociceptive tolerance to delta-9-tetrahydrocannabinol in the rat,https://www.sciencedirect.com/science/article/abs/pii/S0376871614010187?via%3Dihub,Positive,,Animal Study,2014,Tetrahydrocannabinol (THC),Nervous System,Pain; Pain - Acute
2014047,Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain,https://www.sciencedirect.com/science/article/abs/pii/S0014299914007237?via%3Dihub,Positive,,Animal Study,2014,,,Pain - Acute; Pain
2015075,"AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner",https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.13069,Positive,,Animal Study,2015,AM-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Digestive System,Diarrhea; IBD - Inflammatory Bowel Disease; Irritable Bowel Syndrome; Constipation; Gastroparesis; Metabolic Syndrome; Pain
2018073,Antinociceptive effects of JWH015 in female and male rats,https://pubmed.ncbi.nlm.nih.gov/28914627/,Positive,,Animal Study,2018,JWH-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Nervous System,Pain - Nociceptive; Pain; Inflammation; Pain - Acute; Pain - Chronic
2020160,Efficacy of Dronabinol for Acute Pain Management in Adults with Traumatic Injury: Study Protocol of A Randomized Controlled Trial,https://www.mdpi.com/2076-3425/10/3/161,Inconclusive,,Clinical Trial,2020,Pharma THC; Tetrahydrocannabinol (THC),Nervous System,Pain; Pain - Acute; Addiction - Opioid; Inflammation
2020161,Mapping cannabis potency in medical and recreational programs in the United States,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0230167,Negative,,Meta-analysis,2020,Tetrahydrocannabinol (THC),,Addiction - Opioid; Anxiety; Depression; Epilepsy; Pain; Pain - Chronic; Pain - Neuropathy - Diabetic; Pain - Neuropathy - Peripheral
2020162,"In an exploratory randomized, double-blind, placebo-controlled, cross-over study, psychoactive doses of intravenous delta-9-tetrahydrocannabinol fail to produce antinociceptive effects in healthy human volunteers",https://pubmed.ncbi.nlm.nih.gov/32632491/,Negative,,Double Blind Clinical Trial,2020,Capsaicin (CAPS),Nervous System,Pain; Pain - Acute
2020163,"Sedation challenges in patients with E-cigarette, or vaping, product use-associated lung injury (EVALI)",https://pubmed.ncbi.nlm.nih.gov/32878850/,Negative,,Meta-analysis,2020,Tetrahydrocannabinol (THC),Respiratory System,Vaping injury (EVALI); Cannabis Adverse Effects
2010041,A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice,https://academic.oup.com/ijnp/article/13/7/861/667874?login=false,Positive,,Animal Study,2010,Tetrahydrocannabinol (THC),,Behavioral Disorders; Anxiety; Cognitive Dysfunction; Pain; Pain - Acute; Parkinson's Disease; Psychosis; Schizophrenia
2015076,Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice,https://pubmed.ncbi.nlm.nih.gov/25485642/,Positive,,Animal Study,2015,,Nervous System,Pain; Pain - Acute; Pain - Chronic
2017054,Cannabis constituent synergy in a mouse neuropathic pain model,https://pubmed.ncbi.nlm.nih.gov/28885457/,Positive,,Animal Study,2017,Tetrahydrocannabinol (THC),Nervous System,Pain; Pain - Chronic; Pain - Neuropathy - Peripheral
2018074,Comparison of cannabinoids with known analgesics using a novel high throughput zebrafish larval model of nociception,https://www.sciencedirect.com/science/article/abs/pii/S0166432817310239?via%3Dihub,Positive,,Animal Study,2018,Tetrahydrocannabinol (THC),Nervous System,Pain; Pain - Acute
2019072,"US Veterinarians' Knowledge, Experience, and Perception Regarding the Use of Cannabidiol for Canine Medical Conditions",https://www.frontiersin.org/articles/10.3389/fvets.2018.00338/full,Positive,,Meta-analysis -,2019,Pharma CBD,,Veterinary Applications; Alzheimer's Disease; Anorexia; Anxiety; Arthritis - Osteoarthritis; Arthritis; Asthma; Bacterial Infections; Cancer; Cardiovascular Diseases (CVD); Epilepsy; Glaucoma; IBD - Inflammatory Bowel Disease; Hypertension (High Blood Pressure); Inflammation; Pain; Multiple Sclerosis; Nausea and Vomiting; Palliative Care; Pain - Acute
2020164,Cannabinoids in the Treatment of Back Pain,https://pubmed.ncbi.nlm.nih.gov/32097466/,Positive,,Meta-analysis,2020,,Nervous System,Pain; Pain - Chronic; Addiction - Opioid
2020165,Commercial Cannabinoid Oil-Induced Stevens-Johnson Syndrome,https://www.hindawi.com/journals/criopm/2020/6760272/,Negative,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Pain; Sepsis; Skin Diseases
2020166,Cholesterol regulates cannabinoid analgesia through glycine receptors,https://pubmed.ncbi.nlm.nih.gov/32712277/,Positive,,Animal Study,2020,,Nervous System,Pain; Pain - Acute; Pain - Chronic
2021195,"Disposition of cannabinoids and their metabolites in serum, oral fluid, sweat patch and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis",https://pubmed.ncbi.nlm.nih.gov/33155722/,Positive,,Laboratory Study,2021,Cannabidiolic Acid (CBD-a); Tetrahydrocannabinolic Acid (THC-a),Mental/Emotional System; Nervous System,Insomnia and Sleep Disorders; Loss of Appetite
2022305,Evaluating the Antinociceptive Efficacy of Cannabidiol Alone or in Combination with Morphine Using the Formalin Test in Male and Female Mice,https://pubmed.ncbi.nlm.nih.gov/34846928/,Inconclusive,,Animal Study,2022,,,Pain; Pain - Acute; Pain - Chronic; Addiction - Opioid
2022306,Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot,https://www.frontiersin.org/articles/10.3389/fphar.2022.921493/full,Negative,,Meta-analysis,2022,Tetrahydrocannabinol (THC),,Addiction - Cannabis; Anxiety; Cannabis Adverse Effects; Epilepsy; Inflammation; Pain; Pain - Acute; Psychosis
2014048,Reporting of drug induced depression and fatal and non-fatal suicidal behaviour in the UK from 1998 to 2011,https://bmcpharmacoltoxicol.biomedcentral.com/articles/10.1186/2050-6511-15-54,Negative,,Meta-analysis,2014,Synthetic Cannabinoid (unspecified); Pharma THC,Mental/Emotional System; Nervous System,Depression; Suicide Attempt
2017055,"Seeking new acne treatment from natural products, devices and synthetic drug discovery",https://www.tandfonline.com/doi/full/10.1080/19381980.2017.1356520,Positive,,Meta-analysis,2017,,Integumentary System,Acne; Inflammation
2023354,New Drugs for Managing Acne,https://reader.elsevier.com/reader/sd/pii/S0001731022000199?token=B277C40A5A6CA00889C01EB2060C1F39C10329453963890FEDD9A6C7B9893A7086C92CDB0C3DAAEDD169338BB38DAE6D&originRegion=us-east-1&originCreation=20230206183712,Positive,,Meta-analysis,2023,Endocannabinoid (unspecified),Integumentary System,Acne; Bacterial Infections; Inflammation
2022307,Novel and emerging treatment options for acne vulgaris,https://pubmed.ncbi.nlm.nih.gov/36301760/,Positive,,Meta-analysis,2022,Microbiome,Integumentary System,Acne; Inflammation
2013040,Bioactive lipid mediators in skin inflammation and immunity,https://www.sciencedirect.com/science/article/abs/pii/S0163782712000562?via%3Dihub,Positive,,Meta-analysis,2013,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Integumentary System; Nervous System,Inflammation; Skin Diseases; Acne; Allergic Contact Dermatitis; Oxidative Stress; Psoriasis; Wound Healing
2017056,"What is new in the pathophysiology of acne, an overview",https://onlinelibrary.wiley.com/doi/10.1111/jdv.14374,Positive,,Meta-analysis,2017,Endocannabinoid (unspecified); Microbiome,Integumentary System; Nervous System,Acne; Inflammation; Seborrhea
2019073,Bioactive: A new era of bioactive ingredients in topical formulations for inflammatory dermatoses,https://pubmed.ncbi.nlm.nih.gov/31583790/,Positive,,Meta-analysis,2019,Endocannabinoid (unspecified); Microbiome,Integumentary System; Nervous System,Inflammation; Skin Diseases; Acne; Allergic Contact Dermatitis; Eczema; Oxidative Stress; Pruritis
2020167,GPR119 Is a Potent Regulator of Human Sebocyte Biology,https://www.jidonline.org/article/S0022-202X(20)30222-0/fulltext,Positive,,Laboratory Study,2020,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Oleoylethanolamide (OEA),Integumentary System; Nervous System,Acne; Inflammation; Seborrhea; Cancer - Melanoma; Cancer; Diabetes
2020168,Current and emerging treatments targeting the neuroendocrine system for disorders of the skin and its appendages,https://pubmed.ncbi.nlm.nih.gov/32628803/,Positive,,Meta-analysis,2020,Endocannabinoid (unspecified),Integumentary System,Skin Diseases; Acne; Allergic Contact Dermatitis; Hair Loss; Inflammation; Psoriasis
2011046,Endocannabinoid signaling and epidermal differentiation,https://pubmed.ncbi.nlm.nih.gov/21628127/,Positive,,Meta-analysis,2011,Anandamide (AEA); Endocannabinoid (unspecified),Integumentary System,Skin Diseases; Acne; Bacterial Infections; Fungal Infections; Pruritis; Psoriasis; Seborrhea
2022308,"Sebaceous immunobiology - skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations",https://www.frontiersin.org/articles/10.3389/fimmu.2022.1029818/full,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Cannabichromene (CBC); Cannabidivarin (CBDV); Cannabigerol (CBG); Cannabinol (CBN); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Palmitoylethanolamide (PEA); Tetrahydrocannabivarin (THCV); Tetrahydrocannabinol (THC),Integumentary System,Inflammation; Seborrhea; Skin Diseases; Acne; Psoriasis
2020169,The Influence of Hemp Extract in Combination with Ginger on the Metabolic Activity of Metastatic Cells and Microorganisms,https://www.mdpi.com/1420-3049/25/21/4992,Positive,,Laboratory Study,2020,Cannabichromene (CBC); Cannabichromenic Acid (CBC-a); Cannabidiolic Acid (CBD-a); Cannabigerol (CBG); Cannabinol (CBN); Delta-8-THC; Tetrahydrocannabinolic Acid (THC-a); Turmeric,Immune System; Integumentary System; Nervous System,Bacterial Infections; Cancer - Melanoma; Cancer - Metastatic; Oxidative Stress; Cancer; Fungal Infections
2021196,Cannabigerol and cannabichromene in Cannabis sativa L.,https://sciendo.com/article/10.2478/acph-2021-0021,Positive,,Meta-analysis,2021,Cannabichromene (CBC); Cannabigerol (CBG); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Cannabichromenic Acid (CBC-a); Cannabidiolic Acid (CBD-a); Cannabigerolic Acid (CBG-a),,Behavioral Disorders; Anxiety; Bacterial Infections; Cancer - Breast; Cancer; Diabetes; Fungal Infections; IBD - Inflammatory Bowel Disease; Inflammation; Oxidative Stress; Psychosis
2017057,Dermatological aspects of synthetic cannabinoid addiction,https://pubmed.ncbi.nlm.nih.gov/27028361/,Negative,,Clinical Trial,2017,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis; Acne; Addiction - Nicotine; Addiction - Opioid; Hair Loss; Skin Diseases
2017058,Recent advances in the endocrinology of the sebaceous gland,https://www.tandfonline.com/doi/full/10.1080/19381980.2017.1361576,Positive,,Meta-analysis,2017,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Cannabidivarin (CBDV); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Cannabichromene (CBC); Cannabigerol (CBG),,Bacterial Infections; Inflammation; Pain; Pain - Acute; Skin Diseases
2022309,Pharmacokinetics of cannabichromene in a medical cannabis product also containing cannabidiol and Δ9-tetrahydrocannabinol: a pilot study,https://link.springer.com/article/10.1007/s00228-021-03232-8,Positive,,Double Blind Clinical Trial,2022,Cannabichromene (CBC); Monoacylglycerol Lipase (MAGL); Tetrahydrocannabinol (THC),,Depression; Epilepsy; Inflammation; Pain; Neurodegenerative Issues
2019074,Can we teach old drugs new tricks?-Repurposing of neuropharmacological drugs for inflammatory skin diseases,https://onlinelibrary.wiley.com/doi/10.1111/exd.13987,Positive,,Meta-analysis,2019,,Integumentary System; Nervous System,Inflammation; Skin Diseases; Acne; Addiction - Alcohol; Addiction - Opioid; Allergic Contact Dermatitis; Depression; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Hyperthyroidism and Graves' Disease; Hepatitis; Irritable Bowel Syndrome; Kidney Failure; Liver Failure; Multiple Sclerosis; Psoriasis; Wound Healing
2019075,The growing trend of cannabidiol in skincare products,https://www.sciencedirect.com/science/article/abs/pii/S0738081X18302475?via%3Dihub,Positive,,Meta-analysis,2019,,Integumentary System,Skin Diseases; Acne; Eczema; Geriatric Conditions; Inflammation; Longevity; Pain; Pruritis; Psoriasis
2020170,Cannabinoids in Dermatology: Hope or Hype?,https://pubmed.ncbi.nlm.nih.gov/33381641/,Positive,,Meta-analysis,2020,,Integumentary System,Skin Diseases; Acne; Allergic Contact Dermatitis; Eczema; Inflammation; Pruritis
2021197,Pharmacokinetics and Perceptions of Children and Young Adults Using Cannabis for Attention-Deficit/Hyperactivity Disorder and Oppositional Defiant Disorder: Protocol for a Mixed Methods Proof-of-Concept Study,https://pubmed.ncbi.nlm.nih.gov/34661540/,Positive,,Meta-analysis,2021,Cannabichromene (CBC),Mental/Emotional System; Nervous System,ADD and ADHD; Behavioral Disorders; Anxiety; Depression
2022310,Inhibitory Effects of Cannabinoids on Acetylcholinesterase and Butyrylcholinesterase Enzyme Activities,https://www.karger.com/Article/FullText/524086,Inconclusive,,Laboratory Study,2022,Cannabichromene (CBC); Cannabidivarin (CBDV); Cannabigerol (CBG); Cannabigerolic Acid (CBG-a); Cannabinol (CBN); Delta-8-THC,,
2022311,Synthetic Strategies for Rare Cannabinoids Derived from Cannabis sativa,https://pubs.acs.org/doi/10.1021/acs.jnatprod.2c00155,Inconclusive,,Laboratory Study,2022,Cannabichromene (CBC); Cannabigerol (CBG); Delta-8-THC; Tetrahydrocannabinolic Acid (THC-a),,
2022312,Effects of Rare Phytocannabinoids on the Endocannabinoid System of Human Keratinocytes,https://www.mdpi.com/1422-0067/23/10/5430,Positive,,Laboratory Study,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Cannabichromene (CBC); Cannabigerol (CBG); Cannabigerolic Acid (CBG-a); Palmitoylethanolamide (PEA); Tetrahydrocannabivarin (THCV); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),,Skin Diseases
2022313,Dynamic Changes in the Endocannabinoid System during the Aging Process: Focus on the Middle-Age Crisis,https://www.mdpi.com/1422-0067/23/18/10254,Positive,,Animal Study,2022,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Integumentary System,Longevity
2022314,Phytocannabinoid Compositions from Cannabis Act Synergistically with PARP1 Inhibitor against Ovarian Cancer Cells In Vitro and Affect the Wnt Signaling Pathway,https://www.mdpi.com/1420-3049/27/21/7523,Positive,,Laboratory Study,2022,Cannabichromene (CBC); Cannabigerol (CBG); Tetrahydrocannabinol (THC); Cannabinol (CBN),Reproductive System,Cancer - Ovarian; Cancer; Cancer - Cervical; Cancer - Uterine
2022315,Industrial Hemp ( Cannabis sativa L.) Inflorescences as Novel Food: The Effect of Different Agronomical Practices on Chemical Profile,https://www.mdpi.com/2304-8158/11/22/3658,Inconclusive,,Laboratory Study,2022,Cannabichromene (CBC); Cannabigerol (CBG); Cannabidivarin (CBDV); Cannabinol (CBN); Delta-8-THC; Tetrahydrocannabinolic Acid (THC-a),,
2022316,Profiling Cannabinoid Contents and Expression Levels of Corresponding Biosynthetic Genes in Commercial Cannabis (Cannabis sativa L.) Cultivars,https://www.mdpi.com/2223-7747/11/22/3088,Inconclusive,,Laboratory Study,2022,Cannabichromene (CBC); Cannabichromenic Acid (CBC-a); Cannabidiolic Acid (CBD-a); Cannabidivarin (CBDV); Cannabigerol (CBG); Cannabigerolic Acid (CBG-a); Cannabinol (CBN); Delta-8-THC; Tetrahydrocannabivarin (THCV); Tetrahydrocannabinol (THC); Tetrahydrocannabinolic Acid (THC-a),,
2022317,In Silico Binding Analysis of Cannabinoids with Eph Receptors for Therapeutic Use in Gliomas,https://pubmed.ncbi.nlm.nih.gov/36468933/,Positive,,Laboratory Study,2022,Cannabichromene (CBC); Cannabidivarin (CBDV),,Cancer - Brain; Cancer
2019076,What's new in the management of acne vulgaris,https://pubmed.ncbi.nlm.nih.gov/31487336/#affiliation-1,Positive,,Meta-analysis,2019,,Integumentary System,Acne
2022318,Current Cannabidiol Safety: A Review,https://pubmed.ncbi.nlm.nih.gov/36056846/,Positive,,Meta-analysis,2022,,Mental/Emotional System,Cannabis Adverse Effects; Acne; Anxiety; Cancer - Lung; Cancer - Oral; Cancer - Squamous Head/Neck; Cancer; Epilepsy; Infertility (Female); Inflammation; Pain; Pain - Acute; Pain - Chronic; Pain - Inflammatory
2022319,"Interactions of Noradrenergic, Glucocorticoid and Endocannabinoid Systems Intensify and Generalize Fear Memory Traces",https://www.sciencedirect.com/science/article/abs/pii/S0306452221004796?via%3Dihub,Negative,,Animal Study,2022,AM-x Synthetic Cannabinoids; Endocannabinoid (unspecified),Mental/Emotional System,PTSD
2022320,Biomarkers and treatments for mood disorders encompassing the neurosteroid and endocannabinoid systems,https://pubmed.ncbi.nlm.nih.gov/36625096/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified); Palmitoylethanolamide (PEA),,Anxiety; Bipolar Disorder; Depression; Pregnancy; PTSD; Suicide Attempt
2022321,In it together? The case for endocannabinoid–noradrenergic interactions in fear extinction,https://onlinelibrary.wiley.com/doi/10.1111/ejn.15200,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); CP-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Mental/Emotional System,PTSD; Behavioral Disorders; Anxiety
2022322,Potential Utility of Cannabidiol in Stress-Related Disorders,https://pubmed.ncbi.nlm.nih.gov/36409719/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,PTSD; Behavioral Disorders; Anxiety
2022323,Translation of animal endocannabinoid models of PTSD mechanisms to humans: Where to next?,https://www.sciencedirect.com/science/article/abs/pii/S0149763421005340?via%3Dihub,Positive,,Meta-analysis,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Mental/Emotional System; Nervous System,PTSD
2022324,Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments,https://www.sciencedirect.com/science/article/abs/pii/S0028390821004706?via%3Dihub,Positive,,Animal Study,2022,AM-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,PTSD
2022325,Comparison between cannabidiol and sertraline for the modulation of post-traumatic stress disorder-like behaviors and fear memory in mice,https://pubmed.ncbi.nlm.nih.gov/35396940/,Positive,,Animal Study,2022,,Mental/Emotional System,PTSD
2021198,The Current and Potential Application of Medicinal Cannabis Products in Dentistry,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466648/,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified); AM-x Synthetic Cannabinoids; Anandamide (AEA); Cannabichromene (CBC); Cannabidivarin (CBDV); Cannabigerol (CBG); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Palmitoylethanolamide (PEA); Tetrahydrocannabivarin (THCV); Pharma THC; WIN-x Synthetic Cannabinoids,Digestive System; Integumentary System,Cavities; Periodontal Disease; Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Nicotine; Addiction - Opioid; Anxiety; Bacterial Infections; Cancer - Metastatic; Cancer - Squamous Head/Neck; Cancer; Cardiovascular Diseases (CVD); Depression; HIV/AIDS; Inflammation; Pain; Neurodegenerative Issues; Obesity; Pain - Acute; Pain - Dental - Acute
2023355,Alteration of faecal microbiota balance related to long-term deep meditation,https://gpsych.bmj.com/content/36/1/e100893,Positive,,Clinical Trial,2023,Mind-Body Medicine,,Anxiety; Cardiovascular Diseases (CVD); Depression; Irritable Bowel Syndrome
2007017,Cannabinoids ameliorate cerebral dysfunction following liver failure via AMP-activated protein kinase,https://faseb.onlinelibrary.wiley.com/doi/epdf/10.1096/fj.06-7705com,Inconclusive,,Animal Study,2007,Endocannabinoid (unspecified); SR-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC),Digestive System; Nervous System,Encephalitis and Myelitis; Liver Failure
2007018,"HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor",https://aacrjournals.org/mct/article/6/1/173/235180/HU-331-a-novel-cannabinoid-based-anticancer,Positive,,Animal Study,2007,HU-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Nervous System,Cancer; Cancer - Colon; Cancer - Brain; Cancer - Breast; Oxidative Stress
2016068,"Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects",https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0158779&type=printable,Positive,,Animal Study,2016,HU-x Synthetic Cannabinoids; AM-x Synthetic Cannabinoids,Mental/Emotional System,Anxiety; Depression; Psychosis; OCD; Schizophrenia
2019077,The Endocannabinoid System of Animals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770351/,Positive,,Meta-analysis,2019,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Cannabichromene (CBC); Cannabigerol (CBG); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),,Alzheimer's Disease; Anxiety; Arthritis - Rheumatoid; Arthritis; Cancer - Brain; Cancer - Breast; Cancer - Lung; Cancer - Metastatic; Cancer; Cardiac Arrhythmias; Cardiovascular Diseases (CVD); COPD; Fibromyalgia; IBD - Inflammatory Bowel Disease; Hepatitis; Hypertension (High Blood Pressure); Inflammation; Irritable Bowel Syndrome; Migraine; Pain
2022326,Effects of Omega-3 Supplementation on Components of the Endocannabinoid System and Metabolic and Inflammatory Responses in Adipose and Liver of Peripartum Dairy Cows,https://assets.researchsquare.com/files/rs-1481439/v1/d98d26fa-3de1-4cb1-9e9a-a42e406f89e6.pdf?c=1648673538,Inconclusive,,Animal Study,2022,Omega-3; Anandamide (AEA); Other Related Compounds,,Inflammation; Obesity
2022327,Omega 3 Fatty Acid and Cannabidiol Prolong Lifespan and Ameliorates Brain Ischaemia in Mice Fed Chronic High Fat Diet,https://www.scirp.org/journal/paperinformation.aspx?paperid=118370,Positive,,Animal Study,2022,Omega-3,Integumentary System,Longevity; Inflammation; Obesity; Oxidative Stress; Stroke
2022328,Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650335/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Cannabichromene (CBC); Cannabidivarin (CBDV); Cannabigerol (CBG); CP-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); N-Arachidonoyl Dopamine (NADA); Palmitoylethanolamide (PEA); WIN-x Synthetic Cannabinoids,Digestive System; Nervous System,IBD - Inflammatory Bowel Disease; Inflammation; IBD - Crohn's Disease; Irritable Bowel Syndrome; Nausea and Vomiting
2022329,Protective Effects of Cannabidiol on Chemotherapy-Induced Oral Mucositis via the Nrf2/Keap1/ARE Signaling Pathways,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165619/,Positive,,Animal Study,2022,,Nervous System,Cancer; Alzheimer's Disease; Cardiovascular Diseases (CVD); Epilepsy; Inflammation; Loss of Appetite; Oxidative Stress; Parkinson's Disease; Reperfusion Injury; Skin Diseases
2022330,"Endocannabinoids and aging-Inflammation, neuroplasticity, mood and pain",https://www.sciencedirect.com/science/article/abs/pii/S0083672920300558?via%3Dihub,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified),Muscular System; Nervous System; Skeletal System,Geriatric Conditions; Oxidative Stress; Longevity; Metabolic Syndrome
2022331,"The Nose Knows: Aroma, but Not THC Mediates the Subjective Effects of Smoked and Vaporized Cannabis Flower",https://www.mdpi.com/2813-1851/1/2/8,Positive,,Clinical Trial,2022,,,Addiction - Cannabis; Cannabis Hyperemesis Syndrome; Inflammation; Pain; Oxidative Stress
2022332,Potential Implications of Rimonabant on Age-Related Oxidative Stress and Inflammation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773212/,Positive,,Animal Study,2022,Synthetic Cannabinoid (unspecified),Nervous System,Inflammation; Oxidative Stress; Cardiovascular Diseases (CVD)
2014049,"Serum pentadecanoic acid (15:0), a short-term marker of dairy food intake, is inversely associated with incident type 2 diabetes and its underlying disorders",https://academic.oup.com/ajcn/article/100/6/1532/4576600,Positive,,Meta-analysis,2014,Pentadecanoic acid (C15:0),Endocrine System,Diabetes; Atherosclerosis; Cardiovascular Diseases (CVD)
2014050,Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196248/,Positive,,Meta-analysis,2014,Pentadecanoic acid (C15:0),Endocrine System,Diabetes; Metabolic Syndrome
2007019,Fatty acid profile of the erythrocyte membrane preceding development of Type 2 diabetes mellitus,https://pubmed.ncbi.nlm.nih.gov/18042359/,Positive,,Laboratory Study,2007,Pentadecanoic acid (C15:0),Endocrine System,Diabetes; Metabolic Syndrome
2018075,A prospective and longitudinal study of plasma phospholipid saturated fatty acid profile in relation to cardiometabolic biomarkers and the risk of gestational diabetes,https://academic.oup.com/ajcn/article/107/6/1017/5032658,Positive,,Meta-analysis,2018,Pentadecanoic acid (C15:0),Endocrine System; Reproductive System,Diabetes; Metabolic Syndrome; Pregnancy
2002009,Δ9-Tetrahydrocannabinol and Cannabinol Activate Capsaicin-Sensitive Sensory Nerves via a CB1 and CB2 Cannabinoid Receptor-Independent Mechanism,https://www.jneurosci.org/content/22/11/4720,Positive,,Laboratory Study,2002,Cannabinol (CBN); Capsaicin (CAPS); Tetrahydrocannabinol (THC),Nervous System,Pain
2016069,Spatial Distribution of the Cannabinoid Type 1 and Capsaicin Receptors May Contribute to the Complexity of Their Crosstalk,https://www.nature.com/articles/srep33307,Positive,,Laboratory Study,2016,Anandamide (AEA); Capsaicin (CAPS); Fatty Acid Amide Hydrolase (FAAH),,
2008034,The nonpsychoactive Cannabis constituent cannabidiol is a wake-inducing agent,https://pubmed.ncbi.nlm.nih.gov/19045957/,Positive,,Animal Study,2008,,Nervous System,Insomnia and Sleep Disorders
2015077,Palmitoyl Serine: An Endogenous Neuroprotective Endocannabinoid-Like Entity After Traumatic Brain Injury,https://pubmed.ncbi.nlm.nih.gov/25721934/,Positive,,Animal Study,2015,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Fatty Acid Amide Hydrolase (FAAH); Palmitoylethanolamide (PEA),Nervous System,Traumatic Brain Injury
2021199,Does cannabis use in adolescence predict self‐harm or suicide? Results from a Finnish Birth Cohort Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299098/,Negative,,Meta-analysis,2021,,Mental/Emotional System,Behavioral Disorders; Suicide Attempt; Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Cannabis Adverse Effects; Psychosis
2022333,Cannabinoids as Glial Cell Modulators in Ischemic Stroke: Implications for Neuroprotection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199389/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Palmitoylethanolamide (PEA); SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,,Inflammation; Stroke; Addiction - Nicotine; Atherosclerosis; Atrial Fibrillation; Bacterial Infections; Cancer; Cardiovascular Diseases (CVD); Dementia; Hypertension (High Blood Pressure); Metabolic Syndrome; Obesity; Oxidative Stress
2022334,Δ9-Tetrahydrocannabinol (Δ9-THC) Improves Ischemia/Reperfusion Heart Dysfunction and Might Serve as a Cardioprotective Agent in the Future Treatment,https://pubmed.ncbi.nlm.nih.gov/35468673/,Positive,,Animal Study,2022,Tetrahydrocannabinol (THC),Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack; Reperfusion Injury; Inflammation; Oxidative Stress; Stroke
2020171,The Endocannabinoid System May Modulate Sleep Disorders in Aging,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324886/,Inconclusive,,Meta-analysis,2020,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Other Related Compounds; Palmitoylethanolamide (PEA); SR-x Synthetic Cannabinoids,Muscular System; Nervous System; Skeletal System,Geriatric Conditions; Insomnia and Sleep Disorders; Alzheimer's Disease; Anxiety; Cardiovascular Diseases (CVD); Depression; Epilepsy; Neurodegenerative Issues; Osteoporosis; Parkinson's Disease; Schizophrenia
2014051,"Dairy fat intake is associated with glucose tolerance, hepatic and systemic insulin sensitivity, and liver fat but not β-cell function in humans",https://academic.oup.com/ajcn/article/99/6/1385/4577423,Positive,,Meta-analysis,2014,Pentadecanoic acid (C15:0),Endocrine System,Diabetes; Fatty Liver Disease; Metabolic Syndrome
2021200,"Associations of Serum Fatty Acid Proportions with Obesity, Insulin Resistance, Blood Pressure, and Fatty Liver: The Cardiovascular Risk in Young Finns Study",https://academic.oup.com/jn/article/151/4/970/6131873,Positive,,Meta-analysis,2021,Pentadecanoic acid (C15:0),Cardiovascular System; Digestive System; Endocrine System,Cardiovascular Diseases (CVD); Fatty Liver Disease; Hypertension (High Blood Pressure); Metabolic Syndrome; Obesity; Atherosclerosis; Diabetes
2022335,The endocannabinoid anandamide is an airway relaxant in health and disease,https://www.nature.com/articles/s41467-022-34327-0,Positive,,Animal Study,2022,Anandamide (AEA),Respiratory System,Asthma; COPD
2009031,Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats,https://pubmed.ncbi.nlm.nih.gov/19549757/,Positive,,Animal Study,2009,Omega-3; 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Endocrine System,Obesity; Diabetes; Metabolic Syndrome
2016070,Distinctive effects of eicosapentaenoic and docosahexaenoic acids in regulating neural stem cell fate are mediated via endocannabinoid signalling pathways,https://pubmed.ncbi.nlm.nih.gov/27044662/,Inconclusive,,Animal Study,2016,2-Arachidonoyl Glycerol (2-AG); Omega-3,,Neurodegenerative Issues; Stroke
2021201,Maternal omega-3 intake differentially affects the endocannabinoid system in the progeny`s neocortex and hippocampus: Impact on synaptic markers,https://pubmed.ncbi.nlm.nih.gov/34038760/,Inconclusive,,Animal Study,2021,Omega-3,Reproductive System,Pregnancy
2017059,Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer's Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway,https://link.springer.com/article/10.1007/s12035-017-0676-2,Positive,,Animal Study,2017,Endocannabinoid (unspecified),Nervous System,Alzheimer's Disease; Neurodegenerative Issues
2017060,Polyunsaturated Fatty Acids Differentially Modulate Cell Proliferation and Endocannabinoid System in Two Human Cancer Lines,https://pubmed.ncbi.nlm.nih.gov/28577869/,Positive,,Laboratory Study,2017,Omega-3; Omega-6,Nervous System; Reproductive System,Cancer - Brain; Cancer - Breast; Cancer
2013041,Impact of omega-6 polyunsaturated fatty acid supplementation and γ-aminobutyric acid on astrogliogenesis through the endocannabinoid system,https://pubmed.ncbi.nlm.nih.gov/23633391/,Positive,,Laboratory Study,2013,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Omega-6; Monoacylglycerol Lipase (MAGL); AM-x Synthetic Cannabinoids,,
2003006,Exercise activates the endocannabinoid system,https://pubmed.ncbi.nlm.nih.gov/14625449/,Positive,,Meta-analysis,2003,Exercise; Endocannabinoid (unspecified),,Pain; Pain - Acute
2022336,Exercise-induced increases in Anandamide and BDNF during extinction consolidation contribute to reduced threat following reinstatement: Preliminary evidence from a randomized controlled trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487992/,Positive,,Clinical Trial,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Exercise,Mental/Emotional System,PTSD
2013042,Chronic treatment with krill powder reduces plasma triglyceride and anandamide levels in mildly obese men,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680309/,Positive,,Clinical Trial,2013,Omega-3,Endocrine System,Obesity
2022337,Oxytocin acts centrally in the brain to improve leaky gut through the vagus nerve and a cannabinoid signaling in rats,https://www.sciencedirect.com/science/article/abs/pii/S0031938422002207?via%3Dihub,Positive,,Animal Study,2022,Endocannabinoid (unspecified),,Autism; Gastroparesis; Irritable Bowel Syndrome
2019078,Dietary intake of fatty acids and its relationship with FEV1/FVC in patients with chronic obstructive pulmonary disease,https://pubmed.ncbi.nlm.nih.gov/30661707/,Positive,,Meta-analysis,2019,Pentadecanoic acid (C15:0),Respiratory System,COPD; Inflammation
2020172,Capsaicin Is a Negative Allosteric Modulator of the 5-HT3 Receptor,https://www.frontiersin.org/articles/10.3389/fphar.2020.01274/full,Positive,,Laboratory Study,2020,Capsaicin (CAPS),,Anxiety; Chemotherapy-induced Nausea & Vomiting; Depression; Irritable Bowel Syndrome; Pain; Schizophrenia
2020173,GPR6 Structural Insights: Homology Model Construction and Docking Studies,https://www.mdpi.com/1420-3049/25/3/725,Positive,,Meta-analysis,2020,Endocannabinoid (unspecified),,Alzheimer's Disease; Huntington's Disease; Neurodegenerative Issues; Parkinson's Disease
2020174,Role of the endocannabinoid system in the regulation of the skeletal muscle response to exercise,https://www.sciencedirect.com/science/article/pii/S1471489220300229?via%3Dihub,Positive,,Meta-analysis,2020,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Exercise; Fatty Acid Amide Hydrolase (FAAH),,Diabetes; Metabolic Syndrome; Obesity
2021202,Endocannabinoids and Heart Rate Variability Alterations after Exposure to Prolonged Intensive Physical Exercise of the Hellenic Navy SEALs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750887/,Positive,,Clinical Trial,2021,Anandamide (AEA); Exercise; Other Related Compounds; Palmitoylethanolamide (PEA); 2-Arachidonoyl Glycerol (2-AG),,Oxidative Stress
2004016,Endocannabinoids and exercise,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1724924/pdf/v038p00536.pdf,Positive,,Meta-analysis,2004,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Exercise,,
2021203,"Caloric restriction, physical exercise, and CB1 receptor blockade as an efficient combined strategy for bodyweight control and cardiometabolic status improvement in male rats",https://www.nature.com/articles/s41598-021-83709-9#citeas,Positive,,Animal Study,2021,AM-x Synthetic Cannabinoids; Exercise,Endocrine System,Metabolic Syndrome; Cardiovascular Diseases (CVD); Diabetes; Obesity
2020175,Can Physical Activity Support the Endocannabinoid System in the Preventive and Therapeutic Approach to Neurological Disorders?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352563/,Negative,,Meta-analysis,2020,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Exercise,Nervous System,Neurodegenerative Issues; Alzheimer's Disease; Depression
2022338,Urinary Cannabis Metabolite Concentrations in Cannabis Hyperemesis Syndrome,https://pubmed.ncbi.nlm.nih.gov/34224490/,Negative,,Meta-analysis,2022,,Digestive System; Nervous System,Cannabis Hyperemesis Syndrome; Nausea and Vomiting; Cannabis Adverse Effects; IBD - Crohn's Disease; Irritable Bowel Syndrome
2022339,Implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: A literature review,https://www.sciencedirect.com/science/article/abs/pii/S009130572200171X,Positive,,Meta-analysis,2022,,Mental/Emotional System,Autism; Behavioral Disorders; Anxiety; Cognitive Dysfunction; Insomnia and Sleep Disorders
2007020,The Cannabinoid Delta-9-tetrahydrocannabinol Mediates Inhibition of Macrophage Chemotaxis to RANTES/CCL5 through the CB2 Receptor,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2677557/,Positive,,Animal Study,2007,CP-x Synthetic Cannabinoids; O-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC),Nervous System,Inflammation; Oxidative Stress
2010042,Cannabinoid Inhibition of Macrophage Migration to the Trans-Activating (Tat) Protein of HIV-1 Is Linked to the CB2 Cannabinoid Receptor,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846023/,Positive,,Laboratory Study,2010,Endocannabinoid (unspecified); O-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Immune System; Nervous System,HIV/AIDS; Prion Disease
2014052,"The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042856/,Inconclusive,,Animal Study,2014,Endocannabinoid (unspecified); O-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Addiction - Nicotine; Addiction; Addiction - Cocaine; Behavioral Disorders; Pain
2022340,Recent Advances on Type-2 Cannabinoid (CB2) Receptor Agonists and Their Therapeutic Potential,https://pubmed.ncbi.nlm.nih.gov/36028971/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified),,
1968001,"Cannabichromenic Acid, a Genuine Substance of Cannabichromene",https://www.jstage.jst.go.jp/article/cpb1958/16/6/16_6_1157/_article,Inconclusive,,Laboratory Study,1968,Cannabichromenic Acid (CBC-a),,
2012061,The l-α-Lysophosphatidylinositol/GPR55 System and Its Potential Role in Human Obesity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266411/,Positive,,Clinical Trial,2012,Endocannabinoid (unspecified); Lysophosphatidylinositol (LPI),Endocrine System,Obesity; Diabetes; Metabolic Syndrome
2020176,Imbalance of Endocannabinoid/Lysophosphatidylinositol Receptors Marks the Severity of Alzheimer’s Disease in a Preclinical Model: A Therapeutic Opportunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694492/,Positive,,Animal Study,2020,Endocannabinoid (unspecified); Lysophosphatidylinositol (LPI); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); JWH-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL),Nervous System,Alzheimer's Disease; Behavioral Disorders; Anxiety; Cognitive Dysfunction; Dementia; Inflammation; Neurodegenerative Issues
2022341,A Systematic Review and Meta-Analysis on the Effects of Exercise on the Endocannabinoid System,https://pubmed.ncbi.nlm.nih.gov/34870469/,Positive,,Meta-analysis,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Exercise,,Anxiety; Depression; Pain; Pain - Chronic
2020177,Endocannabinoids release after Osteopathic Manipulative Treatment. A brief review,https://pubmed.ncbi.nlm.nih.gov/32554836/,Positive,,Meta-analysis,2020,Mind-Body Medicine; Endocannabinoid (unspecified),,Pain; Pain - Chronic
2007021,Identification of GPR55 as a lysophosphatidylinositol receptor,https://www.sciencedirect.com/science/article/abs/pii/S0006291X07017974?via%3Dihub,Positive,,Laboratory Study,2007,Endocannabinoid (unspecified); Lysophosphatidylinositol (LPI),,
2011047,Minireview: Recent Developments in the Physiology and Pathology of the Lysophosphatidylinositol-Sensitive Receptor GPR55,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417173/,Positive,,Meta-analysis,2011,Endocannabinoid (unspecified); Lysophosphatidylinositol (LPI); Abnormal Cannabidiol (Abn-CBD); AM-x Synthetic Cannabinoids; Anandamide (AEA); O-x Synthetic Cannabinoids; Palmitoylethanolamide (PEA); Pharma THC; WIN-x Synthetic Cannabinoids,,Arthritis - Osteoarthritis; Arthritis; Asthma; Cancer - Brain; Cancer - Breast; Cancer - Cervical; Cancer - Leukemia; Cancer - Liver; Cancer - Lymphoma; Cancer - Myeloma; Cancer - Ovarian; Cancer - Pancreatic; Cancer - Prostate; Cancer - Skin (Non-melanoma); Cancer; Cardiovascular Diseases (CVD); Diabetes; Diabetic Kidney Disease; Inflammation; Pain
2021204,Novel Knowledge-Based Transcriptomic Profiling of Lipid Lysophosphatidylinositol-Induced Endothelial Cell Activation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668339/,Positive,,Laboratory Study,2021,Lysophosphatidylinositol (LPI); Endocannabinoid (unspecified),Cardiovascular System; Nervous System,Atherosclerosis; Cardiovascular Diseases (CVD); Inflammation; Heart Attack; Stroke
1984003,Synthesis and pharmacological activity of some 9-substituted .DELTA.8-tetrahydrocannabinol (THC) analogs,https://pubmed.ncbi.nlm.nih.gov/6323713/,Positive,,Animal Study,1984,Delta-8-THC; Tetrahydrocannabinol (THC),,Pain
1991001,"Synthesis and pharmacological evaluation of ether and related analogues of delta 8-, delta 9-, and delta 9,11-tetrahydrocannabinol",https://pubs.acs.org/doi/abs/10.1021/jm00115a023,Positive,,Animal Study,1991,Delta-8-THC; Tetrahydrocannabinol (THC),,
2022342,Do Endocannabinoids Cause the Runner’s High? Evidence and Open Questions,https://journals.sagepub.com/doi/full/10.1177/10738584211069981,Inconclusive,,Meta-analysis,2022,Anandamide (AEA); Exercise,,Anxiety; Pain; Pain - Acute
2015078,A runner’s high depends on cannabinoid receptors in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620874/,Positive,,Animal Study,2015,Anandamide (AEA); Exercise; Fatty Acid Amide Hydrolase (FAAH),,Anxiety; Pain; Pain - Acute
2003007,"Structure-activity relationships for 1',1'-dimethylalkyl-Delta8-tetrahydrocannabinols",https://pubmed.ncbi.nlm.nih.gov/12628666/,Inconclusive,,Animal Study,2003,Delta-8-THC,,
1993001,Pharmacological evaluation of iodo and nitro analogs of delta 8-THC and delta 9-THC,https://pubmed.ncbi.nlm.nih.gov/8265683/,Inconclusive,,Animal Study,1993,Delta-8-THC; CP-x Synthetic Cannabinoids,,
1991002,Pharmacological evaluation of halogenated delta 8-THC analogs,https://pubmed.ncbi.nlm.nih.gov/1666915/,Inconclusive,,Animal Study,1991,Delta-8-THC,,
1971001,Activity of delta8- and delta9-tetrahydrocannabinol and related compounds in the mouse,https://pubmed.ncbi.nlm.nih.gov/5547729/,Inconclusive,,Animal Study,1971,Delta-8-THC; Tetrahydrocannabinol (THC),,
1973001,Comparative Studies in Man and in Laboratory Animals on ▵8- and ▵9-trans-Tetrahydrocannabinol,https://www.karger.com/Article/Abstract/136375,Inconclusive,,Animal Study,1973,Delta-8-THC; Tetrahydrocannabinol (THC),,
1973002,Delta-8- and delta-9-tetrahydrocannabinol; Comparison in man by oral and intravenous administration,https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt1973143353,Inconclusive,,Meta-analysis,1973,Delta-8-THC; Tetrahydrocannabinol (THC),,
2021205,"Δ8-THC: Legal Status, Widespread Availability, and Safety Concerns",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664123/,Negative,,Meta-analysis,2021,Delta-8-THC; Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2021206,"Consumer Experiences with Delta-8-THC: Medical Use, Pharmaceutical Substitution, and Comparisons with Delta-9-THC",https://pubmed.ncbi.nlm.nih.gov/34797727/,Positive,,Meta-analysis,2021,Delta-8-THC,,Anxiety; Bipolar Disorder; Depression; Pain; Pain - Chronic
1975001,The relaxation response: psychophysiologic aspects and clinical applications,https://pubmed.ncbi.nlm.nih.gov/773864/,Positive,,Meta-analysis,1975,Mind-Body Medicine,Mental/Emotional System,
2008035,Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus,https://pubmed.ncbi.nlm.nih.gov/18058925/,Inconclusive,,Animal Study,2008,Mind-Body Medicine,,
1976001,"Comparison of altered states of consciousness induced by the hallucinogens (--)-delta9-trans-tetrahydrocannabinol (delta9-THC) and N,N-dimethyltryptamine (DMT)",https://pubmed.ncbi.nlm.nih.gov/1070948/,Inconclusive,,Clinical Trial,1976,Mind-Body Medicine,,Cannabis Adverse Effects
2022343,The altered state of consciousness induced by Δ9-THC,https://pubmed.ncbi.nlm.nih.gov/35640529/,Positive,,Clinical Trial,2022,Mind-Body Medicine,,
2021207,Confirming Savoring's Link to Fewer Cannabis Problems,https://pubmed.ncbi.nlm.nih.gov/33225860/,Positive,,Meta-analysis,2021,Mind-Body Medicine,,Addiction - Cannabis; Cannabis Adverse Effects
2020178,Savoring Moderates the Link between Marijuana Use and Marijuana Problems,https://pubmed.ncbi.nlm.nih.gov/31552772/,Positive,,Meta-analysis,2020,Mind-Body Medicine,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2020179,Cannabis as entheogen: survey and interview data on the spiritual use of cannabis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819316/,Positive,,Meta-analysis,2020,Mind-Body Medicine,,
2022344,Spiritual Benefit from Cannabis,https://pubmed.ncbi.nlm.nih.gov/34225558/,Positive,,Meta-analysis,2022,Mind-Body Medicine,,
2017061,Anti-inflammatory ω-3 endocannabinoid epoxides,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544256/,Positive,,Meta-analysis,2017,Omega-3; Anandamide (AEA),Nervous System,Inflammation
2016071,Dietary Omega-6/Omega-3 and Endocannabinoids: Implications for Brain Health and Diseases,https://www.intechopen.com/chapters/50397,Positive,,Meta-analysis,2016,Omega-3; Omega-6,Nervous System,Neurodegenerative Issues; Anxiety; Depression
2012062,Nutritional n-3 polyunsaturated fatty acids deficiency alters cannabinoid receptor signaling pathway in the brain and associated anxiety-like behavior in mice,https://pubmed.ncbi.nlm.nih.gov/22707188/,Positive,,Animal Study,2012,Omega-3; Other Related Compounds,Mental/Emotional System; Nervous System,Anxiety
2007022,Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies,https://pubmed.ncbi.nlm.nih.gov/18037281/,Positive,,Meta-analysis,2007,Omega-3,Nervous System,Neurodegenerative Issues; Alzheimer's Disease; Parkinson's Disease
2022345,Phytocannabinoids regulate inflammation in IL-1β-stimulated human gingival fibroblasts,https://pubmed.ncbi.nlm.nih.gov/36070347/,Positive,,Laboratory Study,2022,Cannabidivarin (CBDV); Cannabigerol (CBG); Endocannabinoid (unspecified),Digestive System,Periodontal Disease; Inflammation; Pain; Pain - Dental - Acute
2022346,The Cytotoxic Effects of Cannabidiol and Cannabigerol on Glioblastoma Stem Cells May Mostly Involve GPR55 and TRPV1 Signalling,https://www.mdpi.com/2072-6694/14/23/5918,Positive,,Laboratory Study,2022,Cannabigerol (CBG),,Cancer - Brain; Cancer
2022347,Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666035/,Positive,,Meta-analysis,2022,Cannabigerolic Acid (CBG-a); Synthetic Cannabinoid (unspecified); Anandamide (AEA); Cannabichromene (CBC); Cannabigerol (CBG); Cannabinol (CBN); Delta-8-THC; Endocannabinoid (unspecified); JWH-x Synthetic Cannabinoids,,Anorexia; Anxiety; Cancer; Glaucoma; IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Inflammation; Pain; Multiple Sclerosis; Nausea and Vomiting; Neurodegenerative Issues; Oxidative Stress; Pain - Eye; Prion Disease; Skin Diseases; Wound Healing; Urinary Incontinence
2016072,A CB2-Selective Cannabinoid Suppresses T-cell Activities and Increases Tregs and IL-10,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528965/,Positive,,Laboratory Study,2016,O-x Synthetic Cannabinoids; Endocannabinoid (unspecified),Immune System,Organ Transplant Failure; IBD - Inflammatory Bowel Disease; Inflammation; Multiple Sclerosis; Osteoporosis; Spinal Cord Injuries; Stroke; Systemic Sclerosis; Wound Healing
2021208,A Cannabinoid 2-Selective Agonist Inhibits Allogeneic Skin Graft Rejection In Vivo,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850832/,Positive,,Animal Study,2021,O-x Synthetic Cannabinoids; 2-Arachidonoyl Glycerol (2-AG); Endocannabinoid (unspecified),Immune System; Integumentary System; Nervous System,Organ Transplant Failure; Wound Healing; COVID-19; IBD - Inflammatory Bowel Disease; Hepatitis; HIV/AIDS; Inflammation
2009032,Caffeine drinking potentiates cannabinoid transmission in the striatum: interaction with stress effects,https://pubmed.ncbi.nlm.nih.gov/19027757/,Positive,,Animal Study,2009,Endocannabinoid (unspecified); Mind-Body Medicine,Mental/Emotional System,
2014053,Increase in the Number of CB1 Immunopositive Neurons in the Amygdaloid Body after Acute Cold Stress Exposure,https://www.researchgate.net/publication/272355424_INCREASE_IN_THE_NUMBER_OF_CB1_IMMUNOPOSITIVE_NEURONS_IN_THE_AMYGDALOID_BODY_AFTER_ACUTE_COLD_STRESS_EXPOSURE,Positive,,Animal Study,2014,Mind-Body Medicine,,
2016073,Endocannabinoid regulation in white and brown adipose tissue following thermogenic activation,https://www.jlr.org/article/S0022-2275(20)35445-6/fulltext#%20,Inconclusive,,Animal Study,2016,Cold Exposure; Endocannabinoid (unspecified),,Diabetes; Metabolic Syndrome; Obesity
2014054,"The endocannabinoid system modulates stress, emotionality, and inflammation",https://www.sciencedirect.com/science/article/abs/pii/S088915911400172X?via%3Dihub,Positive,,Meta-analysis,2014,,Mental/Emotional System; Nervous System,Inflammation
2003008,Endocannabinoids as autoregulatory signaling molecules: coupling to nitric oxide and a possible association with the relaxation response,https://pubmed.ncbi.nlm.nih.gov/12709683/,Positive,,Meta-analysis,2003,Anandamide (AEA); Mind-Body Medicine; Endocannabinoid (unspecified),,
2005016,"Endocannabinoid signaling in stress, medicine and wellness",https://pubmed.ncbi.nlm.nih.gov/16049386/,Positive,,Meta-analysis,2005,Endocannabinoid (unspecified),Mental/Emotional System,Longevity
2018076,"Endocannabinoid system, stress and HPA axis",https://pubmed.ncbi.nlm.nih.gov/30036537/,Positive,,Meta-analysis,2018,Endocannabinoid (unspecified),Nervous System,Oxidative Stress
2011048,Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions,https://pubmed.ncbi.nlm.nih.gov/21278728/,Positive,,Meta-analysis,2011,Omega-3; Endocannabinoid (unspecified),,Anxiety; Depression; Obesity
2016074,Curcumin and hemopressin treatment attenuates cholestasis-induced liver fibrosis in rats: role of CB1 receptors,https://pubmed.ncbi.nlm.nih.gov/26475620/,Positive,,Animal Study,2016,Turmeric,Digestive System,Fibrosis - Liver (Cirrhosis); Fibrosis
2009033,The dietary polyphenols trans-resveratrol and curcumin selectively bind human CB1 cannabinoid receptors with nanomolar affinities and function as antagonists/inverse agonists,https://pubmed.ncbi.nlm.nih.gov/19359525/,Positive,,Animal Study,2009,Turmeric,,Obesity
2022348,Curcumin Protects Diabetic Mice against Isoproterenol-Induced Myocardial Infarction by Modulating CB2 Cannabinoid Receptors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143027/,Positive,,Animal Study,2022,Turmeric,Endocrine System,Diabetes
2013043,Curcumin modulates cannabinoid receptors in liver fibrosis in vivo and inhibits extracellular matrix expression in hepatic stellate cells by suppressing cannabinoid receptor type-1 in vitro,https://pubmed.ncbi.nlm.nih.gov/24076327/,Positive,,Animal Study,2013,Turmeric,Digestive System,Fibrosis - Liver (Cirrhosis); Fibrosis
2022349,Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast cancer cells,https://pubmed.ncbi.nlm.nih.gov/25242400/,Positive,,Laboratory Study,2022,Cannabidiolic Acid (CBD-a),Nervous System; Reproductive System,Cancer - Breast; Cancer
2022350,Non-psychotropic phytocannabinoid interactions with voltage-gated sodium channels: An update on cannabidiol and cannabigerol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691960/,Positive,,Meta-analysis,2022,Cannabigerol (CBG),,Pain; Pain - Acute; Pain - Chronic
1970001,Chemical basis of hashish activity,https://pubmed.ncbi.nlm.nih.gov/4987683/,Inconclusive,,Meta-analysis,1970,Cannabichromene (CBC); Cannabigerol (CBG); Cannabinol (CBN); Tetrahydrocannabinol (THC),,Cannabis Adverse Effects
2018077,Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1–CB2 Heteroreceptor Complexes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021502/,Inconclusive,,Laboratory Study,2018,Cannabigerol (CBG),,
2019079,Identification and characterization of phytocannabinoids as novel dual PPARα/γ agonists by a computational and in vitro experimental approach,https://pubmed.ncbi.nlm.nih.gov/30611848/,Inconclusive,,Laboratory Study,2019,Cannabidiolic Acid (CBD-a); Cannabigerol (CBG); Cannabigerolic Acid (CBG-a),,
1965001,Hashish. IV. The isolation and structure of cannabinolic cannabidiolic and cannabigerolic acids,https://pubmed.ncbi.nlm.nih.gov/5879350/,Inconclusive,,Laboratory Study,1965,Cannabidiolic Acid (CBD-a),,
2017062,Affinity and Efficacy Studies of Tetrahydrocannabinolic Acid A at Cannabinoid Receptor Types One and Two,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510775/,Inconclusive,,Laboratory Study,2017,Tetrahydrocannabinolic Acid (THC-a),,
1942001,Marihuana,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1933888/pdf/bullnyacadmed00560-0006.pdf,Inconclusive,,Clinical Trial,1942,Delta-8-THC,,Cannabis Adverse Effects
2022351,Review of delta-8-tetrahydrocannabinol (Δ8-THC): Comparative pharmacology with Δ9-THC,https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.15865,Inconclusive,,Meta-analysis,2022,Delta-8-THC; Tetrahydrocannabinol (THC),,
2020180,"Lysophosphatidylinositol, an Endogenous Ligand for G Protein-Coupled Receptor 55, Has Anti-inflammatory Effects in Cultured Microglia",https://pubmed.ncbi.nlm.nih.gov/32519268/,Positive,,Laboratory Study,2020,Endocannabinoid (unspecified); Lysophosphatidylinositol (LPI),Nervous System,Inflammation; Oxidative Stress; Neurodegenerative Issues; Traumatic Brain Injury
2021209,Interactions between lysophosphatidylinositol receptor GPR55 and sphingosine-1-phosphate receptor S1P5 in live cells,https://pubmed.ncbi.nlm.nih.gov/34271437/,Positive,,Laboratory Study,2021,Endocannabinoid (unspecified); Lysophosphatidylinositol (LPI),Digestive System,Cancer - Colon; Cancer
2010043,"GPR55, a lysophosphatidylinositol receptor with cannabinoid sensitivity?",https://pubmed.ncbi.nlm.nih.gov/20370712/,Inconclusive,,Meta-analysis,2010,Lysophosphatidylinositol (LPI); Endocannabinoid (unspecified),,
2005017,Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus,https://www.nature.com/articles/nn1521#change-history,Positive,,Laboratory Study,2005,2-Arachidonoyl Glycerol (2-AG); Monoacylglycerol Lipase (MAGL),,
2012063,Activation of Cannabinoid Receptor 2 Attenuates Leukocyte–Endothelial Cell Interactions and Blood–Brain Barrier Dysfunction under Inflammatory Conditions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325902/,Positive,,Laboratory Study,2012,JWH-x Synthetic Cannabinoids; O-x Synthetic Cannabinoids,Nervous System,Inflammation
2012064,A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury,https://pubmed.ncbi.nlm.nih.gov/22903455/,Positive,,Animal Study,2012,Endocannabinoid (unspecified); O-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Behavioral Disorders; Inflammation; Neurodegenerative Issues; Traumatic Brain Injury
2011049,Modulation of Inflammatory Responses by a Cannabinoid-2–Selective Agonist after Spinal Cord Injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235339/,Positive,,Animal Study,2011,O-x Synthetic Cannabinoids,Nervous System; Skeletal System,Inflammation; Spinal Cord Injuries
2021210,Self-administration of inhaled delta-9-tetrahydrocannabinol and synthetic cannabinoids in non-human primates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376089/,Inconclusive,,Animal Study,2021,HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,Mental/Emotional System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2022352,Cannabinoid 1 and mu-Opioid Receptor Agonists Synergistically Inhibit Abdominal Pain and Lack Side Effects in Mice,https://pubmed.ncbi.nlm.nih.gov/35790401/,Positive,,Animal Study,2022,HU-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); Endocannabinoid (unspecified),Nervous System,Pain; Addiction - Opioid; IBD - Inflammatory Bowel Disease
2019080,"Identification of synthetic cannabinoids that were seized, consumed, or associated with deaths in Kuwait in 2018 using GC–MS and LC–MS-MS analysis",https://pubmed.ncbi.nlm.nih.gov/31550599/,Negative,,Meta-analysis,2019,5F-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Addiction - Cocaine; Addiction - Opioid; Addiction - Stimulant
2022353,Cognitive functioning and cannabis use in first-episode psychosis,https://pubmed.ncbi.nlm.nih.gov/34964681/,Inconclusive,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Psychosis
2022354,Cannabis use and attenuated positive and negative symptoms in youth at clinical high risk for psychosis,https://www.sciencedirect.com/science/article/abs/pii/S0920996422003073?via%3Dihub,Negative,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Psychosis
2021211,Prenatal cannabis use disorders and offspring primary and secondary educational outcomes,https://pubmed.ncbi.nlm.nih.gov/34184804/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System,Cannabis Adverse Effects; Cognitive Dysfunction; Neonatal Cerebral Issues; Pregnancy
2022355,"Cannabis use among U.S. military veterans with subthreshold or threshold posttraumatic stress disorder: Psychiatric comorbidities, functioning, and strategies for coping with posttraumatic stress symptoms",https://pubmed.ncbi.nlm.nih.gov/35275431/,Negative,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,PTSD; Addiction - Cannabis; Anxiety; Cognitive Dysfunction; Depression; Pain; Suicide Attempt
2022356,Maternal trajectories of cannabis use and young adult cannabis and nicotine dependence,https://www.sciencedirect.com/science/article/abs/pii/S030646032100397X?via%3Dihub,Negative,,Meta-analysis,2022,,Mental/Emotional System; Nervous System; Reproductive System,Addiction - Cannabis; Addiction - Nicotine; Addiction; Pregnancy; Addiction - Alcohol; Addiction - Cocaine; Addiction - Opioid; Addiction - Stimulant
2022357,Herbal Approaches to Pediatric Functional Abdominal Pain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406842/,Inconclusive,,Meta-analysis,2022,Pharma THC,Digestive System; Nervous System,Irritable Bowel Syndrome; Pain; Behavioral Disorders; Anorexia; Autism; Cachexia; Cannabis Hyperemesis Syndrome; Chemotherapy-induced Nausea & Vomiting; Epilepsy; IBD - Inflammatory Bowel Disease; HIV/AIDS; Inflammation; Nausea and Vomiting; Pain - Chronic
2022358,Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome,https://www.nature.com/articles/s41575-022-00682-y,Positive,,Meta-analysis,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified),Digestive System,Irritable Bowel Syndrome; Pain; Pain - Acute; Inflammation; Pain - Chronic
2021212,Experimental therapies in Irritable Bowel Syndrome,https://journals.pan.pl/Content/120117/2021-01-FMC-01-Wlodarczyk.pdf,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Pharma THC,Digestive System,Irritable Bowel Syndrome; Diarrhea; Inflammation; Pain; Pain - Acute; Pain - Chronic
2022359,Differential activation of G protein‐mediated signaling by synthetic cannabinoid receptor agonists,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043210/,Inconclusive,,Laboratory Study,2022,AB-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); CP-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC); WIN-x Synthetic Cannabinoids,,Cannabis Adverse Effects
2021213,Clinical symptoms and blood concentration of new psychoactive substances (NPS) in intoxicated and hospitalized patients in the Budapest region of Hungary (2018-19),https://pubmed.ncbi.nlm.nih.gov/34080493/,Negative,,Meta-analysis,2021,5F-x Synthetic Cannabinoids,Mental/Emotional System,Cannabis Adverse Effects
2022360,In vitro and in vivo pharmacology of nine novel synthetic cannabinoid receptor agonists,https://www.sciencedirect.com/science/article/abs/pii/S0091305722001460?via%3Dihub,Inconclusive,,Animal Study,2022,5F-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),,Cannabis Adverse Effects
2022361,"Fatal intoxication with new synthetic cannabinoids 5F-MDMB-PICA and 4F-MDMB-BINACA—parent compounds and metabolite identification in blood, urine and cerebrospinal fluid",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194349/,Negative,,Meta-analysis,2022,5F-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Mental/Emotional System,Cannabis Adverse Effects
2002010,Brain monoglyceride lipase participating in endocannabinoid inactivation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC125056/,Inconclusive,,Laboratory Study,2002,2-Arachidonoyl Glycerol (2-AG); Monoacylglycerol Lipase (MAGL),,
2022362,Structure-activity relationships for 5F-MDMB-PICA and its 5F-pentylindole analogs to induce cannabinoid-like effects in mice,https://pubmed.ncbi.nlm.nih.gov/34802041/,Inconclusive,,Animal Study,2022,5F-x Synthetic Cannabinoids; Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),,Cannabis Adverse Effects
2020181,5F-MDMB-PICA metabolite identification and cannabinoid receptor activity,https://pubmed.ncbi.nlm.nih.gov/31461219/,Positive,,Laboratory Study,2020,5F-x Synthetic Cannabinoids,,
2013044,"The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55",https://www.sciencedirect.com/science/article/abs/pii/S1098882313000403?via%3Dihub,Inconclusive,,Laboratory Study,2013,Lysophosphatidylinositol (LPI); Endocannabinoid (unspecified),,
2021214,Peptide targeting of lysophosphatidylinositol-sensing GPR55 for osteoclastogenesis tuning,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073907/,Positive,,Laboratory Study,2021,Lysophosphatidylinositol (LPI); Endocannabinoid (unspecified),,Bone Fractures; Cancer - Metastatic; Cancer; Inflammation; Osteoporosis
2022363,The Effects of Cannabidiol and δ-9-Tetrahydrocannabinol in Social Cognition: A Naturalistic Controlled Study,https://pubmed.ncbi.nlm.nih.gov/35881851/,Negative,,Double Blind Clinical Trial,2022,Tetrahydrocannabinol (THC); Endocannabinoid (unspecified),,Cognitive Dysfunction; Behavioral Disorders; Anxiety; Autism; Bipolar Disorder; Psychosis; PTSD; Schizophrenia
2022364,The Medicinal Natural Products of Cannabis sativa Linn.: A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911748/,Positive,,Meta-analysis,2022,Cannabichromene (CBC); Cannabichromenic Acid (CBC-a); Cannabidiolic Acid (CBD-a); Cannabidivarin (CBDV); Cannabigerol (CBG); Cannabigerolic Acid (CBG-a); Cannabinol (CBN); Delta-8-THC; Tetrahydrocannabivarin (THCV); Pharma THC; Synthetic Cannabinoid (unspecified); Tetrahydrocannabinolic Acid (THC-a),,Allergic Contact Dermatitis; Anxiety; Arthritis - Osteoarthritis; Arthritis - Rheumatoid; Arthritis; Asthma; Bacterial Infections; Burn Injury; Cancer; Cardiovascular Diseases (CVD); Chemotherapy-induced Nausea & Vomiting; Cough; Depression; Epilepsy; Fungal Infections; Hair Loss; Inflammation; Insomnia and Sleep Disorders; Kidney Failure; Malaria
2022365,The Endocannabinoid System and Physical Activity—A Robust Duo in the Novel Therapeutic Approach against Metabolic Disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948925/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Other Related Compounds; Palmitoylethanolamide (PEA); Pharma THC; WIN-x Synthetic Cannabinoids,Endocrine System,Metabolic Syndrome; Anxiety; Cardiovascular Diseases (CVD); Depression; Diabetes; Hypertension (High Blood Pressure); Inflammation; Liver Failure; Obesity; Oxidative Stress
2022366,Updates in the use of cannabis for insomnia,https://pubmed.ncbi.nlm.nih.gov/36102608/,Inconclusive,,Meta-analysis,2022,,,Insomnia and Sleep Disorders; Restless Leg Syndrome
2022367,Exploring the endocannabinoidome in genetically obese (ob/ob) and diabetic (db/db) mice: Links with inflammation and gut microbiota,https://www.sciencedirect.com/science/article/abs/pii/S1388198121001840?via%3Dihub,Positive,,Laboratory Study,2022,Microbiome; 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Palmitoylethanolamide (PEA); Virodhamine (O-AEA),Endocrine System,Inflammation; Metabolic Syndrome; Obesity; Diabetes; Liver Failure
2022368,Inhibition of mitochondrial permeability transition pore and antioxidant effect of Delta-9-tetrahydrocannabinol reduces aluminium phosphide-induced cytotoxicity and dysfunction of cardiac mitochondria,https://www.sciencedirect.com/science/article/abs/pii/S0048357522000840?via%3Dihub,Positive,,Laboratory Study,2022,,Cardiovascular System,Cardiovascular Diseases (CVD); Oxidative Stress
2022369,The Heart and Cannabis (THC) Cohort: Differences in Baseline Health and Behaviors by Cannabis Use,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585109/,Negative,,Meta-analysis,2022,,Cardiovascular System; Mental/Emotional System,Behavioral Disorders; Atherosclerosis; Cardiovascular Diseases (CVD); Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant; MDMA Adverse Effects
2022370,Fatty Acid Amide Hydrolase Deficiency Is Associated with Deleterious Cardiac Effects after Myocardial Ischemia and Reperfusion in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604059/,Positive,,Animal Study,2022,Fatty Acid Amide Hydrolase (FAAH); Synthetic Cannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified),Cardiovascular System; Nervous System,Cardiovascular Diseases (CVD); Chronic Heart Disease; Heart Disease; Inflammation
2020182,Pharmacological activation of CB2 receptor protects against ethanol-induced myocardial injury related to RIP1/RIP3/MLKL-mediated necroptosis,https://pubmed.ncbi.nlm.nih.gov/32681290/,Positive,,Animal Study,2020,AM-x Synthetic Cannabinoids; Endocannabinoid (unspecified); JWH-x Synthetic Cannabinoids,Cardiovascular System; Nervous System,Cardiovascular Diseases (CVD); Heart Attack; Inflammation; Cardiac Arrhythmias
2022371,Adverse Effects of Cannabinoids and Tobacco Consumption on the Cardiovascular System: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484787/,Negative,,Meta-analysis,2022,Synthetic Cannabinoid (unspecified),Cardiovascular System; Mental/Emotional System; Nervous System,Addiction - Nicotine; Addiction; Cannabis Adverse Effects; Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Heart Attack; Atherosclerosis; Chronic Heart Disease; Heart Disease; Oxidative Stress; Stroke
2011050,The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease,https://www.nature.com/articles/mi201118,Positive,,Clinical Trial,2011,Anandamide (AEA); 2-Arachidonoyl Glycerol (2-AG); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Other Related Compounds; Palmitoylethanolamide (PEA),Digestive System; Nervous System,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Inflammation; Diarrhea
2019081,Microdeletion in a FAAH pseudogene identified in a patient with high anandamide concentrations and pain insensitivity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676009/,Positive,,Meta-analysis,2019,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Nervous System,Pain; Anxiety; Pain - Acute; Pain - Chronic; Wound Healing
1997002,Molecular characterization of human and mouse fatty acid amide hydrolases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC20071/,Inconclusive,,Laboratory Study,1997,Fatty Acid Amide Hydrolase (FAAH),,
2017063,Cannabinoid Receptor-2 Ameliorates Inflammation in Murine Model of Crohn’s Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881726/,Positive,,Animal Study,2017,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Other Related Compounds; Palmitoylethanolamide (PEA),Digestive System; Nervous System,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Inflammation; Pain
2019082,Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382821/,Positive,,Clinical Trial,2019,2-Arachidonoyl Glycerol (2-AG); Lysophosphatidylinositol (LPI); Other Related Compounds; Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Palmitoylethanolamide (PEA),Digestive System; Nervous System,Cancer - Colon; Cancer; IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Inflammation
2011051,New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitis,https://pubmed.ncbi.nlm.nih.gov/21612933/,Positive,,Animal Study,2011,Fatty Acid Amide Hydrolase (FAAH); Anandamide (AEA); Endocannabinoid (unspecified),Digestive System; Nervous System,IBD - Inflammatory Bowel Disease; Inflammation
2012065,The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity,https://pubmed.ncbi.nlm.nih.gov/22917662/,Positive,,Meta-analysis,2012,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Digestive System,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Inflammation
2021215,The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632250/,Positive,,Animal Study,2021,Cannabichromene (CBC); 2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Palmitoylethanolamide (PEA); Pharma THC; SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); Virodhamine (O-AEA),Digestive System; Nervous System,IBD - Inflammatory Bowel Disease; Inflammation; Oxidative Stress
2021216,Genetic Variants of Fatty Acid Amide Hydrolase Modulate Acute Inflammatory Responses to Colitis in Adult Male Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670533/,Positive,,Animal Study,2021,Fatty Acid Amide Hydrolase (FAAH); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Monoacylglycerol Lipase (MAGL),Digestive System,IBD - Inflammatory Bowel Disease; Inflammation; Anxiety; Arthritis - Osteoarthritis; Arthritis; Irritable Bowel Syndrome; Multiple Sclerosis
2021217,Comorbid anxiety-like behavior in a rat model of colitis is mediated by an upregulation of corticolimbic fatty acid amide hydrolase,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115350/,Positive,,Animal Study,2021,Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); 2-Arachidonoyl Glycerol (2-AG); Monoacylglycerol Lipase (MAGL); Palmitoylethanolamide (PEA); Virodhamine (O-AEA),Digestive System; Mental/Emotional System; Nervous System,Anxiety; IBD - Inflammatory Bowel Disease; Inflammation; Behavioral Disorders; Depression; PTSD
2013045,3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis,https://pubmed.ncbi.nlm.nih.gov/23849204/,Positive,,Animal Study,2013,Endocannabinoid (unspecified),Digestive System; Nervous System,IBD - Inflammatory Bowel Disease; Inflammation; Depression; Pain
2006012,Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation,https://faseb.onlinelibrary.wiley.com/doi/epdf/10.1096/fj.05-4943fje,Positive,,Animal Study,2006,Anandamide (AEA); 2-Arachidonoyl Glycerol (2-AG); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH),Digestive System,IBD - Inflammatory Bowel Disease; Inflammation
2004017,Comparison of cannabinoid ligands affinities and efficacies in murine tissues and in transfected cells expressing human recombinant cannabinoid receptors,https://www.farm.ucl.ac.be/Full-texts-FARM/Govaerts-2004-2.pdf,Positive,,Laboratory Study,2004,CP-x Synthetic Cannabinoids; Delta-8-THC; HU-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC); WIN-x Synthetic Cannabinoids,,
2021218,"WIN55,212-2, a Dual Modulator of Cannabinoid Receptors and G Protein-Coupled Inward Rectifier Potassium Channels",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146939/,Inconclusive,,Laboratory Study,2021,WIN-x Synthetic Cannabinoids,,
2012066,Δ9-Tetrahydrocannabinol (Δ9-THC) attenuates mouse sperm motility and male fecundity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423255/,Negative,,Animal Study,2012,WIN-x Synthetic Cannabinoids,,Infertility (Male)
2001012,"The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex: an in vivo and in vitro study",https://pubmed.ncbi.nlm.nih.gov/11459762/,Inconclusive,,Animal Study,2001,WIN-x Synthetic Cannabinoids,,Excitotoxicity
1995003,Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors,https://pubmed.ncbi.nlm.nih.gov/7565624/,Inconclusive,,Laboratory Study,1995,Anandamide (AEA); Cannabinol (CBN); CP-x Synthetic Cannabinoids; HU-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC); WIN-x Synthetic Cannabinoids,,
2016075,An update on PPAR activation by cannabinoids,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882496/,Positive,,Meta-analysis,2016,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); N-Arachidonoyl Dopamine (NADA); Palmitoylethanolamide (PEA); Virodhamine (O-AEA); WIN-x Synthetic Cannabinoids,,Cancer; Inflammation; Pain; Pain - Acute; Pain - Chronic
1993002,Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids,https://pubmed.ncbi.nlm.nih.gov/8450470/,Inconclusive,,Laboratory Study,1993,WIN-x Synthetic Cannabinoids,,Pain; Pain - Acute; Pain - Chronic
2023356,Hippocampal CB1 receptor mediates antidepressant-like effect of synthetic cannabinoid-HU210 in acute despair reaction model in mice,https://pubmed.ncbi.nlm.nih.gov/36372093/,Positive,,Animal Study,2023,HU-x Synthetic Cannabinoids,Mental/Emotional System,Depression; Oxidative Stress
1989002,Inhibition of cisplatin-induced emesis in the pigeon by a non-psychotropic synthetic cannabinoid,https://pubmed.ncbi.nlm.nih.gov/2557222/,Positive,,Animal Study,1989,HU-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC),Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
2022372,Unexpected short- and long-term effects of chronic adolescent HU-210 exposure on emotional behavior,https://pubmed.ncbi.nlm.nih.gov/35660545/,Inconclusive,,Animal Study,2022,HU-x Synthetic Cannabinoids,Nervous System,Poisoning by Synthetic Cannabis; Anxiety; Depression
1998002,Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla,https://pubmed.ncbi.nlm.nih.gov/9509998/,Positive,,Animal Study,1998,HU-x Synthetic Cannabinoids,,Pain; Pain - Acute; Pain - Chronic
2000005,"Effects of the cannabinoid receptor agonist, HU 210, on ingestive behaviour and body weight of rats",https://pubmed.ncbi.nlm.nih.gov/10729369/,Positive,,Animal Study,2000,HU-x Synthetic Cannabinoids,Endocrine System,Obesity; Metabolic Syndrome
2000006,Inhibitory effects of the cannabinoid agonist HU 210 on rat sexual behaviour,https://pubmed.ncbi.nlm.nih.gov/10913795/,Negative,,Animal Study,2000,HU-x Synthetic Cannabinoids,Endocrine System; Reproductive System,Libido; Erectile Dysfunction; Poisoning by Synthetic Cannabis
1999008,Learning impairment produced in rats by the cannabinoid agonist HU 210 in a water-maze task,https://pubmed.ncbi.nlm.nih.gov/10548271/,Negative,,Animal Study,1999,HU-x Synthetic Cannabinoids,Nervous System,Poisoning by Synthetic Cannabis; Cannabis Adverse Effects
1989003,Stereochemical effects of 11-OH-delta 8-THC-dimethylheptyl in mice and dogs,https://pubmed.ncbi.nlm.nih.gov/2544901/,Inconclusive,,Animal Study,1989,HU-x Synthetic Cannabinoids,Mental/Emotional System,Cannabis Adverse Effects
2001013,Hu 210: a potent tool for investigations of the cannabinoid system,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6741702/pdf/CNS-7-131.pdf,Positive,,Meta-analysis,2001,HU-x Synthetic Cannabinoids,,Chemotherapy-induced Nausea & Vomiting; Inflammation; Pain; Nausea and Vomiting; Pain - Chronic; Psychosis; Schizophrenia
2016076,The Structure–Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927043/,Inconclusive,,Laboratory Study,2016,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),,
1996001,Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands,https://pubmed.ncbi.nlm.nih.gov/8819477/,Inconclusive,,Laboratory Study,1996,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),,
1993003,"The non-psychotropic cannabinoid (+)-(3S,4S)-7-hydroxy-delta 6- tetrahydrocannabinol 1,1-dimethylheptyl (HU-211) attenuates N-methyl-D-aspartate receptor-mediated neurotoxicity in primary cultures of rat forebrain",https://pubmed.ncbi.nlm.nih.gov/8121633/,Positive,,Laboratory Study,1993,HU-x Synthetic Cannabinoids,,Excitotoxicity; Neurodegenerative Issues
2022373,Deficiency of autism-related Scn2a gene in mice disrupts sleep patterns and circadian rhythms,https://pubmed.ncbi.nlm.nih.gov/35301122/,Positive,,Animal Study,2022,HU-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Autism
1989004,Stereospecific effects of (-)- and (+)-7-hydroxy-delta-6-tetrahydrocannabinol-dimethylheptyl on the immune system of mice,https://pubmed.ncbi.nlm.nih.gov/2561381/#affiliation-1,Inconclusive,,Animal Study,1989,HU-x Synthetic Cannabinoids,,
2008036,Ulcerative colitis in AKR mice is attenuated by intraperitoneally administered anandamide,https://www.jpp.krakow.pl/journal/archive/12_08/pdf/673_12_08_article.pdf,Positive,,Animal Study,2008,Anandamide (AEA); 2-Arachidonoyl Glycerol (2-AG); Endocannabinoid (unspecified); Tetrahydrocannabinol (THC),Digestive System,IBD - Inflammatory Bowel Disease; Inflammation; IBD - Crohn's Disease; Irritable Bowel Syndrome
2011052,Cannabinoid receptor antagonists AM251 and AM630 activate TRPA1 in sensory neurons,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130079/,Positive,,Laboratory Study,2011,AM-x Synthetic Cannabinoids,,
2020183,Synthetic cannabinoids AM-251 and AM-1241 induce cell death in prostate cancer cells,https://aacrjournals.org/cancerres/article/80/16_Supplement/4030/643198/Abstract-4030-Synthetic-cannabinoids-AM-251-and-AM,Positive,,Laboratory Study,2020,AM-x Synthetic Cannabinoids,Nervous System; Reproductive System,Cancer - Prostate; Cancer
2012067,The cannabinoid CB1 receptor antagonists rimonabant (SR141716) and AM251 directly potentiate GABA(A) receptors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423234/,Positive,,Laboratory Study,2012,AM-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,,Excitotoxicity
2011053,"Nonpsychotropic cannabinoids, abnormal cannabidiol and canabigerol-dimethyl heptyl, act at novel cannabinoid receptors to reduce intraocular pressure",https://pubmed.ncbi.nlm.nih.gov/21770780/,Positive,,Animal Study,2011,Abnormal Cannabidiol (Abn-CBD); Synthetic Cannabinoid (unspecified),Nervous System,Glaucoma
2010044,"N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865488/,Inconclusive,,Laboratory Study,2010,Abnormal Cannabidiol (Abn-CBD),,
1977002,A cannabinoid with cardiovascular activity but no overt behavioral effects,https://pubmed.ncbi.nlm.nih.gov/891878/,Positive,,Animal Study,1977,Abnormal Cannabidiol (Abn-CBD),,Cannabis Adverse Effects; Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Poisoning by Synthetic Cannabis
2022374,"Acute effects of 4-EA-NBOMe, 3, 4-DCMP, LY-2183240 and AB-CHFUPYCA on the excitability of rat cortical primary cultured neurons",https://link.springer.com/article/10.1007/s13273-022-00224-2,Inconclusive,,Laboratory Study,2022,AB-x Synthetic Cannabinoids,,Poisoning by Synthetic Cannabis
2020184,The synthetic cannabinoid 5F-MDMB-PICA: A case series,https://pubmed.ncbi.nlm.nih.gov/32683270/,Negative,,Meta-analysis,2020,5F-x Synthetic Cannabinoids,Nervous System,Poisoning by Synthetic Cannabis
2020185,Neurochemical and Behavioral Characterization after Acute and Repeated Exposure to Novel Synthetic Cannabinoid Agonist 5-MDMB-PICA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766979/,Negative,,Animal Study,2020,5F-x Synthetic Cannabinoids,Nervous System,Poisoning by Synthetic Cannabis
1999009,"3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor",https://pubmed.ncbi.nlm.nih.gov/10658595/,Positive,,Laboratory Study,1999,JWH-x Synthetic Cannabinoids,,
2012068,AM-251 and Rimonabant Act as Direct Antagonists at Mu-Opioid Receptors: Implications for Opioid/Cannabinoid Interaction Studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408547/,Inconclusive,,Animal Study,2012,AM-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,,Addiction - Opioid
2018078,"Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gαi/o protein inhibitor",https://pubmed.ncbi.nlm.nih.gov/29407764/,Inconclusive,,Laboratory Study,2018,SR-x Synthetic Cannabinoids,,
1994001,"SR141716A, a potent and selective antagonist of the brain cannabinoid receptor",https://pubmed.ncbi.nlm.nih.gov/8070571/,Inconclusive,,Laboratory Study,1994,SR-x Synthetic Cannabinoids,,
2006013,The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism,https://pubmed.ncbi.nlm.nih.gov/16822929/,Positive,,Laboratory Study,2006,SR-x Synthetic Cannabinoids,Nervous System; Reproductive System,Cancer - Breast; Cancer
2022375,"Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial",https://pubmed.ncbi.nlm.nih.gov/20709233/,Negative,,Double Blind Clinical Trial,2022,SR-x Synthetic Cannabinoids,Cardiovascular System,Cardiovascular Diseases (CVD); Anxiety; Depression; Obesity; Suicide Attempt
2010045,Neuropsychiatric adverse effects signal the end of the line for rimonabant,https://www.nature.com/articles/nrcardio.2010.148#citeas,Negative,,Meta-analysis,2010,SR-x Synthetic Cannabinoids,Nervous System,Poisoning by Synthetic Cannabis; Anxiety; Depression; Suicide Attempt
1998003,"SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor",https://pubmed.ncbi.nlm.nih.gov/9454810/,Positive,,Animal Study,1998,SR-x Synthetic Cannabinoids,,
2019083,Neurocognition and Subjective Experience Following Acute Doses of the Synthetic Cannabinoid JWH-018: Responders Versus Nonresponders,https://www.liebertpub.com/doi/10.1089/can.2018.0047,Negative,,Clinical Trial,2019,JWH-x Synthetic Cannabinoids,Nervous System,Poisoning by Synthetic Cannabis
2017064,Natural (∆9-THC) and synthetic (JWH-018) cannabinoids induce seizures by acting through the cannabinoid CB1 receptor,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585372/,Inconclusive,,Animal Study,2017,AM-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,Nervous System,Poisoning by Synthetic Cannabis; Epilepsy
2022376,Effects of synthetic (JWH-018) cannabinoids treatment on spermatogenesis and sperm function,https://pubmed.ncbi.nlm.nih.gov/31645148/,Negative,,Animal Study,2022,JWH-x Synthetic Cannabinoids,,Poisoning by Synthetic Cannabis; Infertility (Male)
2018079,Repeated Exposure to the “Spice” Cannabinoid JWH-018 Induces Tolerance and Enhances Responsiveness to 5-HT1A Receptor Stimulation in Male Rats,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835089/,Negative,,Animal Study,2018,JWH-x Synthetic Cannabinoids,Nervous System,Poisoning by Synthetic Cannabis; Psychosis
2009034,"Withdrawal Phenomena and Dependence Syndrome After the Consumption of ""Spice Gold""",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2719097/,Negative,,Meta-analysis,2009,JWH-x Synthetic Cannabinoids; CP-x Synthetic Cannabinoids,Nervous System,Poisoning by Synthetic Cannabis
2015079,"Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135",https://pubmed.ncbi.nlm.nih.gov/25921407/,Negative,,Animal Study,2015,5F-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; AM-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis
2000007,Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding,https://web.archive.org/web/20160306162902/https://ewsd.wiv-isp.be/Publications%20on%20new%20psychoactive%20substances/JWH-019/Aung_2000_Alkyl%20chain___E972455D-F1B9-789D-E2A7D189115CD29F.pdf,Positive,,Laboratory Study,2000,JWH-x Synthetic Cannabinoids,,
2010046,Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease,https://pubmed.ncbi.nlm.nih.gov/19833407/,Positive,,Meta-analysis,2010,Anandamide (AEA); CP-x Synthetic Cannabinoids; HU-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC); WIN-x Synthetic Cannabinoids; 2-Arachidonoyl Glycerol (2-AG); N-Arachidonoyl Dopamine (NADA); Virodhamine (O-AEA),,Inflammation
2014055,"Pharmacology, Toxicology, and Adverse Effects of Synthetic Cannabinoid Drugs",https://www.chm.uri.edu/forensics/Gurney_PharmToxAdverseEffectsSynCannDrugs_ForScReview_2014.pdf,Inconclusive,,Meta-analysis,2014,AM-x Synthetic Cannabinoids; CP-x Synthetic Cannabinoids; HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); WIN-x Synthetic Cannabinoids,Nervous System,Poisoning by Synthetic Cannabis
2013046,Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1/2 signaling.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552103/,Inconclusive,,Animal Study,2013,CP-x Synthetic Cannabinoids,,Anxiety; Depression; Schizophrenia
2009035,Atypical Responsiveness of the Orphan Receptor GPR55 to Cannabinoid Ligands,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785612/,Positive,,Laboratory Study,2009,CP-x Synthetic Cannabinoids,,Obesity
2020186,Age-dependent hormesis-like effects of the synthetic cannabinoid CP55940 in C57BL/6 mice,https://www.nature.com/articles/s41514-020-0045-7#citeas,Inconclusive,,Animal Study,2020,CP-x Synthetic Cannabinoids,,Geriatric Conditions
2022377,"Synthetic cannabinoid CP-55,940 induces apoptosis in a human skeletal muscle model via regulation of CB1 receptors and L-type Ca2+ channels",https://pubmed.ncbi.nlm.nih.gov/33174160/,Positive,,Laboratory Study,2022,CP-x Synthetic Cannabinoids,,Cancer - Soft Tissues; Cancer
2022378,Role of cannabis in inflammatory bowel diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049239/,Inconclusive,,Meta-analysis,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); AM-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Pharma THC:CBD; Pharma THC; Synthetic Cannabinoid (unspecified),Digestive System,IBD - Inflammatory Bowel Disease; Inflammation; IBD - Crohn's Disease; Hepatitis; IBD - Ulcerative Colitis; Irritable Bowel Syndrome; Pain; Nausea and Vomiting; Pancreatitis; Stomach Ulcers
2022379,Increased expression of CB2 receptor in the intestinal biopsies of children with inflammatory bowel disease,https://pubmed.ncbi.nlm.nih.gov/35717484/,Positive,,Clinical Trial,2022,Endocannabinoid (unspecified),Digestive System; Nervous System,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Inflammation
2008037,"Nicotine (NC)-induced ""depressive"" behavioral symptoms and effects of antidepressants including cannabinoids (CBs)",https://pubmed.ncbi.nlm.nih.gov/19043277/,Positive,,Animal Study,2008,Virodhamine (O-AEA),Mental/Emotional System; Nervous System,Addiction - Nicotine; Addiction; Depression
2021219,"Pharmacokinetics and Pharmacodynamics of the Synthetic Cannabinoid, 5F-MDMB-PICA, in Male Rats",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511335/,Negative,,Animal Study,2021,5F-x Synthetic Cannabinoids,,Poisoning by Synthetic Cannabis
2007023,"Regulation of transient receptor potential channels of melastatin type 8 (TRPM8): effect of cAMP, cannabinoid CB(1) receptors and endovanilloids",https://pubmed.ncbi.nlm.nih.gov/17428469/,Inconclusive,,Laboratory Study,2007,Anandamide (AEA); N-Arachidonoyl Dopamine (NADA),,
2010047,"Inhibition of monoacylglycerol lipase by troglitazone, N-arachidonoyl dopamine and the irreversible inhibitor JZL184: comparison of two different assays",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010564/,Inconclusive,,Laboratory Study,2010,N-Arachidonoyl Dopamine (NADA); Monoacylglycerol Lipase (MAGL),,
2000008,N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1221424/pdf/11042139.pdf,Positive,,Animal Study,2000,N-Arachidonoyl Dopamine (NADA),,
2017065,Lysophosphatidylinositol-induced activation of the cation channel TRPV2 triggers glucagon-like peptide-1 secretion in enteroendocrine L cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491772/,Inconclusive,,Laboratory Study,2017,Lysophosphatidylinositol (LPI),,
2022380,Lysophosphatidylinositol: a novel link between ABC transporters and G-protein-coupled receptors,https://pubmed.ncbi.nlm.nih.gov/25233417/,Positive,,Meta-analysis,2022,Lysophosphatidylinositol (LPI),,Cancer
2022381,The oncogenic lysophosphatidylinositol (LPI)/GPR55 signaling,https://pubmed.ncbi.nlm.nih.gov/35500681/,Negative,,Meta-analysis,2022,Lysophosphatidylinositol (LPI),Nervous System,Cancer; Cancer - Kidney; Cancer - Brain; Cancer - Leukemia; Cancer - Melanoma
2016077,Lysophosphatidylinositol Signalling and Metabolic Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812335/,Negative,,Meta-analysis,2016,Lysophosphatidylinositol (LPI),Endocrine System,Metabolic Syndrome; Cardiovascular Diseases (CVD); Diabetes; Hypertension (High Blood Pressure); Obesity
2009036,2-Arachidonoyl-sn-glycero-3-phosphoinositol: A Possible Natural Ligand for GPR55,https://pubmed.ncbi.nlm.nih.gov/18845565/,Positive,,Laboratory Study,2009,Lysophosphatidylinositol (LPI),,
2022382,"Cannabinol: History, Syntheses, and Biological Profile of the Greatest “Minor” Cannabinoid",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658060/,Positive,,Meta-analysis,2022,Cannabinol (CBN),,Anorexia Nervosa; Anorexia; Bacterial Infections; Epidermolysis bullosa; Inflammation; Pain; Pain - Acute; Pain - Chronic; Staph Infection
2008038,"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219532/,Inconclusive,,Meta-analysis,2008,Cannabigerol (CBG); Delta-8-THC; Tetrahydrocannabivarin (THCV),,
2002011,International Union of Pharmacology. XXVII. Classification of cannabinoid receptors,https://pubmed.ncbi.nlm.nih.gov/12037135/,Inconclusive,,Meta-analysis,2002,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),,
2016078,Involvement of transient receptor potential A1 channel in algesic and analgesic actions of the organic compound limonene,https://pubmed.ncbi.nlm.nih.gov/27030509/,Inconclusive,,Animal Study,2016,,Nervous System,Pain; Pain - Nociceptive; Oxidative Stress
2020187,Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical improvement after probiotic administration in dogs with chronic signs of colonic dysmotility without mucosal inflammatory changes,https://pubmed.ncbi.nlm.nih.gov/31495983/,Positive,,Animal Study -,2020,Microbiome,,Veterinary Applications; Irritable Bowel Syndrome
2021220,Cannabinoid Receptors Overexpression in a Rat Model of Irritable Bowel Syndrome (IBS) after Treatment with a Ketogenic Diet,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999285/,Positive,,Animal Study,2021,Diet,Digestive System,Irritable Bowel Syndrome
2020188,Irritable Bowel Syndrome: Manipulating the Endocannabinoid System as First-Line Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186328/,Positive,,Meta-analysis,2020,Palmitoylethanolamide (PEA),Digestive System,Irritable Bowel Syndrome
2020189,Endocannabinoid system in irritable bowel syndrome and cannabis as a therapy,https://pubmed.ncbi.nlm.nih.gov/31987224/,Positive,,Meta-analysis,2020,Endocannabinoid (unspecified),Digestive System,Irritable Bowel Syndrome
2022383,Cannabis and the heart: unchartered territory,https://pubmed.ncbi.nlm.nih.gov/36098056/,Inconclusive,,Meta-analysis,2022,,Cardiovascular System,Atherosclerosis; Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Heart Attack; Cardiac Toxicity
2021221,A study of abnormal cannabidiols system-mediated cardiovascular protection in disrupted gut/brain axis associated depression,https://pubmed.ncbi.nlm.nih.gov/34676637/,Inconclusive,,Meta-analysis,2021,Abnormal Cannabidiol (Abn-CBD),Cardiovascular System; Mental/Emotional System; Nervous System,Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Depression; Hypertension (High Blood Pressure)
2022384,Endocannabinoid Levels in Ulcerative Colitis Patients Correlate With Clinical Parameters and Are Affected by Cannabis Consumption,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438407/,Positive,,Clinical Trial,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Palmitoylethanolamide (PEA),Digestive System,IBD - Inflammatory Bowel Disease
2022385,Cannabinoid Therapeutic Effects in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599014/,Positive,,Clinical Meta-analysis,2022,,Digestive System,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease
2022386,"Phycocyanin stimulates ulcerative colitis healing via selective activation of cannabinoid receptor-2, intestinal mucosal healing, Treg accumulation, and p38MAPK/MK2 signaling inhibition",https://pubmed.ncbi.nlm.nih.gov/35777583/,Positive,,Animal Study,2022,Phycocyanin; Microbiome,Digestive System,IBD - Inflammatory Bowel Disease; Inflammation; Microbiome Imbalance
2022387,Cannabinoid Receptor 2 (CB2) Inverse Agonist SMM-189 Induces Expression of Endogenous CB2 and Protein Kinase A That Differentially Modulates the Immune Response and Suppresses Experimental Colitis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147685/,Positive,,Animal Study,2022,Synthetic Cannabinoid (unspecified),Digestive System,IBD - Inflammatory Bowel Disease; IBD - Crohn's Disease
2022388,Cannabis use and the risk of periodontitis: A two-sample Mendelian randomization study,https://onlinelibrary.wiley.com/doi/10.1111/jcpe.13632,Inconclusive,,Meta-analysis,2022,,Digestive System; Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Periodontal Disease; Addiction - Nicotine; Cannabis Adverse Effects
2022389,Herbal Cannabis Use Is Not Associated with Changes in Levels of Endocannabinoids and Metabolic Profile Alterations among Older Adults,https://www.mdpi.com/2075-1729/12/10/1539/htm,Inconclusive,,Clinical Trial,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Palmitoylethanolamide (PEA); Tetrahydrocannabinol (THC); Virodhamine (O-AEA),Cardiovascular System; Endocrine System; Muscular System; Nervous System; Skeletal System,Cardiovascular Diseases (CVD); Geriatric Conditions; Hypertension (High Blood Pressure); Metabolic Syndrome; Inflammation; Obesity; Parkinson's Disease
2022390,Cannabis Use for Endometriosis: Clinical and Legal Challenges in Australia and New Zealand,https://pubmed.ncbi.nlm.nih.gov/34978929/,Positive,,Meta-analysis,2022,,Endocrine System,Endometriosis
2022391,The Cannabis-Induced Epigenetic Regulation of Genes Associated with Major Depressive Disorder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407536/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,Depression; Bipolar Disorder; Epilepsy; Oxidative Stress; Psychosis; Schizophrenia
2022392,Anti-inflammatory effects of cannabidiol against lipopolysaccharides in cardiac sodium channels,https://pubmed.ncbi.nlm.nih.gov/35906756/,Positive,,Laboratory Study,2022,,Cardiovascular System; Immune System,Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Inflammation; Sepsis
2014056,The effect of cannabidiol on ischemia/reperfusion-induced ventricular arrhythmias: the role of adenosine A1 receptors,https://journals.sagepub.com/doi/10.1177/1074248414532013,Positive,,Animal Study,2014,Endocannabinoid (unspecified),Cardiovascular System,Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Heart Attack; Atherosclerosis; Huntington's Disease; Inflammation; Pain; Multiple Sclerosis; Oxidative Stress; Wound Healing
2022393,TRPV1: A Common Denominator Mediating Antinociceptive and Antiemetic Effects of Cannabinoids,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456209/,Positive,,Meta-analysis,2022,Capsaicin (CAPS); Endocannabinoid (unspecified); Anandamide (AEA); N-Arachidonoyl Dopamine (NADA); Pharma CBD; SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Digestive System; Nervous System,Pain; Nausea and Vomiting; Anorexia; Anxiety; Cannabis Adverse Effects; Cannabis Hyperemesis Syndrome; Depression; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; HIV/AIDS; Inflammation; Multiple Sclerosis; Pain - Central Pain Syndrome; Pain - Chronic; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral
2022394,Case Report: Superior Mesenteric Artery Syndrome in an Adolescent With Cannabinoid Hyperemesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898831/,Negative,,Meta-analysis,2022,,Nervous System,Cannabis Hyperemesis Syndrome; Pain; Pain - Chronic
2022395,Cannabinoid hyperemesis syndrome: A 6‐year audit of adult presentations to an urban district hospital,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545654/,Inconclusive,,Meta-analysis,2022,,Nervous System,Cannabis Hyperemesis Syndrome
2022396,Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence,https://pubmed.ncbi.nlm.nih.gov/36307209/,Negative,,Meta-analysis,2022,,Mental/Emotional System; Nervous System; Respiratory System,Addiction - Cannabis; Addiction; Cannabis Hyperemesis Syndrome; COVID-19
2021222,QTc prolongation in cannabis hyperemesis syndrome patients exposed to antiemetics: A retrospective chart review,https://pubmed.ncbi.nlm.nih.gov/34607736/,Inconclusive,,Meta-analysis,2021,,Cardiovascular System,Cannabis Hyperemesis Syndrome; Cardiac Arrhythmias; Cardiovascular Diseases (CVD)
2022397,Differentiating Diabetic Ketoacidosis and Hyperglycemic Ketosis Due to Cannabis Hyperemesis Syndrome in Adults With Type 1 Diabetes,https://pubmed.ncbi.nlm.nih.gov/34880067/,Inconclusive,,Meta-analysis,2022,,Endocrine System,Cannabis Hyperemesis Syndrome; Diabetes; Cannabis Adverse Effects; Metabolic Syndrome
2022398,"Changes in Emergency Department Visits for Cannabis Hyperemesis Syndrome Following Recreational Cannabis Legalization and Subsequent Commercialization in Ontario, Canada",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482056/,Inconclusive,,Meta-analysis,2022,,Nervous System,Cannabis Hyperemesis Syndrome; Cannabis Adverse Effects
2021223,Adolescent Cannabis Hyperemesis Syndrome During the COVID-19 Pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745939/,Negative,,Meta-analysis,2021,,Respiratory System,Cannabis Hyperemesis Syndrome; COVID-19; Cannabis Adverse Effects
2021224,Cannabis hyperemesis syndrome: Incidence and treatment with topical capsaicin,https://pubmed.ncbi.nlm.nih.gov/34756408/,Positive,,Meta-analysis,2021,Capsaicin (CAPS),Mental/Emotional System,Cannabis Adverse Effects; Cannabis Hyperemesis Syndrome
2022399,Cannabinoid hyperemesis syndrome and cannabis withdrawal syndrome: a review of the management of cannabis-related syndrome in the emergency department,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454163/,Negative,,Meta-analysis,2022,Tetrahydrocannabinol (THC); Pharma THC,Digestive System; Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cannabis Hyperemesis Syndrome; Nausea and Vomiting; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Opioid; Anorexia; Anxiety; Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Depression; Heart Attack; Inflammation; Insomnia and Sleep Disorders; Irritable Bowel Syndrome; Obesity; Pancreatitis
2021225,Fact or Faction Regarding the Relationship between Cannabis Use and Violent Behavior,https://pubmed.ncbi.nlm.nih.gov/34893489/,Negative,,Meta-analysis,2021,,Mental/Emotional System,Cannabis Adverse Effects; Domestic Abuse
2022400,"Cannabis use and risks of respiratory and all-cause morbidity and mortality: a population-based, data-linkage, cohort study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240874/#SP1,Inconclusive,,Meta-analysis,2022,,Mental/Emotional System; Nervous System; Respiratory System,Asthma; Bronchitis; Cannabis Adverse Effects; COPD; Acute Respiratory Distress Syndrome; Addiction - Nicotine; Bacterial Infections; Cannabis Hyperemesis Syndrome; Flu; Inflammation; Respiratory Syncytial Virus; Stress
2022401,Cannabidiol in the context of substance use disorder treatment: A systematic review,https://linkinghub.elsevier.com/retrieve/pii/S0306460322001265,Positive,,Meta-analysis,2022,SR-x Synthetic Cannabinoids; 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified),Mental/Emotional System,Addiction - Cannabis; Addiction - Nicotine; Addiction - Opioid; Addiction; Addiction - Alcohol; Addiction - Cocaine; Anxiety; Psychosis
2019084,Electroacupuncture inhibits mast cell degranulation via cannabinoid CB2 receptors in a rat model of allergic contact dermatitis,https://pubmed.ncbi.nlm.nih.gov/31429590/,Positive,,Animal Study,2019,Acupuncture (TCM),Integumentary System,Allergic Contact Dermatitis
2017066,"The endocannabinoid system, a novel and key participant in acupuncture's multiple beneficial effects",https://pubmed.ncbi.nlm.nih.gov/28412017/,Positive,,Meta-analysis,2017,Acupuncture (TCM); Endocannabinoid (unspecified),,Pain; Pain - Chronic; Pain - Inflammatory
2018080,Median nerve stimulation induces analgesia via orexin-initiated endocannabinoid disinhibition in the periaqueductal gray,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233149/,Positive,,Animal Study,2018,2-Arachidonoyl Glycerol (2-AG); Acupuncture (TCM); Monoacylglycerol Lipase (MAGL),Nervous System,Pain; Pain - Chronic
2011054,A novel mechanism for acupuncture-induced analgesia: involvement of orexins and endocannabinoids,https://onlinelibrary.wiley.com/doi/pdf/10.1111/jnc.12777,Positive,,Animal Study,2011,2-Arachidonoyl Glycerol (2-AG); Acupuncture (TCM),Nervous System,Pain; Pain - Chronic
2013047,Electroacupuncture inhibition of hyperalgesia in rats with adjuvant arthritis: involvement of cannabinoid receptor 1 and dopamine receptor subtypes in striatum,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677619/,Positive,,Animal Study,2013,Acupuncture (TCM),Skeletal System,Arthritis - Osteoarthritis; Arthritis
2012069,CB1 and CB2 contribute to antinociceptive and anti-inflammatory effects of electroacupuncture on experimental arthritis of the rat temporomandibular joint,https://pubmed.ncbi.nlm.nih.gov/23181276/,Positive,,Animal Study,2012,Acupuncture (TCM),Nervous System; Skeletal System,Arthritis - Osteoarthritis; Arthritis; Inflammation
2012070,Electroacupuncture inhibits CB1 upregulation induced by ethanol withdrawal in mice,https://pubmed.ncbi.nlm.nih.gov/22613131/,Positive,,Animal Study,2012,Acupuncture (TCM),Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction
2022402,Processing cardiovascular information in the vlPAG during electroacupuncture in rats: roles of endocannabinoids and GABA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2692771/,Positive,,Animal Study,2022,Acupuncture (TCM); Fatty Acid Amide Hydrolase (FAAH),Cardiovascular System,Cardiovascular Diseases (CVD)
2022403,Electroacupuncture Reduces Visceral Pain Via Cannabinoid CB2 Receptors in a Mouse Model of Inflammatory Bowel Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990228/,Positive,,Animal Study,2022,Acupuncture (TCM),Digestive System; Nervous System,IBD - Inflammatory Bowel Disease; Pain; Pain - Chronic
2022404,Electroacupuncture Reduces Anxiety Associated With Inflammatory Bowel Disease By Acting on Cannabinoid CB1 Receptors in the Ventral Hippocampus in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305710/,Positive,,Animal Study,2022,Acupuncture (TCM),Digestive System; Mental/Emotional System; Nervous System,Anxiety; IBD - Inflammatory Bowel Disease
2009037,Endogenous anandamide and cannabinoid receptor-2 contribute to electroacupuncture analgesia in rats,https://pubmed.ncbi.nlm.nih.gov/19409856/,Positive,,Animal Study,2009,Acupuncture (TCM); Anandamide (AEA),Nervous System,Inflammation; Pain - Chronic; Pain; Pain - Acute
2022405,Hypertensive Crisis-Related Hospitalizations and Subsequent Major Adverse Cardiac Events in Young Adults with Cannabis Use Disorder: A Nationwide Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609556/,Negative,,Meta-analysis,2022,Synthetic Cannabinoid (unspecified),Cardiovascular System; Mental/Emotional System,Addiction - Cannabis; Addiction; Cardiovascular Diseases (CVD); Heart Attack; Hypertension (High Blood Pressure); Stroke; Addiction - Alcohol; Addiction - Cocaine; Addiction - Nicotine; Addiction - Stimulant; Arthritis - Rheumatoid; Arthritis; Cancer - Lymphoma; Cancer - Metastatic; Cancer; Cardiac Arrhythmias; Chronic Heart Disease; Chronic Kidney Disease; COPD; Depression
2022406,Cannabis Use Among Young Adults in Washington State After Legalization of Nonmedical Cannabis,https://pubmed.ncbi.nlm.nih.gov/35319936/,Negative,,Meta-analysis,2022,,Mental/Emotional System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2022407,Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548192/,Positive,,Double Blind Clinical Trial,2022,Pharma THC:CBD; Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Anxiety; Depression; Insomnia and Sleep Disorders; Pain; Pain - Chronic
2022408,"Admissions to substance use treatment facilities for cannabis use disorder, 2000–2017: Does legalization matter?",https://pubmed.ncbi.nlm.nih.gov/35368113/,Positive,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2022409,N-acetyl cysteine in the treatment of cannabis use disorder: A systematic review of clinical trials,https://www.sciencedirect.com/science/article/abs/pii/S0306460322000491?via%3Dihub,Inconclusive,,Clinical Meta-analysis,2022,Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Addiction - Alcohol; Addiction - Cocaine; Addiction - Nicotine; Addiction - Stimulant; Cannabis Adverse Effects; Oxidative Stress; Psychosis
2022410,Prevalence and correlates of cannabis use disorder among Australians using cannabis products to treat a medical condition,https://onlinelibrary.wiley.com/doi/10.1111/dar.13444,Negative,,Meta-analysis,2022,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Addiction - Alcohol; Addiction - Nicotine; Addiction - Opioid; Behavioral Disorders; Addiction - Stimulant; Anxiety; Cancer; Chemotherapy-induced Nausea & Vomiting; Depression; Domestic Abuse; Insomnia and Sleep Disorders; Pain; Pain - Chronic; Psychosis
2021226,Cannabis use and medication nonadherence in bipolar disorder: A nationwide inpatient sample database analysis,https://www.sciencedirect.com/science/article/abs/pii/S0165032721013070?via%3Dihub,Negative,,Meta-analysis,2021,,Mental/Emotional System,Addiction - Cannabis; Addiction; Bipolar Disorder
2021227,Prevalence and Correlates of Cannabis Use and Cannabis Use Disorder Among U.S. Veterans: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III),https://pubmed.ncbi.nlm.nih.gov/34407625/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant; Cannabis Adverse Effects
2022411,"Trends in Cannabis Use Disorder Diagnoses in the U.S. Veterans Health Administration, 2005-2019",https://pubmed.ncbi.nlm.nih.gov/35899381/,Negative,,Meta-analysis,2022,,Mental/Emotional System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects; Pain
2022412,HU308 Mitigates Osteoarthritis by Stimulating Sox9-Related Networks of Carbohydrate Metabolism,https://pubmed.ncbi.nlm.nih.gov/36350089/,Positive,,Animal Study,2022,HU-x Synthetic Cannabinoids,Skeletal System,Arthritis - Osteoarthritis; Arthritis; Pain
2020190,Capsaicin Causes Vasorelaxation of Rat Aorta through Blocking of L-type Ca2+ Channels and Activation of CB1 Receptors,https://www.mdpi.com/1420-3049/25/17/3957/htm,Positive,,Animal Study,2020,Capsaicin (CAPS),,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2022413,The association between recreational cannabis use and posttraumatic stress disorder: A systematic review and methodological critique of the literature,https://www.sciencedirect.com/science/article/abs/pii/S037687162200360X?via%3Dihub,Negative,,Meta-analysis,2022,,Mental/Emotional System,Cannabis Adverse Effects; PTSD; Addiction - Cannabis
2022414,Identifying risk-thresholds for the association between frequency of cannabis use and development of cannabis use disorder: A systematic review and meta-analysis,https://www.sciencedirect.com/science/article/abs/pii/S0376871622003192?via%3Dihub,Negative,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Acute Respiratory Distress Syndrome; Addiction - Alcohol; Anxiety; Cannabis Adverse Effects; Cardiovascular Diseases (CVD); Cognitive Dysfunction; Depression; Neonatal Cerebral Issues; Pregnancy; Psychosis; Stress
2022415,Synaptic changes induced by cannabinoid drugs and cannabis use disorder,https://www.sciencedirect.com/science/article/pii/S0969996122000614?via%3Dihub,Inconclusive,,Meta-analysis,2022,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Cannabinol (CBN); CP-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); Tetrahydrocannabinol (THC); WIN-x Synthetic Cannabinoids,Mental/Emotional System,Addiction - Cannabis; Addiction; Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Opioid; Anorexia; Anxiety; Cannabis Adverse Effects; Depression
2022416,Long-term Cannabis Users Show Lower Cognitive Reserves and Smaller Hippocampal Volume in Midlife,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426660/,Negative,,Meta-analysis,2022,,Mental/Emotional System,Cannabis Adverse Effects; Cognitive Dysfunction; Addiction - Cannabis; Alzheimer's Disease; Dementia
2022417,"Associations between Cannabis Use, Cannabis Use Disorder and Mood Disorders: Longitudinal, Genetic, and Neurocognitive Evidence",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520129/,Inconclusive,,Meta-analysis,2022,,Mental/Emotional System,Addiction - Cannabis; Addiction; Bipolar Disorder; Depression; Suicide Attempt
2022418,"The Relations between Youth Cannabis Use, School Cannabis Use-Related Disciplinary Approaches and Student Perceptions of School Support",https://pubmed.ncbi.nlm.nih.gov/35306952/,Inconclusive,,Meta-analysis,2022,,Mental/Emotional System,Cannabis Adverse Effects
2022419,Cannabis use and subjective response to alcohol in the human laboratory,https://www.sciencedirect.com/science/article/abs/pii/S0376871622002186?via%3Dihub,Positive,,Meta-analysis,2022,Tetrahydrocannabinol (THC),Mental/Emotional System,Addiction - Alcohol; Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2022420,Serum Individual Nonesterified Fatty Acids and Risk of Heart Failure in Older Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547188/,Positive,,Meta-analysis,2022,Pentadecanoic acid (C15:0); Pentadecanoylcarnitine (PDC),Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack
2017067,Association between serum phospholipid fatty acid levels and adiposity in Mexican women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496042/,Positive,,Meta-analysis,2017,Pentadecanoic acid (C15:0); Pentadecanoylcarnitine (PDC),,Obesity
2021228,Circulating fatty acids and endocannabinoidome-related mediator profiles associated to human longevity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492808/,Positive,,Meta-analysis,2021,Anandamide (AEA); Pentadecanoic acid (C15:0); 2-Arachidonoyl Glycerol (2-AG); Palmitoylethanolamide (PEA); Pentadecanoylcarnitine (PDC),Integumentary System,Longevity
2022421,Saturated Fatty Acid Intake Is Associated with Total Mortality in a Nationwide Cohort Study,https://academic.oup.com/jn/article/149/1/68/5273185,Positive,,Meta-analysis,2022,Pentadecanoic acid (C15:0); Pentadecanoylcarnitine (PDC),Integumentary System,Longevity
2012071,Plasma phospholipid fatty acid concentration and incident coronary heart disease in men and women: the EPIC-Norfolk prospective study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389034/,Positive,,Meta-analysis,2012,Pentadecanoic acid (C15:0); Pentadecanoylcarnitine (PDC),Cardiovascular System,Cardiovascular Diseases (CVD)
2021229,"Biomarkers of dairy fat intake, incident cardiovascular disease, and all-cause mortality: A cohort study, systematic review, and meta-analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454979/,Positive,,Meta-analysis,2021,Pentadecanoic acid (C15:0); Pentadecanoylcarnitine (PDC),Cardiovascular System,Cardiovascular Diseases (CVD); Longevity
2020191,Meat Protein in High-Fat Diet Induces Adipogensis and Dyslipidemia by Altering Gut Microbiota and Endocannabinoid Dysregulation in the Adipose Tissue of Mice,https://pubmed.ncbi.nlm.nih.gov/32148030/,Positive,,Animal Study,2020,Microbiome,,Microbiome Imbalance; Obesity
2020192,Cannabinoids and the Microbiota-Gut-Brain Axis: Emerging Effects of Cannabidiol and Potential Applications to Alcohol Use Disorders,https://pubmed.ncbi.nlm.nih.gov/31803950/,Positive,,Meta-analysis,2020,Microbiome,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction
2022422,Vitamin D mitigates diabetes-associated metabolic and cognitive dysfunction by modulating gut microbiota and colonic cannabinoid receptor 1,https://pubmed.ncbi.nlm.nih.gov/34942358/,Positive,,Animal Study,2022,Microbiome,Endocrine System,Diabetes; Cognitive Dysfunction; Dystonia; Metabolic Syndrome; Obesity
2020193,Colonization with the commensal fungus Candida albicans perturbs the gut-brain axis through dysregulation of endocannabinoid signaling,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572798/,Positive,,Animal Study,2020,Anandamide (AEA); Microbiome,Digestive System; Immune System; Integumentary System,Fungal Infections; Anxiety; Dystonia
2012072,Cannabinoid signalling regulates inflammation and energy balance: the importance of the brain-gut axis,https://pubmed.ncbi.nlm.nih.gov/22269477/,Positive,,Meta-analysis,2012,Endocannabinoid (unspecified); Microbiome,Nervous System,Inflammation; IBD - Inflammatory Bowel Disease; Metabolic Syndrome; Obesity
2018081,"Gut microbiota, cannabinoid system and neuroimmune interactions: New perspectives in multiple sclerosis",https://pubmed.ncbi.nlm.nih.gov/30171835/,Positive,,Meta-analysis,2018,Endocannabinoid (unspecified); Microbiome,Nervous System,Multiple Sclerosis; Arthritis - Rheumatoid; Arthritis; IBD - Inflammatory Bowel Disease; Inflammation
2019085,Systemic administration of serotonin exacerbates abdominal pain and colitis via interaction with the endocannabinoid system,https://pubmed.ncbi.nlm.nih.gov/30611738/,Positive,,Animal Study,2019,Anandamide (AEA); Endocannabinoid (unspecified),Digestive System,IBD - Inflammatory Bowel Disease
2022423,Three of a Kind: Control of the Expression of Liver-Expressed Antimicrobial Peptide 2 (LEAP2) by the Endocannabinoidome and the Gut Microbiome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746324/,Positive,,Animal Study,2022,Microbiome; Endocannabinoid (unspecified),,Diabetes; Metabolic Syndrome; Microbiome Imbalance; Obesity
2012073,Crosstalk between the gut microbiota and the endocannabinoid system: impact on the gut barrier function and the adipose tissue,https://pubmed.ncbi.nlm.nih.gov/22647050/,Positive,,Meta-analysis,2012,Endocannabinoid (unspecified); Microbiome,Endocrine System,Obesity; Diabetes; Inflammation; Metabolic Syndrome
2022424,(Wh)olistic (E)ndocannabinoidome-Microbiome-Axis Modulation through (N)utrition (WHEN) to Curb Obesity and Related Disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759188/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified); Microbiome; 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Palmitoylethanolamide (PEA),Endocrine System,Obesity; Diabetes; Metabolic Syndrome; Microbiome Imbalance
2014057,"Glucose metabolism: focus on gut microbiota, the endocannabinoid system and beyond",https://pubmed.ncbi.nlm.nih.gov/24631413/,Positive,,Meta-analysis,2014,Endocannabinoid (unspecified); Microbiome,Digestive System,Microbiome Imbalance; Diabetes; Metabolic Syndrome; Obesity
2020194,The endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605024/,Positive,,Meta-analysis,2020,Microbiome,Digestive System,Microbiome Imbalance; ADD and ADHD; Anorexia Nervosa; Anorexia; Anxiety; Autism; Depression; Psychosis; Schizophrenia
2018082,New insights on atherosclerosis: A cross-talk between endocannabinoid systems with gut microbiota,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203867/,Positive,,Meta-analysis,2018,Endocannabinoid (unspecified); Microbiome,Cardiovascular System,Atherosclerosis; Cardiovascular Diseases (CVD); Microbiome Imbalance
2019086,Role of the Endocannabinoidome in Human and Mouse Atherosclerosis,https://pubmed.ncbi.nlm.nih.gov/31448709/,Positive,,Meta-analysis,2019,Endocannabinoid (unspecified); Microbiome,Cardiovascular System,Atherosclerosis; Cardiovascular Diseases (CVD)
2006014,Multiple sclerosis may disrupt endocannabinoid brain protection mechanism,https://www.pnas.org/doi/full/10.1073/pnas.0601847103,Positive,,Meta-analysis,2006,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified),Nervous System,Inflammation; Multiple Sclerosis; Neurodegenerative Issues; Traumatic Brain Injury
2005018,Therapeutic opportunities through modulation of the endocannabinoid system,https://www.sciencedirect.com/sdfe/pdf/download/eid/1-s2.0-S0028390805001152/first-page-pdf,Inconclusive,,Meta-analysis,2005,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Cannabichromene (CBC); Cannabichromenic Acid (CBC-a); Cannabigerol (CBG); Cannabinol (CBN); CP-x Synthetic Cannabinoids; HU-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC); WIN-x Synthetic Cannabinoids,,Inflammation; Pain; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral
2004018,Synthesis and antitumor activity of quinonoid derivatives of cannabinoids,https://pubmed.ncbi.nlm.nih.gov/15239658/,Positive,,Laboratory Study,2004,Cannabinol (CBN); Delta-8-THC,,Cancer; Oxidative Stress
2015080,"Intraperirhinal cortex administration of the synthetic cannabinoid, HU210, disrupts object recognition memory in rats",https://pubmed.ncbi.nlm.nih.gov/25714419/,Negative,,Animal Study,2015,HU-x Synthetic Cannabinoids,Nervous System,Cognitive Dysfunction; Poisoning by Synthetic Cannabis; Behavioral Disorders
2022425,Cannabidiol in canine epilepsy,https://www.sciencedirect.com/science/article/pii/S1090023322001289?via%3Dihub,Inconclusive,,Meta-analysis -,2022,Cannabidiolic Acid (CBD-a),,Epilepsy; Veterinary Applications; Anxiety; Arthritis - Osteoarthritis; Arthritis; Cancer; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Inflammation; Pain; Nausea and Vomiting
2021230,An Update on Perinatal Cannabis Use,https://pubmed.ncbi.nlm.nih.gov/34718147/,Negative,,Meta-analysis,2021,,Reproductive System,Pregnancy; Neonatal Cerebral Issues
2022426,"Mutual Links between the Endocannabinoidome and the Gut Microbiome, with Special Reference to Companion Animals: A Nutritional Viewpoint",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833664/,Positive,,Meta-analysis -,2022,Microbiome; Palmitoylethanolamide (PEA); Endocannabinoid (unspecified),Digestive System,Microbiome Imbalance; Veterinary Applications
2019087,The Expanded Endocannabinoid System/Endocannabinoidome as a Potential Target for Treating Diabetes Mellitus,https://pubmed.ncbi.nlm.nih.gov/31686231/,Positive,,Meta-analysis,2019,Endocannabinoid (unspecified); Microbiome,Endocrine System,Diabetes
2020195,Altered gut microbiota and endocannabinoid system tone in vitamin D deficiency-mediated chronic pain,https://pubmed.ncbi.nlm.nih.gov/30953765/,Positive,,Animal Study,2020,Microbiome; Palmitoylethanolamide (PEA); Vitamin D; 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified),Digestive System; Nervous System,Microbiome Imbalance; Pain; Pain - Chronic
2021231,At the heart of microbial conversations: endocannabinoids and the microbiome in cardiometabolic risk,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078674/,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified); Microbiome,Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Metabolic Syndrome; Microbiome Imbalance; Obesity
2016079,Endocannabinoids--at the crossroads between the gut microbiota and host metabolism,https://pubmed.ncbi.nlm.nih.gov/26678807/,Positive,,Meta-analysis,2016,Endocannabinoid (unspecified); Microbiome,,Inflammation; Metabolic Syndrome; Microbiome Imbalance; Obesity
2020196,Obesity Affects the Microbiota-Gut-Brain Axis and the Regulation Thereof by Endocannabinoids and Related Mediators,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084914/,Positive,,Meta-analysis,2020,Endocannabinoid (unspecified); Microbiome,Endocrine System,Obesity; Microbiome Imbalance
2021232,Endocannabinoid system mediates the association between gut-microbial diversity and anhedonia/amotivation in a general population cohort,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760063/,Positive,,Meta-analysis,2021,Microbiome; Palmitoylethanolamide (PEA),Digestive System,Microbiome Imbalance; Depression; Psychosis
2022427,Role of the Endocannabinoid System in the Regulation of Intestinal Homeostasis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500439/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified); Microbiome,Digestive System,Microbiome Imbalance; IBD - Inflammatory Bowel Disease; Irritable Bowel Syndrome
2021233,The Endocannabinoid System: A Bridge between Alzheimer's Disease and Gut Microbiota,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470731/,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Microbiome,Nervous System,Alzheimer's Disease; Microbiome Imbalance; Neurodegenerative Issues
2021234,"The gut microbiome, endocannabinoids and metabolic disorders",https://pubmed.ncbi.nlm.nih.gov/33337346/,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified); Microbiome,Endocrine System,Metabolic Syndrome; Diabetes; Obesity
2022428,"Interplay of gut microbiome, fatty acids, and the endocannabinoid system in regulating development, progression, immunomodulation, and chemoresistance of cancer",https://pubmed.ncbi.nlm.nih.gov/36055123/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified); Microbiome,,Cancer
2020197,Germ-free mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939599/,Inconclusive,,Animal Study,2020,Microbiome,,Microbiome Imbalance
2020198,Mgll Knockout Mouse Resistance to Diet-Induced Dysmetabolism Is Associated with Altered Gut Microbiota,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765900/,Positive,,Animal Study,2020,2-Arachidonoyl Glycerol (2-AG); Microbiome; Fatty Acid Amide Hydrolase (FAAH),Digestive System,Microbiome Imbalance; Obesity
2018083,"Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice",https://pubmed.ncbi.nlm.nih.gov/28890155/,Positive,,Animal Study,2018,Endocannabinoid (unspecified); Microbiome,Digestive System; Mental/Emotional System; Nervous System,Depression; Microbiome Imbalance
2013048,Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670398/,Positive,,Animal Study,2013,2-Arachidonoyl Glycerol (2-AG); Microbiome; Endocannabinoid (unspecified),Endocrine System,Obesity; Diabetes; Inflammation; Metabolic Syndrome; Microbiome Imbalance
2007024,Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors,https://pubmed.ncbi.nlm.nih.gov/17159985/,Positive,,Animal Study,2007,Microbiome,Nervous System,Pain; Pain - Chronic; IBD - Inflammatory Bowel Disease; Irritable Bowel Syndrome
2022429,The Microbiome and Gut Endocannabinoid System in the Regulation of Stress Responses and Metabolism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130962/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified); Microbiome,Endocrine System; Mental/Emotional System,Metabolic Syndrome; Obesity
2021235,"Mediterranean diet consumption affects the endocannabinoid system in overweight and obese subjects: possible links with gut microbiome, insulin resistance and inflammation",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437855/,Positive,,Clinical Trial,2021,Anandamide (AEA); Microbiome; 2-Arachidonoyl Glycerol (2-AG),Digestive System; Endocrine System; Nervous System,Diabetes; Inflammation; Microbiome Imbalance; Obesity; Metabolic Syndrome
2020199,Effect of gut microbiota on depressive-like behaviors in mice is mediated by the endocannabinoid system,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732982/,Positive,,Animal Study,2020,Endocannabinoid (unspecified); Microbiome,Mental/Emotional System; Nervous System,Depression
2022430,"Impact of cannabinoids on pregnancy, reproductive health and offspring outcomes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530020/,Negative,,Meta-analysis,2022,Pharma THC:CBD,Mental/Emotional System; Reproductive System,Addiction - Cannabis; Addiction; Cognitive Dysfunction; Infertility (Female); Infertility (Male); Neonatal Cerebral Issues; Pregnancy; Behavioral Disorders; Anorexia; Autism; Cancer; Cannabis Adverse Effects; Depression; Inflammation; Menopause; Menstrual Disorders; Pain; Nausea and Vomiting
2021236,Cannabis Use in Pregnancy: A State of the Science Review,https://pubmed.ncbi.nlm.nih.gov/34841645/,Negative,,Meta-analysis,2021,,Nervous System; Reproductive System,Cognitive Dysfunction; Neonatal Cerebral Issues; Pregnancy; Behavioral Disorders; Cannabis Adverse Effects
2022431,Long-term effects of prenatal cannabis exposure: Pathways to adolescent and adult outcomes,https://pubmed.ncbi.nlm.nih.gov/35216971/,Negative,,Meta-analysis,2022,,Mental/Emotional System; Reproductive System,Behavioral Disorders; Cognitive Dysfunction; Pregnancy; Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Nicotine; Addiction - Opioid; Neonatal Cerebral Issues; Psychosis
2022432,Oxidative Stress and Autophagy Mediate Anti-Cancer Properties of Cannabis Derivatives in Human Oral Cancer Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562878/,Positive,,Laboratory Study,2022,Delta-8-THC; Tetrahydrocannabinol (THC),Digestive System,Cancer - Oral; Cancer; Oxidative Stress; Inflammation
2021237,CB1R and iNOS are distinct players promoting pulmonary fibrosis in Hermansky–Pudlak syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255071/,Positive,,Laboratory Study,2021,Anandamide (AEA); Endocannabinoid (unspecified),Nervous System; Respiratory System,Fibrosis - Lung; Fibrosis; Inflammation; Oxidative Stress; Infertility (Female); Infertility (Male)
2021238,Chemical Emissions From Heated Vitamin E Acetate—Insights to Respiratory Risks From Electronic Cigarette Liquid Oil Diluents Used in the Aerosolization of Δ9-THC-Containing Products,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814346/,Negative,,Laboratory Study,2021,Synthetic Cannabinoid (unspecified),Respiratory System,Vaping injury (EVALI); Cannabis Adverse Effects
2022433,"Epilepsy and cannabis: so near, yet so far",https://pubmed.ncbi.nlm.nih.gov/34498262/,Negative,,Meta-analysis,2022,,,Epilepsy; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut
2016080,Antidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055126/,Positive,,Animal Study,2016,HU-x Synthetic Cannabinoids; Turmeric,Mental/Emotional System; Nervous System,Depression
2012074,The CB₁ receptor-mediated endocannabinoid signaling and NGF: the novel targets of curcumin,https://pubmed.ncbi.nlm.nih.gov/22311129/,Positive,,Animal Study,2012,Turmeric; AM-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,,Depression
2017068,Targeting the Endocannabinoid/CB1 Receptor System For Treating Major Depression Through Antidepressant Activities of Curcumin and Dexanabinol-Loaded Solid Lipid Nanoparticles,https://pubmed.ncbi.nlm.nih.gov/28848078/,Positive,,Animal Study,2017,HU-x Synthetic Cannabinoids; Turmeric,Mental/Emotional System; Nervous System,Depression
2011055,Targets of curcumin,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025067/,Positive,,Meta-analysis,2011,Turmeric,,Allergic Contact Dermatitis; Alzheimer's Disease; Arthritis - Osteoarthritis; Arthritis; Asthma; Cancer; Cannabis Allergies; Cardiovascular Diseases (CVD); Cataract; Diabetes; Epilepsy; Fibrosis - Lung; Fibrosis; IBD - Inflammatory Bowel Disease; HIV/AIDS; Inflammation; Metabolic Syndrome; Multiple Sclerosis; Oxidative Stress; Parkinson's Disease
2020200,Curcumin in Depression: Potential Mechanisms of Action and Current Evidence—A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728608/,Positive,,Meta-analysis,2020,Turmeric,Mental/Emotional System; Nervous System,Depression
2022434,Role of the endocannabinoid system in the pathophysiology of endometriosis and therapeutic implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540712/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Palmitoylethanolamide (PEA); Virodhamine (O-AEA); WIN-x Synthetic Cannabinoids,Endocrine System,Endometriosis; Infertility (Female); Inflammation; Pain; Pain - Inflammatory
2022435,Changes in the expression of endocannabinoid system components in an experimental model of chemotherapy-induced peripheral neuropathic pain: Evaluation of sex-related differences,https://pubmed.ncbi.nlm.nih.gov/36179876/,Positive,,Animal Study,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH),Nervous System,Pain; Pain - Cancer; Pain - Neuropathy - Drug-Ind. Polyneuropathy; Pain - Neuropathy - Peripheral; Chemotherapy-induced Nausea & Vomiting
2022436,Medical Cannabis Use Patterns and Adverse Effects in Inflammatory Bowel Disease,https://pubmed.ncbi.nlm.nih.gov/36227025/,Positive,,Meta-analysis,2022,,Digestive System,IBD - Inflammatory Bowel Disease; Anxiety; Depression; Irritable Bowel Syndrome
2019088,Emerging Class of Omega-3 Fatty Acid Endocannabinoids & Their Derivatives,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685292/,Positive,,Meta-analysis,2019,Omega-3,,Cancer; Inflammation; Pain; Pain - Chronic
2022437,Cannabis-Based Products for Chronic Pain : A Systematic Review,https://www.acpjournals.org/doi/10.7326/M21-4520,Positive,,Clinical Meta-analysis,2022,Pharma CBD; Pharma THC:CBD; Pharma THC; Tetrahydrocannabinol (THC),Nervous System,Pain; Pain - Chronic; Addiction - Cannabis; Addiction - Opioid; Arthritis; Cognitive Dysfunction; Inflammation; Pain - Neuropathy - Peripheral; Psychosis
2022438,"Randomised, pragmatic, waitlist controlled trial of cannabis added to prescription opioid support on opioid dose reduction and pain in adults with chronic non-cancer pain: study protocol",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185656/,Inconclusive,,Meta-analysis,2022,Pharma THC:CBD; Pharma THC,,Pain; Pain - Chronic; Addiction - Opioid
2022439,Adverse events of recreational cannabis use during pregnancy reported to the French Addictovigilance Network between 2011 and 2020,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530152/,Negative,,Clinical Trial,2022,,Mental/Emotional System; Nervous System; Reproductive System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects; Neonatal Cerebral Issues; Pregnancy; Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Anxiety; Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Epilepsy; Kidney Failure; Nausea and Vomiting
2022440,Shifting the Paradigm on Cannabis Safety,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864419/,Negative,,Meta-analysis,2022,Pharma CBD,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Addiction - Cannabis; Addiction - Nicotine; Anxiety; Cancer - Lung; Cancer - Oral; Cancer - Testicular; Cancer; Cannabis Hyperemesis Syndrome; Cardiovascular Diseases (CVD); Cognitive Dysfunction; Depression; Epilepsy; IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Infertility (Female); Infertility (Male); Inflammation; Oxidative Stress; Psychosis
2022441,Cannabis and the Violent Crime Surge,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462911/,Negative,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Domestic Abuse; Behavioral Disorders; Depression; Neonatal Cerebral Issues; Pregnancy; Psychosis; Schizophrenia
2021239,Cannabis exposure during adolescence: A uniquely sensitive period for neurobiological effects,https://pubmed.ncbi.nlm.nih.gov/34801175/,Negative,,Meta-analysis,2021,Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,Behavioral Disorders; Cannabis Adverse Effects; Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant; Autism; Psychosis; Schizophrenia
2022442,Cannabis Vaping Among Youth and Young Adults: a Scoping Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9078633/,Negative,,Meta-analysis,2022,,Respiratory System,Vaping injury (EVALI)
2022443,The inverse association of state cannabis vaping prevalence with the e-cigarette or vaping product-use associated lung injury,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0276187,Inconclusive,,Meta-analysis,2022,,Respiratory System,Vaping injury (EVALI)
1988001,Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory,https://pubmed.ncbi.nlm.nih.gov/3228283/,Positive,,Clinical Trial,1988,,,Anorexia Nervosa; Anorexia; Cachexia
1993004,Effect of dronabinol on nutritional status in HIV infection,https://pubmed.ncbi.nlm.nih.gov/8395916/,Positive,,Clinical Trial,1993,Pharma THC,Immune System,HIV/AIDS; Anorexia Nervosa; Anorexia; Cachexia
1997003,Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia,https://pubmed.ncbi.nlm.nih.gov/9223837/,Positive,,Clinical Trial,1997,Pharma THC,Digestive System; Immune System,Anorexia; HIV/AIDS; Cachexia; Loss of Appetite
2015081,Hypothalamic POMC neurons promote cannabinoid-induced feeding,https://www.nature.com/articles/nature14260,Positive,,Animal Study,2015,,,Anorexia Nervosa; Anorexia; Cachexia
2021240,The Effect of Cannabis-Based Medicine in the Treatment of Cachexia: A Systematic Review and Meta-Analysis,https://pubmed.ncbi.nlm.nih.gov/34664988/,Inconclusive,,Clinical Meta-analysis,2021,,Digestive System; Muscular System,Cachexia
2012075,Lower levels of cannabinoid 1 receptor mRNA in female eating disorder patients: association with wrist cutting as impulsive self-injurious behavior,https://pubmed.ncbi.nlm.nih.gov/22542985/,Inconclusive,,Meta-analysis,2012,,Mental/Emotional System,Anorexia Nervosa; Anorexia
2011056,Fish oil promotes survival and protects against cognitive decline in severely undernourished mice by normalizing satiety signals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117120/,Positive,,Animal Study,2011,2-Arachidonoyl Glycerol (2-AG),,Anorexia Nervosa; Anorexia
2009038,Elevated cannabinoid 1 receptor mRNA is linked to eating disorder related behavior and attitudes in females with eating disorders,https://pubmed.ncbi.nlm.nih.gov/19046818/,Inconclusive,,Meta-analysis,2009,,Mental/Emotional System,Anorexia Nervosa; Anorexia
2016081,Association between cerebral cannabinoid 1 receptor availability and body mass index in patients with food intake disorders and healthy subjects: a [(18)F]MK-9470 PET study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545708/,Inconclusive,,Meta-analysis,2016,,Mental/Emotional System,Anorexia Nervosa; Anorexia
1983001,A Double-Blind Trial of Δ9-Tetrahydrocannabinol in Primary Anorexia Nervosa,https://journals.lww.com/psychopharmacology/Abstract/1983/06000/A_Double_Blind_Trial_of__9_Tetrahydrocannabinol_in.4.aspx,Negative,,Double Blind Clinical Trial,1983,,Mental/Emotional System,Anorexia Nervosa; Anorexia
2018084,The effect of dronabinol in a male patient with anorexia nervosa suffering from severe acute urge to be physically active,https://pubmed.ncbi.nlm.nih.gov/29197104/,Positive,,Meta-analysis,2018,Pharma THC,Mental/Emotional System,Anorexia Nervosa; Anorexia
2015082,"Changes in IGF-I, urinary free cortisol and adipokines during dronabinol therapy in anorexia nervosa: Results from a randomised, controlled trial",https://pubmed.ncbi.nlm.nih.gov/26248813/,Positive,,Double Blind Clinical Trial,2015,Pharma THC,Mental/Emotional System,Anorexia Nervosa; Anorexia
2010048,"Activity-based anorexia in C57/BL6 mice: effects of the phytocannabinoid, Delta9-tetrahydrocannabinol (THC) and the anandamide analogue, OMDM-2",https://pubmed.ncbi.nlm.nih.gov/20471226/,Inconclusive,,Animal Study,2010,,Mental/Emotional System,Anorexia Nervosa; Anorexia
2019089,"Effect of dronabinol therapy on physical activity in anorexia nervosa: a randomised, controlled trial",https://pubmed.ncbi.nlm.nih.gov/24890912/,Inconclusive,,Double Blind Clinical Trial,2019,Pharma THC,Mental/Emotional System,Anorexia Nervosa; Anorexia
2017069,Do cannabinoids constitute a therapeutic alternative for anorexia nervosa?,https://pubmed.ncbi.nlm.nih.gov/29194432/,Inconclusive,,Meta-analysis,2017,,Mental/Emotional System,Anorexia Nervosa; Anorexia
2011057,The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058662/,Inconclusive,,Meta-analysis,2011,Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System,Anorexia Nervosa; Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine; Anorexia
2017070,Cannabinoid CB1/CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity‐based anorexia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522993/,Positive,,Animal Study,2017,Tetrahydrocannabinol (THC); WIN-x Synthetic Cannabinoids; CP-x Synthetic Cannabinoids,Digestive System; Mental/Emotional System,Anorexia Nervosa; Anorexia
2011058,The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096804/,Positive,,Animal Study,2011,Tetrahydrocannabinol (THC),Mental/Emotional System,Anorexia Nervosa; Anorexia
2004019,Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: differences between restricting and binging/purging subtypes,https://pubmed.ncbi.nlm.nih.gov/14755457/,Inconclusive,,Meta-analysis,2004,,Mental/Emotional System,Anorexia Nervosa; Anorexia
2014058,Small animal PET imaging of the type 1 cannabinoid receptor in a rodent model for anorexia nervosa,https://pubmed.ncbi.nlm.nih.gov/24006151/,Inconclusive,,Animal Study,2014,,Mental/Emotional System,Anorexia Nervosa; Anorexia
2014059,Association of the c.385C>A (p.Pro129Thr) polymorphism of the fatty acid amide hydrolase gene with anorexia nervosa in the Japanese population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113271/,Inconclusive,,Meta-analysis,2014,Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System,Anorexia Nervosa; Anorexia
2013049,"Dysfunctions of leptin, ghrelin, BDNF and endocannabinoids in eating disorders: beyond the homeostatic control of food intake",https://pubmed.ncbi.nlm.nih.gov/23313276/,Inconclusive,,Meta-analysis,2013,Endocannabinoid (unspecified),Mental/Emotional System,Anorexia Nervosa; Anorexia
2005019,Endocannabinoids and food intake: newborn suckling and appetite regulation in adulthood,https://pubmed.ncbi.nlm.nih.gov/15792943/,Positive,,Meta-analysis,2005,Endocannabinoid (unspecified),,Anorexia Nervosa; Anorexia; Pregnancy
2006015,"Endocannabinoids, feeding and suckling--from our perspective",https://pubmed.ncbi.nlm.nih.gov/16570101/,Inconclusive,,Meta-analysis,2006,Anandamide (AEA),,Anorexia Nervosa; Anorexia; Cachexia; Pregnancy
2011059,Brain type 1 cannabinoid receptor availability in patients with anorexia and bulimia nervosa,https://pubmed.ncbi.nlm.nih.gov/21718968/,Inconclusive,,Meta-analysis,2011,,Mental/Emotional System,Anorexia Nervosa; Anorexia
2011060,Functional polymorphism in the GPR55 gene is associated with anorexia nervosa,https://pubmed.ncbi.nlm.nih.gov/20506567/,Inconclusive,,Meta-analysis,2011,,Mental/Emotional System,Anorexia Nervosa; Anorexia
2017071,2-Arachidonoylglycerol as a possible treatment for anorexia nervosa in animal model in mice,https://pubmed.ncbi.nlm.nih.gov/28606779/,Positive,,Animal Study,2017,2-Arachidonoyl Glycerol (2-AG),Mental/Emotional System,Anorexia Nervosa; Anorexia
2018085,Changes in the Peripheral Endocannabinoid System as a Risk Factor for the Development of Eating Disorders,https://pubmed.ncbi.nlm.nih.gov/29437028/,Positive,,Meta-analysis,2018,Endocannabinoid (unspecified),Mental/Emotional System,Anorexia Nervosa; Anorexia
2009039,"Leptin, ghrelin, and endocannabinoids: potential therapeutic targets in anorexia nervosa",https://pubmed.ncbi.nlm.nih.gov/18926548/,Positive,,Meta-analysis,2009,Endocannabinoid (unspecified),Mental/Emotional System,Anorexia Nervosa; Anorexia
2020201,Altered circulating endocannabinoids in anorexia nervosa during acute and weight-restored phases: A pilot study,https://pubmed.ncbi.nlm.nih.gov/31713283/,Inconclusive,,Meta-analysis,2020,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Mental/Emotional System,Anorexia Nervosa; Anorexia
2021241,Variability in cannabinoid receptor genes is associated with psychiatric comorbidities in anorexia nervosa,https://pubmed.ncbi.nlm.nih.gov/33575982/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System,Anorexia Nervosa; Anorexia
2015083,Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa,https://pubmed.ncbi.nlm.nih.gov/25646322/,Inconclusive,,Meta-analysis,2015,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Other Related Compounds; Palmitoylethanolamide (PEA),Mental/Emotional System,Anorexia Nervosa; Anorexia
2008039,Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2602990/,Inconclusive,,Meta-analysis,2008,Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Mental/Emotional System,Anorexia Nervosa
2005020,"Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa",https://pubmed.ncbi.nlm.nih.gov/15841111/,Inconclusive,,Meta-analysis,2005,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Mental/Emotional System,Anorexia Nervosa; Anorexia
2009040,Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects,https://pubmed.ncbi.nlm.nih.gov/19659925/,Inconclusive,,Meta-analysis,2009,Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System,Anorexia Nervosa; Anorexia
2019090,Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa,https://pubmed.ncbi.nlm.nih.gov/31456239/,Inconclusive,,Animal Study,2019,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Mental/Emotional System,Anorexia Nervosa
1982001,Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects,https://pubmed.ncbi.nlm.nih.gov/6285406/,Positive,,Double Blind Clinical Trial,1982,,Mental/Emotional System,Anxiety; Cannabis Adverse Effects
1981003,Single-dose study of nabilone in anxious volunteers,https://pubmed.ncbi.nlm.nih.gov/6117576/,Inconclusive,,Clinical Trial,1981,Pharma THC,Mental/Emotional System; Nervous System,Anxiety
1981004,The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxiety,https://pubmed.ncbi.nlm.nih.gov/6117575/,Positive,,Double Blind Clinical Trial,1981,Pharma THC,Mental/Emotional System; Nervous System,Anxiety
2014060,"Dronabinol in severe, enduring anorexia nervosa: a randomized controlled trial",https://pubmed.ncbi.nlm.nih.gov/24105610/,Positive,,Double Blind Clinical Trial,2014,Pharma THC,Mental/Emotional System,Anorexia Nervosa; Anorexia
2022444,Medical Cannabis Patients Report Improvements in Health Functioning and Reductions in Opiate Use,https://www.tandfonline.com/doi/full/10.1080/10826084.2022.2107673,Positive,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
2022445,Cannabis use and patterns of psychotic symptomatology in a longitudinal birth cohort,https://pubmed.ncbi.nlm.nih.gov/36137764/,Inconclusive,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Psychosis; Schizophrenia
2022446,Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574068/,Positive,,Clinical Trial,2022,,Mental/Emotional System; Nervous System; Respiratory System,Anxiety; COVID-19
2022447,Cannabis Therapies for Low Back Pain: An Observational Open-Label Study,https://www.rmmj.org.il/userimages/1442/2/PublishFiles/1518Article.pdf,Positive,,Clinical Trial,2022,,Nervous System,Pain; Pain - Chronic
2022448,Cannabis Use Is Inversely Associated with Metabolic Disorders in Hepatitis C-Infected Patients (ANRS CO22 Hepather Cohort),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605108/,Positive,,Meta-analysis,2022,,Digestive System; Endocrine System,Hepatitis; Metabolic Syndrome; Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2022449,Longitudinal effects of cannabis use on attentional processes in patients with first episode of psychosis,https://www.sciencedirect.com/science/article/abs/pii/S0920996422001852?via%3Dihub,Negative,,Clinical Trial,2022,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia; Addiction - Cannabis; Behavioral Disorders; Cannabis Adverse Effects
2022450,Editorial: Early Cannabis Exposure Definitions That Correspond With High Cumulative Lifetime Dose During Adolescence Are the Strongest Predictors of Adverse Health Outcomes,https://pubmed.ncbi.nlm.nih.gov/35248431/,Negative,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2022451,The effects of cannabis use on physical health: A co-twin control study,https://pubmed.ncbi.nlm.nih.gov/34871975/,Inconclusive,,Clinical Trial,2022,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2022452,Clinical manifestations and serious adverse effects after cannabis use: role of age according to sex and coingestion of alcohol,https://pubmed.ncbi.nlm.nih.gov/35833766/,Negative,,Clinical Trial,2022,,Mental/Emotional System,Addiction - Alcohol; Addiction; Cannabis Adverse Effects; Behavioral Disorders; Nausea and Vomiting; Psychosis
2022453,Sex differences in medical cannabis-related adverse effects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009319/,Negative,,Meta-analysis,2022,Cannabichromene (CBC); Cannabigerol (CBG); Cannabinol (CBN); Tetrahydrocannabinolic Acid (THC-a),Mental/Emotional System,Cannabis Adverse Effects; Pain; Pain - Acute; Pain - Chronic
2022454,Long-term and serious harms of medical cannabis and cannabinoids for chronic pain: a systematic review of non-randomised studies,https://bmjopen.bmj.com/content/12/8/e054282,Negative,,Meta-analysis,2022,Anandamide (AEA); Palmitoylethanolamide (PEA); Pharma THC:CBD; Pharma THC,Mental/Emotional System,Cannabis Adverse Effects; Pain; Pain - Chronic; Addiction - Cannabis; Anxiety; Arthritis - Osteoarthritis; Arthritis; Cancer; Depression; Fibromyalgia; Inflammation; Irritable Bowel Syndrome; Multiple Sclerosis; Oxidative Stress; Pain - Neuropathy - Peripheral; Stroke
2021242,Cannabis consumption in young adults with cancer: descriptive study,https://pubmed.ncbi.nlm.nih.gov/35788467/,Positive,,Meta-analysis,2021,,Nervous System,Cancer; Anxiety; Chemotherapy-induced Nausea & Vomiting; Insomnia and Sleep Disorders; Pain; Nausea and Vomiting; Pain - Cancer
2022455,Controversial Link between Cannabis and Anticancer Treatments—Where Are We and Where Are We Going? A Systematic Review of the Literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406903/,Positive,,Meta-analysis,2022,Pharma THC:CBD; Pharma THC; Tetrahydrocannabinol (THC),,Cancer; Anorexia; Anxiety; Cancer - Colon; Cancer - Brain; Cancer - Cervical; Cancer - Leukemia; Cancer - Lung; Cancer - Ovarian; Cancer - Pancreatic; Cancer - Prostate; Cancer - Soft Tissues; Cancer - Stomach; Cancer - Testicular; Cancer - Uterine; Chemotherapy-induced Nausea & Vomiting; Cognitive Dysfunction; Pain; Palliative Care; Pain - Neuropathy - Drug-Ind. Polyneuropathy
2022456,Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220307/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified); Cannabichromene (CBC); Cannabigerol (CBG); Tetrahydrocannabinol (THC),,Cancer; Anxiety; Cancer - Colon; Cancer - Breast; Cancer - Lung; Cancer - Metastatic; Cancer - Prostate; Chemotherapy-induced Nausea & Vomiting; Depression; Inflammation; Insomnia and Sleep Disorders; Pain; Oxidative Stress; Pain - Cancer; Psychosis
2022457,"Cannabis as a potential compound against various malignancies, legal aspects, advancement by exploiting nanotechnology and clinical trials",https://pubmed.ncbi.nlm.nih.gov/35321629/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified),Nervous System,Cancer; Pain; Pain - Cancer
2022458,Therapeutic Potential of Cannabinoids on Tumor Microenvironment: A Molecular Switch in Neoplasia Transformation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425895/,Inconclusive,,Meta-analysis,2022,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,,Cancer; Cancer - Kidney; Anorexia; Cancer - Bladder; Cancer - Brain; Cancer - Breast; Cancer - Lung; Cancer - Metastatic; Cancer - Squamous Head/Neck; Pain; Multiple Sclerosis; Nausea and Vomiting; Palliative Care; Oxidative Stress
2022459,In the weeds: a retrospective study of patient interest in and experience with cannabis at a cancer center,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165925/,Positive,,Meta-analysis,2022,,,Cancer; Cancer - Kidney; Anorexia; Anxiety; Cancer - Colon; Cancer - Bladder; Cancer - Breast; Cancer - Metastatic; Cancer - Ovarian; Cancer - Prostate; Cancer - Squamous Head/Neck; Cancer - Stomach; Chemotherapy-induced Nausea & Vomiting; Depression; Insomnia and Sleep Disorders; Pain; Nausea and Vomiting; Pain - Cancer
2022460,Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9565400/,Positive,,Clinical Trial,2022,Cannabidiolic Acid (CBD-a); Cannabinol (CBN),Nervous System,Pain; Pain - Cancer; Cancer - Breast; Cancer - Metastatic; Cancer - Prostate; Cancer; HIV/AIDS; Insomnia and Sleep Disorders; Nausea and Vomiting; Pain - Chronic
2022461,Long-term observational studies with cannabis-based medicines for chronic non-cancer pain: A systematic review and meta-analysis of effectiveness and safety,https://onlinelibrary.wiley.com/doi/10.1002/ejp.1957,Positive,,Meta-analysis,2022,Fatty Acid Amide Hydrolase (FAAH); Pharma CBD; Pharma THC:CBD; Pharma THC,,Pain; Pain - Chronic; Addiction - Opioid; Anxiety; Depression; Insomnia and Sleep Disorders; Pain - Neuropathy - Peripheral
2022462,Practical Considerations for the Use of Cannabis in Cancer Pain Management—What a Medical Oncologist Should Know,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457511/,Positive,,Meta-analysis,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); AM-x Synthetic Cannabinoids; Pharma CBD; Pharma THC:CBD; Pharma THC; WIN-x Synthetic Cannabinoids,,Cancer; Pain; Pain - Cancer; Addiction - Opioid; Chemotherapy-induced Nausea & Vomiting; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; HIV/AIDS; Nausea and Vomiting; Pain - Neuropathy - Peripheral
2022463,"The Role of Nutritional Status, Gastrointestinal Peptides, and Endocannabinoids in the Prognosis and Treatment of Children with Cancer",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106013/,Inconclusive,,Meta-analysis,2022,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Cannabigerol (CBG); Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); Tetrahydrocannabinol (THC),,Cancer; Anorexia; Bone Fractures; Cancer - Bone; Cancer - Brain; Cancer - Breast; Cancer - Leukemia; Cancer - Lymphoma; Cancer - Melanoma; Cancer - Neuroblastoma; Cancer - Pancreatic; Pain; Obesity; Osteoporosis
2022464,Biological effects of cannabidiol on human cancer cells: Systematic review of the literature,https://www.sciencedirect.com/science/article/abs/pii/S1043661822002122?via%3Dihub,Inconclusive,,Meta-analysis,2022,Cannabinol (CBN); Endocannabinoid (unspecified),,Cancer; Cancer - Colon; Cancer - Bladder; Cancer - Brain; Cancer - Breast; Cancer - Cervical; Cancer - Leukemia; Cancer - Lymphoma; Cancer - Metastatic; Cancer - Myeloma; Cancer - Neuroblastoma; Cancer - Prostate; Cancer - Skin (Non-melanoma); Cancer - Uterine; Inflammation
2022465,Single and Repeated Exposure to Cannabidiol Differently Modulate BDNF Expression and Signaling in the Cortico-Striatal Brain Network,https://www.mdpi.com/2227-9059/10/8/1853/htm,Positive,,Animal Study,2022,Cannabigerol (CBG),,Neurodegenerative Issues; Behavioral Disorders
2022466,"Preclinical Assessment of the Abuse Potential of Purified Botanical Cannabidiol: Self-Administration, Drug Discrimination, and Physical Dependence",https://pubmed.ncbi.nlm.nih.gov/35489780/,Positive,,Meta-analysis,2022,Pharma CBD,Mental/Emotional System,Addiction - Benzodiazepine; Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2022467,A Review on the Bioactivity of Cannabinoids on Zebrafish Models: Emphasis on Neurodevelopment,https://www.mdpi.com/2227-9059/10/8/1820/htm,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified); AM-x Synthetic Cannabinoids; Anandamide (AEA); Cannabichromene (CBC); Cannabidivarin (CBDV); Cannabigerol (CBG); Cannabinol (CBN); CP-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Pharma CBD; Tetrahydrocannabivarin (THCV); Pharma THC; Tetrahydrocannabinol (THC); WIN-x Synthetic Cannabinoids,,Alzheimer's Disease; Anorexia; Anxiety; Arthritis - Rheumatoid; Arthritis; Autism; Cancer; Epilepsy - Dravet Syndrome; Epilepsy; Fibromyalgia; Pain; Multiple Sclerosis; Nausea and Vomiting; Neurodegenerative Issues; Oxidative Stress; Pain - Chronic; Psychosis
2022468,Cannabidiol Increases Seizure Resistance and Improves Behavior in an Scn8a Mouse Model,https://www.frontiersin.org/articles/10.3389/fphar.2022.815950/full#h3,Positive,,Animal Study,2022,,Mental/Emotional System,Behavioral Disorders; Epilepsy; ADD and ADHD; Autism
2022469,A Low Dose of Pure Cannabidiol Is Sufficient to Stimulate the Cytotoxic Function of CIK Cells without Exerting the Downstream Mediators in Pancreatic Cancer Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998663/,Positive,,Laboratory Study,2022,,Endocrine System; Nervous System,Cancer - Pancreatic; Cancer; Inflammation
2022470,Cannabis sativa Extract Induces Apoptosis in Human Pancreatic 3D Cancer Models: Importance of Major Antioxidant Molecules Present Therein,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880463/,Positive,,Laboratory Study,2022,Cannabichromene (CBC); Cannabichromenic Acid (CBC-a); Cannabidiolic Acid (CBD-a); Cannabigerol (CBG); Cannabigerolic Acid (CBG-a); Cannabinol (CBN); Delta-8-THC; Tetrahydrocannabivarin (THCV); Tetrahydrocannabinol (THC); Tetrahydrocannabinolic Acid (THC-a),Endocrine System; Nervous System,Cancer - Pancreatic; Cancer; Oxidative Stress; Inflammation
2022471,Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased β2 adrenergic agonist,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901637/,Positive,,Laboratory Study,2022,Endocannabinoid (unspecified),Endocrine System; Nervous System,Cancer - Pancreatic; Cancer; Cancer - Brain; Cancer - Breast; Cancer - Melanoma
2022472,Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What About Pancreatic Cancer?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931882/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); CP-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC); WIN-x Synthetic Cannabinoids,Endocrine System,Cancer - Pancreatic; Cancer; Cancer - Brain; Cancer - Breast; Cancer - Lung; Cancer - Lymphoma; Cancer - Prostate; Cancer - Skin (Non-melanoma); Pain; Nausea and Vomiting; Palliative Care; Oxidative Stress; Pain - Cancer
2022473,Antitumor Effects of Cannabinoids in Human Pancreatic Ductal Adenocarcinoma Cell Line (Capan-2)-Derived Xenograft Mouse Model,https://www.frontiersin.org/articles/10.3389/fvets.2022.867575/full,Positive,,Animal Study,2022,Tetrahydrocannabinol (THC),Endocrine System; Nervous System,Cancer - Pancreatic; Cancer
2022474,Targeting the Endocannabinoidome in Pancreatic Cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869154/,Positive,,Meta-analysis,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); N-Arachidonoyl Dopamine (NADA); Palmitoylethanolamide (PEA); Virodhamine (O-AEA); WIN-x Synthetic Cannabinoids,Endocrine System,Cancer - Pancreatic; Cancer; Inflammation
2022475,Biophysical Studies and In Vitro Effects of Tumor Cell Lines of Cannabidiol and Its Cyclodextrin Inclusion Complexes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027293/,Positive,,Laboratory Study,2022,Tetrahydrocannabinol (THC),Muscular System; Nervous System,Cancer - Soft Tissues; Cancer; Cachexia; Cancer - Brain; Pain; Nausea and Vomiting; Pain - Cancer
2021243,Cannabinoid interventions for improving cachexia outcomes in cancer: a systematic review and meta‐analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818598/,Inconclusive,,Meta-analysis,2021,Pharma THC:CBD; Pharma THC,Digestive System; Muscular System; Nervous System,Cachexia; Cancer
2022476,"In vitro percutaneous absorption studies of cannabidiol using human skin: Exploring the effect of drug concentration, chemical enhancers, and essential oils",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876728/,Positive,,Laboratory Study,2022,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Cannabichromene (CBC); Cannabidivarin (CBDV); Cannabigerol (CBG); CP-x Synthetic Cannabinoids; Delta-8-THC; HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Palmitoylethanolamide (PEA); Pharma CBD; Tetrahydrocannabivarin (THCV); Virodhamine (O-AEA); WIN-x Synthetic Cannabinoids,Integumentary System; Nervous System,Inflammation; Skin Diseases; Alzheimer's Disease; Cancer; Pain
2022477,Targeting cannabinoid receptor 2 (CB2) limits collagen production-An in vitro study in a primary culture of human fibroblasts,https://onlinelibrary.wiley.com/doi/epdf/10.1111/fcp.12716,Positive,,Laboratory Study,2022,AM-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,Immune System; Integumentary System,Fibrosis - Skin; Fibrosis; Inflammation; Wound Healing; Skin Diseases
2022478,Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221388/,Positive,,Laboratory Study,2022,Cannabigerol (CBG),Digestive System; Immune System; Integumentary System; Nervous System,Cancer - Liver; Cancer; Wound Healing
2022479,Anti-inflammation and gingival wound healing activities of Cannabis sativa L. subsp. sativa (hemp) extract and cannabidiol: An in vitro study,https://www.sciencedirect.com/science/article/abs/pii/S0003996922001212?via%3Dihub,Positive,,Laboratory Study,2022,,Immune System; Integumentary System; Nervous System,Inflammation; Oxidative Stress; Wound Healing; Cancer
2022480,"Dietary supplementation of hemp oil in teddy dogs: Effect on apparent nutrient digestibility, blood biochemistry and metabolomics",https://www.tandfonline.com/doi/full/10.1080/21655979.2022.2043018,Positive,,Animal Study -,2022,,,Veterinary Applications; Arthritis - Rheumatoid; Arthritis; Inflammation; Metabolic Syndrome; Oxidative Stress
2002012,Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study,https://pubmed.ncbi.nlm.nih.gov/12383968/,Positive,,Animal Study,2002,,,Cannabis Adverse Effects
2022481,"An Approach to Biomarker Discovery of Cannabis Use Utilizing Proteomic, Metabolomic, and Lipidomic Analyses",https://pubmed.ncbi.nlm.nih.gov/33998853/,Inconclusive,,Laboratory Study,2022,,,Amino-Acid Metabolism Disorders
2022482,The relationship between cannabis use and taurine: A MRS and metabolomics study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162360/,Positive,,Laboratory Study,2022,,,Amino-Acid Metabolism Disorders
2022483,Use of cannabis in the treatment of animals: a systematic review of randomized clinical trials,https://www.cambridge.org/core/journals/animal-health-research-reviews/article/abs/use-of-cannabis-in-the-treatment-of-animals-a-systematic-review-of-randomized-clinical-trials/4F31AD85A0AAD674055A4F51337D2B96,Positive,,Clinical Meta-analysis -,2022,,,Veterinary Applications; Behavioral Disorders; Arthritis - Osteoarthritis; Arthritis; Epilepsy; Pain; Pain - Chronic
2022484,"A Double-Blind, Randomized, Controlled Crossover Trial of Cannabis in Adults with Tourette Syndrome",https://pubmed.ncbi.nlm.nih.gov/36040329/,Positive,,Double Blind Clinical Trial,2022,,Nervous System,Tics and Tourettes
2022485,Cannabidiol attenuates hypersensitivity and oxidative stress after traumatic spinal cord injury in rats,https://pubmed.ncbi.nlm.nih.gov/36028005/,Positive,,Animal Study,2022,,Nervous System; Skeletal System,Pain; Oxidative Stress; Pain - Neuropathy - Inflammatory Polyneuropathy; Spinal Cord Injuries; Inflammation; Pain - Acute; Pain - Chronic
2022486,Cutaneous Squamous Cell Carcinoma and Lichen Simplex Chronicus Successfully Treated with Topical Cannabinoid Oil: A Case Report and Summary of Cannabinoids in Dermatology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072292/,Positive,,Meta-analysis,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Cannabichromene (CBC); Cannabidiolic Acid (CBD-a); Cannabidivarin (CBDV); Cannabigerol (CBG); Cannabinol (CBN); Endocannabinoid (unspecified); JWH-x Synthetic Cannabinoids; N-Arachidonoyl Dopamine (NADA); Palmitoylethanolamide (PEA); Pharma THC:CBD; Pharma THC; Tetrahydrocannabinolic Acid (THC-a); Virodhamine (O-AEA); WIN-x Synthetic Cannabinoids,Integumentary System,Cancer - Skin (Non-melanoma); Allergic Contact Dermatitis; Anxiety; Bacterial Infections; Cancer - Melanoma; Cancer; Inflammation; Insomnia and Sleep Disorders; Kaposi's Sarcoma; Pruritis; Psychosis; Schizophrenia; Skin Diseases; Wound Healing
2021244,Cannabis Use and Mental Illness: Understanding Circuit Dysfunction Through Preclinical Models,https://www.frontiersin.org/articles/10.3389/fpsyt.2021.597725/full,Inconclusive,,Meta-analysis,2021,AM-x Synthetic Cannabinoids; CP-x Synthetic Cannabinoids; Endocannabinoid (unspecified); Tetrahydrocannabinol (THC); WIN-x Synthetic Cannabinoids,,Addiction - Cannabis; Bipolar Disorder; Depression; Schizophrenia
2022487,The Effect of Cannabidiol for Restless Legs Syndrome/Willis-Ekbom Disease in Parkinson's Disease Patients with REM Sleep Behavior Disorder: A Post Hoc Exploratory Analysis of Phase 2/3 Clinical Trial,https://pubmed.ncbi.nlm.nih.gov/35749710/,Inconclusive,,Double Blind Clinical Trial,2022,,,Parkinson's Disease; Restless Leg Syndrome; Insomnia and Sleep Disorders; Sleep Apnea
2022488,"Rates and correlates of cannabis-associated psychotic symptoms in over 230,000 people who use cannabis",https://www.nature.com/articles/s41398-022-02112-8,Negative,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Psychosis; Addiction - Nicotine; Anxiety; Bipolar Disorder; Depression
2022489,The endocannabinoids anandamide and 2-arachidonoylglycerol modulate the expression of angiogenic factors on HTR8/SVneo placental cells,https://pubmed.ncbi.nlm.nih.gov/35490598/,Inconclusive,,Laboratory Study,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified),Reproductive System,Pregnancy
2021245,"Synthetic Cannabinoid-Related Deaths in England, 2012-2019",https://pubmed.ncbi.nlm.nih.gov/33998886/,Negative,,Meta-analysis,2021,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis; Cannabis Adverse Effects
2022490,Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369424/,Positive,,Animal Study,2022,AM-x Synthetic Cannabinoids; Pharma THC:CBD; Pharma THC,Nervous System,Pain; Pain - Chronic; Pain - Neuropathy - Peripheral
2022491,Acute pancreatitis as a rare adverse event among cannabis users: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239618/,Negative,,Meta-analysis,2022,Anandamide (AEA),Digestive System; Endocrine System; Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Pancreatitis; Addiction - Alcohol; Addiction - Nicotine; Bacterial Meningitis; Anorexia; Anxiety; Atherosclerosis; Cardiovascular Diseases (CVD); Depression; Diarrhea; Epilepsy; Gastro-Esophageal Reflux; IBD - Inflammatory Bowel Disease; HIV/AIDS; Hypertension (High Blood Pressure); Inflammation; Tics and Tourettes; Irritable Bowel Syndrome; Pain
2022492,"[Inhaled marijuana and the lung, a toxic cocktail?]",https://www.sciencedirect.com/science/article/abs/pii/S0761842522002820?via%3Dihub,Negative,,Meta-analysis,2022,,Mental/Emotional System; Nervous System; Respiratory System,Bronchitis; Cannabis Adverse Effects; Addiction - Nicotine; Cancer - Lung; Cancer
2022493,"Design, Characterization, and In Vitro Assays on Muscle Cells of Endocannabinoid-like Molecule Loaded Lipid Nanoparticles for a Therapeutic Anti-Inflammatory Approach to Sarcopenia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951178/,Positive,,Laboratory Study,2022,Palmitoylethanolamide (PEA),Muscular System; Nervous System; Skeletal System,Geriatric Conditions; Sarcopenia
2021246,"Cannabinoid receptor 1 expression is higher in muscle of old vs. young males, and increases upon resistance exercise in older adults",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443742/,Positive,,Meta-analysis,2021,,Muscular System; Nervous System; Skeletal System,Geriatric Conditions; Sarcopenia
2021247,Acute rimonabant treatment promotes protein synthesis in C2C12 myotubes through a CB1-independent mechanism,https://pubmed.ncbi.nlm.nih.gov/32885412/,Inconclusive,,Laboratory Study,2021,SR-x Synthetic Cannabinoids,,Geriatric Conditions; Sarcopenia
2022494,Alterations of the endocannabinoid system and circulating and peripheral tissue levels of endocannabinoids in sarcopenic rats,https://pubmed.ncbi.nlm.nih.gov/34854262/,Inconclusive,,Animal Study,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Palmitoylethanolamide (PEA),Muscular System; Nervous System; Skeletal System,Geriatric Conditions; Sarcopenia
2010049,Mutations in ABHD12 Cause the Neurodegenerative Disease PHARC: An Inborn Error of Endocannabinoid Metabolism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933347/,Inconclusive,,Laboratory Study,2010,2-Arachidonoyl Glycerol (2-AG),,Neurodegenerative Issues; Cataract; Hearing Loss; Pain; Pain - Neuropathy - Peripheral; Retinal Disorders
2019091,Elevated Levels of Arachidonic Acid-Derived Lipids Including Prostaglandins and Endocannabinoids Are Present Throughout ABHD12 Knockout Brains: Novel Insights Into the Neurodegenerative Phenotype,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555221/,Inconclusive,,Animal Study,2019,2-Arachidonoyl Glycerol (2-AG),Nervous System,Neurodegenerative Issues; Cataract; Geriatric Conditions
1988002,Newborn outcomes with maternal marihuana use in Jamaican women,http://cifas.us/pdf/Fieldwork%20and%20Research/Cannabis/Books/Dreher/1988_NewbornOutcomes_DreherEtal.pdf,Positive,,Meta-analysis,1988,,Reproductive System,Pregnancy; Morning sickness
1994002,Prenatal marijuana exposure and neonatal outcomes in Jamaica: an ethnographic study,https://pubmed.ncbi.nlm.nih.gov/8121737/,Positive,,Meta-analysis,1994,,Reproductive System,Pregnancy; Morning sickness
2022495,The intersection between integrative medicine and neuropathic pain: A case report,https://www.sciencedirect.com/science/article/abs/pii/S1550830721000057?via%3Dihub,Positive,,Meta-analysis,2022,Acupuncture (TCM); Mind-Body Medicine,Nervous System,Pain - Neuropathy - Peripheral; Anxiety; Insomnia and Sleep Disorders; Pain; Pain - Chronic; Restless Leg Syndrome
2022496,Experience With Medical Marijuana for Cancer Patients in the Palliative Setting,https://www.cureus.com/articles/102316-experience-with-medical-marijuana-for-cancer-patients-in-the-palliative-setting,Positive,,Meta-analysis,2022,,Nervous System,Cancer; Pain; Palliative Care; Pain - Cancer; Pain - Acute; Pain - Chronic
2021248,Cannabis-induced oceanic boundlessness,https://pubmed.ncbi.nlm.nih.gov/33779383/,Positive,,Clinical Trial,2021,,,Addiction - Alcohol; Addiction - Nicotine; Depression; Pain; Palliative Care; Pain - Cancer
2022497,Alteration of osteoclast activity in childhood cancer survivors: Role of iron and of CB2/TRPV1 receptors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302719/,Positive,,Laboratory Study,2022,Endocannabinoid (unspecified); JWH-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Skeletal System,Osteoporosis
2022498,Self-Reported Cannabis Use Is Associated With a Lower Rate of Persistent Opioid Use After Total Joint Arthroplasty,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493281/,Positive,,Meta-analysis,2022,,Mental/Emotional System,Addiction - Opioid; Addiction; Pain; Pain - Acute; Pain - Chronic
2022499,Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117273/,Positive,,Meta-analysis,2022,AM-x Synthetic Cannabinoids; Anandamide (AEA); Cannabichromene (CBC); Cannabidivarin (CBDV); CP-x Synthetic Cannabinoids; Delta-8-THC; Endocannabinoid (unspecified); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Pharma THC:CBD; Pharma THC; WIN-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
2022500,"Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068870/,Positive,,Animal Study,2022,O-x Synthetic Cannabinoids; Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),Mental/Emotional System,Addiction - Opioid; Addiction; Pain; Pain - Acute
2022501,Cloudy with a chance of munchies: Assessing the impact of recreational marijuana legalization on obesity,https://pubmed.ncbi.nlm.nih.gov/36073115/,Positive,,Meta-analysis,2022,,Endocrine System; Mental/Emotional System,Cannabis Adverse Effects; Obesity
2022502,Efficiency of Inhaled Cannabidiol in Cannabis Use Disorder: The Pilot Study Cannavap,https://www.frontiersin.org/articles/10.3389/fpsyt.2022.899221/full,Positive,,Meta-analysis,2022,Pharma THC:CBD; Pharma THC,Mental/Emotional System,Addiction - Cannabis; Addiction; Addiction - Alcohol; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Anxiety; Cancer; Cannabis Hyperemesis Syndrome; Cardiovascular Diseases (CVD); Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Inflammation; Insomnia and Sleep Disorders
2022503,Cannabinoids as anticancer drugs: current status of preclinical research,https://www.researchgate.net/publication/359178401_Cannabinoids_as_anticancer_drugs_current_status_of_preclinical_research,Positive,,Meta-analysis,2022,Delta-8-THC; 2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; N-Arachidonoyl Dopamine (NADA); Palmitoylethanolamide (PEA); SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); Virodhamine (O-AEA); WIN-x Synthetic Cannabinoids,,Cancer; Cancer - Kidney; Cancer - Brain; Cancer - Breast; Cancer - Cervical; Cancer - Leukemia; Cancer - Lung; Cancer - Melanoma; Cancer - Metastatic; Cancer - Myeloma; Cancer - Neuroblastoma; Cancer - Oral; Cancer - Prostate; Cancer - Squamous Head/Neck; Cancer - Stomach; Loss of Appetite
2022504,"Evaluation of Sex Differences in the Potential of Δ9-Tetrahydrocannabinol, Cannabidiol, Cannabidiolic Acid, and Oleoyl Alanine to Reduce Nausea-Induced Conditioned Gaping Reactions in Sprague-Dawley Rats",https://www.researchgate.net/publication/362810151_Evaluation_of_Sex_Differences_in_the_Potential_of_D_9_-Tetrahydrocannabinol_Cannabidiol_Cannabidiolic_Acid_and_Oleoyl_Alanine_to_Reduce_Nausea-Induced_Conditioned_Gaping_Reactions_in_Sprague-Dawley_Ra,Positive,,Animal Study,2022,Cannabidiolic Acid (CBD-a); Other Related Compounds,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting; Cancer
2022505,Patterns of Use and Self-reported Effectiveness of Cannabis for Hyperemesis Gravidarum,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076215/,Positive,,Meta-analysis,2022,Tetrahydrocannabinol (THC),Digestive System; Mental/Emotional System; Nervous System; Reproductive System,Cannabis Adverse Effects; Morning sickness; Nausea and Vomiting; Pregnancy
2022506,Marijuana-induced myocarditis in a 24-year-old man,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262081/,Negative,,Meta-analysis,2022,Cannabinol (CBN); Tetrahydrocannabinol (THC),Cardiovascular System; Mental/Emotional System,Cannabis Adverse Effects; Cardiovascular Diseases (CVD); Myocarditis; Cardiac Arrhythmias; Heart Attack; Hypertension (High Blood Pressure); Inflammation
2022507,The Long-Term Effectiveness and Safety of Cannabidiol-Enriched Oil in Children With Drug-Resistant Epilepsy,https://pubmed.ncbi.nlm.nih.gov/36049378/,Positive,,Meta-analysis,2022,,,Epilepsy
2021249,A Survey of Cannabis Use in a Large US-Based Cohort of People with Multiple Sclerosis,https://meridian.allenpress.com/ijmsc/article/23/6/245/474717/A-Survey-of-Cannabis-Use-in-a-Large-US-Based,Inconclusive,,Meta-analysis,2021,,,Multiple Sclerosis; Anxiety; Insomnia and Sleep Disorders; Pain; Pain - Chronic
2022508,The Effects of Nutrient Signaling Regulators in Combination with Phytocannabinoids on the Senescence-Associated Phenotype in Human Dermal Fibroblasts,https://www.mdpi.com/1422-0067/23/15/8804/htm,Positive,,Laboratory Study,2022,Tetrahydrocannabinol (THC),Integumentary System,Longevity; Inflammation; Oxidative Stress; Skin Diseases; Wound Healing
2022509,Acute Cannabigerol Administration Lowers Blood Pressure in Mice,https://www.frontiersin.org/articles/10.3389/fphys.2022.871962/full,Positive,,Animal Study,2022,Cannabigerol (CBG); Tetrahydrocannabinol (THC),Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2022510,Cannabis Use as a Protective Factor Against Overweight in HIV-Hepatitis C Virus Co-Infected People (ANRS CO13 HEPAVIH Cohort),https://pubmed.ncbi.nlm.nih.gov/35994579/,Positive,,Meta-analysis,2022,,Digestive System; Immune System,Hepatitis; HIV/AIDS; Metabolic Syndrome; Obesity
2022511,"Medical cannabis authorization patterns, safety, and associated effects in older adults",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494878/,Positive,,Meta-analysis,2022,Tetrahydrocannabinol (THC),Muscular System; Skeletal System,Geriatric Conditions; Pain
2022512,Systematic literature review of human studies assessing the efficacy of cannabidiol for social anxiety,https://www.sciencedirect.com/science/article/pii/S2772598722000551,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified),Mental/Emotional System,Anxiety
2022513,Effects of rich cannabidiol oil on behavioral disturbances in patients with dementia: A placebo controlled randomized clinical trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486160/,Positive,,Double Blind Clinical Trial,2022,Anandamide (AEA); Cannabichromene (CBC); Cannabidivarin (CBDV); Cannabigerol (CBG); Endocannabinoid (unspecified); Tetrahydrocannabinol (THC),,
2022514,"Anhedonia, apathy, pleasure, and effort-based decision-making in adult and adolescent cannabis users and controls",https://pubmed.ncbi.nlm.nih.gov/35999024/,Inconclusive,,Meta-analysis,2022,,Mental/Emotional System,Cannabis Adverse Effects; Behavioral Disorders
2022515,Cannabidiol in Treatment of Autism Spectrum Disorder: A Case Study,https://www.cureus.com/articles/109585-cannabidiol-in-treatment-of-autism-spectrum-disorder-a-case-study,Positive,,Meta-analysis,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Tetrahydrocannabinol (THC),Mental/Emotional System,Autism; ADD and ADHD; Behavioral Disorders; Anxiety; Cognitive Dysfunction; Depression; Diabetes; Epilepsy; Insomnia and Sleep Disorders
2022516,Clinical outcome analysis of patients with autism spectrum disorder: analysis from the UK Medical Cannabis Registry,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500308/,Positive,,Meta-analysis,2022,Anandamide (AEA); Tetrahydrocannabinol (THC),Mental/Emotional System,Autism; Behavioral Disorders; Anxiety; Cannabis Adverse Effects; Cognitive Dysfunction; Depression; Insomnia and Sleep Disorders
2022517,Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461457/,Positive,,Clinical Trial,2022,Pharma THC:CBD; Tetrahydrocannabinol (THC); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Mental/Emotional System,Autism; ADD and ADHD; Behavioral Disorders; Anxiety; Insomnia and Sleep Disorders
2022518,Medical Cannabis for the Treatment of Migraine in Adults: A Review of the Evidence,https://www.frontiersin.org/articles/10.3389/fneur.2022.871187/full,Positive,,Meta-analysis,2022,Pharma THC,Nervous System,Migraine; Cannabis Adverse Effects; Pain; Nausea and Vomiting
2022519,A survey of medical cannabis use during perimenopause and postmenopause,https://journals.lww.com/menopausejournal/Fulltext/2022/09000/A_survey_of_medical_cannabis_use_during.6.aspx,Inconclusive,,Meta-analysis,2022,Endocannabinoid (unspecified),Reproductive System,Menopause; Anxiety; Insomnia and Sleep Disorders; Night Sweats and Excessive Sweating
2022520,Endocannabinoid signalling/cannabinoid receptor 2 is involved in icariin-mediated protective effects against bleomycin-induced pulmonary fibrosis,https://pubmed.ncbi.nlm.nih.gov/35667261/,Positive,,Animal Study,2022,Endocannabinoid (unspecified),Respiratory System,COPD; Fibrosis - Lung; Fibrosis
2022521,"Cannabinoids, Insomnia, and Other Sleep Disorders",https://pubmed.ncbi.nlm.nih.gov/35537535/,Inconclusive,,Meta-analysis,2022,Cannabinol (CBN),,Insomnia and Sleep Disorders
2022522,Anti-inflammatory effects of recreational marijuana in virally suppressed youth with HIV-1 are reversed by use of tobacco products in combination with marijuana,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151353/,Inconclusive,,Clinical Trial,2022,,Immune System,HIV/AIDS; Inflammation; Cannabis Adverse Effects
2022523,Formulation and Characterization of O/W Nanoemulsions of Hemp Seed Oil for Protection from Steatohepatitis: Analysis of Hepatic Free Fatty Acids and Oxidation Markers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316199/,Positive,,Animal Study,2022,,Digestive System,Fatty Liver Disease; Fibrosis - Liver (Cirrhosis); Fibrosis; Hepatitis; Inflammation; Oxidative Stress
2022524,E-cigarette vaping associated acute lung injury (EVALI): state of science and future research needs,https://www.tandfonline.com/doi/full/10.1080/10408444.2022.2082918,Negative,,Meta-analysis,2022,,Respiratory System,Vaping injury (EVALI); ADD and ADHD; Addiction - Nicotine; Behavioral Disorders; Anorexia; Anxiety; Asthma; Cachexia; Cancer - Lung; Cancer; Cardiovascular Diseases (CVD); Chronic Kidney Disease; COPD; Diabetes; Epilepsy; Gastro-Esophageal Reflux; Hypertension (High Blood Pressure); Insomnia and Sleep Disorders; Irritable Bowel Syndrome; Liver Failure
2022525,Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications,https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-022-02459-1,Positive,,Clinical Meta-analysis,2022,Pharma THC:CBD; Pharma THC; Tetrahydrocannabinol (THC),,ADD and ADHD; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Cocaine; Addiction - Opioid; Alzheimer's Disease; Amyotrophic Lateral Sclerosis (ALS); Anorexia Nervosa; Anorexia; Anxiety; Dementia; Depression; Dystonia; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Glaucoma; Huntington's Disease; Insomnia and Sleep Disorders; Tics and Tourettes
2022526,Cannabigerol (CBG) attenuates mechanical hypersensitivity elicited by chemotherapy-induced peripheral neuropathy,https://onlinelibrary.wiley.com/doi/10.1002/ejp.2016,Positive,,Animal Study,2022,AM-x Synthetic Cannabinoids; Cannabigerol (CBG); Endocannabinoid (unspecified); SR-x Synthetic Cannabinoids,Nervous System,Pain; Pain - Neuropathy - Drug-Ind. Polyneuropathy; Pain - Neuropathy - Peripheral
2022527,Predictors of pain reduction among fibromyalgia patients using medical cannabis: a long-term prospective cohort study,https://pubmed.ncbi.nlm.nih.gov/35876631/,Positive,,Clinical Trial,2022,,Muscular System; Nervous System,Fibromyalgia; Pain; Anxiety; Depression; Insomnia and Sleep Disorders; Pain - Chronic
2022528,Quantitative electroencephalographic analysis as a potential biomarker of response to treatment with cannabidiol,https://pubmed.ncbi.nlm.nih.gov/35963151/,Positive,,Clinical Trial,2022,Pharma CBD,,Epilepsy; Cannabis Adverse Effects; Cardiac Arrhythmias; Cardiovascular Diseases (CVD)
2022529,A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927048/,Positive,,Meta-analysis,2022,Pharma CBD,,Cognitive Dysfunction; Epilepsy - Dravet Syndrome; Epilepsy
2022530,Effects of non‐steroidal anti‐inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID‐19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111413/,Positive,,Meta-analysis,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); WIN-x Synthetic Cannabinoids,Nervous System; Respiratory System,COVID-19; Inflammation
2022531,Could Palmitoylethanolamide Be an Effective Treatment for Long-COVID-19? Hypothesis and Insights in Potential Mechanisms of Action and Clinical Applications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970234/,Positive,,Meta-analysis,2022,Palmitoylethanolamide (PEA); Anandamide (AEA),Nervous System; Respiratory System,Cognitive Dysfunction; COVID-19; Allergic Contact Dermatitis; Alzheimer's Disease; Amyotrophic Lateral Sclerosis (ALS); Anxiety; Arthritis - Osteoarthritis; Arthritis; Asthma; Cardiovascular Diseases (CVD); Depression; Flu; Inflammation; Insomnia and Sleep Disorders; Irritable Bowel Syndrome; Pain; Multiple Sclerosis; Myocarditis; Oxidative Stress; Pain - Acute
2022532,Broader and safer clinically-relevant activities of pentadecanoic acid compared to omega-3: Evaluation of an emerging essential fatty acid across twelve primary human cell-based disease systems,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135213/,Positive,,Laboratory Study,2022,Pentadecanoic acid (C15:0); Pentadecanoylcarnitine (PDC),,Cancer; Depression; Inflammation
2020202,Efficacy of dietary odd-chain saturated fatty acid pentadecanoic acid parallels broad associated health benefits in humans: could it be essential?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235264/,Positive,,Animal Study,2020,Pentadecanoic acid (C15:0); Pentadecanoylcarnitine (PDC),,Cardiovascular Diseases (CVD); Diabetes; Fatty Liver Disease; Fibrosis - Liver (Cirrhosis); Fibrosis; Hepatitis; Inflammation; Metabolic Syndrome; Obesity
2022533,Pentadecanoylcarnitine is a newly discovered endocannabinoid with pleiotropic activities relevant to supporting physical and mental health,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399118/,Positive,,Animal Study,2022,Pentadecanoic acid (C15:0); Pentadecanoylcarnitine (PDC),,Anxiety; Depression; Inflammation; Insomnia and Sleep Disorders; Pain; Pain - Chronic
2022534,Differential Effects of D9 Tetrahydrocannabinol (THC)- and Cannabidiol (CBD)-Based Cannabinoid Treatments on Macrophage Immune Function In Vitro and on Gastrointestinal Inflammation in a Murine Model,https://www.mdpi.com/2227-9059/10/8/1793/htm,Positive,,Laboratory Study,2022,Synthetic Cannabinoid (unspecified); Tetrahydrocannabinol (THC); Endocannabinoid (unspecified),Digestive System,IBD - Inflammatory Bowel Disease; Inflammation; Irritable Bowel Syndrome
2022535,Pharmacological management of cannabinoid hyperemesis syndrome: an update of the clinical literature,https://www.tandfonline.com/doi/abs/10.1080/14656566.2022.2049237?journalCode=ieop20,Negative,,Meta-analysis,2022,,Digestive System; Nervous System,Cannabis Hyperemesis Syndrome; Nausea and Vomiting; Cannabis Adverse Effects
2021250,A Systematic Review on Cannabis Hyperemesis Syndrome and Its Management Options,https://www.karger.com/Article/FullText/520417,Negative,,Meta-analysis,2021,Pharma THC; Synthetic Cannabinoid (unspecified),Digestive System; Nervous System,Cannabis Hyperemesis Syndrome; Nausea and Vomiting; Cachexia; Cancer; Cannabis Adverse Effects; COPD; Pain; Pain - Cancer; Parkinson's Disease
2022536,Attitudes and Beliefs of Cancer Patients Demanding Medical Cannabis Use in the North of Thailand,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375599/,Positive,,Meta-analysis,2022,,Nervous System,Cancer; Anorexia; Anxiety; Cancer - Colon; Cancer - Breast; Cancer - Lung; Depression; Pain; Pain - Cancer
1981005,"[Pharmacological studies with an ointment containing menthol, camphene and essential oils for broncholytic and secretolytic effects]",https://pubmed.ncbi.nlm.nih.gov/7194098/,Positive,,Laboratory Study,1981,,Respiratory System,Bronchitis; COPD; Bacterial Infections; Respiratory Syncytial Virus
2022537,Improved Therapeutic Efficacy of CBD with Good Tolerance in the Treatment of Breast Cancer through Nanoencapsulation and in Combination with 20(S)-Protopanaxadiol (PPD),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332327/,Positive,,Laboratory Study,2022,,Reproductive System,Cancer - Breast; Cancer; Anxiety; Cachexia; Depression; Pain; Pain - Cancer
2022538,CBD activation of TRPV1 induces oxidative signaling and subsequent ER stress in breast cancer cell lines,https://pubmed.ncbi.nlm.nih.gov/33604949/,Positive,,Laboratory Study,2022,Endocannabinoid (unspecified),Nervous System; Reproductive System,Cancer - Breast; Cancer; Oxidative Stress
2022539,Investigation of the Effects of the Endogenous Cannabinoid Anandamide on Luminal A Breast Cancer Cell Line MCF-7,https://pubmed.ncbi.nlm.nih.gov/35988272/,Positive,,Laboratory Study,2022,Anandamide (AEA); Endocannabinoid (unspecified),Nervous System; Reproductive System,Cancer - Breast; Cancer
2022540,Cannabidiol Antiproliferative Effect in Triple-Negative Breast Cancer MDA-MB-231 Cells Is Modulated by Its Physical State and by IGF-1,https://www.mdpi.com/1422-0067/23/13/7145/htm,Positive,,Laboratory Study,2022,,Nervous System; Reproductive System,Cancer - Breast; Cancer
2022541,Anti-cancer potential of cannabis terpenes in a Taxol-resistant model of breast cancer,https://pubmed.ncbi.nlm.nih.gov/35704944/,Positive,,Laboratory Study,2022,,Nervous System; Reproductive System,Cancer - Breast; Cancer
2022542,Cannabis with breast cancer treatment: propitious or pernicious?,https://pubmed.ncbi.nlm.nih.gov/35127309/,Negative,,Laboratory Study,2022,,Nervous System; Reproductive System,Cancer - Breast; Cancer
2022543,In vitro evaluation of the interaction of the cannabis constituents cannabichromene and cannabichromenic acid with ABCG2 and ABCB1 transporters,https://pubmed.ncbi.nlm.nih.gov/35306000/,Positive,,Laboratory Study,2022,Cannabichromene (CBC); Cannabichromenic Acid (CBC-a),Nervous System; Reproductive System,Cancer - Breast; Cancer; Depression; Epilepsy; Inflammation
2022544,Activation of cannabinoid receptors in breast cancer cells improves osteoblast viability in cancer-bone interaction model while reducing breast cancer cell survival and migration,https://www.nature.com/articles/s41598-022-11116-9,Positive,,Laboratory Study,2022,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Nervous System; Reproductive System; Skeletal System,Cancer - Bone; Cancer - Breast; Cancer - Metastatic; Cancer; Osteoporosis
2022545,An Examination of the Anti-Cancer Properties of Plant Cannabinoids in Preclinical Models of Mesothelioma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367527/,Positive,,Laboratory Study,2022,Cannabigerol (CBG),Nervous System,Cancer; Inflammation; Cancer - Soft Tissues
2022546,"Cannabis Biomolecule Effects on Cancer Cells and Cancer Stem Cells: Cytotoxic, Anti-Proliferative, and Anti-Migratory Activities",https://pubmed.ncbi.nlm.nih.gov/35454080/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified),,Cancer - Brain; Cancer
2022547,Cannabidiol Promotes Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells in the Inflammatory Microenvironment via the CB2-dependent p38 MAPK Signaling Pathway,https://pubmed.ncbi.nlm.nih.gov/35220282/,Positive,,Animal Study,2022,AM-x Synthetic Cannabinoids; Endocannabinoid (unspecified),Nervous System; Skeletal System,Bone Fractures; Inflammation; Drug-Induced Bone Loss; Osteoporosis
2022548,The perceptions and beliefs of cannabis use among Canadian genitourinary cancer patients,https://pubmed.ncbi.nlm.nih.gov/34582332/,Positive,,Meta-analysis,2022,,Nervous System; Reproductive System; Urinary System,Cancer - Kidney; Cancer - Bladder; Cancer - Prostate; Cancer
2022549,The association of bladder cancer and Cannabis: A systematic review,https://pubmed.ncbi.nlm.nih.gov/35775355/,Inconclusive,,Meta-analysis,2022,,Nervous System; Urinary System,Cancer - Bladder; Cancer
2022550,"Anti-cancer properties of cannflavin A and potential synergistic effects with gemcitabine, cisplatin, and cannabinoids in bladder cancer",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306207/,Positive,,Laboratory Study,2022,Other Related Compounds; Cannabichromene (CBC),Nervous System; Urinary System,Cancer - Bladder; Cancer
2022551,Is early exposure to cannabis associated with bipolar disorder? Results from a Finnish birth cohort study,https://onlinelibrary.wiley.com/doi/10.1111/add.15881,Inconclusive,,Clinical Trial,2022,,Mental/Emotional System; Nervous System,Bipolar Disorder; Addiction - Alcohol; Addiction - Cocaine; Addiction - Opioid; MDMA Adverse Effects
2022552,Role of Cannabinoids in Various Diseases: A Review,https://pubmed.ncbi.nlm.nih.gov/34951355/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified),,Bacterial Infections; COVID-19; Foot Nail Fungus; Fungal Infections; Inflammation; Insomnia and Sleep Disorders; Metabolic Syndrome; Pain; Neurodegenerative Issues; Pain - Acute; Pain - Chronic; Prion Disease; Psychosis
2022553,A Placebo-Controlled Trial of Cannabinoid Treatment for Disruptive Behavior in Children and Adolescents with Autism Spectrum Disorder: Effects on Sleep Parameters as Measured by the CSHQ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312464/,Inconclusive,,Double Blind Clinical Trial,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System,Behavioral Disorders; Autism; Insomnia and Sleep Disorders
2022554,Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis,https://www.mdpi.com/2227-9032/10/8/1553/htm,Inconclusive,,Meta-analysis,2022,Endocannabinoid (unspecified); Tetrahydrocannabinol (THC),Mental/Emotional System,Autism; Schizophrenia; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Psychosis
2022555,The Autism–Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105053/,Inconclusive,,Meta-analysis,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Tetrahydrocannabinol (THC),Mental/Emotional System,Autism; Psychosis; Schizophrenia
2022556,Cell-Type Specific Deletion of CB2 Cannabinoid Receptors in Dopamine Neurons Induced Hyperactivity Phenotype: Possible Relevance to Attention-Deficit Hyperactivity Disorder,https://pubmed.ncbi.nlm.nih.gov/35211038/,Inconclusive,,Animal Study,2022,Endocannabinoid (unspecified),Mental/Emotional System,ADD and ADHD
2022557,Abstinence from Chronic Methylphenidate Exposure Modifies Cannabinoid Receptor 1 Levels in the Brain in a Dose-dependent Manner,https://pubmed.ncbi.nlm.nih.gov/33504296/,Inconclusive,,Animal Study,2022,Endocannabinoid (unspecified),,ADD and ADHD; Behavioral Disorders
2022558,Cannabidiol for the treatment of autism spectrum disorder: hope or hype?,https://pubmed.ncbi.nlm.nih.gov/35904579/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified),Mental/Emotional System,Behavioral Disorders; Autism; Anxiety; Depression; Epilepsy; Insomnia and Sleep Disorders; Neurodegenerative Issues
2022559,"Prenatal cannabis exposure predicts attention problems, without changes on fMRI in adolescents",https://pubmed.ncbi.nlm.nih.gov/35314358/,Negative,,Clinical Trial,2022,,Mental/Emotional System; Nervous System; Reproductive System,ADD and ADHD; Pregnancy; Behavioral Disorders; Cognitive Dysfunction; Neonatal Cerebral Issues
2022560,Cannabis Use in Adults Who Screen Positive for Attention Deficit/Hyperactivity Disorder: CANreduce 2.0 Randomized Controlled Trial Subgroup Analysis,https://pubmed.ncbi.nlm.nih.gov/35442196/,Inconclusive,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,ADD and ADHD; Addiction - Cannabis; Addiction; Behavioral Disorders
2022561,Attention-Deficit Hyperactivity Disorder and Therapeutic Cannabis Use Motives,https://www.sciencedirect.com/science/article/abs/pii/S0193953X22000533?via%3Dihub,Negative,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,ADD and ADHD; Addiction - Cannabis; Addiction; Behavioral Disorders; Cannabis Adverse Effects; Insomnia and Sleep Disorders
2022562,Attention deficit hyperactivity disorder symptoms and cannabis use after one year among students of the i-Share cohort,https://www.cambridge.org/core/journals/european-psychiatry/article/attention-deficit-hyperactivity-disorder-symptoms-and-cannabis-use-after-1-year-among-students-of-the-ishare-cohort/4977ABB7548A1DFA23A566354448EEBE,Negative,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,ADD and ADHD; Addiction - Cannabis; Addiction; Behavioral Disorders; Cannabis Adverse Effects
2022563,Differences in alcohol and cannabis use amongst substance use disorder patients with and without comorbid attention-deficit/hyperactivity disorder,https://sajp.org.za/index.php/sajp/article/view/1786/2598,Negative,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,ADD and ADHD; Addiction - Alcohol; Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2022564,Drugs of Misuse: Focus on Vascular Dysfunction,https://www.onlinecjc.ca/article/S0828-282X(22)00261-6/fulltext,Negative,,Meta-analysis,2022,,Cardiovascular System; Nervous System,Cardiovascular Diseases (CVD); Heart Attack; Stroke; Addiction - Alcohol; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant; Atherosclerosis; Hypertension (High Blood Pressure); MDMA Adverse Effects; Oxidative Stress
2022565,The Association of Cannabis Use Disorder with Acute Limb Ischemia and Critical Limb Ischemia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163779/,Negative,,Meta-analysis,2022,,Cardiovascular System; Mental/Emotional System,Addiction - Cannabis; Addiction; Atherosclerosis; Cardiovascular Diseases (CVD); Reperfusion Injury; Cannabis Adverse Effects; Heart Attack; Inflammation; Stroke
2022566,Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400797/,Negative,,Meta-analysis,2022,AM-x Synthetic Cannabinoids,Cardiovascular System; Nervous System,Atherosclerosis; Cardiovascular Diseases (CVD); Heart Attack; Inflammation; Oxidative Stress
2022567,Marijuana and endothelial dysfunction: new mechanism and therapy,https://pubmed.ncbi.nlm.nih.gov/35701315/,Negative,,Meta-analysis,2022,,Cardiovascular System; Nervous System,Atherosclerosis; Cardiovascular Diseases (CVD); Inflammation; Oxidative Stress
2022568,Adolescent e-cigarette or vaping product use-associated lung injury: A case series and review of the literature,https://pubmed.ncbi.nlm.nih.gov/35072351/,Negative,,Meta-analysis,2022,,Respiratory System,Vaping injury (EVALI); Acute Respiratory Distress Syndrome; Asthma; Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Inflammation; Stress
2022569,Inhaled Marijuana and the Lung,https://pubmed.ncbi.nlm.nih.gov/35609784/,Inconclusive,,Meta-analysis,2022,,Respiratory System,Asthma; Bronchitis; Vaping injury (EVALI)
2022570,Cannabinoid receptor 2 engagement promotes group 2 innate lymphoid cell expansion and enhances airway hyperreactivity,https://pubmed.ncbi.nlm.nih.gov/34673048/,Positive,,Animal Study,2022,Endocannabinoid (unspecified),Nervous System; Respiratory System,Asthma; Inflammation
2022571,Expression and Functions of the CB 2 Receptor in Human Leukocytes,https://www.frontiersin.org/articles/10.3389/fphar.2022.826400/full,Positive,,Laboratory Study,2022,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); JWH-x Synthetic Cannabinoids; Palmitoylethanolamide (PEA),Respiratory System,Asthma; Inflammation; Allergic Contact Dermatitis
2022572,Cannabinoids induce functional Tregs by promoting tolerogenic DCs via autophagy and metabolic reprograming,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732281/,Positive,,Laboratory Study,2022,Endocannabinoid (unspecified); HU-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC); WIN-x Synthetic Cannabinoids,,Inflammation; Allergic Contact Dermatitis; Asthma
2022573,Endocannabinoid metabolism inhibition ameliorates ovalbumin-induced allergic airway inflammation and hyperreactivity in Guinea pigs,https://pubmed.ncbi.nlm.nih.gov/35843343/,Positive,,Animal Study,2022,Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Respiratory System,Asthma; Inflammation
2022574,Exploring cannabis use and perspectives among psoriatic disease patients,https://pubmed.ncbi.nlm.nih.gov/35050419/,Inconclusive,,Clinical Trial,2022,,Integumentary System; Skeletal System,Arthritis; Psoriasis; Arthritis - Osteoarthritis; Pain; Pain - Chronic; Pain - Inflammatory; Skin Diseases
2022575,Impact of the Endocannabinoid System on Bone Formation and Remodeling in p62 KO Mice,https://pubmed.ncbi.nlm.nih.gov/35392569/,Inconclusive,,Animal Study,2022,Endocannabinoid (unspecified); JWH-x Synthetic Cannabinoids,Skeletal System,Osteoporosis
2021251,Anti-Inflammatory and Pro-Autophagy Effects of the Cannabinoid Receptor CB2R: Possibility of Modulation in Type 1 Diabetes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804091/,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Endocannabinoid (unspecified); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,Endocrine System; Nervous System,Diabetes; Inflammation; IBD - Crohn's Disease; Lupus; Multiple Sclerosis
2022576,"Cannabidiol: Influence on B Cells, Peripheral Blood Mononuclear Cells, and Peripheral Blood Mononuclear Cell/Rheumatoid Arthritis Synovial Fibroblast Cocultures",https://pubmed.ncbi.nlm.nih.gov/35920857/,Positive,,Laboratory Study,2022,,Skeletal System,Arthritis - Rheumatoid; Arthritis; Inflammation
2022577,Cannabis for Rheumatic Disease Pain: a Review of Current Literature,https://pubmed.ncbi.nlm.nih.gov/35486218/,Inconclusive,,Meta-analysis,2022,,Skeletal System,Arthritis - Rheumatoid; Arthritis; Pain; Pain - Chronic
2022578,Impact of Δ9-Tetrahydrocannabinol on Rheumatoid Arthritis Synovial Fibroblasts Alone and in Co-Culture with Peripheral Blood Mononuclear Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138512/,Positive,,Laboratory Study,2022,Pharma THC; Endocannabinoid (unspecified),Skeletal System,Arthritis - Rheumatoid; Arthritis; Arthritis - Osteoarthritis; Inflammation
2022579,G Protein-Coupled Receptors in Osteoarthritis,https://www.frontiersin.org/articles/10.3389/fendo.2021.808835/full,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Skeletal System,Arthritis - Osteoarthritis; Arthritis; Lupus; Pain; Pain - Chronic
2022580,Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study,https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-022-00154-9,Positive,,Meta-analysis,2022,,Immune System; Skeletal System,Arthritis - Osteoarthritis; Arthritis - Rheumatoid; Arthritis; Lupus; Inflammation; Pain; Pain - Chronic
2021252,"Are Cannabis, Cannabis-Derived Products, and Synthetic Cannabinoids a Therapeutic Tool for Rheumatoid Arthritis? A Friendly Summary of the Body of Evidence",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860218/,Inconclusive,,Meta-analysis,2021,Synthetic Cannabinoid (unspecified),Skeletal System,Arthritis - Rheumatoid; Arthritis; Arthritis - Osteoarthritis; Cannabis Adverse Effects; Pain; Pain - Chronic
2022581,Cannabinoids in the Orthopedic Setting: A Literature Review,https://pubmed.ncbi.nlm.nih.gov/35245146/,Negative,,Meta-analysis,2022,,Skeletal System,Arthritis - Osteoarthritis; Bone Fractures; Addiction - Opioid; Arthritis; Fibromyalgia; Pain; Multiple Sclerosis; Pain - Acute; Pain - Chronic; Pain - Neuropathy - Peripheral
2022582,"Cannabinoids in rheumatology: Friend, foe or a bystander?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322323/,Inconclusive,,Meta-analysis,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; O-x Synthetic Cannabinoids; Pharma THC:CBD; Pharma THC; SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); Tetrahydrocannabinol (THC); WIN-x Synthetic Cannabinoids,Skeletal System,Arthritis - Rheumatoid; Arthritis; Arthritis - Osteoarthritis; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Fibromyalgia; Lupus; Pain; Multiple Sclerosis; Nausea and Vomiting; Pain - Chronic
2022583,Endothelial dysfunction and angiogenesis: what is missing from COVID-19 and cannabidiol story?,https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-022-00129-w,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified); HU-x Synthetic Cannabinoids; Pharma CBD; Pharma THC:CBD; Tetrahydrocannabinol (THC),Respiratory System,Acute Respiratory Distress Syndrome; COVID-19; Inflammation; Stress; Epilepsy - Dravet Syndrome; Epilepsy; Multiple Sclerosis; Sepsis
2021253,Acute lung injury-from cannabis to COVID,https://www.nature.com/articles/s41379-021-00915-6,Inconclusive,,Meta-analysis,2021,,Respiratory System,Acute Respiratory Distress Syndrome; COVID-19; Fibrosis - Lung; Fibrosis; Stress; Vaping injury (EVALI); Cannabis Adverse Effects; Inflammation
2022584,Cannabinoids receptors in Covid-19: Perpetrators and victims,https://pubmed.ncbi.nlm.nih.gov/36043749/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified),Respiratory System,Acute Respiratory Distress Syndrome; COVID-19; Inflammation; Stress; Prion Disease
2022585,Cannabinoids as Emergent Therapy Against COVID-19,https://pubmed.ncbi.nlm.nih.gov/35512732/,Positive,,Meta-analysis,2022,,Respiratory System,Acute Respiratory Distress Syndrome; COVID-19; Inflammation; Stress
2022586,Amygdalar CB2 cannabinoid receptor mediates fear extinction deficits promoted by orexin-A/hypocretin-1,https://www.sciencedirect.com/science/article/pii/S0753332222003146?via%3Dihub,Positive,,Animal Study,2022,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),,Behavioral Disorders; Anxiety; PTSD
2022587,Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: A randomised controlled trial,https://www.sciencedirect.com/science/article/pii/S0924977X22001699?via%3Dihub,Negative,,Double Blind Clinical Trial,2022,Anandamide (AEA); Synthetic Cannabinoid (unspecified),Mental/Emotional System,Anxiety
2022588,"Curcumin, Resveratrol and Cannabidiol as Natural Key Prototypes in Drug Design for Neuroprotective Agents",https://pubmed.ncbi.nlm.nih.gov/34825873/,Positive,,Meta-analysis,2022,Turmeric,,Neurodegenerative Issues; Alzheimer's Disease; Amyotrophic Lateral Sclerosis (ALS); Dementia; Huntington's Disease; Inflammation; Oxidative Stress; Parkinson's Disease
2022589,The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective?,https://www.mdpi.com/1422-0067/23/9/4504/htm,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified),,Amyotrophic Lateral Sclerosis (ALS); Neurodegenerative Issues; Parkinson's Disease
2022590,Serum Metabolomic Analysis of Male Patients with Cannabis or Amphetamine Use Disorder,https://pubmed.ncbi.nlm.nih.gov/35208253/,Negative,,Clinical Trial,2022,,Endocrine System; Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction - Stimulant; Addiction; Metabolic Syndrome; Cannabis Adverse Effects; MDMA Adverse Effects
2022591,Improved cognition impairment by activating cannabinoid receptor type 2: Modulating CREB/BDNF expression and impeding TLR-4/NFκBp65/M1 microglia signaling pathway in D-galactose-injected ovariectomized rats,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963558/,Positive,,Animal Study,2022,AM-x Synthetic Cannabinoids; Endocannabinoid (unspecified),,Cognitive Dysfunction; Alzheimer's Disease; Dementia; Inflammation; Neurodegenerative Issues
2022592,Gene Expression Analysis of the Endocannabinoid System in Presymptomatic APP/PS1 Mice,https://www.frontiersin.org/articles/10.3389/fphar.2022.864591/full,Positive,,Animal Study,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),,Alzheimer's Disease; Anxiety; Cognitive Dysfunction; Dementia; Neurodegenerative Issues
2022593,The Memory Benefit to Aged APP/PS1 Mice from Long-Term Intranasal Treatment of Low-Dose THC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029288/,Positive,,Animal Study,2022,Endocannabinoid (unspecified),Muscular System; Nervous System; Skeletal System,Geriatric Conditions; Alzheimer's Disease; Cognitive Dysfunction; Inflammation; Neurodegenerative Issues
2022594,Immunomodulatory Role of CB2 Receptors in Emotional and Cognitive Disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051035/,Positive,,Meta-analysis,2022,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Lysophosphatidylinositol (LPI); Monoacylglycerol Lipase (MAGL); Palmitoylethanolamide (PEA); Virodhamine (O-AEA); WIN-x Synthetic Cannabinoids,Immune System; Mental/Emotional System; Nervous System,Behavioral Disorders; Cognitive Dysfunction; Injury Immunodeficiency; Addiction - Cannabis; Alzheimer's Disease; Anxiety; Autism; Bipolar Disorder; Dementia; Depression; Inflammation; Tics and Tourettes; Neurodegenerative Issues; Oxidative Stress; Parkinson's Disease; Psychosis; PTSD; Stroke; Traumatic Brain Injury
2022595,Pharmacological Activation of GPR55 Improved Cognitive Impairment Induced by Lipopolysaccharide in Mice,https://pubmed.ncbi.nlm.nih.gov/35596056/,Positive,,Animal Study,2022,Endocannabinoid (unspecified); O-x Synthetic Cannabinoids,Nervous System,Cognitive Dysfunction; Alzheimer's Disease; Inflammation; Neurodegenerative Issues
2022596,Cannabidiol Enhances Microglial Beta-Amyloid Peptide Phagocytosis and Clearance via Vanilloid Family Type 2 Channel Activation,https://www.mdpi.com/1422-0067/23/10/5367/htm,Positive,,Laboratory Study,2022,Endocannabinoid (unspecified),,Alzheimer's Disease; Neurodegenerative Issues
2022597,Cannabinoid CB 2 Receptors Modulate Microglia Function and Amyloid Dynamics in a Mouse Model of Alzheimer's Disease,https://www.frontiersin.org/articles/10.3389/fphar.2022.841766/full,Positive,,Animal Study,2022,Endocannabinoid (unspecified),,Alzheimer's Disease; Inflammation; Neurodegenerative Issues
2022598,An Ultra-Low Dose of ∆9-Tetrahydrocannabinol Alleviates Alzheimer's Disease-Related Cognitive Impairments and Modulates TrkB Receptor Expression in a 5XFAD Mouse Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408848/,Positive,,Animal Study,2022,,Nervous System,Alzheimer's Disease; Cognitive Dysfunction
2022599,What Do We Know About Medical Cannabis in Neurological Disorders and What Are the Next Steps?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091192/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified); Pharma CBD; Pharma THC:CBD; Pharma THC; Synthetic Cannabinoid (unspecified),,Neurodegenerative Issues; Alzheimer's Disease; Amyotrophic Lateral Sclerosis (ALS); Inflammation; Oxidative Stress; Parkinson's Disease
2022600,Phytocannabinoids and Cannabis-Based Products as Alternative Pharmacotherapy in Neurodegenerative Diseases: From Hypothesis to Clinical Practice,https://www.frontiersin.org/articles/10.3389/fncel.2022.917164/full,Inconclusive,,Meta-analysis,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Cannabigerol (CBG); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Tetrahydrocannabivarin (THCV); Tetrahydrocannabinol (THC),,Neurodegenerative Issues; Alzheimer's Disease; Inflammation; Multiple Sclerosis; Parkinson's Disease
2022601,Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-Analysis,https://www.liebertpub.com/doi/10.1089/can.2021.0187,Inconclusive,,Clinical Meta-analysis,2022,Pharma THC:CBD; Pharma THC; Synthetic Cannabinoid (unspecified),,Cancer; Neurodegenerative Issues; Anxiety; Cancer - Brain; Cancer - Neuroblastoma; Cognitive Dysfunction; Depression; Multiple Sclerosis
2022602,Comparative light and scanning electron microscopic studies of pollen of two marijuana species causing allergies,https://pubmed.ncbi.nlm.nih.gov/35661329/,Negative,,Clinical Trial,2022,,Immune System,Cannabis Allergies; Cannabis Adverse Effects; Nausea and Vomiting
2020203,Cannabinoids and Chronic Liver Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408890/,Positive,,Meta-analysis,2020,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Cannabidiolic Acid (CBD-a); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Tetrahydrocannabivarin (THCV),Digestive System,Alcoholic Liver Disease; Fatty Liver Disease; Hepatitis; Liver Failure; Cancer - Liver; Cancer; Fibrosis - Liver (Cirrhosis); Fibrosis; Inflammation; Oxidative Stress; Toxic Liver Disease
2003009,Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice,https://pubmed.ncbi.nlm.nih.gov/14680762/,Inconclusive,,Animal Study,2003,Endocannabinoid (unspecified),Mental/Emotional System,Addiction - Alcohol; Addiction
2007025,Bidirectional alterations of hippocampal cannabinoid 1 receptors and their endogenous ligands in a rat model of alcohol withdrawal and dependence,https://pubmed.ncbi.nlm.nih.gov/17386072/,Positive,,Animal Study,2007,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); WIN-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction; Cognitive Dysfunction
2009041,"Effect of citral, eugenol, nerolidol and α-terpineol on the ultrastructural changes of Trichophyton mentagrophytes",https://www.sciencedirect.com/science/article/abs/pii/S0367326X09000690?via%3Dihub,Positive,,Laboratory Study,2009,,Digestive System; Immune System; Integumentary System,Fungal Infections
2010050,Clinical and Experimental Pharmacology and Physiology Clinical and Experimental Pharmacology and Physiology Free Access Unravelling the cardiovascular effects induced by α-terpineol: A role for the nitric oxide–cGMP pathway,https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1440-1681.2010.05383.x,Inconclusive,,Animal Study,2010,,Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2022603,Beta-caryophyllene prevents the defects in trabecular bone caused by Vitamin D deficiency through pathways instated by increased expression of klotho,https://online.boneandjoint.org.uk/doi/full/10.1302/2046-3758.118.BJR-2021-0392.R1,Positive,,Animal Study,2022,,Skeletal System,Bone Fractures; Osteoporosis
2013050,Cardiovascular effects induced by α-terpineol in hypertensive rats,https://onlinelibrary.wiley.com/doi/10.1002/ffj.3159,Positive,,Animal Study,2013,,Cardiovascular System; Nervous System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Oxidative Stress
2021254,"Tea tree oil extract causes mitochondrial superoxide production and apoptosis as an anticancer agent, promoting tumor infiltrating neutrophils cytotoxic for breast cancer to induce tumor regression",https://www.sciencedirect.com/science/article/pii/S0753332221005722?via%3Dihub,Positive,,Laboratory Study,2021,Other Related Compounds,Nervous System; Reproductive System,Cancer - Breast; Cancer; Cancer - Colon; Cancer - Brain; Cancer - Leukemia; Cancer - Liver; Cancer - Lung; Cancer - Melanoma; Cancer - Prostate; Oxidative Stress
2022604,Interacting binding insights and conformational consequences of the differential activity of cannabidiol with two endocannabinoid-activated G-protein-coupled receptors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395587/,Positive,,Meta-analysis,2022,AM-x Synthetic Cannabinoids,,Alzheimer's Disease; Epilepsy; Parkinson's Disease
2022605,"Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders",https://www.mdpi.com/1420-3049/27/15/4961/htm,Positive,,Meta-analysis,2022,Abnormal Cannabidiol (Abn-CBD); Synthetic Cannabinoid (unspecified),Nervous System,Inflammation; Alzheimer's Disease; Epilepsy; Pain; Multiple Sclerosis; Neurodegenerative Issues; Pain - Neuropathy - Inflammatory Polyneuropathy; Psychosis; Schizophrenia; Stroke
2014061,Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial,https://pubmed.ncbi.nlm.nih.gov/24430917/,Positive,,Double Blind Clinical Trial,2014,Pharma THC:CBD,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2010051,A cannabinoid CB(1) receptor antagonist ameliorates impairment of recognition memory on withdrawal from MDMA (Ecstasy),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055379/,Positive,,Animal Study,2010,AM-x Synthetic Cannabinoids,,MDMA Adverse Effects
2011061,Artemisia princeps Pamp. Essential Oil and Its Constituents Eucalyptol and α-terpineol Ameliorate Bacterial Vaginosis and Vulvovaginal Candidiasis in Mice by Inhibiting Bacterial Growth and NF-κB Activation,https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0031-1280094,Positive,,Animal Study,2011,,Digestive System; Immune System; Integumentary System; Nervous System,Bacterial Infections; Fungal Infections; Inflammation
2012076,Antimicrobial effect of linalool and α-terpineol against periodontopathic and cariogenic bacteria,https://www.sciencedirect.com/science/article/abs/pii/S1075996412000418?via%3Dihub,Positive,,Laboratory Study,2012,,Digestive System; Immune System,Bacterial Infections; Periodontal Disease; Pain - Dental - Acute
2018086,"α-Terpineol, a natural monoterpene: A review of its biological properties",https://www.degruyter.com/document/doi/10.1515/chem-2018-0040/html,Positive,,Meta-analysis,2018,,,Bacterial Infections; Cancer; Cardiovascular Diseases (CVD); Gastro-Esophageal Reflux; Gastroparesis; Inflammation; Pain; Oxidative Stress; Skin Diseases
2014062,"Terpinen-4-ol and alpha-terpineol (tea tree oil components) inhibit the production of IL-1β, IL-6 and IL-10 on human macrophages",https://link.springer.com/article/10.1007/s00011-014-0749-x,Positive,,Laboratory Study,2014,,Immune System; Nervous System,Bacterial Infections; Inflammation
2022606,Antibacterial and antibiofilm activities of some plant essential oils and synergistic effects of cinnamon essential oil with vancomycin against Clostridioides difficile: in vitro study,https://sfamjournals.onlinelibrary.wiley.com/doi/full/10.1111/lam.13747,Positive,,Laboratory Study,2022,,Immune System,Bacterial Infections
2020204,Melaleuca alternifolia (tea tree) oil and its monoterpene constituents in treating protozoan and helminthic infections,https://www.sciencedirect.com/science/article/pii/S0753332220308179?via%3Dihub,Positive,,Meta-analysis,2020,Other Related Compounds,Digestive System,Parasitic Worms; Inflammation; Leishmaniasis
1969001,"Cannabivarin and Tetrahydrocannabivarin, Two New Constituents of Hashish",https://www.nature.com/articles/232579a0#citeas,Positive,,Laboratory Study,1969,Tetrahydrocannabivarin (THCV),,
2019092,Neurological Improvement with Medical Cannabis in a Progressive Supranuclear Palsy Patient: A Case Report,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489313/,Positive,,Meta-analysis,2019,Cannabidiolic Acid (CBD-a); Tetrahydrocannabinolic Acid (THC-a),Nervous System,Cerebral Palsy
2006016,Evolution of the Anticonvulsant Activity of α-Terpineol,https://www.tandfonline.com/doi/full/10.1080/13880200601028388,Positive,,Animal Study,2006,,,Epilepsy
2022607,Role of the major terpenes of Callistemon citrinus against the oxidative stress during a hypercaloric diet in rats,https://www.sciencedirect.com/science/article/pii/S0753332222008940,Positive,,Animal Study,2022,,Nervous System,Oxidative Stress; Inflammation; Metabolic Syndrome; Obesity
2022608,Anti-Inflammatory and Analgesic Properties of the Cannabis Terpene Myrcene in Rat Adjuvant Monoarthritis,https://www.mdpi.com/1422-0067/23/14/7891/htm,Positive,,Animal Study,2022,AM-x Synthetic Cannabinoids,Nervous System; Skeletal System,Arthritis; Inflammation; Pain
2022609,"Parkinson’s Disease and Dementia with Lewy Bodies, Patients Under Treatment with Standardized Extracts Enriched in Cannabidiol and Cannabigerol: Descriptive Observations in Preparation for a Phase 2a Clinical Trial",https://www.researchgate.net/publication/361208615_Parkinson's_Disease_and_Dementia_with_Lewy_Bodies_Patients_Under_Treatment_with_Standardized_Extracts_Enriched_in_Cannabidiol_and_Cannabigerol_Descriptive_Observations_in_Preparation_for_a_Phase_2a_Cl,Positive,,Meta-analysis,2022,Cannabigerol (CBG); Tetrahydrocannabinol (THC),,Dementia; Parkinson's Disease; Alzheimer's Disease; Anxiety; Insomnia and Sleep Disorders; Pain; Psychosis
2021255,Cannabis and the skin,https://pubmed.ncbi.nlm.nih.gov/34785006/,Positive,,Meta-analysis,2021,,,Acne; Cancer - Melanoma; Cancer - Skin (Non-melanoma); Cancer; Eczema; Epidermolysis bullosa; Inflammation; Lupus; Pain; Pain - Chronic; Pruritis; Psoriasis; Systemic Sclerosis; Wound Healing
2022610,Cannabidiol Inhibits Inflammation Induced by Cutibacterium acnes-Derived Extracellular Vesicles via Activation of CB2 Receptor in Keratinocytes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379120/,Positive,,Laboratory Study,2022,,Integumentary System,Acne; Bacterial Infections; Inflammation
2022611,A Survey of Topical Cannabis Use in Canada,https://pubmed.ncbi.nlm.nih.gov/34798780/,Positive,,Meta-analysis,2022,,,Acne; Arthritis - Osteoarthritis; Arthritis; Eczema; Geriatric Conditions; Migraine; Pruritis; Psoriasis
2021256,"Topical and nutricosmetic products for healthy hair and dermal antiaging using “dual‐acting” (2 for 1) plant‐based peptides, hormones, and cannabinoids",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332470/,Inconclusive,,Meta-analysis,2021,,Muscular System; Skeletal System,Geriatric Conditions; Hair Loss; Longevity
2022612,Marijuana smoking and cataract,https://pubmed.ncbi.nlm.nih.gov/35093261/,Negative,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cataract; Pain; Pain - Eye
2022613,A Case Report on Cannabinoid Hyperemesis Syndrome in Palliative Care: How Good Intentions Can Go Wrong,https://www.karger.com/Article/FullText/524746,Negative,,Meta-analysis,2022,Pharma THC,Digestive System; Nervous System,Cannabis Hyperemesis Syndrome; Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting; Palliative Care; Anorexia; Cachexia; Cancer - Lung; Cancer; Cannabis Adverse Effects; Diarrhea
2022614,"Essential oils as anticancer agents: Potential role in malignancies, drug delivery mechanisms, and immune system enhancement",https://www.sciencedirect.com/science/article/pii/S0753332221013019,Positive,,Meta-analysis,2022,,Nervous System,Cancer; Inflammation; Pain; Oxidative Stress; Pain - Cancer
2020205,Therapeutic potential of nanolipoidal α-terpineol in combating keratitis induced by Pseudomonas aeruginosa in the murine model,https://www.sciencedirect.com/science/article/abs/pii/S0378517320311601,Positive,,Laboratory Study,2020,,Immune System; Nervous System,Bacterial Infections; Inflammation
2020206,"Synthesis, characterization of α-terpineol-loaded PMMA nanoparticles as proposed of therapy for melanoma",https://www.sciencedirect.com/science/article/abs/pii/S2352492819304593,Positive,,Laboratory Study,2020,,Integumentary System,Cancer - Melanoma; Cancer
2020207,The effect of α-terpineol enantiomers on biomarkers of rats fed a high-fat diet,https://www.cell.com/heliyon/fulltext/S2405-8440(20)30597-1?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2405844020305971%3Fshowall%3Dtrue#%20,Positive,,Animal Study,2020,,Endocrine System; Nervous System,Inflammation; Obesity; Oxidative Stress; Liver Failure; Metabolic Syndrome
2022615,Gastroprotective effect of α-terpineol-loaded polymethyl methacrylate particles on gastric injury model,https://www.sciencedirect.com/science/article/abs/pii/S1773224721006699,Positive,,Animal Study,2022,,Nervous System,Inflammation; Gastro-Esophageal Reflux
2022616,Cannabidiol Regulates PPARγ-Dependent Vesicle Formation as well as Cell Death in A549 Human Lung Cancer Cells,https://www.mdpi.com/1424-8247/15/7/836/htm,Positive,,Laboratory Study,2022,,Nervous System; Respiratory System,Cancer - Lung; Cancer
2022617,In Vitro Effect of Δ9-Tetrahydrocannabinol and Cannabidiol on Cancer-Associated Fibroblasts Isolated from Lung Cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223514/,Positive,,Laboratory Study,2022,,Nervous System; Respiratory System,Cancer - Lung; Cancer
2022618,A cannabidiol-containing alginate based hydrogel as novel multifunctional wound dressing for promoting wound healing,https://pubmed.ncbi.nlm.nih.gov/35523648/,Positive,,Animal Study,2022,,Immune System; Integumentary System; Nervous System,Inflammation; Oxidative Stress; Wound Healing; Bacterial Infections
2022619,Evidence-based Potential Therapeutic Applications of Cannabinoids in Wound Management,https://pubmed.ncbi.nlm.nih.gov/35588193/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified),Immune System; Integumentary System; Nervous System,Wound Healing; Inflammation
2022620,Characterization of the Biological Activity of the Ethanolic Extract from the Roots of Cannabis sativa L. Grown in Aeroponics,https://pubmed.ncbi.nlm.nih.gov/35624724/,Positive,,Laboratory Study,2022,,Nervous System,Inflammation; Oxidative Stress; Wound Healing
2022621,Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort,https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-022-00138-9,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified); Tetrahydrocannabivarin (THCV),Digestive System,Hepatitis; Diabetes; Inflammation; Liver Failure; Metabolic Syndrome; Obesity
2017072,A Pulsed Electromagnetic Field Protects against Glutamate-Induced Excitotoxicity by Modulating the Endocannabinoid System in HT22 Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292622/,Positive,,Laboratory Study,2017,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Nervous System,Excitotoxicity; Neurodegenerative Issues
2022622,The endocannabinoid system as a target for the treatment of neuronal damage,https://pubmed.ncbi.nlm.nih.gov/20230193/,Positive,,Meta-analysis,2022,,Nervous System,Excitotoxicity; Inflammation; Neurodegenerative Issues; Oxidative Stress
2022623,"The relationship between anxious-depressive symptoms and harmful cannabis use: Multiple mediation models via rumination, negative urgency, protective behavioral strategies and refusal self-efficacy",https://www.sciencedirect.com/science/article/pii/S0010440X22000268?via%3Dihub,Negative,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Anxiety; Cannabis Adverse Effects; Depression
2022624,Cannabidiol (CBD) in the Self-Treatment of Depression-Exploratory Study and a New Phenomenon of Concern for Psychiatrists,https://www.frontiersin.org/articles/10.3389/fpsyt.2022.837946/full,Positive,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Depression; Anxiety
2022625,"The modulatory effects of alkaloid extracts of Cannabis sativa, Datura stramonium, Nicotiana tabacum and male Carica papaya on neurotransmitter, neurotrophic and neuroinflammatory systems linked to anxiety and depression",https://pubmed.ncbi.nlm.nih.gov/35665872/,Positive,,Animal Study,2022,,Mental/Emotional System; Nervous System,Anxiety; Depression; Inflammation; Oxidative Stress
1996002,NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies),https://ntp.niehs.nih.gov/ntp/htdocs/lt_rpts/tr446.pdf,Positive,,Animal Study,1996,Tetrahydrocannabinol (THC),Integumentary System,Longevity
2022626,Association between cannabis use with urological cancers: A population-based cohort study and a mendelian randomization study in the UK biobank,https://pubmed.ncbi.nlm.nih.gov/35975633/,Positive,,Meta-analysis,2022,,Reproductive System; Urinary System,Cancer - Kidney; Cancer - Bladder; Cancer - Prostate; Cancer
2022627,Oral cannabidiol for prevention of acute and transient chemotherapy-induced peripheral neuropathy,https://pubmed.ncbi.nlm.nih.gov/35933415/,Positive,,Clinical Trial,2022,,,Pain; Pain - Neuropathy - Drug-Ind. Polyneuropathy
2022628,Medicinal Cannabis for the Treatment of Chronic Refractory Pain: An Investigation of the Adverse Event Profile and Health-Related Quality of Life Impact of an Oral Formulation,https://karger.com/mca/article/5/1/20/825054/Medicinal-Cannabis-for-the-Treatment-of-Chronic,Positive,,Clinical Trial,2022,Pharma THC:CBD,Nervous System,Pain; Pain - Chronic
2022629,Is in-utero exposure to cannabis associated with the risk of attention deficit with or without hyperactivity disorder? A cohort study within the Quebec Pregnancy Cohort,https://pubmed.ncbi.nlm.nih.gov/35940828/,Inconclusive,,Meta-analysis,2022,,Mental/Emotional System,ADD and ADHD
2022630,Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence,https://www.mdpi.com/1422-0067/23/10/5526/htm,Inconclusive,,Meta-analysis,2022,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); CP-x Synthetic Cannabinoids; Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); WIN-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Depression; Anxiety
2022631,Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder,https://pubmed.ncbi.nlm.nih.gov/35711159/,Negative,,Clinical Meta-analysis,2022,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Bipolar Disorder; Depression; Anxiety; Cannabis Adverse Effects; Psychosis
2022632,Cannabis and binge alcohol use among older individuals with major depressive episode,https://pubmed.ncbi.nlm.nih.gov/34666638/,Negative,,Meta-analysis,2022,,Mental/Emotional System,Addiction - Alcohol; Addiction - Cannabis; Addiction; Depression
2022633,Association Between Prenatal Cannabis Use and Psychotropic Medication Use in Pregnant Patients With Depression and Anxiety,https://pubmed.ncbi.nlm.nih.gov/35020701/,Negative,,Meta-analysis,2022,,Mental/Emotional System; Reproductive System,Addiction - Benzodiazepine; Addiction - Cannabis; Addiction; Anxiety; Depression; Pregnancy
2022634,"E-Cigarette and Cannabis Use Patterns, Depression, and Suicide Behaviors Among US Youth: Analysis of 2019 Youth Risk Behavior Survey Data",https://pubmed.ncbi.nlm.nih.gov/35792818/,Negative,,Meta-analysis,2022,,Mental/Emotional System,Addiction - Cannabis; Addiction - Nicotine; Addiction; Depression; Cannabis Adverse Effects; Suicide Attempt
2022635,"The CannTeen Study: Cannabis use disorder, depression, anxiety, and psychotic-like symptoms in adolescent and adult cannabis users and age-matched controls",https://journals.sagepub.com/doi/10.1177/02698811221108956,Negative,,Meta-analysis,2022,,Mental/Emotional System,Addiction - Cannabis; Addiction; Anxiety; Depression; Cannabis Adverse Effects
2022636,Frequent Cannabis Use Moderates the Relationship Between Sexual Dysfunction and Depression Among Female German Adults,https://pubmed.ncbi.nlm.nih.gov/35431149/,Negative,,Meta-analysis,2022,,Endocrine System; Mental/Emotional System; Nervous System; Reproductive System,Depression; Libido; Addiction - Alcohol; Addiction - Nicotine; Cannabis Adverse Effects; Erectile Dysfunction
2022637,Medical cannabis use in Canada and its impact on anxiety and depression: A retrospective study,https://www.sciencedirect.com/science/article/abs/pii/S0165178122001834?via%3Dihub,Positive,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Anxiety; Depression
2021257,CB2 cannabinoid receptor agonist selectively inhibits the mechanosensitivity of mucosal afferents in the guinea pig bladder,https://journals.physiology.org/doi/full/10.1152/ajprenal.00065.2021,Positive,,Laboratory Study,2021,Anandamide (AEA); Endocannabinoid (unspecified),Urinary System,Cystitis; Inflammation; Pain
2021258,Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease - A Systematic Review,https://www.frontiersin.org/articles/10.3389/fimmu.2021.790803/full,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Cannabigerol (CBG); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Digestive System,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Inflammation; Irritable Bowel Syndrome; Oxidative Stress
2022638,Cannabis and Its Potential Protective Role Against Inflammatory Bowel Disease: A Scoping Review,https://www.cureus.com/articles/67264-cannabis-and-its-potential-protective-role-against-inflammatory-bowel-disease-a-scoping-review,Inconclusive,,Meta-analysis,2022,Tetrahydrocannabinol (THC),Digestive System,IBD - Inflammatory Bowel Disease; IBD - Crohn's Disease
2022639,Incidence and Predictors of Cannabis-Related Poisoning and Mental and Behavioral Disorders among Patients with Medical Cannabis Authorization: A Cohort Study,https://pubmed.ncbi.nlm.nih.gov/35866679/,Inconclusive,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2022640,Cannabis consumption is associated with lower COVID-19 severity among hospitalized patients: a retrospective cohort analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356466/,Positive,,Meta-analysis,2022,Tetrahydrocannabinol (THC),Respiratory System,COVID-19; Inflammation
2022641,"Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 2 - categorical bivariate analysis and attributable fractions",https://pubmed.ncbi.nlm.nih.gov/35354495/,Negative,,Meta-analysis,2022,Tetrahydrocannabinol (THC),,Cancer; Addiction - Nicotine; Cancer - Colon; Cancer - Bladder; Cancer - Brain; Cancer - Breast; Cancer - Cervical; Cancer - Leukemia; Cancer - Liver; Cancer - Lung; Cancer - Lymphoma; Cancer - Melanoma; Cancer - Myeloma; Cancer - Oral; Cancer - Ovarian; Cancer - Pancreatic; Cancer - Prostate; Cancer - Squamous Head/Neck; Cancer - Stomach; Cancer - Thyroid
2022642,Role of Caryophyllane Sesquiterpenes in the Entourage Effect of Felina 32 Hemp Inflorescence Phytocomplex in Triple Negative MDA-MB-468 Breast Cancer Cells,https://pubmed.ncbi.nlm.nih.gov/34771097/,Positive,,Laboratory Study,2022,Cannabichromene (CBC),Reproductive System,Cancer - Breast; Cancer
2022643,Cannabis sativa CBD Extract Shows Promising Antibacterial Activity against Salmonella typhimurium and S. newington,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099639/,Positive,,Laboratory Study,2022,,Immune System,Bacterial Infections
2022644,Medical cannabis use by rheumatology patients in routine clinical care: results from The Ontario Best Practices Research Initiative,https://pubmed.ncbi.nlm.nih.gov/35616591/,Negative,,Meta-analysis,2022,,Skeletal System,Arthritis - Osteoarthritis; Arthritis - Rheumatoid; Arthritis; Anxiety; Pain; Pain - Chronic
2022645,The Anti-Inflammatory Effects of Cannabidiol (CBD) on Acne,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9078861/,Positive,,Meta-analysis,2022,,Integumentary System; Nervous System,Acne; Inflammation; Skin Diseases
2022646,The regulatory and modulatory roles of TRP family channels in malignant tumors and relevant therapeutic strategies,https://www.sciencedirect.com/science/article/pii/S2211383521004329?via%3Dihub,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified); Tetrahydrocannabinol (THC),Nervous System,Cancer; Cancer - Metastatic
2022647,The Origin and Biomedical Relevance of Cannabigerol,https://pubmed.ncbi.nlm.nih.gov/35887277/,Positive,,Meta-analysis,2022,Cannabigerol (CBG); Tetrahydrocannabinol (THC),,
2022648,Serum Cannabinoid 24 h and 1 Week Steady State Pharmacokinetic Assessment in Cats Using a CBD/CBDA Rich Hemp Paste,https://www.frontiersin.org/articles/10.3389/fvets.2022.895368/full,Inconclusive,,Animal Study,2022,Cannabidiolic Acid (CBD-a); Tetrahydrocannabinol (THC),,Anxiety; Arthritis - Osteoarthritis; Arthritis; Cancer; Epilepsy; Pain; Skin Diseases
2022649,The Metabolic Efficacy of a Cannabidiolic Acid (CBDA) Derivative in Treating Diet- and Genetic-Induced Obesity,https://pubmed.ncbi.nlm.nih.gov/35628417/,Positive,,Animal Study,2022,Cannabidiolic Acid (CBD-a); HU-x Synthetic Cannabinoids,Endocrine System,Obesity; Metabolic Syndrome
2022650,The effect of a mixed cannabidiol and cannabidiolic acid based oil on client-owned dogs with atopic dermatitis,https://onlinelibrary.wiley.com/doi/10.1111/vde.13077,Positive,,Animal Study -,2022,Cannabidiolic Acid (CBD-a),Integumentary System,Pruritis; Skin Diseases; Veterinary Applications; Allergic Contact Dermatitis; Inflammation; Pain
2022651,"Cannabidiol but not cannabidiolic acid reduces behavioural sensitisation to methamphetamine in rats, at pharmacologically effective doses",https://link.springer.com/article/10.1007/s00213-022-06119-3,Positive,,Animal Study,2022,Cannabidiolic Acid (CBD-a),Mental/Emotional System; Nervous System,Addiction - Stimulant; Addiction; Addiction - Alcohol; Addiction - Opioid; Anxiety; Depression; MDMA Adverse Effects; Psychosis
2022652,Cannabidiol Downregulates Myocardial de Novo Ceramide Synthesis Pathway in a Rat Model of High-Fat Diet-Induced Obesity,https://pubmed.ncbi.nlm.nih.gov/35216351/,Positive,,Animal Study,2022,,Cardiovascular System; Endocrine System,Cardiovascular Diseases (CVD); Metabolic Syndrome; Obesity
2022653,"Cannabidiol-Treated Ovariectomized Mice Show Improved Glucose, Energy, and Bone Metabolism With a Bloom in Lactobacillus",https://www.frontiersin.org/articles/10.3389/fphar.2022.900667/full,Positive,,Animal Study,2022,,Endocrine System; Nervous System; Reproductive System; Skeletal System,Inflammation; Menopause; Metabolic Syndrome; Osteoporosis; Ovarian Dysfunction; Diabetes
2022654,Antiseizure Effects of Cannabidiol Leading to Increased Peroxisome Proliferator-Activated Receptor Gamma Levels in the Hippocampal CA3 Subfield of Epileptic Rats,https://pubmed.ncbi.nlm.nih.gov/35631322/,Positive,,Animal Study,2022,,Nervous System,Epilepsy
2022655,Distinct Effects of Cannabidiol on Sphingolipid Metabolism in Subcutaneous and Visceral Adipose Tissues Derived from High-Fat-Diet-Fed Male Wistar Rats,https://pubmed.ncbi.nlm.nih.gov/35628194/,Positive,,Animal Study,2022,,Endocrine System,Metabolic Syndrome; Diabetes
2022656,"Effect of cannabidiol on apoptosis and cellular interferon and interferon-stimulated gene responses to the SARS-CoV-2 genes ORF8, ORF10 and M protein",https://www.sciencedirect.com/science/article/pii/S0024320522003241?via%3Dihub#s0010,Positive,,Laboratory Study,2022,,Respiratory System,COVID-19
2022657,Effects of Cannabidiol on Parkinson's Disease in a Transgenic Mouse Model by Gut-Brain Metabolic Analysis,https://www.hindawi.com/journals/ecam/2022/1525113/,Positive,,Animal Study,2022,,Nervous System,Parkinson's Disease; Neurodegenerative Issues
2022658,Prescription cannabidiol for seizure disorder management: Initial drug-drug interaction management by specialty pharmacists,https://pubmed.ncbi.nlm.nih.gov/35675751/,Positive,,Meta-analysis,2022,Pharma CBD,Nervous System,Epilepsy - Lennox-Gastaut; Epilepsy; Cannabis Adverse Effects
2022659,Cannabidiol for Functional Dyspepsia With Normal Gastric Emptying: A Randomized Controlled Trial,https://pubmed.ncbi.nlm.nih.gov/35537858/,Inconclusive,,Double Blind Clinical Trial,2022,Fatty Acid Amide Hydrolase (FAAH),,Gastro-Esophageal Reflux; Gastroparesis; Nausea and Vomiting; Stomach Ulcers
2022660,Cannabidiol for Treatment-Resistant Anxiety Disorders in Young People: An Open-Label Trial,https://pubmed.ncbi.nlm.nih.gov/35921510/,Positive,,Clinical Trial,2022,,Mental/Emotional System; Nervous System,Anxiety
2022661,Systematic Review on Transdermal/Topical Cannabidiol Trials: A Reconsidered Way Forward,https://www.liebertpub.com/doi/10.1089/can.2021.0154,Inconclusive,,Meta-analysis,2022,,Integumentary System; Mental/Emotional System; Nervous System,Behavioral Disorders; Pain; Skin Diseases
2021259,An adaptive randomized clinical trial in interstitial cystitis/bladder pain syndrome evaluating efficacy of ASP3652 and the relationship between disease characteristics and Hunner's lesions,https://pubmed.ncbi.nlm.nih.gov/32734461/,Inconclusive,,Clinical Trial,2021,Fatty Acid Amide Hydrolase (FAAH); Synthetic Cannabinoid (unspecified),,
2021260,Components of the Endogenous Cannabinoid System as Potential Biomarkers for Interstitial Cystitis/Bladder Pain Syndrome,https://pubmed.ncbi.nlm.nih.gov/35054185/,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified),Urinary System,Cystitis; Pain; Pain - Chronic
2022662,Peripheral Cannabinoid-1 Receptor Blockade Ameliorates Cystitis Severity,https://www.liebertpub.com/doi/10.1089/can.2022.0077,Positive,,Animal Study,2022,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),Urinary System,Cystitis
2022663,A Randomized Controlled Trial of Topical Cannabidiol for the Treatment of Thumb Basal Joint Arthritis,https://pubmed.ncbi.nlm.nih.gov/35637038/,Positive,,Double Blind Clinical Trial,2022,,Skeletal System,Arthritis; Pain; Pain - Chronic
2022664,Cannabinoid extract in microdoses ameliorates mnemonic and nonmnemonic Alzheimer’s disease symptoms: a case report,https://jmedicalcasereports.biomedcentral.com/articles/10.1186/s13256-022-03457-w#citeas,Positive,,Meta-analysis,2022,,Nervous System,Alzheimer's Disease; Anxiety; Bipolar Disorder; Cognitive Dysfunction; Depression; Inflammation; Neurodegenerative Issues; Psychosis
2022665,Cannabis-related allergies: An international overview and consensus recommendations,https://onlinelibrary.wiley.com/doi/10.1111/all.15237,Positive,,Meta-analysis,2022,,Immune System,Cannabis Allergies; Cannabis Adverse Effects
2022666,Healthcare provider and medical cannabis patient communication regarding referral and medication substitution: the Canadian context,https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-022-00141-0,Inconclusive,,Meta-analysis,2022,,,Addiction - Alcohol; Addiction - Nicotine
2022667,Targeting the Achilles’ Heel of Multidrug-Resistant Staphylococcus aureus by the Endocannabinoid Anandamide,https://www.mdpi.com/1422-0067/23/14/7798/htm,Positive,,Laboratory Study,2022,Anandamide (AEA),Immune System,Bacterial Infections
2020208,"A Potential Involvement of Anandamide in the Modulation of HO/NOS Systems: Women, Menopause, and “Medical Cannabinoids”",https://www.mdpi.com/1422-0067/21/22/8801/htm,Positive,,Animal Study,2020,Anandamide (AEA); Endocannabinoid (unspecified),Reproductive System,Menopause; Cardiovascular Diseases (CVD); Oxidative Stress
2002013,"Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues",https://febs.onlinelibrary.wiley.com/doi/full/10.1016/S0014-5793%2802%2902341-4,Positive,,Laboratory Study,2002,Other Related Compounds; 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),,
2005021,"Delta-9-tetrahydrocannabinol and cannabidiol, but not ondansetron, interfere with conditioned retching reactions elicited by a lithium-paired context in Suncus murinus: An animal model of anticipatory nausea and vomiting",https://pubmed.ncbi.nlm.nih.gov/16197970/,Positive,,Animal Study,2005,,Digestive System,Nausea and Vomiting; Cancer
2022668,Case Report: Cannabidiol-Induced Skin Rash: A Case Series and Key Recommendations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161546/,Negative,,Meta-analysis,2022,,Immune System; Integumentary System; Mental/Emotional System,Allergic Contact Dermatitis; Cannabis Adverse Effects; Cannabis Allergies; Pruritis; Skin Diseases
2022669,Epidemiology of Δ8THC-Related Carcinogenesis in USA: A Panel Regression and Causal Inferential Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265369/,Negative,,Meta-analysis,2022,Delta-8-THC,,Cancer - Kidney; Cancer - Colon; Cancer - Bladder; Cancer - Breast; Cancer - Cervical; Cancer - Leukemia; Cancer - Liver; Cancer - Lung; Cancer - Lymphoma; Cancer - Myeloma; Cancer - Neuroblastoma; Cancer - Oral; Cancer - Ovarian; Cancer - Pancreatic; Cancer - Prostate; Cancer - Skin (Non-melanoma); Cancer - Soft Tissues; Cancer - Squamous Head/Neck; Cancer - Stomach; Cancer - Testicular
2022670,Comparative Study of Δ9-Tetrahydrocannabinol and Cannabidiol on Melanogenesis in Human Epidermal Melanocytes from Different Pigmentation Phototypes: A Pilot Study,https://pubmed.ncbi.nlm.nih.gov/35736025/,Positive,,Laboratory Study,2022,Tetrahydrocannabinol (THC),,Oxidative Stress; Skin Diseases
2022671,Topical cannabidiol (CBD) in skin pathology – A comprehensive review and prospects for new therapeutic opportunities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210160/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified),,Abnormal Hair Growth; Acne; Bacterial Infections; Cancer - Melanoma; Cancer - Skin (Non-melanoma); Cancer - Squamous Head/Neck; Cancer; Hair Loss; Inflammation; Pain; Pruritis; Wound Healing
2022672,Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878527/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Cannabichromene (CBC); Cannabigerol (CBG); Cannabinol (CBN); Delta-8-THC; Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); Palmitoylethanolamide (PEA); Pharma CBD; Pharma THC:CBD; Tetrahydrocannabivarin (THCV); Pharma THC; SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); Tetrahydrocannabinol (THC); Tetrahydrocannabinolic Acid (THC-a); Virodhamine (O-AEA),Integumentary System,Allergic Contact Dermatitis; Eczema; Inflammation; Psoriasis; Skin Diseases; Arthritis - Rheumatoid; Arthritis; Cancer; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Malaria; Pain
2020209,Anthelmintic Activity of Yeast Particle-Encapsulated Terpenes,https://pubmed.ncbi.nlm.nih.gov/32605043/,Positive,,Laboratory Study,2020,,Digestive System,Parasitic Worms
2020210,Cannabidiol disrupts conditioned fear expression and cannabidiolic acid reduces trauma-induced anxiety-related behaviour in mice,https://pubmed.ncbi.nlm.nih.gov/32483052/,Positive,,Animal Study,2020,Cannabidiolic Acid (CBD-a),Mental/Emotional System; Nervous System,Anxiety; Epilepsy; Pain; Nausea and Vomiting
2020211,Effect of combined doses of Δ 9-tetrahydrocannabinol and cannabidiol or tetrahydrocannabinolic acid and cannabidiolic acid on acute nausea in male Sprague-Dawley rats,https://pubmed.ncbi.nlm.nih.gov/31897571/,Positive,,Animal Study,2020,Cannabidiolic Acid (CBD-a); SR-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); Tetrahydrocannabinolic Acid (THC-a),Digestive System,Nausea and Vomiting; Chemotherapy-induced Nausea & Vomiting; Morning sickness; Motion Sickness
2021261,A molecular explanation of cardiovascular protection through abnormal cannabidiol: Involving the dysfunctional β-adrenergic and ATP-sensitive K+ channel activity in cardiovascular compromised preterm infants,https://pubmed.ncbi.nlm.nih.gov/34309957/,Inconclusive,,Meta-analysis,2021,Abnormal Cannabidiol (Abn-CBD),,Cardiovascular Diseases (CVD); Diabetes; Metabolic Syndrome
2021262,Analytical findings in a non-fatal intoxication with the synthetic cannabinoid 5F-ADB (5F-MDMB-PINACA): a case report,https://link.springer.com/article/10.1007/s00414-021-02717-6,Negative,,Meta-analysis,2021,5F-x Synthetic Cannabinoids,Mental/Emotional System,Cannabis Adverse Effects
2006017,Unheated Cannabis sativa extracts and its major compound THC-acid have potential immuno-modulating properties not mediated by CB1 and CB2 receptor coupled pathways,https://www.sciencedirect.com/science/article/pii/S1567576905002882?via%3Dihub,Positive,,Laboratory Study,2006,Tetrahydrocannabinolic Acid (THC-a),,
2022673,Modulation of Recombinant Human T-Type Calcium Channels by Δ 9-Tetrahydrocannabinolic Acid In Vitro,https://pubmed.ncbi.nlm.nih.gov/33998881/,Positive,,Laboratory Study,2022,Tetrahydrocannabinolic Acid (THC-a),,Epilepsy; Pain; Neurodegenerative Issues
2022674,Anti-inflammatory and chondroprotective activity of (+)-α-pinene: structural and enantiomeric selectivity,https://pubmed.ncbi.nlm.nih.gov/24455984/,Positive,,Laboratory Study,2022,Mind-Body Medicine,,Arthritis - Osteoarthritis; Inflammation; Arthritis
2022675,Plant-Derived Nanoscale-Encapsulated Antioxidants for Oral and Topical Uses: A Brief Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998173/,Positive,,Meta-analysis,2022,,,Inflammation; Oxidative Stress
2022676,"Chemical Composition, Enantiomeric Distribution and Anticholinesterase and Antioxidant Activity of the Essential Oil of Diplosthephium juniperinum",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105165/,Positive,,Laboratory Study,2022,,,Oxidative Stress; Inflammation
2022677,"Hypoglycemic, Hypolipidemic, and Anti-Inflammatory Effects of Beta-Pinene in Diabetic Rats",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129963/,Positive,,Animal Study,2022,,Endocrine System; Nervous System,Inflammation; Metabolic Syndrome; Diabetes
2022678,Potentiation of the Activity of Antibiotics against ATCC and MDR Bacterial Strains with (+)-α-Pinene and (-)-Borneol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159878/,Positive,,Laboratory Study,2022,,Immune System,Bacterial Infections
2022679,Antimicrobial Activity of Essential Oils Evaluated In Vitro against Escherichia coli and Staphylococcus aureus,https://pubmed.ncbi.nlm.nih.gov/35884233/,Positive,,Laboratory Study,2022,,Immune System,Bacterial Infections
2022680,An In Silico Investigation to Explore Anti-Cancer Potential of Foeniculum vulgare Mill. Phytoconstituents for the Management of Human Breast Cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268524/,Positive,,Laboratory Study,2022,,Reproductive System,Cancer - Breast; Cancer
2022681,Combinatorial Antimicrobial Efficacy and Mechanism of Linalool Against Clinically Relevant Klebsiella pneumoniae,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010000/,Positive,,Laboratory Study,2022,,Immune System,Bacterial Infections; Oxidative Stress
2022682,Advanced in Vitro Safety Assessment of Herbal Medicines for the Treatment of Non-Psychotic Mental Disorders in Pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259859/,Inconclusive,,Laboratory Study,2022,,,Neonatal Cerebral Issues; Anxiety; Depression; Insomnia and Sleep Disorders; Pregnancy
2022683,Endoplasmic Reticulum Stress and Impairment of Ribosome Biogenesis Mediate the Apoptosis Induced by Ocimum x africanum Essential Oil in a Human Gastric Cancer Cell Line,https://pubmed.ncbi.nlm.nih.gov/35744062/,Positive,,Laboratory Study,2022,,,Cancer - Stomach; Cancer
2022684,Immunomodulatory effect of Linalool (Lin) against CCl 4 -induced hepatotoxicity and oxidative damage in rats,https://pubmed.ncbi.nlm.nih.gov/35748559/,Positive,,Animal Study,2022,Endocannabinoid (unspecified),Digestive System,Hepatitis; Inflammation; Injury Immunodeficiency; Liver Failure; Toxic Liver Disease
2022685,Ameliorative effects of ribes rubrum oil against gastric ulcers caused by indomethacin in experimental models,https://pubmed.ncbi.nlm.nih.gov/35002392/,Positive,,Animal Study,2022,Endocannabinoid (unspecified),Digestive System,Inflammation; Stomach Ulcers; Gastro-Esophageal Reflux
2022686,"Lavandula dentata L.: Phytochemical Analysis, Antioxidant, Antifungal and Insecticidal Activities of Its Essential Oil",https://pubmed.ncbi.nlm.nih.gov/35161292/,Positive,,Laboratory Study,2022,Endocannabinoid (unspecified),Digestive System; Immune System; Integumentary System; Nervous System,Fungal Infections; Inflammation; Oxidative Stress
2022687,Anti-inflammatory effects of lavender and eucalyptus essential oils on the in vitro cell culture model of bladder pain syndrome using T24 cells,https://bmccomplementmedtherapies.biomedcentral.com/articles/10.1186/s12906-022-03604-2,Positive,,Laboratory Study,2022,Endocannabinoid (unspecified),Nervous System; Urinary System,Cystitis; Inflammation
2022688,Antispasmodic Effect of Bergamot Essential Oil on Rat Isolated Gut Tissues,https://pubmed.ncbi.nlm.nih.gov/35456609/,Positive,,Laboratory Study,2022,Endocannabinoid (unspecified),,Inflammation; Irritable Bowel Syndrome
2022689,Inhalation of low-dose basil (Ocimum basilicum) essential oil improved cardiovascular health and plasma lipid markers in high fat diet-induced obese rats,https://pubmed.ncbi.nlm.nih.gov/35591766/,Positive,,Animal Study,2022,Endocannabinoid (unspecified),Endocrine System,Metabolic Syndrome; Atherosclerosis; Cardiovascular Diseases (CVD); Obesity
2022690,Olfactory Stimulation with Volatile Aroma Compounds of Basil ( Ocimum basilicum L.) Essential Oil and Linalool Ameliorates White Fat Accumulation and Dyslipidemia in Chronically Stressed Rats,https://pubmed.ncbi.nlm.nih.gov/35565791/,Positive,,Animal Study,2022,Endocannabinoid (unspecified),,Atherosclerosis; Cardiovascular Diseases (CVD); Chronic Heart Disease; Heart Disease; Inflammation; Metabolic Syndrome
2020212,Antibacterial activity and mechanism of linalool against Pseudomonas aeruginosa,https://pubmed.ncbi.nlm.nih.gov/31962183/,Positive,,Laboratory Study,2020,Endocannabinoid (unspecified),,Bacterial Infections
2016082,"α-Pinene, linalool, and 1-octanol contribute to the topical anti-inflammatory and analgesic activities of frankincense by inhibiting COX-2",https://pubmed.ncbi.nlm.nih.gov/26721216/,Positive,,Animal Study,2016,Endocannabinoid (unspecified),Nervous System,Inflammation; Pain
2022691,"Terpenes and terpenoids as main bioactive compounds of essential oils, their roles in human health and potential application as natural food preservatives",https://www.sciencedirect.com/science/article/pii/S2590157522000153?via%3Dihub,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified),,Bacterial Infections; Cancer; Inflammation; Oxidative Stress
2022692,"Medicinal Herbs in the Relief of Neurological, Cardiovascular, and Respiratory Symptoms after COVID-19 Infection A Literature Review",https://pubmed.ncbi.nlm.nih.gov/35741026/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified),Respiratory System,COVID-19; Anxiety; Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Chronic Heart Disease; Cognitive Dysfunction; Cough; Dementia; Depression; Heart Attack; Heart Disease; Hypertension (High Blood Pressure); Inflammation; Neurodegenerative Issues
2022693,Anticancer activity of linalool: comparative investigation of ultrastructural changes and apoptosis in breast cancer cells,https://pubmed.ncbi.nlm.nih.gov/35727696/,Positive,,Laboratory Study,2022,Endocannabinoid (unspecified),Nervous System; Reproductive System,Cancer - Breast; Cancer
2022694,"Acaricidal and anthelmintic efficacy of Ocimum basilicum essential oil and its major constituents estragole and linalool, with insights on acetylcholinesterase inhibition",https://pubmed.ncbi.nlm.nih.gov/35714433/,Positive,,Animal Study,2022,Endocannabinoid (unspecified),Digestive System,Parasitic Worms
2018087,Linalool bioactive properties and potential applicability in drug delivery systems,https://www.sciencedirect.com/science/article/abs/pii/S0927776518305253?via%3Dihub,Positive,,Meta-analysis,2018,Mind-Body Medicine,,Behavioral Disorders; Anxiety; Atherosclerosis; Bacterial Infections; Cancer; Cardiovascular Diseases (CVD); Cognitive Dysfunction; Depression; Inflammation; Pain; Neurodegenerative Issues; Oxidative Stress; Wound Healing
2022695,"Antimicrobial, Multidrug Resistance Reversal and Biofilm Formation Inhibitory Effect of Origanum majorana Extracts, Essential Oil and Monoterpenes",https://www.mdpi.com/2223-7747/11/11/1432/htm,Positive,,Laboratory Study,2022,,Immune System,Bacterial Infections
2022696,Anti-candidal Effect of Ocimum sanctum: A Systematic Review on Microbial Studies,https://pubmed.ncbi.nlm.nih.gov/35677004/,Positive,,Clinical Meta-analysis,2022,,Digestive System; Immune System; Integumentary System,Fungal Infections
2022697,"Potential anti-Parkinsonian's effect of S-(+)-linalool from Cinnamomum osmophloeum ct. linalool leaves are associated with mitochondrial regulation via gas-1, nuo-1, and mev-1 in Caenorhabditis elegans",https://pubmed.ncbi.nlm.nih.gov/35665972/,Positive,,Laboratory Study,2022,,Nervous System,Parkinson's Disease; Neurodegenerative Issues
2022698,A Narrative Review of the Antitumor Activity of Monoterpenes from Essential Oils: An Update,https://www.hindawi.com/journals/bmri/2022/6317201/,Positive,,Meta-analysis,2022,,Nervous System,Cancer
2021263,A scoping review of the use of cannabidiol in psychiatric disorders,https://pubmed.ncbi.nlm.nih.gov/34952255/,Positive,,Clinical Meta-analysis,2021,,,Addiction - Cannabis; Addiction - Nicotine; Addiction - Opioid; Anxiety; Insomnia and Sleep Disorders; Psychosis; PTSD; Schizophrenia
2022699,Nationwide Trends in Hospitalizations and Outcomes of Pulmonary Circulation Disorders Among Patients With Cannabis Use Disorder in the United States,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983119/,Negative,,Meta-analysis,2022,,Mental/Emotional System; Respiratory System,Addiction - Cannabis; Addiction; Vaping injury (EVALI); Addiction - Alcohol; Addiction - Cocaine; Addiction - Nicotine; Cannabis Adverse Effects; Cardiovascular Diseases (CVD); COPD; Hypertension (High Blood Pressure); Inflammation; MDMA Adverse Effects
2022700,Relation of Cannabis Use to Elevated Atherosclerotic Cardiovascular Disease Risk Score,https://pubmed.ncbi.nlm.nih.gov/34930616/,Negative,,Meta-analysis,2022,,Cardiovascular System,Atherosclerosis; Cardiovascular Diseases (CVD); Heart Attack
2015084,CB1 cannabinoid receptors mediate endochondral skeletal growth attenuation by Δ9-tetrahydrocannabinol,https://pubmed.ncbi.nlm.nih.gov/25573322/,Positive,,Animal Study,2015,2-Arachidonoyl Glycerol (2-AG); Endocannabinoid (unspecified); Tetrahydrocannabinol (THC),,Bone Fractures; Osteoporosis
2007026,Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis,https://pubmed.ncbi.nlm.nih.gov/17202146/,Positive,,Laboratory Study,2007,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,Nervous System,Cancer - Brain; Cancer
2018088,Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia,https://pubmed.ncbi.nlm.nih.gov/30496751/,Positive,,Animal Study,2018,AM-x Synthetic Cannabinoids; Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,Schizophrenia; Behavioral Disorders; Cognitive Dysfunction
2013051,Towards a better cannabis drug,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3838682/,Positive,,Meta-analysis,2013,,,Addiction - Cocaine; Addiction - Opioid; Cognitive Dysfunction
2011062,Skeletal lipidomics: regulation of bone metabolism by fatty acid amide family,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165954/,Positive,,Meta-analysis,2011,Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH),Skeletal System,Osteoporosis; Bone Fractures; Drug-Induced Bone Loss
2018089,N-Oleoyl-glycine reduces nicotine reward and withdrawal in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408981/,Positive,,Animal Study,2018,Fatty Acid Amide Hydrolase (FAAH); Anandamide (AEA); Palmitoylethanolamide (PEA); Virodhamine (O-AEA),Mental/Emotional System; Nervous System,Addiction - Nicotine; Addiction; Traumatic Brain Injury
2019093,"Differential response to plant- and human-derived odorants in field surveillance of the dengue vector, Aedes aegypti",https://pubmed.ncbi.nlm.nih.gov/31494122/,Positive,,Animal Study,2019,,,Parasitic Worms; Prion Disease
2020213,"Endocannabinoid modulation of dopamine release during reward seeking, interval timing, and avoidance",https://pubmed.ncbi.nlm.nih.gov/32663486/,Positive,,Meta-analysis,2020,2-Arachidonoyl Glycerol (2-AG); Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,Behavioral Disorders; Huntington's Disease; Neurodegenerative Issues; Parkinson's Disease
2021264,Progress on the application of positron emission tomography imaging of cannabinoid type 1 receptor in neuropsychiatric diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732249/,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified),Nervous System,Neurodegenerative Issues; Addiction - Cannabis; Alzheimer's Disease; Depression; Huntington's Disease; Parkinson's Disease; PTSD; Schizophrenia
2022701,HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922772/,Positive,,Meta-analysis,2022,,Digestive System; Immune System,Hepatitis; HIV/AIDS; Addiction - Cannabis
2022702,"Chronic health conditions, acute health events, and healthcare utilization among adults over age 50 in Hawai'i who use cannabis: A matched cohort study",https://pubmed.ncbi.nlm.nih.gov/35279458/,Negative,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Atherosclerosis; Cannabis Hyperemesis Syndrome; Cardiovascular Diseases (CVD); COPD; Heart Attack; Hypertension (High Blood Pressure); Pain; Nausea and Vomiting; Pain - Chronic; Stroke
2020214,Can Cannabis Cure Cancer?,https://jamanetwork.com/journals/jamaoncology/article-abstract/2758576,Inconclusive,,Meta-analysis,2020,,Integumentary System; Nervous System,Cancer - Squamous Head/Neck; Cancer
2022703,Effects of cannabidiol without delta-9-tetrahydrocannabinol on canine atopic dermatitis: A retrospective assessment of 8 cases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922375/,Negative,,Animal Study - Veterinary Clinical Trial,2022,,Integumentary System; Nervous System,Inflammation; Skin Diseases; Veterinary Applications; Allergic Contact Dermatitis
2022704,"Pharmacokinetics, Safety, and Synovial Fluid Concentrations of Single- and Multiple-Dose Oral Administration of 1 and 3 mg/kg Cannabidiol in Horses",https://pubmed.ncbi.nlm.nih.gov/35307550/,Positive,,Animal Study -,2022,,,Veterinary Applications
2022705,"The menaquinone pathway is important for susceptibility of Staphylococcus aureus to the antibiotic adjuvant, cannabidiol",https://www.sciencedirect.com/science/article/pii/S0944501322000143?via%3Dihub,Positive,,Laboratory Study -,2022,,Immune System,Staph Infection; Veterinary Applications; Bacterial Infections
2022706,Pharmacokinetic Evaluation of a Cannabidiol Supplement in Horses,https://pubmed.ncbi.nlm.nih.gov/34923070/,Positive,,Animal Study -,2022,,,Veterinary Applications
2022707,Feeding treats containing cannabidiol (CBD) did not alter canine immune response to immunization with a novel antigen,https://pubmed.ncbi.nlm.nih.gov/34953408/,Positive,,Animal Study -,2022,,,Veterinary Applications
2022708,Short term feeding of industrial hemp with a high cannabidiolic acid (CBDA) content increases lying behavior and reduces biomarkers of stress and inflammation in Holstein steers,https://www.nature.com/articles/s41598-022-07795-z,Positive,,Animal Study - Veterinary Clinical Trial,2022,Cannabidiolic Acid (CBD-a),Mental/Emotional System; Nervous System,Inflammation; Veterinary Applications
2022709,"Marijuana toxicosis in dogs in Melbourne, Australia, following suspected ingestion of human faeces: 15 cases (2011-2020)",https://pubmed.ncbi.nlm.nih.gov/34786688/,Negative,,Meta-analysis -,2022,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Veterinary Applications
2022710,Single dose and chronic oral administration of cannabigerol and cannabigerolic acid-rich hemp extract in fed and fasted dogs: Physiological effect and pharmacokinetic evaluation,https://pubmed.ncbi.nlm.nih.gov/35246858/,Positive,,Animal Study -,2022,Cannabigerol (CBG); Cannabigerolic Acid (CBG-a),,Veterinary Applications
2022711,Marijuana toxicosis in 2 donkeys,https://pubmed.ncbi.nlm.nih.gov/35037522/,Negative,,Animal Study -,2022,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Veterinary Applications
2022712,Plasma Pharmacokinetics of Cannabidiol Following Oral Administration of Cannabidiol Oil to Dairy Calves,https://www.frontiersin.org/articles/10.3389/fvets.2022.789495/full,Positive,,Animal Study -,2022,,,Veterinary Applications
2021265,Current review of hemp-based medicines in dogs,https://pubmed.ncbi.nlm.nih.gov/34605042/,Positive,,Meta-analysis -,2021,,,Veterinary Applications; Arthritis - Osteoarthritis; Arthritis; Epilepsy
2020215,"Cannabis, One Health, and Veterinary Medicine: Cannabinoids' Role in Public Health, Food Safety, and Translational Medicine",https://pubmed.ncbi.nlm.nih.gov/32017686/,Positive,,Meta-analysis -,2020,,,Veterinary Applications
2022713,"Tobacco, but Neither Cannabis Smoking Nor Co-Drug Use, Is Associated With Hearing Loss in the National Health and Nutrition Examination Survey, 2011 to 2012 and 2015 to 2016",https://pubmed.ncbi.nlm.nih.gov/35383601/,Inconclusive,,Meta-analysis,2022,,,Hearing Loss; Addiction - Cannabis; Addiction - Nicotine; Cannabis Adverse Effects
2019094,Assessment of quality and consistency of monoclonal antibodies for CB1 and CB2 in head and neck squamous cell carcinoma,https://pubmed.ncbi.nlm.nih.gov/31037797/,Positive,,Laboratory Study,2019,Endocannabinoid (unspecified),Integumentary System; Nervous System,Cancer - Squamous Head/Neck; Cancer
2017073,Cannabinoids Regulate the Diameter of Pericyte-Containing Retinal Capillaries in Rats,https://www.karger.com/Article/FullText/484193,Positive,,Animal Study,2017,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); WIN-x Synthetic Cannabinoids; AM-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,,Pain; Pain - Eye
2020216,A population-based survey to assess the association between cannabis and quality of life among colorectal cancer survivors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197173/,Negative,,Meta-analysis,2020,,Digestive System,Cancer - Colon; Cancer
2021266,Cannabinoid Quinones—A Review and Novel Observations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003933/,Positive,,Meta-analysis,2021,HU-x Synthetic Cannabinoids; Cannabinol (CBN),,Cancer; Amyotrophic Lateral Sclerosis (ALS); Cancer - Liver; Cancer - Lymphoma; Cancer - Melanoma; Huntington's Disease; Inflammation; Multiple Sclerosis; Oxidative Stress; Parkinson's Disease
2018090,Chronic treatment with the phytocannabinoid Cannabidivarin (CBDV) rescues behavioural alterations and brain atrophy in a mouse model of Rett syndrome,https://pubmed.ncbi.nlm.nih.gov/30056123/,Positive,,Animal Study,2018,Cannabidivarin (CBDV); Endocannabinoid (unspecified),Nervous System,Rett Syndrome; Behavioral Disorders; Autism; Epilepsy
2021267,Letter to the Editor: Ordering the Chaos in Cannabinoid-Related Research: Is it Time for a Task Force on Taxonomy?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064949/,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified),,
2021268,Is there a rational basis for cannabinoids research and development in ocular pain therapy? A systematic review of preclinical evidence,https://www.sciencedirect.com/science/article/pii/S0753332221012919?via%3Dihub,Inconclusive,,Meta-analysis,2021,Delta-8-THC; Endocannabinoid (unspecified); HU-x Synthetic Cannabinoids,Nervous System,Pain - Eye; Inflammation; Pain
2010052,Effect of palmitoylethanolamide-polydatin combination on chronic pelvic pain associated with endometriosis: preliminary observations,https://pubmed.ncbi.nlm.nih.gov/20176435/,Positive,,Clinical Trial,2010,Palmitoylethanolamide (PEA),Endocrine System,Endometriosis; Menstrual Disorders; Urinary Tract Infection
2021269,The CB 1 Receptor Differentially Regulates IFN-γ Production In Vitro and in Experimental Autoimmune Encephalomyelitis,https://pubmed.ncbi.nlm.nih.gov/33998867/,Positive,,Laboratory Study,2021,Endocannabinoid (unspecified),Nervous System,Encephalitis and Myelitis; Inflammation
1994003,Suppression of experimetal autoimmune encephalomyelitis by cannabinoids Author links open overlay panel,https://pubmed.ncbi.nlm.nih.gov/7852052/,Positive,,Animal Study,1994,Delta-8-THC,,Encephalitis and Myelitis
2018091,Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer’s disease by exerting anti-inflammatory and neuroprotective effects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802581/,Positive,,Animal Study,2018,Palmitoylethanolamide (PEA),Nervous System,Alzheimer's Disease; Neurodegenerative Issues
2015085,Palmitoylethanolamide treatment reduces retinal inflammation in streptozotocin-induced diabetic rats,https://pubmed.ncbi.nlm.nih.gov/26607470/,Positive,,Animal Study,2015,Palmitoylethanolamide (PEA),Endocrine System; Nervous System,Diabetes; Inflammation; Retinal Disorders; Pain; Pain - Neuropathy - Diabetic
2015086,Palmitoylethanolamide Inhibits Glutamate Release in Rat Cerebrocortical Nerve Terminals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394492/,Positive,,Animal Study,2015,Palmitoylethanolamide (PEA); AM-x Synthetic Cannabinoids,Nervous System,Neurodegenerative Issues; Epilepsy; Parkinson's Disease; Stroke
2020217,The Protective Effects of Pre- and Post-Administration of Micronized Palmitoylethanolamide Formulation on Postoperative Pain in Rats,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589788/,Positive,,Animal Study,2020,Palmitoylethanolamide (PEA),Nervous System,Pain; Pain - Acute; Inflammation
2017074,Palmitoylethanolamide and Polydatin combination reduces inflammation and oxidative stress in vascular injury,https://linkinghub.elsevier.com/retrieve/pii/S1043661817305674,Positive,,Animal Study,2017,Palmitoylethanolamide (PEA),Cardiovascular System,Atherosclerosis; Cardiovascular Diseases (CVD); Inflammation; Oxidative Stress
2021270,Tetrahydrocannabinol (THC) Exacerbates Inflammatory Bowel Disease in Adolescent and Adult Female Rats,https://pubmed.ncbi.nlm.nih.gov/33727159/,Negative,,Animal Study,2021,,Digestive System; Nervous System,IBD - Inflammatory Bowel Disease; Pain
2016083,Enhancement of Anandamide-Mediated Endocannabinoid Signaling Corrects Autism-Related Social Impairment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549436/,Positive,,Animal Study,2016,Anandamide (AEA); AM-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System,Autism; Behavioral Disorders; Fragile X Syndrome
2019095,The Endocannabinoid System as a Window Into Microglial Biology and Its Relationship to Autism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759510/,Positive,,Meta-analysis,2019,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Mental/Emotional System; Nervous System,Autism; Inflammation; Neonatal Cerebral Issues
2021271,Cannabis and cannabidiol use among autistic and non-autistic adults in the UK: a propensity score-matched analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685162/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System,Autism; Addiction - Cannabis
2020218,Medicinal Use of Cannabis in Children and Pregnant Women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000159/,Positive,,Meta-analysis,2020,,Reproductive System,Pregnancy; ADD and ADHD; Addiction - Alcohol; Anxiety; Autism; Insomnia and Sleep Disorders; Morning sickness; Nausea and Vomiting; Neonatal Cerebral Issues
2021272,Behavioral aspects and neurobiological properties underlying medical cannabis treatment in Shank3 mouse model of autism spectrum disorder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514476/,Positive,,Animal Study,2021,AM-x Synthetic Cannabinoids; Endocannabinoid (unspecified); Tetrahydrocannabinol (THC); WIN-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Autism
2020219,Maternal cannabis use in pregnancy and child neurodevelopmental outcomes,https://pubmed.ncbi.nlm.nih.gov/32778828/,Negative,,Meta-analysis,2020,,Reproductive System,Pregnancy; Cannabis Adverse Effects; Neonatal Cerebral Issues
2020220,Cannabis Exposure During Critical Windows of Development: Epigenetic and Molecular Pathways Implicated in Neuropsychiatric Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458902/,Negative,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; ADD and ADHD; Behavioral Disorders; Autism; Cognitive Dysfunction; Neonatal Cerebral Issues; Pregnancy; Schizophrenia
2021273,Peri-Pregnancy Cannabis Use and Autism Spectrum Disorder in the Offspring: Findings from the Study to Explore Early Development,https://link.springer.com/article/10.1007/s10803-021-05339-4,Negative,,Meta-analysis,2021,,Mental/Emotional System,Autism; Neonatal Cerebral Issues; Pregnancy
2021274,Perinatal Cannabis Exposures and Autism Spectrum Disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525188/,Inconclusive,,Meta-analysis,2021,Cannabichromene (CBC),Mental/Emotional System,Autism; Nausea and Vomiting; Neonatal Cerebral Issues; Pregnancy
2018092,"Palmitoylethanolamide prevents neuroinflammation, reduces astrogliosis and preserves recognition and spatial memory following induction of neonatal anoxia-ischemia",https://pubmed.ncbi.nlm.nih.gov/30058012/,Positive,,Animal Study,2018,Palmitoylethanolamide (PEA); Virodhamine (O-AEA),Nervous System,Stroke
2019096,A co-ultramicronized palmitoylethanolamide/luteolin composite mitigates clinical score and disease-relevant molecular markers in a mouse model of experimental autoimmune encephalomyelitis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587257/,Positive,,Animal Study,2019,Palmitoylethanolamide (PEA),Nervous System,Encephalitis and Myelitis; Multiple Sclerosis; Injury Immunodeficiency
2018093,Palmitoylethanolamide Blunts Amyloid-β42-Induced Astrocyte Activation and Improves Neuronal Survival in Primary Mouse Cortical Astrocyte-Neuron Co-Cultures,https://pubmed.ncbi.nlm.nih.gov/29154284/,Positive,,Laboratory Study,2018,Palmitoylethanolamide (PEA),Nervous System,Alzheimer's Disease; Inflammation; Neurodegenerative Issues
2019097,Short-Term Ultramicronized Palmitoylethanolamide Therapy in Patients with Myasthenia Gravis: a Pilot Study to Possible Future Implications of Treatment,https://pubmed.ncbi.nlm.nih.gov/30706796/,Positive,,Clinical Trial,2019,Palmitoylethanolamide (PEA),Nervous System,Myasthenia Gravis
2018094,Prophylactic Palmitoylethanolamide Prolongs Survival and Decreases Detrimental Inflammation in Aged Mice With Bacterial Meningitis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250830/,Positive,,Animal Study,2018,Palmitoylethanolamide (PEA); 2-Arachidonoyl Glycerol (2-AG); Endocannabinoid (unspecified),Immune System; Nervous System,Bacterial Infections; Inflammation
2018095,Palmitoylethanolamide counteracts autistic-like behaviours in BTBR T+tf/J mice: Contribution of central and peripheral mechanisms,https://www.sciencedirect.com/science/article/pii/S0889159118305488?via%3Dihub,Positive,,Animal Study,2018,Palmitoylethanolamide (PEA),Mental/Emotional System; Nervous System,Autism; Behavioral Disorders; Inflammation; Oxidative Stress
2021275,Efficacy of a fixed combination of palmitoylethanolamide and acetyl-l-carnitine (PEA+ALC FC) in the treatment of neuropathies secondary to rheumatic diseases,https://pubmed.ncbi.nlm.nih.gov/34056884/,Positive,,Clinical Trial,2021,Palmitoylethanolamide (PEA),Nervous System; Skeletal System,Arthritis - Rheumatoid; Arthritis; Pain; Pain - Chronic; Pain - Neuropathy - Peripheral; Inflammation; Pain - Neuropathy - Inflammatory Polyneuropathy
2016084,Ultramicronized palmitoylethanolamide (PEA-um(®)) in the treatment of idiopathic pulmonary fibrosis,https://pubmed.ncbi.nlm.nih.gov/27402190/,Positive,,Animal Study,2016,Palmitoylethanolamide (PEA),Respiratory System,Fibrosis - Lung; Fibrosis; Inflammation
2018096,"Impaired anandamide/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784910/,Positive,,Animal Study,2018,Anandamide (AEA); Palmitoylethanolamide (PEA); Fatty Acid Amide Hydrolase (FAAH); Virodhamine (O-AEA),Mental/Emotional System; Nervous System,Behavioral Disorders; Cognitive Dysfunction; Anxiety; Depression
2021276,In vivo brain levels of acetylcholine and 5-hydroxytryptamine after oleoylethanolamide or palmitoylethanolamide administrations are mediated by PPARα engagement,https://pubmed.ncbi.nlm.nih.gov/34396611/,Positive,,Animal Study,2021,Palmitoylethanolamide (PEA); Virodhamine (O-AEA),,Insomnia and Sleep Disorders
2012077,Mast cell–glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481533/,Positive,,Meta-analysis,2012,Anandamide (AEA); Palmitoylethanolamide (PEA); Fatty Acid Amide Hydrolase (FAAH); SR-x Synthetic Cannabinoids,Nervous System,Inflammation; Pain; Neurodegenerative Issues; Alzheimer's Disease; Amyotrophic Lateral Sclerosis (ALS); Depression; Epilepsy; Injury Immunodeficiency; Parkinson's Disease; Schizophrenia; Stroke
2022714,Palmitoylethanolamide dampens neuroinflammation and anxiety-like behavior in obese mice,https://www.sciencedirect.com/science/article/pii/S088915912200037X?via%3Dihub,Positive,,Animal Study,2022,Palmitoylethanolamide (PEA),Endocrine System; Mental/Emotional System,Anxiety; Inflammation; Metabolic Syndrome; Obesity; Behavioral Disorders; Neurodegenerative Issues
2018097,Palmitoylethanolamide attenuates cocaine-induced behavioral sensitization and conditioned place preference in mice,https://www.sciencedirect.com/science/article/abs/pii/S0091305717305981?via%3Dihub,Positive,,Animal Study,2018,Palmitoylethanolamide (PEA),Mental/Emotional System,Addiction - Cocaine; Addiction
2013052,"Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator",https://pubmed.ncbi.nlm.nih.gov/23813098/,Positive,,Meta-analysis,2013,Anandamide (AEA); Palmitoylethanolamide (PEA); Virodhamine (O-AEA),Nervous System,Inflammation; Neurodegenerative Issues
2019098,Ultramicronized Palmitoylethanolamide (um-PEA) as Add-on Treatment in Fibromyalgia Syndrome (FMS): Retrospective Observational Study on 407 Patients,https://pubmed.ncbi.nlm.nih.gov/30827269/,Positive,,Meta-analysis,2019,Palmitoylethanolamide (PEA),Muscular System,Fibromyalgia; Pain; Pain - Chronic
2019099,N-Palmitoylethanolamide-Oxazoline Protects against Middle Cerebral Artery Occlusion Injury in Diabetic Rats by Regulating the SIRT1 Pathway,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801841/,Positive,,Animal Study,2019,Palmitoylethanolamide (PEA),Endocrine System,Diabetes; Inflammation; Metabolic Syndrome; Oxidative Stress
2020221,First evidence on the role of palmitoylethanolamide in energy homeostasis in fish,https://www.sciencedirect.com/science/article/abs/pii/S0018506X19302326?via%3Dihub,Positive,,Animal Study,2020,Palmitoylethanolamide (PEA),,Anorexia; Metabolic Syndrome
2016085,Palmitoylethanolamide Reverses Paclitaxel-Induced Allodynia in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074488/,Positive,,Animal Study,2016,Palmitoylethanolamide (PEA); SR-x Synthetic Cannabinoids,Nervous System,Pain - Neuropathy - Peripheral; Cancer; Pain; Pain - Acute
2005022,"Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals",https://www.sciencedirect.com/science/article/abs/pii/S1090023305002741?via%3Dihub,Positive,,Meta-analysis,2005,Palmitoylethanolamide (PEA),Nervous System,Inflammation; Pain; Pain - Acute
2019100,The Potential Benefits of Palmitoylethanolamide in Palliation: A Qualitative Systematic Review,https://pubmed.ncbi.nlm.nih.gov/31113223/,Positive,,Meta-analysis,2019,Palmitoylethanolamide (PEA),Nervous System,Palliative Care; Autism; Bacterial Infections; Depression; Flu; Pain; Parkinson's Disease; Stroke
2019101,Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933707/,Positive,,Laboratory Study,2019,Palmitoylethanolamide (PEA); 2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Nervous System,Inflammation; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain; Pain - Chronic; Pain - Neuropathy - Diabetic
2018098,Micronized palmitoylethanolamide reduces joint pain and glial cell activation,https://pubmed.ncbi.nlm.nih.gov/30121836/,Positive,,Animal Study,2018,Palmitoylethanolamide (PEA),Muscular System,Temporomandibular Disorders; Inflammation; Pain; Pain - Chronic
2020222,Tolerability of Palmitoylethanolamide in a Pediatric Population Suffering from Migraine: A Pilot Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196162/,Positive,,Clinical Trial,2020,Palmitoylethanolamide (PEA),Nervous System,Migraine
2020223,"Ultramicronized Palmitoylethanolamide and Paracetamol, a New Association to Relieve Hyperalgesia and Pain in a Sciatic Nerve Injury Model in Rat",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278943/,Positive,,Animal Study,2020,Palmitoylethanolamide (PEA),Nervous System,Pain; Pain - Inflammatory; Pain - Neuropathy - Peripheral; Inflammation; Oxidative Stress; Pain - Neuropathy - Inflammatory Polyneuropathy
2011063,Sedative effects of vapor inhalation of the essential oil of Microtoena patchoulii and its related compounds,https://pubmed.ncbi.nlm.nih.gov/21287406/,Positive,,Animal Study,2011,,,Insomnia and Sleep Disorders
2009042,Acetylcholinesterase and butyrylcholinesterase inhibitory activity of Pinus species essential oils and their constituents,https://www.tandfonline.com/doi/full/10.3109/14756360903389856,Positive,,Laboratory Study,2009,,,Alzheimer's Disease
2022715,Why Do Marijuana and Synthetic Cannabimimetics Induce Acute Myocardial Infarction in Healthy Young People?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997492/,Negative,,Meta-analysis,2022,2-Arachidonoyl Glycerol (2-AG); Abnormal Cannabidiol (Abn-CBD); AM-x Synthetic Cannabinoids; Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Lysophosphatidylinositol (LPI); Monoacylglycerol Lipase (MAGL); O-x Synthetic Cannabinoids; Other Related Compounds; Palmitoylethanolamide (PEA); Pharma CBD; Pharma THC:CBD; Pharma THC; SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); Tetrahydrocannabinol (THC); Virodhamine (O-AEA),Cardiovascular System; Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cardiovascular Diseases (CVD); Heart Attack
2022716,Cannabis Use is Associated with Prevalent Coronary Artery Disease,https://pubmed.ncbi.nlm.nih.gov/35427587/,Negative,,Meta-analysis,2022,,Cardiovascular System,Atherosclerosis; Cardiovascular Diseases (CVD); Heart Attack
2020224,Safety and Efficacy of Cannabis in Autism Spectrum Disorder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759327/,Positive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Autism; Anxiety; Cognitive Dysfunction; Depression; Urinary Incontinence
2021277,Exploring the Relationship Between ADHD Symptoms and Daily Cannabis Consequences in Emerging Adulthood: The Role of Cannabis Motives,https://pubmed.ncbi.nlm.nih.gov/33823970/,Negative,,Clinical Trial,2021,,Mental/Emotional System,ADD and ADHD; Cannabis Adverse Effects; Behavioral Disorders; Insomnia and Sleep Disorders
2021278,Neurodevelopmental Effects of Cannabis Use in Adolescents and Emerging Adults with ADHD: A Systematic Review,https://pubmed.ncbi.nlm.nih.gov/34138796/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,ADD and ADHD
2022717,Cannabis for the Treatment of Attention Deficit Hyperactivity Disorder: A Report of 3 Cases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832253/,Positive,,Meta-analysis,2022,,Mental/Emotional System,ADD and ADHD
2022718,"Activation of GPR55 attenuates cognitive impairment, oxidative stress, neuroinflammation, and synaptic dysfunction in a streptozotocin-induced Alzheimer's mouse model",https://pubmed.ncbi.nlm.nih.gov/35090841/,Positive,,Animal Study,2022,Endocannabinoid (unspecified); O-x Synthetic Cannabinoids,,Alzheimer's Disease; Cognitive Dysfunction; Inflammation; Oxidative Stress
2022719,Endocannabinoid system contributions to sex-specific adolescent neurodevelopment,https://www.sciencedirect.com/science/article/abs/pii/S0278584621001974?via%3Dihub,Inconclusive,,Meta-analysis,2022,Endocannabinoid (unspecified),Mental/Emotional System,Behavioral Disorders; Cognitive Dysfunction
2022720,Cannabinoid and vanilloid pathways mediate opposing forms of synaptic plasticity in corticotropin-releasing hormone neurons,https://pubmed.ncbi.nlm.nih.gov/35034400/,Positive,,Laboratory Study,2022,2-Arachidonoyl Glycerol (2-AG); Endocannabinoid (unspecified),,Oxidative Stress
2019102,Micronized Palmitoylethanolamide: A Post Hoc Analysis of a Controlled Study in Patients with Low Back Pain – Sciatica,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132032/,Positive,,Meta-analysis,2019,Palmitoylethanolamide (PEA),Nervous System,Pain - Chronic; Inflammation; Pain; Pain - Neuropathy - Peripheral
2021279,Cannabinoid control of hippocampal functions: the where matters,https://febs.onlinelibrary.wiley.com/doi/10.1111/febs.15907,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified),,Behavioral Disorders; Alzheimer's Disease; Autism; Cognitive Dysfunction; Epilepsy; Inflammation; Insomnia and Sleep Disorders; Psychosis; Schizophrenia
2022721,Endocannabinoid signaling in glioma,https://onlinelibrary.wiley.com/doi/10.1002/glia.24173,Positive,,Meta-analysis,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); WIN-x Synthetic Cannabinoids,,Cancer - Brain; Cancer; Cancer - Neuroblastoma
2022722,Anandamide Hydrolysis Inhibition Reverses the Long-Term Behavioral and Gene Expression Alterations Induced by MK-801 in Male Rats: Differential CB1 and CB2 Receptor-Mediated Effects,https://pubmed.ncbi.nlm.nih.gov/35092675/,Positive,,Animal Study,2022,Anandamide (AEA); Endocannabinoid (unspecified),Mental/Emotional System,Behavioral Disorders; Cognitive Dysfunction; Schizophrenia; Psychosis
2022723,Footshock-Induced Abstinence from Compulsive Methamphetamine Self-administration in Rat Model Is Accompanied by Increased Hippocampal Expression of Cannabinoid Receptors (CB1 and CB2),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857101/,Inconclusive,,Animal Study,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Mental/Emotional System; Nervous System,Addiction - Stimulant; Addiction; Inflammation; MDMA Adverse Effects; Neurodegenerative Issues; Oxidative Stress
2022724,Prefrontal cortical distribution of muscarinic M2 and cannabinoid-1 (CB1) receptors in adult male mice with or without chronic adolescent exposure to Δ9-tetrahydrocannabinol,https://pubmed.ncbi.nlm.nih.gov/35151230/,Negative,,Animal Study,2022,Endocannabinoid (unspecified); Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cognitive Dysfunction
2022725,"Candidate Therapeutics by Screening for Multitargeting Ligands: Combining the CB2 Receptor With CB1, PPARγ and 5-HT4 Receptors",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918518/,Positive,,Laboratory Study,2022,,,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Inflammation; Irritable Bowel Syndrome
2022726,"The interactive effects of verapamil and CB1 cannabinoid receptor antagonist/inverse agonist, AM251 on passive avoidance learning and memory in rat",https://pubmed.ncbi.nlm.nih.gov/34845169/,Positive,,Animal Study,2022,AM-x Synthetic Cannabinoids; Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,Behavioral Disorders
2022727,Opposite physiological and pathological mTORC1-mediated roles of the CB1 receptor in regulating renal tubular function,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980033/,Inconclusive,,Animal Study,2022,,Urinary System,Chronic Kidney Disease; Diabetes
2022728,Spinal cannabinoid CB1 or CB2 receptors activation attenuates mechanical allodynia in streptozotocin-induced diabetic rats,https://pubmed.ncbi.nlm.nih.gov/32804775/,Positive,,Animal Study,2022,AM-x Synthetic Cannabinoids; Endocannabinoid (unspecified); JWH-x Synthetic Cannabinoids,Endocrine System,Diabetes; Pain - Neuropathy - Diabetic; Metabolic Syndrome; Pain; Pain - Chronic; Pain - Neuropathy - Peripheral
2020225,Terpenes/Terpenoids in Cannabis: Are They Important?,https://www.karger.com/Article/FullText/509733#,Positive,,Meta-analysis,2020,,,Anxiety; Cancer; Depression; Epilepsy; Fungal Infections; Gastro-Esophageal Reflux; Inflammation; Pain; Neurodegenerative Issues; Oxidative Stress; Pain - Acute; Pain - Chronic; Pain - Neuropathy - Peripheral; Psychosis
2020226,The Cannabis Terpenes,https://www.mdpi.com/1420-3049/25/24/5792/htm,Positive,,Meta-analysis,2020,,,Anxiety; Bacterial Infections; Cancer; Depression; Fungal Infections; Gastro-Esophageal Reflux; Inflammation; Pain; Neurodegenerative Issues; Oxidative Stress; Pain - Acute; Pain - Chronic; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral
2022729,Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945712/,Positive,,Meta-analysis,2022,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); Pharma THC; WIN-x Synthetic Cannabinoids,Nervous System,Huntington's Disease; Inflammation; Multiple Sclerosis; Neurodegenerative Issues; Parkinson's Disease; Bacterial Meningitis; Behavioral Disorders; Cognitive Dysfunction; IBD - Inflammatory Bowel Disease; Irritable Bowel Syndrome; Stroke
2021280,Activation of GPR55 attenuates cognitive impairment and neurotoxicity in a mouse model of Alzheimer's disease induced by Aβ 1-42 through inhibiting RhoA/ROCK2 pathway,https://pubmed.ncbi.nlm.nih.gov/34363866/,Positive,,Animal Study,2021,Endocannabinoid (unspecified),Nervous System,Alzheimer's Disease; Cognitive Dysfunction; Inflammation; Oxidative Stress; Dementia
2022730,Cannabidiol Treatment Improves Glucose Metabolism and Memory in Streptozotocin-Induced Alzheimer’s Disease Rat Model: A Proof-of-Concept Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835532/,Positive,,Animal Study,2022,,Nervous System,Alzheimer's Disease; Inflammation; Neurodegenerative Issues; Dementia; Metabolic Syndrome
2022731,Orchestration of the circadian clock and its association with Alzheimer's disease: Role of endocannabinoid signaling,https://pubmed.ncbi.nlm.nih.gov/34844016/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified),Nervous System,Alzheimer's Disease; Inflammation; Insomnia and Sleep Disorders; Neurodegenerative Issues
2022732,Impact of the cannabinoid system in Alzheimer's diseases,https://pubmed.ncbi.nlm.nih.gov/35105293/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified),,Alzheimer's Disease; Dementia; Neurodegenerative Issues
2022733,"Effect of the MAGL/FAAH Dual Inhibitor JZL-195 on Streptozotocin-Induced Alzheimer's Disease-like Sporadic Dementia in Mice with an Emphasis on Aβ, HSP-70, Neuroinflammation, and Oxidative Stress",https://pubmed.ncbi.nlm.nih.gov/35316021/,Positive,,Animal Study,2022,Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),,Alzheimer's Disease; Dementia; Inflammation; Neurodegenerative Issues; Oxidative Stress
2022734,Differential expression of the neuronal CB1 cannabinoid receptor in the hippocampus of male Ts65Dn Down syndrome mouse model,https://www.sciencedirect.com/science/article/pii/S1044743122000112?via%3Dihub,Positive,,Animal Study,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Other Related Compounds,Nervous System,Down Syndrome
2022735,Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773886/,Positive,,Animal Study,2022,AM-x Synthetic Cannabinoids; 2-Arachidonoyl Glycerol (2-AG); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Mental/Emotional System,Schizophrenia
2022736,Role of the cannabinoid CB1 receptor in methamphetamine-induced social and recognition memory impairment,https://pubmed.ncbi.nlm.nih.gov/35429587/,Inconclusive,,Animal Study,2022,SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Addiction - Stimulant; Addiction; Cognitive Dysfunction; MDMA Adverse Effects
2022737,Activation of CB1 pathway in the perirhinal cortex is necessary but not sufficient for destabilization of contextual fear memory in rats,https://www.sciencedirect.com/science/article/abs/pii/S0166432821004617?via%3Dihub,Positive,,Animal Study,2022,Endocannabinoid (unspecified),,Cognitive Dysfunction
2021281,Improved cyclobutyl nabilone analogs as potent CB1 receptor agonists,https://pubmed.ncbi.nlm.nih.gov/35051750/,Positive,,Animal Study,2021,AM-x Synthetic Cannabinoids; Endocannabinoid (unspecified); Pharma THC,,
2021282,Transcriptomic Profiling in Mice With CB1 receptor Deletion in Primary Sensory Neurons Suggests New Analgesic Targets for Neuropathic Pain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762320/,Positive,,Animal Study,2021,AM-x Synthetic Cannabinoids; Endocannabinoid (unspecified),Nervous System,Pain - Chronic; Pain - Neuropathy - Peripheral; Inflammation; Pain; Pain - Acute
2022738,Mitochondrial Localization of CB1 in Progesterone-producing Cells of Ovarian Interstitial Glands of Adult Mice,https://pubmed.ncbi.nlm.nih.gov/34915761/,Positive,,Laboratory Study,2022,Endocannabinoid (unspecified),,
2020227,Astrocytic palmitoylethanolamide pre-exposure exerts neuroprotective effects in astrocyte-neuron co-cultures from a triple transgenic mouse model of Alzheimer's disease,https://pubmed.ncbi.nlm.nih.gov/32622942/,Positive,,Laboratory Study,2020,Palmitoylethanolamide (PEA),Nervous System,Alzheimer's Disease; Inflammation; Neurodegenerative Issues; Oxidative Stress
2019103,Micronized Palmitoylethanolamide-Polydatin Reduces the Painful Symptomatology in Patients with Interstitial Cystitis/Bladder Pain Syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885282/,Positive,,Clinical Trial,2019,Palmitoylethanolamide (PEA),Urinary System,Cystitis; Pain; Pain - Chronic; Inflammation; Urinary Incontinence; Urinary Tract Infection
2002014,The palmitoylethanolamide family: a new class of anti-inflammatory agents?,https://pubmed.ncbi.nlm.nih.gov/11945130/,Positive,,Meta-analysis,2002,Palmitoylethanolamide (PEA); Anandamide (AEA),Nervous System,Inflammation; Pain; Multiple Sclerosis; Pain - Chronic
2021283,The Nutraceutical N-Palmitoylethanolamide (PEA) Reveals Widespread Molecular Effects Unmasking New Therapeutic Targets in Murine Varicocele,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996616/,Positive,,Animal Study,2021,Palmitoylethanolamide (PEA),Reproductive System,Infertility (Male)
2019104,N-Palmitoylethanolamide Exerts Antidepressant-Like Effects in Rats: Involvement of PPAR α Pathway in the Hippocampus,https://jpet.aspetjournals.org/content/369/1/163,Positive,,Animal Study,2019,Palmitoylethanolamide (PEA),Mental/Emotional System; Nervous System,Depression
2021284,Micro Composite Palmitoylethanolamide/Rutin Reduces Vascular Injury through Modulation of the Nrf2/HO-1 and NF-kB Pathways,https://pubmed.ncbi.nlm.nih.gov/33781184/,Positive,,Laboratory Study,2021,Palmitoylethanolamide (PEA),Cardiovascular System; Nervous System,Atherosclerosis; Cardiovascular Diseases (CVD); Inflammation; Oxidative Stress
2013053,Measurement of palmitoylethanolamide and other N-acylethanolamines during physiological and pathological conditions,https://pubmed.ncbi.nlm.nih.gov/23394528/,Positive,,Meta-analysis,2013,Palmitoylethanolamide (PEA),,Inflammation; Metabolic Syndrome
2018099,N-palmitoylethanolamide Prevents Parkinsonian Phenotypes in Aged Mice,https://pubmed.ncbi.nlm.nih.gov/29552727/,Positive,,Animal Study,2018,Palmitoylethanolamide (PEA),Nervous System,Neurodegenerative Issues; Parkinson's Disease
2015087,"Palmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndrome",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631430/,Positive,,Meta-analysis,2015,Fatty Acid Amide Hydrolase (FAAH); Palmitoylethanolamide (PEA),Nervous System,Inflammation; Pain; Pain - Acute; Pain - Chronic; Spinal Cord Injuries
2021285,Anti-inflammatory activity of palmitoylethanolamide ameliorates osteoarthritis induced by monosodium iodoacetate in Sprague–Dawley rats,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514352/,Positive,,Animal Study,2021,Palmitoylethanolamide (PEA),Nervous System; Skeletal System,Arthritis - Osteoarthritis; Arthritis; Inflammation; Oxidative Stress
2020228,Palmitoylethanolamide counteracts hepatic metabolic inflexibility modulating mitochondrial function and efficiency in diet-induced obese mice,https://faseb.onlinelibrary.wiley.com/doi/epdf/10.1096/fj.201901510RR,Positive,,Animal Study,2020,Palmitoylethanolamide (PEA),Endocrine System,Metabolic Syndrome; Diabetes; Fatty Liver Disease; Hepatitis; Oxidative Stress
2018100,Palmitoylethanolamide Promotes a Proresolving Macrophage Phenotype and Attenuates Atherosclerotic Plaque Formation,https://www.ahajournals.org/doi/10.1161/ATVBAHA.118.311185,Positive,,Animal Study,2018,Anandamide (AEA); Palmitoylethanolamide (PEA),Cardiovascular System,Atherosclerosis; Cardiovascular Diseases (CVD); Inflammation
2019105,Effects of cannabidivarin (CBDV) on brain excitation and inhibition systems in adults with and without Autism Spectrum Disorder (ASD): a single dose trial during magnetic resonance spectroscopy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868232/,Inconclusive,,Double Blind Clinical Trial,2019,Cannabidivarin (CBDV),Mental/Emotional System; Nervous System,Autism
2010053,Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain.,https://pubmed.ncbi.nlm.nih.gov/20353771/,Positive,,Meta-analysis,2010,Anandamide (AEA); Other Related Compounds; Palmitoylethanolamide (PEA); Virodhamine (O-AEA),Nervous System,Inflammation; Cognitive Dysfunction
2021286,Management of Acute Lung Injury: Palmitoylethanolamide as a New Approach,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197255/,Positive,,Animal Study,2021,Palmitoylethanolamide (PEA),Respiratory System,Acute Respiratory Distress Syndrome; COVID-19; Inflammation; Stress
2013054,Effect of diet on tissue levels of palmitoylethanolamide,https://pubmed.ncbi.nlm.nih.gov/23394522/,Inconclusive,,Animal Study,2013,Anandamide (AEA); Endocannabinoid (unspecified); Palmitoylethanolamide (PEA),Nervous System,Inflammation; Addiction - Alcohol; Anorexia; Neurodegenerative Issues
2020229,Impaired Duodenal Palmitoylethanolamide Release Underlies Acid-Induced Mast Cell Activation in Functional Dyspepsia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858681/,Positive,,Laboratory Study,2020,Endocannabinoid (unspecified); Palmitoylethanolamide (PEA),Digestive System; Nervous System,Gastro-Esophageal Reflux; Inflammation
2013055,Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma,https://pubmed.ncbi.nlm.nih.gov/22697514/,Positive,,Meta-analysis,2013,Palmitoylethanolamide (PEA),Nervous System,Inflammation; Mast Cell Activation Syndrome; Oxidative Stress
2020230,PPARα-Dependent Effects of Palmitoylethanolamide Against Retinal Neovascularization and Fibrosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401460/,Positive,,Animal Study,2020,Palmitoylethanolamide (PEA),Nervous System,Inflammation; Macular Degeneration; Retinal Disorders
2021287,Palmitoylethanolamide and Its Biobehavioral Correlates in Autism Spectrum Disorder: A Systematic Review of Human and Animal Evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073263/,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified); Palmitoylethanolamide (PEA),Mental/Emotional System,Autism; Inflammation; Behavioral Disorders
2020231,Palmitoylethanolamide counteracts brain fog improving depressive-like behaviour in obese mice: Possible role of synaptic plasticity and neurogenesis,https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.15071,Positive,,Animal Study,2020,Palmitoylethanolamide (PEA),Mental/Emotional System; Nervous System,Depression; Metabolic Syndrome; Obesity
2020232,Palmitoylethanolamide (PEA) reduces postoperative adhesions after experimental strabismus surgery in rabbits by suppressing canonical and non-canonical TGFβ signaling through PPARα,https://pubmed.ncbi.nlm.nih.gov/33385371/,Positive,,Animal Study,2020,Palmitoylethanolamide (PEA),,Pain; Pain - Eye
2005023,The search for the palmitoylethanolamide receptor,https://pubmed.ncbi.nlm.nih.gov/15963531/,Positive,,Meta-analysis,2005,Endocannabinoid (unspecified); Palmitoylethanolamide (PEA),,Inflammation; Pain; Pain - Acute; Pain - Chronic
2014063,Harnessing the anti-inflammatory potential of palmitoylethanolamide,https://www.sciencedirect.com/science/article/abs/pii/S1359644614002414?via%3Dihub,Positive,,Meta-analysis,2014,Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Palmitoylethanolamide (PEA),Nervous System,Inflammation; Neurodegenerative Issues
2021288,Palmitoylethanolamide Modulation of Microglia Activation: Characterization of Mechanisms of Action and Implication for Its Neuroprotective Effects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002502/,Positive,,Laboratory Study,2021,Palmitoylethanolamide (PEA),,Inflammation
2021289,Effect of Ultra-Micronized-Palmitoylethanolamide and Acetyl-l-Carnitine on Experimental Model of Inflammatory Pain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922157/,Positive,,Animal Study,2021,Palmitoylethanolamide (PEA); Endocannabinoid (unspecified),Nervous System,Pain; Pain - Inflammatory; Pain - Neuropathy - Peripheral; Inflammation; Oxidative Stress; Pain - Chronic
2017075,Ultra-micronized Palmitoylethanolamide: An Efficacious Adjuvant Therapy for Parkinson's Disease,https://pubmed.ncbi.nlm.nih.gov/28325153/,Positive,,Clinical Trial,2017,Palmitoylethanolamide (PEA),,Parkinson's Disease; Inflammation; Neurodegenerative Issues
2014064,Is there a role for palmitoylethanolamide in the treatment of depression?,https://pubmed.ncbi.nlm.nih.gov/24630855/,Positive,,Meta-analysis,2014,Palmitoylethanolamide (PEA),Mental/Emotional System; Nervous System,Depression
2015088,Palmitoylethanolamide attenuates PTZ-induced seizures through CB1 and CB2 receptors,https://pubmed.ncbi.nlm.nih.gov/26370914/,Positive,,Animal Study,2015,Palmitoylethanolamide (PEA); AM-x Synthetic Cannabinoids,Nervous System,Epilepsy
2016086,Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis,https://pubmed.ncbi.nlm.nih.gov/27720681/,Positive,,Animal Study,2016,Palmitoylethanolamide (PEA); AM-x Synthetic Cannabinoids,Integumentary System,Allergic Contact Dermatitis; Skin Diseases
2008040,A diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner,https://pubmed.ncbi.nlm.nih.gov/18562209/,Positive,,Animal Study,2008,Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Integumentary System,Longevity; Cognitive Dysfunction; Geriatric Conditions; Neurodegenerative Issues
2012078,Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1⁻/⁻ mice,https://pubmed.ncbi.nlm.nih.gov/20724033/,Positive,,Animal Study,2012,,Integumentary System; Muscular System; Nervous System; Skeletal System,Geriatric Conditions; Longevity; Cognitive Dysfunction
2020233,Endocannabinoid Signaling for GABAergic-Microglia (Mis)Communication in the Brain Aging,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887316/,Positive,,Meta-analysis,2020,,Integumentary System,Longevity; Cognitive Dysfunction; Geriatric Conditions; Neurodegenerative Issues
2003010,Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC298783/,Positive,,Animal Study,2003,SR-x Synthetic Cannabinoids,Integumentary System; Muscular System; Skeletal System,Geriatric Conditions; Longevity
2008041,Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET,https://pubmed.ncbi.nlm.nih.gov/18077184/,Inconclusive,,Clinical Trial,2008,Synthetic Cannabinoid (unspecified),Integumentary System; Muscular System; Nervous System; Skeletal System,Geriatric Conditions; Longevity
1998004,Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats,https://pubmed.ncbi.nlm.nih.gov/9748581/,Positive,,Laboratory Study,1998,,Integumentary System,Longevity; Cognitive Dysfunction; Geriatric Conditions
1998005,Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5'O-(thio)-triphosphate binding in the basal ganglia of aged rats,https://pubmed.ncbi.nlm.nih.gov/9578396/,Positive,,Laboratory Study,1998,Synthetic Cannabinoid (unspecified),,Geriatric Conditions; Longevity
2012079,Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464170/,Positive,,Laboratory Study,2012,,,Geriatric Conditions; Longevity
2022739,Effect of Cannabidiol on the Neural Glyoxalase Pathway Function and Longevity of Several C. elegans Strains Including a C. elegans Alzheimer's Disease Model,https://pubmed.ncbi.nlm.nih.gov/35385645/,Positive,,Laboratory Study,2022,,Integumentary System; Nervous System,Alzheimer's Disease; Longevity
2018101,Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer's Disease: In Vitro and In Vivo Evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822864/,Positive,,Animal Study,2018,Palmitoylethanolamide (PEA),Nervous System,Alzheimer's Disease; Neurodegenerative Issues
2022740,Evidence-based management of multiple sclerosis spasticity with nabiximols oromucosal spray in clinical practice: a 10-year recap,https://www.futuremedicine.com/doi/10.2217/nmt-2022-0002,Positive,,Clinical Meta-analysis,2022,Pharma THC:CBD; Tetrahydrocannabinol (THC),,Multiple Sclerosis; Cognitive Dysfunction; Insomnia and Sleep Disorders; Pain; Pain - Chronic
2021290,"Safety and tolerability of nabiximols oromucosal spray: a review of more than 15 years"" accumulated evidence from clinical trials",https://pubmed.ncbi.nlm.nih.gov/34092180/,Positive,,Clinical Meta-analysis,2021,Pharma THC:CBD,Nervous System,Multiple Sclerosis; Arthritis - Rheumatoid; Arthritis; Chorea; Pain; Neurodegenerative Issues; Pain - Cancer; Pain - Chronic; Pain - Neuropathy - Peripheral
2022741,"Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial",https://pubmed.ncbi.nlm.nih.gov/35316689/,Positive,,Double Blind Clinical Trial,2022,Pharma THC:CBD; Tetrahydrocannabinol (THC),Mental/Emotional System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects; Insomnia and Sleep Disorders; Pain; Pain - Chronic
2022742,Effectiveness and Tolerability of Dronabinol Use in Patients with Chronic Pain: A Retrospective Analysis of 12-Week Open-Label Real-World Data Provided by the German Pain e-Registry,https://academic.oup.com/painmedicine/advance-article/doi/10.1093/pm/pnac010/6519324?login=false,Positive,,Meta-analysis,2022,Pharma THC; Tetrahydrocannabinol (THC),Nervous System,Pain; Pain - Chronic; Insomnia and Sleep Disorders; Quality of Life
2022743,Efficacy and safety of cannabidivarin treatment of epilepsy in girls with Rett syndrome: A phase 1 clinical trial,https://pubmed.ncbi.nlm.nih.gov/35364618/,Positive,,Clinical Trial,2022,Cannabidivarin (CBDV),,Rett Syndrome; Epilepsy
2020234,Potential Mechanisms Involved in Palmitoylethanolamide-Induced Vasodepressor Effects in Rats,https://pubmed.ncbi.nlm.nih.gov/32248195/,Positive,,Animal Study,2020,Palmitoylethanolamide (PEA); AM-x Synthetic Cannabinoids,Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2013056,"Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain",https://pubmed.ncbi.nlm.nih.gov/24178954/,Positive,,Meta-analysis,2013,Palmitoylethanolamide (PEA),Nervous System,Inflammation; Pain; Pain - Central Pain Syndrome; Pain - Chronic
2013057,Palmitoylethanolamide in homeostatic and traumatic central nervous system injuries,https://pubmed.ncbi.nlm.nih.gov/23394520/,Positive,,Meta-analysis,2013,Palmitoylethanolamide (PEA),Nervous System,Pain; Pain - Central Pain Syndrome; Inflammation; Spinal Cord Injuries; Traumatic Brain Injury
2021291,Engineered Lactobacillus paracasei Producing Palmitoylethanolamide (PEA) Prevents Colitis in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999950/,Positive,,Animal Study,2021,Palmitoylethanolamide (PEA),Digestive System; Nervous System,IBD - Inflammatory Bowel Disease; Inflammation; Oxidative Stress
2021292,Ultramicronized Palmitoylethanolamide in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583705/,Positive,,Animal Study,2021,Palmitoylethanolamide (PEA),Immune System,Sepsis; COVID-19; Inflammation
2018102,"Role of palmitoylethanolamide (PEA) in depression: Translational evidence: Special Section on ""Translational and Neuroscience Studies in Affective Disorders"".",https://pubmed.ncbi.nlm.nih.gov/30391203/,Positive,,Meta-analysis,2018,Endocannabinoid (unspecified); Palmitoylethanolamide (PEA),Mental/Emotional System,Depression; Anxiety; Pain; Pain - Neuropathy - Peripheral; Traumatic Brain Injury
2019106,Therapeutic Efficacy of Palmitoylethanolamide and Its New Formulations in Synergy with Different Antioxidant Molecules Present in Diets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769461/,Positive,,Meta-analysis,2019,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Palmitoylethanolamide (PEA),Nervous System,Inflammation; Oxidative Stress
2014065,Palmitoylethanolamide in CNS health and disease,https://pubmed.ncbi.nlm.nih.gov/24844438/,Positive,,Meta-analysis,2014,Palmitoylethanolamide (PEA); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System; Nervous System,Behavioral Disorders; Neurodegenerative Issues; Inflammation; Metabolic Syndrome; Pain
2020235,Food supplements based on palmitoylethanolamide plus hydroxytyrosol from olive tree or Bacopa monnieri extracts for neurological diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023129/,Positive,,Meta-analysis,2020,Other Related Compounds; Palmitoylethanolamide (PEA),Nervous System,Neurodegenerative Issues; Alzheimer's Disease; Inflammation; Pain; Oxidative Stress; Parkinson's Disease
2022744,The cannabinoid receptor I (CB1) enhanced the osteogenic differentiation of BMSCs by rescue impaired mitochondrial metabolism function under inflammatory condition,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781353/,Positive,,Laboratory Study,2022,Endocannabinoid (unspecified),Digestive System,Inflammation; Periodontal Disease; Pain; Pain - Acute; Pain - Dental - Acute
2022745,CB1 receptor antagonist AM4113 reverts the effects of cannabidiol on cue and stress-induced reinstatement of cocaine-seeking behaviour in mice,https://www.sciencedirect.com/science/article/pii/S0278584621002219?via%3Dihub,Negative,,Animal Study,2022,AM-x Synthetic Cannabinoids; Endocannabinoid (unspecified),Mental/Emotional System,Addiction - Cocaine; Addiction
2022746,Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027088/,Positive,,Animal Study,2022,Endocannabinoid (unspecified); SR-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Anxiety; Behavioral Disorders; Cognitive Dysfunction; Depression
2022747,Neuroplastic alterations in cannabinoid receptors type 1 (CB1) in animal models of epileptic seizures,https://pubmed.ncbi.nlm.nih.gov/35460705/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified),,Epilepsy
2022748,Influence of N-Arachidonoyl Dopamine and N-Docosahexaenoyl Dopamine on the Expression of Neurotrophic Factors in Neuronal Differentiated Cultures of Human Induced Pluripotent Stem Cells under Conditions of Oxidative Stress,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773408/,Positive,,Laboratory Study,2022,Endocannabinoid (unspecified); N-Arachidonoyl Dopamine (NADA),,Oxidative Stress; Inflammation; Neurodegenerative Issues; Parkinson's Disease
2022749,"Memory Consolidation Depends on Endogenous Hippocampal Levels of Anandamide: CB1 and M4, but Possibly not TRPV1 Receptors Mediate AM404 effects",https://pubmed.ncbi.nlm.nih.gov/35436517/,Positive,,Animal Study,2022,AM-x Synthetic Cannabinoids; Anandamide (AEA),,
2022750,Acute and long-term effects of cannabinoids on hypertension and kidney injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005691/,Negative,,Animal Study,2022,Anandamide (AEA),Cardiovascular System; Urinary System,Cardiovascular Diseases (CVD); Chronic Kidney Disease; Hypertension (High Blood Pressure)
2022751,"Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: Results from two pilot, proof-of-concept, randomized, placebo-controlled trials",https://pubmed.ncbi.nlm.nih.gov/35107855/,Inconclusive,,Clinical Trial,2022,Ayahuasca,Mental/Emotional System,Anxiety
2022752,Fatty Acid Amide Hydrolase (FAAH) Inhibition Plays a Key Role in Counteracting Acute Lung Injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910911/,Positive,,Animal Study,2022,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),,Inflammation; Oxidative Stress; Fibrosis - Lung; Fibrosis
2022753,"Anandamide-Modulated Changes in Metabolism, Glycosylation Profile and Migration of Metastatic Melanoma Cells",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946642/,Positive,,Laboratory Study,2022,Anandamide (AEA),Integumentary System; Nervous System,Cancer - Melanoma; Cancer; Oxidative Stress
2022754,The role of the cannabinoid system in fear memory and extinction in male and female mice,https://pubmed.ncbi.nlm.nih.gov/35176534/,Inconclusive,,Animal Study,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); WIN-x Synthetic Cannabinoids,Mental/Emotional System,PTSD
2020236,An optimized spectrophotometric assay reveals increased activity of enzymes involved in 2-arachidonoyl glycerol turnover in the cerebral cortex of a rat model of Alzheimer's disease,https://pubmed.ncbi.nlm.nih.gov/32813905/,Positive,,Animal Study,2020,2-Arachidonoyl Glycerol (2-AG); Monoacylglycerol Lipase (MAGL),Nervous System,Alzheimer's Disease
2012080,Modulation of l-α-Lysophosphatidylinositol/GPR55 Mitogen-activated Protein Kinase (MAPK) Signaling by Cannabinoids,https://www.jbc.org/article/S0021-9258(20)53496-0/fulltext#%20,Inconclusive,,Laboratory Study,2012,AB-x Synthetic Cannabinoids; AM-x Synthetic Cannabinoids; Cannabidiolic Acid (CBD-a); Cannabidivarin (CBDV); Cannabigerol (CBG); Cannabigerolic Acid (CBG-a); CP-x Synthetic Cannabinoids; HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Lysophosphatidylinositol (LPI); Tetrahydrocannabivarin (THCV); SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,,Cancer; Pain
2022755,Sex differences in the acute effects of intravenous (IV) delta-9 tetrahydrocannabinol (THC),https://link.springer.com/article/10.1007/s00213-022-06135-3,Inconclusive,,Double Blind Clinical Trial,2022,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2021293,Cannabinoids for the treatment of refractory neuropathic pruritus in amyotrophic lateral sclerosis: A case report,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796147/,Positive,,Meta-analysis,2021,Pharma THC:CBD,Integumentary System; Nervous System,Amyotrophic Lateral Sclerosis (ALS); Pruritis; Skin Diseases
2022756,An Updated Analysis of Clinical Outcome Measures Across Patients From the UK Medical Cannabis Registry,https://www.liebertpub.com/doi/10.1089/can.2021.0145,Positive,,Clinical Trial,2022,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Anxiety; Fibromyalgia; Insomnia and Sleep Disorders; Pain; Pain - Chronic; Pain - Neuropathy - Peripheral
2022757,Cannabinoid-Related Acute Pancreatitis: An Update from International Literature and Individual Case Safety Reports,https://link.springer.com/article/10.1007/s40264-022-01146-7,Negative,,Meta-analysis,2022,Pharma THC,Digestive System; Endocrine System; Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Pancreatitis
2021294,Role of PI3K/Akt axis in mitigating hippocampal ischemia-reperfusion injury via CB1 receptor stimulation by paracetamol and FAAH inhibitor in rat,https://pubmed.ncbi.nlm.nih.gov/34968475/,Positive,,Animal Study,2021,AM-x Synthetic Cannabinoids; Anandamide (AEA); Endocannabinoid (unspecified),,Stroke; COVID-19
2022758,Circulating endocannabinoids and genetic polymorphisms as predictors of posttraumatic stress disorder symptom severity: heterogeneity in a community-based cohort,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807700/,Inconclusive,,Clinical Trial,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,PTSD
2021295,"The influence of FAAH genetic variation on physiological, cognitive, and neural signatures of fear acquisition and extinction learning in women with PTSD",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715233/,Positive,,Clinical Trial,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Mental/Emotional System,PTSD
2022759,Inhibiting the endocannabinoid degrading enzymes FAAH and MAGL during zebrafish embryogenesis alters sensorimotor function,https://pubmed.ncbi.nlm.nih.gov/35438163/,Positive,,Laboratory Study,2022,Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),,
2022760,Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027089/,Positive,,Meta-analysis,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Palmitoylethanolamide (PEA); Virodhamine (O-AEA),Nervous System,Migraine
2021296,"Safety, Tolerability, and Pharmacokinetics of FAAH Inhibitor BIA 10-2474: A Double-Blind, Randomized, Placebo-Controlled Study in Healthy Volunteers",https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.2290,Negative,,Double Blind Clinical Trial,2021,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),,
2022761,Medical Cannabis Activity Against Inflammation: Active Compounds and Modes of Action,https://www.frontiersin.org/articles/10.3389/fphar.2022.908198/full,Positive,,Meta-analysis,2022,Cannabigerol (CBG); Tetrahydrocannabinol (THC),Nervous System,Inflammation
2020237,"Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind and controlled placebo clinical trial",https://pubmed.ncbi.nlm.nih.gov/35617670/,Positive,,Double Blind Clinical Trial,2020,,Mental/Emotional System; Nervous System,Autism
2022762,"Cannabinoids in the management of behavioral, psychological, and motor symptoms of neurocognitive disorders: a mixed studies systematic review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922797/,Positive,,Meta-analysis,2022,Pharma THC; Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Behavioral Disorders; Cognitive Dysfunction; Psychosis; Alzheimer's Disease; Dementia; Huntington's Disease; Insomnia and Sleep Disorders; Parkinson's Disease
2021297,The Potential of Salivary Lipid-Based Cannabis-Responsive Biomarkers to Evaluate Medical Cannabis Treatment in Children with Autism Spectrum Disorder,https://www.liebertpub.com/doi/10.1089/can.2021.0224,Positive,,Clinical Trial,2021,,Mental/Emotional System,Autism
2022763,Fetal Exposure to Cannabis and Childhood Metabolic Outcomes: The Healthy Start Study,https://academic.oup.com/jcem/advance-article/doi/10.1210/clinem/dgac101/6554396?login=false,Negative,,Clinical Trial,2022,Cannabichromene (CBC); Cannabidivarin (CBDV); Cannabigerol (CBG); Cannabinol (CBN),Endocrine System,Metabolic Syndrome; Diabetes; Pregnancy
2022764,Does body mass index explain the apparent anti-inflammatory effects of cannabis use? Results From a cohort study of sexual and gender minority youth,https://pubmed.ncbi.nlm.nih.gov/35182843/,Positive,,Clinical Trial,2022,,Nervous System,Inflammation
2021298,Potent T cell-mediated anti-inflammatory role of the selective CB2 agonist lenabasum in multiple sclerosis,https://pubmed.ncbi.nlm.nih.gov/34543449/,Positive,,Laboratory Study,2021,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),Nervous System,Encephalitis and Myelitis; Multiple Sclerosis; Injury Immunodeficiency
2022765,"Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945692/,Positive,,Meta-analysis,2022,Pharma THC:CBD; Tetrahydrocannabinol (THC); WIN-x Synthetic Cannabinoids,,Multiple Sclerosis
2022766,Penile self-amputation due to cannabis-induced psychosis: a case report,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801084/,Negative,,Meta-analysis,2022,,Mental/Emotional System,Cannabis Adverse Effects; Psychosis
2021299,"Cannabinoid control of gingival immune activation in chronically SIV-infected rhesus macaques involves modulation of the indoleamine-2,3-dioxygenase-1 pathway and salivary microbiome",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715300/,Positive,,Animal Study,2021,Microbiome,Digestive System,Periodontal Disease; Bacterial Infections; HIV/AIDS; Inflammation
2022767,The Safety of Dronabinol and Nabilone: A Systematic Review and Meta-Analysis of Clinical Trials,https://www.mdpi.com/1424-8247/15/1/100/htm,Positive,,Clinical Meta-analysis,2022,Pharma THC,Mental/Emotional System,Cannabis Adverse Effects; Alzheimer's Disease; Cancer; Cardiovascular Diseases (CVD); Dementia; Fibromyalgia; Migraine; Pain; Nausea and Vomiting; Neurodegenerative Issues; Spinal Cord Injuries
2022768,Age-related changes in CB1 receptor expression and function and the behavioral effects of cannabinoid receptor ligands,https://www.sciencedirect.com/science/article/abs/pii/S0091305722000181?via%3Dihub,Inconclusive,,Animal Study,2022,Endocannabinoid (unspecified),Mental/Emotional System,Behavioral Disorders
2021300,Dronabinol inhibits alveolar bone remodeling in tooth movement of rats,https://pubmed.ncbi.nlm.nih.gov/34924285/,Negative,,Animal Study,2021,Pharma THC,Mental/Emotional System; Nervous System; Skeletal System,Cannabis Adverse Effects; Drug-Induced Bone Loss; Bone Fractures
2022769,Clinical Management of Sleep and Sleep Disorders With Cannabis and Cannabinoids: Implications to Practicing Psychiatrists,https://pubmed.ncbi.nlm.nih.gov/35221321/,Positive,,Meta-analysis,2022,Pharma THC,,Insomnia and Sleep Disorders; Anxiety; Depression; PTSD; Sleep Apnea
2022770,"Over 1 year later: smokers' EVALI awareness, knowledge and perceived impact on e-cigarette interest",https://pubmed.ncbi.nlm.nih.gov/35228318/,Negative,,Meta-analysis,2022,,Respiratory System,Vaping injury (EVALI); Cannabis Adverse Effects
2021301,Cannabis-based medicine in treatment of patients with Gilles de la Tourette syndrome,https://pubmed.ncbi.nlm.nih.gov/34708399/,Positive,,Meta-analysis,2021,Pharma THC:CBD,Nervous System,Tics and Tourettes
2022771,Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869966/,Positive,,Laboratory Study,2022,,Immune System; Nervous System,HIV/AIDS; Neurodegenerative Issues; Prion Disease; Inflammation
2022772,Cannabis suppresses antitumor immunity by inhibiting JAK/STAT signaling in T cells through CNR2,https://www.nature.com/articles/s41392-022-00918-y,Negative,,Animal Study,2022,Anandamide (AEA),,Cancer; Cancer - Colon; Cancer - Melanoma
2022773,The Effectiveness and Safety of Medical Cannabis for Treating Cancer Related Symptoms in Oncology Patients,https://www.frontiersin.org/articles/10.3389/fpain.2022.861037/full,Positive,,Meta-analysis,2022,,Nervous System,Cancer
2022774,Topical cannabidiol-based treatment for psoriasis: A dual-centre randomized placebo-controlled study,https://pubmed.ncbi.nlm.nih.gov/35536599/,Positive,,Clinical Trial,2022,,Integumentary System,Psoriasis
2022775,Cannabis use in patients with insomnia and sleep disorders: Retrospective chart review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067069/,Positive,,Meta-analysis,2022,,Nervous System,Insomnia and Sleep Disorders
2021302,Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834510/,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); N-Arachidonoyl Dopamine (NADA); Palmitoylethanolamide (PEA),Nervous System,Neurodegenerative Issues; Alzheimer's Disease; Amyotrophic Lateral Sclerosis (ALS); Epilepsy; Huntington's Disease; Inflammation; Pain; Multiple Sclerosis; Oxidative Stress; Pain - Chronic; Parkinson's Disease; Stroke; Traumatic Brain Injury
2018103,Effects of Fatty Acid Amide Hydroxylase Inhibitor URB597 on the Catecholaminergic Activity of the Adrenal Medulla in Stressed Male and Female Rats,https://pubmed.ncbi.nlm.nih.gov/34794150/,Positive,,Animal Study,2018,Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System; Nervous System,Inflammation; Oxidative Stress
2021303,The effects of systemic and local fatty acid amide hydrolase and monoacylglycerol lipase inhibitor treatments on the metabolomic profile of lungs,https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/epdf/10.1002/bmc.5231,Positive,,Animal Study,2021,Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Nervous System,Inflammation; Asthma; Fibrosis - Lung; Fibrosis
2022776,Higher trait neuroticism is associated with greater fatty acid amide hydrolase binding in borderline and antisocial personality disorders,https://www.nature.com/articles/s41598-022-04789-9,Positive,,Clinical Trial,2022,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System; Nervous System,Behavioral Disorders; Bipolar Disorder; Familial Mediterranean Fever; Fever; Grief and Bereavement
2022777,A review on structurally diversified synthesized molecules as monoacylglycerol lipase inhibitors and their therapeutic uses,https://pubmed.ncbi.nlm.nih.gov/35232358/,Inconclusive,,Meta-analysis,2022,Endocannabinoid (unspecified); Monoacylglycerol Lipase (MAGL),,Alzheimer's Disease; Cancer - Colon; Cancer - Oral; Cancer; Inflammation; Pain; Neurodegenerative Issues; Parkinson's Disease
2022778,"Inhibition of monoacylglycerol lipase restrains proliferation, migration, invasion, tumor growth and induces apoptosis in cervical cancer",https://pubmed.ncbi.nlm.nih.gov/34877750/,Positive,,Laboratory Study,2022,Monoacylglycerol Lipase (MAGL),Reproductive System,Cancer - Cervical; Cancer
2022779,Monoacylglycerol Lipase (MAGL) Inhibition Impedes the Osteosarcoma Progression by Regulating Epithelial Mesenchymal Transition,https://pubmed.ncbi.nlm.nih.gov/35067491/,Positive,,Laboratory Study,2022,Monoacylglycerol Lipase (MAGL),Skeletal System,Cancer - Bone; Cancer
2022780,Cannabis Vapor Exposure Alters Neural Circuit Oscillatory Activity in a Neurodevelopmental Model of Schizophrenia: Exploring the Differential Impact of Cannabis Constituents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752653/,Inconclusive,,Animal Study,2022,,Mental/Emotional System; Nervous System,Schizophrenia; Psychosis
2022781,Clinical effects of a single dose of cannabinoids to patients with chronic lymphocytic leukemia,https://www.tandfonline.com/doi/full/10.1080/10428194.2021.2020776,Negative,,Clinical Trial,2022,Pharma THC:CBD; Tetrahydrocannabinol (THC),Immune System,Cancer - Leukemia; Cancer - Lymphoma; Cancer
2022782,"Pharmacokinetics, Safety, and Tolerability of a Medicinal Cannabis Formulation in Patients with Chronic Non-cancer Pain on Long-Term High Dose Opioid Analgesia: A Pilot Study",https://link.springer.com/article/10.1007/s40122-021-00344-y,Positive,,Clinical Trial,2022,Tetrahydrocannabinol (THC),Nervous System,Pain; Pain - Chronic; Addiction - Opioid
2022783,Endocannabinoid signaling in brain diseases: Emerging relevance of glial cells,https://onlinelibrary.wiley.com/doi/10.1002/glia.24172,Positive,,Meta-analysis,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); N-Arachidonoyl Dopamine (NADA); Palmitoylethanolamide (PEA); Virodhamine (O-AEA),,Neurodegenerative Issues
2021304,Medical Cannabis as a Substitute for Prescription Agents: A Systematic Review and Meta-analysis,https://www.tandfonline.com/doi/abs/10.1080/14659891.2022.2070870#.YofosNr8m_w.linkedin,Positive,,Meta-analysis,2021,,,Anxiety; Depression; Pain; Pain - Chronic
2022784,Tonic endocannabinoid signaling supports sleep through development in both sexes,https://pubmed.ncbi.nlm.nih.gov/35395682/,Positive,,Animal Study,2022,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Endocannabinoid (unspecified),,Insomnia and Sleep Disorders
2022785,Activation of the endocannabinoid system mediates cardiac hypertrophy induced by rosiglitazone,https://pubmed.ncbi.nlm.nih.gov/35190698/,Positive,,Laboratory Study,2022,Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH),Cardiovascular System,Cardiovascular Diseases (CVD); Diabetes; Metabolic Syndrome
2022786,The Endocannabinoid System as a Biomarker for Diagnostic and Therapeutic Applications in Depression and Anxiety,https://pubmed.ncbi.nlm.nih.gov/35382720/,Inconclusive,,Meta-analysis,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Mental/Emotional System,Anxiety; Depression
2021305,"Effects of tetrahydrocannabinols on human oral cancer cell proliferation, apoptosis, autophagy, oxidative stress, and DNA damage",https://www.sciencedirect.com/science/article/abs/pii/S0003996921001631?via%3Dihub,Positive,,Laboratory Study,2021,Delta-8-THC,Digestive System; Nervous System,Cancer - Oral; Cancer; Oxidative Stress
2022787,Geospatiotemporal and causal inference study of cannabis and other drugs as risk factors for female breast cancer USA 2003–2017,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978645/,Negative,,Meta-analysis,2022,Cannabigerol (CBG),Nervous System; Reproductive System,Cancer - Breast; Cancer; Addiction - Alcohol
2021306,Sex-Specific Cannabidiol- and Iloperidone-Induced Neuronal Activity Changes in an In Vitro MAM Model System of Schizophrenia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197248/,Inconclusive,,Animal Study,2021,,Mental/Emotional System,Psychosis; Schizophrenia
2022788,Phytol and Heptacosane Are Possible Tools to Overcome Multidrug Resistance in an In Vitro Model of Acute Myeloid Leukemia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952646/,Positive,,Laboratory Study,2022,,Immune System; Nervous System,Cancer - Leukemia; Cancer
2021307,Pharmacologic Antagonization of Cannabinoid Receptor 1 Improves Cholestasis in Abcb4-/- Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873597/,Positive,,Animal Study,2021,Endocannabinoid (unspecified); SR-x Synthetic Cannabinoids,Digestive System,Hepatitis; Fibrosis - Liver (Cirrhosis); Fibrosis; Liver Failure
2021308,"Essential Oil from the Leaves of Chromolaena odorata, and Sesquiterpene Caryophyllene Oxide Induce Sedative Activity in Mice",https://pubmed.ncbi.nlm.nih.gov/34358077/,Inconclusive,,Animal Study,2021,Other Related Compounds,,Insomnia and Sleep Disorders
2021309,Myrtenal and β-caryophyllene oxide screened from Liquidambaris Fructus suppress NLRP3 inflammasome components in rheumatoid arthritis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480017/,Positive,,Animal Study,2021,Other Related Compounds,Skeletal System,Arthritis - Rheumatoid; Arthritis; Inflammation
2021310,Distribution of inhaled volatile β-caryophyllene and dynamic changes of liver metabolites in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813867/,Inconclusive,,Animal Study,2021,,,
2021311,Effect of β-Caryophyllene on insulin resistance in skeletal muscle of high fat diet and fructose-induced type-2 diabetic rats,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049097/,Positive,,Animal Study,2021,,Endocrine System,Diabetes; Metabolic Syndrome
2020238,β-Caryophyllene nanoparticles design and development: Controlled drug delivery of cannabinoid CB2 agonist as a strategic tool towards neurodegeneration,https://www.sciencedirect.com/science/article/pii/S0928493120337437?via%3Dihub,Positive,,Laboratory Study,2020,,,Neurodegenerative Issues
2021312,Computational insight into the protective mechanism of Allium iranicum Wendelbo. Alliaceae in a mouse model of Staphylococcosis: focus on dietary phytocannabinoid trans-caryophyllene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867674/,Positive,,Animal Study,2021,Other Related Compounds,Immune System,Staph Infection
2022789,β-Caryophyllene suppresses ferroptosis induced by cerebral ischemia reperfusion via activation of the NRF2/HO-1 signaling pathway in MCAO/R rats,https://pubmed.ncbi.nlm.nih.gov/35550220/,Positive,,Animal Study,2022,,Nervous System,Stroke
2022790,Potential protective effect of beta-caryophyllene against cadmium chloride-induced damage to the male reproductive system in mouse,https://www.sciencedirect.com/science/article/abs/pii/S089062382200034X?via%3Dihub,Positive,,Laboratory Study,2022,,Nervous System; Reproductive System,Infertility (Male); Oxidative Stress; Inflammation
2021313,Natural Products with Potential for Nonhormonal Male Contraception,https://pubmed.ncbi.nlm.nih.gov/34633803/,Positive,,Meta-analysis,2021,Other Related Compounds,Reproductive System,Pregnancy
2021314,Antinociceptive Activity of Compounds from the Aqueous Extract of Melampodium divaricatum,https://pubmed.ncbi.nlm.nih.gov/34138517/,Positive,,Animal Study,2021,Other Related Compounds,Nervous System,Pain - Acute; Pain
2021315,Anticonvulsant activity of β-caryophyllene in association with pregabalin in a seizure model in rats,https://pubmed.ncbi.nlm.nih.gov/34942451/,Positive,,Animal Study,2021,,Nervous System,Epilepsy
2022791,"Non-psychotropic Cannabis sativa L. phytocomplex modulates microglial inflammatory response through CB2 receptors-, endocannabinoids-, and NF-κB-mediated signaling",https://onlinelibrary.wiley.com/doi/10.1002/ptr.7458,Positive,,Laboratory Study,2022,Endocannabinoid (unspecified); Other Related Compounds,Nervous System,Inflammation; Neurodegenerative Issues
2021316,"Volatiles, phenolic compounds, antioxidant and antibacterial properties of kohlrabi leaves",https://pubmed.ncbi.nlm.nih.gov/34154474/,Positive,,Laboratory Study,2021,Other Related Compounds,Immune System; Nervous System,Bacterial Infections; Oxidative Stress
2021317,Effect of α-pinene and thymoquinone on the differentiation of bone marrow mesenchymal stem cells into neuroprogenitor cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905589/,Positive,,Laboratory Study,2021,,,Neurodegenerative Issues
2022792,Apoptotic effect of β-pinene on oral squamous cell carcinoma as one of the major compounds from essential oil of medicinal plant Piper rivinoides Kunth,https://pubmed.ncbi.nlm.nih.gov/33678083/,Positive,,Laboratory Study,2022,,Integumentary System,Cancer - Squamous Head/Neck; Cancer
2022793,Neuroprotective effect of alpha-pinene is mediated by suppression of the TNF-α/NF-κB pathway in Alzheimer's disease rat model,https://pubmed.ncbi.nlm.nih.gov/35174932/,Positive,,Animal Study,2022,Mind-Body Medicine,,Alzheimer's Disease; Behavioral Disorders; Anxiety; Cognitive Dysfunction; Dementia; Inflammation; Neurodegenerative Issues; Oxidative Stress
2021318,β-Pinene alleviates arsenic (As)-induced oxidative stress by modulating enzymatic antioxidant activities in roots of Oryza sativa,https://www.sciencedirect.com/science/article/pii/S0147651321011921?via%3Dihub,Positive,,Laboratory Study,2021,,,Oxidative Stress
2021319,Antioxidant and Cytoprotective Potential of the Essential Oil Pistacia lentiscus var. chia and Its Major Components Myrcene and α-Pinene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830477/,Positive,,Laboratory Study,2021,,Immune System; Integumentary System,Oxidative Stress; Wound Healing; Skin Diseases
2022794,"The Effects of β-Pinene, a Pine Needle Oil Monoterpene, on Adenovirus Type 3",https://pubmed.ncbi.nlm.nih.gov/35001315/,Positive,,Laboratory Study,2022,,,Bronchitis; Prion Disease; Respiratory Syncytial Virus
2021320,In Vitro and In Silico Inhibition of Staphylococcus aureus Efflux Pump NorA by α-Pinene and Limonene,https://pubmed.ncbi.nlm.nih.gov/34268598/,Positive,,Laboratory Study,2021,,Immune System,Bacterial Infections; Staph Infection
2021321,Neuroprotective effect of α-pinene self-emulsifying nanoformulation against 6-OHDA induced neurotoxicity on human SH-SY5Y cells and its in vivo validation for anti-Parkinson's effect,https://onlinelibrary.wiley.com/doi/10.1002/jbt.22902,Positive,,Animal Study,2021,,,Oxidative Stress; Parkinson's Disease; Neurodegenerative Issues
2021322,Inhibition of Efflux Pumps by Monoterpene (α-pinene) and Impact on Staphylococcus aureus Resistance to Tetracycline and Erythromycin,https://pubmed.ncbi.nlm.nih.gov/32748743/,Positive,,Laboratory Study,2021,,Immune System,Bacterial Infections; Staph Infection
2021323,The Mode of Action of Cyclic Monoterpenes (−)-Limonene and (+)-α-Pinene on Bacterial Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227088/,Positive,,Laboratory Study,2021,,Immune System,Bacterial Infections; Oxidative Stress
2021324,Antifungal action of α-pinene against Candida spp. isolated from patients with otomycosis and effects of its association with boric acid,https://pubmed.ncbi.nlm.nih.gov/33094646/,Positive,,Laboratory Study,2021,,Nervous System,Middle Ear Infection
2021325,A Review of the Potential Use of Pinene and Linalool as Terpene-Based Medicines for Brain Health: Discovering Novel Therapeutics in the Flavours and Fragrances of Cannabis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426550/,Positive,,Meta-analysis,2021,,,Alzheimer's Disease; Anxiety; Cognitive Dysfunction; Depression; Geriatric Conditions; Inflammation; Insomnia and Sleep Disorders; Migraine; Stroke
2021326,α-Pinene Enhances the Anticancer Activity of Natural Killer Cells via ERK/AKT Pathway,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826552/,Positive,,Animal Study,2021,,Nervous System,Cancer
2021327,Wound Healing Activity of α-Pinene and α-Phellandrene,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123182/,Positive,,Animal Study,2021,,Immune System; Integumentary System; Nervous System,Wound Healing
2022795,"In vitro, In vivo and In silico Antihyperglycemic Activity of Some Semi-Synthetic Phytol Derivatives",https://pubmed.ncbi.nlm.nih.gov/33327922/,Positive,,Animal Study,2022,,,Diabetes
2022796,"Phytol loaded PLGA nanoparticles ameliorate scopolamine-induced cognitive dysfunction by attenuating cholinesterase activity, oxidative stress and apoptosis in Wistar rat",https://pubmed.ncbi.nlm.nih.gov/32406811/,Positive,,Animal Study,2022,,Nervous System,Cognitive Dysfunction; Alzheimer's Disease
2021328,Liposomal drug delivery of Corchorus olitorius leaf extract containing phytol using design of experiment (DoE): In-vitro anticancer and in-vivo anti-inflammatory studies,https://pubmed.ncbi.nlm.nih.gov/33360927/,Positive,,Animal Study,2021,,Nervous System,Cancer; Inflammation
2021329,Phytol Down-Regulates Expression of Some Cancer Stem Cell Markers and Decreases Side Population Proportion in Human Embryonic Carcinoma NCCIT Cells,https://pubmed.ncbi.nlm.nih.gov/32700607/,Positive,,Laboratory Study,2021,,Nervous System,Cancer
2021330,Phytol suppresses parasitemia and ameliorates anaemia and oxidative brain damage in mice infected with Plasmodium berghei,https://pubmed.ncbi.nlm.nih.gov/33736972/,Positive,,Animal Study,2021,,Immune System,Malaria
2016087,Antitumour Activity of the Microencapsulation of Annona vepretorum Essential Oil,https://pubmed.ncbi.nlm.nih.gov/26348780/,Positive,,Animal Study,2016,,,Cancer - Melanoma; Cancer
2010054,"Anticonvulsant and anxiolytic evaluation of leaf extracts of Ocimum gratissimum, a culinary herb",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140126/,Positive,,Animal Study,2010,,Mental/Emotional System,Anxiety; Epilepsy
2013058,"Antifungal, antioxidant and anti-inflammatory activities of Oenanthe crocata L. essential oil",https://pubmed.ncbi.nlm.nih.gov/24012643/,Positive,,Laboratory Study,2013,,Nervous System,Inflammation; Oxidative Stress
2021331,"A review on the traditional uses, phytochemistry, and pharmacological activities of clove basil (Ocimum gratissimum L.)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642617/,Positive,,Meta-analysis,2021,,,Bacterial Infections; Epilepsy; Inflammation
2022797,"Higher Risk, Higher Reward? Self‐Reported Effects of Real‐World Cannabis Use in Parkinson's Disease",https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mdc3.13414,Positive,,Meta-analysis,2022,,,Parkinson's Disease; Anxiety; Depression; Insomnia and Sleep Disorders; Pain; Pain - Chronic
2022798,"Tetrahydrocannabinol fails to reduce hair pulling or skin picking: results of a double-blind, placebo-controlled study of dronabinol",https://pubmed.ncbi.nlm.nih.gov/34825898/,Inconclusive,,Double Blind Clinical Trial,2022,Pharma THC,Integumentary System,Compulsive hair pulling
2022799,"Olivetolic acid, a cannabinoid precursor in Cannabis sativa, but not CBGA methyl ester exhibits a modest anticonvulsant effect in a mouse model of Dravet syndrome",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725448/,Positive,,Animal Study,2022,Cannabigerolic Acid (CBG-a),Nervous System,Epilepsy - Dravet Syndrome; Epilepsy
2022800,The endocannabinoid system and drug-associated contextual memories,https://pubmed.ncbi.nlm.nih.gov/33491992/,Positive,,Meta-analysis,2022,Synthetic Cannabinoid (unspecified); Tetrahydrocannabinol (THC),,Addiction - Alcohol; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant
2022801,"Delta-9-Tetrahydrocannabinol, Cannabidiol, and Acute Psychotomimetic States: A Balancing Act of the Principal Phyto-Cannabinoids on Human Brain and Behavior",https://pubmed.ncbi.nlm.nih.gov/35319274/,Positive,,Double Blind Clinical Trial,2022,,Mental/Emotional System,Psychosis; Behavioral Disorders; Cognitive Dysfunction
2022802,Impact of mucoadhesive agent inclusion on the intraocular pressure lowering profile of Δ 9-tetrahydrocannabinol-valine-hemisuccinate loaded nanoemulsions in New Zealand white rabbits,https://pubmed.ncbi.nlm.nih.gov/35151817/,Positive,,Animal Study,2022,,,Glaucoma; Pain; Pain - Eye
2022803,Cannabinoids: Therapeutic Use in Clinical Practice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952215/,Positive,,Clinical Meta-analysis,2022,Anandamide (AEA); Cannabidivarin (CBDV); Cannabigerol (CBG); Delta-8-THC; Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Pharma CBD; Pharma THC:CBD; Pharma THC; Synthetic Cannabinoid (unspecified); Tetrahydrocannabinol (THC),,Alzheimer's Disease; Cancer; COVID-19; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; HIV/AIDS; Neurodegenerative Issues; Parkinson's Disease; Prion Disease; Skin Diseases
2022804,Receptor-targeted nanoparticles modulate cannabinoid anticancer activity through delayed cell internalization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789857/,Positive,,Laboratory Study,2022,,,Cancer
2022805,Adolescents are more sensitive than adults to acute behavioral and cognitive effects of THC,https://www.nature.com/articles/s41386-022-01281-w,Negative,,Double Blind Clinical Trial,2022,Pharma THC; Tetrahydrocannabinol (THC),Mental/Emotional System,Behavioral Disorders; Cannabis Adverse Effects; Cognitive Dysfunction
2022806,Metabolites of Cannabis Induce Cardiac Toxicity and Morphological Alterations in Cardiac Myocytes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835806/,Negative,,Laboratory Study,2022,,,Cardiac Toxicity; Cardiovascular Diseases (CVD); Fibrosis - Cardiac; Fibrosis; Heart Attack; Myocarditis
2022807,Tetrahydrocannabinol-Positive Trauma Patients With Traumatic Brain Injury,https://pubmed.ncbi.nlm.nih.gov/35305485/,Positive,,Meta-analysis,2022,,,Stroke; Traumatic Brain Injury
2022808,Chronic delta-9-tetrahydrocannabinol exposure impacts testicular volume and male reproductive health in rhesus macaques,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983573/,Negative,,Animal Study,2022,,,Pregnancy
2022809,Cannabidiol induces autophagy and improves neuronal health associated with SIRT1 mediated longevity,https://link.springer.com/article/10.1007/s11357-022-00559-7#citeas,Positive,,Laboratory Study,2022,,Muscular System; Nervous System; Skeletal System,Geriatric Conditions; Neurodegenerative Issues; Sarcopenia
2018104,Effects of non‐euphoric plant cannabinoids on muscle quality and performance of dystrophic mdx mice,https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.14460,Positive,,Laboratory Study,2018,Cannabidivarin (CBDV); Tetrahydrocannabivarin (THCV),Muscular System; Nervous System,Inflammation; Muscular Dystrophy & Myotonic Disorders
2013059,Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression,https://peerj.com/articles/214/,Positive,,Laboratory Study,2013,Cannabidivarin (CBDV),Nervous System,Epilepsy
2012081,Cannabidivarin is anticonvulsant in mouse and rat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525866/,Positive,,Animal Study,2012,Cannabidivarin (CBDV),Nervous System,Epilepsy
2021332,Sedation and Acute Encephalopathy in a Pediatric Patient Following Ingestion of Delta-8-Tetrahydrocannabinol Gummies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594112/,Negative,,Meta-analysis,2021,Delta-8-THC,Mental/Emotional System,Cannabis Adverse Effects; Cognitive Dysfunction; Encephalitis and Myelitis; Neonatal Cerebral Issues
2020239,Cannabinoid Combination Induces Cytoplasmic Vacuolation in MCF-7 Breast Cancer Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587381/,Positive,,Laboratory Study,2020,Cannabigerol (CBG); Cannabinol (CBN); Tetrahydrocannabinol (THC),Nervous System; Reproductive System,Cancer - Breast; Cancer
2020240,Cannabinol in the spotlight: Toxicometabolomic study and behavioral analysis of zebrafish embryos exposed to the unknown cannabinoid,https://pubmed.ncbi.nlm.nih.gov/32200177/,Negative,,Animal Study,2020,Cannabinol (CBN),Cardiovascular System; Endocrine System; Mental/Emotional System; Nervous System,Behavioral Disorders; Amino-Acid Metabolism Disorders; Cardiovascular Diseases (CVD); Neonatal Cerebral Issues
2014066,"Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review",https://pubmed.ncbi.nlm.nih.gov/24160757/,Inconclusive,,Meta-analysis,2014,Cannabinol (CBN); Tetrahydrocannabinol (THC); AM-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,,
2019107,The Potential for Pharmacokinetic Interactions Between Cannabis Products and Conventional Medications,https://pubmed.ncbi.nlm.nih.gov/31433338/,Negative,,Laboratory Study,2019,Cannabinol (CBN),,Cannabis Adverse Effects
2004020,"Human skin permeation of Delta8-tetrahydrocannabinol, cannabidiol and cannabinol",https://pubmed.ncbi.nlm.nih.gov/15025853/,Positive,,Laboratory Study,2004,Cannabinol (CBN); Delta-8-THC,,Skin Diseases
2014067,The influence of endocannabinoid receptor 1 gene variations on anthropometric and metabolic parameters of women with polycystic ovary syndrome,https://pubmed.ncbi.nlm.nih.gov/24971918/,Inconclusive,,Meta-analysis,2014,,Endocrine System,Polycystic Ovary Disease
2015089,Selected CNR1 polymorphisms and hyperandrogenemia as well as fat mass and fat distribution in women with polycystic ovary syndrome,https://pubmed.ncbi.nlm.nih.gov/25093427/,Positive,,Laboratory Study,2015,,Endocrine System,Polycystic Ovary Disease
2017076,Endocannabinoid receptor blockade increases vascular endothelial growth factor and inflammatory markers in obese women with polycystic ovary syndrome,https://pubmed.ncbi.nlm.nih.gov/27651218/,Inconclusive,,Clinical Trial,2017,SR-x Synthetic Cannabinoids,Endocrine System,Polycystic Ovary Disease
2017077,Restored Plasma Anandamide and Endometrial Expression of Fatty Acid Amide Hydrolase in Women With Polycystic Ovary Syndrome by the Combination Use of Diane-35 and Metformin,https://pubmed.ncbi.nlm.nih.gov/28291580/,Positive,,Laboratory Study,2017,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Endocrine System,Polycystic Ovary Disease
2020241,The Basal Pharmacology of Palmitoylethanolamide,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662788/,Positive,,Meta-analysis,2020,Palmitoylethanolamide (PEA),,Inflammation; Pain; Pain - Chronic
2016088,"Cannabidivarin for HIV-Associated Neuropathic Pain: A Randomized, Blinded, Controlled Clinical Trial",https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.2016,Inconclusive,,Double Blind Clinical Trial,2016,Cannabidivarin (CBDV),Immune System; Nervous System,HIV/AIDS; Pain; Pain - Neuropathy - Peripheral
2021333,A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures,https://www.liebertpub.com/doi/10.1089/can.2020.0075,Inconclusive,,Double Blind Clinical Trial,2021,Cannabidivarin (CBDV),Nervous System,Epilepsy
2021334,Polyphenols and Cannabidiol Modulate Transcriptional Regulation of Th1/Th2 Inflammatory Genes Related to Canine Atopic Dermatitis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982812/,Positive,,Laboratory Study -,2021,,,Veterinary Applications; Inflammation; Skin Diseases
2021335,"Cannabidiol and mental health: possibilities, uncertainties, and controversies for addiction treatment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555646/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Cocaine; Addiction - Opioid; Addiction; Behavioral Disorders; Alcoholic Liver Disease; Anxiety; Cognitive Dysfunction; Depression; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Psychosis
2021336,Topical Cannabinoids for Treating Chemotherapy-Induced Neuropathy: A Case Series,https://journals.sagepub.com/doi/10.1177/15347354211061739,Positive,,Meta-analysis,2021,,Nervous System,Cancer; Pain; Pain - Neuropathy - Peripheral; Inflammation
2015090,Endocannabinoid system activation may be associated with insulin resistance in women with polycystic ovary syndrome,https://pubmed.ncbi.nlm.nih.gov/25935491/,Negative,,Meta-analysis,2015,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Endocrine System,Polycystic Ovary Disease
2017078,Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512818/,Inconclusive,,Meta-analysis,2017,SR-x Synthetic Cannabinoids,Endocrine System,Polycystic Ovary Disease
2014068,Cannabinoid receptor 1 gene polymorphisms and nonalcoholic Fatty liver disease in women with polycystic ovary syndrome and in healthy controls,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127238/,Inconclusive,,Meta-analysis,2014,,Digestive System; Endocrine System,Fatty Liver Disease; Polycystic Ovary Disease
2022810,Analysis of 2-Arachidonoylglycerol Levels in Polycystic Ovary Syndrome in the Context of Hormonal and Metabolic Alterations and Across the Classical Phenotypes,https://pubmed.ncbi.nlm.nih.gov/35235418/,Inconclusive,,Meta-analysis,2022,2-Arachidonoyl Glycerol (2-AG),Endocrine System,Polycystic Ovary Disease
2020242,"Chemical Constituents Involved in E-Cigarette, or Vaping Product Use-Associated Lung Injury (EVALI)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355865/,Negative,,Meta-analysis,2020,Tetrahydrocannabinol (THC),Respiratory System,Vaping injury (EVALI)
2021337,"Case of e-cigarette or vaping product use-associated lung injury (EVALI) in London, UK",https://pubmed.ncbi.nlm.nih.gov/33837028/,Negative,,Meta-analysis,2021,,Respiratory System,Vaping injury (EVALI)
2020243,E-cigarette or vaping product use-associated lung injury and state-level cannabis policies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819308/,Inconclusive,,Meta-analysis,2020,,Respiratory System,Vaping injury (EVALI)
2020244,"Update: Characteristics of a Nationwide Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury - United States, August 2019-January 2020",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367698/,Inconclusive,,Meta-analysis,2020,,Respiratory System,Vaping injury (EVALI)
2022811,"Cannabis vaping: existing and emerging modalities, chemistry, and pulmonary toxicology",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882064/,Negative,,Meta-analysis,2022,Cannabichromene (CBC); Cannabidiolic Acid (CBD-a); Cannabigerol (CBG); Delta-8-THC; Tetrahydrocannabinol (THC); Tetrahydrocannabinolic Acid (THC-a),Respiratory System,Vaping injury (EVALI)
2020245,Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032996/,Negative,,Meta-analysis,2020,,Respiratory System,Vaping injury (EVALI)
2019108,Vitamin E Acetate as a Plausible Cause of Acute Vaping-related Illness,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952050/,Negative,,Meta-analysis,2019,,Respiratory System,Vaping injury (EVALI)
2020246,Analysis of Cannabinoid-Containing Fluids in Illicit Vaping Cartridges Recovered from Pulmonary Injury Patients: Identification of Vitamin E Acetate as a Major Diluent,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151740/,Negative,,Meta-analysis,2020,,Respiratory System,Vaping injury (EVALI)
2021338,A 20-Year-Old Man with e-Cigarette or Vaping Product Use-Associated Lung Injury (EVALI) and Thrombotic Coagulopathy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056776/,Negative,,Meta-analysis,2021,,Respiratory System,Vaping injury (EVALI)
2022812,Low-Dose Delta-9-Tetrahydrocannabinol as Beneficial Treatment for Aged APP/PS1 Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910894/,Positive,,Animal Study,2022,Pharma CBD; Pharma THC,Nervous System,Alzheimer's Disease; Cognitive Dysfunction; Neurodegenerative Issues; Parkinson's Disease
2022813,Maternal-fetal transmission of delta-9-tetrahydrocannabinol (THC) and its metabolites following inhalation and injection exposure during pregnancy in rats,https://pubmed.ncbi.nlm.nih.gov/34882838/,Inconclusive,,Animal Study,2022,,Reproductive System,Neonatal Cerebral Issues; Pregnancy
2022814,Chronic edible dosing of Δ9-tetrahydrocannabinol (THC) in nonhuman primates reduces systemic platelet activity and function,https://journals.physiology.org/doi/full/10.1152/ajpcell.00373.2021,Negative,,Animal Study,2022,Tetrahydrocannabinol (THC),Cardiovascular System,Bleeding Disorders
2018105,"Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trial",https://pubmed.ncbi.nlm.nih.gov/29486338/,Positive,,Double Blind Clinical Trial,2018,Palmitoylethanolamide (PEA),Mental/Emotional System; Nervous System,Depression
2020247,"Effects of Palmitoylethanolamide Combined with Luteoline on Frontal Lobe Functions, High Frequency Oscillations, and GABAergic Transmission in Patients with Frontotemporal Dementia",https://pubmed.ncbi.nlm.nih.gov/32623398/,Positive,,Clinical Trial,2020,Palmitoylethanolamide (PEA),Nervous System,Dementia
2020248,"Effect of palmitoylethanolamide on inner retinal function in glaucoma: a randomized, single blind, crossover, clinical trial by pattern-electroretinogram",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320139/,Positive,,Double Blind Clinical Trial,2020,Palmitoylethanolamide (PEA),Nervous System,Glaucoma; Quality of Life
2016089,"Ultramicronized palmitoylethanolamide in spinal cord injury neuropathic pain: a randomized, double-blind, placebo-controlled trial",https://journals.lww.com/pain/Fulltext/2016/09000/Ultramicronized_palmitoylethanolamide_in_spinal.25.aspx,Inconclusive,,Double Blind Clinical Trial,2016,Palmitoylethanolamide (PEA),Skeletal System,Spinal Cord Injuries; Pain; Pain - Chronic
2020249,"The Effect of Orally Dosed Levagen+™ (palmitoylethanolamide) on Exercise Recovery in Healthy Males—A Double-Blind, Randomized, Placebo-Controlled Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146510/,Positive,,Double Blind Clinical Trial,2020,Palmitoylethanolamide (PEA),,Inflammation; Pain; Pain - Acute
2018106,Palmitoylethanolamide as adjunctive therapy for autism: Efficacy and safety results from a randomized controlled trial,https://pubmed.ncbi.nlm.nih.gov/29807317/,Positive,,Double Blind Clinical Trial,2018,Palmitoylethanolamide (PEA),Mental/Emotional System; Nervous System,Autism
2021339,"GPR119 and GPR55 as Receptors for Fatty Acid Ethanolamides, Oleoylethanolamide and Palmitoylethanolamide",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864322/,Positive,,Meta-analysis,2021,Palmitoylethanolamide (PEA),,Diabetes; Inflammation; Metabolic Syndrome; Pain; Obesity; Pain - Chronic
2021340,Chronic Pain in Dogs and Cats: Is There Place for Dietary Intervention with Micro-Palmitoylethanolamide?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065429/,Positive,,Meta-analysis -,2021,Palmitoylethanolamide (PEA),,Veterinary Applications
2020250,ALIAmides Update: Palmitoylethanolamide and Its Formulations on Management of Peripheral Neuropathic Pain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432736/,Positive,,Meta-analysis,2020,Palmitoylethanolamide (PEA),Nervous System,Pain; Pain - Neuropathy - Peripheral
2021341,Micronized / ultramicronized palmitoylethanolamide (PEA) as natural neuroprotector against COVID-19 inflammation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137339/,Positive,,Meta-analysis,2021,Palmitoylethanolamide (PEA),Respiratory System,COVID-19; Inflammation
2019109,"Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial",https://pubmed.ncbi.nlm.nih.gov/31054246/,Positive,,Double Blind Clinical Trial,2019,Palmitoylethanolamide (PEA),Digestive System; Nervous System,IBD - Inflammatory Bowel Disease; Inflammation
2017079,Micronized palmitoylethanolamide/trans-polydatin treatment of endometriosis-related pain: a meta-analysis,https://pubmed.ncbi.nlm.nih.gov/28617258/,Positive,,Meta-analysis,2017,Palmitoylethanolamide (PEA),Endocrine System; Nervous System,Endometriosis; Pain; Pain - Chronic
2021342,"Randomized clinical trial ""olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin"": preliminary results",https://pubmed.ncbi.nlm.nih.gov/34156697/,Positive,,Clinical Trial,2021,Palmitoylethanolamide (PEA),Respiratory System,COVID-19
2020251,Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries—A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765232/,Positive,,Meta-analysis,2020,Palmitoylethanolamide (PEA),Nervous System,Inflammation; Alzheimer's Disease; Amyotrophic Lateral Sclerosis (ALS); Autism; Multiple Sclerosis; Neurodegenerative Issues; Parkinson's Disease
2017080,The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429331/,Positive,,Meta-analysis,2017,Palmitoylethanolamide (PEA),,Alzheimer's Disease; Amyotrophic Lateral Sclerosis (ALS); Inflammation; Pain; Multiple Sclerosis; Neurodegenerative Issues; Pain - Acute; Pain - Chronic; Parkinson's Disease; Stroke; Traumatic Brain Injury
2016090,"Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094513/,Positive,,Meta-analysis,2016,Palmitoylethanolamide (PEA),Nervous System,Pain - Chronic; Inflammation; Pain; Pain - Acute
2017081,Efficacy of Palmitoylethanolamide for Pain: A Meta-Analysis,https://pubmed.ncbi.nlm.nih.gov/28727699/,Positive,,Clinical Meta-analysis,2017,Palmitoylethanolamide (PEA),Nervous System,Pain; Pain - Acute; Pain - Chronic; Pain - Neuropathy - Peripheral
2021343,Palmitoylethanolamide: A Natural Compound for Health Management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157570/,Positive,,Meta-analysis,2021,Palmitoylethanolamide (PEA),,Bacterial Infections; Inflammation; Pain; Pain - Chronic
2022815,Will Cannabigerol Trigger Neuroregeneration after a Spinal Cord Injury? An In Vitro Answer from NSC-34 Scratch-Injured Cells Transcriptome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875351/,Positive,,Laboratory Study,2022,Cannabigerol (CBG),Skeletal System,Spinal Cord Injuries; Inflammation; Oxidative Stress
2020252,Phytocannabinoid-dependent mTORC1 regulation is dependent upon inositol polyphosphate multikinase activity,https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.15351,Positive,,Laboratory Study,2020,Cannabidiolic Acid (CBD-a); Cannabidivarin (CBDV); Cannabigerol (CBG),,Multiple Sclerosis
2021344,Inhibition of sodium conductance by cannabigerol contributes to a reduction of dorsal root ganglion neuron excitability,https://pubmed.ncbi.nlm.nih.gov/35297036/,Positive,,Laboratory Study,2021,Cannabigerol (CBG),,Pain; Pain - Acute
2022816,The chemical composition of ethanolic extracts from six genotypes of medical cannabis (Cannabis sativa L.) and their selective cytotoxic activity,https://pubmed.ncbi.nlm.nih.gov/34995571/,Positive,,Laboratory Study,2022,Tetrahydrocannabinol (THC),,Cancer - Colon; Cancer - Liver; Cancer
2022817,"Fabrication, physicochemical characterization and In vitro anticancer activity of nerolidol encapsulated solid lipid nanoparticles in human colorectal cell line",https://pubmed.ncbi.nlm.nih.gov/35489319/,Positive,,Laboratory Study,2022,,Digestive System; Nervous System,Cancer - Colon; Cancer
2022818,The Ameliorate Effects of Nerolidol on Thioacetamide-induced Oxidative Damage in Heart and Kidney Tissue,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892551/,Positive,,Animal Study,2022,,Urinary System,Drug-Induced Nephropathy; Cardiovascular Diseases (CVD); Chronic Kidney Disease; Oxidative Stress
2022819,"""I got a bunch of weed to help me through the withdrawals"": Naturalistic cannabis use reported in online opioid and opioid recovery community discussion forums",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824349/,Positive,,Meta-analysis,2022,,Mental/Emotional System,Addiction - Opioid; Addiction
2022820,The endocannabinoid system in social anxiety disorder: from pathophysiology to novel therapeutics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827369/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),Mental/Emotional System,Anxiety
2022821,"Cannabis use among Danish patients with cancer: a cross-sectional survey of sociodemographic traits, quality of life, and patient experiences",https://pubmed.ncbi.nlm.nih.gov/34453567/,Positive,,Meta-analysis,2022,,,Cancer
2022822,The Effects of Cannabinoids on Sleep,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036386/,Inconclusive,,Meta-analysis,2022,,,Insomnia and Sleep Disorders
2022823,A critical review of cannabis in medicine and dentistry: A look back and the path forward,https://onlinelibrary.wiley.com/doi/10.1002/cre2.564,Inconclusive,,Meta-analysis,2022,,,Cavities; Inflammation; Pain; Pain - Acute
2022824,Effects of Cannabis in Parkinson's Disease: A Systematic Review and Meta-Analysis,https://pubmed.ncbi.nlm.nih.gov/34958046/,Positive,,Clinical Meta-analysis,2022,,,Parkinson's Disease
2022825,Cannabis use as a moderator of cognitive behavioral therapy for insomnia,https://pubmed.ncbi.nlm.nih.gov/34870584/,Inconclusive,,Double Blind Clinical Trial,2022,,,Insomnia and Sleep Disorders
2022826,Anxiety sensitivity and cannabis use motives among trauma-exposed young adult cannabis users,https://pubmed.ncbi.nlm.nih.gov/35365953/,Inconclusive,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Anxiety
2022827,Cannabis use and social anxiety in young adulthood: A meta-analysis,https://pubmed.ncbi.nlm.nih.gov/35184002/,Negative,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Anxiety; Addiction - Cannabis
2022828,Occupational contact urticaria to cannabis sativa,https://pubmed.ncbi.nlm.nih.gov/35411398/,Negative,,Meta-analysis,2022,,Immune System,Cannabis Allergies; Allergic Contact Dermatitis
2022829,Pharmacological effects of cannabidiol by transient receptor potential channels,https://pubmed.ncbi.nlm.nih.gov/35483477/,Positive,,Meta-analysis,2022,,,Acne; Cancer; Cardiovascular Diseases (CVD); Epilepsy; Hypertension (High Blood Pressure); Inflammation; Pain; Pain - Acute; Pain - Chronic
2022830,Daily Consumption of Lemon and Ginger Herbal Infusion Caused Tumor Regression and Activation of the Immune System in a Mouse Model of Breast Cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043650/,Positive,,Animal Study,2022,,Reproductive System,Cancer - Breast; Cancer
2022831,Anti- Salmonella and Antibiofilm Potency of Salvia officinalis L. Essential Oil against Antibiotic-Resistant Salmonella enterica,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031110/,Positive,,Laboratory Study,2022,,Immune System,Bacterial Infections
2022832,"Agathis robusta Bark Essential Oil Effectiveness against COVID-19: Chemical Composition, In Silico and In Vitro Approaches",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912836/,Positive,,Laboratory Study,2022,,Respiratory System,COVID-19
2022833,Fabrication and assessment of folic acid conjugated-chitosan modified PLGA nanoparticle for delivery of alpha terpineol in colon cancer,https://pubmed.ncbi.nlm.nih.gov/35260045/,Positive,,Animal Study,2022,,Digestive System; Nervous System,Cancer - Colon; Cancer
2022834,PEGylated Lecithin-Chitosan Nanoparticle-Encapsulated Alphα-Terpineol for In Vitro Anticancer Effects,https://pubmed.ncbi.nlm.nih.gov/35314914/,Positive,,Laboratory Study,2022,,Nervous System,Cancer
2022835,Alpha-terpineol prevents myocardial damage against isoproterenol-MI induced in Wistar-Kyoto rats: new possible to promote cardiovascular integrity,https://pubmed.ncbi.nlm.nih.gov/34740575/,Positive,,Animal Study,2022,,Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack
2022836,Alpha-terpineol grafted acetylated lentinan as an anti-bacterial adhesion agent,https://pubmed.ncbi.nlm.nih.gov/34893242/,Positive,,Laboratory Study,2022,,Immune System,Bacterial Infections
2022837,Antibacterial Activities and Synergistic Interaction of Citrus Essential Oils and Limonene with Gentamicin against Clinically Isolated Methicillin-Resistant Staphylococcus aureus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901352/,Positive,,Laboratory Study,2022,,Immune System,Staph Infection
2022838,Evaluation of the Pathogenic-Mixed Biofilm Formation of Pseudomonas aeruginosa/Staphylococcus aureus and Treatment with Limonene on Three Different Materials by a Dynamic Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955688/,Positive,,Laboratory Study,2022,,Immune System,Bacterial Infections
2022839,"D-limonene (5 (one-methyl-four-[1-methylethenyl]) cyclohexane) diminishes CCl4-induced cardiac toxicity by alleviating oxidative stress, inflammatory and cardiac markers",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037211/,Positive,,Animal Study,2022,,Cardiovascular System,Cardiovascular Diseases (CVD)
2011064,Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects,https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01238.x,Positive,,Meta-analysis,2011,,,Anxiety; Cancer - Breast; Cancer; Depression; Oxidative Stress
2013060,Preventive and ameliorating effects of citrus D-limonene on dyslipidemia and hyperglycemia in mice with high-fat diet-induced obesity,https://pubmed.ncbi.nlm.nih.gov/23838456/,Positive,,Animal Study,2013,,Endocrine System,Diabetes; Metabolic Syndrome; Obesity
2022840,Effectiveness of Nutritional Ingredients on Upper Gastrointestinal Conditions and Symptoms: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839470/,Positive,,Meta-analysis,2022,,,Gastro-Esophageal Reflux; Nausea and Vomiting
2022841,A peripheral CB2 cannabinoid receptor mechanism suppresses chemotherapy-induced peripheral neuropathy: evidence from a CB2 reporter mouse,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942871/,Positive,,Animal Study,2022,AM-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),,Pain; Pain - Neuropathy - Drug-Ind. Polyneuropathy
2022842,"The Liberalization of Cannabis Possession Laws and Birth Outcomes: A State-Level Fixed Effects Analysis, 2003–2019",https://link.springer.com/article/10.1007/s11113-022-09714-6#citeas,Inconclusive,,Meta-analysis,2022,,Reproductive System,Pregnancy
2022843,An investigation of cannabis use for insomnia in depression and anxiety in a naturalistic sample,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052466/,Positive,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Anxiety; Depression; Insomnia and Sleep Disorders
2019110,Cannabidiol directly targets mitochondria and disturbs calcium homeostasis in acute lymphoblastic leukemia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791884/,Positive,,Laboratory Study,2019,,Immune System; Nervous System,Cancer - Leukemia; Cancer
2019111,Diverse TRPV1 responses to cannabinoids,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557596/,Inconclusive,,Laboratory Study,2019,Cannabinol (CBN); Cannabigerol (CBG),,Pain; Pain - Chronic; Pain - Neuropathy - Peripheral
2001014,Vanilloid receptor ligands: hopes and realities for the future,https://pubmed.ncbi.nlm.nih.gov/11587243/,Positive,,Meta-analysis,2001,,,Shingles (Herpes Zoster)
2008042,Further characterisation of a rat model of varicella zoster virus (VZV)-associated pain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394505/,Positive,,Animal Study,2008,WIN-x Synthetic Cannabinoids,Integumentary System,Herpes; Shingles (Herpes Zoster); Pain; Pain - Neuropathy - Peripheral
2022844,"Downregulation of hepatic fat accumulation, inflammation and fibrosis by nerolidol in purpose built western-diet-induced multiple-hit pathogenesis of NASH animal model",https://pubmed.ncbi.nlm.nih.gov/35447548/,Positive,,Animal Study,2022,,Digestive System,Fibrosis - Liver (Cirrhosis); Fibrosis; Hepatitis; Inflammation; Metabolic Syndrome; Obesity
2022845,Anticancer and antioxidant profiling effects of Nerolidol against DMBA induced oral experimental carcinogenesis,https://pubmed.ncbi.nlm.nih.gov/35243731/,Positive,,Animal Study,2022,,Integumentary System; Nervous System,Cancer - Squamous Head/Neck; Cancer
2022846,"Nerolidol: a potential approach in rheumatoid arthritis through reduction of TNF-α, IL-1β, IL-6, NF-kB, COX-2 and antioxidant effect in CFA-induced arthritic model",https://pubmed.ncbi.nlm.nih.gov/35212850/,Positive,,Animal Study,2022,,Skeletal System,Arthritis - Rheumatoid; Arthritis
2022847,Nerolidol attenuates isoproterenol-induced acute myocardial infarction in rats,https://pubmed.ncbi.nlm.nih.gov/35050389/,Positive,,Animal Study,2022,,Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack
2022848,Nerolidol induced apoptosis via PI3K/JNK regulation through cell cycle arrest in MG-63 osteosarcoma cells,https://pubmed.ncbi.nlm.nih.gov/35357761/,Positive,,Laboratory Study,2022,,Skeletal System,Cancer - Bone; Cancer
2022849,"The Effect of Ocimum basilicum L. and Its Main Ingredients on Respiratory Disorders: An Experimental, Preclinical, and Clinical Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762307/,Positive,,Meta-analysis,2022,,,Asthma; Bronchitis; Cancer - Lung; Cancer; COPD; Fibrosis - Lung; Fibrosis
2022850,"Synergistic effects of carvacrol, α-terpinene, γ-terpinene, ρ-cymene and linalool against Gardnerella species",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924259/,Positive,,Laboratory Study,2022,,Immune System,Bacterial Infections
2022851,Protection of CCl 4-induced hepatic and renal damage by linalool,https://pubmed.ncbi.nlm.nih.gov/32657163/,Positive,,Animal Study,2022,,,Chronic Kidney Disease; Liver Failure
2022852,"Anti-neuropathic pain mechanistic study of A. conyzoides essential oil, Precocene II, Caryophyllene, or Longifolene as single agent and in combination with pregabalin",https://pubmed.ncbi.nlm.nih.gov/35440325/,Positive,,Animal Study,2022,,Nervous System,Pain - Neuropathy - Peripheral; Pain; Pain - Acute; Pain - Chronic
2022853,"Combination of 1,8-cineole and beta-caryophyllene synergistically reverses cardiac hypertrophy in isoprenaline-induced mice and H9c2 cells",https://pubmed.ncbi.nlm.nih.gov/35489272/,Positive,,Animal Study,2022,,Cardiovascular System,Cardiovascular Diseases (CVD)
2022854,"Anti-Inflammatory Effect of Beta-Caryophyllene Mediated by the Involvement of TRPV1, BDNF and trkB in the Rat Cerebral Cortex after Hypoperfusion/Reperfusion",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998979/,Positive,,Animal Study,2022,,Cardiovascular System,Cardiovascular Diseases (CVD); Reperfusion Injury; Inflammation
2022855,The Food Additive β-Caryophyllene Exerts Its Neuroprotective Effects Through the JAK2-STAT3-BACE1 Pathway,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919047/,Positive,,Laboratory Study,2022,,,Alzheimer's Disease; Neurodegenerative Issues
2022856,"Antinociceptive, anti-inflammatory, and cytotoxic properties of Origanum vulgare essential oil, rich with β-caryophyllene and β-caryophyllene oxide",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977206/,Positive,,Animal Study,2022,,,Inflammation; Pain; Pain - Acute
2022857,"RIFM fragrance ingredient safety assessment, β-caryophyllene, CAS Registry Number 87-44-5",https://pubmed.ncbi.nlm.nih.gov/34848252/,Inconclusive,,Meta-analysis,2022,,,Cannabis Adverse Effects
2022858,Beta-caryophyllene attenuates short-term recurrent seizure activity and blood-brain-barrier breakdown after pilocarpine-induced status epilepticus in rats,https://pubmed.ncbi.nlm.nih.gov/35300975/,Positive,,Animal Study,2022,,Nervous System,Epilepsy
2021345,Ameliorative effect of myrcene in mouse model of Alzheimer's disease,https://pubmed.ncbi.nlm.nih.gov/34592305/,Positive,,Animal Study,2021,,,Alzheimer's Disease
2020253,Antibacterial and antibiofilm effects of α-humulene against Bacteroides fragilis,https://pubmed.ncbi.nlm.nih.gov/32073898/,Positive,,Laboratory Study,2020,,Immune System,Bacterial Infections; IBD - Inflammatory Bowel Disease
2021346,Humulene Inhibits Acute Gastric Mucosal Injury by Enhancing Mucosal Integrity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150829/,Positive,,Animal Study,2021,,,Addiction - Alcohol; Gastro-Esophageal Reflux; IBD - Inflammatory Bowel Disease; Oxidative Stress
2021347,Expression of the putative cannabinoid receptor GPR55 is increased in endometrial carcinoma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604869/,Inconclusive,,Laboratory Study,2021,Lysophosphatidylinositol (LPI),Reproductive System,Cancer - Uterine; Cancer
2021348,Expression of Lysophosphatidylinositol Signaling-relevant Molecules in Colorectal Cancer,https://pubmed.ncbi.nlm.nih.gov/33952459/,Negative,,Laboratory Study,2021,Lysophosphatidylinositol (LPI),Digestive System; Nervous System,Cancer - Colon; Cancer
2012082,Lysophosphatidylinositol signalling: new wine from an old bottle,https://pubmed.ncbi.nlm.nih.gov/22285325/,Negative,,Meta-analysis,2012,Lysophosphatidylinositol (LPI),Nervous System,Cancer
2016091,Role of the lysophosphatidylinositol/GPR55 axis in cancer,https://pubmed.ncbi.nlm.nih.gov/26588872/,Negative,,Meta-analysis,2016,Lysophosphatidylinositol (LPI),Nervous System,Cancer
2018107,The LPI/GPR55 axis enhances human breast cancer cell migration via HBXIP and p-MLC signaling,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843836/,Negative,,Animal Study,2018,Lysophosphatidylinositol (LPI),Nervous System; Reproductive System,Cancer - Breast; Cancer
2019112,l-α-Lysophosphatidylinositol (LPI) aggravates myocardial ischemia/reperfusion injury via a GPR55/ROCK-dependent pathway,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533556/,Inconclusive,,Laboratory Study,2019,Lysophosphatidylinositol (LPI),Cardiovascular System,Cardiovascular Diseases (CVD); Reperfusion Injury; Heart Attack
2022859,"Inhibition of triple negative breast cancer-associated inflammation, tumor growth and brain colonization by targeting monoacylglycerol lipase",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964799/,Positive,,Laboratory Study,2022,Monoacylglycerol Lipase (MAGL),Reproductive System,Cancer - Breast; Cancer
2022860,Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia,https://pubmed.ncbi.nlm.nih.gov/35347586/,Positive,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Inflammation; Oxidative Stress; Schizophrenia; Behavioral Disorders; Bipolar Disorder; Cognitive Dysfunction; Depression; Injury Immunodeficiency
2022861,Chronic Administration of Cannabinoid Receptor 2 Agonist (JWH-133) Increases Ectopic Ovarian Tumor Growth and Endocannabinoids (Anandamide and 2-Arachidonoyl Glycerol) Levels in Immunocompromised SCID Female Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886292/,Negative,,Animal Study,2022,JWH-x Synthetic Cannabinoids,Nervous System; Reproductive System,Cancer - Ovarian; Cancer
2022862,2-Arachidonoyl glycerol suppresses gastric emptying via the cannabinoid receptor 1-cholecystokinin signaling pathway in mice,https://pubmed.ncbi.nlm.nih.gov/35266554/,Inconclusive,,Animal Study,2022,2-Arachidonoyl Glycerol (2-AG),,Constipation; Diarrhea
2022863,Clinical Data on Canabinoids: Translational Research in the Treatment of Autism Spectrum Disorders,https://pubmed.ncbi.nlm.nih.gov/35453548/,Positive,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Autism
2022864,Role of Cannabidiol and Tetrahydrocannabivarin on Paclitaxel-induced neuropathic pain in rodents,https://pubmed.ncbi.nlm.nih.gov/35303507/,Positive,,Animal Study,2022,Tetrahydrocannabivarin (THCV),,Pain; Pain - Neuropathy - Drug-Ind. Polyneuropathy
2022865,Anti-Inflammatory and Antiviral Effects of Cannabinoids in Inhibiting and Preventing SARS-CoV-2 Infection,https://pubmed.ncbi.nlm.nih.gov/35456990/,Positive,,Meta-analysis,2022,Cannabidiolic Acid (CBD-a); Cannabigerolic Acid (CBG-a),Respiratory System,COVID-19
2022866,"Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 1 - continuous bivariate analysis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966217/,Negative,,Meta-analysis,2022,Cannabichromene (CBC); Cannabigerol (CBG); Cannabinol (CBN),,Cancer
2022867,Recreational cannabis legalizations associated with reductions in prescription drug utilization among Medicaid enrollees,https://pubmed.ncbi.nlm.nih.gov/35429072/,Positive,,Meta-analysis,2022,,,Anxiety; Depression; Epilepsy; Insomnia and Sleep Disorders; Pain; Pain - Chronic; Psychosis
2022868,Geraniol relieves mycoplasma pneumonia infection-induced lung injury in mice through the regulation of ERK/JNK and NF-κB signaling pathways,https://pubmed.ncbi.nlm.nih.gov/35038199/,Positive,,Animal Study,2022,,Immune System,Bacterial Infections
2022869,Geraniol enhances inhibitory inputs to the paraventricular thalamic nucleus and induces sedation in mice,https://pubmed.ncbi.nlm.nih.gov/35144136/,Positive,,Animal Study,2022,,,Epilepsy; Insomnia and Sleep Disorders
2022870,Dose-dependent alteration of neurobehavioral activities by geraniol a component of essential oil: A study in rats,https://pubmed.ncbi.nlm.nih.gov/35228183/,Positive,,Animal Study,2022,,,Anxiety; Depression; Oxidative Stress
2022871,Mechanistic Insights into Ameliorating Effect of Geraniol on D-Galactose Induced Memory Impairment in Rats,https://pubmed.ncbi.nlm.nih.gov/35235140/,Positive,,Animal Study,2022,,,Cognitive Dysfunction
2022872,"Geraniol ameliorates the progression of high fat-diet/streptozotocin-induced type 2 diabetes mellitus in rats via regulation of caspase-3, Bcl-2, and Bax expression",https://pubmed.ncbi.nlm.nih.gov/35312192/,Positive,,Animal Study,2022,,Endocrine System,Diabetes
2022873,Enhancing Cytotoxicity of Tamoxifen Using Geranium Oil,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942665/,Positive,,Laboratory Study,2022,,,Cancer - Breast; Cancer
2019113,Effects of Eucalyptol in respiratory system mechanics on acute lung injury after exposure to short-term cigarette smoke,https://pubmed.ncbi.nlm.nih.gov/31022470/,Positive,,Animal Study,2019,,Respiratory System,Acute Respiratory Distress Syndrome; Stress; Addiction - Nicotine
2021349,"Antimicrobial activity and mode of action of 1,8-cineol against carbapenemase-producing Klebsiella pneumoniae",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531306/,Positive,,Laboratory Study,2021,,Immune System,Bacterial Infections
2022874,Eucalyptol targets PI3K/Akt/mTOR Pathway to inhibit Skin Cancer Metastasis,https://pubmed.ncbi.nlm.nih.gov/35165685/,Positive,,Animal Study,2022,,Integumentary System,Cancer - Melanoma; Cancer - Metastatic; Cancer - Skin (Non-melanoma); Cancer
2021350,"Dose-Related Inhibition of Capsaicin Responses by Cannabinoids CBG, CBD, THC and their Combination in Cultured Sensory Neurons",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627890/,Positive,,Laboratory Study,2021,Cannabigerol (CBG); Cannabichromene (CBC); Capsaicin (CAPS),Nervous System,Pain - Chronic; Pain; Pain - Acute
2022875,In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties,https://pubmed.ncbi.nlm.nih.gov/35056807/,Positive,,Laboratory Study,2022,Cannabigerol (CBG),Integumentary System,Inflammation; Skin Diseases
2021351,Components of the Endocannabinoid System and Effects of Cannabinoids Against Bone Diseases: A Mini-Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815309/,Positive,,Meta-analysis,2021,,Skeletal System,Bone Fractures; Cancer - Bone; Cancer; Osteoporosis; Arthritis - Osteoarthritis; Arthritis
2022876,Cannabis Use and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage,https://www.ahajournals.org/doi/10.1161/STROKEAHA.121.035650,Negative,,Meta-analysis,2022,,,Stroke
2022877,"Cannabis Use Disorder Is Associated With Longer In-Hospital Lengths of Stay, Higher Rates of Medical Complications, and Costs of Care Following Primary 1- to 2-Level Lumbar Fusion",https://pubmed.ncbi.nlm.nih.gov/35395920/,Negative,,Meta-analysis,2022,,Mental/Emotional System,Cannabis Adverse Effects; Addiction - Cannabis
2022878,Medicinal cannabis in children and adolescents with autism spectrum disorder: A scoping review,https://pubmed.ncbi.nlm.nih.gov/34403168/,Positive,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Autism
2022879,Arrhythmic Effects of Cannabis in Ischemic Heart Disease,https://pubmed.ncbi.nlm.nih.gov/35353598/,Inconclusive,,Meta-analysis,2022,,Cardiovascular System,Cardiac Arrhythmias; Cardiovascular Diseases (CVD)
2022880,European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940878/,Positive,,Meta-analysis,2022,,Nervous System,Tics and Tourettes
2022881,A mixed methods analysis of cannabis use routines for chronic pain management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750808/,Positive,,Meta-analysis,2022,,Nervous System,Pain; Pain - Chronic
2022882,Autism and associated disorders: cannabis as a potential therapy,https://pubmed.ncbi.nlm.nih.gov/35320905/,Positive,,Meta-analysis,2022,Cannabidivarin (CBDV); Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Autism
2022883,Cannabis use among patients with cutaneous lymphoma: A cross-sectional survey,https://pubmed.ncbi.nlm.nih.gov/35395396/,Positive,,Meta-analysis,2022,,Immune System; Nervous System,Cancer - Lymphoma; Cancer; Pruritis
2022884,Standardized Cannabis Smoke Extract Induces Inflammation in Human Lung Fibroblasts,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996138/,Negative,,Laboratory Study,2022,,Nervous System,Inflammation
2022885,Cannabis smoking and glaucoma in the UK Biobank cohort,https://pubmed.ncbi.nlm.nih.gov/35093258/,Inconclusive,,Meta-analysis,2022,,Nervous System,Glaucoma
2022886,Cannabis use in Parkinson's disease-A nationwide online survey study,https://pubmed.ncbi.nlm.nih.gov/35178701/,Positive,,Meta-analysis,2022,,Nervous System,Parkinson's Disease
2022887,Consumer Perspectives on and Utilization of Medical Cannabis to Treat Dermatologic Conditions,https://pubmed.ncbi.nlm.nih.gov/35005866/,Positive,,Meta-analysis,2022,,,Acne; Inflammation; Psoriasis
2022888,Cannabis legalization and cannabis-involved pregnancy hospitalizations in Colorado,https://pubmed.ncbi.nlm.nih.gov/35150750/,Negative,,Meta-analysis,2022,,Reproductive System,Pregnancy; Cannabis Adverse Effects
2022889,Cannabis-based medicines and medical cannabis for patients with neuropathic pain and other pain disorders: Nationwide register-based pharmacoepidemiologic comparison with propensity score matched controls,https://pubmed.ncbi.nlm.nih.gov/34624164/,Positive,,Meta-analysis,2022,,,Pain; Pain - Chronic; Pain - Inflammatory; Pain - Neuropathy - Peripheral
2022890,"Association of medical cannabis licensure with prescription opioid receipt: A population-based, individual-level retrospective cohort study",https://pubmed.ncbi.nlm.nih.gov/34695720/,Inconclusive,,Meta-analysis,2022,,,Addiction - Opioid; Pain; Pain - Chronic
2022891,Medical Cannabis and Utilization of Nonhospice Palliative Care Services: Complements and Alternatives at End of Life,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759444/,Positive,,Meta-analysis,2022,,,Palliative Care
2022892,"Integrated Medical Cannabis Consultations in a Palliative Care Program: Policies, Procedures, and Progress after Six Years of Practice",https://pubmed.ncbi.nlm.nih.gov/35319304/,Positive,,Meta-analysis,2022,,,Palliative Care; Cancer; Pain; Pain - Chronic; Pain - Neuropathy - Peripheral
2022893,Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada,https://pubmed.ncbi.nlm.nih.gov/35020045/,Positive,,Meta-analysis,2022,,,Anorexia; Depression; Insomnia and Sleep Disorders; Migraine; Pain; Nausea and Vomiting; Pain - Chronic; Psychosis; PTSD
2021352,"Medical Cannabis Use Among Older Adults in Canada: Self-Reported Data on Types and Amount Used, and Perceived Effects",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696251/,Positive,,Meta-analysis,2021,,,Addiction - Benzodiazepine; Addiction - Opioid; Anxiety; Cancer; Depression; Insomnia and Sleep Disorders; Pain; Neurodegenerative Issues; Pain - Chronic
2022894,"Routes of administration, reasons for use, and approved indications of medical cannabis in oncology: a scoping review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953058/,Positive,,Meta-analysis,2022,,,Cancer; Anorexia; Pain; Nausea and Vomiting; Pain - Chronic
2022895,Medical cannabis use in Canadians with multiple sclerosis,https://pubmed.ncbi.nlm.nih.gov/35382939/,Positive,,Meta-analysis,2022,,,Multiple Sclerosis
2022896,Medical Cannabis in Pediatric Oncology: Friend or Foe?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954266/,Positive,,Meta-analysis,2022,,Nervous System,Cancer
2022897,Cannabinoids reduce opioid use in older patients with pain : Retrospective three-year analysis of data from a general practice,https://pubmed.ncbi.nlm.nih.gov/35384481/,Positive,,Meta-analysis,2022,Pharma THC:CBD; Pharma THC,Nervous System,Pain; Pain - Chronic
2022898,Efficacy of medicinal cannabis for appetite-related symptoms in people with cancer: A systematic review,https://pubmed.ncbi.nlm.nih.gov/35360989/,Positive,,Clinical Meta-analysis,2022,Pharma THC,Digestive System,Anorexia; Cancer; Anorexia Nervosa; Cachexia
2022899,The Efficacy of Cannabis in Reducing Back Pain: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907633/,Positive,,Clinical Meta-analysis,2022,Pharma THC; Tetrahydrocannabinol (THC),Nervous System,Pain; Pain - Chronic
1894001,"Report of the Indian Hemp Drugs Commission, 1893-1894 (Volume 2)",https://archive.org/details/b32222920_0002/page/n5/mode/2up,Negative,,Meta-analysis,1894,,Mental/Emotional System,Psychosis
1889001,The use of Indian hemp in the treatment of chronic chloral and chronic opium poisoning,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(00)30567-0/fulltext,Positive,,Meta-analysis,1889,,Mental/Emotional System,Addiction - Opioid; Addiction
1884001,"J. L. Milton, M.D., (1884). On the Pathology and Treatment of Gonorrhœa. New York: W. Wood & Co.",https://play.google.com/store/books/details/On_the_Pathology_and_Treatment_of_Gonorrh%C5%93a?id=xVimu7TrYhUC&gl=US,Inconclusive,,Meta-analysis,1884,,Immune System,Gonorrhea
1874001,"Medical Lexicon, A Dictionary of Medical Science, by Robley Dunglison M.D., 1874. Page, 413.",https://play.google.com/books/reader?id=Dwe6AAAAIAAJ&pg=GBS.PA412&hl=en,Positive,,Meta-analysis,1874,,Immune System,Gonorrhea; Inflammation
1893001,"Report of the Indian Hemp Drugs Commission, 1893-1894 (Volume 1)",https://archive.org/details/b32222920_0001/page/182/mode/2up,Positive,,Meta-analysis,1893,,,Addiction - Alcohol; Anxiety; Arthritis - Gout; Arthritis - Rheumatoid; Arthritis; Asthma; Bronchitis; Cannabis Adverse Effects; Cardiovascular Diseases (CVD); Constipation; Cough; Depression; Diabetes; Diarrhea; Encephalitis and Myelitis; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Gonorrhea; Hemorrhoids
2021353,The antimicrobial potential of cannabidiol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815910/,Positive,,Laboratory Study,2021,,Immune System,Bacterial Infections; Gonorrhea; Staph Infection
2016092,Type-2 cannabinoid receptors in neurodegeneration,https://pubmed.ncbi.nlm.nih.gov/27450295/,Positive,,Meta-analysis,2016,Synthetic Cannabinoid (unspecified),,Neurodegenerative Issues; Alzheimer's Disease; Chorea; Huntington's Disease; Parkinson's Disease
2015091,"Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others",https://pubmed.ncbi.nlm.nih.gov/26408163/,Positive,,Meta-analysis,2015,Endocannabinoid (unspecified),Nervous System,Alzheimer's Disease; Chorea; Huntington's Disease; Parkinson's Disease; Neurodegenerative Issues
2011065,The multiplicity of action of cannabinoids: implications for treating neurodegeneration,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6493861/,Positive,,Meta-analysis,2011,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),Nervous System,Neurodegenerative Issues; Cardiovascular Diseases (CVD); Huntington's Disease; Multiple Sclerosis; Parkinson's Disease; Reperfusion Injury; Stroke
2012083,Cannabinoids: novel medicines for the treatment of Huntington's disease,https://pubmed.ncbi.nlm.nih.gov/22280340/,Positive,,Meta-analysis,2012,Pharma THC:CBD,Nervous System,Huntington's Disease; Chorea; Dystonia
1869001,On the Use of Indian Hemp in Chorea,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327014/,Positive,,Meta-analysis,1869,,Nervous System,Chorea
2021354,Use of Cannabis in Fetal Alcohol Spectrum Disorder,https://pubmed.ncbi.nlm.nih.gov/33614955/,Positive,,Meta-analysis,2021,,,Neonatal Cerebral Issues; ADD and ADHD; Addiction - Alcohol
2021355,Therapeutic potential of cannabidivarin for epilepsy and autism spectrum disorder,https://pubmed.ncbi.nlm.nih.gov/33895189/,Inconclusive,,Meta-analysis,2021,Cannabidivarin (CBDV),Mental/Emotional System,Autism; Epilepsy
2021356,Dravet syndrome,https://pubmed.ncbi.nlm.nih.gov/33395108/,Positive,,Meta-analysis,2021,,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy
2021357,Electrochemical sensing: A prognostic tool in the fight against COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825925/,Positive,,Meta-analysis,2021,,Respiratory System,COVID-19; Inflammation
2022900,Cannabidiol promotes apoptosis of osteosarcoma cells in vitro and in vivo by activating the SP1-CBX2 axis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902565/,Positive,,Animal Study,2022,,Skeletal System,Cancer - Bone; Cancer
2022901,Cannabidiol activates neuronal Kv7 channels,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856652/,Positive,,Laboratory Study,2022,,,Epilepsy
2022902,Cannabidiol for the Management of Endometriosis and Chronic Pelvic Pain,https://pubmed.ncbi.nlm.nih.gov/34839061/,Inconclusive,,Meta-analysis,2022,,Endocrine System; Nervous System,Endometriosis; Pain; Pain - Chronic
2022903,Cannabidiol on the Path from the Lab to the Cancer Patient: Opportunities and Challenges,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951434/,Positive,,Meta-analysis,2022,,Nervous System,Cancer
2021358,Cannabinol and Sleep: Separating Fact from Fiction,https://pubmed.ncbi.nlm.nih.gov/34468204/,Inconclusive,,Meta-analysis,2021,Cannabinol (CBN),,Insomnia and Sleep Disorders
2022904,Cannabinol modulates neuroprotection and intraocular pressure: A potential multi-target therapeutic intervention for glaucoma,https://pubmed.ncbi.nlm.nih.gov/34921975/,Positive,,Animal Study,2022,Cannabinol (CBN),Nervous System,Glaucoma
1978001,Toward drugs derived from Cannabis,https://www.researchgate.net/publication/22789350_Toward_drugs_derived_from_Cannabis,Positive,,Meta-analysis,1978,Tetrahydrocannabinol (THC); Pharma THC,,Asthma; Cardiovascular Diseases (CVD); Cough; Epilepsy; Glaucoma; Hypertension (High Blood Pressure); Inflammation; Insomnia and Sleep Disorders; Pain; Nausea and Vomiting; Pain - Chronic
2011066,Chronic spinal cord injury pain: pharmacological and non-pharmacological treatments and treatment effectiveness,https://pubmed.ncbi.nlm.nih.gov/20695788/,Positive,,Meta-analysis,2011,,Nervous System; Skeletal System,Pain; Pain - Chronic; Spinal Cord Injuries
2006018,Treatments for Chronic Pain in Persons With Spinal Cord Injury: A Survey Study,https://europepmc.org/article/MED/16739554,Positive,,Meta-analysis,2006,,Nervous System; Skeletal System,Pain; Pain - Chronic; Spinal Cord Injuries
2018108,Cannabis shenanigans: advocating for the restoration of an effective treatment of pain following spinal cord injury,https://europepmc.org/article/PMC/PMC6081457,Positive,,Meta-analysis,2018,,Skeletal System,Spinal Cord Injuries; Pain; Pain - Chronic
2021359,Results From an Italian Expanded Access Program on Cannabidiol Treatment in Highly Refractory Dravet Syndrome and Lennox–Gastaut Syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173151/,Positive,,Clinical Trial,2021,Pharma CBD,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2021360,Safety and Efficacy of Medical Cannabis in Autism Spectrum Disorder Compared with Commonly Used Medications,https://pubmed.ncbi.nlm.nih.gov/34432543/,Positive,,Meta-analysis,2021,,Mental/Emotional System,Autism
2021361,Recent Updates in Psychopharmacology for the Core and Associated Symptoms of Autism Spectrum Disorder,https://pubmed.ncbi.nlm.nih.gov/34643815/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System,Autism
1973003,"Marijuana : medical papers, 1839-1972",https://www.ncbi.nlm.nih.gov/nlmcatalog/101757234,Inconclusive,,Meta-analysis,1973,Cannabinol (CBN),,Addiction - Alcohol; Addiction - Cannabis; Addiction - Opioid; Cannabis Adverse Effects; Pain; Pain - Chronic; Psychosis
2021362,Specific Compositions of Cannabis sativa Compounds Have Cytotoxic Activity and Inhibit Motility and Colony Formation of Human Glioblastoma Cells In Vitro,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038598/,Positive,,Laboratory Study,2021,AM-x Synthetic Cannabinoids; Cannabigerol (CBG); Cannabinol (CBN); Tetrahydrocannabivarin (THCV); SR-x Synthetic Cannabinoids,Nervous System,Cancer - Brain; Cancer
2020254,Behavioral and Molecular Effects Induced by Cannabidiol and Valproate Administration in the GASH/Sal Model of Acute Audiogenic Seizures,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862126/,Inconclusive,,Animal Study,2020,Anandamide (AEA),Nervous System,Epilepsy
2021363,Perioperative Cannabis as a Potential Solution for Reducing Opioid and Benzodiazepine Dependence,https://pubmed.ncbi.nlm.nih.gov/33263719/,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Benzodiazepine; Addiction - Opioid; Addiction; Pain; Pain - Acute; Cancer; Inflammation
2022905,"Botanically-Derived Δ 9-Tetrahydrocannabinol and Cannabidiol, and Their 1:1 Combination, Modulate Toll-like Receptor 3 and 4 Signalling in Immune Cells from People with Multiple Sclerosis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951523/,Positive,,Laboratory Study,2022,Pharma THC:CBD,Nervous System,Multiple Sclerosis
2022906,Analysis of toxicity effects of delta-9-tetrahydrocannabinol on isolated rat heart mitochondria,https://pubmed.ncbi.nlm.nih.gov/34431445/,Positive,,Laboratory Study,2022,,Cardiovascular System,Cardiovascular Diseases (CVD)
2022907,Comparative Pharmacokinetics of Δ 9-Tetrahydrocannabinol in Adolescent and Adult Male and Female Rats,https://pubmed.ncbi.nlm.nih.gov/35353551/,Inconclusive,,Animal Study,2022,,,Cannabis Adverse Effects
2022908,Anxiety and cognitive-related effects of Δ 9-tetrahydrocannabinol (THC) are differentially mediated through distinct GSK-3 vs. Akt-mTOR pathways in the nucleus accumbens of male rats,https://pubmed.ncbi.nlm.nih.gov/34860284/,Inconclusive,,Animal Study,2022,,Mental/Emotional System,Anxiety
2022909,Acute effects of oral delta-9-tetrahydrocannabinol (THC) on autonomic cardiac activity and their relation to subjective and anxiogenic effects,https://pubmed.ncbi.nlm.nih.gov/34665890/,Negative,,Clinical Trial,2022,,Cardiovascular System,Cardiovascular Diseases (CVD)
2022910,"Unknown risks of psychosis and addiction with delta-8-THC: A call for research, regulation, and clinical caution",https://onlinelibrary.wiley.com/doi/10.1111/add.15873,Inconclusive,,Meta-analysis,2022,Delta-8-THC,,Cannabis Adverse Effects; Psychosis
2022911,Analytical and medico-legal problems linked to the presence of delta-8-tetrahydrocannabinol (delta-8-THC): Results from urine drug testing in Sweden,https://pubmed.ncbi.nlm.nih.gov/34734479/,Inconclusive,,Meta-analysis,2022,Delta-8-THC,,
2022912,Public interest in ∆ 8-Tetrahydrocannabinol (delta-8-THC) increased in US states that restricted ∆ 9-Tetrahydrocannabinol (delta-9-THC) use,https://pubmed.ncbi.nlm.nih.gov/34952279/,Inconclusive,,Meta-analysis,2022,Delta-8-THC,,
2022913,"Popularity of Delta-8 THC on the Internet Across US States, 2021",https://pubmed.ncbi.nlm.nih.gov/35080939/,Positive,,Meta-analysis,2022,Delta-8-THC,,
2022914,Delta-8-THC: Delta-9-THC’s nicer younger sibling?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725316/,Positive,,Meta-analysis,2022,Delta-8-THC,,Cannabis Adverse Effects; Pain; Pain - Chronic
2022915,Fine Particulate Matter Exposure From Secondhand Cannabis Bong Smoking,https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2790510?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=033022,Negative,,Meta-analysis,2022,,Mental/Emotional System,Cannabis Adverse Effects
2014069,"Preliminary, open-label, pilot study of add-on oral Δ9-tetrahydrocannabinol in chronic post-traumatic stress disorder",https://pubmed.ncbi.nlm.nih.gov/24935052/,Positive,,Clinical Trial,2014,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,PTSD; Addiction - Cannabis; Insomnia and Sleep Disorders
2020255,"Evaluation of repeated or acute treatment with cannabidiol (CBD), cannabidiolic acid (CBDA) or CBDA methyl ester (HU-580) on nausea and/or vomiting in rats and shrews",https://pubmed.ncbi.nlm.nih.gov/32488349/,Positive,,Animal Study,2020,Cannabidiolic Acid (CBD-a); HU-x Synthetic Cannabinoids,Digestive System,Nausea and Vomiting; Chemotherapy-induced Nausea & Vomiting; Morning sickness; Motion Sickness
2015092,"HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576666/,Positive,,Animal Study,2015,HU-x Synthetic Cannabinoids,Nervous System; Skeletal System,Arthritis - Rheumatoid; Inflammation; Arthritis - Osteoarthritis; Arthritis
1940001,Use of Hemp Drugs in India,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5208024/pdf/indmedgaz72473-0044.pdf,Negative,,Meta-analysis,1940,,,Addiction - Cannabis; Cannabis Adverse Effects; Libido
2020256,Industrial Hemp (Cannabis sativa subsp. sativa) as an Emerging Source for Value-Added Functional Food Ingredients and Nutraceuticals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571072/,Positive,,Meta-analysis,2020,,,Anxiety; Arthritis - Rheumatoid; Arthritis; Cancer; Cardiovascular Diseases (CVD); Depression; Eczema; Insomnia and Sleep Disorders; Neurodegenerative Issues; PTSD
2022916,"A Coala-T-Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment",https://pubmed.ncbi.nlm.nih.gov/34636036/,Positive,,Meta-analysis,2022,,Reproductive System,Cancer - Breast; Cancer; Anxiety; Insomnia and Sleep Disorders; Pain; Nausea and Vomiting; Pain - Acute; Pain - Chronic; Pain - Neuropathy - Peripheral
1918001,"Dispensatory of the United States, 20th ed. (1918)",http://dclytle.net/wp-content/uploads/2015/11/DUS20.pdf,Positive,,Meta-analysis,1918,,,Anxiety; Depression; Insomnia and Sleep Disorders; Tetanus; Migraine; Pain; Pain - Chronic; Pain - Neuropathy - Peripheral
1845001,"On Traumatic Tetanus and Its Treatment, with Some Remarks on the Extract of Cannabis Indica of Commerce",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2558904/pdf/provmedsurgj00221-0005.pdf,Positive,,Meta-analysis,1845,,Immune System,Tetanus
1845002,Case of Traumatic Tetanus — Exhibition of the Extract of Indian Hemp (Cannabis Indica)—Death—Autopsy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2558623/pdf/provmedsurgj00216-0004.pdf,Inconclusive,,Meta-analysis,1845,,Immune System,Tetanus
2021364,Add-on cannabidiol in patients with Dravet syndrome: Results of a long-term open-label extension trial,https://onlinelibrary.wiley.com/doi/10.1111/epi.17036,Positive,,Clinical Trial,2021,,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy
2021365,The Effects of Cannabis sativa L. Extract on Oxidative Stress Markers In Vivo,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303441/,Positive,,Animal Study,2021,Cannabidiolic Acid (CBD-a); Cannabigerol (CBG),Nervous System,Inflammation; Oxidative Stress
2021366,New possibilities for neuroprotection in neonatal hypoxic-ischemic encephalopathy,https://link.springer.com/article/10.1007/s00431-021-04320-8,Positive,,Meta-analysis,2021,,Nervous System,Inflammation; Neonatal Cerebral Issues; Oxidative Stress
2021367,Lifestyle Interventions Improving Cannabinoid Tone During COVID-19 Lockdowns May Enhance Compliance With Preventive Regulations and Decrease Psychophysical Health Complications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322115/,Positive,,Meta-analysis,2021,Mind-Body Medicine; 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System,Behavioral Disorders; Anxiety; COVID-19; Grief and Bereavement
1843001,"On the Preparations of the Indian Hemp, or Gunjah–Cannabis Indica Their Effects on the Animal System in Health, and their Utility in the Treatment of Tetanus and other Convulsive Diseases",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2490264/pdf/provmedsurgj00865-0001.pdf,Positive,,Meta-analysis,1843,,Immune System; Nervous System,Epilepsy; Tetanus; Arthritis - Rheumatoid; Arthritis; Cholera
2021368,Cannabidiol Does Not Impact Acute Anabolic or Inflammatory Signaling in Skeletal Muscle In Vitro,https://www.liebertpub.com/doi/10.1089/can.2021.0132,Inconclusive,,Laboratory Study,2021,,Nervous System,Inflammation
1904001,Insanity Following the Use of Indian Hemp,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5162468/pdf/indmedgaz71518-0001.pdf,Negative,,Meta-analysis,1904,,Mental/Emotional System,Psychosis; Addiction - Cannabis; Cannabis Adverse Effects; Schizophrenia
1866001,Ergot of Rye and Indian Hemp in Obstinate Cases of Menorrhagia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5170301/pdf/indmedgaz70192-0020b.pdf,Positive,,Meta-analysis,1866,,Reproductive System,Menstrual Disorders
1885001,Indian Hemp as a Cause of Insanity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5184608/pdf/indmedgaz70926-0019a.pdf,Negative,,Meta-analysis,1885,,Mental/Emotional System,Psychosis; Schizophrenia
1940002,"Structure of Cannabidiol, a Product Isolated from the Marihuana Extract of Minnesota Wild Hemp. I",https://pubs.acs.org/doi/abs/10.1021/ja01858a058,Inconclusive,,Laboratory Study,1940,,,Cannabis Adverse Effects
1945001,Marihuana activity of cannabinol,https://pubmed.ncbi.nlm.nih.gov/17818194/,Inconclusive,,Meta-analysis,1945,Cannabinol (CBN),Mental/Emotional System; Nervous System,Cannabis Adverse Effects
1896001,"Chemistry, Pharmacy and Other Allied Subjects-Indian Hemp Constituents-Guttapercha from Leaves-Antipyrin as a Poison-Anti-Choleraic Serum-Two Kinds of X Rays-Oxygen Gas as a Restorative-Pepsin Digestion-Aseptic Surgical Catgut-Mercuric Cyanide in Ophthalmic Practice-Endosine in Intestinal Catarrh-Quinosol: A New Antiseptic-Malakin in Acute Rheumatism - Electric Treatment of Diabetes-Mustard Oil as a Poison in Trinidad-Tuberculosis in Goats-The X Rays in Dentistry-The Action of the Röntgen Rays on Certain Microbes-Diagnostic Value of the X Rays-""Photographing Thought""",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5146125/pdf/indmedgaz71339-0032.pdf,Inconclusive,,Meta-analysis,1896,Cannabinol (CBN),,Cannabis Adverse Effects
2022917,Decreasing sperm quality in mice subjected to chronic cannabidiol exposure: New insights of cannabidiol-mediated male reproductive toxicity,https://www.sciencedirect.com/science/article/abs/pii/S0009279721003811?via%3Dihub,Negative,,Animal Study,2022,Endocannabinoid (unspecified),Nervous System; Reproductive System,Infertility (Male); Oxidative Stress; Erectile Dysfunction; Libido
1858001,Tetanus Treated with Extract of Indian Hemp: Recovery,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5311814/pdf/edinbmedj73649-0014.pdf,Positive,,Meta-analysis,1858,,Immune System,Tetanus; Dystonia; Epilepsy
1878001,Hemp (Ganja) Smoking in Tetanus on a New Principle,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130873/pdf/indmedgaz70685-0012.pdf,Positive,,Meta-analysis,1878,,Immune System,Tetanus; Dystonia; Epilepsy
1849001,Indian Hemp in Facial Neuralgia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059591/pdf/amjdentsci80437-0079c.pdf,Positive,,Meta-analysis,1849,,Nervous System,Pain - Neuropathy - Peripheral; Pain; Pain - Acute; Pain - Chronic
1871001,"Observations and Experiments on the Use of Opium, Bromide of Potassium, and Cannabis Indica in Insanity, Especially in Regard to the Effects of the Two Latter Given Together",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5163426/pdf/brforeignmcrev73153-0209.pdf,Positive,,Meta-analysis,1871,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
1886001,On the Therapeutic Value of Tinctura Cannabis Indica in the Treatment of Dysentery,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5000962/pdf/indmedgaz71000-0001.pdf,Positive,,Meta-analysis,1886,,Digestive System,Diarrhea
1843002,Observations on the medicinal properties of the Cannabis Sativa of India,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2116906/pdf/medcht00056-0220.pdf,Positive,,Meta-analysis,1843,,,Arthritis - Gout; Arthritis - Rheumatoid; Arthritis; Asthma; Cancer - Ovarian; Cancer; Cough; Depression; Flu; Insomnia and Sleep Disorders; Pain; Palliative Care; Pain - Acute; Tuberculosis
1847001,"A Case of Dysmenorrhœa in Which the Tincture of Cannabis Indica Was Employed, with Some Observations upon That Drug",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2487155/,Negative,,Meta-analysis,1847,,Reproductive System,Menstrual Disorders
1887001,Mr. McHale on Cannabis Indica for Dysentery,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5128521/?page=1,Positive,,Meta-analysis,1887,,Digestive System,Diarrhea
2020257,Phytocannabinoids promote viability and functional adipogenesis of bone marrow-derived mesenchymal stem cells through different molecular targets,https://pubmed.ncbi.nlm.nih.gov/32061773/,Positive,,Laboratory Study,2020,Cannabigerol (CBG); Cannabidiolic Acid (CBD-a); Cannabigerolic Acid (CBG-a); Tetrahydrocannabivarin (THCV),,Diabetes; Metabolic Syndrome; Obesity
2021369,Perspectives of pediatric oncologists and palliative care physicians on the therapeutic use of cannabis in children with cancer,https://onlinelibrary.wiley.com/doi/10.1002/cnr2.1551,Positive,,Meta-analysis,2021,,Nervous System,Cancer; Anorexia; Cachexia; Depression; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Insomnia and Sleep Disorders; Pain; Nausea and Vomiting; Pain - Chronic
2021370,Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune Response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987002/,Positive,,Laboratory Study,2021,Cannabichromene (CBC); Cannabidiolic Acid (CBD-a); Cannabigerol (CBG),Nervous System; Respiratory System,COVID-19; Inflammation; Cancer - Lung; Cancer
2021371,Analgesic Potential of Terpenes Derived from Cannabis sativa,https://pharmrev.aspetjournals.org/content/73/4/1269,Positive,,Meta-analysis,2021,Echinacea,Nervous System,Inflammation; Pain; Pain - Chronic; Addiction - Opioid; Arthritis - Osteoarthritis; Arthritis; Cancer; Migraine; Pain - Acute
1883001,Cannabis Indica,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2372636/?page=1,Positive,,Meta-analysis,1883,,,Cholera; Tetanus
1885002,Cannabis Indica,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903954/?page=1,Positive,,Meta-analysis,1885,,Digestive System,Pain; Pain - Acute; Pain - Dental - Acute; Cavities
1890001,Cannabis Indica,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5236730/?page=2,Positive,,Meta-analysis,1890,,,Alzheimer's Disease; Arthritis - Gout; Arthritis; Dementia; Dystonia; Insomnia and Sleep Disorders; Menstrual Disorders; Migraine; Pain; Pain - Chronic
1839001,"On the Preparations of the Indian Hemp, or Gunjah (Cannabis Indica), Their Effects on the Animal System in Health, and Their Utility in the Treatment of Tetanus and Other Convulsive Diseases",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592602/?page=2,Positive,,Meta-analysis -,1839,,Immune System; Nervous System,Epilepsy; Tetanus; Veterinary Applications; Anorexia; Arthritis - Rheumatoid; Arthritis; Cholera; Diarrhea; Dystonia; Insomnia and Sleep Disorders; Libido
2017082,Chemosensitizing Properties of β-Caryophyllene and β-Caryophyllene Oxide in Combination with Doxorubicin in Human Cancer Cells,https://pubmed.ncbi.nlm.nih.gov/28314281/,Positive,,Laboratory Study,2017,,Nervous System,Cancer
2022918,Long-term use of cannabidiol-enriched medical cannabis in a prospective cohort of children with drug-resistant developmental and epileptic encephalopathy,https://pubmed.ncbi.nlm.nih.gov/34999381/,Positive,,Clinical Trial,2022,,,Epilepsy; Encephalitis and Myelitis
2022919,Risks and Benefits of Cannabis and Cannabinoids in Psychiatry,https://pubmed.ncbi.nlm.nih.gov/34875873/,Inconclusive,,Clinical Meta-analysis,2022,,,Psychosis
2022920,Cannabis Use among Patients with Alopecia Areata: A Cross-Sectional Survey Study,https://pubmed.ncbi.nlm.nih.gov/35300098/,Positive,,Meta-analysis,2022,,Integumentary System,Hair Loss
2022921,"Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer Care",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882944/,Positive,,Meta-analysis,2022,,Nervous System,Cancer; Pain; Nausea and Vomiting; Pain - Cancer
2022922,Cannabis and End-of-Life Care: A Snapshot of Hospice Planning and Experiences Among Illinois Medical Cannabis Patients With A Terminal Diagnosis,https://pubmed.ncbi.nlm.nih.gov/34002633/,Positive,,Meta-analysis,2022,,,Palliative Care
2022923,Who mixes tobacco with cannabis and does mixing relate to nicotine dependence?,https://pubmed.ncbi.nlm.nih.gov/35085951/,Negative,,Meta-analysis,2022,,Mental/Emotional System,Addiction - Nicotine; Addiction
2022924,UK Medical Cannabis Registry: an analysis of clinical outcomes of medicinal cannabis therapy for generalized anxiety disorder,https://pubmed.ncbi.nlm.nih.gov/34937473/,Positive,,Meta-analysis,2022,,Mental/Emotional System,Anxiety
2022925,UK Medical Cannabis Registry palliative care patients cohort: initial experience and outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725528/,Positive,,Meta-analysis,2022,,,Palliative Care; Anxiety; Depression; Pain; Pain - Cancer
2022926,Medical Cannabis and Psychiatric Disorders: Implications for Psychiatric Nurses,https://pubmed.ncbi.nlm.nih.gov/32772621/,Inconclusive,,Meta-analysis,2022,,,Alzheimer's Disease; Anxiety; Dementia; Tics and Tourettes; OCD; PTSD
2021372,The terpenes camphene and alpha-bisabolol inhibit inflammatory and neuropathic pain via Cav3.2 T-type calcium channels,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591808/,Positive,,Animal Study,2021,,Nervous System,Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral; Inflammation; Pain; Pain - Chronic
2022927,"Effect of Medical Marijuana Card Ownership on Pain, Insomnia, and Affective Disorder Symptoms in Adults: A Randomized Clinical Trial",https://pubmed.ncbi.nlm.nih.gov/35302633/,Inconclusive,,Clinical Trial,2022,,Nervous System,Insomnia and Sleep Disorders; Pain; Pain - Chronic; Addiction - Cannabis; Behavioral Disorders; Anxiety; Bipolar Disorder; Depression
2022928,Use of Marijuana: Effect on Brain Health: A Scientific Statement From the American Heart Association,https://pubmed.ncbi.nlm.nih.gov/35142225/,Negative,,Meta-analysis,2022,,,Cognitive Dysfunction; Stroke
2022929,"Marijuana in Orthopaedics: Effects on Bone Health, Wound-Healing, Surgical Complications, and Pain Management",https://pubmed.ncbi.nlm.nih.gov/35180183/,Inconclusive,,Meta-analysis,2022,,Immune System; Integumentary System; Skeletal System,Bone Fractures; Wound Healing
2022930,Birth Outcomes of Neonates Exposed to Marijuana in Utero: A Systematic Review and Meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796018/,Negative,,Meta-analysis,2022,,Reproductive System,Pregnancy
2022931,Marijuana Use Results in Increased Time to Union in Surgically Treated Pediatric Fracture Patients,https://pubmed.ncbi.nlm.nih.gov/34387569/,Negative,,Meta-analysis,2022,,Skeletal System,Bone Fractures; Wound Healing
2022932,Medical cannabis and cannabinoids for impaired sleep: a systematic review and meta-analysis of randomized clinical trials,https://pubmed.ncbi.nlm.nih.gov/34546363/,Positive,,Clinical Meta-analysis,2022,,,Insomnia and Sleep Disorders; Pain; Pain - Chronic
2022933,Medical Cannabis Use Reduces Opioid Prescriptions in Patients With Osteoarthritis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873278/,Positive,,Clinical Trial,2022,,Skeletal System,Arthritis - Osteoarthritis; Arthritis; Addiction - Opioid; Pain; Pain - Chronic
2022934,Medical Cannabis for Gynecologic Pain Conditions: A Systematic Review,https://pubmed.ncbi.nlm.nih.gov/35104069/,Positive,,Meta-analysis,2022,,,Cancer - Uterine; Cancer; Cystitis; Endometriosis; Pain; Ovarian Dysfunction; Pain - Chronic
2021373,Cannabidiol in the prelimbic cortex modulates the comorbid condition between the chronic neuropathic pain and depression-like behaviour in rats: The role of medial prefrontal cortex 5-HT 1A and CB 1 receptors,https://www.sciencedirect.com/science/article/abs/pii/S036192302100191X?via%3Dihub,Positive,,Animal Study,2021,AM-x Synthetic Cannabinoids; Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,Depression; Pain - Chronic; Pain
2021374,Adjunctive Management of Opioid Withdrawal with the Nonopioid Medication Cannabidiol,https://www.liebertpub.com/doi/10.1089/can.2021.0089,Positive,,Meta-analysis,2021,,Mental/Emotional System,Addiction - Opioid; Addiction; Cardiovascular Diseases (CVD); Depression; Hypertension (High Blood Pressure); Inflammation; Insomnia and Sleep Disorders; Pain; Nausea and Vomiting; Pain - Acute; Pain - Chronic
2021375,Metabolic Consequences of Gestational Cannabinoid Exposure,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430813/,Negative,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH),Endocrine System; Reproductive System,Metabolic Syndrome; Pregnancy; Cardiovascular Diseases (CVD); Diabetes; Obesity
2022935,Recreational Marijuana Use and Coronary Artery Dissection: A Case Series,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890676/,Negative,,Meta-analysis,2022,,Cardiovascular System,Cardiovascular Diseases (CVD)
2022936,Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732831/,Inconclusive,,Meta-analysis,2022,,,Pain; Pain - Chronic
2022937,Observational study of medical marijuana as a treatment for treatment-resistant epilepsies,https://onlinelibrary.wiley.com/doi/10.1002/acn3.51537,Inconclusive,,Meta-analysis,2022,Tetrahydrocannabinol (THC),Nervous System,Epilepsy; Epilepsy - Lennox-Gastaut
2022938,Marijuana and Myocardial Infarction in the UK Biobank Cohort,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826760/,Positive,,Meta-analysis,2022,,Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack
2022939,Medical marijuana for inflammatory bowel disease: the highs and lows,https://pubmed.ncbi.nlm.nih.gov/34919496/,Positive,,Meta-analysis,2022,,Digestive System,IBD - Inflammatory Bowel Disease
2022940,Medical Marijuana Efficacy: A Survey,https://www.scirp.org/journal/paperinformation.aspx?paperid=115717,Positive,,Meta-analysis,2022,,,Addiction - Opioid; Anxiety; Inflammation; Insomnia and Sleep Disorders; Migraine; Pain; Pain - Chronic
2022941,The Effectiveness of Common Cannabis Products for Treatment of Nausea,https://pubmed.ncbi.nlm.nih.gov/35258504/,Positive,,Meta-analysis,2022,,Digestive System,Nausea and Vomiting; Chemotherapy-induced Nausea & Vomiting; Morning sickness; Motion Sickness
2022942,Medical Cannabis for Gilles de la Tourette Syndrome: An Open-Label Prospective Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926524/,Positive,,Clinical Trial,2022,,,Tics and Tourettes
2021376,Regulatory Effect of Cannabidiol (CBD) on Decreased β-Catenin Expression in Alopecia Models by Testosterone and PMA Treatment in Dermal Papilla Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220510/,Positive,,Laboratory Study,2021,,Integumentary System,Hair Loss; Abnormal Hair Growth
2021377,Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996784/,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Abnormal Cannabidiol (Abn-CBD); AM-x Synthetic Cannabinoids; Anandamide (AEA); Cannabichromene (CBC); Cannabichromenic Acid (CBC-a); Cannabidiolic Acid (CBD-a); Cannabigerol (CBG); Cannabigerolic Acid (CBG-a); Cannabinol (CBN); CP-x Synthetic Cannabinoids; Delta-8-THC; Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Lysophosphatidylinositol (LPI); Monoacylglycerol Lipase (MAGL); Tetrahydrocannabivarin (THCV); Tetrahydrocannabinolic Acid (THC-a); WIN-x Synthetic Cannabinoids,,
2021378,Curcumae Longae Rhizoma and Saussureae Radix Inhibit Nitric Oxide Production and Cannabinoid Receptor 2 Down-regulation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997760/,Positive,,Laboratory Study,2021,,,Inflammation
2022943,Curcumin induces peripheral antinociception by opioidergic and cannabinoidergic mechanism: Pharmacological evidence,https://pubmed.ncbi.nlm.nih.gov/35032552/,Positive,,Animal Study,2022,Turmeric; 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Other Related Compounds,,Pain - Neuropathy - Peripheral; Pain; Pain - Acute; Pain - Chronic
2022944,Endocannabinoid System in Polycystic Kidney Disease,https://pubmed.ncbi.nlm.nih.gov/35263737/,Positive,,Meta-analysis,2022,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Other Related Compounds,Urinary System,Chronic Kidney Disease; Hemodialysis; Kidney Failure
2022945,Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics,https://pubmed.ncbi.nlm.nih.gov/35244889/,Positive,,Meta-analysis,2022,,Nervous System,Cancer
2022946,The Role of the Possible Receptors and Intracellular Pathways in Protective Effect of Exogenous Anandamide in Kindling Model of Epilepsy,https://pubmed.ncbi.nlm.nih.gov/35112235/,Positive,,Animal Study,2022,Anandamide (AEA),Nervous System,Epilepsy
2022947,"Viphyllin TM, a Standardized Black Pepper Seed Extract Exerts Antinociceptive Effects in Murine Pain Models via Activation of Cannabinoid Receptor CB2, Peroxisome Proliferator-Activated Receptor-Alpha and TRPV1 Ion Channels",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827412/,Positive,,Animal Study,2022,,Nervous System,Pain; Pain - Acute
2022948,"Essential oil of Piper purusanum C.DC (Piperaceae) and its main sesquiterpenes: biodefensives against malaria and dengue vectors, without lethal effect on non-target aquatic fauna",https://pubmed.ncbi.nlm.nih.gov/35179689/,Positive,,Animal Study,2022,,Immune System,Malaria; Parasitic Worms
2022949,Potential use for chronic pain: Poly(Ethylene Glycol)-Poly(Lactic-Co-Glycolic Acid) nanoparticles enhance the effects of Cannabis-Based terpenes on calcium influx in TRPV1-Expressing cells,https://pubmed.ncbi.nlm.nih.gov/35104595/,Positive,,Laboratory Study,2022,,Nervous System,Pain; Pain - Chronic
2022950,Cannabinoid 2 receptor agonist and L-arginine combination attenuates diabetic cardiomyopathy in rats via NF-ĸβ inhibition,https://pubmed.ncbi.nlm.nih.gov/34860602/,Positive,,Animal Study,2022,,Cardiovascular System,Cardiovascular Diseases (CVD); Inflammation; Oxidative Stress
2022951,"Different Cytotoxic Effects of Vetiver Oil on Three Types of Cancer Cells, Mainly Targeting CNR2 on TNBC",https://pubmed.ncbi.nlm.nih.gov/35092394/,Positive,,Laboratory Study,2022,,Nervous System; Reproductive System,Cancer - Breast; Cancer
2022952,Antibacterial and Anti-Biofilm Activities of Essential Oil Compounds against New Delhi Metallo-β-Lactamase-1-Producing Uropathogenic Klebsiella pneumoniae Strains,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868355/,Positive,,Laboratory Study,2022,,Immune System,Bacterial Infections
2022953,Cannabis terpenes display variable protective and anti-aggregatory actions against neurotoxic β amyloid in vitro: highlighting the protective bioactivity of α-bisabolol in motorneuronal-like NSC-34 cells,https://pubmed.ncbi.nlm.nih.gov/35278524/,Positive,,Laboratory Study,2022,,,Alzheimer's Disease; Neurodegenerative Issues
2022954,Protective antioxidative and anti-inflammatory actions of β-caryophyllene against sulfasalazine-induced nephrotoxicity in rat,https://pubmed.ncbi.nlm.nih.gov/35068213/,Positive,,Animal Study,2022,,Nervous System; Urinary System,Drug-Induced Nephropathy; Inflammation; Oxidative Stress
2022955,β-Caryophyllene promotes oxidative stress and apoptosis in KB cells through activation of mitochondrial-mediated pathway - An in-vitro and in-silico study,https://pubmed.ncbi.nlm.nih.gov/31583906/,Positive,,Laboratory Study,2022,,Nervous System,Cancer; Inflammation
2022956,"Beta-caryophyllene as an antioxidant, anti-inflammatory and re-epithelialization activities in a rat skin wound excision model",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831077/,Positive,,Animal Study,2022,,Immune System; Integumentary System; Nervous System,Inflammation; Oxidative Stress; Wound Healing
2021379,Anti-inflammatory Effect of Cannabidiol and Palmitoylethanolamide Containing Topical Formulation on Skin in a 12-O-Tetradecanoylphorbol-13-Acetate-Induced Dermatitis Model in Mice,https://pubmed.ncbi.nlm.nih.gov/33654018/,Positive,,Animal Study,2021,,Integumentary System,Inflammation; Skin Diseases
2021380,Tolerability profile of topical cannabidiol and palmitoylethanolamide: a compilation of single-centre randomized evaluator-blinded clinical and in vitro studies in normal skin,https://pubmed.ncbi.nlm.nih.gov/34022073/,Positive,,Clinical Trial,2021,,Integumentary System,Skin Diseases
2021381,UV induced changes in proteome of rats plasma are reversed by dermally applied cannabidiol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526570/,Positive,,Animal Study,2021,,Integumentary System,Skin Diseases; Cancer - Melanoma; Cancer; Inflammation; Oxidative Stress
2021382,Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864168/,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Cannabidiolic Acid (CBD-a); Endocannabinoid (unspecified); Tetrahydrocannabivarin (THCV); Tetrahydrocannabinolic Acid (THC-a),Digestive System,Fatty Liver Disease; Liver Failure; Metabolic Syndrome; Obesity
2021383,A Review of the Current Evidence Connecting Seborrheic Dermatitis and Parkinson's Disease and the Potential Role of Oral Cannabinoids,https://www.karger.com/Article/FullText/512189,Positive,,Meta-analysis,2021,,Integumentary System,Inflammation; Parkinson's Disease; Seborrhea; Neurodegenerative Issues
2021384,Rates of self-directed perioperative cannabidiol use in patients undergoing total hip or knee arthroplasty,https://pubmed.ncbi.nlm.nih.gov/34102871/,Inconclusive,,Meta-analysis,2021,,,Pain - Acute; Pain
2022957,Long-term Cannabis-based oil therapy and pain medications prescribing patterns: an Italian observational study,https://pubmed.ncbi.nlm.nih.gov/35253178/,Positive,,Meta-analysis,2022,,Nervous System,Pain; Pain - Chronic
2022958,Association between Current and Cumulative Cannabis use and Heart Rate. The Coronary Artery Risk Development in Young Adults (CARDIA) Study,https://pubmed.ncbi.nlm.nih.gov/35245494/,Inconclusive,,Meta-analysis,2022,,Cardiovascular System,Cardiovascular Diseases (CVD)
2021385,Cannabidiol (CBD) oil toxicity mimicking extraglandular complications of Sjögren’s syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962723/,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Insomnia and Sleep Disorders; Night Sweats and Excessive Sweating
2021386,Medical Cannabis for Headache Pain: a Primer for Clinicians,https://pubmed.ncbi.nlm.nih.gov/34628531/,Positive,,Meta-analysis,2021,,,Pain; Pain - Chronic; Addiction - Opioid; Migraine
2021387,Development of central precocious puberty following cannabinoid use for paediatric epilepsy: causal or coincidence?,https://casereports.bmj.com/content/14/4/e239678,Positive,,Meta-analysis,2021,,Nervous System,Epilepsy
2021388,Cannabinoid Use in a Tertiary Headache Clinic: A Cross-Sectional Survey,https://pubmed.ncbi.nlm.nih.gov/34511153/,Positive,,Meta-analysis,2021,,,Pain; Pain - Chronic
2021389,Potential Role of Cannabidiol on Sports Recovery: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369499/,Positive,,Meta-analysis,2021,,,Anxiety; Cognitive Dysfunction; Insomnia and Sleep Disorders; Pain; Oxidative Stress; Pain - Acute
2021390,Effects of Acute Drug Administration on Emotion: A Review of Pharmacological MRI Studies,https://pubmed.ncbi.nlm.nih.gov/34631363/,Inconclusive,,Meta-analysis,2021,,,Addiction - Alcohol; Addiction - Opioid; Cannabis Adverse Effects; MDMA Adverse Effects
2021391,Borneol-modified tanshinone IIA liposome improves cerebral ischemia reperfusion injury by suppressing NF-κB and ICAM-1 expression,https://pubmed.ncbi.nlm.nih.gov/33834937/,Positive,,Animal Study,2021,,Cardiovascular System,Cardiovascular Diseases (CVD); Reperfusion Injury; Stroke
2021392,A pain killer without analgesic tolerance designed by co-targeting PSD-95-nNOS interaction and α2-containning GABA A Rs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058733/,Positive,,Animal Study,2021,,Nervous System,Pain; Pain - Chronic
2021393,"Borneol in cardio-cerebrovascular diseases: Pharmacological actions, mechanisms, and therapeutics",https://pubmed.ncbi.nlm.nih.gov/33892091/,Positive,,Meta-analysis,2021,,Cardiovascular System,Cardiovascular Diseases (CVD)
2021394,Borneol: a Promising Monoterpenoid in Enhancing Drug Delivery Across Various Physiological Barriers,https://pubmed.ncbi.nlm.nih.gov/33913042/,Positive,,Meta-analysis,2021,,,
2021395,Quaternary ammonium salts based on (-)-borneol as effective inhibitors of influenza virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116641/,Positive,,Laboratory Study,2021,,Immune System; Respiratory System,Flu
2021396,"Chemical Composition, Antibacterial, and Anti-Inflammatory Activities of Essential Oils from Flower, Leaf, and Stem of Rhynchanthus beesianus",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102109/,Positive,,Laboratory Study,2021,,Immune System; Nervous System,Bacterial Infections; Inflammation
2021397,Neuroprotective Phytochemicals in Experimental Ischemic Stroke: Mechanisms and Potential Clinical Applications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102108/,Positive,,Meta-analysis,2021,,Nervous System,Stroke
2021398,Progress in Borneol Intervention for Ischemic Stroke: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129537/,Positive,,Meta-analysis,2021,,Nervous System,Stroke
2021399,Synergic Neuroprotection Between Ligusticum Chuanxiong Hort and Borneol Against Ischemic Stroke by Neurogenesis via Modulating Reactive Astrogliosis and Maintaining the Blood–Brain Barrier,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242197/,Positive,,Animal Study,2021,,Nervous System,Stroke
2021400,Nose-to-brain delivery of borneol modified tanshinone IIA nanoparticles in prevention of cerebral ischemia/reperfusion injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245080/,Positive,,Laboratory Study,2021,,Cardiovascular System,Cardiovascular Diseases (CVD); Reperfusion Injury; Stroke
2021401,"Compound Danshen Dripping Pill ameliorates post ischemic myocardial inflammation through synergistically regulating MAPK, PI3K/AKT and PPAR signaling pathways",https://pubmed.ncbi.nlm.nih.gov/34390798/,Positive,,Animal Study,2021,,Cardiovascular System; Nervous System,Cardiovascular Diseases (CVD); Inflammation
2022959,Multiple regulation and targeting effects of borneol in the neurovascular unit in neurodegenerative diseases,https://pubmed.ncbi.nlm.nih.gov/34491621/,Positive,,Meta-analysis,2022,,Nervous System,Neurodegenerative Issues; Inflammation
2021402,Y-2 reduces oxidative stress and inflammation and improves neurological function of collagenase-induced intracerebral hemorrhage rats,https://pubmed.ncbi.nlm.nih.gov/34536364/,Positive,,Animal Study,2021,,Nervous System,Inflammation; Oxidative Stress; Stroke
2021403,A Functionalized Octahedral Palladium Nanozyme as a Radical Scavenger for Ameliorating Alzheimer's Disease,https://pubmed.ncbi.nlm.nih.gov/34641674/,Positive,,Animal Study,2021,,,Alzheimer's Disease; Oxidative Stress
2021404,Evaluation of the analgesic potential and safety of Cinnamomum camphora chvar. Borneol essential oil,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810075/,Positive,,Animal Study,2021,,,Pain; Pain - Acute
2022960,Borneol enhances the protective effect against cerebral ischemia/reperfusion injury by promoting the access of astragaloside IV and the components of Panax notoginseng saponins into the brain,https://pubmed.ncbi.nlm.nih.gov/34763313/,Positive,,Animal Study,2022,,Cardiovascular System,Cardiovascular Diseases (CVD); Reperfusion Injury; Stroke
2022961,Neuroprotective effects of synthetic borneol and natural borneol based on the neurovascular unit against cerebral ischaemic injury,https://pubmed.ncbi.nlm.nih.gov/34888686/,Positive,,Laboratory Study,2022,,,Stroke
2021405,Recent Progress on the Synergistic Antitumor Effect of a Borneol-Modified Nanocarrier Drug Delivery System,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655685/,Positive,,Meta-analysis,2021,,,Cancer
2022962,"A Novel Compound, Tanshinol Borneol Ester, Ameliorates Pressure Overload-Induced Cardiac Hypertrophy by Inhibiting Oxidative Stress via the mTOR/β-TrCP/NRF2 Pathway",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850779/,Positive,,Animal Study,2022,,Cardiovascular System,Cardiovascular Diseases (CVD); Oxidative Stress
2022963,Borneol reduces sympathetic vasomotor hyperactivity and restores depressed baroreflex sensitivity in rats with renovascular hypertension,https://pubmed.ncbi.nlm.nih.gov/35194168/,Positive,,Animal Study,2022,,Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2022964,Borneol and Tetrandrine Modulate the Blood-Brain Barrier and Blood-Tumor Barrier to Improve the Therapeutic Efficacy of 5-Fluorouracil in Brain Metastasis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855435/,Positive,,Animal Study,2022,,,Cancer - Brain; Cancer
2021406,Cannabidiol‐mediated RISK PI3K/AKT and MAPK/ERK pathways decreasing reperfusion myocardial damage,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236079/,Positive,,Animal Study,2021,,Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack
2021407,Cannabidiol Selectively Binds to the Voltage-Gated Sodium Channel Nav1.4 in Its Slow-Inactivated State and Inhibits Sodium Current,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465134/,Positive,,Laboratory Study,2021,,Muscular System,Muscular Dystrophy & Myotonic Disorders
2021408,(+)-trans-Cannabidiol-2-hydroxy pentyl is a dual CB 1 R antagonist/CB 2 R agonist that prevents diabetic nephropathy in mice,https://pubmed.ncbi.nlm.nih.gov/34019978/,Positive,,Animal Study,2021,,Endocrine System; Urinary System,Diabetes; Diabetic Kidney Disease; Kidney Failure; Metabolic Syndrome; Pain; Pain - Neuropathy - Diabetic
2021409,"""Light cannabis"" consumption in a sample of young adults: Preliminary pharmacokinetic data and psychomotor impairment evaluation",https://pubmed.ncbi.nlm.nih.gov/33971503/,Positive,,Clinical Trial,2021,,,Cognitive Dysfunction
2021410,"A pilot safety, tolerability and pharmacokinetic study of an oro-buccal administered cannabidiol-dominant anti-inflammatory formulation in healthy individuals: a randomized placebo-controlled single-blinded study",https://pubmed.ncbi.nlm.nih.gov/34357480/,Inconclusive,,Clinical Trial,2021,,Nervous System,Inflammation
2021411,Possible actions of cannabidiol in obsessive-compulsive disorder by targeting the WNT/β-catenin pathway,https://www.nature.com/articles/s41380-021-01086-1,Positive,,Meta-analysis,2021,,Mental/Emotional System,OCD; Inflammation; Oxidative Stress
2021412,"A clinician survey of use assessment, documentation, and education about cannabis in persons with cystic fibrosis",https://pubmed.ncbi.nlm.nih.gov/34232573/,Inconclusive,,Meta-analysis,2021,,Respiratory System,Fibrosis - Lung; Fibrosis
2021413,Efficacy and safety of paediatric medicinal cannabis use: A scoping review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194766/,Negative,,Meta-analysis,2021,Pharma CBD; Pharma THC,,Behavioral Disorders; Cancer - Cervical; Cancer; Cerebral Palsy; Epidermolysis bullosa; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Pain; Traumatic Brain Injury
2022965,Cannabidiol reverses memory impairments and activates components of the Akt/GSK3β pathway in an experimental model of estrogen depletion,https://www.sciencedirect.com/science/article/abs/pii/S0166432821004435?via%3Dihub,Positive,,Animal Study,2022,,Reproductive System,Cognitive Dysfunction; Menopause; Alzheimer's Disease
2021414,The Effectiveness of Cannabis and Cannabis Derivatives in Treating Lower Back Pain in the Aged Population: A Systematic Review,https://pubmed.ncbi.nlm.nih.gov/34515130/,Inconclusive,,Meta-analysis,2021,Pharma CBD; Pharma THC,Muscular System; Nervous System; Skeletal System,Geriatric Conditions; Pain; Pain - Chronic; Anxiety; Insomnia and Sleep Disorders; Pain - Acute
2021415,Cannabidiol-dihydroartemisinin conjugates for ameliorating neuroinflammation with reduced cytotoxicity,https://pubmed.ncbi.nlm.nih.gov/33852975/,Positive,,Laboratory Study,2021,,,Inflammation
2021416,Endocannabinoid System as Therapeutic Target of PTSD: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000573/,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Pharma THC,Mental/Emotional System; Nervous System,PTSD
2021417,Cannabidiol Effectively Promoted Cell Death in Bladder Cancer and the Improved Intravesical Adhesion Drugs Delivery Strategy Could Be Better Used for Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471856/,Positive,,Laboratory Study,2021,,Nervous System,Cancer
2021418,The electrophysiological effects of cannabidiol on action potentials and transmembrane potassium currents in rabbit and dog cardiac ventricular preparations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241752/,Negative,,Laboratory Study,2021,,Cardiovascular System,Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Heart Attack
2021419,"Modification of the hemodynamic and molecular features of phosphine, a potent mitochondrial toxicant in the heart, by cannabidiol",https://pubmed.ncbi.nlm.nih.gov/34711111/,Positive,,Animal Study,2021,,Cardiovascular System; Nervous System,Cardiovascular Diseases (CVD); Heart Attack; Oxidative Stress
2021420,Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876066/,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Cannabidiolic Acid (CBD-a); Cannabinol (CBN); Synthetic Cannabinoid (unspecified),Nervous System,Inflammation; COVID-19
2019114,Human lung epithelial cells cultured in the presence of radon-emitting rock experience gene expression changes similar to those associated with tobacco smoke exposure,https://pubmed.ncbi.nlm.nih.gov/30396064/,Inconclusive,,Laboratory Study,2019,,,Radiation sickness
2017083,The Fatty Acid Amide Hydrolase Inhibitor URB937 Ameliorates Radiation-Induced Lung Injury in a Mouse Model,https://pubmed.ncbi.nlm.nih.gov/28478515/,Positive,,Animal Study,2017,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),,Radiation sickness
2007027,Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1949344/,Positive,,Animal Study,2007,CP-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids; Delta-8-THC; Tetrahydrocannabinol (THC),Digestive System,Nausea and Vomiting; Radiation sickness
1984004,An initial evaluation of Nabilone in the control of radiotherapy-induced nausea and vomiting,https://pubmed.ncbi.nlm.nih.gov/6329586/,Positive,,Clinical Trial,1984,Pharma THC,,Radiation sickness
2021421,Prosocial Effects of Nonpsychotropic Cannabis sativa in Mice,https://pubmed.ncbi.nlm.nih.gov/34370607/,Positive,,Animal Study,2021,,,Behavioral Disorders; Anxiety
2021422,Case Report: CBD Cigarettes for Harm Reduction and Adjunctive Therapy in a Patient With Schizophrenia and Substance Use Disorder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339295/,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction - Cocaine; Addiction; Schizophrenia; Addiction - Opioid
2021423,The effects of cannabidiol and analgesic expectancies on experimental pain reactivity in healthy adults: A balanced placebo design trial,https://pubmed.ncbi.nlm.nih.gov/34251840/,Positive,,Clinical Trial,2021,,Nervous System,Pain
2021424,Medium-throughput zebrafish optogenetic platform identifies deficits in subsequent neural activity following brief early exposure to cannabidiol and Δ9-tetrahydrocannabinol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169761/,Negative,,Animal Study,2021,,Nervous System,Neonatal Cerebral Issues
2021425,Cannabidiol inhibits SARS-Cov-2 spike (S) protein-induced cytotoxicity and inflammation through a PPARγ-dependent TLR4/NLRP3/Caspase-1 signaling suppression in Caco-2 cell line,https://onlinelibrary.wiley.com/doi/10.1002/ptr.7302,Positive,,Laboratory Study,2021,,Respiratory System,COVID-19
2021426,Cannabidiol Confers Neuroprotection in Rats in a Model of Transient Global Cerebral Ischemia: Impact of Hippocampal Synaptic Neuroplasticity,https://pubmed.ncbi.nlm.nih.gov/34302281/,Positive,,Animal Study,2021,,,Stroke; Cognitive Dysfunction
2021427,"Cannabidiol Exposure During the Mouse Adolescent Period Is Without Harmful Behavioral Effects on Locomotor Activity, Anxiety, and Spatial Memory",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426900/,Positive,,Animal Study,2021,,Mental/Emotional System; Nervous System,Anxiety; Cognitive Dysfunction; Autism
2021428,Plasma and joint tissue pharmacokinetics of two doses of oral cannabidiol oil in guinea pigs (Cavia porcellus),https://pubmed.ncbi.nlm.nih.gov/34658021/,Inconclusive,,Animal Study,2021,,Skeletal System,Arthritis
2021429,Cannabidiol reduces lesion volume and restores vestibulomotor and cognitive function following moderately severe traumatic brain injury,https://www.sciencedirect.com/science/article/abs/pii/S0014488621002521?via%3Dihub,Positive,,Animal Study,2021,,,Traumatic Brain Injury; Inflammation
2021430,Protein Kinases Mediate Anti-Inflammatory Effects of Cannabidiol and Estradiol Against High Glucose in Cardiac Sodium Channels,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115126/,Positive,,Laboratory Study,2021,,,Inflammation; Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Diabetes; Oxidative Stress
2021431,Cannabidiol and Sertraline Regulate Behavioral and Brain Gene Expression Alterations in an Animal Model of PTSD,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273267/,Positive,,Animal Study,2021,,Mental/Emotional System,PTSD
2022966,Effects of Epidiolex® (Cannabidiol) on seizure-related emergency department visits and hospital admissions: A retrospective cohort study,https://pubmed.ncbi.nlm.nih.gov/35051868/,Positive,,Meta-analysis,2022,Pharma CBD,,Epilepsy
2022967,Examining the Use of Antidepressants for Adolescents with Depression/Anxiety Who Regularly Use Cannabis: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744706/,Inconclusive,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Anxiety; Depression
2022968,"Functional interactions between cannabinoids, omega-3 fatty acids, and peroxisome proliferator-activated receptors: Implications for mental health pharmacotherapies",https://pubmed.ncbi.nlm.nih.gov/33108021/,Inconclusive,,Meta-analysis,2022,,,Anxiety; Depression; Psychosis; Schizophrenia
2022969,Development and characterization of cannabidiol-loaded alginate copper hydrogel for repairing open bone defects in vitro,https://pubmed.ncbi.nlm.nih.gov/35114435/,Positive,,Laboratory Study,2022,,Immune System; Integumentary System; Nervous System; Skeletal System,Bone Fractures; Wound Healing
2022970,Cannabinoids for the treatment of cannabis use disorder: New avenues for reaching and helping youth?,https://pubmed.ncbi.nlm.nih.gov/34822876/,Positive,,Meta-analysis,2022,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System,Addiction - Cannabis; Addiction
2022971,Cannabidiol protects against Alzheimer's disease in C. elegans via ROS scavenging activity of its phenolic hydroxyl groups,https://pubmed.ncbi.nlm.nih.gov/35181336/,Positive,,Animal Study,2022,,Nervous System,Alzheimer's Disease
2022972,Cannabidiol inhibits methamphetamine-induced dopamine release via modulation of the DRD1-MeCP2-BDNF-TrkB signaling pathway,https://pubmed.ncbi.nlm.nih.gov/34997862/,Positive,,Laboratory Study,2022,,Mental/Emotional System; Nervous System,Addiction - Stimulant; Addiction
2022973,Cannabidiol Interferes with Establishment of Δ 9-Tetrahydrocannabinol-Induced Nausea Through a 5-HT 1A Mechanism,https://pubmed.ncbi.nlm.nih.gov/33998876/,Positive,,Animal Study,2022,,Digestive System; Mental/Emotional System,Cannabis Adverse Effects; Nausea and Vomiting; Chemotherapy-induced Nausea & Vomiting; Morning sickness; Motion Sickness
2022974,Antioxidant and anti-apoptotic effects of cannabidiol in model of ischemic stroke in rats,https://pubmed.ncbi.nlm.nih.gov/35031355/,Positive,,Animal Study,2022,,Nervous System,Oxidative Stress; Stroke
2022975,"Cannabidiol, a Regulator of Intracellular Calcium and Calpain",https://pubmed.ncbi.nlm.nih.gov/35196129/,Positive,,Meta-analysis,2022,,,Neurodegenerative Issues
2022976,Use of cannabidiol in the treatment of epilepsy,https://pubmed.ncbi.nlm.nih.gov/35211946/,Positive,,Meta-analysis,2022,,Nervous System,Epilepsy
2022977,GPR18-Mediated Relaxation of Human Isolated Pulmonary Arteries,https://pubmed.ncbi.nlm.nih.gov/35163351/,Positive,,Laboratory Study,2022,Synthetic Cannabinoid (unspecified),,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2022978,Cannabidiol Inhibits Multiple Ion Channels in Rabbit Ventricular Cardiomyocytes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850628/,Negative,,Animal Study,2022,,Cardiovascular System,Cardiovascular Diseases (CVD)
2022979,In vitro effects of cannabidiol and its main metabolites in mouse and human Sertoli cells,https://pubmed.ncbi.nlm.nih.gov/34871667/,Negative,,Laboratory Study,2022,,,Infertility (Male)
2022980,A scoping review on cannabidiol therapy in tuberous sclerosis: Current evidence and perspectives for future development,https://pubmed.ncbi.nlm.nih.gov/35151190/,Positive,,Meta-analysis,2022,,,Epilepsy
2022981,Case report: Medical cannabis-warfarin drug-drug interaction,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744571/,Inconclusive,,Meta-analysis,2022,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2022982,Cannabinoids for the Treatment of Dermatologic Conditions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841811/,Positive,,Meta-analysis,2022,Pharma THC,,Compulsive hair pulling; Epidermolysis bullosa; Inflammation; Systemic Sclerosis
2022983,Biochemical aspects and therapeutic mechanisms of cannabidiol in epilepsy,https://pubmed.ncbi.nlm.nih.gov/33031814/,Positive,,Meta-analysis,2022,,,Epilepsy; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Neurodegenerative Issues
2022984,"Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals",https://pubmed.ncbi.nlm.nih.gov/35093949/,Positive,,Meta-analysis,2022,Pharma THC:CBD; Pharma THC; Pharma CBD,,Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant; Anorexia; Epilepsy; Pain; Nausea and Vomiting; Neurodegenerative Issues; Pain - Chronic; PTSD
2022985,Cannabidiol and substance use disorder: Dream or reality,https://pubmed.ncbi.nlm.nih.gov/35032495/,Positive,,Meta-analysis,2022,,,Addiction - Cocaine; Addiction - Opioid; Addiction - Stimulant
2022986,Comparison of the Effectiveness and Tolerability of Nabiximols (THC:CBD) Oromucosal Spray versus Oral Dronabinol (THC) as Add-on Treatment for Severe Neuropathic Pain in Real-World Clinical Practice: Retrospective Analysis of the German Pain e-Registry,https://pubmed.ncbi.nlm.nih.gov/35140513/,Positive,,Meta-analysis,2022,Pharma THC:CBD; Pharma THC,,Pain; Pain - Chronic
2022987,Cannabidiol (CBD) treatment improves spatial memory in 14-month-old female TAU58/2 transgenic mice,https://pubmed.ncbi.nlm.nih.gov/35202719/,Positive,,Animal Study,2022,,,Alzheimer's Disease; Cognitive Dysfunction; Anxiety; Neurodegenerative Issues
2022988,Time to Onset of Cannabidiol (CBD) Treatment Effect and Resolution of Adverse Events in Tuberous Sclerosis Complex: Post Hoc Analysis of Randomized Controlled Phase 3 Trial GWPCARE6,https://pubmed.ncbi.nlm.nih.gov/35175622/,Inconclusive,,Meta-analysis,2022,,,Epilepsy
2022989,"Anti-inflammatory potential of cannabidiol (CBD) on combination of caecal slurry, LPS, and E. coli-induced systemic inflammatory response syndrome (SIRS) in Sprague Dawley Rats",https://pubmed.ncbi.nlm.nih.gov/34997430/,Positive,,Animal Study,2022,,,Inflammation
2022990,Cannabidiol (CBD) in Cancer Management,https://pubmed.ncbi.nlm.nih.gov/35205633/,Positive,,Meta-analysis,2022,,,Cancer
2022991,Evaluation of the Possible Anticonvulsant Effect of Δ 9-Tetrahydrocannabinolic Acid in Murine Seizure Models,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864425/,Inconclusive,,Animal Study,2022,Tetrahydrocannabinolic Acid (THC-a),Nervous System,Epilepsy
2021432,Exercise-induced euphoria and anxiolysis do not depend on endogenous opioids in humans,https://pubmed.ncbi.nlm.nih.gov/33582575/,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Mental/Emotional System,Anxiety
2021433,The role of fatty acid amide hydrolase enzyme inhibitors in Alzheimer's disease,https://pubmed.ncbi.nlm.nih.gov/34931308/,Positive,,Meta-analysis,2021,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),,Alzheimer's Disease
2021434,Cannabidiol Modulates Mitochondrial Redox and Dynamics in MCF7 Cancer Cells: A Study Using Fluorescence Lifetime Imaging Microscopy of NAD(P)H,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144465/,Inconclusive,,Laboratory Study,2021,,,Oxidative Stress; Cancer
2021435,"Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117353/,Positive,,Double Blind Clinical Trial,2021,Anandamide (AEA),Mental/Emotional System,Psychosis; Schizophrenia
2021436,Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study,https://pubmed.ncbi.nlm.nih.gov/34412109/,Positive,,Double Blind Clinical Trial,2021,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2021437,Effect of Cannabidiol on Interictal Epileptiform Activity and Sleep Architecture in Children with Intractable Epilepsy: A Prospective Open-Label Study,https://link.springer.com/article/10.1007/s40263-021-00867-0,Positive,,Clinical Trial,2021,Pharma CBD,Nervous System,Epilepsy; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut
2022992,"Pain response to cannabidiol in induced acute nociceptive pain, allodynia, and hyperalgesia by using a model mimicking acute pain in healthy adults in a randomized trial (CANAB I)",https://journals.lww.com/pain/Fulltext/2022/01000/Pain_response_to_cannabidiol_in_induced_acute.24.aspx,Inconclusive,,Double Blind Clinical Trial,2022,Pharma CBD,Nervous System,Pain; Pain - Acute
2021438,Novel cannabidiol aspartame combination treatment (JW-100) significantly reduces ISGA score in atopic dermatitis: Results from a randomized double-blinded placebo-controlled interventional study,https://pubmed.ncbi.nlm.nih.gov/34056830/,Positive,,Double Blind Clinical Trial,2021,,Integumentary System,Skin Diseases
2021439,"Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations",https://pubmed.ncbi.nlm.nih.gov/34652500/,Inconclusive,,Animal Study,2021,,Nervous System,Pain; Pain - Acute
2021440,Synergistic Interactions of Cannabidiol with Chemotherapeutic Drugs in MCF7 Cells: Mode of Interaction and Proteomics Analysis of Mechanisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469885/,Positive,,Laboratory Study,2021,,Nervous System; Reproductive System,Cancer - Breast; Cancer
2021441,Cannabidiol promotes neurogenesis in the dentate gyrus during an abstinence period in rats following chronic exposure to methamphetamine,https://pubmed.ncbi.nlm.nih.gov/34143376/,Positive,,Animal Study,2021,,Mental/Emotional System; Nervous System,Addiction - Stimulant; Addiction; MDMA Adverse Effects
2021442,CBD Alleviates Liver Injuries in Alcoholics With High-Fat High-Cholesterol Diet Through Regulating NLRP3 Inflammasome–Pyroptosis Pathway,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493333/,Positive,,Animal Study,2021,,Digestive System; Nervous System,Alcoholic Liver Disease; Inflammation; Liver Failure; Oxidative Stress; Addiction - Alcohol
2022993,Targeting the Endocannabinoid System in the Treatment of Posttraumatic Stress Disorder: A Promising Case of Preclinical-Clinical Translation?,https://pubmed.ncbi.nlm.nih.gov/34598785/,Positive,,Meta-analysis,2022,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System,PTSD
2021443,The role of endocannabinoid pathway in the neuropathology of Alzheimer's disease: Can the inhibitors of MAGL and FAAH prove to be potential therapeutic targets against the cognitive impairment associated with Alzheimer's disease?,https://pubmed.ncbi.nlm.nih.gov/34217798/,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Nervous System,Alzheimer's Disease
2021444,Early life stress and development of the endocannabinoid system: A bidirectional process in programming future coping,https://pubmed.ncbi.nlm.nih.gov/31849055/,Inconclusive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Mental/Emotional System; Reproductive System,Pregnancy
2021445,Cannabinoid Signaling in Auditory Function and Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165240/,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),,Hearing Loss; Tinnitus
2021446,Anticancer Potential of Small-Molecule Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase,https://pubmed.ncbi.nlm.nih.gov/33834617/,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Nervous System,Cancer; Cancer - Colon; Cancer - Breast; Cancer - Ovarian; Cancer - Prostate
2019115,Cannabinoids in Breast Cancer: Differential Susceptibility According to Subtype,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746990/,Positive,,Meta-analysis,2019,Endocannabinoid (unspecified),Nervous System; Reproductive System,Cancer - Breast; Cancer
2018109,An Analysis of Endocannabinoid Concentrations and Mood Following Singing and Exercise in Healthy Volunteers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275239/,Positive,,Meta-analysis,2018,Anandamide (AEA),,
2020258,Inner Engineering Practices and Advanced 4-day Isha Yoga Retreat Are Associated with Cannabimimetic Effects with Increased Endocannabinoids and Short-Term and Sustained Improvement in Mental Health: A Prospective Observational Study of Meditators,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293737/,Positive,,Meta-analysis,2020,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Exercise; Mind-Body Medicine,,Anxiety; Cognitive Dysfunction; Depression; Pain; PTSD
2021447,Quality of Life and a Surveillant Endocannabinoid System,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581450/,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified); Mind-Body Medicine,,Autism; Inflammation; Pain; Neurodegenerative Issues; Pain - Chronic
2021448,The endocannabinoid system in the amygdala and modulation of fear,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511205/,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified),Mental/Emotional System,PTSD; Behavioral Disorders; Anxiety; Cognitive Dysfunction
2021449,Endocannabinoid System in Pregnancy Maintenance and Labor: A Mini-Review,https://pubmed.ncbi.nlm.nih.gov/34220722/,Inconclusive,,Meta-analysis,2021,Endocannabinoid (unspecified),Reproductive System,Pregnancy
2021450,Endocannabinoid-mediated synaptic plasticity and substance use disorders,https://pubmed.ncbi.nlm.nih.gov/34538595/,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),,Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Nicotine; Addiction - Opioid
2021451,Endocannabinoid-serotonin systems interaction in health and disease,https://pubmed.ncbi.nlm.nih.gov/33541682/,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified),,Anxiety; Depression; Epilepsy; Psychosis
2021452,The cannabinoid system and microglia in health and disease,https://pubmed.ncbi.nlm.nih.gov/33845074/,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),,Alzheimer's Disease; Amyotrophic Lateral Sclerosis (ALS); Anxiety; Depression; Inflammation; Pain; Multiple Sclerosis; Neurodegenerative Issues; Pain - Chronic; Parkinson's Disease; Schizophrenia
2013061,Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525790/,Positive,,Animal Study,2013,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Nervous System,Pain; Pain - Neuropathy - Drug-Ind. Polyneuropathy; Pain - Neuropathy - Peripheral
2021453,A Role for Peripheral Anandamide and 2-Arachidonoylglycerol in Short-Term Food Intake and Orexigenic Hypothalamic Responses in a Species with Continuous Nutrient Delivery,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540326/,Positive,,Animal Study -,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),,Veterinary Applications; Anorexia; Cachexia; Metabolic Syndrome; Obesity
2021454,Endogenous anandamide and self-reported pain are significantly reduced after a 2-week multimodal treatment with and without radon therapy in patients with knee osteoarthritis: a pilot study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213596/,Inconclusive,,Clinical Trial,2021,Anandamide (AEA),Skeletal System,Arthritis - Osteoarthritis; Arthritis
2022994,Inhibition of anandamide hydrolysis does not rescue respiratory abnormalities observed in an animal model of Parkinson's disease,https://pubmed.ncbi.nlm.nih.gov/34907627/,Positive,,Animal Study,2022,Anandamide (AEA); Synthetic Cannabinoid (unspecified),Nervous System,Parkinson's Disease
2021455,Fear extinction learning and anandamide: an fMRI study in healthy humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961038/,Positive,,Meta-analysis,2021,Anandamide (AEA),,Anxiety; PTSD
2021456,The major endocannabinoid anandamide (AEA) induces apoptosis of human granulosa cells,https://pubmed.ncbi.nlm.nih.gov/34126378/,Positive,,Laboratory Study,2021,Anandamide (AEA),Reproductive System,Infertility (Female)
2021457,Protective effects of anandamide against cisplatin-induced peripheral neuropathy in rats,https://pubmed.ncbi.nlm.nih.gov/34118805/,Positive,,Animal Study,2021,Anandamide (AEA),Nervous System,Pain; Pain - Neuropathy - Drug-Ind. Polyneuropathy; Pain - Neuropathy - Peripheral
2021458,Serum anandamide level as a potential indicator for nonalcoholic fatty liver disease severity,https://pubmed.ncbi.nlm.nih.gov/33731590/,Inconclusive,,Meta-analysis,2021,Anandamide (AEA),Digestive System,Fatty Liver Disease
2021459,Anandamide Exerts a Differential Effect on Human Placenta Before and After the Onset of Labor,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176211/,Inconclusive,,Laboratory Study,2021,Anandamide (AEA),Reproductive System,Pregnancy
2011067,Anandamide capacitates bull spermatozoa through CB1 and TRPV1 activation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037938/,Positive,,Laboratory Study -,2011,Anandamide (AEA),,Veterinary Applications; Infertility (Male)
2022995,"Protective actions of vitamin D, anandamide and melatonin during vascular inflammation: Epigenetic mechanisms involved",https://pubmed.ncbi.nlm.nih.gov/34856208/,Positive,,Meta-analysis,2022,Anandamide (AEA),Nervous System,Inflammation; Atherosclerosis; Cardiovascular Diseases (CVD)
2021460,"The rise and fall of anandamide: processes that control synthesis, degradation, and storage",https://pubmed.ncbi.nlm.nih.gov/33713246/,Positive,,Meta-analysis,2021,Anandamide (AEA),,
2021461,Neuroprotective Effects of Cannabidiol but Not Δ9-Tetrahydrocannabinol in Rat Hippocampal Slices Exposed to Oxygen-Glucose Deprivation: Studies with Cannabis Extracts and Selected Cannabinoids,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468213/,Inconclusive,,Laboratory Study,2021,Cannabidiolic Acid (CBD-a); Cannabinol (CBN); Delta-8-THC; Tetrahydrocannabinolic Acid (THC-a),Nervous System,Neurodegenerative Issues; Stroke; Inflammation
2021462,Computational Approach Reveals Pronociceptive Potential of Cannabidiol in Osteoarthritis: Role of Transient Receptor Potential Channels,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541018/,Positive,,Animal Study,2021,Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH),Skeletal System,Arthritis; Inflammation
2021463,Cannabidiol - A phytocannabinoid that widely affects sphingolipid metabolism under conditions of brain insulin resistance,https://www.sciencedirect.com/science/article/pii/S0753332221008404?via%3Dihub,Positive,,Animal Study,2021,,Endocrine System,Metabolic Syndrome; Alzheimer's Disease; Diabetes; Neurodegenerative Issues; Obesity
2021464,Cannabidiol prevents lipopolysaccharide-induced sickness behavior and alters cytokine and neurotrophic factor levels in the brain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254454/,Positive,,Animal Study,2021,,,Depression; Inflammation; Neurodegenerative Issues
2021465,Cannabidiol Induces Autophagy to Protects Neural Cells From Mitochondrial Dysfunction by Upregulating SIRT1 to Inhibits NF-κB and NOTCH Pathways,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042325/,Positive,,Laboratory Study,2021,,Nervous System,Parkinson's Disease
2021466,The Differential Effect of Cannabidiol on the Composition and Physicochemical Properties of Keratinocyte and Fibroblast Membranes from Psoriatic Patients and Healthy People,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913938/,Positive,,Laboratory Study,2021,,Integumentary System; Nervous System,Inflammation; Oxidative Stress; Psoriasis
2021467,Cannabidiol-Driven Alterations to Inflammatory Protein Landscape of Lipopolysaccharide-Activated Macrophages In Vitro May Be Mediated by Autophagy and Oxidative Stress,https://www.liebertpub.com/doi/10.1089/can.2020.0109,Positive,,Laboratory Study,2021,,Nervous System,Inflammation; Oxidative Stress
2021468,Juvenile cannabidiol chronic treatments produce robust changes in metabolic markers in adult male Wistar rats,https://pubmed.ncbi.nlm.nih.gov/34478689/,Inconclusive,,Animal Study,2021,,Endocrine System,Metabolic Syndrome; Cardiovascular Diseases (CVD); Diabetes; Stroke
2021469,"Seizure frequency, quality of life, behavior, cognition, and sleep in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol",https://pubmed.ncbi.nlm.nih.gov/34560358/,Positive,,Clinical Trial,2021,Pharma CBD,Mental/Emotional System; Nervous System,Behavioral Disorders; Epilepsy; Insomnia and Sleep Disorders
2021470,Cannabidiol Isolated From Cannabis sativa L. Protects Intestinal Barrier From In Vitro Inflammation and Oxidative Stress,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115937/,Positive,,Laboratory Study,2021,Cannabidiolic Acid (CBD-a); Tetrahydrocannabinolic Acid (THC-a),Digestive System; Nervous System,IBD - Inflammatory Bowel Disease; Inflammation; Oxidative Stress
2021471,"Cannabidiol effectively reverses mechanical and thermal allodynia, hyperalgesia, and anxious behaviors in a neuropathic pain model: Possible role of CB1 and TRPV1 receptors",https://www.sciencedirect.com/science/article/abs/pii/S0028390821002677?via%3Dihub#preview-section-snippets,Positive,,Animal Study,2021,,Mental/Emotional System; Nervous System,Anxiety; Pain - Acute; Pain - Chronic; Pain - Neuropathy - Peripheral; Pain
2021472,Oxidative Stress and Its Consequences in the Blood of Rats Irradiated with UV: Protective Effect of Cannabidiol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224002/,Positive,,Animal Study,2021,,Nervous System,Inflammation; Oxidative Stress; Allergic Contact Dermatitis; Cancer - Melanoma; Cancer - Skin (Non-melanoma); Cancer; Psoriasis
2021473,Protective effects of cannabidiol on the membrane proteins of skin keratinocytes exposed to hydrogen peroxide via participation in the proteostasis network,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321952/,Positive,,Laboratory Study,2021,,,Inflammation; Oxidative Stress
2021474,The Monoacylglycerol Lipase Inhibitor JZL184 Inhibits Lung Cancer Cell Invasion and Metastasis via the CB 1 Cannabinoid Receptor,https://pubmed.ncbi.nlm.nih.gov/33632876/,Positive,,Animal Study,2021,2-Arachidonoyl Glycerol (2-AG); Monoacylglycerol Lipase (MAGL),Nervous System; Respiratory System,Cancer - Lung; Cancer
2021475,Plasmatic endocannabinoids are decreased in subjects with ultra-high risk of psychosis,https://pubmed.ncbi.nlm.nih.gov/34716624/,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Mental/Emotional System,Psychosis; Schizophrenia
2021476,Hair endocannabinoid concentrations in individuals with acute and weight-recovered anorexia nervosa,https://www.sciencedirect.com/science/article/abs/pii/S0278584621000026?via%3Dihub,Positive,,Meta-analysis,2021,Anandamide (AEA); 2-Arachidonoyl Glycerol (2-AG),Mental/Emotional System,Anorexia Nervosa; Anorexia
2020259,Diacylglycerol lipase alpha in astrocytes is involved in maternal care and affective behaviors,https://onlinelibrary.wiley.com/doi/10.1002/glia.23903,Inconclusive,,Animal Study,2020,2-Arachidonoyl Glycerol (2-AG); Monoacylglycerol Lipase (MAGL),Mental/Emotional System; Nervous System; Reproductive System,Depression; Pregnancy
2021477,Protective role of endocannabinoid signaling in an animal model of haloperidol-induced tardive dyskinesia,https://pubmed.ncbi.nlm.nih.gov/33933537/,Positive,,Animal Study,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),,Chorea; Dystonia
2021478,New Insights in the Involvement of the Endocannabinoid System and Natural Cannabinoids in Nicotine Dependence,https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8715672/,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Mental/Emotional System,Addiction - Nicotine; Addiction
2021479,Circulating endocannabinoids and prospective risk for depression in trauma-injury survivors,https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7876629/,Inconclusive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Mental/Emotional System,Depression
2021480,Targeting the endocannabinoid system with microbial interventions to improve gut integrity,https://pubmed.ncbi.nlm.nih.gov/33186639/,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified); Microbiome,,Depression; IBD - Inflammatory Bowel Disease; Obesity
2021481,Targeting diacylglycerol lipase reduces alcohol consumption in preclinical models,https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8409586/,Positive,,Animal Study,2021,2-Arachidonoyl Glycerol (2-AG); Monoacylglycerol Lipase (MAGL),Mental/Emotional System,Addiction - Alcohol; Addiction
2021482,Circulating Endocannabinoids as Diagnostic Markers of Canine Chronic Enteropathies: A Pilot Study,https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8187750/,Inconclusive,,Animal Study -,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),,Veterinary Applications
2021483,Endocannabinoid markers in autism spectrum disorder: A scoping review of human studies,https://pubmed.ncbi.nlm.nih.gov/34775294/,Inconclusive,,Clinical Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Mental/Emotional System,Autism
2021484,Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox,https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8293381/,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified),Urinary System,Chronic Kidney Disease
2022996,Enhancing endocannabinoid signalling in astrocytes promotes recovery from traumatic brain injury,https://pubmed.ncbi.nlm.nih.gov/35136958/,Positive,,Animal Study,2022,2-Arachidonoyl Glycerol (2-AG); Monoacylglycerol Lipase (MAGL),Nervous System,Traumatic Brain Injury; Alzheimer's Disease; Dementia
2021485,The Endocannabinoid System as Modulator of Exercise Benefits in Mental Health,https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8719298/,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Exercise; Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),,Depression
2021486,Neurobiological Processes Induced by Aerobic Exercise through the Endocannabinoidome,https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8072750/,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),,Anxiety; Depression; Inflammation; Neurodegenerative Issues; Oxidative Stress
2021487,The role of endocannabinoids in pregnancy,https://pubmed.ncbi.nlm.nih.gov/34736335/,Inconclusive,,Meta-analysis,2021,Synthetic Cannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Reproductive System,Pregnancy
2021488,Endocannabinoid Metabolism and Traumatic Brain Injury,https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8616221/,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Monoacylglycerol Lipase (MAGL),,Traumatic Brain Injury; Alzheimer's Disease
2021489,"Human laryngeal squamous cell carcinoma cell line release of endogenous anandamide and 2-arachidonoylglycerol, and their antiproliferative effect via exogenous supplementation: an in vitro study",https://pubmed.ncbi.nlm.nih.gov/33797678/,Positive,,Laboratory Study,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Digestive System; Nervous System,Cancer - Oral; Cancer
2021490,Inhibition of 2-Arachidonoylglycerol Metabolism Alleviates Neuropathology and Improves Cognitive Function in a Tau Mouse Model of Alzheimer's Disease,https://pubmed.ncbi.nlm.nih.gov/33939165/,Positive,,Animal Study,2021,Monoacylglycerol Lipase (MAGL),Nervous System,Alzheimer's Disease
2021491,Anti-aversive effect of 2-arachidonoylglycerol in the dorsolateral periaqueductal gray of male rats in contextual fear conditioning and Vogel tests,https://pubmed.ncbi.nlm.nih.gov/34074811/,Positive,,Animal Study,2021,2-Arachidonoyl Glycerol (2-AG),,Behavioral Disorders; Anxiety; PTSD
2021492,The endocannabinoid 2-arachidonoylglycerol and dual ABHD6/MAGL enzyme inhibitors display neuroprotective and anti-inflammatory actions in the in vivo retinal model of AMPA excitotoxicity,https://pubmed.ncbi.nlm.nih.gov/33450278/,Positive,,Animal Study,2021,2-Arachidonoyl Glycerol (2-AG),Nervous System,Retinal Disorders; Inflammation
2021493,Modulatory effect of 2-arachidonoylglycerol on voltage-gated sodium currents in rat caudate nucleus neurons with kainic acid-induced injury,https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8527220/,Positive,,Animal Study,2021,2-Arachidonoyl Glycerol (2-AG),Nervous System,Excitotoxicity
2021494,Inverse correlation between plasma 2-arachidonoylglycerol levels and subjective severity of depression,https://pubmed.ncbi.nlm.nih.gov/33559925/,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG),Mental/Emotional System; Nervous System,Depression
2021495,The endocannabinoid 2-arachidonoylglycerol inhibits endothelial function and repair,https://pubmed.ncbi.nlm.nih.gov/32810540/,Negative,,Animal Study,2021,2-Arachidonoyl Glycerol (2-AG),,Atherosclerosis; Cardiovascular Diseases (CVD)
2021496,Targeting 2-arachidonoylglycerol signalling in the neurobiology and treatment of depression,https://pubmed.ncbi.nlm.nih.gov/33905617/,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Monoacylglycerol Lipase (MAGL),Mental/Emotional System; Nervous System,Depression
2015093,Distinct roles of the endocannabinoids anandamide and 2-arachidonoylglycerol in social behavior and emotionality at different developmental ages in rats,https://pubmed.ncbi.nlm.nih.gov/25914159/,Inconclusive,,Animal Study,2015,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),,Anxiety; Depression
2022997,The Relationship Between Plasma Tetrahydrocannabinol Levels and Intraocular Pressure in Healthy Adult Subjects,https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8801518/,Positive,,Clinical Trial,2022,,,Glaucoma
2022998,Marijuana Use Associated with Decreased Mortality in Trauma Patients,https://pubmed.ncbi.nlm.nih.gov/35114802/,Positive,,Meta-analysis,2022,,Immune System; Integumentary System; Nervous System,Wound Healing
2021497,Novel cannabidiol−carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease,https://pubmed.ncbi.nlm.nih.gov/34371367/,Positive,,Meta-analysis,2021,,Nervous System,Alzheimer's Disease
2021498,"A Research Domain Criteria Approach to Gambling Disorder and Behavioral Addictions: Decision-Making, Response Inhibition, and the Role of Cannabidiol",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484302/,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Behavioral Disorders; ADD and ADHD; Addiction - Alcohol; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid
2021499,Evaluating cannabidiol (CBD) expectancy effects on acute stress and anxiety in healthy adults: a randomized crossover study,https://link.springer.com/article/10.1007/s00213-021-05823-w,Inconclusive,,Clinical Trial,2021,,Mental/Emotional System,Anxiety
2021500,Potential therapeutic uses of cannabinoids to treat behavioural problems in children and adolescents with developmental disorders,https://www1.racgp.org.au/ajgp/2021/june/uses-of-cannabinoids-to-treat-behavioural-problems,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Behavioral Disorders; ADD and ADHD; Anxiety; Autism; Cannabis Adverse Effects; Cerebral Palsy; Cognitive Dysfunction; Depression; Down Syndrome; Epilepsy; Fragile X Syndrome; Intermittent Explosive Disorder
2021501,Cannabidiol-induced activation of the metallothionein pathway impedes anticancer effects of disulfiram and its metabolite CuET,https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.13114,Negative,,Laboratory Study,2021,,,Cancer
2021502,Combined Antiseizure Efficacy of Cannabidiol and Clonazepam in a Conditional Mouse Model of Dravet Syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301289/,Positive,,Animal Study,2021,,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy
2021503,Cannabidiol Inhibition of Murine Primary Nociceptors: Tight Binding to Slow Inactivated States of Nav1.8 Channels,https://www.jneurosci.org/content/41/30/6371,Positive,,Animal Study,2021,,Nervous System,Pain - Nociceptive; Pain; Pain - Acute
2021504,Cannabidiol modifies the seizure expression and effects of antiseizure drugs in a rat model of recurrent severe seizures,https://pubmed.ncbi.nlm.nih.gov/33879386/,Positive,,Animal Study,2021,,,Epilepsy
2020260,Evaluation of the Inhibitory Activities of COVID‐19 of Melaleuca cajuputi Oil Using Docking Simulation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300966/,Positive,,Laboratory Study,2020,,Respiratory System,COVID-19
2020261,"Geranium and Lemon Essential Oils and Their Active Compounds Downregulate Angiotensin-Converting Enzyme 2 (ACE2), a SARS-CoV-2 Spike Receptor-Binding Domain, in Epithelial Cells",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355681/,Positive,,Laboratory Study,2020,,Respiratory System,COVID-19
2021505,"Less COVID-19 deaths in southern and insular Italy explained by forest bathing, Mediterranean environment, and antiviral plant volatile organic compounds",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408569/,Positive,,Meta-analysis,2021,,Respiratory System,COVID-19
2021506,In silico identification of compounds from Nigella sativa seed oil as potential inhibitors of SARS-CoV-2 targets,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952832/,Positive,,Laboratory Study,2021,,Respiratory System,COVID-19
2022999,Cannabinol inhibits oxytosis/ferroptosis by directly targeting mitochondria independently of cannabinoid receptors,https://pubmed.ncbi.nlm.nih.gov/34999187/,Positive,,Laboratory Study,2022,Cannabinol (CBN),Nervous System,Neurodegenerative Issues; Oxidative Stress
2021507,Cannabis Exposure Decreases Need for Blood Pressure Support During General Anesthesia in Orthopedic Trauma Surgery,https://www.liebertpub.com/doi/10.1089/can.2021.0009,Positive,,Meta-analysis,2021,,,Wound Healing
2020262,Letter to the Editor: Possible Drug–Drug Interactions Between Cannabinoids and Candidate COVID-19 Drugs,https://www.liebertpub.com/doi/10.1089/can.2020.0054,Inconclusive,,Meta-analysis,2020,,Respiratory System,COVID-19
2021508,Cannabidiol-enriched medical cannabis as add-on therapy in children with treatment-resistant West syndrome: A study of eight patients,https://pubmed.ncbi.nlm.nih.gov/34624613/,Positive,,Clinical Trial,2021,,Nervous System,Epilepsy
2021509,Cannabidiol loaded extracellular vesicles sensitize triple-negative breast cancer to doxorubicin in both in-vitro and in vivo models,https://pubmed.ncbi.nlm.nih.gov/34324983/,Positive,,Laboratory Study,2021,,Reproductive System,Cancer - Breast; Cancer; Inflammation
20221000,Candidate Psychotropics against SARS - CoV - 2: A Narrative Review,https://pubmed.ncbi.nlm.nih.gov/34399430/,Positive,,Meta-analysis,2022,,Respiratory System,COVID-19
20221001,Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses,https://www.science.org/doi/10.1126/sciadv.abi6110,Positive,,Animal Study,2022,,Respiratory System,COVID-19
2021510,A secondary approach with conventional medicines and supplements to recuperate current COVID-19 status,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313489/,Positive,,Meta-analysis,2021,,Respiratory System,COVID-19
2021511,Unsubstantiated health claims for COVID-19 infections are led by cannabidiol: return of snake oil medicine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651501/,Inconclusive,,Meta-analysis,2021,,Respiratory System,COVID-19
2021512,"Structurally modified compounds of hydroxychloroquine, remdesivir and tetrahydrocannabinol against main protease of SARS-CoV-2, a possible hope for COVID-19: Docking and molecular dynamics simulation studies",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051003/,Positive,,Laboratory Study,2021,,Respiratory System,COVID-19
2021513,"Targeting of Protein's Messenger RNA for Viral Replication, Assembly and Release in SARS-CoV-2 Using Whole Genomic Data From South Africa: Therapeutic Potentials of Cannabis Sativa L",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448283/,Positive,,Laboratory Study,2021,,Respiratory System,COVID-19
2021514,A potential role for cannabichromene in modulating TRP channels during acute respiratory distress syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485768/,Positive,,Animal Study,2021,Cannabichromene (CBC),Respiratory System,Acute Respiratory Distress Syndrome; COVID-19; Stress
2021515,Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome through Modulation of Microbiome in the Gut-Lung Axis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699344/,Positive,,Animal Study,2021,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Microbiome,Digestive System; Respiratory System,Acute Respiratory Distress Syndrome; Microbiome Imbalance; Stress; COVID-19
2021516,"WIN 55,212-2 shows anti-inflammatory and survival properties in human iPSC-derived cardiomyocytes infected with SARS-CoV-2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504461/,Positive,,Laboratory Study,2021,WIN-x Synthetic Cannabinoids,Respiratory System,COVID-19
2021517,Mechanism deconvolution of Qing Fei Pai Du decoction for treatment of Coronavirus Disease 2019 (COVID-19) by label-free integrative pharmacology assays,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329432/,Positive,,Laboratory Study,2021,,Respiratory System,COVID-19
2021518,Cannabidiol Inhibits In Vitro Human Liver Microsomal Metabolism of Remdesivir: A Promising Adjuvant for COVID-19 Treatment,https://pubmed.ncbi.nlm.nih.gov/34918945/,Positive,,Laboratory Study,2021,,Respiratory System,COVID-19
2021519,Cannabinoids for SARS-CoV-2 and is there evidence of their therapeutic efficacy?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573844/,Positive,,Meta-analysis,2021,,Respiratory System,COVID-19
20221002,A narrative review of molecular mechanism and therapeutic effect of Cannabidiol (CBD),https://pubmed.ncbi.nlm.nih.gov/35083862/,Positive,,Meta-analysis,2022,,,Anxiety; Cancer; COVID-19; Epilepsy; Inflammation; Pain; Neurodegenerative Issues; Pain - Chronic; Psychosis
2021520,Antimicrobial and Antiviral (SARS-CoV-2) Potential of Cannabinoids and Cannabis sativa: A Comprehensive Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658882/,Positive,,Meta-analysis,2021,,Respiratory System,COVID-19
2021521,The potential of cannabinoids and inhibitors of endocannabinoid degradation in respiratory diseases,https://pubmed.ncbi.nlm.nih.gov/34648805/,Positive,,Meta-analysis,2021,,Respiratory System,COVID-19; Cancer - Lung; Cancer; COPD; Fibrosis - Lung; Fibrosis
2021522,In quest of a new therapeutic approach in COVID-19: the endocannabinoid system,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989954/,Positive,,Meta-analysis,2021,,Respiratory System,COVID-19
20221003,Medical Cannabis Use Reduces Opioid Prescriptions in Patients With Chronic Back Pain,https://www.cureus.com/articles/82949-medical-cannabis-use-reduces-opioid-prescriptions-in-patients-with-chronic-back-pain,Positive,,Meta-analysis,2022,,,Pain; Pain - Chronic
2021523,Epidemiology of cannabidiol related cases reported in the National Poison Data System - 2019-2020,https://pubmed.ncbi.nlm.nih.gov/33975134/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2021524,Cannabidiol efficiently suppressed the acquisition and expression of methamphetamine-induced conditioned place preference in the rat,https://www.sciencedirect.com/science/article/abs/pii/S0166432821000450?via%3Dihub,Positive,,Animal Study,2021,,,Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Opioid; MDMA Adverse Effects
2021525,"Differential contribution of CB1, CB2, 5-HT1A, and PPAR-γ receptors to cannabidiol effects on ischemia-induced emotional and cognitive impairments",https://onlinelibrary.wiley.com/doi/10.1111/ejn.15134,Positive,,Animal Study,2021,,Nervous System,Cognitive Dysfunction; Stroke; Anxiety
2021526,Cannabidiol (CBD) Alters the Functionality of Neutrophils (PMN). Implications in the Refractory Epilepsy Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001508/,Negative,,Laboratory Study,2021,,Nervous System,Epilepsy; Inflammation; Oxidative Stress
2021527,Cannabidiol Attenuates MK-801-Induced Cognitive Symptoms of Schizophrenia in the Passive Avoidance Test in Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513030/,Positive,,Animal Study,2021,,Mental/Emotional System; Nervous System,Cognitive Dysfunction; Psychosis; Schizophrenia
2021528,Transcriptomic Changes and the Roles of Cannabinoid Receptors and PPARγ in Developmental Toxicities Following Exposure to Δ9-Tetrahydrocannabinol and Cannabidiol,https://pubmed.ncbi.nlm.nih.gov/33892503/,Negative,,Animal Study,2021,,Nervous System; Reproductive System,Neonatal Cerebral Issues; Pregnancy
2021529,"1,8-cineole ameliorates ischaemic brain damage via TRPC6/CREB pathways in rats",https://pubmed.ncbi.nlm.nih.gov/33877307/,Positive,,Animal Study,2021,,Nervous System,Stroke
2021530,Essential oils as an effective alternative for the treatment of COVID-19: Molecular interaction analysis of protease (Mpro) with pharmacokinetics and toxicological properties,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874929/,Positive,,Laboratory Study,2021,,Respiratory System,COVID-19
2021531,Appropriate use of essential oils and their components in the management of upper respiratory tract symptoms in patients with COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997686/,Positive,,Meta-analysis,2021,,Respiratory System,COVID-19
2021532,Mechanistic insights into Candida biofilm eradication potential of eucalyptol,https://pubmed.ncbi.nlm.nih.gov/33226719/,Positive,,Laboratory Study,2021,,Digestive System; Immune System; Integumentary System,Fungal Infections
2021533,Preventive Effect of Eucalyptol on the Formation of Aorta Lesions in the Diabetic-Atherosclerotic Rat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223915/,Positive,,Animal Study,2021,,Cardiovascular System,Atherosclerosis; Cardiovascular Diseases (CVD); Inflammation; Oxidative Stress
2021534,Eucalyptol ameliorates early brain injury after subarachnoid haemorrhage via antioxidant and anti-inflammatory effects in a rat model,https://pubmed.ncbi.nlm.nih.gov/33550883/,Positive,,Animal Study,2021,,Nervous System,Inflammation; Oxidative Stress; Stroke
2021535,Can Eucalyptol Replace Antibiotics?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398027/,Positive,,Meta-analysis,2021,,Immune System,Bacterial Infections
2021536,Lavender and coriander essential oils and their main component linalool exert a protective effect against amyloid-β neurotoxicity,https://pubmed.ncbi.nlm.nih.gov/32785956/,Positive,,Laboratory Study,2021,Mind-Body Medicine,Nervous System,Alzheimer's Disease; Dementia
2021537,GABA- and Glycine-Mimetic Responses of Linalool on the Substantia Gelatinosa of the Trigeminal Subnucleus Caudalis in Juvenile Mice: Pain Management through Linalool-Mediated Inhibitory Neurotransmission,https://pubmed.ncbi.nlm.nih.gov/34247560/,Positive,,Animal Study,2021,,,Pain; Pain - Chronic
20221004,Rewarding effect of ethanol-induced conditioned place preference in mice: Effect of the monoterpenoid linalool,https://pubmed.ncbi.nlm.nih.gov/34800613/,Positive,,Animal Study,2022,,Mental/Emotional System,Addiction - Alcohol; Addiction
2021538,Chemopreventive potential of linalool in targeting lung cancer biomarkers: An in silico & in vitro investigation,https://pubmed.ncbi.nlm.nih.gov/34503432/,Positive,,Laboratory Study,2021,,Respiratory System,Cancer - Lung; Cancer
2021539,Mechanistic Evaluation of Linalool Effect against Renal Ischemia- Reperfusion Injury in Rats,https://pubmed.ncbi.nlm.nih.gov/34020490/,Positive,,Animal Study,2021,,Cardiovascular System,Cardiovascular Diseases (CVD); Reperfusion Injury; Chronic Kidney Disease
2021540,Orexinergic descending inhibitory pathway mediates linalool odor-induced analgesia in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085205/,Positive,,Animal Study,2021,,,Pain; Pain - Acute
20221005,Biphasic effect of the dietary phytochemical linalool on angiogenesis and metastasis,https://pubmed.ncbi.nlm.nih.gov/34994923/,Inconclusive,,Laboratory Study,2022,,,Cancer - Metastatic; Cancer
2021541,Linalool exhibits therapeutic and protective effects in a rat model of doxorubicin-induced kidney injury by modulating oxidative stress,https://pubmed.ncbi.nlm.nih.gov/33682561/,Positive,,Animal Study,2021,,,Oxidative Stress
2021542,"Linalool reverses benzene-induced cytotoxicity, oxidative stress and lysosomal/mitochondrial damages in human lymphocytes",https://pubmed.ncbi.nlm.nih.gov/34304650/,Positive,,Laboratory Study,2021,,,Oxidative Stress
2021543,Linalool Alleviates A β 42-Induced Neurodegeneration via Suppressing ROS Production and Inflammation in Fly and Rat Models of Alzheimer's Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972854/,Positive,,Animal Study,2021,,,Alzheimer's Disease; Inflammation; Neurodegenerative Issues
2021544,THC Reduces Ki67-Immunoreactive Cells Derived from Human Primary Glioblastoma in a GPR55-Dependent Manner,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959141/,Positive,,Laboratory Study,2021,Anandamide (AEA); Endocannabinoid (unspecified),Nervous System,Cancer - Brain; Cancer
2021545,Linalool attenuates acquisition and reinstatement and accelerates the extinction of nicotine-induced conditioned place preference in male mice,https://pubmed.ncbi.nlm.nih.gov/33852814/,Positive,,Animal Study,2021,,Mental/Emotional System,Addiction - Nicotine; Addiction
2021546,Cardioprotective Effect of Linalool against Isoproterenol-Induced Myocardial Infarction,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915311/,Positive,,Animal Study,2021,,Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack
2021547,"Cannabidiol has a unique effect on global brain activity: a pharmacological, functional MRI study in awake mice",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142641/,Positive,,Animal Study,2021,,,PTSD
2021548,Cannabidiol versus risperidone for treatment of recent-onset psychosis with comorbid cannabis use: study protocol for a randomized controlled clinical trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364057/,Inconclusive,,Double Blind Clinical Trial,2021,,Mental/Emotional System,Addiction - Cannabis; Addiction; Psychosis
2021549,Cannabidiol enhanced the development of sensitization to the expression of methamphetamine-induced conditioned place preference in male rats,https://pubmed.ncbi.nlm.nih.gov/33725638/,Inconclusive,,Animal Study,2021,,Mental/Emotional System,Addiction - Stimulant; Addiction; Addiction - Cannabis; Addiction - Cocaine; MDMA Adverse Effects
2021550,Purified Cannabidiol isolate does not inhibit active caspase-1 release in NLRP inflammasome-mediated UVB or ATP-activated keratinocytes or appear to reduce key inflammatory cytokines in UVB-irradiate keratinocytes,https://pubmed.ncbi.nlm.nih.gov/33559194/,Inconclusive,,Laboratory Study,2021,,Nervous System,Inflammation; Cancer - Skin (Non-melanoma); Cancer
2021551,Involvement of Hippocampal D1-Like Dopamine Receptors in the Inhibitory Effect of Cannabidiol on Acquisition and Expression of Methamphetamine-Induced Conditioned Place Preference,https://pubmed.ncbi.nlm.nih.gov/33993443/,Positive,,Animal Study,2021,,Mental/Emotional System; Nervous System,Addiction - Stimulant; Addiction; Addiction - Cocaine
2021552,Linalool as a Therapeutic and Medicinal Tool in Depression Treatment: A Review,https://pubmed.ncbi.nlm.nih.gov/34544345/,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Depression
2021553,Linalool odor‐induced analgesia is triggered by TRPA1-independent pathway in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077846/,Positive,,Animal Study,2021,,Nervous System,Pain; Pain - Acute
2021554,Recent updates on bioactive properties of linalool,https://pubmed.ncbi.nlm.nih.gov/34611674/,Positive,,Meta-analysis,2021,,,Anxiety; Bacterial Infections; Cancer; Depression; Neurodegenerative Issues
20221006,"Medical cannabis oil for benign essential blepharospasm: a prospective, randomized controlled pilot study",https://pubmed.ncbi.nlm.nih.gov/35067772/,Positive,,Double Blind Clinical Trial,2022,,,Dystonia
20221007,Medical Cannabis Used as an Alternative Treatment for Chronic Pain Demonstrates Reduction in Chronic Opioid Use - A Prospective Study,https://pubmed.ncbi.nlm.nih.gov/35051158/,Positive,,Meta-analysis,2022,,,Pain; Pain - Chronic; Addiction - Opioid
2013062,Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579248/,Positive,,Meta-analysis,2013,,Nervous System,Neurodegenerative Issues; Huntington's Disease; Inflammation; Neonatal Cerebral Issues; Parkinson's Disease
2002015,Tetrahydrocannabinol and endocannabinoids in feeding and appetite,https://pubmed.ncbi.nlm.nih.gov/12182965/,Inconclusive,,Meta-analysis,2002,SR-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC),Mental/Emotional System,Loss of Appetite; Anorexia; Obesity
2020263,An evaluation of the anti-hyperalgesic effects of cannabidiolic acid-methyl ester in a preclinical model of peripheral neuropathic pain,https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.14997,Positive,,Animal Study,2020,Cannabidiolic Acid (CBD-a),Nervous System,Pain; Pain - Chronic; Pain - Neuropathy - Peripheral
2021555,"Limonene, a citrus monoterpene, non-complexed and complexed with hydroxypropyl-β-cyclodextrin attenuates acute and chronic orofacial nociception in rodents: Evidence for involvement of the PKA and PKC pathway",https://pubmed.ncbi.nlm.nih.gov/35026511/,Positive,,Animal Study,2021,,Nervous System,Pain; Pain - Acute; Pain - Chronic
2021556,D-Limonene Is a Potential Monoterpene to Inhibit PI3K/Akt/IKK-α/NF-κB p65 Signaling Pathway in Coronavirus Disease 2019 Pulmonary Fibrosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985179/,Positive,,Animal Study,2021,,Respiratory System,COVID-19; Fibrosis - Lung; Fibrosis
2021557,Limonene-carvacrol: A combination of monoterpenes with enhanced antileishmanial activity,https://pubmed.ncbi.nlm.nih.gov/33823240/,Positive,,Laboratory Study,2021,,Integumentary System,Leishmaniasis
2021558,Limonene through Attenuation of Neuroinflammation and Nitrite Level Exerts Antidepressant-Like Effect on Mouse Model of Maternal Separation Stress,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864762/,Positive,,Animal Study,2021,,Mental/Emotional System; Nervous System,Depression; Inflammation
2021559,Anticancer activity of limonene: A systematic review of target signaling pathways,https://pubmed.ncbi.nlm.nih.gov/33864293/,Positive,,Meta-analysis,2021,,Nervous System,Cancer
2021560,Effect of d-limonene and its derivatives on breast cancer in human trials: a scoping review and narrative synthesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349000/,Positive,,Clinical Meta-analysis,2021,,Nervous System; Reproductive System,Cancer - Breast; Cancer
2021561,Mechanism of Action of Limonene in Tumor Cells: A Systematic Review and Meta-Analysis,https://pubmed.ncbi.nlm.nih.gov/33106139/,Positive,,Meta-analysis,2021,,,Cancer
2020264,Limonene-induced activation of A 2A adenosine receptors reduces airway inflammation and reactivity in a mouse model of asthma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524888/,Positive,,Animal Study,2020,,Respiratory System,Asthma
2021562,Neuroprotective Potential of Limonene and Limonene Containing Natural Products,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348102/,Positive,,Meta-analysis,2021,,,Neurodegenerative Issues; Alzheimer's Disease; Anxiety; Epilepsy; Multiple Sclerosis; Stroke
2021563,D-limonene: A multifunctional compound with potent therapeutic effects,https://pubmed.ncbi.nlm.nih.gov/33289132/,Positive,,Meta-analysis,2021,,,Cancer; Cardiovascular Diseases (CVD); Diabetes; Inflammation; Oxidative Stress
2018110,Limonene: Aroma of innovation in health and disease,https://pubmed.ncbi.nlm.nih.gov/29427589/,Positive,,Meta-analysis,2018,,,Cancer; Diabetes; Inflammation; Pain; Oxidative Stress; Pain - Chronic
2021564,Limonene has anti-anxiety activity via adenosine A2A receptor-mediated regulation of dopaminergic and GABAergic neuronal function in the striatum,https://pubmed.ncbi.nlm.nih.gov/33548867/,Positive,,Animal Study,2021,,Mental/Emotional System,Anxiety
2021565,"Can limonene be a possible candidate for evaluation as an agent or adjuvant against infection, immunity, and inflammation in COVID-19?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810623/,Positive,,Meta-analysis,2021,,Respiratory System,COVID-19
2021566,Geraniol exerts its antiproliferative action by modulating molecular targets in lung and skin carcinoma cells,https://pubmed.ncbi.nlm.nih.gov/33826182/,Positive,,Laboratory Study,2021,,Integumentary System; Respiratory System,Cancer - Lung; Cancer - Melanoma; Cancer - Skin (Non-melanoma); Cancer
2021567,Geraniol isolated from lemon grass to mitigate doxorubicin-induced cardiotoxicity through Nrf2 and NF-κB signaling,https://pubmed.ncbi.nlm.nih.gov/34343525/,Positive,,Animal Study,2021,,,Cardiovascular Diseases (CVD); Inflammation; Oxidative Stress
2021568,Geraniol Averts Methotrexate-Induced Acute Kidney Injury via Keap1/Nrf2/HO-1 and MAPK/NF-κB Pathways,https://pubmed.ncbi.nlm.nih.gov/34889889/,Positive,,Animal Study,2021,,,Chronic Kidney Disease
2021569,"Sedative effects of l-menthol, d-camphor, phenylethyl alcohol, and geraniol",https://pubmed.ncbi.nlm.nih.gov/33389551/,Positive,,Animal Study,2021,,,Anxiety; Insomnia and Sleep Disorders
2021570,Geraniol protects against cyclosporine A-induced renal injury in rats: Role of Wnt/β-catenin and PPARγ signaling pathways,https://pubmed.ncbi.nlm.nih.gov/34968469/,Positive,,Animal Study,2021,,Urinary System,Chronic Kidney Disease
2021571,Antidiabetic Potential of Naturally Occurring Sesquiterpenes: A Review,https://pubmed.ncbi.nlm.nih.gov/33676391/,Positive,,Meta-analysis,2021,,Endocrine System,Diabetes
2021572,"In Vitro Effects of Low Doses of β-Caryophyllene, Ascorbic Acid and d-Glucosamine on Human Chondrocyte Viability and Inflammation",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005039/,Positive,,Laboratory Study,2021,,,Inflammation; Arthritis - Osteoarthritis; Arthritis; Oxidative Stress
2021573,"Evaluation of the terpenes β-caryophyllene, α-terpineol, and γ-terpinene in the mouse chronic constriction injury model of neuropathic pain: possible cannabinoid receptor involvement",https://pubmed.ncbi.nlm.nih.gov/34846548/,Positive,,Animal Study,2021,,,Pain; Pain - Chronic
2021574,A standardized black pepper seed extract containing β-caryophyllene improves cognitive function in scopolamine-induced amnesia model mice via regulation of brain-derived neurotrophic factor and MAPK proteins,https://pubmed.ncbi.nlm.nih.gov/34778972/,Positive,,Animal Study,2021,,,Cognitive Dysfunction
2021575,Lifetime Cannabis Use Disorder Is Not Associated With Lifetime Impulsive Behavior and Severe Violence in Patients With Schizophrenia Spectrum Disorders From a High-Security Hospital,https://pubmed.ncbi.nlm.nih.gov/34735097/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System,Schizophrenia; Addiction - Cannabis; Domestic Abuse; Intermittent Explosive Disorder
2021576,Intranasal temperature-sensitive hydrogels of cannabidiol inclusion complex for the treatment of post-traumatic stress disorder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343172/,Positive,,Animal Study,2021,,Mental/Emotional System; Nervous System,PTSD; Inflammation
2021577,Attenuation of Oxidative Stress and Inflammatory Response by Chronic Cannabidiol Administration Is Associated with Improved n-6/n-3 PUFA Ratio in the White and Red Skeletal Muscle in a Rat Model of High-Fat Diet-Induced Obesity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151284/,Positive,,Animal Study,2021,,Endocrine System; Nervous System,Inflammation; Obesity; Oxidative Stress; Fatty Liver Disease; Metabolic Syndrome
2021578,Brief Report: Suspected Cannabis-Induced Mania and Psychosis in Young Adult Males with Autism Spectrum Disorder,https://pubmed.ncbi.nlm.nih.gov/34505186/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Autism
2021579,Cannabidiol Induces Apoptosis and Perturbs Mitochondrial Function in Human and Canine Glioma Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385407/,Positive,,Laboratory Study -,2021,,Nervous System,Cancer - Brain; Cancer; Veterinary Applications
2021580,A cannabis oracle? Delphi method not a substitute for randomized controlled trials of cannabinoids as therapeutics,https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-021-00074-0,Negative,,Meta-analysis,2021,,,Pain; Pain - Chronic
2021581,Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193732/,Positive,,Laboratory Study,2021,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia; Inflammation; Oxidative Stress
2021582,Changes in Phospholipid/Ceramide Profiles and Eicosanoid Levels in the Plasma of Rats Irradiated with UV Rays and Treated Topically with Cannabidiol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395479/,Positive,,Animal Study,2021,,Nervous System,Oxidative Stress; Cancer - Skin (Non-melanoma); Cancer; Inflammation
2021583,Cannabidiol attenuates cognitive deficits and neuroinflammation induced by early alcohol exposure in a mice model,https://www.sciencedirect.com/science/article/pii/S0753332221005953?via%3Dihub,Positive,,Animal Study,2021,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction; Cognitive Dysfunction; Inflammation; Neonatal Cerebral Issues; Pregnancy
2021584,Long-term safety and efficacy of add-on cannabidiol in patients with Lennox-Gastaut syndrome: Results of a long-term open-label extension trial,https://onlinelibrary.wiley.com/doi/10.1111/epi.17000,Positive,,Double Blind Clinical Trial,2021,Pharma CBD,Nervous System,Epilepsy - Lennox-Gastaut; Epilepsy
2021585,"Contribution of the Adenosine 2A Receptor to Behavioral Effects of Tetrahydrocannabinol, Cannabidiol and PECS-101",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434367/,Negative,,Animal Study,2021,,,Anxiety; Cannabis Adverse Effects; Epilepsy; Inflammation; Insomnia and Sleep Disorders; Pain - Nociceptive; Pain; Neurodegenerative Issues; Oxidative Stress
2021586,Values and preferences towards medical cannabis among people living with chronic pain: a mixed-methods systematic review,https://bmjopen.bmj.com/content/11/9/e050831,Inconclusive,,Meta-analysis,2021,,Nervous System,Pain; Pain - Chronic
2021587,Epileptic Phenotype and Cannabidiol Efficacy in a Williams–Beuren Syndrome Patient With Atypical Deletion: A Case Report,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217744/,Positive,,Meta-analysis,2021,Pharma CBD,Nervous System,Epilepsy; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut
2021588,Tamoxifen Sensitizes Acute Lymphoblastic Leukemia Cells to Cannabidiol by Targeting Cyclophilin-D and Altering Mitochondrial Ca2+ Homeostasis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395529/,Positive,,Laboratory Study,2021,,Immune System,Cancer - Leukemia; Cancer
2021589,Citalopram and Cannabidiol: In Vitro and In Vivo Evidence of Pharmacokinetic Interactions Relevant to the Treatment of Anxiety Disorders in Young People,https://journals.lww.com/psychopharmacology/Abstract/2021/09000/Citalopram_and_Cannabidiol__In_Vitro_and_In_Vivo.4.aspx,Negative,,Laboratory Study,2021,,Mental/Emotional System; Nervous System,Anxiety; Depression
2021590,Antidepressant-like effects of cannabidiol in a rat model of early-life stress with or without adolescent cocaine exposure,https://pubmed.ncbi.nlm.nih.gov/34076862/,Positive,,Animal Study,2021,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction; Depression
2021591,Understanding the complex pharmacology of cannabidiol: Mounting evidence suggests a common binding site with cholesterol,https://www.sciencedirect.com/science/article/pii/S104366182100092X?casa_token=Rztq35i5VX0AAAAA:jySAThcqpkHhjHutkd8hzIRcUNeEQmT-E6F-kO6TNnDMcXN_kVGOJ4nuHrbfEPFQyLdskji-fA,Inconclusive,,Meta-analysis,2021,Fatty Acid Amide Hydrolase (FAAH); Pharma CBD,,Cardiovascular Diseases (CVD); Heart Attack
2021592,Differentially expressed genes induced by β-caryophyllene in a rat model of cerebral ischemia-reperfusion injury,https://pubmed.ncbi.nlm.nih.gov/33705733/,Positive,,Animal Study,2021,,Cardiovascular System,Cardiovascular Diseases (CVD); Reperfusion Injury; Stroke
2021593,Plant-Derived Trans-β-Caryophyllene Boosts Glucose Metabolism and ATP Synthesis in Skeletal Muscle Cells through Cannabinoid Type 2 Receptor Stimulation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999495/,Positive,,Laboratory Study,2021,,,Diabetes; Metabolic Syndrome
2021594,Therapeutic potential of beta-caryophyllene against aflatoxin B1-Induced liver toxicity: biochemical and molecular insights in rats,https://pubmed.ncbi.nlm.nih.gov/34506763/,Positive,,Animal Study,2021,,,Cancer - Liver; Cancer; Fibrosis - Liver (Cirrhosis); Fibrosis; Fungal Infections; Inflammation; Oxidative Stress
2021595,β-Caryophyllene induces apoptosis and inhibits cell proliferation by deregulation of STAT-3/mTOR/AKT signaling in human bladder cancer cells: An in vitro study,https://pubmed.ncbi.nlm.nih.gov/34318533/,Positive,,Laboratory Study,2021,,Nervous System; Urinary System,Cancer - Bladder; Cancer
2021596,β-Caryophyllene may attenuate hyperoxaluria-induced kidney dysfunction in rats by regulating stress marker KIM-1/MCP-1 and NF-κB signaling pathway,https://pubmed.ncbi.nlm.nih.gov/34468068/,Positive,,Animal Study,2021,,Urinary System,Kidney Failure
20221008,"Sex Differences in the Association Between Cannabis Use and Diabetes Mellitus among U.S. Adults: The National Health and Nutritional Examination Survey, 2013-2018",https://pubmed.ncbi.nlm.nih.gov/34981965/,Positive,,Meta-analysis,2022,,Endocrine System,Diabetes
2020265,Synthesis of the Major Mammalian Metabolites of THCV,https://pubmed.ncbi.nlm.nih.gov/32649196/,Inconclusive,,Meta-analysis,2020,Tetrahydrocannabivarin (THCV),,
2020266,Cannabinoids and Cannabinoid Receptors: The Story so Far,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339067/,Inconclusive,,Meta-analysis,2020,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Cannabichromene (CBC); Cannabidiolic Acid (CBD-a); Cannabigerol (CBG); Cannabinol (CBN); Tetrahydrocannabivarin (THCV); Tetrahydrocannabinolic Acid (THC-a),,
2016093,The CB1 Neutral Antagonist Tetrahydrocannabivarin Reduces Default Mode Network and Increases Executive Control Network Resting State Functional Connectivity in Healthy Volunteers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772823/,Positive,,Double Blind Clinical Trial,2016,Tetrahydrocannabivarin (THCV),,Obesity
2021597,Cannabidiol Enhances Intestinal Cannabinoid Receptor Type 2 Receptor Expression and Activation Increasing Regulatory T Cells and Reduces Murine Acute Graft-versus-Host Disease without Interfering with the Graft-versus-Leukemia Response,https://pubmed.ncbi.nlm.nih.gov/33658314/,Positive,,Laboratory Study,2021,,Immune System; Nervous System,Cancer - Leukemia; Cancer; Graft-versus-Host-Disease; Organ Transplant Failure
2021598,Preclinical investigation of β-caryophyllene as a therapeutic agent in an experimental murine model of Dravet syndrome,https://pubmed.ncbi.nlm.nih.gov/34875285/,Positive,,Animal Study,2021,,,Epilepsy - Dravet Syndrome; Epilepsy
2021599,Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats,https://www.sciencedirect.com/science/article/abs/pii/S0028390821002550?via%3Dihub,Positive,,Animal Study,2021,,Nervous System,Parkinson's Disease
2021600,β-Caryophyllene inhibits Fas- receptor and caspase-mediated apoptosis signaling pathway and endothelial dysfunction in experimental myocardial infarction,https://pubmed.ncbi.nlm.nih.gov/34816538/,Positive,,Animal Study,2021,,Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack
2021601,"Caryophyllene Oxide, the Active Compound Isolated from Leaves of Hymenaea courbaril L. (Fabaceae) with Antiproliferative and Apoptotic Effects on PC-3 Androgen-Independent Prostate Cancer Cell Line",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538860/,Positive,,Laboratory Study,2021,,Nervous System; Reproductive System,Cancer - Prostate; Cancer
2021602,Acute cannabidiol treatment attenuates ethanol-induced place preference and reduces aggressivity in group-housed male rats,https://pubmed.ncbi.nlm.nih.gov/34662589/,Positive,,Animal Study,2021,,Mental/Emotional System,Addiction - Alcohol; Addiction; Alcoholic Liver Disease
20221009,Antinociceptive and chondroprotective effects of prolonged β-caryophyllene treatment in the animal model of osteoarthritis: Focus on tolerance development,https://www.sciencedirect.com/science/article/pii/S0028390821004652?via%3Dihub,Positive,,Animal Study -,2022,,Skeletal System,Arthritis - Osteoarthritis; Arthritis; Veterinary Applications
2021603,Chronic cannabidiol (CBD) administration induces anticonvulsant and antiepileptogenic effects in a genetic model of epilepsy,https://pubmed.ncbi.nlm.nih.gov/33887676/,Positive,,Animal Study,2021,,,Epilepsy
2021604,Time to onset of cannabidiol treatment effects in Dravet syndrome: Analysis from two randomized controlled trials,https://onlinelibrary.wiley.com/doi/10.1111/epi.16974,Positive,,Clinical Meta-analysis,2021,Pharma CBD,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy; Epilepsy - Lennox-Gastaut
20221010,Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants,https://pubmed.ncbi.nlm.nih.gov/35007072/,Positive,,Laboratory Study,2022,Cannabidiolic Acid (CBD-a); Cannabigerolic Acid (CBG-a),Respiratory System,COVID-19
20221011,Prospective effects of loneliness on frequency of alcohol and marijuana use,https://pubmed.ncbi.nlm.nih.gov/34543868/,Inconclusive,,Meta-analysis,2022,,,Addiction - Alcohol; Addiction - Cannabis; Cannabis Adverse Effects
20221012,"Concurrent use of e-cigarettes and cannabis and associated COVID-19 symptoms, testing, and diagnosis among student e-cigarette users at four U.S. Universities",https://pubmed.ncbi.nlm.nih.gov/34776303/,Negative,,Meta-analysis,2022,,Respiratory System,COVID-19
2021605,Design of Negative and Positive Allosteric Modulators of the Cannabinoid CB 2 Receptor Derived from the Natural Product Cannabidiol,https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00561,Positive,,Laboratory Study,2021,,,Addiction - Opioid; Cannabis Adverse Effects; Inflammation; Pain; Pain - Acute; Pain - Chronic
2021606,"Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review",https://pubmed.ncbi.nlm.nih.gov/33530732/,Inconclusive,,Clinical Meta-analysis,2021,,Mental/Emotional System; Nervous System,Anxiety; Bipolar Disorder; PTSD; Depression
2021607,Cannabidiol impairs the rewarding effects of methamphetamine: Involvement of dopaminergic receptors in the nucleus accumbens,https://pubmed.ncbi.nlm.nih.gov/34662693/,Positive,,Animal Study,2021,,Mental/Emotional System; Nervous System,Addiction - Stimulant; Addiction; Addiction - Opioid; MDMA Adverse Effects
2021608,Cannabidiol in Pharmacoresistant Epilepsy: Clinical Pharmacokinetic Data From an Expanded Access Program,https://www.frontiersin.org/articles/10.3389/fphar.2021.637801/full,Positive,,Clinical Trial,2021,Pharma CBD,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2021609,The Effect of Cannabidiol on UV-Induced Changes in Intracellular Signaling of 3D-Cultured Skin Keratinocytes,https://www.mdpi.com/1422-0067/22/3/1501/htm,Positive,,Laboratory Study,2021,,,Cancer - Skin (Non-melanoma); Cancer; Inflammation; Oxidative Stress
2014070,Early phytocannabinoid chemistry to endocannabinoids and beyond,https://pubmed.ncbi.nlm.nih.gov/25315390/,Positive,,Meta-analysis,2014,Tetrahydrocannabinol (THC),,
2020267,It Is Our Turn to Get Cannabis High: Put Cannabinoids in Food and Health Baskets,https://www.mdpi.com/1420-3049/25/18/4036/htm,Positive,,Meta-analysis,2020,Pharma CBD; Pharma THC:CBD; Pharma THC; Cannabichromene (CBC); Cannabigerol (CBG); Cannabinol (CBN); Tetrahydrocannabivarin (THCV),,
2021610,Cannabis sativa L. may reduce aggressive behaviour towards humans in shelter dogs,https://www.nature.com/articles/s41598-021-82439-2#Tab1,Positive,,Animal Study -,2021,,,Veterinary Applications
2020268,Topical cannabis‐based medicines – A novel paradigm and treatment for non‐uremic calciphylaxis leg ulcers: An open label trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540661/,Positive,,Clinical Trial,2020,,Immune System; Integumentary System; Nervous System,Wound Healing
20221013,Disparity between Perceptual Fall Risk and Physiological Fall Risk in Older Cannabis Users: A Pilot Study,https://www.mdpi.com/1660-4601/19/1/109/html,Inconclusive,,Meta-analysis,2022,,Muscular System; Nervous System; Skeletal System,Geriatric Conditions; Cannabis Adverse Effects; Sarcopenia
2020269,Increased Likelihood of Falling in Older Cannabis Users vs. Non-Users,https://www.mdpi.com/2076-3425/11/2/134/htm,Negative,,Meta-analysis,2020,,Mental/Emotional System; Muscular System; Nervous System; Skeletal System,Cannabis Adverse Effects; Geriatric Conditions
2021611,"β-Caryophyllene, a natural bicyclic sesquiterpene attenuates β-adrenergic agonist-induced myocardial injury in a cannabinoid receptor-2 dependent and independent manner",https://pubmed.ncbi.nlm.nih.gov/33588052/,Positive,,Animal Study,2021,,Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack
2021612,β-Caryophyllene attenuates lipopolysaccharide-induced acute lung injury via inhibition of the MAPK signalling pathway,https://pubmed.ncbi.nlm.nih.gov/34313776/,Positive,,Animal Study,2021,,,Inflammation; Acute Respiratory Distress Syndrome; Stress
2021613,β-Caryophyllene from Chilli Pepper Inhibits the Proliferation of Non-Small Cell Lung Cancer Cells by Affecting miR-659-3p-Targeted Sphingosine Kinase 1 (SphK1),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670862/,Positive,,Laboratory Study,2021,,Respiratory System,Cancer - Lung; Cancer
2021614,Therapeutic effects of β-caryophyllene on proliferative disorders and inflammation of the gerbil prostate,https://pubmed.ncbi.nlm.nih.gov/34125438/,Positive,,Animal Study,2021,,Reproductive System,Cancer - Prostate; Cancer; Inflammation
2021615,β-Caryophyllene Ameliorates MSU-Induced Gouty Arthritis and Inflammation Through Inhibiting NLRP3 and NF-κB Signal Pathway: In Silico and In Vivo,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103215/,Positive,,Animal Study,2021,,Nervous System; Skeletal System,Arthritis - Gout; Arthritis - Osteoarthritis; Arthritis; Inflammation
2021616,β-Caryophyllene Induces Apoptosis and Inhibits Angiogenesis in Colorectal Cancer Models,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508804/,Positive,,Animal Study,2021,,Digestive System; Nervous System,Cancer - Colon; Cancer
2021617,β-caryophyllene ameliorated obesity-associated airway hyperresponsiveness through some non-conventional targets,https://pubmed.ncbi.nlm.nih.gov/34175589/,Positive,,Animal Study,2021,,Endocrine System,Obesity
2021618,Changes in Hepatic Phospholipid Metabolism in Rats under UV Irradiation and Topically Treated with Cannabidiol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388943/,Positive,,Animal Study,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Virodhamine (O-AEA),,Liver Failure; Oxidative Stress
2021619,"A Phase 1 Open-Label, Fixed-Sequence Pharmacokinetic Drug Interaction Trial to Investigate the Effect of Cannabidiol on the CYP1A2 Probe Caffeine in Healthy Subjects",https://accp1.onlinelibrary.wiley.com/doi/10.1002/cpdd.950,Negative,,Clinical Trial,2021,Pharma CBD,,Epilepsy - Lennox-Gastaut; Epilepsy
2020270,β-caryophyllene improves sexual performance via modulation of crucial enzymes relevant to erectile dysfunction in rats,https://pubmed.ncbi.nlm.nih.gov/33868981/,Inconclusive,,Animal Study,2020,,Endocrine System; Reproductive System,Erectile Dysfunction; Libido
2021620,Improvement of Oxidative Stress and Mitochondrial Dysfunction by β-Caryophyllene: A Focus on the Nervous System,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066981/,Positive,,Meta-analysis,2021,,Nervous System,Oxidative Stress
2021621,"Beta-Caryophyllene, a CB2R Selective Agonist, Protects Against Cognitive Impairment Caused by Neuro-inflammation and Not in Dementia Due to Ageing Induced by Mitochondrial Dysfunction",https://pubmed.ncbi.nlm.nih.gov/33530917/,Positive,,Animal Study,2021,,Nervous System,Cognitive Dysfunction; Inflammation
2021622,"Anticonvulsant, Anxiolytic and Antidepressant Properties of the β-caryophyllene in Swiss Mice: Involvement of Benzodiazepine-GABAAergic, Serotonergic and Nitrergic Systems",https://pubmed.ncbi.nlm.nih.gov/32386503/,Positive,,Animal Study,2021,,Mental/Emotional System; Nervous System,Anxiety; Depression; Epilepsy
2021623,β-Caryophyllene ameliorates the Mycoplasmal pneumonia through the inhibition of NF-κB signal transduction in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324997/,Positive,,Animal Study,2021,,,Inflammation
2020271,"β-Caryophyllene, a dietary terpenoid, inhibits nicotine taking and nicotine seeking in rodents",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161544/,Positive,,Animal Study,2020,,Mental/Emotional System; Nervous System,Addiction - Nicotine; Addiction
2020272,β-caryophyllene alleviates cerebral ischemia/ reperfusion injury in mice by activating autophagy,https://pubmed.ncbi.nlm.nih.gov/32237496/,Positive,,Animal Study,2020,,Cardiovascular System,Cardiovascular Diseases (CVD); Reperfusion Injury
2019116,"β-caryophyllene, a dietary phytocannabinoid attenuates oxidative stress, inflammation, apoptosis and prevents structural alterations of the myocardium against doxorubicin-induced acute cardiotoxicity in rats: An in vitro and in vivo study",https://pubmed.ncbi.nlm.nih.gov/31216443/,Positive,,Animal Study,2019,,,Inflammation; Oxidative Stress
2020273,Beta-Caryophyllene Suppresses Ovarian Cancer Proliferation by Inducing Cell Cycle Arrest and Apoptosis,https://pubmed.ncbi.nlm.nih.gov/32106806/,Positive,,Laboratory Study,2020,,Nervous System; Reproductive System,Cancer - Ovarian; Cancer
2019117,β-Caryophyllene as a Potential Protective Agent Against Myocardial Injury: The Role of Toll-Like Receptors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572120/,Positive,,Animal Study,2019,,Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack
2021624,Sleep-wake cycle disturbances and NeuN-altered expression in adult rats after cannabidiol treatments during adolescence,https://pubmed.ncbi.nlm.nih.gov/33635384/,Negative,,Clinical Trial,2021,,Nervous System,Insomnia and Sleep Disorders
2021625,Time to onset of cannabidiol (CBD) treatment effect in Lennox–Gastaut syndrome: Analysis from two randomized controlled trials,https://onlinelibrary.wiley.com/doi/10.1111/epi.16878,Positive,,Clinical Meta-analysis,2021,Pharma CBD,Nervous System,Epilepsy - Lennox-Gastaut; Epilepsy
2020274,Antibacterial Activity and Mode of Action of β-caryophyllene on Bacillus cereus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256763/,Positive,,Laboratory Study,2020,,Immune System,Bacterial Infections
2020275,Inhibitory Effects of β-Caryophyllene on Helicobacter pylori Infection In Vitro and In Vivo,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037973/,Positive,,Animal Study,2020,,Immune System,Bacterial Infections; Cancer - Stomach; Cancer; Fungal Infections; Inflammation; Stomach Ulcers
2019118,Efficacy of β-caryophyllene for periodontal disease related factors,https://pubmed.ncbi.nlm.nih.gov/30826504/,Positive,,Laboratory Study,2019,,Digestive System,Periodontal Disease; Pain - Dental - Acute
2020276,Olfactory Exposure to β-Caryophyllene Increases Testosterone Levels in Women's Saliva,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471126/,Positive,,Meta-analysis,2020,,Endocrine System; Reproductive System,Libido
2020277,Protective Effects of ( E)-β-Caryophyllene (BCP) in Chronic Inflammation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692661/,Positive,,Meta-analysis,2020,,Nervous System,Inflammation
2021626,"β-caryophyllene, an FDA-Approved Food Additive, Inhibits Methamphetamine-Taking and Methamphetamine-Seeking Behaviors Possibly via CB2 and Non-CB2 Receptor Mechanisms",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458938/,Positive,,Animal Study,2021,,Mental/Emotional System; Nervous System,Addiction - Stimulant; Addiction
2021627,Beta-caryophyllene inhibits cocaine addiction-related behavior by activation of PPARα and PPARγ: repurposing a FDA-approved food additive for cocaine use disorder,https://pubmed.ncbi.nlm.nih.gov/33069159/,Positive,,Animal Study,2021,,Mental/Emotional System; Nervous System,Addiction - Cocaine; Addiction
2021628,A 3-year-old child with multi-drug resistant epilepsy responding to pharmacological and nonpharmacological treatments,https://pubmed.ncbi.nlm.nih.gov/33843424/,Positive,,Meta-analysis,2021,,Nervous System,Epilepsy
2021629,"Quantitation of Δ8-THC, Δ9-THC, Cannabidiol, and Ten Other Cannabinoids and Metabolites in Oral Fluid by HPLC-MS/MS",https://academic.oup.com/jat/advance-article/doi/10.1093/jat/bkaa184/6018445,Inconclusive,,Laboratory Study,2021,Cannabichromene (CBC); Cannabigerol (CBG); Cannabinol (CBN); Delta-8-THC; Tetrahydrocannabivarin (THCV); Tetrahydrocannabinolic Acid (THC-a),,
2021630,Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4,https://pubmed.ncbi.nlm.nih.gov/33629929/,Positive,,Animal Study,2021,,,Cancer - Brain; Cancer
2021631,Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects,https://pubmed.ncbi.nlm.nih.gov/34157363/,Positive,,Animal Study,2021,,Mental/Emotional System,Depression
2021632,Short and long-term neuroprotective effects of cannabidiol after neonatal peripheral nerve axotomy,https://pubmed.ncbi.nlm.nih.gov/34303725/,Positive,,Animal Study,2021,,,Neonatal Cerebral Issues
2021633,"The Cannabinoids Tetrahydrocannabinol, Cannabinol, Cannabidiol, Tetrahydrocannabivarin, and 11-nor-9-carboxy-∆9-THC in Hair",https://academic.oup.com/jat/advance-article/doi/10.1093/jat/bkab068/6307345,Positive,,Laboratory Study,2021,Cannabinol (CBN); Tetrahydrocannabivarin (THCV),,
2021634,Cannabidiol attenuates pulmonary arterial hypertension by improving vascular smooth muscle cells mitochondrial function,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039951/,Positive,,Animal Study,2021,,Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2021635,Effects of Cannabidiol on the In Vitro Lymphocyte Pro-Inflammatory Cytokine Production of Senior Horses,https://pubmed.ncbi.nlm.nih.gov/34281647/,Positive,,Laboratory Study -,2021,,,Veterinary Applications
2021636,Cannabidiol Product Dosing and Decision-Making in a National Survey of Individuals with Fibromyalgia,https://pubmed.ncbi.nlm.nih.gov/34214700/,Positive,,Meta-analysis,2021,,Muscular System,Fibromyalgia
2021637,Functional Connectivity Derived From Electroencephalogram in Pharmacoresistant Epileptic Encephalopathy Using Cannabidiol as Adjunctive Antiepileptic Therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940673/,Positive,,Clinical Trial,2021,Pharma THC:CBD,Nervous System,Epilepsy
2021638,Screening and confirmation methods for the qualitative identification of nine phytocannabinoids in urine by LC-MS/MS,https://www.sciencedirect.com/science/article/pii/S0009912021002460?via%3Dihub,Inconclusive,,Laboratory Study,2021,Cannabigerol (CBG); Cannabinol (CBN); Tetrahydrocannabivarin (THCV); Pharma THC; Synthetic Cannabinoid (unspecified),,
2021639,Efficacy of Phytocannabinoids in Epilepsy Treatment: Novel Approaches and Recent Advances,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070313/,Inconclusive,,Meta-analysis,2021,Cannabidivarin (CBDV); Cannabigerol (CBG),Nervous System,Epilepsy
2021640,An Evaluation of Understudied Phytocannabinoids and Their Effects in Two Neuronal Models,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434068/,Inconclusive,,Laboratory Study,2021,2-Arachidonoyl Glycerol (2-AG); Cannabichromene (CBC); Cannabidiolic Acid (CBD-a); Tetrahydrocannabivarin (THCV),,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2020278,Validation of a liquid chromatography tandem mass spectrometry (LC-MS/MS) method to detect cannabinoids in whole blood and breath,https://pubmed.ncbi.nlm.nih.gov/31527291/,Positive,,Laboratory Study,2020,Cannabinol (CBN); Tetrahydrocannabivarin (THCV),,
2021641,Identification and quantification of cannabinoids in postmortem fluids and tissues by liquid chromatography-tandem mass spectrometry,https://pubmed.ncbi.nlm.nih.gov/34198104/,Inconclusive,,Laboratory Study,2021,Cannabigerol (CBG); Cannabinol (CBN); Tetrahydrocannabivarin (THCV),,
2021642,Cannabis sativa as a Treatment for Obesity: From Anti-Inflammatory Indirect Support to a Promising Metabolic Re-Establishment Target,https://pubmed.ncbi.nlm.nih.gov/34242511/,Positive,,Meta-analysis,2021,Tetrahydrocannabivarin (THCV),Endocrine System,Inflammation; Obesity
2021643,Differential Interactions of Selected Phytocannabinoids with Human CYP2D6 Polymorphisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455456/,Inconclusive,,Laboratory Study,2021,Anandamide (AEA); Cannabichromene (CBC); Cannabigerol (CBG); Cannabinol (CBN); Tetrahydrocannabivarin (THCV); Tetrahydrocannabinol (THC),,
2021644,Fast liquid chromatography-tandem mass spectrometry method for the simultaneous determination of phytocannabinoids in oily based preparations,https://pubmed.ncbi.nlm.nih.gov/34062478/,Inconclusive,,Laboratory Study,2021,Cannabidiolic Acid (CBD-a); Cannabigerol (CBG); Cannabinol (CBN); Tetrahydrocannabivarin (THCV); Tetrahydrocannabinolic Acid (THC-a),,
2021645,Development and Optimization of Supercritical Fluid Extraction Setup Leading to Quantification of 11 Cannabinoids Derived from Medicinal Cannabis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227983/,Inconclusive,,Laboratory Study,2021,Cannabichromene (CBC); Cannabidiolic Acid (CBD-a); Cannabidivarin (CBDV); Cannabigerol (CBG); Cannabigerolic Acid (CBG-a); Cannabinol (CBN); Delta-8-THC; Tetrahydrocannabivarin (THCV); Tetrahydrocannabinol (THC); Tetrahydrocannabinolic Acid (THC-a),,
2021646,Lung cancer patient who had declined conventional cancer treatment: could the self-administration of ‘CBD oil’ be contributing to the observed tumour regression?,https://casereports.bmj.com/content/14/10/e244195,Positive,,Meta-analysis,2021,,Respiratory System,Cancer - Lung; Cancer
2021647,"Self-Reported Effects of Cannabis on ADHD Symptoms, ADHD Medication Side Effects, and ADHD-Related Executive Dysfunction",https://journals.sagepub.com/doi/10.1177/10870547211050949,Positive,,Meta-analysis,2021,,Mental/Emotional System,ADD and ADHD
2021648,Cannabis Use Is Inversely Associated with Overweight and Obesity in Hepatitis B Virus-Infected Patients (ANRS CO22 Hepather Cohort),https://pubmed.ncbi.nlm.nih.gov/34648718/,Positive,,Meta-analysis,2021,,Digestive System; Endocrine System,Hepatitis; Obesity
2013063,Single doses of THC and cocaine decrease proficiency of impulse control in heavy cannabis users,https://bedrocan.com/wp-content/uploads/2013-single-doses-of-thc-and-cocaine-decrease-proficiency-of-impulse-control-in-heavy-cannabis-users_van-wel.pdf,Negative,,Double Blind Clinical Trial,2013,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2013064,"Weed or Wheel! fMRI, Behavioural, and Toxicological Investigations of How Cannabis Smoking Affects Skills Necessary for Driving",https://bedrocan.com/wp-content/uploads/2013-weed-or-wheel-fmri-behavioural-and-toxicological-investigations-of-how-cannabis-smoking-affects-skills-necessary-for-driving_battistella.pdf,Negative,,Clinical Trial,2013,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2016094,Subjective aggression during alcohol and cannabis intoxication before and after aggression exposure,https://bedrocan.com/wp-content/uploads/2016-subjective-aggression-during-alcohol-and-cannabis-intoxication-before-and-after-aggression-exposure_de-sousa.pdf,Positive,,Double Blind Clinical Trial,2016,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction; Cannabis Adverse Effects
2016095,Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males,https://bedrocan.com/wp-content/uploads/2016-are-adolescents-more-vulnerable-to-the-harmful-effects-of-cannabis-than-adults-a-placebo-controlled-study-in-human-males_mokrysz.pdf,Inconclusive,,Double Blind Clinical Trial,2016,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2017084,Brain reactivity to alcohol and cannabis marketing during sobriety and intoxication,https://pubmed.ncbi.nlm.nih.gov/26769333/,Inconclusive,,Clinical Trial,2017,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2018111,"Medical Cannabis in Patients with Chronic Pain: Effect on Pain Relief, Pain Disability, and Psychological aspects. A Prospective Non randomized Single Arm Clinical Trial",https://bedrocan.com/wp-content/uploads/medical-cannabis-in-patients-with-chronic-pain-poli_2018.pdf,Positive,,Clinical Trial,2018,Tetrahydrocannabinol (THC),Nervous System,Pain; Pain - Chronic; Anxiety; Depression
2019119,Cannabis induced increase in striatal glutamate associated with loss of functional corticostriatal connectivity,https://pubmed.ncbi.nlm.nih.gov/30553697/,Inconclusive,,Double Blind Clinical Trial,2019,,,Cannabis Adverse Effects
2019120,Dissociable effects of cannabis with and without cannabidiol on the human brain's resting-state functional connectivity,https://pubmed.ncbi.nlm.nih.gov/31013455/,Inconclusive,,Double Blind Clinical Trial,2019,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid
2020279,The use of medical grade cannabis in Italy for drug-resistant epilepsy: a case series,https://bedrocan.com/wp-content/uploads/the-use-of-medical-grade-cannabis-in-italy-for-drug-resistant-epilepsy-pane_2020.pdf,Positive,,Meta-analysis,2020,Tetrahydrocannabinol (THC),Nervous System,Epilepsy
2020280,Adding medical cannabis to standard analgesic treatment for fibromyalgia: a prospective observational study,https://bedrocan.com/wp-content/uploads/adding-medical-cannabis-to-standard-analgesic-treatment-giorgi_2020.pdf,Positive,,Clinical Trial,2020,,Muscular System,Fibromyalgia
2020281,Cannabis treatment in hospitalized patients using the SYQE inhaler: Results of a pilot open-label study,https://bedrocan.com/wp-content/uploads/cannabis-treatment-in-hospitalized-patients_vulfsons_2020.pdf,Positive,,Clinical Trial,2020,Tetrahydrocannabinol (THC); Cannabinol (CBN),,Chorea; IBD - Crohn's Disease; Pain; Multiple Sclerosis; Nausea and Vomiting; Pain - Cancer; Pain - Chronic
2020282,Ending the pain of children with severe epilepsy? An audit of the impact of medical cannabis in 10 patients,https://journals.sagepub.com/doi/full/10.1177/2050324520974487,Positive,,Meta-analysis,2020,,Nervous System,Epilepsy
2020283,Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment,https://pubmed.ncbi.nlm.nih.gov/32360362/,Positive,,Animal Study,2020,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2019121,Acute naloxone-precipitated morphine withdrawal elicits nausea-like somatic behaviors in rats in a manner suppressed by N-oleoylglycine,https://pubmed.ncbi.nlm.nih.gov/31712968/,Positive,,Animal Study,2019,Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
2012084,Cannabis—A Valuable Drug That Deserves Better Treatment,https://www.mayoclinicproceedings.org/article/S0025-6196(11)00027-9/fulltext#%20,Inconclusive,,Meta-analysis,2012,Endocannabinoid (unspecified); Pharma THC:CBD; Pharma THC; Synthetic Cannabinoid (unspecified),,Anxiety; Cannabis Hyperemesis Syndrome; Diabetes; HIV/AIDS; Inflammation; Nausea and Vomiting; Psychosis; Schizophrenia
2010055,Novel natural and synthetic ligands of the endocannabinoid system,https://pubmed.ncbi.nlm.nih.gov/20166928/,Positive,,Meta-analysis,2010,Endocannabinoid (unspecified); Other Related Compounds; Synthetic Cannabinoid (unspecified),,
2008043,Endocannabinoids in liver disease and hepatic encephalopathy,https://pubmed.ncbi.nlm.nih.gov/18781986/,Positive,,Meta-analysis,2008,Endocannabinoid (unspecified),Digestive System; Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction; Liver Failure; Encephalitis and Myelitis; Fibrosis - Liver (Cirrhosis); Fibrosis; Hepatitis
2003011,Cannabis and alcohol--a close friendship,https://pubmed.ncbi.nlm.nih.gov/12823949/,Inconclusive,,Meta-analysis,2003,,Mental/Emotional System,Addiction - Alcohol; Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2021649,Observed Impact of Long-term Consumption of Oral Cannabidiol on Liver Function in Healthy Adults,https://www.liebertpub.com/doi/10.1089/can.2021.0114,Inconclusive,,Meta-analysis,2021,,,Fatty Liver Disease; Fibrosis - Liver (Cirrhosis); Fibrosis
2021650,Inhalant Cannabidiol Inhibits Glioblastoma Progression Through Regulation of Tumor Microenvironment,https://pubmed.ncbi.nlm.nih.gov/34918964/,Positive,,Animal Study,2021,,,Cancer - Brain; Cancer
2021651,CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature,https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-021-00108-7,Positive,,Clinical Trial,2021,,Mental/Emotional System,Autism
2021652,Feeding Cannabidiol (CBD)-Containing Treats Did Not Affect Canine Daily Voluntary Activity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118201/,Positive,,Animal Study -,2021,,,Veterinary Applications
2021653,Reducing Effect of Cannabidiol on Alcohol Self-Administration in Sardinian Alcohol-Preferring Rats,https://pubmed.ncbi.nlm.nih.gov/33998889/,Positive,,Animal Study,2021,,Mental/Emotional System,Addiction - Alcohol; Addiction
2021654,Neuroprotective Effect of Cannabidiol Against Hydrogen Peroxide in Hippocampal Neuron Culture,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891195/,Positive,,Laboratory Study,2021,,,Oxidative Stress
2021655,Cannabidiol antidepressant-like effect in the lipopolysaccharide model in mice: Modulation of inflammatory pathways,https://pubmed.ncbi.nlm.nih.gov/33513342/,Positive,,Animal Study,2021,,Mental/Emotional System,Depression; Inflammation
2021656,Roles of Cannabidiol in the treatment and prevention of Alzheimer's disease by multi-target actions,https://pubmed.ncbi.nlm.nih.gov/33797364/,Positive,,Meta-analysis,2021,,,Alzheimer's Disease
2021657,Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson’s Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396349/,Positive,,Animal Study,2021,,,Parkinson's Disease
2021658,Exacerbation of eyelid myoclonia in patients with epilepsy and eyelid myoclonia receiving cannabidiol,https://pubmed.ncbi.nlm.nih.gov/34642157/,Negative,,Meta-analysis,2021,,Nervous System,Epilepsy
2019122,"Spontaneous, anecdotal, retrospective, open-label study on the efficacy, safety and tolerability of cannabis galenical preparation (Bedrocan)",https://bedrocan.com/wp-content/uploads/2019_spontaneous-anecdotal-retrospective-open-label-study-on_palmieri.pdf,Positive,,Clinical Trial,2019,,,Pain; Pain - Chronic
2021659,Medical cannabis for severe treatment resistant epilepsy in children: a case-series of 10 patients,https://bmjpaedsopen.bmj.com/content/5/1/e001234,Positive,,Clinical Trial,2021,,Nervous System,Epilepsy
2021660,Medical Cannabis Certification Is Associated With Decreased Opiate Use in Patients With Chronic Pain: A Retrospective Cohort Study in Delaware,https://www.cureus.com/articles/77114-medical-cannabis-certification-is-associated-with-decreased-opiate-use-in-patients-with-chronic-pain-a-retrospective-cohort-study-in-delaware,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction; Pain; Pain - Chronic
2021661,The Cannabidiol Analog PECS-101 Prevents Chemotherapy-Induced Neuropathic Pain via PPARγ Receptors,https://pubmed.ncbi.nlm.nih.gov/34904193/,Positive,,Animal Study,2021,Synthetic Cannabinoid (unspecified),Nervous System,Pain; Pain - Neuropathy - Drug-Ind. Polyneuropathy
2021662,"Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses",https://www.frontiersin.org/articles/10.3389/fphar.2021.777804/full,Positive,,Meta-analysis,2021,Cannabichromene (CBC); Cannabidiolic Acid (CBD-a); Cannabigerol (CBG); Cannabigerolic Acid (CBG-a); Cannabinol (CBN); Tetrahydrocannabinolic Acid (THC-a),,
2021663,Antinociceptive and Anti-Inflammatory Properties of Cannabidiol Alone and in Combination with Standardized Bioflavonoid Composition,https://pubmed.ncbi.nlm.nih.gov/33570460/,Positive,,Animal Study,2021,,Nervous System,Inflammation; Pain; Pain - Acute; Pain - Chronic
2021664,Protective Effects of Cannabidiol on the Membrane Proteome of UVB-Irradiated Keratinocytes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001542/,Positive,,Laboratory Study,2021,,Integumentary System,Sunburn; Oxidative Stress
2021665,The endocannabinoid system as a therapeutic target for schizophrenia: Failures and potentials,https://pubmed.ncbi.nlm.nih.gov/34146641/,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Schizophrenia; Psychosis
2021666,Combination therapy with cannabidiol and chemotherapeutics in canine urothelial carcinoma cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341525/,Positive,,Laboratory Study -,2021,,,Veterinary Applications
2021667,Cannabidiol Does Not Impair Anabolic Signaling Following Eccentric Contractions in Rats,https://pubmed.ncbi.nlm.nih.gov/33621949/,Positive,,Animal Study,2021,,Nervous System,Inflammation
2021668,Cannabidiol treatment of severe refractory epilepsy in children and young adults,https://pubmed.ncbi.nlm.nih.gov/33913416/,Positive,,Meta-analysis,2021,,,Epilepsy; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut
2021669,Disease-Dependent Antiapoptotic Effects of Cannabidiol for Keratinocytes Observed upon UV Irradiation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470797/,Positive,,Laboratory Study,2021,,,Psoriasis; Sunburn
2021670,Effects of cannabidiol in cannabis flower: Implications for harm reduction,https://pubmed.ncbi.nlm.nih.gov/34467598/,Positive,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2021671,"Effects on the Post-translational Modification of H3K4Me3, H3K9ac, H3K9Me2, H3K27Me3, and H3K36Me2 Levels in Cerebral Cortex, Hypothalamus and Pons of Rats after a Systemic Administration of Cannabidiol: A Preliminary Study",https://pubmed.ncbi.nlm.nih.gov/32972354/,Inconclusive,,Laboratory Study,2021,,,Insomnia and Sleep Disorders
2021672,Cognitive and behavioral effects of cannabidiol in patients with treatment-resistant epilepsy,https://pubmed.ncbi.nlm.nih.gov/33246899/,Positive,,Clinical Trial,2021,,,Epilepsy
2021673,Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038773/,Positive,,Meta-analysis,2021,,,Glaucoma
2021674,Regulatory Effects of Cannabidiol on Mitochondrial Functions: A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159073/,Inconclusive,,Meta-analysis,2021,,,Oxidative Stress
2020284,"JZL184, A Monoacylglycerol Lipase Inhibitor, Induces Bone Loss in a Multiple Myeloma Model of Immunocompetent Mice",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271071/,Inconclusive,,Animal Study,2020,Monoacylglycerol Lipase (MAGL),Cardiovascular System; Skeletal System,Cancer - Myeloma; Osteoporosis; Cancer - Breast; Cancer - Prostate; Cancer
2021675,"Novel Δ8‐Tetrahydrocannabinol Vaporizers Contain Unlabeled Adulterants, Unintended Byproducts of Chemical Synthesis, and Heavy Metals",https://pubmed.ncbi.nlm.nih.gov/34889611/,Negative,,Laboratory Study,2021,Delta-8-THC; Synthetic Cannabinoid (unspecified),,Poisoning by Synthetic Cannabis
2021676,Efficacy of cannabis-based medications compared to placebo for the treatment of chronic neuropathic pain: a systematic review with meta-analysis,https://pc.jdapm.org/DOIx.php?id=10.17245/jdapm.2021.21.6.479,Positive,,Clinical Meta-analysis,2021,Cannabidivarin (CBDV); Pharma THC:CBD; Pharma THC,Nervous System,Pain; Pain - Chronic
2021677,Beta-Caryophyllene Exhibits Anti-Proliferative Effects through Apoptosis Induction and Cell Cycle Modulation in Multiple Myeloma Cells,https://pubmed.ncbi.nlm.nih.gov/34830893/,Positive,,Laboratory Study,2021,AM-x Synthetic Cannabinoids,Cardiovascular System,Cancer - Myeloma
2021678,"Knowledge, Perception, and Use of Cannabis Therapy in Patients with Inflammatory Bowel Disease",https://pubmed.ncbi.nlm.nih.gov/34792923/,Positive,,Meta-analysis,2021,,Digestive System,IBD - Inflammatory Bowel Disease
2015094,Targeting cannabinoid receptor-2 pathway by phenylacetylamide suppresses the proliferation of human myeloma cells through mitotic dysregulation and cytoskeleton disruption,https://pubmed.ncbi.nlm.nih.gov/25640641/,Positive,,Laboratory Study,2015,,Cardiovascular System,Cancer - Myeloma
2020285,High Expression of Cannabinoid Receptor 2 on Cytokine-Induced Killer Cells and Multiple Myeloma Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312510/,Positive,,Laboratory Study,2020,,Cardiovascular System,Cancer - Myeloma
2014071,The endocannabinoid system and appetite: relevance for food reward,https://www.cambridge.org/core/journals/nutrition-research-reviews/article/endocannabinoid-system-and-appetite-relevance-for-food-reward/30C65E719848770761B6BEA7D0C1E9CB,Inconclusive,,Meta-analysis,2014,Synthetic Cannabinoid (unspecified); Endocannabinoid (unspecified),Endocrine System,Obesity; Anorexia Nervosa; Anorexia; Cachexia; Metabolic Syndrome
2021679,A geospatiotemporal and causal inference epidemiological exploration of substance and cannabinoid exposure as drivers of rising US pediatric cancer rates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908679/,Negative,,Meta-analysis,2021,Cannabigerol (CBG),,Cancer; Addiction - Alcohol; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Cannabis Adverse Effects
2021680,The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of In Vivo Studies,https://www.liebertpub.com/doi/10.1089/can.2020.0105,Positive,,Meta-analysis,2021,Cannabigerol (CBG),Nervous System,Inflammation; Pain; Pain - Neuropathy - Peripheral
2021681,"Cannabinoid exposure as a major driver of pediatric acute lymphoid Leukaemia rates across the USA: combined geospatial, multiple imputation and causal inference study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414697/,Negative,,Meta-analysis,2021,Cannabichromene (CBC); Cannabigerol (CBG); Cannabinol (CBN),Immune System,Cancer - Leukemia; Cancer; Neonatal Cerebral Issues
2021682,Protective Effects of Cannabidivarin and Cannabigerol on Cells of the Blood–Brain Barrier Under Ischemic Conditions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380798/,Positive,,Laboratory Study,2021,Cannabidivarin (CBDV); Cannabigerol (CBG); Tetrahydrocannabivarin (THCV),,Inflammation; Stroke; Cardiovascular Diseases (CVD)
2021683,Anti-Bacterial Properties of Cannabigerol Toward Streptococcus mutans,https://www.frontiersin.org/articles/10.3389/fmicb.2021.656471/full,Positive,,Laboratory Study,2021,Cannabigerol (CBG),Digestive System; Immune System,Bacterial Infections; Periodontal Disease
2011068,Cannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes,https://pubmed.ncbi.nlm.nih.gov/21484568/,Positive,,Meta-analysis,2011,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified),Endocrine System,Diabetes; Metabolic Syndrome; Obesity
2020286,Sleep and neurochemical modulation by cannabidiolic acid methyl ester in rats,https://pubmed.ncbi.nlm.nih.gov/31838151/,Positive,,Animal Study,2020,HU-x Synthetic Cannabinoids; Cannabidiolic Acid (CBD-a),Nervous System,Insomnia and Sleep Disorders; Anxiety; Depression; Nausea and Vomiting
2005024,Cannabinoids: between neuroprotection and neurotoxicity,https://pubmed.ncbi.nlm.nih.gov/16375685/,Positive,,Meta-analysis,2005,2-Arachidonoyl Glycerol (2-AG); Endocannabinoid (unspecified),,Neurodegenerative Issues
2016096,Prospects for Creation of Cardioprotective Drugs Based on Cannabinoid Receptor Agonists,https://pubmed.ncbi.nlm.nih.gov/26487546/,Positive,,Meta-analysis,2016,Endocannabinoid (unspecified),Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack
2011069,Endocannabinoids and traumatic brain injury,https://bpspubs.onlinelibrary.wiley.com/doi/epdf/10.1111/j.1476-5381.2011.01343.x,Positive,,Meta-analysis,2011,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified),Nervous System,Traumatic Brain Injury
2007028,Cannabinoids in health and disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202504/,Positive,,Meta-analysis,2007,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; Pharma CBD; Pharma THC:CBD; Pharma THC; Synthetic Cannabinoid (unspecified); Tetrahydrocannabinol (THC); WIN-x Synthetic Cannabinoids,,Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Alzheimer's Disease; Anorexia; Cardiovascular Diseases (CVD); Cognitive Dysfunction; Epilepsy; Glaucoma; Huntington's Disease; Inflammation; Tics and Tourettes; Metabolic Syndrome; Pain; Multiple Sclerosis; Neurodegenerative Issues; Obesity; Osteoporosis
2016097,Cannabis - the Israeli perspective,https://www.degruyter.com/document/doi/10.1515/jbcpp-2015-0091/html,Positive,,Meta-analysis,2016,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Delta-8-THC,,Anorexia; Bone Fractures; Cachexia; Cancer; Cardiovascular Diseases (CVD); Cognitive Dysfunction; Epilepsy; IBD - Crohn's Disease; Inflammation; Tics and Tourettes; Pain; Nausea and Vomiting; Neurodegenerative Issues; Obesity; Organ Transplant Failure; Parkinson's Disease; Psychosis; PTSD; Traumatic Brain Injury
2002016,Cannabidiol: an overview of some pharmacological aspects,https://pubmed.ncbi.nlm.nih.gov/12412831/,Positive,,Meta-analysis,2002,Anandamide (AEA),,Anxiety; Arthritis - Rheumatoid; Arthritis; Epilepsy; Nausea and Vomiting; Neurodegenerative Issues; Oxidative Stress; Psychosis
2009043,Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb,https://pubmed.ncbi.nlm.nih.gov/19729208/,Positive,,Meta-analysis,2009,Tetrahydrocannabivarin (THCV),,Cancer; Diabetes; Inflammation; Neurodegenerative Issues; Obesity
2015095,Endocannabinoid signaling at the periphery: 50 years after THC,https://www.cell.com/trends/pharmacological-sciences/fulltext/S0165-6147(15)00034-6?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0165614715000346%3Fshowall%3Dtrue,Inconclusive,,Meta-analysis,2015,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified),,
2021684,Anti-Biofilm Activity of Cannabigerol against Streptococcus mutans,https://www.mdpi.com/2076-2607/9/10/2031/htm,Positive,,Laboratory Study,2021,Cannabigerol (CBG),Immune System,Bacterial Infections
2021685,"Cannabidiol disrupts apoptosis, autophagy and invasion processes of placental trophoblasts",https://pubmed.ncbi.nlm.nih.gov/34302491/,Negative,,Laboratory Study,2021,,Reproductive System,Pregnancy; Neonatal Cerebral Issues
2021686,Safety and tolerability of escalating cannabinoid doses in healthy cats,https://pubmed.ncbi.nlm.nih.gov/33769105/,Positive,,Animal Study -,2021,,,Veterinary Applications
2021687,"Efficacy of Cannabidiol for Δ-9-Tetrahydrocannabinol-Induced Psychotic Symptoms, Schizophrenia, and Cannabis Use Disorders: A Narrative Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005219/,Positive,,Clinical Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Psychosis; Schizophrenia
2021688,Cannabidiol in the management of bruxism in behavioral variant of frontotemporal degeneration,https://pubmed.ncbi.nlm.nih.gov/33934685/,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Behavioral Disorders; Cognitive Dysfunction; Neurodegenerative Issues
2021689,"A Mini-Review of Relationships Between Cannabis Use and Neural Foundations of Reward Processing, Inhibitory Control and Working Memory",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100188/,Negative,,Meta-analysis,2021,,Nervous System,Cognitive Dysfunction; Addiction - Alcohol; Addiction - Benzodiazepine; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant
2021690,Longitudinal impact of cannabidiol on EEG measures in subjects with treatment-resistant epilepsy,https://pubmed.ncbi.nlm.nih.gov/34273739/,Positive,,Clinical Trial,2021,Pharma CBD,Nervous System,Epilepsy
2021691,Reasons for using cannabidiol: a cross-sectional study of French cannabidiol users,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495963/,Inconclusive,,Meta-analysis,2021,,,Anxiety; Insomnia and Sleep Disorders; Oxidative Stress
2021692,The plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice,https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2010.00756.x,Positive,,Laboratory Study,2021,Tetrahydrocannabivarin (THCV),Nervous System,Inflammation; Pain; Pain - Inflammatory
2021693,Δ9-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats,https://onlinelibrary.wiley.com/doi/10.1111/j.1528-1167.2010.02523.x,Positive,,Animal Study,2021,Tetrahydrocannabivarin (THCV),Nervous System,Epilepsy
2021694,"Cannabinoid metabolites as inhibitors of major hepatic CYP450 enzymes, with implications for cannabis-drug interactions",https://pubmed.ncbi.nlm.nih.gov/34493602/,Negative,,Laboratory Study,2021,Cannabinol (CBN),,Cannabis Adverse Effects; Liver Failure
2021695,Cannabidiol Protects Human Skin Keratinocytes from Hydrogen-Peroxide-Induced Oxidative Stress via Modulation of the Caspase-1-IL-1β Axis,https://pubmed.ncbi.nlm.nih.gov/33955754/,Positive,,Laboratory Study,2021,,Nervous System,Oxidative Stress
2021696,Safety and Tolerability of Transdermal Cannabidiol Gel in Children With Developmental and Epileptic Encephalopathies: A Nonrandomized Controlled Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417764/,Positive,,Clinical Trial,2021,,Nervous System,Encephalitis and Myelitis; Epilepsy
2021697,Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum,https://pubmed.ncbi.nlm.nih.gov/34015384/,Positive,,Animal Study,2021,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2021698,Cannabidiol prevents amphetamine relapse and modulates D1- and D2-receptor levels in mesocorticolimbic brain areas of rats,https://pubmed.ncbi.nlm.nih.gov/33951588/,Positive,,Animal Study,2021,,Mental/Emotional System,Addiction - Stimulant; Addiction
2021699,"Cellular distribution of cannabinoid-related receptors TRPV1, PPAR-gamma, GPR55 and GPR3 in the equine cervical dorsal root ganglia",https://pubmed.ncbi.nlm.nih.gov/34418142/,Positive,,Animal Study -,2021,,,Veterinary Applications
2021700,Cannabinoids: A Cause of Severe Bradycardia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378321/,Negative,,Meta-analysis,2021,,Cardiovascular System,Cardiac Arrhythmias; Cardiovascular Diseases (CVD)
2021701,"Cannabidiol Cigarettes as Adjunctive Treatment for Psychotic Disorders - A Randomized, Open-Label Pilot-Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599279/,Positive,,Double Blind Clinical Trial,2021,,Mental/Emotional System,Psychosis
2021702,Cannabis based medicines and cannabis dependence: A critical review of issues and evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278552/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
20221014,Drug-drug interaction between cannabidiol and phenobarbital in healthy dogs,https://pubmed.ncbi.nlm.nih.gov/34727050/,Positive,,Animal Study -,2022,,,Veterinary Applications
2021703,"From the Clinic to the Laboratory, and Back Again: Investigations on Cannabinoids and Endocannabinoid System Modulators for Treating Schizophrenia",https://www.frontiersin.org/articles/10.3389/fpsyt.2021.682611/full,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2021704,Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment,https://pubmed.ncbi.nlm.nih.gov/34655773/,Inconclusive,,Meta-analysis,2021,Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2021705,Cannabidiol Signaling in the Eye and Its Potential as an Ocular Therapeutic Agent,https://www.cellphysiolbiochem.com/Articles/000371/,Positive,,Meta-analysis,2021,,Nervous System,Cataract; Glaucoma; Inflammation; Pain; Neurodegenerative Issues; Oxidative Stress; Pain - Eye; Retinal Disorders
2021706,Long-term safety and efficacy of highly purified cannabidiol for treatment refractory epilepsy,https://pubmed.ncbi.nlm.nih.gov/33667843/,Positive,,Clinical Trial,2021,Pharma CBD,,Epilepsy
2021707,Pharmacokinetics and effects on arachidonic acid metabolism of low doses of cannabidiol following oral administration to horses,https://pubmed.ncbi.nlm.nih.gov/33723919/,Inconclusive,,Animal Study -,2021,,,Veterinary Applications
2021708,"Demographics, Perceptions, and Use of Medical Marijuana among Patients in Florida",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525215/,Positive,,Meta-analysis,2021,,,Anxiety; Pain; Pain - Chronic
2021709,Health Outcomes among Adults Initiating Medical Cannabis for Chronic Pain: A 3-month Prospective Study Incorporating Ecological Momentary Assessment (EMA),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525881/,Positive,,Meta-analysis,2021,,Nervous System,Pain; Pain - Chronic
2021710,"The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination",https://pubmed.ncbi.nlm.nih.gov/34082108/,Positive,,Animal Study,2021,Cannabigerol (CBG),Nervous System,Inflammation
2021711,"Cannabidiol Use, Substitution for Medications, and Perceptions of Effectiveness in Women with Chronic Pelvic Pain",https://www.sciencedirect.com/science/article/pii/S1553465021008955#!,Positive,,Meta-analysis,2021,,Nervous System,Pain; Pain - Chronic; Addiction - Benzodiazepine; Addiction - Opioid; Anxiety; Cannabis Adverse Effects; Depression; Endometriosis; Fibromyalgia; Insomnia and Sleep Disorders; Irritable Bowel Syndrome; Pain - Inflammatory
2021712,The Use of Cannabinoids for Insomnia in Daily Life: Naturalistic Study,https://pubmed.ncbi.nlm.nih.gov/34704957/,Positive,,Meta-analysis,2021,,Nervous System,Insomnia and Sleep Disorders
2021713,Alteration of the Canine Metabolome After a 3-Week Supplementation of Cannabidiol (CBD) Containing Treats: An Exploratory Study of Healthy Animals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322615/,Positive,,Animal Study -,2021,,,Veterinary Applications
2021714,Effect of Cannabidiol (CBD) on Canine Inflammatory Response: An Ex Vivo Study on LPS Stimulated Whole Blood,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473042/,Positive,,Laboratory Study -,2021,,,Veterinary Applications
2021715,Localisation of Cannabinoid and Cannabinoid-Related Receptors in the Horse Ileum,https://pubmed.ncbi.nlm.nih.gov/34416995/,Inconclusive,,Laboratory Study -,2021,,,Veterinary Applications
2021716,Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeutics,https://pubmed.ncbi.nlm.nih.gov/33940011/,Inconclusive,,Meta-analysis,2021,,,Anxiety; Epilepsy; Multiple Sclerosis; PTSD
2021717,"Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial",https://www.liebertpub.com/doi/10.1089/can.2021.0093,Inconclusive,,Double Blind Clinical Trial,2021,,Respiratory System,COVID-19
2021718,"Perceived Efficacy, Reduced Prescription Drug Use, and Minimal Side Effects of Cannabis in Patients with Chronic Orthopedic Pain",https://www.liebertpub.com/doi/10.1089/can.2021.0088,Positive,,Meta-analysis,2021,,Nervous System,Pain; Pain - Chronic
2021719,"Cannabidiol-based natural health products for companion animals: Recent advances in the management of anxiety, pain, and inflammation",https://pubmed.ncbi.nlm.nih.gov/34391060/,Positive,,Meta-analysis -,2021,,Mental/Emotional System; Nervous System,Anxiety; Inflammation; Pain; Veterinary Applications; Arthritis - Osteoarthritis; Arthritis; Pain - Acute; Pain - Chronic
2021720,"In Vitro Studies on Therapeutic Effects of Cannabidiol in Neural Cells: Neurons, Glia, and Neural Stem Cells",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512311/,Positive,,Meta-analysis,2021,,,Inflammation; Neurodegenerative Issues
2021721,A single oral dose of cannabidiol did not reduce upper limb tremor in patients with essential tremor,https://pubmed.ncbi.nlm.nih.gov/33465546/,Inconclusive,,Double Blind Clinical Trial,2021,,Nervous System,Essential Tremor; Dystonia; Multiple Sclerosis; Parkinson's Disease
2021722,Two-center experience of cannabidiol use in adults with Dravet syndrome,https://www.seizure-journal.com/article/S1059-1311(21)00165-5/fulltext,Positive,,Clinical Trial,2021,Pharma CBD,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy; Epilepsy - Lennox-Gastaut; Quality of Life
2021723,"Cannabis, Cannabidiol Oils and Tetrahydrocannabinol—What Do Veterinarians Need to Know?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003882/,Inconclusive,,Meta-analysis -,2021,,,Veterinary Applications
2021724,Cannabinoids in Audiogenic Seizures: From Neuronal Networks to Future Perspectives for Epilepsy Treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904685/,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified),Nervous System,Epilepsy
2021725,CBD Promotes Oral Ulcer Healing via Inhibiting CMPK2-Mediated Inflammasome,https://pubmed.ncbi.nlm.nih.gov/34269108/,Positive,,Animal Study,2021,,Immune System; Integumentary System,Inflammation; Wound Healing
2021726,Cannabidiol selectively inhibits the contraction of rat small resistance arteries: Possible role for CGRP and voltage-gated calcium channels,https://pubmed.ncbi.nlm.nih.gov/33275960/,Positive,,Laboratory Study,2021,,,Cardiovascular Diseases (CVD)
2021727,The long-term efficacy of cannabidiol in the treatment of refractory epilepsy,https://pubmed.ncbi.nlm.nih.gov/34050682/,Positive,,Meta-analysis,2021,Pharma CBD,,Epilepsy
2021728,"Potential role of cannabidiol in Parkinson’s disease by targeting the WNT/β-catenin pathway, oxidative stress and inflammation",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064164/,Positive,,Meta-analysis,2021,,,Parkinson's Disease; Inflammation; Neurodegenerative Issues; Oxidative Stress
2021729,The effect of cannabidiol on canine neoplastic cell proliferation and mitogen-activated protein kinase activation during autophagy and apoptosis,https://pubmed.ncbi.nlm.nih.gov/33247539/,Positive,,Laboratory Study,2021,,,Cancer
2021730,Chronic administration of synthetic cannabidiol induces antidepressant effects involving modulation of serotonin and noradrenaline levels in the hippocampus,https://pubmed.ncbi.nlm.nih.gov/33388355/,Positive,,Animal Study,2021,,Mental/Emotional System,Depression
2021731,A pilot randomised placebo-controlled trial of cannabidiol to reduce severe behavioural problems in children and adolescents with intellectual disability,https://pubmed.ncbi.nlm.nih.gov/32478863/,Positive,,Double Blind Clinical Trial,2021,,,Cognitive Dysfunction; ADD and ADHD; Autism
2021732,Cytochrome P450-Catalyzed Metabolism of Cannabidiol to the Active Metabolite 7-Hydroxy-Cannabidiol,https://pubmed.ncbi.nlm.nih.gov/34330718/,Negative,,Laboratory Study,2021,Pharma CBD,,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Hepatitis; Liver Failure
2021733,Different responses of repetitive behaviours in juvenile and young adult mice to Δ 9 -tetrahydrocannabinol and cannabidiol may affect decision making for Tourette syndrome,https://pubmed.ncbi.nlm.nih.gov/33125731/,Negative,,Animal Study,2021,,,Tics and Tourettes
2021734,Cannabidiol modulation of hippocampal glutamate in early psychosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278563/,Positive,,Double Blind Clinical Trial,2021,,Mental/Emotional System,Psychosis; Addiction - Stimulant; Schizophrenia
2021735,Cannabis/Cannabinoids for Treating COVID-19 Associated Neuropsychiatric Complications,https://link.springer.com/article/10.1007%2Fs11481-021-10013-8,Inconclusive,,Meta-analysis,2021,,Respiratory System,COVID-19; Addiction - Cannabis; Addiction - Nicotine; Addiction - Opioid; Anxiety; Depression
2021736,Cannabidiol (CBD) Use by Older Adults for Acute and Chronic Pain,https://pubmed.ncbi.nlm.nih.gov/34191653/,Positive,,Meta-analysis,2021,,,Pain; Pain - Chronic
2021737,Cannabidiol and Abnormal Liver Chemistries in Healthy Adults: Results of a Phase I Clinical Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246741/,Positive,,Meta-analysis,2021,Pharma CBD,Digestive System; Mental/Emotional System,Cannabis Adverse Effects; Hepatitis; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2021738,New therapeutic approach in Dravet syndrome and Lennox-Gastaut syndrome with cannabidiol,https://www.neurologia.com/articulo/2021017/eng,Positive,,Meta-analysis,2021,Pharma CBD,,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2021739,Chronic Treatment with Cannabidiolic Acid (CBDA) Reduces Thermal Pain Sensitivity in Male Mice and Rescues the Hyperalgesia in a Mouse Model of Rett Syndrome,https://www.sciencedirect.com/science/article/abs/pii/S0306452220306254?via%3Dihub,Positive,,Animal Study,2021,Cannabidiolic Acid (CBD-a),Nervous System,Pain - Acute; Rett Syndrome; Anxiety; Cognitive Dysfunction; Pain; Nausea and Vomiting; Neonatal Cerebral Issues; Pain - Chronic
2017085,"Therapeutic use of cannabinoids-dose finding, effects and pilot data of effects in chronic migraine and cluster headache",https://www.tga.gov.au/pain-randomised-controlled-trials-and-other-studies,Positive,,Clinical Trial,2017,,,Migraine
2021740,Medication Overuse Headache in Chronic Migraine Patients Using Cannabis: A Case-Referent Study,https://www.researchgate.net/publication/349136276_Medication_Overuse_Headache_in_Chronic_Migraine_Patients_Using_Cannabis_A_Case-Referent_Study,Negative,,Meta-analysis,2021,,,Migraine
2021741,Can Cannabidiol Affect the Efficacy of Chemotherapy and Epigenetic Treatments in Cancer?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160970/,Positive,,Meta-analysis,2021,Pharma CBD,Digestive System; Nervous System; Reproductive System,Cancer - Ovarian; Cancer; Chemotherapy-induced Nausea & Vomiting; Anxiety; Inflammation; Pain; Nausea and Vomiting; Pain - Acute; Pain - Chronic
2021742,Efficacy of cannabinoids against glioblastoma multiforme: A systematic review,https://pubmed.ncbi.nlm.nih.gov/33812759/,Positive,,Meta-analysis,2021,,,Cancer; Cancer - Neuroblastoma
2021743,"Cannabidiol Interactions with Medications, Illicit Substances, and Alcohol: a Comprehensive Review",https://pubmed.ncbi.nlm.nih.gov/33515191/,Negative,,Meta-analysis,2021,Pharma CBD,,Addiction - Alcohol; Addiction - Nicotine; Addiction - Opioid; Depression; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2021744,Cannabinoids—A New Perspective in Adjuvant Therapy for Pulmonary Hypertension,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472313/,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Monoacylglycerol Lipase (MAGL),Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Fibrosis - Lung; Fibrosis
2021745,The Effects of Cannabidiol Oil on Noninvasive Measures of Muscle Damage in Men,https://journals.lww.com/acsm-msse/fulltext/2021/07000/the_effects_of_cannabidiol_oil_on_noninvasive.17.aspx,Inconclusive,,Double Blind Clinical Trial,2021,,Nervous System,Pain; Pain - Acute; Inflammation
2021746,Cannabidiol Modulates the Motor Profile and NMDA Receptor-related Alterations Induced by Ketamine,https://pubmed.ncbi.nlm.nih.gov/32950556/,Inconclusive,,Animal Study,2021,,,Schizophrenia
2021747,Global Trends in Cannabis and Cannabidiol Research from the Year 1940 to 2019,https://pubmed.ncbi.nlm.nih.gov/32479242/,Positive,,Meta-analysis,2021,Pharma CBD,,
2021748,Cannabidiol as prophylaxis for SARS-CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269703/,Negative,,Meta-analysis,2021,Pharma CBD,Respiratory System,COVID-19; Bacterial Infections; Inflammation; Neurodegenerative Issues
2021749,Repurposing Cannabidiol as a Potential Drug Candidate for Anti-Tumor Therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071421/,Positive,,Meta-analysis,2021,,Nervous System,Cancer; Inflammation
2021750,Understanding the Modulatory Effects of Cannabidiol on Alzheimer’s Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472755/,Positive,,Meta-analysis,2021,Pharma CBD,,Alzheimer's Disease; Neurodegenerative Issues; Cognitive Dysfunction
2020287,Cannabidiol for the Treatment of Neonatal Hypoxic-Ischemic Brain Injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830676/,Positive,,Meta-analysis,2020,,Nervous System,Neonatal Cerebral Issues; Cerebral Palsy; Inflammation; Oxidative Stress; Stroke
2021751,Cannabidiol-enriched oil in children and adults with treatment-resistant epilepsy-does tolerance exist?,https://www.brainanddevelopment.com/article/S0387-7604(20)30183-2/fulltext,Negative,,Meta-analysis,2021,,Nervous System,Epilepsy
2021752,Cannabidiol and the corticoraphe circuit in post-traumatic stress disorder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408530/,Positive,,Meta-analysis,2021,Anandamide (AEA),Mental/Emotional System,PTSD; Anxiety; Insomnia and Sleep Disorders
2021753,"Isolation, Synthesis And Structure Determination Of Cannabidiol Derivatives And Their Cytotoxic Activities",https://pubmed.ncbi.nlm.nih.gov/31282748/,Positive,,Laboratory Study,2021,,,Cancer
2020288,"Cannabidiol for epilepsy (Lennox-Gastaut syndrome, Dravet syndrome)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900273/,Positive,,Clinical Meta-analysis,2020,Pharma CBD,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2021754,Could Cannabidiol Be a Treatment for Coronavirus Disease-19-Related Anxiety Disorders?,https://pubmed.ncbi.nlm.nih.gov/33614948/,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System; Respiratory System,Anxiety; COVID-19; Depression; Insomnia and Sleep Disorders; PTSD
2021755,Possible Enhancement of Photodynamic Therapy (PDT) Colorectal Cancer Treatment when Combined with Cannabidiol,https://pubmed.ncbi.nlm.nih.gov/32294046/,Positive,,Meta-analysis,2021,,,Cancer
2021756,Cannabidiol (CBD) and cognition in epilepsy,https://www.epilepsybehavior.com/article/S1525-5050(21)00577-1/fulltext,Positive,,Meta-analysis,2021,,,Epilepsy
2021757,Improved Bioavailability with Dry Powder Cannabidiol Inhalation: A Phase 1 Clinical Study,https://jpharmsci.org/article/S0022-3549(21)00413-5/fulltext,Positive,,Clinical Trial,2021,Pharma CBD,,Anxiety; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Insomnia and Sleep Disorders; Pain; Pain - Chronic
2021758,The Role of Cannabidiol in Neurological Disorders,https://pubmed.ncbi.nlm.nih.gov/33970090/,Positive,,Meta-analysis,2021,,,Alzheimer's Disease; Amyotrophic Lateral Sclerosis (ALS); Autism; Bipolar Disorder; Cerebral Palsy; Cognitive Dysfunction; Migraine; Multiple Sclerosis; Muscular Dystrophy & Myotonic Disorders; Neurodegenerative Issues; Parkinson's Disease; Stroke
2021759,Effects of cannabidiol (CBD) on the inhibition of melanoma cells in vitro,https://pubmed.ncbi.nlm.nih.gov/33428525/,Positive,,Laboratory Study,2021,,Integumentary System; Nervous System,Cancer - Melanoma; Cancer
2021760,Cannabidiol and Neurodevelopmental Disorders in Children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175856/,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Microbiome,,ADD and ADHD; Behavioral Disorders; Anxiety; Autism; Bipolar Disorder; Cerebral Palsy; Depression; Down Syndrome; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Fragile X Syndrome; Inflammation; Insomnia and Sleep Disorders; Tics and Tourettes; Oxidative Stress; Pregnancy; Psychosis; Schizophrenia
2021761,Cannabinoids in the landscape of cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310855/,Positive,,Meta-analysis,2021,Synthetic Cannabinoid (unspecified),Nervous System,Cancer
2021762,Cannabidiol in the Treatment of Epilepsy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946683/,Positive,,Meta-analysis,2021,Pharma CBD,Nervous System,Epilepsy; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut
2021763,Exploiting cannabinoid and vanilloid mechanisms for epilepsy treatment,https://pubmed.ncbi.nlm.nih.gov/31839498/,Inconclusive,,Meta-analysis,2021,Anandamide (AEA),Nervous System,Epilepsy
2020289,"Cannabis, Cannabinoids, and Brain Morphology: A Review of the Evidence",https://pubmed.ncbi.nlm.nih.gov/32948510/,Inconclusive,,Meta-analysis,2020,,,Cognitive Dysfunction
2020290,Lennox–Gastaut Syndrome: Perspective of a Parent and a Physician,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140167/,Positive,,Meta-analysis,2020,Pharma CBD,Nervous System,Epilepsy - Lennox-Gastaut; Epilepsy
2021764,Cannabidiol for Mood Disorders: A Call for More Research,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918874/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Behavioral Disorders; Depression; Bipolar Disorder; Cognitive Dysfunction; Pain; Multiple Sclerosis; Pain - Chronic
2021765,Medicinal applications of cannabis/cannabinoids,https://pubmed.ncbi.nlm.nih.gov/32652488/,Inconclusive,,Meta-analysis,2021,Pharma CBD,Nervous System,Insomnia and Sleep Disorders; Pain; Epilepsy
2008044,Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system,https://pubmed.ncbi.nlm.nih.gov/18275004/,Positive,,Meta-analysis,2008,Echinacea; Fatty Acid Amide Hydrolase (FAAH),,Inflammation; Pain
2021766,"Can Echinacea be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019",https://www.sciencedirect.com/science/article/pii/S2405844021000955,Positive,,Meta-analysis,2021,Echinacea; Anandamide (AEA),Respiratory System,COVID-19; Bacterial Infections; Flu; Inflammation; Oxidative Stress; Staph Infection
2006019,Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects,https://pubmed.ncbi.nlm.nih.gov/16547349/,Positive,,Laboratory Study,2006,Anandamide (AEA); Echinacea; SR-x Synthetic Cannabinoids,Nervous System,Inflammation
2021767,The pro-apoptosis effects of Echinacea purpurea and Cannabis sativa extracts in human lung cancer cells through caspase-dependent pathway,https://pubmed.ncbi.nlm.nih.gov/33446187/,Positive,,Laboratory Study,2021,Echinacea; AM-x Synthetic Cannabinoids,Respiratory System,Cancer - Lung; Cancer
2011070,Alkamides and a neolignan from Echinacea purpurea roots and the interaction of alkamides with G-protein-coupled cannabinoid receptors,https://pubmed.ncbi.nlm.nih.gov/21764086/,Positive,,Laboratory Study,2011,Echinacea,,
2007029,The role of alkamides as an active principle of echinacea,https://pubmed.ncbi.nlm.nih.gov/17538868/,Inconclusive,,Meta-analysis,2007,Echinacea,,Inflammation
2021768,Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821324/,Positive,,Double Blind Clinical Trial,2021,Pharma CBD,Nervous System,Epilepsy
2021769,Evaluation of the Effect of Cannabidiol on Naturally Occurring Osteoarthritis-Associated Pain: A Pilot Study in Dogs,https://pubmed.ncbi.nlm.nih.gov/33450016/,Inconclusive,,Animal Study,2021,,Nervous System; Skeletal System,Arthritis - Osteoarthritis; Arthritis; Pain; Pain - Chronic
2021770,Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754080/,Positive,,Double Blind Clinical Trial,2021,Pharma CBD,Nervous System,Epilepsy
2021771,"Food effects on the formulation, dosing, and administration of cannabidiol (CBD) in humans: A systematic review of clinical studies",https://pubmed.ncbi.nlm.nih.gov/33583102/,Inconclusive,,Meta-analysis,2021,Pharma CBD,,
2010056,"Antinociceptive effect of the cannabinoid agonist, WIN 55,212-2, in the orofacial and temporomandibular formalin tests",https://pubmed.ncbi.nlm.nih.gov/19318283/,Positive,,Animal Study,2010,WIN-x Synthetic Cannabinoids,Muscular System,Temporomandibular Disorders
2007030,Blockade of central cyclooxygenase (COX) pathways enhances the cannabinoid-induced antinociceptive effects on inflammatory temporomandibular joint (TMJ) nociception,https://pubmed.ncbi.nlm.nih.gov/17321048/,Positive,,Animal Study,2007,WIN-x Synthetic Cannabinoids,Muscular System,Temporomandibular Disorders
2017086,Delta-9-tetrahydrocannabinol decreases masticatory muscle sensitization in female rats through peripheral cannabinoid receptor activation,https://pubmed.ncbi.nlm.nih.gov/28722246/,Positive,,Animal Study,2017,Tetrahydrocannabinol (THC),Muscular System,Temporomandibular Disorders
2008045,Low doses of cannabinoids enhance the antinociceptive effects of intracisternally-administered mGluRs groups II and III agonists in formalin-induced TMJ nociception in rats,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2590926/,Positive,,Animal Study,2008,WIN-x Synthetic Cannabinoids,Muscular System,Temporomandibular Disorders
2020291,Efficacy of topical interventions for temporomandibular disorders compared to placebo or control therapy: a systematic review with meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783375/,Positive,,Clinical Meta-analysis,2020,,Muscular System,Temporomandibular Disorders
2020292,"Inhalation Administration of the Bicyclic Ethers 1,8- and 1,4-cineole Prevent Anxiety and Depressive-Like Behaviors in Mice",https://www.mdpi.com/1420-3049/25/8/1884,Positive,,Animal Study,2020,,Mental/Emotional System; Nervous System,Anxiety; Depression
2020293,Challenges at the Time of COVID-19: Opportunities and Innovations in Antivirals from Nature,https://pubmed.ncbi.nlm.nih.gov/32434254/,Positive,,Meta-analysis,2020,Echinacea,Respiratory System,COVID-19
2017087,"Intranasal co-administration of 1,8-cineole with influenza vaccine provide cross-protection against influenza virus infection",https://pubmed.ncbi.nlm.nih.gov/28899494/,Positive,,Animal Study,2017,,Immune System; Respiratory System,Flu
2020294,Eucalyptol alleviates inflammation and pain responses in a mouse model of gout arthritis,https://pubmed.ncbi.nlm.nih.gov/31883118/,Positive,,Animal Study,2020,,Skeletal System,Arthritis - Gout; Arthritis - Osteoarthritis; Arthritis
2020295,"Proapoptotic Activity of Achillea membranacea Essential Oil and Its Major Constituent 1,8-Cineole against A2780 Ovarian Cancer Cells",https://pubmed.ncbi.nlm.nih.gov/32235558/,Positive,,Laboratory Study,2020,,Nervous System; Reproductive System,Cancer - Ovarian; Cancer
2018112,"Effects of dietary 1,8-cineole supplementation on physiological, immunological and antioxidant responses to crowding stress in rainbow trout (Oncorhynchus mykiss)",https://pubmed.ncbi.nlm.nih.gov/30010015/,Positive,,Animal Study,2018,,Mental/Emotional System; Nervous System,Oxidative Stress
2020296,"Is 1,8-Cineole-Rich Extract of Small Cardamom Seeds More Effective in Preventing Alzheimer's Disease than 1,8-Cineole Alone?",https://pubmed.ncbi.nlm.nih.gov/31628580/,Positive,,Laboratory Study,2020,Mind-Body Medicine,Nervous System,Alzheimer's Disease; Neurodegenerative Issues
2018113,"1,8-Cineole blocks voltage-gated L-type calcium channels in tracheal smooth muscle",https://pubmed.ncbi.nlm.nih.gov/30206706/,Positive,,Animal Study,2018,,,Asthma; Bronchitis; COPD; Cough
2020297,"1,8-Cineole promotes G0/G1 cell cycle arrest and oxidative stress-induced senescence in HepG2 cells and sensitizes cells to anti-senescence drugs",https://pubmed.ncbi.nlm.nih.gov/31926243/,Positive,,Laboratory Study,2020,,Digestive System; Nervous System,Cancer - Liver; Cancer
2015096,Possible opioid-saving effect of cannabis-based medicine using individual-based data from the Norwegian Prescription Database,https://onlinelibrary.wiley.com/doi/10.1111/bcpt.13660,Negative,,Meta-analysis,2015,Pharma THC:CBD,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
2021772,Tetrahydrocannabinol and cannabidiol as an oromucosal spray in a 1:1 ratio: a therapeutic option for patients with central post-stroke pain syndrome?,https://pubmed.ncbi.nlm.nih.gov/34230048/,Positive,,Meta-analysis,2021,Pharma THC:CBD,,Pain; Pain - Central Pain Syndrome; Stroke; Pain - Chronic
2021773,Efficacy of Δ9 -Tetrahydrocannabinol (THC) Alone or in Combination With a 1:1 Ratio of Cannabidiol (CBD) in Reversing the Spatial Learning Deficits in Old Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435893/,Negative,,Animal Study,2021,Pharma THC:CBD,,Cognitive Dysfunction
2021774,Cost-effectiveness of adding Sativex® spray to spasticity care in Belgium: using bootstrapping instead of Monte Carlo simulation for probabilistic sensitivity analyses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214588/,Positive,,Meta-analysis,2021,Pharma THC:CBD,,Multiple Sclerosis
2021775,The Utility of Delta-9-Tetrahydrocannibinol Therapy in a Multiple Sclerosis Patient with a Neoplastic Brain Lesion,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191345/,Positive,,Meta-analysis,2021,Pharma THC:CBD,Nervous System,Multiple Sclerosis
2021776,"Treatment with Delta-9-tetrahydrocannabinol/cannabidiol in Multiple Sclerosis: Influence on the Autonomy Profile according to the International Classification of Functioning, Disability and Health",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523373/,Positive,,Meta-analysis,2021,Pharma THC:CBD,Nervous System,Multiple Sclerosis
2021777,Nabiximols in Chronic Neuropathic Pain: A Meta-Analysis of Randomized Placebo-Controlled Trials,https://pubmed.ncbi.nlm.nih.gov/33561282/,Positive,,Clinical Meta-analysis,2021,Pharma THC:CBD,Nervous System,Pain; Pain - Chronic
2021778,Activity of (-)-Camphene Derivatives Against Mycobacterium tuberculosis in Acidic pH,https://pubmed.ncbi.nlm.nih.gov/31702530/,Positive,,Laboratory Study,2021,,Respiratory System,Tuberculosis
2020298,(-)-Camphene-based derivatives as potential antibacterial agents against Staphylococcus aureus and Enterococcus spp,https://pubmed.ncbi.nlm.nih.gov/33215538/,Positive,,Laboratory Study,2020,,Immune System,Bacterial Infections; Staph Infection
2020299,Camphene Attenuates Skeletal Muscle Atrophy by Regulating Oxidative Stress and Lipid Metabolism in Rats,https://pubmed.ncbi.nlm.nih.gov/33287349/,Positive,,Animal Study,2020,,Digestive System; Muscular System; Nervous System,Cachexia; Oxidative Stress
2014072,Dietary camphene attenuates hepatic steatosis and insulin resistance in mice,https://pubmed.ncbi.nlm.nih.gov/23818423/,Positive,,Animal Study,2014,,Digestive System,Fatty Liver Disease; Diabetes
2021779,"Effectiveness, safety and tolerability of nabiximols oromucosal spray versus typical oral long-acting opioid analgesics in patients with severe neuropathic back pain: analysis of 6-month real-world data from the German Pain e-Registry",https://academic.oup.com/painmedicine/advance-article/doi/10.1093/pm/pnab263/6364198,Positive,,Meta-analysis,2021,Pharma THC:CBD,Nervous System,Pain - Chronic; Pain - Neuropathy - Peripheral; Pain
2021780,Short and long term effects of Nabiximols on balance and walking assessed by 3D-gait analysis in people with Multiple Sclerosis and spasticity,https://pubmed.ncbi.nlm.nih.gov/33862313/,Positive,,Clinical Trial,2021,Pharma THC:CBD,Nervous System,Multiple Sclerosis
2021781,Effect of nabiximols on Goal Attainment Scale scores in patients with treatment-resistant multiple sclerosis spasticity,https://pubmed.ncbi.nlm.nih.gov/33641348/,Positive,,Meta-analysis,2021,Pharma THC:CBD,Nervous System,Multiple Sclerosis
2021782,Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218396/,Positive,,Meta-analysis,2021,Pharma THC:CBD,Nervous System,Multiple Sclerosis
2021783,"A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039032/,Positive,,Double Blind Clinical Trial,2021,Pharma THC:CBD,Nervous System,Cancer; Cancer - Brain
2021784,Cannabis and Autoimmunity: Possible Mechanisms of Action,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313508/#cit0022,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Cannabichromene (CBC); Cannabigerol (CBG); Cannabinol (CBN); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); N-Arachidonoyl Dopamine (NADA); Other Related Compounds; Virodhamine (O-AEA),,Arthritis - Rheumatoid; Arthritis; Inflammation; Irritable Bowel Syndrome; Multiple Sclerosis
2013065,The endocannabinoid system and the brain,https://pubmed.ncbi.nlm.nih.gov/22804774/,Inconclusive,,Meta-analysis,2013,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Tetrahydrocannabinol (THC),,Anxiety; Cognitive Dysfunction; Depression; Neurodegenerative Issues
2021785,Delivering therapeutic cannabinoids via skin: Current state and future perspectives,https://pubmed.ncbi.nlm.nih.gov/33964365/,Positive,,Meta-analysis,2021,Pharma CBD; Pharma THC:CBD; Pharma THC,,
2021786,Nabiximols and botulinum toxin injections for patients with multiple sclerosis: efficacy on spasticity and spasms in a single-centre experience,https://pubmed.ncbi.nlm.nih.gov/33742336/,Positive,,Meta-analysis,2021,Pharma THC:CBD,Nervous System,Multiple Sclerosis
2003012,Inhibition of acetylcholine-mediated effects by borneol,https://pubmed.ncbi.nlm.nih.gov/12473382/,Positive,,Laboratory Study,2003,,,Pain; Pain - Acute
2011071,Salvianic borneol ester reduces β-amyloid oligomers and prevents cytotoxicity,https://www.tandfonline.com/doi/full/10.3109/13880209.2011.559585,Positive,,Laboratory Study,2011,,,Alzheimer's Disease
2013066,Effect of borneol on cytochrome P450 3A enzyme and midazolam pharmacokinetics in rats,https://pubmed.ncbi.nlm.nih.gov/23589122/,Inconclusive,,Animal Study,2013,,,
2005025,(+)- And (-)-borneol: efficacious positive modulators of GABA action at human recombinant alpha1beta2gamma2L GABA(A) receptors,https://pubmed.ncbi.nlm.nih.gov/15763546/,Positive,,Laboratory Study,2005,,,Pain; Pain - Acute
2013067,"Borneol, a bicyclic monoterpene alcohol, reduces nociceptive behavior and inflammatory response in mice",https://www.hindawi.com/journals/tswj/2013/808460/,Positive,,Animal Study,2013,,Nervous System,Inflammation
2011072,Borneol alleviates oxidative stress via upregulation of Nrf2 and Bcl-2 in SH-SY5Y cells,https://www.tandfonline.com/doi/full/10.3109/13880209.2012.700718,Positive,,Laboratory Study,2011,,Nervous System,Oxidative Stress; Alzheimer's Disease
2014073,Comparative pharmacokinetics of borneol in cerebral ischemia-reperfusion and sham-operated rats,https://link.springer.com/article/10.1631%2Fjzus.B1300141,Positive,,Animal Study,2014,,Nervous System,Stroke
2017088,In vivo effect of borneol on rat hepatic CYP2B expression and activity,https://pubmed.ncbi.nlm.nih.gov/27889497/,Inconclusive,,Animal Study,2017,,,
2018114,"Evaluation of (-)-borneol derivatives against the Zika vector, Aedes aegypti and a non-target species, Artemia sp",https://pubmed.ncbi.nlm.nih.gov/30187415/,Positive,,Animal Study,2018,,,
2020300,"Preparation, Characterization and in vivo Study of Borneol-Baicalin-Liposomes for Treatment of Cerebral Ischemia-Reperfusion Injury",https://www.dovepress.com/preparation-characterization-and-in-vivo-study-of-borneol-baicalin-lip-peer-reviewed-fulltext-article-IJN,Positive,,Animal Study,2020,,Nervous System,Stroke
2015097,(+)-Borneol alleviates mechanical hyperalgesia in models of chronic inflammatory and neuropathic pain in mice,https://www.sciencedirect.com/science/article/abs/pii/S001429991500285X?via%3Dihub#preview-section-snippets,Positive,,Animal Study,2015,,Nervous System,Pain; Pain - Chronic; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral; Inflammation
2018115,Natural borneol is a novel chemosensitizer that enhances temozolomide-induced anticancer efficiency against human glioma by triggering mitochondrial dysfunction and reactive oxide species-mediated oxidative damage,https://www.dovepress.com/natural-borneol-is-a-novel-chemosensitizer-that-enhances-temozolomide--peer-reviewed-fulltext-article-OTT,Positive,,Laboratory Study,2018,,Nervous System,Cancer - Brain; Cancer
2020301,Engineering EHD1-Targeted Natural Borneol Nanoemulsion Potentiates Therapeutic Efficacy of Gefitinib against Nonsmall Lung Cancer,https://pubmed.ncbi.nlm.nih.gov/32927941/,Positive,,Laboratory Study,2020,,Nervous System; Respiratory System,Cancer - Lung; Cancer
2017089,Borneol enhances the antidepressant effects of asiaticoside by promoting its distribution into the brain,https://pubmed.ncbi.nlm.nih.gov/28263826/,Positive,,Animal Study,2017,,Mental/Emotional System; Nervous System,Depression
2016098,"Borneol inhibits TRPA1, a proinflammatory and noxious pain-sensing cation channel",https://pubmed.ncbi.nlm.nih.gov/26142526/,Positive,,Laboratory Study,2016,,Nervous System,Inflammation; Pain - Inflammatory; Pain - Nociceptive; Pain
2019123,Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson’s disease,https://www.tandfonline.com/doi/full/10.1080/10717544.2019.1636420,Positive,,Laboratory Study,2019,,Nervous System,Parkinson's Disease
2017090,(+)-Borneol is neuroprotective against permanent cerebral ischemia in rats by suppressing production of proinflammatory cytokines,https://pubmed.ncbi.nlm.nih.gov/28808202/,Positive,,Animal Study,2017,,Nervous System,Stroke
2019124,Metabolomics Study on the Effects of Salvianolic Acid B and Borneol for Treating Cerebral Ischemia in Rats by Ultra-Performance Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry,https://pubmed.ncbi.nlm.nih.gov/30411995/,Positive,,Animal Study,2019,,Nervous System,Stroke; Inflammation
2019125,Improving glioblastoma therapeutic outcomes via doxorubicin-loaded nanomicelles modified with borneol,https://pubmed.ncbi.nlm.nih.gov/31260781/,Positive,,Laboratory Study,2019,,Nervous System,Cancer
2019126,Pep-1&borneol-Bifunctionalized Carmustine-Loaded Micelles Enhance Anti-Glioma Efficacy Through Tumor-Targeting and BBB-Penetrating,https://pubmed.ncbi.nlm.nih.gov/30537472/,Positive,,Laboratory Study,2019,,Nervous System,Cancer - Brain; Cancer
2018116,Natural Borneol Enhances Paclitaxel-Induced Apoptosis of ESCC Cells by Inactivation of the PI3K/AKT,https://pubmed.ncbi.nlm.nih.gov/29660811/,Positive,,Laboratory Study,2018,,,Cancer
2016099,[Borneol promotes oral absorption and penetration into brain of puerarin and catalpol],https://pubmed.ncbi.nlm.nih.gov/28905612/,Positive,,Animal Study,2016,,,
2016100,Antiepileptogenic effects of borneol in pentylenetetrazole-induced kindling in mice,https://pubmed.ncbi.nlm.nih.gov/26887325/,Positive,,Animal Study,2016,,Nervous System,Epilepsy; Inflammation; Oxidative Stress
2020302,Enhanced Anti-Glioma Efficacy by Borneol Combined With CGKRK-Modified Paclitaxel Self-Assembled Redox-Sensitive Nanoparticles,https://www.frontiersin.org/articles/10.3389/fphar.2020.00558/full,Positive,,Laboratory Study,2020,,Nervous System,Cancer - Brain; Cancer
2020303,Effect of different doses of borneol on the pharmacokinetics of vinpocetine in rat plasma and brain after intraocular administration,https://pubmed.ncbi.nlm.nih.gov/31424307/,Positive,,Animal Study,2020,,,
2016101,Borneol Is a TRPM8 Agonist that Increases Ocular Surface Wetness,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0158868,Positive,,Animal Study,2016,,,
2017091,L-Borneol induces transient opening of the blood-brain barrier and enhances the therapeutic effect of cisplatin,https://pubmed.ncbi.nlm.nih.gov/28471848/,Positive,,Animal Study,2017,,,Cancer
2020304,Analgesic and anti-inflammatory effects and mechanism of action of borneol on photodynamic therapy of acne,https://pubmed.ncbi.nlm.nih.gov/31978868/,Positive,,Animal Study,2020,,Integumentary System; Nervous System,Acne; Inflammation; Pain; Pain - Inflammatory
2019127,New insights on relaxant effects of (-)-borneol monoterpene in rat aortic rings,https://pubmed.ncbi.nlm.nih.gov/30240490/,Positive,,Animal Study,2019,,,Cardiovascular Diseases (CVD)
2017092,Borneol Attenuates Ultrasound-Targeted Microbubble Destruction-Induced Blood–Brain Barrier Opening in Focal Cerebral Ischemia,https://www.frontiersin.org/articles/10.3389/fneur.2017.00704/full,Positive,,Animal Study,2017,,Nervous System,Stroke
2020305,Effects of Borneol on the Release of Compound Danshen Colon-Specific Osmotic Pump Capsule In Vitro and Pharmacokinetics Study in Beagle Dogs,https://pubmed.ncbi.nlm.nih.gov/33174133/,Positive,,Laboratory Study,2020,,,
2020306,Durable Antibacterial Cotton Fabrics Based on Natural Borneol-Derived Anti-MRSA Agents,https://pubmed.ncbi.nlm.nih.gov/32338449/,Positive,,Laboratory Study,2020,,Immune System,Bacterial Infections
2018117,(+)-Borneol suppresses conditioned fear recall and anxiety-like behaviors in mice,https://www.sciencedirect.com/science/article/abs/pii/S0006291X17324105?via%3Dihub,Positive,,Animal Study,2018,,Mental/Emotional System; Nervous System,Anxiety; Pain; Pain - Acute
2017093,Antifungal graphene oxide-borneol composite,https://www.sciencedirect.com/science/article/abs/pii/S092777651730601X?via%3Dihub,Positive,,Laboratory Study,2017,,Digestive System; Immune System; Integumentary System,Fungal Infections
2020307,Borneol-modified chitosan: Antimicrobial adhesion properties and application in skin flora protection,https://www.sciencedirect.com/science/article/abs/pii/S0144861719310458?via%3Dihub,Positive,,Laboratory Study,2020,,Immune System,Bacterial Infections
2018118,The Role and Mechanism of Borneol to Open the Blood-Brain Barrier,https://journals.sagepub.com/doi/10.1177/1534735418767553,Positive,,Animal Study,2018,,,
2020308,Inhibitory actions of borneol on the substantia gelatinosa neurons of the trigeminal subnucleus caudalis in mice,https://www.kjpp.net/journal/view.html?doi=10.4196/kjpp.2020.24.5.433,Positive,,Animal Study,2020,,Nervous System,Pain - Nociceptive; Pain
2021787,Borneol inhibits CD4 + T cells proliferation by down-regulating miR-26a and miR-142-3p to attenuate asthma,https://pubmed.ncbi.nlm.nih.gov/33272847/,Positive,,Animal Study,2021,,Respiratory System,Asthma; Inflammation
2019128,Influence of Orally Administered Borneol on the Expression of Hepatic Transporters in Rats,https://pubmed.ncbi.nlm.nih.gov/30105488/,Inconclusive,,Animal Study,2019,,,
2020309,Borneol promotes apoptosis of Human Glioma Cells through regulating HIF-1a expression via mTORC1/eIF4E pathway,https://www.jcancer.org/v11p4810.htm,Positive,,Animal Study,2020,,Nervous System,Cancer - Brain; Cancer
2020310,Natural borneol sensitizes human glioma cells to cisplatin-induced apoptosis by triggering ROS-mediated oxidative damage and regulation of MAPKs and PI3K/AKT pathway,https://www.tandfonline.com/doi/full/10.1080/13880209.2019.1703756,Positive,,Laboratory Study,2020,,Nervous System,Cancer - Brain; Cancer
2021788,Borneol protects against cerulein-induced oxidative stress and inflammation in acute pancreatitis mice model,https://pubmed.ncbi.nlm.nih.gov/33166053/,Positive,,Animal Study,2021,,Digestive System; Endocrine System,Pancreatitis; Inflammation
2018119,Borneol and Luteolin from Chrysanthemum morifolium Regulate Ubiquitin Signal Degradation,https://pubmed.ncbi.nlm.nih.gov/29995407/,Positive,,Laboratory Study,2018,,,Cancer
2017094,[Effect factors and mechanisms of borneol's bidirectional regulation on blood-brain barrier permeability],https://pubmed.ncbi.nlm.nih.gov/28822169/,Inconclusive,,Meta-analysis,2017,,,
2021789,(+/-)-Borneol Reverses Mitoxantrone Resistance against P-Glycoprotein,https://pubmed.ncbi.nlm.nih.gov/33378196/,Positive,,Laboratory Study,2021,,,Bacterial Infections; Cancer
2019129,"Design, characterization and comparison of transdermal delivery of colchicine via borneol-chemically-modified and borneol-physically-modified ethosome",https://www.tandfonline.com/doi/full/10.1080/10717544.2018.1559258,Positive,,Laboratory Study,2019,Mind-Body Medicine,Skeletal System,Arthritis - Gout; Arthritis
2018120,Borneol and Α-asarone as adjuvant agents for improving blood-brain barrier permeability of puerarin and tetramethylpyrazine by activating adenosine receptors,https://www.tandfonline.com/doi/full/10.1080/10717544.2018.1516005,Positive,,Laboratory Study,2018,,,Stroke
2021790,Vapor exposure to Δ9-tetrahydrocannabinol (THC) slows locomotion of the Maine lobster (Homarus americanus),https://pubmed.ncbi.nlm.nih.gov/34197845/,Negative,,Animal Study -,2021,,,Pain - Nociceptive; Anxiety; Pain; Veterinary Applications
2012085,Borneol administration protects primary rat hepatocytes against exogenous oxidative DNA damage,https://academic.oup.com/mutage/article/27/5/581/997987,Positive,,Animal Study,2012,,Digestive System,Alcoholic Liver Disease
2018121,"The protective roles of L-borneolum, D-borneolum and synthetic borneol in cerebral ischaemia via modulation of the neurovascular unit",https://pubmed.ncbi.nlm.nih.gov/29728011/,Positive,,Animal Study,2018,,,Stroke; Inflammation
2013068,Study on the anti-cerebral ischemia effect of borneol and its mechanism,https://pubmed.ncbi.nlm.nih.gov/24653571/,Positive,,Animal Study,2013,,,Stroke
2017095,"Ameliorative effect of borneol, a natural bicyclic monoterpene against hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic Wistar rats",https://pubmed.ncbi.nlm.nih.gov/29028586/,Positive,,Animal Study,2017,,Endocrine System,Diabetes; Cardiovascular Diseases (CVD); Inflammation
2019130,Synthesis and in vitro study of novel borneol derivatives as potent inhibitors of the influenza A virus,https://pubs.rsc.org/en/content/articlelanding/2017/MD/C6MD00657D,Positive,,Laboratory Study,2019,,Immune System; Respiratory System,Flu
2014074,Antibacterial adhesion of borneol-based polymer via surface chiral stereochemistry,https://pubs.acs.org/doi/10.1021/am505481q,Positive,,Laboratory Study,2014,,,Bacterial Infections
2012086,Investigation of mechanisms involved in (-)-borneol-induced vasorelaxant response on rat thoracic aorta,https://onlinelibrary.wiley.com/doi/10.1111/j.1742-7843.2011.00784.x,Positive,,Laboratory Study,2012,,,Cardiovascular Diseases (CVD)
2012087,The effect of camphor and borneol on rat thymocyte viability and oxidative stress,https://www.mdpi.com/1420-3049/17/9/10258/htm,Positive,,Laboratory Study,2012,,,Inflammation
2014075,Effect of acyclic monoterpene alcohols and their derivatives on TRP channels,https://pubmed.ncbi.nlm.nih.gov/25455494/,Positive,,Laboratory Study,2014,,,
2020311,Therapeutic Potential of β-Caryophyllene: A Dietary Cannabinoid in Diabetes and Associated Complications,https://www.mdpi.com/2072-6643/12/10/2963/htm,Positive,,Meta-analysis,2020,,Endocrine System,Diabetes
2021791,Seizure and Interictal Electroencephalographic (EEG) Changes with Cannabinoid Concentrate Use,https://pubmed.ncbi.nlm.nih.gov/33866321/,Negative,,Meta-analysis,2021,,,Epilepsy
2020312,Explication of CB 1 receptor contributions to the hypothermic effects of Δ 9-tetrahydrocannabinol (THC) when delivered by vapor inhalation or parenteral injection in rats,https://pubmed.ncbi.nlm.nih.gov/32717503/,Inconclusive,,Animal Study,2020,AM-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,,
2021792,THC Exposure is Reflected in the Microstructure of the Cerebral Cortex and Amygdala of Young Adults,https://academic.oup.com/cercor/article/30/9/4949/5831483,Inconclusive,,Clinical Trial,2021,,Respiratory System,Cognitive Dysfunction; COPD
2020313,Effects of ∆9-tetrahydrocannabinol on aversive memories and anxiety: a review from human studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448997/,Positive,,Clinical Meta-analysis,2020,,Mental/Emotional System; Nervous System,Anxiety; PTSD
2020314,Cannabis Improves Obsessive-Compulsive Disorder—Case Report and Review of the Literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396551/,Positive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,OCD
2020315,Totality of the Evidence Suggests Prenatal Cannabis Exposure Does Not Lead to Cognitive Impairments: A Systematic and Critical Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225289/,Inconclusive,,Meta-analysis,2020,,Reproductive System,Pregnancy
2020316,Cannabidiol enhances cytotoxicity of anti-cancer drugs in human head and neck squamous cell carcinoma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692486/,Positive,,Animal Study,2020,,Integumentary System; Nervous System,Cancer - Squamous Head/Neck; Cancer
2013069,Understanding the molecular aspects of tetrahydrocannabinol and cannabidiol as antioxidants,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269679/,Positive,,Laboratory Study,2013,Tetrahydrocannabinol (THC),Nervous System,Pain - Nociceptive; Pain; Oxidative Stress
2014076,Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201700/,Positive,,Animal Study,2014,Synthetic Cannabinoid (unspecified); AM-x Synthetic Cannabinoids,Nervous System,Inflammation; Pain; Pain - Acute
2013070,The endocannabinoid system and emotional processing: a pharmacological fMRI study with ∆9-tetrahydrocannabinol,https://pubmed.ncbi.nlm.nih.gov/23928295/,Positive,,Double Blind Clinical Trial,2013,Tetrahydrocannabinol (THC),,Anxiety; Depression
2012088,Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing,https://pubmed.ncbi.nlm.nih.gov/22213786/,Inconclusive,,Double Blind Clinical Trial,2012,,Mental/Emotional System; Nervous System,Psychosis
2021793,Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458732/,Positive,,Meta-analysis,2021,,Mental/Emotional System,Anxiety; Depression
2021794,Adolescent cannabis use and adult psychoticism: A longitudinal co-twin control analysis using data from two cohorts,https://pubmed.ncbi.nlm.nih.gov/34553951/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System,Psychosis
2021795,Marijuana liberalization policies and perinatal health,https://pubmed.ncbi.nlm.nih.gov/34626876/,Inconclusive,,Meta-analysis,2021,,Reproductive System,Pregnancy
2003013,Modulation of anxiety through blockade of anandamide hydrolysis,https://pubmed.ncbi.nlm.nih.gov/12461523/,Positive,,Animal Study,2003,Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System,Anxiety
2021796,Increased risk for COVID-19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021,https://onlinelibrary.wiley.com/doi/10.1002/wps.20921,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects; COVID-19
2021797,"Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms",https://www.liebertpub.com/doi/abs/10.1089/can.2021.0058?journalCode=can#.YWMiq2QOBoY.linkedin,Positive,,Meta-analysis,2021,Cannabigerol (CBG),,Anxiety; Depression; Insomnia and Sleep Disorders; Pain; Pain - Chronic
2021798,Evaluating the Safety of Cannabinoid-Based Medicines for Older Adults,https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2775734,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Geriatric Conditions
2020317,Antidepressant-like effects of β-caryophyllene on restraint plus stress-induced depression,https://www.sciencedirect.com/science/article/abs/pii/S0166432819313348?via%3Dihub,Positive,,Animal Study,2020,,Mental/Emotional System; Nervous System,Depression; Inflammation; Pain
2020318,Plant Natural Sources of the Endocannabinoid ( E)-β-Caryophyllene: A Systematic Quantitative Analysis of Published Literature,https://pubmed.ncbi.nlm.nih.gov/32906779/,Inconclusive,,Meta-analysis,2020,,,
2020319,Epigenetic alterations in cytochrome P450 oxidoreductase (Por) in sperm of rats exposed to tetrahydrocannabinol (THC),https://www.nature.com/articles/s41598-020-69204-7,Negative,,Animal Study,2020,,,Pregnancy
2020320,Cannabidiol and Sports Performance: a Narrative Review of Relevant Evidence and Recommendations for Future Research,https://sportsmedicine-open.springeropen.com/articles/10.1186/s40798-020-00251-0,Positive,,Meta-analysis,2020,,,Anxiety; Bacterial Infections; Bone Fractures; Cognitive Dysfunction; Gastroparesis; Inflammation; Insomnia and Sleep Disorders; Pain; Pain - Acute; Traumatic Brain Injury
2020321,Towards Better Delivery of Cannabidiol (CBD),https://www.mdpi.com/1424-8247/13/9/219/htm,Inconclusive,,Meta-analysis,2020,Pharma CBD,,
2020322,Link between personality and response to THC exposure,https://www.sciencedirect.com/science/article/abs/pii/S0166432819313907?via%3Dihub,Inconclusive,,Animal Study,2020,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Anxiety; Depression
2020323,Δ 9-Tetrahydrocannabinol (THC) impairs visual working memory performance: a randomized crossover trial,https://www.nature.com/articles/s41386-020-0690-3,Negative,,Double Blind Clinical Trial,2020,Pharma THC,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cognitive Dysfunction
2020324,The effects of Cannabidiol (CBD) and Delta-9-Tetrahydrocannabinol (THC) on the recognition of emotions in facial expressions: A systematic review of randomized controlled trials,https://www.sciencedirect.com/science/article/abs/pii/S0149763420305030?via%3Dihub,Inconclusive,,Clinical Meta-analysis,2020,,,Anxiety; Depression
2020325,Endocannabinoid genetic variation enhances vulnerability to THC reward in adolescent female mice,https://www.science.org/doi/10.1126/sciadv.aay1502,Negative,,Animal Study,2020,Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cognitive Dysfunction
2020326,Adjunctive Cannabidiol in Patients with Dravet Syndrome: A Systematic Review and Meta-Analysis of Efficacy and Safety,https://pubmed.ncbi.nlm.nih.gov/32040850/,Positive,,Clinical Meta-analysis,2020,,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy
2020327,Cannabidiol Drugs Clinical Trial Outcomes and Adverse Effects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053164/,Positive,,Clinical Meta-analysis,2020,Pharma CBD,,Addiction - Cannabis; Addiction - Opioid; Epilepsy; IBD - Inflammatory Bowel Disease; Parkinson's Disease; Schizophrenia
2020328,Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review,https://pubmed.ncbi.nlm.nih.gov/31948424/,Positive,,Meta-analysis,2020,,,ADD and ADHD; Anxiety; Depression; Insomnia and Sleep Disorders; Psychosis; PTSD; Schizophrenia
2020329,The role of cannabidiol oil in schizophrenia treatment. A systematic review and meta-analysis,https://pubmed.ncbi.nlm.nih.gov/32599446/,Inconclusive,,Clinical Meta-analysis,2020,,Mental/Emotional System; Nervous System,Schizophrenia
2020330,The Association Between Cannabis Use and Schizophrenia: Causative or Curative? A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442038/,Inconclusive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Schizophrenia
2020331,"Complementary Therapies in Parkinson Disease: a Review of Acupuncture, Tai Chi, Qi Gong, Yoga, and Cannabis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851283/,Inconclusive,,Meta-analysis,2020,,Nervous System,Parkinson's Disease
2016102,Myocarditis associated with cannabis use in a 15-year-old boy: A rare case report,https://pubmed.ncbi.nlm.nih.gov/26519676/,Negative,,Meta-analysis,2016,,Cardiovascular System; Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cardiovascular Diseases (CVD); Myocarditis
2020332,Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis,https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(20)30074-2/fulltext#seccestitle80,Negative,,Clinical Meta-analysis,2020,,Mental/Emotional System; Nervous System,Psychosis; Anxiety; Cognitive Dysfunction; Depression
2020333,"Evaluation of the preclinical analgesic efficacy of naturally derived, orally administered oil forms of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their 1:1 combination",https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0234176,Positive,,Animal Study,2020,Cannabidiolic Acid (CBD-a); Tetrahydrocannabinol (THC),Nervous System,Pain; Pain - Chronic; Pain - Neuropathy - Peripheral; Inflammation; Pain - Neuropathy - Inflammatory Polyneuropathy
2020334,Perinatal THC exposure via lactation induces lasting alterations to social behavior and prefrontal cortex function in rats at adulthood,https://pubmed.ncbi.nlm.nih.gov/32428929/,Negative,,Animal Study,2020,,Nervous System; Reproductive System,Neonatal Cerebral Issues; Pregnancy
2021799,Reversing the Psychiatric Effects of Neurodevelopmental Cannabinoid Exposure: Exploring Pharmacotherapeutic Interventions for Symptom Improvement,https://www.mdpi.com/1422-0067/22/15/7861/htm,Negative,,Meta-analysis,2021,,Nervous System,Cognitive Dysfunction; Anxiety; Bipolar Disorder; Psychosis; Schizophrenia
2021800,Cannabinoids and bladder symptoms in multiple sclerosis,https://pubmed.ncbi.nlm.nih.gov/34216995/,Positive,,Meta-analysis,2021,,,Multiple Sclerosis; Anxiety; Depression; Insomnia and Sleep Disorders; Pain; Pain - Chronic; Urinary Incontinence; Urinary Tract Infection
2021801,"The Link between Cannabis Use, Immune System, and Viral Infections",https://www.mdpi.com/1999-4915/13/6/1099/htm,Negative,,Meta-analysis,2021,,Digestive System; Immune System,Hepatitis; HIV/AIDS; COVID-19; Inflammation
2021802,Beneficial Effects of Cannabis on Blood-Brain Barrier Function in Human Immunodeficiency Virus,https://pubmed.ncbi.nlm.nih.gov/32296832/,Positive,,Clinical Trial,2021,,Immune System,HIV/AIDS; Inflammation; Traumatic Brain Injury
2021803,Marijuana-related Reversible Cerebral Vasoconstriction Syndrome,https://pubmed.ncbi.nlm.nih.gov/33028773/,Negative,,Meta-analysis,2021,,,Stroke
2021804,Cannabidiol prevents priming- and stress-induced reinstatement of the conditioned place preference induced by cocaine in mice,https://pubmed.ncbi.nlm.nih.gov/33427014/,Positive,,Animal Study,2021,,Mental/Emotional System,Addiction - Cocaine; Addiction
2021805,What cannabis can learn from Covid: Hydroxychloroquine research suggests the next step for medical cannabis research,https://www.sciencedirect.com/science/article/abs/pii/S0955395921000311?via%3Dihub,Inconclusive,,Meta-analysis,2021,,Respiratory System,COVID-19
2021806,Genetic Liability to Cannabis Use Disorder and COVID-19 Hospitalization,https://www.sciencedirect.com/science/article/pii/S2667174321000513?via%3Dihub,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System; Respiratory System,Addiction - Cannabis; Addiction; COVID-19; Addiction - Nicotine
2021807,Cannabis Use among Cancer Survivors amid the COVID-19 Pandemic: Results from the COVID-19 Cannabis Health Study,https://www.mdpi.com/2072-6694/13/14/3495,Inconclusive,,Clinical Trial,2021,,,Cancer; Anorexia; COVID-19; Epilepsy; Insomnia and Sleep Disorders; Migraine; Nausea and Vomiting
2021808,COVID-19 and Cannabis: Playing Saint or Devil?,https://www.eajm.org/en/covid-19-and-cannabis-playing-saint-or-devil-133325,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified),Respiratory System,COVID-19; Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Inflammation
2021809,Determining the magnitude and duration of acute Δ9-tetrahydrocannabinol (Δ9-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review,https://www.sciencedirect.com/science/article/pii/S0149763421000178?via%3Dihub,Negative,,Clinical Meta-analysis,2021,,,Cognitive Dysfunction
2021810,PPARγ receptors are involved in the effects of cannabidiol on orofacial dyskinesia and cognitive dysfunction induced by typical antipsychotic in mice,https://pubmed.ncbi.nlm.nih.gov/34048863/,Positive,,Animal Study,2021,,Mental/Emotional System,Cognitive Dysfunction; Psychosis; Inflammation; Neurodegenerative Issues
2021811,"Cannabis and Cognitive Functioning: From Acute to Residual Effects, From Randomized Controlled Trials to Prospective Designs",https://www.frontiersin.org/articles/10.3389/fpsyt.2021.596601/full#h2,Negative,,Clinical Meta-analysis,2021,,Mental/Emotional System,Cannabis Adverse Effects; Cognitive Dysfunction
2021812,Acute effects of partial CB 1 receptor agonists on cognition - A meta-analysis of human studies,https://pubmed.ncbi.nlm.nih.gov/32791166/,Negative,,Clinical Meta-analysis,2021,Pharma THC,,Cognitive Dysfunction
2019131,Considering abuse liability and neurocognitive effects of cannabis and cannabis-derived products when assessing analgesic efficacy: A comprehensive review of randomized-controlled studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279709/,Positive,,Clinical Meta-analysis,2019,,Nervous System,Pain; Pain - Chronic; Addiction - Cannabis; Cognitive Dysfunction
2020335,Beyond THC and Endocannabinoids,https://pubmed.ncbi.nlm.nih.gov/31580774/,Inconclusive,,Meta-analysis,2020,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH),,Cancer; Cardiovascular Diseases (CVD); Inflammation; Kidney Failure
2018122,Cannabidiol inhibits priming-induced reinstatement of methamphetamine in REM sleep deprived rats,https://www.sciencedirect.com/science/article/abs/pii/S027858461730218X?via%3Dihub,Positive,,Animal Study,2018,,Mental/Emotional System; Nervous System,Addiction - Stimulant; Addiction; Insomnia and Sleep Disorders
2020336,Cannabidiol attenuates methamphetamine-induced conditioned place preference via the Sigma1R/AKT/GSK-3β/CREB signaling pathway in rats,https://academic.oup.com/toxres/article/9/3/202/5831937?login=true,Positive,,Animal Study,2020,,Mental/Emotional System; Nervous System,Addiction - Stimulant; Addiction
2021813,Marijuana-induced acute myocardial infarction in a young adult male,https://pubmed.ncbi.nlm.nih.gov/34257123/,Negative,,Meta-analysis,2021,,Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack
2021814,Application of medical cannabis in unstable angina and coronary artery disease: A case report,https://journals.lww.com/md-journal/Fulltext/2021/03190/Application_of_medical_cannabis_in_unstable_angina.87.aspx,Positive,,Meta-analysis,2021,,Cardiovascular System,Atherosclerosis; Cardiovascular Diseases (CVD); Heart Attack; Inflammation
2021815,The perceived effects of cannabis products in the management of seizures in CDKL5 Deficiency Disorder,https://www.epilepsybehavior.com/article/S1525-5050(21)00411-X/fulltext,Positive,,Clinical Trial,2021,,Nervous System,Epilepsy
2021816,Evaluation of cannabidiol's inhibitory effect on alpha-glucosidase and its stability in simulated gastric and intestinal fluids,https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-021-00077-x,Positive,,Laboratory Study,2021,,Endocrine System,Diabetes
2021817,Inhibition of Fatty Acid Amide Hydrolase (FAAH) During Adolescence and Exposure to Early Life Stress may Exacerbate Depression-like Behaviors in Male and Female Rats,https://pubmed.ncbi.nlm.nih.gov/33359656/,Positive,,Animal Study,2021,Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System; Nervous System,Depression
2021818,"The sexualised use of cannabis among young sexual minority men: ""I'm actually enjoying this for the first time""",https://pubmed.ncbi.nlm.nih.gov/32462998/,Positive,,Clinical Trial,2021,,Endocrine System; Reproductive System,Libido; Erectile Dysfunction
2021819,"β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19",https://www.frontiersin.org/articles/10.3389/fphar.2021.590201/full,Inconclusive,,Meta-analysis,2021,,Respiratory System,COVID-19; Bacterial Infections; Cardiovascular Diseases (CVD); Cognitive Dysfunction; Diarrhea; Fatty Liver Disease; Fungal Infections; Inflammation; Kidney Failure; Parasitic Worms; Stroke
2021820,Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Actions of Phytocannabinoids or Endocannabinoids on TRPA1 and TRPV1 Channels,https://www.liebertpub.com/doi/10.1089/can.2019.0099,Negative,,Laboratory Study,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Cannabichromene (CBC); Cannabichromenic Acid (CBC-a); Cannabidiolic Acid (CBD-a); Cannabigerolic Acid (CBG-a); Tetrahydrocannabivarin (THCV); Tetrahydrocannabinolic Acid (THC-a),,
2021821,Grinding and Fractionation during Distillation Alter Hemp Essential Oil Profile and Its Antimicrobial Activity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504750/,Positive,,Laboratory Study,2021,,Immune System,Bacterial Infections; Staph Infection
2021822,In Vitro Evaluation of the Activity of Terpenes and Cannabidiol against Human Coronavirus E229,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065867/,Positive,,Laboratory Study,2021,,Respiratory System,COVID-19
2021823,"Identification of Chemotypic Markers in Three Chemotype Categories of Cannabis Using Secondary Metabolites Profiled in Inflorescences, Leaves, Stem Bark, and Roots",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283674/,Positive,,Laboratory Study,2021,Cannabichromene (CBC); Cannabidiolic Acid (CBD-a); Cannabigerolic Acid (CBG-a); Tetrahydrocannabivarin (THCV),,
2021824,Characterization of chemotype-dependent terpenoids profile in cannabis by headspace gas-chromatography coupled to time-of-flight mass spectrometry,https://pubmed.ncbi.nlm.nih.gov/34111731/,Positive,,Laboratory Study,2021,,,
2021825,Myrcene—What Are the Potential Health Benefits of This Flavouring and Aroma Agent?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326332/,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified),,Anxiety; Atherosclerosis; Cancer; Cardiovascular Diseases (CVD); Depression; Diabetes; Epilepsy; Geriatric Conditions; Inflammation; Pain - Nociceptive; Pain; Neurodegenerative Issues; Oxidative Stress
2020337,Terpenoids From Cannabis Do Not Mediate an Entourage Effect by Acting at Cannabinoid Receptors,https://www.frontiersin.org/articles/10.3389/fphar.2020.00359/full,Negative,,Laboratory Study,2020,2-Arachidonoyl Glycerol (2-AG),,
2021826,The relationship between cannabis use and IVF outcome—a cohort study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424823/,Inconclusive,,Meta-analysis,2021,,Reproductive System,Infertility (Female)
2021827,"Therapeutic Potential of Cannabidiol, Cannabidiolic Acid, and Cannabidiolic Acid Methyl Ester as Treatments for Nausea and Vomiting",https://www.researchgate.net/publication/352333335_Therapeutic_Potential_of_Cannabidiol_Cannabidiolic_Acid_and_Cannabidiolic_Acid_Methyl_Ester_as_Treatments_for_Nausea_and_Vomiting,Positive,,Animal Study,2021,Cannabidiolic Acid (CBD-a),Digestive System,Nausea and Vomiting; Chemotherapy-induced Nausea & Vomiting; Morning sickness; Motion Sickness
2013071,Anandamide deficiency and heightened neuropathic pain in aged mice,https://pubmed.ncbi.nlm.nih.gov/23597506/,Positive,,Animal Study,2013,Anandamide (AEA),,Pain; Pain - Neuropathy - Peripheral
2021828,Cannabidiol prevents several of the behavioral alterations related to cocaine addiction in mice,https://pubmed.ncbi.nlm.nih.gov/34157334/,Positive,,Animal Study,2021,,Mental/Emotional System; Nervous System,Addiction - Cocaine; Addiction
2021829,Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic,https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-021-00078-w#citeas,Positive,,Meta-analysis,2021,,,Anxiety; Depression; Pain
2021830,"The impact of cannabis use on male sexual function: A 10-year, single-center experience",https://pubmed.ncbi.nlm.nih.gov/34171210/,Positive,,Meta-analysis,2021,,Endocrine System; Reproductive System,Libido; Erectile Dysfunction
2021831,Cannabidiol for Rapid Eye Movement Sleep Behavior Disorder,https://pubmed.ncbi.nlm.nih.gov/33754375/,Positive,,Double Blind Clinical Trial,2021,,,REM Sleep Behavior Disorder; Insomnia and Sleep Disorders; Parkinson's Disease
2021832,Oral Cannabinoid Preparations for the Treatment of Chronic Migraine: A Retrospective Study,https://pubmed.ncbi.nlm.nih.gov/34347088/,Positive,,Clinical Trial,2021,Cannabinol (CBN),,Migraine
2021833,Measuring the Change in Health-Related Quality of Life in Patients Using Marijuana for Pain Relief,https://www.karger.com/Article/FullText/517857,Positive,,Meta-analysis,2021,,,Pain; Pain - Chronic
2021834,Tic Reduction in Adult Onset Gilles De La Tourette Syndrome Using as Required Nabiximols Spray,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344952/,Positive,,Meta-analysis,2021,Pharma THC:CBD,,Tics and Tourettes
2021835,A Systematic Review of Fibromyalgia and Recent Advancements in Treatment: Is Medicinal Cannabis a New Hope?,https://www.cureus.com/articles/65839-a-systematic-review-of-fibromyalgia-and-recent-advancements-in-treatment-is-medicinal-cannabis-a-new-hope,Positive,,Meta-analysis,2021,Pharma THC,Muscular System,Fibromyalgia
2021836,Clinical outcome data of first cohort of chronic pain patients treated with cannabis-based sublingual oils in the United Kingdom - analysis from the UK Medical Cannabis Registry,https://pubmed.ncbi.nlm.nih.gov/34473850/,Positive,,Meta-analysis,2021,,,Pain; Pain - Chronic; Insomnia and Sleep Disorders
2021837,"Medical Cannabis, Headaches, and Migraines: A Review of the Current Literature",https://www.cureus.com/articles/67643-medical-cannabis-headaches-and-migraines-a-review-of-the-current-literature,Positive,,Meta-analysis,2021,,,Migraine
2021838,Cannabidiol enhances verbal episodic memory in healthy young participants: A randomized clinical trial,https://www.sciencedirect.com/science/article/pii/S002239562100546X#!,Positive,,Double Blind Clinical Trial,2021,,Mental/Emotional System,Cannabis Adverse Effects; Cognitive Dysfunction
2021839,Spontaneous and Naloxone-Precipitated Withdrawal Behaviors From Chronic Opiates are Accompanied by Changes in N-Oleoylglycine and N-Oleoylalanine Levels in the Brain and Ameliorated by Treatment With These Mediators,https://www.researchgate.net/publication/354613764_Spontaneous_and_Naloxone-Precipitated_Withdrawal_Behaviors_From_Chronic_Opiates_are_Accompanied_by_Changes_in_N-Oleoylglycine_and_N-Oleoylalanine_Levels_in_the_Brain_and_Ameliorated_by_Treatment_With_,Positive,,Animal Study,2021,Endocannabinoid (unspecified),,
2021840,"Novel CBG Derivatives Can Reduce Inflammation, Pain and Obesity",https://www.researchgate.net/publication/354616317_Novel_CBG_Derivatives_Can_Reduce_Inflammation_Pain_and_Obesity,Positive,,Animal Study,2021,Cannabigerol (CBG),Endocrine System,Inflammation; Pain; Obesity; Pain - Chronic
20221015,"Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis: a randomized, double-blind placebo-controlled trial",https://pubmed.ncbi.nlm.nih.gov/34510141/,Inconclusive,,Double Blind Clinical Trial,2022,Synthetic Cannabinoid (unspecified),Skeletal System,Arthritis; Anxiety; Depression; Pain
2021841,The Effect of Medical Cannabis on Pain Level and Quality of Sleep among Rheumatology Clinic Outpatients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440085/,Positive,,Meta-analysis,2021,,Nervous System,Insomnia and Sleep Disorders; Pain; Pain - Chronic; Addiction - Opioid; Arthritis - Rheumatoid; Arthritis; Cannabis Adverse Effects; Chorea; Fibromyalgia; Inflammation; Pain - Inflammatory; Pain - Neuropathy - Peripheral
2021842,Opioid and healthcare service use in medical cannabis patients with chronic pain: a prospective study,https://pubmed.ncbi.nlm.nih.gov/34521640/,Positive,,Meta-analysis,2021,,Nervous System,Pain; Pain - Chronic; Addiction - Opioid
1998006,Regulation of delta opioid receptors by delta9-tetrahydrocannabinol in NG108-15 hybrid cells,https://pubmed.ncbi.nlm.nih.gov/9771917/,Inconclusive,,Laboratory Study,1998,Tetrahydrocannabinol (THC),,Cancer - Neuroblastoma; Cancer
2009044,Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide,https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1038/sj.bjp.0704029,Inconclusive,,Laboratory Study,2009,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Other Related Compounds,,Cancer - Neuroblastoma; Cancer
2021843,Cannabis Use in People With Obsessive-Compulsive Symptomatology: Results From a Mexican Epidemiological Sample,https://www.frontiersin.org/articles/10.3389/fpsyt.2021.664228/full,Negative,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; OCD; Cannabis Adverse Effects; Depression
2021844,Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders,https://www.frontiersin.org/articles/10.3389/fphar.2021.626010/full,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Pharma CBD; Pharma THC:CBD,,Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant; Cognitive Dysfunction; MDMA Adverse Effects; Psychosis
2021845,Epidemiology of cannabis use and associated outcomes among kidney transplant recipients: A meta-analysis,https://pubmed.ncbi.nlm.nih.gov/32558277/,Inconclusive,,Meta-analysis,2021,,Immune System,Organ Transplant Failure
2021846,Cannabis-Induced Pancreatitis in a Young Adult Male,https://journals.sagepub.com/doi/10.1177/23247096211035238,Negative,,Meta-analysis,2021,,Digestive System; Endocrine System,Pancreatitis
2021847,The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients,https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-021-00091-z,Negative,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2020338,Precipitated Δ9-THC withdrawal reduces motivation for sucrose reinforcement in mice,https://pubmed.ncbi.nlm.nih.gov/32526216/,Negative,,Animal Study,2020,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2020339,Δ 9-Tetrahydrocannabinol (THC) Impairs CD8 + T Cell-Mediated Activation of Astrocytes,https://pubmed.ncbi.nlm.nih.gov/32215844/,Positive,,Laboratory Study,2020,,Nervous System,Inflammation
2020340,Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis,https://onlinelibrary.wiley.com/doi/10.1111/add.15253,Inconclusive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2020341,THC Regulates Tearing via Cannabinoid CB1 Receptors,https://iovs.arvojournals.org/article.aspx?articleid=2770718,Inconclusive,,Animal Study,2020,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); CP-x Synthetic Cannabinoids,,Pain; Pain - Eye; Uveitis
2019132,Time to drop the stigma: cannabinoids are drugs that may alleviate pain in people with epidermolysis bullosa,https://pubmed.ncbi.nlm.nih.gov/30933348/,Positive,,Meta-analysis,2019,,Integumentary System,Epidermolysis bullosa
2019133,Combined tetrahydrocannabinol and cannabidiol to treat pain in epidermolysis bullosa: a report of three cases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379189/,Positive,,Meta-analysis,2019,Pharma THC:CBD,Integumentary System,Epidermolysis bullosa
2018123,Self-initiated use of topical cannabidiol oil for epidermolysis bullosa,https://pubmed.ncbi.nlm.nih.gov/29786144/,Positive,,Meta-analysis,2018,,Integumentary System,Epidermolysis bullosa
2021848,Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419930/,Positive,,Meta-analysis,2021,,Integumentary System,Epidermolysis bullosa
2021849,The Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome by Downregulating miRNA that Target Inflammatory Pathways,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113864/,Positive,,Animal Study,2021,Anandamide (AEA),Respiratory System,Acute Respiratory Distress Syndrome; Stress
2020342,Administration of Δ9-Tetrahydrocannabinol (THC) Post-Staphylococcal Enterotoxin B Exposure Protects Mice From Acute Respiratory Distress Syndrome and Toxicity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308536/,Positive,,Animal Study,2020,,Respiratory System,Acute Respiratory Distress Syndrome; Stress
2020343,Protective effects of Δ 9 -tetrahydrocannabinol against enterotoxin-induced acute respiratory distress syndrome are mediated by modulation of microbiota,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436585/,Positive,,Animal Study,2020,,Respiratory System,Acute Respiratory Distress Syndrome; Stress; COVID-19
2021850,Vaping Cannabis Butane Hash Oil Leads to Severe Acute Respiratory Distress Syndrome-A Case of EVALI in a Teenager With Hypertrophic Cardiomyopathy,https://pubmed.ncbi.nlm.nih.gov/32686568/,Negative,,Meta-analysis,2021,,Respiratory System,Acute Respiratory Distress Syndrome; Stress
2021851,Evaluation of Patient Reported Safety and Efficacy of Cannabis From a Survey of Medical Cannabis Patients in Canada,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172603/,Positive,,Meta-analysis,2021,,,Arthritis - Osteoarthritis; Arthritis - Rheumatoid; Arthritis; Insomnia and Sleep Disorders; Pain; Pain - Chronic; PTSD
2021852,Cannabis in the management of PTSD: a systematic review,https://pubmed.ncbi.nlm.nih.gov/34183989/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,PTSD
2021853,Community nurses' support for patients with fibromyalgia who use cannabis to manage pain,https://pubmed.ncbi.nlm.nih.gov/33539238/,Positive,,Meta-analysis,2021,,Muscular System,Fibromyalgia
2021854,Cannabis use among military veterans: A great deal to gain or lose?,https://pubmed.ncbi.nlm.nih.gov/33486280/,Negative,,Meta-analysis,2021,,,Addiction - Cannabis; Cannabis Adverse Effects
2021855,"Cannabis use, pain interference, and prescription opioid receipt among persons with HIV: a target trial emulation study",https://pubmed.ncbi.nlm.nih.gov/34180721/,Inconclusive,,Meta-analysis,2021,,Immune System,HIV/AIDS; Addiction - Opioid; Pain; Pain - Chronic
2021856,Treating pain related to Ehlers-Danlos syndrome with medical cannabis,https://pubmed.ncbi.nlm.nih.gov/34301703/,Positive,,Meta-analysis,2021,,Muscular System,Ehlers-Danlos Syndrome; Pain; Pain - Acute; Pain - Chronic
2015098,The therapeutic potential of cannabinoids for movement disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357541/,Positive,,Meta-analysis,2015,,Nervous System,Chorea; Huntington's Disease; Parkinson's Disease; Dystonia
2021857,Reverse Takotsubo Cardiomyopathy Precipitated by Chronic Cocaine and Cannabis Use,https://pubmed.ncbi.nlm.nih.gov/34426937/,Negative,,Meta-analysis,2021,,Cardiovascular System; Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cardiac Toxicity; Cardiovascular Diseases (CVD)
2021858,"Cannabidiol and Sodium Channel Pharmacology: General Overview, Mechanism, and Clinical Implications",https://journals.sagepub.com/doi/10.1177/10738584211017009,Positive,,Meta-analysis,2021,,,Epilepsy - Dravet Syndrome; Epilepsy
2021859,UHPLC-MS/MS Analysis of Cannabidiol and Its Metabolites in Serum of Patients with Resistant Epilepsy Treated with CBD Formulations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308640/,Inconclusive,,Laboratory Study,2021,Pharma CBD,Nervous System,Epilepsy
2021860,Cross-sectional and longitudinal evaluation of cannabidiol (CBD) product use and health among people with epilepsy,https://www.epilepsybehavior.com/article/S1525-5050(21)00466-2/fulltext,Positive,,Meta-analysis,2021,,Nervous System,Epilepsy
2021861,From an Alternative Medicine to a New Treatment for Refractory Epilepsies: Can Cannabidiol Follow the Same Path to Treat Neuropsychiatric Disorders?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905048/,Positive,,Meta-analysis,2021,,Nervous System,Epilepsy
2021862,"Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy",https://pubmed.ncbi.nlm.nih.gov/34384142/,Positive,,Animal Study,2021,Cannabigerolic Acid (CBG-a),Nervous System,Epilepsy - Dravet Syndrome; Epilepsy
2021863,Pharmacokinetics of cannabidiol in children with refractory epileptic encephalopathy,https://pubmed.ncbi.nlm.nih.gov/33280111/,Inconclusive,,Clinical Trial,2021,,Nervous System,Encephalitis and Myelitis; Epilepsy
2021864,Cannabidiol modulation of oxidative stress and signalling,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385185/,Positive,,Meta-analysis,2021,,Nervous System,Oxidative Stress
2021865,Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005394/,Positive,,Clinical Meta-analysis,2021,,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2021866,Cannabidiol for the treatment of Lennox-Gastaut syndrome and Dravet syndrome: experts' recommendations for its use in clinical practice in Spain,https://pubmed.ncbi.nlm.nih.gov/34486101/,Positive,,Meta-analysis,2021,,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2021867,Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further research,https://pubmed.ncbi.nlm.nih.gov/33347884/,Positive,,Meta-analysis,2021,,Nervous System,Epilepsy
2020344,Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation,https://pubmed.ncbi.nlm.nih.gov/31968549/,Positive,,Animal Study,2020,Delta-8-THC; AM-x Synthetic Cannabinoids,Nervous System,Pain; Pain - Eye; Uveitis
2021868,Proceeding report of the Fourth Symposium on Hidradenitis Suppurativa Advances 2019,https://www.jaad.org/article/S0190-9622(20)30989-0/fulltext,Positive,,Meta-analysis,2021,,Integumentary System,Acne Inversa; Acne
2021869,The Effects of Cannabis: Implications for the Surgical Patient,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963514/,Inconclusive,,Meta-analysis,2021,,Immune System; Integumentary System; Nervous System,Wound Healing; Pain; Pain - Acute
2021870,Effects of repeated adolescent exposure to cannabis smoke on cognitive outcomes in adulthood,https://journals.sagepub.com/doi/10.1177/0269881120965931,Negative,,Animal Study,2021,Cannabinol (CBN),Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cognitive Dysfunction; Anxiety
2021871,[Cannabis use among patients with inflammatory bowel disease],https://pubmed.ncbi.nlm.nih.gov/33764022/,Inconclusive,,Meta-analysis,2021,,Nervous System,Inflammation; Pain
2021872,Cannabis use of patients with inflammatory bowel disease in Germany: a cross-sectional survey,https://pubmed.ncbi.nlm.nih.gov/34157755/,Inconclusive,,Clinical Trial,2021,,Digestive System,IBD - Inflammatory Bowel Disease; IBD - Crohn's Disease
2019134,Prescription Pain Reliever Use and Misuse among Cannabis Users Aged 50+ Years,https://pubmed.ncbi.nlm.nih.gov/32374215/,Negative,,Meta-analysis,2019,,Nervous System,Pain; Addiction - Opioid; Pain - Acute; Pain - Chronic
2021873,"Use of Cannabis for Harm Reduction Among People at High Risk for Overdose in Vancouver, Canada (2016-2018)",https://pubmed.ncbi.nlm.nih.gov/33734849/,Inconclusive,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction - Cocaine; Addiction - Opioid; Addiction; Cannabis Adverse Effects
2021874,"Clinical Trials of Cannabidiol for Substance Use Disorders: Outcome Measures, Surrogate Endpoints, and Biomarkers",https://www.frontiersin.org/articles/10.3389/fpsyt.2021.565617/full,Positive,,Clinical Meta-analysis,2021,,,Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant
2021875,"Biomechanical Effects of Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD), the Major Constituents of Cannabis, in a Sprague Dawley Rat Achilles Tendon Surgical Repair Model: A Pilot Study",https://pubmed.ncbi.nlm.nih.gov/34097540/,Inconclusive,,Animal Study,2021,,Immune System; Integumentary System,Wound Healing
2021876,Cannabidiol microinjection into the nucleus accumbens attenuated nociceptive behaviors in an animal model of tonic pain,https://pubmed.ncbi.nlm.nih.gov/34324957/,Positive,,Animal Study,2021,,Nervous System,Pain; Pain - Chronic; Inflammation
2021877,Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model,https://pubmed.ncbi.nlm.nih.gov/33741405/,Positive,,Animal Study,2021,,Nervous System,Pain; Pain - Neuropathy - Peripheral; Pain - Chronic
2021878,Modulatory Potential of Cannabidiol on the Opioid-Induced Inflammatory Response,https://pubmed.ncbi.nlm.nih.gov/34115948/,Positive,,Meta-analysis,2021,,,Inflammation; Addiction - Opioid
2021879,Cannabidiol as a Treatment for Chronic Pain: A Survey of Patients’ Perspectives and Attitudes,https://www.dovepress.com/cannabidiol-as-a-treatment-for-chronic-pain-a-survey-of-patientsrsquo--peer-reviewed-fulltext-article-JPR,Positive,,Clinical Trial,2021,,,Pain; Pain - Chronic
2021880,Use and caregiver-reported efficacy of medical cannabis in children and adolescents in Switzerland,https://link.springer.com/article/10.1007%2Fs00431-021-04202-z,Positive,,Meta-analysis,2021,Synthetic Cannabinoid (unspecified),,Anorexia; Epilepsy; Pain; Nausea and Vomiting
2021881,Prevalence and impact of comorbid chronic pain and cigarette smoking among people living with HIV,https://pubmed.ncbi.nlm.nih.gov/33594924/,Negative,,Meta-analysis,2021,,Immune System,HIV/AIDS; Pain; Pain - Chronic; Addiction - Cannabis
2021882,Pain Profiles among Young Adult Cannabis Users: An Analysis of Antecedent Factors and Distal Outcomes,https://pubmed.ncbi.nlm.nih.gov/33882778/,Positive,,Meta-analysis,2021,,,Pain; Insomnia and Sleep Disorders; Pain - Acute; Pain - Chronic
2021883,Cannabis Use Disorders Lead to Hospitalizations for Peptic Ulcer Disease: Insights From a Nationwide Inpatient Sample Analysis,https://www.cureus.com/articles/60681-cannabis-use-disorders-lead-to-hospitalizations-for-peptic-ulcer-disease-insights-from-a-nationwide-inpatient-sample-analysis,Negative,,Meta-analysis,2021,,Digestive System; Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Gastro-Esophageal Reflux; Cannabis Adverse Effects
2021884,Relationships between age at first substance use and persistence of cannabis use and cannabis use disorder,https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-11023-0,Negative,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2021885,The association between cannabis use disorder and the outcome following primary total hip arthroplasty : analysis of a nationwide administrative claims database,https://online.boneandjoint.org.uk/doi/full/10.1302/0301-620X.103B7.BJJ-2020-2424.R1,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2021886,Persistent Cannabis Abuse and Risk for Hospitalization for Acute Pancreatitis: A Cross-Sectional Study in United States Hospitals,https://www.cureus.com/articles/60049-persistent-cannabis-abuse-and-risk-for-hospitalization-for-acute-pancreatitis-a-cross-sectional-study-in-united-states-hospitals,Negative,,Meta-analysis,2021,,Digestive System; Endocrine System,Pancreatitis
2021887,"Cannabis use disorder, anger, and violence in Iraq/Afghanistan-era veterans",https://pubmed.ncbi.nlm.nih.gov/33933928/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; PTSD
2021888,Cannabis use disorder and increased risk of arrhythmia-related hospitalization in young adults,https://pubmed.ncbi.nlm.nih.gov/34432919/,Negative,,Meta-analysis,2021,,Cardiovascular System; Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cardiac Arrhythmias; Cardiovascular Diseases (CVD)
2021889,"Risk and protective factors for cannabis, cocaine, and opioid use disorders: An umbrella review of meta-analyses of observational studies",https://pubmed.ncbi.nlm.nih.gov/33737104/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction - Cocaine; Addiction - Opioid; Addiction
2021890,"Results from a randomized, double-blind, placebo-controlled, crossover, multimodal-MRI pilot study of gabapentin for co-occurring bipolar and cannabis use disorders",https://pubmed.ncbi.nlm.nih.gov/34390300/,Positive,,Clinical Trial,2021,,Mental/Emotional System,Addiction - Cannabis; Addiction; Bipolar Disorder
2021891,Therapeutic Attributes of Endocannabinoid System against Neuro-Inflammatory Autoimmune Disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199938/,Positive,,Meta-analysis,2021,,Nervous System,Inflammation; Arthritis - Osteoarthritis; Arthritis; Cancer; Diabetes; Multiple Sclerosis
2021892,Gastroparesis with Cannabis Use: A Retrospective Study from the Nationwide Inpatient Sample,https://pubmed.ncbi.nlm.nih.gov/34096455/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System,Cannabis Adverse Effects
2021893,"Association between gestational cannabis exposure and maternal, perinatal, placental, and childhood outcomes",https://pubmed.ncbi.nlm.nih.gov/33280638/,Negative,,Meta-analysis,2021,,Reproductive System,Pregnancy
2021894,Real-Time Imaging of Immune Modulation by Cannabinoids Using Intravital Fluorescence Microscopy,https://pubmed.ncbi.nlm.nih.gov/34042507/,Positive,,Meta-analysis,2021,,,Arthritis - Osteoarthritis; Arthritis; Cystitis; Diabetes; Inflammation; Sepsis
2021895,Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211923/,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Other Related Compounds; WIN-x Synthetic Cannabinoids,Immune System; Nervous System,HIV/AIDS; Pain; Pain - Neuropathy - Peripheral
2021896,"A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of β-caryophyllene, a dietary cannabinoid",https://pubmed.ncbi.nlm.nih.gov/34091179/,Positive,,Meta-analysis,2021,,,Cardiovascular Diseases (CVD); Inflammation; Neurodegenerative Issues; Oxidative Stress
2021897,Effects of Cannabidiol and Beta-Caryophyllene Alone or in Combination in a Mouse Model of Permanent Ischemia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999270/,Positive,,Animal Study,2021,,,Stroke
2021898,In vitro cholinesterase inhibitory action of Cannabis sativa L. Cannabaceae and in silico study of its selected phytocompounds,https://pubmed.ncbi.nlm.nih.gov/33520592/,Positive,,Laboratory Study,2021,,,
2021899,α-Pinene: A never-ending story,https://pubmed.ncbi.nlm.nih.gov/34365295/,Positive,,Meta-analysis,2021,,,Cough
2021900,Toxicology of flavoring- and cannabis-containing e-liquids used in electronic delivery systems,https://pubmed.ncbi.nlm.nih.gov/33746051/,Positive,,Meta-analysis,2021,,,Cannabis Adverse Effects
2021901,Recent Advances in Antioxidant Polymers: From Sustainable and Natural Monomers to Synthesis and Applications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347842/,Inconclusive,,Meta-analysis,2021,,,Oxidative Stress
2021902,Cannabis Consumption Onset and Addiction: Data from the Second Brazilian Drugs and Alcohol Survey (BNADS),https://pubmed.ncbi.nlm.nih.gov/34256678/,Negative,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Addiction - Alcohol; Depression
2021903,"The relation between cannabis use, dependence severity and white matter microstructure: A diffusion tensor imaging study",https://onlinelibrary.wiley.com/doi/10.1111/adb.13081,Negative,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; ADD and ADHD; Anxiety; Cannabis Adverse Effects; Depression
2021904,Cannabinoid receptor type 2 gene is associated with comorbidity of schizophrenia and cannabis dependence and fatty acid amide hydrolase gene is associated with cannabis dependence in the Spanish population,https://adicciones.es/index.php/adicciones/article/view/1587/1247,Negative,,Clinical Trial,2021,Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System,Schizophrenia; Addiction - Cannabis; Cannabis Adverse Effects; Psychosis
2021905,The Alerting and Orienting Systems of Attention Are Modified by Cannabis Dependence,https://pubmed.ncbi.nlm.nih.gov/34261554/,Negative,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cognitive Dysfunction; Addiction - Alcohol; Cannabis Adverse Effects
2021906,The effect of daily aerobic cycling exercise on sleep quality during inpatient cannabis withdrawal: A randomised controlled trial,https://pubmed.ncbi.nlm.nih.gov/33078435/,Positive,,Clinical Trial,2021,,Nervous System,Insomnia and Sleep Disorders; Addiction - Cannabis; Cannabis Adverse Effects
2021907,Longitudinal course of mental health symptoms among veterans with and without cannabis use disorder,https://pubmed.ncbi.nlm.nih.gov/34351175/,Negative,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Addiction - Alcohol; Anxiety; Cannabis Adverse Effects; Cognitive Dysfunction; Depression; PTSD
2021908,Evaluating cannabis use risk reduction as an alternative clinical outcome for cannabis use disorder.,https://pubmed.ncbi.nlm.nih.gov/34197135/,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2021909,Psychiatric Comorbidity and Addiction Severity Differences in Patients With ADHD Seeking Treatment for Cannabis or Cocaine Use Disorders,https://pubmed.ncbi.nlm.nih.gov/31550967/,Negative,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,ADD and ADHD; Addiction - Cocaine; Addiction - Opioid; Cannabis Adverse Effects
2021910,Cannabis use disorder trajectories and their prospective predictors in a large population-based sample of young Swiss men,https://pubmed.ncbi.nlm.nih.gov/32621560/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2021911,The Impact of Marijuana on Antidepressant Treatment in Adolescents: Clinical and Pharmacologic Considerations,https://www.mdpi.com/2075-4426/11/7/615/htm,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Depression; Cannabis Adverse Effects
2021912,Recreational cannabis use causing non-ischaemic cardiomyopathy and cardioembolism in a young adult,https://pubmed.ncbi.nlm.nih.gov/34078626/,Negative,,Meta-analysis,2021,,Cardiovascular System,Cardiovascular Diseases (CVD); Cannabis Adverse Effects; Stroke
2021913,Chronic Marijuana Consumption Leading to High-Grade Atrioventricular Block in a Young Male,https://www.cureus.com/articles/62841-chronic-marijuana-consumption-leading-to-high-grade-atrioventricular-block-in-a-young-male,Negative,,Meta-analysis,2021,,Cardiovascular System,Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Cannabis Adverse Effects
2021914,Cognitive performance and lifetime cannabis use in patients with first-episode schizophrenia spectrum disorder,https://pubmed.ncbi.nlm.nih.gov/33973827/,Positive,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Schizophrenia; Cannabis Adverse Effects; Psychosis
2021915,Persistence of Δ-9-Tetrahydrocannabinol in Human Breast Milk,https://pubmed.ncbi.nlm.nih.gov/33683306/,Positive,,Clinical Trial,2021,,Reproductive System,Pregnancy
2021916,Marijuana Use during Pregnancy and Preterm Birth: A Prospective Cohort Study,https://pubmed.ncbi.nlm.nih.gov/32236911/,Positive,,Meta-analysis,2021,,Reproductive System,Pregnancy
2021917,Perceptions about cannabis use during pregnancy: a rapid best-framework qualitative synthesis,https://europepmc.org/article/med/32754880,Inconclusive,,Meta-analysis,2021,,Reproductive System,Pregnancy
2021918,Are Canadian Cannabis Dispensaries Counselling Pregnant Women Appropriately?,https://pubmed.ncbi.nlm.nih.gov/33153938/,Inconclusive,,Meta-analysis,2021,,Reproductive System,Pregnancy; Nausea and Vomiting
2021919,Marijuana use and sleep quality during pregnancy,https://pubmed.ncbi.nlm.nih.gov/34102934/,Inconclusive,,Clinical Trial,2021,,Reproductive System,Pregnancy; Insomnia and Sleep Disorders
2021920,"Desistance, Self-treatment, or Substitution: Decisions about Cannabis Use During Pregnancy",https://onlinelibrary.wiley.com/doi/10.1111/jmwh.13205,Inconclusive,,Meta-analysis,2021,,Reproductive System,Pregnancy; Addiction - Cannabis; Addiction - Cocaine; Addiction - Opioid; Anxiety; Cannabis Adverse Effects; Nausea and Vomiting
2021921,Cannabidiol (CBD) as a novel treatment in the early phases of psychosis,https://link.springer.com/article/10.1007%2Fs00213-021-05905-9,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Psychosis; Anxiety; Depression; Schizophrenia
2021922,"A latent class analysis of cannabis use products in a general population sample of adolescents and their association with paranoia, hallucinations, cognitive disorganisation and grandiosity",https://pubmed.ncbi.nlm.nih.gov/33545621/,Negative,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Psychosis; Anxiety; Cannabis Adverse Effects; Insomnia and Sleep Disorders
2021923,Cannabis for Restless Legs Syndrome,https://pubmed.ncbi.nlm.nih.gov/33537945/,Positive,,Meta-analysis,2021,,,Restless Leg Syndrome
2021924,Increase in Cannabis Use Among Adults with Rheumatic Diseases: Results from a 2014-2019 US Observational Study,https://pubmed.ncbi.nlm.nih.gov/34269524/,Positive,,Clinical Trial,2021,,Skeletal System,Arthritis - Rheumatoid; Arthritis
2018124,Responses to social evaluative stress in regular cannabis smokers,https://journals.sagepub.com/doi/10.1177/0269881120972337,Inconclusive,,Clinical Trial,2018,,Mental/Emotional System,
2021925,Structural correlates of sensorimotor dysfunction in heavy cannabis users,https://onlinelibrary.wiley.com/doi/10.1111/adb.13032,Negative,,Clinical Trial,2021,Endocannabinoid (unspecified),Mental/Emotional System,Cannabis Adverse Effects; Addiction - Cannabis; Cognitive Dysfunction
2021926,Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update,https://www.sciencedirect.com/science/article/pii/S0955395921002863?via%3Dihub,Positive,,Meta-analysis,2021,,Mental/Emotional System,Cannabis Adverse Effects
2021927,"Early, Chronic, and Acute Cannabis Exposure and Their Relationship With Cognitive and Behavioral Harms",https://www.frontiersin.org/articles/10.3389/fpsyt.2021.643556/full,Negative,,Clinical Trial,2021,,Mental/Emotional System,Cannabis Adverse Effects; Addiction - Alcohol; Addiction - Cannabis
2021928,Cannabis and Inflammation in HIV: A Review of Human and Animal Studies,https://www.mdpi.com/1999-4915/13/8/1521/htm,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Immune System,HIV/AIDS; Inflammation
2021929,Cognition and Cortical Thickness in Heavy Cannabis Users,https://pubmed.ncbi.nlm.nih.gov/33080597/,Negative,,Clinical Trial,2021,,Mental/Emotional System,Cannabis Adverse Effects; Addiction - Cannabis; Cognitive Dysfunction
2021930,A primer on medicinal cannabis safety and potential adverse effects,https://www1.racgp.org.au/ajgp/2021/june/a-primer-on-medicinal-cannabis-safety-and-potentia,Inconclusive,,Meta-analysis,2021,Pharma CBD; Pharma THC,,Addiction - Cannabis; Cannabis Adverse Effects; Cannabis Hyperemesis Syndrome; Cardiovascular Diseases (CVD); Psychosis
2021931,Approved cannabinoids for medical purposes - Comparative systematic review and meta-analysis for sleep and appetite,https://pubmed.ncbi.nlm.nih.gov/34181977/,Inconclusive,,Clinical Meta-analysis,2021,Pharma CBD; Pharma THC,,Insomnia and Sleep Disorders; Anorexia; Cannabis Adverse Effects
2021932,"Co-exposure of cocaine and cannabinoids and its association with select biological, behavioural and health outcomes: A systematic scoping review of multi-disciplinary studies",https://pubmed.ncbi.nlm.nih.gov/34273801/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cocaine; Addiction; Cannabis Adverse Effects
2021933,Use of Capsaicin Cream in Cannabinoid Hyperemesis Syndrome in Patients Presenting to the Emergency Department,https://pubmed.ncbi.nlm.nih.gov/33998315/,Inconclusive,,Clinical Trial,2021,Capsaicin (CAPS),,Cannabis Hyperemesis Syndrome
2021934,Cannabinoid Hyperemesis Syndrome in Pediatrics: An Emerging Problem,https://pubmed.ncbi.nlm.nih.gov/34470869/,Negative,,Meta-analysis,2021,,,Cannabis Hyperemesis Syndrome
2021935,Cannabinoid Hyperemesis Syndrome in an Athlete,https://www.jabfm.org/content/34/4/811,Negative,,Meta-analysis,2021,,,Cannabis Hyperemesis Syndrome
2021936,Response to 'Fool’s gold: diseased marijuana and cannabis hyperemesis syndrome',https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223642/,Inconclusive,,Meta-analysis,2021,,,Cannabis Hyperemesis Syndrome
2021937,Fool’s gold: diseased marijuana and cannabis hyperemesis syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223652/,Inconclusive,,Meta-analysis,2021,,,Cannabis Hyperemesis Syndrome
2021938,Adverse events of recreational cannabis use reported to the French addictovigilance network (2012-2017),https://pubmed.ncbi.nlm.nih.gov/34282851/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Addiction - Cannabis; Behavioral Disorders; Cancer; Cannabis Hyperemesis Syndrome; Cardiovascular Diseases (CVD); Stroke; Suicide Attempt
2021939,"The Physiological Effects, Including Risks and Potential Benefits, of Cannabis for Patients Undergoing Elective Orthopedic Procedures",https://pubmed.ncbi.nlm.nih.gov/33561869/,Inconclusive,,Meta-analysis,2021,,Nervous System,Pain; Pain - Acute
2021940,Persistent exposure to Δ 9- tetrahydrocannabinol during adolescence does not affect nociceptive responding in adult mice,https://pubmed.ncbi.nlm.nih.gov/34183435/,Inconclusive,,Animal Study,2021,,Nervous System,Pain; Inflammation
2021941,[Cannabis and cannabinoids for the treatment of acute and chronic pain],https://pubmed.ncbi.nlm.nih.gov/34196726/,Inconclusive,,Meta-analysis,2021,,Nervous System,Pain; Pain - Acute; Pain - Chronic
2021942,"Cannabis Use among Older Persons with Arthritis, Cancer and Multiple Sclerosis: Are We Comparing Apples and Oranges?",https://pubmed.ncbi.nlm.nih.gov/33922425/,Positive,,Clinical Trial,2021,,Nervous System; Skeletal System,Arthritis - Osteoarthritis; Arthritis; Cancer; Multiple Sclerosis; Insomnia and Sleep Disorders
2006020,The effects of concurrent cannabis use among ecstasy users: neuroprotective or neurotoxic?,https://pubmed.ncbi.nlm.nih.gov/16915582/,Negative,,Meta-analysis,2006,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; MDMA Adverse Effects
2011073,The relationships of 'ecstasy' (MDMA) and cannabis use to impaired executive inhibition and access to semantic long-term memory,https://pubmed.ncbi.nlm.nih.gov/21898599/,Negative,,Clinical Trial,2011,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; MDMA Adverse Effects; Cognitive Dysfunction
2008046,Is emotional intelligence impaired in ecstasy-polydrug users?,https://pubmed.ncbi.nlm.nih.gov/18801831/,Inconclusive,,Clinical Trial,2008,,,MDMA Adverse Effects; Anxiety; Cannabis Adverse Effects; Depression
2009045,"Cannabis coadministration potentiates the effects of ""ecstasy"" on heart rate and temperature in humans",https://pubmed.ncbi.nlm.nih.gov/19440186/,Inconclusive,,Clinical Trial,2009,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Cannabis Adverse Effects; MDMA Adverse Effects
2010057,"Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations: alone and in combination with ethanol or THC (delta-9-tetrahydrocannabinol)",https://pubmed.ncbi.nlm.nih.gov/20924751/,Positive,,Clinical Trial,2010,,Mental/Emotional System,Addiction - Alcohol; Addiction; Cannabis Adverse Effects; MDMA Adverse Effects
2011074,Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats,https://pubmed.ncbi.nlm.nih.gov/21763331/,Positive,,Animal Study,2011,Tetrahydrocannabinol (THC),,MDMA Adverse Effects; Cannabis Adverse Effects
2012089,Δ9-Tetrahydrocannabinol attenuates MDMA-induced hyperthermia in rhesus monkeys,https://pubmed.ncbi.nlm.nih.gov/22138434/,Positive,,Animal Study,2012,Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Cannabis Adverse Effects; MDMA Adverse Effects
2007031,"Combined immunomodulating properties of 3,4-methylenedioxymethamphetamine (MDMA) and cannabis in humans",https://pubmed.ncbi.nlm.nih.gov/17523988/,Negative,,Clinical Trial,2007,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; MDMA Adverse Effects
2007032,MDMA attenuates THC withdrawal syndrome in mice,https://pubmed.ncbi.nlm.nih.gov/17387458/,Positive,,Animal Study,2007,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Cannabis Adverse Effects; MDMA Adverse Effects
2004021,Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation,https://pubmed.ncbi.nlm.nih.gov/14722704/,Negative,,Clinical Trial,2004,,Mental/Emotional System,Cannabis Adverse Effects; MDMA Adverse Effects; Anxiety; Cognitive Dysfunction; Depression; Grief and Bereavement; OCD; Psychosis
2010058,"Cannabinoids, opioids and MDMA: neuropsychological interactions related to addiction",https://pubmed.ncbi.nlm.nih.gov/20017726/,Negative,,Meta-analysis,2010,Endocannabinoid (unspecified),,MDMA Adverse Effects; Addiction - Opioid; Cannabis Adverse Effects
2013072,"Modulation of 3,4-methylenedioxymethamphetamine effects by endocannabinoid system",https://pubmed.ncbi.nlm.nih.gov/23574444/,Negative,,Meta-analysis,2013,Endocannabinoid (unspecified),,MDMA Adverse Effects; Cannabis Adverse Effects
2012090,The effects of multitasking on psychological stress reactivity in recreational users of cannabis and MDMA,https://pubmed.ncbi.nlm.nih.gov/22389081/,Negative,,Meta-analysis,2012,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; MDMA Adverse Effects
2020345,Adverse pharmacokinetic interactions between illicit substances and clinical drugs,https://pubmed.ncbi.nlm.nih.gov/31826670/,Negative,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Addiction - Cocaine; Addiction; Cannabis Adverse Effects; MDMA Adverse Effects
2011075,"MDMA & Cannabis: A Mini-Review of Cognitive, Behavioral, and Neurobiological Effects of Co-Consumption",https://pubmed.ncbi.nlm.nih.gov/21696342/,Negative,,Meta-analysis,2011,,Mental/Emotional System,Cannabis Adverse Effects; MDMA Adverse Effects
2021943,"Cannabinoids and myocardial ischemia: Novel insights, updated mechanisms, and implications for myocardial infarction",https://pubmed.ncbi.nlm.nih.gov/34102966/,Negative,,Meta-analysis,2021,,Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack; Atherosclerosis
2021944,Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829325/,Positive,,Meta-analysis,2021,,Nervous System,Encephalitis and Myelitis; Multiple Sclerosis
2021945,Cannabis for Chronic Osteoarthritis Pain: A Case of an Older Person,https://pubmed.ncbi.nlm.nih.gov/34144723/,Positive,,Meta-analysis,2021,,Nervous System; Skeletal System,Arthritis - Osteoarthritis; Arthritis; Degenerative Disc; Pain; Pain - Chronic
2021946,Recreational cannabis laws and opioid-related emergency department visit rates,https://pubmed.ncbi.nlm.nih.gov/34252228/,Positive,,Meta-analysis,2021,,Mental/Emotional System,Addiction - Opioid; Addiction
2021947,Inflammatory Bowel Disease and Cannabis: A Practical Approach for Clinicians,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279986/,Inconclusive,,Meta-analysis,2021,,Digestive System,IBD - Inflammatory Bowel Disease
2021948,Recreational cannabis legalization and alcohol purchasing: a difference-in-differences analysis,https://pubmed.ncbi.nlm.nih.gov/34233755/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System,Addiction - Alcohol; Addiction
2021949,Public health impacts to date of the legalisation of medical and recreational cannabis use in the USA,https://pubmed.ncbi.nlm.nih.gov/34010617/,Negative,,Meta-analysis,2021,,Mental/Emotional System,Cannabis Adverse Effects
2021950,Are vaporizers a lower-risk alternative to smoking cannabis?,https://pubmed.ncbi.nlm.nih.gov/34448130/,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2021951,Long-Term Consequences of Adolescent Exposure to THC-Rich/CBD-Poor and CBD-Rich/THC-Poor Combinations: A Comparison with Pure THC Treatment in Female Rats,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396365/,Inconclusive,,Animal Study,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2021952,The Impact of Early Life Exposure to Cannabis: The Role of the Endocannabinoid System,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395329/,Negative,,Meta-analysis,2021,,Reproductive System,Pregnancy
2021953,"Cannabis Product Ingestions in Pediatric Patients: Ranges of Exposure, Effects, and Outcomes",https://pubmed.ncbi.nlm.nih.gov/34117620/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2021954,The effects of cannabis and cannabinoids on the endocrine system,https://pubmed.ncbi.nlm.nih.gov/34460075/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Diabetes; Infertility (Male); Metabolic Syndrome; Pregnancy
2021955,Duration of Neurocognitive Impairment With Medical Cannabis Use: A Scoping Review,https://www.frontiersin.org/articles/10.3389/fpsyt.2021.638962/full#h5,Positive,,Clinical Meta-analysis,2021,,Mental/Emotional System,Cannabis Adverse Effects; Cognitive Dysfunction; Pain
2021956,Adverse Effects of Recreational and Medical Cannabis,https://pubmed.ncbi.nlm.nih.gov/33897066/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Addiction - Cannabis; Pain; Neurodegenerative Issues; Pain - Chronic
2021957,Young Aboriginal people in Australia who have never used marijuana in the ‘Next Generation Youth Well-being study’: A strengths-based approach,https://pubmed.ncbi.nlm.nih.gov/33930633/,Negative,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Anxiety; Depression
2021958,"Pain, cannabis use, and physical and mental health indicators among veterans and nonveterans: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III",https://pubmed.ncbi.nlm.nih.gov/34108436/,Negative,,Meta-analysis,2021,,Nervous System,Pain; Pain - Chronic; Addiction - Cannabis; Behavioral Disorders; Anxiety; Depression
2021959,Opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies,https://bmjopen.bmj.com/content/11/7/e047717,Inconclusive,,Meta-analysis,2021,,Nervous System,Pain - Chronic; Addiction - Opioid; Constipation; Insomnia and Sleep Disorders; Pain; Nausea and Vomiting; Pain - Cancer
2021960,Prevalence of Cannabidiol Use in Patients With Spine Complaints: Results of an Anonymous Survey,http://www.ijssurgery.com/content/15/4/663,Positive,,Meta-analysis,2021,,,Behavioral Disorders; Anxiety; Insomnia and Sleep Disorders; Pain; Pain - Acute; Pain - Chronic
2021961,"Pharmacology, Clinical Effects, and Therapeutic Potential of Cannabinoids for Gastrointestinal and Liver Diseases",https://pubmed.ncbi.nlm.nih.gov/32673642/,Inconclusive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),,Constipation; Diarrhea; IBD - Inflammatory Bowel Disease; Hepatitis; Inflammation; Nausea and Vomiting; Pancreatitis
2021962,Effects of cannabis on visual function and self-perceived visual quality,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814053/,Negative,,Clinical Trial,2021,,,Cataract; Glaucoma; Macular Degeneration; Pain; Night Blindness; Pain - Eye; Retinal Disorders; Uveitis
2021963,Cannabidiol: pharmacology and therapeutic targets,https://pubmed.ncbi.nlm.nih.gov/33221931/,Positive,,Meta-analysis,2021,,,Epilepsy - Dravet Syndrome; Epilepsy - FIRES; Epilepsy - Lennox-Gastaut; Epilepsy; Inflammation; Pain; Neurodegenerative Issues; Pain - Chronic
2021964,Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review,https://pubmed.ncbi.nlm.nih.gov/33332002/,Inconclusive,,Meta-analysis,2021,,,Anxiety; Diarrhea; Loss of Appetite; Pain; Nausea and Vomiting; Pain - Chronic; Psychosis
2021965,Adverse Effects of Recreational and Medical Cannabis,https://pubmed.ncbi.nlm.nih.gov/33897066/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System,Cannabis Adverse Effects; Loss of Appetite; Pain; Nausea and Vomiting; Neurodegenerative Issues; Pain - Chronic
2021966,Cannabis and Depression,https://pubmed.ncbi.nlm.nih.gov/33332004/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System,Depression
2021967,Cannabinoids and the eye,https://pubmed.ncbi.nlm.nih.gov/32763339/,Inconclusive,,Meta-analysis,2021,,Nervous System,Glaucoma; Retinal Disorders; Cataract; Inflammation; Pain; Pain - Eye
2021968,The endocannabinoid system - current implications for drug development,https://onlinelibrary.wiley.com/doi/10.1111/joim.13229,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Tetrahydrocannabinol (THC),,Addiction - Cannabis; Pain; Pain - Chronic; PTSD
2021969,Developing a real-world evidence base for prescribed cannabis in the United Kingdom: preliminary findings from Project Twenty21,https://pubmed.ncbi.nlm.nih.gov/33970291/,Positive,,Meta-analysis,2021,,,Anxiety; Depression; Insomnia and Sleep Disorders; Pain; Pain - Chronic
2021970,Efficacy of topical capsaicin for cannabinoid hyperemesis syndrome in a pediatric and adult emergency department,https://pubmed.ncbi.nlm.nih.gov/34242945/,Positive,,Clinical Trial,2021,Capsaicin (CAPS),,Cannabis Hyperemesis Syndrome; Pain; Nausea and Vomiting; Pain - Acute
2021971,"Investigation of antinociceptive, antipyretic, antiasthmatic, and spasmolytic activities of Brazilian Cannabis sativa L. roots in rodents",https://www.sciencedirect.com/science/article/pii/S0378874121004864?via%3Dihub,Positive,,Animal Study,2021,,Immune System; Nervous System; Respiratory System,Asthma; Inflammation; Pain; Pain - Acute
2021972,Surveillance of work-related asthma including the emergence of a cannabis-associated case series in Washington State,https://pubmed.ncbi.nlm.nih.gov/34288786/,Positive,,Meta-analysis,2021,,Mental/Emotional System; Respiratory System,Asthma; Cannabis Adverse Effects
2021973,[An unusual allergy : cannabis-fruit and vegetable syndrome],https://pubmed.ncbi.nlm.nih.gov/33830699/,Positive,,Meta-analysis,2021,,Immune System,Cannabis Allergies
2021974,"""If I knew I could get that every hour instead of alcohol, I would take the cannabis"": need and feasibility of cannabis substitution implementation in Canadian managed alcohol programs",https://pubmed.ncbi.nlm.nih.gov/34162375/,Positive,,Meta-analysis,2021,,Mental/Emotional System,Addiction - Alcohol; Addiction
2021975,Contribution of Fatty Acid Amide Hydrolase to Alcohol Use Disorder: A Systematic Review,https://pubmed.ncbi.nlm.nih.gov/33989054/,Inconclusive,,Meta-analysis,2021,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System,Addiction - Alcohol; Addiction
2021976,Cannabinoids for skin diseases and hair regrowth,https://pubmed.ncbi.nlm.nih.gov/34363728/,Inconclusive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Integumentary System,Abnormal Hair Growth; Hair Loss
2021977,Knowledge and attitudes of Italian medical oncologists and palliative care physicians toward medical use of cannabis in cancer care: a national survey,https://pubmed.ncbi.nlm.nih.gov/34176017/,Positive,,Meta-analysis,2021,,,Cancer; Insomnia and Sleep Disorders; Loss of Appetite; Pain; Nausea and Vomiting; Pain - Cancer
2021978,Exploring the Use of Medical Marijuana for Supportive Care of Oncology Patients,"https://www.advancedpractitioner.com/issues/volume-12,-number-2-(mar-2021)/exploring-the-use-of-medical-marijuana-for-supportive-care-of-oncology-patients.aspx",Positive,,Meta-analysis,2021,,,Cancer; Insomnia and Sleep Disorders; Pain; Nausea and Vomiting; Pain - Cancer
2021979,"Symptoms, adverse events, and outcomes in the use of medicinal cannabis in children and adolescents with autism spectrum disorder: a scoping review protocol","https://journals.lww.com/jbisrir/Fulltext/2021/05000/Symptoms,_adverse_events,_and_outcomes_in_the_use.21.aspx",Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Autism
2021980,Emotion regulation in emerging adults with major depressive disorder and frequent cannabis use,https://www.sciencedirect.com/science/article/pii/S221315822100019X?via%3Dihub#s0010,Inconclusive,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Depression; Addiction - Cannabis
2021981,Pharmacological Properties of the Plant-Derived Natural products Cannabinoids and Implications for Cardiovascular Health,https://pubmed.ncbi.nlm.nih.gov/33861448/,Inconclusive,,Meta-analysis,2021,,Cardiovascular System,Cardiovascular Diseases (CVD); Atherosclerosis; Heart Attack
2021982,An overview on plants cannabinoids endorsed with cardiovascular effects,https://www.sciencedirect.com/science/article/pii/S0753332221007459?via%3Dihub,Positive,,Meta-analysis,2021,,Cardiovascular System,Cardiovascular Diseases (CVD)
2021983,Cannabis Seed Oil Alleviates Experimental Atherosclerosis by Ameliorating Vascular Inflammation in Apolipoprotein-E-Deficient Mice,https://pubmed.ncbi.nlm.nih.gov/34037390/,Positive,,Animal Study,2021,,Cardiovascular System,Atherosclerosis; Cardiovascular Diseases (CVD); Inflammation
2021984,Female but not male rats show biphasic effects of low doses of Δ 9-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects?,https://www.sciencedirect.com/science/article/abs/pii/S0028390821002392?via%3Dihub,Inconclusive,,Animal Study,2021,,Mental/Emotional System; Nervous System,Anxiety
2021985,Impact of Acute and Chronic Cannabis Use on Stress Response Regulation: Challenging the Belief That Cannabis Is an Effective Method for Coping,https://www.frontiersin.org/articles/10.3389/fpsyg.2021.687106/full,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Behavioral Disorders; Anxiety; Cannabis Adverse Effects; Cognitive Dysfunction; Depression; Domestic Abuse; Pregnancy; PTSD
2021986,Human Laboratory Models of Cannabis Use: Applications for Clinical and Translational Psychiatry Research,https://www.frontiersin.org/articles/10.3389/fpsyt.2021.626150/full,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Behavioral Disorders; Anxiety; Bipolar Disorder; Cancer; Cannabis Adverse Effects; Cognitive Dysfunction; COVID-19; Depression; HIV/AIDS; Insomnia and Sleep Disorders; Pain; Multiple Sclerosis; Nausea and Vomiting; Neurodegenerative Issues; OCD; Pain - Chronic; Psychosis; PTSD
2021987,"Effects of vapourized THC and voluntary alcohol drinking during adolescence on cognition, reward, and anxiety-like behaviours in rats",https://www.sciencedirect.com/science/article/abs/pii/S0278584620304577?via%3Dihub,Inconclusive,,Animal Study,2021,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction; Anxiety; Cognitive Dysfunction
2021988,The Cannabis Constituent Cannabigerol Does Not Disrupt Fear Memory Processes or Stress-Induced Anxiety in Mice,https://pubmed.ncbi.nlm.nih.gov/34182770/,Inconclusive,,Animal Study,2021,Cannabigerol (CBG),Mental/Emotional System; Nervous System,Anxiety; Cognitive Dysfunction; PTSD
2021989,The effect of cannabis in the treatment of Hodgkin's lymphoma in a pregnant patient - extensive case report and literature review,https://pubmed.ncbi.nlm.nih.gov/33721427/,Inconclusive,,Meta-analysis,2021,,Immune System; Nervous System; Reproductive System,Cancer - Lymphoma; Cancer; Pregnancy
2021990,"Associations among marijuana use, health-related quality of life, exercise, depression and sleep in cancer survivors",https://pubmed.ncbi.nlm.nih.gov/33599000/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Depression
2021991,Specific phytocannabinoid compositions are associated with analgesic response and adverse effects in chronic pain patients treated with medical cannabis,https://pubmed.ncbi.nlm.nih.gov/34000362/,Inconclusive,,Meta-analysis,2021,,Nervous System,Pain; Pain - Chronic
2021992,Effect of COVID-19 Pandemic on Cannabis Use in Cancer Patients,https://pubmed.ncbi.nlm.nih.gov/33657874/,Inconclusive,,Meta-analysis,2021,,Nervous System; Respiratory System,Cancer; COVID-19
2021993,"Use of cannabis in urological cancer patients: A review to evaluate risk for cancer development, therapeutic use, and symptom management",https://pubmed.ncbi.nlm.nih.gov/34171211/,Inconclusive,,Meta-analysis,2021,,Nervous System; Reproductive System; Urinary System,Cancer - Kidney; Cancer - Bladder; Cancer - Prostate; Cancer - Testicular; Cancer
2021994,Cannabis and pain: a scoping review,https://pubmed.ncbi.nlm.nih.gov/34280454/,Inconclusive,,Meta-analysis,2021,,Nervous System,Pain; Pain - Acute; Pain - Cancer; Pain - Chronic
2021995,Understanding cancer survivors' reasons to medicate with cannabis: A qualitative study based on the theory of planned behavior,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826491/,Inconclusive,,Meta-analysis,2021,,Nervous System,Cancer
2021996,"General risks of harm with cannabinoids, cannabis, and cannabis-based medicine possibly relevant to patients receiving these for pain management: an overview of systematic reviews",https://pubmed.ncbi.nlm.nih.gov/32941319/,Inconclusive,,Meta-analysis,2021,,Nervous System,Pain; Pain - Chronic
2021997,"Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials",https://pubmed.ncbi.nlm.nih.gov/32804836/,Inconclusive,,Clinical Meta-analysis,2021,Pharma THC; Pharma THC:CBD,,Menstrual Disorders; Pain; Pain - Acute; Pain - Cancer; Pain - Central Pain Syndrome; Pain - Chronic; Pain - Eye; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral
2021998,A Novel Mechanism of Cannabidiol in Suppressing Hepatocellular Carcinoma by Inducing GSDME Dependent Pyroptosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327166/,Positive,,Animal Study,2021,,Digestive System,Cancer - Liver; Cancer
2021999,Multiple clinical risks for cannabis users during the COVID-19 pandemic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816063/,Negative,,Meta-analysis,2021,,Respiratory System,COVID-19
20211000,Tetrahydrocannabinol and Its Major Metabolites are Not (or are poor) Substrates or Inhibitors of Human P-glycoprotein (P-gp/ABCB1) and Breast Cancer Resistance Protein (BCRP/ABCG2),https://pubmed.ncbi.nlm.nih.gov/34326138/,Inconclusive,,Laboratory Study,2021,,Nervous System; Reproductive System,Cancer - Breast; Cancer
20211001,Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298633/,Positive,,Laboratory Study,2021,Cannabidiolic Acid (CBD-a),Reproductive System,Cancer - Breast; Cancer
20211002,Epidemiological overview of multidimensional chromosomal and genome toxicity of cannabis exposure in congenital anomalies and cancer development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260794/,Negative,,Meta-analysis,2021,Cannabigerol (CBG); Cannabichromene (CBC),,Cancer - Breast; Cancer - Leukemia; Cancer - Liver; Cancer - Pancreatic; Cancer - Thyroid; Cancer; Down Syndrome
20211003,An Agathokakological Tale of Δ 9-THC: Exploration of Possible Biological Targets,https://pubmed.ncbi.nlm.nih.gov/33001012/,Positive,,Meta-analysis,2021,,Cardiovascular System,Cardiovascular Diseases (CVD); Neurodegenerative Issues
20211004,Cannabis as an Anticancer Agent: A Review of Clinical Data and Assessment of Case Reports,https://pubmed.ncbi.nlm.nih.gov/34370591/,Inconclusive,,Clinical Meta-analysis,2021,,,Cancer
20211005,"Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from Cannabis sativa L. Promising Compounds?",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124362/,Positive,,Meta-analysis,2021,,,Cancer; Cancer - Colon; Cancer - Brain; Cancer - Breast; Cancer - Lung
20211006,Induced Fit Docking and Automated QSAR Studies Reveal the ER-α Inhibitory Activity of Cannabis sativa in Breast Cancer,https://pubmed.ncbi.nlm.nih.gov/33563181/,Positive,,Laboratory Study,2021,Cannabitriol (CBT),Nervous System; Reproductive System,Cancer - Breast; Cancer
20211007,Epigenetic Regulation of Cannabinoid-Mediated Attenuation of Inflammation and Its Impact on the Use of Cannabinoids to Treat Autoimmune Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307988/,Positive,,Meta-analysis,2021,,,Acute Respiratory Distress Syndrome; IBD - Inflammatory Bowel Disease; Inflammation; Multiple Sclerosis; Stress
2020346,Understanding Cannabis-Based Therapeutics in Sports Medicine,https://pubmed.ncbi.nlm.nih.gov/32936058/,Positive,,Meta-analysis,2020,,Nervous System,Pain; Neurodegenerative Issues; Oxidative Stress; Pain - Acute; Pain - Chronic; Pain - Inflammatory; Pain - Neuropathy - Peripheral; Traumatic Brain Injury
20211008,"Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews",https://pubmed.ncbi.nlm.nih.gov/32804833/,Inconclusive,,Clinical Meta-analysis,2021,,Nervous System,Pain - Chronic; Menstrual Disorders; Pain; Pain - Acute; Pain - Cancer; Pain - Central Pain Syndrome; Pain - Eye; Pain - Neuropathy - Peripheral
20211009,"International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management",https://pubmed.ncbi.nlm.nih.gov/34138827/,Positive,,Meta-analysis,2021,,,Pain - Chronic; Menstrual Disorders; Pain; Pain - Acute; Pain - Cancer; Pain - Central Pain Syndrome; Pain - Eye; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral
20211010,A Phase 2 Randomised Clinical Trial Assessing the Tolerability of Two Different Ratios of Medicinal Cannabis in Patients With High Grade Gliomas,https://pubmed.ncbi.nlm.nih.gov/34094937/,Positive,,Clinical Trial,2021,,,Cancer - Brain; Cancer
20211011,Perioperative Pain and Addiction Interdisciplinary Network (PAIN): consensus recommendations for perioperative management of cannabis and cannabinoid-based medicine users by a modified Delphi process,https://pubmed.ncbi.nlm.nih.gov/33129489/,Inconclusive,,Meta-analysis,2021,,,Pain; Pain - Acute; Nausea and Vomiting
20211012,Adverse effects of heavy cannabis use: even plants can harm the brain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216111/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System,Cannabis Adverse Effects
20211013,The (Poly)Pharmacology of Cannabidiol in Neurological and Neuropsychiatric Disorders: Molecular Mechanisms and Targets,https://pubmed.ncbi.nlm.nih.gov/34062987/,Positive,,Meta-analysis,2021,,,Anxiety; Epilepsy; Schizophrenia
20211014,Cannabis-related diagnosis in pregnancy and adverse maternal and infant outcomes,https://pubmed.ncbi.nlm.nih.gov/34049105/,Negative,,Meta-analysis,2021,,Reproductive System,Pregnancy; Neonatal Cerebral Issues
20211015,Cannabis dabbing: An emerging trend,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078006/,Negative,,Meta-analysis,2021,,Mental/Emotional System,Cannabis Adverse Effects
20211016,From heavy cannabis use to psychosis: is it time to take action?,https://pubmed.ncbi.nlm.nih.gov/34039454/,Negative,,Meta-analysis,2021,,Mental/Emotional System,Psychosis
20211017,Decision Making and Impulsivity in Young Adult Cannabis Users,https://pubmed.ncbi.nlm.nih.gov/34276500/,Negative,,Meta-analysis,2021,,Mental/Emotional System,Cannabis Adverse Effects
20211018,Down and High: Reflections Regarding Depression and Cannabis,https://www.frontiersin.org/articles/10.3389/fpsyt.2021.625158/full,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Depression
20211019,"Weeding out the truth: a systematic review and meta-analysis on the transition from cannabis use to opioid use and opioid use disorders, abuse or dependence",https://pubmed.ncbi.nlm.nih.gov/34264545/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction; Cannabis Adverse Effects
20211020,Altered fronto-occipital connectivity during visual selective attention in regular cannabis users,https://pubmed.ncbi.nlm.nih.gov/33241479/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
20211021,Impaired motor cortical plasticity associated with cannabis use disorder in young adults,https://pubmed.ncbi.nlm.nih.gov/32323450/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
20211022,LPS-mediated neutrophil VEGF-A release is modulated by cannabinoid receptor activation,https://pubmed.ncbi.nlm.nih.gov/32573828/,Positive,,Laboratory Study,2021,,Immune System,Sepsis
2016103,Endocannabinoids in the gastrointestinal tract,https://journals.physiology.org/doi/full/10.1152/ajpgi.00294.2015,Inconclusive,,Meta-analysis,2016,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),,Bacterial Infections; Cancer - Colon; Cancer; Constipation; Diarrhea; IBD - Inflammatory Bowel Disease; Inflammation; Irritable Bowel Syndrome; Metabolic Syndrome; Nausea and Vomiting; Obesity
2020347,Endocannabinoids Inhibit the Induction of Virulence in Enteric Pathogens,https://pubmed.ncbi.nlm.nih.gov/33031742/,Positive,,Animal Study,2020,2-Arachidonoyl Glycerol (2-AG); Microbiome,Immune System,Bacterial Infections; IBD - Inflammatory Bowel Disease; Irritable Bowel Syndrome; Microbiome Imbalance
20211023,Endocannabinoids Attenuate the Virulence of Certain Enteropathogenic Bacteria,https://pubmed.ncbi.nlm.nih.gov/33388214/,Positive,,Meta-analysis,2021,2-Arachidonoyl Glycerol (2-AG); Endocannabinoid (unspecified),Immune System,Bacterial Infections; IBD - Inflammatory Bowel Disease
20211024,Cannabinoid Hyperemesis Syndrome Survey and Genomic Investigation,https://www.liebertpub.com/doi/pdf/10.1089/can.2021.0046,Negative,,Meta-analysis,2021,,Nervous System,Cannabis Hyperemesis Syndrome
20211025,"Endocannabinoids, cannabinoids and the regulation of anxiety",https://pubmed.ncbi.nlm.nih.gov/34116110/,Inconclusive,,Meta-analysis,2021,Anandamide (AEA),Mental/Emotional System; Nervous System,Anxiety
20211026,Integrated cognitive-behavioral therapy for comorbid cannabis use and anxiety disorders: The impact of severity of cannabis use,https://pubmed.ncbi.nlm.nih.gov/34264732/,Positive,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Anxiety; Addiction - Cannabis
20211027,Assessing Changes in Symptoms of Depression and Anxiety During Four Weeks of Cannabis Abstinence Among Adolescents,https://www.frontiersin.org/articles/10.3389/fpsyt.2021.689957/full,Inconclusive,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,Anxiety; Depression
20211028,"Social Anxiety, Cannabis Use Motives, and Social Context's Impact on Willingness to Use Cannabis",https://pubmed.ncbi.nlm.nih.gov/34064313/,Inconclusive,,Clinical Trial,2021,,Mental/Emotional System,Anxiety
20211029,Cannabinoid receptor agonists from Conus venoms alleviate pain-related behavior in rats,https://pubmed.ncbi.nlm.nih.gov/33774007/,Positive,,Animal Study,2021,,,Pain; Pain - Chronic
20211030,"State Medical Marijuana Laws and Initiation of Cigarettes among Adolescents in the U.S., 1991-2015",https://publications.sciences.ucf.edu/cannabis/index.php/Cannabis/article/view/90/48,Positive,,Meta-analysis,2021,,Mental/Emotional System,Addiction - Nicotine; Addiction
20211031,Efficacy and Safety of Cannabidiol Plus Standard Care vs Standard Care Alone for the Treatment of Emotional Exhaustion and Burnout Among Frontline Health Care Workers During the COVID-19 Pandemic,https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2782994,Positive,,Clinical Trial,2021,,Mental/Emotional System,Anxiety; Depression
20211032,"Evaluating the Suitability and Potential Efficiency of Cannabis sativa Oil for Patients with Primary Burning Mouth Syndrome: A Prospective, Open-Label, Single-Arm Pilot Study",https://pubmed.ncbi.nlm.nih.gov/33123730/,Positive,,Clinical Trial,2021,,Digestive System,Burning Mouth Syndrome
20211033,Cannabis Improves Stuttering: Case Report and Interview with the Patient,https://pubmed.ncbi.nlm.nih.gov/34314602/,Positive,,Meta-analysis,2021,,Mental/Emotional System,Stuttering
2020348,Cannabis and Vulvodynia Symptoms: A Preliminary Report,https://www.researchgate.net/publication/342666382_Cannabis_and_Vulvodynia_Symptoms_A_Preliminary_Report,Positive,,Meta-analysis,2020,,,Menopause; Pain; Pain - Chronic
2020349,The Effects of Cannabis on Female Reproductive Health Across the Life Course,https://www.researchgate.net/publication/348055685_The_Effects_of_Cannabis_on_Female_Reproductive_Health_Across_the_Life_Course,Inconclusive,,Meta-analysis,2020,,,Menopause; Neonatal Cerebral Issues; Pregnancy
2016104,Expectancy mediated effects of marijuana on menopause symptoms,https://www.researchgate.net/publication/296480775_Expectancy_mediated_effects_of_marijuana_on_menopause_symptoms,Positive,,Meta-analysis,2016,,Reproductive System,Menopause
1986004,Effects of acute marijuana smoking in post-menopausal women,https://pubmed.ncbi.nlm.nih.gov/3094054/,Negative,,Double Blind Clinical Trial,1986,,Reproductive System,Menopause
20211034,"The impact of cannabis use on vasomotor symptoms, mood, insomnia and sexuality in perimenopausal and postmenopausal women: a systematic review",https://pubmed.ncbi.nlm.nih.gov/33759668/,Inconclusive,,Meta-analysis,2021,,Reproductive System,Menopause
20211035,Developmental cannabidiol exposure increases anxiety and modifies genome-wide brain DNA methylation in adult female mice,https://clinicalepigeneticsjournal.biomedcentral.com/articles/10.1186/s13148-020-00993-4#Sec2,Inconclusive,,Animal Study,2021,Pharma CBD,Mental/Emotional System; Nervous System,Anxiety; Cognitive Dysfunction; Neonatal Cerebral Issues; Pregnancy
20211036,Potential and Limits of Cannabinoids in Alzheimer's Disease Therapy,https://pubmed.ncbi.nlm.nih.gov/34204237/,Inconclusive,,Meta-analysis,2021,,Nervous System,Alzheimer's Disease
20211037,"Cannabis use and posttraumatic stress disorder comorbidity: Epidemiology, biology and the potential for novel treatment approaches",https://pubmed.ncbi.nlm.nih.gov/33648669/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,PTSD; Addiction - Cannabis; Anxiety; Psychosis
20211038,Pros and Cons of the Cannabinoid System in Cancer: Focus on Hematological Malignancies,https://pubmed.ncbi.nlm.nih.gov/34202812/,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified),Immune System; Nervous System,Cancer - Leukemia; Cancer - Lymphoma; Cancer; Cancer - Myeloma
20211039,"Daily, but not occasional, cannabis use is selectively associated with more impulsive delay discounting and hyperactive ADHD symptoms in binge-drinking young adults",https://pubmed.ncbi.nlm.nih.gov/33638699/,Inconclusive,,Clinical Trial,2021,,Mental/Emotional System; Nervous System,ADD and ADHD; Addiction - Alcohol; Cognitive Dysfunction
20211040,Potential therapeutic benefits of cannabinoid products in adult psychiatric disorders: A systematic review and meta-analysis of randomised controlled trials,https://pubmed.ncbi.nlm.nih.gov/34119912/,Inconclusive,,Clinical Meta-analysis,2021,,Mental/Emotional System; Nervous System,Behavioral Disorders; ADD and ADHD; Addiction - Cocaine; Addiction - Nicotine; Anorexia Nervosa; Anorexia; Anxiety; Bipolar Disorder; PTSD; Schizophrenia
2020350,Cannabis induced cardiac arrhythmias: a case series,https://academic.oup.com/ehjcr/article/4/6/1/6032752,Negative,,Meta-analysis,2020,,Cardiovascular System,Atrial Fibrillation; Cardiac Arrhythmias; Cardiovascular Diseases (CVD)
2020351,The association of cannabis use and cardiac dysrhythmias: a systematic review,https://www.tandfonline.com/doi/abs/10.1080/15563650.2020.1743847?journalCode=ictx20,Negative,,Clinical Meta-analysis,2020,,Cardiovascular System,Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Atrial Fibrillation; Heart Attack
2019135,Canadian clinical practice guidelines for the use of plant-based cannabis and cannabinoid-based products in the management of chronic non-cancer pain and co-occurring conditions: protocol for a systematic literature review,https://pubmed.ncbi.nlm.nih.gov/32448797/,Inconclusive,,Meta-analysis,2019,,Nervous System,Pain; Pain - Chronic; Anxiety; Depression; PTSD
20211041,A Phase-2 Pilot Study of a Therapeutic Combination of Δ 9-Tetrahydracannabinol and Palmitoylethanolamide for Adults With Tourette's Syndrome,https://pubmed.ncbi.nlm.nih.gov/34340527/,Positive,,Clinical Trial,2021,Other Related Compounds,Nervous System,Tics and Tourettes
2001015,CB1 cannabinoid receptor-mediated neurite remodeling in mouse neuroblastoma N1E-115 cells,https://pubmed.ncbi.nlm.nih.gov/11494371/,Inconclusive,,Animal Study,2001,HU-x Synthetic Cannabinoids,,Cancer - Neuroblastoma; Cancer
1997004,"Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1218241/,Inconclusive,,Laboratory Study,1997,,,Cancer - Neuroblastoma; Cancer
1997005,Isolation and expression of a mouse CB1 cannabinoid receptor gene. Comparison of binding properties with those of native CB1 receptors in mouse brain and N18TG2 neuroblastoma cells,https://pubmed.ncbi.nlm.nih.gov/9037253/,Inconclusive,,Laboratory Study,1997,CP-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Nervous System,Cancer - Neuroblastoma; Cancer
1996003,"Potential biosynthetic connections between the two cannabimimetic eicosanoids, anandamide and 2-arachidonoyl-glycerol, in mouse neuroblastoma cells",https://pubmed.ncbi.nlm.nih.gov/8858137/,Inconclusive,,Laboratory Study,1996,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Nervous System,Cancer - Neuroblastoma; Cancer
2002017,The cannabinoid agonist DALN positively modulates L-type voltage-dependent calcium-channels in N18TG2 neuroblastoma cells,https://pubmed.ncbi.nlm.nih.gov/12007836/,Inconclusive,,Laboratory Study,2002,,Nervous System,Cancer - Neuroblastoma; Cancer
1995004,Stimulation of anandamide biosynthesis in N-18TG2 neuroblastoma cells by delta 9-tetrahydrocannabinol (THC),https://pubmed.ncbi.nlm.nih.gov/7702643/,Inconclusive,,Laboratory Study,1995,,,Cancer - Neuroblastoma; Cancer
2003014,A predominant role for inhibition of the adenylate cyclase/protein kinase A pathway in ERK activation by cannabinoid receptor 1 in N1E-115 neuroblastoma cells,https://pubmed.ncbi.nlm.nih.gov/14517212/,Inconclusive,,Laboratory Study,2003,WIN-x Synthetic Cannabinoids,,Cancer - Neuroblastoma; Cancer
1993005,"Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells",https://pubmed.ncbi.nlm.nih.gov/8371711/,Inconclusive,,Laboratory Study,1993,Anandamide (AEA); WIN-x Synthetic Cannabinoids; CP-x Synthetic Cannabinoids,Nervous System,Cancer - Neuroblastoma; Cancer
2012091,"Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug",https://www.scielo.br/j/rbp/a/CmqhFzYTRG9SJr8PZnFhTjK/?lang=en#,Positive,,Meta-analysis,2012,,Mental/Emotional System; Nervous System,Anxiety; OCD; PTSD
2012092,Endocannabinoid analogues exacerbate marble-burying behavior in mice via TRPV1 receptor,https://pubmed.ncbi.nlm.nih.gov/22248639/,Inconclusive,,Animal Study,2012,Anandamide (AEA); AM-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System,OCD
2017096,Symptoms of obsessive-compulsive disorder predict cannabis misuse,https://pubmed.ncbi.nlm.nih.gov/28453999/,Negative,,Meta-analysis,2017,,Mental/Emotional System,OCD
1996004,Effects of perinatal exposure to delta 9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain,https://pubmed.ncbi.nlm.nih.gov/8968950/,Negative,,Animal Study,1996,Tetrahydrocannabinol (THC),Nervous System,Neonatal Cerebral Issues
1996005,Perinatal cannabinoid exposure modifies the sociosexual approach behavior and the mesolimbic dopaminergic activity of adult male rats,https://pubmed.ncbi.nlm.nih.gov/8800663/,Negative,,Animal Study,1996,,Nervous System,Neonatal Cerebral Issues
1996006,Perinatal delta 9-tetrahydrocannabinol exposure in rats modifies the responsiveness of midbrain dopaminergic neurons in adulthood to a variety of challenges with dopaminergic drugs,https://pubmed.ncbi.nlm.nih.gov/8912798/,Inconclusive,,Animal Study,1996,Tetrahydrocannabinol (THC),Nervous System,Neonatal Cerebral Issues
1996007,Effect of maternal delta 9-tetrahydrocannabinol on developing serotonergic system,https://pubmed.ncbi.nlm.nih.gov/8982648/,Negative,,Animal Study,1996,,Nervous System,Neonatal Cerebral Issues
2004022,The involvement of VEGF receptors and MAPK in the cannabinoid potentiation of Ca2+ flux into N18TG2 neuroblastoma cells,https://pubmed.ncbi.nlm.nih.gov/14741403/,Inconclusive,,Laboratory Study,2004,,,Cancer - Neuroblastoma; Cancer
2008047,Improvement in refractory obsessive compulsive disorder with dronabinol,https://pubmed.ncbi.nlm.nih.gov/18381920/,Positive,,Meta-analysis,2008,Pharma THC,Mental/Emotional System; Nervous System,OCD
2009046,Marijuana use in potential liver transplant candidates,https://pubmed.ncbi.nlm.nih.gov/19067667/,Inconclusive,,Meta-analysis,2009,,Immune System,Organ Transplant Failure
2009047,"Rimonabant affects cyclosporine a, but not tacrolimus pharmacokinetics in renal transplant recipients",https://pubmed.ncbi.nlm.nih.gov/19384170/,Negative,,Meta-analysis,2009,SR-x Synthetic Cannabinoids,Immune System,Organ Transplant Failure
2011076,Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035076/,Positive,,Animal Study,2011,AM-x Synthetic Cannabinoids,Immune System,Organ Transplant Failure
2011077,Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: Evidence from an experimental murine model,https://pubmed.ncbi.nlm.nih.gov/21673072/,Positive,,Animal Study,2011,Tetrahydrocannabinol (THC),Immune System,Graft-versus-Host-Disease; Organ Transplant Failure
2013073,"Cannabinoids Inhibit T-cells via Cannabinoid Receptor 2 in an in vitro Assay for Graft Rejection, the Mixed Lymphocyte Reaction",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864984/,Positive,,Animal Study,2013,JWH-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC); O-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Immune System,Organ Transplant Failure
2015099,Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study,https://pubmed.ncbi.nlm.nih.gov/26033282/,Positive,,Clinical Trial,2015,,Immune System,Graft-versus-Host-Disease; Organ Transplant Failure
2016105,High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993910/,Negative,,Meta-analysis,2016,Tetrahydrocannabinol (THC),Immune System,Organ Transplant Failure
2019136,Marijuana use should not preclude consideration for kidney transplantation,https://pubmed.ncbi.nlm.nih.gov/31498490/,Inconclusive,,Meta-analysis,2019,,Immune System,Organ Transplant Failure
2017097,Influence of history of cannabis smoking in selected donors on the outcomes of lung transplantation,https://pubmed.ncbi.nlm.nih.gov/28077504/,Inconclusive,,Meta-analysis,2017,,Immune System,Organ Transplant Failure
2011078,Behavioral effects of fatty acid amide hydrolase inhibition on morphine withdrawal symptoms,https://pubmed.ncbi.nlm.nih.gov/21763761/,Positive,,Animal Study,2011,Fatty Acid Amide Hydrolase (FAAH); Anandamide (AEA),Mental/Emotional System,Addiction - Opioid; Addiction
1996008,Successfully treated invasive pulmonary aspergillosis associated with smoking marijuana in a renal transplant recipient,https://pubmed.ncbi.nlm.nih.gov/8685958/,Negative,,Meta-analysis,1996,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
1988003,"Fatal aspergillosis associated with smoking contaminated marijuana, in a marrow transplant recipient",https://pubmed.ncbi.nlm.nih.gov/3293934/,Negative,,Meta-analysis,1988,,Mental/Emotional System,Cannabis Adverse Effects
20211042,"CBG, CBD, Δ9-THC, CBN, CBGA, CBDA and Δ9-THCA as antioxidant agents and their intervention abilities in antioxidant action",https://pubmed.ncbi.nlm.nih.gov/33964342/,Positive,,Laboratory Study,2021,Cannabidiolic Acid (CBD-a); Cannabigerol (CBG); Cannabigerolic Acid (CBG-a); Cannabinol (CBN); Tetrahydrocannabinolic Acid (THC-a),Nervous System,Oxidative Stress
2018125,Marijuana and Psychosis: Policy Implications for Treatment Providers,https://pubmed.ncbi.nlm.nih.gov/30071983/,Negative,,Meta-analysis,2018,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2018126,Longitudinal assessment of the effect of cannabis use on hospital readmission rates in early psychosis: A 6-year follow-up in an inpatient cohort,https://pubmed.ncbi.nlm.nih.gov/30121541/,Negative,,Meta-analysis,2018,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2018127,Acceptance of pharmaceutical cannabis substitution by cannabis using patients with schizophrenia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149068/,Positive,,Double Blind Clinical Trial,2018,,Mental/Emotional System; Nervous System,Schizophrenia; Psychosis
2018128,Differences in demographic and clinical characteristics between cannabis users and non-drug users: A retrospective study of patients at first hospitalization due to psychotic symptoms,https://pubmed.ncbi.nlm.nih.gov/30130713/,Inconclusive,,Meta-analysis,2018,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2016106,Cannabis for Refractory Psoriasis-High Hopes for a Novel Treatment and a Literature Review,https://pubmed.ncbi.nlm.nih.gov/27164964/,Positive,,Meta-analysis,2016,,Integumentary System,Psoriasis
2018129,Effects of Δ(9)-tetrahydrocannabinol (THC) on human amniotic epithelial cell proliferation and migration,https://pubmed.ncbi.nlm.nih.gov/29191629/,Negative,,Animal Study,2018,,Reproductive System,Pregnancy
2018130,RhoA/MLC signaling pathway is involved in Δ⁹-tetrahydrocannabinol-impaired placental angiogenesis,https://pubmed.ncbi.nlm.nih.gov/29307655/,Negative,,Animal Study,2018,Tetrahydrocannabinol (THC),Reproductive System,Pregnancy
2018131,"Cannabis Use During the Perinatal Period in a State With Legalized Recreational and Medical Marijuana: The Association Between Maternal Characteristics, Breastfeeding Patterns, and Neonatal Outcomes",https://pubmed.ncbi.nlm.nih.gov/29605394/,Negative,,Meta-analysis,2018,,Reproductive System,Pregnancy
2018132,Transfer of Inhaled Cannabis Into Human Breast Milk,https://pubmed.ncbi.nlm.nih.gov/29630019/,Negative,,Meta-analysis,2018,Tetrahydrocannabinol (THC),Reproductive System,Pregnancy
2018133,Medicinal Cannabis in Pregnancy - Panacea or Noxious Weed?,https://pubmed.ncbi.nlm.nih.gov/29978658/,Negative,,Meta-analysis,2018,,Reproductive System,Pregnancy
2018134,Maternal and paternal cannabis use during pregnancy and the risk of psychotic-like experiences in the offspring,https://pubmed.ncbi.nlm.nih.gov/29983267/,Negative,,Meta-analysis,2018,,Mental/Emotional System; Nervous System; Reproductive System,Pregnancy; Psychosis
20211043,Cannabis and Cannabinoids in Reproduction and Fertility: Where We Stand,https://pubmed.ncbi.nlm.nih.gov/33970442/,Negative,,Meta-analysis,2021,,Reproductive System,Infertility (Male); Pregnancy
2020352,Evidence for the Endocannabinoid System as a Therapeutic Target in the Treatment of Cannabis Use Disorder,https://pubmed.ncbi.nlm.nih.gov/33816054/,Positive,,Meta-analysis,2020,Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
20211044,"The endocannabinoid system, cannabis, and cannabidiol: Implications in urology and men's health",https://pubmed.ncbi.nlm.nih.gov/34168527/,Inconclusive,,Meta-analysis,2021,,,Cancer - Testicular; Cancer; Urinary Tract Infection
20211045,Causal inference multiple imputation investigation of the impact of cannabinoids and other substances on ethnic differentials in US testicular cancer incidence,https://pubmed.ncbi.nlm.nih.gov/34246312/,Negative,,Meta-analysis,2021,,Nervous System; Reproductive System,Cancer - Testicular; Cancer
20211046,Daily Cannabis Use is Associated With Lower CNS Inflammation in People With HIV,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288448/,Positive,,Meta-analysis,2021,,Immune System; Nervous System,HIV/AIDS; Inflammation
2012093,Fear-induced suppression of nociceptive behaviour and activation of Akt signalling in the rat periaqueductal grey: role of fatty acid amide hydrolase,https://pubmed.ncbi.nlm.nih.gov/21926424/,Inconclusive,,Animal Study,2012,Fatty Acid Amide Hydrolase (FAAH),,Pain; Pain - Acute
20211047,Risk and benefit of cannabis prescription for chronic non-cancer pain,https://pubmed.ncbi.nlm.nih.gov/34338621/,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction; Pain; Pain - Chronic
20211048,"Cannabidiol (CBD) For the Treatment of Painful Diabetic Peripheral Neuropathy of the Feet: A Placebo-Controlled, Double-Blind, Randomized Trial",https://www.longdom.org/open-access/cannabidiol-cbd-for-the-treatment-of-painful-diabetic-peripheral-neuropathy-of-the-feet-a-placebocontrolled-doubleblind-.pdf,Positive,,Double Blind Clinical Trial,2021,,,Pain; Pain - Neuropathy - Diabetic; Anxiety
20211049,Psychedelics for Brain Injury: A Mini-Review,https://www.frontiersin.org/articles/10.3389/fneur.2021.685085/full?&utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&field=&journalName=Frontiers_in_Neurology&id=685085,Positive,,Meta-analysis,2021,,Nervous System,Traumatic Brain Injury; Oxidative Stress; Stroke
2007033,Agonist selective modulation of tyrosine hydroxylase expression by cannabinoid ligands in a murine neuroblastoma cell line,https://pubmed.ncbi.nlm.nih.gov/17540007/,Inconclusive,,Laboratory Study,2007,Tetrahydrocannabinol (THC),Nervous System,Cancer - Neuroblastoma; Cancer
2007034,Cannabinoid receptor-mediated translocation of NO-sensitive guanylyl cyclase and production of cyclic GMP in neuronal cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170565/,Inconclusive,,Laboratory Study,2007,,Nervous System,Cancer - Neuroblastoma; Cancer
1997006,Maternal exposure to delta 9-tetrahydrocannabinol (delta 9-THC) alters indolamine levels and turnover in adult male and female rat brain regions,https://pubmed.ncbi.nlm.nih.gov/9222530/,Inconclusive,,Animal Study,1997,Tetrahydrocannabinol (THC),,Neonatal Cerebral Issues; Pregnancy
1997007,Perinatal delta(9)-tetrahydrocannabinol exposure alters the responsiveness of hypothalamic dopaminergic neurons to dopamine-acting drugs in adult rats,https://pubmed.ncbi.nlm.nih.gov/9392783/,Inconclusive,,Animal Study,1997,Tetrahydrocannabinol (THC),,Neonatal Cerebral Issues; Pregnancy
2011079,Synthetic delta-9-tetrahydrocannabinol elicits schizophrenia-like negative symptoms which are distinct from sedation,https://pubmed.ncbi.nlm.nih.gov/23055415/,Positive,,Double Blind Clinical Trial,2011,Pharma THC,,Poisoning by Synthetic Cannabis
2018135,Sex-dependent effects of in utero cannabinoid exposure on cortical function,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162091/,Inconclusive,,Animal Study,2018,Anandamide (AEA); Tetrahydrocannabinol (THC); WIN-x Synthetic Cannabinoids,Reproductive System,Pregnancy; Neonatal Cerebral Issues
2018136,"An epidemiological, developmental and clinical overview of cannabis use during pregnancy",https://pubmed.ncbi.nlm.nih.gov/30171964/,Inconclusive,,Meta-analysis,2018,,Reproductive System,Pregnancy
2013074,Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings,https://pubmed.ncbi.nlm.nih.gov/22971158/,Negative,,Meta-analysis,2013,Synthetic Cannabinoid (unspecified); JWH-x Synthetic Cannabinoids,Nervous System,Poisoning by Synthetic Cannabis
2013075,Acute Psychosis Associated with Recreational Use of Benzofuran 6-(2-Aminopropyl)Benzofuran (6-APB) and Cannabis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770991/,Negative,,Meta-analysis,2013,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis
2014077,"""Spice""--synthetic cannabinoids with dangerous effects",https://pubmed.ncbi.nlm.nih.gov/25386644/,Negative,,Meta-analysis,2014,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis
2015100,The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects,https://pubmed.ncbi.nlm.nih.gov/25586398/,Negative,,Meta-analysis,2015,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis
2017098,"Acute Poisonings from Synthetic Cannabinoids — 50 U.S. Toxicology Investigators Consortium Registry Sites, 2010–2015",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972329/,Negative,,Meta-analysis,2017,Synthetic Cannabinoid (unspecified),,Poisoning by Synthetic Cannabis
2016107,Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis,https://pubmed.ncbi.nlm.nih.gov/27462088/,Negative,,Meta-analysis,2016,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis
2017099,Acute effects of synthetic cannabinoids: Update 2015,https://pubmed.ncbi.nlm.nih.gov/27715709/,Negative,,Meta-analysis,2017,Synthetic Cannabinoid (unspecified),,Poisoning by Synthetic Cannabis
2017100,Focus on cannabinoids and synthetic cannabinoids,https://pubmed.ncbi.nlm.nih.gov/27861784/,Negative,,Meta-analysis,2017,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis
2017101,"Cannabis, cannabinoids, and health",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741114/,Negative,,Meta-analysis,2017,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis
2016108,Acute Toxicity Associated with Use of 5F-Derivations of Synthetic Cannabinoid Receptor Agonists with Analytical Confirmation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135680/,Negative,,Meta-analysis,2016,,Nervous System,Poisoning by Synthetic Cannabis
2012094,A case of self amputation of penis by cannabis induced psychosis,https://pubmed.ncbi.nlm.nih.gov/22847056/,Negative,,Meta-analysis,2012,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2014078,Smoking synthetic marijuana leads to self-mutilation requiring bilateral amputations,https://pubmed.ncbi.nlm.nih.gov/24762846/,Negative,,Meta-analysis,2014,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis
2013076,Synthetic cannabinoid overdose in a 20-year-old male US soldier,https://pubmed.ncbi.nlm.nih.gov/23327506/,Negative,,Meta-analysis,2013,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis
2012095,"Spice, bath salts, and the U.S. military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces",https://pubmed.ncbi.nlm.nih.gov/23025133/,Negative,,Meta-analysis,2012,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis
2012096,Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong,https://pubmed.ncbi.nlm.nih.gov/22447803/,Negative,,Meta-analysis,2012,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis
2011080,Synthetic cannabinoid JWH-018 and psychosis: an explorative study,https://pubmed.ncbi.nlm.nih.gov/21316162/,Negative,,Meta-analysis,2011,JWH-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Poisoning by Synthetic Cannabis; Psychosis
2010059,The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes,https://pubmed.ncbi.nlm.nih.gov/20056392/,Negative,,Meta-analysis,2010,Synthetic Cannabinoid (unspecified),,Poisoning by Synthetic Cannabis
2017102,The effects of synthetic cannabinoid UR-144 on the human body-A review of 39 cases,https://pubmed.ncbi.nlm.nih.gov/28283378/,Negative,,Meta-analysis,2017,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis
2017103,"Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset",https://pubmed.ncbi.nlm.nih.gov/28412921/,Negative,,Meta-analysis,2017,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis
2017104,"Antidote to cannabinoid intoxication: the CB1 receptor inverse agonist, AM251, reverses hypothermic effects of the CB1 receptor agonist, CB‐13, in mice",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647190/,Positive,,Animal Study,2017,AM-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Poisoning by Synthetic Cannabis
2018137,Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA,https://pubmed.ncbi.nlm.nih.gov/29072524/,Negative,,Meta-analysis,2018,JWH-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis
2018138,Psychosis and synthetic cannabinoids,https://pubmed.ncbi.nlm.nih.gov/30125871/,Negative,,Meta-analysis,2018,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis
2018139,Spicing it up - synthetic cannabinoid receptor agonists and psychosis - a systematic review,https://pubmed.ncbi.nlm.nih.gov/30454908/,Negative,,Meta-analysis,2018,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis
20211050,Synthetic cannabis: adverse events reported to the New Zealand Pharmacovigilance Centre,https://pubmed.ncbi.nlm.nih.gov/33156704/,Negative,,Meta-analysis,2021,Synthetic Cannabinoid (unspecified),,Poisoning by Synthetic Cannabis
20211051,Catatonia Related to Cannabis and Synthetic Cannabinoids: A Review,https://pubmed.ncbi.nlm.nih.gov/33902405/,Negative,,Meta-analysis,2021,Synthetic Cannabinoid (unspecified),Mental/Emotional System,Cannabis Adverse Effects; Poisoning by Synthetic Cannabis
20211052,"Abuse Potential of Synthetic Cannabinoids: AM-1248, CB-13, and PB-22",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255142/,Negative,,Animal Study,2021,AM-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),,Poisoning by Synthetic Cannabis
2018140,Cannabis‐based medicines for chronic neuropathic pain in adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494210/,Positive,,Meta-analysis,2018,Pharma THC:CBD; Pharma THC,Nervous System,Pain; Pain - Chronic
2018141,Cannabis analgesia in chronic neuropathic pain is associated with altered brain connectivity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177269/,Positive,,Double Blind Clinical Trial,2018,Tetrahydrocannabinol (THC),Nervous System,Pain; Pain - Chronic
2018142,Cannabis for chronic pain: Not a simple solution,https://www.ccjm.org/content/85/12/950,Inconclusive,,Meta-analysis,2018,,Nervous System,Pain; Pain - Chronic; Pain - Neuropathy - Peripheral
2018143,"Cannabis for peripheral neuropathy: The good, the bad, and the unknown",https://pubmed.ncbi.nlm.nih.gov/30526755/,Positive,,Meta-analysis,2018,,Nervous System,Pain; Pain - Neuropathy - Peripheral
20211053,Cannabidiol reduces withdrawal symptoms in nicotine-dependent rats,https://pubmed.ncbi.nlm.nih.gov/33909102/,Positive,,Animal Study,2021,,Mental/Emotional System,Addiction - Nicotine; Addiction
2020353,Current application of cannabidiol (CBD) in the management and treatment of neurological disorders,https://pubmed.ncbi.nlm.nih.gov/32556748/,Positive,,Meta-analysis,2020,,Nervous System,Neurodegenerative Issues
2018144,Data Are Needed on the Potential Adverse Effects of Marijuana Use in Pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419734/,Inconclusive,,Meta-analysis,2018,,Reproductive System,Pregnancy
1981006,Tetrahydrocannabinol potentiates reserpine-induced hypokinesia,https://pubmed.ncbi.nlm.nih.gov/6273940/,Positive,,Animal Study,1981,,Nervous System,Chorea; Neurodegenerative Issues; Huntington's Disease; Parkinson's Disease
2000009,Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease,https://pubmed.ncbi.nlm.nih.gov/10877836/,Positive,,Animal Study,2000,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),,Parkinson's Disease
2005026,Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease,https://pubmed.ncbi.nlm.nih.gov/15837565/,Positive,,Animal Study,2005,HU-x Synthetic Cannabinoids,,Parkinson's Disease
2005027,Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1),https://pubmed.ncbi.nlm.nih.gov/15668727/,Positive,,Meta-analysis,2005,,Mental/Emotional System,Depression; Parkinson's Disease
2007035,Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models,https://pubmed.ncbi.nlm.nih.gov/17287809/,Positive,,Animal Study,2007,Other Related Compounds,Nervous System,Parkinson's Disease; Huntington's Disease
2007036,Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties,https://pubmed.ncbi.nlm.nih.gov/17196181/,Positive,,Animal Study,2007,HU-x Synthetic Cannabinoids,,Parkinson's Disease
2008048,Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB1 and TRPV1 receptors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2128772/?tool=pmcentrez,Positive,,Animal Study,2008,Other Related Compounds; Anandamide (AEA); WIN-x Synthetic Cannabinoids,Nervous System,Parkinson's Disease
2008049,"The cannabinoid CP55,940 prolongs survival and improves locomotor activity in Drosophila melanogaster against paraquat: implications in Parkinson's disease",https://pubmed.ncbi.nlm.nih.gov/18538428/,Positive,,Animal Study,2008,WIN-x Synthetic Cannabinoids,Nervous System,Parkinson's Disease
2009048,The endocannabinoid system as a target for the treatment of motor dysfunction,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697699/,Positive,,Meta-analysis,2009,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),,Huntington's Disease; Parkinson's Disease
2013077,Loss of cannabinoid CB1 receptor expression in the 6-hydroxydopamine-induced nigrostriatal terminal lesion model of Parkinson’s disease in the rat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659808/,Positive,,Animal Study,2013,,,Parkinson's Disease
2010060,Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: A neuroprotective therapeutic modality,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848893/?tool=pubmed,Positive,,Meta-analysis,2010,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Nervous System,Neurodegenerative Issues; Oxidative Stress; Alzheimer's Disease; Huntington's Disease; Parkinson's Disease; Stroke; Traumatic Brain Injury
2011081,Cannabinoid receptor type 1 protects nigrostriatal dopaminergic neurons against MPTP neurotoxicity by inhibiting microglial activation,https://pubmed.ncbi.nlm.nih.gov/22079984/,Positive,,Animal Study,2011,HU-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,,Parkinson's Disease
20211054,Reevaluating America's Latest Pharmaceutical Trend: The Cardiovascular Risk of Cannabis,https://pubmed.ncbi.nlm.nih.gov/32781422/,Negative,,Meta-analysis,2021,,Cardiovascular System,Cardiovascular Diseases (CVD)
2013078,"Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ(9) -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats",https://pubmed.ncbi.nlm.nih.gov/23902479/,Positive,,Animal Study,2013,Cannabidivarin (CBDV); Tetrahydrocannabivarin (THCV),Digestive System,Nausea and Vomiting
2015101,"The phytocannabinoid, Δ⁹-tetrahydrocannabivarin, can act through 5-HT₁A receptors to produce antipsychotic effects",https://pubmed.ncbi.nlm.nih.gov/25363799/,Positive,,Animal Study,2015,Tetrahydrocannabivarin (THCV),Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2020354,High fat-fed GPR55 null mice display impaired glucose tolerance without concomitant changes in energy balance or insulin sensitivity but are less responsive to the effects of the cannabinoids rimonabant or Δ(9)-tetrahydrocannabivarin on weight gain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451014/,Positive,,Animal Study,2020,Tetrahydrocannabivarin (THCV); SR-x Synthetic Cannabinoids,Endocrine System,Diabetes; Obesity
2015102,Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301686/,Positive,,Meta-analysis,2015,Tetrahydrocannabivarin (THCV),,
2007037,"The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189766/,Positive,,Animal Study,2007,Tetrahydrocannabivarin (THCV),Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2008050,The phytocannabinoid Delta(9)-tetrahydrocannabivarin modulates inhibitory neurotransmission in the cerebellum,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2438968/,Positive,,Laboratory Study,2008,Tetrahydrocannabivarin (THCV),,Epilepsy
2019137,Effects of Delta9-tetrahydrocannabivarin on [35S]GTPgammaS binding in mouse brain cerebellum and piriform cortex membranes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483398/,Inconclusive,,Laboratory Study,2019,Tetrahydrocannabivarin (THCV),,
2020355,Δ9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes,https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-020-0016-7,Positive,,Meta-analysis,2020,Tetrahydrocannabivarin (THCV),Endocrine System,Diabetes; Obesity; Fatty Liver Disease
2016109,"The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial",https://pubmed.ncbi.nlm.nih.gov/26577065/,Inconclusive,,Double Blind Clinical Trial,2016,Tetrahydrocannabivarin (THCV); Tetrahydrocannabinol (THC),,Psychosis
2011082,Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson's disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165958/,Positive,,Animal Study,2011,Tetrahydrocannabivarin (THCV),,Parkinson's Disease
2011083,Homeostatic changes of the endocannabinoid system in Parkinson's disease,https://pubmed.ncbi.nlm.nih.gov/21412829/,Positive,,Meta-analysis,2011,,,Parkinson's Disease
2012097,Regional changes in type 1 cannabinoid receptor availability in Parkinson's disease in vivo,https://pubmed.ncbi.nlm.nih.gov/21459482/,Inconclusive,,Clinical Trial,2012,,Nervous System,Parkinson's Disease
2014079,The decrease of dopamine D2/D3 receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB1 cannabinoid receptors in Parkinson’s disease: A preliminary autoradiographic study with the selective dopamine D2/D3 antagonist [3H]raclopride and the novel CB1 inverse agonist [125I]SD7015,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180092/,Positive,,Laboratory Study,2014,,Nervous System,Parkinson's Disease
2013079,The combination of oral L-DOPA/rimonabant for effective dyskinesia treatment and cytological preservation in a rat model of Parkinson's disease and L-DOPA-induced dyskinesia,https://pubmed.ncbi.nlm.nih.gov/24196024/,Positive,,Animal Study,2013,SR-x Synthetic Cannabinoids,,Parkinson's Disease
2013080,Delta 9-THC is protective through PPAR gamma dependent mitochondrial biogenesis in a cell culture model of Parkinson’s disease,https://www.researchgate.net/publication/257599285_Delta_9-TETRAHYDROCANNABINOL_IS_PROTECTIVE_THROUGH_PPAR_gamma_DEPENDENT_MITOCHONDRIAL_BIOGENESIS_IN_A_CELL_CULTURE_MODEL_OF_PARKINSON%27S_DISEASE,Positive,,Laboratory Study,2013,Tetrahydrocannabinol (THC),Nervous System,Parkinson's Disease
2010061,Evaluation of the role of striatal cannabinoid CB1 receptors on movement activity of parkinsonian rats induced by reserpine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730975/,Positive,,Animal Study,2010,AM-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),,Parkinson's Disease
2017105,Cannabinoids in Parkinson's Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436333/,Inconclusive,,Meta-analysis,2017,,,Parkinson's Disease
2008051,Reciprocal influences of CB1 cannabinoid receptor agonists on ERK and JNK signalling in N1E-115 cells,https://febs.onlinelibrary.wiley.com/doi/full/10.1016/j.febslet.2008.10.022,Inconclusive,,Laboratory Study,2008,CP-x Synthetic Cannabinoids; HU-x Synthetic Cannabinoids,Nervous System,Cancer - Neuroblastoma; Cancer
2012098,∆(9)-Tetrahydrocannabinol decreases NOP receptor density and mRNA levels in human SH-SY5Y cells,https://pubmed.ncbi.nlm.nih.gov/21603976/,Inconclusive,,Laboratory Study,2012,,,Pain - Nociceptive; Cancer - Neuroblastoma; Cancer
1998007,Boron trifluoride etherate on silica-A modified Lewis acid reagent (VII). Antitumor activity of cannabigerol against human oral epitheloid carcinoma cells,https://pubmed.ncbi.nlm.nih.gov/9875457/,Positive,,Laboratory Study,1998,Cannabigerol (CBG),Digestive System; Nervous System,Cancer - Oral; Cancer
2012099,"Concomitant consumption of marijuana, alcohol and tobacco in oral squamous cell carcinoma development and progression: recent advances and challenges",https://pubmed.ncbi.nlm.nih.gov/22727410/,Inconclusive,,Meta-analysis,2012,,Digestive System; Nervous System,Cancer - Oral; Cancer
2014080,Association of marijuana smoking with oropharyngeal and oral tongue cancers: Pooled analysis from the INHANCE Consortium,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947141/,Inconclusive,,Meta-analysis,2014,,Digestive System; Nervous System,Cancer - Oral; Cancer
1998008,Perinatal delta9-tetrahydrocannabinol exposure reduces proenkephalin gene expression in the caudate-putamen of adult female rats,https://pubmed.ncbi.nlm.nih.gov/9734704/,Negative,,Animal Study,1998,Tetrahydrocannabinol (THC),Reproductive System,Pregnancy; Addiction - Opioid
1998009,Maternal exposure to delta9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central mu opioid receptors in adult offspring female rats,https://pubmed.ncbi.nlm.nih.gov/9757010/,Negative,,Animal Study,1998,Tetrahydrocannabinol (THC),Reproductive System,Pregnancy; Addiction - Opioid
1999010,"Perinatal delta9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA(B), but not GABA(A), receptor agonists in adult rats",https://pubmed.ncbi.nlm.nih.gov/10386831/,Inconclusive,,Animal Study,1999,Tetrahydrocannabinol (THC),Reproductive System,Pregnancy; Neonatal Cerebral Issues
1999011,Cannabinoid receptor binding and mRNA levels in several brain regions of adult male and female rats perinatally exposed to delta9-tetrahydrocannabinol,https://pubmed.ncbi.nlm.nih.gov/10402157/,Inconclusive,,Animal Study,1999,SR-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC),Nervous System; Reproductive System,Neonatal Cerebral Issues; Pregnancy
2000010,Prenatal Delta(9)-tetrahydrocannabinol exposure modifies proenkephalin gene expression in the fetal rat brain: sex-dependent differences,https://pubmed.ncbi.nlm.nih.gov/10727732/,Negative,,Animal Study,2000,Tetrahydrocannabinol (THC),Reproductive System,Neonatal Cerebral Issues; Pregnancy
2002018,Reduced glial fibrillary acidic protein and glutamine synthetase expression in astrocytes and Bergmann glial cells in the rat cerebellum caused by delta(9)-tetrahydrocannabinol administration during development,https://pubmed.ncbi.nlm.nih.gov/12457068/,Negative,,Animal Study,2002,,Reproductive System,Pregnancy; Neonatal Cerebral Issues
2003015,Perinatal exposure to delta 9-tetrahydrocannabinol increases presynaptic dopamine D2 receptor sensitivity: a behavioral study in rats,https://pubmed.ncbi.nlm.nih.gov/12895674/,Negative,,Animal Study,2003,,Reproductive System,Neonatal Cerebral Issues; Pregnancy
2003016,Effects of perinatal exposure to delta 9-tetrahydrocannabinol on operant morphine-reinforced behavior,https://pubmed.ncbi.nlm.nih.gov/12895675/,Inconclusive,,Animal Study,2003,,Reproductive System,Neonatal Cerebral Issues; Pregnancy
2004023,Down-regulation of the AMPA glutamate receptor subunits GluR1 and GluR2/3 in the rat cerebellum following pre- and perinatal delta9-tetrahydrocannabinol exposure,https://pubmed.ncbi.nlm.nih.gov/15233572/,Negative,,Animal Study,2004,,Reproductive System,Neonatal Cerebral Issues; Pregnancy
2004024,Cannabinoids and gene expression during brain development,https://pubmed.ncbi.nlm.nih.gov/15545023/,Inconclusive,,Meta-analysis,2004,,Reproductive System,Neonatal Cerebral Issues; Pregnancy
2006021,Perinatal exposure to delta(9)-tetrahydrocannabinol alters heroin-induced place conditioning and fos-immunoreactivity,https://pubmed.ncbi.nlm.nih.gov/15920503/,Negative,,Animal Study,2006,Tetrahydrocannabinol (THC),,Neonatal Cerebral Issues; Addiction - Opioid
2005028,Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods,https://pubmed.ncbi.nlm.nih.gov/16148439/,Negative,,Meta-analysis,2005,,Reproductive System,Pregnancy; Neonatal Cerebral Issues; Psychosis
2005029,The cannabinoid system and its importance in the perinatal period,https://pubmed.ncbi.nlm.nih.gov/16266619/,Positive,,Meta-analysis,2005,,,Neonatal Cerebral Issues
2006022,Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751782/,Positive,,Animal Study,2006,Anandamide (AEA),,Excitotoxicity; Neonatal Cerebral Issues
2019138,"The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning",https://pubmed.ncbi.nlm.nih.gov/19335936/,Negative,,Double Blind Clinical Trial,2019,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2018145,Age moderates the association between frequent cannabis use and negative schizotypy over time,https://pubmed.ncbi.nlm.nih.gov/30053703/,Inconclusive,,Meta-analysis,2018,,Mental/Emotional System,Psychosis; Schizophrenia
20211055,"Randomized, placebo-controlled, 28-day safety and pharmacokinetics evaluation of repeated oral cannabidiol administration in healthy dogs",https://pubmed.ncbi.nlm.nih.gov/33904801/,Inconclusive,,Animal Study -,2021,,,Veterinary Applications
2020356,Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug-Drug Interactions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231229/,Negative,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
20211056,Orally Active Peptide Vector Allows Using Cannabis to Fight Pain While Avoiding Side Effects,https://pubmed.ncbi.nlm.nih.gov/33887904/,Positive,,Laboratory Study,2021,,Nervous System,Pain; Pain - Chronic
20211057,An Unexpected Case of Cannabis-Induced Pancreatitis,https://pubmed.ncbi.nlm.nih.gov/33717760/,Negative,,Meta-analysis,2021,,Digestive System; Endocrine System,Pancreatitis
2006023,Cannabinoid receptors as a target for therapy of ovarian cancer,https://cancerres.aacrjournals.org/content/66/8_Supplement/1084.1,Positive,,Laboratory Study,2006,WIN-x Synthetic Cannabinoids,Nervous System; Reproductive System,Cancer - Ovarian; Cancer
2010062,Cannabinoid Receptors as Target for Treatment of Osteoporosis: A Tale of Two Therapies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001217/?tool=pubmed,Positive,,Meta-analysis,2010,,Skeletal System,Osteoporosis
2011084,The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapy,https://pubmed.ncbi.nlm.nih.gov/21237298/,Positive,,Meta-analysis,2011,,Skeletal System,Osteoporosis
2012100,Role of cannabinoids in the regulation of bone remodeling,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499879/,Positive,,Meta-analysis,2012,Endocannabinoid (unspecified),Skeletal System,Osteoporosis
20211058,A Literature Review of Cannabis and Myocardial Infarction—What Clinicians May Not Be Aware Of,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801213/,Negative,,Meta-analysis,2021,,Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack
20211059,"""Less pain with more gain""-Managing wound-related pain with cannabis-based medicines",https://pubmed.ncbi.nlm.nih.gov/33455032/,Positive,,Meta-analysis,2021,,Immune System; Integumentary System,Pain; Pain - Chronic; Wound Healing
20211060,Cannabis use assessment and its impact on pain in rheumatologic diseases: a systematic review and meta-analysis,https://pubmed.ncbi.nlm.nih.gov/33159797/,Positive,,Meta-analysis,2021,,Skeletal System,Arthritis - Rheumatoid; Arthritis
20211061,Cannabidiol Treatment Results in a Common Gene Expression Response Across Aggressive Cancer Cells from Various Origins,https://pubmed.ncbi.nlm.nih.gov/33912679/,Positive,,Laboratory Study,2021,,Nervous System,Cancer; Cancer - Brain; Cancer - Breast; Cancer - Metastatic; Cancer - Prostate; Cancer - Squamous Head/Neck
2014081,Calcium regulation by temperature-sensitive transient receptor potential channels in human uveal melanoma cells,https://pubmed.ncbi.nlm.nih.gov/24084605/,Positive,,Laboratory Study,2014,,Integumentary System; Nervous System,Cancer - Melanoma; Cancer
2002019,Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease,https://pubmed.ncbi.nlm.nih.gov/12091357/,Positive,,Laboratory Study,2002,Anandamide (AEA); Tetrahydrocannabinol (THC); HU-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Immune System; Nervous System,Cancer - Lymphoma; Cancer
2003017,"High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma",https://pubmed.ncbi.nlm.nih.gov/12970790/,Inconclusive,,Laboratory Study,2003,,Immune System,Cancer - Lymphoma; Cancer
2003018,"The peripheral cannabinoid receptor Cb2, a novel oncoprotein, induces a reversible block in neutrophilic differentiation",https://ashpublications.org/blood/article/101/4/1336/105900/The-peripheral-cannabinoid-receptor-Cb2-a-novel,Positive,,Laboratory Study,2003,2-Arachidonoyl Glycerol (2-AG); SR-x Synthetic Cannabinoids,Immune System,Cancer - Leukemia; Cancer
2005030,Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma,https://pubmed.ncbi.nlm.nih.gov/16337199/,Positive,,Laboratory Study,2005,Anandamide (AEA); WIN-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Immune System,Cancer - Lymphoma; Cancer
2007038,The expression of the peripheral cannabinoid receptor on cells of the immune system and non-Hodgkin's lymphomas,https://pubmed.ncbi.nlm.nih.gov/17613768/,Inconclusive,,Laboratory Study,2007,,Immune System; Nervous System,Cancer - Lymphoma; Cancer
20211062,"The dose-dependent analgesic effects, abuse liability, safety and tolerability of oral cannabidiol in healthy humans",https://pubmed.ncbi.nlm.nih.gov/34223660/,Inconclusive,,Double Blind Clinical Trial,2021,,Nervous System,Pain - Nociceptive; Pain; Pain - Neuropathy - Peripheral; Pain - Acute
20211063,Modulation of striatal functional connectivity differences in adults with and without autism spectrum disorder in a single-dose randomized trial of cannabidivarin,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252312/,Positive,,Double Blind Clinical Trial,2021,Cannabidivarin (CBDV),Mental/Emotional System; Nervous System,Autism
20211064,Legalization of cannabis use in Canada: Impacts on the cannabis use profiles of youth seeking services for substance use,https://pubmed.ncbi.nlm.nih.gov/34116825/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2010063,Increased cannabinoid receptor 1-immunoreactive nerve fibers in overactive and painful bladder disorders and their correlation with symptoms,https://pubmed.ncbi.nlm.nih.gov/20346490/,Positive,,Laboratory Study,2010,,Urinary System,Urinary Tract Infection
2011085,Inhibitory effect of standardized cannabis sativa extract and its ingredient cannabidiol on rat and human bladder contractility,https://pubmed.ncbi.nlm.nih.gov/21310467/,Inconclusive,,Laboratory Study,2011,,Urinary System,Urinary Tract Infection
20211065,Cannabis and the Gut-Brain Axis Communication in HIV Infection,https://pubmed.ncbi.nlm.nih.gov/33912676/,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified); Microbiome,Immune System,HIV/AIDS; Microbiome Imbalance
20211066,Self-Reported Cannabis Use and Markers of Inflammation in Men Who Have Sex With Men With and Without HIV,https://pubmed.ncbi.nlm.nih.gov/33912681/,Inconclusive,,Meta-analysis,2021,,Immune System; Nervous System,HIV/AIDS; Inflammation
2007039,Pharmacological Inhibition of CB1 Cannabinoid Receptor Protects Against Doxorubicin-Induced Cardiotoxicity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2239316/,Positive,,Animal Study,2007,AM-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids; HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,Cardiovascular System,Cardiac Toxicity; Cardiovascular Diseases (CVD)
2011086,"WIN55,212-2 induces cytoplasmic vacuolation in apoptosis-resistant MCL cells",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223692/,Positive,,Laboratory Study,2011,WIN-x Synthetic Cannabinoids,Immune System; Nervous System,Cancer - Lymphoma; Cancer
2013081,Expression and Functional Relevance of Cannabinoid Receptor 1 in Hodgkin Lymphoma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857220/,Positive,,Laboratory Study,2013,AM-x Synthetic Cannabinoids,Immune System; Nervous System,Cancer - Lymphoma; Cancer
2014082,Perturbations of the endocannabinoid system in mantle cell lymphoma: correlations to clinical and pathological features,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278325/,Inconclusive,,Laboratory Study,2014,Fatty Acid Amide Hydrolase (FAAH),Immune System; Nervous System,Cancer - Lymphoma; Cancer
2016110,"The potential relevance of the endocannabinoid, 2-arachidonoylglycerol, in diffuse large B-cell lymphoma",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751914/,Inconclusive,,Laboratory Study,2016,2-Arachidonoyl Glycerol (2-AG),Immune System,Cancer - Lymphoma; Cancer; Obesity
1998010,Immunology in medical practice. XIV. Central nervous system complications in systemic autoimmune diseases,https://pubmed.ncbi.nlm.nih.gov/9623096/,Inconclusive,,Meta-analysis,1998,,,Arthritis - Rheumatoid; Arthritis; Lupus
1974001,A pilot study of orally administered Δ1-trans-tetrahydrocannabinol in the management of patients undergoing radiotherapy for carcinoma of the bronchus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1402430/?page=1,Positive,,Clinical Trial,1974,Pharma THC,Respiratory System,Cancer - Lung; Cancer
1992002,No increase in carcinogen-DNA adducts in the lungs of monkeys exposed chronically to marijuana smoke,https://pubmed.ncbi.nlm.nih.gov/1488780/,Inconclusive,,Animal Study,1992,,,Cancer - Lung; Cancer; COPD
2005031,Cannabis and tobacco smoke are not equally carcinogenic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1277837/?tool=pubmed,Inconclusive,,Meta-analysis,2005,,Nervous System; Respiratory System,Cancer - Lung; Cancer
2010064,Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cells,https://pubmed.ncbi.nlm.nih.gov/20668920/,Positive,,Laboratory Study,2010,,Nervous System; Respiratory System,Cancer - Lung; Cancer
2012101,"Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non-Small Cell Lung Cancer Growth and Metastasis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025486/?tool=pubmed,Positive,,Laboratory Study,2012,JWH-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Nervous System; Respiratory System,Cancer - Lung; Cancer
2012102,Anti-proliferative and anti-angiogenic effects of CB2R agonist (JWH-133) in non-small lung cancer cells (A549) and human umbilical vein endothelial cells: an in vitro investigation,https://pubmed.ncbi.nlm.nih.gov/22578958/,Positive,,Laboratory Study,2012,JWH-x Synthetic Cannabinoids,Nervous System; Respiratory System,Cancer - Lung; Cancer
2013082,Effects of marijuana smoking on the lung,https://pubmed.ncbi.nlm.nih.gov/23802821/,Inconclusive,,Meta-analysis,2013,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cancer - Lung; Cancer; COPD
2013083,Cannabis and the Lung: No More Smoking Gun?,https://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201302-034ED,Negative,,Meta-analysis,2013,,Nervous System; Respiratory System,Cancer - Lung; Cancer; COPD
2014083,Cannabis smoking and respiratory health: Consideration of the literature,https://onlinelibrary.wiley.com/doi/full/10.1111/resp.12298,Negative,,Meta-analysis,2014,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cancer - Lung; Cancer; COPD; Cough
2015103,Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262725/,Negative,,Meta-analysis,2015,,Nervous System; Respiratory System,Cancer - Lung; Cancer
2016111,The antitumor activity of plant-derived non-psychoactive cannabinoids,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470774/,Positive,,Meta-analysis,2016,,Respiratory System,Cancer - Lung; Cancer
2016112,Cannabidiol promotes browning in 3T3-L1 adipocytes,https://pubmed.ncbi.nlm.nih.gov/27067870/,Positive,,Laboratory Study,2016,,Endocrine System,Obesity; Metabolic Syndrome
2016113,The novel cannabinoid antagonist SM-11 reduces hedonic aspect of food intake through a dopamine-dependent mechanism,https://pubmed.ncbi.nlm.nih.gov/27521837/,Positive,,Animal Study,2016,Synthetic Cannabinoid (unspecified),Endocrine System,Obesity; Metabolic Syndrome
2018146,Cannabinoid Receptor Signaling in Central Regulation of Feeding Behavior: A Mini-Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442223/,Positive,,Meta-analysis,2018,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),,Anorexia; Cachexia; Loss of Appetite; Metabolic Syndrome; Obesity
2017106,Incretin secretion in humans is under the influence of cannabinoid receptors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625085/,Inconclusive,,Double Blind Clinical Trial,2017,Pharma THC,Endocrine System,Obesity; Metabolic Syndrome
2018147,Polyunsaturated fatty acids and endocannabinoids in health and disease,https://pubmed.ncbi.nlm.nih.gov/28686542/,Positive,,Meta-analysis,2018,Omega-3; 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),,Cognitive Dysfunction; Inflammation; Metabolic Syndrome; Obesity
2017107,Peripheral cannabinoid-1 receptor blockade restores hypothalamic leptin signaling,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641628/,Positive,,Animal Study,2017,Synthetic Cannabinoid (unspecified),Endocrine System,Obesity
2017108,Obesity-Related CKD: When Kidneys Get the Munchies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698082/,Inconclusive,,Meta-analysis,2017,,Endocrine System; Urinary System,Chronic Kidney Disease; Obesity
2018148,Structure-Based Identification of Potent Natural Product Chemotypes as Cannabinoid Receptor 1 Inverse Agonists,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222380/,Inconclusive,,Laboratory Study,2018,Synthetic Cannabinoid (unspecified),,Metabolic Syndrome; Obesity
2014084,TRP channels in lower urinary tract dysfunction,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008998/,Positive,,Meta-analysis,2014,,Urinary System,Urinary Tract Infection
2016114,New therapeutic strategies for the treatment of male lower urinary tract symptoms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853157/,Positive,,Meta-analysis,2016,,Urinary System,Urinary Tract Infection
20211067,Cannabis Use is Associated With Reduced 30-Day All-cause Readmission Among Hospitalized Patients With Irritable Bowel Syndrome: A Nationwide Analysis,https://pubmed.ncbi.nlm.nih.gov/33471483/,Positive,,Meta-analysis,2021,,Digestive System,Irritable Bowel Syndrome
20211068,In vivo and in vitro anti-inflammatory activity evaluation of Lebanese Cannabis sativa L. ssp. indica (Lam.),https://pubmed.ncbi.nlm.nih.gov/33359187/,Positive,,Animal Study,2021,,,Inflammation; Arthritis - Osteoarthritis; Arthritis
20211069,Endocannabinoid and dopaminergic system: the pas de deux underlying human motivation and behaviors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105194/,Inconclusive,,Meta-analysis,2021,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),,Metabolic Syndrome; Obesity
20211070,Involvement of the endocannabinoid system in the inhibition of Sindbis virus replication: a preliminary study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066438/,Inconclusive,,Laboratory Study,2021,AM-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),,Prion Disease
20211071,Association of Cannabis Use During Adolescence With Neurodevelopment,https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2781289,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2017109,Cognitive motor deficits in cannabis users,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966282/,Inconclusive,,Meta-analysis,2017,,Nervous System,Cognitive Dysfunction
2017110,Effects of Adolescent Cannabinoid Self-Administration in Rats on Addiction-Related Behaviors and Working Memory,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506802/,Inconclusive,,Animal Study,2017,WIN-x Synthetic Cannabinoids,Nervous System,Cognitive Dysfunction; Addiction - Cannabis; Cannabis Adverse Effects
2016115,Are deficits in cognition associated with psychotic-like experiences after cannabis?,https://pubmed.ncbi.nlm.nih.gov/27859664/,Negative,,Meta-analysis,2016,,Nervous System,Cognitive Dysfunction; Cannabis Adverse Effects; Psychosis
20211072,Periodontal status in cannabis smokers. A systematic review,https://pubmed.ncbi.nlm.nih.gov/33929931/,Negative,,Meta-analysis,2021,,Digestive System,Periodontal Disease; Cavities
20211073,Hempseed (Cannabis sativa) offers effective alternative over statins in ameliorating hypercholesterolemia associated nephropathy,https://pubmed.ncbi.nlm.nih.gov/33861983/,Positive,,Animal Study,2021,,,Atherosclerosis; Cardiovascular Diseases (CVD); Inflammation; Metabolic Syndrome; Obesity
20211074,“Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations,https://www.ejinme.com/article/S0953-6205(21)00152-7/fulltext,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
20211075,Effects of Cannabis Consumption on Sleep,https://pubmed.ncbi.nlm.nih.gov/33537943/,Inconclusive,,Meta-analysis,2021,,Nervous System,Insomnia and Sleep Disorders
20211076,Palmitoylethanolamide and hemp oil extract exert synergistic anti-nociceptive effects in mouse models of acute and chronic pain,https://pubmed.ncbi.nlm.nih.gov/33722712/,Positive,,Animal Study,2021,,Nervous System,Pain; Pain - Acute; Pain - Chronic
20211077,Chemical and Bioinformatics Analyses of the Anti-Leishmanial and Anti-Oxidant Activities of Hemp Essential Oil,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917915/,Positive,,Animal Study,2021,,Integumentary System; Nervous System,Leishmaniasis; Oxidative Stress
20211078,"Marijuana, but not alcohol, use frequency associated with greater loneliness, psychological distress, and less flourishing among young adults",https://pubmed.ncbi.nlm.nih.gov/33250378/,Negative,,Meta-analysis,2021,,,Anxiety; Depression
20211079,Anticancer property of Hemp Bioactive Peptides in Hep3B liver cancer cells through Akt/GSK3β/β‐catenin signaling pathway,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020916/,Positive,,Laboratory Study,2021,,Digestive System; Nervous System,Cancer - Liver; Cancer
20211080,Cannabidiolic acid exhibits entourage-like improvements of anticonvulsant activity in an acute rat model of seizures,https://pubmed.ncbi.nlm.nih.gov/33310415/,Positive,,Animal Study,2021,Cannabidiolic Acid (CBD-a),Nervous System,Epilepsy
20211081,"Experience of migraine, its severity, and perceived efficacy of treatments among cannabis users",https://pubmed.ncbi.nlm.nih.gov/33227352/,Positive,,Meta-analysis,2021,,Nervous System,Migraine
20211082,"New Insights on Hemp Oil Enriched in Cannabidiol: Decarboxylation, Antioxidant Properties and In Vitro Anticancer Effect",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150740/,Positive,,Laboratory Study,2021,,Nervous System,Cancer
20211083,Comorbid Cannabis Use Disorder with Major Depression and Generalized Anxiety Disorder: A Systematic Review with Meta-analysis of Nationally Representative Epidemiological Surveys,https://pubmed.ncbi.nlm.nih.gov/33360749/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
20211084,Use of Cannabis and Cannabinoids in Patients With Cancer,https://pubmed.ncbi.nlm.nih.gov/33070617/,Positive,,Meta-analysis,2021,,,Cancer
20211085,"Metabolomic Profile and Antioxidant/Anti-Inflammatory Effects of Industrial Hemp Water Extract in Fibroblasts, Keratinocytes and Isolated Mouse Skin Specimens",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823476/,Positive,,Laboratory Study,2021,Cannabidiolic Acid (CBD-a),,Inflammation; Oxidative Stress
20211086,Acute effects of hemp protein consumption on glycemic and satiety control: results of two randomized crossover trials,https://pubmed.ncbi.nlm.nih.gov/33493023/,Positive,,Clinical Trial,2021,,Endocrine System,Diabetes; Metabolic Syndrome; Obesity
20211087,Endocannabinoid System and Its Regulation by Polyunsaturated Fatty Acids and Full Spectrum Hemp Oils,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196941/,Positive,,Meta-analysis,2021,,,Metabolic Syndrome
20211088,"Annual incidence of cannabis-induced psychosis, other substance-induced psychoses and dually diagnosed schizophrenia and cannabis use disorder in Denmark from 1994 to 2016",https://pubmed.ncbi.nlm.nih.gov/31839011/,Negative,,Meta-analysis,2021,,Mental/Emotional System,Cannabis Adverse Effects; Psychosis; Schizophrenia
20211089,Hemp ( Cannabis sativa L.) Seed and Co-Products Inclusion in Diets for Dairy Ruminants: A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002700/,Positive,,Meta-analysis,2021,,,Anorexia; Cachexia
20211090,A Review of Hemp as Food and Nutritional Supplement,https://pubmed.ncbi.nlm.nih.gov/33614949/,Positive,,Meta-analysis,2021,,,Anorexia; Anxiety; Cachexia; Epilepsy; Metabolic Syndrome; Oxidative Stress
2018149,An Assessment of the Genotoxicity and Subchronic Toxicity of a Supercritical Fluid Extract of the Aerial Parts of Hemp,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011091/,Positive,,Animal Study,2018,,,Metabolic Syndrome; Obesity
2020357,"Effects of Hemp Extract on Markers of Wellness, Stress Resilience, Recovery and Clinical Biomarkers of Safety in Overweight, But Otherwise Healthy Subjects",https://pubmed.ncbi.nlm.nih.gov/32456572/,Positive,,Double Blind Clinical Trial,2020,,Cardiovascular System; Mental/Emotional System,Atherosclerosis; Cardiovascular Diseases (CVD); Insomnia and Sleep Disorders; Metabolic Syndrome; Obesity; Oxidative Stress
2016116,Cannabis-induced Moto-Cognitive Dysfunction in Wistar Rats: Ameliorative Efficacy of Nigella Sativa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101984/,Positive,,Animal Study,2016,,,Cognitive Dysfunction
2017111,"Consequences of Adolescent Exposure to the Cannabinoid Receptor Agonist WIN55,212-2 on Working Memory in Female Rats",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519521/,Positive,,Animal Study,2017,WIN-x Synthetic Cannabinoids,Nervous System,Cognitive Dysfunction
2016117,Comparisons of Δ9-Tetrahydrocannabinol and Anandamide on a Battery of Cognition-Related Behavior in Nonhuman Primates,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809315/,Positive,,Animal Study,2016,Anandamide (AEA); Tetrahydrocannabinol (THC),Nervous System,Cognitive Dysfunction
20211091,Calling for Openness to the Study of Cannabis Use in Chronic Pelvic Pain,https://pubmed.ncbi.nlm.nih.gov/33132057/,Positive,,Meta-analysis,2021,,,Pain; Pain - Chronic
20211092,Cannabinoids and Pain: The Highs and Lows,https://pubmed.ncbi.nlm.nih.gov/33781494/,Positive,,Meta-analysis,2021,,,Pain; Pain - Chronic
1992003,Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1907498/?page=1,Inconclusive,,Laboratory Study,1992,CP-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC),,Cancer - Neuroblastoma; Cancer
1985001,Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes,https://pubmed.ncbi.nlm.nih.gov/2984538/,Inconclusive,,Laboratory Study,1985,Synthetic Cannabinoid (unspecified),,Cancer - Neuroblastoma; Cancer
2012103,Identification of receptors and enzymes for endocannabinoids in NSC-34 cells: relevance for in vitro studies with cannabinoids in motor neuron diseases,https://pubmed.ncbi.nlm.nih.gov/22206832/,Positive,,Laboratory Study,2012,Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Nervous System,Neurodegenerative Issues; Amyotrophic Lateral Sclerosis (ALS)
2014085,"Cannabinoid effects on β amyloid fibril and aggregate formation, neuronal and microglial-activated neurotoxicity in vitro",https://pubmed.ncbi.nlm.nih.gov/24030360/,Positive,,Laboratory Study,2014,2-Arachidonoyl Glycerol (2-AG); Abnormal Cannabidiol (Abn-CBD); JWH-x Synthetic Cannabinoids; O-x Synthetic Cannabinoids,,Neurodegenerative Issues
2015104,Cannabidiol Exposure During Neuronal Differentiation Sensitizes Cells Against Redox-Active Neurotoxins,https://pubmed.ncbi.nlm.nih.gov/25108670/,Positive,,Laboratory Study,2015,,Nervous System,Cancer - Neuroblastoma; Cancer
2007040,Perinatal exposure to delta-9-tetrahydrocannabinol causes enduring cognitive deficits associated with alteration of cortical gene expression and neurotransmission in rats,https://pubmed.ncbi.nlm.nih.gov/17578508/,Negative,,Animal Study,2007,,Nervous System,Neonatal Cerebral Issues
2007041,Role of cannabinoidergic mechanisms in ethanol self-administration and ethanol seeking in rat adult offspring following perinatal exposure to Delta9-tetrahydrocannabinol,https://pubmed.ncbi.nlm.nih.gov/17618662/,Inconclusive,,Animal Study,2007,SR-x Synthetic Cannabinoids; Tetrahydrocannabinolic Acid (THC-a); Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction; Neonatal Cerebral Issues
2014086,Fetal cannabinoid receptors and the “dis-joint-ed” brain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000085/,Negative,,Animal Study,2014,Tetrahydrocannabinol (THC),Nervous System,Neonatal Cerebral Issues; Pregnancy
2017112,Nutritional n-3 PUFA Deficiency Abolishes Endocannabinoid Gating of Hippocampal Long-Term Potentiation,https://pubmed.ncbi.nlm.nih.gov/26946127/,Inconclusive,,Animal Study,2017,Endocannabinoid (unspecified),,Pregnancy
1998011,Perinatal delta9-tetrahydrocannabinol exposure did not alter dopamine transporter and tyrosine hydroxylase mRNA levels in midbrain dopaminergic neurons of adult male and female rats,https://pubmed.ncbi.nlm.nih.gov/9761594/,Inconclusive,,Animal Study,1998,Tetrahydrocannabinol (THC),Reproductive System,Pregnancy
2003019,"Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions",https://www.freepatentsonline.com/y2005/0165088.html,Positive,,Meta-analysis,2003,Cannabidiolic Acid (CBD-a),Digestive System,Nausea and Vomiting
1997008,Pain relief with oral cannabinoids in familial Mediterranean fever,https://pubmed.ncbi.nlm.nih.gov/9165969/,Positive,,Meta-analysis,1997,Tetrahydrocannabinol (THC),Digestive System,Familial Mediterranean Fever; Fever
20211093,Pediatric cannabis intoxication trends in the pre and post-legalization era,https://pubmed.ncbi.nlm.nih.gov/34137352/,Negative,,Meta-analysis,2021,,Mental/Emotional System,Cannabis Adverse Effects
20211094,Effect of Cannabinoid 2 Receptor Modulation on the Peripheral Immune Response in Central Nervous System Injury-Induced Immunodeficiency Syndrome,https://pubmed.ncbi.nlm.nih.gov/33998888/,Positive,,Animal Study,2021,AM-x Synthetic Cannabinoids; HU-x Synthetic Cannabinoids,Immune System; Nervous System,Injury Immunodeficiency; Spinal Cord Injuries; Stroke; Traumatic Brain Injury
20211095,Monoacylglycerol Lipase Inhibition Using JZL184 Attenuates Paw Inflammation and Functional Deficits in a Mouse Model of Inflammatory Arthritis,https://pubmed.ncbi.nlm.nih.gov/34042520/,Positive,,Animal Study,2021,Monoacylglycerol Lipase (MAGL),Skeletal System,Arthritis - Osteoarthritis; Arthritis
20211096,CB2 agonism controls pain and subchondral bone degeneration induced by mono-iodoacetate: Implications GPCR functional bias and tolerance development,https://pubmed.ncbi.nlm.nih.gov/33482616/,Positive,,Animal Study,2021,JWH-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Skeletal System,Arthritis - Osteoarthritis; Arthritis
20211097,"The CANBACK trial: a randomised, controlled clinical trial of oral cannabidiol for people presenting to the emergency department with acute low back pain",https://pubmed.ncbi.nlm.nih.gov/33846971/,Inconclusive,,Double Blind Clinical Trial,2021,,Nervous System,Pain; Pain - Acute
20211098,"Characterization of the peripheral FAAH inhibitor, URB937, in animal models of acute and chronic migraine",https://pubmed.ncbi.nlm.nih.gov/33129939/,Positive,,Animal Study,2021,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Nervous System,Migraine
20211099,Cannabis sativa subsp. sativa's pharmacological properties and health effects: A scoping review of current evidence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815160/,Positive,,Meta-analysis,2021,,,Acne; Arthritis - Osteoarthritis; Arthritis; Bacterial Infections; Cardiovascular Diseases (CVD); Constipation; Diabetes; Hypertension (High Blood Pressure); Inflammation
20211100,"A randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall patient satisfaction",https://pubmed.ncbi.nlm.nih.gov/34085149/,Positive,,Clinical Trial,2021,,Nervous System,Pain; Pain - Cancer; Addiction - Opioid
20211101,"Treating Insomnia Symptoms with Medicinal Cannabis: A Randomized, Cross-Over Trial of the Efficacy of a Cannabinoid Medicine Compared with Placebo",https://pubmed.ncbi.nlm.nih.gov/34115851/,Positive,,Double Blind Clinical Trial,2021,,Nervous System,Insomnia and Sleep Disorders
2020358,A Literature Analysis on Medicinal Use and Research of Cannabis in the Meiji Era of Japan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540234/,Positive,,Meta-analysis,2020,,,Asthma; Gastro-Esophageal Reflux; Insomnia and Sleep Disorders; Pain; Neurodegenerative Issues; Pain - Chronic; Tuberculosis
20211102,Prolonged Medical Cannabis Treatment is Associated With Quality of Life Improvement and Reduction of Analgesic Medication Consumption in Chronic Pain Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172141/,Positive,,Meta-analysis,2021,,Nervous System,Pain; Pain - Chronic; Addiction - Opioid
2018150,CB1 receptors in the paraventricular nucleus of the hypothalamus modulate the release of 5-HT and GABA to stimulate food intake in rats,https://pubmed.ncbi.nlm.nih.gov/30217553/,Positive,,Animal Study,2018,Endocannabinoid (unspecified),,
20211103,Trends in Prevalence and Outcomes of Cannabis Use Among Chronic Obstructive Pulmonary Disease Hospitalizations: A Nationwide Population-Based Study 2005-2014,https://pubmed.ncbi.nlm.nih.gov/33998884/,Positive,,Meta-analysis,2021,,Respiratory System,COPD
2010065,"The effects of the synthetic cannabinoid receptor agonists, WIN55,212-2 and CP55,940, on salicylate-induced tinnitus in rats",https://pubmed.ncbi.nlm.nih.gov/20630477/,Inconclusive,,Animal Study,2010,CP-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Nervous System,Tinnitus
2016118,Expression of Dopamine Receptor 1A and Cannabinoid Receptor 1 Genes in the Cochlea and Brain after Salicylate-Induced Tinnitus,https://pubmed.ncbi.nlm.nih.gov/27658122/,Inconclusive,,Animal Study,2016,,Nervous System,Tinnitus
2017113,"Effects of the cannabinoid CB 1 agonist ACEA on salicylate ototoxicity, hyperacusis and tinnitus in guinea pigs",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5714060/,Inconclusive,,Animal Study,2017,Synthetic Cannabinoid (unspecified),Nervous System,Tinnitus
2019139,Cannabinoid receptor down-regulation in the ventral cochlear nucleus in a salicylate model of tinnitus,https://pubmed.ncbi.nlm.nih.gov/17376618/,Inconclusive,,Animal Study,2019,,Nervous System,Tinnitus
2019140,Capsaicin Protects Against Cisplatin Ototoxicity by Changing the STAT3/STAT1 Ratio and Activating Cannabinoid (CB2) Receptors in the Cochlea,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411993/,Positive,,Animal Study,2019,,Nervous System,Hearing Loss
2020359,"Cannabinoids, Inner Ear, Hearing, and Tinnitus: A Neuroimmunological Perspective",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719758/,Positive,,Meta-analysis,2020,,Nervous System,Tinnitus
2020360,Does cannabis alleviate tinnitus? A review of the current literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752070/,Inconclusive,,Meta-analysis,2020,,Nervous System,Tinnitus
20211104,The Effects of Acute Δ 9-Tetrahydrocannabinol on Striatal Glutamatergic Function: A Proton Magnetic Resonance Spectroscopy Study,https://pubmed.ncbi.nlm.nih.gov/34099186/,Inconclusive,,Double Blind Clinical Trial,2021,,,Psychosis
20211105,Psychotomimetic symptoms after a moderate dose of a synthetic cannabinoid (JWH-018): implications for psychosis,https://pubmed.ncbi.nlm.nih.gov/33501595/,Negative,,Double Blind Clinical Trial,2021,JWH-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Psychosis
20211106,Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review,https://pubmed.ncbi.nlm.nih.gov/33536109/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Anxiety; Depression; Psychosis
20211107,Are psychotic-like experiences related to a discontinuation of cannabis consumption in young adults?,https://pubmed.ncbi.nlm.nih.gov/33493775/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Psychosis
20211108,Relationship between cannabis use and psychotic experiences in college students,https://pubmed.ncbi.nlm.nih.gov/33887647/,Negative,,Meta-analysis,2021,,Mental/Emotional System,Psychosis
20211109,Creatine kinase levels in psychotic patients who use cannabinoids,https://pubmed.ncbi.nlm.nih.gov/33165025/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System,Psychosis
20211110,"Cannabis use, self-perceived risk, perceived peer approval and parental attitudes among youth at clinical high-risk for psychosis",https://pubmed.ncbi.nlm.nih.gov/33942529/,Negative,,Meta-analysis,2021,,Mental/Emotional System,Psychosis
20211111,Schizophrenia and the Environment: Within-Person Analyses May be Required to Yield Evidence of Unconfounded and Causal Association-The Example of Cannabis and Psychosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084443/,Negative,,Meta-analysis,2021,,Mental/Emotional System,Cannabis Adverse Effects; Psychosis
20211112,The Behavioral Sequelae of Cannabis Use in Healthy People: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920961/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
20211113,Prospects for the Use of Cannabinoids in Psychiatric Disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994770/,Inconclusive,,Meta-analysis,2021,,,Anxiety; Dementia; Depression; Insomnia and Sleep Disorders
20211114,The relationship between cannabis and schizophrenia: a genetically informed perspective,https://pubmed.ncbi.nlm.nih.gov/33950550/,Negative,,Meta-analysis,2021,,Mental/Emotional System,Schizophrenia; Addiction - Cannabis; Psychosis
20211115,"Cannabinoids, reward processing, and psychosis",https://pubmed.ncbi.nlm.nih.gov/33644820/,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System,Psychosis
20211116,When Cannabis Use Goes Wrong: Mental Health Side Effects of Cannabis Use That Present to Emergency Services,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917124/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Anxiety; Psychosis; Schizophrenia; Suicide Attempt
20211117,The Yin and Yang of Cannabis: A Systematic Review of Human Neuroimaging Evidence of the Differential Effects of Δ 9-Tetrahydrocannabinol and Cannabidiol,https://pubmed.ncbi.nlm.nih.gov/33414100/,Positive,,Meta-analysis,2021,,,Psychosis
20211118,The independent and combined effects of cannabis use and systemic inflammation during the early stages of psychosis: exploring the two-hit hypothesis,https://pubmed.ncbi.nlm.nih.gov/33736715/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Psychosis
20211119,"Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis",https://pubmed.ncbi.nlm.nih.gov/31994476/,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Psychosis
20211120,The association of cannabis use with quality of life and psychosocial functioning in psychosis,https://pubmed.ncbi.nlm.nih.gov/33461022/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Psychosis
20211121,Use of medical cannabis by patients with fibromyalgia in Canada after cannabis legalisation: a cross-sectional study,https://pubmed.ncbi.nlm.nih.gov/33938797/,Positive,,Meta-analysis,2021,,Muscular System,Fibromyalgia
2019141,Glial Cells and Their Contribution to the Mechanisms of Action of Cannabidiol in Neuropsychiatric Disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890128/,Positive,,Meta-analysis,2019,,,Anxiety; Depression; Epilepsy; Neurodegenerative Issues; Psychosis; Schizophrenia; Traumatic Brain Injury
20211122,Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917759/,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Anxiety; Depression
2019142,Cannabidiol induces antidepressant and anxiolytic-like effects in experimental type-1 diabetic animals by multiple sites of action,https://pubmed.ncbi.nlm.nih.gov/33464458/,Positive,,Animal Study,2019,,Endocrine System; Mental/Emotional System; Nervous System,Anxiety; Depression; Diabetes
20211123,"Safety and tolerability of nabiximols oromucosal spray: a review of real-world experience in observational studies, registries, and case reports",https://pubmed.ncbi.nlm.nih.gov/33749480/,Positive,,Meta-analysis,2021,Pharma THC:CBD,Nervous System,Multiple Sclerosis; Chorea; Pain; Neurodegenerative Issues; Pain - Chronic
20211124,Therapeutic Prospects of Cannabinoids in the Immunomodulation of Prevalent Autoimmune Diseases,https://pubmed.ncbi.nlm.nih.gov/34030476/,Positive,,Meta-analysis,2021,,,Arthritis - Rheumatoid; Arthritis; Diabetes; Lupus; Multiple Sclerosis
20211125,Emerging role of cannabinoids and synthetic cannabinoid receptor 1/cannabinoid receptor 2 receptor agonists in cancer treatment and chemotherapy-associated cancer management,https://www.cancerjournal.net/article.asp?issn=0973-1482;year=2021;volume=17;issue=1;spage=1;epage=9;aulast=Shah,Positive,,Meta-analysis,2021,,Nervous System,Cancer; Alzheimer's Disease; Anxiety; Cachexia; Pain; Multiple Sclerosis; Nausea and Vomiting; Pain - Chronic
20211126,Cannabidiol and Other Cannabinoids in Demyelinating Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001020/,Positive,,Meta-analysis,2021,,Nervous System,Multiple Sclerosis; Stroke; Traumatic Brain Injury
20211127,Impaired awareness: Why people with multiple sclerosis continue using cannabis despite evidence to the contrary,https://pubmed.ncbi.nlm.nih.gov/34087949/,Inconclusive,,Clinical Trial,2021,,,Multiple Sclerosis
20211128,Safety and efficacy of low-dose medical cannabis oils in multiple sclerosis,https://pubmed.ncbi.nlm.nih.gov/33387864/,Positive,,Clinical Trial,2021,Pharma THC:CBD; Pharma THC; Pharma CBD,,Multiple Sclerosis
2019143,"A Multicriteria Decision Analysis Comparing Pharmacotherapy for Chronic Neuropathic Pain, Including Cannabinoids and Cannabis-Based Medical Products",https://pubmed.ncbi.nlm.nih.gov/33998895/,Positive,,Meta-analysis,2019,Pharma CBD; Pharma THC:CBD; Pharma THC,Nervous System,Pain; Pain - Chronic
20211129,Practical Strategies Using Medical Cannabis to Reduce Harms Associated With Long Term Opioid Use in Chronic Pain,https://www.frontiersin.org/articles/10.3389/fphar.2021.633168/full,Positive,,Meta-analysis,2021,,,Pain; Pain - Chronic; Addiction - Opioid
20211130,Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A New Route in the Fight Against COVID-19?,https://pubmed.ncbi.nlm.nih.gov/33267756/,Positive,,Meta-analysis,2021,,,Anorexia; Cachexia; Cancer; COVID-19; Glaucoma; Pain; Nausea and Vomiting; Neurodegenerative Issues; Pain - Chronic
20211131,Can Medical Cannabis Therapies be Cost-Effective in the Non-Surgical Management of Chronic Knee Pain?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970188/,Positive,,Meta-analysis,2021,,,Pain; Pain - Chronic
20211132,Safety and Efficacy of Medicinal Cannabis in the Treatment of Fibromyalgia: A Systematic Review,https://pubmed.ncbi.nlm.nih.gov/33337931/,Positive,,Meta-analysis,2021,,Muscular System,Fibromyalgia
20211133,Progression of cannabis withdrawal symptoms in people using medical cannabis for chronic pain,https://pubmed.ncbi.nlm.nih.gov/33400332/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Pain; Pain - Chronic
20211134,Medical Cannabis for Chronic Noncancer Pain: A Systematic Review of Health Care Recommendations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878090/,Positive,,Meta-analysis,2021,,,Pain; Pain - Chronic; HIV/AIDS
20211135,Cannabis for Chronic Pain: A Rapid Systematic Review of Randomized Control Trials,https://pubmed.ncbi.nlm.nih.gov/33353819/,Positive,,Clinical Meta-analysis,2021,,Nervous System,Pain; Pain - Chronic
20211136,Interim Results of the Survey Accompanying the Prescription of Cannabis-Based Medicines in Germany Regarding Dronabinol,https://www.aerzteblatt.de/int/archive/article/218127,Positive,,Meta-analysis,2021,Pharma THC,,Pain; Pain - Chronic
20211137,Cannabis and cannabinoid use in autism spectrum disorder: a systematic review,https://www.scielo.br/j/trends/a/LBmJK6d8bqr5jVK6fp3CHXt/?lang=en,Positive,,Meta-analysis,2021,,Mental/Emotional System,Autism
2020361,Medical cannabis in supportive cancer care: lessons from Canada,https://pubmed.ncbi.nlm.nih.gov/32172409/,Positive,,Meta-analysis,2020,,Nervous System,Cancer; Palliative Care
2020362,Medical Cannabis for the Management of Pain and Quality of Life in Chronic Pain Patients: A Prospective Observational Study,https://pubmed.ncbi.nlm.nih.gov/32556203/,Positive,,Meta-analysis,2020,,Nervous System,Pain; Pain - Chronic; Addiction - Opioid
20211138,Medical cannabis treatment for chronic pain: Outcomes and prediction of response,https://pubmed.ncbi.nlm.nih.gov/33065768/,Positive,,Meta-analysis,2021,,,Pain; Pain - Chronic
20211139,Selective cannabis strain allergy in a patient presenting with a local allergic reaction,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130344/,Negative,,Meta-analysis,2021,,Immune System,Cannabis Allergies
20211140,Effects of Cannabidiol Chewing Gum on Perceived Pain and Well-Being of Irritable Bowel Syndrome Patients: A Placebo-Controlled Crossover Exploratory Intervention Study with Symptom-Driven Dosing,https://pubmed.ncbi.nlm.nih.gov/33998882/,Inconclusive,,Double Blind Clinical Trial,2021,,Digestive System,Irritable Bowel Syndrome
20211141,A cannabidiol-loaded Mg-gallate metal-organic framework-based potential therapeutic for glioblastomas,https://pubmed.ncbi.nlm.nih.gov/33657198/,Positive,,Laboratory Study,2021,,,Cancer - Brain; Cancer
20211142,State of the science: cannabis and cannabinoids in palliative medicine-the potential,https://pubmed.ncbi.nlm.nih.gov/33903260/,Inconclusive,,Meta-analysis,2021,Pharma THC:CBD,Nervous System,Palliative Care
2019144,"Synthetic, non-intoxicating 8,9-dihydrocannabidiol for the mitigation of seizures",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533278/,Positive,,Animal Study,2019,Synthetic Cannabinoid (unspecified),Nervous System,Epilepsy
20211143,White matter integrity after cannabidiol administration for treatment resistant epilepsy,https://pubmed.ncbi.nlm.nih.gov/33725662/,Positive,,Clinical Trial,2021,Pharma CBD,,Epilepsy
20211144,Attitudes towards and use of cannabis in New Zealand patients with inflammatory bowel disease: an exploratory study,https://pubmed.ncbi.nlm.nih.gov/33651776/,Positive,,Meta-analysis,2021,,Digestive System,IBD - Inflammatory Bowel Disease
20211145,Symptoms and Extraintestinal Manifestations in Active Cannabis Users with Inflammatory Bowel Disease,https://pubmed.ncbi.nlm.nih.gov/33998892/,Inconclusive,,Meta-analysis,2021,,Digestive System,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease
20211146,"Olorinab (APD371), a peripherally acting, highly selective, full agonist of the cannabinoid receptor 2, reduces colitis-induced acute and chronic visceral hypersensitivity in rodents",https://pubmed.ncbi.nlm.nih.gov/33863856/,Positive,,Animal Study,2021,Synthetic Cannabinoid (unspecified),Digestive System,IBD - Inflammatory Bowel Disease
2020363,Activation of Cannabinoid Receptor 2 Prevents Colitis-Associated Colon Cancer through Myeloid Cell De-activation Upstream of IL-22 Production,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501437/,Positive,,Animal Study,2020,,Digestive System,IBD - Inflammatory Bowel Disease
2020364,Cannabinoid receptor activation on hematopoietic cells and enterocytes protects against colitis,https://pubmed.ncbi.nlm.nih.gov/33331878/,Positive,,Animal Study,2020,,Digestive System,IBD - Inflammatory Bowel Disease
2016119,Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid 2-Arachidonoylglycerol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763355/,Inconclusive,,Clinical Trial,2016,,Nervous System,Insomnia and Sleep Disorders; Metabolic Syndrome; Obesity
2020365,"Cannabinoids, Endocannabinoids and Sleep",https://www.frontiersin.org/articles/10.3389/fnmol.2020.00125/full,Inconclusive,,Meta-analysis,2020,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Nervous System,Insomnia and Sleep Disorders
20211147,Investigation of in vitro odonto/osteogenic capacity of cannabidiol on human dental pulp cell,https://pubmed.ncbi.nlm.nih.gov/33872753/,Positive,,Laboratory Study,2021,,Integumentary System,Cavities; Pain; Pain - Acute; Pain - Dental - Acute
20211148,Efficacy of topical capsaicin for the treatment of cannabinoid hyperemesis syndrome: A retrospective cohort study,https://pubmed.ncbi.nlm.nih.gov/33561623/,Inconclusive,,Meta-analysis,2021,Capsaicin (CAPS),,Cannabis Hyperemesis Syndrome
20211149,Gabapentin attenuates somatic signs of precipitated THC withdrawal in mice,https://pubmed.ncbi.nlm.nih.gov/33845073/,Negative,,Animal Study,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
20211150,"Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings",https://pubmed.ncbi.nlm.nih.gov/33891706/,Negative,,Meta-analysis,2021,Tetrahydrocannabinolic Acid (THC-a),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
20211151,Cannabidiol oxidation product HU-331 is a potential anticancer cannabinoid-quinone: a narrative review,https://pubmed.ncbi.nlm.nih.gov/33892826/,Positive,,Meta-analysis,2021,HU-x Synthetic Cannabinoids,,Cancer
2004025,Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial,https://pubmed.ncbi.nlm.nih.gov/15561385/,Positive,,Double Blind Clinical Trial,2004,Pharma THC:CBD; Pharma THC,Muscular System,Brachial Plexus Disorders; Pain; Pain - Chronic
2018151,Marijuana use is associated with hypersensitivity to multiple allergens in US adults,https://pubmed.ncbi.nlm.nih.gov/29172121/,Negative,,Meta-analysis,2018,,Immune System,Cannabis Allergies
2019145,Characterization of Cannabis sativa allergens,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726218/,Negative,,Meta-analysis,2019,,Immune System,Cannabis Allergies
2019146,IgE-mediated hypersensitivity reactions to cannabis in laboratory personnel,https://pubmed.ncbi.nlm.nih.gov/21832832/,Negative,,Meta-analysis,2019,,Immune System,Cannabis Allergies
2019147,Exploring the Diagnosis and Profile of Cannabis Allergy,https://pubmed.ncbi.nlm.nih.gov/30273677/,Inconclusive,,Meta-analysis,2019,,Immune System,Cannabis Allergies
20211152,Substituting Cannabidiol for Opioids and Pain Medications Among Individuals with Fibromyalgia: a Large Online Survey,https://www.jpain.org/article/S1526-5900(21)00220-0/fulltext#%20,Positive,,Meta-analysis,2021,,Muscular System,Fibromyalgia
2020366,A Large-Scale Naturalistic Examination of the Acute Effects of Cannabis on Pain,https://www.liebertpub.com/doi/10.1089/can.2020.0068,Positive,,Meta-analysis,2020,,Nervous System,Pain; Pain - Acute; Pain - Chronic; Pain - Inflammatory; Pain - Neuropathy - Peripheral
20211153,Topical Cannabis-Based Medicines – A Novel Adjuvant Treatment for Venous Leg Ulcers: An Open-Label Trial,https://pubmed.ncbi.nlm.nih.gov/34013652/,Positive,,Meta-analysis,2021,,Immune System; Integumentary System,Wound Healing
20211154,Self-reported reductions in tobacco and nicotine use following medical cannabis initiation: Results from a cross-sectional survey of authorized medical cannabis patients in Canada,https://www.journalofsubstanceabusetreatment.com/article/S0740-5472(21)00207-5/fulltext,Positive,,Meta-analysis,2021,,Mental/Emotional System,Addiction - Nicotine; Addiction
2016120,Pharmacological Treatment of Cannabis-Related Disorders: A Narrative Review,https://pubmed.ncbi.nlm.nih.gov/27549375/,Inconclusive,,Meta-analysis,2016,Pharma THC,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
20211155,Alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061688/,Positive,,Animal Study,2021,2-Arachidonoyl Glycerol (2-AG); Monoacylglycerol Lipase (MAGL); Other Related Compounds,Mental/Emotional System,Autism
2019148,Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890086/,Positive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Autism; Schizophrenia
2016121,Pharmacological inhibition of fatty acid amide hydrolase attenuates social behavioural deficits in male rats prenatally exposed to valproic acid,https://pubmed.ncbi.nlm.nih.gov/27592249/,Positive,,Animal Study,2016,Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System; Nervous System,Behavioral Disorders; Autism
2016122,Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048215/,Positive,,Animal Study,2016,Anandamide (AEA),Mental/Emotional System; Nervous System,Autism
2019149,Endocannabinoid System Dysregulation from Acetaminophen Use May Lead to Autism Spectrum Disorder: Could Cannabinoid Treatment Be Efficacious?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037883/,Inconclusive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Autism
2019150,Endocannabinoid system in the neurodevelopment of GABAergic interneurons: implications for neurological and psychiatric disorders,https://pubmed.ncbi.nlm.nih.gov/33781002/,Inconclusive,,Meta-analysis,2019,Endocannabinoid (unspecified),,Autism; Depression; Epilepsy; Neurodegenerative Issues; Schizophrenia
2020367,Cannabis: An Emerging Occupational Allergen?,https://pubmed.ncbi.nlm.nih.gov/32322894/,Positive,,Meta-analysis,2020,,Immune System,Cannabis Allergies
2016123,An emerging allergen: Cannabis sativa allergy in a climate of recent legalization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371810/,Positive,,Meta-analysis,2016,,Immune System,Cannabis Allergies
2020368,Allergic and Respiratory Symptoms in Employees of Indoor Cannabis Grow Facilities,https://pubmed.ncbi.nlm.nih.gov/32459852/,Inconclusive,,Meta-analysis,2020,,Immune System,Cannabis Allergies
2008052,Sensitization and allergy to Cannabis sativa leaves in a population of tomato (Lycopersicon esculentum)-sensitized patients,https://pubmed.ncbi.nlm.nih.gov/18268387/,Inconclusive,,Clinical Trial,2008,,Immune System,Cannabis Allergies
2020369,Chronic cannabidiol (CBD) treatment did not exhibit beneficial effects in 4-month-old male TAU58/2 transgenic mice,https://pubmed.ncbi.nlm.nih.gov/32562718/,Inconclusive,,Animal Study,2020,,Nervous System,Alzheimer's Disease
20211156,"Cannabidiol regulates CB1-pSTAT3 signaling for neurite outgrowth, prolongs lifespan, and improves health span in Caenorhabditis elegans of Aβ pathology models",https://pubmed.ncbi.nlm.nih.gov/33817834/,Positive,,Animal Study,2021,,Nervous System,Alzheimer's Disease
2017114,Identification of IgE- binding pollen protein from Cannabis sativa in pollen-hypersensitive patients from north Pakistan,https://pubmed.ncbi.nlm.nih.gov/28603110/,Negative,,Clinical Trial,2017,,Immune System,Cannabis Allergies
2015105,Cannabis Allergy: What do We Know Anno 2015,https://pubmed.ncbi.nlm.nih.gov/26178655/,Negative,,Meta-analysis,2015,,Immune System,Cannabis Allergies
2013084,Risking the skin for some joints,https://pubmed.ncbi.nlm.nih.gov/23888582/,Negative,,Meta-analysis,2013,,Immune System,Cannabis Allergies
1980001,Occupational immediate type allergy to hemp pollen and hashish,https://pubmed.ncbi.nlm.nih.gov/6447587/,Negative,,Meta-analysis,1980,,Immune System,Cannabis Allergies
2015106,The safety and efficacy of 3% Cannabis seeds extract cream for reduction of human cheek skin sebum and erythema content,https://pubmed.ncbi.nlm.nih.gov/26142529/,Positive,,Double Blind Clinical Trial,2015,,Integumentary System,Skin Diseases; Acne; Inflammation; Seborrhea
2020370,The potential role of cannabinoids in dermatology,https://pubmed.ncbi.nlm.nih.gov/31599175/,Positive,,Meta-analysis,2020,,,Acne; Allergic Contact Dermatitis; Cancer - Melanoma; Cancer - Skin (Non-melanoma); Cancer; Pain; Pain - Chronic; Pruritis; Psoriasis
2020371,The role of exposome in acne: results from an international patient survey,https://pubmed.ncbi.nlm.nih.gov/31785166/,Inconclusive,,Meta-analysis,2020,,Integumentary System,Acne
2014087,Harnessing neuroendocrine controls of keratin expression: a new therapeutic strategy for skin diseases?,https://pubmed.ncbi.nlm.nih.gov/24823963/,Positive,,Meta-analysis,2014,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),,Abnormal Hair Growth; Hair Loss; Psoriasis; Wound Healing
2019151,Occupational cannabis exposure and allergy risks,https://pubmed.ncbi.nlm.nih.gov/30554157/,Positive,,Clinical Trial,2019,,Immune System,Cannabis Allergies
20211157,Effects of a Novel GPR55 Antagonist on the Arachidonic Acid Cascade in LPS-Activated Primary Microglial Cells,https://pubmed.ncbi.nlm.nih.gov/33801492/,Positive,,Laboratory Study,2021,Synthetic Cannabinoid (unspecified),,Alzheimer's Disease; Depression; Inflammation
20211158,Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130522/,Inconclusive,,Animal Study,2021,,Nervous System,Alzheimer's Disease; Neurodegenerative Issues
20211159,Anti-Inflammatory Effects of Fatty Acid Amide Hydrolase Inhibition in Monocytes/Macrophages from Alzheimer's Disease Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066292/,Positive,,Laboratory Study,2021,Fatty Acid Amide Hydrolase (FAAH),Nervous System,Alzheimer's Disease
20211160,Destabilization of the Alzheimer's amyloid-β protofibrils by THC: A molecular dynamics simulation study,https://pubmed.ncbi.nlm.nih.gov/33725642/,Positive,,Laboratory Study,2021,,Nervous System,Alzheimer's Disease
20211161,(m)RVD-hemopressin (α) and (m)VD-hemopressin (α) improve the memory-impairing effect of scopolamine in novel object and object location recognition tasks in mice,https://pubmed.ncbi.nlm.nih.gov/33171279/,Positive,,Animal Study,2021,Synthetic Cannabinoid (unspecified),,Alzheimer's Disease
20211162,Endocannabinoid-mediated neuromodulation in the main olfactory bulb at the interface of environmental stimuli and central neural processing,https://pubmed.ncbi.nlm.nih.gov/33724578/,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified),,Alzheimer's Disease; Parkinson's Disease
20211163,"Component of Cannabis, Cannabidiol, as a Possible Drug against the Cytotoxicity of Aβ(31–35) and Aβ(25–35) Peptides: An Investigation by Molecular Dynamics and Well-Tempered Metadynamics Simulations",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023578/,Positive,,Laboratory Study,2021,,Nervous System,Alzheimer's Disease
20211164,Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122338/,Positive,,Meta-analysis,2021,,,Alzheimer's Disease; Cancer; Epilepsy; Multiple Sclerosis; Neurodegenerative Issues
20211165,"The Neuroprotective properties, Functions and Roles of Cannabis sativa in selected diseases related to the Nervous System",https://pubmed.ncbi.nlm.nih.gov/33504317/,Positive,,Meta-analysis,2021,,,Alzheimer's Disease; Cognitive Dysfunction; Neurodegenerative Issues; Parkinson's Disease
20211166,Phytocannabinoids: General Aspects and Pharmacological Potential in Neurodegenerative Diseases,https://pubmed.ncbi.nlm.nih.gov/32691712/,Positive,,Meta-analysis,2021,,,Alzheimer's Disease; Huntington's Disease; Neurodegenerative Issues; Parkinson's Disease
20211167,"Attitudes, beliefs, and changing trends of cannabidiol (CBD) oil use among caregivers of individuals with Alzheimer's disease",https://pubmed.ncbi.nlm.nih.gov/33418066/,Positive,,Meta-analysis,2021,,Nervous System,Alzheimer's Disease
20211168,Cannabis Sativa L. Flower and Bud Extracts inhibited In vitro Cholinesterases and b-Secretase Enzymes Activities: Possible Mechanisms of Cannabis use in Alzheimer Disease,https://pubmed.ncbi.nlm.nih.gov/33618651/,Positive,,Laboratory Study,2021,,,Alzheimer's Disease
20211169,Cannabis Use among Persons with Dementia and Their Caregivers: Lighting up an Emerging Issue for Clinical Gerontologists,https://pubmed.ncbi.nlm.nih.gov/33250000/,Positive,,Meta-analysis,2021,,Nervous System,Dementia; Alzheimer's Disease
2019152,Treatment of Chronic Pruritus With Medical Marijuana,https://jamanetwork.com/journals/jamadermatology/article-abstract/2778442,Positive,,Meta-analysis,2019,,Integumentary System,Pruritis
2020372,Anandamide prevents the adhesion of filamentous Candida albicans to cervical epithelial cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426432/,Positive,,Laboratory Study,2020,Anandamide (AEA),Digestive System; Immune System; Integumentary System,Fungal Infections
2020373,Potential combinations of endocannabinoid/endocannabinoid-like compounds and antibiotics against methicillin-resistant Staphylococcus aureus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159245/,Positive,,Laboratory Study,2020,Anandamide (AEA),Immune System,Bacterial Infections; Staph Infection
20211170,"Anandamide alters the membrane properties, halts the cell division and prevents drug efflux in multidrug resistant Staphylococcus aureus",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062478/,Positive,,Laboratory Study,2021,Anandamide (AEA),Immune System,Bacterial Infections; Staph Infection
20211171,Characterization of cannabis use by patients with myotonic dystrophy type 1: A pilot study,https://pubmed.ncbi.nlm.nih.gov/33509648/,Inconclusive,,Meta-analysis,2021,,Muscular System,Muscular Dystrophy & Myotonic Disorders
2020374,Patterns of Medical Cannabis Use Among Older Adults from a Cannabis Dispensary in New York State,https://pubmed.ncbi.nlm.nih.gov/33998868/,Inconclusive,,Meta-analysis,2020,,,Cancer; Pain; Pain - Cancer; Pain - Chronic; Parkinson's Disease
20211172,THC and CBD effects on alcohol use among alcohol and cannabis co-users,https://pubmed.ncbi.nlm.nih.gov/33764086/,Positive,,Meta-analysis,2021,,Mental/Emotional System,Addiction - Alcohol; Addiction
20211173,"Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088205/,Positive,,Meta-analysis,2021,,Mental/Emotional System,Addiction - Opioid; Addiction; Pain; Pain - Chronic
2011087,Too Many Mouldy Joints – Marijuana and Chronic Pulmonary Aspergillosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103256/,Negative,,Meta-analysis,2011,,Digestive System; Immune System; Integumentary System,Fungal Infections
2016124,Marijuana Smoking in Patients With Leukemia,https://pubmed.ncbi.nlm.nih.gov/27556668/,Negative,,Meta-analysis,2016,,Digestive System; Immune System; Integumentary System,Fungal Infections
2008053,Invasive pulmonary aspergillosis associated with marijuana use in a man with colorectal cancer,https://pubmed.ncbi.nlm.nih.gov/18445848/,Negative,,Meta-analysis,2008,,Digestive System; Immune System; Integumentary System,Fungal Infections
2001016,Early invasive pulmonary aspergillosis in a leukemia patient linked to aspergillus contaminated marijuana smoking,https://pubmed.ncbi.nlm.nih.gov/11911432/,Negative,,Meta-analysis,2001,,Digestive System; Immune System; Integumentary System,Fungal Infections
2019153,Pulmonary mucormycosis associated with medical marijuana use,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330507/,Negative,,Meta-analysis,2019,,Digestive System; Immune System; Integumentary System,Fungal Infections
2020375,"Cannabis Use and Fungal Infections in a Commercially Insured Population, United States, 2016",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7258471/,Negative,,Meta-analysis,2020,,Digestive System; Immune System; Integumentary System,Fungal Infections
1983002,Marijuana smoking and fungal sensitization,https://www.jacionline.org/article/0091-6749(83)90067-2/pdf,Negative,,Meta-analysis,1983,,Digestive System; Immune System; Integumentary System,Fungal Infections
2016125,"Effects of cannabinoid receptor activation by CP55,940 on normal bladder function and irritation-induced bladder overactivity in non-awake anaesthetised rats",https://pubmed.ncbi.nlm.nih.gov/26942594/,Positive,,Animal Study,2016,CP-x Synthetic Cannabinoids,Urinary System,Urinary Tract Infection
2018152,Anti-Proliferative Properties and Proapoptotic Function of New CB2 Selective Cannabinoid Receptor Agonist in Jurkat Leukemia Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073364/,Positive,,Laboratory Study,2018,Synthetic Cannabinoid (unspecified),Immune System; Nervous System,Cancer - Leukemia; Cancer
2017115,Cannabis sativa allergy: looking through the fog,https://pubmed.ncbi.nlm.nih.gov/27590896/,Negative,,Meta-analysis,2017,,Immune System,Cannabis Allergies
2020376,Cannabis allergy in a child with asthma chronically exposed to marijuana,https://pubmed.ncbi.nlm.nih.gov/31323337/,Negative,,Meta-analysis,2020,,Immune System,Cannabis Allergies
2011088,Allergic hypersensitivity to cannabis in patients with allergy and illicit drug users,https://pubmed.ncbi.nlm.nih.gov/21272987/,Negative,,Meta-analysis,2011,,Immune System,Cannabis Allergies
2019154,Cannabis allergy: what the clinician needs to know in 2019,https://pubmed.ncbi.nlm.nih.gov/30946607/,Negative,,Meta-analysis,2019,,Immune System,Cannabis Allergies
2019155,Cannabis-Associated Asthma and Allergies,https://pubmed.ncbi.nlm.nih.gov/28921405/,Negative,,Meta-analysis,2019,,Immune System,Cannabis Allergies
2020377,Occupational Allergies to Cannabis,https://pubmed.ncbi.nlm.nih.gov/33161961/,Inconclusive,,Meta-analysis,2020,,Immune System,Cannabis Allergies
2012104,Interictal type 1 cannabinoid receptor binding is increased in female migraine patients,https://pubmed.ncbi.nlm.nih.gov/22077199/,Positive,,Meta-analysis,2012,,Nervous System,Migraine
2011089,Effects of anandamide in migraine: data from an animal model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072518/,Positive,,Animal Study,2011,Anandamide (AEA),Nervous System,Migraine
2013085,Use of cannabis among 139 cluster headache sufferers,https://pubmed.ncbi.nlm.nih.gov/23197349/,Positive,,Meta-analysis,2013,,,Migraine
20211174,THC and CBD produce divergent effects on perception and panic behaviours via distinct cortical molecular pathways,https://pubmed.ncbi.nlm.nih.gov/32623021/,Inconclusive,,Animal Study,2021,,,Anxiety; PTSD
2019156,A randomised controlled trial of vaporised Δ 9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects,https://pubmed.ncbi.nlm.nih.gov/30661105/,Inconclusive,,Double Blind Clinical Trial,2019,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2020378,Cannabis sativa: Much more beyond Δ 9-tetrahydrocannabinol,https://pubmed.ncbi.nlm.nih.gov/32335286/,Positive,,Meta-analysis,2020,,,Autism; Epilepsy; Pain; Neurodegenerative Issues; Pain - Chronic
2020379,"Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181184/,Positive,,Meta-analysis,2020,,,Inflammation
2020380,Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids Including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357058/,Positive,,Meta-analysis,2020,,,Cannabis Adverse Effects
2019157,"Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial",https://pubmed.ncbi.nlm.nih.gov/30554828/,Positive,,Double Blind Clinical Trial,2019,Pharma THC:CBD,Nervous System,Neurodegenerative Issues; Amyotrophic Lateral Sclerosis (ALS)
2018153,Endocannabinoid engagement of CB2 regulates RSV-induced immunity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000200/,Positive,,Meta-analysis,2018,Endocannabinoid (unspecified),Respiratory System,Respiratory Syncytial Virus
2006024,Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors,https://pubmed.ncbi.nlm.nih.gov/16489449/,Positive,,Laboratory Study,2006,Tetrahydrocannabinol (THC); SR-x Synthetic Cannabinoids,,
2017116,Molecular Targets of the Phytocannabinoids-A Complex Picture,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345356/,Inconclusive,,Meta-analysis,2017,Cannabichromene (CBC); Cannabigerol (CBG); Cannabinol (CBN); Delta-8-THC; Tetrahydrocannabivarin (THCV); Tetrahydrocannabinol (THC),,
2019158,Priority Considerations for Medicinal Cannabis-Related Research,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757233/,Positive,,Meta-analysis,2019,,,Alzheimer's Disease; Amyotrophic Lateral Sclerosis (ALS); Anxiety; Autism; Cancer; Depression; Epilepsy; Glaucoma; IBD - Inflammatory Bowel Disease; Hepatitis; HIV/AIDS; Huntington's Disease; Pain; Multiple Sclerosis; Muscular Dystrophy & Myotonic Disorders; Nausea and Vomiting; Pain - Chronic; Parkinson's Disease; Psychosis; PTSD
2017117,Tumor-promoting effects of cannabinoid receptor type 1 in human melanoma cells,https://pubmed.ncbi.nlm.nih.gov/28131817/,Negative,,Laboratory Study,2017,,Integumentary System; Nervous System,Cancer - Melanoma; Cancer
20211175,Endocannabinoid Gene × Gene Interaction Association to Alcohol Use Disorder in Two Adolescent Cohorts,https://pubmed.ncbi.nlm.nih.gov/33959052/,Inconclusive,,Meta-analysis,2021,Monoacylglycerol Lipase (MAGL); Other Related Compounds,Mental/Emotional System,Addiction - Alcohol; Addiction
20211176,Morphine Induces Upregulation of Neuronally Expressed CB2 Receptors in the Spinal Dorsal Horn of Rats,https://pubmed.ncbi.nlm.nih.gov/33912678/,Positive,,Animal Study,2021,,,Pain; Pain - Chronic
2020381,Cannabis use among Canadian adults with cancer (2007-2016): results from a national survey,https://pubmed.ncbi.nlm.nih.gov/33216657/,Positive,,Meta-analysis,2020,,Nervous System,Cancer
20211177,Is marijuana really a gateway drug? A nationally representative test of the marijuana gateway hypothesis using a propensity score matching design,https://link.springer.com/article/10.1007/s11292-021-09464-z,Inconclusive,,Meta-analysis,2021,,,Addiction - Alcohol; Addiction - Cocaine; Addiction - Opioid; Addiction - Stimulant
20211178,A systematic review and meta-analysis of randomized controlled trials of cardiovascular toxicity of medical cannabinoids,https://pubmed.ncbi.nlm.nih.gov/33952424/,Negative,,Clinical Meta-analysis,2021,,Cardiovascular System,Cardiac Arrhythmias; Cardiovascular Diseases (CVD)
2008054,Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in Wistar rats,https://pubmed.ncbi.nlm.nih.gov/18452035/,Negative,,Animal Study,2008,Tetrahydrocannabinol (THC),Reproductive System,Pregnancy; Behavioral Disorders
2008055,Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets,https://pubmed.ncbi.nlm.nih.gov/18679164/,Positive,,Animal Study,2008,,,Cardiovascular Diseases (CVD); Neonatal Cerebral Issues; Oxidative Stress; Reperfusion Injury
2009049,The endocannabinoid system during development: emphasis on perinatal events and delayed effects,https://pubmed.ncbi.nlm.nih.gov/19647111/,Inconclusive,,Meta-analysis,2009,2-Arachidonoyl Glycerol (2-AG),Reproductive System,Pregnancy
2011090,Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents,https://pubmed.ncbi.nlm.nih.gov/20556598/,Negative,,Meta-analysis,2011,,Mental/Emotional System,Behavioral Disorders
2011091,Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia-ischemia in newborn pigs,https://pubmed.ncbi.nlm.nih.gov/21654550/,Positive,,Animal Study,2011,,,Neonatal Cerebral Issues; Cardiovascular Diseases (CVD); Cognitive Dysfunction; Oxidative Stress; Reperfusion Injury
2014088,Long-term consequences of perinatal fatty acid amino hydrolase inhibition,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954482/,Inconclusive,,Animal Study,2014,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),,Addiction - Cocaine; Cognitive Dysfunction; Depression
2015107,Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes,https://pubmed.ncbi.nlm.nih.gov/25960036/,Inconclusive,,Meta-analysis,2015,,,Cannabis Adverse Effects; Pregnancy
2016126,"Prenatal, perinatal, and adolescent exposure to marijuana: Relationships with aggressive behavior",https://pubmed.ncbi.nlm.nih.gov/27345271/,Negative,,Meta-analysis,2016,,,Domestic Abuse; Intermittent Explosive Disorder
2016127,Fetal Syndrome of Endocannabinoid Deficiency (FSECD) In Maternal Obesity,https://pubmed.ncbi.nlm.nih.gov/27959272/,Inconclusive,,Meta-analysis,2016,,Endocrine System; Reproductive System,Obesity; Pregnancy
1996009,Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1217444/,Positive,,Laboratory Study,1996,Other Related Compounds,Nervous System,Cancer - Neuroblastoma; Cancer
1996010,Determination of the cannabinoid receptors in mouse x rat hybridoma NG108-15 cells and rat GH4C1 cells,https://pubmed.ncbi.nlm.nih.gov/8832654/,Inconclusive,,Laboratory Study,1996,CP-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,,Cancer - Brain; Cancer - Neuroblastoma; Cancer
1996011,Tau protein after delta-9-tetrahydrocannabinol in a human neuroblastoma cell line,https://pubmed.ncbi.nlm.nih.gov/8981058/,Inconclusive,,Laboratory Study,1996,,Nervous System,Cancer - Neuroblastoma; Alzheimer's Disease; Cancer
1996012,"2-Arachidonoylglycerol, a putative endogenous cannabinoid receptor ligand, induces rapid, transient elevation of intracellular free Ca2+ in neuroblastoma x glioma hybrid NG108-15 cells",https://pubmed.ncbi.nlm.nih.gov/8954083/,Inconclusive,,Laboratory Study,1996,,Nervous System,Cancer - Brain; Cancer - Neuroblastoma; Cancer
2008056,Disruption of IFN-γ-Mediated Antiviral Activity in Neurons: The Role of Cannabinoids,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556635/,Inconclusive,,Laboratory Study,2008,WIN-x Synthetic Cannabinoids,,Inflammation; Prion Disease
2016128,"JWH-133, a Selective Cannabinoid CB₂ Receptor Agonist, Exerts Toxic Effects on Neuroblastoma SH-SY5Y Cells",https://pubmed.ncbi.nlm.nih.gov/26842917/,Positive,,Laboratory Study,2016,JWH-x Synthetic Cannabinoids,Nervous System,Cancer - Neuroblastoma; Cancer
1992004,Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC525583/,Inconclusive,,Laboratory Study,1992,WIN-x Synthetic Cannabinoids,,Cancer - Brain; Cancer - Neuroblastoma; Cancer
1991003,Differential effects of delta-9-tetrahydrocannabinol and its 11-hydroxy metabolite on sodium current in neuroblastoma cells,https://pubmed.ncbi.nlm.nih.gov/1662110/,Inconclusive,,Laboratory Study,1991,Tetrahydrocannabinol (THC),Nervous System,Cancer - Neuroblastoma; Cancer
1991004,Delta-9-tetrahydrocannabinol depresses inward sodium current in mouse neuroblastoma cells,https://pubmed.ncbi.nlm.nih.gov/1646421/,Inconclusive,,Laboratory Study,1991,Tetrahydrocannabinol (THC),Nervous System,Cancer - Neuroblastoma; Cancer
1987001,Interaction of delta-9-tetrahydrocannabinol with rat B103 neuroblastoma cells,https://pubmed.ncbi.nlm.nih.gov/2821958/,Positive,,Laboratory Study,1987,,Nervous System,Cancer - Neuroblastoma; Cancer
1995005,The prenatal exposure to delta 9-tetrahydrocannabinol affects the gene expression and the activity of tyrosine hydroxylase during early brain development,https://pubmed.ncbi.nlm.nih.gov/7776847/,Inconclusive,,Animal Study,1995,Tetrahydrocannabinol (THC),Reproductive System,Pregnancy
1993006,Distribution of indoleamines and [3H]paroxetine binding in rat brain regions following acute or perinatal delta 9-tetrahydrocannabinol treatments,https://pubmed.ncbi.nlm.nih.gov/7504790/,Inconclusive,,Animal Study,1993,Tetrahydrocannabinol (THC),,
1991005,Effects of pre- and perinatal exposure to hashish extracts on the ontogeny of brain dopaminergic neurons,https://pubmed.ncbi.nlm.nih.gov/1922791/,Inconclusive,,Animal Study,1991,,Reproductive System,Pregnancy
1988004,Perinatal exposure to cannabinoids alters neurochemical development in rat brain,https://pubmed.ncbi.nlm.nih.gov/2895481/,Inconclusive,,Animal Study,1988,Delta-8-THC,Reproductive System,Pregnancy
1984005,An investigation of prenatal cannabis exposure and minor physical anomalies in a low risk population,https://pubmed.ncbi.nlm.nih.gov/6514096/,Negative,,Meta-analysis,1984,,Mental/Emotional System,Cannabis Adverse Effects
2018154,Oleoylethanolamide and Palmitoylethanolamide Protect Cultured Cortical Neurons Against Hypoxia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148719/,Positive,,Animal Study,2018,Other Related Compounds,,Cardiovascular Diseases (CVD); Oxidative Stress; Reperfusion Injury
2018155,Patient Counseling Guidelines for the Use of Cannabis for the Treatment of Chemotherapy-Induced Nausea/Vomiting and Chronic Pain,https://pubmed.ncbi.nlm.nih.gov/31070496/,Positive,,Meta-analysis,2018,,Digestive System; Nervous System,Chemotherapy-induced Nausea & Vomiting; Pain; Nausea and Vomiting; Pain - Cancer; Pain - Chronic
2014089,Recurrent myopericarditis as a complication of Marijuana use,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921097/,Negative,,Meta-analysis,2014,,Cardiovascular System,Cardiovascular Diseases (CVD); Myocarditis
2018156,A Review of Herbal Therapy in Multiple Sclerosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311642/,Positive,,Meta-analysis,2018,,Nervous System,Multiple Sclerosis
2003020,"Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions",https://www.freepatentsonline.com/y2005/0165088.html,Positive,,Meta-analysis,2003,Cannabidiolic Acid (CBD-a),Digestive System,Nausea and Vomiting; Chemotherapy-induced Nausea & Vomiting; Morning sickness; Motion Sickness
2014090,Dexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system,https://pubmed.ncbi.nlm.nih.gov/24508383/,Positive,,Animal Study,2014,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Digestive System,Motion Sickness; Nausea and Vomiting
2018157,Melatonin attenuates Δ 9-tetrahydrocannabinol-induced reduction in rat sperm motility and kinematics in-vitro,https://pubmed.ncbi.nlm.nih.gov/29454037/,Positive,,Animal Study,2018,Tetrahydrocannabinol (THC),Reproductive System,Infertility (Male)
1998012,Cannabis for migraine treatment: the once and future prescription? An historical and scientific review,https://pubmed.ncbi.nlm.nih.gov/9696453/,Positive,,Meta-analysis,1998,,,Migraine
2013086,Endocannabinoids in the Brainstem Modulate Dural Trigeminovascular Nociceptive Traffic via CB1 and “Triptan” Receptors: Implications in Migraine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771033/,Positive,,Animal Study,2013,Anandamide (AEA); 2-Arachidonoyl Glycerol (2-AG); Fatty Acid Amide Hydrolase (FAAH); SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); WIN-x Synthetic Cannabinoids,Nervous System,Migraine
2010066,Alterations of the endocannabinoid system in an animal model of migraine: evaluation in cerebral areas of rat,https://pubmed.ncbi.nlm.nih.gov/19515121/,Positive,,Animal Study,2010,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),,Migraine
2009050,Cluster attacks responsive to recreational cannabis and dronabinol,https://pubmed.ncbi.nlm.nih.gov/19220500/,Positive,,Meta-analysis,2009,Pharma THC,,Migraine
2008057,Degradation of endocannabinoids in chronic migraine and medication overuse headache,https://pubmed.ncbi.nlm.nih.gov/18358734/,Inconclusive,,Meta-analysis,2008,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Nervous System,Migraine
2006025,Biochemical changes in endocannabinoid system are expressed in platelets of female but not male migraineurs,https://pubmed.ncbi.nlm.nih.gov/16472333/,Inconclusive,,Meta-analysis,2006,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Nervous System,Migraine
2012105,Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1,https://pubmed.ncbi.nlm.nih.gov/22198381/,Positive,,Animal Study,2012,Tetrahydrocannabinol (THC),Nervous System; Respiratory System,Cancer - Lung; Cancer
2014091,Advances in transient receptor potential vanilloid-2 channel expression and function in tumor growth and progression,https://pubmed.ncbi.nlm.nih.gov/25001513/,Inconclusive,,Meta-analysis,2014,,Integumentary System; Nervous System,Cancer - Metastatic; Cancer - Squamous Head/Neck; Cancer; Cancer - Bladder; Cancer - Prostate
2014092,Regulation of circulating endocannabinoids associated with cancer and metastases in mice and humans,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278301/,Inconclusive,,Meta-analysis,2014,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Nervous System,Cancer - Metastatic; Cancer
2016129,Endocannabinoids as Guardians of Metastasis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783962/,Positive,,Meta-analysis,2016,Pharma THC:CBD,,Cancer - Metastatic; Cancer
2007042,The endocannabinoid network: insight into the regulation of the neuroendocrine and metabolic systems,https://pubmed.ncbi.nlm.nih.gov/17684453/,Positive,,Meta-analysis,2007,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),Endocrine System,Metabolic Syndrome; Obesity
2008058,Pharmacotherapeutic targeting of the endocannabinoid signaling system: Drugs for obesity and the metabolic syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681125/,Positive,,Meta-analysis,2008,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),Endocrine System,Metabolic Syndrome; Obesity
2014093,Emerging Issues for our Nation's Health: The Intersection of Marijuana Use and Cardiometabolic Disease Risk,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992187/,Inconclusive,,Meta-analysis,2014,,Endocrine System,Metabolic Syndrome
2016130,Metabolic syndrome in people with a psychotic illness: is cannabis protective?,https://pubmed.ncbi.nlm.nih.gov/26965714/,Positive,,Meta-analysis,2016,,Endocrine System,Metabolic Syndrome
2016131,A cross-sectional analysis of the association between marijuana and cigarette smoking with metabolic syndrome among adults in the United States,https://pubmed.ncbi.nlm.nih.gov/27049971/,Negative,,Meta-analysis,2016,,Cardiovascular System; Endocrine System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Metabolic Syndrome
2002020,Cannabis Treatments in Obstetrics and Gynecology: A Historical Review,https://www.researchgate.net/publication/228559586_Cannabis_Treatments_in_Obstetrics_and_Gynecology_A_Historical_Review,Positive,,Meta-analysis,2002,,,Menstrual Disorders
2006026,Dronabinol for supportive therapy in patients with malignant melanoma and liver metastases,https://pubmed.ncbi.nlm.nih.gov/16408219/,Positive,,Clinical Trial,2006,Pharma THC,Digestive System; Integumentary System,Cancer - Liver; Cancer - Melanoma; Cancer - Metastatic; Cancer; Nausea and Vomiting; Palliative Care
2011092,The antimitogenic effect of the cannabinoid receptor agonist WIN55212-2 on human melanoma cells is mediated by the membrane lipid raft,https://pubmed.ncbi.nlm.nih.gov/21807457/,Positive,,Laboratory Study,2011,WIN-x Synthetic Cannabinoids,Integumentary System,Cancer - Melanoma; Cancer
2012106,Revisiting CB1 receptor as drug target in human melanoma,https://pubmed.ncbi.nlm.nih.gov/22447182/,Positive,,Animal Study,2012,Synthetic Cannabinoid (unspecified),Integumentary System,Cancer - Melanoma; Cancer
2012107,Cannabinoid receptor 2 is upregulated in melanoma,https://pubmed.ncbi.nlm.nih.gov/23361273/,Inconclusive,,Laboratory Study,2012,,Integumentary System; Nervous System,Cancer - Melanoma; Cancer
2013087,Anticancer activity of anandamide in human cutaneous melanoma cells,https://pubmed.ncbi.nlm.nih.gov/24041928/,Positive,,Laboratory Study,2013,Anandamide (AEA),Integumentary System; Nervous System,Cancer - Melanoma; Cancer
2011093,The manifold actions of endocannabinoids on female and male reproductive events,https://pubmed.ncbi.nlm.nih.gov/21196184/,Inconclusive,,Meta-analysis,2011,Endocannabinoid (unspecified),Reproductive System,Infertility (Male)
2014094,Relationship between seminal plasma levels of anandamide congeners palmitoylethanolamide and oleoylethanolamide and semen quality,https://pubmed.ncbi.nlm.nih.gov/25212838/,Negative,,Meta-analysis,2014,,Reproductive System,Infertility (Male)
2015108,"Marijuana, phytocannabinoids, the endocannabinoid system, and male fertility",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4651943/,Negative,,Meta-analysis,2015,,Reproductive System,Infertility (Male)
2015109,Invited Commentary: The Association Between Marijuana Use and Male Reproductive Health,https://pubmed.ncbi.nlm.nih.gov/26283091/,Negative,,Meta-analysis,2015,,Reproductive System,Infertility (Male)
2016132,Melatonin and vitamin C exacerbate Cannabis sativa-induced testicular damage when administered separately but ameliorate it when combined in rats,https://pubmed.ncbi.nlm.nih.gov/26479341/,Inconclusive,,Animal Study,2016,,Reproductive System,Infertility (Male)
2005032,Efficacy of dietary hempseed oil in patients with atopic dermatitis,https://pubmed.ncbi.nlm.nih.gov/16019622/,Positive,,Clinical Trial,2005,,Integumentary System,Eczema; Allergic Contact Dermatitis
20211179,"Pharmacological inhibition of the primary endocannabinoid producing enzyme, DGL-α, induces autism spectrum disorder-like and co-morbid phenotypes in adult C57BL/J mice",https://pubmed.ncbi.nlm.nih.gov/33886158/,Positive,,Animal Study,2021,Other Related Compounds,Mental/Emotional System,Autism
20211180,Cannabinoids pharmacological effects are beyond the palliative effects: CB2 cannabinoid receptor agonist induced cytotoxicity and apoptosis in human colorectal cancer cells (HT-29),https://pubmed.ncbi.nlm.nih.gov/33886060/,Positive,,Laboratory Study,2021,Synthetic Cannabinoid (unspecified),Digestive System; Nervous System,Cancer - Colon; Cancer
20211181,"Within-subject, double-blinded, randomized, and placebo-controlled evaluation of the combined effects of the cannabinoid dronabinol and the opioid hydromorphone in a human laboratory pain model",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055479/,Positive,,Double Blind Clinical Trial,2021,Pharma THC,,Pain; Pain - Acute; Pain - Chronic
20211182,Exposure to Δ9-tetrahydrocannabinol during rat pregnancy leads to impaired cardiac dysfunction in postnatal life,https://pubmed.ncbi.nlm.nih.gov/33879850/,Negative,,Animal Study,2021,,Mental/Emotional System; Nervous System; Reproductive System,Cannabis Adverse Effects; Pregnancy
20211183,The associations between prenatal cannabis use disorder and neonatal outcomes,https://pubmed.ncbi.nlm.nih.gov/33887075/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
20211184,Cannabis withdrawal induced brief psychotic disorder: a case study during the national lockdown secondary to the COVID-19 pandemic,https://pubmed.ncbi.nlm.nih.gov/33884940/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
20211185,Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050080/,Positive,,Animal Study,2021,WIN-x Synthetic Cannabinoids,,
20211186,Cannabidiol in low back pain: scientific rationale for clinical trials in low back pain,https://pubmed.ncbi.nlm.nih.gov/33861675/,Positive,,Meta-analysis,2021,,,Pain; Pain - Acute; Pain - Chronic
20211187,Cannabidiol converts NFκB into a tumor suppressor in glioblastoma with defined antioxidative properties,https://pubmed.ncbi.nlm.nih.gov/33864076/,Positive,,Laboratory Study,2021,,Nervous System,Cancer - Brain; Cancer
20211188,"Oral CBD-rich cannabis induces clinical but not endoscopic response in patients with Crohn's disease, a randomized controlled trial",https://academic.oup.com/ecco-jcc/article/15/11/1799/6226910?login=false,Positive,,Double Blind Clinical Trial,2021,,Digestive System,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Quality of Life
20211189,Effects of daily Δ 9-Tetrahydrocannabinol (THC) alone or combined with cannabidiol (CBD) on cognition-based behavior and activity in adolescent nonhuman primates,https://pubmed.ncbi.nlm.nih.gov/33640678/,Inconclusive,,Animal Study,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
20211190,Behavioral and pharmacological effects of cannabidiol (CBD) and the CBD analogue KLS-13019 in mouse models of pain and reinforcement,https://pubmed.ncbi.nlm.nih.gov/33822373/,Positive,,Animal Study,2021,Synthetic Cannabinoid (unspecified),Nervous System,Pain; Pain - Neuropathy - Drug-Ind. Polyneuropathy
20211191,Maternal and Fetal Pharmacokinetic Analysis of Cannabidiol during Pregnancy in Mice,https://pubmed.ncbi.nlm.nih.gov/33531413/,Inconclusive,,Animal Study,2021,,Reproductive System,Pregnancy
20211192,"A phase I trial of the safety, tolerability and pharmacokinetics of cannabidiol administered as single-dose oil solution and single and multiple doses of a sublingual wafer in healthy volunteers",https://pubmed.ncbi.nlm.nih.gov/33075170/,Positive,,Clinical Trial,2021,Pharma THC:CBD,,
20211193,Cancer patient's attitudes of using medicinal cannabis for sleep,https://pubmed.ncbi.nlm.nih.gov/33847549/,Positive,,Meta-analysis,2021,,Nervous System,Cancer; Insomnia and Sleep Disorders
20211194,Role of marijuana components on the regenerative ability of stem cells,https://pubmed.ncbi.nlm.nih.gov/33349985/,Positive,,Laboratory Study,2021,,Immune System; Integumentary System; Nervous System,Wound Healing
20211195,In silico inquest reveals the efficacy of Cannabis in the treatment of post-Covid-19 related neurodegeneration,https://pubmed.ncbi.nlm.nih.gov/33810774/,Positive,,Laboratory Study,2021,,Respiratory System,COVID-19
20211196,Cannabis sativa and Skin Health: Dissecting the Role of Phytocannabinoids,https://pubmed.ncbi.nlm.nih.gov/33851375/,Positive,,Meta-analysis,2021,,Integumentary System,Acne; Cancer - Melanoma; Pruritis; Psoriasis; Seborrhea; Skin Diseases
20211197,Associations between adolescent cannabis use and young-adult functioning in three longitudinal twin studies,https://pubmed.ncbi.nlm.nih.gov/33782115/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cognitive Dysfunction
20211198,The role of cannabis in pain management among people living with HIV who use drugs: A qualitative study,https://pubmed.ncbi.nlm.nih.gov/33843074/,Positive,,Meta-analysis,2021,,Immune System,HIV/AIDS
20211199,Trait mindfulness and cannabis use-related factors in adolescents and young adults with frequent use,https://pubmed.ncbi.nlm.nih.gov/33798028/,Positive,,Meta-analysis,2021,Mind-Body Medicine,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
20211200,"Cannabis use, pulmonary function, and lung cancer susceptibility: A Mendelian randomization study",https://pubmed.ncbi.nlm.nih.gov/33852959/,Negative,,Meta-analysis,2021,,Integumentary System,Cancer - Squamous Head/Neck; Cancer
20211201,Archaeobotanical evidence of the use of medicinal cannabis in a secular context unearthed from South China,https://pubmed.ncbi.nlm.nih.gov/33848611/,Positive,,Meta-analysis,2021,,,Arthritis - Osteoarthritis; Arthritis; Menstrual Disorders; Pain; Pain - Chronic
20211202,Cannabis-based medicines and pain: a review of potential synergistic and entourage effects,https://www.futuremedicine.com/doi/10.2217/pmt-2020-0110,Positive,,Meta-analysis,2021,,,Pain; Pain - Acute; Pain - Chronic
20211203,"Cannabis, schizophrenia genetic risk, and psychotic experiences: a cross-sectional study of 109,308 participants from the UK Biobank",https://pubmed.ncbi.nlm.nih.gov/33837184/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
20211204,Association of Cannabis Use With Self-harm and Mortality Risk Among Youths With Mood Disorders,https://pubmed.ncbi.nlm.nih.gov/33464286/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
20211205,Craving management: Exploring factors that influence momentary craving-related risk of cannabis use among young adults,https://pubmed.ncbi.nlm.nih.gov/33383565/,Inconclusive,,Meta-analysis,2021,Mind-Body Medicine,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
20211206,A systematic review of neuroimaging and acute cannabis exposure in age-of-risk for psychosis,https://www.nature.com/articles/s41398-021-01295-w,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System,Psychosis; Schizophrenia
20211207,Hot-Water Bathing Improves Symptoms in Patients with Cyclic Vomiting Syndrome and Is Modulated by Chronic Cannabis Use,https://pubmed.ncbi.nlm.nih.gov/32472256/,Negative,,Meta-analysis,2021,,,Cannabis Hyperemesis Syndrome
20211208,Inhaled Cannabis Suppresses Chemotherapy-Induced Neuropathic Nociception by Decoupling the Raphe Nucleus: A Functional Imaging Study in Rats,https://pubmed.ncbi.nlm.nih.gov/33622657/,Positive,,Animal Study,2021,Tetrahydrocannabinol (THC),,Pain; Pain - Neuropathy - Drug-Ind. Polyneuropathy
20211209,Cannabis attitudes and patterns of use among followers of the Allergy & Asthma Network,https://pubmed.ncbi.nlm.nih.gov/33465453/,Positive,,Meta-analysis,2021,,Respiratory System,Asthma
20211210,Cannabis use disorder and perioperative outcomes in vascular surgery,https://pubmed.ncbi.nlm.nih.gov/32861869/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cardiovascular Diseases (CVD); Heart Attack; Stroke; Wound Healing
20211211,Cannabinoids in Neurologic Illnesses,https://pubmed.ncbi.nlm.nih.gov/33223086/,Inconclusive,,Meta-analysis,2021,,Nervous System,Neurodegenerative Issues
2020382,HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort),https://pubmed.ncbi.nlm.nih.gov/31286317/,Positive,,Meta-analysis,2020,,Digestive System; Immune System,Hepatitis; HIV/AIDS
20211212,A patient perspective of complementary and integrative medicine (CIM) for migraine treatment: a social media survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877058/,Inconclusive,,Meta-analysis,2021,Mind-Body Medicine,Nervous System,Migraine
2018158,Associations Between Marijuana Use and Cardiovascular Risk Factors and Outcomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157910/,Inconclusive,,Meta-analysis,2018,,Cardiovascular System,Cardiovascular Diseases (CVD)
20211213,Marijuana Use Among Adult Liver Transplant Candidates and Recipients,https://pubmed.ncbi.nlm.nih.gov/33829569/,Inconclusive,,Meta-analysis,2021,,Immune System,Organ Transplant Failure
20211214,Cannabis in Parkinson's Disease: The Patients' View,https://pubmed.ncbi.nlm.nih.gov/33216043/,Positive,,Meta-analysis,2021,,Nervous System,Parkinson's Disease
2019159,Weeding through the haze: a survey on cannabis use among people living with Parkinson's disease in the US,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930177/,Positive,,Meta-analysis,2019,,Nervous System,Parkinson's Disease
20211215,"No pain, all gain? Interim analyses from a longitudinal, observational study examining the impact of medical cannabis treatment on chronic pain and related symptoms",https://pubmed.ncbi.nlm.nih.gov/33764103/,Positive,,Meta-analysis,2021,,Nervous System,Pain; Pain - Chronic; Anxiety; Insomnia and Sleep Disorders
20211216,Cannabis use is associated with reduced risk of exposure to fentanyl among people on opioid agonist therapy during a community-wide overdose crisis,https://pubmed.ncbi.nlm.nih.gov/33342591/,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
20211217,Cannabis Significantly Reduces the Use of Prescription Opioids and Improves Quality of Life in Authorized Patients: Results of a Large Prospective Study,https://pubmed.ncbi.nlm.nih.gov/33367882/,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction; Pain; Pain - Chronic
20211218,The impact of medical and recreational marijuana laws on opioid prescribing in employer‐sponsored health insurance,https://pubmed.ncbi.nlm.nih.gov/33624387/,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
20211219,Cannabis Use and Nonfatal Opioid Overdose among Patients Enrolled in Methadone Maintenance Treatment,https://pubmed.ncbi.nlm.nih.gov/33749499/,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
20211220,"AM251, a cannabinoid receptor 1 antagonist, prevents human fibroblasts differentiation and collagen deposition induced by TGF-β - An in vitro study",https://pubmed.ncbi.nlm.nih.gov/33220269/,Positive,,Animal Study,2021,AM-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Integumentary System,Fibrosis - Skin; Fibrosis
20211221,Cannabidiol reduces soman-induced lethality and seizure severity in female plasma carboxylesterase knockout mice treated with midazolam,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856212/,Positive,,Animal Study,2021,,Nervous System,Epilepsy
20211222,Allosteric modulation of the cannabinoid 2 receptor confers seizure resistance in mice,https://pubmed.ncbi.nlm.nih.gov/33450277/,Positive,,Animal Study,2021,Synthetic Cannabinoid (unspecified),,Epilepsy
20211223,A scoping review on the effect of cannabis on pain intensity in people with spinal cord injury,https://pubmed.ncbi.nlm.nih.gov/33465022/,Inconclusive,,Meta-analysis,2021,,Skeletal System,Spinal Cord Injuries
20211224,Cannabis sativa Linnaeus as traditional phytomedicine by folk medicine practitioners of Bangladesh,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980557/,Positive,,Meta-analysis,2021,,,Arthritis - Rheumatoid; Arthritis; Bacterial Infections; Cancer; Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Insomnia and Sleep Disorders; Pruritis
20211225,Prenatal Cannabinoid Exposure: Emerging Evidence of Physiological and Neuropsychiatric Abnormalities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841012/,Negative,,Meta-analysis,2021,Tetrahydrocannabinol (THC),Reproductive System,Pregnancy
20211226,Advancing the science on cannabis concentrates and behavioural health,https://pubmed.ncbi.nlm.nih.gov/33783029/,Negative,,Meta-analysis,2021,,Mental/Emotional System,Cannabis Adverse Effects
20211227,"Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922403/,Positive,,Meta-analysis,2021,,Respiratory System,COVID-19
20211228,The Endocannabinoid System Contributes to Electroacupuncture Analgesia,https://pubmed.ncbi.nlm.nih.gov/33679287/,Positive,,Meta-analysis,2021,,,Inflammation; Pain; Pain - Acute; Pain - Chronic
20211229,Cannabinoid Signalling in Immune-Reproductive Crosstalk during Human Pregnancy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000565/,Negative,,Meta-analysis,2021,,Reproductive System,Pregnancy
20211230,Cannabinoid Use for Appetite Stimulation and Weight Gain in Cancer Care: Does Recent Evidence Support an Update of the European Society for Clinical Nutrition and Metabolism Clinical Guidelines?,https://pubmed.ncbi.nlm.nih.gov/33666957/,Inconclusive,,Meta-analysis,2021,,Digestive System; Muscular System; Nervous System,Anorexia; Cachexia; Cancer
20211231,The antimicrobial effect behind Cannabis sativa,https://bpspubs.onlinelibrary.wiley.com/doi/10.1002/prp2.761,Positive,,Meta-analysis,2021,Anandamide (AEA); Cannabichromene (CBC); Cannabichromenic Acid (CBC-a); Cannabidiolic Acid (CBD-a); Cannabigerol (CBG); Cannabigerolic Acid (CBG-a); Cannabinol (CBN); Tetrahydrocannabinolic Acid (THC-a),Immune System,Bacterial Infections
20211232,Effects of Cannabinoid Agonists and Antagonists on Sleep in Laboratory Animals,https://pubmed.ncbi.nlm.nih.gov/33537939/,Positive,,Meta-analysis,2021,,,Insomnia and Sleep Disorders
20211233,Use of Medical Cannabis to Treat Traumatic Brain Injury,https://pubmed.ncbi.nlm.nih.gov/33256496/,Positive,,Meta-analysis,2021,,,Traumatic Brain Injury
20211234,Cannabis and Migraine: It's Complicated,https://pubmed.ncbi.nlm.nih.gov/33630181/,Positive,,Meta-analysis,2021,Tetrahydrocannabinol (THC),Nervous System,Migraine
20211235,Time-Dependent Changes in THC Concentrations in Deceased Persons,https://pubmed.ncbi.nlm.nih.gov/32435813/,Positive,,Laboratory Study,2021,Tetrahydrocannabinol (THC),,
20211236,"A systematic review and meta-analysis of cannabis-based medicines, cannabinoids and endocannabinoid system modulators tested for antinociceptive effects in animal models of injury-related or pathological persistent pain",https://pubmed.ncbi.nlm.nih.gov/33729209/,Positive,,Meta-analysis,2021,Other Related Compounds,Nervous System,Pain - Nociceptive; Pain; Pain - Chronic; Pain - Inflammatory; Pain - Neuropathy - Peripheral
20211237,The Effect of CB1 Antagonism on Hepatic Oxidative/Nitrosative Stress and Inflammation in Nonalcoholic Fatty Liver Disease,https://pubmed.ncbi.nlm.nih.gov/32124686/,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified),Digestive System,Fatty Liver Disease; Inflammation; Oxidative Stress
20211238,Non-Cannabinoid Metabolites of Cannabis sativa L. with Therapeutic Potential,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923270/,Positive,,Meta-analysis,2021,,,COVID-19
20211239,The Immunopathology of COVID-19 and the Cannabis Paradigm,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907157/,Inconclusive,,Meta-analysis,2021,,Respiratory System,COVID-19
20211240,Endocannabinoids and cortical plasticity: CB1R as a possible regulator of the excitation/inhibition balance in health and disease,https://pubmed.ncbi.nlm.nih.gov/33427341/,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,Schizophrenia; Psychosis
20211241,Medical Cannabis in Oncology: a Valuable Unappreciated Remedy or an Undesirable Risk?,https://pubmed.ncbi.nlm.nih.gov/33439370/,Inconclusive,,Meta-analysis,2021,,Nervous System,Cancer; Anxiety; Cachexia; Depression; Insomnia and Sleep Disorders; Pain; Nausea and Vomiting; Palliative Care; Pain - Cancer
20211242,"Novel selective agonist of GPR18, PSB-KK-1415 exerts potent anti-inflammatory and anti-nociceptive activities in animal models of intestinal inflammation and inflammatory pain",https://pubmed.ncbi.nlm.nih.gov/33058313/,Positive,,Animal Study,2021,Synthetic Cannabinoid (unspecified),Digestive System; Nervous System,IBD - Inflammatory Bowel Disease; Inflammation; Pain; Pain - Inflammatory; Pain - Neuropathy - Inflammatory Polyneuropathy
20211243,Targeting the CB 2 receptor and other endocannabinoid elements to delay disease progression in amyotrophic lateral sclerosis,https://pubmed.ncbi.nlm.nih.gov/33486755/,Positive,,Meta-analysis,2021,Synthetic Cannabinoid (unspecified); Endocannabinoid (unspecified),Nervous System,Amyotrophic Lateral Sclerosis (ALS)
20211244,Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats,https://pubmed.ncbi.nlm.nih.gov/33285233/,Positive,,Animal Study,2021,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Schizophrenia; Psychosis
20211245,Transcranial direct current stimulation (tDCS) produce anti-anxiety response in acute stress exposure rats via activation of amygdala CB1R,https://pubmed.ncbi.nlm.nih.gov/33279640/,Positive,,Animal Study,2021,,Mental/Emotional System; Nervous System,Anxiety
20211246,"Modulation of Noradrenergic and Serotonergic Systems by Cannabinoids: Electrophysiological, Neurochemical and Behavioral Evidence",https://pubmed.ncbi.nlm.nih.gov/33537940/,Positive,,Meta-analysis,2021,,,Anxiety; Insomnia and Sleep Disorders; Pain; Pain - Acute; Pain - Chronic
20211247,"Effect of acute and subchronic administration of (R)-WIN55,212-2 induced neuroprotection and anti inflammatory actions in rat retina: CB1 and CB2 receptor involvement",https://pubmed.ncbi.nlm.nih.gov/33220388/,Positive,,Animal Study,2021,WIN-x Synthetic Cannabinoids,Nervous System,Retinal Disorders; Excitotoxicity
20211248,Chronic cannabidiol treatment reduces the carbachol-induced coronary constriction and left ventricular cardiomyocyte width of the isolated hypertensive rat heart,https://pubmed.ncbi.nlm.nih.gov/33338514/,Inconclusive,,Animal Study,2021,,Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
20211249,CB1 Receptor Signaling Modulates Amygdalar Plasticity during Context-Cocaine Memory Reconsolidation to Promote Subsequent Cocaine Seeking,https://pubmed.ncbi.nlm.nih.gov/33257326/,Positive,,Animal Study,2021,AM-x Synthetic Cannabinoids,Mental/Emotional System,Addiction - Cocaine; Addiction
20211250,Activation of the cannabinoid receptor type 2 by the agonist JWH133 promotes the first wave of in vitro spermatogenesis,https://pubmed.ncbi.nlm.nih.gov/33112479/,Positive,,Laboratory Study,2021,JWH-x Synthetic Cannabinoids,Reproductive System,Infertility (Male); Cancer
20211251,URB597 Prevents the Short-Term Excitotoxic Cell Damage in Rat Cortical Slices: Role of Cannabinoid 1 Receptors,https://pubmed.ncbi.nlm.nih.gov/33141426/,Positive,,Laboratory Study,2021,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),,Excitotoxicity
20211252,β-Caryophyllene exerts protective antioxidant effects through the activation of NQO1 in the MPTP model of Parkinson's disease,https://pubmed.ncbi.nlm.nih.gov/33271195/,Positive,,Animal Study,2021,,,Parkinson's Disease
20211253,Stroke and cannabis use in patients with no cardiovascular risk factors: a systematic review of case reports,https://pubmed.ncbi.nlm.nih.gov/29277524/,Negative,,Meta-analysis,2021,,,Stroke
20211254,Effects of systemic endocannabinoid manipulation on social and exploratory behavior in prairie voles (Microtus ochrogaster),https://pubmed.ncbi.nlm.nih.gov/33130926/,Inconclusive,,Animal Study,2021,Anandamide (AEA),,Anxiety
20211255,"Chronic cannabinoid exposure produces tolerance to the dopamine releasing effects of WIN 55,212-2 and heroin in adult male rats",https://pubmed.ncbi.nlm.nih.gov/33115642/,Inconclusive,,Animal Study,2021,WIN-x Synthetic Cannabinoids,,Addiction - Opioid
20211256,Further evidence of anxiety- and depression-like behavior for total genetic ablation of cannabinoid receptor type 1,https://pubmed.ncbi.nlm.nih.gov/33171148/,Positive,,Animal Study,2021,,Mental/Emotional System,Anxiety; Depression
20211257,Δ-9-tetrahydrocannabinol dose increase leads to warfarin drug interaction and elevated INR,https://pubmed.ncbi.nlm.nih.gov/32828704/,Negative,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Bleeding Disorders
20211258,Should You Recommend Cannabinoids for This Patient With Painful Neuropathy? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center,https://pubmed.ncbi.nlm.nih.gov/33556279/,Positive,,Meta-analysis,2021,,,Pain; Pain - Chronic
20211259,A cannabinoid type 2 (CB2) receptor agonist augments NOS-dependent responses of cerebral arterioles during type 1 diabetes,https://pubmed.ncbi.nlm.nih.gov/32979391/,Positive,,Animal Study,2021,JWH-x Synthetic Cannabinoids,Endocrine System,Diabetes
20211260,Interaction of cannabidiol with other antiseizure medications: A narrative review,https://pubmed.ncbi.nlm.nih.gov/33541771/,Positive,,Meta-analysis,2021,,,Epilepsy
20211261,From a Designer Drug to the Discovery of Selective Cannabinoid Type 2 Receptor Agonists with Favorable Pharmacokinetic Profiles for the Treatment of Systemic Sclerosis,https://pubmed.ncbi.nlm.nih.gov/33382613/,Positive,,Animal Study,2021,Synthetic Cannabinoid (unspecified),Integumentary System,Systemic Sclerosis
20211262,"Cannabinoid and Opioid Use Among Total Joint Arthroplasty Patients: A 6-Year, Single-Institution Study",https://pubmed.ncbi.nlm.nih.gov/33002174/,Positive,,Meta-analysis,2021,,Mental/Emotional System,Addiction - Opioid; Addiction; Pain; Pain - Acute; Pain - Chronic; Wound Healing
20211263,Therapeutic and Cosmetic Uses of Cannabis: Cannabinoids for Acne Treatment and Skin -Rejuvenation,https://pubmed.ncbi.nlm.nih.gov/33658112/,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),Integumentary System,Acne
20211264,Endocannabinoids increase human adipose stem cell differentiation and growth factor secretion in vitro,https://pubmed.ncbi.nlm.nih.gov/33459498/,Positive,,Laboratory Study,2021,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),,
20211265,Morbidity and mortality associated with prescription cannabinoid drug use in COPD,https://pubmed.ncbi.nlm.nih.gov/32999059/,Negative,,Meta-analysis,2021,,Respiratory System,COPD
20211266,The Activation of Cannabinoid Type-2 Receptor with JWH-133 Protects Uterine Ischemia/Reperfusion-Induced Damage,https://pubmed.ncbi.nlm.nih.gov/33105141/,Positive,,Animal Study,2021,JWH-x Synthetic Cannabinoids,Cardiovascular System,Cardiovascular Diseases (CVD); Reperfusion Injury
20211267,Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders,https://pubmed.ncbi.nlm.nih.gov/33332006/,Positive,,Meta-analysis,2021,,,Epilepsy
20211268,"Antinociceptive effects of minor cannabinoids, terpenes and flavonoids in Cannabis",https://pubmed.ncbi.nlm.nih.gov/33709984/,Positive,,Meta-analysis,2021,,,Pain; Pain - Acute; Pain - Chronic
20211269,Δ9-Tetrahydrocannabinolic Acid markedly alleviates liver fibrosis and inflammation in mice,https://pubmed.ncbi.nlm.nih.gov/33341026/,Positive,,Animal Study,2021,Tetrahydrocannabinolic Acid (THC-a),Digestive System,Fibrosis - Liver (Cirrhosis); Fibrosis; Inflammation
2019160,Preinjury Use of Marijuana and Outcomes in Trauma Patients,https://pubmed.ncbi.nlm.nih.gov/32818783/,Positive,,Meta-analysis,2019,,,Cardiovascular Diseases (CVD); Reperfusion Injury; Wound Healing
20211270,Synthetic Cannabinoids Induce Autophagy and Mitochondrial Apoptotic Pathways in Human Glioblastoma Cells Independently of Deficiency in TP53 or PTEN Tumor Suppressors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865605/,Positive,,Laboratory Study,2021,JWH-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,,Cancer - Brain; Cancer
20211271,Natural Cannabinoids as Templates for Sleep Disturbances Treatments,https://pubmed.ncbi.nlm.nih.gov/33537941/,Positive,,Meta-analysis,2021,,Nervous System,Insomnia and Sleep Disorders
20211272,The Effect of Cannabinoids on the Brain's Circadian Clock,https://pubmed.ncbi.nlm.nih.gov/33537942/,Inconclusive,,Meta-analysis,2021,,,Insomnia and Sleep Disorders
2020383,Cannabinoids: A New Perspective on Epileptogenesis and Seizure Treatment in Early Life in Basic and Clinical Studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835327/,Positive,,Meta-analysis,2020,,Nervous System,Epilepsy
20211273,Understanding the possible role of endocannabinoid system in obesity,https://pubmed.ncbi.nlm.nih.gov/33249225/,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified),Endocrine System,Metabolic Syndrome; Obesity
20211274,CB 1 allosteric modulators and their therapeutic potential in CNS disorders,https://pubmed.ncbi.nlm.nih.gov/33152384/,Positive,,Meta-analysis,2021,Synthetic Cannabinoid (unspecified),,
20211275,Nephrologist Views Regarding Cannabinoid Use in Advanced Chronic Kidney Disease and Dialysis: A Survey,https://pubmed.ncbi.nlm.nih.gov/32805405/,Positive,,Meta-analysis,2021,,Urinary System,Chronic Kidney Disease; Hemodialysis; Cancer - Kidney; Cancer; Diabetic Kidney Disease; Kidney Failure; Kidney Stones
20211276,Unveiling the mechanism of action behind the anti-cancer properties of cannabinoids in ER + breast cancer cells: Impact on aromatase and steroid receptors,https://pubmed.ncbi.nlm.nih.gov/33722705/,Positive,,Laboratory Study,2021,Anandamide (AEA); Tetrahydrocannabinol (THC),Reproductive System,Cancer - Breast; Cancer
20211277,Disentangling the lasting effects of adolescent cannabinoid exposure,https://pubmed.ncbi.nlm.nih.gov/32791165/,Negative,,Meta-analysis,2021,,Mental/Emotional System,Cannabis Adverse Effects
20211278,Molecular Mechanisms for the Inflammation-Resolving Actions of Lenabasum,https://pubmed.ncbi.nlm.nih.gov/33239333/,Positive,,Meta-analysis,2021,Synthetic Cannabinoid (unspecified),Nervous System,Inflammation; Lupus; Systemic Sclerosis
20211279,High and Mighty? Cannabinoids and the microbiome in pain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905370/,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified); Microbiome,,Pain - Chronic; Inflammation; Pain; Pain - Acute
20211280,Cannabinoid signalling and effects of cannabis on the male reproductive system,https://pubmed.ncbi.nlm.nih.gov/33214706/,Inconclusive,,Meta-analysis,2021,Endocannabinoid (unspecified),Reproductive System,Infertility (Male); Erectile Dysfunction; Libido
20211281,Antinociception mechanisms of action of cannabinoid-based medicine: an overview for anesthesiologists and pain physicians,https://pubmed.ncbi.nlm.nih.gov/33239391/,Positive,,Meta-analysis,2021,,,Inflammation; Pain; Pain - Acute; Pain - Chronic; Pain - Neuropathy - Inflammatory Polyneuropathy
20211282,Cannabinoids modulate food preference and consumption in Drosophila melanogaster,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907270/,Positive,,Animal Study,2021,Anandamide (AEA); 2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Cannabichromene (CBC); Cannabigerol (CBG); CP-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,,Metabolic Syndrome; Obesity
20211283,Cannabinoids for major neurocognitive disorder: case report and literature review,https://pubmed.ncbi.nlm.nih.gov/33648697/,Positive,,Meta-analysis,2021,,Nervous System,Neurodegenerative Issues
20211284,"Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies",https://pubmed.ncbi.nlm.nih.gov/33729211/,Positive,,Meta-analysis,2021,,Nervous System,Pain - Nociceptive; Pain; Pain - Chronic; Pain - Inflammatory; Pain - Neuropathy - Peripheral
20211285,Therapeutic potential of cannabinoids in combination cancer therapy,https://pubmed.ncbi.nlm.nih.gov/33422460/,Positive,,Meta-analysis,2021,,Nervous System,Cancer
20211286,"Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications",https://pubmed.ncbi.nlm.nih.gov/33669071/,Negative,,Meta-analysis,2021,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis
20211287,Cannabinoids in glioblastoma multiforme-hype or hope?,https://pubmed.ncbi.nlm.nih.gov/33623077/,Positive,,Meta-analysis,2021,,Nervous System,Cancer - Brain; Cancer
20211288,Emerging potential of cannabidiol in reversing proteinopathies,https://pubmed.ncbi.nlm.nih.gov/33181336/,Positive,,Meta-analysis,2021,,,Alzheimer's Disease; Amyotrophic Lateral Sclerosis (ALS); Huntington's Disease; Multiple Sclerosis; Parkinson's Disease
20211289,Consensus-based recommendations for titrating cannabinoids and tapering opioids for chronic pain control,https://pubmed.ncbi.nlm.nih.gov/33249713/,Positive,,Meta-analysis,2021,,Nervous System,Pain; Pain - Chronic; Addiction - Opioid
2020384,"The Long-Term, Prospective, Therapeutic Impact of Cannabis on Post-Traumatic Stress Disorder",https://www.liebertpub.com/doi/10.1089/can.2020.0056,Positive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,PTSD
20211290,The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial,https://pubmed.ncbi.nlm.nih.gov/33730032/,Positive,,Double Blind Clinical Trial,2021,,Mental/Emotional System; Nervous System,PTSD
20211291,Potential of cannabinoids as treatments for autism spectrum disorders,https://pubmed.ncbi.nlm.nih.gov/33689997/,Positive,,Meta-analysis,2021,,Mental/Emotional System,Autism
20211292,"Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer's, Parkinson's, and Huntington's Diseases",https://pubmed.ncbi.nlm.nih.gov/33332005/,Positive,,Meta-analysis,2021,,Nervous System,Alzheimer's Disease; Huntington's Disease; Parkinson's Disease
20211293,Cannabinoids for the Treatment of Opioid Use Disorder: Where is the Evidence?,https://pubmed.ncbi.nlm.nih.gov/32909980/,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
20211294,Cannabinoids for Agitation in Alzheimer's Disease,https://pubmed.ncbi.nlm.nih.gov/33573996/,Positive,,Meta-analysis,2021,,Nervous System,Alzheimer's Disease; Dementia
20211295,The Role of Cannabinoids as Anticancer Agents in Pediatric Oncology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796497/,Inconclusive,,Meta-analysis,2021,,Nervous System,Cancer; Cancer - Brain; Cancer - Leukemia; Cancer - Neuroblastoma; Cancer - Soft Tissues
20211296,Cannabinoids and orthopedic surgery: a systematic review of therapeutic studies,https://pubmed.ncbi.nlm.nih.gov/33446183/,Positive,,Meta-analysis,2021,,,Pain; Pain - Acute
20211297,Cannabinoids in the management of frontotemporal dementia: a case series,https://pubmed.ncbi.nlm.nih.gov/33190583/,Positive,,Meta-analysis,2021,,Nervous System,Dementia; Alzheimer's Disease; OCD
20211298,Healing autism spectrum disorder with cannabinoids: a neuroinflammatory story,https://pubmed.ncbi.nlm.nih.gov/33358985/,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Autism
20211299,Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches,https://pubmed.ncbi.nlm.nih.gov/33290767/,Positive,,Laboratory Study,2021,,Respiratory System,COVID-19
20211300,Cannabinoids in dermatologic surgery,https://pubmed.ncbi.nlm.nih.gov/33422628/,Positive,,Meta-analysis,2021,,,Inflammation; Pain; Pain - Acute; Wound Healing
20211301,Role of cannabinoids in alcohol-induced neuroinflammation,https://pubmed.ncbi.nlm.nih.gov/32758518/,Positive,,Meta-analysis,2021,Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction; Inflammation
2020385,Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review,https://pubmed.ncbi.nlm.nih.gov/33113429/,Positive,,Meta-analysis,2020,,Endocrine System,Metabolic Syndrome; Diabetes; Fibrosis - Liver (Cirrhosis); Fibrosis; Oxidative Stress
2019161,"Cannabidiol, cannabinol and their combinations act as peripheral analgesics in a rat model of myofascial pain",https://pubmed.ncbi.nlm.nih.gov/31158702/,Positive,,Animal Study,2019,Cannabinol (CBN),Muscular System,Temporomandibular Disorders; Dystonia; Fibromyalgia
2020386,In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684313/,Inconclusive,,Laboratory Study,2020,Cannabichromene (CBC); Cannabichromenic Acid (CBC-a); Cannabidiolic Acid (CBD-a); Cannabigerol (CBG); Tetrahydrocannabivarin (THCV); Tetrahydrocannabinolic Acid (THC-a),,
20211302,Cannabis-Derived Compounds Cannabichromene and Δ9-Tetrahydrocannabinol Interact and Exhibit Cytotoxic Activity against Urothelial Cell Carcinoma Correlated with Inhibition of Cell Migration and Cytoskeleton Organization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830447/,Positive,,Laboratory Study,2021,Cannabichromene (CBC); Tetrahydrocannabinol (THC),Nervous System; Urinary System,Cancer - Bladder; Cancer
20211303,"Cannabichromene, Related Phytocannabinoids, and 5-Fluoro-cannabichromene Have Anticonvulsant Properties in a Mouse Model of Dravet Syndrome",https://pubmed.ncbi.nlm.nih.gov/33395525/,Positive,,Animal Study,2021,Cannabichromene (CBC); Cannabichromenic Acid (CBC-a),Nervous System,Epilepsy - Dravet Syndrome; Epilepsy
2020387,Rapid Antibacterial Activity of Cannabichromenic Acid against Methicillin-Resistant Staphylococcus aureus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460474/,Positive,,Laboratory Study,2020,Cannabichromenic Acid (CBC-a),Immune System,Bacterial Infections; Staph Infection
20211304,Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson's disease using 6-hydroxydopamine-lesioned mice,https://pubmed.ncbi.nlm.nih.gov/33338634/,Positive,,Animal Study,2021,Cannabigerol (CBG),Nervous System,Parkinson's Disease
20211305,"A Comparative In Vitro Study of the Neuroprotective Effect Induced by Cannabidiol, Cannabigerol, and Their Respective Acid Forms: Relevance of the 5-HT 1A Receptors",https://pubmed.ncbi.nlm.nih.gov/32886342/,Positive,,Laboratory Study,2021,Cannabigerol (CBG),,Neurodegenerative Issues; Oxidative Stress
2020388,A systematic review of minor phytocannabinoids with promising neuroprotective potential,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484504/,Positive,,Meta-analysis,2020,Cannabichromene (CBC); Cannabigerol (CBG); Tetrahydrocannabinol (THC),,Alzheimer's Disease; Epilepsy; Huntington's Disease; Neurodegenerative Issues; Parkinson's Disease
2019162,Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome,https://pubmed.ncbi.nlm.nih.gov/31686510/,Positive,,Animal Study,2019,Cannabidiolic Acid (CBD-a),,Epilepsy - Dravet Syndrome; Epilepsy
20211306,Antioxidant function of phytocannabinoids: Molecular basis of their stability and cytoprotective properties under UV-irradiation,https://pubmed.ncbi.nlm.nih.gov/33453360/,Positive,,Laboratory Study,2021,Cannabinol (CBN); Cannabichromene (CBC); Cannabigerol (CBG),,Oxidative Stress
2019163,Preliminary assessment of medical cannabis consumption by cancer survivors,https://pubmed.ncbi.nlm.nih.gov/33197667/,Positive,,Meta-analysis,2019,,Nervous System,Cancer
20211307,Cannabis Use during Pregnancy and Risk of Adverse Birth Outcomes: A Longitudinal Cohort Study,https://pubmed.ncbi.nlm.nih.gov/33040062/,Negative,,Meta-analysis,2021,,Reproductive System,Pregnancy
20211308,"Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893882/,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Anxiety; Insomnia and Sleep Disorders
2020389,The use of cannabis for Hyperemesis Gravidarum (HG),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819334/,Positive,,Meta-analysis,2020,,Digestive System; Reproductive System,Morning sickness; Nausea and Vomiting; Pregnancy
20211309,Associations Between Prenatal Cannabis Exposure and Childhood Outcomes: Results From the ABCD Study,https://pubmed.ncbi.nlm.nih.gov/32965490/,Negative,,Meta-analysis,2021,,Reproductive System,Pregnancy
2019164,Involvement of Spinal Cannabinoid CB 2 Receptors in Exercise-Induced Antinociception,https://pubmed.ncbi.nlm.nih.gov/31473278/,Positive,,Animal Study,2019,,Nervous System,Inflammation; Pain; Pain - Acute; Pain - Chronic
2020390,Cannabinoid Receptors and Their Relationship With Chronic Pain: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557112/,Positive,,Meta-analysis,2020,,Nervous System,Inflammation; Pain; Pain - Chronic; Arthritis - Osteoarthritis; Arthritis
2012108,The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021987/,Positive,,Animal Study,2012,O-x Synthetic Cannabinoids,Nervous System,Inflammation; Pain - Neuropathy - Peripheral; Pain; Pain - Acute; Pain - Chronic
20211310,Cannabidiol Ameliorates Cognitive Function via Regulation of IL-33 and TREM2 Upregulation in a Murine Model of Alzheimer's Disease,https://pubmed.ncbi.nlm.nih.gov/33612548/,Positive,,Animal Study,2021,,Nervous System,Alzheimer's Disease; Cognitive Dysfunction; Dementia
2018159,Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma,https://pubmed.ncbi.nlm.nih.gov/30125556/,Positive,,Animal Study,2018,Pharma THC:CBD,Nervous System,Cancer - Brain; Cancer
2018160,Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide,https://pubmed.ncbi.nlm.nih.gov/30195736/,Positive,,Animal Study,2018,,Nervous System,Cancer - Brain; Cancer
2014095,The combination of cannabidiol and Δ9-tetrahydrocannabinol enhances the anticancer effects of radiation in an orthotopic murine glioma model,https://mct.aacrjournals.org/content/13/12/2955,Positive,,Animal Study,2014,Tetrahydrocannabinol (THC),Nervous System,Cancer - Brain; Cancer
20211311,Assessment of Cannabidiol and Δ9-Tetrahydrocannabiol in Mouse Models of Medulloblastoma and Ependymoma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829707/,Positive,,Animal Study,2021,Tetrahydrocannabinol (THC),Nervous System,Cancer - Brain; Cancer
2020391,Phytocannabinoids in Neurological Diseases: Could They Restore a Physiological GABAergic Transmission?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038116/,Inconclusive,,Meta-analysis,2020,,,Alzheimer's Disease; Amyotrophic Lateral Sclerosis (ALS); Anxiety; Autism; Epilepsy; Parkinson's Disease
2020392,Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215817/,Positive,,Meta-analysis,2020,,Digestive System,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease
2020393,Cannabidiol (CBD) Inhibited Rhodamine-123 Efflux in Cultured Vascular Endothelial Cells and Astrocytes Under Hypoxic Conditions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090129/,Positive,,Laboratory Study,2020,,,Epilepsy; Oxidative Stress
2020394,CBD Effects on TRPV1 Signaling Pathways in Cultured DRG Neurons,https://pubmed.ncbi.nlm.nih.gov/32982390/,Positive,,Laboratory Study,2020,,,Pain; Pain - Acute; Pain - Chronic
2020395,CBD modulates DNA methylation in the prefrontal cortex and hippocampus of mice exposed to forced swim,https://pubmed.ncbi.nlm.nih.gov/32348868/,Positive,,Animal Study,2020,,Mental/Emotional System,Behavioral Disorders; Cognitive Dysfunction; Depression; PTSD
2020396,Cannabidiol (CBD) reduces cocaine-environment memory in mice,https://pubmed.ncbi.nlm.nih.gov/33127382/,Positive,,Animal Study,2020,,Mental/Emotional System; Nervous System,Addiction - Cocaine; Addiction
2020397,Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials,https://pubmed.ncbi.nlm.nih.gov/32271618/,Inconclusive,,Clinical Meta-analysis,2020,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2020398,CBD for the treatment of pain: What is the evidence?,https://pubmed.ncbi.nlm.nih.gov/32636158/,Inconclusive,,Meta-analysis,2020,,,Pain; Pain - Acute; Pain - Chronic
2005033,"Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta",https://pubmed.ncbi.nlm.nih.gov/15659311/,Inconclusive,,Animal Study,2005,Anandamide (AEA); N-Arachidonoyl Dopamine (NADA),,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2020399,Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700528/,Positive,,Meta-analysis,2020,,,Arthritis - Osteoarthritis; Arthritis; Inflammation
2020400,"Cytotoxic Effects of Cannabinoids on Human HT-29 Colorectal Adenocarcinoma Cells: Different Mechanisms of THC, CBD, and CB83",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432098/,Positive,,Laboratory Study,2020,Synthetic Cannabinoid (unspecified),Digestive System; Nervous System,Cancer - Colon; Cancer
2020401,Effect of aerosolized nicotine on human bronchial epithelial cells is amplified after co-administration with cannabidiol (CBD): a pilot in vitro study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271510/,Negative,,Laboratory Study,2020,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2020402,The effects of cannabidiol on male reproductive system: A literature review,https://pubmed.ncbi.nlm.nih.gov/31313338/,Negative,,Meta-analysis,2020,,,Erectile Dysfunction; Infertility (Male); Libido
2020403,Prescribed medical cannabis in women with gynecologic malignancies: A single-institution survey-based study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653050/,Positive,,Meta-analysis,2020,,Nervous System; Reproductive System,Cancer - Cervical; Cancer - Ovarian; Cancer - Uterine; Cancer
20211312,Patterns of Medical Cannabis Use among Patients Diagnosed with Multiple Sclerosis,https://pubmed.ncbi.nlm.nih.gov/33636612/,Positive,,Meta-analysis,2021,,,Multiple Sclerosis
20211313,Use of cannabinoids for the treatment of patients with post-traumatic stress disorder,https://pubmed.ncbi.nlm.nih.gov/33662194/,Positive,,Meta-analysis,2021,Tetrahydrocannabinol (THC); Pharma THC,Mental/Emotional System,PTSD
2020404,Cannabidiol: A Brief Review of Its Therapeutic and Pharmacologic Efficacy in the Management of Joint Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176325/,Positive,,Meta-analysis,2020,,Skeletal System,Arthritis - Osteoarthritis; Arthritis; Pain; Pain - Acute; Pain - Chronic
2020405,An Analysis of the Putative CBD Binding Site in the Ionotropic Cannabinoid Receptors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755602/,Positive,,Laboratory Study,2020,,,Inflammation; Pain; Pain - Chronic
2020406,PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285054/,Positive,,Laboratory Study,2020,,Nervous System; Reproductive System,Cancer - Ovarian; Cancer - Uterine; Cancer
2020407,A Balanced Approach for Cannabidiol Use in Chronic Pain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204604/,Inconclusive,,Meta-analysis,2020,,Nervous System,Pain; Pain - Chronic
20211314,Cannabidiol (CBD) enhanced the hippocampal immune response and autophagy of APP/PS1 Alzheimer's mice uncovered by RNA-seq,https://pubmed.ncbi.nlm.nih.gov/33096116/,Positive,,Animal Study,2021,,,Alzheimer's Disease
2020408,"Cannabidiol or CBD Oil: Help, Hope, and Hype for Psychiatric and Neurologic Conditions",https://pubmed.ncbi.nlm.nih.gov/32508204/,Positive,,Meta-analysis,2020,Tetrahydrocannabinol (THC),,Epilepsy
2020409,CBD Suppression of EAE Is Correlated with Early Inhibition of Splenic IFN-γ + CD8+ T Cells and Modest Inhibition of Neuroinflammation,https://pubmed.ncbi.nlm.nih.gov/32440886/,Positive,,Animal Study,2020,,Nervous System,Encephalitis and Myelitis; Multiple Sclerosis
2020410,Use of cannabidiol in anxiety and anxiety-related disorders,https://www.japha.org/article/S1544-3191(19)30514-X/fulltext,Positive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Anxiety
2020411,COVID-19 and Cannabidiol (CBD),https://pubmed.ncbi.nlm.nih.gov/33323690/,Inconclusive,,Meta-analysis,2020,,Respiratory System,COVID-19
2020412,Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736837/,Positive,,Meta-analysis,2020,,,Acne; Eczema; Hair Loss; Inflammation; Pruritis; Psoriasis; Seborrhea
2013088,Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptor activation in mice,https://pubmed.ncbi.nlm.nih.gov/23791616/,Positive,,Animal Study,2013,,Nervous System,Chorea; Dystonia; Parkinson's Disease
20211315,Anti-Biofilm Activity of Cannabidiol against Candida albicans,https://www.researchgate.net/publication/349495697_Anti-Biofilm_Activity_of_Cannabidiol_against_Candida_albicans,Positive,,Laboratory Study,2021,,Digestive System; Immune System; Integumentary System,Fungal Infections
20211316,The longitudinal relationship between cannabis use and hypertension,https://pubmed.ncbi.nlm.nih.gov/33644920/,Inconclusive,,Meta-analysis,2021,,Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
20211317,The association between cannabis use and outcome in pharmacological treatment for opioid use disorder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903683/,Positive,,Meta-analysis,2021,,Mental/Emotional System,Addiction - Opioid; Addiction
20211318,Effect of cannabis on oxaliplatin-induced peripheral neuropathy among oncology patients: a retrospective analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876573/,Positive,,Clinical Trial,2021,,,Pain - Neuropathy - Peripheral; Cancer; Pain; Pain - Cancer
2018161,A Systematic Review and Meta-Analysis of the In Vivo Haemodynamic Effects of Δ9-Tetrahydrocannabinol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874709/,Inconclusive,,Meta-analysis,2018,Tetrahydrocannabinol (THC),,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
1976002,Vasoconstrictor actions of delta8- and delta9-tetrahydrocannabinol in the rat,https://pubmed.ncbi.nlm.nih.gov/4606/,Inconclusive,,Animal Study,1976,Delta-8-THC,,
1984006,Cross-tolerance to the hypothermic effect of delta 8-tetrahydrocannabinol 11-hydroxy-delta 8-tetrahydrocannabinol and chlorpromazine in the mouse,https://pubmed.ncbi.nlm.nih.gov/2990949/,Inconclusive,,Animal Study,1984,Delta-8-THC,,
1986005,"Effect of repeated administration of 11-hydroxy-delta 8-tetrahydrocannabinol, an active metabolite of delta 8-tetrahydrocannabinol, on the hepatic microsomal drug-metabolizing enzyme system of mice",https://pubmed.ncbi.nlm.nih.gov/3013200/,Inconclusive,,Animal Study,1986,Delta-8-THC,,
2004026,Very low doses of delta 8-THC increase food consumption and alter neurotransmitter levels following weight loss,https://pubmed.ncbi.nlm.nih.gov/15099912/,Positive,,Animal Study,2004,Delta-8-THC,Endocrine System,Obesity; Diabetes; Metabolic Syndrome
2004027,In vitro/in vivo correlation studies for transdermal delta 8-THC development,https://pubmed.ncbi.nlm.nih.gov/15067692/,Inconclusive,,Laboratory Study,2004,Delta-8-THC,,
2019165,Cannabinoid Use in Patients With Gastroparesis and Related Disorders: Prevalence and Benefit,https://pubmed.ncbi.nlm.nih.gov/30865015/,Positive,,Meta-analysis,2019,Pharma THC,Digestive System,Gastroparesis
2019166,Cannabis for Gastroparesis: Hype or Hope?,https://journals.lww.com/ajg/Citation/2019/06000/Cannabis_for_Gastroparesis__Hype_or_Hope_.13.aspx,Inconclusive,,Meta-analysis,2019,,Digestive System,Gastroparesis
2020413,Impact of Cannabinoids on Symptoms of Refractory Gastroparesis: A Single-center Experience,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970440/,Positive,,Clinical Trial,2020,Pharma THC,Digestive System,Gastroparesis
2020414,"Marijuana Use in Patients with Symptoms of Gastroparesis: Prevalence, Patient Characteristics, and Perceived Benefit",https://pubmed.ncbi.nlm.nih.gov/31758430/,Positive,,Meta-analysis,2020,,Digestive System,Gastroparesis
20211319,Cannabis compounds exhibit anti-inflammatory activity in vitro in COVID-19-related inflammation in lung epithelial cells and pro-inflammatory activity in macrophages,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809280/,Inconclusive,,Laboratory Study,2021,Cannabigerol (CBG); Tetrahydrocannabivarin (THCV),Respiratory System,COVID-19; Inflammation
20211320,Efficacy of combined therapy with fish oil and phytocannabinoids in murine intestinal inflammation,https://pubmed.ncbi.nlm.nih.gov/32996187/,Positive,,Animal Study,2021,Cannabigerol (CBG),Digestive System,IBD - Inflammatory Bowel Disease; Inflammation
20211321,"Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities",https://pubmed.ncbi.nlm.nih.gov/33246167/,Positive,,Meta-analysis,2021,,,Cancer
20211322,Cannabis use and reduced risk of elevated fatty liver index in HIV-HCV co-infected patients: a longitudinal analysis (ANRS CO13 HEPAVIH),https://pubmed.ncbi.nlm.nih.gov/33538612/,Positive,,Meta-analysis,2021,,Digestive System; Immune System,Hepatitis; HIV/AIDS
20211323,Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma,https://pubmed.ncbi.nlm.nih.gov/33562819/,Positive,,Laboratory Study,2021,Cannabigerol (CBG),,Cancer - Brain; Cancer
2020415,Cannabidiol (CBD) as a treatment of acute and chronic back pain: A case series and literature review,https://pubmed.ncbi.nlm.nih.gov/32421842/,Positive,,Meta-analysis,2020,,Nervous System,Pain; Pain - Acute; Pain - Chronic
2020416,Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463000/,Positive,,Laboratory Study,2020,,Skeletal System,Arthritis - Rheumatoid; Arthritis
2020417,Cannabidiol (CBD) as a Promising Anti-Cancer Drug,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693730/,Positive,,Meta-analysis,2020,,Nervous System,Cancer
2020418,The proposed mechanisms of action of CBD in epilepsy,https://pubmed.ncbi.nlm.nih.gov/32053110/,Positive,,Meta-analysis,2020,,Nervous System,Epilepsy
2020419,A cautious hope for cannabidiol (CBD) in rheumatology care,https://pubmed.ncbi.nlm.nih.gov/32144889/,Positive,,Meta-analysis,2020,,Skeletal System,Arthritis - Rheumatoid; Arthritis
2020420,Cross-generational THC Exposure Weakly Attenuates Cocaine's Rewarding Effects in Adult Male Offspring,https://pubmed.ncbi.nlm.nih.gov/32891609/,Positive,,Animal Study,2020,,Mental/Emotional System; Nervous System,Addiction - Cocaine; Addiction
1986006,Prolonged cataleptogenic effects of potentized homoeopathic drugs,https://www.academia.edu/36177293/Prolonged_cataleptogenic_effects_of_potentized_homoeopathic_drugs?auto=download,Negative,,Animal Study,1986,,,Dystonia; Epilepsy; Parkinson's Disease; Spinal Cord Injuries
20211324,"Medical cannabis for the treatment of fibromyalgia syndrome: a retrospective, open-label case series",https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-021-00060-6#citeas,Positive,,Meta-analysis,2021,Tetrahydrocannabinol (THC),Muscular System,Fibromyalgia
2019167,Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: A randomized controlled trial,https://pubmed.ncbi.nlm.nih.gov/33571293/,Positive,,Double Blind Clinical Trial,2019,,Digestive System,IBD - Inflammatory Bowel Disease; IBD - Ulcerative Colitis; IBD - Crohn's Disease
2009051,Up-regulation of TRPV1 in mononuclear cells of end-stage kidney disease patients increases susceptibility to N-arachidonoyl-dopamine (NADA)-induced cell death,https://pubmed.ncbi.nlm.nih.gov/19619644/,Positive,,Laboratory Study,2009,N-Arachidonoyl Dopamine (NADA),Urinary System,Hemodialysis; Kidney Failure; Chronic Kidney Disease; Diabetic Kidney Disease
2007043,"Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret",https://pubmed.ncbi.nlm.nih.gov/17459108/,Positive,,Animal Study,2007,Anandamide (AEA); N-Arachidonoyl Dopamine (NADA),Digestive System,Nausea and Vomiting; Chemotherapy-induced Nausea & Vomiting; Morning sickness; Motion Sickness
2007044,N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors,https://pubmed.ncbi.nlm.nih.gov/16760924/,Inconclusive,,Laboratory Study,2007,N-Arachidonoyl Dopamine (NADA),,
2017118,Neuroprotective Properties of Endocannabinoids N-Arachidonoyl Dopamine and N-Docosahexaenoyl Dopamine Examined in Neuronal Precursors Derived from Human Pluripotent Stem Cells,https://pubmed.ncbi.nlm.nih.gov/29223163/,Positive,,Laboratory Study,2017,N-Arachidonoyl Dopamine (NADA),Nervous System,Oxidative Stress
2014096,Hypoximimetic activity of N-acyl-dopamines. N-arachidonoyl-dopamine stabilizes HIF-1α protein through a SIAH2-dependent pathway,https://pubmed.ncbi.nlm.nih.gov/25090972/,Positive,,Laboratory Study,2014,N-Arachidonoyl Dopamine (NADA),,Cardiovascular Diseases (CVD); Neonatal Cerebral Issues; Oxidative Stress; Reperfusion Injury
2017119,N-Arachidonoyl Dopamine Inhibits NRAS Neoplastic Transformation by Suppressing Its Plasma Membrane Translocation,https://pubmed.ncbi.nlm.nih.gov/27760835/,Positive,,Laboratory Study,2017,N-Arachidonoyl Dopamine (NADA),Nervous System,Cancer
2016133,Identification of N-arachidonoyl dopamine as a highly biased ligand at cannabinoid CB1 receptors,https://pubmed.ncbi.nlm.nih.gov/26398720/,Inconclusive,,Laboratory Study,2016,N-Arachidonoyl Dopamine (NADA),,
2011094,The antinociceptive potency of N-arachidonoyl-dopamine (NADA) and its interaction with endomorphin-1 at the spinal level,https://pubmed.ncbi.nlm.nih.gov/21624393/,Positive,,Animal Study,2011,N-Arachidonoyl Dopamine (NADA),,Inflammation; Pain; Pain - Acute; Pain - Chronic
2012109,The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytes,https://pubmed.ncbi.nlm.nih.gov/22301114/,Positive,,Laboratory Study,2012,N-Arachidonoyl Dopamine (NADA),Digestive System,Fibrosis - Liver (Cirrhosis); Fibrosis
2014097,"The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036321/,Positive,,Laboratory Study,2014,N-Arachidonoyl Dopamine (NADA),,Inflammation
2017120,N-Arachidonoyl Dopamine: A Novel Endocannabinoid and Endovanilloid with Widespread Physiological and Pharmacological Activities,https://pubmed.ncbi.nlm.nih.gov/29082315/,Positive,,Laboratory Study,2017,N-Arachidonoyl Dopamine (NADA),,Inflammation; Pain; Pain - Acute; Pain - Chronic; Wound Healing
2017121,N-Arachidonoyl Dopamine Modulates Acute Systemic Inflammation via Nonhematopoietic TRPV1,https://pubmed.ncbi.nlm.nih.gov/28701511/,Positive,,Laboratory Study,2017,N-Arachidonoyl Dopamine (NADA),Nervous System,Inflammation
20211325,N-arachidonoyl dopamine inhibits epithelial-mesenchymal transition of breast cancer cells through ERK signaling and decreasing the cellular cholesterol,https://pubmed.ncbi.nlm.nih.gov/33393692/,Positive,,Laboratory Study,2021,N-Arachidonoyl Dopamine (NADA),Reproductive System,Cancer - Breast; Cancer
20211326,"Neuroprotective and neurotoxic effects of endocannabinoid-like compounds, N-arachidonoyl dopamine and N-docosahexaenoyl dopamine in differentiated cultures of induced pluripotent stem cells derived from patients with Parkinson's disease",https://pubmed.ncbi.nlm.nih.gov/33248189/,Positive,,Laboratory Study,2021,N-Arachidonoyl Dopamine (NADA),,Parkinson's Disease
20211327,Cannabinoid treatment for autism: a proof-of-concept randomized trial,https://pubmed.ncbi.nlm.nih.gov/33536055/,Positive,,Double Blind Clinical Trial,2021,,Mental/Emotional System,Autism
2007045,Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism,https://pubmed.ncbi.nlm.nih.gov/17906680/,Positive,,Laboratory Study,2007,Virodhamine (O-AEA),,
2009052,(Endo)cannabinoids mediate different Ca2+ entry mechanisms in human bronchial epithelial cells,https://pubmed.ncbi.nlm.nih.gov/19255745/,Positive,,Laboratory Study,2009,CP-x Synthetic Cannabinoids; Virodhamine (O-AEA),,
2014098,Mechanism of platelet activation induced by endocannabinoids in blood and plasma,https://pubmed.ncbi.nlm.nih.gov/23789792/,Inconclusive,,Laboratory Study,2014,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Monoacylglycerol Lipase (MAGL); Virodhamine (O-AEA),Cardiovascular System,Bleeding Disorders; Cardiovascular Diseases (CVD)
2012110,The endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55,https://pubmed.ncbi.nlm.nih.gov/22454039/,Positive,,Laboratory Study,2012,Virodhamine (O-AEA),,Inflammation
2004028,Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery,https://pubmed.ncbi.nlm.nih.gov/15233865/,Positive,,Laboratory Study,2004,Virodhamine (O-AEA),,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2007046,"Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells",https://pubmed.ncbi.nlm.nih.gov/17558435/,Positive,,Laboratory Study,2007,CP-x Synthetic Cannabinoids; Virodhamine (O-AEA),,COVID-19; Inflammation
2002021,"Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor",https://pubmed.ncbi.nlm.nih.gov/12023533/,Positive,,Laboratory Study,2002,Virodhamine (O-AEA),,
2014099,"Activation of platelets by the endocannabinoids 2-arachidonoylglycerol and virodhamine is mediated by their conversion to arachidonic acid and thromboxane A2, not by activation of cannabinoid receptors",https://pubmed.ncbi.nlm.nih.gov/24102401/,Inconclusive,,Laboratory Study,2014,Virodhamine (O-AEA),,
2018162,Endocannabinoid Virodhamine Is an Endogenous Inhibitor of Human Cardiovascular CYP2J2 Epoxygenase,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262108/,Inconclusive,,Laboratory Study,2018,Virodhamine (O-AEA),,
2018163,Interactions of endocannabinoid virodhamine and related analogs with human monoamine oxidase-A and -B,https://pubmed.ncbi.nlm.nih.gov/29958841/,Inconclusive,,Laboratory Study,2018,Virodhamine (O-AEA),,Neurodegenerative Issues
20211328,"Virodhamine, an endocannabinoid, induces megakaryocyte differentiation by regulating MAPK activity and function of mitochondria",https://pubmed.ncbi.nlm.nih.gov/32696508/,Inconclusive,,Laboratory Study,2021,Virodhamine (O-AEA),,
20211329,Cannabidiol Use for Fibromyalgia: Prevalence of Use and Perceptions of Effectiveness in a Large Online Survey,https://pubmed.ncbi.nlm.nih.gov/33400996/,Positive,,Meta-analysis,2021,,Muscular System,Fibromyalgia
20211330,The Impact of Marijuana Use on Liver Transplant Recipients: A 900 Patient Single Center Experience,https://pubmed.ncbi.nlm.nih.gov/33406299/,Positive,,Meta-analysis,2021,,Immune System,Organ Transplant Failure
2020421,Association Between Marijuana Use and Cardiovascular Disease in US Adults,https://pubmed.ncbi.nlm.nih.gov/33409101/,Positive,,Meta-analysis,2020,,Cardiovascular System,Cardiovascular Diseases (CVD)
20211331,The antimicrobial potential of cannabidiol,https://pubmed.ncbi.nlm.nih.gov/33469147/,Positive,,Laboratory Study,2021,,Immune System,Staph Infection
20211332,Mixed methods study of the potential therapeutic benefits from medical cannabis for patients in Florida,https://www.sciencedirect.com/science/article/pii/S0965229921000108,Positive,,Meta-analysis,2021,,,Arthritis - Osteoarthritis; Arthritis; Chemotherapy-induced Nausea & Vomiting; Depression; Epilepsy; Morning sickness; Pain; Motion Sickness; Nausea and Vomiting; Pain - Chronic
2020422,Cannabinoids in the Management of Acute Pain: A Systematic Review and Meta-analysis,https://pubmed.ncbi.nlm.nih.gov/33381643/,Positive,,Meta-analysis,2020,,Nervous System,Pain; Pain - Acute
20211333,Effects of cannabis use on alcohol consumption in a sample of treatment-engaged heavy drinkers in Colorado,https://pubmed.ncbi.nlm.nih.gov/33464670/,Positive,,Meta-analysis,2021,,Mental/Emotional System,Addiction - Alcohol; Addiction
2020423,A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy: a case report,https://jmedicalcasereports.biomedcentral.com/articles/10.1186/s13256-020-02478-7#citeas,Positive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Autism
20211334,Cannabis is associated with blood pressure reduction in older adults - A 24-hours ambulatory blood pressure monitoring study,https://pubmed.ncbi.nlm.nih.gov/33483174/,Positive,,Clinical Trial,2021,,Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
20211335,Evaluation of THC-Related Neuropsychiatric Symptoms Among Adults Aged 50 Years and Older: A Systematic Review and Metaregression Analysis,https://pubmed.ncbi.nlm.nih.gov/33528550/,Negative,,Clinical Meta-analysis,2021,Pharma THC; Pharma THC:CBD,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
20211336,Cannabidiol as a Treatment for Craving and Relapse in Individuals with Cocaine Use Disorder: a Randomized Placebo‐Controlled Trial,https://pubmed.ncbi.nlm.nih.gov/33464660/,Inconclusive,,Double Blind Clinical Trial,2021,,Mental/Emotional System,Addiction - Cocaine; Addiction
20211337,"The effectiveness of inhaled Cannabis flower for the treatment of agitation/irritability, anxiety, and common stress",https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-020-00051-z,Positive,,Meta-analysis,2021,,Mental/Emotional System,Anxiety; Oxidative Stress
20211338,Association between county level cannabis dispensary counts and opioid related mortality rates in the United States: panel data study,https://www.bmj.com/content/372/bmj.m4957,Positive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
20211339,Homegrown perceptions about the medical use and potential abuse of CBD and THC,https://www.sciencedirect.com/science/article/pii/S030646032030928X?via%3Dihub,Inconclusive,,Meta-analysis,2021,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
20211340,A Survey on the Effect That Medical Cannabis Has on Prescription Opioid Medication Usage for the Treatment of Chronic Pain at Three Medical Cannabis Practice Sites,https://pubmed.ncbi.nlm.nih.gov/33409086/,Positive,,Meta-analysis,2021,,Nervous System,Pain; Pain - Chronic; Addiction - Opioid
20211341,Opioid Prescribing in Canada following the Legalization of Cannabis: A Clinical and Economic Time-Series Analysis,https://pubmed.ncbi.nlm.nih.gov/33491149/,Positive,,Meta-analysis,2021,,,Addiction - Opioid; Pain; Pain - Chronic
20211342,Patient-reported outcomes in those consuming medical cannabis: a prospective longitudinal observational study in chronic pain patients,https://pubmed.ncbi.nlm.nih.gov/33469735/,Positive,,Meta-analysis,2021,,Nervous System,Pain; Pain - Chronic
2012111,"Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study",https://pubmed.ncbi.nlm.nih.gov/22095142/,Positive,,Clinical Trial,2012,,Nervous System,Inflammation; IBD - Crohn's Disease; Irritable Bowel Syndrome
2020424,The Impact of Feeding Cannabidiol (CBD) Containing Treats on Canine Response to a Noise-Induced Fear Response Test,https://pubmed.ncbi.nlm.nih.gov/33195551/,Inconclusive,,Animal Study -,2020,,,Veterinary Applications
2020425,Pharmacokinetic and Safety Evaluation of Various Oral Doses of a Novel 1:20 THC:CBD Cannabis Herbal Extract in Dogs,https://pubmed.ncbi.nlm.nih.gov/33134364/,Positive,,Animal Study -,2020,,,Veterinary Applications
2020426,Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer,https://pubmed.ncbi.nlm.nih.gov/32340151/,Positive,,Meta-analysis,2020,,Nervous System,Cancer
2002022,Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients,https://pubmed.ncbi.nlm.nih.gov/12412840/,Inconclusive,,Double Blind Clinical Trial,2002,Pharma THC,Immune System,HIV/AIDS
2002023,The effects of cannabinoids on the pharmacokinetics of indinavir and nelfinavir,https://pubmed.ncbi.nlm.nih.gov/11872997/,Inconclusive,,Double Blind Clinical Trial,2002,Pharma THC,Immune System,HIV/AIDS
2019168,Cannabis use in myotonic dystrophy patients in Germany and USA: a pilot survey,https://pubmed.ncbi.nlm.nih.gov/30552503/,Positive,,Meta-analysis,2019,,Muscular System,Muscular Dystrophy & Myotonic Disorders
2020427,"Cannabinoid-profiled agents improve cell survival via reduction of oxidative stress and inflammation, and Nrf2 activation in a toxic model combining hyperglycemia+Aβ 1-42 peptide in rat hippocampal neurons",https://pubmed.ncbi.nlm.nih.gov/32781098/,Positive,,Laboratory Study,2020,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); CP-x Synthetic Cannabinoids; Other Related Compounds; WIN-x Synthetic Cannabinoids,Nervous System,Alzheimer's Disease
20211343,Adolescent binge-ethanol accelerates cognitive impairment and β-amyloid production and dysregulates endocannabinoid signaling in the hippocampus of APP/PSE mice,https://pubmed.ncbi.nlm.nih.gov/32043730/,Inconclusive,,Animal Study,2021,Monoacylglycerol Lipase (MAGL); Other Related Compounds,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction; Alzheimer's Disease
2013089,The pseudokinase tribbles homologue-3 plays a crucial role in cannabinoid anticancer action,https://pubmed.ncbi.nlm.nih.gov/23567453/,Positive,,Animal Study,2013,Tetrahydrocannabinol (THC),Nervous System,Cancer
2019169,Should Oncologists Recommend Cannabis?,https://pubmed.ncbi.nlm.nih.gov/31161270/,Positive,,Meta-analysis,2019,,Nervous System,Cancer
2020428,"The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease",https://pubmed.ncbi.nlm.nih.gov/32937917/,Positive,,Meta-analysis,2020,,,Cardiovascular Diseases (CVD); Heart Attack; Myocarditis; Reperfusion Injury
2006027,The Prevalence of Marijuana Smoking in Young Adults with Sickle Cell Disease A Longitudinal Study,https://westindies.scielo.org/pdf/wimj/v55n4/a04v55n4.pdf,Inconclusive,,Meta-analysis,2006,,Cardiovascular System,Sickle Cell Disorders
2007047,"Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL-2H3 mast cells",https://pubmed.ncbi.nlm.nih.gov/17339608/,Positive,,Laboratory Study,2007,,Immune System,Mast Cell Activation Syndrome
2005034,Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin,https://pubmed.ncbi.nlm.nih.gov/15927811/,Positive,,Laboratory Study,2005,,Nervous System,Inflammation; Mast Cell Activation Syndrome
2017122,Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome,https://pubmed.ncbi.nlm.nih.gov/28164346/,Positive,,Double Blind Clinical Trial,2017,Other Related Compounds,Digestive System,Irritable Bowel Syndrome; Mast Cell Activation Syndrome
2008059,Cannabinomimetic control of mast cell mediator release: new perspective in chronic inflammation,https://pubmed.ncbi.nlm.nih.gov/18426495/,Positive,,Meta-analysis,2008,,Immune System,Mast Cell Activation Syndrome
2020429,Cannabis Use for Restless Legs Syndrome and Uremic Pruritus in in patients treated with maintenance dialysis: A Survey,https://pubmed.ncbi.nlm.nih.gov/32963792/,Positive,,Meta-analysis,2020,,Nervous System,Restless Leg Syndrome
2019170,More evidence of cannabis efficacy in restless legs syndrome,https://pubmed.ncbi.nlm.nih.gov/31820197/,Positive,,Meta-analysis,2019,,Nervous System,Restless Leg Syndrome
2017123,Cannabis for restless legs syndrome: a report of six patients,https://pubmed.ncbi.nlm.nih.gov/28655453/,Positive,,Meta-analysis,2017,,Nervous System,Restless Leg Syndrome
2015110,A safer alternative: Cannabis substitution as harm reduction,https://pubmed.ncbi.nlm.nih.gov/25919477/,Positive,,Meta-analysis,2015,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction; Addiction - Cocaine; Addiction - Opioid
2020430,"Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors",https://pubmed.ncbi.nlm.nih.gov/32151683/,Positive,,Animal Study,2020,,Mental/Emotional System; Nervous System,Schizophrenia
2020431,Cannabidiol as a treatment option for schizophrenia: recent evidence and current studies,https://pubmed.ncbi.nlm.nih.gov/32073423/,Positive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Schizophrenia
2020432,Persistent cannabis use as an independent risk factor for violent behaviors in patients with schizophrenia,https://pubmed.ncbi.nlm.nih.gov/32393793/,Inconclusive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Schizophrenia
2020433,Cannabis Use in Inpatients With Schizophrenia Spectrum Disorders at a Community Hospital,https://pubmed.ncbi.nlm.nih.gov/32362972/,Inconclusive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Schizophrenia
2020434,Cannabis-induced psychosis: clinical characteristics and its differentiation from schizophrenia with and without cannabis use,https://pubmed.ncbi.nlm.nih.gov/32677690/,Negative,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Psychosis
2020435,"Cannabis, schizophrenia and cognition: the contribution of brain connectivity",https://pubmed.ncbi.nlm.nih.gov/32100035/,Positive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Schizophrenia
20211344,Fighting the storm: could novel anti-TNFα and anti-IL-6 C. sativa cultivars tame cytokine storm in COVID-19?,https://www.aging-us.com/article/202500/text,Inconclusive,,Laboratory Study,2021,Tetrahydrocannabinolic Acid (THC-a); Cannabigerol (CBG); Cannabigerolic Acid (CBG-a); Cannabinol (CBN),Respiratory System,COVID-19
2020436,Cannabidiol (CBD) but not tetrahydrocannabinol (THC) dysregulate in vitro decidualization of human endometrial stromal cells by disruption of estrogen signaling,https://pubmed.ncbi.nlm.nih.gov/31953017/,Negative,,Laboratory Study,2020,,Reproductive System,Pregnancy
2020437,Use of cannabidiol (CBD) for the treatment of chronic pain,https://pubmed.ncbi.nlm.nih.gov/33004159/,Positive,,Meta-analysis,2020,Pharma THC:CBD,Nervous System,Pain; Pain - Chronic
2020438,Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro,https://pubmed.ncbi.nlm.nih.gov/32049991/,Positive,,Laboratory Study,2020,,Nervous System; Respiratory System,Cancer - Lung; Cancer
2020439,The pharmacological case for cannabigerol (CBG),https://pubmed.ncbi.nlm.nih.gov/33168643/,Positive,,Meta-analysis,2020,Cannabigerol (CBG),,IBD - Inflammatory Bowel Disease; Huntington's Disease; Multiple Sclerosis; Parkinson's Disease
2015111,Neural effects of cannabinoid CB1 neutral antagonist tetrahydrocannabivarin on food reward and aversion in healthy volunteers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438540/,Positive,,Double Blind Clinical Trial,2015,Tetrahydrocannabivarin (THCV),Mental/Emotional System,Loss of Appetite; Obesity
2020440,Cannabis and Cognition: Connecting the Dots towards the Understanding of the Relationship,https://pubmed.ncbi.nlm.nih.gov/32120842/,Negative,,Meta-analysis,2020,Synthetic Cannabinoid (unspecified),Nervous System,Cognitive Dysfunction
2020441,Downregulation of the CB1-Mediated Endocannabinoid Signaling Underlies D-Galactose-Induced Memory Impairment,https://pubmed.ncbi.nlm.nih.gov/32848596/,Inconclusive,,Animal Study,2020,,Nervous System,Cognitive Dysfunction
2020442,Mobile Assessment of Acute Effects of Marijuana on Cognitive Functioning in Young Adults: Observational Study,https://pubmed.ncbi.nlm.nih.gov/32154789/,Negative,,Meta-analysis,2020,,Nervous System,Cognitive Dysfunction
2020443,Cognitive Function Impairments Linked to Alcohol and Cannabis Use During Adolescence: A Study of Gender Differences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154290/,Negative,,Meta-analysis,2020,,Nervous System,Cognitive Dysfunction
2020444,A review investigating the relationship between cannabis use and adolescent cognitive functioning,https://pubmed.ncbi.nlm.nih.gov/32818908/,Negative,,Meta-analysis,2020,,Nervous System,Cognitive Dysfunction
2020445,Acute and residual mood and cognitive performance of young adults following smoked cannabis,https://pubmed.ncbi.nlm.nih.gov/32360692/,Inconclusive,,Double Blind Clinical Trial,2020,,Nervous System,Cognitive Dysfunction
2020446,Illicit Cannabis Usage as a Management Strategy in New Zealand Women with Endometriosis: An Online Survey,https://pubmed.ncbi.nlm.nih.gov/33275491/,Positive,,Meta-analysis,2020,,Endocrine System,Endometriosis
2020447,"Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial",https://www.annalsofoncology.org/article/S0923-7534(20)39996-8/fulltext#secsectitle0080,Positive,,Double Blind Clinical Trial,2020,Pharma THC:CBD,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting; Cancer
2020448,Pediatric Cannabinoid Hyperemesis: A Single Institution 10-Year Case Series,https://pubmed.ncbi.nlm.nih.gov/33127240/,Negative,,Meta-analysis,2020,,Nervous System,Cannabis Hyperemesis Syndrome
2020449,A patient with acute abdominal pain and vomiting due to the cannabinoid hyperemesis syndrome,https://pubmed.ncbi.nlm.nih.gov/31994714/,Negative,,Meta-analysis,2020,,Nervous System,Cannabis Hyperemesis Syndrome
2020450,Diagnosis and Acute Management of Adolescent Cannabinoid Hyperemesis Syndrome: A Systematic Review,https://pubmed.ncbi.nlm.nih.gov/33036874/,Negative,,Meta-analysis,2020,,Nervous System,Cannabis Hyperemesis Syndrome
2020451,Topical Capsaicin for Treating Cannabinoid Hyperemesis Syndrome,https://pubmed.ncbi.nlm.nih.gov/33294233/,Positive,,Meta-analysis,2020,Capsaicin (CAPS),Nervous System,Cannabis Hyperemesis Syndrome
2020452,Management of Cannabinoid Hyperemesis Syndrome: Focus on Capsaicin,https://pubmed.ncbi.nlm.nih.gov/32613883/,Positive,,Meta-analysis,2020,Capsaicin (CAPS),Nervous System,Cannabis Hyperemesis Syndrome
2020453,Cannabinoid hyperemesis syndrome in two French emergency departments: a prospective cohort,https://pubmed.ncbi.nlm.nih.gov/32564375/,Negative,,Meta-analysis,2020,,Nervous System,Cannabis Hyperemesis Syndrome
2020454,"Cannabinoid hyperemesis syndrome: definition, pathophysiology, clinical spectrum, insights into acute and long-term management",https://pubmed.ncbi.nlm.nih.gov/33115959/,Negative,,Meta-analysis,2020,,Nervous System,Cannabis Hyperemesis Syndrome
2020455,Cannabinoid hyperemesis syndrome in the pregnant patient: clinical case and literature review,https://pubmed.ncbi.nlm.nih.gov/33115404/,Negative,,Meta-analysis,2020,,Nervous System,Cannabis Hyperemesis Syndrome
2020456,Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms,https://pubmed.ncbi.nlm.nih.gov/32656345/,Negative,,Meta-analysis,2020,,Nervous System,Cannabis Hyperemesis Syndrome
2020457,Efficacy and safety of topical capsaicin for cannabinoid hyperemesis syndrome in the emergency department,https://pubmed.ncbi.nlm.nih.gov/31482758/,Positive,,Meta-analysis,2020,,Nervous System,Cannabis Hyperemesis Syndrome
2020458,Patterns of Cannabis Use in Patients With Cyclic Vomiting Syndrome,https://pubmed.ncbi.nlm.nih.gov/31352091/,Inconclusive,,Meta-analysis,2020,,Nervous System,Cannabis Hyperemesis Syndrome
2020459,Endocannabinoid system and cannabis hyperemesis syndrome: a narrative update,https://pubmed.ncbi.nlm.nih.gov/33208685/,Negative,,Meta-analysis,2020,,Nervous System,Cannabis Hyperemesis Syndrome
2020460,Cannabis Hyperemesis Syndrome: A Still Under-Recognized Syndrome,https://pubmed.ncbi.nlm.nih.gov/32399447/,Negative,,Meta-analysis,2020,,Nervous System,Cannabis Hyperemesis Syndrome
2020461,Cannabis hyperemesis syndrome: an update on the pathophysiology and management,https://pubmed.ncbi.nlm.nih.gov/33162734/,Negative,,Meta-analysis,2020,,Nervous System,Cannabis Hyperemesis Syndrome
2020462,Natural cannabinoids suppress the cytokine storm in sepsis-like in vitro model,https://pubmed.ncbi.nlm.nih.gov/32933892/,Positive,,Laboratory Study,2020,Pharma THC:CBD,Immune System,Sepsis
2020463,"Cannabis Sativa Revisited-Crosstalk between microRNA Expression, Inflammation, Oxidative Stress, and Endocannabinoid Response System in Critically Ill Patients with Sepsis",https://pubmed.ncbi.nlm.nih.gov/32012914/,Positive,,Meta-analysis,2020,,Immune System,Sepsis
2020464,"The ameliorating effect of cannabinoid type 2 receptor activation on brain, lung, liver and heart damage in cecal ligation and puncture-induced sepsis model in rats",https://pubmed.ncbi.nlm.nih.gov/31767546/,Positive,,Animal Study,2020,JWH-x Synthetic Cannabinoids,Immune System,Sepsis
2020465,A Cannabinoid Receptor-Mediated Mechanism Participates in the Neuroprotective Effects of Oleamide Against Excitotoxic Damage in Rat Brain Synaptosomes and Cortical Slices,https://pubmed.ncbi.nlm.nih.gov/31286434/,Positive,,Laboratory Study,2020,Other Related Compounds,Nervous System,Excitotoxicity
2020466,Use of complementary therapies for chronic pain management in patients with reported Ehlers-Danlos syndrome or hypermobility spectrum disorders,https://pubmed.ncbi.nlm.nih.gov/32909698/,Positive,,Meta-analysis,2020,,Muscular System,Ehlers-Danlos Syndrome
2008060,Antimutagenic and mutagenic activities of some terpenes in the bacterial reverse mutation assay,https://pubmed.ncbi.nlm.nih.gov/18514567/,Positive,,Laboratory Study,2008,,,Geriatric Conditions
2020467,The Effects of Cannabis Use on Cognitive Function in Healthy Aging: A Systematic Scoping Review,https://pubmed.ncbi.nlm.nih.gov/33159510/,Positive,,Meta-analysis,2020,,Muscular System; Nervous System; Skeletal System,Geriatric Conditions
2020468,Interaction of Cannabis Use and Aging: From Molecule to Mind,https://pubmed.ncbi.nlm.nih.gov/31570066/,Inconclusive,,Meta-analysis,2020,,Muscular System; Nervous System; Skeletal System,Geriatric Conditions
2020469,"Developmental exposure to Δ 9-tetrahydrocannabinol (THC) causes biphasic effects on longevity, inflammation, and reproduction in aged zebrafish (Danio rerio)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286997/,Inconclusive,,Animal Study,2020,,Muscular System; Nervous System; Skeletal System,Geriatric Conditions; Sarcopenia
2020470,Developmental exposure to cannabidiol (CBD) alters longevity and health span of zebrafish (Danio rerio),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205952/,Inconclusive,,Animal Study,2020,,Muscular System; Nervous System; Skeletal System,Geriatric Conditions; Sarcopenia
2020471,A New Palmitoylethanolamide Form Combined with Antioxidant Molecules to Improve Its Effectivess on Neuronal Aging,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408069/,Positive,,Laboratory Study,2020,Other Related Compounds,Muscular System; Nervous System; Skeletal System,Geriatric Conditions; Sarcopenia
2020472,Age-dependent Alteration in Mitochondrial Dynamics and Autophagy in Hippocampal Neuron of Cannabinoid CB1 Receptor-deficient Mice,https://pubmed.ncbi.nlm.nih.gov/32294520/,Positive,,Animal Study,2020,,Muscular System; Nervous System; Skeletal System,Geriatric Conditions; Sarcopenia
2020473,Melatonin and cannabinoids: mitochondrial-targeted molecules that may reduce inflammaging in neurodegenerative diseases,https://pubmed.ncbi.nlm.nih.gov/32154907/,Positive,,Meta-analysis,2020,,Muscular System; Nervous System; Skeletal System,Geriatric Conditions; Inflammation; Neurodegenerative Issues; Alzheimer's Disease; Oxidative Stress; Parkinson's Disease
2018164,Cannabinoid receptor types 1 and 2 and peroxisome proliferator-activated receptor-α: distribution in the skin of clinically healthy cats and cats with hypersensitivity dermatitis,https://pubmed.ncbi.nlm.nih.gov/29920828/,Positive,,Meta-analysis -,2018,,,Veterinary Applications
2018165,"Localization of cannabinoid receptors CB1, CB2, GPR55, and PPARα in the canine gastrointestinal tract",https://pubmed.ncbi.nlm.nih.gov/29882158/,Positive,,Meta-analysis -,2018,,,Veterinary Applications
2019171,Cellular Distribution of Canonical and Putative Cannabinoid Receptors in Canine Cervical Dorsal Root Ganglia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761858/,Inconclusive,,Meta-analysis -,2019,,,Veterinary Applications
2019172,Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with intractable idiopathic epilepsy,https://pubmed.ncbi.nlm.nih.gov/31067185/,Positive,,Meta-analysis -,2019,,,Veterinary Applications
2019173,"Pharmacokinetics of Bedrocan®, a cannabis oil extract, in fasting and fed dogs: An explorative study",https://pubmed.ncbi.nlm.nih.gov/30580232/,Inconclusive,,Animal Study -,2019,,,Veterinary Applications
2020474,"Cannabinoid, Terpene, and Heavy Metal Analysis of 29 Over-the-Counter Commercial Veterinary Hemp Supplements",https://pubmed.ncbi.nlm.nih.gov/32346530/,Inconclusive,,Meta-analysis -,2020,,,Veterinary Applications
2020475,Cannabis use during pregnancy and postpartum,https://pubmed.ncbi.nlm.nih.gov/32060189/,Negative,,Meta-analysis,2020,,Reproductive System,Pregnancy
2013090,Elevated anandamide and related N-acylethanolamine levels occur in the peripheral blood of women with ectopic pregnancy and are mirrored by changes in peripheral fatty acid amide hydrolase activity,https://pubmed.ncbi.nlm.nih.gov/23372171/,Inconclusive,,Meta-analysis,2013,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Other Related Compounds; Virodhamine (O-AEA),Reproductive System,Pregnancy
2020476,"Serum cannabidiol, tetrahydrocannabinol (THC), and their native acid derivatives after transdermal application of a low-THC Cannabis sativa extract in beagles",https://pubmed.ncbi.nlm.nih.gov/32735381/,Positive,,Animal Study -,2020,Cannabidiolic Acid (CBD-a); Tetrahydrocannabinolic Acid (THC-a),,Veterinary Applications
2019174,Nabiximols for the Treatment of Cannabis Dependence: A Randomized Clinical Trial,https://pubmed.ncbi.nlm.nih.gov/31305874/,Positive,,Double Blind Clinical Trial,2019,Pharma THC:CBD,Mental/Emotional System,Addiction - Cannabis; Addiction
2020477,Cannabis use during pregnancy in the United States: The role of depression,https://pubmed.ncbi.nlm.nih.gov/32143978/,Inconclusive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Depression; Pregnancy
2020478,Considerations and Implications of Cannabidiol Use During Pregnancy,https://pubmed.ncbi.nlm.nih.gov/32524214/,Inconclusive,,Meta-analysis,2020,,Reproductive System,Pregnancy
2020479,Cannabis use disorder among veterans: Comorbidity and mental health treatment utilization,https://pubmed.ncbi.nlm.nih.gov/31856950/,Negative,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2020480,Deconstructing the neurobiology of cannabis use disorder,https://pubmed.ncbi.nlm.nih.gov/32251385/,Negative,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2020481,"Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial",https://pubmed.ncbi.nlm.nih.gov/32735782/,Positive,,Double Blind Clinical Trial,2020,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2019175,Effects of cannabidiol on alcohol-related outcomes: A review of preclinical and human research,https://pubmed.ncbi.nlm.nih.gov/31120285/,Positive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction
2019176,Cannabidiol as a Novel Candidate Alcohol Use Disorder Pharmacotherapy: A Systematic Review,https://pubmed.ncbi.nlm.nih.gov/30698831/,Positive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction
2020482,Serum endocannabinoid levels in suicide attempters: A pilot study,https://pubmed.ncbi.nlm.nih.gov/32994115/,Inconclusive,,Meta-analysis,2020,Anandamide (AEA); Other Related Compounds,Mental/Emotional System,Suicide Attempt
20211345,"Burden of cannabis use and disorder in the U.S. veteran population: Psychiatric comorbidity, suicidality, and service utilization",https://pubmed.ncbi.nlm.nih.gov/33017681/,Negative,,Meta-analysis,2021,,Mental/Emotional System,Suicide Attempt
2020483,"Cannabis Use as a Risk Factor for Depression, Anxiety, and Suicidality: Epidemiological Associations and Implications for Nurses",https://pubmed.ncbi.nlm.nih.gov/32487935/,Negative,,Meta-analysis,2020,,Mental/Emotional System,Suicide Attempt
2020484,"Association between the use of Cannabis and elevated suicide risk in high school adolescents from Santa Marta, Colombia",https://pubmed.ncbi.nlm.nih.gov/33030835/,Negative,,Meta-analysis,2020,,Mental/Emotional System,Suicide Attempt
2004029,"Major depressive disorder, suicidal ideation, and suicide attempt in twins discordant for cannabis dependence and early-onset cannabis use",https://pubmed.ncbi.nlm.nih.gov/15466676/,Negative,,Meta-analysis,2004,,Mental/Emotional System,Suicide Attempt
20211346,Cannabinoid use and self-injurious behaviours: A systematic review and meta-analysis,https://pubmed.ncbi.nlm.nih.gov/32956965/,Negative,,Meta-analysis,2021,,Mental/Emotional System,Suicide Attempt
2020485,Suicidality and Cannabidiol: Opportunities and Challenges,https://pubmed.ncbi.nlm.nih.gov/33059579/,Positive,,Meta-analysis,2020,,Mental/Emotional System,Suicide Attempt
1970002,Cannabis substitution. An adjunctive therapeutic tool in the treatment of alcoholism,https://pubmed.ncbi.nlm.nih.gov/5422576/,Positive,,Meta-analysis,1970,,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction
2020486,Cannabinoids as an Emerging Therapy for Posttraumatic Stress Disorder and Substance Use Disorders,https://pubmed.ncbi.nlm.nih.gov/31895187/,Positive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,PTSD
2020487,Cannabis use and posttraumatic stress disorder: prospective evidence from a longitudinal study of veterans,https://pubmed.ncbi.nlm.nih.gov/32546286/,Negative,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,PTSD
2020488,Short and Long-Term Effects of Cannabis on Symptoms of Post-Traumatic Stress Disorder,https://pubmed.ncbi.nlm.nih.gov/32469819/,Positive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,PTSD
2020489,"Sex differences in bipolar disorder: Impact of lifetime cannabis use on clinical course, functioning, and quality of life in bipolar disorder",https://pubmed.ncbi.nlm.nih.gov/32056886/,Negative,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Bipolar Disorder
2020490,Neurostructural Correlates of Cannabis Use in Adolescent Bipolar Disorder,https://pubmed.ncbi.nlm.nih.gov/33103721/,Inconclusive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Bipolar Disorder
2020491,The Effectiveness of Cannabis Flower for Immediate Relief from Symptoms of Depression,https://pubmed.ncbi.nlm.nih.gov/32607086/,Positive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Depression
2020492,Effects of Chronic Cannabidiol Treatment in the Rat Chronic Unpredictable Mild Stress Model of Depression,https://pubmed.ncbi.nlm.nih.gov/32455953/,Positive,,Animal Study,2020,,Mental/Emotional System; Nervous System,Depression
2020493,"Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders",https://pubmed.ncbi.nlm.nih.gov/33228239/,Positive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Anxiety; Depression; Psychosis
2020494,"Temporal Changes in the Cross-Sectional Associations between Cannabis Use, Suicidal Ideation, and Depression in a Nationally Representative Sample of Canadian Adults in 2012 Compared to 2002",https://pubmed.ncbi.nlm.nih.gov/31177831/,Negative,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Depression; Suicide Attempt
2020495,"Cannabis use, depression and suicidal ideation in adolescence: direction of associations in a population based cohort",https://pubmed.ncbi.nlm.nih.gov/32663935/,Inconclusive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Depression; Suicide Attempt
2020496,Moderating role of cannabis use between insight and depression in early psychosis,https://pubmed.ncbi.nlm.nih.gov/31780343/,Inconclusive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Depression; Psychosis; Schizophrenia
2020497,"Cannabis use, depression and self-harm: phenotypic and genetic relationships",https://pubmed.ncbi.nlm.nih.gov/31833150/,Inconclusive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Depression; Suicide Attempt
2019177,Cannabidiol as a suggested candidate for treatment of autism spectrum disorder,https://pubmed.ncbi.nlm.nih.gov/30171992/,Positive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Autism
2008061,Cannabis improves symptoms of ADHD,http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.542.4810&rep=rep1&type=pdf,Positive,,Meta-analysis,2008,Pharma THC,Mental/Emotional System,ADD and ADHD
2020498,Treatment of social anxiety disorder and attenuated psychotic symptoms with cannabidiol,https://pubmed.ncbi.nlm.nih.gov/33028567/,Positive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Anxiety
2020499,Use of Cannabidiol for the Treatment of Anxiety: A Short Synthesis of Pre-Clinical and Clinical Evidence,https://pubmed.ncbi.nlm.nih.gov/32923656/,Positive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Anxiety
2020500,Cannabis Use and Prospective Long-Term Association with Anxiety: A Systematic Review and Meta-Analysis of Longitudinal Studies: Usage du cannabis et association prospective à long terme avec l'anxiété: une revue systématique et une méta-analyse d'études longitudinales,https://pubmed.ncbi.nlm.nih.gov/32909828/,Inconclusive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Anxiety
2020501,"Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties",https://pubmed.ncbi.nlm.nih.gov/33008420/,Inconclusive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Anxiety
2020502,Does cannabis use increase anxiety disorders? A literature review,https://pubmed.ncbi.nlm.nih.gov/31592815/,Inconclusive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Anxiety
2020503,Cannabis use among US adults with anxiety from 2008 to 2017: The role of state-level cannabis legalization,https://pubmed.ncbi.nlm.nih.gov/32707516/,Inconclusive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Anxiety
2020504,Cannabis-Related Impairment and Social Anxiety: The Role of Use to Manage Negative and Positive Affect in Social Situations,https://pubmed.ncbi.nlm.nih.gov/31535902/,Negative,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Anxiety
2020505,The role of cannabis in treating anxiety: an update,https://pubmed.ncbi.nlm.nih.gov/31688192/,Inconclusive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Anxiety
2020506,Healing activity of hydrogel containing nanoemulsified β-caryophyllene,https://pubmed.ncbi.nlm.nih.gov/32205230/,Positive,,Animal Study,2020,,Immune System; Integumentary System; Nervous System,Wound Healing
1997009,Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock,https://pubmed.ncbi.nlm.nih.gov/9394002/,Positive,,Animal Study,1997,SR-x Synthetic Cannabinoids,Cardiovascular System,Hemorrhagic Shock
2020507,Cannabidiol alleviates hemorrhagic shock-induced neural apoptosis in rats by inducing autophagy through activation of the PI3K/AKT pathway,https://pubmed.ncbi.nlm.nih.gov/32215966/,Positive,,Animal Study,2020,,Cardiovascular System,Hemorrhagic Shock; Cardiovascular Diseases (CVD); Reperfusion Injury; Stroke
2002024,Cannabinoid CB(1) receptor blockade enhances the protective effect of melanocortins in hemorrhagic shock in the rat,https://pubmed.ncbi.nlm.nih.gov/12007925/,Positive,,Animal Study,2002,SR-x Synthetic Cannabinoids,Cardiovascular System,Hemorrhagic Shock
2009053,CB1 cannabinoid receptor participates in the vascular hyporeactivity resulting from hemorrhagic shock in rats,https://pubmed.ncbi.nlm.nih.gov/19493421/,Positive,,Animal Study,2009,AM-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Cardiovascular System,Hemorrhagic Shock
2019178,Bone Anabolic Response in the Calvaria Following Mild Traumatic Brain Injury is Mediated by the Cannabinoid-1 Receptor,https://pubmed.ncbi.nlm.nih.gov/31700010/,Positive,,Animal Study,2019,Anandamide (AEA),Nervous System,Traumatic Brain Injury
2020508,The Therapeutic Potential and Usage Patterns of Cannabinoids in People with Spinal Cord Injuries: A Systematic Review,https://pubmed.ncbi.nlm.nih.gov/32310048/,Positive,,Meta-analysis,2020,,Skeletal System,Spinal Cord Injuries
2020509,Cutaneous endocannabinoid system: Does it have a role on skin wound healing bearing fibrosis?,https://pubmed.ncbi.nlm.nih.gov/32454223/,Positive,,Meta-analysis,2020,Endocannabinoid (unspecified),Integumentary System,Fibrosis - Skin; Fibrosis; Wound Healing
2020510,Effects of topical treatment of cannabidiol extract in a unique manuka factor 5 manuka honey carrier on second intention wound healing on equine distal limb wounds: a preliminary study,https://pubmed.ncbi.nlm.nih.gov/32096215/,Inconclusive,,Animal Study,2020,,,Veterinary Applications; Wound Healing
2019179,The therapeutic potential of cannabinoids for integumentary wound management,https://pubmed.ncbi.nlm.nih.gov/33205468/,Positive,,Meta-analysis,2019,Endocannabinoid (unspecified),Immune System; Integumentary System; Nervous System,Wound Healing
2019180,Beta-caryophyllene enhances wound healing through multiple routes,https://pubmed.ncbi.nlm.nih.gov/31841509/,Positive,,Animal Study,2019,,Immune System; Integumentary System; Nervous System,Wound Healing
2020511,A new role for anandamide: defective link between the systemic and skin endocannabinoid systems in hypertrophic human wound healing,https://pubmed.ncbi.nlm.nih.gov/32636441/,Positive,,Meta-analysis,2020,Anandamide (AEA); 2-Arachidonoyl Glycerol (2-AG); Endocannabinoid (unspecified),Immune System; Integumentary System; Nervous System,Fibrosis - Skin; Fibrosis; Wound Healing
2019181,Cannabidiol-loaded microspheres incorporated into osteoconductive scaffold enhance mesenchymal stem cell recruitment and regeneration of critical-sized bone defects,https://pubmed.ncbi.nlm.nih.gov/31029357/,Positive,,Animal Study,2019,,Skeletal System,Bone Fractures; Osteoporosis
2019182,Marijuana use and mortality following orthopedic surgical procedures,https://pubmed.ncbi.nlm.nih.gov/29558287/,Positive,,Meta-analysis,2019,,Skeletal System,Bone Fractures
2020512,The Cannabinoids Effect on Bone Formation and Bone Healing,https://pubmed.ncbi.nlm.nih.gov/32705630/,Positive,,Meta-analysis,2020,Endocannabinoid (unspecified),Skeletal System,Bone Fractures
2020513,Cannabis use is associated with greater total sleep time in middle-aged and older adults with and without HIV: A preliminary report utilizing digital health technologies,https://pubmed.ncbi.nlm.nih.gov/32905460/,Positive,,Meta-analysis,2020,,Immune System; Nervous System,HIV/AIDS; Insomnia and Sleep Disorders
2020514,Daily and near-daily cannabis use is associated with HIV viral load suppression in people living with HIV who use cocaine,https://pubmed.ncbi.nlm.nih.gov/32748649/,Positive,,Meta-analysis,2020,,Immune System,HIV/AIDS
2020515,Impact of Cannabis Use on Brain Structure and Function in Suppressed HIV Infection,https://pubmed.ncbi.nlm.nih.gov/32968547/,Inconclusive,,Meta-analysis,2020,,Immune System,HIV/AIDS
2020516,"Self-reported Cannabis Use and Changes in Body Mass Index, CD4 T-cell Counts, and HIV-1 RNA Suppression in Treated Persons with HIV",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698426/,Inconclusive,,Meta-analysis,2020,,Immune System,HIV/AIDS
2020517,Rimonabant suppresses RNA transcription of hepatitis B virus by inhibiting hepatocyte nuclear factor 4α,https://pubmed.ncbi.nlm.nih.gov/31981244/,Positive,,Laboratory Study,2020,SR-x Synthetic Cannabinoids,Digestive System,Hepatitis
2020518,Cannabidiol (CBD) Consumption and Perceived Impact on Extrahepatic Symptoms in Patients with Autoimmune Hepatitis,https://pubmed.ncbi.nlm.nih.gov/31363952/,Positive,,Meta-analysis,2020,,Digestive System,Hepatitis
2020519,Cannabis Use May Reduce Healthcare Utilization and Improve Hospital Outcomes in Patients with Cirrhosis,https://pubmed.ncbi.nlm.nih.gov/33157269/,Inconclusive,,Meta-analysis,2020,,Digestive System,Fibrosis - Liver (Cirrhosis); Fibrosis
2020520,Cannabinoids in the Treatment of Insomnia Disorder: A Systematic Review and Meta-Analysis,https://pubmed.ncbi.nlm.nih.gov/33244728/,Positive,,Clinical Meta-analysis,2020,,Nervous System,Insomnia and Sleep Disorders
2020521,Recreational Cannabis Use Before and After Legalization in Women With Pelvic Pain,https://pubmed.ncbi.nlm.nih.gov/33278297/,Positive,,Meta-analysis,2020,,Nervous System,Pain; Pain - Chronic
2020522,Use of Cannabis for Self-Management of Chronic Pelvic Pain,https://pubmed.ncbi.nlm.nih.gov/33252316/,Positive,,Meta-analysis,2020,,Nervous System,Pain; Pain - Chronic
2008062,Targeting the endocannabinoid system: to enhance or reduce?,https://www.nature.com/articles/nrd2553,Positive,,Meta-analysis,2008,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),,Addiction - Alcohol; Addiction - Nicotine; Alzheimer's Disease; Anxiety; Cancer - Thyroid; Cancer; Cardiovascular Diseases (CVD); Depression; Diabetes; Epilepsy; IBD - Crohn's Disease; Hepatitis; Hypertension (High Blood Pressure); Inflammation; Irritable Bowel Syndrome; Metabolic Syndrome; Pain; Multiple Sclerosis; Nausea and Vomiting; Neurodegenerative Issues
2020523,Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing Studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563787/,Positive,,Meta-analysis,2020,Pharma CBD; Pharma THC:CBD; Pharma THC,Mental/Emotional System; Nervous System,Autism
2018166,Role of Cannabinoids in Obesity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163475/,Positive,,Meta-analysis,2018,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); JWH-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Endocrine System,Obesity
2018167,Orosensory Detection of Dietary Fatty Acids Is Altered in CB1R−/− Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213063/,Positive,,Laboratory Study,2018,Anandamide (AEA); SR-x Synthetic Cannabinoids,,Cachexia; Obesity
2018168,Time-dependent effect of phytocannabinoid treatments in fat cells,https://pubmed.ncbi.nlm.nih.gov/29464872/,Positive,,Laboratory Study,2018,Tetrahydrocannabinol (THC),,Diabetes; Obesity
2020524,Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677512/,Inconclusive,,Meta-analysis,2020,,Respiratory System,COVID-19
2020525,"CB2 receptor-selective agonists as candidates for targeting infection, inflammation, and immunity in SARS-CoV-2 infections",https://pubmed.ncbi.nlm.nih.gov/33190277/,Positive,,Meta-analysis,2020,,Respiratory System,COVID-19
2020526,"Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503745/,Positive,,Animal Study,2020,,Respiratory System,COVID-19
2020527,Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239000/,Inconclusive,,Meta-analysis,2020,,Respiratory System,COVID-19
2020528,Opioids/cannabinoids as a potential therapeutic approach in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441794/,Inconclusive,,Meta-analysis,2020,,Respiratory System,COVID-19
2020529,Cannabidiol Modulates Cytokine Storm in Acute Respiratory Distress Syndrome Induced by Simulated Viral Infection Using Synthetic RNA,https://www.liebertpub.com/doi/10.1089/can.2020.0043,Positive,,Animal Study,2020,,Respiratory System,COVID-19
2020530,Cannabinoids and the Coronavirus,https://www.liebertpub.com/doi/10.1089/can.2020.0035,Inconclusive,,Meta-analysis,2020,,Respiratory System,COVID-19
2020531,Coronavirus Disease-2019 Treatment Strategies Targeting Interleukin-6 Signaling and Herbal Medicine,https://pubmed.ncbi.nlm.nih.gov/32857671/,Inconclusive,,Meta-analysis,2020,,Respiratory System,COVID-19
2020532,In search of preventive strategies: novel high-CBD Cannabis sativa extracts modulate ACE2 expression in COVID-19 gateway tissues,https://pubmed.ncbi.nlm.nih.gov/33221759/,Inconclusive,,Laboratory Study,2020,,Respiratory System,COVID-19
2020533,Genetic Liability to Cannabis Use Disorder and COVID-19 Hospitalization,https://www.medrxiv.org/content/10.1101/2020.11.15.20229971v1,Negative,,Meta-analysis,2020,,Respiratory System,COVID-19
2020534,Can Unconventional Immunomodulatory Agents Help Alleviate COVID-19 Symptoms and Severity?,https://msphere.asm.org/content/5/3/e00288-20,Inconclusive,,Meta-analysis,2020,,Respiratory System,COVID-19
2020535,Cannabis for COVID-19: can cannabinoids quell the cytokine storm?,https://www.future-science.com/doi/10.2144/fsoa-2020-0124,Positive,,Meta-analysis,2020,,Respiratory System,COVID-19
2020536,The potential of cannabidiol in the COVID-19 pandemic,https://pubmed.ncbi.nlm.nih.gov/32519753/,Positive,,Meta-analysis,2020,,Respiratory System,COVID-19
2020537,Therapeutic Cannabis and COVID-19: between opportunism and infoxication,https://adicciones.es/index.php/adicciones/article/view/1603/1157,Negative,,Meta-analysis,2020,,Respiratory System,COVID-19
2020538,Targeting Cannabinoid Receptor 2 on Peripheral Leukocytes to Attenuate Inflammatory Mechanisms Implicated in HIV-Associated Neurocognitive Disorder,https://pubmed.ncbi.nlm.nih.gov/32409991/,Positive,,Meta-analysis,2020,,Immune System,HIV/AIDS
2020539,"Larval susceptibility of Aloe barbadensis and Cannabis sativa against Culex quinquefasciatus, the filariasis vector",https://pubmed.ncbi.nlm.nih.gov/19297997/,Positive,,Laboratory Study,2020,,,Malaria; Parasitic Worms
2020540,"Mosquitocidal and Anti-Inflammatory Properties of The Essential Oils Obtained from Monoecious, Male, and Female Inflorescences of Hemp ( Cannabis sativa L.) and Their Encapsulation in Nanoemulsions",https://pubmed.ncbi.nlm.nih.gov/32751258/,Positive,,Animal Study,2020,,,Malaria
2020541,Cannabis treatment in hospitalized patients using the SYQE inhaler: Results of a pilot open-label study,https://pubmed.ncbi.nlm.nih.gov/31196236/,Positive,,Clinical Trial,2020,,,Pain; Pain - Chronic
2020542,Antioxidant and antimicrobial activity of two standardized extracts from a new Chinese accession of non-psychotropic Cannabis sativa L,https://pubmed.ncbi.nlm.nih.gov/33034400/,Positive,,Laboratory Study,2020,Tetrahydrocannabivarin (THCV),Immune System; Nervous System,Oxidative Stress; Staph Infection
2020543,"Isolation, Purification, and Antimicrobial Characterization of Cannabidiolic Acid and Cannabidiol from Cannabis sativa L",https://pubmed.ncbi.nlm.nih.gov/32545687/,Positive,,Laboratory Study,2020,Cannabidiolic Acid (CBD-a),Immune System,Staph Infection
2020544,Cannabinoids-Promising Antimicrobial Drugs orIntoxicants with Benefits?,https://pubmed.ncbi.nlm.nih.gov/32498408/,Positive,,Meta-analysis,2020,,Immune System,Staph Infection
2020545,Uncovering the Hidden Antibiotic Potential of Cannabis,https://pubmed.ncbi.nlm.nih.gov/32017534/,Positive,,Animal Study,2020,Cannabigerol (CBG),Immune System,Staph Infection
2020546,Cannabis Use Is Associated With Increased Risk for Diabetic Ketoacidosis in Adults With Type 1 Diabetes: Findings From the T1D Exchange Clinic Registry,https://pubmed.ncbi.nlm.nih.gov/31628116/,Negative,,Meta-analysis,2020,,Endocrine System,Diabetes
2020547,Cannabis use is associated with a lower risk of diabetes in chronic hepatitis C-infected patients (ANRS CO22 Hepather cohort),https://pubmed.ncbi.nlm.nih.gov/32810343/,Positive,,Meta-analysis,2020,,Digestive System; Endocrine System,Diabetes; Fibrosis - Liver (Cirrhosis); Fibrosis; Hepatitis
2020548,The effects of recreational cannabis use on glycemic outcomes and self-management behaviours in people with type 1 and type 2 diabetes: a rapid review,https://pubmed.ncbi.nlm.nih.gov/32807222/,Negative,,Meta-analysis,2020,,Endocrine System,Diabetes; Metabolic Syndrome
2020549,A Secondary Analysis from a Randomized Trial on the Effect of Plasma Tetrahydrocannabinol Levels on Pain Reduction in Painful Diabetic Peripheral Neuropathy,https://pubmed.ncbi.nlm.nih.gov/32565122/,Positive,,Clinical Meta-analysis,2020,Tetrahydrocannabinol (THC),Endocrine System; Nervous System,Diabetes; Pain; Pain - Neuropathy - Diabetic; Pain - Chronic
2020550,Cannabis consumption might exert deleterious effects on sperm nuclear quality in infertile men,https://pubmed.ncbi.nlm.nih.gov/32001159/,Negative,,Meta-analysis,2020,,Reproductive System,Infertility (Male)
2020551,The association between cannabis use and testicular function in men: a systematic review and meta-analysis,https://pubmed.ncbi.nlm.nih.gov/33251770/,Negative,,Meta-analysis,2020,,Reproductive System,Infertility (Male)
2020552,Delta-9 THC can be detected and quantified in the semen of men who are chronic users of inhaled cannabis,https://pubmed.ncbi.nlm.nih.gov/32356125/,Inconclusive,,Meta-analysis,2020,,Reproductive System,Infertility (Male)
2020553,Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol,https://pubmed.ncbi.nlm.nih.gov/32194509/,Positive,,Meta-analysis,2020,,Endocrine System,Obesity; Diabetes; Metabolic Syndrome
2020554,Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs,https://pubmed.ncbi.nlm.nih.gov/32512776/,Positive,,Meta-analysis,2020,,Endocrine System,Obesity
2020555,Chronic Cannabidiol Administration Attenuates Skeletal Muscle De Novo Ceramide Synthesis Pathway and Related Metabolic Effects in a Rat Model of High-Fat Diet-Induced Obesity,https://pubmed.ncbi.nlm.nih.gov/32859125/,Positive,,Animal Study,2020,,Endocrine System,Diabetes; Metabolic Syndrome; Obesity
2020556,Dietary Hemp Seeds More Effectively Attenuate Disorders in Genetically Obese Rats than Their Lipid Fraction,https://pubmed.ncbi.nlm.nih.gov/32275310/,Positive,,Animal Study,2020,,Endocrine System,Metabolic Syndrome; Obesity
2020557,Cannabis Extracts Affected Metabolic Syndrome Parameters in Mice Fed High-Fat/Cholesterol Diet,https://pubmed.ncbi.nlm.nih.gov/32923658/,Inconclusive,,Animal Study,2020,,Digestive System; Endocrine System,Fatty Liver Disease; Metabolic Syndrome; Microbiome Imbalance
2020558,"A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain",https://pubmed.ncbi.nlm.nih.gov/32345916/,Positive,,Animal Study,2020,,Nervous System; Skeletal System,Arthritis; Inflammation
2003021,Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial,https://pubmed.ncbi.nlm.nih.gov/12716250/,Positive,,Double Blind Clinical Trial,2003,,,Tics and Tourettes
2003022,Treatment of Tourette syndrome with delta-9-tetrahydrocannabinol (delta 9-THC): no influence on neuropsychological performance,https://pubmed.ncbi.nlm.nih.gov/12589392/,Positive,,Double Blind Clinical Trial,2003,Tetrahydrocannabinol (THC),,Tics and Tourettes
2020559,The neurocognitive effects of a past cannabis use disorder in a diverse sample of people living with HIV,https://pubmed.ncbi.nlm.nih.gov/32951441/,Positive,,Meta-analysis,2020,,Immune System,HIV/AIDS
2020560,"The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis",https://www.japha.org/article/S1544-3191(19)30353-X/fulltext,Positive,,Clinical Meta-analysis,2020,Pharma THC:CBD; Pharma THC,Nervous System,Pain; Pain - Cancer
2020561,"Cannabinoids CB2 Receptors, One New Promising Drug Target for Chronic and Degenerative Pain Conditions in Equine Veterinary Patients",https://pubmed.ncbi.nlm.nih.gov/31952645/,Positive,,Meta-analysis -,2020,Synthetic Cannabinoid (unspecified),,Veterinary Applications
2020562,Pharmacokinetics of Sativex® in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders,https://pubmed.ncbi.nlm.nih.gov/32054131/,Positive,,Animal Study -,2020,Pharma THC:CBD,,Veterinary Applications
2020563,Evaluation of the potential use of cannabidiol in the treatment of cocaine use disorder: A systematic review,https://pubmed.ncbi.nlm.nih.gov/32645315/,Positive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Addiction - Cocaine; Addiction
2020564,The other side of the leaf: Seizures associated with synthetic cannabinoid use,https://pubmed.ncbi.nlm.nih.gov/31958643/,Negative,,Meta-analysis,2020,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis
2020565,Synthetic cannabinoid receptor agonists-induced recurrent seizure in elderly patient,https://pubmed.ncbi.nlm.nih.gov/31839517/,Negative,,Meta-analysis,2020,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis
2020566,Antinociceptive and Immune Effects of Delta-9-Tetrahydrocannabinol or Cannabidiol in Male Versus Female Rats with Persistent Inflammatory Pain,https://pubmed.ncbi.nlm.nih.gov/32179573/,Positive,,Animal Study,2020,,Nervous System,Inflammation; Pain
2020567,Cannabinoids in the Pathophysiology of Skin Inflammation,https://pubmed.ncbi.nlm.nih.gov/32033005/,Positive,,Meta-analysis,2020,,Integumentary System; Nervous System,Inflammation; Skin Diseases; Cancer - Melanoma; Cancer - Skin (Non-melanoma); Cancer
2020568,Scoping Review and Meta-Analysis Suggests that Cannabis Use May Reduce Cancer Risk in the United States,https://www.liebertpub.com/doi/10.1089/can.2019.0095,Positive,,Meta-analysis,2020,,Nervous System,Cancer
2020569,Medical cannabis and cognitive performance in middle to old adults treated for chronic pain,https://pubmed.ncbi.nlm.nih.gov/32964502/,Positive,,Meta-analysis,2020,,Nervous System,Cognitive Dysfunction; Pain; Pain - Chronic
2020570,Cannabis and the Cornea,https://pubmed.ncbi.nlm.nih.gov/32159404/,Positive,,Meta-analysis,2020,,Nervous System,Pain; Pain - Eye; Cataract
2020571,Cannabinoids use in adolescents and young adults with cancer: a single-center survey,https://pubmed.ncbi.nlm.nih.gov/32178596/,Positive,,Meta-analysis,2020,,Nervous System,Cancer; Anxiety; Pain; Nausea and Vomiting; Pain - Cancer
2020572,Cannabidiol in cancer treatment,https://pubmed.ncbi.nlm.nih.gov/31897700/,Positive,,Meta-analysis,2020,,Nervous System,Cancer; Pain; Pain - Cancer
2020573,Potential therapeutic treatments of cancer-induced bone pain,https://pubmed.ncbi.nlm.nih.gov/32349095/,Positive,,Meta-analysis,2020,,Nervous System,Cancer; Pain; Pain - Cancer
2020574,Association of a Variant of CNR1 Gene Encoding Cannabinoid Receptor 1 With Gilles de la Tourette Syndrome,https://pubmed.ncbi.nlm.nih.gov/32194619/,Positive,,Meta-analysis,2020,Endocannabinoid (unspecified),,Tics and Tourettes
2020575,Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies,https://pubmed.ncbi.nlm.nih.gov/32603954/,Inconclusive,,Meta-analysis,2020,,Nervous System,Insomnia and Sleep Disorders
2020576,"Expression of GPR55 and either cannabinoid CB 1 or CB 2 heteroreceptor complexes in the caudate, putamen, and accumbens nuclei of control, parkinsonian, and dyskinetic non-human primates",https://pubmed.ncbi.nlm.nih.gov/32691218/,Positive,,Animal Study,2020,,Nervous System,Parkinson's Disease
2020577,"Arachidonyl-2'-chloroethylamide (ACEA), a synthetic agonist of cannabinoid receptor, increases CB 1 R gene expression and reduces dyskinesias in a rat model of Parkinson's disease",https://pubmed.ncbi.nlm.nih.gov/32413434/,Positive,,Animal Study,2020,Synthetic Cannabinoid (unspecified),Nervous System,Parkinson's Disease
2020578,Targeting the cannabinoid receptor CB2 in a mouse model of l-dopa induced dyskinesia,https://pubmed.ncbi.nlm.nih.gov/31669673/,Positive,,Animal Study,2020,HU-x Synthetic Cannabinoids,Nervous System,Parkinson's Disease
2020579,Beneficial effects of the phytocannabinoid Δ 9-THCV in L-DOPA-induced dyskinesia in Parkinson's disease,https://pubmed.ncbi.nlm.nih.gov/32387338/,Positive,,Animal Study,2020,Tetrahydrocannabivarin (THCV),Nervous System,Parkinson's Disease
2020580,Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson's Disease,https://pubmed.ncbi.nlm.nih.gov/31973235/,Positive,,Meta-analysis,2020,Endocannabinoid (unspecified),Nervous System,Parkinson's Disease
2009054,Cannabidiol for the treatment of psychosis in Parkinson's disease,https://pubmed.ncbi.nlm.nih.gov/18801821/,Positive,,Clinical Trial,2009,,Mental/Emotional System; Nervous System,Parkinson's Disease; Psychosis
2020581,Cannabidiol in Parkinson’s disease,https://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462020000200126&tlng=en,Inconclusive,,Meta-analysis,2020,,Nervous System,Parkinson's Disease
2020582,Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease,https://pubmed.ncbi.nlm.nih.gov/31706993/,Positive,,Animal Study,2020,Anandamide (AEA),Nervous System,Parkinson's Disease
2020583,Endocannabinoid Signalling in Parkinson's Disease: A Perspective on Associated Therapeutic Interventions,https://pubmed.ncbi.nlm.nih.gov/32872273/,Positive,,Meta-analysis,2020,Endocannabinoid (unspecified),Nervous System,Parkinson's Disease
2020584,Medical cannabis as an alternative therapeutics for Parkinsons' disease: Systematic review,https://pubmed.ncbi.nlm.nih.gov/32351233/,Positive,,Meta-analysis,2020,,Nervous System,Parkinson's Disease
2020585,Cannabidiol exerts protective effects in an in vitro model of Parkinson's disease activating AKT/mTOR pathway,https://pubmed.ncbi.nlm.nih.gov/32184097/,Positive,,Laboratory Study,2020,,Nervous System,Parkinson's Disease
2020586,Biological bases for a possible effect of cannabidiol in Parkinson's disease,https://pubmed.ncbi.nlm.nih.gov/31314869/,Positive,,Meta-analysis,2020,,Nervous System,Parkinson's Disease
2020587,Receptor mechanisms mediating the anti-neuroinflammatory effects of endocannabinoid system modulation in a rat model of migraine,https://pubmed.ncbi.nlm.nih.gov/32639078/,Positive,,Animal Study,2020,,Nervous System,Migraine
2019183,Peripheral changes of endocannabinoid system components in episodic and chronic migraine patients: A pilot study,https://pubmed.ncbi.nlm.nih.gov/32967434/,Positive,,Meta-analysis,2019,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Nervous System,Migraine
2020588,Migraine Frequency Decrease Following Prolonged Medical Cannabis Treatment: A Cross-Sectional Study,https://pubmed.ncbi.nlm.nih.gov/32526965/,Positive,,Meta-analysis,2020,,Nervous System,Migraine
2020589,Alleviative effects of Cannabis flower on migraine and headache,https://pubmed.ncbi.nlm.nih.gov/32758396/,Positive,,Meta-analysis,2020,,Nervous System,Migraine
2020590,Analgesic Effects and Impairment in Locomotor Activity Induced by Cannabinoid/Opioid Combinations in Rat Models of Chronic Pain,https://pubmed.ncbi.nlm.nih.gov/32781705/,Positive,,Animal Study,2020,WIN-x Synthetic Cannabinoids,Nervous System,Pain; Pain - Chronic
2020591,"The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial",https://onlinelibrary.wiley.com/doi/full/10.1002/ejp.1605,Positive,,Double Blind Clinical Trial,2020,,Nervous System,Pain; Pain - Chronic
2020592,Medical cannabis for orthopaedic patients with chronic musculoskeletal pain: does evidence support its use?,https://pubmed.ncbi.nlm.nih.gov/32655704/,Positive,,Meta-analysis,2020,,Nervous System,Pain; Pain - Chronic
2020593,A Review of Scientific Evidence for THC:CBD Oromucosal Spray (Nabiximols) in the Management of Chronic Pain,https://pubmed.ncbi.nlm.nih.gov/32104061/,Positive,,Meta-analysis,2020,Pharma THC:CBD,Nervous System,Pain; Pain - Chronic
2020594,The Role of Cannabidiol (CBD) in Chronic Pain Management: An Assessment of Current Evidence,https://pubmed.ncbi.nlm.nih.gov/31980957/,Positive,,Meta-analysis,2020,Pharma THC:CBD,Nervous System,Pain; Pain - Chronic
2020595,Medical cannabinoids and their indications in chronic pain,https://pubmed.ncbi.nlm.nih.gov/32672015/,Positive,,Meta-analysis,2020,,Nervous System,Pain; Pain - Chronic
2020596,Analgesic Effects of Cannabinoids for Chronic Non-cancer Pain: a Systematic Review and Meta-Analysis with Meta-Regression,https://pubmed.ncbi.nlm.nih.gov/32172501/,Positive,,Clinical Meta-analysis,2020,,Nervous System,Pain; Pain - Chronic
2020597,Orally consumed cannabinoids provide long-lasting relief of allodynia in a mouse model of chronic neuropathic pain,https://pubmed.ncbi.nlm.nih.gov/31812152/,Positive,,Animal Study,2020,,Nervous System,Pain; Pain - Chronic
2020598,Daring discourse - no: cannabinoids should not be used for acute postoperative pain management,https://pubmed.ncbi.nlm.nih.gov/32471920/,Inconclusive,,Meta-analysis,2020,,Nervous System,Pain; Pain - Acute
2020599,Analgesic efficacy of cannabinoids for acute pain management after surgery: a systematic review and meta-analysis,https://pubmed.ncbi.nlm.nih.gov/32471924/,Negative,,Clinical Meta-analysis,2020,,Nervous System,Pain; Pain - Acute
2020600,"A Comprehensive Patient and Public Involvement Program Evaluating Perception of Cannabis-Derived Medicinal Products in the Treatment of Acute Postoperative Pain, Nausea, and Vomiting Using a Qualitative Thematic Framework",https://pubmed.ncbi.nlm.nih.gov/32322678/,Positive,,Meta-analysis,2020,,Digestive System; Nervous System,Pain; Nausea and Vomiting; Pain - Acute
2020601,No Evidence of Altered Reactivity to Experimentally Induced Pain Among Regular Cannabis Users,https://pubmed.ncbi.nlm.nih.gov/32433075/,Positive,,Clinical Trial,2020,,Nervous System,Pain; Pain - Acute
2020602,Δ 9 -Tetrahydrocannabinol promotes oligodendrocyte development and CNS myelination in vivo,https://pubmed.ncbi.nlm.nih.gov/32956517/,Positive,,Animal Study,2020,2-Arachidonoyl Glycerol (2-AG),Nervous System,Multiple Sclerosis
2020603,Gene Expression Analysis of Astrocyte and Microglia Endocannabinoid Signaling during Autoimmune Demyelination,https://pubmed.ncbi.nlm.nih.gov/32846891/,Positive,,Laboratory Study,2020,2-Arachidonoyl Glycerol (2-AG),Nervous System,Multiple Sclerosis
2020604,Long-term assessment of the cognitive effects of nabiximols in patients with multiple sclerosis: A pilot study,https://pubmed.ncbi.nlm.nih.gov/32526487/,Positive,,Clinical Trial,2020,Pharma THC:CBD,Nervous System,Multiple Sclerosis
2020605,"Dose-dependent effect of cannabinoid WIN-55,212-2 on myelin repair following a demyelinating insult",https://www.nature.com/articles/s41598-019-57290-1#rightslink,Positive,,Animal Study,2020,WIN-x Synthetic Cannabinoids,Nervous System,Multiple Sclerosis
2020606,"The endocannabinoid system dual-target ligand N-cycloheptyl-1,2-dihydro-5-bromo-1-(4-fluorobenzyl)-6-methyl-2-oxo-pyridine-3-carboxamide improves disease severity in a mouse model of multiple sclerosis",https://pubmed.ncbi.nlm.nih.gov/33002735/,Positive,,Animal Study,2020,Synthetic Cannabinoid (unspecified),Nervous System,Multiple Sclerosis
2020607,Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study,https://pubmed.ncbi.nlm.nih.gov/32335779/,Positive,,Clinical Trial,2020,Pharma THC:CBD,Nervous System,Multiple Sclerosis
2020608,Effects of EHP-101 on inflammation and remyelination in murine models of Multiple sclerosis,https://pubmed.ncbi.nlm.nih.gov/32599064/,Positive,,Animal Study,2020,Synthetic Cannabinoid (unspecified),Nervous System,Multiple Sclerosis
2020609,Cannabinoid CB2 Receptor Functional Variation (Q63R) Is Associated with Multiple Sclerosis in Iranian Subjects,https://pubmed.ncbi.nlm.nih.gov/31407233/,Positive,,Meta-analysis,2020,,Nervous System,Multiple Sclerosis
2020610,"The Broad Concept of ""Spasticity-Plus Syndrome"" in Multiple Sclerosis: A Possible New Concept in the Management of Multiple Sclerosis Symptoms",https://pubmed.ncbi.nlm.nih.gov/32256440/,Positive,,Meta-analysis,2020,Pharma THC:CBD,Nervous System,Multiple Sclerosis
2020611,Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis,https://pubmed.ncbi.nlm.nih.gov/32130684/,Positive,,Meta-analysis,2020,Pharma THC:CBD,Nervous System,Multiple Sclerosis
2020612,Cannabinoids in multiple sclerosis: A neurophysiological analysis,https://pubmed.ncbi.nlm.nih.gov/32632918/,Positive,,Clinical Trial,2020,Pharma THC:CBD,Nervous System,Multiple Sclerosis
2020613,The effects of chronic Δ-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) use on cerebral glucose metabolism in multiple sclerosis: a pilot study,https://pubmed.ncbi.nlm.nih.gov/31841355/,Inconclusive,,Meta-analysis,2020,,Nervous System,Multiple Sclerosis; Diabetes; Metabolic Syndrome
2020614,Discontinuing cannabis improves depression in people with multiple sclerosis: A short report,https://pubmed.ncbi.nlm.nih.gov/32589554/,Inconclusive,,Meta-analysis,2020,,Nervous System,Multiple Sclerosis
2020615,The pharmacological effects of inhaled cannabis on pain in patients with multiple sclerosis: risks versus rewards,https://pubmed.ncbi.nlm.nih.gov/32860528/,Positive,,Meta-analysis,2020,,Nervous System,Multiple Sclerosis; Pain; Pain - Neuropathy - Peripheral
2020616,Cannabis use in people with multiple sclerosis and spasticity: A cross-sectional analysis,https://pubmed.ncbi.nlm.nih.gov/32086163/,Positive,,Meta-analysis,2020,,Nervous System,Multiple Sclerosis
2020617,Cannabis and multiple sclerosis,https://pubmed.ncbi.nlm.nih.gov/32515670/,Positive,,Meta-analysis,2020,Pharma THC:CBD,Nervous System,Multiple Sclerosis
2020618,The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis,https://link.springer.com/article/10.1007/s00011-020-01341-1,Positive,,Clinical Meta-analysis,2020,,Nervous System,Pain; Multiple Sclerosis; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral
2020619,Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada,https://pubmed.ncbi.nlm.nih.gov/31855842/,Positive,,Meta-analysis,2020,,Nervous System,Multiple Sclerosis
2020620,Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review,https://pubmed.ncbi.nlm.nih.gov/32140100/,Positive,,Meta-analysis,2020,,Nervous System,Multiple Sclerosis
2013091,Marijuana's dose-dependent effects in daily marijuana smokers,https://pubmed.ncbi.nlm.nih.gov/23937597/,Negative,,Double Blind Clinical Trial,2013,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cardiovascular Diseases (CVD)
2015112,Cognitive performance in a placebo-controlled pharmacotherapy trial for youth with marijuana dependence,https://pubmed.ncbi.nlm.nih.gov/25661990/,Negative,,Double Blind Clinical Trial,2015,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects; Cognitive Dysfunction
2011095,Effects of cannabinoid CB1 receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys,https://pubmed.ncbi.nlm.nih.gov/21029743/,Inconclusive,,Animal Study,2011,CP-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Nervous System,Dystonia
2002025,A Dramatic Response to Inhaled Cannabis in a Woman with Central Thalamic Pain and Dystonia,https://www.jpsmjournal.com/article/S0885-3924(02)00426-8/fulltext,Positive,,Meta-analysis,2002,,Nervous System,Dystonia; Pain; Pain - Central Pain Syndrome
2020621,Cannabinoids and dystonia: an issue yet to be defined,https://pubmed.ncbi.nlm.nih.gov/31848779/,Positive,,Meta-analysis,2020,,Nervous System,Dystonia
2020622,Effects of co-administration of rapamycin and evening primrose/hemp seed oil supplement on immunologic factors and cell membrane fatty acids in experimental autoimmune encephalomyelitis,https://pubmed.ncbi.nlm.nih.gov/32712065/,Positive,,Animal Study,2020,,Nervous System,Encephalitis and Myelitis
2001017,Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study,https://pubmed.ncbi.nlm.nih.gov/11739835/,Positive,,Double Blind Clinical Trial,2001,Pharma THC,,Parkinson's Disease; Dystonia
1986007,Open label evaluation of cannabidiol in dystonic movement disorders,https://pubmed.ncbi.nlm.nih.gov/3793381/,Positive,,Clinical Trial,1986,,Nervous System,Dystonia
2015113,"Cannabis in the Treatment of Dystonia, Dyskinesias, and Tics",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604174/,Positive,,Clinical Meta-analysis,2015,Tetrahydrocannabinol (THC); Pharma CBD; Pharma THC,Nervous System,Chorea; Dystonia; Tics and Tourettes
2002026,"Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia",https://pubmed.ncbi.nlm.nih.gov/11835452/,Inconclusive,,Double Blind Clinical Trial,2002,Pharma THC,Nervous System,Dystonia
2017124,"Medical Cannabis, a Beneficial High in Treatment of Blepharospasm? An Early Observation",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764009/,Positive,,Meta-analysis,2017,,Nervous System,Blepharospasm; Dystonia; Chorea
2020623,Association between cannabis and the eyelids: A comprehensive review,https://pubmed.ncbi.nlm.nih.gov/31747112/,Inconclusive,,Meta-analysis,2020,,,Blepharospasm; Dystonia
2020624,"Ingestion of a THC-Rich Cannabis Oil in People with Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial",https://academic.oup.com/painmedicine/article/21/10/2212/5942556?login=false,Positive,,Double Blind Clinical Trial,2020,Cannabichromene (CBC); Cannabigerol (CBG); Cannabinol (CBN); Tetrahydrocannabivarin (THCV),Muscular System,Fibromyalgia; Depression; Insomnia and Sleep Disorders; Pain; Quality of Life
1986008,Effects Of Cannabidiol In Huntington's Disease,http://druglibrary.org/schaffer/hemp/medical/hunting1.htm,Positive,,Clinical Trial,1986,,Nervous System,Huntington's Disease
2020625,"Medical Marijuana Effects in Movement Disorders, Focus on Huntington Disease; A Literature Review",https://pubmed.ncbi.nlm.nih.gov/33064979/,Positive,,Meta-analysis,2020,,Nervous System,Huntington's Disease; Chorea
2020626,Cannabidiol normalizes resting-state functional connectivity in treatment-resistant epilepsy,https://pubmed.ncbi.nlm.nih.gov/32745959/,Positive,,Clinical Trial,2020,Pharma CBD,Nervous System,Epilepsy
2020627,Development of cannabidiol as a treatment for severe childhood epilepsies,https://pubmed.ncbi.nlm.nih.gov/32986848/,Positive,,Meta-analysis,2020,,Nervous System,Epilepsy
2020628,"Cannabis, More Than the Euphoria: Its Therapeutic Use in Drug-Resistant Epilepsy",https://pubmed.ncbi.nlm.nih.gov/32832296/,Positive,,Meta-analysis,2020,,Nervous System,Epilepsy
2020629,The anticonvulsant effects of cannabidiol in experimental models of epileptic seizures: From behavior and mechanisms to clinical insights,https://pubmed.ncbi.nlm.nih.gov/31954723/,Positive,,Meta-analysis,2020,,Nervous System,Epilepsy
2020630,Cannabis constituents reduce seizure behavior in chemically-induced and scn1a-mutant zebrafish,https://pubmed.ncbi.nlm.nih.gov/32585475/,Positive,,Animal Study,2020,Cannabinol (CBN),Nervous System,Epilepsy
2020631,The Use of Cannabis as a Treatment for Epilepsy in Adult Patients: Are Side Effects a Limitation of Use?,https://pubmed.ncbi.nlm.nih.gov/31895185/,Positive,,Meta-analysis,2020,,Nervous System,Epilepsy
2020632,Epilepsy and cannabidiol: a guide to treatment,https://onlinelibrary.wiley.com/doi/full/10.1684/epd.2020.1141,Positive,,Clinical Meta-analysis,2020,,Nervous System,Epilepsy
2020633,Barriers in accessing medical cannabis for children with drug-resistant epilepsy in Canada: A qualitative study,https://pubmed.ncbi.nlm.nih.gov/32570201/,Positive,,Meta-analysis,2020,,Nervous System,Epilepsy
2020634,Endocannabinoid System and Cannabinoid 1 Receptors in Patients With Pharmacoresistant Temporal Lobe Epilepsy and Comorbid Mood Disorders,https://pubmed.ncbi.nlm.nih.gov/32435186/,Positive,,Meta-analysis,2020,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Nervous System,Epilepsy
2020635,Cannabidiol anticonvulsant effect is mediated by the PI3Kγ pathway,https://pubmed.ncbi.nlm.nih.gov/32574650/,Positive,,Animal Study,2020,,Nervous System,Epilepsy
2020636,Anticonvulsive Properties of Cannabidiol in a Model of Generalized Seizure Are Transient Receptor Potential Vanilloid 1 Dependent,https://pubmed.ncbi.nlm.nih.gov/32656346/,Positive,,Animal Study,2020,,Nervous System,Epilepsy
2020637,Neural Stem Cells and Cannabinoids in the Spotlight as Potential Therapy for Epilepsy,https://www.mdpi.com/1422-0067/21/19/7309/htm,Positive,,Meta-analysis,2020,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Nervous System,Epilepsy
2020638,Inverse Agonism of Cannabinoid Receptor Type 2 Confers Anti-inflammatory and Neuroprotective Effects Following Status Epileptics,https://pubmed.ncbi.nlm.nih.gov/32378121/,Positive,,Animal Study,2020,,Nervous System,Epilepsy
2020639,Anandamide Metabolites Protect against Seizures through the TRP Channel Water Witch in Drosophila melanogaster,https://pubmed.ncbi.nlm.nih.gov/32492422/,Positive,,Animal Study,2020,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Nervous System,Epilepsy
2020640,Cannabis Treatment in Children with Epilepsy: Practices of Canadian Neurologists,https://pubmed.ncbi.nlm.nih.gov/32127067/,Positive,,Meta-analysis,2020,,Nervous System,Epilepsy
2020641,Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy,https://pubmed.ncbi.nlm.nih.gov/32751761/,Positive,,Meta-analysis,2020,,Nervous System,Epilepsy
2020642,Cannabinoids Rescue Cocaine-Induced Seizures by Restoring Brain Glycine Receptor Dysfunction,https://www.cell.com/cell-reports/fulltext/S2211-1247(20)30287-4?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2211124720302874%3Fshowall%3Dtrue,Positive,,Animal Study,2020,,Mental/Emotional System; Nervous System,Addiction - Cocaine; Addiction; Epilepsy
2020643,CB2R orchestrates neuronal autophagy through regulation of the mTOR signaling pathway in the hippocampus of developing rats with status epilepticus,https://pubmed.ncbi.nlm.nih.gov/31894322/,Positive,,Animal Study,2020,AM-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,Nervous System,Epilepsy
2020644,Comparison of the Neurotoxic and Seizure-Inducing Effects of Synthetic and Endogenous Cannabinoids with Δ 9-Tetrahydrocannabinol,https://pubmed.ncbi.nlm.nih.gov/32322674/,Negative,,Animal Study,2020,AM-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,Nervous System,Poisoning by Synthetic Cannabis
2020645,The role of cannabinoids in epilepsy treatment: a critical review of efficacy results from clinical trials,https://pubmed.ncbi.nlm.nih.gov/31916540/,Inconclusive,,Clinical Meta-analysis,2020,,Nervous System,Epilepsy
2019184,Cannabinoids for drug-resistant seizures in a critically ill patient-Case report and literature review,https://pubmed.ncbi.nlm.nih.gov/31770462/,Positive,,Meta-analysis,2019,,Nervous System,Epilepsy - Lennox-Gastaut; Epilepsy
2020646,Cannabinoids in the Treatment of Epilepsy: Current Status and Future Prospects,https://pubmed.ncbi.nlm.nih.gov/32103958/,Positive,,Meta-analysis,2020,,Nervous System,Epilepsy
2020647,"Response to cannabidiol in epilepsy of infancy with migrating focal seizures associated with KCNT1 mutations: An open-label, prospective, interventional study",https://pubmed.ncbi.nlm.nih.gov/31926846/,Positive,,Clinical Trial,2020,,Nervous System,Epilepsy
2020648,Efficacy and adverse event profile of cannabidiol and medicinal cannabis for treatment-resistant epilepsy: Systematic review and meta-analysis,https://pubmed.ncbi.nlm.nih.gov/31731110/,Positive,,Clinical Meta-analysis,2020,,Nervous System,Epilepsy
2020649,A perspective on cannabinoids for treating epilepsy: Do they really change the landscape?,https://pubmed.ncbi.nlm.nih.gov/31770546/,Positive,,Meta-analysis,2020,,Nervous System,Epilepsy
2020650,Cannabis for Pediatric Epilepsy,https://pubmed.ncbi.nlm.nih.gov/31895184/,Positive,,Meta-analysis,2020,,Nervous System,Epilepsy
2020651,The Endocannabinoid System and Synthetic Cannabinoids in Preclinical Models of Seizure and Epilepsy,https://pubmed.ncbi.nlm.nih.gov/31895186/,Positive,,Meta-analysis,2020,Synthetic Cannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Nervous System,Epilepsy
2020652,Cannabidiol inhibits febrile seizure by modulating AMPA receptor kinetics through its interaction with the N-terminal domain of GluA1/GluA2,https://pubmed.ncbi.nlm.nih.gov/32805354/,Positive,,Animal Study,2020,,Nervous System,Epilepsy - FIRES; Epilepsy
1949001,Anti-epileptic Action of Marijuana-Active Subtances,https://calgarycmmc.com/E-books/E%20Books%20A-B-C/Anti-epileptic_Action.pdf,Positive,,Clinical Trial,1949,Cannabinol (CBN); Tetrahydrocannabinol (THC),Nervous System,Cerebral Palsy; Epilepsy; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut
2020653,Economic Evaluation of Cannabinoid Oil for Dravet Syndrome: A Cost-Utility Analysis,https://pubmed.ncbi.nlm.nih.gov/32406036/,Positive,,Meta-analysis,2020,,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy
2020654,Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome,https://pubmed.ncbi.nlm.nih.gov/33026899/,Positive,,Meta-analysis,2020,,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2020655,Interactions between cannabidiol and Δ 9 -tetrahydrocannabinol in modulating seizure susceptibility and survival in a mouse model of Dravet syndrome,https://pubmed.ncbi.nlm.nih.gov/32608111/,Positive,,Animal Study,2020,,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy
2020656,Clinical trial simulations of the interaction between cannabidiol and clobazam and effect on drop-seizure frequency,https://pubmed.ncbi.nlm.nih.gov/31657863/,Positive,,Meta-analysis,2020,,Nervous System,Epilepsy - Lennox-Gastaut; Epilepsy; Epilepsy - Dravet Syndrome
2020657,Phenotype-Based Screening of Synthetic Cannabinoids in a Dravet Syndrome Zebrafish Model,https://www.frontiersin.org/articles/10.3389/fphar.2020.00464/full,Positive,,Animal Study,2020,AB-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy
2019185,Cannabinoid 2 Receptor-Based Modulation of the Immune Response in Experimental Models of CNS Injury,https://dalspace.library.dal.ca/handle/10222/75823,Positive,,Meta-analysis,2019,AM-x Synthetic Cannabinoids; HU-x Synthetic Cannabinoids,Immune System; Nervous System,Injury Immunodeficiency
2003023,"Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial",https://pubmed.ncbi.nlm.nih.gov/12965981/,Positive,,Double Blind Clinical Trial,2003,Pharma THC,Immune System,HIV/AIDS
2016134,Integrating cannabis into clinical cancer care,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791148/,Positive,,Meta-analysis,2016,Pharma THC:CBD,,Cancer; Anorexia; Cancer - Colon; Cachexia; Cancer - Breast; Cancer - Lung; Cancer - Lymphoma; Cancer - Melanoma; Cancer - Myeloma; Cancer - Pancreatic; Pain; Nausea and Vomiting; Pain - Cancer; Pain - Neuropathy - Drug-Ind. Polyneuropathy
2019186,Cannabinoid as Beneficial Replacement Therapy for Psychotropics to Treat Neuropsychiatric Symptoms in Severe Alzheimer's Dementia: A Clinical Case Report,https://pubmed.ncbi.nlm.nih.gov/32477187/,Positive,,Meta-analysis,2019,Pharma THC,Nervous System,Alzheimer's Disease
2020658,Endocannabinoid system alterations in Alzheimer's disease: A systematic review of human studies,https://pubmed.ncbi.nlm.nih.gov/32980333/,Inconclusive,,Meta-analysis,2020,,Nervous System,Alzheimer's Disease
2020659,"The Cannabinoid Receptor Agonist WIN55,212-2 Ameliorates Hippocampal Neuronal Damage After Chronic Cerebral Hypoperfusion Possibly Through Inhibiting Oxidative Stress and ASK1-p38 Signaling",https://pubmed.ncbi.nlm.nih.gov/31808139/,Positive,,Animal Study,2020,WIN-x Synthetic Cannabinoids,Nervous System,Oxidative Stress; Alzheimer's Disease; Cognitive Dysfunction; Dementia
2020660,Cannabinoids for the Neuropsychiatric Symptoms of Dementia: A Systematic Review and Meta-Analysis,https://pubmed.ncbi.nlm.nih.gov/31835954/,Positive,,Meta-analysis,2020,,Nervous System,Dementia; Cognitive Dysfunction
2020661,Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson’s and Alzheimer’s Diseases: a Review,https://link.springer.com/article/10.1007%2Fs12035-020-02054-6,Positive,,Meta-analysis,2020,,Nervous System,Alzheimer's Disease; Parkinson's Disease
2019187,Impact of Cannabis-Based Medicine on Alzheimer's disease by Focusing on the Amyloid β- Modifications: A Systematic Study,https://pubmed.ncbi.nlm.nih.gov/32640965/,Positive,,Meta-analysis,2019,,Nervous System,Alzheimer's Disease
2020662,Activation of cannabinoid receptor 2 protects rat hippocampal neurons against Aβ-induced neuronal toxicity,https://pubmed.ncbi.nlm.nih.gov/32592731/,Positive,,Animal Study,2020,JWH-x Synthetic Cannabinoids,Nervous System,Alzheimer's Disease; Dementia
2019188,"Agitation, Oxidative Stress, and Cytokines in Alzheimer Disease: Biomarker Analyses From a Clinical Trial With Nabilone for Agitation",https://pubmed.ncbi.nlm.nih.gov/31547752/,Positive,,Double Blind Clinical Trial,2019,Pharma THC,Nervous System,Alzheimer's Disease; Oxidative Stress; Inflammation; Neurodegenerative Issues
2020663,Emerging Promise of Cannabinoids for the Management of Pain and Associated Neuropathological Alterations in Alzheimer's Disease,https://www.frontiersin.org/articles/10.3389/fphar.2020.01097/full,Positive,,Meta-analysis,2020,,Nervous System,Alzheimer's Disease; Pain; Cognitive Dysfunction; Inflammation; Neurodegenerative Issues; Oxidative Stress
2020664,Effect of Inhaled Cannabis for Pain in Adults With Sickle Cell Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368173/,Positive,,Double Blind Clinical Trial,2020,,Cardiovascular System,Sickle Cell Disorders; Addiction - Opioid; Pain; Pain - Acute; Pain - Chronic
2018169,Endocannabinoids in Body Weight Control,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027162/,Positive,,Meta-analysis,2018,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); Other Related Compounds; SR-x Synthetic Cannabinoids,Endocrine System,Obesity
2018170,Theoretical Explanation for Reduced Body Mass Index and Obesity Rates in Cannabis Users,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340377/,Positive,,Meta-analysis,2018,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); SR-x Synthetic Cannabinoids,Endocrine System,Obesity; Metabolic Syndrome
2018171,The effects of cannabidiol on impulsivity and memory during abstinence in cigarette dependent smokers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954148/,Inconclusive,,Double Blind Clinical Trial,2018,,Mental/Emotional System; Nervous System,Addiction - Nicotine; Addiction; Cognitive Dysfunction; Intermittent Explosive Disorder
2017125,Long-lasting alterations of hippocampal GABAergic neurotransmission in adult rats following perinatal Δ 9-THC exposure,https://pubmed.ncbi.nlm.nih.gov/28104530/,Positive,,Animal Study,2017,Tetrahydrocannabinol (THC); SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Neonatal Cerebral Issues; Pregnancy
2017126,High-Dose Cannabidiol Induced Hypotension after Global Hypoxia-Ischemia in Piglets,https://pubmed.ncbi.nlm.nih.gov/28564654/,Inconclusive,,Animal Study,2017,,Nervous System,Neurodegenerative Issues; Cardiovascular Diseases (CVD); Neonatal Cerebral Issues
2018172,Pediatric Death Due to Myocarditis After Exposure to Cannabis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965161/,Negative,,Meta-analysis,2018,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cardiovascular Diseases (CVD); Myocarditis
2018173,Cannabidiol to Improve Mobility in People with Multiple Sclerosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874292/,Positive,,Meta-analysis,2018,,Nervous System,Multiple Sclerosis
2018174,The influence of THC:CBD oromucosal spray on driving ability in patients with multiple sclerosis‐related spasticity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943754/,Inconclusive,,Meta-analysis,2018,,,Multiple Sclerosis
2018175,Cannabinoids for Treatment of MS Symptoms: State of the Evidence,https://pubmed.ncbi.nlm.nih.gov/29923025/,Positive,,Meta-analysis,2018,Tetrahydrocannabinol (THC),Nervous System,Multiple Sclerosis
2018176,"Multiple Sclerosis, Cannabis Use, and Clinical Disability: A Preliminary [18F]-Fluorodeoxyglucose Positron Emission Tomography Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186162/,Inconclusive,,Meta-analysis,2018,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Multiple Sclerosis
2018177,Delta-9-Tetrahydrocannabinol (∆9-THC) Induce Neurogenesis and Improve Cognitive Performances of Male Sprague Dawley Rats,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766723/,Positive,,Animal Study,2018,Tetrahydrocannabinol (THC),Nervous System,Cognitive Dysfunction
2017127,Δ9-Tetrahydrocannabinol decreases willingness to exert cognitive effort in male rats,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373702/,Positive,,Animal Study,2017,Tetrahydrocannabinol (THC); Fatty Acid Amide Hydrolase (FAAH); SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cognitive Dysfunction
2017128,Acute memory and psychotomimetic effects of cannabis and tobacco both ‘joint’ and individually: a placebo-controlled trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647681/,Negative,,Double Blind Clinical Trial,2017,Tetrahydrocannabinol (THC),Mental/Emotional System,Addiction - Nicotine; Addiction; Cannabis Adverse Effects; Cognitive Dysfunction; COPD
2017129,Cannabis and cognitive functioning in multiple sclerosis: The role of gender,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468765/,Negative,,Meta-analysis,2017,,Nervous System,Cognitive Dysfunction; Multiple Sclerosis; Cannabis Adverse Effects
2018178,Memory impairment in HIV-infected individuals with early and late initiation of regular marijuana use,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842094/,Negative,,Meta-analysis,2018,,Immune System; Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cognitive Dysfunction; HIV/AIDS
2018179,"Lifetime Marijuana and Alcohol Use, and Cognitive Dysfunction in People with Human Immunodeficiency Virus Infection",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979270/,Inconclusive,,Meta-analysis,2018,Tetrahydrocannabinol (THC),Immune System; Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction; Cognitive Dysfunction; HIV/AIDS; Cannabis Adverse Effects
2017130,"Chronic Adolescent Δ9-Tetrahydrocannabinol Treatment of Male Mice Leads to Long-Term Cognitive and Behavioral Dysfunction, Which Are Prevented by Concurrent Cannabidiol Treatment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655843/,Positive,,Animal Study,2017,Tetrahydrocannabinol (THC); CP-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cognitive Dysfunction; Schizophrenia
2018180,Prospects of Cannabidiol for Easing Status Epilepticus-Induced Epileptogenesis and Related Comorbidities,https://pubmed.ncbi.nlm.nih.gov/29372545/,Positive,,Meta-analysis,2018,,Nervous System,Epilepsy; Cognitive Dysfunction; Depression
2018181,Evaluation of cognitive functions in individuals with synthetic cannabinoid use disorder and comparison to individuals with cannabis use disorder,https://pubmed.ncbi.nlm.nih.gov/29407568/,Inconclusive,,Meta-analysis,2018,,Mental/Emotional System,Cannabis Adverse Effects; Poisoning by Synthetic Cannabis; Cognitive Dysfunction
2018182,Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837889/,Negative,,Animal Study,2018,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cognitive Dysfunction
2018183,Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137521/,Inconclusive,,Meta-analysis,2018,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cognitive Dysfunction
2018184,"Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure",https://pubmed.ncbi.nlm.nih.gov/29935939/,Inconclusive,,Double Blind Clinical Trial,2018,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cognitive Dysfunction; Psychosis
2018185,"Marijuana Matters: Reviewing the Impact of Marijuana on Cognition, Brain Structure and Function, & Exploring Policy Implications and Barriers to Research",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455965/,Inconclusive,,Meta-analysis,2018,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cognitive Dysfunction
2018186,Early Cannabis Use and Neurocognitive Risk: A Prospective Functional Neuroimaging Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561344/,Inconclusive,,Meta-analysis,2018,,Nervous System,Cognitive Dysfunction; Cannabis Adverse Effects
2017131,Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578009/,Positive,,Meta-analysis,2017,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Nervous System,Migraine
2018187,"Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968020/,Positive,,Meta-analysis,2018,Anandamide (AEA); Cannabidiolic Acid (CBD-a); Fatty Acid Amide Hydrolase (FAAH); Tetrahydrocannabinol (THC); Tetrahydrocannabinolic Acid (THC-a),Nervous System; Skeletal System,Arthritis - Osteoarthritis; Arthritis; Migraine; Pain; Pain - Chronic
2018188,"Effects of cannabis use on body mass, fasting glucose and lipids during the first 12 months of treatment in schizophrenia spectrum disorders",https://pubmed.ncbi.nlm.nih.gov/29519756/,Inconclusive,,Meta-analysis,2018,,Endocrine System; Mental/Emotional System; Nervous System,Metabolic Syndrome; Schizophrenia; Loss of Appetite; Obesity
2018189,Cannabinoids in health and disease: pharmacological potential in metabolic syndrome and neuroinflammation,https://pubmed.ncbi.nlm.nih.gov/29601300/,Positive,,Meta-analysis,2018,,Endocrine System; Mental/Emotional System,Loss of Appetite; Metabolic Syndrome
2017132,Activation of cannabinoid receptor type 2 by JWH133 alleviates bleomycin-induced pulmonary fibrosis in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732744/,Positive,,Animal Study,2017,JWH-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Respiratory System,Fibrosis - Lung; Fibrosis
2017133,Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609560/,Positive,,Meta-analysis,2017,,Respiratory System,Cancer - Lung; Cancer
2003024,"Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716",https://pubmed.ncbi.nlm.nih.gov/12447606/,Positive,,Animal Study,2003,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Tetrahydrocannabinol (THC); SR-x Synthetic Cannabinoids,Mental/Emotional System,Loss of Appetite
2012112,The role of the endocannabinoid system in eating disorders: pharmacological implications,https://pubmed.ncbi.nlm.nih.gov/22785439/,Positive,,Meta-analysis,2012,,,Anorexia Nervosa; Anorexia; Cachexia
2017134,Consequence of dopamine D2 receptor blockade on the hyperphagic effect induced by cannabinoid CB1 and CB2 receptors in layers,https://www.tandfonline.com/doi/abs/10.1080/00071668.2017.1357799?journalCode=cbps20,Positive,,Animal Study,2017,2-Arachidonoyl Glycerol (2-AG),,Loss of Appetite
2008063,Cannabinoids and capsaicin improve liver function following thioacetamide-induced acute injury in mice,https://pubmed.ncbi.nlm.nih.gov/19086956/,Positive,,Animal Study,2008,Capsaicin (CAPS); 2-Arachidonoyl Glycerol (2-AG); HU-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Digestive System,Liver Failure
2008064,Role of cannabinoids in chronic liver diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2761570/,Positive,,Meta-analysis,2008,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); HU-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,,Fibrosis - Liver (Cirrhosis); Fibrosis; Liver Failure
2011096,Endocannabinoids in Liver Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073545/#R83,Positive,,Meta-analysis,2011,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,,Alcoholic Liver Disease; Fatty Liver Disease; Fibrosis - Liver (Cirrhosis); Fibrosis; Liver Failure
2011097,Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057300/,Positive,,Animal Study,2011,,Digestive System,Liver Failure
2015114,Protective Role of Cannabinoid Receptor 2 Activation in Galactosamine/Lipopolysaccharide-Induced Acute Liver Failure through Regulation of Macrophage Polarization and MicroRNAs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407720/,Positive,,Animal Study,2015,JWH-x Synthetic Cannabinoids,Digestive System,Liver Failure
2015115,"Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758282/,Positive,,Laboratory Study,2015,WIN-x Synthetic Cannabinoids; AM-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,Digestive System,Cancer - Liver; Cancer
2016135,Exogenous hepatitis B virus envelope proteins induce endoplasmic reticulum stress: involvement of cannabinoid axis in liver cancer cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991457/,Inconclusive,,Laboratory Study,2016,AM-x Synthetic Cannabinoids,Digestive System,Cancer - Liver; Cancer; Hepatitis
2016136,Cannabinoid Receptors Are Overexpressed in CLL but of Limited Potential for Therapeutic Exploitation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4889125/,Inconclusive,,Laboratory Study,2016,AM-x Synthetic Cannabinoids; Anandamide (AEA); JWH-x Synthetic Cannabinoids,Immune System,Cancer - Leukemia; Cancer
2014100,Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease,https://pubmed.ncbi.nlm.nih.gov/24407485/,Negative,,Meta-analysis,2014,,Digestive System,IBD - Crohn's Disease
2018190,Cannabinoid pharmacology and therapy in gut disorders,https://pubmed.ncbi.nlm.nih.gov/30076849/,Positive,,Meta-analysis,2018,,,Cancer - Colon; Cancer; Irritable Bowel Syndrome; Nausea and Vomiting
2018191,The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719110/,Positive,,Meta-analysis,2018,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); CP-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); Palmitoylethanolamide (PEA); Tetrahydrocannabinol (THC),,Pain; Pain - Neuropathy - Inflammatory Polyneuropathy
2018192,Effect of cannabidiolic acid and ∆ 9-tetrahydrocannabinol on carrageenan-induced hyperalgesia and edema in a rodent model of inflammatory pain,https://pubmed.ncbi.nlm.nih.gov/30225659/,Positive,,Animal Study,2018,Cannabidiolic Acid (CBD-a); Tetrahydrocannabinol (THC); AM-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Nervous System,Pain; Pain - Neuropathy - Inflammatory Polyneuropathy
2018193,The Anti-Inflammatory Properties of Terpenoids from Cannabis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308289/,Positive,,Animal Study,2018,,Nervous System,Inflammation
2019189,Utilization of medicinal cannabis for pain by individuals with spinal cord injury,https://www.nature.com/articles/s41394-019-0208-6#citeas,Positive,,Meta-analysis,2019,,Nervous System; Skeletal System,Pain; Pain - Chronic; Spinal Cord Injuries
2019190,Self-Reported Efficacy of Cannabis for Endometriosis Pain,https://www.sciencedirect.com/science/article/pii/S1553465019310921#!,Positive,,Meta-analysis,2019,,Endocrine System,Endometriosis
2019191,"Cannabis use disorder among people using cannabis daily/almost daily in the United States, 2002-2016",https://pubmed.ncbi.nlm.nih.gov/31698323/,Inconclusive,,Meta-analysis,2019,,Mental/Emotional System,Addiction - Cannabis; Addiction
2019192,"Myorelaxant Effect of Transdermal Cannabidiol Application in Patients with TMD: A Randomized, Double-Blind Trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912397/,Positive,,Double Blind Clinical Trial,2019,,Muscular System,Pain; Pain - Chronic; Temporomandibular Disorders
2020665,Investigating the causal effect of cannabis use on cognitive function with a quasi-experimental co-twin design,https://pubmed.ncbi.nlm.nih.gov/31753729/,Inconclusive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cognitive Dysfunction
1984007,Endocrine effects of marijuana in the male: preclinical studies,https://pubmed.ncbi.nlm.nih.gov/6090909/,Inconclusive,,Meta-analysis,1984,,,Hyperthyroidism and Graves' Disease
2019193,"Spicae aetheroleum in uncomplicated acute bronchitis: a double-blind, randomised clinical trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435634/,Positive,,Double Blind Clinical Trial,2019,,Respiratory System,Bronchitis
2013092,Efficacy of cineole in patients suffering from acute bronchitis: a placebo-controlled double-blind trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842692/,Positive,,Double Blind Clinical Trial,2013,,Respiratory System,Bronchitis; Cough
2018194,Medical Cannabis Use by Hodgkin Lymphoma Patients: Experience of a Single Center,https://pubmed.ncbi.nlm.nih.gov/30343297/,Positive,,Meta-analysis,2018,,Immune System; Nervous System,Cancer - Lymphoma; Cancer
2018195,"Cannabis Use, Lung Cancer, and Related Issues",https://www.jto.org/article/S1556-0864(18)30038-8/fulltext#%20,Positive,,Meta-analysis,2018,Pharma THC,Respiratory System,Cancer - Lung; Cancer; Anorexia; Anxiety; Pain; Nausea and Vomiting; Pain - Cancer
2018196,"Role of Endocannabinoids on Sweet Taste Perception, Food Preference, and Obesity-related Disorders",https://academic.oup.com/chemse/article/43/1/3/4411748,Positive,,Meta-analysis,2018,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Endocrine System,Obesity; Diabetes; Loss of Appetite
2018197,"Salivary endocannabinoids and N-acylethanolamines upon mastication of a semisolid food: implications in fat taste, appetite and food liking",https://pubmed.ncbi.nlm.nih.gov/29235594/,Inconclusive,,Double Blind Clinical Trial,2018,2-Arachidonoyl Glycerol (2-AG),,Loss of Appetite
2018198,"Cannabinoids for the treatment of neuropsychiatric symptoms, pain and weight loss in dementia",https://pubmed.ncbi.nlm.nih.gov/29256923/,Positive,,Meta-analysis,2018,,Nervous System,Neurodegenerative Issues; Alzheimer's Disease; Loss of Appetite
2018199,Cannabidiol in the Lennox-Gastaut Syndrome,https://www.nejm.org/doi/10.1056/NEJMc1807878?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed,Positive,,Meta-analysis,2018,,Nervous System,Epilepsy - Lennox-Gastaut; Epilepsy
2018200,Cannabis for the Treatment of Epilepsy: an Update,https://pubmed.ncbi.nlm.nih.gov/30194563/,Positive,,Meta-analysis,2018,,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2018201,Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis,https://pubmed.ncbi.nlm.nih.gov/30390221/,Positive,,Meta-analysis,2018,,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2016137,Isolation and Characterization of New Cannabis Constituents from a High Potency Variety,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887452/,Positive,,Laboratory Study,2016,,Immune System; Integumentary System,Bacterial Infections; Leishmaniasis
2011098,Cannabinoid as a neuroprotective strategy in perinatal hypoxic-ischemic injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560303/,Inconclusive,,Meta-analysis,2011,,Reproductive System,Labor and Delivery Issues; Pregnancy
1983003,The effects of marijuana use during pregnancy. II. A study in a low-risk home-delivery population,https://pubmed.ncbi.nlm.nih.gov/6617473/,Negative,,Meta-analysis,1983,,Reproductive System,Labor and Delivery Issues; Pregnancy
2010067,Characteristics of pregnant illicit drug users and associations between cannabis use and perinatal outcome in a population-based study,https://pubmed.ncbi.nlm.nih.gov/20171023/,Inconclusive,,Meta-analysis,2010,,Reproductive System,Labor and Delivery Issues; Pregnancy
2014101,Cannabis use during pregnancy in France in 2010,https://pubmed.ncbi.nlm.nih.gov/24621183/,Negative,,Meta-analysis,2014,,Reproductive System,Labor and Delivery Issues; Pregnancy
2015116,New horizons for newborn brain protection: enhancing endogenous neuroprotection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680177/,Positive,,Meta-analysis,2015,HU-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Reproductive System,Labor and Delivery Issues
2016138,Anandamide and its metabolites: what are their roles in the kidney?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267779/,Positive,,Meta-analysis,2016,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); AM-x Synthetic Cannabinoids,,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2016139,Cannabinoid receptors in the kidney,https://pubmed.ncbi.nlm.nih.gov/27367912/,Positive,,Meta-analysis,2016,,,Kidney Failure
2012113,Cannabidiol Inhibits Growth and Induces Programmed Cell Death in Kaposi Sarcoma–Associated Herpesvirus-Infected Endothelium,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527984/,Positive,,Laboratory Study,2012,,Integumentary System,Kaposi's Sarcoma
2017135,Survey Report on Parents and Patients Related to the Use of Cannabidiol Symptomatic Epilepsy Secondary to Tuberous Sclerosis Complex (TSC) in Mexico,https://www.researchgate.net/publication/320185468_Survey_Report_on_Parents_and_Patients_Related_to_the_Use_of_Cannabidiol_Symptomatic_Epilepsy_Secondary_to_Tuberous_Sclerosis_Complex_TSC_in_Mexico,Positive,,Meta-analysis,2017,,Nervous System,Epilepsy - Lennox-Gastaut; Epilepsy
2020666,"Quality of Life, Mental Health, Personality and Patterns of Use in Self-Medicated Cannabis Users with Chronic Diseases: A 12-Month Longitudinal Study",https://pubmed.ncbi.nlm.nih.gov/32083789/,Positive,,Meta-analysis,2020,,Mental/Emotional System,Anxiety
2020667,Cerebrospinal fluid endocannabinoid levels in Gilles de la Tourette syndrome,https://pubmed.ncbi.nlm.nih.gov/32272483/,Positive,,Clinical Trial,2020,Anandamide (AEA); Palmitoylethanolamide (PEA); Endocannabinoid (unspecified),Nervous System,Tics and Tourettes
2020668,Daily Cannabis Users with Sickle Cell Disease Show Fewer Admissions than Others with Similar Pain Complaints,https://www.liebertpub.com/doi/10.1089/can.2019.0036,Positive,,Meta-analysis,2020,,Cardiovascular System,Sickle Cell Disorders
2010068,Endocannabinoids and Schizophrenia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034083/,Inconclusive,,Meta-analysis,2010,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); CP-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH); SR-x Synthetic Cannabinoids,Mental/Emotional System,Schizophrenia; Metabolic Syndrome
2020669,Cannabinoids for the treatment of chronic pruritus: A review,https://pubmed.ncbi.nlm.nih.gov/31987788/,Positive,,Meta-analysis,2020,,Integumentary System,Pruritis
2020670,Cannabis use during pregnancy and its relationship with fetal developmental outcomes and psychiatric disorders. A systematic review,https://pubmed.ncbi.nlm.nih.gov/32066469/,Inconclusive,,Meta-analysis,2020,,Reproductive System,Pregnancy; ADD and ADHD
2020671,Maternal smoking and cannabis use during pregnancy and infant outcomes,https://pubmed.ncbi.nlm.nih.gov/31926099/,Inconclusive,,Meta-analysis,2020,,Reproductive System,Pregnancy
2020672,Cannabidiol for Viral Diseases: Hype or Hope?,https://www.liebertpub.com/doi/full/10.1089/can.2019.0060,Inconclusive,,Meta-analysis,2020,,Nervous System,"Prion Disease; Ebola Virus Disease; Encephalitis and Myelitis; Epstein-Barr, Mono; Flu; Hepatitis; HIV/AIDS; Kaposi's Sarcoma"
2020673,Characteristics and circumstances of synthetic cannabinoid-related death,https://pubmed.ncbi.nlm.nih.gov/31389266/,Inconclusive,,Meta-analysis,2020,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis
2020674,Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson's disease,https://pubmed.ncbi.nlm.nih.gov/31909680/,Positive,,Double Blind Clinical Trial,2020,,Nervous System,Parkinson's Disease; Essential Tremor
2020675,Evaluating the co-use of opioids and cannabis for pain among current users using hypothetical purchase tasks,https://pubmed.ncbi.nlm.nih.gov/32267192/,Positive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
2020676,The Impact of Medical Cannabis on Intermittent and Chronic Opioid Users with Back Pain: How Cannabis Diminished Prescription Opioid Usage,https://www.liebertpub.com/doi/10.1089/can.2019.0039,Positive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
2020677,Lifetime Average Cannabis Use in Relation to Hypertriglyceridemic Waist Phenotype in U.S. Adults: A Population-Based Cross-Sectional Study,https://www.liebertpub.com/doi/10.1089/can.2019.0048,Positive,,Meta-analysis,2020,,,Obesity
2020678,Cannabis use disorder and the lungs,https://pubmed.ncbi.nlm.nih.gov/32285993/,Negative,,Meta-analysis,2020,,,Bronchitis; Cancer - Lung; Cancer; COPD
2020679,CRISPR/Cas9 gene editing demonstrates metabolic importance of GPR55 in the modulation of GIP release and pancreatic beta cell function,https://pubmed.ncbi.nlm.nih.gov/31923454/,Positive,,Animal Study,2020,Abnormal Cannabidiol (Abn-CBD); AM-x Synthetic Cannabinoids; O-x Synthetic Cannabinoids,Endocrine System,Diabetes
2020680,Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?,https://pubmed.ncbi.nlm.nih.gov/32471272/,Positive,,Meta-analysis,2020,,Respiratory System,COVID-19
2020681,The nephrologist's guide to cannabis and cannabinoids,https://pubmed.ncbi.nlm.nih.gov/31972598/,Inconclusive,,Meta-analysis,2020,,,Chronic Kidney Disease; Kidney Failure
2020682,Dual inhibition of cannabinoid CB 1 receptor and inducible NOS attenuates obesity-induced chronic kidney disease,https://pubmed.ncbi.nlm.nih.gov/31454063/,Positive,,Animal Study,2020,Synthetic Cannabinoid (unspecified),Urinary System,Chronic Kidney Disease; Obesity; Oxidative Stress
2014102,Cannabinoid mouth spray brought help to a severely spastic young man,https://pubmed.ncbi.nlm.nih.gov/25158585/,Positive,,Meta-analysis,2014,,,Multiple Sclerosis
2020683,Efficacy and safety of nabiximols cannabinoid medicine for paediatric spasticity in cerebral palsy or traumatic brain injury: a randomized controlled trial,https://pubmed.ncbi.nlm.nih.gov/32342496/,Inconclusive,,Double Blind Clinical Trial,2020,Pharma THC:CBD,Nervous System,Cerebral Palsy
2020684,Comparison of Efficacy of Cannabinoids versus Commercial Oral Care Products in Reducing Bacterial Content from Dental Plaque: A Preliminary Observation,https://pubmed.ncbi.nlm.nih.gov/32038896/,Positive,,Laboratory Study,2020,Cannabichromene (CBC); Cannabigerol (CBG); Cannabigerolic Acid (CBG-a); Cannabinol (CBN),Integumentary System,Cavities
2020685,Abrupt withdrawal of cannabidiol (CBD): A randomized trial,https://www.sciencedirect.com/science/article/abs/pii/S1525505019311163,Positive,,Double Blind Clinical Trial,2020,Pharma CBD,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects
2019194,Cannabinoids and bone regeneration,https://pubmed.ncbi.nlm.nih.gov/30702341/,Positive,,Meta-analysis,2019,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Skeletal System,Bone Fractures
2020686,Cannabis use: A co-existing condition in first-episode bipolar mania patients,https://pubmed.ncbi.nlm.nih.gov/31818791/,Inconclusive,,Meta-analysis,2020,,,Bipolar Disorder
2019195,Endocannabinoid System Components as Potential Biomarkers in Psychiatry,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197485/,Positive,,Meta-analysis,2019,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); WIN-x Synthetic Cannabinoids,,ADD and ADHD; Anorexia; Anxiety; Bipolar Disorder; Depression; PTSD; Schizophrenia
2020687,Cannabidiol as a Treatment for Mood Disorders: A Systematic Review,https://pubmed.ncbi.nlm.nih.gov/31830820/,Inconclusive,,Meta-analysis,2020,,,Anxiety; Bipolar Disorder; Depression
2020688,Cannabidiol is an effective helper compound in combination with bacitracin to kill Gram-positive bacteria,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057955/,Positive,,Laboratory Study,2020,,Immune System,Bacterial Infections; Staph Infection
2020689,Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients,https://pubmed.ncbi.nlm.nih.gov/32017685/,Positive,,Meta-analysis,2020,Cannabinol (CBN),Mental/Emotional System; Nervous System,ADD and ADHD
2019196,A case study for the use of medical cannabis in generalized anxiety disorder,https://discoveriesjournals.org/discoveries/D.2019.02.OACS.Walkaden.pdf,Positive,,Meta-analysis,2019,,Mental/Emotional System,Anxiety
2020690,"Cannabidiol treatment in an adolescent with multiple substance abuse, social anxiety and depression",https://link.springer.com/article/10.1007/s40211-020-00334-0#Sec2,Positive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Addiction; Anxiety; Depression; Addiction - Cannabis; Addiction - Cocaine; Cannabis Adverse Effects; MDMA Adverse Effects
1970003,Marihuana Bronchitis,https://jamanetwork.com/journals/jama/article-abstract/351608,Inconclusive,,Meta-analysis,1970,,Respiratory System,Bronchitis
2016140,Cannabis--Position Paper of the German Respiratory Society,https://pubmed.ncbi.nlm.nih.gov/26935046/,Positive,,Meta-analysis,2016,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Asthma; Bronchitis; Cancer - Lung; Cancer
2019197,The Differences in the Proteome Profile of Cannabidiol-Treated Skin Fibroblasts following UVA or UVB Irradiation in 2D and 3D Cell Cultures,https://pubmed.ncbi.nlm.nih.gov/31466340/,Inconclusive,,Laboratory Study,2019,,,Sunburn
2019198,Cannabidiol Regulates the Expression of Keratinocyte Proteins Involved in the Inflammation Process through Transcriptional Regulation,https://pubmed.ncbi.nlm.nih.gov/31382646/,Positive,,Laboratory Study,2019,,Integumentary System,Sunburn
2017136,Comparison of protective effect of ascorbic acid on redox and endocannabinoid systems interactions in in vitro cultured human skin fibroblasts exposed to UV radiation and hydrogen peroxide,https://pubmed.ncbi.nlm.nih.gov/28285367/,Inconclusive,,Laboratory Study,2017,,,Sunburn
2019199,COPD secondary or associated with cannabis dependence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626119/,Negative,,Meta-analysis,2019,,Mental/Emotional System; Nervous System; Respiratory System,Cannabis Adverse Effects; COPD
2013093,Cannabis use and impairment of respiratory function,https://pubmed.ncbi.nlm.nih.gov/23664286/,Negative,,Meta-analysis,2013,,Respiratory System,Bronchitis
2014103,Marijuana and lung diseases,https://pubmed.ncbi.nlm.nih.gov/24384575/,Negative,,Meta-analysis,2014,,,Bronchitis; Cancer - Lung; Cancer
2020691,Medical Cannabis in Asthmatic Patients,https://pubmed.ncbi.nlm.nih.gov/32286026/,Positive,,Meta-analysis,2020,,Respiratory System,Asthma; Bronchitis
2020692,Electronic Delivery (Vaping) Of Cannabis And Nicotine,https://pubmed.ncbi.nlm.nih.gov/31424744/,Inconclusive,,Meta-analysis,2020,,,Bronchitis; Cough
2019200,Impact of changes in regular use of marijuana and/or tobacco on chronic bronchitis,https://pubmed.ncbi.nlm.nih.gov/22497563/,Negative,,Meta-analysis,2019,,Respiratory System,Bronchitis
2012114,Involvement of the endogenous cannabinoid 2 ligand 2-arachidonyl glycerol in allergic inflammation,https://pubmed.ncbi.nlm.nih.gov/22652530/,Inconclusive,,Animal Study,2012,2-Arachidonoyl Glycerol (2-AG),Integumentary System; Respiratory System,Allergic Contact Dermatitis; Bronchitis
2006028,Inhaled marijuana smoke disrupts mitochondrial energetics in pulmonary epithelial cells in vivo,https://journals.physiology.org/doi/full/10.1152/ajplung.00371.2005?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed&,Negative,,Animal Study,2006,,Respiratory System,Bronchitis
2002027,Respiratory and immunologic consequences of marijuana smoking,https://pubmed.ncbi.nlm.nih.gov/12412839/,Negative,,Meta-analysis,2002,,,Bronchitis; Cancer - Lung; Cancer
2019201,Cannabinoids determination in bronchoalveolar lavages of cannabis smokers with lung disease,https://pubmed.ncbi.nlm.nih.gov/30231009/,Inconclusive,,Laboratory Study,2019,Cannabinol (CBN),,Bronchitis; Cough
2015117,Does marijuana pose risks for chronic airflow obstruction?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342838/,Inconclusive,,Meta-analysis,2015,,,Bronchitis; Cancer - Lung; Cancer; COPD
2015118,The effects of marijuana exposure on expiratory airflow. A study of adults who participated in the U.S. National Health and Nutrition Examination Study,https://pubmed.ncbi.nlm.nih.gov/25521349/,Inconclusive,,Meta-analysis,2015,,,Bronchitis; COPD
2018202,Marijuana and the lung: hysteria or cause for concern?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118880/,Inconclusive,,Meta-analysis,2018,,,Bronchitis; Cancer - Lung; Cancer; Cannabis Adverse Effects; COPD; Cough
2016141,Effect of cannabis smoking on lung function and respiratory symptoms: a structured literature review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072387/,Negative,,Meta-analysis,2016,,,Bronchitis; Cancer - Lung; Cancer; COPD; Cough
2016142,Damaging Effects of Cannabis Use on the Lungs,https://pubmed.ncbi.nlm.nih.gov/27573646/,Negative,,Meta-analysis,2016,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Bronchitis; Cancer - Lung; Cancer; Cough
2008065,Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers,https://pubmed.ncbi.nlm.nih.gov/18580179/,Inconclusive,,Double Blind Clinical Trial,2008,Tetrahydrocannabinol (THC),Integumentary System,Sunburn; Pain; Pain - Acute
2013094,Terpene compound drug as medical expulsive therapy for ureterolithiasis: a meta-analysis,https://pubmed.ncbi.nlm.nih.gov/23503876/,Positive,,Meta-analysis,2013,,Urinary System,Kidney Stones
1987002,The value of Rowatinex in the treatment of ureterolithiasis,https://pubmed.ncbi.nlm.nih.gov/3549909/,Positive,,Double Blind Clinical Trial,1987,,Urinary System,Kidney Stones
2009055,Effect of Rowatinex on calculus clearance after extracorporeal shock wave lithotripsy,https://pubmed.ncbi.nlm.nih.gov/19241334/,Positive,,Double Blind Clinical Trial,2009,,Urinary System,Kidney Stones
2011099,"Evaluation of the efficiency of tamsulosin and Rowatinex in patients with distal ureteral stones: a prospective, randomized, controlled study",https://pubmed.ncbi.nlm.nih.gov/20535638/,Inconclusive,,Double Blind Clinical Trial,2011,,Urinary System,Kidney Stones
1992005,Rowatinex for the treatment of ureterolithiasis,https://pubmed.ncbi.nlm.nih.gov/1431192/,Positive,,Double Blind Clinical Trial,1992,,Urinary System,Kidney Stones
2014104,The Effect of Terpene Combination on Ureter Calculus Expulsion After Extracorporeal Shock Wave Lithotripsy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897628/,Positive,,Clinical Trial,2014,,Urinary System,Kidney Stones
2020693,"Dosage, Efficacy and Safety of Cannabidiol Administration in Adults: A Systematic Review of Human Trials",https://pubmed.ncbi.nlm.nih.gov/32231748/,Positive,,Clinical Meta-analysis,2020,,,Anxiety; Psychosis; Schizophrenia
2020694,Epigenetic regulation of the cannabinoid receptor CB1 in an activity-based rat model of anorexia nervosa,https://pubmed.ncbi.nlm.nih.gov/32275093/,Positive,,Animal Study,2020,,Mental/Emotional System,Anorexia Nervosa; Anorexia
20211347,Treatment studies with cannabinoids in anorexia nervosa: a systematic review,https://pubmed.ncbi.nlm.nih.gov/32240516/,Inconclusive,,Clinical Meta-analysis,2021,Pharma THC,Mental/Emotional System,Anorexia Nervosa; Anorexia
2020695,Targeting Cannabinoid Receptor Activation and BACE-1 Activity Counteracts TgAPP Mice Memory Impairment and Alzheimer's Disease Lymphoblast Alterations,https://pubmed.ncbi.nlm.nih.gov/31898159/,Positive,,Meta-analysis,2020,Synthetic Cannabinoid (unspecified),Nervous System,Alzheimer's Disease; Dementia; Cognitive Dysfunction
2020696,A Systematic Review of Clinical Studies on the Effect of Psychoactive Cannabinoids in Psychiatric Conditions in Alzheimer Dementia,https://pubmed.ncbi.nlm.nih.gov/32118591/,Inconclusive,,Clinical Meta-analysis,2020,,Nervous System,Alzheimer's Disease; Dementia
2020697,From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases,https://pubmed.ncbi.nlm.nih.gov/32210795/,Positive,,Meta-analysis,2020,,Nervous System,Neurodegenerative Issues; Alzheimer's Disease; Inflammation; Oxidative Stress; Parkinson's Disease
2020698,Crosstalk between the M 1 muscarinic acetylcholine receptor and the endocannabinoid system: A relevance for Alzheimer's disease?,https://pubmed.ncbi.nlm.nih.gov/31978506/,Positive,,Meta-analysis,2020,,Nervous System,Alzheimer's Disease
2020699,"Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer's disease",https://pubmed.ncbi.nlm.nih.gov/32109623/,Positive,,Meta-analysis,2020,,Nervous System,Alzheimer's Disease; Epilepsy
2020700,Cannabinoid Receptor 2 Modulates Maturation of Dendritic Cells and Their Capacity to Induce Hapten-Induced Contact Hypersensitivity,https://pubmed.ncbi.nlm.nih.gov/31940843/,Positive,,Animal Study,2020,,Integumentary System,Allergic Contact Dermatitis
2020701,An inverse agonist of estrogen-related receptor γ regulates 2-arachidonoylglycerol synthesis by modulating diacylglycerol lipase expression in alcohol-intoxicated mice,https://pubmed.ncbi.nlm.nih.gov/31912162/,Positive,,Animal Study,2020,2-Arachidonoyl Glycerol (2-AG); Other Related Compounds,Digestive System,Alcoholic Liver Disease
2019202,A new target to ameliorate the damage of periodontal disease: The role of transient receptor potential vanilloid type-1 in contrast to that of specific cannabinoid receptors in rats,https://pubmed.ncbi.nlm.nih.gov/31077362/,Positive,,Animal Study,2019,AM-x Synthetic Cannabinoids,Digestive System,Periodontal Disease; Pain - Dental - Acute
2016143,Anti-Inflammatory and Osteoprotective Effects of Cannabinoid-2 Receptor Agonist HU-308 in a Rat Model of Lipopolysaccharide-Induced Periodontitis,https://pubmed.ncbi.nlm.nih.gov/26846967/,Positive,,Animal Study,2016,HU-x Synthetic Cannabinoids,Digestive System,Periodontal Disease; Pain - Dental - Acute
2020702,The peripheral CB 1 receptor antagonist JD5037 attenuates liver fibrosis via a CB 1 receptor/β-arrestin1/Akt pathway,https://pubmed.ncbi.nlm.nih.gov/32017042/,Positive,,Animal Study,2020,Synthetic Cannabinoid (unspecified),Digestive System,Fibrosis - Liver (Cirrhosis); Fibrosis
2008066,Cannabinoids Inhibit HIV-1 Gp120-Mediated Insults in Brain Microvascular Endothelial Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3735224/,Positive,,Laboratory Study,2008,CP-x Synthetic Cannabinoids; 2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Other Related Compounds,Immune System,HIV/AIDS
2018203,"Association of Cannabis, Stimulant, and Alcohol use with Mortality Prognosis Among HIV-Infected Men",https://pubmed.ncbi.nlm.nih.gov/28887669/,Inconclusive,,Meta-analysis,2018,,Immune System,HIV/AIDS; Cannabis Adverse Effects
2020703,The L-α-lysophosphatidylinositol/GPR55 system induces the development of non-alcoholic steatosis and steatohepatitis,https://pubmed.ncbi.nlm.nih.gov/32329085/,Positive,,Animal Study,2020,Lysophosphatidylinositol (LPI),Digestive System,Fatty Liver Disease
2020704,"The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease",https://pubmed.ncbi.nlm.nih.gov/32210914/,Positive,,Animal Study,2020,Abnormal Cannabidiol (Abn-CBD),Digestive System,Fatty Liver Disease; Metabolic Syndrome; Obesity
2011100,Treatment of Crohn's Disease With Cannabis: An Observational Study,https://pubmed.ncbi.nlm.nih.gov/21910367/,Positive,,Meta-analysis,2011,,Digestive System,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease
2018204,"Opioid, Alcohol, and Cannabis Misuse Among Patients With Hidradenitis Suppurativa: A Population-Based Analysis in the United States",https://pubmed.ncbi.nlm.nih.gov/29499293/,Inconclusive,,Meta-analysis,2018,,Integumentary System,Acne Inversa; Addiction - Alcohol; Addiction - Cannabis; Addiction - Opioid
2011101,Screening for Antiviral Activities of Isolated Compounds from Essential Oils,https://www.hindawi.com/journals/ecam/2011/253643/,Positive,,Laboratory Study,2011,,Integumentary System,Herpes; Shingles (Herpes Zoster)
2015119,Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH),https://pubmed.ncbi.nlm.nih.gov/25778750/,Positive,,Meta-analysis,2015,,Digestive System; Endocrine System; Immune System,Hepatitis; HIV/AIDS; Metabolic Syndrome; Diabetes
2015120,Elevated Levels of Endocannabinoids in Chronic Hepatitis C May Modulate Cellular Immune Response and Hepatic Stellate Cell Activation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425004/,Inconclusive,,Laboratory Study,2015,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Digestive System,Hepatitis
2017137,Potential of Cannabidiol for the Treatment of Viral Hepatitis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330095/,Positive,,Laboratory Study,2017,,Digestive System,Hepatitis
2017138,Hepatitis A virus infection associated with cannabis use,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764743/,Negative,,Meta-analysis,2017,,Digestive System,Hepatitis
2018205,Use of Cannabis and Risk of Advanced Liver Fibrosis in Patients With Chronic Hepatitis C Virus Infection: A Systematic Review and Meta-Analysis,https://pubmed.ncbi.nlm.nih.gov/30398032/,Negative,,Meta-analysis,2018,,Digestive System,Fibrosis - Liver (Cirrhosis); Fibrosis; Hepatitis
2013095,Cardioprotective Effect of Cannabidiol in Rats Exposed to Doxorubicin Toxicity,https://pubmed.ncbi.nlm.nih.gov/23721741/,Positive,,Animal Study,2013,,,Cardiovascular Diseases (CVD); Heart Attack
2018206,"Cannabinoids and Gastrointestinal Motility: Pharmacology, Clinical Effects, and Potential Therapeutics in Humans",https://pubmed.ncbi.nlm.nih.gov/29745439/,Positive,,Meta-analysis,2018,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Digestive System,Constipation; Gastroparesis
2010069,Expression and Activity of Fatty Acid Amide Hydrolase in the Colon in Children With Slow Transit Constipation,https://pubmed.ncbi.nlm.nih.gov/20099163/,Inconclusive,,Clinical Trial,2010,Fatty Acid Amide Hydrolase (FAAH),Digestive System,Constipation
2007048,Atrial Fibrillation and Marijuana Smoking,https://pubmed.ncbi.nlm.nih.gov/18031530/,Negative,,Meta-analysis,2007,,Cardiovascular System,Atrial Fibrillation; Cardiovascular Diseases (CVD)
2005035,"Paroxysmal Atrial Fibrillation After Recreational Marijuana Smoking: Another ""Holiday Heart""?",https://pubmed.ncbi.nlm.nih.gov/16220412/,Negative,,Meta-analysis,2005,,Cardiovascular System,Atrial Fibrillation; Cardiovascular Diseases (CVD)
2000011,Paroxysmal Atrial Fibrillation in a Young Female Patient Following Marijuana Intoxication--A Case Report of Possible Association,https://pubmed.ncbi.nlm.nih.gov/11208344/,Negative,,Meta-analysis,2000,,Cardiovascular System,Atrial Fibrillation; Cardiovascular Diseases (CVD)
2000012,Atrial Fibrillation Associated With Marijuana Use,https://link.springer.com/content/pdf/10.1007/s002460010063.pdf,Negative,,Meta-analysis,2000,,Cardiovascular System,Atrial Fibrillation; Cardiovascular Diseases (CVD)
1976003,Effect of Marihuana on Hearing,https://pubmed.ncbi.nlm.nih.gov/933252/,Inconclusive,,Clinical Trial,1976,,Nervous System,Hearing Loss
2018207,Therapeutic Cannabis and Endocannabinoid Signaling System Modulator Use in Otolaryngology Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057224/,Positive,,Meta-analysis,2018,,,Cancer - Oral; Cancer - Skin (Non-melanoma); Cancer - Squamous Head/Neck; Cancer - Thyroid; Cancer
2018208,Association of Marijuana Use With Psychosocial and Quality of Life Outcomes Among Patients With Head and Neck Cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248184/,Positive,,Meta-analysis,2018,,Integumentary System; Nervous System,Cancer - Squamous Head/Neck; Cancer
2018209,Marijuana and head and neck cancer: an epidemiological review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249858/,Inconclusive,,Meta-analysis,2018,,Integumentary System; Nervous System,Cancer - Squamous Head/Neck; Cancer
2016144,An Event-Related Potential Study on the Effects of Cannabis on Emotion Processing,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0149764,Negative,,Meta-analysis,2016,,,Grief and Bereavement
2003025,Neuroprotective Effect of(−)Δ9-Tetrahydrocannabinol and Cannabidiol in N-Methyl-d-Aspartate-Induced Retinal Neurotoxicity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1892413/,Positive,,Animal Study,2003,SR-x Synthetic Cannabinoids,Nervous System,Glaucoma
2016145,Cannabinoids for Treatment of Glaucoma,https://pubmed.ncbi.nlm.nih.gov/26840343/,Inconclusive,,Meta-analysis,2016,,Nervous System,Glaucoma
2009056,CB(2) Cannabinoid Receptor Activation Is Cardioprotective in a Mouse Model of ischemia/reperfusion,https://pubmed.ncbi.nlm.nih.gov/19162037/,Positive,,Animal Study,2009,JWH-x Synthetic Cannabinoids,Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack; Reperfusion Injury
2004030,Cannabidiol Prevents Infarction via the non-CB1 Cannabinoid Receptor Mechanism,https://pubmed.ncbi.nlm.nih.gov/15640760/,Positive,,Animal Study,2004,Tetrahydrocannabinol (THC),Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack
1981007,Marijuana and Second-Degree AV Block,https://pubmed.ncbi.nlm.nih.gov/6261403/,Negative,,Meta-analysis,1981,,Cardiovascular System,Cardiac Arrhythmias; Cardiovascular Diseases (CVD)
2011102,"Cannabidiol Protects Against Hepatic Ischemia/Reperfusion Injury by Attenuating Inflammatory Signaling and Response, Oxidative/Nitrative Stress, and Cell Death",https://pubmed.ncbi.nlm.nih.gov/21362471/,Positive,,Animal Study,2011,,Cardiovascular System,Cardiovascular Diseases (CVD); Reperfusion Injury; Inflammation
2012115,Δ8-Tetrahydrocannabivarin Prevents Hepatic Ischaemia/Reperfusion Injury by Decreasing Oxidative Stress and Inflammatory Responses Through Cannabinoid CB2 Receptors,https://pubmed.ncbi.nlm.nih.gov/21470208/,Positive,,Animal Study,2012,Tetrahydrocannabivarin (THCV),Cardiovascular System,Cardiovascular Diseases (CVD); Reperfusion Injury; Inflammation
2008067,Cannabis Smoking and Periodontal Disease Among Young Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823391/pdf/nihms173277.pdf,Negative,,Meta-analysis,2008,,Digestive System,Periodontal Disease
2020705,Cannabinoid Type 2 Receptor Agonist JWH133 Decreases Blood Pressure of Spontaneously Hypertensive Rats Through Relieving Inflammation in the Rostral Ventrolateral Medulla of the Brain,https://pubmed.ncbi.nlm.nih.gov/32238784/,Positive,,Animal Study,2020,JWH-x Synthetic Cannabinoids,Cardiovascular System; Nervous System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Inflammation
2009057,Cannabis Use and Destructive Periodontal Diseases Among Adolescents,https://pubmed.ncbi.nlm.nih.gov/19236530/,Inconclusive,,Meta-analysis,2009,,Digestive System,Periodontal Disease
2020706,Stimulation of Atypical Cannabinoid Receptor GPR55 Abolishes the Symptoms of Detrusor Overactivity in Spontaneously Hypertensive Rats,https://pubmed.ncbi.nlm.nih.gov/32360768/,Positive,,Animal Study,2020,O-x Synthetic Cannabinoids,Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Cystitis; Urinary Incontinence
2017139,Relationship Between Frequent Recreational Cannabis (Marijuana and Hashish) Use and Periodontitis in Adults in the United States: National Health and Nutrition Examination Survey 2011 to 2012,https://aap.onlinelibrary.wiley.com/doi/abs/10.1902/jop.2016.160370,Negative,,Meta-analysis,2017,,Digestive System,Periodontal Disease
2017140,"Demographic trends among older cannabis users in the United States, 2006–13",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5300687/,Inconclusive,,Meta-analysis,2017,,,Geriatric Conditions
2020707,Stimulation of Brain Cannabinoid CB 1 Receptors Can Ameliorate Hypertension in Spontaneously Hypertensive Rats,https://pubmed.ncbi.nlm.nih.gov/32141630/,Positive,,Animal Study,2020,Synthetic Cannabinoid (unspecified),Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2018210,Characteristics and Patterns of Marijuana Use in Community-Dwelling Older Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476562/,Positive,,Meta-analysis,2018,,Muscular System; Skeletal System,Geriatric Conditions; Anxiety; Depression; Insomnia and Sleep Disorders; Pain
2020708,"Chronic Cannabidiol Administration Fails to Diminish Blood Pressure in Rats With Primary and Secondary Hypertension Despite Its Effects on Cardiac and Plasma Endocannabinoid System, Oxidative Stress and Lipid Metabolism",https://pubmed.ncbi.nlm.nih.gov/32075117/,Inconclusive,,Animal Study,2020,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Other Related Compounds,Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2020709,Endocannabinoids and Stroke Prevention: Review of Clinical Studies,https://pubmed.ncbi.nlm.nih.gov/32322672/,Positive,,Clinical Meta-analysis,2020,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Nervous System,Stroke
2019203,The GPR55 Antagonist CID16020046 Protects Against ox-LDL-induced Inflammation in Human Aortic Endothelial Cells (HAECs),https://pubmed.ncbi.nlm.nih.gov/31904362/,Positive,,Laboratory Study,2019,Synthetic Cannabinoid (unspecified),Cardiovascular System,Atherosclerosis; Cardiovascular Diseases (CVD)
2019204,Chronic Marijuana and Synthetic Cannabinoid-Induced Toxic Myocarditis and End-Stage Cardiomyopathy: Management With Mechanical Circulatory Support as a Bridge-to-Transplantation,https://pubmed.ncbi.nlm.nih.gov/30606509/,Negative,,Meta-analysis,2019,Synthetic Cannabinoid (unspecified),Cardiovascular System; Nervous System,Cardiovascular Diseases (CVD); Myocarditis; Poisoning by Synthetic Cannabis
2020710,Marijuana Use and Coronary Artery Disease in Young Adults,https://pubmed.ncbi.nlm.nih.gov/31995626/,Inconclusive,,Meta-analysis,2020,,Cardiovascular System,Cardiovascular Diseases (CVD)
2019205,Cannabis Use and Acute Coronary Syndrome,https://pubmed.ncbi.nlm.nih.gov/30964363/,Negative,,Meta-analysis,2019,,Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack
2019206,2-Arachidonoylglycerol Mobilizes Myeloid Cells and Worsens Heart Function After Acute Myocardial Infarction,https://pubmed.ncbi.nlm.nih.gov/30295758/,Inconclusive,,Animal Study,2019,2-Arachidonoyl Glycerol (2-AG); Monoacylglycerol Lipase (MAGL),Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack
2020711,Effectiveness of Cannabinoids for Treatment of Dementia: A Systematic Review of Randomized Controlled Trials,https://pubmed.ncbi.nlm.nih.gov/32186469/,Positive,,Clinical Meta-analysis,2020,Pharma THC,Nervous System,Cognitive Dysfunction; Alzheimer's Disease
2019207,Fatty Acid Amide Hydrolase Inhibition Normalises Bladder Function and Reduces Pain Through Normalising the Anandamide/Palmitoylethanolamine Ratio in the Inflamed Bladder of Rats,https://pubmed.ncbi.nlm.nih.gov/31522241/,Positive,,Animal Study,2019,Fatty Acid Amide Hydrolase (FAAH); Anandamide (AEA); Other Related Compounds,Urinary System,Cystitis
2020712,An Overview of Cannabis Based Treatment in Crohn's Disease,https://pubmed.ncbi.nlm.nih.gov/32149543/,Positive,,Meta-analysis,2020,,Digestive System,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Irritable Bowel Syndrome
2019208,Regional Changes in the Type 1 Cannabinoid Receptor Are Associated With Cognitive Dysfunction in Parkinson's Disease,https://pubmed.ncbi.nlm.nih.gov/31342135/,Inconclusive,,Meta-analysis,2019,,Nervous System,Cognitive Dysfunction; Parkinson's Disease
2020713,Cannabinoids in Chronic Non-Cancer Pain: A Systematic Review and Meta-Analysis,https://pubmed.ncbi.nlm.nih.gov/32127750/,Positive,,Meta-analysis,2020,,Nervous System,Pain; Pain - Chronic
2019209,Restored Self: A Phenomenological Study of Pain Relief by Cannabis,https://pubmed.ncbi.nlm.nih.gov/30215782/,Positive,,Meta-analysis,2019,,Nervous System,Pain; Pain - Chronic
2020714,Medical Cannabis as an Alternative for Opioids for Chronic Pain: A Case Report,https://pubmed.ncbi.nlm.nih.gov/32110409/,Positive,,Meta-analysis,2020,,Nervous System,Pain; Pain - Chronic
2020715,Medical cannabis and insomnia in older adults with chronic pain: a cross-sectional study,https://pubmed.ncbi.nlm.nih.gov/31959585/,Inconclusive,,Meta-analysis,2020,,Nervous System,Insomnia and Sleep Disorders; Pain; Pain - Chronic
2018211,Medical Cannabis Use in Older Patients: Update on Medical Knowledge,https://pubmed.ncbi.nlm.nih.gov/30415756/,Inconclusive,,Meta-analysis,2018,,Muscular System; Nervous System; Skeletal System,Geriatric Conditions; Sarcopenia
2002028,Cannabinoid Receptor Agonism Inhibits Transient Lower Esophageal Sphincter Relaxations and Reflux in Dogs,https://pubmed.ncbi.nlm.nih.gov/12360475/?dopt=Abstract,Positive,,Animal Study -,2002,SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Digestive System,Gastro-Esophageal Reflux; Veterinary Applications
2004031,Involvement of cannabinoid receptors in gut motility and visceral perception,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574910/,Positive,,Meta-analysis,2004,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Tetrahydrocannabinol (THC); WIN-x Synthetic Cannabinoids,,Gastro-Esophageal Reflux; IBD - Crohn's Disease; Irritable Bowel Syndrome
2007049,Cannabinoid Type 1 Receptor Modulates Intestinal Propulsion by an Attenuation of Intestinal Motor Responses Within the Myenteric Part of the Peristaltic Reflex,https://pubmed.ncbi.nlm.nih.gov/17727394/?dopt=Abstract,Positive,,Laboratory Study,2007,AM-x Synthetic Cannabinoids; Anandamide (AEA),,IBD - Crohn's Disease; Irritable Bowel Syndrome
2020716,Matched pilot study examining cannabis-based dronabinol for acute pain following traumatic injury,https://tsaco.bmj.com/content/5/1/e000391.abstract,Positive,,Meta-analysis,2020,Pharma THC,Nervous System,Pain; Pain - Acute
2017141,The Role of Cannabinoids on Esophageal Function—What We Know Thus Far,https://www.liebertpub.com/doi/10.1089/can.2017.0031,Inconclusive,,Meta-analysis,2017,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Digestive System,Gastro-Esophageal Reflux
2019210,"Cannabinoid Receptors Signaling in the Development, Epigenetics, and Tumours of Male Germ Cells",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981618/,Inconclusive,,Meta-analysis,2019,,Nervous System; Reproductive System,Cancer - Testicular; Cancer
2017142,Cannabis use and incidence of testicular cancer: a 42-year follow-up of Swedish men between 1970 and 2011,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812006/,Negative,,Meta-analysis,2017,,Nervous System; Reproductive System,Cancer - Testicular; Cancer
2015121,Cannabis exposure and risk of testicular cancer: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642772/,Negative,,Meta-analysis,2015,,Reproductive System,Cancer - Testicular; Cancer
2011103,Marijuana use and testicular germ cell tumors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017734/,Negative,,Meta-analysis,2011,,Reproductive System,Cancer - Testicular; Cancer
2016146,"Cannabinoids, Inflammation, and Fibrosis",https://pubmed.ncbi.nlm.nih.gov/27435265/,Positive,,Meta-analysis,2016,Cannabichromene (CBC); Cannabinol (CBN); Pharma THC:CBD; Pharma THC,,Cardiovascular Diseases (CVD); Fibrosis - Cardiac; Fibrosis - Liver (Cirrhosis); Fibrosis - Lung; Fibrosis - Skin; Fibrosis; Inflammation
2008068,Anandamide and Neutrophil Function in Patients With Fibromyalgia,https://pubmed.ncbi.nlm.nih.gov/18395993/,Positive,,Meta-analysis,2008,Anandamide (AEA),Muscular System,Fibromyalgia; Oxidative Stress
2008069,"Clinical Endocannabinoid Deficiency (CECD): Can This Concept Explain Therapeutic Benefits of Cannabis in Migraine, Fibromyalgia, Irritable Bowel Syndrome and Other Treatment-Resistant Conditions?",https://pubmed.ncbi.nlm.nih.gov/18404144/,Inconclusive,,Meta-analysis,2008,Endocannabinoid (unspecified),Digestive System; Muscular System; Nervous System,Fibromyalgia; Irritable Bowel Syndrome; Migraine
2011104,Cannabis Use in Patients with Fibromyalgia: Effect on Symptoms Relief and Health-Related Quality of Life,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080871/,Positive,,Meta-analysis,2011,,Muscular System,Fibromyalgia
2012116,Association of Herbal Cannabis Use With Negative Psychosocial Parameters in Patients With Fibromyalgia,https://pubmed.ncbi.nlm.nih.gov/22730275/,Inconclusive,,Meta-analysis,2012,,Mental/Emotional System; Muscular System; Nervous System,Cannabis Adverse Effects; Fibromyalgia
2014105,"Clinical Endocannabinoid Deficiency (CECD) Revisited: Can This Concept Explain the Therapeutic Benefits of Cannabis in Migraine, Fibromyalgia, Irritable Bowel Syndrome and Other Treatment-Resistant Conditions?",https://pubmed.ncbi.nlm.nih.gov/24977967/,Inconclusive,,Meta-analysis,2014,Endocannabinoid (unspecified),Digestive System; Muscular System; Nervous System,Fibromyalgia; Irritable Bowel Syndrome; Migraine
2016147,"Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576607/,Inconclusive,,Meta-analysis,2016,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Pharma THC:CBD; Pharma THC; WIN-x Synthetic Cannabinoids,Digestive System; Muscular System,Fibromyalgia; Irritable Bowel Syndrome; Migraine
2016148,Cannabinoids for fibromyalgia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457965/,Inconclusive,,Meta-analysis,2016,Pharma THC,Muscular System,Fibromyalgia
2014106,Cannabinoid Receptor Type 1 Immunoreactivity and Disease Severity in Human Epithelial Ovarian Tumors,https://pubmed.ncbi.nlm.nih.gov/24721263/,Positive,,Laboratory Study,2014,,Nervous System; Reproductive System,Cancer - Ovarian; Cancer
2018212,The Consumption of Cannabis by Fibromyalgia Patients in Israel,https://pubmed.ncbi.nlm.nih.gov/30140459/,Positive,,Meta-analysis,2018,,Muscular System,Fibromyalgia
2017143,Drowsiness and Uncommon Fever in a Child After Cannabis Ingestion,https://pubmed.ncbi.nlm.nih.gov/28751294/,Negative,,Meta-analysis,2017,,,Cannabis Adverse Effects
2007050,Selective CB2 up‐regulation in women affected by endometrial inflammation,https://onlinelibrary.wiley.com/doi/full/10.1111/j.1582-4934.2007.00085.x,Inconclusive,,Meta-analysis,2007,,Endocrine System,Endometriosis; Inflammation
2012117,"Progesterone-dependent Regulation of Endometrial Cannabinoid Receptor Type 1 (CB1-R) Expression is Disrupted in Women with Endometriosis and in Isolated Stromal Cells Exposed to TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin)",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462249/,Inconclusive,,Laboratory Study,2012,,Endocrine System,Endometriosis
2017144,The Clinical Significance of Endocannabinoids in Endometriosis Pain Management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436335/,Positive,,Meta-analysis,2017,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Palmitoylethanolamide (PEA); Tetrahydrocannabinol (THC); WIN-x Synthetic Cannabinoids,Endocrine System,Endometriosis
2006029,Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1458883/?tool=pmcentrez,Positive,,Animal Study,2006,2-Arachidonoyl Glycerol (2-AG),,Encephalitis and Myelitis; Multiple Sclerosis
2015122,"Comparison of Antispasmodic Effects of Dracocephalum Kotschyi Essential Oil, Limonene and α-Terpineol",https://pubmed.ncbi.nlm.nih.gov/26487887/,Positive,,Animal Study,2015,,,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease
2012118,α-Terpineol Reduces Mechanical Hypernociception and Inflammatory Response,https://pubmed.ncbi.nlm.nih.gov/22380944/,Positive,,Animal Study,2012,,Nervous System,Inflammation; Pain
2011105,Gastroprotective Activity of α-Terpineol in Two Experimental Models of Gastric Ulcer in Rats,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304384/,Positive,,Animal Study,2011,,Digestive System,Stomach Ulcers
2020717,Antidepressant-Like Effect of Terpineol in an Inflammatory Model of Depression: Involvement of the Cannabinoid System and D2 Dopamine Receptor,https://www.mdpi.com/2218-273X/10/5/792,Positive,,Animal Study,2020,AM-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Depression
2018213,Antibacterial Activity and Time-kill Kinetics of Positive Enantiomer of α-Pinene Against Strains of Staphylococcus Aureus and Escherichia Coli,https://pubmed.ncbi.nlm.nih.gov/29998807/,Positive,,Laboratory Study,2018,,Immune System,Bacterial Infections; Staph Infection
2015123,Synergistic Antitumor Effect of α-Pinene and β-Pinene With Paclitaxel Against Non-Small-Cell Lung Carcinoma (NSCLC),https://pubmed.ncbi.nlm.nih.gov/25188609/,Positive,,Laboratory Study,2015,,Nervous System; Respiratory System,Cancer - Lung; Cancer
2019211,"Attenuating Effect of α-Pinene on Neurobehavioural Deficit, Oxidative Damage and Inflammatory Response Following Focal Ischaemic Stroke in Rat",https://pubmed.ncbi.nlm.nih.gov/31523814/,Positive,,Animal Study,2019,,Nervous System,Stroke
2015124,Gastroprotective Effect of Alpha-Pinene and Its Correlation With Antiulcerogenic Activity of Essential Oils Obtained From Hyptis Species,https://pubmed.ncbi.nlm.nih.gov/25709221/,Positive,,Animal Study,2015,,Digestive System,Stomach Ulcers
2016149,"α-Pinene, a Major Constituent of Pine Tree Oils, Enhances Non-Rapid Eye Movement Sleep in Mice Through GABAA-benzodiazepine Receptors",https://pubmed.ncbi.nlm.nih.gov/27573669/,Positive,,Animal Study,2016,,Nervous System,Insomnia and Sleep Disorders
2016150,In Vitro Assessment of Cytogenetic and Oxidative Effects of α-Pinene,https://pubmed.ncbi.nlm.nih.gov/24081629/,Positive,,Laboratory Study,2016,,Nervous System,Oxidative Stress
2018214,"Antifungal Activity, Mode of Action, Docking Prediction and Anti-biofilm Effects of (+)-β-Pinene Enantiomers Against Candida Spp",https://pubmed.ncbi.nlm.nih.gov/30430938/,Positive,,Laboratory Study,2018,,Digestive System; Immune System; Integumentary System,Fungal Infections
2019212,A Fragrant Environment Containing α-Pinene Suppresses Tumor Growth in Mice by Modulating the Hypothalamus/Sympathetic Nerve/Leptin Axis and Immune System,https://journals.sagepub.com/doi/10.1177/1534735419845139,Positive,,Animal Study,2019,,,Cancer; Cancer - Melanoma
2019213,α-Pinene Regulates miR-221 and Induces G 2/M Phase Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells,https://pubmed.ncbi.nlm.nih.gov/30473536/,Positive,,Laboratory Study,2019,,Digestive System; Nervous System,Cancer - Liver; Cancer
2019214,Comparative Study of Alpha- And Beta-Pinene Effect on PTZ-induced Convulsions in Mice,https://pubmed.ncbi.nlm.nih.gov/30230028/,Inconclusive,,Animal Study,2019,,,Epilepsy
2018215,α-Pinene Inhibits Human Prostate Cancer Growth in a Mouse Xenograft Model,https://pubmed.ncbi.nlm.nih.gov/29069647/,Positive,,Animal Study,2018,,Reproductive System,Cancer - Prostate; Cancer
2019215,Attenuation Effects of Alpha-Pinene Inhalation on Mice With Dizocilpine-Induced Psychiatric-Like Behaviour,https://www.hindawi.com/journals/ecam/2019/2745453/,Positive,,Animal Study,2019,,Mental/Emotional System; Nervous System,Schizophrenia
2019216,α-Pinene Induces Apoptotic Cell Death via Caspase Activation in Human Ovarian Cancer Cells,https://pubmed.ncbi.nlm.nih.gov/31482864/,Positive,,Laboratory Study,2019,,Nervous System; Reproductive System,Cancer - Ovarian; Cancer
1987003,"Effect of a Secretolytic and a Combination of Pinene, Limonene and Cineole on Mucociliary Clearance in Patients With Chronic Obstructive Pulmonary Disease",https://pubmed.ncbi.nlm.nih.gov/3449066/,Positive,,Clinical Trial,1987,,Respiratory System,COPD
2009058,Effect of Phytoncide From Trees on Human Natural Killer Cell Function,https://journals.sagepub.com/doi/10.1177/039463200902200410,Positive,,Clinical Trial,2009,,Mental/Emotional System,
2019217,Schinus Molle Essential Oil as a Potential Source of Bioactive Compounds: Antifungal and Antibacterial Properties,https://pubmed.ncbi.nlm.nih.gov/30431699/,Positive,,Laboratory Study,2019,,Digestive System; Immune System; Integumentary System,Fungal Infections; Bacterial Infections
2016151,Ocimum Gratissimum Essential Oil and Its Isolated Compounds (Eugenol and Myrcene) Reduce Neuropathic Pain in Mice,https://pubmed.ncbi.nlm.nih.gov/26584457/,Positive,,Animal Study,2016,,Nervous System,Pain; Pain - Neuropathy - Peripheral
2020718,Cannabidiol (CBD),https://www.ncbi.nlm.nih.gov/books/NBK556048/,Positive,,Meta-analysis,2020,,,Alzheimer's Disease; Anxiety; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Inflammation; Neurodegenerative Issues; Parkinson's Disease
2002029,"Central Effects of Citral, Myrcene and Limonene, Constituents of Essential Oil Chemotypes From Lippia Alba (Mill.) n.e. Brown",https://pubmed.ncbi.nlm.nih.gov/12587690/,Positive,,Animal Study,2002,Mind-Body Medicine,,Anxiety; Insomnia and Sleep Disorders
2016152,The Protective Cardiac Effects of β-Myrcene After Global Cerebral ıschemia/Reperfusion in C57BL/J6 Mouse,https://pubmed.ncbi.nlm.nih.gov/27487280/,Positive,,Animal Study,2016,,Cardiovascular System; Nervous System,Cardiovascular Diseases (CVD); Chronic Heart Disease; Heart Disease; Reperfusion Injury; Stroke
2011106,"Antioxidative Effects of Curcumin, β-Myrcene and 1,8-cineole Against 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced Oxidative Stress in Rats Liver",https://pubmed.ncbi.nlm.nih.gov/21245202/,Positive,,Animal Study,2011,,,Oxidative Stress; Liver Failure
1993007,Study on Embryo-Foetotoxicity of Beta-Myrcene in the Rat,https://pubmed.ncbi.nlm.nih.gov/8444385/,Inconclusive,,Animal Study,1993,,,Pregnancy
2019218,Genotoxic Effects Induced by Beta-Myrcene Following Metabolism by Liver HepG2/C3A Human Cells,https://www.tandfonline.com/doi/abs/10.1080/15287394.2019.1577195,Negative,,Laboratory Study,2019,,,Fatty Liver Disease; Liver Failure
2018216,Could Beta-Myrcene Be an Alternative to Albendazole for the Treatment of Experimental Cystic Echinococcosis?,https://www.sciencedirect.com/science/article/abs/pii/S0001706X18303061,Positive,,Laboratory Study,2018,,Digestive System,Parasitic Worms
2019219,Acute Effects of Essential Oil Blend Containing Phlai Oil on Mood Among Healthy Male Volunteers: Randomized Controlled Trial,https://pubmed.ncbi.nlm.nih.gov/31618177/,Positive,,Clinical Trial,2019,Mind-Body Medicine,,Anxiety
2011107,Activity of Melaleuca Alternifolia (Tea Tree) Oil on Influenza Virus A/PR/8: Study on the Mechanism of Action,https://pubmed.ncbi.nlm.nih.gov/21095205/,Positive,,Laboratory Study,2011,,Immune System; Respiratory System,Flu
2019220,"Microbiological Tests of Natural Limonene and the Compounds Obtained After Isomerization of Limonene in the Presence of Ti-SBA-15 Catalyst-α-Terpinene, γ-Terpinene, Terpinolene, and p-Cymene",https://pubmed.ncbi.nlm.nih.gov/31398102/,Positive,,Laboratory Study,2019,,Digestive System; Immune System; Integumentary System,Bacterial Infections; Fungal Infections; Staph Infection; Acne; Allergic Contact Dermatitis
2016153,Association of Terpinolene and Diclofenac Presents Antinociceptive and Anti-Inflammatory Synergistic Effects in a Model of Chronic Inflammation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918787/,Positive,,Animal Study,2016,,Nervous System,Inflammation; Pain; Pain - Chronic; Pain - Acute
2019221,Wound Healing Activity of Terpinolene and α-Phellandrene by Attenuating Inflammation and Oxidative Stress in Vitro,https://pubmed.ncbi.nlm.nih.gov/30792116/,Positive,,Laboratory Study,2019,,Immune System; Integumentary System; Nervous System,Oxidative Stress; Wound Healing
2014107,γ-Terpineol Inhibits Cell Growth and Induces Apoptosis in Human Liver Cancer BEL-7402 Cells in Vitro,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230123/,Positive,,Laboratory Study,2014,,Digestive System; Nervous System,Cancer - Liver; Cancer
2014108,Antibacterial Activity of α-Terpineol May Induce Morphostructural Alterations in Escherichia Coli,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323317/,Positive,,Laboratory Study,2014,,Immune System,Bacterial Infections
2018217,Safety and Efficacy of 4-terpineol Against Microorganisms Associated With Blepharitis and Common Ocular Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093255/,Positive,,Laboratory Study,2018,,Immune System,Bacterial Infections
2013096,α-Terpineol Induces Fatty Liver in Mice Mediated by the AMP-activated Kinase and Sterol Response Element Binding Protein Pathway,https://pubmed.ncbi.nlm.nih.gov/23274539/,Negative,,Laboratory Study,2013,,Digestive System,Fatty Liver Disease
2010070,Comparative Study on the Antiviral Activity of Selected Monoterpenes Derived From Essential Oils,https://pubmed.ncbi.nlm.nih.gov/19653195/,Positive,,Laboratory Study,2010,,Integumentary System,Herpes; Prion Disease; Shingles (Herpes Zoster)
2018218,"Discovery of a Novel Series of α-Terpineol Derivatives as Promising Anti-Asthmatic Agents: Their Design, Synthesis, and Biological Evaluation",https://pubmed.ncbi.nlm.nih.gov/29202404/,Positive,,Animal Study,2018,,Respiratory System,Asthma
2019222,Analgesic Effect of α-Terpineol on Neuropathic Pain Induced by Chronic Constriction Injury in Rat Sciatic Nerve: Involvement of Spinal Microglial Cells and Inflammatory Cytokines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043874/,Positive,,Animal Study,2019,,Nervous System,Pain; Pain - Neuropathy - Diabetic; Pain - Neuropathy - Peripheral
2016154,α-Terpineol Attenuates Morphine-Induced Physical Dependence and Tolerance in Mice: Role of Nitric Oxide,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818369/,Positive,,Animal Study,2016,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
2018219,Role of l-arginine/SNAP/NO/cGMP/K ATP Channel Signalling Pathway in Antinociceptive Effect of α-Terpineol in Mice,https://pubmed.ncbi.nlm.nih.gov/29380385/,Positive,,Animal Study,2018,,Nervous System,Pain - Nociceptive; Pain; Pain - Acute; Pain - Chronic
2019223,Antidiarrheal Activity of α-Terpineol in Mice,https://pubmed.ncbi.nlm.nih.gov/30540974/,Positive,,Animal Study,2019,,Digestive System,Diarrhea
2006030,Delta9-tetrahydrocannabinol-induced Apoptosis in Jurkat Leukemia T Cells Is Regulated by Translocation of Bad to Mitochondria,https://pubmed.ncbi.nlm.nih.gov/16908594/,Positive,,Laboratory Study,2006,Tetrahydrocannabinol (THC),Immune System; Nervous System,Cancer - Leukemia; Cancer
2016155,Phytol Has Antibacterial Property by Inducing Oxidative Stress Response in Pseudomonas Aeruginosa,https://pubmed.ncbi.nlm.nih.gov/27667264/,Positive,,Laboratory Study,2016,,Immune System; Nervous System,Bacterial Infections; Oxidative Stress
2017145,"Phytol Induces ROS Mediated Apoptosis by Induction of Caspase 9 and 3 Through Activation of TRAIL, FAS and TNF Receptors and Inhibits Tumor Progression Factor Glucose 6 Phosphate Dehydrogenase in Lung Carcinoma Cell Line (A549)",https://pubmed.ncbi.nlm.nih.gov/28575806/,Positive,,Laboratory Study,2017,,Nervous System; Respiratory System,Cancer - Lung; Cancer
2009059,Phytol-induced hepatotoxicity in mice,https://pubmed.ncbi.nlm.nih.gov/19188468/,Negative,,Animal Study,2009,,Digestive System,Toxic Liver Disease; Hepatitis
2018220,Phytol-loaded PLGA Nanoparticle as a Modulator of Alzheimer's Toxic Aβ Peptide Aggregation and Fibrillation Associated With Impaired Neuronal Cell Function,https://pubmed.ncbi.nlm.nih.gov/29069924/,Positive,,Laboratory Study,2018,Mind-Body Medicine,Nervous System,Alzheimer's Disease; Cognitive Dysfunction; Oxidative Stress
2019224,Phytol Ameliorated Benzo(a)pyrene Induced Lung Carcinogenesis in Swiss Albino Mice via Inhibition of Oxidative Stress and Apoptosis,https://pubmed.ncbi.nlm.nih.gov/30520250/,Positive,,Animal Study,2019,,Respiratory System,Cancer - Lung; Cancer; Oxidative Stress
2018221,A Phytol-Enriched Diet Activates PPAR-α in the Liver and Brown Adipose Tissue to Ameliorate Obesity-Induced Metabolic Abnormalities,https://pubmed.ncbi.nlm.nih.gov/29377597/,Positive,,Animal Study,2018,,Endocrine System,Metabolic Syndrome; Obesity
2018222,Phytol Shows Anti-Angiogenic Activity and Induces Apoptosis in A549 Cells by Depolarizing the Mitochondrial Membrane Potential,https://pubmed.ncbi.nlm.nih.gov/29908495/,Positive,,Laboratory Study,2018,,Nervous System; Respiratory System,Cancer - Lung; Cancer
2018223,Phytol Stimulates the Browning of White Adipocytes Through the Activation of AMP-activated Protein Kinase (AMPK) α in Mice Fed High-Fat Diet,https://pubmed.ncbi.nlm.nih.gov/29570193/,Positive,,Animal Study,2018,,Endocrine System,Metabolic Syndrome; Obesity
2018224,Dietary Phytol Reduces Clinical Symptoms in Experimental Autoimmune Encephalomyelitis (EAE) at Least Partially by Modulating NOX2 Expression,https://pubmed.ncbi.nlm.nih.gov/30151738/,Positive,,Animal Study,2018,,,Encephalitis and Myelitis
2018225,Synergistic Interaction of β-Caryophyllene With Aromadendrene Oxide 2 and Phytol Induces Apoptosis on Skin Epidermoid Cancer Cells,https://pubmed.ncbi.nlm.nih.gov/30166097/,Positive,,Laboratory Study,2018,,Integumentary System; Nervous System,Cancer - Skin (Non-melanoma); Cancer
2018226,Association of Phytol With Toxic and Cytotoxic Activities in an Antitumoral Perspective: A Meta-Analysis and Systemic Review,https://pubmed.ncbi.nlm.nih.gov/30129418/,Inconclusive,,Meta-analysis,2018,,,Cancer
2011108,Anti-scratching Behavioral Effect of the Essential Oil and Phytol Isolated From Artemisia Princeps Pamp. In Mice,https://pubmed.ncbi.nlm.nih.gov/20645242/,Positive,,Animal Study,2011,,Integumentary System,Allergic Contact Dermatitis
2015125,Phytol in a Pharma-Medico-Stance,https://pubmed.ncbi.nlm.nih.gov/26296761/,Positive,,Meta-analysis,2015,,,Bacterial Infections; Cancer; Cardiovascular Diseases (CVD); Diabetes
2008070,Phytochemical Analysis and in Vitro Antiviral Activities of the Essential Oils of Seven Lebanon Species,https://pubmed.ncbi.nlm.nih.gov/18357554/,Positive,,Laboratory Study,2008,,Nervous System,Prion Disease
2011109,"Fresh, dried or smoked? repellent properties of volatiles emitted from ethnomedicinal plant leaves against malaria and yellow fever vectors in Ethiopia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285543/,Positive,,Animal Study,2011,,,Malaria
2015126,Selected Compounds Structurally Related to Acyclic Sesquiterpenoids and Their Antibacterial and Cytotoxic Activity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272674/,Positive,,Laboratory Study,2015,,Immune System; Integumentary System; Nervous System,Bacterial Infections; Cancer - Leukemia; Cancer - Melanoma; Cancer; Staph Infection; Cancer - Lung
2019225,Anticonvulsant Essential Oils and Their Relationship with Oxidative Stress in Epilepsy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995584/,Positive,,Meta-analysis,2019,,Nervous System,Epilepsy; Oxidative Stress
2015127,Evaluation of mutagenic and antimicrobial properties of brown propolis essential oil from the Brazilian Cerrado biome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598219/,Positive,,Laboratory Study,2015,,Immune System,Bacterial Infections; Staph Infection
2019226,Antimicrobial Activity of Essential Oil of Baccharis dracunculifolia DC (Asteraceae) Aerial Parts at Flowering Period,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361755/,Positive,,Laboratory Study,2019,,Digestive System; Immune System; Integumentary System,Bacterial Infections; Fungal Infections; Staph Infection
2019227,Nerolidol Suppresses the Inflammatory Response during Lipopolysaccharide-Induced Acute Lung Injury via the Modulation of Antioxidant Enzymes and the AMPK/Nrf-2/HO-1 Pathway,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885193/,Positive,,Animal Study,2019,,,Asthma; COPD; Cough; Inflammation
2017146,The Effects of Selected Sesquiterpenes from Myrica rubra Essential Oil on the Efficacy of Doxorubicin in Sensitive and Resistant Cancer Cell Lines,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152637/,Positive,,Laboratory Study,2017,,Nervous System,Cancer; Cancer - Lymphoma; Cancer - Ovarian
2017147,"Chemical Composition, Antibacterial Activity, and Synergistic Effects with Conventional Antibiotics and Nitric Oxide Production Inhibitory Activity of Essential Oil from Geophila repens (L.) I.M. Johnst",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151674/,Positive,,Laboratory Study,2017,,Immune System,Bacterial Infections
2015128,In Vitro Antimalarial Activity of Different Inhibitors of the Plasmodial Isoprenoid Synthesis Pathway,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505249/,Positive,,Laboratory Study,2015,,Immune System,Malaria
2014109,Terpenes Increase the Lipid Dynamics in the Leishmania Plasma Membrane at Concentrations Similar to Their IC50 Values,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125203/,Positive,,Laboratory Study,2014,,Integumentary System,Leishmaniasis
2016156,Neuroprotective effect of nerolidol against neuroinflammation and oxidative stress induced by rotenone,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994214/,Positive,,Animal Study,2016,,,Inflammation; Oxidative Stress; Neurodegenerative Issues; Parkinson's Disease
2017148,Nerolidol and Farnesol Inhibit Some Cytochrome P450 Activities but Did Not Affect Other Xenobiotic-Metabolizing Enzymes in Rat and Human Hepatic Subcellular Fractions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154719/,Inconclusive,,Laboratory Study,2017,,,
2016157,Nerolidol: A Sesquiterpene Alcohol with Multi-Faceted Pharmacological and Biological Activities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272852/,Positive,,Meta-analysis,2016,,,Bacterial Infections; Oxidative Stress
2017149,Terpene Synthases From Cannabis Sativa,https://pubmed.ncbi.nlm.nih.gov/28355238/,Inconclusive,,Laboratory Study,2017,,,
2019228,Sesquiterpenes α-Humulene and β-Caryophyllene Oxide Enhance the Efficacy of 5-fluorouracil and Oxaliplatin in Colon Cancer Cells,https://pubmed.ncbi.nlm.nih.gov/31259712/,Positive,,Laboratory Study,2019,,Digestive System; Nervous System,Cancer - Colon; Cancer
2019229,α-Humulene Inhibits Hepatocellular Carcinoma Cell Proliferation and Induces Apoptosis Through the Inhibition of Akt Signaling,https://www.sciencedirect.com/science/article/pii/S0278691519306209,Positive,,Laboratory Study,2019,,Digestive System; Nervous System,Cancer - Liver; Cancer
2016158,Anti-Candida Activity of Geraniol Involves Disruption of Cell Membrane Integrity and Function,https://pubmed.ncbi.nlm.nih.gov/27554866/,Positive,,Laboratory Study,2016,,Digestive System; Immune System; Integumentary System,Fungal Infections
2017150,Effect of Geraniol on Rat Cardiomyocytes and Its Potential Use as a Cardioprotective Natural Compound,https://pubmed.ncbi.nlm.nih.gov/28131760/,Positive,,Animal Study,2017,,Cardiovascular System; Nervous System,Cardiovascular Diseases (CVD); Oxidative Stress
2016159,Geraniol Improves Endothelial Function by Inhibiting NOX-2 Derived Oxidative Stress in High Fat Diet Fed Mice,https://pubmed.ncbi.nlm.nih.gov/27107694/,Positive,,Animal Study,2016,,Nervous System,Oxidative Stress; Atherosclerosis; Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2018227,In Vivo Protective Effect of Geraniol on Colonization of Staphylococcus Epidermidis in Rat Jugular Vein Catheter Model,https://pubmed.ncbi.nlm.nih.gov/29893828/,Positive,,Animal Study,2018,,Immune System,Staph Infection
2019230,Management of chronic pain with Jalaprakshalana (water-wash) Shodhita (processed) Bhanga (Cannabis sativa L.) in cancer patients with deprived quality of life: An open-label single arm clinical trial,https://pubmed.ncbi.nlm.nih.gov/31831967/,Positive,,Clinical Trial,2019,,Nervous System,Pain; Pain - Cancer
2020719,The Efficacy of Medical Marijuana in the Treatment of Cancer-Related Pain,https://pubmed.ncbi.nlm.nih.gov/32101075/,Positive,,Meta-analysis,2020,,Nervous System,Pain; Pain - Cancer; Addiction - Opioid; Palliative Care
2016160,Arachidonoyl-ethanolamide Activates Endoplasmic Reticulum Stress-Apoptosis in Tumorigenic Keratinocytes: Role of cyclooxygenase-2 and Novel J-series Prostamides,https://pubmed.ncbi.nlm.nih.gov/25557612/,Positive,,Laboratory Study,2016,Anandamide (AEA),Integumentary System; Nervous System,Cancer - Skin (Non-melanoma); Cancer
2016161,Anandamide-induced Endoplasmic Reticulum Stress and Apoptosis Are Mediated by Oxidative Stress in Non-Melanoma Skin Cancer: Receptor-independent Endocannabinoid Signaling,https://pubmed.ncbi.nlm.nih.gov/26513129/,Positive,,Laboratory Study,2016,Anandamide (AEA),Integumentary System; Nervous System,Cancer - Skin (Non-melanoma); Cancer
2020720,Treatment With Cannabinoids as a Promising Approach for Impairing Fibroblast Activation and Prostate Cancer Progression,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037293/,Positive,,Laboratory Study,2020,WIN-x Synthetic Cannabinoids,Nervous System; Reproductive System,Cancer - Prostate; Cancer
2016162,Geraniol Improves the Impaired Vascular Reactivity in Diabetes and Metabolic Syndrome Through Calcium Channel Blocking Effect,https://pubmed.ncbi.nlm.nih.gov/27131411/,Positive,,Animal Study,2016,,Endocrine System,Diabetes; Metabolic Syndrome
2015129,"Geraniol Ameliorates TNBS-induced Colitis: Involvement of Wnt/β-catenin, p38MAPK, NFκB, and PPARγ Signaling Pathways",https://pubmed.ncbi.nlm.nih.gov/26165751/,Positive,,Animal Study,2015,,Digestive System,IBD - Inflammatory Bowel Disease
2014110,Geraniol Blocks Calcium and Potassium Channels in the Mammalian Myocardium: Useful Effects to Treat Arrhythmias,https://pubmed.ncbi.nlm.nih.gov/24862086/,Positive,,Laboratory Study,2014,,Cardiovascular System,Cardiac Arrhythmias; Cardiovascular Diseases (CVD)
2014111,Geraniol-a Flavoring Agent With Multifunctional Effects in Protecting the Gastric and Duodenal Mucosa,https://pubmed.ncbi.nlm.nih.gov/24337826/,Positive,,Animal Study,2014,,,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Irritable Bowel Syndrome
2016163,Protective Effect of Geraniol on the Transgenic Drosophila Model of Parkinson's Disease,https://pubmed.ncbi.nlm.nih.gov/27026137/,Positive,,Animal Study,2016,,,Parkinson's Disease; Oxidative Stress
2017151,Geraniol Attenuates 4NQO-induced Tongue Carcinogenesis Through Downregulating the Activation of NF-κB in Rats,https://pubmed.ncbi.nlm.nih.gov/28397014/,Positive,,Animal Study,2017,,Digestive System; Nervous System,Cancer - Oral; Cancer; Inflammation
2018228,"Geraniol and Geranyl Acetate Induce Potent Anticancer Effects in Colon Cancer Colo-205 Cells by Inducing Apoptosis, DNA Damage and Cell Cycle Arrest",https://pubmed.ncbi.nlm.nih.gov/29745075/,Positive,,Laboratory Study,2018,,Digestive System; Nervous System,Cancer - Colon; Cancer
2015130,Geraniol Suppresses Angiogenesis by Downregulating Vascular Endothelial Growth Factor (VEGF)/VEGFR-2 Signaling,https://pubmed.ncbi.nlm.nih.gov/26154255/,Positive,,Animal Study,2015,,Nervous System,Cancer
2016164,Treatment With Geraniol Ameliorates Methionine-Choline-Deficient Diet-Induced Non-Alcoholic Steatohepatitis in Rats,https://pubmed.ncbi.nlm.nih.gov/26695085/,Positive,,Animal Study,2016,,Digestive System,Fatty Liver Disease
2017152,Effect of Treatment With Geraniol on Ovalbumin-Induced Allergic Asthma in Mice,https://pubmed.ncbi.nlm.nih.gov/27117312/,Positive,,Animal Study,2017,,Nervous System; Skeletal System,Pain; Pain - Neuropathy - Peripheral; Spinal Cord Injuries
2016165,Effect of Treatment With Geraniol on Ovalbumin-Induced Allergic Asthma in Mice,https://pubmed.ncbi.nlm.nih.gov/27117312/,Positive,,Animal Study,2016,,Respiratory System,Asthma
2020721,"Eucalyptol (1,8 cineole) from eucalyptus essential oil a potential inhibitor of COVID 19 corona virus infection by Molecular docking studies",https://www.preprints.org/manuscript/202003.0455/v1#,Positive,,Laboratory Study,2020,,Respiratory System,COVID-19
2020722,In Search of Preventative Strategies: Novel Anti-Inflammatory High-CBD Cannabis Sativa Extracts Modulate ACE2 Expression in COVID-19 Gateway Tissues,https://www.preprints.org/manuscript/202004.0315/v1,Positive,,Laboratory Study,2020,,Respiratory System,COVID-19
2016166,Geraniol Suppresses Prostate Cancer Growth Through Down-Regulation of E2F8,https://pubmed.ncbi.nlm.nih.gov/27683099/,Positive,,Laboratory Study,2016,,Nervous System; Reproductive System,Cancer - Prostate; Cancer
2019231,Thymoquinone and Geraniol Alleviate Cisplatin-Induced Neurotoxicity in Rats Through Downregulating the p38 MAPK/STAT-1 Pathway and Oxidative Stress,https://pubmed.ncbi.nlm.nih.gov/31047895/,Positive,,Animal Study,2019,,Nervous System,Pain; Pain - Neuropathy - Drug-Ind. Polyneuropathy; Oxidative Stress
2016167,Preventive Effect of Geraniol on Diethylnitrosamine-Induced Hepatocarcinogenesis in Rats,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816747/,Positive,,Animal Study,2016,,Digestive System,Cancer - Liver; Cancer
2017153,Geraniol Alleviates Diabetic Cardiac Complications: Effect on Cardiac Ischemia and Oxidative Stress,https://pubmed.ncbi.nlm.nih.gov/28178614/,Positive,,Animal Study,2017,,Cardiovascular System; Endocrine System; Nervous System,Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Diabetes; Oxidative Stress
2018229,Geraniol as a Novel Antivirulence Agent Against Bacillary Dysentery-Causing Shigella Sonnei,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955184/,Positive,,Laboratory Study,2018,,Immune System,Bacterial Infections; Prion Disease
2017154,The Effect of Geraniol on Liver Regeneration After Hepatectomy in Rats,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411747/,Positive,,Animal Study,2017,,,Alcoholic Liver Disease; Fatty Liver Disease; Hepatitis; Liver Failure; Toxic Liver Disease
2018230,Dietary Geraniol Ameliorates Intestinal Dysbiosis and Relieves Symptoms in Irritable Bowel Syndrome Patients: A Pilot Study,https://pubmed.ncbi.nlm.nih.gov/30567535/,Positive,,Clinical Trial,2018,,Digestive System,Irritable Bowel Syndrome
2019232,Pharmacological Properties of Geraniol - A Review,https://pubmed.ncbi.nlm.nih.gov/30308694/,Positive,,Meta-analysis,2019,,,Bacterial Infections; Cancer; Inflammation; Oxidative Stress
2017155,"Chemical Composition, Anti-Biofilm Activity and Potential Cytotoxic Effect on Cancer Cells of Rosmarinus Officinalis L. Essential Oil From Tunisia",https://pubmed.ncbi.nlm.nih.gov/28969677/,Positive,,Laboratory Study,2017,,Immune System; Nervous System,Bacterial Infections; Cancer
2009060,Plant Derived Antioxidants - Geraniol and Camphene Protect Rat Alveolar Macrophages Against t-BHP Induced Oxidative Stress,https://pubmed.ncbi.nlm.nih.gov/19135518/,Positive,,Laboratory Study,2009,,Nervous System,Oxidative Stress; Asthma; COPD; Cough
2015131,Camphene Isolated From Essential Oil of Piper Cernuum (Piperaceae) Induces Intrinsic Apoptosis in Melanoma Cells and Displays Antitumor Activity in Vivo,https://pubmed.ncbi.nlm.nih.gov/26471302/,Positive,,Laboratory Study,2015,,Integumentary System; Nervous System,Cancer - Melanoma; Cancer
2019233,Synthesis of Novel (-)-Camphene-based Thiosemicarbazones and Evaluation of Anti- Mycobacterium tuberculosis Activity,https://pubmed.ncbi.nlm.nih.gov/29792346/,Positive,,Laboratory Study,2019,,Respiratory System,Tuberculosis
2020723,Synergistic Cytotoxic Activity of Cannabinoids From cannabis sativa Against Cutaneous T-cell Lymphoma (CTCL) in-vitro and ex-vivo,https://www.oncotarget.com/article/27528/text/,Positive,,Laboratory Study,2020,Cannabigerol (CBG); Cannabichromene (CBC),Immune System; Nervous System,Cancer - Lymphoma; Cancer
2018231,Response of Paracoccidioides Lutzii to the Antifungal Camphene Thiosemicarbazide Determined by Proteomic Analysis,https://pubmed.ncbi.nlm.nih.gov/30311782/,Positive,,Laboratory Study,2018,,Digestive System; Immune System; Integumentary System,Fungal Infections
2016168,"Camphene, a Plant Derived Monoterpene, Exerts Its Hypolipidemic Action by Affecting SREBP-1 and MTP Expression",https://pubmed.ncbi.nlm.nih.gov/26784701/,Positive,,Laboratory Study,2016,,Cardiovascular System,Cardiovascular Diseases (CVD)
2018232,Additive Neuroprotective Effect of Borneol With Mesenchymal Stem Cells on Ischemic Stroke in Mice,https://www.frontiersin.org/articles/10.3389/fphys.2017.01133/full,Positive,,Animal Study,2018,,,Stroke
2016169,(+)-Borneol Attenuates Oxaliplatin-Induced Neuropathic Hyperalgesia in Mice,https://pubmed.ncbi.nlm.nih.gov/26730517/,Positive,,Animal Study,2016,,Nervous System,Pain; Pain - Neuropathy - Peripheral
2017156,(+)-Borneol Improves the Efficacy of Edaravone Against DSS-induced Colitis by Promoting M2 Macrophages Polarization via JAK2-STAT3 Signaling Pathway,https://pubmed.ncbi.nlm.nih.gov/29028547/,Positive,,Laboratory Study,2017,,Digestive System,IBD - Inflammatory Bowel Disease
2018233,(+)-Borneol suppresses conditioned fear recall and anxiety-like behaviors in mice,https://pubmed.ncbi.nlm.nih.gov/29223397/,Positive,,Animal Study,2018,Mind-Body Medicine,Mental/Emotional System; Nervous System,Anxiety; PTSD
2019234,Borneol for Regulating the Permeability of the Blood-Brain Barrier in Experimental Ischemic Stroke: Preclinical Evidence and Possible Mechanism,https://pubmed.ncbi.nlm.nih.gov/30863478/,Positive,,Meta-analysis,2019,,Nervous System,Stroke; Inflammation; Oxidative Stress
2020724,"Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Mass Balance of Single and Continuous Intravenous Infusion of SPT-07A in Healthy Volunteers",https://pubmed.ncbi.nlm.nih.gov/32147750/,Positive,,Double Blind Clinical Trial,2020,,Nervous System,Stroke
2004032,Transdermal Absorption of (-)-Linalool Induces Autonomic Deactivation but Has No Impact on Ratings of Well-Being in Humans,https://pubmed.ncbi.nlm.nih.gov/15238993/,Positive,,Double Blind Clinical Trial,2004,,Cardiovascular System; Mental/Emotional System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2006031,Chirality Influences the Effects of Linalool on Physiological Parameters of Stress,https://pubmed.ncbi.nlm.nih.gov/16983600/,Positive,,Clinical Trial,2006,,Cardiovascular System; Mental/Emotional System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2013097,Physical and Psychologic Effects of Aromatherapy Inhalation on Pregnant Women: A Randomized Controlled Trial,https://pubmed.ncbi.nlm.nih.gov/23410527/,Inconclusive,,Double Blind Clinical Trial,2013,,Mental/Emotional System; Reproductive System,Pregnancy
2017157,Aromatherapy Improves Work Performance Through Balancing the Autonomic Nervous System,https://pubmed.ncbi.nlm.nih.gov/27763785/,Positive,,Double Blind Clinical Trial,2017,,Mental/Emotional System,
2016170,Antioxidant Activity of Linalool in Patients With Carpal Tunnel Syndrome,https://pubmed.ncbi.nlm.nih.gov/26831333/,Positive,,Double Blind Clinical Trial,2016,,Nervous System,Oxidative Stress; Cardiovascular Diseases (CVD); Pain; Pain - Neuropathy - Peripheral; Reperfusion Injury
2013098,Characterization of Anxiolytic and Neuropharmacological Activities of Silexan,https://pubmed.ncbi.nlm.nih.gov/23361848/,Positive,,Animal Study,2013,,Mental/Emotional System; Nervous System,Anxiety; Insomnia and Sleep Disorders
2019235,Effects of Lavender on Anxiety: A Systematic Review and Meta-Analysis,https://www.sciencedirect.com/science/article/pii/S0944711319303411?via%3Dihub,Positive,,Meta-analysis,2019,,Mental/Emotional System,Anxiety
2012119,"Phase II Trial on the Effects of Silexan in Patients With Neurasthenia, Post-Traumatic Stress Disorder or Somatization Disorder",https://pubmed.ncbi.nlm.nih.gov/22475718/,Positive,,Clinical Trial,2012,,Mental/Emotional System; Nervous System,PTSD; Anxiety
2017158,"Efficacy of Silexan in Subthreshold Anxiety: Meta-Analysis of Randomised, Placebo-Controlled Trials",https://link.springer.com/article/10.1007/s00406-017-0852-4,Positive,,Clinical Meta-analysis,2017,,Mental/Emotional System; Nervous System,Anxiety; Depression; Insomnia and Sleep Disorders
2019236,The Antibacterial Activity of Lavender Essential Oil Alone and In Combination With Octenidine Dihydrochloride Against MRSA Strains,https://pubmed.ncbi.nlm.nih.gov/31888005/,Positive,,Laboratory Study,2019,,Immune System,Staph Infection
2015132,"Efficacy of Silexan in Mixed anxiety-depression--A Randomized, Placebo-Controlled Trial",https://pubmed.ncbi.nlm.nih.gov/26718792/,Positive,,Double Blind Clinical Trial,2015,,Mental/Emotional System; Nervous System,Anxiety; Depression
2010071,"Silexan, an Orally Administered Lavandula Oil Preparation, Is Effective in the Treatment of 'Subsyndromal' Anxiety Disorder: A Randomized, Double-Blind, Placebo Controlled Trial",https://pubmed.ncbi.nlm.nih.gov/20512042/,Positive,,Double Blind Clinical Trial,2010,,Mental/Emotional System,Anxiety; Insomnia and Sleep Disorders
2010072,"A Multi-Center, Double-Blind, Randomised Study of the Lavender Oil Preparation Silexan in Comparison to Lorazepam for Generalized Anxiety Disorder",https://pubmed.ncbi.nlm.nih.gov/19962288/,Positive,,Double Blind Clinical Trial,2010,,Mental/Emotional System; Nervous System,Anxiety
1998013,Phase I and Pharmacokinetic Study of D-limonene in Patients With Advanced Cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee,https://pubmed.ncbi.nlm.nih.gov/9654110/,Positive,,Clinical Trial,1998,,Nervous System,Cancer; Cancer - Breast
2017159,Pharmacokinetic Evaluation of β-Caryophyllene Alcohol in Rats and Beagle Dogs,https://pubmed.ncbi.nlm.nih.gov/28891397/,Inconclusive,,Animal Study -,2017,,,Asthma; Inflammation; Veterinary Applications
2019237,Excito-repellent Activity of β-Caryophyllene Oxide Against Aedes Aegypti and Anopheles Minimus,https://pubmed.ncbi.nlm.nih.gov/31121148/,Positive,,Animal Study,2019,,,Malaria
2019238,"β-Caryophyllene, a CB2-Receptor-Selective Phytocannabinoid, Suppresses Mechanical Allodynia in a Mouse Model of Antiretroviral-Induced Neuropathic Pain",https://pubmed.ncbi.nlm.nih.gov/31892132/,Positive,,Animal Study,2019,AM-x Synthetic Cannabinoids,Nervous System,Pain; Pain - Neuropathy - Drug-Ind. Polyneuropathy
2019239,"Inhibitory Effects of β-Caryophyllene on Helicobacter pylori Infection: A Randomized Double-blind, Placebo-controlled Study",https://pubmed.ncbi.nlm.nih.gov/31650795/,Positive,,Double Blind Clinical Trial,2019,,Immune System,Bacterial Infections
2020725,The Endocannabinoid System Alleviates Pain in a Murine Model of Cancer-Induced Bone Pain,https://pubmed.ncbi.nlm.nih.gov/32054717/,Positive,,Animal Study,2020,2-Arachidonoyl Glycerol (2-AG); Monoacylglycerol Lipase (MAGL),Nervous System; Reproductive System,Cancer - Breast; Cancer - Metastatic; Cancer; Pain; Pain - Cancer
2019240,Elevated AA/EPA Ratio Represents an Inflammatory Biomarker in Tumor Tissue of Metastatic Colorectal Cancer Patients,https://www.mdpi.com/1422-0067/20/8/2050/htm,Positive,,Meta-analysis,2019,Endocannabinoid (unspecified),Digestive System; Nervous System,Cancer - Colon; Cancer - Metastatic; Cancer
2019241,"Paradoxical Effects of JZL184, an Inhibitor of Monoacylglycerol Lipase, on Bone Remodelling in Healthy and Cancer-Bearing Mice",https://pubmed.ncbi.nlm.nih.gov/31151929/,Positive,,Animal Study,2019,2-Arachidonoyl Glycerol (2-AG); Monoacylglycerol Lipase (MAGL),Nervous System; Skeletal System,Cancer - Bone; Cancer - Metastatic; Cancer
2019242,Dramatic Response to Laetrile and Cannabidiol (CBD) Oil in a Patient With Metastatic Low Grade Serous Ovarian Carcinoma,https://www.sciencedirect.com/science/article/pii/S2352578919300517?via%3Dihub,Positive,,Meta-analysis,2019,,Nervous System; Reproductive System,Cancer - Metastatic; Cancer - Ovarian; Cancer
2019243,Flavonoid Derivative of Cannabis Demonstrates Therapeutic Potential in Preclinical Models of Metastatic Pancreatic Cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663976/,Positive,,Animal Study,2019,,Endocrine System; Nervous System,Cancer - Metastatic; Cancer - Pancreatic; Cancer
2017160,Standardized Cannabis sativa Extract Attenuates Tau and Stathmin Gene Expression in the Melanoma Cell Line,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673704/,Positive,,Laboratory Study,2017,,Integumentary System; Nervous System,Cancer - Melanoma; Cancer - Metastatic; Cancer
2008071,A Pilot Study of Perillyl Alcohol in Pancreatic Cancer,https://pubmed.ncbi.nlm.nih.gov/18498869/,Positive,,Clinical Trial,2008,,Endocrine System; Nervous System,Cancer - Pancreatic; Cancer
2013099,Perillyl Alcohol as a Protective Modulator Against Rat Hepatocarcinogenesis via Amelioration of Oxidative Damage and Cell Proliferation,https://pubmed.ncbi.nlm.nih.gov/23536516/,Positive,,Animal Study,2013,,Digestive System; Nervous System,Cancer - Liver; Cancer; Oxidative Stress
2018234,Evaluation of Phytomedicinal Potential of Perillyl Alcohol in an in Vitro Parkinson's Disease Model,https://pubmed.ncbi.nlm.nih.gov/30188583/,Positive,,Laboratory Study,2018,,,Parkinson's Disease
2003026,A Phase I Trial of Perillyl Alcohol in Patients With Advanced Solid Tumors,https://pubmed.ncbi.nlm.nih.gov/12695855/,Inconclusive,,Clinical Trial,2003,,,Cancer
2019244,Monoterpenoid Perillyl Alcohol Impairs Metabolic Flexibility of Candida Albicans by Inhibiting Glyoxylate Cycle,https://pubmed.ncbi.nlm.nih.gov/29129690/,Positive,,Laboratory Study,2019,,Digestive System; Immune System; Integumentary System,Fungal Infections
2017161,"Perillyl Alcohol Protects Human Renal Tubular Epithelial Cells From Hypoxia/Reoxygenation Injury via Inhibition of ROS, Endoplasmic Reticulum Stress and Activation of PI3K/Akt/eNOS Pathway",https://pubmed.ncbi.nlm.nih.gov/28886525/,Positive,,Laboratory Study,2017,,Cardiovascular System; Nervous System,Cardiovascular Diseases (CVD); Oxidative Stress; Reperfusion Injury
2019245,Perillyl Alcohol and Perillic Acid Exert Efficient Action Upon HSV-1 Maturation and Release of Infective Virus,https://pubmed.ncbi.nlm.nih.gov/31099756/,Positive,,Laboratory Study,2019,,Integumentary System,Herpes; Shingles (Herpes Zoster)
2018235,Perillyl Alcohol Alleviates Amyloid-β Peptides-Induced Mitochondrial Dysfunction and Cytotoxicity in SH-SY5Y Cells,https://www.sciencedirect.com/science/article/pii/S0141813017328404?via%3Dihub,Positive,,Laboratory Study,2018,,,Alzheimer's Disease
2012120,Perillyl Alcohol for the Treatment of Temozolomide-Resistant Gliomas,https://pubmed.ncbi.nlm.nih.gov/22933703/,Positive,,Animal Study,2012,,Nervous System,Cancer - Brain; Cancer
2018236,Intranasal Perillyl Alcohol for Glioma Therapy: Molecular Mechanisms and Clinical Development,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321279/,Positive,,Meta-analysis,2018,,,Cancer - Brain; Cancer
2012121,"Patients with Asthma Benefit from Concomitant Therapy with Cineole: A Placebo-Controlled, Double-Blind Trial",https://www.researchgate.net/publication/230857803_Patients_with_Asthma_Benefit_from_Concomitant_Therapy_with_Cineole_A_Placebo-Controlled_Double-Blind_Trial,Positive,,Double Blind Clinical Trial,2012,,Respiratory System,Asthma
2017162,"Suppression of inflammatory and infection responses in lung macrophages by eucalyptus oil and its constituent 1,8-cineole: Role of pattern recognition receptors TREM-1 and NLRP3, the MAP kinase regulator MKP-1, and NFκB",https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0188232,Positive,,Laboratory Study,2017,,Respiratory System,Asthma; COPD; Cough
2009061,Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: a placebo-controlled double-blind trial,http://europepmc.org/article/MED/19624838,Positive,,Double Blind Clinical Trial,2009,,Respiratory System,COPD
2003027,Anti-inflammatory activity of 1.8-cineol (eucalyptol) in bronchial asthma: a double-blind placebo-controlled trial,https://www.sciencedirect.com/science/article/pii/S0954611103914326,Positive,,Double Blind Clinical Trial,2003,,Respiratory System,Asthma
2014112,Anti-inflammatory Properties of the Monoterpene 1.8-cineole: Current Evidence for Co-Medication in Inflammatory Airway Diseases,https://pubmed.ncbi.nlm.nih.gov/24831245/,Positive,,Meta-analysis,2014,,Respiratory System,Asthma; COPD
2014113,"The Effect of 1,8-Cineole Inhalation on Preoperative Anxiety: A Randomized Clinical Trial",https://www.hindawi.com/journals/ecam/2014/820126/,Positive,,Clinical Trial,2014,,Mental/Emotional System; Nervous System,Anxiety
2020726,Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation,https://pubmed.ncbi.nlm.nih.gov/31932491/,Inconclusive,,Animal Study,2020,Synthetic Cannabinoid (unspecified),Integumentary System; Nervous System,Cancer - Squamous Head/Neck; Cancer
2008072,Cannabis use and cancer of the head and neck: Case-control study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2277494/,Inconclusive,,Meta-analysis,2008,,Integumentary System; Nervous System,Cancer - Squamous Head/Neck; Cancer
2004033,Marijuana use and risk of oral squamous cell carcinoma,https://www.ncbi.nlm.nih.gov/pubmed/15173020,Inconclusive,,Meta-analysis,2004,,Digestive System,Cancer - Oral; Cancer; Cancer - Squamous Head/Neck
1999012,Marijuana Use and Increased Risk of Squamous Cell Carcinoma of the Head and Neck,https://pubmed.ncbi.nlm.nih.gov/10613339/,Negative,,Meta-analysis,1999,,Integumentary System,Cancer - Squamous Head/Neck; Cancer
2008073,Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597267/,Positive,,Laboratory Study,2008,Virodhamine (O-AEA); O-x Synthetic Cannabinoids; Other Related Compounds; SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2019246,Interferon γ Treatment Increases Endocannabinoid and Related N-acylethanolamine Levels in T84 Human Colon Carcinoma Cells,https://pubmed.ncbi.nlm.nih.gov/29313885/,Inconclusive,,Laboratory Study,2019,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Digestive System; Nervous System,Cancer - Colon; Cancer
2019247,"HTR1D, TIMP1, SERPINE1, MMP3 and CNR2 Affect the Survival of Patients With Colon Adenocarcinoma",https://pubmed.ncbi.nlm.nih.gov/31452735/,Inconclusive,,Laboratory Study,2019,,Digestive System; Nervous System,Cancer - Colon; Cancer
2019248,Down-Regulation of Cannabinoid Type 1 (CB1) Receptor and Its Downstream Signaling Pathways in Metastatic Colorectal Cancer,https://pubmed.ncbi.nlm.nih.gov/31121931/,Positive,,Laboratory Study,2019,,Digestive System; Nervous System,Cancer - Colon; Cancer - Metastatic; Cancer
2019249,Cannabidiol-induced Apoptosis Is Mediated by Activation of Noxa in Human Colorectal Cancer Cells,https://pubmed.ncbi.nlm.nih.gov/30660647/,Positive,,Laboratory Study,2019,,Digestive System; Nervous System,Cancer - Colon; Cancer
2018237,"Appraising the ""Entourage Effect"": Antitumor Action of a Pure Cannabinoid Versus a Botanical Drug Preparation in Preclinical Models of Breast Cancer",https://pubmed.ncbi.nlm.nih.gov/29940172/,Positive,,Animal Study,2018,Pharma THC,Nervous System; Reproductive System,Cancer - Breast; Cancer
2019250,Antitumor Activity of Abnormal Cannabidiol and Its Analog O-1602 in Taxol-Resistant Preclinical Models of Breast Cancer,https://pubmed.ncbi.nlm.nih.gov/31611800/,Positive,,Animal Study,2019,Abnormal Cannabidiol (Abn-CBD); O-x Synthetic Cannabinoids,Nervous System; Reproductive System,Cancer - Breast; Cancer
2019251,Characterization of Cancer-Induced Nociception in a Murine Model of Breast Carcinoma,https://pubmed.ncbi.nlm.nih.gov/30850915/,Positive,,Animal Study,2019,WIN-x Synthetic Cannabinoids,Nervous System; Reproductive System,Cancer - Breast; Cancer; Pain; Pain - Cancer; Cancer - Bone; Cancer - Metastatic
2020727,Insight of Druggable Cannabinoids Against Estrogen Receptor β in Breast Cancer,https://pubmed.ncbi.nlm.nih.gov/32116130/,Positive,,Laboratory Study,2020,,Nervous System; Reproductive System,Cancer - Breast; Cancer
2019252,Anticancer Effects of n-3 EPA and DHA and Their Endocannabinoid Derivatives on Breast Cancer Cell Growth and Invasion,https://pubmed.ncbi.nlm.nih.gov/31679810/,Positive,,Laboratory Study,2019,Other Related Compounds,Nervous System; Reproductive System,Cancer - Breast; Cancer
2020728,n-3 Polyunsaturated Fatty Acid Amides: New Avenues in the Prevention and Treatment of Breast Cancer,https://pubmed.ncbi.nlm.nih.gov/32224850/,Positive,,Meta-analysis,2020,,Nervous System; Reproductive System,Cancer - Breast; Cancer
2020729,CBD Loaded Microparticles as a Potential Formulation to Improve Paclitaxel and Doxorubicin-Based Chemotherapy in Breast Cancer,https://pubmed.ncbi.nlm.nih.gov/31811927/,Positive,,Laboratory Study,2020,,Nervous System; Reproductive System,Cancer - Breast; Cancer
2020730,Cannabinoids and Hormone Receptor-Positive Breast Cancer Treatment,https://pubmed.ncbi.nlm.nih.gov/32106399/,Positive,,Meta-analysis,2020,Anandamide (AEA),Nervous System; Reproductive System,Cancer - Breast; Cancer
2020731,Cannabinoid Signaling in Glioma Cells,https://pubmed.ncbi.nlm.nih.gov/32034716/,Positive,,Meta-analysis,2020,Endocannabinoid (unspecified),Nervous System,Cancer - Brain; Cancer
2017163,Bladder Cancer Cell Growth and Motility Implicate Cannabinoid 2 Receptor-Mediated Modifications of Sphingolipids Metabolism,https://pubmed.ncbi.nlm.nih.gov/28191815/,Positive,,Laboratory Study,2017,JWH-x Synthetic Cannabinoids,Nervous System; Urinary System,Cancer - Bladder; Cancer
2000013,Phase I pharmacokinetic trial of perillyl alcohol in patients with refractory solid malignancies,https://www.ncbi.nlm.nih.gov/pubmed/10955786/,Inconclusive,,Clinical Trial,2000,,,Cancer - Breast; Cancer - Prostate; Cancer
2004034,A phase I trial of perillyl alcohol administered four times daily for 14 days out of 28 days,https://www.ncbi.nlm.nih.gov/pubmed/15205914/,Inconclusive,,Clinical Trial,2004,,,Cancer
1985002,Phase 1 Trial of Levonantradol in Chemotherapy-Induced Emesis,https://pubmed.ncbi.nlm.nih.gov/4083271/,Positive,,Clinical Trial,1985,CP-x Synthetic Cannabinoids,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
1985003,Antiemetic Efficacy of Levonantradol Compared to delta-9-tetrahydrocannabinol for Chemotherapy-Induced Nausea and Vomiting,https://pubmed.ncbi.nlm.nih.gov/2981616/,Positive,,Double Blind Clinical Trial,1985,CP-x Synthetic Cannabinoids,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
2015133,Endocannabinoids and Acute Pain Following Total Knee Arthroplasty,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299927/,Positive,,Meta-analysis,2015,2-Arachidonoyl Glycerol (2-AG),Nervous System,Pain; Pain - Acute; Wound Healing
2011110,Increased Expression of Cannabinoid CB1 Receptors in Achilles Tendinosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169627/,Positive,,Laboratory Study,2011,,Skeletal System,Tendon Disorders
2015134,"Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA",https://pubmed.ncbi.nlm.nih.gov/26134475/,Positive,,Laboratory Study,2015,5F-x Synthetic Cannabinoids; AB-x Synthetic Cannabinoids,Nervous System,Poisoning by Synthetic Cannabis
2016171,"Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues",https://pubmed.ncbi.nlm.nih.gov/27421060/,Positive,,Meta-analysis,2016,5F-x Synthetic Cannabinoids,Nervous System,Poisoning by Synthetic Cannabis
2015135,Cytotoxicity of Endogenous Lipids N-acyl Dopamines and Their Possible Metabolic Derivatives for Human Cancer Cell Lines of Different Histological Origin,https://pubmed.ncbi.nlm.nih.gov/25964542/,Positive,,Laboratory Study,2015,N-Arachidonoyl Dopamine (NADA),,Cancer; Cancer - Bone; Cancer - Brain; Cancer - Leukemia; Cancer - Lymphoma; Cancer - Neuroblastoma
2002030,Endocannabinoids and related fatty acid derivatives in pain modulation,https://www.sciencedirect.com/science/article/abs/pii/S0009308402001524,Positive,,Meta-analysis,2002,Anandamide (AEA); N-Arachidonoyl Dopamine (NADA); 2-Arachidonoyl Glycerol (2-AG); Other Related Compounds; Virodhamine (O-AEA),,Pain; Pain - Acute; Pain - Chronic
2009062,Opposite effects of anandamide and n‐arachidonoyl dopamine in the regulation of prostaglandin E2 and 8‐iso‐PGF2α formation in primary glial cells,https://onlinelibrary.wiley.com/doi/full/10.1111/j.1471-4159.2009.05966.x,Positive,,Laboratory Study,2009,N-Arachidonoyl Dopamine (NADA); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),,Inflammation
2019253,Early-life N-arachidonoyl-dopamine exposure increases antioxidant capacity of the brain tissues and reduces functional deficits after neonatal hypoxia in rats,https://www.sciencedirect.com/science/article/abs/pii/S0736574819300425,Positive,,Animal Study,2019,N-Arachidonoyl Dopamine (NADA),Nervous System,Neonatal Cerebral Issues
2004035,Characterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574254/,Positive,,Animal Study,2004,N-Arachidonoyl Dopamine (NADA),,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2009063,Time-Dependent Vascular Effects of Endocannabinoids Mediated by Peroxisome Proliferator-Activated Receptor Gamma (PPARγ),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676321/,Positive,,Animal Study,2009,Anandamide (AEA); N-Arachidonoyl Dopamine (NADA),Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Atherosclerosis
2017164,Cannabinoid Derivatives Exert a Potent Anti-Myeloma Activity Both in Vitro and in Vivo,https://pubmed.ncbi.nlm.nih.gov/27778331/,Positive,,Animal Study,2017,WIN-x Synthetic Cannabinoids,Cardiovascular System,Cancer - Myeloma
2009064,Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128286/,Positive,,Animal Study,2009,JWH-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids; AM-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Nervous System; Reproductive System,Cancer - Breast; Cancer - Metastatic; Cancer
2016172,Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216961/,Positive,,Meta-analysis,2016,Lysophosphatidylinositol (LPI),Nervous System; Reproductive System,Cancer - Breast; Cancer - Metastatic; Cancer
2017165,Hepatotoxicity Associated to Synthetic Cannabinoids Use,https://pubmed.ncbi.nlm.nih.gov/28379600/,Negative,,Meta-analysis,2017,Synthetic Cannabinoid (unspecified),Digestive System; Nervous System,Poisoning by Synthetic Cannabis; Toxic Liver Disease
2019254,"Drug-drug Interaction Studies with Coadministration of Cannabidiol (CBD) and Clobazam, Valproate, Stiripentol or Midazolam in Healthy Volunteers and Adults with Epilepsy",https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0039-1698213,Inconclusive,,Clinical Trial,2019,,,Epilepsy
2003028,Effects of Cannabidiol (CBD) on Regional Cerebral Blood Flow,https://www.nature.com/articles/1300340,Positive,,Double Blind Clinical Trial,2003,,,Anxiety
2009065,CB1 Receptors Mediate the Analgesic Effects of Cannabinoids on Colorectal Distension-Induced Visceral Pain in Rodents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6666086/,Positive,,Animal Study,2009,Anandamide (AEA); WIN-x Synthetic Cannabinoids,Nervous System,Pain; Pain - Acute; Hemorrhoids; Irritable Bowel Syndrome
2012122,Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668621/,Positive,,Animal Study,2012,,Digestive System,IBD - Inflammatory Bowel Disease; Hemorrhoids
2011111,The cannabinoid receptor agonist delta-9-tetrahydrocannabinol does not affect visceral sensitivity to rectal distension in healthy volunteers and IBS patients,https://www.ncbi.nlm.nih.gov/pubmed/20718944,Inconclusive,,Double Blind Clinical Trial,2011,Pharma THC,Digestive System,Irritable Bowel Syndrome; Hemorrhoids
2020732,Perception of Benefits and Harms of Medical Cannabis Among Seriously Ill Patients in an Outpatient Palliative Care Practice,https://pubmed.ncbi.nlm.nih.gov/31539298/,Positive,,Meta-analysis,2020,,Nervous System,Palliative Care
2020733,Tetrahydrocannabinol and Cannabidiol Use in an Outpatient Palliative Medicine Population,https://pubmed.ncbi.nlm.nih.gov/31986898/,Positive,,Meta-analysis,2020,,Nervous System,Palliative Care
2019255,Medical Cannabis Use in Palliative Care: Review of Clinical Effectiveness and Guidelines – An Update,https://pubmed.ncbi.nlm.nih.gov/31873991/,Positive,,Meta-analysis,2019,Pharma THC:CBD; Pharma THC; Tetrahydrocannabinol (THC),Nervous System,Palliative Care
2019256,An Open-Label Pilot Study Testing the Feasibility of Assessing Total Symptom Burden in Trials of Cannabinoid Medications in Palliative Care,https://pubmed.ncbi.nlm.nih.gov/31800354/,Positive,,Clinical Trial,2019,,Nervous System,Palliative Care
2012123,"Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour.",https://www.ncbi.nlm.nih.gov/pubmed/21796370,Positive,,Animal Study,2012,Cannabigerol (CBG); Tetrahydrocannabivarin (THCV),Mental/Emotional System; Nervous System,OCD; Anxiety
2019257,Top Ten Tips Palliative Care Clinicians Should Know About Medical Cannabis,https://pubmed.ncbi.nlm.nih.gov/30638427/,Positive,,Meta-analysis,2019,,Nervous System,Palliative Care
2019258,Cannabis and Cannabinoids in Palliative Care,https://pubmed.ncbi.nlm.nih.gov/31161228/,Positive,,Meta-analysis,2019,,Nervous System,Palliative Care
2018238,Cannabis in Palliative Care: Current Challenges and Practical Recommendations,https://pubmed.ncbi.nlm.nih.gov/30180728/,Positive,,Meta-analysis,2018,,Nervous System,Palliative Care
2018239,Medicinal Cannabinoids in Palliative Care,https://pubmed.ncbi.nlm.nih.gov/29923616/,Inconclusive,,Meta-analysis,2018,,,Palliative Care
2017166,Cannabinoids in Pain Management and Palliative Medicine,https://pubmed.ncbi.nlm.nih.gov/29017688/,Inconclusive,,Meta-analysis,2017,,Nervous System,Palliative Care
2017167,Cannabis Use in Palliative Oncology: A Review of the Evidence for Popular Indications,https://pubmed.ncbi.nlm.nih.gov/28457056/,Positive,,Meta-analysis,2017,,Nervous System,Palliative Care; Anorexia; Anxiety; Insomnia and Sleep Disorders; Pain; Pain - Cancer
2016173,"Cannabinoids in Palliative Care: Systematic Review and Meta-Analysis of Efficacy, Tolerability and Safety",https://pubmed.ncbi.nlm.nih.gov/26809975/,Inconclusive,,Clinical Meta-analysis,2016,,Nervous System,Palliative Care; Alzheimer's Disease; Anorexia; Cancer; HIV/AIDS; Insomnia and Sleep Disorders; Pain; Nausea and Vomiting
2013100,"The Medical Necessity for Medicinal Cannabis: Prospective, Observational Study Evaluating the Treatment in Cancer Patients on Supportive or Palliative Care",https://pubmed.ncbi.nlm.nih.gov/23956774/,Positive,,Meta-analysis,2013,,Nervous System,Palliative Care
2011112,Cannabis in Palliative Medicine: Improving Care and Reducing Opioid-Related Morbidity,https://pubmed.ncbi.nlm.nih.gov/21444324/,Positive,,Meta-analysis,2011,,Mental/Emotional System,Addiction - Opioid; Addiction; Palliative Care
2011113,"Assessment of Hospice Health Professionals' Knowledge, Views, and Experience With Medical Marijuana",https://pubmed.ncbi.nlm.nih.gov/22077541/,Positive,,Meta-analysis,2011,,,Palliative Care
2008074,Use of Cannabinoids in Palliative Medicine,https://pubmed.ncbi.nlm.nih.gov/18389029/,Positive,,Meta-analysis,2008,,,Palliative Care
2008075,Cannabinoids in Chronic Pain and Palliative Care,https://pubmed.ncbi.nlm.nih.gov/19378523/,Positive,,Meta-analysis,2008,,Nervous System,Pain; Palliative Care; Pain - Chronic
2007051,Cannabinoids:their Role in Pain and Palliation,https://pubmed.ncbi.nlm.nih.gov/18032352/,Positive,,Meta-analysis,2007,,Nervous System,Palliative Care
2019259,Cannabidiol (CBD) Reduces Anxiety-Related Behavior in Mice via an FMRP-independent Mechanism,https://pubmed.ncbi.nlm.nih.gov/31063743/,Positive,,Animal Study,2019,,Nervous System,Fragile X Syndrome
2016174,Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model,https://pubmed.ncbi.nlm.nih.gov/27589806/,Positive,,Animal Study,2016,SR-x Synthetic Cannabinoids,,Fragile X Syndrome
2015136,Homer Protein-Metabotropic Glutamate Receptor Binding Regulates Endocannabinoid Signaling and Affects Hyperexcitability in a Mouse Model of Fragile X Syndrome,https://pubmed.ncbi.nlm.nih.gov/25740522/,Positive,,Animal Study,2015,,Nervous System,Fragile X Syndrome
2015137,Endocannabinoid-mediated Improvement on a Test of Aversive Memory in a Mouse Model of Fragile X Syndrome,https://pubmed.ncbi.nlm.nih.gov/25979787/,Positive,,Animal Study,2015,Fatty Acid Amide Hydrolase (FAAH); AM-x Synthetic Cannabinoids; Anandamide (AEA),Nervous System,Fragile X Syndrome
2013101,Targeting the Endocannabinoid System in the Treatment of Fragile X Syndrome,https://pubmed.ncbi.nlm.nih.gov/23542787/,Positive,,Animal Study,2013,,Nervous System,Fragile X Syndrome
2010073,Enhanced Endocannabinoid Signaling Elevates Neuronal Excitability in Fragile X Syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906112/#!po=70.8333,Positive,,Animal Study,2010,,,Fragile X Syndrome
2001018,Concurrent substance use and outcome in combined behavioral and naltrexone therapy for opiate dependence,https://pubmed.ncbi.nlm.nih.gov/11506261/,Positive,,Clinical Trial,2001,,Mental/Emotional System,Addiction - Opioid; Addiction
2009066,Intermittent Marijuana Use Is Associated with Improved Retention in Naltrexone Treatment for Opiate-Dependence,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2753886/#!po=2.77778,Positive,,Clinical Trial,2009,,Mental/Emotional System,Addiction - Opioid; Addiction
2018240,High-intensity Cannabis Use Is Associated With Retention in Opioid Agonist Treatment: A Longitudinal Analysis,https://pubmed.ncbi.nlm.nih.gov/30238568/,Positive,,Meta-analysis,2018,Tetrahydrocannabinol (THC),Mental/Emotional System,Addiction - Opioid; Addiction
2018241,Emerging Evidence for Cannabis' Role in Opioid Use Disorder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135562/#!po=90.7895,Positive,,Meta-analysis,2018,,Mental/Emotional System,Addiction - Opioid; Addiction
2020734,The impact of naturalistic cannabis use on self-reported opioid withdrawal,https://www.journalofsubstanceabusetreatment.com/article/S0740-5472(19)30564-1/pdf,Positive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
2018242,"Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science",https://pubmed.ncbi.nlm.nih.gov/30152161/,Positive,,Meta-analysis,2018,,,Migraine; Pain; Pain - Chronic
2018243,Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population,https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2676999,Positive,,Meta-analysis,2018,,Mental/Emotional System,Addiction - Opioid; Addiction
2007052,Dose-dependent Effects of Smoked Cannabis on Capsaicin-Induced Pain and Hyperalgesia in Healthy Volunteers,https://pubmed.ncbi.nlm.nih.gov/18073554/,Inconclusive,,Double Blind Clinical Trial,2007,Capsaicin (CAPS),Nervous System,Pain; Pain - Acute
2012124,"Smoked Cannabis for Spasticity in Multiple Sclerosis: A Randomized, Placebo-Controlled Trial",https://pubmed.ncbi.nlm.nih.gov/22586334/,Positive,,Double Blind Clinical Trial,2012,,Nervous System,Multiple Sclerosis; Dystonia
2015138,Cannabinoids for Medical Use A Systematic Review and Meta-analysis,https://jamanetwork.com/journals/jama/fullarticle/2338251,Positive,,Meta-analysis,2015,,,Cachexia; Dystonia; Insomnia and Sleep Disorders; Tics and Tourettes; Pain; Pain - Chronic
2016175,Inhaled cannabis for chronic neuropathic pain: an individual patient data meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666747/,Positive,,Clinical Meta-analysis,2016,,Nervous System,Pain; Pain - Chronic; Pain - Neuropathy - Peripheral
2019260,A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012851/,Positive,,Double Blind Clinical Trial,2019,,Nervous System,Pain; Pain - Central Pain Syndrome
2015139,"Cannabinoid CB1 Receptor Agonists Do Not Decrease, but may Increase Acoustic Trauma-Induced Tinnitus in Rats",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364172/,Negative,,Animal Study,2015,Pharma THC:CBD,Nervous System,Tinnitus
2018244,The Endocannabinoid/Cannabinoid Receptor 2 System Protects Against Cisplatin-Induced Hearing Loss,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110918/,Positive,,Animal Study,2018,AM-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,Nervous System,Hearing Loss; Tinnitus
2016176,"Cannabinoids, cannabinoid receptors and tinnitus",https://www.sciencedirect.com/science/article/pii/S0378595515300368?via%3Dihub,Negative,,Meta-analysis,2016,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); CP-x Synthetic Cannabinoids,Nervous System,Tinnitus
2019261,What Is the Evidence for Cannabis Use in Otolaryngology?: A Narrative Review,https://pubmed.ncbi.nlm.nih.gov/31174932/,Inconclusive,,Meta-analysis,2019,,,Tinnitus
2017168,The Use of Cannabis for Headache Disorders,https://www.liebertpub.com/doi/10.1089/can.2016.0033,Positive,,Meta-analysis,2017,,Nervous System,Migraine
2019262,Recreational Marijuana Legalization and Prescription Opioids Received by Medicaid Enrollees,https://pubmed.ncbi.nlm.nih.gov/30390550/,Positive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
2020735,Cannabis Exposure Is Associated With a Lower Likelihood of Neurocognitive Impairment in People Living With HIV,https://pubmed.ncbi.nlm.nih.gov/31809361/,Positive,,Meta-analysis,2020,,Immune System; Nervous System,Cognitive Dysfunction; HIV/AIDS
2017169,Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by Clostridium difficile toxin A in Caco-2 cells,https://journals.sagepub.com/doi/full/10.1177/2050640617698622,Positive,,Laboratory Study,2017,AM-x Synthetic Cannabinoids,Digestive System,Diarrhea
2017170,Clinical Profile of Cannabis-Associated Acute Pancreatitis,https://www.dldjournalonline.com/article/S1590-8658(17)31060-5/abstract,Negative,,Meta-analysis,2017,,Digestive System; Endocrine System,Pancreatitis
2017171,The Effect of Cannabis Consumption on the Development and Severity of Acute Pancreatitis,https://www.gastrojournal.org/article/S0016-5085(17)31267-2/fulltext,Inconclusive,,Meta-analysis,2017,,Digestive System; Endocrine System,Pancreatitis
2015140,High-intensity Cannabis Use Associated With Lower Plasma Human Immunodeficiency virus-1 RNA Viral Load Among Recently Infected People Who Use Injection Drugs,https://pubmed.ncbi.nlm.nih.gov/25389027/,Positive,,Meta-analysis,2015,,Immune System,HIV/AIDS
2015141,Cannabinoid receptors: Their impact in epidermal differentiation and possible role in treatment of psoriasis,https://www.researchgate.net/publication/279067945_Topical_cannabinoid_receptor_1_agonist_attenuates_the_cutaneous_inflammatory_responses_in_oxazolone-induced_atopic_dermatitis_model,Positive,,Animal Study,2015,,Integumentary System,Psoriasis
2020736,Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1,https://www.sciencedirect.com/science/article/pii/S2213231719306470,Positive,,Animal Study,2020,,Integumentary System,Psoriasis; Allergic Contact Dermatitis; Eczema; Seborrhea
2014114,Cannabinoids and the Endocannabinoid System in Lower Urinary Tract Function and Dysfunction,https://pubmed.ncbi.nlm.nih.gov/24285567/,Positive,,Meta-analysis,2014,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Urinary System,Urinary Tract Infection
2011114,Cannabinoids: Potential Targets for Bladder Dysfunction,https://pubmed.ncbi.nlm.nih.gov/21290238/,Positive,,Meta-analysis,2011,,Urinary System,Urinary Tract Infection
2019263,Cannabinoid type-1 Receptor Blockade Restores Neurological Phenotypes in Two Models for Down Syndrome,https://pubmed.ncbi.nlm.nih.gov/30685352/,Positive,,Animal Study,2019,,Nervous System,Down Syndrome
2014115,"Monoacylglycerol Lipase Inhibitor JZL184 Improves Behavior and Neural Properties in Ts65Dn Mice, a Model of Down Syndrome",https://pubmed.ncbi.nlm.nih.gov/25474204/,Positive,,Animal Study,2014,2-Arachidonoyl Glycerol (2-AG); Monoacylglycerol Lipase (MAGL),Nervous System,Down Syndrome
2015142,Monoacylglycerol Lipase Regulates Fever Response,https://pubmed.ncbi.nlm.nih.gov/26287872/,Positive,,Animal Study,2015,Monoacylglycerol Lipase (MAGL),Immune System,Epilepsy - FIRES; Epilepsy
2008076,Behavioral and Temperature Effects of Delta 9-tetrahydrocannabinol in Human-Relevant Doses in Rats,https://pubmed.ncbi.nlm.nih.gov/18619424/,Positive,,Animal Study,2008,Pharma THC; Tetrahydrocannabinol (THC),,Epilepsy - FIRES; Epilepsy
2002031,The Role of Endocannabinoids in the Hypothalamic Regulation of Visceral Function,https://pubmed.ncbi.nlm.nih.gov/12052044/,Positive,,Meta-analysis,2002,,Immune System,Epilepsy - FIRES; Epilepsy
2005036,"Delta9-tetrahydrocannbinol Accounts for the Antinociceptive, Hypothermic, and Cataleptic Effects of Marijuana in Mice",https://pubmed.ncbi.nlm.nih.gov/15831444/,Positive,,Animal Study,2005,Pharma THC; Tetrahydrocannabinol (THC); SR-x Synthetic Cannabinoids,Immune System; Nervous System,Pain; Pain - Acute; Epilepsy - FIRES; Epilepsy
2004036,"Cannabinoids Prevent the Acute Hyperthermia and Partially Protect Against the 5-HT Depleting Effects of MDMA (""Ecstasy"") in Rats",https://pubmed.ncbi.nlm.nih.gov/15081792/,Positive,,Animal Study,2004,CP-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Immune System,MDMA Adverse Effects; Anxiety; Epilepsy - FIRES; Epilepsy
2003029,Drug-induced Hypothermia Reduces Ischemic Damage: Effects of the Cannabinoid HU-210,https://pubmed.ncbi.nlm.nih.gov/12829867/,Positive,,Animal Study,2003,HU-x Synthetic Cannabinoids,Immune System,Cardiovascular Diseases (CVD); Epilepsy - FIRES; Epilepsy; Heart Attack; Oxidative Stress; Stroke
1977003,"Profound Hypothermia in Mammals Treated With Tetrahydrocannabinols, Morphine, or Chlorpromazine",https://pubmed.ncbi.nlm.nih.gov/913617/,Positive,,Animal Study,1977,,Immune System,Epilepsy - FIRES; Epilepsy
1998014,Modulation of delta9-tetrahydrocannabinol-induced Hypothermia by Fluoxetine in the Rat,https://pubmed.ncbi.nlm.nih.gov/9723953/,Positive,,Animal Study,1998,,Immune System,Epilepsy - FIRES; Epilepsy
1982002,Changes in Body Temperature and Oxygen Consumption Rate of Conscious Mice Produced by Intrahypothalamic and Intracerebroventricular Injections of Delta 9-tetrahydrocannabinol,https://pubmed.ncbi.nlm.nih.gov/6313110/,Positive,,Animal Study,1982,,Immune System,Epilepsy - FIRES; Epilepsy
1976004,Marijuana Smoking and Cold Tolerance in Man,https://pubmed.ncbi.nlm.nih.gov/779756/,Positive,,Double Blind Clinical Trial,1976,,Immune System,Epilepsy - FIRES; Epilepsy
1973004,Evaluation of the Hypothermic Action of Tetrahydrocannabinols in Mice and Squirrel Monkeys,http://jpet.aspetjournals.org/content/187/3/568,Positive,,Animal Study,1973,,Immune System,Epilepsy - FIRES; Epilepsy
1978002,The Effects of Cannabinoids on Body Temperature and Brain Catecholamine Synthesis,https://pubmed.ncbi.nlm.nih.gov/663408/,Positive,,Animal Study,1978,Tetrahydrocannabinol (THC),Immune System,Epilepsy - FIRES; Epilepsy
1975002,"Absence of Interaction Between delta9-tetrahydrocannabinol (delta-THC) and Cannabidiol (CBD) in Aggression, Muscle Control and Body Temperature Experiments in Mice",https://pubmed.ncbi.nlm.nih.gov/1171491/,Positive,,Animal Study,1975,,Immune System,Epilepsy - FIRES; Epilepsy
1977004,The effect of delta9-tetrahydrocannabinol on body temperature and brain amine concentrations in the rat at differnt ambient temperatures,https://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC1667176&blobtype=pdf,Positive,,Animal Study,1977,,Immune System,Epilepsy - FIRES; Epilepsy
1979001,"In Body Temperature: Regulation, Drug Effects and Therapeutic Implications. Chapter 20.",https://books.google.com/books/about/Body_temperature.html?id=ztJqAAAAMAAJ,Positive,,Meta-analysis,1979,,Immune System,Epilepsy - FIRES; Epilepsy
1972001,Effect of cannabis and certain of its constituents on pentobarbitone sleeping time and phenazone metabolism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1666020/?page=2,Positive,,Animal Study,1972,,Immune System,Epilepsy - FIRES; Epilepsy
2015143,Dupuytren’s Contracture: Case Study,http://www.os-extra.cannabisclinicians.org/wp-content/uploads/2015/12/13-Findings-and-Observations-Sully.pdf,Positive,,Meta-analysis,2015,,Muscular System,Dupuytren's Contracture
2010074,Role of Cannabinoids in the Development of Fatty Liver (Steatosis),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844512/,Negative,,Meta-analysis,2010,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Digestive System,Fatty Liver Disease; Hepatitis
2010075,Endocannabinoids and their role in fatty liver disease,https://www.ncbi.nlm.nih.gov/pubmed/20460921,Negative,,Meta-analysis,2010,Endocannabinoid (unspecified),Digestive System,Fatty Liver Disease; Fibrosis - Liver (Cirrhosis); Fibrosis; Hepatitis
2010076,Potential Role of the Cannabinoid Receptor CB in the Pathogenesis of Erosive and Non-Erosive Gastro-Oesophageal Reflux Disease,https://pubmed.ncbi.nlm.nih.gov/20497140/,Inconclusive,,Meta-analysis,2010,,Digestive System,Gastro-Esophageal Reflux
2017172,Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404771/,Positive,,Meta-analysis,2017,,Digestive System,Fatty Liver Disease
2004037,Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774264/,Negative,,Meta-analysis,2004,,,Cannabis Hyperemesis Syndrome; Nausea and Vomiting
1985004,The Effects of Marijuana on Human Physical Aggression,https://pubmed.ncbi.nlm.nih.gov/3003332/,Inconclusive,,Clinical Trial,1985,,Mental/Emotional System,Intermittent Explosive Disorder
1995006,Provocation Frequency and Its Role in Determining the Effects of Smoked Marijuana on Human Aggressive Responding,https://pubmed.ncbi.nlm.nih.gov/11224349/,Inconclusive,,Clinical Trial,1995,,Mental/Emotional System,Intermittent Explosive Disorder
2007053,Testing the Self-Medication Hypothesis of Depression and Aggression in Cannabis-Dependent Subjects,https://pubmed.ncbi.nlm.nih.gov/17202003/,Negative,,Meta-analysis,2007,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Depression; Intermittent Explosive Disorder; Cannabis Adverse Effects
2017173,Intermittent Explosive Disorder and Substance Use Disorder: Analysis of The National Comorbity Study - Replication Sample,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128355/#__ffn_sectitle,Inconclusive,,Meta-analysis,2017,,Mental/Emotional System,Intermittent Explosive Disorder
2019264,Cannabidiol attenuates aggressive behavior induced by social isolation in mice: Involvement of 5-HT1A and CB1 receptors,https://www.sciencedirect.com/science/article/pii/S0278584618308340,Positive,,Animal Study,2019,,Mental/Emotional System,Intermittent Explosive Disorder
2019265,Myrcene and terpene regulation of TRPV1,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768052/#__ffn_sectitle,Positive,,Laboratory Study,2019,,Nervous System,Pain; Pain - Nociceptive; Pain - Acute; Pain - Chronic
2007054,Modulation of Airway Responses to Influenza A/PR/8/34 by 9-Tetrahydrocannabinol in C57BL/6 Mice,https://www.researchgate.net/publication/6114513_Modulation_of_Airway_Responses_to_Influenza_APR834_by_9-Tetrahydrocannabinol_in_C57BL6_Mice,Negative,,Animal Study,2007,Tetrahydrocannabinol (THC),Immune System; Respiratory System,Flu
2008077,Targeted Deletion of Cannabinoid Receptors CB1 and CB2 Produced Enhanced Inflammatory Responses to Influenza A/PR/8/34 in the Absence and Presence of Delta9-tetrahydrocannabinol,https://pubmed.ncbi.nlm.nih.gov/18073275-targeted-deletion-of-cannabinoid-receptors-cb1-and-cb2-produced-enhanced-inflammatory-responses-to-influenza-apr834-in-the-absence-and-presence-of-delta9-tetrahydrocannabinol/,Inconclusive,,Animal Study,2008,,Immune System; Respiratory System,Flu; Inflammation
1973005,Anti-Edema And Analgesic Properties of Δ9-Tetrahydrocannabinol (THC),http://jpet.aspetjournals.org/content/186/3/646.abstract?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=marihuana&searchid=1&FIRSTINDEX=2160&resourcetype=HWCIT,Positive,,Animal Study,1973,Tetrahydrocannabinol (THC),Cardiovascular System; Immune System; Integumentary System; Respiratory System,Edema
2011115,Low-volume Binary Drug Therapy for the Treatment of Hypovolemia,https://pubmed.ncbi.nlm.nih.gov/21330941/,Positive,,Animal Study,2011,,Cardiovascular System,Hemorrhagic Shock
2011116,Pharmacokinetics of a Combination of Δ9-tetrahydro-cannabinol and Celecoxib in a Porcine Model of Hemorrhagic Shock,https://pubmed.ncbi.nlm.nih.gov/21341278/,Positive,,Animal Study,2011,,Cardiovascular System,Hemorrhagic Shock
2019266,Cannabis Roots: A Traditional Therapy with Future Potential for Treating Inflammation and Pain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628559/#!po=22.5000,Positive,,Meta-analysis,2019,,Nervous System,Inflammation; Arthritis - Gout; Arthritis - Osteoarthritis; Arthritis; Burn Injury
2011117,Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206470/,Positive,,Animal Study,2011,,Immune System; Respiratory System,Flu
2013102,Δ9-Tetrahydrocannabinol Impairs the Inflammatory Response to Influenza Infection: Role of Antigen-Presenting Cells and the Cannabinoid Receptors 1 and 2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551428/,Negative,,Animal Study,2013,Tetrahydrocannabinol (THC),Immune System; Respiratory System,Flu
2003030,An Endogenous Cannabinoid Tone Attenuates Cholera Toxin-Induced Fluid Accumulation in Mice,https://pubmed.ncbi.nlm.nih.gov/12949722/,Inconclusive,,Animal Study,2003,Anandamide (AEA); CP-x Synthetic Cannabinoids,Digestive System; Immune System,Cholera; Diarrhea
1999013,"Differential Cholera-Toxin Sensitivity of Supraspinal Antinociception Induced by the Cannabinoid Agonists delta9-THC, WIN 55,212-2 and Anandamide in Mice",https://www.ncbi.nlm.nih.gov/pubmed/10218903,Inconclusive,,Animal Study,1999,WIN-x Synthetic Cannabinoids; Anandamide (AEA),Digestive System; Immune System,Cholera
2008078,A Comparative Study on Cannabidiol-Induced Apoptosis in Murine Thymocytes and EL-4 Thymoma Cells,https://pubmed.ncbi.nlm.nih.gov/18387516/,Positive,,Laboratory Study,2008,,Endocrine System; Nervous System,Cancer - Thymus; Cancer
2004038,Cannabinoid Agonists in the Treatment of Blepharospasm--A Case Report Study,https://pubmed.ncbi.nlm.nih.gov/15159681/,Positive,,Meta-analysis,2004,Pharma THC; Tetrahydrocannabinol (THC),,Blepharospasm; Dystonia; Chorea
2016177,Decreased Expression of Fatty Acid Amide Hydrolase in Women With Polycystic Ovary Syndrome,https://www.tandfonline.com/doi/abs/10.1080/09513590.2016.1269742?journalCode=igye20,Positive,,Laboratory Study,2016,Fatty Acid Amide Hydrolase (FAAH),Endocrine System,Polycystic Ovary Disease; Ovarian Dysfunction
2018245,Genetic and pharmacological regulation of the endocannabinoid CB1 receptor in Duchenne muscular dystrophy,https://www.nature.com/articles/s41467-018-06267-1#citeas,Positive,,Laboratory Study,2018,SR-x Synthetic Cannabinoids,Muscular System,Muscular Dystrophy & Myotonic Disorders
2009067,Endogenous cannabinoids induce fever through the activation of CB1 receptors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765314/,Positive,,Animal Study,2009,Anandamide (AEA); AM-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH),Immune System,
2002032,Evidence for functional CB1 cannabinoid receptor expressed in the rat thyroid,https://www.ncbi.nlm.nih.gov/pubmed/12153749/,Positive,,Animal Study,2002,SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,,Cancer - Thyroid; Cancer; Hyperthyroidism and Graves' Disease
2015144,"Efficacy of orally administered Silexan in patients with anxiety-related restlessness and disturbed sleep – A randomized, placebo-controlled trial",https://www.sciencedirect.com/science/article/abs/pii/S0924977X15002424?via%3Dihub,Positive,,Double Blind Clinical Trial,2015,,Mental/Emotional System; Nervous System,Anxiety; Insomnia and Sleep Disorders
2019267,"Effects of Silexan on the Serotonin-1A Receptor and Microstructure of the Human Brain: A Randomized, Placebo-Controlled, Double-Blind, Cross-Over Study with Molecular and Structural Neuroimaging",https://academic.oup.com/ijnp/article/18/4/pyu063/664013,Positive,,Double Blind Clinical Trial,2019,,,Anxiety
2017174,Essential oil of lavender in anxiety disorders: Ready for prime time?,https://mhc.cpnp.org/doi/full/10.9740/mhc.2017.07.147,Positive,,Meta-analysis,2017,,Mental/Emotional System,Anxiety
2019268,Medical Marijuana Laws and Suicide,https://www.tandfonline.com/doi/full/10.1080/13811118.2019.1612803?scroll=top&needAccess=true,Positive,,Meta-analysis,2019,,Mental/Emotional System,Suicide Attempt
2018246,The association between cannabis use and suicidal behavior in patients with psychiatric disorders: an analysis of sex differences,https://bsd.biomedcentral.com/articles/10.1186/s13293-018-0182-x,Inconclusive,,Meta-analysis,2018,,Mental/Emotional System,Suicide Attempt
2014116,Medical Marijuana Laws and Suicides by Gender and Age,https://pubmed.ncbi.nlm.nih.gov/24432945/,Positive,,Meta-analysis,2014,,Mental/Emotional System,Suicide Attempt
2013103,Cannabis use and suicidal ideation,https://www.sciencedirect.com/science/article/abs/pii/S016762961300009X,Inconclusive,,Meta-analysis,2013,,Mental/Emotional System,Suicide Attempt
2008079,Influence of Cannabis Use on Suicidal Ideations Among 491 High-School Students,https://pubmed.ncbi.nlm.nih.gov/18558148/,Inconclusive,,Meta-analysis,2008,,Mental/Emotional System,Suicide Attempt
2009068,Cannabis and Suicide: Longitudinal Study,https://pubmed.ncbi.nlm.nih.gov/19949196-cannabis-and-suicide-longitudinal-study/,Inconclusive,,Meta-analysis,2009,,Mental/Emotional System,Suicide Attempt
2019269,Cannabinoid-sensitive receptors in cardiac physiology and ischaemia,https://www.ncbi.nlm.nih.gov/pubmed/30890410,Positive,,Meta-analysis,2019,,,Atherosclerosis; Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Heart Attack; Hypertension (High Blood Pressure)
2017175,Associations between Cannabis Use and Physical Health Problems in Early Midlife: A Longitudinal Comparison of Persistent Cannabis versus Tobacco Users,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936934/,Negative,,Meta-analysis,2017,,Digestive System,Periodontal Disease; Inflammation; Metabolic Syndrome
2005037,Cardiovascular complications induced by cannabis smoking: a case report and review of the literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1726916/pdf/v022p00679.pdf,Negative,,Meta-analysis,2005,,Cardiovascular System; Mental/Emotional System; Nervous System,Atrial Fibrillation; Cannabis Adverse Effects; Cardiovascular Diseases (CVD); Cardiac Arrhythmias; Heart Attack
2005038,Cannabis as a precipitant of cardiovascular emergencies,https://www.ncbi.nlm.nih.gov/pubmed/16168820,Negative,,Meta-analysis,2005,,Cardiovascular System,Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Cannabis Adverse Effects; Heart Attack
2007055,Marijuana as a trigger of cardiovascular events: speculation or scientific certainty?,https://www.ncbi.nlm.nih.gov/pubmed/17005273,Negative,,Meta-analysis,2007,,Cardiovascular System,Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Cannabis Adverse Effects
2007056,Acute cannabis intoxication mimicking brugada-like ST segment abnormalities,https://www.ncbi.nlm.nih.gov/pubmed/17291603,Negative,,Meta-analysis,2007,Tetrahydrocannabinol (THC),Cardiovascular System,Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Cannabis Adverse Effects
2019270,Cannabis and acute coronary syndrome with ST segment elevation,https://www.ncbi.nlm.nih.gov/pubmed/24182845,Negative,,Meta-analysis,2019,,Cardiovascular System,Cardiac Arrhythmias; Cardiovascular Diseases (CVD)
2018247,Recurrent STEMI Precipitated by Marijuana Use: Case Report and Literature Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173205/,Negative,,Meta-analysis,2018,Tetrahydrocannabinol (THC),Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack
2014117,"Lavender oil preparation Silexan is effective in generalized anxiety disorder--a randomized, double-blind comparison to placebo and paroxetine",https://academic.oup.com/ijnp/article/17/6/859/691858?login=false,Positive,,Double Blind Clinical Trial,2014,,Mental/Emotional System; Nervous System,Anxiety
2010077,"Evidence for a Role of Endocannabinoids, Astrocytes and p38 Phosphorylation in the Resolution of Postoperative Pain",https://pubmed.ncbi.nlm.nih.gov/20531936/,Positive,,Animal Study,2010,AM-x Synthetic Cannabinoids; Endocannabinoid (unspecified),Nervous System,Pain; Pain - Acute; Hemorrhoids
2006032,Delta(9)-tetrahydrocannabinol and the Opioid Receptor Agonist Piritramide Do Not Act Synergistically in Postoperative Pain,https://pubmed.ncbi.nlm.nih.gov/16389542/,Inconclusive,,Double Blind Clinical Trial,2006,Pharma THC; Tetrahydrocannabinol (THC),Nervous System,Pain; Pain - Acute
2005039,Cannabinoid CB2 Receptor Agonist Activity in the Hindpaw Incision Model of Postoperative Pain,https://pubmed.ncbi.nlm.nih.gov/16316653/,Positive,,Animal Study,2005,AM-x Synthetic Cannabinoids; HU-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Nervous System,Pain; Pain - Acute
2008080,Linalool in Essential Plant Oils: Pharmacological Effects,https://www.researchgate.net/publication/244484974_Linalool_in_Essential_Plant_Oils_Pharmacological_Effects,Positive,,Meta-analysis,2008,,,Inflammation; Pain
2018248,Combined CB2 receptor agonist and photodynamic therapy synergistically inhibit tumor growth in triple negative breast cancer,https://www.sciencedirect.com/science/article/abs/pii/S1572100018301571?via%3Dihub,Positive,,Laboratory Study,2018,,Nervous System; Reproductive System,Cancer - Breast; Cancer
2019271,Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees,https://pubmed.ncbi.nlm.nih.gov/29610827/,Positive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
2019272,Medical Cannabis Legalization and Opioid Prescriptions: Evidence on US Medicaid Enrollees During 1993-2014,https://pubmed.ncbi.nlm.nih.gov/29989239/,Positive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
2019273,Use of Cannabis to Relieve Pain and Promote Sleep by Customers at an Adult Use Dispensary,https://pubmed.ncbi.nlm.nih.gov/31264536/,Positive,,Meta-analysis,2019,,Nervous System,Insomnia and Sleep Disorders; Pain; Pain - Chronic
2019274,Medical Cannabis: Effects on Opioid and Benzodiazepine Requirements for Pain Control,https://pubmed.ncbi.nlm.nih.gov/31129977/,Positive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Addiction - Benzodiazepine; Addiction - Opioid; Addiction; Pain; Pain - Chronic
2019275,Frequency of Cannabis and Illicit Opioid Use Among People Who Use Drugs and Report Chronic Pain: A Longitudinal Analysis,https://pubmed.ncbi.nlm.nih.gov/31743343/,Positive,,Meta-analysis,2019,,Nervous System,Pain; Pain - Chronic; Addiction - Opioid
2017176,"Cannabidiolic acid methyl ester, a stable synthetic analogue of cannabidiolic acid, can produce 5‐HT1A receptor‐mediated suppression of nausea and anxiety in rats",https://www.researchgate.net/publication/320559604_Cannabidiolic_acid_methyl_ester_a_stable_synthetic_analogue_of_cannabidiolic_acid_can_produce_5-HT1A_receptor-mediated_suppression_of_nausea_and_anxiety_in_rats,Positive,,Animal Study,2017,Cannabidiolic Acid (CBD-a); HU-x Synthetic Cannabinoids,Digestive System; Mental/Emotional System; Nervous System,Anxiety; Nausea and Vomiting; Chemotherapy-induced Nausea & Vomiting; Morning sickness; Motion Sickness
2018249,Antimicrobial potential of endocannabinoid and endocannabinoid-like compounds against methicillin-resistant Staphylococcus aureus,https://www.researchgate.net/publication/329349577_Antimicrobial_potential_of_endocannabinoid_and_endocannabinoid-like_compounds_against_methicillin-resistant_Staphylococcus_aureus,Positive,,Laboratory Study,2018,Anandamide (AEA); Other Related Compounds,Immune System,Bacterial Infections; Staph Infection
2019276,Enhancing effects of acute exposure to cannabis smoke on working memory performance,https://www.sciencedirect.com/science/article/pii/S1074742718302776#!,Positive,,Animal Study,2019,SR-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC),Nervous System,Cognitive Dysfunction
2019277,Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study,https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(18)30110-5/fulltext,Inconclusive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction; Pain; Pain - Chronic
2019278,Marijuana smoking and markers of testicular function among men from a fertility centre,https://academic.oup.com/humrep/article-abstract/34/4/715/5307080?redirectedFrom=fulltext#130399353,Positive,,Meta-analysis,2019,,Reproductive System,Infertility (Male)
2019279,Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333745/,Positive,,Clinical Trial,2019,,Mental/Emotional System; Nervous System,Autism
2019280,Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism,https://www.sciencedirect.com/science/article/abs/pii/S1357272518300852?fbclid=IwAR37qi00LNavsZ-daJXnJKSYgplHahQeDglK1HzVWaByZktlUCFi4Weain8,Positive,,Laboratory Study,2019,2-Arachidonoyl Glycerol (2-AG); Other Related Compounds,Immune System,Lupus
2019281,Association between cannabis laws and opioid prescriptions among privately insured adults in the US,https://www.sciencedirect.com/science/article/pii/S0091743519301860?via%3Dihub,Positive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
2019282,Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial,https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2019.18101191,Positive,,Double Blind Clinical Trial,2019,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
2019283,The Endocannabinoid System: A New Treatment Target for Obsessive Compulsive Disorder?,https://www.researchgate.net/publication/333498177_The_Endocannabinoid_System_A_New_Treatment_Target_for_Obsessive_Compulsive_Disorder,Positive,,Meta-analysis,2019,Pharma THC; Pharma CBD; Pharma THC:CBD,Mental/Emotional System; Nervous System,OCD
2019284,"The cannabinoid receptor 2 agonist, β-caryophyllene, improves working memory and reduces circulating levels of specific proinflammatory cytokines in aged male mice",https://www.sciencedirect.com/science/article/pii/S0166432819304516?via%3Dihub,Positive,,Animal Study,2019,,,Cognitive Dysfunction; Inflammation
2019285,"Lifetime marijuana use in relation to insulin resistance in lean, overweight, and obese US adults",https://onlinelibrary.wiley.com/doi/abs/10.1111/1753-0407.12958,Positive,,Meta-analysis,2019,,Endocrine System,Diabetes; Metabolic Syndrome; Obesity
2019286,The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667203/,Positive,,Clinical Trial,2019,Pharma THC:CBD,Nervous System,Multiple Sclerosis
2019287,"Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6866665/,Positive,,Animal Study,2019,Pharma THC:CBD; Microbiome,Digestive System; Nervous System,Encephalitis and Myelitis; Microbiome Imbalance; Multiple Sclerosis
2019288,The Effects of Medical Marijuana Dispensaries on Adverse Opioid Outcomes,https://mpra.ub.uni-muenchen.de/89613/1/MPRA_paper_89613.pdf,Positive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
2019289,The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease,https://www.sciencedirect.com/science/article/pii/S0278584619302210,Negative,,Meta-analysis,2019,,Nervous System,Parkinson's Disease
2019290,Measuring Disturbance of the Endocannabinoid System in Psychosis A Systematic Review and Meta-analysis,https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2735110?fbclid=IwAR14NzUeedgBDFdGcPc3Tn34GzUaY4r_MIpKOp4eKBdOzVYw6Jy-YiO6CG0,Inconclusive,,Meta-analysis,2019,Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2019291,Association between medical cannabis laws and opioid overdose mortality has reversed over time,https://www.pnas.org/content/116/26/12624,Negative,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
2019292,The effect of cannabis laws on opioid use,https://www.ncbi.nlm.nih.gov/pubmed/31590091,Positive,,Meta-analysis,2019,,Nervous System,Pain; Pain - Chronic; Addiction - Opioid
2019293,A Pilot Study of a Medical Cannabis - Opioid Reduction Program,http://www.sciencepublishinggroup.com/journal/paperinfo?journalid=653&doi=10.11648/j.ajpn.20190703.14,Positive,,Meta-analysis,2019,,Mental/Emotional System,Addiction - Opioid; Addiction; Pain; Pain - Chronic
2019294,Substitution of marijuana for opioids in a national survey of US adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777788/,Positive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction; Pain; Pain - Chronic
2019295,"HU-671, a Novel Oleoyl Serine Derivative, Exhibits Enhanced Efficacy in Reversing Ovariectomy-Induced Osteoporosis and Bone Marrow Adiposity",https://www.researchgate.net/publication/336609010_HU-671_a_Novel_Oleoyl_Serine_Derivative_Exhibits_Enhanced_Efficacy_in_Reversing_Ovariectomy-Induced_Osteoporosis_and_Bone_Marrow_Adiposity,Positive,,Animal Study,2019,HU-x Synthetic Cannabinoids,Skeletal System,Osteoporosis
2001019,Marijuana for the Management of Proximal Myotonic Myopathy,https://www.jpsmjournal.com/article/S0885-3924(01)00252-4/fulltext,Positive,,Meta-analysis,2001,,Muscular System,Muscular Dystrophy & Myotonic Disorders
2019296,A role for cannabinoids in the treatment of myotonia? Report of compassionate use in a small cohort of patients,https://link.springer.com/article/10.1007%2Fs00415-019-09593-6,Positive,,Clinical Trial,2019,Pharma THC:CBD,Muscular System,Muscular Dystrophy & Myotonic Disorders
2019297,Cannabinoid-induced increase of quantal size and enhanced neuromuscular transmission,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856814/,Positive,,Animal Study,2019,WIN-x Synthetic Cannabinoids,Nervous System,Myasthenia Gravis
2019298,Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal,https://www.ncbi.nlm.nih.gov/pubmed/30502644,Positive,,Meta-analysis,2019,,Nervous System,Multiple Sclerosis
2019299,Illegal cannabis use is common among Danes with multiple sclerosis,https://www.ncbi.nlm.nih.gov/pubmed/31129415,Positive,,Meta-analysis,2019,,Nervous System,Multiple Sclerosis
2019300,Caring for people with multiple sclerosis who use cannabis for symptom control,https://www.ncbi.nlm.nih.gov/pubmed/31166770,Positive,,Meta-analysis,2019,,Nervous System,Multiple Sclerosis
2019301,Cannabis and multiple sclerosis,https://www.ncbi.nlm.nih.gov/pubmed/31201234,Positive,,Meta-analysis,2019,,Nervous System,Multiple Sclerosis
2019302,Cannabis-based product use in a multiple sclerosis cohort,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764052/,Positive,,Meta-analysis,2019,,Nervous System,Multiple Sclerosis
2019303,Striking lung cancer response to self-administration of cannabidiol: A case report and literature review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385325/,Positive,,Meta-analysis,2019,,Respiratory System,Cancer - Lung; Cancer
2019304,Pulmonary effects of inhaled cannabis smoke,https://www.ncbi.nlm.nih.gov/pubmed/31298945,Inconclusive,,Meta-analysis,2019,,,Cancer - Lung; Cancer; Cannabis Adverse Effects; COPD; Cough
2019305,The Association Between Tetrahydrocannabinol and Lower Urinary Tract Symptoms Utilizing the National Health and Nutrition Examination Survey,https://www.ncbi.nlm.nih.gov/pubmed/30142408,Positive,,Meta-analysis,2019,,Urinary System,Urinary Tract Infection
2019306,"Cannabis for Neuropathic Pain in Multiple Sclerosis—High Expectations, Poor Data",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817484/,Positive,,Meta-analysis,2019,,Nervous System,Multiple Sclerosis
2019307,"Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712515/,Positive,,Animal Study,2019,Pharma THC:CBD,,Multiple Sclerosis
2019308,Adolescent Δ9-Tetrahydrocannabinol Exposure and Astrocyte-Specific Genetic Vulnerability Converge on Nuclear Factor-κB-Cyclooxygenase-2 Signaling to Impair Memory in Adulthood,https://www.ncbi.nlm.nih.gov/pubmed/30219209,Negative,,Animal Study,2019,,Nervous System,Cognitive Dysfunction
2019309,Adolescent cannabis use and its associations with decision-making and episodic memory: Preliminary results from a longitudinal study,https://www.ncbi.nlm.nih.gov/pubmed/30869932,Negative,,Meta-analysis,2019,,Nervous System,Cognitive Dysfunction
2019310,Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis,https://www.ncbi.nlm.nih.gov/pubmed/31363742,Negative,,Clinical Trial,2019,,Nervous System,Cognitive Dysfunction; Multiple Sclerosis
2019311,Phytomedicines in the Treatment of Migraine,https://www.ncbi.nlm.nih.gov/pubmed/30627973,Inconclusive,,Meta-analysis,2019,,Nervous System,Migraine
2019312,Significance of the endocannabinoid system in migraine,https://www.ncbi.nlm.nih.gov/pubmed/30962405,Positive,,Meta-analysis,2019,,Nervous System,Migraine
2019313,A hunger for hunger: A review of palliative therapies for cancer-associated anorexia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252156/,Positive,,Meta-analysis,2019,,,Anorexia; Loss of Appetite
2019314,Opposite roles of cannabinoid receptor 1 and 2 in hepatocarcinogenesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594387/,Positive,,Animal Study,2019,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); WIN-x Synthetic Cannabinoids,Digestive System; Nervous System,Cancer - Liver; Cancer; Fibrosis - Liver (Cirrhosis); Fibrosis
2019315,Assessment of Cannabinoids Agonist and Antagonist in Invasion Potential of K562 Cancer Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707105/,Positive,,Laboratory Study,2019,WIN-x Synthetic Cannabinoids; AM-x Synthetic Cannabinoids,Immune System; Nervous System,Cancer - Leukemia; Cancer - Metastatic; Cancer
2019316,Efficacy of cannabinoids in paediatric epilepsy,https://www.ncbi.nlm.nih.gov/pubmed/30402932,Positive,,Meta-analysis,2019,,Nervous System,Epilepsy; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut
2019317,"Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders",https://www.ncbi.nlm.nih.gov/pubmed/30910443,Positive,,Meta-analysis,2019,,,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2019318,Purified Cannabidiol for Treatment of Refractory Epilepsies in Pediatric Patients with Developmental and Epileptic Encephalopathy,https://www.ncbi.nlm.nih.gov/pubmed/31179531,Positive,,Clinical Trial,2019,,,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2019319,Treatment of Seizures Associated with Lennox-Gastaut and Dravet Syndromes: A Focus on Cannabidiol Oral Solution,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487974/,Positive,,Meta-analysis,2019,Pharma CBD,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2019320,Cannabidiol in Anxiety and Sleep: A Large Case Series,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326553/,Positive,,Meta-analysis,2019,,Mental/Emotional System,Anxiety; Insomnia and Sleep Disorders
2019321,Acute effect of vaporized Cannabis on sleep and electrocortical activity,https://www.ncbi.nlm.nih.gov/pubmed/30822492,Positive,,Animal Study,2019,,,Insomnia and Sleep Disorders
2019322,Cannabis Expectancies for Sleep,https://www.ncbi.nlm.nih.gov/pubmed/31319769,Positive,,Meta-analysis,2019,,Nervous System,Insomnia and Sleep Disorders
2019323,Cannabidiol partially blocks the sleepiness in hypocretin-deficient rats: Preliminary data,https://www.ncbi.nlm.nih.gov/pubmed/31642794,Positive,,Animal Study,2019,,,Insomnia and Sleep Disorders
2019324,Perceived Efficacy of Medical Cannabis in the Treatment of Co-Occurring Health-Related Quality of Life Symptoms,https://www.ncbi.nlm.nih.gov/pubmed/31693457,Positive,,Meta-analysis,2019,,,Anxiety; Depression; Insomnia and Sleep Disorders; Pain
2019325,Higher odds of irritable bowel syndrome among hospitalized patients using cannabis: a propensity-matched analysis,https://www.ncbi.nlm.nih.gov/pubmed/30807448,Inconclusive,,Meta-analysis,2019,,Digestive System,Irritable Bowel Syndrome; Cannabis Adverse Effects
2019326,A Novel Standardized Cannabis sativa L. Extract and Its Constituent Cannabidiol Inhibit Human Polymorphonuclear Leukocyte Functions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515348/,Positive,,Laboratory Study,2019,,Nervous System,Inflammation; Arthritis - Rheumatoid; Arthritis; Cardiovascular Diseases (CVD); Diabetes; Diabetic Kidney Disease; IBD - Crohn's Disease; Irritable Bowel Syndrome; Pain; Multiple Sclerosis; Pain - Neuropathy - Diabetic
2019327,Cannabis Use and Markers of Systemic Inflammation: The Coronary Artery Risk Development in Young Adults Study,https://www.ncbi.nlm.nih.gov/pubmed/31150645,Inconclusive,,Meta-analysis,2019,,Nervous System,Inflammation
2019328,Cannabis and Cannabinoids on Treatment of Inflammation: A Patent Review,https://www.ncbi.nlm.nih.gov/pubmed/31237222,Positive,,Meta-analysis,2019,,Nervous System,Inflammation
2019329,Cannabis sativa L. extract and cannabidiol inhibit in vitro mediators of skin inflammation and wound injury,https://www.ncbi.nlm.nih.gov/pubmed/31250491,Positive,,Laboratory Study,2019,,Immune System; Integumentary System; Nervous System,Inflammation; Wound Healing; Allergic Contact Dermatitis; Eczema; Seborrhea
2019330,Cannabichromene is a cannabinoid CB2 receptor agonist,https://www.ncbi.nlm.nih.gov/pubmed/31368508,Positive,,Laboratory Study,2019,Cannabichromene (CBC); AM-x Synthetic Cannabinoids; CP-x Synthetic Cannabinoids,,Inflammation; Pain; Pain - Acute
2019331,Cannabinoids and inflammation: Implications for People Living with HIV,https://www.ncbi.nlm.nih.gov/pubmed/31408029,Inconclusive,,Meta-analysis,2019,,Immune System; Nervous System,HIV/AIDS; Inflammation
2019332,Cannabidiol As A Novel Therapeutic Strategy For Oral Inflammatory Diseases: A Review Of Current Knowledge And Future Perspectives,https://www.ncbi.nlm.nih.gov/pubmed/31634872,Positive,,Meta-analysis,2019,,Nervous System,Inflammation; Arthritis - Osteoarthritis; Arthritis; Asthma; IBD - Inflammatory Bowel Disease
2019333,Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS/NF-κB-dependent signaling and glucose consumption,https://www.ncbi.nlm.nih.gov/pubmed/31647138,Positive,,Laboratory Study,2019,,Nervous System,Inflammation; Oxidative Stress
2019334,Cannabinoids induce latent sensitization in a preclinical model of medication overuse headache,https://www.ncbi.nlm.nih.gov/pubmed/31311288,Negative,,Animal Study,2019,WIN-x Synthetic Cannabinoids,Nervous System,Migraine
2019335,Associations Between Cannabis Use and Cardiometabolic Risk Factors: A Longitudinal Study of Men,https://www.ncbi.nlm.nih.gov/pubmed/30589665,Positive,,Meta-analysis,2019,,Cardiovascular System; Endocrine System,Cardiovascular Diseases (CVD); Metabolic Syndrome
2019336,Lifestyle and Metabolic Syndrome: Contribution of the Endocannabinoidome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722643/,Positive,,Meta-analysis,2019,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Microbiome; Monoacylglycerol Lipase (MAGL); Other Related Compounds; Tetrahydrocannabivarin (THCV); Tetrahydrocannabinol (THC); Virodhamine (O-AEA),Digestive System; Endocrine System,Metabolic Syndrome; Microbiome Imbalance
2019337,Tetrahydrocannabinolic acid A (THCA-A) reduces adiposity and prevents metabolic disease caused by diet-induced obesity,https://www.ncbi.nlm.nih.gov/pubmed/31706843,Positive,,Animal Study,2019,Tetrahydrocannabinolic Acid (THC-a),Endocrine System,Metabolic Syndrome
2019338,Cannabis and symptoms of PMS and PMDD,https://www.tandfonline.com/doi/full/10.1080/16066359.2017.1294165?src=recsys,Positive,,Meta-analysis,2019,,Reproductive System,Menstrual Disorders
2019339,"Review of Common Alternative Herbal ""Remedies"" for Skin Cancer",https://www.ncbi.nlm.nih.gov/pubmed/30096105,Positive,,Meta-analysis,2019,,Integumentary System; Nervous System,Cancer - Melanoma; Cancer - Skin (Non-melanoma); Cancer
2019340,Cannabis Impacts Tumor Response Rate to Nivolumab in Patients with Advanced Malignancies,https://www.ncbi.nlm.nih.gov/pubmed/30670598,Inconclusive,,Meta-analysis,2019,,Integumentary System; Nervous System; Respiratory System; Urinary System,Cancer - Kidney; Cancer - Lung; Cancer - Melanoma; Cancer
2019341,Cannabinoids as a Potential New and Novel Treatment for Melanoma: A Pilot Study in a Murine Model,https://www.ncbi.nlm.nih.gov/pubmed/30691796,Positive,,Animal Study,2019,,Integumentary System,Cancer - Melanoma; Cancer
2018250,Association between use of marijuana and time to pregnancy in men and women: findings from the National Survey of Family Growth,https://www.ncbi.nlm.nih.gov/pubmed/29555335,Inconclusive,,Meta-analysis,2018,,Reproductive System,Infertility (Male)
2019342,Cannabis and Male Fertility: A Systematic Review,https://www.ncbi.nlm.nih.gov/pubmed/30916627,Negative,,Meta-analysis,2019,,Reproductive System,Infertility (Male)
2019343,Molecular docking analysis of phyto-constituents from Cannabis sativa with pfDHFR,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563669/,Positive,,Laboratory Study,2019,,Immune System,Malaria
2019344,Cannabidiol Affects the Bezold-Jarisch Reflex via TRPV1 and 5-HT3 Receptors and Has Peripheral Sympathomimetic Effects in Spontaneously Hypertensive and Normotensive Rats,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6538767/,Positive,,Animal Study,2019,,Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2019345,Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319597/,Positive,,Animal Study,2019,AM-x Synthetic Cannabinoids,Mental/Emotional System,Anxiety; Pain; Depression
2019346,"Cannabis Consumption in People Living with HIV: Reasons for Use, Secondary Effects, and Opportunities for Health Education",https://www.ncbi.nlm.nih.gov/pubmed/31579835,Inconclusive,,Meta-analysis,2019,,Immune System,HIV/AIDS; Anxiety; Cannabis Adverse Effects; Hepatitis; Pain
2019347,Synergistic effects of marijuana abuse and HIV infection on neural activation during a cognitive interference task,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713620/,Negative,,Meta-analysis,2019,,Immune System,HIV/AIDS; Cannabis Adverse Effects; Cognitive Dysfunction
2019348,Cannabinoid Attenuation of Intestinal Inflammation in Chronic SIV-Infected Rhesus Macaques Involves T Cell Modulation and Differential Expression of Micro-RNAs and Pro-inflammatory Genes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503054/,Positive,,Animal Study,2019,Tetrahydrocannabinol (THC),,Inflammation; IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; HIV/AIDS; Irritable Bowel Syndrome
2019349,Alcohol and Cannabis Consumption Does Not Diminish Cure Rates in a Real-World Cohort of Chronic Hepatitis C Virus Infected Patients on Opioid Substitution Therapy—Data From the German Hepatitis C-Registry (DHC-R),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440029/,Inconclusive,,Meta-analysis,2019,,Digestive System,Hepatitis
2019350,Problematic Cannabis Use and Risk of Complications in Patients with Chronic Hepatitis C,https://www.ncbi.nlm.nih.gov/pubmed/31431849,Negative,,Meta-analysis,2019,,Digestive System; Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Hepatitis
2019351,Inhalation of marijuana affects Drosophila heart function,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737967/,Inconclusive,,Animal Study,2019,Cannabinol (CBN),Cardiovascular System,Cardiac Arrhythmias; Cardiovascular Diseases (CVD)
2019352,Cannabis and Hearing Care: Hearing Loss and Tinnitus,https://journals.lww.com/thehearingjournal/Pages/articleviewer.aspx?year=2019&issue=08000&article=00012&type=Fulltext,Inconclusive,,Meta-analysis,2019,,Nervous System,Hearing Loss; Tinnitus
2019353,Survival outcomes of marijuana users in p16 positive oropharynx cancer patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720071/,Inconclusive,,Meta-analysis,2019,,,Cancer - Squamous Head/Neck; Cancer
2019354,Awareness of Emotional Expressions in Cannabis Users: An Event-Related Potential Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367265/,Inconclusive,,Meta-analysis,2019,,,Anxiety; Grief and Bereavement
2019355,Medical use of cannabis for glaucoma,https://www.canadianjournalofophthalmology.ca/article/S0008-4182(18)31163-3/abstract,Inconclusive,,Meta-analysis,2019,,Nervous System,Glaucoma
2019356,Treatment of Fragile X Syndrome with Cannabidiol: A Case Series Study and Brief Review of the Literature,https://www.ncbi.nlm.nih.gov/pubmed/30944868,Positive,,Meta-analysis,2019,,Nervous System,Fragile X Syndrome
2019357,"A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676516/,Positive,,Clinical Trial,2019,Pharma CBD,Nervous System,Fragile X Syndrome
2019358,Effect of adding medical cannabis to analgesic treatment in patients with low back pain related to fibromyalgia: an observational cross-over single centre study,https://www.ncbi.nlm.nih.gov/pubmed/30418116,Positive,,Clinical Trial,2019,,Muscular System,Fibromyalgia
2019359,Safety and Efficacy of Medical Cannabis in Fibromyalgia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616435/,Positive,,Meta-analysis,2019,Tetrahydrocannabinol (THC),Muscular System,Fibromyalgia
2019360,A systematic review of cannabidiol dosing in clinical populations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710502/,Positive,,Clinical Meta-analysis,2019,,,Addiction - Cannabis; Anxiety; Bipolar Disorder; Diabetes; Epilepsy - Dravet Syndrome; Epilepsy - FIRES; Epilepsy - Lennox-Gastaut; Epilepsy; Fatty Liver Disease; Fragile X Syndrome; Glaucoma; IBD - Crohn's Disease; Huntington's Disease; Insomnia and Sleep Disorders; Pain; Pain - Chronic; Parkinson's Disease; Schizophrenia
2019361,Cannabis consumption and non-alcoholic fatty liver disease. A three years longitudinal study in first episode non-affective psychosis patients,https://www.ncbi.nlm.nih.gov/pubmed/31228640,Positive,,Meta-analysis,2019,,Digestive System,Fatty Liver Disease; Fibrosis - Liver (Cirrhosis); Fibrosis
2019362,Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612909/,Positive,,Meta-analysis,2019,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Tetrahydrocannabivarin (THCV); Tetrahydrocannabinol (THC),Digestive System,Fatty Liver Disease
2019363,"Endocannabinoid System in Hepatic Glucose Metabolism, Fatty Liver Disease, and Cirrhosis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566399/,Positive,,Meta-analysis,2019,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); JWH-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); O-x Synthetic Cannabinoids; Other Related Compounds; SR-x Synthetic Cannabinoids,Digestive System,Fatty Liver Disease; Fibrosis - Liver (Cirrhosis); Fibrosis
2019364,Δ8 -Tetrahydrocannabivarin has potent anti-nicotine effects in several rodent models of nicotine dependence,https://www.ncbi.nlm.nih.gov/pubmed/31454413,Positive,,Animal Study,2019,Tetrahydrocannabivarin (THCV),Mental/Emotional System; Nervous System,Addiction - Nicotine; Addiction
2019365,Cannabidiol Protects Dopaminergic Neuronal Cells from Cadmium,https://www.ncbi.nlm.nih.gov/pubmed/31718076,Positive,,Laboratory Study,2019,,Nervous System,Neurodegenerative Issues
2019366,Novel interventions to reduce oxidative-stress related brain injury in neonatal asphyxia,https://www.ncbi.nlm.nih.gov/pubmed/31039399,Positive,,Meta-analysis,2019,,Cardiovascular System; Nervous System,Cardiovascular Diseases (CVD); Neonatal Cerebral Issues; Reperfusion Injury
2019367,Cannabinoids: the lows and the highs of chemotherapy-induced nausea and vomiting,https://www.ncbi.nlm.nih.gov/pubmed/30720344,Positive,,Meta-analysis,2019,,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
2019368,The role of the endocannabinoid system in female reproductive tissues,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332911/,Positive,,Meta-analysis,2019,Endocannabinoid (unspecified),Nervous System; Reproductive System,Cancer - Ovarian; Cancer
2019369,Cannabis Dependence or Abuse in Kidney Transplantation: Implications for Posttransplant Outcomes,https://www.ncbi.nlm.nih.gov/pubmed/30747847,Negative,,Meta-analysis,2019,,Immune System,Organ Transplant Failure
2019370,Microbiomic differences at cancer-prone oral mucosa sites with marijuana usage,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722050/,Inconclusive,,Meta-analysis,2019,,Digestive System; Nervous System,Cancer - Oral; Cancer
2019371,Cannabinoid therapy in epilepsy,https://www.ncbi.nlm.nih.gov/pubmed/30676535,Inconclusive,,Meta-analysis,2019,,Nervous System,Epilepsy; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut
2019372,Are there mortality risks for patients with epilepsy who use cannabis treatments as monotherapy?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348695/,Negative,,Meta-analysis,2019,,Nervous System,Epilepsy; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut
2019373,Cannabis for refractory epilepsy in children: A review focusing on CDKL5 Deficiency Disorder,https://www.ncbi.nlm.nih.gov/pubmed/30771550,Positive,,Meta-analysis,2019,,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2019374,Cannabis use is both independently associated with and mediates worse psychosocial health in patients with epilepsy,https://www.ncbi.nlm.nih.gov/pubmed/30826738,Negative,,Meta-analysis,2019,,Nervous System,Epilepsy; Cannabis Adverse Effects; Depression
2019375,Pharmacokinetics and Tolerability of Multiple Doses of Pharmaceutical-Grade Synthetic Cannabidiol in Pediatric Patients with Treatment-Resistant Epilepsy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534520/,Inconclusive,,Clinical Trial,2019,,,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Cannabis Adverse Effects
2019376,Cannabidiol: A Review of Clinical Efficacy and Safety in Epilepsy,https://www.ncbi.nlm.nih.gov/pubmed/31053391,Positive,,Meta-analysis,2019,,Nervous System,Epilepsy; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut
2019377,Disposition of oral delta-9 tetrahydrocannabinol (THC) in children receiving cannabis extracts for epilepsy,https://www.ncbi.nlm.nih.gov/pubmed/31111749,Inconclusive,,Meta-analysis,2019,,Nervous System,Epilepsy; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut
2011118,Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis,https://www.sciencedirect.com/science/article/abs/pii/S0006899311005178#!,Positive,,Animal Study,2011,2-Arachidonoyl Glycerol (2-AG),,Encephalitis and Myelitis
2019378,Antinociceptive effects of mixtures of mu opioid receptor agonists and cannabinoid receptor agonists in rats: impact of drug and fixed-dose ratio,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766417/,Positive,,Animal Study,2019,CP-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Mental/Emotional System,Addiction - Opioid; Addiction; Pain - Nociceptive; Pain; Pain - Acute; Pain - Chronic
2019379,Δ9-tetrahydrocannabinol attenuates oxycodone self-administration under extended access conditions,https://www.ncbi.nlm.nih.gov/pubmed/30980837,Positive,,Animal Study,2019,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
2019380,Opioid-enhancing antinociceptive effects of delta-9-tetrahydrocannabinol and amitriptyline in rhesus macaques,https://www.ncbi.nlm.nih.gov/pubmed/31464475,Positive,,Animal Study,2019,SR-x Synthetic Cannabinoids,Mental/Emotional System,Addiction - Opioid; Addiction; Pain - Nociceptive; Pain; Pain - Acute; Pain - Chronic
2019381,Cannabinoid Receptor Type 1 and Its Role as an Analgesic: An Opioid Alternative?,https://www.ncbi.nlm.nih.gov/pubmed/31596190,Positive,,Meta-analysis,2019,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction; Pain; Pain - Chronic
2019382,State marijuana laws and opioid overdose mortality,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717967/,Positive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
2019383,"GPR3, GPR6, and GPR12 as novel molecular targets: their biological functions and interaction with cannabidiol",https://www.ncbi.nlm.nih.gov/pubmed/29941868,Positive,,Laboratory Study,2019,,,Alzheimer's Disease; Parkinson's Disease
2019384,"Potential metabolic and behavioural roles of the putative endocannabinoid receptors GPR18, GPR55 and GPR119 in feeding",https://www.ncbi.nlm.nih.gov/pubmed/31146657,Inconclusive,,Meta-analysis,2019,Endocannabinoid (unspecified),,Anorexia Nervosa; Anorexia; Cachexia; Metabolic Syndrome; Obesity
2019385,The influence of the fatty acid amide hydrolase 385C>A single nucleotide polymorphisms on obesity susceptibility,https://www.ncbi.nlm.nih.gov/pubmed/31286394,Inconclusive,,Meta-analysis,2019,Fatty Acid Amide Hydrolase (FAAH); Endocannabinoid (unspecified),Endocrine System,Obesity
2019386,Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study,https://www.ncbi.nlm.nih.gov/pubmed/31711352,Positive,,Clinical Trial,2019,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction; Pain; Pain - Chronic; Ehlers-Danlos Syndrome
2019387,Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy,https://www.ncbi.nlm.nih.gov/pubmed/31247132,Inconclusive,,Meta-analysis,2019,,Nervous System,Epilepsy
2019388,Short- and Long-Term Effects of Cannabis on Headache and Migraine,https://www.ncbi.nlm.nih.gov/pubmed/31715263,Positive,,Meta-analysis,2019,,Nervous System,Migraine
2019389,Effects of CBD-Enriched Cannabis sativa Extract on Autism Spectrum Disorder Symptoms: An Observational Study of 18 Participants Undergoing Compassionate Use,https://www.frontiersin.org/articles/10.3389/fneur.2019.01145/full,Positive,,Clinical Trial,2019,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Autism
2019390,"Plants come to mind: phytocannabinoids, endocannabinoids and the control of seizures",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597308/,Positive,,Meta-analysis,2019,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Nervous System,Epilepsy; Epilepsy - Dravet Syndrome
2019391,Simultaneous Quantification of 13 Cannabinoids and Metabolites in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry in Adult Epilepsy Patients,https://www.ncbi.nlm.nih.gov/pubmed/30520828,Inconclusive,,Meta-analysis,2019,Cannabichromene (CBC); Cannabichromenic Acid (CBC-a); Cannabigerol (CBG); Cannabigerolic Acid (CBG-a); Cannabinol (CBN); Tetrahydrocannabivarin (THCV); Tetrahydrocannabinol (THC); Tetrahydrocannabinolic Acid (THC-a),Nervous System,Epilepsy
2019392,Cannabis-based products for pediatric epilepsy: A systematic review,https://www.ncbi.nlm.nih.gov/pubmed/30515765,Positive,,Meta-analysis,2019,,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2019393,Marijuana use among patients with epilepsy at a tertiary care center,https://www.ncbi.nlm.nih.gov/pubmed/31252269,Inconclusive,,Meta-analysis,2019,,Nervous System,Epilepsy
2019394,Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy,https://www.ncbi.nlm.nih.gov/pubmed/31372958,Positive,,Meta-analysis,2019,,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2019395,Cannabis and Epilepsy,https://www.ncbi.nlm.nih.gov/pubmed/31385740,Positive,,Meta-analysis,2019,,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2019396,Using recreational cannabis to treat insomnia: Evidence from over-the-counter sleep aid sales in Colorado,https://www.sciencedirect.com/science/article/abs/pii/S0965229919308027,Positive,,Meta-analysis,2019,,Nervous System,Insomnia and Sleep Disorders
2019397,Anxiolytic Effects of Repeated Cannabidiol Treatment in Teenagers With Social Anxiety Disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856203/,Positive,,Double Blind Clinical Trial,2019,,Mental/Emotional System,Anxiety
2019398,The Effectiveness of Topical Cannabidiol Oil in Symptomatic Relief of Peripheral Neuropathy of the Lower Extremities,https://www.ncbi.nlm.nih.gov/pubmed/31793418,Positive,,Double Blind Clinical Trial,2019,,Nervous System,Pain; Pain - Neuropathy - Peripheral
2019399,The impact of cannabis access laws on opioid prescribing,https://www.sciencedirect.com/science/article/pii/S0167629618309020?via%3Dihub,Positive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
2019400,The neuropsychopharmacology of cannabis: A review of human imaging studies,https://www.ncbi.nlm.nih.gov/pubmed/30347211,Negative,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Psychosis; Schizophrenia
2019401,The interaction between the ZNF804A gene and cannabis use on the risk of psychosis in a non-clinical sample.,https://www.ncbi.nlm.nih.gov/pubmed/30118824,Negative,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2019402,"Cannabis, a Significant Risk Factor for Violent Behavior in the Early Phase Psychosis. Two Patterns of Interaction of Factors Increase the Risk of Violent Behavior: Cannabis Use Disorder and Impulsivity; Cannabis Use Disorder, Lack of Insight and Treatment Adherence",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039574/,Negative,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Psychosis; Addiction - Cannabis; Cannabis Adverse Effects
2019403,Δ-9-Tetrahydrocannabinol and Cannabidiol produce dissociable effects on prefrontal cortical executive function and regulation of affective behaviors,https://www.ncbi.nlm.nih.gov/pubmed/30538288,Inconclusive,,Animal Study,2019,,,Behavioral Disorders; Anxiety; Bipolar Disorder; Cognitive Dysfunction; Depression
2019404,"The safety, tolerability, and effectiveness of PTL-101, an oral cannabidiol formulation, in pediatric intractable epilepsy: A phase II, open-label, single-center study",https://www.epilepsybehavior.com/article/S1525-5050(19)30305-1/fulltext#%20,Positive,,Clinical Trial,2019,,,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2019405,Cannabis acute use impacts symptoms and functionality in a cohort of antipsychotic naïve First Episode of Psychosis individuals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293028/,Negative,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2019406,The neuropsychological profiles of young psychosis patients with and without current cannabis use,https://www.ncbi.nlm.nih.gov/pubmed/30621505,Inconclusive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2019407,Increased BDNF-TrkB signaling in the nucleus accumbens plays a role in the risk for psychosis after cannabis exposure during adolescence,https://www.ncbi.nlm.nih.gov/pubmed/30629965,Inconclusive,,Animal Study,2019,WIN-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2019408,Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis,https://www.ncbi.nlm.nih.gov/pubmed/30770892,Negative,,Double Blind Clinical Trial,2019,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2019409,Cannabis and psychosis: triangulating the evidence,https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(19)30086-0/fulltext,Negative,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Psychosis
2019410,Cannabis-based treatments as an alternative remedy for epilepsy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708987/,Positive,,Meta-analysis,2019,,Nervous System,Epilepsy; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut
2019411,The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study,https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(19)30048-3/fulltext,Negative,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2019412,Psychotic-like experiences and cannabis use in adolescents from the general population,https://www.ncbi.nlm.nih.gov/pubmed/31017998,Inconclusive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2019413,Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis,https://www.ncbi.nlm.nih.gov/pubmed/31076188,Inconclusive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2019414,Prospective evaluation of oral cannabis extracts in children with epilepsy,https://www.seizure-journal.com/article/S1059-1311(19)30110-4/fulltext,Inconclusive,,Clinical Trial,2019,,,Epilepsy
2019415,Cannabis and psychosis: revisiting a nineteenth century study of 'Indian Hemp and Insanity' in Colonial British India,https://www.ncbi.nlm.nih.gov/pubmed/31131781,Inconclusive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2019416,Cannabis and Psychosis: Are We any Closer to Understanding the Relationship?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546656/,Inconclusive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2019417,Hypothalamic-pituitary-adrenal axis function and exposure to stress factors and cannabis use in recent-onset psychosis,https://www.ncbi.nlm.nih.gov/pubmed/31244371,Inconclusive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2019418,The Relevance of Sex in the Association of Synthetic Cannabinoid Use With Psychosis and Agitation in an Inpatient Population,https://www.ncbi.nlm.nih.gov/pubmed/31265768,Negative,,Meta-analysis,2019,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis; Psychosis
2019419,The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678854/,Positive,,Meta-analysis,2019,Pharma THC:CBD,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Psychosis; Schizophrenia
2019420,Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use,https://www.ncbi.nlm.nih.gov/pubmed/31361020,Negative,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2019421,Stopping cannabis use benefits outcome in psychosis: findings from 10-year follow-up study in the PAFIP-cohort,https://www.ncbi.nlm.nih.gov/pubmed/31381129,Negative,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2019422,Stress-induced cortical dopamine response is altered in subjects at clinical high risk for psychosis using cannabis,https://www.ncbi.nlm.nih.gov/pubmed/31389139,Inconclusive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2019423,Association of CNR1 genotypes with changes in neurocognitive performance after eighteen-month treatment in patients with first-episode psychosis,https://www.ncbi.nlm.nih.gov/pubmed/31398679,Inconclusive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Psychosis; Cognitive Dysfunction; Neurodegenerative Issues; Schizophrenia
2019424,Cannabis use and psychosis: a review of reviews,https://www.ncbi.nlm.nih.gov/pubmed/31563981,Negative,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2019425,Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials,https://www.researchgate.net/publication/332433579_Use_of_Cannabidiol_in_the_Treatment_of_Epilepsy_Efficacy_and_Security_in_Clinical_Trials,Positive,,Clinical Meta-analysis,2019,,Nervous System,Epilepsy
2019426,Cannabidiol reduces seizures following CNS infection with Theiler's murine encephalomyelitis virus,https://onlinelibrary.wiley.com/doi/full/10.1002/epi4.12351,Positive,,Animal Study,2019,,Nervous System,Encephalitis and Myelitis
2019427,Self-management strategies amongst Australian women with endometriosis: a national online survey,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332532/,Positive,,Meta-analysis,2019,,Endocrine System,Endometriosis
2019428,Dosage Related Efficacy and Tolerability of Cannabidiol in Children With Treatment-Resistant Epileptic Encephalopathy: Preliminary Results of the CARE-E Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616248/,Positive,,Clinical Trial,2019,Cannabichromene (CBC),,Epilepsy; Epilepsy - Dravet Syndrome
2001020,"Neuroprotection by Δ9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity",https://www.jneurosci.org/content/21/17/6475.abstract,Positive,,Animal Study,2001,Tetrahydrocannabinol (THC); SR-x Synthetic Cannabinoids,,Excitotoxicity; Neurodegenerative Issues
2018251,The relationship between cannabis use and diabetes: Results from the National Epidemiologic Survey on Alcohol and Related Conditions III,https://www.ncbi.nlm.nih.gov/pubmed/30288813,Positive,,Meta-analysis,2018,,,Diabetes
2019429,Association Between Cannabis Use and Risk for Diabetic Ketoacidosis in Adults With Type 1 Diabetes,https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2712560,Negative,,Meta-analysis,2019,,,Pain; Pain - Neuropathy - Diabetic
2019430,Effects of Cannabidiol on Diabetes Outcomes and Chronic Cerebral Hypoperfusion Comorbidities in Middle-Aged Rats,https://www.ncbi.nlm.nih.gov/pubmed/30430393,Positive,,Animal Study,2019,,Endocrine System; Nervous System,Cognitive Dysfunction; Diabetes
2019431,"The effects of delta-9-tetrahydrocannabinol on Krüppel-like factor-4 expression, redox homeostasis, and inflammation in the kidney of diabetic rat",https://www.ncbi.nlm.nih.gov/pubmed/31081965,Positive,,Animal Study,2019,,Endocrine System; Nervous System; Urinary System,Diabetes; Diabetic Kidney Disease; Inflammation
2019432,Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings,https://www.ncbi.nlm.nih.gov/pubmed/31601406,Positive,,Meta-analysis,2019,,,Addiction - Alcohol; Anxiety; Epilepsy - Dravet Syndrome; Epilepsy; Parkinson's Disease; Psychosis; Schizophrenia
2019433,"Characterizing psychosis-relevant phenomena and cognitive function in a unique population with isolated, chronic and very heavy cannabis exposure",https://www.ncbi.nlm.nih.gov/pubmed/31615592,Negative,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2019434,Cannabis Use and the Risk of Psychosis and Affective Disorders,https://www.ncbi.nlm.nih.gov/pubmed/31647377,Negative,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Bipolar Disorder; Psychosis; Schizophrenia
2019435,Cannabis and Psychosis Through the Lens of DSM-5,https://www.ncbi.nlm.nih.gov/pubmed/31661851,Inconclusive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Psychosis; Schizophrenia
2020737,The Changing Legal Landscape of Cannabis Use and Its Role in Youth-onset Psychosis,https://www.ncbi.nlm.nih.gov/pubmed/31708043,Inconclusive,,Meta-analysis,2020,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2019436,Cannabis use in subjects at ultra high risk for psychosis,https://www.ncbi.nlm.nih.gov/pubmed/31732360,Negative,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2019437,Cannabidiol as a potential treatment for psychosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843725/,Positive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2020738,Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6742916/,Positive,,Animal Study,2020,,Integumentary System,Skin Diseases
2019438,"Dermatology-Related Uses of Medical Cannabis Promoted by Dispensaries in Canada, Europe, and the United States",https://www.ncbi.nlm.nih.gov/pubmed/30380925,Inconclusive,,Meta-analysis,2019,,Integumentary System,Skin Diseases; Acne; Allergic Contact Dermatitis; Cancer - Melanoma; Cancer; Herpes; Lupus; Pruritis; Psoriasis
2009069,Cannabinoid system in the skin - a possible target for future therapies in dermatology,https://onlinelibrary.wiley.com/doi/full/10.1111/j.1600-0625.2009.00923.x,Positive,,Meta-analysis,2009,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),,Cancer - Melanoma; Cancer - Skin (Non-melanoma); Cancer; Inflammation; Kaposi's Sarcoma; Pruritis
2019439,Towards the use of non-psychoactive cannabinoids for prostate cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570005/,Positive,,Meta-analysis,2019,,Nervous System; Reproductive System,Cancer - Prostate; Cancer
2015145,Proapoptotic effect of endocannabinoids in prostate cancer cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358087/,Positive,,Laboratory Study,2015,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Other Related Compounds; SR-x Synthetic Cannabinoids,Reproductive System,Cancer - Prostate; Cancer
2019440,Cannabis: From a Plant That Modulates Feeding Behaviors toward Developing Selective Inhibitors of the Peripheral Endocannabinoid System for the Treatment of Obesity and Metabolic Syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563239/,Positive,,Meta-analysis,2019,AM-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Endocrine System,Metabolic Syndrome; Obesity; Chronic Kidney Disease; Diabetes; Fatty Liver Disease
2019441,Prevalence and predictors of cannabis use among men receiving androgen-deprivation therapy for advanced prostate cancer,https://www.ncbi.nlm.nih.gov/pubmed/31658007,Positive,,Clinical Trial,2019,,Nervous System; Reproductive System,Cancer - Prostate; Cancer
2018252,Marijuana Use in Pregnancy and While Breastfeeding,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370295/,Negative,,Meta-analysis,2018,,Reproductive System,Pregnancy
2019442,Preconception and prenatal cannabis use and the risk of behavioural and emotional problems in the offspring; a multi-informant prospective longitudinal study,https://www.ncbi.nlm.nih.gov/pubmed/30239742,Negative,,Meta-analysis,2019,,Reproductive System,Pregnancy
2019443,Diabetes Canada Position Statement on Recreational Cannabis Use in Adults and Adolescents With Type 1 and Type 2 Diabetes,https://www.ncbi.nlm.nih.gov/pubmed/31375177,Inconclusive,,Meta-analysis,2019,,Endocrine System,Diabetes
2019444,"Effects of Cannabis Use in Youth and Young Adults With Type 1 Diabetes: The Highs, the Lows, the Don't Knows",https://www.ncbi.nlm.nih.gov/pubmed/31401053,Inconclusive,,Meta-analysis,2019,,Endocrine System,Diabetes; Cannabis Adverse Effects
2019445,Cannabidiol improves metabolic dysfunction in middle-aged diabetic rats submitted to a chronic cerebral hypoperfusion,https://www.ncbi.nlm.nih.gov/pubmed/31499052,Positive,,Animal Study,2019,,Cardiovascular System; Endocrine System,Cardiovascular Diseases (CVD); Diabetes
2019446,Effects of Prenatal Marijuana Exposure on Neuropsychological Outcomes in Children Aged 1–11 Years: A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261687/,Inconclusive,,Meta-analysis,2019,,Reproductive System,Pregnancy
2019447,Detection of In Utero Cannabis Exposure in Umbilical Cord Tissue by a Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method,https://www.ncbi.nlm.nih.gov/pubmed/30350293,Inconclusive,,Laboratory Study,2019,Cannabinol (CBN),Reproductive System,Pregnancy
2019448,Cannabinoid exposure during pregnancy and its impact on immune function,https://www.ncbi.nlm.nih.gov/pubmed/30374520,Negative,,Meta-analysis,2019,,Reproductive System,Pregnancy
2019449,"Trends and correlates of cannabis use in pregnancy: a population-based study in Ontario, Canada from 2012 to 2017",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335373/,Negative,,Meta-analysis,2019,,Reproductive System,Pregnancy
2019450,Cannabis Abuse or Dependence During Pregnancy: A Population-Based Cohort Study on 12 Million Births,https://www.ncbi.nlm.nih.gov/pubmed/30448107,Negative,,Meta-analysis,2019,,Reproductive System,Pregnancy
2019451,"Synthetic cannabinoids and endometrial stromal cell fate: Dissimilar effects of JWH-122, UR-144 and WIN55,212-2",https://www.ncbi.nlm.nih.gov/pubmed/30502353,Inconclusive,,Laboratory Study,2019,JWH-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids; AM-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),,Pregnancy
2019452,Brief Commentary: Marijuana Use During Gestation and Lactation-Harmful Until Proved Safe,https://doi.org/10.7326/M18-3175,Negative,,Meta-analysis,2019,,Reproductive System,Pregnancy
2019453,Beliefs and attitudes regarding prenatal marijuana use: Perspectives of pregnant women who report use,https://www.ncbi.nlm.nih.gov/pubmed/30658220,Inconclusive,,Meta-analysis,2019,,Reproductive System,Pregnancy
2019454,Adverse outcome pathway of developmental neurotoxicity resulting from prenatal exposures to cannabis contaminated with organophosphate pesticide residues,https://www.ncbi.nlm.nih.gov/pubmed/30668982,Negative,,Meta-analysis,2019,,Reproductive System,Pregnancy
2019455,Cannabis Use in Pregnancy in British Columbia and Selected Birth Outcomes,https://www.ncbi.nlm.nih.gov/pubmed/30744979,Negative,,Meta-analysis,2019,,Reproductive System,Pregnancy
2019456,Associations of first trimester co-use of tobacco and Cannabis with prenatal immune response and psychosocial well-being,https://www.ncbi.nlm.nih.gov/pubmed/30936023,Inconclusive,,Meta-analysis,2019,,Reproductive System,Pregnancy
2019457,Δ9-Tetrahydrocannabinol leads to endoplasmic reticulum stress and mitochondrial dysfunction in human BeWo trophoblasts,https://www.ncbi.nlm.nih.gov/pubmed/31054322,Negative,,Laboratory Study,2019,,Reproductive System,Pregnancy
2019458,Marijuana-derived cannabinoids inhibit uterine endometrial stromal cell decidualization and compromise trophoblast-endometrium cross-talk,https://www.ncbi.nlm.nih.gov/pubmed/31154070,Negative,,Laboratory Study,2019,Cannabinol (CBN),Reproductive System,Pregnancy
2019459,"Association Between Self-reported Prenatal Cannabis Use and Maternal, Perinatal, and Neonatal Outcomes",https://www.ncbi.nlm.nih.gov/pubmed/31211826,Negative,,Meta-analysis,2019,,Reproductive System,Pregnancy
2019460,Monitoring the effects of perinatal cannabis and synthetic cannabinoid exposure,https://www.ncbi.nlm.nih.gov/pubmed/31268967,Negative,,Meta-analysis,2019,,Reproductive System,Pregnancy
2019461,"Self-reported Daily, Weekly, and Monthly Cannabis Use Among Women Before and During Pregnancy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646980/,Inconclusive,,Meta-analysis,2019,,Reproductive System,Pregnancy
2019462,Interaction of maternal choline levels and prenatal Marijuana's effects on the offspring,https://www.ncbi.nlm.nih.gov/pubmed/31364525,Negative,,Meta-analysis,2019,,Reproductive System,Pregnancy
2019463,Prenatal drug exposure and neurodevelopmental programming of glucocorticoid signalling,https://www.ncbi.nlm.nih.gov/pubmed/31469457,Inconclusive,,Meta-analysis,2019,,Reproductive System,Pregnancy
2019464,Routes of cannabis administration among females in the year before and during pregnancy: Results from a pilot project,https://www.ncbi.nlm.nih.gov/pubmed/31600645,Inconclusive,,Meta-analysis,2019,,Reproductive System,Pregnancy
2019465,Consequences of Perinatal Cannabis Exposure,https://www.ncbi.nlm.nih.gov/pubmed/31604585,Negative,,Animal Study,2019,Synthetic Cannabinoid (unspecified),Reproductive System,Pregnancy
2019466,Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone,https://www.ncbi.nlm.nih.gov/pubmed/31611707,Negative,,Animal Study,2019,,Reproductive System,Pregnancy
2019467,"Sex-specific behavioral deficits induced at early life by prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 depend on mGlu5 receptor signaling",https://www.ncbi.nlm.nih.gov/pubmed/31658362,Inconclusive,,Animal Study,2019,WIN-x Synthetic Cannabinoids,Reproductive System,Pregnancy
2019468,Validity of Self-reported Cannabis Use Among Pregnant Females in Northern California,https://www.ncbi.nlm.nih.gov/pubmed/31688149,Inconclusive,,Meta-analysis,2019,,,Pregnancy
2019469,Women's perspectives about cannabis use during pregnancy and the postpartum period: An integrative review,https://www.ncbi.nlm.nih.gov/pubmed/30552948,Inconclusive,,Meta-analysis,2019,,Reproductive System,Pregnancy
2019470,Effects of cannabis tetrahydrocannabinol on endocannabinoid homeostasis in human placenta,https://www.ncbi.nlm.nih.gov/pubmed/30659320,Negative,,Laboratory Study,2019,,Reproductive System,Pregnancy
2019471,Marijuana use in young mothers and adverse pregnancy outcomes: a retrospective cohort study,https://www.ncbi.nlm.nih.gov/pubmed/31334907,Negative,,Meta-analysis,2019,,Reproductive System,Pregnancy
2019472,Marijuana Use in Pregnancy: A Review,https://www.ncbi.nlm.nih.gov/pubmed/31343707,Negative,,Meta-analysis,2019,,Reproductive System,Pregnancy
2019473,Countering the Modern Metabolic Disease Rampage With Ancestral Endocannabinoid System Alignment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533883/,Positive,,Meta-analysis,2019,2-Arachidonoyl Glycerol (2-AG); Synthetic Cannabinoid (unspecified),,Diabetes; Metabolic Syndrome; Obesity
2019474,Role of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540410/,Positive,,Meta-analysis,2019,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Endocrine System,Diabetes; Fatty Liver Disease; Fibrosis - Liver (Cirrhosis); Fibrosis; Metabolic Syndrome; Obesity
2019475,Modulation of the endocannabinoid system by sex hormones: Implications for posttraumatic stress disorder,https://www.ncbi.nlm.nih.gov/pubmed/30017748,Positive,,Meta-analysis,2019,Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,PTSD
2019476,Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161644/,Positive,,Meta-analysis,2019,,,Anxiety; Depression; Epilepsy; Insomnia and Sleep Disorders; Parkinson's Disease; PTSD; Schizophrenia
2019477,Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies,https://www.ncbi.nlm.nih.gov/pubmed/30166624,Inconclusive,,Meta-analysis,2019,,,Addiction - Alcohol; Addiction - Cannabis; Anorexia Nervosa; Anorexia; PTSD; Schizophrenia
2019478,Cannabinoid interventions for PTSD: Where to next?,https://www.ncbi.nlm.nih.gov/pubmed/30946942,Positive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,PTSD
2019479,Post-traumatic stress and marijuana outcomes: The mediating role of marijuana protective behavioral strategies,https://www.ncbi.nlm.nih.gov/pubmed/31361581,Inconclusive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,PTSD
2019480,Benefit of Tetrahydrocannabinol versus Cannabidiol for Common Palliative Care Symptoms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776252/,Positive,,Meta-analysis,2019,,Nervous System,Palliative Care; Anorexia; Anxiety; Depression; Insomnia and Sleep Disorders; Pain; Pain - Neuropathy - Peripheral; PTSD
2019481,Cannabidiol (CBD) use in psychiatric disorders: A systematic review.,https://www.ncbi.nlm.nih.gov/pubmed/31412258,Inconclusive,,Meta-analysis,2019,,,Anxiety; Psychosis; PTSD
2019482,Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780141/,Positive,,Meta-analysis,2019,Pharma THC,Mental/Emotional System; Nervous System,PTSD
2019483,"Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential",https://www.ncbi.nlm.nih.gov/pubmed/31577377,Negative,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Anxiety; Bipolar Disorder; Depression; PTSD
2019484,Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482919/,Positive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,PTSD; Behavioral Disorders; Anxiety; Bipolar Disorder; Cognitive Dysfunction; Depression; Insomnia and Sleep Disorders
2019485,Substance Abuse Poisoning Reported to the Poisons Information Centre Erfurt from 2002 to 2016,https://www.ncbi.nlm.nih.gov/pubmed/29719914,Negative,,Meta-analysis,2019,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis
2019486,THC and gabapentin interactions in a mouse neuropathic pain model,https://www.ncbi.nlm.nih.gov/pubmed/30312630,Positive,,Animal Study,2019,,Nervous System,Pain; Pain - Neuropathy - Peripheral
2019487,Plant-derived medicines for neuropathies: a comprehensive review of clinical evidence,https://www.ncbi.nlm.nih.gov/pubmed/30768427,Positive,,Clinical Meta-analysis,2019,,Nervous System,Pain; Pain - Neuropathy - Peripheral
2019488,Antiallodynic Effects of Cannabinoid Receptor 2 (CB2R) Agonists on Retrovirus Infection-Induced Neuropathic Pain,https://www.hindawi.com/journals/prm/2019/1260353/,Positive,,Animal Study,2019,HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,Nervous System,Pain; Pain - Neuropathy - Peripheral; Inflammation; Prion Disease
2019489,Marijuana for Parkinson’s Disease?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450681/,Positive,,Meta-analysis,2019,,Nervous System,Parkinson's Disease
2019490,Evidence for the use of cannabinoids in Parkinson's disease,https://www.ncbi.nlm.nih.gov/pubmed/31131434,Positive,,Meta-analysis,2019,,Nervous System,Parkinson's Disease
2019491,Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson's Disease and L-DOPA-Induced Dyskinesia.,https://www.ncbi.nlm.nih.gov/pubmed/31637586,Positive,,Meta-analysis,2019,Synthetic Cannabinoid (unspecified),Nervous System,Parkinson's Disease; Inflammation
2019492,Pros and Cons of Marijuana in Treatment of Parkinson’s Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682376/,Positive,,Meta-analysis,2019,Anandamide (AEA); Tetrahydrocannabinol (THC),Nervous System,Parkinson's Disease
2017177,Changes in the Brain Endocannabinoid System in Rat Models of Depression,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360820/,Inconclusive,,Animal Study,2017,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Mental/Emotional System; Nervous System,Depression
2018253,Orbitofrontal connectivity is associated with depression and anxiety in marijuana-using adolescents,https://pubmed.ncbi.nlm.nih.gov/30025312/,Inconclusive,,Clinical Trial,2018,,Mental/Emotional System; Nervous System,Anxiety; Depression; Cannabis Adverse Effects
2018254,Integrating endocannabinoid signaling in the regulation of anxiety and depression,https://www.nature.com/articles/s41401-018-0051-5,Inconclusive,,Meta-analysis,2018,Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,Anxiety; Depression
2019493,Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain,https://pubmed.ncbi.nlm.nih.gov/29863609/,Positive,,Animal Study,2019,Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System; Nervous System,Depression; Pain; Pain - Chronic
2018255,Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels,https://www.ncbi.nlm.nih.gov/pubmed/29885468,Positive,,Animal Study,2018,,Mental/Emotional System,Depression
2018256,The role of depressive symptoms in treatment of adolescent cannabis use disorder with N-Acetylcysteine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082384/,Inconclusive,,Meta-analysis,2018,,,Addiction - Cannabis; Depression
2018257,Impacts of cannabinoid receptor ligands on nicotine- and chronic mild stress-induced cognitive and depression-like effects in mice,https://www.sciencedirect.com/science/article/pii/S0166432818301876#!,Positive,,Animal Study,2018,AM-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Cognitive Dysfunction; Depression
2018258,Negative urgency partially accounts for the relationship between major depressive disorder and marijuana problems,https://bpded.biomedcentral.com/articles/10.1186/s40479-018-0087-7,Inconclusive,,Meta-analysis,2018,,Mental/Emotional System,Depression; Addiction - Cannabis
2019494,"The relationship among depressive symptoms, urgency, and problematic alcohol and cannabis use in community adults",https://www.ncbi.nlm.nih.gov/pubmed/30130721,Inconclusive,,Meta-analysis,2019,,,Addiction - Alcohol; Addiction - Cannabis; Depression
2018259,Sub-chronic treatment with cannabidiol but not with URB597 induced a mild antidepressant-like effect in diabetic rats,https://www.ncbi.nlm.nih.gov/pubmed/29885450,Positive,,Animal Study,2018,,Mental/Emotional System,Depression; Diabetes
2018260,"Prevalence of alcohol, tobacco, cannabis and other illicit substance use in a population of Canadian adolescents with type 1 diabetes compared to a general adolescent population",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951101/,Inconclusive,,Meta-analysis,2018,,,Diabetes
2019495,"Sex Differences in the Association Between Cannabis Use and Suicidal Ideation and Attempts, Depression, and Psychological Distress Among Canadians",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591888/,Negative,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Depression; Suicide Attempt; Cannabis Adverse Effects
2019496,"Age‐varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519223/,Negative,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Anxiety; Depression; Psychosis; Addiction - Cannabis
2019497,Cannabinoids in depressive disorders,https://www.ncbi.nlm.nih.gov/pubmed/30290188,Positive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Depression
2019498,"Interrelationships among depression, anxiety, flourishing, and cannabis use in youth",https://www.ncbi.nlm.nih.gov/pubmed/30321693,Inconclusive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Anxiety; Depression
2019499,"The Effect of Age of Initiation of Cannabis Use on Psychosis, Depression, and Anxiety among Youth under 25 Years",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591882/,Inconclusive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Anxiety; Depression; Psychosis; Schizophrenia
2019500,Effects of cannabidiol in males and females in two different rat models of depression,https://www.ncbi.nlm.nih.gov/pubmed/30571957,Positive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Depression
2019501,Cannabis use behaviors and prevalence of anxiety and depressive symptoms in a cohort of Canadian medicinal cannabis users,https://www.ncbi.nlm.nih.gov/pubmed/30738930,Inconclusive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Anxiety; Depression; Addiction - Cannabis
2018261,"Oral Ingestion of Cannabis sativa: Risks, Benefits, and Effects on Malaria-Infected Hosts",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260522/,Positive,,Animal Study,2018,,Immune System,Malaria
2019502,"Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood: A Systematic Review and Meta-analysis",https://www.ncbi.nlm.nih.gov/pubmed/30758486,Negative,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Anxiety; Depression; Suicide Attempt
2019503,Marijuana use and major depressive disorder are additively associated with reduced verbal learning and altered cortical thickness,https://www.ncbi.nlm.nih.gov/pubmed/30809764,Negative,,Meta-analysis,2019,,,Cannabis Adverse Effects; Depression
2004039,A case of cannabis-induced pancreatitis,https://www.ncbi.nlm.nih.gov/pubmed/14730121,Negative,,Meta-analysis,2004,,Digestive System; Endocrine System,Pancreatitis
2019504,Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695363/,Negative,,Meta-analysis,2019,Synthetic Cannabinoid (unspecified),,Addiction - Alcohol; Addiction - Cannabis; Anxiety; Cannabis Adverse Effects; Depression; Insomnia and Sleep Disorders; MDMA Adverse Effects; OCD; Psychosis
2007057,Cannabinoid-induced pancreatitis: a case series,https://www.ncbi.nlm.nih.gov/pubmed/17873462,Negative,,Meta-analysis,2007,,Digestive System; Endocrine System,Pancreatitis
2013104,Cannabis-induced acute pancreatitis,https://www.ncbi.nlm.nih.gov/pubmed/23892868/,Negative,,Meta-analysis,2013,,Digestive System; Endocrine System,Pancreatitis
2019505,"Demographic, Cannabis Use, and Depressive Correlates of Cannabis Use Consequences in Regular Cannabis Users",https://www.ncbi.nlm.nih.gov/pubmed/31016818,Negative,,Meta-analysis,2019,,,Cannabis Adverse Effects; Depression
2013105,Cannabis: a rare cause of acute pancreatitis,https://www.ncbi.nlm.nih.gov/pubmed/22749694,Negative,,Meta-analysis,2013,,Digestive System; Endocrine System,Pancreatitis
2019506,“HASH”ing out pancreatitis: the new increasingly common culprit,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735343/,Negative,,Meta-analysis,2019,,Digestive System; Endocrine System,Pancreatitis
2019507,A Rare Case of Cannabis-induced Acute Pancreatitis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693792/,Negative,,Meta-analysis,2019,,Digestive System; Endocrine System,Pancreatitis
2008081,Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453762/?tool=pubmed,Positive,,Meta-analysis,2008,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Skeletal System,Arthritis - Osteoarthritis; Arthritis - Rheumatoid; Arthritis
2008082,Inhibitory effect of synthetic cannabinoids on cytokine production in rheumatoid fibroblast-like synoviocytes,https://www.ncbi.nlm.nih.gov/pubmed/18799087,Positive,,Laboratory Study,2008,CP-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Nervous System; Skeletal System,Arthritis - Rheumatoid; Arthritis; Inflammation
2012125,Neuromodulators for pain management in rheumatoid arthritis,https://www.ncbi.nlm.nih.gov/pubmed/22258992,Positive,,Meta-analysis,2012,,Skeletal System,Arthritis - Rheumatoid; Arthritis
2014118,Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis,https://www.ncbi.nlm.nih.gov/pubmed/24440992,Positive,,Laboratory Study,2014,HU-x Synthetic Cannabinoids,Skeletal System,Arthritis - Rheumatoid; Arthritis
2014119,Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243420/,Positive,,Animal Study,2014,JWH-x Synthetic Cannabinoids,Skeletal System,Arthritis - Rheumatoid; Arthritis
2015146,The endocannabinoid system and its therapeutic implications in rheumatoid arthritis,https://www.ncbi.nlm.nih.gov/pubmed/25791728,Positive,,Meta-analysis,2015,,Skeletal System,Arthritis - Rheumatoid; Arthritis
2015147,Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261058/,Positive,,Meta-analysis,2015,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Other Related Compounds; Virodhamine (O-AEA),,Arthritis - Rheumatoid; Arthritis; Inflammation; Multiple Sclerosis
2016178,"Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis): A systematic review of randomized controlled trials",https://www.ncbi.nlm.nih.gov/pubmed/26767993,Inconclusive,,Clinical Meta-analysis,2016,Pharma THC,Muscular System; Skeletal System,Arthritis - Osteoarthritis; Arthritis - Rheumatoid; Arthritis; Fibromyalgia
2019508,Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms,https://www.ncbi.nlm.nih.gov/pubmed/31039391,Positive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Depression
2019509,Mapping the pathways between recreational cannabis use and mood disorders: A Behaviour Sequence Analysis approach,https://www.ncbi.nlm.nih.gov/pubmed/31131494,Inconclusive,,Meta-analysis,2019,,,Anxiety; Depression; Psychosis
2019510,"Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: Systematic review and meta-analysis",https://www.ncbi.nlm.nih.gov/pubmed/31207470,Inconclusive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Anxiety; Depression; Pain; Pain - Chronic
2019511,Medical Marijuana Dependence Among Chronic Pain Patients Suffering From Depression and Anxiety,https://www.ncbi.nlm.nih.gov/pubmed/31339242,Negative,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Anxiety; Depression; Pain; Pain - Chronic; Addiction - Cannabis; Cannabis Adverse Effects
2019512,"The ""entourage effect"": Terpenes coupled with cannabinoids for the treatment of mood disorders and anxiety disorders",https://www.ncbi.nlm.nih.gov/pubmed/31481004,Positive,,Meta-analysis,2019,,,Depression
2016179,Cannabinoids and autoimmune diseases: A systematic review,https://www.ncbi.nlm.nih.gov/pubmed/26876387,Positive,,Meta-analysis,2016,,,Diabetes; Inflammation; Irritable Bowel Syndrome; Multiple Sclerosis
1987004,Effect of pharmacological agents on male reproduction,https://www.ncbi.nlm.nih.gov/pubmed/?term=cannabis+decrease+libido,Inconclusive,,Meta-analysis,1987,,,Libido
2017178,Association Between Marijuana Use and Sexual Frequency in the United States: A Population-Based Study,https://www.ncbi.nlm.nih.gov/pubmed/29110804,Positive,,Meta-analysis,2017,,Endocrine System; Reproductive System,Libido; Erectile Dysfunction
2017179,Individual prolactin reactivity modulates response of nucleus accumbens to erotic stimuli during acute cannabis intoxication: an fMRI pilot study,https://www.ncbi.nlm.nih.gov/pubmed/28401285,Positive,,Clinical Trial,2017,,Endocrine System; Reproductive System,Libido; Erectile Dysfunction
2019513,Effects of Cannabinoids on Female Sexual Function,https://www.sciencedirect.com/science/article/pii/S2050052119300770?via%3Dihub,Positive,,Meta-analysis,2019,,Endocrine System; Reproductive System,Libido; Erectile Dysfunction
2019514,The Relationship between Marijuana Use Prior to Sex and Sexual Function in Women,https://www.sciencedirect.com/science/article/pii/S2050116119300091#!,Positive,,Meta-analysis,2019,,Endocrine System; Reproductive System,Libido; Erectile Dysfunction
2016180,"The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858820/,Positive,,Laboratory Study,2016,WIN-x Synthetic Cannabinoids,Nervous System; Skeletal System,Arthritis - Rheumatoid; Inflammation; Arthritis - Osteoarthritis; Arthritis
2018262,Cannabis for the treatment of Crohn's disease,https://www.ncbi.nlm.nih.gov/pubmed/30407616,Inconclusive,,Meta-analysis,2018,,Digestive System,IBD - Crohn's Disease
2019515,Association Between Cannabis Use and Complications Related to Crohn's Disease: A Retrospective Cohort Study,https://www.ncbi.nlm.nih.gov/pubmed/30825109,Positive,,Meta-analysis,2019,,Digestive System,IBD - Crohn's Disease
2019516,Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn's Disease,https://www.ncbi.nlm.nih.gov/pubmed/31320109,Inconclusive,,Meta-analysis,2019,,Digestive System,IBD - Crohn's Disease
2019517,Insights into the role of cannabis in the management of inflammatory bowel disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727090/,Positive,,Meta-analysis,2019,,,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Irritable Bowel Syndrome
2019518,Patients' and clinicians' perspectives of co-use of cannabis and opioids for chronic non-cancer pain management in primary care,https://www.ncbi.nlm.nih.gov/pubmed/30472467,Inconclusive,,Meta-analysis,2019,,Nervous System,Pain; Pain - Chronic
2019519,Mental health functioning and severity of cannabis withdrawal among medical cannabis users with chronic pain,https://www.ncbi.nlm.nih.gov/pubmed/30500688,Inconclusive,,Meta-analysis,2019,,,Addiction - Cannabis; Pain; Pain - Chronic
2019520,"Opioid and Cannabis Co-Use among Adults With Chronic Pain: Relations to Substance Misuse, Mental Health, and Pain Experience",https://www.ncbi.nlm.nih.gov/pubmed/30557213,Inconclusive,,Meta-analysis,2019,,Nervous System,Pain; Pain - Chronic; Addiction - Opioid
2019521,Pills to Pot: Observational Analyses of Cannabis Substitution Among Medical Cannabis Users With Chronic Pain,https://www.ncbi.nlm.nih.gov/pubmed/30690169,Positive,,Meta-analysis,2019,,Nervous System,Pain; Pain - Chronic
2019522,Position Statement: A Pragmatic Approach for Medical Cannabis and Patients with Rheumatic Diseases,https://www.ncbi.nlm.nih.gov/pubmed/30647183,Inconclusive,,Meta-analysis,2019,,Skeletal System,Arthritis - Rheumatoid; Arthritis
2019523,Suppression of CpG-ODN-mediated IFNα and TNFα response in human plasmacytoid dendritic cells (pDC) by cannabinoid receptor 2 (CB2)-specific agonists,https://www.ncbi.nlm.nih.gov/pubmed/30807757,Positive,,Meta-analysis,2019,JWH-x Synthetic Cannabinoids,,Arthritis - Rheumatoid; Arthritis; Inflammation; Lupus
2019524,Joints for joints: cannabinoids in the treatment of rheumatoid arthritis,https://www.ncbi.nlm.nih.gov/pubmed/30920973,Positive,,Meta-analysis,2019,,Skeletal System,Arthritis - Rheumatoid; Arthritis
2019525,Cannabinoid receptors as therapeutic targets for autoimmune diseases: where do we stand?,https://www.ncbi.nlm.nih.gov/pubmed/31158514,Positive,,Meta-analysis,2019,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),,Arthritis - Rheumatoid; Arthritis; Diabetes; Multiple Sclerosis
2019526,Medical cannabis and cannabinoids in rheumatology: where are we now?,https://www.ncbi.nlm.nih.gov/pubmed/31512536,Positive,,Meta-analysis,2019,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),Skeletal System,Arthritis - Rheumatoid; Arthritis
2019527,Cannabinoids in the treatment of rheumatic diseases: Pros and cons,https://www.ncbi.nlm.nih.gov/pubmed/31648042,Positive,,Meta-analysis,2019,,Immune System; Skeletal System,Arthritis - Rheumatoid; Arthritis; Lupus
2019528,Patient preferences for rheumatoid arthritis treatment,https://www.ncbi.nlm.nih.gov/pubmed/30747733,Positive,,Meta-analysis,2019,,Skeletal System,Arthritis - Rheumatoid; Arthritis
2009070,Endocannabinoids in the Retina: From Marijuana to Neuroprotection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584875/,Positive,,Meta-analysis,2009,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Other Related Compounds; SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); WIN-x Synthetic Cannabinoids,Nervous System,Retinal Disorders
2017180,Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy,https://www.ncbi.nlm.nih.gov/pubmed/27569993,Positive,,Animal Study,2017,AM-x Synthetic Cannabinoids; HU-x Synthetic Cannabinoids,,Inflammation; Retinal Disorders
2017181,Cannabinoid receptors and TRPA1 on neuroprotection in a model of retinal ischemia,https://www.ncbi.nlm.nih.gov/pubmed/27876485,Positive,,Animal Study,2017,AM-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Nervous System,Glaucoma; Retinal Disorders
2018263,Neuroprotection by (Endo)Cannabinoids in Glaucoma and Retinal Neurodegenerative Diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120105/,Positive,,Meta-analysis,2018,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); WIN-x Synthetic Cannabinoids,Nervous System,Glaucoma; Retinal Disorders
2017182,CB2 receptor activation causes an ERK1/2-dependent inflammatory response in human RPE cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701010/,Negative,,Laboratory Study,2017,JWH-x Synthetic Cannabinoids,Nervous System,Inflammation; Macular Degeneration; Retinal Disorders
2019529,Bilateral multiple exudative retinal detachments and macular edema in a patient diagnosed with synthetic cannabinoid (Bonzai) intoxication,https://www.ncbi.nlm.nih.gov/pubmed/29275529,Negative,,Meta-analysis,2019,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis; Retinal Disorders
2011119,Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats,https://www.ncbi.nlm.nih.gov/pubmed/21930120,Positive,,Animal Study,2011,,Cardiovascular System,Cardiovascular Diseases (CVD); Reperfusion Injury
2012126,Cannabidiol treatment ameliorates ischemia/reperfusion renal injury in rats,https://www.ncbi.nlm.nih.gov/pubmed/22877651,Positive,,Animal Study,2012,,Cardiovascular System,Cardiovascular Diseases (CVD); Reperfusion Injury
2016181,Increased Renal 2-Arachidonoylglycerol Level Is Associated with Improved Renal Function in a Mouse Model of Acute Kidney Injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531066/,Positive,,Animal Study,2016,2-Arachidonoyl Glycerol (2-AG); Monoacylglycerol Lipase (MAGL),Cardiovascular System; Nervous System,Cardiovascular Diseases (CVD); Oxidative Stress; Reperfusion Injury; Inflammation
2019530,A Cost-Effectiveness Model for Adjunctive Smoked Cannabis in the Treatment of Chronic Neuropathic Pain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446169/,Inconclusive,,Meta-analysis,2019,,,Pain; Pain - Chronic
2019531,Cannabis Use Preferences and Decision-making Among a Cross-sectional Cohort of Medical Cannabis Patients with Chronic Pain,https://www.ncbi.nlm.nih.gov/pubmed/31132510,Inconclusive,,Meta-analysis,2019,,Nervous System,Pain; Pain - Chronic
2019532,Cannabidiol: A New Hope for Patients With Dravet or Lennox-Gastaut Syndromes,https://www.ncbi.nlm.nih.gov/pubmed/30616356,Positive,,Meta-analysis,2019,,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2019533,Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome,https://www.ncbi.nlm.nih.gov/pubmed/30938373,Inconclusive,,Meta-analysis,2019,,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2018264,Investigating the Therapeutic Mechanism of Cannabidiol in a Human Induced Pluripotent Stem Cell (iPSC)-Based Model of Dravet Syndrome,https://www.ncbi.nlm.nih.gov/pubmed/31186344,Positive,,Laboratory Study,2018,,,Epilepsy - Dravet Syndrome; Epilepsy
2019534,Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions,https://www.ncbi.nlm.nih.gov/pubmed/31625159,Positive,,Animal Study,2019,,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2015148,A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666428/,Negative,,Meta-analysis,2015,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis
2013106,AKI Associated with Synthetic Cannabinoids: A Case Series,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613952/,Negative,,Meta-analysis,2013,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis
2016182,Synthetic cannabinoid hyperemesis resulting in rhabdomyolysis and acute renal failure,https://www.ncbi.nlm.nih.gov/pubmed/26422191,Negative,,Meta-analysis,2016,Synthetic Cannabinoid (unspecified),Nervous System,Cannabis Hyperemesis Syndrome; Poisoning by Synthetic Cannabis
2017183,Spice-y Kidney Failure: A Case Report and Systematic Review of Acute Kidney Injury Attributable to the Use of Synthetic Cannabis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424589/,Negative,,Meta-analysis,2017,Synthetic Cannabinoid (unspecified),,Poisoning by Synthetic Cannabis
2018265,Impact of cannabidiol treatment on regulatory T-17 cells and neutrophil polarization in acute kidney injury,https://www.ncbi.nlm.nih.gov/pubmed/29897289,Positive,,Animal Study,2018,,Urinary System,Kidney Failure; Cardiovascular Diseases (CVD); Reperfusion Injury
2018266,The Therapeutic Potential of Cannabinoids in Dermatology,https://www.ncbi.nlm.nih.gov/pubmed/30517778,Positive,,Meta-analysis,2018,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),Integumentary System,Skin Diseases; Acne; Cancer - Skin (Non-melanoma); Cancer; Pruritis; Systemic Sclerosis
2009071,Cannabinoid CB2 receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637559/,Positive,,Animal Study,2009,O-x Synthetic Cannabinoids,Cardiovascular System; Nervous System,Cardiovascular Diseases (CVD); Reperfusion Injury; Stroke
2011120,Acute effects of a selective cannabinoid-2 receptor agonist on neuroinflammation in a model of traumatic brain injury,https://www.ncbi.nlm.nih.gov/pubmed/21332427/,Positive,,Animal Study,2011,O-x Synthetic Cannabinoids,,Stroke; Traumatic Brain Injury
2015149,A selective cannabinoid CB2 agonist attenuates damage and improves memory retention following stroke in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552583/,Positive,,Animal Study,2015,O-x Synthetic Cannabinoids,Nervous System,Stroke; Cognitive Dysfunction
2015150,Time-Dependent Protection of CB2 Receptor Agonist in Stroke,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505877/,Positive,,Animal Study,2015,AM-x Synthetic Cannabinoids,Nervous System,Stroke
2015151,Cannabinoid receptor type 1 agonist ACEA improves motor recovery and protects neurons in ischemic stroke in mice,https://www.ncbi.nlm.nih.gov/pubmed/26296704/,Positive,,Animal Study,2015,AM-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Nervous System,Stroke
2015152,"Non-Selective Cannabinoid Receptor Antagonists, Hinokiresinols Reduce Infiltration of Microglia/Macrophages into Ischemic Brain Lesions in Rat via Modulating 2-Arachidonolyglycerol-Induced Migration and Mitochondrial Activity",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627794/,Positive,,Animal Study,2015,2-Arachidonoyl Glycerol (2-AG),Nervous System,Stroke
2016183,"The CB1 Antagonist, SR141716A, Is Protective in Permanent Photothrombotic Cerebral Ischemia",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002388/,Positive,,Animal Study,2016,SR-x Synthetic Cannabinoids,Nervous System,Stroke
2016184,Role of hypothalamic cannabinoid receptors in post-stroke depression in rats,https://www.ncbi.nlm.nih.gov/pubmed/26778127/,Positive,,Animal Study,2016,,,Depression; Stroke
2017184,Strokes are possible complications of cannabinoids use,https://www.ncbi.nlm.nih.gov/pubmed/28237318/,Inconclusive,,Meta-analysis,2017,,,Poisoning by Synthetic Cannabis; Stroke
2019535,In vivo TSPO and cannabinoid receptor type 2 availability early in post-stroke neuroinflammation in rats: a positron emission tomography study,https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0851-4,Positive,,Animal Study,2019,,Nervous System,Stroke
2017185,Correlation Between Cannabidiol-Induced Reduction of Infarct Volume and Inflammatory Factors Expression in Ischemic Stroke Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440923/,Positive,,Animal Study,2017,,,Stroke
2018267,Detrimental effects of 2-arachidonoylglycerol on whole blood platelet aggregation and on cerebral blood flow after a focal ischemic insult in rats,https://www.ncbi.nlm.nih.gov/pubmed/29351454,Inconclusive,,Animal Study,2018,2-Arachidonoyl Glycerol (2-AG); Synthetic Cannabinoid (unspecified),,Stroke
2010078,The endocannabinoid system links gut microbiota to adipogenesis,https://www.embopress.org/doi/pdf/10.1038/msb.2010.46,Positive,,Animal Study,2010,Microbiome; HU-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Digestive System; Endocrine System,Microbiome Imbalance; Obesity
2018268,"Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142691/,Positive,,Animal Study,2018,,Nervous System,Epilepsy; Pain - Nociceptive; Pain; Stroke
2016185,Endocannabinoids in the Gut,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940133/,Positive,,Meta-analysis,2016,Endocannabinoid (unspecified); Microbiome; Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids,,Microbiome Imbalance
2019536,Surprising outcomes in cannabinoid CB1/CB2 receptor double knockout mice in two models of ischemia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810406/,Positive,,Animal Study,2019,,Nervous System,Stroke
2019537,The endocannabinoid system and stroke: A focused review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458776/,Positive,,Meta-analysis,2019,Synthetic Cannabinoid (unspecified),Nervous System,Stroke
2019538,Evidence of the efficacy and safety of cannabis medicines for chronic pain management : A methodological minefield,https://www.ncbi.nlm.nih.gov/pubmed/31139839,Positive,,Meta-analysis,2019,,Nervous System,Pain; Pain - Chronic
2019539,"Efficacy and safety of cannabidiol followed by an open label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicenter, randomized, placebo-controlled study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561449/,Inconclusive,,Double Blind Clinical Trial,2019,Pharma THC:CBD,Skeletal System,Arthritis - Rheumatoid; Arthritis; Pain; Pain - Chronic
2019540,"Cannabis-based medicines for chronic pain: indications, selection of drugs, effectiveness and safety : Experiences of pain physicians in Saarland",https://www.ncbi.nlm.nih.gov/pubmed/31201550,Inconclusive,,Meta-analysis,2019,Pharma THC,Nervous System,Pain; Pain - Chronic
2002033,The endogenous cannabinoid system controls extinction of aversive memories,https://www.ncbi.nlm.nih.gov/pubmed/12152079,Positive,,Animal Study,2002,SR-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,PTSD
2004040,Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis,https://pubmed.ncbi.nlm.nih.gov/15331569/,Positive,,Animal Study,2004,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; CP-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Mental/Emotional System,
2005040,Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling,https://www.ncbi.nlm.nih.gov/pubmed/15787710,Positive,,Animal Study,2005,2-Arachidonoyl Glycerol (2-AG); SR-x Synthetic Cannabinoids,Mental/Emotional System,
2007058,Interactions Between Endocannabinoids and Stress-Induced Decreased Sensitivity to Natural Reward,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1876712/,Positive,,Animal Study,2007,CP-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH); SR-x Synthetic Cannabinoids,Mental/Emotional System,
2008083,Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice,https://pubmed.ncbi.nlm.nih.gov/17684478/,Positive,,Animal Study,2008,SR-x Synthetic Cannabinoids,Mental/Emotional System,
2008084,The role of the endocannabinoid system in the regulation of hypothalamic-pituitary-adrenal axis activity,https://www.ncbi.nlm.nih.gov/pubmed/18426497,Positive,,Meta-analysis,2008,Endocannabinoid (unspecified),Mental/Emotional System,Anxiety; Depression; Obesity
2010079,Repeated Homotypic Stress Elevates 2-Arachidonoylglycerol Levels and Enhances Short-Term Endocannabinoid Signaling at Inhibitory Synapses in Basolateral Amygdala,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881681/,Positive,,Animal Study,2010,2-Arachidonoyl Glycerol (2-AG),Mental/Emotional System,
2010080,Deficiency in Endocannabinoid Signaling in the Nucleus Accumbens Induced by Chronic Unpredictable Stress,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055309/,Positive,,Animal Study,2010,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); WIN-x Synthetic Cannabinoids,Mental/Emotional System,Depression
2010081,Repeated Stress Impairs Endocannabinoid Signaling in the Paraventricular Nucleus of the Hypothalamus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6633493/,Inconclusive,,Animal Study,2010,AM-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); WIN-x Synthetic Cannabinoids,Mental/Emotional System,
2010082,Functional Interactions between Stress and the Endocannabinoid System: From Synaptic Signaling to Behavioral Output,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073528/,Positive,,Meta-analysis,2010,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System,
2011121,Corticosterone Mediates Reciprocal Changes in CB1 and TRPV1 Receptors in Primary Sensory Neurons in the Chronically Stressed Rat,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3031761/,Inconclusive,,Animal Study,2011,Fatty Acid Amide Hydrolase (FAAH); WIN-x Synthetic Cannabinoids,Mental/Emotional System,
2011122,Chronic restraint stress impairs endocannabinoid mediated suppression of GABAergic signaling in the hippocampus of adult male rats,https://pubmed.ncbi.nlm.nih.gov/21527320/,Positive,,Animal Study,2011,,Mental/Emotional System,
2011123,Recruitment of Prefrontal Cortical Endocannabinoid Signaling by Glucocorticoids Contributes to Termination of the Stress Response,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179266/,Positive,,Animal Study,2011,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Synthetic Cannabinoid (unspecified); WIN-x Synthetic Cannabinoids,Mental/Emotional System,
2014120,A critical role for prefrontocortical endocannabinoid signaling in the regulation of stress and emotional behavior,https://pubmed.ncbi.nlm.nih.gov/24582908/,Positive,,Meta-analysis,2014,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),Mental/Emotional System,
2014121,Cannabinoids Prevent the Effects of a Footshock Followed by Situational Reminders on Emotional Processing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200492/,Positive,,Animal Study,2014,WIN-x Synthetic Cannabinoids; AM-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,PTSD
2019541,Cannabis-based medicines for chronic pain management: current and future prospects,https://www.ncbi.nlm.nih.gov/pubmed/31356363,Positive,,Meta-analysis,2019,,Nervous System,Pain; Pain - Chronic
2015153,Inhibition of anandamide hydrolysis enhances noradrenergic and GABAergic transmission in the prefrontal cortex and basolateral amygdala of rats subjected to acute swim stress,https://pubmed.ncbi.nlm.nih.gov/25581607/,Inconclusive,,Animal Study,2015,Synthetic Cannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); SR-x Synthetic Cannabinoids,Mental/Emotional System,
2019542,Delta-9-tetrahydrocannabinol potentiates fear memory salience through functional modulation of mesolimbic dopaminergic activity states,https://www.ncbi.nlm.nih.gov/pubmed/29776015,Negative,,Animal Study,2019,,Mental/Emotional System,PTSD
2019543,Disagreement and Uncertainty Among Experts About how to Respond to Marijuana Use in Patients on Long-term Opioids for Chronic Pain: Results of a Delphi Study,https://www.ncbi.nlm.nih.gov/pubmed/31393585,Inconclusive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction; Pain; Pain - Chronic
2019544,Previous cannabis exposure modulates the acute effects of delta-9-tetrahydrocannabinol on attentional salience and fear processing,https://www.ncbi.nlm.nih.gov/pubmed/30138003,Negative,,Double Blind Clinical Trial,2019,,Mental/Emotional System,PTSD
2019545,"Is there a relationship between cannabis use problems, emotion dysregulation, and mental health problems among adults with chronic pain?",https://www.ncbi.nlm.nih.gov/pubmed/31407604,Negative,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Cannabis Adverse Effects; Pain; Pain - Chronic
2019546,Cannabis-derived medicines for the treatment of chronic pain : Problems resulting from medical appraisals in the experience of the Medical Advisory Board of the Statutory Health Insurance Funds North,https://www.ncbi.nlm.nih.gov/pubmed/31531729,Positive,,Meta-analysis,2019,,Nervous System,Pain; Pain - Chronic
2019547,Medical Cannabis for the Treatment of Chronic Pain: A Review of Clinical Effectiveness and Guidelines,https://www.ncbi.nlm.nih.gov/books/NBK546424/,Positive,,Meta-analysis,2019,,Nervous System,Pain; Pain - Chronic
2018269,Residual effects of cannabis use on attentional bias towards fearful faces,https://www.ncbi.nlm.nih.gov/pubmed/30244002,Negative,,Meta-analysis,2018,,Mental/Emotional System,PTSD
2019548,Concomitant THC and stress adolescent exposure induces impaired fear extinction and related neurobiological changes in adulthood,https://www.ncbi.nlm.nih.gov/pubmed/30439419,Negative,,Animal Study,2019,,,Anxiety; PTSD
2019549,"Serious psychological distress and daily cannabis use, 2008 to 2016: Potential implications for mental health?",https://www.ncbi.nlm.nih.gov/pubmed/30825793,Inconclusive,,Meta-analysis,2019,,Mental/Emotional System,
2019550,"Comparison of Cortisol Stress Response in Patients with Panic Disorder, Cannabis-Induced Panic Disorder, and Healthy Controls",https://www.ncbi.nlm.nih.gov/pubmed/30879013,Inconclusive,,Clinical Trial,2019,,Mental/Emotional System; Nervous System,Anxiety
2009072,Beneficial effects of a Cannabis sativa extract treatment on diabetes-induced neuropathy and oxidative stress,https://www.ncbi.nlm.nih.gov/pubmed/19441010,Positive,,Animal Study,2009,,Nervous System,Pain; Oxidative Stress; Pain - Neuropathy - Diabetic
2019551,Impaired cognitive performance under psychosocial stress in cannabis-dependent men is associated with attenuated precuneus activity,https://www.ncbi.nlm.nih.gov/pubmed/31509368,Negative,,Clinical Trial,2019,,Mental/Emotional System,
2010083,Randomized Placebo-Controlled Double-Blind Clinical Trial of Cannabis-Based Medicinal Product (Sativex) in Painful Diabetic Neuropathy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797957/,Inconclusive,,Double Blind Clinical Trial,2010,Pharma THC:CBD; Tetrahydrocannabinol (THC),,Pain; Pain - Neuropathy - Diabetic; Depression
2019552,Does cannabis use modify the effect of post-traumatic stress disorder on severe depression and suicidal ideation? Evidence from a population-based cross-sectional study of Canadians,https://www.ncbi.nlm.nih.gov/pubmed/31684805,Positive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Depression; PTSD; Suicide Attempt
2019553,"Psychological wellbeing, burnout and substance use amongst medical students in New Zealand",https://www.ncbi.nlm.nih.gov/pubmed/31701792,Inconclusive,,Meta-analysis,2019,,Mental/Emotional System,
2018270,Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098033/,Positive,,Animal Study,2018,,Mental/Emotional System,Addiction - Alcohol; Addiction - Cocaine; Addiction; Anxiety
2019554,Motives Matter: Cannabis use motives moderate the associations between stress and negative affect,https://www.ncbi.nlm.nih.gov/pubmed/31706141,Inconclusive,,Meta-analysis,2019,,Mental/Emotional System,Anxiety; Depression
2019555,"Endocannabinoids, stress signaling, and the locus coeruleus-norepinephrine system",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582240/,Positive,,Meta-analysis,2019,Endocannabinoid (unspecified),,Anxiety; PTSD
2019556,Cannabidiol Treatment Might Promote Resilience to Cocaine and Methamphetamine Use Disorders: A Review of Possible Mechanisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680550/,Inconclusive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Addiction - Cocaine; Addiction - Stimulant; Addiction
2006033,Cannabinoids in acute gastric damage and pancreatitis,https://www.ncbi.nlm.nih.gov/pubmed/17218765,Inconclusive,,Animal Study,2006,AM-x Synthetic Cannabinoids; Anandamide (AEA),Digestive System; Endocrine System,Pancreatitis; Stomach Ulcers
2019557,Medical cannabis for chronic pain: can it make a difference in pain management?,https://www.ncbi.nlm.nih.gov/pubmed/31535218,Positive,,Meta-analysis,2019,,Nervous System,Pain; Pain - Chronic
2019558,Position paper on medical cannabis and cannabis-based medicines in pain medicine,https://www.ncbi.nlm.nih.gov/pubmed/31541311,Inconclusive,,Meta-analysis,2019,,,Pain; Pain - Cancer; Pain - Chronic
2009073,Synergy between Enzyme Inhibitors of Fatty Acid Amide Hydrolase and Cyclooxygenase in Visceral Nociception,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2670588/,Positive,,Animal Study,2009,Fatty Acid Amide Hydrolase (FAAH); SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Digestive System,Stomach Ulcers
2019559,High-Frequency Medical Cannabis Use Is Associated With Worse Pain Among Individuals With Chronic Pain,https://www.ncbi.nlm.nih.gov/pubmed/31560957,Inconclusive,,Meta-analysis,2019,,Nervous System,Pain; Pain - Chronic; Cannabis Adverse Effects
2019560,"Cannabinoids, Pain, and Opioid Use Reduction: The Importance of Distilling and Disseminating Existing Data",https://www.ncbi.nlm.nih.gov/pubmed/31579833,Inconclusive,,Meta-analysis,2019,,,Addiction - Opioid; Pain; Pain - Acute; Pain - Chronic
2009074,Analysis of the effect of neuropeptides and cannabinoids in gastric mucosal defense initiated centrally in the rat,https://www.ncbi.nlm.nih.gov/pubmed/20388951,Positive,,Animal Study,2009,Anandamide (AEA); WIN-x Synthetic Cannabinoids,Digestive System,Stomach Ulcers
2019561,"Cannabinoids, cannabis, and cannabis-based medicine for pain management: a protocol for an overview of systematic reviews and a systematic review of randomised controlled trials",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749927/,Inconclusive,,Clinical Meta-analysis,2019,,,Pain; Pain - Chronic
2011124,Role of sensory nerves in gastroprotective effect of anandamide in rats,https://www.ncbi.nlm.nih.gov/pubmed/21673369,Positive,,Animal Study,2011,Anandamide (AEA),Digestive System,Stomach Ulcers
2012127,Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738192/,Positive,,Animal Study,2012,Fatty Acid Amide Hydrolase (FAAH),Digestive System,Stomach Ulcers; Arthritis - Osteoarthritis; Arthritis; Inflammation
2013107,Repeated Low-Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains Cannabinoid Receptor Type 1–Mediated Antinociceptive and Gastroprotective Effects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657109/,Positive,,Animal Study,2013,Monoacylglycerol Lipase (MAGL); CP-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Digestive System,Stomach Ulcers
2012128,Cannabinoid CB1 Receptors Mediate the Gastroprotective Effect of Neurotensin,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586888/,Positive,,Animal Study,2012,AM-x Synthetic Cannabinoids,Digestive System,Stomach Ulcers
2013108,"Pro-resolution, protective and anti-nociceptive effects of a cannabis extract in the rat gastrointestinal tract",https://www.ncbi.nlm.nih.gov/pubmed/23756391,Positive,,Animal Study,2013,,Digestive System,IBD - Inflammatory Bowel Disease; Stomach Ulcers
2014122,Angiotensin II-induced activation of central AT1 receptors exerts endocannabinoid-mediated gastroprotective effect in rats,https://www.ncbi.nlm.nih.gov/pubmed/24145131,Positive,,Animal Study,2014,AM-x Synthetic Cannabinoids,Digestive System,Stomach Ulcers
2018271,MAGL inhibition modulates gastric secretion and motility following NSAID exposure in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976484/,Positive,,Animal Study,2018,Endocannabinoid (unspecified); Monoacylglycerol Lipase (MAGL),Digestive System,Stomach Ulcers
2009075,Pharmacological synergism between cannabinoids and paclitaxel in gastric cancer cell lines,https://www.ncbi.nlm.nih.gov/pubmed/19394652,Positive,,Laboratory Study,2009,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Digestive System; Nervous System,Cancer - Stomach; Cancer
2010084,Effect of a synthetic cannabinoid agonist on the proliferation and invasion of gastric cancer cells,https://pubmed.ncbi.nlm.nih.gov/20336665/,Positive,,Laboratory Study,2010,WIN-x Synthetic Cannabinoids,Digestive System; Nervous System,Cancer - Stomach; Cancer
2011125,Antiproliferative mechanism of a cannabinoid agonist by cell cycle arrest in human gastric cancer cells,https://www.ncbi.nlm.nih.gov/pubmed/21312237,Positive,,Laboratory Study,2011,WIN-x Synthetic Cannabinoids,Digestive System,Cancer - Stomach; Cancer
2013109,Cannabinoid receptor agonist as an alternative drug in 5-fluorouracil-resistant gastric cancer cells,https://www.ncbi.nlm.nih.gov/pubmed/23749906,Positive,,Laboratory Study,2013,WIN-x Synthetic Cannabinoids,Digestive System; Nervous System,Cancer - Stomach; Cancer
2019562,Cannabidiol Induces Cell Cycle Arrest and Cell Apoptosis in Human Gastric Cancer SGC-7901 Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723681/,Positive,,Laboratory Study,2019,,Digestive System; Nervous System,Cancer - Stomach; Cancer
2019563,Effects of Cannabinoid Administration for Pain: A Meta-Analysis and Meta-Regression,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663642/,Positive,,Meta-analysis,2019,,,Pain; Pain - Chronic
2019564,Effectiveness and tolerability of THC:CBD oromucosal spray as add-on measure in patients with severe chronic pain: analysis of 12-week open-label real-world data provided by the German Pain e-Registry,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535492/,Positive,,Meta-analysis,2019,Pharma THC:CBD,,Pain; Pain - Chronic
2005041,A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophrenia,https://www.ncbi.nlm.nih.gov/pubmed/15721218,Inconclusive,,Meta-analysis,2005,Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System; Nervous System,Addiction - Stimulant; Addiction; Psychosis; Schizophrenia
2010085,Effects of cannabinoid-receptor antagonists on maintenance and reinstatement of methamphetamine self-administration in rhesus monkeys,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2974174/,Positive,,Animal Study,2010,AM-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Addiction - Stimulant; Addiction
2011126,"Association Study of Two Cannabinoid Receptor Genes, CNR1 and CNR2, with Methamphetamine Dependence",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137178/,Inconclusive,,Meta-analysis,2011,,Mental/Emotional System,Addiction - Stimulant; Addiction; Psychosis; Schizophrenia
2013110,Assessment of the abuse potential of MDMA in the conditioned place preference paradigm: role of CB1 receptors,https://www.ncbi.nlm.nih.gov/pubmed/23959085,Inconclusive,,Animal Study,2013,,Mental/Emotional System; Nervous System,Addiction - Stimulant; Addiction; MDMA Adverse Effects
2016186,Prevention of drug priming- and cue-induced reinstatement of MDMA-seeking behaviors by the CB1 cannabinoid receptor antagonist AM251,https://pubmed.ncbi.nlm.nih.gov/26796595/,Positive,,Animal Study,2016,AM-x Synthetic Cannabinoids,Mental/Emotional System,Addiction - Stimulant; Addiction; MDMA Adverse Effects
2018272,Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in rats,https://www.ncbi.nlm.nih.gov/pubmed/30260267,Positive,,Animal Study,2018,,Mental/Emotional System; Nervous System,Addiction - Stimulant; Addiction
2017186,"Formulation, Characterization and Properties of Hemp Seed Oil and Its Emulsions",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154611/,Positive,,Laboratory Study,2017,,Immune System,Bacterial Infections; Staph Infection
2018273,"Chromatographic Analyses, In Vitro Biological Activities, and Cytotoxicity of Cannabis sativa L. Essential Oil: A Multidisciplinary Study",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320915/,Positive,,Laboratory Study,2018,,,Bacterial Infections; Cancer - Colon; Cancer - Breast; Cancer; Fungal Infections; Staph Infection
2001021,"Cannabinoidergic and opioidergic inhibition of spinal reflexes in the decerebrated, spinalized rabbit",https://www.ncbi.nlm.nih.gov/pubmed/11249966,Positive,,Animal Study,2001,HU-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Skeletal System,Spinal Cord Injuries
2003031,"Upregulation of spinal cannabinoid-1-receptors following nerve injury enhances the effects of Win 55,212-2 on neuropathic pain behaviors in rats",https://www.ncbi.nlm.nih.gov/pubmed/14499445,Positive,,Animal Study,2003,WIN-x Synthetic Cannabinoids,Skeletal System,Spinal Cord Injuries
2005042,"AM404, an inhibitor of anandamide reuptake decreases Fos-immunoreactivity in the spinal cord of neuropathic rats after non-noxious stimulation",https://www.ncbi.nlm.nih.gov/pubmed/15680264,Positive,,Animal Study,2005,AM-x Synthetic Cannabinoids,Skeletal System,Spinal Cord Injuries
2006034,Different effects of opioid and cannabinoid receptor agonists on C-fiber-induced extracellular signal-regulated kinase activation in dorsal horn neurons in normal and spinal nerve-ligated rats,https://www.ncbi.nlm.nih.gov/pubmed/16221738,Positive,,Animal Study,2006,Synthetic Cannabinoid (unspecified),Skeletal System,Spinal Cord Injuries
2009076,"Sustained antinociceptive effect of cannabinoid receptor agonist WIN 55,212-2 over time in rat model of neuropathic spinal cord injury pain",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743245/,Positive,,Animal Study,2009,WIN-x Synthetic Cannabinoids,Skeletal System,Spinal Cord Injuries
2010086,"A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury",https://www.ncbi.nlm.nih.gov/pubmed/20434606,Positive,,Double Blind Clinical Trial,2010,Pharma THC; Tetrahydrocannabinol (THC),Skeletal System,Spinal Cord Injuries
2010087,Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study,https://www.ncbi.nlm.nih.gov/pubmed/20855984,Positive,,Double Blind Clinical Trial,2010,Pharma THC; Tetrahydrocannabinol (THC),Skeletal System,Spinal Cord Injuries
2011127,Activation of spinal and supraspinal cannabinoid-1 receptors lead to antinociception in a rat model of neuropathic spinal cord injury pain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159760/,Positive,,Animal Study,2011,WIN-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Skeletal System,Spinal Cord Injuries
2017187,Cannabinoids and the kidney: effects in health and disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792153/,Inconclusive,,Meta-analysis,2017,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); HU-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); WIN-x Synthetic Cannabinoids,,Chronic Kidney Disease; Kidney Failure
2018274,Marijuana and Cannabinoids in ESRD and Earlier Stages of CKD,https://www.ncbi.nlm.nih.gov/pubmed/28811049,Inconclusive,,Meta-analysis,2018,,,Chronic Kidney Disease; Kidney Failure
2019565,Endocannabinoid System and the Kidneys: From Renal Physiology to Injury and Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653784/,Positive,,Meta-analysis,2019,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); WIN-x Synthetic Cannabinoids,,Chronic Kidney Disease; Kidney Failure; Pain; Pain - Neuropathy - Diabetic
2012129,Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481534/,Positive,,Meta-analysis,2012,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); 2-Arachidonoyl Glycerol (2-AG); Other Related Compounds; Synthetic Cannabinoid (unspecified); Virodhamine (O-AEA),Skeletal System,Spinal Cord Injuries
2016187,Cannabinoids to treat spinal cord injury,https://www.ncbi.nlm.nih.gov/pubmed/25805333,Positive,,Meta-analysis,2016,,Skeletal System,Spinal Cord Injuries
2017188,Cannabis use in persons with traumatic spinal cord injury in Denmark,https://www.ncbi.nlm.nih.gov/pubmed/28101559,Inconclusive,,Meta-analysis,2017,,Skeletal System,Spinal Cord Injuries
2017189,Cannabidiol administration reduces sublesional cancellous bone loss in rats with severe spinal cord injury,https://www.ncbi.nlm.nih.gov/pubmed/28479140,Positive,,Animal Study,2017,,Skeletal System,Spinal Cord Injuries
2019566,"The non-psychoactive phytocannabinoid cannabidiol (CBD) attenuates pro-inflammatory mediators, T cell infiltration, and thermal sensitivity following spinal cord injury in mice",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447028/,Positive,,Animal Study,2019,,Skeletal System,Inflammation; Spinal Cord Injuries
2011128,Is There a Legitimate Role for the Therapeutic Use of Cannabinoids for Symptom Management in Chronic Kidney Disease?,https://www.jpsmjournal.com/article/S0885-3924(10)00979-6/fulltext#sec10,Positive,,Meta-analysis,2011,Tetrahydrocannabinol (THC),Urinary System,Chronic Kidney Disease; Kidney Failure
2017190,"Cannabis, Cannabinoids, and Sleep: a Review of the Literature",https://www.ncbi.nlm.nih.gov/pubmed/28349316,Positive,,Meta-analysis,2017,Pharma THC,,Insomnia and Sleep Disorders; Pain - Chronic; REM Sleep Behavior Disorder; Sleep Apnea
2010088,Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis,https://www.ncbi.nlm.nih.gov/pubmed/20617520,Positive,,Animal Study,2010,Synthetic Cannabinoid (unspecified),Integumentary System,Fibrosis - Skin; Fibrosis; Systemic Sclerosis; Inflammation
2012130,Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1,https://www.ncbi.nlm.nih.gov/pubmed/22915616,Positive,,Animal Study,2012,Fatty Acid Amide Hydrolase (FAAH),Integumentary System,Fibrosis - Skin; Fibrosis; Systemic Sclerosis
2019567,A Review of Cannabis in Chronic Kidney Disease Symptom Management,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388458/,Positive,,Meta-analysis,2019,Pharma THC:CBD,Urinary System,Chronic Kidney Disease
2019568,"VCE‐004.3, a cannabidiol aminoquinone derivative, prevents bleomycin‐induced skin fibrosis and inflammation through PPARγ‐ and CB2 receptor‐dependent pathways",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135789/,Positive,,Animal Study,2019,Synthetic Cannabinoid (unspecified),Integumentary System; Nervous System,Fibrosis - Skin; Fibrosis; Inflammation; Systemic Sclerosis
2018275,"EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis",https://www.ncbi.nlm.nih.gov/pubmed/30076848,Positive,,Animal Study,2018,Synthetic Cannabinoid (unspecified),Integumentary System,Fibrosis - Skin; Fibrosis; Systemic Sclerosis; Inflammation
2019569,A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars,https://www.researchgate.net/publication/332523483_A_therapeutic_effect_of_cbd-enriched_ointment_in_inflammatory_skin_diseases_and_cutaneous_scars,Positive,,Meta-analysis,2019,,Integumentary System,Psoriasis; Skin Diseases; Fibrosis - Skin; Fibrosis
2007059,Marijuana: an effective antiepileptic treatment in partial epilepsy? A case report and review of the literature,https://www.ncbi.nlm.nih.gov/pubmed/17609644,Positive,,Meta-analysis,2007,,,Cerebral Palsy; Epilepsy
2018276,Medical Cannabis for Pediatric Moderate to Severe Complex Motor Disorders,https://www.ncbi.nlm.nih.gov/pubmed/29766748,Positive,,Clinical Trial,2018,Tetrahydrocannabinol (THC),Nervous System,Cerebral Palsy; Insomnia and Sleep Disorders; Parkinson's Disease
2019570,Cannabinoid drugs: will they relieve or exacerbate tinnitus?,https://www.ncbi.nlm.nih.gov/pubmed/30507635,Inconclusive,,Meta-analysis,2019,,Nervous System,Tinnitus
2018277,Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPARγ receptors,https://www.ncbi.nlm.nih.gov/pubmed/30217539,Positive,,Animal Study,2018,,Nervous System,Inflammation; Chorea; Dystonia; Oxidative Stress
2019571,Nabilone administration in refractory chronic diarrhea: a case series,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593541/,Positive,,Meta-analysis,2019,Pharma THC,Digestive System,Diarrhea
2014123,Decreased enteric fatty acid amide hydrolase activity is associated with colonic inertia in slow transit constipation,https://www.ncbi.nlm.nih.gov/pubmed/23926887,Positive,,Clinical Trial,2014,Fatty Acid Amide Hydrolase (FAAH),Digestive System,Constipation
2015154,Cannabinoid 2 receptor antagonism reverses central nervous system injury-induced immune deficiency syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472342/,Positive,,Animal Study,2015,AM-x Synthetic Cannabinoids,,Sepsis; Toxic Shock Syndrome
2015155,The rapidly increasing trend of cannabis use in burn injury,https://www.ncbi.nlm.nih.gov/pubmed/25412052,Inconclusive,,Meta-analysis,2015,,Integumentary System,Burn Injury
2014124,"Cannabinoid Receptor Type 1 Antagonist, AM-251, Attenuates Mechanical Allodynia and Thermal Hyperalgesia after Burn Injury",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237656/,Positive,,Animal Study,2014,AM-x Synthetic Cannabinoids,Integumentary System; Nervous System,Burn Injury; Pain; Pain - Acute; Inflammation
2008085,Frequency and irregularity of heart rate in drivers suspected of driving under the influence of cannabis,https://www.ncbi.nlm.nih.gov/pubmed/19046727,Negative,,Meta-analysis,2008,,,Cannabis Adverse Effects; Cardiac Arrhythmias; Cardiovascular Diseases (CVD)
2009077,Ventricular tachycardia due to marijuana use in a heart transplant patient,https://www.ncbi.nlm.nih.gov/pubmed/19401137,Negative,,Meta-analysis,2009,,,Cannabis Adverse Effects; Cardiac Arrhythmias; Cardiovascular Diseases (CVD)
2012131,Toxic effects of marijuana on the cardiovascular system,https://www.ncbi.nlm.nih.gov/pubmed/22194141,Negative,,Meta-analysis,2012,,Cardiovascular System; Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Cardiac Arrhythmias; Cardiovascular Diseases (CVD)
2014125,Is recent cannabis use associated with acute coronary syndromes? An illustrative case series,https://www.ncbi.nlm.nih.gov/pubmed/24783463,Negative,,Meta-analysis,2014,,Cardiovascular System,Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Heart Attack; Cannabis Adverse Effects
2016188,Cannabis induced asystole,https://www.ncbi.nlm.nih.gov/pubmed/26520167,Negative,,Meta-analysis,2016,,,Cannabis Adverse Effects; Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Heart Attack
2018278,Burden of arrhythmia in recreational marijuana users,https://www.internationaljournalofcardiology.com/article/S0167-5273(18)31100-8/fulltext,Negative,,Meta-analysis,2018,,Cardiovascular System,Atrial Fibrillation; Cardiac Arrhythmias; Cardiovascular Diseases (CVD)
2019572,Pseudo-Wellens' syndrome secondary to concurrent cannabis and phencyclidine intoxication,https://www.ncbi.nlm.nih.gov/pubmed/29960973,Negative,,Meta-analysis,2019,,,Cannabis Adverse Effects; Cardiac Arrhythmias; Cardiovascular Diseases (CVD)
2018279,Marijuana Induced Type I Brugada Pattern: A Case Report,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173320/,Negative,,Meta-analysis,2018,Tetrahydrocannabinol (THC),Cardiovascular System,Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Cannabis Adverse Effects
2018280,"Coma, Seizures, Atrioventricular Block, and Hypoglycemia in an ADB-FUBINACA Body-Packer",https://www.ncbi.nlm.nih.gov/pubmed/30297193,Negative,,Meta-analysis,2018,Synthetic Cannabinoid (unspecified),Mental/Emotional System,Cannabis Adverse Effects
2019573,Cardiovascular effects of marijuana,https://www.ncbi.nlm.nih.gov/pubmed/30447899,Negative,,Meta-analysis,2019,,Cardiovascular System,Cardiovascular Diseases (CVD); Atrial Fibrillation; Cardiac Arrhythmias
2005043,Cannabinoid hyperemesis with the unusual symptom of compulsive bathing,https://www.ncbi.nlm.nih.gov/pubmed/16010960,Negative,,Meta-analysis,2005,,Nervous System,Cannabis Hyperemesis Syndrome
2019574,“Cannabis hyperemesis” causation questioned,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1856368/,Inconclusive,,Meta-analysis,2019,,Nervous System,Cannabis Hyperemesis Syndrome
2009078,Cannabinoid hyperemesis syndrome: Clinical diagnosis of an underrecognized manifestation of chronic cannabis abuse,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2658859/,Negative,,Meta-analysis,2009,,Nervous System,Cannabis Hyperemesis Syndrome
2009079,Cannabinoid hyperemesis presenting to a New Zealand hospital,https://www.ncbi.nlm.nih.gov/pubmed/19319174,Negative,,Meta-analysis,2009,,,Cannabis Hyperemesis Syndrome
2009080,Cyclical hyperemesis secondary to cannabis abuse,https://www.ncbi.nlm.nih.gov/pubmed/19477551,Negative,,Meta-analysis,2009,,Nervous System,Cannabis Hyperemesis Syndrome
2010089,"The cannabis hyperemesis syndrome characterized by persistent nausea and vomiting, abdominal pain, and compulsive bathing associated with chronic marijuana use: a report of eight cases in the United States",https://www.ncbi.nlm.nih.gov/pubmed/20130993,Negative,,Meta-analysis,2010,,Nervous System,Cannabis Hyperemesis Syndrome
2010090,Cannabis and hyperemesis,https://www.ncbi.nlm.nih.gov/pubmed/30282296,Negative,,Meta-analysis,2010,,Nervous System,Cannabis Hyperemesis Syndrome
2010091,Cannabinoid hyperemesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886568/,Negative,,Meta-analysis,2010,,Nervous System,Cannabis Hyperemesis Syndrome
2010092,Cannabinoid-Induced Hyperemesis: A Conundrum—From Clinical Recognition to Basic Science Mechanisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036650/,Negative,,Meta-analysis,2010,,Nervous System,Cannabis Hyperemesis Syndrome
2010093,Pediatric cannabinoid hyperemesis: two cases,https://www.ncbi.nlm.nih.gov/pubmed/21131803,Negative,,Meta-analysis,2010,,Nervous System,Cannabis Hyperemesis Syndrome
2011129,Cannabinoid hyperemesis syndrome,https://www.ncbi.nlm.nih.gov/pubmed/21426598,Negative,,Meta-analysis,2011,,,Cannabis Hyperemesis Syndrome
2011130,Cannabinoid-induced hyperemesis,https://www.ncbi.nlm.nih.gov/pubmed/21462097,Negative,,Meta-analysis,2011,,,Cannabis Hyperemesis Syndrome
2011131,Cannabinoid hyperemesis syndrome as the underlying cause of intractable nausea and vomiting,https://www.ncbi.nlm.nih.gov/pubmed/21464265,Negative,,Meta-analysis,2011,,,Cannabis Hyperemesis Syndrome
2012132,Cannabis hyperemesis syndrome,https://www.ncbi.nlm.nih.gov/pubmed/21692016,Negative,,Meta-analysis,2012,,Nervous System,Cannabis Hyperemesis Syndrome
2011132,Cannabinoid hyperemesis syndrome inducing acute prerenal failure and electrolyte disturbance,https://www.ncbi.nlm.nih.gov/pubmed/21877303,Negative,,Meta-analysis,2011,,,Cannabis Hyperemesis Syndrome; Kidney Failure
2011133,Hyperemesis and a high water bill,https://www.ncbi.nlm.nih.gov/pubmed/22069047,Negative,,Meta-analysis,2011,,,Cannabis Hyperemesis Syndrome
2013111,Cannabinoid Hyperemesis Syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/,Negative,,Meta-analysis,2013,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Cannabigerol (CBG),Digestive System; Nervous System,Cannabis Hyperemesis Syndrome; Nausea and Vomiting
2012133,Association of Marijuana Use and Cyclic Vomiting Syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763664/,Negative,,Meta-analysis,2012,,Digestive System; Nervous System,Cannabis Hyperemesis Syndrome; Nausea and Vomiting
2012134,Cannabinoid Hyperemesis: A Case Series of 98 Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538402/,Negative,,Meta-analysis,2012,,Nervous System,Cannabis Hyperemesis Syndrome
2005044,"Alcohol, marijuana, cocaine use, and relationship quality among HIV serodiscordant male couples",https://www.ncbi.nlm.nih.gov/pubmed/16320436,Inconclusive,,Meta-analysis,2005,,,Domestic Abuse
2013112,"Mouse Models for Studying Pain In Sickle Disease: Effects of Strain, Age, and Acuteness",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3779783/,Positive,,Animal Study,2013,CP-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL),Cardiovascular System,Sickle Cell Disorders
2014126,Substance Use Disorders and Intimate Partner Violence Perpetration among Male and Female Offenders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801342/,Inconclusive,,Meta-analysis,2014,,,Addiction - Alcohol; Addiction - Cannabis; Addiction - Opioid; Domestic Abuse
2014127,Priapism in a patient with sickle cell trait using marijuana,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025395/,Inconclusive,,Meta-analysis,2014,,Cardiovascular System,Sickle Cell Disorders
2019575,Monoacylglycerol lipase inhibition as potential treatment for interstitial cystitis,https://pubmed.ncbi.nlm.nih.gov/31443753/,Positive,,Animal Study,2019,2-Arachidonoyl Glycerol (2-AG),Urinary System,Cystitis
2016189,Sickle Cell Crisis Complicated by Synthetic Cannabinoid Abuse: A Case Report,https://www.ncbi.nlm.nih.gov/pubmed/26956672,Negative,,Meta-analysis,2016,Synthetic Cannabinoid (unspecified),Cardiovascular System,Poisoning by Synthetic Cannabis; Sickle Cell Disorders
2014128,Evaluation of selective cannabinoid CB(1) and CB(2) receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis,https://pubmed.ncbi.nlm.nih.gov/24561047/,Positive,,Animal Study,2014,JWH-x Synthetic Cannabinoids,Urinary System,Cystitis
2008086,Endogenous cannabinoids contribute to remote ischemic preconditioning via cannabinoid CB2 receptors in the rat heart,https://www.ncbi.nlm.nih.gov/pubmed/17950273,Positive,,Animal Study,2008,AM-x Synthetic Cannabinoids; Endocannabinoid (unspecified),Cardiovascular System,Cardiac Arrhythmias; Cardiovascular Diseases (CVD)
2012135,Cannabinoid hyperemesis syndrome: a case series and review of previous reports,https://www.ncbi.nlm.nih.gov/pubmed/22480624,Negative,,Meta-analysis,2012,,Digestive System; Nervous System,Cannabis Hyperemesis Syndrome; Nausea and Vomiting
2013113,Compulsive showering and marijuana use – the cannabis hyperemisis syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757911/,Negative,,Meta-analysis,2013,,Nervous System,Cannabis Hyperemesis Syndrome
2013114,Cannabinoid Hyper-emesis Syndrome: An Enigma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868097/,Negative,,Meta-analysis,2013,,,Cannabis Hyperemesis Syndrome
2009081,R(+)-methanandamide-induced apoptosis of human cervical carcinoma cells involves a cyclooxygenase-2-dependent pathway,https://www.ncbi.nlm.nih.gov/pubmed/19015962,Positive,,Laboratory Study,2009,Other Related Compounds,Nervous System; Reproductive System,Cancer - Cervical; Cancer
2008087,The influence of mast cell mediators on migration of SW756 cervical carcinoma cells,https://pubmed.ncbi.nlm.nih.gov/18296861/,Positive,,Laboratory Study,2008,2-Arachidonoyl Glycerol (2-AG); WIN-x Synthetic Cannabinoids,Nervous System; Reproductive System,Cancer - Cervical; Cancer
2011134,Marijuana Use is Not Associated with Cervical Human Papillomavirus Natural History or Cervical Neoplasia in HIV-seropositive or HIV-seronegative Women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874245/,Inconclusive,,Meta-analysis,2011,,Nervous System; Reproductive System,Cancer - Cervical; Cancer
2016190,Cannabinoid Hyperemesis Syndrome: An Emerging Drug-Induced Disease,https://www.ncbi.nlm.nih.gov/pubmed/24413371,Negative,,Meta-analysis,2016,,Nervous System,Cannabis Hyperemesis Syndrome
2013115,Cannabinoid Hyperemesis Syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847982/,Negative,,Meta-analysis,2013,,Nervous System,Cannabis Hyperemesis Syndrome
2014129,No opiates against cannabis hyperemesis syndrome,https://www.ncbi.nlm.nih.gov/pubmed/24519114,Negative,,Meta-analysis,2014,,Nervous System,Cannabis Hyperemesis Syndrome; Addiction - Opioid
2014130,A rare case of cannabis hyperemesis syndrome relieved by hot water bathing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873632/,Negative,,Meta-analysis,2014,,Nervous System,Cannabis Hyperemesis Syndrome
2014131,Cannabinoid Hyperemesis Syndrome: A Case Report and Review of Pathophysiology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453416/,Negative,,Meta-analysis,2014,,Nervous System,Cannabis Hyperemesis Syndrome
2014132,"A Gut Gone to Pot: A Case of Cannabinoid Hyperemesis Syndrome due to K2, a Synthetic Cannabinoid",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020538/,Negative,,Meta-analysis,2014,Synthetic Cannabinoid (unspecified),Nervous System,Cannabis Hyperemesis Syndrome
2014133,Marijuana Use and Maternal Experiences of Severe Nausea During Pregnancy in Hawai‘i,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174692/,Negative,,Meta-analysis,2014,,Reproductive System,Morning sickness; Nausea and Vomiting; Pregnancy
2019576,Effects of Cannabis sativa extract on haloperidol-induced catalepsy and oxidative stress in the mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928014/,Positive,,Animal Study,2019,,,Oxidative Stress; Chorea; Dystonia; Multiple Sclerosis; Neurodegenerative Issues; Parkinson's Disease
2014134,A Novel Hemp Seed Meal Protein Hydrolysate Reduces Oxidative Stress Factors in Spontaneously Hypertensive Rats,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276990/,Positive,,Animal Study,2014,,Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Oxidative Stress
2017191,Cannabinoid CB2 Receptors are Involved in the Protection of RAW264.7 Macrophages Against the Oxidative Stress: An in Vitro Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289301/,Positive,,Laboratory Study,2017,Cannabigerol (CBG); AM-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Nervous System,Oxidative Stress
2018281,"In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073490/,Positive,,Laboratory Study,2018,Cannabigerol (CBG),,Inflammation; Oxidative Stress; Alzheimer's Disease; Multiple Sclerosis; Neurodegenerative Issues; Parkinson's Disease
2018282,"Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304621/,Positive,,Meta-analysis,2018,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Cannabidiolic Acid (CBD-a); Pharma CBD; Pharma THC:CBD; Pharma THC,Nervous System,Cancer; Inflammation; Oxidative Stress; Pain; Pain - Cancer
2014135,Cannabinoid hyperemesis syndrome should be considered by recurrent vomiting,https://www.ncbi.nlm.nih.gov/pubmed/25394844,Inconclusive,,Meta-analysis,2014,,Nervous System,Cannabis Hyperemesis Syndrome
2014136,Case of cannabinoid hyperemesis syndrome with long-term follow-up,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266847/,Negative,,Meta-analysis,2014,,Nervous System,Cannabis Hyperemesis Syndrome
2015156,Cannabinoid hyperemesis syndrome: about 6 cases,https://www.ncbi.nlm.nih.gov/pubmed/25547957,Negative,,Meta-analysis,2015,,Digestive System,Cannabis Hyperemesis Syndrome; Nausea and Vomiting
2015157,A non-classical cannabinoid syndrome,https://www.ncbi.nlm.nih.gov/pubmed/25567676,Negative,,Meta-analysis,2015,,Nervous System,Cannabis Hyperemesis Syndrome
2019577,"DNA Damaging Effects, Oxidative Stress Responses and Cholinesterase Activity in Blood and Brain of Wistar Rats Exposed to Δ9-Tetrahydrocannabinol",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515386/,Negative,,Animal Study,2019,Pharma THC,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Oxidative Stress
2015158,"13-Year-Old Girl With Recurrent, Episodic, Persistent Vomiting: Out of the Pot and Into the Fire",https://pediatrics.aappublications.org/content/135/4/e1060,Inconclusive,,Meta-analysis,2015,,Nervous System,Cannabis Hyperemesis Syndrome; Nausea and Vomiting
2015159,Cannabinoid hyperemesis syndrome: a cause of refractory nausea and vomiting in pregnancy,https://www.ncbi.nlm.nih.gov/pubmed/25774930,Negative,,Meta-analysis,2015,,Nervous System,Cannabis Hyperemesis Syndrome; Pregnancy
2015160,Cannabinoid Hyperemesis Syndrome: A Case Report and Literature Review,https://www.ncbi.nlm.nih.gov/pubmed/25896565,Negative,,Meta-analysis,2015,,Nervous System,Cannabis Hyperemesis Syndrome
2015161,Cannabinoid hyperemesis syndrome causing prolonged nausea and vomiting in patients with cannabis abuse,https://www.ncbi.nlm.nih.gov/pubmed/25922240,Negative,,Meta-analysis,2015,,Nervous System,Cannabis Hyperemesis Syndrome
2015162,Cannabis hyperemesis syndrome: A case report review of treatment,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598496/,Negative,,Meta-analysis,2015,,Nervous System,Cannabis Hyperemesis Syndrome
2015163,Cannabinoid Hyperemesis Syndrome: A Paradoxical Cannabis Effect,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525754/,Negative,,Meta-analysis,2015,,Nervous System,Cannabis Hyperemesis Syndrome
2015164,Cannabinoid Hyperemesis Syndrome in a 17-Year-Old Adolescent,https://www.ncbi.nlm.nih.gov/pubmed/26372366,Negative,,Meta-analysis,2015,,Nervous System,Cannabis Hyperemesis Syndrome
2015165,Cannabinoid hyperemesis syndrome: an important differential diagnosis of persistent unexplained vomiting,https://www.ncbi.nlm.nih.gov/pubmed/26445382,Negative,,Meta-analysis,2015,,Nervous System,Cannabis Hyperemesis Syndrome
2015166,Diagnosing and treating cannabinoid hyperemesis,https://www.ncbi.nlm.nih.gov/pubmed/26638755,Inconclusive,,Meta-analysis,2015,,Nervous System,Cannabis Hyperemesis Syndrome
2016191,Use of β-caryophyllene to combat bacterial dental plaque formation in dogs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045627/,Positive,,Animal Study -,2016,,Integumentary System,Cavities; Veterinary Applications
1992006,Review of the effects of cannabis smoking on oral health,https://www.ncbi.nlm.nih.gov/pubmed/1563817,Negative,,Meta-analysis,1992,,,Cavities; Periodontal Disease
2005045,General and oral health implications of cannabis use,https://www.ncbi.nlm.nih.gov/pubmed/16050084,Negative,,Meta-analysis,2005,Tetrahydrocannabinol (THC),,Cannabis Adverse Effects; Cavities; Periodontal Disease
2009082,Cannabis and caries--does regular cannabis use increase the risk of caries in cigarette smokers?,https://www.ncbi.nlm.nih.gov/pubmed/20112637,Negative,,Meta-analysis,2009,,Integumentary System,Cavities
2015167,Cannabinoid hyperemesis syndrome: a guide for the practicing clinician,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691917/,Negative,,Meta-analysis,2015,,Nervous System,Cannabis Hyperemesis Syndrome
2016192,Case Report of Intractable Vomiting and Abdominal Pain Related to Heavy Daily Cannabis Use,https://www.ncbi.nlm.nih.gov/pubmed/28817852,Negative,,Meta-analysis,2016,Tetrahydrocannabinol (THC),Nervous System,Cannabis Hyperemesis Syndrome
2016193,High prevalence of cannabinoid hyperemesis syndrome in marijuana users,https://www.ncbi.nlm.nih.gov/pubmed/29105413,Negative,,Meta-analysis,2016,,Nervous System,Cannabis Hyperemesis Syndrome
2016194,An Overlooked Victim of Cannabis: Losing Several Years of Well-being and Inches of Jejunum on the Way to Unravel Her Hyperemesis Enigma,https://www.ncbi.nlm.nih.gov/pubmed/26757305,Negative,,Meta-analysis,2016,Pharma THC,Nervous System,Cannabis Hyperemesis Syndrome
2016195,Cannabinoid hyperemesis syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735328/,Negative,,Meta-analysis,2016,Tetrahydrocannabinol (THC),,Cannabis Hyperemesis Syndrome
2016196,Cannabinoid hyperemesis syndrome masquerading as an eating disorder,https://www.ncbi.nlm.nih.gov/pubmed/26842268,Inconclusive,,Meta-analysis,2016,,Nervous System,Cannabis Hyperemesis Syndrome; Anorexia
2016197,Cannabinoid hyperemesis syndrome. A report of six new cases and a summary of previous reports,https://www.ncbi.nlm.nih.gov/pubmed/26990261,Inconclusive,,Meta-analysis,2016,,,Cannabis Hyperemesis Syndrome
1997010,"Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production by dexanabinol (HU-211), a nonpsychotropic cannabinoid",https://www.ncbi.nlm.nih.gov/pubmed/9353414,Positive,,Animal Study,1997,HU-x Synthetic Cannabinoids,Cardiovascular System; Immune System,Sepsis; Toxic Shock Syndrome
2004041,Presynaptic cannabinoid CB1 receptors are involved in the inhibition of the neurogenic vasopressor response during septic shock in pithed rats,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1575049/,Positive,,Animal Study,2004,SR-x Synthetic Cannabinoids,Immune System,Sepsis; Toxic Shock Syndrome
2004042,Reductions in levels of bacterial superantigens/cannabinoids by plasma exchange in a patient with severe toxic shock syndrome,https://www.ncbi.nlm.nih.gov/pubmed/15675223,Inconclusive,,Meta-analysis,2004,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Cardiovascular System,Toxic Shock Syndrome; Sepsis; Staph Infection
2001022,Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock,https://www.ncbi.nlm.nih.gov/pubmed/11412008,Inconclusive,,Meta-analysis,2001,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Cardiovascular System; Immune System,Sepsis; Toxic Shock Syndrome
2008088,Combination therapy with direct hemoperfusion using polymyxin B-immobilized fiber and oral vancomycin improves fulminant pseudomembranous colitis by reducing the elevated endogenous cannabinoids and inflammatory cytokines: report of a case,https://www.ncbi.nlm.nih.gov/pubmed/18705306,Positive,,Meta-analysis,2008,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified),,Sepsis
2019578,"Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture",https://www.ncbi.nlm.nih.gov/pubmed/20561509,Positive,,Animal Study,2019,,Immune System,Sepsis; Cognitive Dysfunction; Oxidative Stress
2019579,Cannabinoid derivatives acting as dual PPARγ/CB2 agonists as therapeutic agents for systemic sclerosis,https://www.ncbi.nlm.nih.gov/pubmed/30825431,Positive,,Animal Study,2019,Synthetic Cannabinoid (unspecified),Integumentary System,Systemic Sclerosis; Inflammation
2019580,Cannabis sativa as a Potential Treatment for Systemic Sclerosis,https://www.ima.org.il/FilesUpload/IMAJ/0/344/172422.pdf,Positive,,Meta-analysis,2019,,Integumentary System,Systemic Sclerosis
2016198,Cannabinoid hyperemesis syndrome: A review of the literature,https://www.ncbi.nlm.nih.gov/pubmed/27017363,Inconclusive,,Meta-analysis,2016,,Nervous System,Cannabis Hyperemesis Syndrome
2018283,The role of cannabinoid signaling in acute and chronic kidney diseases,https://pubmed.ncbi.nlm.nih.gov/29706358/,Positive,,Meta-analysis,2018,Synthetic Cannabinoid (unspecified),,Diabetic Kidney Disease; Kidney Failure
2018284,Effect of Vaporized Cannabis on Exertional Breathlessness and Exercise Endurance in Advanced Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial,https://www.ncbi.nlm.nih.gov/pubmed/30049223,Inconclusive,,Double Blind Clinical Trial,2018,,Respiratory System,COPD
2019581,Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832375/,Positive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Schizophrenia
2018285,Vaping Cannabis and Chronic Obstructive Pulmonary Disease,https://www.atsjournals.org/doi/10.1513/AnnalsATS.201807-463ED,Inconclusive,,Meta-analysis,2018,Tetrahydrocannabinol (THC),,COPD
2018286,Cannabis consumption and psychosis or schizophrenia development,https://www.ncbi.nlm.nih.gov/pubmed/30442059,Negative,,Meta-analysis,2018,,Mental/Emotional System,Psychosis; Schizophrenia
2019582,Ventral hippocampal overexpression of Cannabinoid Receptor Interacting Protein 1 (CNRIP1) produces a schizophrenia-like phenotype in the rat,https://www.ncbi.nlm.nih.gov/pubmed/30522798,Inconclusive,,Animal Study,2019,,Mental/Emotional System; Nervous System,Schizophrenia
2019583,"Schizophrenia, cannabis use and Catechol-O-Methyltransferase (COMT): Modeling the interplay on cognition",https://www.ncbi.nlm.nih.gov/pubmed/30790675,Positive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Schizophrenia; Cognitive Dysfunction
2019584,Cannabis use disorders may protect against certain disorders of the digestive organs in people with schizophrenia but not in healthy controls,https://www.ncbi.nlm.nih.gov/pubmed/30880659,Positive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Schizophrenia; IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Irritable Bowel Syndrome
2019585,History of Lifetime Cannabis Use Is Associated with Better Cognition and Worse Real-World Functioning in Schizophrenia Spectrum Disorders,https://www.ncbi.nlm.nih.gov/pubmed/30897572,Inconclusive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Schizophrenia
2019586,Association of smoked cannabis with treatment resistance in schizophrenia,https://www.ncbi.nlm.nih.gov/pubmed/31229838,Negative,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Schizophrenia
2014137,Antischistosomal Activity of the Terpene Nerolidol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271124/,Positive,,Laboratory Study,2014,,Integumentary System,Snail Fever
2013116,Altered Expression of Type-1 and Type-2 Cannabinoid Receptors in Celiac Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631143/,Positive,,Laboratory Study,2013,Anandamide (AEA),Digestive System,Celiac Disease
2005046,Effects of cannabinoid treatment on Chagas disease pathogenesis: balancing inhibition of parasite invasion and immunosuppression,https://www.ncbi.nlm.nih.gov/pubmed/16207246,Positive,,Animal Study,2005,WIN-x Synthetic Cannabinoids,Cardiovascular System,Chagas Disease
2016199,Cyclic vomiting and abdominal pain from prolonged cannabis use,https://www.ncbi.nlm.nih.gov/pubmed/27219080,Negative,,Meta-analysis,2016,,Nervous System,Cannabis Hyperemesis Syndrome
2016200,Successful Treatment of Suspected Cannabinoid Hyperemesis Syndrome Using Haloperidol in the Outpatient Setting,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997062/,Negative,,Meta-analysis,2016,,Nervous System,Cannabis Hyperemesis Syndrome
2016201,Cannabis Hyperemesis Syndrome in the Emergency Department: How Can a Specialized Addiction Team Be Useful? A Pilot Study,https://www.ncbi.nlm.nih.gov/pubmed/27485997,Inconclusive,,Meta-analysis,2016,,Nervous System,Cannabis Hyperemesis Syndrome
2016202,Cannabinoid Hyperemesis Syndrome: A Case Report of Cyclic Severe Hyperemesis and Abdominal Pain with Long-Term Cannabis Use,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131230/,Negative,,Meta-analysis,2016,,Nervous System,Cannabis Hyperemesis Syndrome
2017192,"Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment—a Systematic Review",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330965/,Inconclusive,,Meta-analysis,2017,,Nervous System,Cannabis Hyperemesis Syndrome
2017193,Is haloperidol the wonder drug for cannabinoid hyperemesis syndrome?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256592/,Inconclusive,,Meta-analysis,2017,,Nervous System,Cannabis Hyperemesis Syndrome; Nausea and Vomiting
2017194,Coronary vasospasm complicating cannabinoid hyperemesis syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135018/,Negative,,Meta-analysis,2017,,,Cannabis Hyperemesis Syndrome; Cardiovascular Diseases (CVD)
2017195,Pharmacologic Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review,https://www.ncbi.nlm.nih.gov/pubmed/28370228,Negative,,Meta-analysis,2017,,Nervous System,Cannabis Hyperemesis Syndrome
2017196,"Cannabinoid hyperemesis and the cyclic vomiting syndrome in adults: recognition, diagnosis, acute and long-term treatment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360975/,Negative,,Meta-analysis,2017,,Digestive System,Cannabis Hyperemesis Syndrome; Nausea and Vomiting
2017197,Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency department: a case series,https://www.ncbi.nlm.nih.gov/pubmed/28494183,Inconclusive,,Meta-analysis,2017,Capsaicin (CAPS),Nervous System,Cannabis Hyperemesis Syndrome
2017198,Cannabinoid hyperemesis syndrome: A disorder of the HPA axis and sympathetic nervous system?,https://www.ncbi.nlm.nih.gov/pubmed/28571820,Inconclusive,,Meta-analysis,2017,,,Cannabis Hyperemesis Syndrome
2018287,A case of cannabinoid hyperemesis syndrome with Heliobacter pylori and preeclampsia during pregnancy,https://www.ncbi.nlm.nih.gov/pubmed/28723278,Negative,,Meta-analysis,2018,,,Cannabis Hyperemesis Syndrome; Pregnancy
2018288,Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment,https://www.ncbi.nlm.nih.gov/pubmed/28730896,Negative,,Meta-analysis,2018,Capsaicin (CAPS),Nervous System,Cannabis Hyperemesis Syndrome
2018289,Cannabinoid hyperemesis syndrome presentation to the emergency department: A two-year multicenter retrospective chart review in a major urban area,https://www.ncbi.nlm.nih.gov/pubmed/28835305,Inconclusive,,Meta-analysis,2018,,,Cannabis Hyperemesis Syndrome
2018290,Emergency Department Treatment of Cannabinoid Hyperemesis Syndrome: A Review,https://www.ncbi.nlm.nih.gov/pubmed/28953512,Inconclusive,,Meta-analysis,2018,,,Cannabis Hyperemesis Syndrome
2006035,"Tuberculosis Outbreak in Marijuana Users, Seattle, Washington, 2004",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291049/,Inconclusive,,Meta-analysis,2006,,Respiratory System,Tuberculosis
2011135,"Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165959/,Positive,,Animal Study,2011,,Nervous System,Multiple Sclerosis; Tuberculosis
2019587,Cannabis use and the risk of tuberculosis: a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660970/,Inconclusive,,Meta-analysis,2019,,Respiratory System,Tuberculosis
2014138,Pharmacotherapy of trichotillomania (hair pulling disorder): an updated systematic review,https://www.ncbi.nlm.nih.gov/pubmed/25399534,Positive,,Meta-analysis,2014,Pharma THC,Integumentary System,Compulsive hair pulling
1997011,Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant,https://www.ncbi.nlm.nih.gov/pubmed/9042110/,Positive,,Animal Study,1997,HU-x Synthetic Cannabinoids,Nervous System,Traumatic Brain Injury
2001023,An endogenous cannabinoid (2-AG) is neuroprotective after brain injury,https://www.ncbi.nlm.nih.gov/pubmed/11586361/,Positive,,Animal Study,2001,2-Arachidonoyl Glycerol (2-AG),,Traumatic Brain Injury
2002034,Cannabinoids and brain injury: therapeutic implications,https://www.ncbi.nlm.nih.gov/pubmed/11815270/,Positive,,Meta-analysis,2002,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),Nervous System,Traumatic Brain Injury
2004043,Cannabinoids as neuroprotective agents in traumatic brain injury,https://www.ncbi.nlm.nih.gov/pubmed/15281893,Positive,,Meta-analysis,2004,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),,Traumatic Brain Injury
2008089,Peroxisome Proliferator-Activated Receptors: “Key” Regulators of Neuroinflammation after Traumatic Brain Injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2276625/,Positive,,Meta-analysis,2008,2-Arachidonoyl Glycerol (2-AG); Endocannabinoid (unspecified); HU-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Nervous System,Traumatic Brain Injury
2014139,Effect of marijuana use on outcomes in traumatic brain injury,https://www.ncbi.nlm.nih.gov/pubmed/25264643,Positive,,Meta-analysis,2014,Tetrahydrocannabinol (THC),Nervous System,Chronic Traumatic Encephalopathy; Traumatic Brain Injury
2018291,Perioperative Management of Severe Traumatic Brain Injury: What Is New?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096919/,Positive,,Meta-analysis,2018,HU-x Synthetic Cannabinoids,,Traumatic Brain Injury; Inflammation
2018292,Selective activation of cannabinoid receptor-2 reduces neuroinflammation after traumatic brain injury via alternative macrophage polarization,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767553/,Positive,,Animal Study,2018,AM-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),,Traumatic Brain Injury; Inflammation
2018293,Cannabis Use in Individuals With Spinal Cord Injury or Moderate to Severe Traumatic Brain Injury in Colorado,https://www.ncbi.nlm.nih.gov/pubmed/29524396,Positive,,Meta-analysis,2018,,Skeletal System,Spinal Cord Injuries; Traumatic Brain Injury
2019588,Role of CB2 Receptor in the Recovery of Mice after Traumatic Brain Injury,https://www.ncbi.nlm.nih.gov/pubmed/30489198,Positive,,Animal Study,2019,HU-x Synthetic Cannabinoids,Nervous System,Traumatic Brain Injury
2019589,Cannabis in the Treatment of Traumatic Brain Injury: A Primer for Clinicians,https://www.ncbi.nlm.nih.gov/pubmed/31551104,Positive,,Meta-analysis,2019,,Nervous System,Traumatic Brain Injury; Depression; Psychosis
2019590,Oral Cannabidiol Prevents Allodynia and Neurological Dysfunctions in a Mouse Model of Mild Traumatic Brain Injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476923/,Positive,,Animal Study,2019,,Nervous System,Traumatic Brain Injury; Anxiety; Depression; Pain; Pain - Chronic
2006036,"Effects of AM281, a cannabinoid antagonist, on circulatory deterioration and cytokine production in an endotoxin shock model: comparison with norepinephrine",https://www.ncbi.nlm.nih.gov/pubmed/17072693,Positive,,Animal Study,2006,AM-x Synthetic Cannabinoids,Cardiovascular System,Toxic Shock Syndrome
2016203,Do cannabinoids have a role to play in Tourettes syndrome?,https://www.ncbi.nlm.nih.gov/pubmed/28032854,Inconclusive,,Meta-analysis,2016,,Nervous System,Tics and Tourettes
2019591,Pure delta-9-tetrahydrocannabinol and its combination with cannabidiol in treatment-resistant Tourette syndrome: A case report,https://www.ncbi.nlm.nih.gov/pubmed/30058466,Positive,,Meta-analysis,2019,,Nervous System,Tics and Tourettes
2019592,The Potential of Cannabinoid-Based Treatments in Tourette Syndrome,https://www.ncbi.nlm.nih.gov/pubmed/30977108,Positive,,Meta-analysis,2019,,Nervous System,Tics and Tourettes
2019593,"Patients with tic disorders: widely known, yet underserved",https://www.ncbi.nlm.nih.gov/pubmed/31627240,Inconclusive,,Meta-analysis,2019,,Nervous System,Tics and Tourettes
2019594,Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pubmed/31672337,Inconclusive,,Meta-analysis,2019,,,ADD and ADHD; Anxiety; Bipolar Disorder; Depression; Tics and Tourettes; Psychosis
2001024,Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth,https://www.ncbi.nlm.nih.gov/pubmed/11687506,Positive,,Animal Study,2001,Anandamide (AEA),Endocrine System,Cancer - Thyroid; Cancer
2003032,Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis,https://www.ncbi.nlm.nih.gov/pubmed/12958205,Positive,,Animal Study,2003,Anandamide (AEA),Endocrine System,Cancer - Thyroid; Cancer
2014140,Repositioning therapy for thyroid cancer: new insights on established medications,https://www.ncbi.nlm.nih.gov/pubmed/24446492,Positive,,Meta-analysis,2014,,Endocrine System; Nervous System,Cancer - Thyroid; Cancer
2019595,Inflammation and CB2 signaling drive novel changes in the ocular lipidome and regulate immune cell activity in the eye,https://www.ncbi.nlm.nih.gov/pubmed/30232034,Positive,,Animal Study,2019,HU-x Synthetic Cannabinoids,Immune System; Nervous System,Uveitis
2019596,Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767236/,Positive,,Laboratory Study,2019,Synthetic Cannabinoid (unspecified),Immune System; Nervous System,Uveitis
2014141,Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136976/,Positive,,Animal Study,2014,Fatty Acid Amide Hydrolase (FAAH); AM-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Digestive System,IBD - Inflammatory Bowel Disease; Irritable Bowel Syndrome
2017199,The Anti-Inflammatory Effect and Intestinal Barrier Protection of HU210 Differentially Depend on TLR4 Signaling in Dextran Sulfate Sodium-Induced Murine Colitis,https://www.ncbi.nlm.nih.gov/pubmed/27995407,Positive,,Animal Study,2017,HU-x Synthetic Cannabinoids,Digestive System,IBD - Inflammatory Bowel Disease; Irritable Bowel Syndrome
2017200,Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome in Adolescents: A Case Series,https://pediatrics.aappublications.org/content/140/6/e20163795,Negative,,Meta-analysis,2017,Capsaicin (CAPS),Nervous System,Cannabis Hyperemesis Syndrome
2017201,Cannabinoid hyperemesis syndrome: Review of the literature and of cases reported to the French addictovigilance network,https://www.ncbi.nlm.nih.gov/pubmed/29132050,Negative,,Meta-analysis,2017,,Nervous System,Cannabis Hyperemesis Syndrome
2018294,Cannabinoid Hyperemesis Syndrome: Pathophysiology and Treatment in the Emergency Department,https://www.ncbi.nlm.nih.gov/pubmed/29310960,Negative,,Meta-analysis,2018,,,Cannabis Hyperemesis Syndrome
2018295,Cannabinoid Hyperemesis Syndrome and the Consulting Psychiatrist: A Case Study of Diagnosis and Treatment for an Emerging Disorder in Psychiatric Practice,https://www.ncbi.nlm.nih.gov/pubmed/29320384,Negative,,Meta-analysis,2018,,,Cannabis Hyperemesis Syndrome
2018296,The Prevalence of Cannabinoid Hyperemesis Syndrome Among Regular Marijuana Smokers in an Urban Public Hospital,https://onlinelibrary.wiley.com/doi/full/10.1111/bcpt.12962,Inconclusive,,Meta-analysis,2018,,,Cannabis Hyperemesis Syndrome
2019597,Successful Treatment of Cannabinoid Hyperemesis Syndrome with Topical Capsaicin,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758720/,Negative,,Meta-analysis,2019,Capsaicin (CAPS),Nervous System,Cannabis Hyperemesis Syndrome
2018297,Cannabinoid Hyperemesis Syndrome: Public Health Implications and a Novel Model Treatment Guideline,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851514/,Negative,,Meta-analysis,2018,,,Cannabis Hyperemesis Syndrome
2019598,Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases,https://www.ncbi.nlm.nih.gov/pubmed/29768651,Negative,,Meta-analysis,2019,,Nervous System,Cannabis Hyperemesis Syndrome
2019599,Recurrent Nausea and Vomiting in a Pregnant Woman with Chronic Marijuana Use,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165623/,Negative,,Meta-analysis,2019,,Nervous System,Cannabis Hyperemesis Syndrome
2019600,Cannabis hyperemesis syndrome,https://www.ncbi.nlm.nih.gov/pubmed/30323105,Negative,,Meta-analysis,2019,,Nervous System,Cannabis Hyperemesis Syndrome
2019601,"A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis",https://www.ncbi.nlm.nih.gov/pubmed/29538683,Positive,,Double Blind Clinical Trial,2019,,Digestive System,IBD - Inflammatory Bowel Disease; IBD - Ulcerative Colitis; IBD - Crohn's Disease
2019602,Cannabis for the treatment of ulcerative colitis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516819/,Inconclusive,,Meta-analysis,2019,,Digestive System,IBD - Inflammatory Bowel Disease; IBD - Ulcerative Colitis; IBD - Crohn's Disease
2019603,Association between cannabis use and complications related to ulcerative colitis in hospitalized patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708902/,Positive,,Meta-analysis,2019,,Digestive System,IBD - Inflammatory Bowel Disease; IBD - Ulcerative Colitis; IBD - Crohn's Disease
2019604,Cannabis for the Treatment of Crohn's Disease and Ulcerative Colitis: Evidence From Cochrane Reviews,https://www.ncbi.nlm.nih.gov/pubmed/31613959,Inconclusive,,Meta-analysis,2019,,Digestive System,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; IBD - Ulcerative Colitis
2019605,Plasma anandamide and related n-acylethanolamide levels are not elevated in pregnancies complicated by hyperemesis gravidarum,https://www.ncbi.nlm.nih.gov/pubmed/24117326,Inconclusive,,Clinical Trial,2019,Anandamide (AEA); Other Related Compounds,Digestive System; Reproductive System,Morning sickness; Nausea and Vomiting; Pregnancy
2019606,"Toxicology of Marijuana, Synthetic Cannabinoids, and Cannabidiol in Dogs and Cats",https://mybestbudca.com/wp-content/uploads/1-s2.0-S0195561618300871-main.pdf,Positive,,Meta-analysis -,2019,Synthetic Cannabinoid (unspecified),,Veterinary Applications; Epilepsy; Inflammation; Pruritis
2019607,Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038832/,Positive,,Meta-analysis -,2019,,,Veterinary Applications
2019608,A survey of veterinary student attitudes concerning whether marijuana could have therapeutic value for animals,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613771/,Positive,,Meta-analysis -,2019,,,Veterinary Applications
2019609,Recent trends in cyclic vomiting syndrome-associated hospitalisations with liberalisation of cannabis use in the state of Colorado,https://www.ncbi.nlm.nih.gov/pubmed/30426628,Negative,,Meta-analysis,2019,,Digestive System; Nervous System,Cannabis Hyperemesis Syndrome; Nausea and Vomiting
2019610,Emergency Department and Radiological Cost of Delayed Diagnosis of Cannabinoid Hyperemesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339733/,Negative,,Meta-analysis,2019,,Nervous System,Cannabis Hyperemesis Syndrome
2019611,The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome,https://www.ncbi.nlm.nih.gov/pubmed/30729854,Inconclusive,,Meta-analysis,2019,,Nervous System,Cannabis Hyperemesis Syndrome
2019612,Cannabinoid hyperemesis syndrome: An unrecognized cause of nausea and vomiting,https://www.ncbi.nlm.nih.gov/pubmed/30913155,Negative,,Meta-analysis,2019,,Nervous System,Cannabis Hyperemesis Syndrome
2019613,Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors,https://www.sciencedirect.com/science/article/pii/S0969996113001939?via%3Dihub,Positive,,Animal Study,2019,Synthetic Cannabinoid (unspecified),,Inflammation; Multiple Sclerosis; Prion Disease
2019614,Cannabinoids and Dementia: A Review of Clinical and Preclinical Data,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033945/,Positive,,Meta-analysis,2019,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); CP-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Pharma THC; SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); WIN-x Synthetic Cannabinoids,,Dementia; Alzheimer's Disease; Huntington's Disease; Parkinson's Disease
2019615,Selective Modulator of Cannabinoid Receptor Type 2 Reduces Memory Impairment and Infarct Size During Cerebral Hypoperfusion and Vascular Dementia,https://www.ncbi.nlm.nih.gov/pubmed/27586843,Positive,,Animal Study,2019,,Nervous System,Dementia; Alzheimer's Disease; Cognitive Dysfunction; Neurodegenerative Issues
2019616,Cannabis Hyperemesis Syndrome in Palliative Care: A Case Study and Narrative Review,https://www.ncbi.nlm.nih.gov/pubmed/31084461,Negative,,Meta-analysis,2019,,Nervous System,Cannabis Hyperemesis Syndrome
2019617,Spontaneuos pneumomediastinum secondary to cannabinoid hyperemesis syndrome,https://www.ncbi.nlm.nih.gov/pubmed/31133765,Negative,,Meta-analysis,2019,,Nervous System,Cannabis Hyperemesis Syndrome
2019618,Cannabis hyperemesis syndrome: still under recognized after all these years,https://www.ncbi.nlm.nih.gov/pubmed/31188343,Inconclusive,,Meta-analysis,2019,,Nervous System,Cannabis Hyperemesis Syndrome
2019619,Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788295/,Inconclusive,,Meta-analysis,2019,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Digestive System; Nervous System,Cannabis Hyperemesis Syndrome; Nausea and Vomiting
2019620,Cannabinoid hyperemesis syndrome: A case study and discussion,https://www.ncbi.nlm.nih.gov/pubmed/31274681,Inconclusive,,Meta-analysis,2019,,Nervous System,Cannabis Hyperemesis Syndrome
2019621,Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274085/,Positive,,Meta-analysis,2019,,Nervous System,Dementia; Cognitive Dysfunction
2019622,Medical Cannabis for the Treatment of Dementia: A Review of Clinical Effectiveness and Guidelines,https://www.ncbi.nlm.nih.gov/books/NBK546328/,Positive,,Meta-analysis,2019,Pharma THC,Muscular System; Nervous System; Skeletal System,Dementia; Geriatric Conditions; Cognitive Dysfunction
2019623,Emerging Role of Aprepitant in Cannabis Hyperemesis Syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682377/,Inconclusive,,Meta-analysis,2019,,Nervous System,Cannabis Hyperemesis Syndrome
2019624,Efficacy and safety of topical capsaicin for cannabinoid hyperemesis syndrome in the emergency department,https://www.ncbi.nlm.nih.gov/pubmed/31482758,Positive,,Meta-analysis,2019,Capsaicin (CAPS),Nervous System,Cannabis Hyperemesis Syndrome
2019625,Hair cannabinoid concentrations in emergency patients with cannabis hyperemesis syndrome,https://www.ncbi.nlm.nih.gov/pubmed/30806339,Inconclusive,,Meta-analysis,2019,,Nervous System,Cannabis Hyperemesis Syndrome
2019626,Resolution of Cannabinoid Hyperemesis Syndrome with Benzodiazepines: A Case Series,https://www.ncbi.nlm.nih.gov/pubmed/31280510,Inconclusive,,Meta-analysis,2019,,Nervous System,Cannabis Hyperemesis Syndrome
2019627,Cannabinoid hyperemesis syndrome: a review of the literature,https://www.ncbi.nlm.nih.gov/pubmed/31488758,Inconclusive,,Meta-analysis,2019,,Nervous System,Cannabis Hyperemesis Syndrome
2019628,Heavy Cannabis Use Associated with Wernicke's Encephalopathy,https://www.ncbi.nlm.nih.gov/pubmed/31523540,Inconclusive,,Meta-analysis,2019,,,Cannabis Hyperemesis Syndrome
2019629,Burden of Comorbidities in Hospitalizations for Cannabis Use-associated Intractable Vomiting during Post-legalization Period,https://www.ncbi.nlm.nih.gov/pubmed/31511820,Inconclusive,,Meta-analysis,2019,Cannabichromenic Acid (CBC-a),Nervous System,Cannabis Hyperemesis Syndrome; Cannabis Adverse Effects
2019630,Cannabis hyperemesis syndrome: still under recognised after all these years,https://www.rcpe.ac.uk/college/journal/letters-editor-60,Negative,,Meta-analysis,2019,,Nervous System,Cannabis Hyperemesis Syndrome
2019631,"Disentangling longitudinal relations between youth cannabis use, peer cannabis use, and conduct problems: developmental cascading links to cannabis use disorder",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519359/,Inconclusive,,Meta-analysis,2019,,,Addiction - Cannabis
2019632,Time since first cannabis use and 12-month prevalence of cannabis use disorder among youth and emerging adults in the United States,https://www.ncbi.nlm.nih.gov/pubmed/30474910,Inconclusive,,Meta-analysis,2019,,,Addiction - Cannabis
2019633,Higher average potency across the United States is associated with progression to first cannabis use disorder symptom,https://www.ncbi.nlm.nih.gov/pubmed/30573162,Inconclusive,,Meta-analysis,2019,,,Addiction - Cannabis
2019634,An update on cannabis use disorder with comment on the impact of policy related to therapeutic and recreational cannabis use,https://www.ncbi.nlm.nih.gov/pubmed/30604051,Inconclusive,,Meta-analysis,2019,,,Addiction - Cannabis
2019635,"The Cerebellum, THC, and Cannabis Addiction: Findings from Animal and Human Studies",https://www.ncbi.nlm.nih.gov/pubmed/30610540,Inconclusive,,Meta-analysis,2019,,,Addiction - Cannabis
2019636,"Associations between state-level policy liberalism, cannabis use, and cannabis use disorder from 2004 to 2012: Looking beyond medical cannabis law status",https://www.ncbi.nlm.nih.gov/pubmed/30685092,Inconclusive,,Meta-analysis,2019,,,Addiction - Cannabis
2019637,Cannabis use disorders and psychiatric comorbidities,https://www.ncbi.nlm.nih.gov/pubmed/30869262,Inconclusive,,Meta-analysis,2019,,,Addiction - Cannabis; Anxiety; Psychosis
2019638,Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: a narrative review and new findings,https://www.ncbi.nlm.nih.gov/pubmed/30870044,Inconclusive,,Meta-analysis,2019,,,Addiction - Cannabis
2019639,Cannabis use disorders may protect against certain disorders of the digestive organs in people with schizophrenia but not in healthy controls,https://www.ncbi.nlm.nih.gov/pubmed/30880659,Inconclusive,,Meta-analysis,2019,,,Addiction - Cannabis; Irritable Bowel Syndrome; Psychosis; Schizophrenia
2019640,Screen of drug use: Diagnostic accuracy for cannabis use disorder,https://www.ncbi.nlm.nih.gov/pubmed/30933714,Inconclusive,,Meta-analysis,2019,,,Addiction - Cannabis
2019641,Feasibility and effects of galantamine on cognition in humans with cannabis use disorder,https://www.ncbi.nlm.nih.gov/pubmed/31082417,Inconclusive,,Double Blind Clinical Trial,2019,,,Addiction - Cannabis; Cannabis Adverse Effects
2019642,"Big Five personality traits and alcohol, nicotine, cannabis, and gambling disorder comorbidity",https://www.ncbi.nlm.nih.gov/pubmed/31094546,Inconclusive,,Meta-analysis,2019,,,Addiction - Alcohol; Addiction - Cannabis; Addiction - Nicotine
2019643,Cannabis use disorder and suicide attempts in bipolar disorder: A meta-analysis,https://www.ncbi.nlm.nih.gov/pubmed/31121199,Inconclusive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction; Bipolar Disorder; Suicide Attempt; Cannabis Adverse Effects
2019644,Cannabis Use Disorder and Epilepsy: A Cross-National Analysis of 657 072 Hospitalized Patients,https://www.ncbi.nlm.nih.gov/pubmed/31124592,Inconclusive,,Meta-analysis,2019,,Nervous System,Epilepsy; Addiction - Cannabis
2019645,Threat Responsiveness as a Function of Cannabis and Alcohol Use Disorder Severity,https://www.ncbi.nlm.nih.gov/pubmed/31170004,Inconclusive,,Meta-analysis,2019,,,Addiction - Alcohol; Addiction - Cannabis
2019646,Genome-wide association study implicates CHRNA2 in cannabis use disorder,https://www.ncbi.nlm.nih.gov/pubmed/31209380,Inconclusive,,Meta-analysis,2019,,,Addiction - Cannabis
2019647,Individualized assessment and treatment program (IATP) for cannabis use disorder: Randomized controlled trial with and without contingency management,https://www.ncbi.nlm.nih.gov/pubmed/31318225,Inconclusive,,Clinical Trial,2019,,Mental/Emotional System,Addiction - Cannabis; Addiction
2019648,Guanfacine extended-release for cannabis use disorder: a pilot feasibility trial,https://www.ncbi.nlm.nih.gov/pubmed/31339797,Inconclusive,,Clinical Trial,2019,,Mental/Emotional System,Addiction - Cannabis; Addiction
2019649,Pharmacotherapies for Cannabis Use Disorders: Clinical Challenges and Promising Therapeutic Agents,https://www.ncbi.nlm.nih.gov/pubmed/31375922,Inconclusive,,Meta-analysis,2019,Fatty Acid Amide Hydrolase (FAAH),,
2019650,Longitudinal Alterations in Prefrontal Resting Brain Connectivity in Non-Treatment-Seeking Young Adults With Cannabis Use Disorder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6670783/,Negative,,Meta-analysis,2019,,,Cannabis Adverse Effects; Cognitive Dysfunction
1994004,The trypanocidal effect of Cannabis sativa constituents in experimental animal trypanosomiasis,https://www.ncbi.nlm.nih.gov/pubmed/7900270,Positive,,Animal Study,1994,,Cardiovascular System,Chagas Disease
2019651,"Heavy cannabis use, dependence and the brain: a clinical perspective",https://www.ncbi.nlm.nih.gov/pubmed/31408248,Inconclusive,,Meta-analysis,2019,Tetrahydrocannabinol (THC),,Addiction - Cannabis; Neurodegenerative Issues
2019652,Use of Guanfacine for Cannabis Use Disorder and Related Symptomology,https://www.ncbi.nlm.nih.gov/pubmed/31483544,Inconclusive,,Clinical Trial,2019,,Mental/Emotional System,Addiction - Cannabis; Addiction
2019653,Decreased drinking in adults with co-occurring cannabis and alcohol use disorders in a treatment trial for marijuana dependence: Evidence of a secondary benefit?,https://www.ncbi.nlm.nih.gov/pubmed/31487577,Positive,,Meta-analysis,2019,,Mental/Emotional System,Addiction - Alcohol; Addiction - Cannabis; Addiction
2019654,Cannabis use disorders among adults in the United States during a time of increasing use of cannabis,https://www.ncbi.nlm.nih.gov/pubmed/31586809,Inconclusive,,Meta-analysis,2019,,,Addiction - Cannabis
2019655,"Attentional bias, craving and cannabis use in an inpatient sample of adolescents and young adults diagnosed with cannabis use disorder: The moderating role of cognitive control",https://www.ncbi.nlm.nih.gov/pubmed/31605838,Inconclusive,,Meta-analysis,2019,,,Addiction - Cannabis
2019656,Characterising heterogeneity in the use of different cannabis products: latent class analysis with 55 000 people who use cannabis and associations with severity of cannabis dependence,https://www.ncbi.nlm.nih.gov/pubmed/31607281,Negative,,Meta-analysis,2019,,,Addiction - Cannabis
2019657,Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder,https://www.ncbi.nlm.nih.gov/pubmed/30530238,Inconclusive,,Meta-analysis,2019,,,Addiction - Cannabis
2019658,Pharmacotherapies for cannabis dependence,https://www.ncbi.nlm.nih.gov/pubmed/30687936,Inconclusive,,Meta-analysis,2019,,,Addiction - Cannabis
2019659,Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders,https://www.ncbi.nlm.nih.gov/pubmed/31549358,Positive,,Meta-analysis,2019,AM-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Tetrahydrocannabivarin (THCV); Pharma THC,,Addiction - Cannabis; Addiction - Opioid
2019660,"Burden of Persistent Vomiting With Cannabis Use Disorder: Report From 55,549 Hospitalizations in the United States",https://www.ncbi.nlm.nih.gov/pubmed/31405569,Negative,,Meta-analysis,2019,,Nervous System,Cannabis Hyperemesis Syndrome; Addiction - Cannabis; Nausea and Vomiting
2019661,Rising Trends in Hospitalizations for Cardiovascular Events among Young Cannabis Users (18–39 Years) without Other Substance Abuse,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723728/,Negative,,Meta-analysis,2019,,,Cannabis Adverse Effects; Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Heart Attack; Stroke
2019662,Cannabis Inhalation and Voice Disorders: A Systematic Review,https://www.ncbi.nlm.nih.gov/pubmed/31393535,Negative,,Meta-analysis,2019,,,Cannabis Adverse Effects; Fibrosis - Lung; Fibrosis
2019663,"Cannabis intoxication after accidental ingestion in infants: urine and plasma concentrations of Δ-9-tetrahydrocannabinol (THC), THC-COOH and 11-OH-THC in 10 patients",https://www.ncbi.nlm.nih.gov/pubmed/31441354,Inconclusive,,Meta-analysis,2019,,,Cannabis Adverse Effects
2019664,Cannabis Use as a Risk Factor for Takotsubo (Stress) Cardiomyopathy: Exploring the Evidence from Brain-Heart Link,https://www.ncbi.nlm.nih.gov/pubmed/31473817,Negative,,Meta-analysis,2019,,Cardiovascular System,Cardiovascular Diseases (CVD); Cannabis Adverse Effects
2019665,Recurrent Cardiogenic Shock Associated with Cannabis Use: Report of a Case and Review of the Literature,https://www.ncbi.nlm.nih.gov/pubmed/30638971,Negative,,Meta-analysis,2019,,,Cannabis Adverse Effects
2019666,Acute cannabis toxicity,https://www.ncbi.nlm.nih.gov/pubmed/30676820,Negative,,Meta-analysis,2019,,,Cannabis Adverse Effects
2019667,Cannabinoid toxicity in pediatrics,https://www.ncbi.nlm.nih.gov/pubmed/30694824,Negative,,Meta-analysis,2019,,,Anxiety; Cannabis Adverse Effects; Cannabis Hyperemesis Syndrome; Cognitive Dysfunction
2019668,Positive and Negative Effects of Cannabis and Cannabinoids on Health,https://www.ncbi.nlm.nih.gov/pubmed/30703255,Inconclusive,,Meta-analysis,2019,,,Cannabis Adverse Effects; Cognitive Dysfunction; Schizophrenia
2019669,"Syndromic Surveillance of Emergency Department Visits for Acute Adverse Effects of Marijuana, Tri-County Health Department, Colorado, 2016-2017",https://www.ncbi.nlm.nih.gov/pubmed/30721641,Inconclusive,,Meta-analysis,2019,,,Cannabis Adverse Effects
2019670,Joint effects of stress and chronic cannabis use on prospective memory,https://www.ncbi.nlm.nih.gov/pubmed/30762090,Inconclusive,,Meta-analysis,2019,,,Cannabis Adverse Effects; Cognitive Dysfunction; Oxidative Stress
2019671,Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders,https://www.ncbi.nlm.nih.gov/pubmed/30793421,Negative,,Meta-analysis,2019,,,Neurodegenerative Issues; Schizophrenia
2019672,A meta-analytic investigation of the associations between cannabis use and cannabis-related negative consequences,https://www.ncbi.nlm.nih.gov/pubmed/30843713,Negative,,Meta-analysis,2019,,,Cannabis Adverse Effects
2019673,Cannabis as a cause of death: A review,https://www.ncbi.nlm.nih.gov/pubmed/30925348,Negative,,Meta-analysis,2019,,,Cannabis Adverse Effects
2019674,Unilateral cilioretinal artery occlusion following cannabis use,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437321/,Negative,,Meta-analysis,2019,,,Cannabis Adverse Effects
2019675,Cannabidiol Adverse Effects and Toxicity,https://www.ncbi.nlm.nih.gov/pubmed/31161980,Negative,,Meta-analysis,2019,,,Cannabis Adverse Effects; Insomnia and Sleep Disorders; Nausea and Vomiting
2019676,Adverse Effects of Cannabis Use on Neurocognitive Functioning: A Systematic Review of Meta- Analytic Studies,https://www.ncbi.nlm.nih.gov/pubmed/31232216,Negative,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects; Behavioral Disorders; Neurodegenerative Issues
2019677,Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678684/,Negative,,Meta-analysis,2019,,,Bacterial Infections; Cachexia; Cannabis Adverse Effects; Insomnia and Sleep Disorders
2019678,Cannabis use is associated with potentially heritable widespread changes in autism candidate gene DLGAP2 DNA methylation in sperm,https://www.ncbi.nlm.nih.gov/pubmed/31451081,Negative,,Laboratory Study,2019,,Mental/Emotional System; Nervous System,Autism; Cannabis Adverse Effects
2019679,Adolescent-onset heavy cannabis use associated with significantly reduced glial but not neuronal markers and glutamate levels in the hippocampus,https://www.ncbi.nlm.nih.gov/pubmed/31478302,Negative,,Meta-analysis,2019,,,Behavioral Disorders; Anxiety; Cannabis Adverse Effects
2019680,The Risk of Cardiovascular Events on Cannabis' Highest Day,https://www.ncbi.nlm.nih.gov/pubmed/31542258,Inconclusive,,Meta-analysis,2019,,,Cannabis Adverse Effects; Cardiovascular Diseases (CVD)
2019681,An overview of the adverse effects of cannabis use for Canadian physicians,https://www.ncbi.nlm.nih.gov/pubmed/31563157,Negative,,Meta-analysis,2019,,,Anxiety; Cannabis Adverse Effects; Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Schizophrenia
2019682,Marijuana and Cardiac Arrhythmias: A Scoping Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6774643/,Negative,,Meta-analysis,2019,,Cardiovascular System,Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Atrial Fibrillation; Cannabis Adverse Effects
2019683,Hepatotoxicity of a Cannabidiol-Rich Cannabis Extract in the Mouse Model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539990/,Negative,,Animal Study,2019,,,Cannabis Adverse Effects; Liver Failure
2019684,Marijuana-induced Coronary Vasospasm with Persistent Inter-coronary Connection: A Case Report and Review of Literature,https://pubmed.ncbi.nlm.nih.gov/31497413/,Inconclusive,,Meta-analysis,2019,,,Cannabis Adverse Effects
2019685,An Integrated Review of Cannabis and Cannabinoids in Adult Oncologic Pain Management,https://www.ncbi.nlm.nih.gov/pubmed/30527857,Positive,,Meta-analysis,2019,,,Pain; Pain - Cancer
2019686,Cannabis for cancer - illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology,https://www.ncbi.nlm.nih.gov/pubmed/30572744,Positive,,Meta-analysis,2019,,,Anorexia; Anxiety; Pain; Nausea and Vomiting; Pain - Cancer
2019687,"A Comprehensive Review of Cannabis in Patients with Cancer: Availability in the USA, General Efficacy, and Safety",https://www.ncbi.nlm.nih.gov/pubmed/30707319,Inconclusive,,Meta-analysis,2019,Pharma CBD,Nervous System,Cancer; Epilepsy - Lennox-Gastaut; Epilepsy; Pain; Pain - Cancer
2013117,Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists,https://www.ncbi.nlm.nih.gov/pubmed/23463621,Positive,,Laboratory Study,2013,Synthetic Cannabinoid (unspecified),Endocrine System; Nervous System,Cancer - Pancreatic; Cancer
2019688,Naturally occurring compounds as pancreatic cancer therapeutic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226042/,Positive,,Meta-analysis,2019,,Endocrine System; Nervous System,Cancer - Pancreatic; Cancer; Insomnia and Sleep Disorders; Pain; Pain - Cancer; Pain - Neuropathy - Drug-Ind. Polyneuropathy
2018298,Cannabidiol regulates behavioural alterations and gene expression changes induced by spontaneous cannabinoid withdrawal,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003647/,Positive,,Animal Study,2018,CP-x Synthetic Cannabinoids,,
2019689,Cannabinoids: a new approach for pain control?,https://www.ncbi.nlm.nih.gov/pubmed/30789867,Positive,,Meta-analysis,2019,,,Pain; Pain - Cancer
2019690,Impact of Medical Cannabis on Patient-Reported Symptoms for Patients With Cancer Enrolled in Minnesota's Medical Cannabis Program,https://www.ncbi.nlm.nih.gov/pubmed/30860938,Positive,,Meta-analysis,2019,,Nervous System,Cancer; Pain; Nausea and Vomiting
2019691,Patterns of Medical Cannabis Use among Cancer Patients from a Medical Cannabis Dispensary in New York State,https://www.ncbi.nlm.nih.gov/pubmed/30909786,Inconclusive,,Meta-analysis,2019,,Nervous System,Cancer; Pain; Pain - Acute; Pain - Chronic
2019692,Using Cannabis to Treat Cancer-Related Pain,https://www.ncbi.nlm.nih.gov/pubmed/31053395,Positive,,Meta-analysis,2019,,Nervous System,Cancer; Pain; Pain - Cancer
2019693,"Efficacy, tolerability and safety of cannabis-based medicines for cancer pain : A systematic review with meta-analysis of randomized controlled trials",https://www.ncbi.nlm.nih.gov/pubmed/31073761,Inconclusive,,Clinical Meta-analysis,2019,Pharma THC,Nervous System,Pain; Pain - Cancer; Addiction - Opioid
2019694,Potential Use of Cannabinoids for the Treatment of Pancreatic Cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352507/,Positive,,Meta-analysis,2019,AM-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH); JWH-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Endocrine System; Nervous System,Cancer - Pancreatic; Cancer
2019695,New Prospect for Cancer Cachexia: Medical Cannabinoid,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360413/,Positive,,Meta-analysis,2019,Pharma THC,Digestive System; Muscular System,Cachexia
2019696,Chemotherapy‐induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711413/,Positive,,Animal Study,2019,Cannabigerol (CBG),Digestive System; Muscular System,Cachexia; Anorexia; Chemotherapy-induced Nausea & Vomiting; Loss of Appetite; Metabolic Syndrome
2019697,Medical Cannabinoids for Cancer Cachexia: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612387/,Positive,,Meta-analysis,2019,,Digestive System; Muscular System; Nervous System,Cachexia; Cancer; Anorexia Nervosa; Anorexia; Diabetes; HIV/AIDS; Metabolic Syndrome; Pain; Multiple Sclerosis; Nausea and Vomiting; Obesity
2019698,The Effects of Dosage-Controlled Cannabis Capsules on Cancer-Related Cachexia and Anorexia Syndrome in Advanced Cancer Patients: Pilot Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785913/,Positive,,Clinical Trial,2019,Tetrahydrocannabinol (THC),Digestive System; Muscular System,Anorexia; Cachexia; Cancer; Pain
2019699,Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139213/,Positive,,Laboratory Study,2019,,Nervous System,Cancer; Cancer - Brain; Cancer - Breast
2019700,Therapeutic targeting of HER2–CB2R heteromers in HER2-positive breast cancer,https://www.pnas.org/content/116/9/3863,Positive,,Animal Study,2019,,Nervous System; Reproductive System,Cancer - Breast; Cancer
2019701,Enhancing Breast Cancer Treatment Using a Combination of Cannabidiol and Gold Nanoparticles for Photodynamic Therapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801525/,Positive,,Meta-analysis,2019,,Nervous System; Reproductive System,Cancer - Breast; Cancer
2019702,Future Aspects for Cannabinoids in Breast Cancer Therapy,https://www.researchgate.net/publication/332188002_Future_Aspects_for_Cannabinoids_in_Breast_Cancer_Therapy,Positive,,Meta-analysis,2019,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Cannabidiolic Acid (CBD-a); Cannabigerol (CBG); Cannabinol (CBN); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); O-x Synthetic Cannabinoids; Pharma THC:CBD; Tetrahydrocannabivarin (THCV); Pharma THC; Tetrahydrocannabinolic Acid (THC-a); WIN-x Synthetic Cannabinoids,Nervous System; Reproductive System,Cancer - Breast; Cancer
2019703,The onus of cannabinoids in interrupting the molecular odyssey of breast cancer: A critical perspective on UPRER and beyond,https://www.sciencedirect.com/science/article/pii/S1319016419300064,Positive,,Meta-analysis,2019,Endocannabinoid (unspecified); Pharma THC; Synthetic Cannabinoid (unspecified),Nervous System; Reproductive System,Cancer - Breast; Cancer
2019704,Concomitant Treatment of Malignant Brain Tumours With CBD - A Case Series and Review of the Literature,https://www.ncbi.nlm.nih.gov/pubmed/31570484,Positive,,Clinical Trial,2019,,,Cancer - Brain; Cancer
2017202,Heavy Cannabis Use Is Associated With Low Bone Mineral Density and an Increased Risk of Fractures,https://www.ncbi.nlm.nih.gov/pubmed/27593602,Negative,,Meta-analysis,2017,,Skeletal System,Bone Fractures
2017203,Emerging therapeutic targets in cancer induced bone disease: A focus on the peripheral type 2 cannabinoid receptor,https://www.ncbi.nlm.nih.gov/pubmed/28274851,Positive,,Meta-analysis,2017,,Nervous System; Skeletal System,Cancer - Bone; Cancer - Metastatic; Cancer
2015168,Regulation of inflammation and proliferation of human bladder carcinoma cells by type-1 and type-2 cannabinoid receptors,https://www.ncbi.nlm.nih.gov/pubmed/25445433/,Inconclusive,,Laboratory Study,2015,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids,Nervous System; Urinary System,Cancer - Bladder; Cancer
2019705,Systematic review of the potential role of cannabinoids as antiproliferative agents for urological cancers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434502/,Inconclusive,,Meta-analysis,2019,2-Arachidonoyl Glycerol (2-AG),Nervous System; Reproductive System; Urinary System,Cancer - Kidney; Cancer - Bladder; Cancer - Prostate; Cancer - Testicular; Cancer; Cancer - Brain; Cancer - Breast
2019706,"The Relationship between Cannabis and Male Infertility, Sexual Health, and Neoplasm: a Systematic Review",https://www.ncbi.nlm.nih.gov/pubmed/30767424,Inconclusive,,Meta-analysis,2019,,Endocrine System; Reproductive System,Cancer; Infertility (Male); Libido; Cancer - Bladder; Cancer - Prostate; Cancer - Testicular; Erectile Dysfunction
2018299,"Cortical thickness, cortical surface area and subcortical volumes in schizophrenia and bipolar disorder patients with cannabis use",https://www.ncbi.nlm.nih.gov/pubmed/29254657,Negative,,Meta-analysis,2018,,Mental/Emotional System; Nervous System,Bipolar Disorder; Schizophrenia
2019707,Cannabis and Mood Disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329464/,Inconclusive,,Meta-analysis,2019,,,Bipolar Disorder; Depression
2019708,Patterns of cannabis use and clinical correlates among individuals with Major Depressive Disorder and Bipolar Disorder,https://www.ncbi.nlm.nih.gov/pubmed/29069624,Inconclusive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Bipolar Disorder; Depression
2019709,Bipolar disorder and the endocannabinoid system,https://www.ncbi.nlm.nih.gov/pubmed/31159897,Positive,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Bipolar Disorder
2019710,The prevalence and clinical correlates of cannabis use and cannabis use disorder among patients with bipolar disorder: A systematic review with meta-analysis and meta-regression,https://www.ncbi.nlm.nih.gov/pubmed/30974123,Negative,,Meta-analysis,2019,,Mental/Emotional System; Nervous System,Bipolar Disorder
2019711,"Antimicrobial activity of Cannabis sativa, Thuja orientalis and Psidium guajava leaf extracts against methicillin-resistant Staphylococcus aureus",https://www.ncbi.nlm.nih.gov/pubmed/30120078,Positive,,Laboratory Study,2019,,Immune System,Bacterial Infections
2019712,Biologically Active Cannabinoids from High-Potency Cannabis sativa,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886613/,Positive,,Laboratory Study,2019,,,Bacterial Infections; Fungal Infections; Leishmaniasis; Malaria
2019713,Lower circulating endocannabinoid levels in children with autism spectrum disorder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354384/,Inconclusive,,Meta-analysis,2019,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Other Related Compounds; Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Mental/Emotional System; Nervous System,Autism
2019714,Effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784992/,Inconclusive,,Double Blind Clinical Trial,2019,,Mental/Emotional System; Nervous System,Autism
2019715,Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems-A Retrospective Feasibility Study,https://www.ncbi.nlm.nih.gov/pubmed/30382443,Positive,,Clinical Trial,2019,,Mental/Emotional System; Nervous System,Behavioral Disorders; Autism
2019716,The effect of cannabidiol (CBD) on low-frequency activity and functional connectivity in the brain of adults with and without autism spectrum disorder (ASD),https://journals.sagepub.com/doi/10.1177/0269881119858306#articleCitationDownloadContainer,Positive,,Double Blind Clinical Trial,2019,,Mental/Emotional System; Nervous System,Autism
2019717,Translating Endocannabinoid Biology into Clinical Practice: Cannabidiol for Stroke Prevention,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665427/,Positive,,Meta-analysis,2019,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Nervous System,Stroke; Atherosclerosis; Cardiovascular Diseases (CVD); Metabolic Syndrome; Obesity
2019718,The Cardiovascular Effects of Marijuana: Are the Potential Adverse Effects Worth the High?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461323/,Negative,,Meta-analysis,2019,,,Atherosclerosis; Cardiovascular Diseases (CVD)
2019719,Indoor cannabis smoke and children's health,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441784/,Negative,,Meta-analysis,2019,,,Asthma; Cough; Eczema
2019720,"Regular cannabis use, with and without tobacco co-use, is associated with respiratory disease",https://www.ncbi.nlm.nih.gov/pubmed/31557578,Negative,,Meta-analysis,2019,,Respiratory System,Asthma; COPD
2019721,A longitudinal study of cannabis use increasing the use of asthma medication in young Norwegian adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390535/,Positive,,Meta-analysis,2019,,Respiratory System,Asthma
2019722,Cannabinoid Regulation of Fear and Anxiety: an Update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486906/,Positive,,Meta-analysis,2019,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Mental/Emotional System; Nervous System,Anxiety
2019723,Reduction of Benzodiazepine Use in Patients Prescribed Medical Cannabis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757237/,Positive,,Meta-analysis,2019,,Mental/Emotional System,Addiction - Benzodiazepine; Addiction; Anxiety; Oxidative Stress
2017204,The Impact of Δ9-THC on the Psychological Symptoms of Anorexia Nervosa: A Pilot Study,https://www.ncbi.nlm.nih.gov/pubmed/29735812,Positive,,Clinical Trial,2017,Tetrahydrocannabinol (THC),Mental/Emotional System,Anorexia Nervosa; Anorexia
2019724,Can we turn mice into men?: An Editorial for Effects of cannabinoids in Amyotrophic Lateral Sclerosis (ALS) murine models: a systematic review and meta-analysis page 284.,https://www.ncbi.nlm.nih.gov/pubmed/30982996,Positive,,Meta-analysis,2019,,Nervous System,Amyotrophic Lateral Sclerosis (ALS)
2019725,Medical Cannabis in Treatment of Resistant Familial Mediterranean Fever,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753661/,Positive,,Meta-analysis,2019,,Digestive System,Familial Mediterranean Fever; Fever
2018300,Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295937/,Positive,,Animal Study,2018,Tetrahydrocannabinol (THC),Nervous System,Glaucoma
2019726,Cannabidiol Reverses Deficits in Hippocampal LTP in a Model of Alzheimer’s Disease,https://pubmed.ncbi.nlm.nih.gov/29574668/,Positive,,Laboratory Study,2019,,Nervous System,Alzheimer's Disease
2019727,Prescription of a THC/CBD-Based Medication to Patients with Dementia: A Pilot Study in Geneva,https://www.researchgate.net/publication/332213446_Prescription_of_a_THCCBD-Based_Medication_to_Patients_with_Dementia_A_Pilot_Study_in_Geneva,Positive,,Clinical Trial,2019,,Nervous System,Dementia; Neurodegenerative Issues; Alzheimer's Disease; Cognitive Dysfunction
2019728,Safety and effectiveness of cannabinoids for the treatment of neuropsychiatric symptoms in dementia: a systematic review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535742/,Positive,,Meta-analysis,2019,Pharma THC,Nervous System,Neurodegenerative Issues
2017205,"Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury",https://www.researchgate.net/publication/319965199_Cannabidiol_attenuates_alcohol-induced_liver_steatosis_metabolic_dysregulation_inflammation_and_neutrophil-mediated_injury,Positive,,Animal Study,2017,,Digestive System; Nervous System,Alcoholic Liver Disease; Inflammation; Fatty Liver Disease; Metabolic Syndrome; Oxidative Stress
2019729,Use of Cannabis in Gastroenterological and Hepatic Disorders,https://academic.oup.com/jcag/article/2/1/37/5166404,Inconclusive,,Meta-analysis,2019,,,Alcoholic Liver Disease; Anorexia; Cannabis Hyperemesis Syndrome; Fatty Liver Disease; IBD - Crohn's Disease; Nausea and Vomiting
2019730,The sesquiterpene beta-caryophyllene oxide attenuates ethanol drinking and place conditioning in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581871/,Positive,,Animal Study,2019,AM-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction
2003033,Lack of analgesic efficacy of oral delta-9-tetrahydrocannabinol in postoperative pain.,https://pubmed.ncbi.nlm.nih.gov/14581124/,Inconclusive,,Double Blind Clinical Trial,2003,Tetrahydrocannabinol (THC),,Pain; Pain - Acute
1981008,Evaluation of intramuscular levonantradol and placebo in acute postoperative pain.,https://pubmed.ncbi.nlm.nih.gov/7028791/,Positive,,Double Blind Clinical Trial,1981,Pharma THC; Synthetic Cannabinoid (unspecified); Tetrahydrocannabinol (THC),Nervous System,Pain; Pain - Acute
1977005,Effects of intravenous tetrahydrocannabinol on experimental and surgical pain. Psychological correlates of the analgesic response.,https://www.ncbi.nlm.nih.gov/pubmed/832447,Inconclusive,,Double Blind Clinical Trial,1977,,Immune System; Integumentary System; Nervous System,Pain; Pain - Acute; Wound Healing; Ehlers-Danlos Syndrome
2019731,Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429381/,Positive,,Meta-analysis,2019,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Cannabigerol (CBG); Fatty Acid Amide Hydrolase (FAAH); JWH-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); O-x Synthetic Cannabinoids; Other Related Compounds; Pharma THC:CBD; Tetrahydrocannabivarin (THCV); WIN-x Synthetic Cannabinoids,Integumentary System,Skin Diseases; Abnormal Hair Growth; Acne; Cancer - Melanoma; Cancer - Skin (Non-melanoma); Cancer; Hair Loss; Psoriasis; Seborrhea
2018301,"Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver.",https://www.ncbi.nlm.nih.gov/pubmed/30301768,Positive,,Animal Study,2018,Monoacylglycerol Lipase (MAGL),Digestive System,Fibrosis - Liver (Cirrhosis); Fibrosis
2019732,Upregulation of Anandamide Hydrolysis in the Basolateral Complex of Amygdala Reduces Fear Memory Expression and Indices of Stress and Anxiety.,https://www.ncbi.nlm.nih.gov/pubmed/30573646,Positive,,Animal Study,2019,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Other Related Compounds,Mental/Emotional System; Nervous System,Anxiety
2019733,Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks.,https://www.ncbi.nlm.nih.gov/pubmed/30677422,Positive,,Animal Study,2019,Monoacylglycerol Lipase (MAGL); 2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); JWH-x Synthetic Cannabinoids; Other Related Compounds; Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Anxiety
2018302,Role of the endocannabinoid system in neurological disorders.,https://www.sciencedirect.com/science/article/abs/pii/S0736574818302995,Positive,,Meta-analysis,2018,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Other Related Compounds,Mental/Emotional System,Autism
2008090,Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma.,https://www.ncbi.nlm.nih.gov/pubmed/18197164,Positive,,Laboratory Study,2008,JWH-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Endocrine System,Cancer - Thyroid; Cancer
2010094,"A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis.",https://www.ncbi.nlm.nih.gov/pubmed/19189054,Positive,,Laboratory Study,2010,Anandamide (AEA); Endocannabinoid (unspecified),Endocrine System; Nervous System,Cancer - Thyroid; Cancer
2019734,Role of miRNA in the regulation of cannabidiol-mediated apoptosis in neuroblastoma cells.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343753/,Positive,,Laboratory Study,2019,,Nervous System,Cancer - Neuroblastoma; Cancer
2018303,Survey Results of Pain Treatments in Adults with Cerebral Palsy.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3036542/,Positive,,Meta-analysis,2018,,,Cerebral Palsy
2008091,Glial expression of cannabinoid CB(2) receptors and fatty acid amide hydrolase are beta amyloid-linked events in Down's syndrome.,https://www.ncbi.nlm.nih.gov/pubmed/18068305/,Positive,,Laboratory Study,2008,Fatty Acid Amide Hydrolase (FAAH),Nervous System,Down Syndrome
2015169,AM251 induces apoptosis and G2/M cell cycle arrest in A375 human melanoma cells.,https://www.ncbi.nlm.nih.gov/pubmed/25974027,Positive,,Laboratory Study,2015,AM-x Synthetic Cannabinoids,Integumentary System,Cancer - Melanoma; Cancer
2018304,Identification of Synergistic Interaction Between Cannabis-Derived Compounds for Cytotoxic Activity in Colorectal Cancer Cell Lines and Colon Polyps That Induces Apoptosis-Related Cell Death and Distinct Gene Expression,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038055/,Positive,,Laboratory Study,2018,Cannabidiolic Acid (CBD-a); Cannabigerolic Acid (CBG-a); Tetrahydrocannabinol (THC); Tetrahydrocannabinolic Acid (THC-a); Cannabigerol (CBG),Digestive System; Nervous System,Cancer - Colon; Cancer
2014142,"Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid.",https://www.ncbi.nlm.nih.gov/pubmed/25269802,Positive,,Animal Study,2014,Cannabigerol (CBG),Digestive System,Cancer - Colon; Cancer
2014143,Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol.,https://www.ncbi.nlm.nih.gov/pubmed/24373545,Positive,,Laboratory Study,2014,,Digestive System; Nervous System,Cancer - Colon; Cancer
2018305,"Case Report: Clinical Outcome and Image Response of Two Patients With Secondary High-Grade Glioma Treated With Chemoradiation, PCV, and Cannabidiol",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345719/,Positive,,Meta-analysis,2018,,Nervous System,Cancer - Brain; Cancer
2007060,"Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users.",https://link.springer.com/article/10.1007/s00702-007-0715-7#citeas,Positive,,Meta-analysis,2007,,,MDMA Adverse Effects; Oxidative Stress
2005047,Ecstasy/MDMA and cannabis: The complexities of their interactive neuropsychobiological effects,https://www.researchgate.net/publication/8144850_EcstasyMDMA_and_cannabis_The_complexities_of_their_interactive_neuropsychobiological_effects,Positive,,Meta-analysis,2005,,Nervous System,MDMA Adverse Effects
2017206,Topical Medical Cannabis: A New Treatment for Wound Pain—Three Cases of Pyoderma Gangrenosum,https://www.jpsmjournal.com/article/S0885-3924(17)30351-2/fulltext,Positive,,Clinical Trial,2017,Tetrahydrocannabinol (THC),Integumentary System,Gangrene; Wound Healing
2014144,Protective effects of geraniol (a monoterpene) in a diabetic neuropathy rat model: attenuation of behavioral impairments and biochemical perturbations,https://www.ncbi.nlm.nih.gov/pubmed/24752916,Positive,,Animal Study,2014,,Endocrine System; Mental/Emotional System; Nervous System,Behavioral Disorders; Diabetes; Pain - Neuropathy - Diabetic; Inflammation; Neurodegenerative Issues; Oxidative Stress
2015170,Geraniol attenuates fibrosis and exerts anti-inflammatory effects on diet induced atherogenesis by NF-κB signaling pathway.,https://www.ncbi.nlm.nih.gov/pubmed/26004525,Positive,,Animal Study,2015,,Cardiovascular System,Atherosclerosis; Cardiovascular Diseases (CVD)
2001025,"Geraniol, a Component of Plant Essential Oils, Inhibits Growth and Polyamine Biosynthesis in Human Colon Cancer Cells",https://www.ncbi.nlm.nih.gov/pubmed/11408542,Positive,,Laboratory Study,2001,,Digestive System,Cancer - Colon; Cancer
2016204,The antitumor effects of geraniol: Modulation of cancer hallmark pathways,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809657/,Positive,,Meta-analysis,2016,,,Cancer; Cancer - Colon; Cancer - Breast; Cancer - Liver; Cancer - Lung; Cancer - Pancreatic; Cancer - Prostate
2009083,Preventive and therapeutic anti-inflammatory properties of the sesquiterpene α-humulene in experimental airways allergic inflammation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785529/,Positive,,Laboratory Study,2009,,Respiratory System,Asthma
2007061,Anti-inflammatory effects of compounds alpha-humulene and (-)-trans-caryophyllene isolated from the essential oil of Cordia verbenacea.,https://www.ncbi.nlm.nih.gov/pubmed/17559833,Positive,,Animal Study,2007,,,Inflammation
2003034,Antitumor activity of balsam fir oil: production of reactive oxygen species induced by alpha-humulene as possible mechanism of action.,https://www.ncbi.nlm.nih.gov/pubmed/12802719,Positive,,Laboratory Study,2003,,,Cancer
2010095,Anti-inflammatory effects of limonene from yuzu (Citrus junos Tanaka) essential oil on eosinophils.,https://www.ncbi.nlm.nih.gov/pubmed/20492298,Positive,,Laboratory Study,2010,,Nervous System; Respiratory System,Asthma; Inflammation
2014145,Skin repair properties of d-Limonene and perillyl alcohol in murine models.,https://www.ncbi.nlm.nih.gov/pubmed/24160248,Positive,,Laboratory Study,2014,,,Allergic Contact Dermatitis; Eczema; Psoriasis; Skin Diseases
2012136,"D-Limonene modulates inflammation, oxidative stress and Ras-ERK pathway to inhibit murine skin tumorigenesis.",https://www.ncbi.nlm.nih.gov/pubmed/22318307,Positive,,Animal Study,2012,,Integumentary System; Nervous System,Cancer - Skin (Non-melanoma); Inflammation; Oxidative Stress; Cancer - Melanoma; Cancer
2014146,Plasma metabolomic profiles of breast cancer patients after short-term limonene intervention.,https://www.ncbi.nlm.nih.gov/pubmed/25388013,Positive,,Laboratory Study,2014,,Nervous System; Reproductive System,Cancer - Breast; Cancer
2006037,Involvement of adenosine A1 and A2A receptors in (-)-linalool-induced antinociception.,https://www.ncbi.nlm.nih.gov/pubmed/16343551,Positive,,Laboratory Study,2006,,Nervous System,Pain
2010096,Linalool blocks excitability in peripheral nerves and voltage-dependent Na+ current in dissociated dorsal root ganglia neurons,https://www.sciencedirect.com/science/article/pii/S0014299910007119,Positive,,Laboratory Study,2010,,Nervous System,Pain
2000014,Linalool modifies the nicotinic receptor-ion channel kinetics at the mouse neuromuscular junction.,https://www.ncbi.nlm.nih.gov/pubmed/10887049,Positive,,Animal Study,2000,,Mental/Emotional System,Addiction - Nicotine; Addiction; Alzheimer's Disease
2009084,Stress Repression in Restrained Rats by (R)-(−)-Linalool Inhalation and Gene Expression Profiling of Their Whole Blood Cells,https://pubs.acs.org/doi/abs/10.1021/jf900420g?journalCode=jafcau,Positive,,Animal Study,2009,,,Anxiety
2012137,Antidepressant activity of Litsea glaucescens essential oil: Identification of β-pinene and linalool as active principles,https://www.sciencedirect.com/science/article/pii/S0378874112004953#f0020,Positive,,Laboratory Study,2012,Mind-Body Medicine,Mental/Emotional System; Nervous System,Depression; Anxiety; Diarrhea; Epilepsy; Grief and Bereavement; Insomnia and Sleep Disorders; Pain; Nausea and Vomiting; Pregnancy; PTSD
2018306,Bacteria colonising Penstemon digitalis show volatile and tissue-specific responses to a natural concentration range of the floral volatile linalool.,https://www.ncbi.nlm.nih.gov/pubmed/29540962,Positive,,Laboratory Study,2018,,Immune System,Bacterial Infections
2014147,Antitumor Activity of Monoterpenes Found in Essential Oils,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220615/,Positive,,Meta-analysis,2014,,Nervous System,Cancer
2015171,"Anti-invasive effect of β-myrcene, a component of the essential oil from Pinus koraiensis cones, in metastatic MDA-MB-231 human breast cancer cells",https://link.springer.com/article/10.1007/s13765-015-0081-3#page-1,Positive,,Laboratory Study,2015,,Nervous System; Reproductive System,Cancer - Breast; Cancer
2008092,"Protective effect of linalool, myrcene and eucalyptol against t-butyl hydroperoxide induced genotoxicity in bacteria and cultured human cells",https://www.sciencedirect.com/science/article/pii/S0278691508006492,Positive,,Laboratory Study,2008,,Nervous System,Oxidative Stress; Cancer
1991006,Myrcene mimics the peripheral analgesic activity of lemongrass tea,https://www.sciencedirect.com/science/article/pii/037887419190187I,Positive,,Laboratory Study,1991,,,Pain
2015172,"Evaluation of the anti-inflammatory, anti-catabolic and pro-anabolic effects of E-caryophyllene, myrcene and limonene in a cell model of osteoarthritis",https://www.sciencedirect.com/science/article/pii/S0014299915000412,Positive,,Animal Study,2015,,Skeletal System,Arthritis - Osteoarthritis; Arthritis
2013118,Antioxidant effects of nerolidol in mice hippocampus after open field test.,https://www.ncbi.nlm.nih.gov/pubmed/23765368,Positive,,Animal Study,2013,,Nervous System,Oxidative Stress; Anxiety; Neurodegenerative Issues
2006038,The effect of terpene concentrations on the skin penetration of diclofenac sodium.,https://www.ncbi.nlm.nih.gov/pubmed/17174049,Positive,,Laboratory Study,2006,,,Eczema; Psoriasis; Skin Diseases
2016205,Antimalarial activity of the terpene nerolidol.,https://www.ncbi.nlm.nih.gov/pubmed/27742206,Positive,,Animal Study,2016,,Immune System,Malaria
2016206,Assessment of anxiolytic effect of nerolidol in mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980937/,Positive,,Animal Study,2016,,Mental/Emotional System; Nervous System,Anxiety
2005048,Antileishmanial Activity of the Terpene Nerolidol,https://aac.asm.org/content/49/5/1679.long,Positive,,Laboratory Study,2005,,Immune System,Bacterial Infections
2007062,Antifungal effect of eugenol and nerolidol against Microsporum gypseum in a guinea pig model.,https://www.ncbi.nlm.nih.gov/pubmed/17202684,Positive,,Animal Study,2007,,Digestive System; Immune System; Integumentary System,Fungal Infections; Skin Diseases
2014148,Biological Activities and Composition of Ferulago carduchorum Essential Oil.,https://www.ncbi.nlm.nih.gov/pubmed/26114148,Positive,,Laboratory Study,2014,,Digestive System; Immune System; Integumentary System,Fungal Infections
2014149,"Chemical composition, antibacterial and antioxidant profile of essential oil from Murraya koenigii (L.) leaves",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104627/,Positive,,Laboratory Study,2014,,Immune System,Bacterial Infections
2004044,Anticonvulsant activity and chemical composition of Artemisia dracunculus L. essential oil.,https://www.ncbi.nlm.nih.gov/pubmed/15325732,Positive,,Laboratory Study,2004,,,Epilepsy - Lennox-Gastaut; Epilepsy
2013119,Antioxidative properties and inhibition of key enzymes relevant to type-2 diabetes and hypertension by essential oils from black pepper,https://www.ncbi.nlm.nih.gov/pubmed/24348547,Positive,,Laboratory Study,2013,,Cardiovascular System; Endocrine System,Cardiovascular Diseases (CVD); Diabetes; Hypertension (High Blood Pressure)
2014150,Chemical composition and anti-inflammation activity of essential oils from Citrus unshiu flower.,https://www.ncbi.nlm.nih.gov/pubmed/25026734,Positive,,Laboratory Study,2014,,Nervous System,Inflammation
2012138,Anticonvulsant effect of phytol in a pilocarpine model in mice,https://www.ncbi.nlm.nih.gov/pubmed/22750154,Positive,,Animal Study,2012,,,Epilepsy - Lennox-Gastaut; Epilepsy
2015173,Activation of Caspase-9/3 and Inhibition of Epithelial Mesenchymal Transition are Critically Involved in Antitumor Effect of Phytol in Hepatocellular Carcinoma Cells.,https://www.ncbi.nlm.nih.gov/pubmed/25892665,Positive,,Laboratory Study,2015,,Digestive System; Nervous System,Cancer - Liver; Cancer
2015174,Phytol Induces Apoptosis and ROS-Mediated Protective Autophagy in Human Gastric Adenocarcinoma AGS Cells,https://www.omicsonline.org/open-access/phytol-induces-apoptosis-and-rosmediated-protective-autophagy-in-humangastric-adenocarcinoma-ags-cells-2161-1009-1000211.php?aid=62502,Positive,,Laboratory Study,2015,,Digestive System,Cancer - Colon; Cancer - Liver; Cancer - Breast; Cancer - Lung; Cancer
2002035,"Prevention of vitamin A teratogenesis by phytol or phytanic acid results from reduced metabolism of retinol to the teratogenic metabolite, all-trans-retinoic acid.",https://www.ncbi.nlm.nih.gov/pubmed/11896294,Positive,,Laboratory Study,2002,,,Labor and Delivery Issues
2014151,Anxiolytic-like effects of phytol: Possible involvement of GABAergic transmission,https://www.sciencedirect.com/science/article/pii/S0006899313015308?via%3Dihub#s0010,Positive,,Animal Study,2014,,Mental/Emotional System; Nervous System,Anxiety; Oxidative Stress
2005049,Inhibition of Acetylcholinesterase Activity by Bicyclic Monoterpenoids,https://pubs.acs.org/doi/pdf/10.1021/jf040019b,Positive,,Laboratory Study,2005,,,Cognitive Dysfunction; Neurodegenerative Issues
2007063,"Inhibitory effect of b-pinene, a-pinene and eugenol on the growth of potential infectious endocarditis causing Gram-positive bacteria",http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-93322007000100015,Positive,,Laboratory Study,2007,,Immune System,Bacterial Infections
2011136,Comparative anti-infectious bronchitis virus (IBV) activity of (-)-pinene: effect on nucleocapsid (N) protein.,https://www.ncbi.nlm.nih.gov/pubmed/21350392,Positive,,Laboratory Study,2011,,Immune System,Bacterial Infections
2012139,Protective effects of alpha-pinene in mice with cerulein-induced acute pancreatitis,https://www.ncbi.nlm.nih.gov/pubmed/22982349,Positive,,Animal Study,2012,,Digestive System; Endocrine System,Pancreatitis
2016207,"α-Terpineol, a monoterpene alcohol, complexed with β-cyclodextrin exerts antihyperalgesic effect in animal model for fibromyalgia aided with docking study.",https://www.ncbi.nlm.nih.gov/pubmed/27231091,Positive,,Animal Study,2016,,Muscular System,Fibromyalgia
2011137,α-Terpineol reduces nociceptive behavior in mice.,https://www.tandfonline.com/doi/full/10.3109/13880209.2010.529616,Positive,,Animal Study,2011,,Nervous System,Pain
2015175,Genotoxic and oxidative damage potentials in human lymphocytes after exposure to terpinolene in vitro.,https://www.ncbi.nlm.nih.gov/pubmed/24590926,Positive,,Laboratory Study,2015,,Nervous System,Oxidative Stress
2013120,Anticancer and antioxidant properties of terpinolene in rat brain cells,https://www.ncbi.nlm.nih.gov/pubmed/24084350,Positive,,Laboratory Study,2013,,,Cancer - Brain; Cancer
2005050,Essential oil composition and antimicrobial activity of Diplotaenia damavandica.,http://www.znaturforsch.com/ac/v60c/s60c0821.pdf,Positive,,Laboratory Study,2005,,Immune System,Bacterial Infections
2005051,The monoterpene terpinolene from the oil of Pinus mugo L. in concert with alpha-tocopherol and beta-carotene effectively prevents oxidation of LDL.,https://www.ncbi.nlm.nih.gov/pubmed/16008117,Positive,,Laboratory Study,2005,,,Cardiovascular Diseases (CVD)
2017207,Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.,https://www.ncbi.nlm.nih.gov/pubmed/28981597,Positive,,Meta-analysis,2017,,Nervous System,Alzheimer's Disease
2019735,CB1 positive allosteric modulation attenuates Δ9-THC withdrawal and NSAID-induced gastric inflammation.,https://www.ncbi.nlm.nih.gov/pubmed/30597181,Positive,,Animal Study,2019,Synthetic Cannabinoid (unspecified),,Addiction - Cannabis
2018307,Cannabinoid-mediated retinal rescue correlates with improved circadian parameters in retinal dystrophic rats.,https://www.ncbi.nlm.nih.gov/pubmed/30605663,Positive,,Animal Study,2018,HU-x Synthetic Cannabinoids,Nervous System,Retinal Disorders; Insomnia and Sleep Disorders
2019736,Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Hippocampus: Cannabidiol Blunts Δ9-Tetrahydrocannabinol-Induced Cognitive Impairment.,https://www.ncbi.nlm.nih.gov/pubmed/30610611,Positive,,Laboratory Study,2019,,Mental/Emotional System; Nervous System,Cannabis Adverse Effects
2019737,Blood-brain barrier disturbances in diabetes-associated dementia: Therapeutic potential for cannabinoids.,https://www.sciencedirect.com/science/article/abs/pii/S1043661818314634?via%3Dihub,Positive,,Meta-analysis,2019,,Endocrine System; Nervous System,Cognitive Dysfunction; Diabetes
2014152,A Controlled Family Study of Cannabis Users with and without Psychosis.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319545/,Positive,,Meta-analysis,2014,,Mental/Emotional System,Psychosis; Schizophrenia
2018308,The protective effects of β-caryophyllene on LPS-induced primary microglia M1/M2 imbalance: A mechanistic evaluation.,https://www.ncbi.nlm.nih.gov/pubmed/30620895,Positive,,Laboratory Study,2018,,,Alzheimer's Disease; Inflammation; Multiple Sclerosis
2019738,Cannabis and Turmeric as Complementary Treatments for IBD and Other Digestive Diseases.,https://www.ncbi.nlm.nih.gov/pubmed/30635796,Positive,,Meta-analysis,2019,Turmeric,Digestive System,IBD - Inflammatory Bowel Disease; Irritable Bowel Syndrome
2018309,Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336869/,Positive,,Meta-analysis,2018,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Autism
2018310,Standardized cannabis in multiple sclerosis: a case report.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806860/,Positive,,Meta-analysis,2018,Tetrahydrocannabinol (THC); Cannabinol (CBN),Nervous System,Multiple Sclerosis
2018311,An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia,https://journals.lww.com/pain/fulltext/2019/04000/an_experimental_randomized_study_on_the_analgesic.11.aspx,Positive,,Double Blind Clinical Trial,2018,,Muscular System; Nervous System,Fibromyalgia; Pain; Pain - Chronic
2017208,The Experiences of Medical Marijuana Patients: A Scoping Review of the Qualitative Literature.,https://www.researchgate.net/publication/317313175_The_Experiences_of_Medical_Marijuana_Patients_A_Scoping_Review_of_the_Qualitative_Literature,Positive,,Meta-analysis,2017,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),,Neurodegenerative Issues; Oxidative Stress
2016208,Cannabinoids As Potential Treatment for Chemotherapy-Induced Nausea and Vomiting.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960260/,Positive,,Meta-analysis,2016,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Cannabidiolic Acid (CBD-a); CP-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); Other Related Compounds; Pharma THC; SR-x Synthetic Cannabinoids; Tetrahydrocannabinolic Acid (THC-a); WIN-x Synthetic Cannabinoids,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
2016209,Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869612/,Positive,,Meta-analysis,2016,Pharma THC,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting; Cancer - Breast; Cancer - Lung
2016210,"Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting--a systematic review of systematic reviews.",https://www.ncbi.nlm.nih.gov/pubmed/26787227,Positive,,Meta-analysis,2016,Pharma THC:CBD; Pharma THC,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
2016211,Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood.,https://www.ncbi.nlm.nih.gov/pubmed/26836199,Positive,,Meta-analysis,2016,,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
2016212,Cannabinoids for Symptom Management and Cancer Therapy: The Evidence.,https://www.ncbi.nlm.nih.gov/pubmed/27407130,Positive,,Meta-analysis,2016,Endocannabinoid (unspecified); Pharma THC:CBD; Pharma THC; Synthetic Cannabinoid (unspecified),,Nausea and Vomiting
2015176,Meta-analysis of adjunctive non-NK1 receptor antagonist medications for the control of acute and delayed chemotherapy-induced nausea and vomiting.,https://www.ncbi.nlm.nih.gov/pubmed/25145507,Positive,,Meta-analysis,2015,,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
2015177,Endocannabinoid Mechanisms Influencing Nausea.,https://www.ncbi.nlm.nih.gov/pubmed/26638766,Positive,,Meta-analysis,2015,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified),Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
2015178,Therapeutic potential of cannabinoids in counteracting chemotherapy-induced adverse effects: an exploratory review.,https://www.ncbi.nlm.nih.gov/pubmed/25504799,Positive,,Meta-analysis,2015,,Digestive System,Cancer; Chemotherapy-induced Nausea & Vomiting; Cardiac Toxicity; Cardiovascular Diseases (CVD); Drug-Induced Bone Loss; Drug-Induced Nephropathy; Hearing Loss; Insomnia and Sleep Disorders; Loss of Appetite; Pain; Nausea and Vomiting; Pain - Cancer; Pain - Neuropathy - Drug-Ind. Polyneuropathy
2015179,Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy.,https://www.ncbi.nlm.nih.gov/pubmed/26561338,Positive,,Meta-analysis,2015,,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
2012140,Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting.,https://www.ncbi.nlm.nih.gov/pubmed/22491047,Positive,,Meta-analysis,2012,Pharma THC,Digestive System,Nausea and Vomiting
2012141,Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481523/,Positive,,Meta-analysis,2012,Tetrahydrocannabinol (THC); Pharma THC:CBD; Pharma THC,,Anorexia; Pain; Multiple Sclerosis; Nausea and Vomiting; Pain - Cancer; Pain - Neuropathy - Diabetic; Pain - Neuropathy - Peripheral
2011138,Update and new trends in antiemetic therapy: the continuing need for novel therapies.,https://www.ncbi.nlm.nih.gov/pubmed/20947707,Positive,,Meta-analysis,2011,,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
2011139,Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogenetics.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042115/,Positive,,Meta-analysis,2011,Pharma THC,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
2010097,Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997305/,Positive,,Double Blind Clinical Trial,2010,Pharma THC:CBD,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
2009085,"Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative/Nitrosative Stress, Inflammation, and Cell Death.",http://www.medicinalgenomics.com/wp-content/uploads/2011/12/CBD-Attentuates-Cisplatin-nephrotoxicity.pdf,Positive,,Animal Study,2009,,Urinary System,Drug-Induced Nephropathy
2009086,Efficacy of Crude Marijuana and Synthetic Delta-9-Tetrahydrocannabinol as Treatment for Chemotherapy-Induced Nausea and Vomiting: A Systematic Literature Review.,https://www.ncbi.nlm.nih.gov/pubmed/19596652,Positive,,Meta-analysis,2009,Pharma THC,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
2007064,Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting,https://www.ncbi.nlm.nih.gov/pubmed/17355735,Positive,,Double Blind Clinical Trial,2007,Pharma THC,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
2003035,Established and potential therapeutic applications of cannabinoids in oncology.,https://www.ncbi.nlm.nih.gov/pubmed/12618922,Positive,,Meta-analysis,2003,Pharma THC,,Anorexia; Nausea and Vomiting
2001026,Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review.,https://www.bmj.com/content/323/7303/16,Positive,,Meta-analysis,2001,Pharma THC; Tetrahydrocannabinol (THC); CP-x Synthetic Cannabinoids,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
1995007,An efficient new cannabinoid antiemetic in pediatric oncology.,http://www.druglibrary.org/olsen/hemp/iha/iha02210.html,Positive,,Clinical Trial,1995,Delta-8-THC,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
1991007,Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting,https://www.sciencedirect.com/science/article/pii/088539249190026Z,Positive,,Double Blind Clinical Trial,1991,Pharma THC; Tetrahydrocannabinol (THC),Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
1988005,A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues,https://www.ncbi.nlm.nih.gov/pubmed/2838294,Positive,,Clinical Trial,1988,Pharma THC; Tetrahydrocannabinol (THC),Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
1988006,Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy,https://www.ncbi.nlm.nih.gov/pubmed/2847994,Positive,,Clinical Trial,1988,,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
1988007,Inhalation marijuana as an antiemetic for cancer chemotherapy,https://www.researchgate.net/publication/19925671_Inhalation_marijuana_as_an_antiemetic_for_cancer_chemotherapy,Positive,,Clinical Trial,1988,,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
1987005,"Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial.",https://www.ncbi.nlm.nih.gov/pubmed/3035479,Positive,,Double Blind Clinical Trial,1987,,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
1987006,A double-blind randomised cross-over comparison of nabilone and metoclopramide in the control of radiation-induced nausea.,https://www.ncbi.nlm.nih.gov/pubmed/2822337,Inconclusive,,Double Blind Clinical Trial,1987,,Digestive System,Nausea and Vomiting; Radiation sickness
1986009,Nabilone and metoclopramide in the treatment of nausea and vomiting due to cisplatinum: a double blind study,https://www.researchgate.net/publication/20146292_Nabilone_and_metoclopramide_in_the_treatment_of_nausea_and_vomiting_due_to_cisplatinum_A_double_blind_study,Positive,,Double Blind Clinical Trial,1986,,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
1986010,Nabilone: an alternative antiemetic for cancer chemotherapy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1777777/pdf/archdisch00710-0090.pdf,Positive,,Double Blind Clinical Trial,1986,Pharma THC,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
1986011,Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis,https://www.ncbi.nlm.nih.gov/pubmed/3017596,Positive,,Double Blind Clinical Trial,1986,Pharma THC; Synthetic Cannabinoid (unspecified),Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
1985005,A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy,https://www.ncbi.nlm.nih.gov/pubmed/3002167,Positive,,Double Blind Clinical Trial,1985,Pharma THC,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
1983004,"Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011510/pdf/brjcancer00422-0036.pdf,Positive,,Double Blind Clinical Trial,1983,,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
1983005,"Randomized comparative trial of a new anti-emetic: nabilone, in cancer patients treated with cisplatin.",https://www.ncbi.nlm.nih.gov/pubmed/6311306,Positive,,Double Blind Clinical Trial,1983,Pharma THC,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
1983006,A randomised multicentre single blind comparison of a cannabinoid anti-emetic (Levonantradol) with chlorpromazine in patients receiving their first cytotoxic chemotherapy,https://www.sciencedirect.com/science/article/pii/0277537983900329,Positive,,Double Blind Clinical Trial,1983,CP-x Synthetic Cannabinoids,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
1982003,Cannabis and cancer chemotherapy. A comparison of oral delta-9-THC and prochlorperazine,https://www.researchgate.net/publication/16912614_Cannabis_and_cancer_chemotherapy_A_comparison_of_oral_delta-9-THC_and_prochlorperazine,Positive,,Double Blind Clinical Trial,1982,,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
1983007,"A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy",https://www.researchgate.net/publication/16895835_A_double-blind_controlled_trial_of_nabilone_vs_prochlorperazine_for_refractory_emesis_induced_by_cancer_chemotherapy,Positive,,Double Blind Clinical Trial,1983,Pharma THC,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
1982004,A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting.,https://www.sciencedirect.com/science/article/pii/S0305737282800352,Positive,,Double Blind Clinical Trial,1982,Pharma THC; Tetrahydrocannabinol (THC),Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
1981009,Antiemetic Effect of Δ9‐Tetrahydrocannabinol in Chemotherapy‐Associated Nausea and Emesis As Compared to Placebo and Compazine.,https://accp1.onlinelibrary.wiley.com/doi/abs/10.1002/j.1552-4604.1981.tb02578.x,Positive,,Double Blind Clinical Trial,1981,Tetrahydrocannabinol (THC),Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
1979002,Superiority of Nabilone over Prochlorperazine as an Antiemetic in Patients Receiving Cancer Chemotherapy.,https://www.nejm.org/doi/full/10.1056/NEJM197906073002302,Positive,,Double Blind Clinical Trial,1979,Tetrahydrocannabinol (THC),Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
1975003,Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer Chemotherapy.,https://www.nejm.org/doi/full/10.1056/NEJM197510162931603,Positive,,Double Blind Clinical Trial,1975,,Digestive System,Chemotherapy-induced Nausea & Vomiting; Nausea and Vomiting
2017209,Cannabis and lung. What we know and everything we don't know yet.,https://www.ncbi.nlm.nih.gov/pubmed/29126755,Inconclusive,,Meta-analysis,2017,,Respiratory System,COPD
2011140,Cannabinoid effects on ventilation and breathlessness: a pilot study of efficacy and safety.,https://www.ncbi.nlm.nih.gov/pubmed/21436223,Positive,,Double Blind Clinical Trial,2011,Tetrahydrocannabinol (THC),Respiratory System,COPD
2017210,Single and combined effects of Δ9 -tetrahydrocannabinol and cannabidiol in a mouse model of chemotherapy-induced neuropathic pain.,https://www.ncbi.nlm.nih.gov/pubmed/28548225,Positive,,Animal Study,2017,Tetrahydrocannabinol (THC),,Pain; Pain - Neuropathy - Drug-Ind. Polyneuropathy
2005052,"Dronabinol, a possible new therapeutic option in patients with COPD and pulmonal cachexia",https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-2005-864298?lang=de#V493_1,Positive,,Clinical Trial,2005,,Digestive System; Muscular System; Respiratory System,Cachexia; COPD; Anorexia; Loss of Appetite
2016213,Spontaneous Cannabinoid Receptor 2 (CB2) Expression in the Cochlea of Adult Albino Rat and Its Up-Regulation after Cisplatin Treatment.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5001640/,Positive,,Animal Study,2016,,Nervous System,Hearing Loss
2016214,Experimental Cannabinoid 2 Receptor Inhibition in CNS Injury-Induced Immunodeficiency Syndrome.,https://www.ncbi.nlm.nih.gov/pubmed/26999797,Positive,,Animal Study,2016,AM-x Synthetic Cannabinoids,Immune System; Nervous System,Injury Immunodeficiency
1976005,Antitussive activity of some naturally occurring cannabinoids in anesthetized cats.,https://www.ncbi.nlm.nih.gov/pubmed/1248507,Positive,,Animal Study,1976,Cannabinol (CBN); Tetrahydrocannabinol (THC),Respiratory System,Cough
2016215,"Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review.",https://www.ncbi.nlm.nih.gov/pubmed/26809974,Positive,,Meta-analysis,2016,,Digestive System,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Irritable Bowel Syndrome
2018312,CB1 cannabinoid receptor ligands augment the antidepressant-like activity of biometals (magnesium and zinc) in the behavioural tests.,https://www.ncbi.nlm.nih.gov/pubmed/29380383,Positive,,Animal Study,2018,AM-x Synthetic Cannabinoids; Other Related Compounds,Mental/Emotional System; Nervous System,Depression
2016216,Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors.,https://www.ncbi.nlm.nih.gov/pubmed/26801828,Positive,,Animal Study,2016,AM-x Synthetic Cannabinoids; Anandamide (AEA),Mental/Emotional System; Nervous System,Depression
2016217,Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors.,https://www.ncbi.nlm.nih.gov/pubmed/26711860,Positive,,Animal Study,2016,AM-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Depression
2015180,Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828487/,Positive,,Meta-analysis,2015,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Mental/Emotional System; Nervous System,Depression; Inflammation
2016218,Prohedonic Effect of Cannabidiol in a Rat Model of Depression.,https://www.ncbi.nlm.nih.gov/pubmed/27010632,Positive,,Animal Study,2016,,Mental/Emotional System; Nervous System,Depression
2012142,Effect of delta-9-tetrahydrocannabinol on behavioral despair and on pre- and postsynaptic serotonergic transmission.,https://www.ncbi.nlm.nih.gov/pubmed/22386778,Positive,,Animal Study,2012,Tetrahydrocannabinol (THC); SR-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Depression
2007065,Cannabinoids Elicit Antidepressant-Like Behavior and Activate Serotonergic Neurons through the Medial Prefrontal Cortex.,http://www.jneurosci.org/content/27/43/11700,Positive,,Animal Study,2007,WIN-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Depression
2007066,Local enhancement of cannabinoid CB1 receptor signalling in the dorsal hippocampus elicits an antidepressant-like effect.,https://www.ncbi.nlm.nih.gov/pubmed/17762511,Positive,,Animal Study,2007,AM-x Synthetic Cannabinoids; HU-x Synthetic Cannabinoids; Other Related Compounds,Mental/Emotional System,Depression
2003036,A Case of Cannabinoid Rotation in a Young Woman With Chronic Cystitis.,https://www.jpsmjournal.com/article/S0885-3924%2802%2900601-2/fulltext,Positive,,Meta-analysis,2003,Pharma THC; Tetrahydrocannabinol (THC),Urinary System,Cystitis
2013121,Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors.,https://pubmed.ncbi.nlm.nih.gov/28610718/,Positive,,Animal Study,2013,Tetrahydrocannabinol (THC),Integumentary System,Allergic Contact Dermatitis
2009087,Protective role of palmitoylethanolamide in contact allergic dermatitis.,https://www.researchgate.net/publication/38085515_Protective_role_of_palmitoylethanolamide_in_contact_allergic_dermatitis,Positive,,Animal Study,2009,Other Related Compounds,Integumentary System,Allergic Contact Dermatitis
2007067,Attenuation of Allergic Contact Dermatitis Through the Endocannabinoid System.,https://www.researchgate.net/publication/6279498_Attenuation_of_Allergic_Contact_Dermatitis_Through_the_Endocannabinoid_System,Positive,,Animal Study,2007,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Tetrahydrocannabinol (THC); 2-Arachidonoyl Glycerol (2-AG); Monoacylglycerol Lipase (MAGL); SR-x Synthetic Cannabinoids,Integumentary System,Allergic Contact Dermatitis
2017211,Echinacea purpurea-derived alkylamides exhibit potent anti-inflammatory effects and alleviate clinical symptoms of atopic eczema.,https://pubmed.ncbi.nlm.nih.gov/28610718/,Positive,,Clinical Trial,2017,Echinacea,Integumentary System; Nervous System,Eczema; Inflammation
2016219,Experimental cannabidiol treatment reduces early pancreatic inflammation in type 1 diabetes.,https://www.ncbi.nlm.nih.gov/pubmed/27767974,Positive,,Animal Study,2016,,Endocrine System,Diabetes
2015181,Cannabis Smoking and Diabetes Mellitus: Results from Meta-Analysis with Eight Independent Replication Sample.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801109/,Positive,,Meta-analysis,2015,,Endocrine System,Diabetes
2015182,Fetal endocannabinoids orchestrate the organization of pancreatic islet microarchitecture.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653226/,Positive,,Animal Study,2015,Anandamide (AEA); Monoacylglycerol Lipase (MAGL); 2-Arachidonoyl Glycerol (2-AG); Fatty Acid Amide Hydrolase (FAAH),,Diabetes
2014153,A role for trans-caryophyllene in the moderation of insulin secretion.,https://www.ncbi.nlm.nih.gov/pubmed/24486541,Positive,,Laboratory Study,2014,,Endocrine System,Diabetes
2013122,The cannabinoid Δ9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671751/,Positive,,Animal Study,2013,Tetrahydrocannabivarin (THCV); AM-x Synthetic Cannabinoids,Endocrine System,Diabetes; Obesity
2013123,CB1 Cannabinoid Receptors Couple to Focal Adhesion Kinase to Control Insulin Release.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820903/,Positive,,Animal Study,2013,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); JWH-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); O-x Synthetic Cannabinoids; Other Related Compounds,Endocrine System,Diabetes
2012143,Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3289985/,Positive,,Meta-analysis,2012,,Endocrine System,Diabetes
2010098,"Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, inflammatory and cell death signaling pathways in diabetic cardiomyopathy.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3026637/,Positive,,Animal Study,2010,,Cardiovascular System; Endocrine System; Nervous System,Cardiovascular Diseases (CVD); Diabetes; Inflammation; Oxidative Stress
2009088,Cannabinoid CB(1) receptor activation stimulates neurite outgrowth and inhibits capsaicin-induced Ca(2+) influx in an in vitro model of diabetic neuropathy.,https://pubmed.ncbi.nlm.nih.gov/19501110/,Positive,,Laboratory Study,2009,AM-x Synthetic Cannabinoids; HU-x Synthetic Cannabinoids,Endocrine System; Nervous System,Diabetes; Pain; Pain - Neuropathy - Diabetic
2009089,Cannabidiol Arrests Onset of Autoimmune Diabetes in NOD Mice.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2270485/,Positive,,Animal Study,2009,,Endocrine System,Diabetes
2005053,Cannabidiol lowers incidence of diabetes in non-obese diabetic mice.,https://www.tandfonline.com/doi/full/10.1080/08916930500356674,Positive,,Animal Study,2005,,Endocrine System,Diabetes
2006039,Neuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1592672/,Positive,,Animal Study,2006,,Endocrine System; Nervous System,Diabetes; Neurodegenerative Issues; Oxidative Stress; Retinal Disorders
2004045,Cannabinoids blocks tactile allodynia in diabetic mice without attenuation of its antinociceptive effect.,https://www.ncbi.nlm.nih.gov/pubmed/15342139,Positive,,Animal Study,2004,WIN-x Synthetic Cannabinoids,Endocrine System; Nervous System,Diabetes; Pain; Pain - Neuropathy - Diabetic
2001027,Examination of the immunosuppressive effect of delta9-tetrahydrocannabinol in streptozotocin-induced autoimmune diabetes.,https://www.ncbi.nlm.nih.gov/pubmed/11357882,Positive,,Animal Study,2001,Tetrahydrocannabinol (THC),Endocrine System,Diabetes
2016220,Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804326/,Positive,,Laboratory Study,2016,Monoacylglycerol Lipase (MAGL); 2-Arachidonoyl Glycerol (2-AG); Other Related Compounds,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy
2014154,Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707667/,Positive,,Meta-analysis,2014,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Pharma THC:CBD; SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Nervous System,Epilepsy; Inflammation; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant; Anxiety; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Neonatal Cerebral Issues; Neurodegenerative Issues; Oxidative Stress; Psychosis; Schizophrenia
2013124,Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157067/,Positive,,Meta-analysis,2013,,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2015183,Evidence for a Role of Adolescent Endocannabinoid Signaling in Regulating HPA Axis Stress Responsivity and Emotional Behavior Development.,https://www.ncbi.nlm.nih.gov/pubmed/26638764,Positive,,Meta-analysis,2015,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System,Behavioral Disorders
2012144,Minireview: Endocannabinoids and gonadal hormones: bidirectional interactions in physiology and behavior.,https://www.ncbi.nlm.nih.gov/pubmed/22210740,Positive,,Meta-analysis,2012,Endocannabinoid (unspecified),,Behavioral Disorders
2004046,Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice.,https://www.ncbi.nlm.nih.gov/pubmed/15078564?dopt=Citation,Inconclusive,,Animal Study,2004,,Mental/Emotional System; Nervous System,Anxiety; Behavioral Disorders
2013125,Prospects for cannabinoid therapies in viral encephalitis.,https://www.ncbi.nlm.nih.gov/pubmed/24021420,Positive,,Animal Study,2013,HU-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Nervous System,Encephalitis and Myelitis
2014155,A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984273/,Positive,,Animal Study,2014,Cannabigerol (CBG); AM-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); WIN-x Synthetic Cannabinoids,Nervous System,Encephalitis and Myelitis; Multiple Sclerosis
1998015,The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway.,https://pubmed.ncbi.nlm.nih.gov/9738948/,Positive,,Animal Study,1998,Anandamide (AEA); Other Related Compounds,Nervous System,Encephalitis and Myelitis; Multiple Sclerosis
2010099,Endocannabinoid involvement in endometriosis.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2972363/,Positive,,Animal Study,2010,AM-x Synthetic Cannabinoids; Endocannabinoid (unspecified); WIN-x Synthetic Cannabinoids,Endocrine System,Endometriosis
2010100,Antiproliferative Effects of Cannabinoid Agonists on Deep Infiltrating Endometriosis.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993285/,Positive,,Animal Study,2010,WIN-x Synthetic Cannabinoids,Endocrine System,Endometriosis
2018313,Cannabidiol Regulates Long Term Potentiation Following Status Epilepticus: Mediation by Calcium Stores and Serotonin.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808210/,Positive,,Animal Study,2018,,Nervous System,Epilepsy
2017212,Report from a Survey of Parents Regarding the Use of Cannabidiol (Medicinal cannabis) in Mexican Children with Refractory Epilepsy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368357/,Positive,,Meta-analysis,2017,,,Epilepsy
2017213,Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of Mesial Temporal Lobe Epilepsy.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355474/,Positive,,Animal Study,2017,,,Epilepsy; Neurodegenerative Issues
2017214,Assessing the role of serotonergic receptors in cannabidiol's anticonvulsant efficacy.,https://www.epilepsybehavior.com/article/S1525-5050(17)30122-1/fulltext,Positive,,Animal Study,2017,,,Epilepsy
2017215,Interactions between cannabidiol and commonly used antiepileptic drugs.,https://www.ncbi.nlm.nih.gov/pubmed/28782097,Positive,,Clinical Trial,2017,Pharma CBD,,Epilepsy
2017216,Could Cannabidiol be a Treatment Option for Intractable Childhood and Adolescent Epilepsy?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540685/,Positive,,Meta-analysis,2017,,Nervous System,Epilepsy
2017217,"Quality of Life in Childhood Epilepsy in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568670/,Positive,,Meta-analysis,2017,,Nervous System,Epilepsy
2016221,Plant-Derived and Endogenous Cannabinoids in Epilepsy.,https://www.ncbi.nlm.nih.gov/pubmed/26892745,Positive,,Meta-analysis,2016,,,Epilepsy
2016222,The cannabinoid receptor agonist WIN55.212 reduces consequences of status epilepticus in rats.,https://www.ncbi.nlm.nih.gov/pubmed/27520083,Positive,,Animal Study,2016,WIN-x Synthetic Cannabinoids,,Epilepsy
2016223,Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043219/,Positive,,Meta-analysis,2016,Tetrahydrocannabinol (THC),,Epilepsy
2016224,Marijuana use in adults admitted to a Canadian epilepsy monitoring unit.,https://www.ncbi.nlm.nih.gov/pubmed/27568641,Positive,,Meta-analysis,2016,,Nervous System,Epilepsy
2016225,"From Cannabis to Cannabidiol to Treat Epilepsy, Where Are We?",https://www.ncbi.nlm.nih.gov/pubmed/27587196,Positive,,Meta-analysis,2016,,Nervous System,Epilepsy
2016226,"Involvement of TRPV1 channels in the activity of the cannabinoid WIN 55,212-2 in an acute rat model of temporal lobe epilepsy.",https://www.ncbi.nlm.nih.gov/pubmed/26970948,Positive,,Animal Study,2016,WIN-x Synthetic Cannabinoids,Nervous System,Epilepsy
2016227,Anticonvulsant activity of β-caryophyllene against pentylenetetrazol-induced seizures.,https://www.epilepsybehavior.com/article/S1525-5050(15)00695-2/fulltext,Positive,,Animal Study,2016,,,Epilepsy
2016228,Cannabidiol Post-Treatment Alleviates Rat Epileptic-Related Behaviors and Activates Hippocampal Cell Autophagy Pathway Along with Antioxidant Defense in Chronic Phase of Pilocarpine-Induced Seizure.,https://link.springer.com/article/10.1007%2Fs12031-015-0703-6,Positive,,Animal Study,2016,,,Epilepsy
2016229,Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958898/,Positive,,Laboratory Study,2016,,Nervous System,Epilepsy; Epilepsy - Dravet Syndrome
2015184,Weeding out bad waves: towards selective cannabinoid circuit control in epilepsy.,https://www.ncbi.nlm.nih.gov/pubmed/25891509,Positive,,Meta-analysis,2015,Endocannabinoid (unspecified),,Epilepsy
2015185,Drug–drug interaction between clobazam and cannabidiol in children with refractory epilepsy,https://onlinelibrary.wiley.com/doi/full/10.1111/epi.13060,Positive,,Clinical Trial,2015,Pharma CBD,Nervous System,Epilepsy
2014156,Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se.,https://www.ncbi.nlm.nih.gov/pubmed/24642454,Positive,,Animal Study,2014,Cannabigerol (CBG),Nervous System,Epilepsy; Epilepsy - Dravet Syndrome
2014157,Efficacy and Safety of Epidiolex (Cannabidiol) in Children and Young Adults with Treatment-Resistant Epilepsy: Initial Data From an Expanded Access Program.,https://www.aesnet.org/abstractslisting/efficacy-and-safety-of-epidiolex-(cannabidiol)-in-children-and-young-adults-with-treatment-resistant-epilepsy--initial-data-from-an-expanded-access-program,Positive,,Clinical Trial,2014,Pharma CBD,Nervous System,Epilepsy; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut
2010101,Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819831/,Positive,,Animal Study,2010,AM-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Nervous System,Epilepsy
2010102,Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy.,https://onlinelibrary.wiley.com/doi/full/10.1111/j.1528-1167.2009.02334.x,Positive,,Clinical Trial,2010,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Nervous System,Epilepsy
2010103,Temporal characterization of changes in hippocampal cannabinoid CB1 receptor expression following pilocarpine-induced status epilepticus.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841984/,Positive,,Animal Study,2010,WIN-x Synthetic Cannabinoids,Nervous System,Epilepsy
2016230,Activation Of Cannabinoid Receptor Type II By AM1241 Ameliorates Myocardial Fibrosis Via Nrf2-Mediated Inhibition Of TGF-β1/Smad3 Pathway In Myocardial Infarction Mice,https://www.karger.com/Article/FullText/447855,Positive,,Animal Study,2016,AM-x Synthetic Cannabinoids,Cardiovascular System,Cardiovascular Diseases (CVD); Fibrosis - Cardiac; Fibrosis
2008093,Nabilone For The Treatment Of Paraneoplastic Night Sweats: A Report Of Four Cases,https://www.researchgate.net/publication/23182409_Nabilone_for_the_Treatment_of_Paraneoplastic_Night_Sweats_A_Report_of_Four_Cases,Positive,,Meta-analysis,2008,,Integumentary System,Night Sweats and Excessive Sweating
2003037,Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors.,https://www.jci.org/articles/view/16116,Positive,,Animal Study,2003,JWH-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Integumentary System,Cancer - Skin (Non-melanoma); Cancer
2016231,Medical Cannabis in the Palliation of Malignant Wounds—A Case Report,https://www.jpsmjournal.com/article/S0885-3924%2816%2930328-1/fulltext#/article/S0885-3924(16)30328-1/fulltext,Positive,,Meta-analysis,2016,,Integumentary System,Cancer - Skin (Non-melanoma); Cancer
2008094,Cannabinoid receptor-1 modulation induces apoptosis of human melanoma cells,http://cancerres.aacrjournals.org/content/68/9_Supplement/2678,Positive,,Laboratory Study,2008,AM-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Integumentary System; Nervous System,Cancer - Melanoma; Cancer
2004047,Endocannabinoids and Their Implications for Epilepsy.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1176361/,Positive,,Meta-analysis,2004,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Tetrahydrocannabinol (THC),Nervous System,Epilepsy
2009090,A Population-based Case-Control Study of Marijuana Use and Head and Neck Squamous Cell Carcinoma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2812803/,Positive,,Meta-analysis,2009,,Integumentary System,Cancer - Squamous Head/Neck; Cancer
2003038,International Association for Cannabis as Medicine.,http://www.cannabis-med.org/meeting/Cologne2003/reader.pdf,Positive,,Meta-analysis,2003,,,Epilepsy
2001028,"Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice.",https://onlinelibrary.wiley.com/doi/10.1046/j.1528-1157.2001.41499.x,Positive,,Animal Study,2001,Palmitoylethanolamide (PEA),,Epilepsy
1980002,Chronic Administration of Cannabidiol to Healthy Volunteers and Epileptic Patients.,https://www.researchgate.net/publication/15784820_Chronic_Administration_of_Cannabidiol_to_Healthy_Volunteers_and_Epileptic_Patients,Positive,,Double Blind Clinical Trial,1980,,Nervous System,Epilepsy
2017218,Inhibitor of Endocannabinoid Deactivation Protects Against In Vitro and In Vivo Neurotoxic Effects of Paraoxon.,https://www.ncbi.nlm.nih.gov/pubmed/28803438,Positive,,Animal Study,2017,AM-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH),,Excitotoxicity; Neurodegenerative Issues
2014158,A New Generation Fatty Acid Amide Hydrolase Inhibitor Protects Against Kainate-induced Excitotoxicity.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124033/,Positive,,Animal Study,2014,AM-x Synthetic Cannabinoids; Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Nervous System,Excitotoxicity; Epilepsy; Neurodegenerative Issues
1997012,Pain relief with oral cannabinoids in familial Mediterranean fever.,https://pubmed.ncbi.nlm.nih.gov/9165969/,Positive,,Double Blind Clinical Trial,1997,,Digestive System,Familial Mediterranean Fever; Fever
2016232,β-Caryophyllene attenuates palmitate-induced lipid accumulation through AMPK signaling by activating CB2 receptor in human HepG2 hepatocytes.,https://www.ncbi.nlm.nih.gov/pubmed/27234712,Positive,,Laboratory Study,2016,,Digestive System,Fatty Liver Disease
2007068,A Novel Role of Cannabinoids: Implication in the Fever Induced by Bacterial Lipopolysaccharide.,https://www.ncbi.nlm.nih.gov/pubmed/17194800,Positive,,Animal Study,2007,WIN-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Immune System,
2009091,The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial.,http://www.medicine.mcgill.ca/epidemiology/joseph/publications/Medical/ware2010.pdf,Positive,,Double Blind Clinical Trial,2009,,Muscular System; Nervous System,Fibromyalgia; Insomnia and Sleep Disorders
2008095,Nabilone for the treatment of pain in fibromyalgia.,https://www.ncbi.nlm.nih.gov/pubmed/17974490,Positive,,Double Blind Clinical Trial,2008,Tetrahydrocannabinol (THC),Muscular System,Fibromyalgia
2015186,"Cannabidiol, a Major Non-Psychotropic Cannabis Constituent Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts.",https://onlinelibrary.wiley.com/doi/full/10.1002/jbmr.2513,Positive,,Animal Study,2015,,Skeletal System,Bone Fractures; Osteoporosis
2014159,Effect of Delta-9-Tetrahydrocannabinol on Mouse Resistance to Systemic Candida albicans Infection.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110019/,Negative,,Animal Study,2014,Tetrahydrocannabinol (THC),Digestive System; Immune System; Integumentary System,Fungal Infections
2009092,"Chemical synthesis, pharmacological characterization, and possible formation in unicellular fungi of 3-hydroxy-anandamide/",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656659/,Negative,,Laboratory Study,2009,Anandamide (AEA),,Fungal Infections
2016233,Gastric acid inhibitory and gastric protective effects of Cannabis and cannabinoids.,https://www.sciencedirect.com/science/article/pii/S1995764516300712,Positive,,Meta-analysis,2016,Endocannabinoid (unspecified),Digestive System,Gastro-Esophageal Reflux; Stomach Ulcers
2009093,"Effect of Δ9-tetrahydrocannabinol, a cannabinoid receptor agonist, on the triggering of transient lower oesophageal sphincter relaxations in dogs and humans.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697772/,Positive,,Double Blind Clinical Trial,2009,SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Digestive System,Gastro-Esophageal Reflux
1996013,"Gastric cytoprotection of the non-steroidal anti-inflammatory sesquiterpene, beta-caryophyllene.",https://www.ncbi.nlm.nih.gov/pubmed/9005452/,Positive,,Animal Study,1996,,Digestive System,Gastro-Esophageal Reflux
2007069,Dronabinol and retinal hemodynamics in humans.,https://www.ncbi.nlm.nih.gov/pubmed/17188063,Positive,,Clinical Trial,2007,Pharma THC; Tetrahydrocannabinol (THC),Nervous System,Glaucoma
2006040,Effect of Sublingual Application of Cannabinoids on Intraocular Pressure: A Pilot Study.,https://journals.lww.com/glaucomajournal/Abstract/2006/10000/Effect_of_Sublingual_Application_of_Cannabinoids.1.aspx,Positive,,Double Blind Clinical Trial,2006,Tetrahydrocannabinol (THC),Nervous System,Glaucoma
2000015,Involvement of cannabinoid receptors in the intraocular pressure-lowering effects of WIN55212-2.,https://pubmed.ncbi.nlm.nih.gov/10604940/,Positive,,Animal Study,2000,WIN-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,,Glaucoma
1998016,Marijuana Smoking vs Cannabinoids for Glaucoma Therapy.,https://jamanetwork.com/journals/jamaophthalmology/fullarticle/264203,Positive,,Meta-analysis,1998,,,Glaucoma
1981010,Topical delta 9-tetrahydrocannabinol and aqueous dynamics in glaucoma.,https://www.ncbi.nlm.nih.gov/pubmed/6271841,Inconclusive,,Double Blind Clinical Trial,1981,Tetrahydrocannabinol (THC),Nervous System,Glaucoma
1980003,Effect of marihuana on intraocular and blood pressure in glaucoma.,https://www.ncbi.nlm.nih.gov/pubmed/7053160,Positive,,Clinical Trial,1980,Tetrahydrocannabinol (THC),Nervous System,Glaucoma; Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
1979003,Effects of tetrahydrocannabinol on arterial and intraocular hypertension.,https://www.ncbi.nlm.nih.gov/pubmed/468444,Positive,,Clinical Trial,1979,,Cardiovascular System; Nervous System,Cardiovascular Diseases (CVD); Glaucoma; Hypertension (High Blood Pressure)
1977006,Effect of delta-9-tetrahydrocannabinol on intraocular pressure in humans.,https://www.ncbi.nlm.nih.gov/pubmed/329423,Positive,,Clinical Trial,1977,,Nervous System,Glaucoma
2004048,Cannabinoids and glaucoma.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1772142/,Positive,,Meta-analysis,2004,HU-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC),Nervous System,Glaucoma
1971002,Marihuana smoking and intraocular pressure.,https://www.ncbi.nlm.nih.gov/pubmed/5109652,Positive,,Clinical Trial,1971,,Nervous System,Glaucoma
2017219,Effect of Marijuana Use on Thyroid Function and Autoimmunity.,https://www.ncbi.nlm.nih.gov/pubmed/27799014,Positive,,Meta-analysis,2017,,Endocrine System,Hyperthyroidism and Graves' Disease
2015187,Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461586/,Positive,,Animal Study,2015,,Cardiovascular System,Cardiac Toxicity; Cardiovascular Diseases (CVD)
2014160,Ligand activation of cannabinoid receptors attenuates hypertrophy of neonatal rat cardiomyocytes.,https://www.ncbi.nlm.nih.gov/pubmed/24979612,Positive,,Animal Study,2014,Anandamide (AEA); JWH-x Synthetic Cannabinoids,Cardiovascular System,Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Chronic Heart Disease; Heart Disease
2013126,An ultra-low dose of tetrahydrocannabinol provides cardioprotection.,https://www.ncbi.nlm.nih.gov/pubmed/23537701,Positive,,Animal Study,2013,Tetrahydrocannabinol (THC),Cardiovascular System,Cardiovascular Diseases (CVD); Chronic Heart Disease; Heart Disease
2010104,Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion.,https://www.ncbi.nlm.nih.gov/pubmed/20590615,Positive,,Animal Study,2010,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Cardiovascular System,Cardiovascular Diseases (CVD)
2007070,Cannabinoids and cardiovascular disease: the outlook for clinical treatments.,https://www.ncbi.nlm.nih.gov/pubmed/17627561,Positive,,Meta-analysis,2007,,Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2007071,"Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.",https://www.physiology.org/doi/full/10.1152/ajpheart.00098.2007,Positive,,Animal Study,2007,,Cardiovascular System,Cardiovascular Diseases (CVD); Chronic Heart Disease; Heart Attack; Heart Disease; Reperfusion Injury
2006041,The endogenous cardiac cannabinoid system: a new protective mechanism against myocardial ischemia.,https://www.ncbi.nlm.nih.gov/pubmed/16618028,Positive,,Meta-analysis,2006,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Synthetic Cannabinoid (unspecified); Tetrahydrocannabinol (THC),Cardiovascular System,Cardiovascular Diseases (CVD); Chronic Heart Disease; Heart Attack; Heart Disease
2006042,Delta-9-tetrahydrocannabinol protects cardiac cells from hypoxia via CB2 receptor activation and nitric oxide production.,https://link.springer.com/article/10.1007/s11010-006-2346-y#/page-1,Positive,,Laboratory Study,2006,,Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack
2004049,Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism.,https://www.ncbi.nlm.nih.gov/pubmed/15640760,Positive,,Animal Study,2004,Tetrahydrocannabinol (THC); SR-x Synthetic Cannabinoids,Cardiovascular System,Cardiovascular Diseases (CVD)
2016234,High prevalence of cannabis use among Aka foragers of the Congo Basin and its possible relationship to helminthiasis.,https://www.ncbi.nlm.nih.gov/pubmed/26031406,Positive,,Meta-analysis,2016,Tetrahydrocannabinol (THC); Tetrahydrocannabinolic Acid (THC-a),Digestive System,Parasitic Worms
2013127,Synergistic Effect of Lupenone and Caryophyllene Oxide against Trypanosoma cruzi.,https://www.hindawi.com/journals/ecam/2013/435398/,Positive,,Animal Study,2013,,Cardiovascular System,Chagas Disease
2014161,In vitro antibacterial activity of Cannabis sativa leaf extracts to some selective pathogenicbacterial strains.,https://www.theroc.us/researchlibrary/In%20vitro%20antibacterial%20activity%20of%20Cannabis%20sativa%20leaf%20extracts%20to%20some%20selective%20pathogenicbacterial%20strains.pdf,Positive,,Laboratory Study,2014,,Digestive System; Immune System,Bacterial Infections; Microbiome Imbalance
2007072,Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228252/,Positive,,Animal Study,2007,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); JWH-x Synthetic Cannabinoids; Other Related Compounds; SR-x Synthetic Cannabinoids,Digestive System,Liver Failure
2014162,Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication.,https://www.ncbi.nlm.nih.gov/pubmed/24704332,Inconclusive,,Laboratory Study,2014,2-Arachidonoyl Glycerol (2-AG),Digestive System,Hepatitis
2008096,Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828293/,Positive,,Animal Study,2008,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); AM-x Synthetic Cannabinoids; CP-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Digestive System,Hepatitis
2011141,Influence of Cannabis Use on Severity of Hepatitis C Disease.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184401/,Negative,,Meta-analysis,2011,,Digestive System,Hepatitis; Fibrosis - Liver (Cirrhosis); Fibrosis
2006043,Cannabis use improves retention and virological outcomes in patients treated for hepatitis C.,https://www.ncbi.nlm.nih.gov/pubmed/16957511,Positive,,Meta-analysis,2006,,Digestive System,Hepatitis
2006044,Treatment for hepatitis C virus and cannabis use in illicit drug user patients: implications and questions.,https://www.ncbi.nlm.nih.gov/pubmed/16957507,Positive,,Meta-analysis,2006,,Digestive System,Hepatitis
2005054,Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C.,https://www.ncbi.nlm.nih.gov/pubmed/15892090,Negative,,Meta-analysis,2005,,Digestive System,Fibrosis - Liver (Cirrhosis); Fibrosis; Hepatitis
2003039,A novel synthetic cannabinoid derivative inhibits inflammatory liver damage via negative cytokine regulation.,https://pubmed.ncbi.nlm.nih.gov/14645663/,Positive,,Laboratory Study,2003,Synthetic Cannabinoid (unspecified),Digestive System,Hepatitis
2010105,Adjuvant topical therapy with a cannabinoid receptor agonist in facial postherpetic neuralgia.,https://www.ncbi.nlm.nih.gov/pubmed/19744255,Positive,,Clinical Trial,2010,Endocannabinoid (unspecified); Other Related Compounds,Integumentary System,Herpes; Pain; Pain - Neuropathy - Peripheral; Shingles (Herpes Zoster)
2010106,Cannabinoids and Viral Infections.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903762/,Inconclusive,,Laboratory Study,2010,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); JWH-x Synthetic Cannabinoids; Other Related Compounds; SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Integumentary System,"Herpes; Epstein-Barr, Mono; Hepatitis; HIV/AIDS; Kaposi's Sarcoma; Respiratory Syncytial Virus; Shingles (Herpes Zoster)"
1991008,Suppressive effect of delta-9-tetrahydrocannabinol on herpes simplex virus infectivity in vitro.,https://pubmed.ncbi.nlm.nih.gov/1848937/,Positive,,Laboratory Study,1991,Tetrahydrocannabinol (THC),Integumentary System,Herpes; Shingles (Herpes Zoster)
1987007,Inhibition of cell-associated herpes simplex virus type 2 glycoproteins by delta 9-tetrahydrocannabinol.,https://pubmed.ncbi.nlm.nih.gov/3033681/,Positive,,Laboratory Study,1987,,Integumentary System,Herpes; Shingles (Herpes Zoster)
1980004,The effect of delta-9-tetrahydrocannabinol on herpes simplex virus replication.,http://jgv.microbiologyresearch.org/content/journal/jgv/10.1099/0022-1317-49-2-427,Positive,,Laboratory Study,1980,,Integumentary System,Herpes; Shingles (Herpes Zoster)
2018314,Δ9-Tetrahydrocannabinold (THC) suppresses secretion of IFNα by plasmacytoid dendritic cells (pDC) from healthy and HIV-infected individuals.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527743/,Positive,,Laboratory Study,2018,,Immune System,HIV/AIDS
2017220,No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort).,https://www.ncbi.nlm.nih.gov/pubmed/27073179,Inconclusive,,Meta-analysis,2017,,Immune System,HIV/AIDS
2015188,Modulation of HIVGP120 Antigen-Specific Immune Responses In Vivo by Δ9-Tetrahydrocannabinol.,https://www.ncbi.nlm.nih.gov/pubmed/25900076,Positive,,Animal Study,2015,,Immune System,HIV/AIDS
2014163,Modulation of Gut-Specific Mechanisms by Chronic Δ9-Tetrahydrocannabinol Administration in Male Rhesus Macaques Infected with Simian Immunodeficiency Virus: A Systems Biology Analysis.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046212/,Positive,,Animal Study,2014,Tetrahydrocannabinol (THC),,HIV/AIDS
2015189,Chronic Administration of Δ9-Tetrahydrocannabinol Induces Intestinal Anti-Inflammatory MicroRNA Expression during Acute Simian Immunodeficiency Virus Infection of Rhesus Macaques.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4300675/,Positive,,Animal Study,2015,Tetrahydrocannabinol (THC),Immune System,Injury Immunodeficiency; HIV/AIDS
2015190,Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089388/,Positive,,Laboratory Study,2015,CP-x Synthetic Cannabinoids; Pharma THC; 2-Arachidonoyl Glycerol (2-AG); Abnormal Cannabidiol (Abn-CBD); O-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Immune System,HIV/AIDS
2015191,Δ9-tetrahydrocannabinol treatment during human monocyte differentiation reduces macrophage susceptibility to HIV-1 infection.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019698/,Positive,,Laboratory Study,2015,Tetrahydrocannabinol (THC); JWH-x Synthetic Cannabinoids; O-x Synthetic Cannabinoids,Immune System,HIV/AIDS
2013128,The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS.,https://www.ncbi.nlm.nih.gov/pubmed/23633327,Inconclusive,,Clinical Meta-analysis,2013,Endocannabinoid (unspecified); Pharma THC; Synthetic Cannabinoid (unspecified),Immune System,HIV/AIDS
2013129,Attenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629438/,Positive,,Laboratory Study,2013,JWH-x Synthetic Cannabinoids; O-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Immune System,HIV/AIDS
2013130,Marijuana Smoking Does Not Accelerate Progression of Liver Disease in HIV–Hepatitis C Coinfection: A Longitudinal Cohort Analysis.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3739469/,Inconclusive,,Meta-analysis,2013,,Digestive System; Immune System,Fibrosis - Liver (Cirrhosis); Fibrosis; Hepatitis; HIV/AIDS
2013131,"2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release antimicrobial effectors against E. coli, S. aureus, HSV-1, and RSV.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995105/,Positive,,Laboratory Study,2013,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); O-x Synthetic Cannabinoids; Other Related Compounds; SR-x Synthetic Cannabinoids,Integumentary System; Respiratory System,Herpes; Respiratory Syncytial Virus; Shingles (Herpes Zoster)
2012145,A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200580/,Positive,,Double Blind Clinical Trial,2012,Tetrahydrocannabinol (THC),Immune System,HIV/AIDS; Anorexia; Diabetes; Metabolic Syndrome
2011142,Cannabinoid Administration Attenuates the Progression of Simian Immunodeficiency Virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131805/,Positive,,Animal Study,2011,,Immune System; Nervous System,Injury Immunodeficiency; HIV/AIDS; Inflammation
2010107,Efficacy and Tolerability of High-Dose Dronabinol Maintenance in HIV-Positive Marijuana Smokers: A Controlled Laboratory Study.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325767/,Positive,,Double Blind Clinical Trial,2010,Pharma THC; Tetrahydrocannabinol (THC),Immune System,HIV/AIDS
2010108,Immunoregulation of a CB2 Receptor Agonist in a Murine Model of NeuroAIDS,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109320/,Positive,,Animal Study,2010,,Immune System,HIV/AIDS
2005055,Mechanisms of HIV-1 inhibition by the lipid mediator N-arachidonoyldopamine.,https://www.ncbi.nlm.nih.gov/pubmed/16148147,Positive,,Laboratory Study,2005,Anandamide (AEA); Other Related Compounds,Immune System,HIV/AIDS
2017221,"Effects of a Sativex-Like Combination of Phytocannabinoids on Disease Progression in R6/2 Mice, an Experimental Model of Huntington’s Disease.",https://www.mdpi.com/1422-0067/18/4/684/htm,Positive,,Animal Study,2017,Tetrahydrocannabinol (THC),Nervous System,Huntington's Disease
2017222,Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731255/,Positive,,Animal Study,2017,Cannabidiolic Acid (CBD-a); Cannabigerol (CBG); Cannabigerolic Acid (CBG-a); Tetrahydrocannabinol (THC); Tetrahydrocannabinolic Acid (THC-a),Nervous System,Huntington's Disease; Neurodegenerative Issues
2016235,Biased Type 1 Cannabinoid Receptor Signaling Influences Neuronal Viability in a Cell Culture Model of Huntington Disease.,https://www.ncbi.nlm.nih.gov/pubmed/26700564,Positive,,Laboratory Study,2016,CP-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); WIN-x Synthetic Cannabinoids,Nervous System,Huntington's Disease
2015192,Chronic cannabinoid receptor stimulation selectively prevents motor impairments in a mouse model of Huntington's disease.,https://www.ncbi.nlm.nih.gov/pubmed/25123645,Positive,,Animal Study,2015,WIN-x Synthetic Cannabinoids,Nervous System,Huntington's Disease
2015193,Neuroprotective Properties of Cannabigerol in Huntington’s Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322067/,Positive,,Animal Study,2015,Cannabigerol (CBG),,Huntington's Disease
2014164,A restricted population of CB1 cannabinoid receptors with neuroprotective activity.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050577/,Positive,,Animal Study,2014,,,Neurodegenerative Issues; Huntington's Disease
2014165,The cytokine and endocannabinoid systems are co-regulated by NF-κB p65/RelA in cell culture and transgenic mouse models of Huntington's disease and in striatal tissue from Huntington's disease patients.,https://www.ncbi.nlm.nih.gov/pubmed/24360910,Positive,,Laboratory Study,2014,,Nervous System,Huntington's Disease
2013132,Cannabinoids increase type 1 cannabinoid receptor expression in a cell culture model of striatal neurons: implications for Huntington's disease.,https://www.ncbi.nlm.nih.gov/pubmed/23602984,Positive,,Laboratory Study,2013,Anandamide (AEA); Other Related Compounds,Nervous System,Huntington's Disease
2012146,"Sativex-like Combination of Phytocannabinoids is Neuroprotective in Malonate-Lesioned Rats, an Inflammatory Model of Huntington’s Disease: Role of CB1 and CB2 Receptors.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382456/,Positive,,Animal Study,2012,AM-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Nervous System,Huntington's Disease; Neurodegenerative Issues
2012147,Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington's disease.,https://www.ncbi.nlm.nih.gov/pubmed/22207189,Positive,,Animal Study,2012,WIN-x Synthetic Cannabinoids,Nervous System,Huntington's Disease
2011143,Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease.,https://www.ncbi.nlm.nih.gov/pubmed/21674569,Positive,,Animal Study,2011,Pharma THC:CBD; Tetrahydrocannabinol (THC); AM-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Nervous System,Huntington's Disease
2011144,Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.,https://www.ncbi.nlm.nih.gov/pubmed/20929960,Positive,,Animal Study,2011,,Nervous System,Huntington's Disease
2010109,Behavioural and molecular consequences of chronic cannabinoid treatment in Huntington's disease transgenic mice.,https://www.ncbi.nlm.nih.gov/pubmed/20600638,Positive,,Animal Study,2010,HU-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH),Nervous System,Huntington's Disease
2010110,Neuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington's disease.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931573/,Positive,,Laboratory Study,2010,HU-x Synthetic Cannabinoids,Nervous System,Huntington's Disease
2009094,A pilot study using nabilone for symptomatic treatment in Huntington's disease.,https://www.ncbi.nlm.nih.gov/pubmed/19845035,Positive,,Double Blind Clinical Trial,2009,,Nervous System,Huntington's Disease
2010111,Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington’s disease.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2706932/,Positive,,Animal Study,2010,SR-x Synthetic Cannabinoids,Nervous System,Huntington's Disease; Neurodegenerative Issues
2007073,"Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors.",https://www.ncbi.nlm.nih.gov/pubmed/17672854,Positive,,Animal Study,2007,HU-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),,Huntington's Disease
2003040,The endocannabinoid system and Huntington's disease.,https://www.ncbi.nlm.nih.gov/pubmed/14529364,Positive,,Meta-analysis,2003,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),,Huntington's Disease
2003041,Effects of cannabinoids in the rat model of Huntington's disease generated by an intrastriatal injection of malonate.,https://www.ncbi.nlm.nih.gov/pubmed/12858038,Positive,,Animal Study,2003,SR-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC),,Huntington's Disease
2002036,Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.,https://www.ncbi.nlm.nih.gov/pubmed/11842443,Positive,,Animal Study,2002,AM-x Synthetic Cannabinoids; Anandamide (AEA),Nervous System,Huntington's Disease
2001029,Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease.,https://www.ncbi.nlm.nih.gov/pubmed/11447320,Positive,,Animal Study,2001,Anandamide (AEA); 2-Arachidonoyl Glycerol (2-AG),,Huntington's Disease
2000016,"The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease.",https://www.ncbi.nlm.nih.gov/pubmed/10828533,Positive,,Laboratory Study,2000,,,Huntington's Disease
1993008,Loss of cannabinoid receptors in the substantia nigra in Huntington's disease.,https://www.ncbi.nlm.nih.gov/pubmed/8255419,Positive,,Laboratory Study,1993,CP-x Synthetic Cannabinoids,Nervous System,Huntington's Disease
1991009,Controlled clinical trial of cannabidiol in Huntington's disease.,https://www.ncbi.nlm.nih.gov/pubmed/1839644,Inconclusive,,Double Blind Clinical Trial,1991,,,Huntington's Disease
1998017,Marijuana for intractable hiccups.,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(05)78270-2/fulltext,Positive,,Meta-analysis,1998,,Nervous System,Hiccups; HIV/AIDS
2017223,A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470879/,Positive,,Double Blind Clinical Trial,2017,,,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2016236,Heterologous regulation of the cannabinoid type 1 receptor by angiotensin II in astrocytes of spontaneously hypertensive rats.,https://www.ncbi.nlm.nih.gov/pubmed/27529509,Positive,,Animal Study,2016,,Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2012148,"Enhanced vasorelaxant effects of the endocannabinoid-like mediator, oleamide, in hypertension.",https://www.sciencedirect.com/science/article/pii/S0014299912002671?via%3Dihub,Positive,,Animal Study,2012,Fatty Acid Amide Hydrolase (FAAH); Other Related Compounds,Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2009095,Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697765/,Positive,,Animal Study,2009,Anandamide (AEA); WIN-x Synthetic Cannabinoids; AM-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH); Synthetic Cannabinoid (unspecified),Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2004050,Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2756479/,Positive,,Animal Study,2004,AM-x Synthetic Cannabinoids; Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2004051,Anandamide content and interaction of endocannabinoid/GABA modulatory effects in the NTS on baroreflex-evoked sympathoinhibition.,https://www.ncbi.nlm.nih.gov/pubmed/14615281/,Positive,,Animal Study,2004,Anandamide (AEA); SR-x Synthetic Cannabinoids,Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
1999014,Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide.,https://www.ncbi.nlm.nih.gov/pubmed/10440374,Positive,,Laboratory Study,1999,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); CP-x Synthetic Cannabinoids; HU-x Synthetic Cannabinoids; Other Related Compounds; SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2016237,Type 2 cannabinoid receptor contributes to the physiological regulation of spermatogenesis.,https://www.ncbi.nlm.nih.gov/pubmed/26671998,Positive,,Laboratory Study,2016,JWH-x Synthetic Cannabinoids,Reproductive System,Infertility (Male)
2016238,Characterization of non-olfactory GPCRs in human sperm with a focus on GPR18.,https://www.nature.com/articles/srep32255,Positive,,Laboratory Study,2016,Other Related Compounds,Reproductive System,Infertility (Male)
2014166,Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage.,https://www.ncbi.nlm.nih.gov/pubmed/25042014,Positive,,Animal Study,2014,Tetrahydrocannabinol (THC); HU-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Nervous System,Cognitive Dysfunction; Neurodegenerative Issues; Encephalitis and Myelitis
2018315,Fatty acid amide hydrolase (FAAH) blockade ameliorates experimental colitis by altering microRNA expression and suppressing inflammation.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154806/,Positive,,Animal Study,2018,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Digestive System,IBD - Inflammatory Bowel Disease; IBD - Crohn's Disease; Irritable Bowel Syndrome
2017224,Prevalence and Patterns of Marijuana Use in Young Adults With Inflammatory Bowel Disease.,https://www.ncbi.nlm.nih.gov/pubmed/27846066,Positive,,Meta-analysis,2017,,,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Irritable Bowel Syndrome
2011145,β-Caryophyllene Inhibits Dextran Sulfate Sodium-Induced Colitis in Mice through CB2 Receptor Activation and PPARγ Pathway.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070571/,Positive,,Animal Study,2011,AM-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Digestive System,IBD - Inflammatory Bowel Disease
2008097,"Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2451037/,Positive,,Animal Study,2008,Fatty Acid Amide Hydrolase (FAAH); JWH-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Digestive System,IBD - Inflammatory Bowel Disease
2008098,Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors.,https://www.ncbi.nlm.nih.gov/pubmed/18493729,Positive,,Animal Study,2008,Other Related Compounds,Digestive System,IBD - Inflammatory Bowel Disease; IBD - Crohn's Disease; Irritable Bowel Syndrome
2017225,Smoked marijuana attenuates performance and mood disruptions during simulated night shift work.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578830/,Positive,,Double Blind Clinical Trial,2017,Tetrahydrocannabinol (THC),,Insomnia and Sleep Disorders
2014167,Potential Effects of Cannabidiol as a Wake-Promoting Agent.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023456/,Positive,,Meta-analysis,2014,,Nervous System,Insomnia and Sleep Disorders
2013133,Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats.,https://journals.sagepub.com/doi/abs/10.1177/0269881112474524,Positive,,Animal Study,2013,,Nervous System,Insomnia and Sleep Disorders
2013134,Around‐the‐clock oral THC effects on sleep in male chronic daily cannabis smokers.,https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1521-0391.2013.12003.x,Positive,,Clinical Trial,2013,Tetrahydrocannabinol (THC),Nervous System,Insomnia and Sleep Disorders; Cannabis Adverse Effects
2003042,Effect of D-9-Tetrahydrocannabinol and Cannabidiol on Nocturnal Sleep and Early-Morning Behavior in Young Adults,http://safeaccess.ca/research/pdf/Nicholson_CBME_Sleep.pdf,Positive,,Double Blind Clinical Trial,2003,Tetrahydrocannabinol (THC),,Insomnia and Sleep Disorders
1998018,Anandamida modulates sleep and memory in rats.,https://www.researchgate.net/publication/13474027_Anandamida_modulates_sleep_and_memory_in_rats,Positive,,Animal Study,1998,Anandamide (AEA); Other Related Compounds,Nervous System,Insomnia and Sleep Disorders
1982005,The effect of chronically administered delta-9-tetrahydrocannabinol upon the polygraphically monitored sleep of normal volunteers.,https://www.ncbi.nlm.nih.gov/pubmed/6299682,Positive,,Double Blind Clinical Trial,1982,,Nervous System,Insomnia and Sleep Disorders
1981011,Hypnotic And Antiepileptic Effects Of Cannabidiol,https://www.ncbi.nlm.nih.gov/pubmed/7028792,Positive,,Clinical Meta-analysis,1981,,Nervous System,Epilepsy; Insomnia and Sleep Disorders; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut
1977007,Hypnoticlike effects of cannabidiol in the rat,https://link.springer.com/article/10.1007/BF00497858#citeas,Positive,,Animal Study,1977,,Nervous System,Insomnia and Sleep Disorders
2006045,Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test,https://www.sciencedirect.com/science/article/pii/S0278584606002612,Positive,,Animal Study,2006,,Mental/Emotional System; Nervous System,Anxiety
1976006,Effects of marijuana extract and tetrahydrocannabinol on electroencephalographic sleep patterns,https://www.researchgate.net/publication/22956648_Effects_of_marijuana_extract_and_tetrahydrocannabinol_on_electroencephalographic_sleep_patterns,Positive,,Clinical Trial,1976,Cannabinol (CBN),,Insomnia and Sleep Disorders
1975004,Effect of chronic marijuana administration of stages of primate sleep-wakefulness.,https://www.ncbi.nlm.nih.gov/pubmed/166711,Positive,,Animal Study,1975,Tetrahydrocannabinol (THC),,Insomnia and Sleep Disorders
1975005,Effects of high dosage delta-9-tetrahydrocannabinol on sleep patterns in man.,https://www.ncbi.nlm.nih.gov/pubmed/164314/,Positive,,Clinical Trial,1975,,,Insomnia and Sleep Disorders
1973006,Δ9-Tetrahydrocannabinol and the sleep-wakefulness cycle in rabbits,https://www.sciencedirect.com/science/article/abs/pii/0031938473900036,Positive,,Animal Study,1973,Tetrahydrocannabinol (THC),Nervous System,Insomnia and Sleep Disorders
2014168,Protective Effects of Cannabidiol on Lesion-Induced Intervertebral Disc Degeneration.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269422/,Positive,,Animal Study,2014,,Skeletal System,Degenerative Disc
2018316,"Involvement of spinal cannabinoid receptors in the antipruritic effects of WIN 55,212-2, a cannabinoid receptor agonist.",https://www.ncbi.nlm.nih.gov/pubmed/29424035,Positive,,Animal Study,2018,WIN-x Synthetic Cannabinoids,Integumentary System,Pruritis
2016239,"Systemic and spinal administration of FAAH, MAGL inhibitors and dual FAAH/MAGL inhibitors produce antipruritic effect in mice.",https://www.ncbi.nlm.nih.gov/pubmed/27126057,Positive,,Animal Study,2016,Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Integumentary System,Pruritis
2010112,Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936031/,Positive,,Animal Study,2010,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Other Related Compounds,Cardiovascular System,Cardiac Arrhythmias; Cardiovascular Diseases (CVD); Reperfusion Injury
2014169,Couples’ marijuana use is inversely related to their intimate partner violence over the first nine years of marriage,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282761/,Positive,,Meta-analysis,2014,,Mental/Emotional System,Domestic Abuse
2015194,The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases.,https://www.degruyter.com/view/j/jbcpp.2016.27.issue-3/jbcpp-2015-0055/jbcpp-2015-0055.xml,Positive,,Meta-analysis,2015,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Urinary System,Chronic Kidney Disease; Diabetic Kidney Disease
2012149,Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844813/,Positive,,Animal Study,2012,AM-x Synthetic Cannabinoids,Endocrine System; Urinary System,Diabetic Kidney Disease
1993009,Parents' Use Of Cocaine And Marijuana And Increased Risk Of Rhabdomyosarcoma In Their Children,https://www.ncbi.nlm.nih.gov/pubmed/8318638,Inconclusive,,Meta-analysis,1993,,Muscular System,Cancer - Soft Tissues; Cancer
2010113,"CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931565/,Positive,,Animal Study,2010,AM-x Synthetic Cannabinoids; Anandamide (AEA); SR-x Synthetic Cannabinoids; 2-Arachidonoyl Glycerol (2-AG),Urinary System,Drug-Induced Nephropathy
2009096,Cannabinoid Receptor 1 Is A Potential Drug Target For Treatment Of Translocation-positive Rhabdomyosarcoma,https://www.ncbi.nlm.nih.gov/pubmed/19509271,Positive,,Laboratory Study,2009,HU-x Synthetic Cannabinoids,Muscular System,Cancer - Soft Tissues; Cancer
2016240,Association between Plasma Endocannabinoids and Appetite in Hemodialysis Patients: a Pilot Study.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919598/,Positive,,Meta-analysis,2016,Anandamide (AEA); Other Related Compounds,Urinary System,Hemodialysis
2012150,Role of arachidonoylethanolamine in blood pressure regulation in volume-resistant patients on peritoneal dialysis.,https://www.ncbi.nlm.nih.gov/pubmed/22447110,Positive,,Clinical Trial,2012,Anandamide (AEA),Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Hemodialysis
2016241,"Chemical Characterization and Trypanocidal, Leishmanicidal and Cytotoxicity Potential of Lantana camara L. (Verbenaceae) Essential Oil.",https://www.mdpi.com/1420-3049/21/2/209/htm,Positive,,Laboratory Study,2016,,Integumentary System,Leishmaniasis; Chagas Disease
2012151,Chemical and biological analyses of the essential oils and main constituents of Piper species.,https://www.ncbi.nlm.nih.gov/pubmed/22330429,Positive,,Laboratory Study,2012,,Integumentary System,Leishmaniasis
2015195,Perceived Efficacy Of Cannabidiol-enriched Cannabis Extracts For Treatment Of Pediatric Epilepsy: A Potential Role For Infantile Spasms And Lennox-Gastaut Syndrome (LGS).,https://www.ncbi.nlm.nih.gov/pubmed/25935511,Positive,,Meta-analysis,2015,,,Epilepsy - Lennox-Gastaut; Epilepsy
2017226,Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon?,https://www.ncbi.nlm.nih.gov/pubmed/27884725,Positive,,Meta-analysis,2017,Anandamide (AEA); 2-Arachidonoyl Glycerol (2-AG); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Tetrahydrocannabinol (THC),Endocrine System; Reproductive System,Libido; Erectile Dysfunction
2017227,Masturbation to Orgasm Stimulates the Release of the Endocannabinoid 2-Arachidonoylglycerol in Humans.,https://www.jsm.jsexmed.org/article/S1743-6095(17)31443-1/fulltext,Positive,,Double Blind Clinical Trial,2017,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Other Related Compounds,Endocrine System; Reproductive System,Libido; Erectile Dysfunction
2007074,Endocannabinoid Hedonic Hotspot for Sensory Pleasure: Anandamide in Nucleus Accumbens Shell Enhances ‘Liking’ of a Sweet Reward.,"https://lsa.umich.edu/psych/research&labs/berridge/publications/Mahler,%20Smith%20&%20Berridge%20Endocannabinoid%20hedonic%20hotspot%20Neuropsychopharm%202007.pdf",Positive,,Animal Study,2007,Anandamide (AEA),Endocrine System; Reproductive System,Libido; Erectile Dysfunction
2011146,Cannabinoid Receptor Type I Modulates Alcohol-Induced Liver Fibrosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321809/,Positive,,Animal Study,2011,2-Arachidonoyl Glycerol (2-AG); SR-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC),Digestive System,Alcoholic Liver Disease; Fibrosis - Liver (Cirrhosis); Fibrosis
2008099,The endocannabinoid system as a novel target for the treatment of liver fibrosis.,https://www.ncbi.nlm.nih.gov/pubmed/17412522,Positive,,Meta-analysis,2008,Synthetic Cannabinoid (unspecified),Digestive System,Fibrosis - Liver (Cirrhosis); Fibrosis
2016242,The endocannabinoid system - a target for the treatment of LUTS?,https://www.ncbi.nlm.nih.gov/pubmed/27377161,Positive,,Meta-analysis,2016,Endocannabinoid (unspecified),Urinary System,Urinary Tract Infection
2015196,Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of cerebral malaria.,https://www.ncbi.nlm.nih.gov/pubmed/25595981,Positive,,Animal Study,2015,,Immune System; Nervous System,Cognitive Dysfunction; Malaria; Neurodegenerative Issues; Anxiety
1997013,Composition and antimalarial activity in vitro of the essential oil of Tetradenia riparia.,https://www.ncbi.nlm.nih.gov/pubmed/9225614,Positive,,Laboratory Study,1997,,Immune System,Malaria
2010114,Cannabidiol was ineffective for manic episode of bipolar affective disorder.,https://www.ncbi.nlm.nih.gov/pubmed/18801823,Inconclusive,,Double Blind Clinical Trial,2010,,Mental/Emotional System,Bipolar Disorder
2007075,The effect of extreme marijuana use on the long-term course of bipolar I illness: a single case study.,https://www.ncbi.nlm.nih.gov/pubmed/17703715,Positive,,Meta-analysis,2007,,Mental/Emotional System,Bipolar Disorder
2005056,Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential.,https://www.ukcia.org/research/CannabinoidsInBipolarAffectiveDisorder.pdf,Positive,,Meta-analysis,2005,Anandamide (AEA); Pharma THC:CBD; Pharma THC,Mental/Emotional System; Nervous System,Bipolar Disorder
1998019,The use of cannabis as a mood stabilizer in bipolar disorder: anecdotal evidence and the need for clinical research.,https://www.ncbi.nlm.nih.gov/pubmed/9692379,Positive,,Meta-analysis,1998,,Mental/Emotional System; Nervous System,Bipolar Disorder
2016243,Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population.,https://www.ncbi.nlm.nih.gov/pubmed/26749285,Positive,,Meta-analysis,2016,,,Migraine
2015197,"Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …",https://www.ncbi.nlm.nih.gov/pubmed/26015168,Positive,,Meta-analysis,2015,,,Migraine
2006046,Dronabinol Reduces Signs And Symptoms Of Idiopathic Intracranial Hypertension: A Case Report.,https://www.ncbi.nlm.nih.gov/pubmed/16503778,Positive,,Meta-analysis,2006,Pharma THC,Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure); Migraine
2001030,Hemp for headache: An in-depth historical and scientific review of cannabis in migraine treatment.,https://www.researchgate.net/publication/228469706_Hemp_for_headache_An_in-depth_historical_and_scientific_review_of_cannabis_in_migraine_treatment,Positive,,Meta-analysis,2001,Anandamide (AEA); Other Related Compounds; Pharma THC; Tetrahydrocannabinol (THC),,Migraine
1985006,Cannabinoids block release of serotonin from platelets induced by plasma from migraine patients.,https://www.ncbi.nlm.nih.gov/pubmed/2997048,Positive,,Laboratory Study,1985,,,Migraine
2006047,Survey of medicinal cannabis use among childbearing women: patterns of its use in pregnancy and retroactive self-assessment of its efficacy against 'morning sickness'.,https://www.ncbi.nlm.nih.gov/pubmed/16401527,Positive,,Meta-analysis,2006,,Digestive System; Reproductive System,Morning sickness; Nausea and Vomiting
2010115,"Motion Sickness, Stress And The Endocannabinoid System.",https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010752,Positive,,Clinical Trial,2010,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Mental/Emotional System; Nervous System,Motion Sickness; Nausea and Vomiting
2008100,The Effects of Cannabidiol and Tetrahydrocannabinol on Motion‐Induced Emesis in Suncus murinus.,https://onlinelibrary.wiley.com/doi/full/10.1111/j.1742-7843.2008.00253.x,Positive,,Animal Study,2008,Tetrahydrocannabinol (THC); AM-x Synthetic Cannabinoids,Nervous System,Motion Sickness; Nausea and Vomiting
2008101,Antibacterial Cannabinoids from Cannabis sativa: A Structure−Activity Study.,https://pubs.acs.org/doi/abs/10.1021/np8002673,Positive,,Laboratory Study,2008,Cannabichromene (CBC); Cannabigerol (CBG); Cannabinol (CBN); Tetrahydrocannabinol (THC),Immune System,Staph Infection
2008102,Non-cannabinoid constituents from a high potency Cannabis sativa variety.,https://pubmed.ncbi.nlm.nih.gov/18774146/,Positive,,Laboratory Study,2008,,,Leishmaniasis; Malaria; Staph Infection
2014170,The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2.,https://www.ncbi.nlm.nih.gov/pubmed/24293211/,Positive,,Laboratory Study,2014,,Cardiovascular System,Cancer - Myeloma
2016244,"Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363603/,Positive,,Laboratory Study,2016,Tetrahydrocannabinol (THC); AM-x Synthetic Cannabinoids,Cardiovascular System,Cancer - Myeloma
2018317,2-AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs.,https://www.ncbi.nlm.nih.gov/pubmed/29484707,Positive,,Animal Study,2018,2-Arachidonoyl Glycerol (2-AG); Monoacylglycerol Lipase (MAGL),,Multiple Sclerosis
2017228,Medical cannabis: Another piece in the mosaic of autoimmunity?,https://www.ncbi.nlm.nih.gov/pubmed/27859024,Positive,,Meta-analysis,2017,,Nervous System,Inflammation; Arthritis - Rheumatoid; Arthritis; Diabetes; Fibromyalgia; Irritable Bowel Syndrome; Multiple Sclerosis
2017229,Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis.,https://www.ncbi.nlm.nih.gov/pubmed/27079840,Positive,,Meta-analysis,2017,Pharma THC:CBD; Tetrahydrocannabinol (THC),Nervous System,Multiple Sclerosis
2016245,A cost-effectiveness model for the use of a cannabis-derived oromucosal spray for the treatment of spasticity in multiple sclerosis.,https://www.ncbi.nlm.nih.gov/pubmed/26750641,Positive,,Meta-analysis,2016,Pharma THC:CBD,,Multiple Sclerosis
2016246,THC:CBD Observational Study Data: Evolution of Resistant MS Spasticity and Associated Symptoms.,https://www.ncbi.nlm.nih.gov/pubmed/26901343,Positive,,Meta-analysis,2016,,Nervous System,Multiple Sclerosis
2016247,"THC:CBD in Daily Practice: Available Data from UK, Germany and Spain.",https://www.ncbi.nlm.nih.gov/pubmed/26901342,Positive,,Meta-analysis,2016,Pharma THC:CBD,,Multiple Sclerosis
2016248,The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity.,https://www.ncbi.nlm.nih.gov/pubmed/27003093,Positive,,Clinical Trial,2016,Pharma THC:CBD; Tetrahydrocannabinol (THC),Nervous System,Multiple Sclerosis
2016249,Efficacy and safety of nabiximols (Sativex(®)) on multiple sclerosis spasticity in a real-life Italian monocentric study.,https://www.ncbi.nlm.nih.gov/pubmed/26474875,Positive,,Meta-analysis,2016,Pharma THC:CBD; Tetrahydrocannabinol (THC),Nervous System,Multiple Sclerosis
2009097,A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules.,https://www.ncbi.nlm.nih.gov/pubmed/19059482,Positive,,Animal Study,2009,WIN-x Synthetic Cannabinoids,Nervous System,Multiple Sclerosis
2009098,"Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study.",https://www.ncbi.nlm.nih.gov/pubmed/18978501,Positive,,Double Blind Clinical Trial,2009,Pharma THC:CBD; Tetrahydrocannabinol (THC),Nervous System,Multiple Sclerosis
2009099,Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis.,https://www.ncbi.nlm.nih.gov/pubmed/18603457,Positive,,Double Blind Clinical Trial,2009,Pharma THC:CBD; Tetrahydrocannabinol (THC),Nervous System,Pain; Multiple Sclerosis
2008103,Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis.,https://www.ncbi.nlm.nih.gov/pubmed/18535023,Positive,,Clinical Trial,2008,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Other Related Compounds,Nervous System,Multiple Sclerosis
2008104,"Current Status of Cannabis Treatment of Multiple Sclerosis with an Illustrative Case Presentation of a Patient with MS, Complex Vocal Tics, Paroxysmal Dystonia, and Marijuana Dependence Treated with Dronabinol.",https://www.cambridge.org/core/journals/cns-spectrums/article/current-status-of-cannabis-treatment-of-multiple-sclerosis-with-an-illustrative-case-presentation-of-a-patient-with-ms-complex-vocal-tics-paroxysmal-dystonia-and-marijuana-dependence-treated-with-dronabinol/91A7239F1DFDB7C33722E38B279C93B3,Positive,,Meta-analysis,2008,Pharma THC; Tetrahydrocannabinol (THC),Mental/Emotional System,Addiction - Cannabis; Addiction; Multiple Sclerosis
2007076,"Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial",https://www.ncbi.nlm.nih.gov/pubmed/18035205,Positive,,Clinical Trial,2007,Pharma THC:CBD; Tetrahydrocannabinol (THC),Nervous System,Pain; Multiple Sclerosis; Pain - Central Pain Syndrome
2007077,Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis,https://www.ncbi.nlm.nih.gov/pubmed/17355549,Positive,,Double Blind Clinical Trial,2007,Tetrahydrocannabinol (THC),Nervous System,Multiple Sclerosis
2007078,The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis.,https://academic.oup.com/brain/article/130/10/2543/373024,Positive,,Clinical Trial,2007,Anandamide (AEA); 2-Arachidonoyl Glycerol (2-AG); CP-x Synthetic Cannabinoids; HU-x Synthetic Cannabinoids; Other Related Compounds; SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),,Multiple Sclerosis
2007079,"Control of Spasticity in a Multiple Sclerosis Model is mediated by CB1, not CB2, Cannabinoid Receptors.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189718/,Positive,,Animal Study,2007,CP-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Nervous System,Multiple Sclerosis
2006048,Sativex®: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain.,https://www.tandfonline.com/doi/abs/10.1517/14656566.7.5.607?journalCode=ieop20,Positive,,Meta-analysis,2006,Pharma THC:CBD; Tetrahydrocannabinol (THC),Nervous System,Pain; Multiple Sclerosis; Pain - Neuropathy - Peripheral
2006049,Therapeutic action of cannabinoid on axonal injury induced by peroxynitrite.,https://www.ncbi.nlm.nih.gov/pubmed/16473327,Positive,,Animal Study,2006,HU-x Synthetic Cannabinoids,,Multiple Sclerosis; Traumatic Brain Injury
2005057,Cannabinoids in multiple sclerosis -- therapeutically reasonable?,https://www.ncbi.nlm.nih.gov/pubmed/16052440,Positive,,Meta-analysis,2005,,Nervous System,Multiple Sclerosis
2005058,Sativex for the management of multiple sclerosis symptoms.,https://www.ncbi.nlm.nih.gov/pubmed/16317825,Positive,,Meta-analysis,2005,Pharma THC:CBD; Tetrahydrocannabinol (THC),,Multiple Sclerosis
2005059,"Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis",https://www.ncbi.nlm.nih.gov/pubmed/16186518,Positive,,Double Blind Clinical Trial,2005,Pharma THC:CBD; Tetrahydrocannabinol (THC),Nervous System,Pain; Multiple Sclerosis; Pain - Central Pain Syndrome; Insomnia and Sleep Disorders
2004052,"Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo- controlled study on 160 patients",https://www.ukcia.org/research/GenOrSpecEffectsOnMSSymptoms.pdf,Positive,,Double Blind Clinical Trial,2004,Tetrahydrocannabinol (THC),,Multiple Sclerosis
2003043,Cannabis Use as Described by People with Multiple Sclerosis.,https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/cannabis-use-as-described-by-people-with-multiple-sclerosis/813459EEEAEF212EB93FC6DC1E7E3807,Positive,,Meta-analysis,2003,,,Multiple Sclerosis
2000017,Cannabinoids Control Spasticity And Tremor In A Multiple Sclerosis Model.,https://www.ncbi.nlm.nih.gov/pubmed/10716447,Positive,,Animal Study,2000,JWH-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids; Other Related Compounds,,Multiple Sclerosis
1997014,The Perceived Effects Of Smoked Cannabis On Patients With Multiple Sclerosis.,http://www.druglibrary.org/crl/movement/Consroe%20et.al%2097%20Multiple%20Sclerosis_%20Eur.Neurol.pdf,Positive,,Meta-analysis,1997,,,Multiple Sclerosis
1995008,Nabilone In The Treatment Of Multiple Sclerosis.,http://www.medicalcannabis.it/nabilone.htm,Positive,,Clinical Trial,1995,Pharma THC; Tetrahydrocannabinol (THC),,Multiple Sclerosis
1993010,Short-term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers,https://deepblue.lib.umich.edu/bitstream/handle/2027.42/110106/cptclpt199433.pdf?sequence=1,Negative,,Double Blind Clinical Trial,1993,Tetrahydrocannabinol (THC),,Multiple Sclerosis
1999015,Δ9-Tetrahydrocannabinol Induces Apoptosis In Human Prostate PC-3 Cells Via A Receptor-independent Mechanism,https://www.sciencedirect.com/science/article/pii/S001457939901073X,Positive,,Laboratory Study,1999,Tetrahydrocannabinol (THC); AM-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Nervous System; Reproductive System,Cancer - Prostate; Cancer
2003044,Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production.,https://www.ncbi.nlm.nih.gov/pubmed/12746841?dopt=Abstract,Positive,,Laboratory Study,2003,Anandamide (AEA),Reproductive System,Cancer - Prostate; Cancer
2005060,Cannabinoid Receptor As A Novel Target For The Treatment Of Prostate Cancer,http://cancerres.aacrjournals.org/content/65/5/1635,Positive,,Laboratory Study,2005,WIN-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Nervous System; Reproductive System,Cancer - Prostate; Cancer
2009100,Increased Expressions Of Cannabinoid Receptor-1 And Transient Receptor Potential Vanilloid-1 In Human Prostate Carcinoma,https://www.ncbi.nlm.nih.gov/pubmed/18830626,Positive,,Laboratory Study,2009,,Reproductive System,Cancer - Prostate; Cancer
2012152,The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339795/?tool=pubmed,Positive,,Meta-analysis,2012,SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Nervous System; Reproductive System,Cancer - Prostate; Cancer
2013135,Non-THC Cannabinoids Inhibit Prostate Carcinoma Growth In Vitro And In Vivo: Pro-apoptotic Effects And Underlying Mechanisms,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570006/,Positive,,Animal Study,2013,Cannabichromene (CBC); Cannabidiolic Acid (CBD-a); Cannabigerol (CBG); Cannabigerolic Acid (CBG-a); Cannabinol (CBN); Tetrahydrocannabivarin (THCV); Tetrahydrocannabinolic Acid (THC-a),Nervous System; Reproductive System,Cancer - Prostate; Cancer
1989005,Effect of cannabinoids on spasticity and ataxia in multiple sclerosis.,https://pubmed.ncbi.nlm.nih.gov/2709054/,Positive,,Meta-analysis,1989,,,Multiple Sclerosis
1988008,Delta-9-THC in the Treatment of Spasticity Associated with Multiple Sclerosis,https://www.tandfonline.com/doi/abs/10.1300/J251v07n01_04,Positive,,Double Blind Clinical Trial,1988,Tetrahydrocannabinol (THC),Nervous System,Multiple Sclerosis
1981012,Treatment of human spasticity with delta 9-tetrahydrocannabinol.,https://www.ncbi.nlm.nih.gov/pubmed/6271839,Positive,,Double Blind Clinical Trial,1981,,Skeletal System,Spinal Cord Injuries; Multiple Sclerosis; Stroke
1987008,Effects of cannabinoids on levels of acetylcholine and choline and on turnover rate of acetylcholine in various regions of the mouse brain.,https://www.ncbi.nlm.nih.gov/pubmed/3620017,Positive,,Animal Study,1987,Cannabinol (CBN),,Myasthenia Gravis
2016250,Cannabidiol Limits T Cell-Mediated Chronic Autoimmune Myocarditis: Implications to Autoimmune Disorders and Organ Transplantation.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004721/,Positive,,Animal Study,2016,,Cardiovascular System; Immune System,Cardiovascular Diseases (CVD); Myocarditis; Organ Transplant Failure; Oxidative Stress
2016251,Effects of Cannabidiol and Hypothermia on Short-Term Brain Damage in New-Born Piglets after Acute Hypoxia-Ischemia.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940392/,Positive,,Animal Study,2016,,Nervous System,Neonatal Cerebral Issues; Neurodegenerative Issues; Oxidative Stress
2016252,Short-term effects of cannabidiol after global hypoxia-ischemia in newborn piglets.,https://www.ncbi.nlm.nih.gov/pubmed/27441365,Inconclusive,,Animal Study,2016,,Nervous System,Neonatal Cerebral Issues; Neurodegenerative Issues; Oxidative Stress
2011147,Therapeutic potential of the endocannabinoid system in perinatal asphyxia.,https://www.ncbi.nlm.nih.gov/pubmed/22127663,Positive,,Meta-analysis,2011,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),,Neonatal Cerebral Issues; Neurodegenerative Issues
2016253,In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791143/,Positive,,Animal Study,2016,,Nervous System,Cancer - Neuroblastoma; Cancer
2017230,The cannabinoid beta-caryophyllene (BCP) induces neuritogenesis in PC12 cells by a cannabinoid-receptor-independent mechanism.,https://www.sciencedirect.com/science/article/pii/S0009279716305920,Positive,,Laboratory Study,2017,,,Neurodegenerative Issues; Oxidative Stress
2012153,Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders.,https://www.ncbi.nlm.nih.gov/pubmed/21870037,Positive,,Animal Study,2012,,Nervous System,Cognitive Dysfunction; Neurodegenerative Issues
2010116,THC Prevents MDMA Neurotoxicity in Mice.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824821/,Positive,,Animal Study,2010,AM-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC),,Neurodegenerative Issues
2009101,Selective CB2 Receptor Agonism Protects Central Neurons from Remote Axotomy-Induced Apoptosis through the PI3K/Akt Pathway.,http://www.jneurosci.org/content/jneuro/29/14/4564.full.pdf,Positive,,Laboratory Study,2009,JWH-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Nervous System,Neurodegenerative Issues; Oxidative Stress
2005061,"Comparison of Cannabidiol, Antioxidants, and Diuretics in Reversing Binge Ethanol-Induced Neurotoxicity.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183207/,Positive,,Animal Study,2005,,Digestive System; Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction; Alcoholic Liver Disease; Neurodegenerative Issues; Cognitive Dysfunction; Oxidative Stress
2016254,Endocannabinoid signaling enhances visual responses through modulation of intracellular chloride levels in retinal ganglion cells.,https://elifesciences.org/articles/15932,Positive,,Animal Study,2016,AM-x Synthetic Cannabinoids; Anandamide (AEA); Endocannabinoid (unspecified); Monoacylglycerol Lipase (MAGL); Other Related Compounds; WIN-x Synthetic Cannabinoids,Nervous System,Night Blindness
2004053,Cannabis improves night vision: a case study of dark adaptometry and scotopic sensitivity in kif smokers of the Rif mountains of northern Morocco.,http://files.iowamedicalmarijuana.org/science/misc/Russo%20et%20al.%20Cannabis%20Night%20Vision%20JEP%202004.pdf,Positive,,Meta-analysis,2004,,,Night Blindness
2016255,Got Munchies? Estimating the Relationship between Marijuana Use and Body Mass Index.,https://www.ncbi.nlm.nih.gov/pubmed/27572145,Positive,,Meta-analysis,2016,,Endocrine System; Mental/Emotional System,Loss of Appetite; Metabolic Syndrome; Diabetes; Obesity
2015198,Cannabis use in relation to obesity and insulin resistance in the Inuit population.,https://www.ncbi.nlm.nih.gov/pubmed/25557382,Positive,,Meta-analysis,2015,,Endocrine System,Diabetes; Metabolic Syndrome; Obesity
2013136,"The impact of marijuana use on glucose, insulin, and insulin resistance among US adults.",https://pubmed.ncbi.nlm.nih.gov/23684393/,Positive,,Meta-analysis,2013,,Endocrine System,Diabetes; Metabolic Syndrome; Obesity
2011148,Obesity and cannabis use: results from 2 representative national surveys.,https://pubmed.ncbi.nlm.nih.gov/21868374/,Positive,,Meta-analysis,2011,,Endocrine System,Obesity
2014171,Cannabidiol reverses the mCPP-induced increase in marble-burying behavior.,https://www.ncbi.nlm.nih.gov/pubmed/?term=OCD+cannabinoids+cannabis,Positive,,Animal Study,2014,,Mental/Emotional System; Nervous System,OCD
2016256,Endocannabinoid Modulation of Orbitostriatal Circuits Gates Habit Formation.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911264/,Positive,,Animal Study,2016,,Mental/Emotional System; Nervous System,OCD; Addiction - Alcohol; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant
2015199,Δ⁹-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541500/,Positive,,Animal Study,2015,,Immune System,Organ Transplant Failure; Wound Healing
2015200,Ultra Low Dose Delta 9-Tetrahydrocannabinol Protects Mouse Liver from Ischemia Reperfusion Injury.,https://www.karger.com/Article/FullText/430165,Positive,,Animal Study,2015,Anandamide (AEA); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,Digestive System; Immune System,Liver Failure; Organ Transplant Failure; Neurodegenerative Issues; Oxidative Stress
2015201,The cannabinoid receptor 2 is involved in acute rejection of cardiac allografts.,https://www.ncbi.nlm.nih.gov/pubmed/25744392,Positive,,Animal Study,2015,,Immune System,Organ Transplant Failure
2010117,Do Cannabinoids have a therapeutic role in transplantation?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923447/,Positive,,Meta-analysis,2010,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); CP-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); WIN-x Synthetic Cannabinoids,Immune System,Organ Transplant Failure
2010118,Cannabinoids and bone: friend or foe?,https://www.ncbi.nlm.nih.gov/pubmed/20532878,Positive,,Meta-analysis,2010,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),Skeletal System,Osteoporosis; Arthritis - Osteoarthritis; Arthritis
2016257,The endocannabinoid system and bone.,https://www.ncbi.nlm.nih.gov/pubmed/27734700,Positive,,Meta-analysis,2016,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Synthetic Cannabinoid (unspecified),Skeletal System,Osteoporosis
2017231,Cannabis use and bone mineral density: NHANES 2007-2010.,https://www.ncbi.nlm.nih.gov/pubmed/28286929,Inconclusive,,Meta-analysis,2017,,Skeletal System,Osteoporosis
2016258,A collaboration investigating endocannabinoid signalling in brain and bone.,https://www.ncbi.nlm.nih.gov/pubmed/26887036,Positive,,Meta-analysis,2016,,Skeletal System,Osteoporosis
2009102,Cannabinoids and the skeleton: from marijuana to reversal of bone loss.,https://www.ncbi.nlm.nih.gov/pubmed/19634029,Positive,,Meta-analysis,2009,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),Skeletal System,Drug-Induced Bone Loss; Osteoporosis
2006050,"Peripheral cannabinoid receptor, CB2, regulates bone mass",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1334629/,Positive,,Animal Study,2006,HU-x Synthetic Cannabinoids,Skeletal System,Osteoporosis; Geriatric Conditions; Longevity
2005062,Cannabinoid receptor type 2 gene is associated with human osteoporosis.,https://academic.oup.com/hmg/article/14/22/3389/614315,Positive,,Animal Study,2005,,Skeletal System,Osteoporosis
2017232,Cannabidiol upregulates melanogenesis through CB1 dependent pathway by activating p38 MAPK and p42/44 MAPK.,https://www.sciencedirect.com/science/article/pii/S0009279716304343,Positive,,Laboratory Study,2017,,Integumentary System,Sunburn; Cancer - Melanoma; Cancer - Skin (Non-melanoma); Cancer
2017233,Extract of Fructus Cannabis Ameliorates Learning and Memory Impairment Induced by D-Galactose in an Aging Rats Model.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671716/,Positive,,Animal Study,2017,,Nervous System,Cognitive Dysfunction; Neurodegenerative Issues; Oxidative Stress
2016259,Modulation of cellular redox homeostasis by the endocannabinoid system.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852457/,Positive,,Meta-analysis,2016,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; CP-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,,Oxidative Stress; Neurodegenerative Issues
2017234,"Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative.",https://www.researchgate.net/publication/318448788_Antinociceptive_effects_of_HUF-101_a_fluorinated_cannabidiol_derivative,Positive,,Animal Study,2017,AM-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); WIN-x Synthetic Cannabinoids,Nervous System,Pain - Nociceptive; Pain
2017235,Cannabidiol Is a Potential Therapeutic for the Affective-Motivational Dimension of Incision Pain in Rats.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478794/,Positive,,Animal Study,2017,,,Pain; Pain - Acute
2017236,Cannabidiol-Δ9-tetrahydrocannabinol interactions on acute pain and locomotor activity.,https://www.sciencedirect.com/science/article/pii/S0376871617301680,Positive,,Animal Study,2017,Tetrahydrocannabinol (THC),,Pain; Pain - Acute
2016260,The prescription of medical cannabis by a transitional pain service to wean a patient with complex pain from opioid use following liver transplantation: a case report.,https://www.ncbi.nlm.nih.gov/pubmed/26507533,Positive,,Meta-analysis,2016,,Mental/Emotional System,Addiction - Opioid; Addiction; Pain; Pain - Chronic
2006051,Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine.,https://www.ncbi.nlm.nih.gov/pubmed/16375890/,Positive,,Double Blind Clinical Trial,2006,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction; Pain; Pain - Acute
2006052,A multicenter dose-escalation study of the analgesic and adverse effects of an oral cannabis extract (Cannador) for postoperative pain management.,http://anesthesiology.pubs.asahq.org/article.aspx?articleid=1922969,Positive,,Clinical Trial,2006,,,Pain; Pain - Acute
1997015,delta-9-Tetrahydrocannabinol increases prodynorphin and proenkephalin gene expression in the spinal cord of the rat.,https://www.ncbi.nlm.nih.gov/pubmed/9244374/,Positive,,Animal Study,1997,,,Pain; Pain - Central Pain Syndrome; Addiction - Opioid
2017237,Allodynia Lowering Induced by Cannabinoids and Endocannabinoids (ALICE).,https://www.ncbi.nlm.nih.gov/pubmed/28237514,Positive,,Meta-analysis,2017,Endocannabinoid (unspecified),Nervous System,Pain; Pain - Chronic; Pain - Neuropathy - Peripheral
2017238,Compensatory Activation of Cannabinoid CB2 Receptor Inhibition of GABA Release in the Rostral Ventromedial Medulla in Inflammatory Pain.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242409/,Positive,,Animal Study,2017,AM-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,,Pain; Pain - Chronic; Pain - Neuropathy - Inflammatory Polyneuropathy
2017239,Cannabis and intractable chronic pain: an explorative retrospective analysis of Italian cohort of 614 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449133/,Positive,,Clinical Trial,2017,,,Pain - Chronic; Pain; Pain - Cancer
2017240,The cannabinoid system and pain.,https://www.sciencedirect.com/science/article/pii/S002839081730285X,Positive,,Meta-analysis,2017,Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Nervous System,Pain; Pain - Chronic
2017241,Medical use of cannabis in Switzerland: analysis of approved exceptional licences.,https://www.ncbi.nlm.nih.gov/pubmed/28695562,Positive,,Meta-analysis,2017,Pharma THC; Tetrahydrocannabinol (THC),,Pain; Multiple Sclerosis; Pain - Chronic; Spinal Cord Injuries
2017242,Associations between medical cannabis and prescription opioid use in chronic pain patients: A preliminary cohort study.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690609/,Positive,,Clinical Trial,2017,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction; Pain; Pain - Chronic
2016261,"β-caryophyllene, a dietary cannabinoid, complexed with β-cyclodextrin produced anti-hyperalgesic effect involving the inhibition of Fos expression in superficial dorsal horn",https://www.sciencedirect.com/science/article/abs/pii/S0024320516300996?via%3Dihub,Positive,,Animal Study,2016,,Nervous System,Pain; Pain - Chronic
2016262,The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain: A Prospective Open-label Study.,https://www.ncbi.nlm.nih.gov/pubmed/26889611,Positive,,Clinical Trial,2016,,Nervous System,Pain; Pain - Chronic
2011149,Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3243008/,Positive,,Clinical Meta-analysis,2011,Pharma THC:CBD; Pharma THC,Nervous System,Pain; Pain - Chronic; Pain - Neuropathy - Peripheral; Arthritis - Rheumatoid; Arthritis; Fibromyalgia
2008105,"Open-Label, Add-on Study of Tetrahydrocannabinol for Chronic Nonmalignant Pain",https://www.researchgate.net/publication/23555812_Open-Label_Add-on_Study_of_Tetrahydrocannabinol_for_Chronic_Nonmalignant_Pain,Positive,,Clinical Trial,2008,Tetrahydrocannabinol (THC),,Pain; Pain - Chronic; Fibromyalgia; Insomnia and Sleep Disorders; Loss of Appetite; Quality of Life
2008106,Effect of cannabinoid receptor agonists on streptozotocin-induced hyperalgesia in diabetic neuropathy.,https://www.ncbi.nlm.nih.gov/pubmed/18810243,Positive,,Animal Study,2008,AM-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids; Other Related Compounds,Nervous System,Pain; Pain - Neuropathy - Diabetic
2003045,Cannabis Reduces Opioid Dose in the Treatment of Chronic Non-Cancer Pain.,https://www.jpsmjournal.com/article/S0885-3924(03)00142-8/fulltext,Positive,,Meta-analysis,2003,Tetrahydrocannabinol (THC),,Pain; Pain - Chronic
2017243,Experts' perspectives on the role of medical marijuana in oncology: A semistructured interview study,https://www.researchgate.net/publication/312026131_Experts%27_Perspectives_on_the_Role_of_Medical_Marijuana_in_Oncology_a_semi-structured_interview_study_Medical_Marijuana_in_Oncology,Positive,,Meta-analysis,2017,,Nervous System,Cancer; Nausea and Vomiting; Pain - Cancer
2018318,"Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain.",https://www.ncbi.nlm.nih.gov/pubmed/28923526,Positive,,Double Blind Clinical Trial,2018,Pharma THC:CBD; Tetrahydrocannabinol (THC),,Pain; Pain - Cancer
2017244,A selective review of medical cannabis in cancer pain management.,https://www.ncbi.nlm.nih.gov/pubmed/28866904,Positive,,Meta-analysis,2017,Pharma THC:CBD; Tetrahydrocannabinol (THC),Nervous System,Pain; Pain - Cancer
2011150,Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin.,https://pubmed.ncbi.nlm.nih.gov/21514666/,Positive,,Animal Study,2011,AM-x Synthetic Cannabinoids; Anandamide (AEA); Tetrahydrocannabinol (THC),,Pain
2010119,"Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain.",https://www.jpsmjournal.com/article/S0885-3924(09)00787-8/fulltext,Positive,,Double Blind Clinical Trial,2010,Tetrahydrocannabinol (THC),,Pain; Pain - Cancer
1975006,The analgesic properties of delta-9-tetrahydrocannabinol and codeine.,https://www.ncbi.nlm.nih.gov/pubmed/50159,Positive,,Clinical Trial,1975,,,Pain; Pain - Cancer
2018319,"The Cannabinoids Δ8THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812319/,Positive,,Animal Study,2018,Delta-8-THC; HU-x Synthetic Cannabinoids; AM-x Synthetic Cannabinoids,Immune System,Pain; Pain - Eye; Pain - Neuropathy - Inflammatory Polyneuropathy; Uveitis
2012154,"Pain relief assessment by aromatic essential oil massage on outpatients with primary dysmenorrhea: a randomized, double-blind clinical trial.",https://www.ncbi.nlm.nih.gov/pubmed/22435409,Positive,,Double Blind Clinical Trial,2012,,Reproductive System,Menstrual Disorders
2002037,Survey on the Medical Use of Cannabis and THC in Germany.,https://www.tandfonline.com/doi/abs/10.1300/J175v03n02_03,Positive,,Meta-analysis,2002,,,Menstrual Disorders
2009103,"Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066045/,Positive,,Double Blind Clinical Trial,2009,Tetrahydrocannabinol (THC),Immune System; Nervous System,HIV/AIDS; Pain; Pain - Neuropathy - Peripheral
2007080,Cannabis In Painful HIV-associated Sensory Neuropathy: A Randomized Placebo-controlled Trial,https://pubmed.ncbi.nlm.nih.gov/17296917/,Positive,,Double Blind Clinical Trial,2007,Tetrahydrocannabinol (THC),Immune System; Nervous System,HIV/AIDS; Pain; Pain - Neuropathy - Peripheral
2015202,Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152762/,Positive,,Double Blind Clinical Trial,2015,,,Pain; Pain - Neuropathy - Diabetic
2004054,"The effect of WIN 55,212-2, a cannabinoid agonist, on tactile allodynia in diabetic rats.",https://www.ncbi.nlm.nih.gov/pubmed/15519750?dopt=Abstract,Positive,,Animal Study,2004,WIN-x Synthetic Cannabinoids,,Pain; Pain - Neuropathy - Diabetic
2018320,"Systematic review of systematic reviews for medical cannabinoids: Pain, nausea and vomiting, spasticity, and harms.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964405/,Positive,,Meta-analysis,2018,,Digestive System; Nervous System,Chemotherapy-induced Nausea & Vomiting; Pain; Nausea and Vomiting; Multiple Sclerosis; Pain - Chronic; Pain - Neuropathy - Peripheral
2017245,Cannabinoids and Pain: Sites and Mechanisms of Action.,https://www.ncbi.nlm.nih.gov/pubmed/28826543,Positive,,Meta-analysis,2017,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),,Pain; Pain - Acute; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral
2016263,"Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies.",https://www.ncbi.nlm.nih.gov/pubmed/26830780,Positive,,Clinical Meta-analysis,2016,Pharma THC:CBD; Pharma THC; Synthetic Cannabinoid (unspecified),Nervous System,Pain; Pain - Chronic; Pain - Neuropathy - Peripheral
2014172,"The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a study",https://www.researchgate.net/publication/264713234_The_Pharmacokinetics_Efficacy_Safety_and_Ease_of_Use_of_a_Novel_Portable_Metered-Dose_Cannabis_Inhaler_in_Patients_With_Chronic_Neuropathic_Pain_A_Phase_1a_Study,Positive,,Clinical Trial,2014,Cannabinol (CBN),Nervous System,Pain; Pain - Chronic; Pain - Neuropathy - Peripheral
2013137,Low Dose Vaporized Cannabis Significantly Improves Neuropathic Pain.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566631/,Positive,,Double Blind Clinical Trial,2013,Tetrahydrocannabinol (THC),Nervous System,Pain - Neuropathy - Peripheral; Pain; Pain - Central Pain Syndrome
2008107,"A Randomized, Placebo-Controlled, Crossover Trial of Cannabis Cigarettes in Neuropathic Pain.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968043/,Positive,,Double Blind Clinical Trial,2008,Tetrahydrocannabinol (THC),Nervous System,Pain - Neuropathy - Peripheral; Pain; Pain - Central Pain Syndrome
2005063,"Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: review of the available pre-clinical data, and first human studies.",https://www.ncbi.nlm.nih.gov/pubmed/15910891/,Positive,,Meta-analysis,2005,Other Related Compounds,Nervous System,Pain; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral
2004055,Are oral cannabinoids safe and effective in refractory neuropathic pain?,https://www.ncbi.nlm.nih.gov/pubmed/14987627,Inconclusive,,Double Blind Clinical Trial,2004,,,Pain; Pain - Chronic; Pain - Neuropathy - Peripheral; Anxiety; Quality of Life
2003046,Efficacy of two cannabis‐based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial,https://onlinelibrary.wiley.com/doi/full/10.1046/j.1365-2044.2003.03408_3.x,Positive,,Double Blind Clinical Trial,2003,Pharma THC:CBD; Tetrahydrocannabinol (THC),Muscular System,Brachial Plexus Disorders; Pain - Central Pain Syndrome; Pain; Pain - Acute
2003047,Analgesic Effect of the Synthetic Cannabinoid CT-3 on Chronic Neuropathic Pain: A Randomized Controlled Trial,https://www.ncbi.nlm.nih.gov/pubmed/14519710,Positive,,Double Blind Clinical Trial,2003,Delta-8-THC,,Pain; Pain - Chronic; Pain - Neuropathy - Peripheral
2013138,Involvement of peripheral cannabinoid and opioid receptors in β-caryophyllene-induced antinociception.,https://www.ncbi.nlm.nih.gov/pubmed/23138934,Positive,,Animal Study,2013,AM-x Synthetic Cannabinoids,Nervous System,Pain
2017246,Modulation of Human Peripheral Blood Mononuclear Cell Signaling by Medicinal Cannabinoids.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5258717/,Positive,,Double Blind Clinical Trial,2017,Tetrahydrocannabinol (THC),,Pancreatitis
2017247,Severity and outcomes of acute alcoholic pancreatitis in cannabis users.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539398/,Positive,,Meta-analysis,2017,,Digestive System; Endocrine System,Pancreatitis
2005064,Antifibrogenic role of the cannabinoid receptor CB2 in the liver.,http://www.academia.edu/5921035/Antifibrogenic_role_of_the_cannabinoid_receptor_CB2_in_the_liver,Positive,,Animal Study,2005,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); JWH-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC),Digestive System,Fibrosis - Liver (Cirrhosis); Fibrosis
2008108,Cannabinoids Reduce Markers of Inflammation and Fibrosis in Pancreatic Stellate Cells.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2253501/,Positive,,Laboratory Study,2008,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); WIN-x Synthetic Cannabinoids,Digestive System; Endocrine System,Pancreatitis
2008109,"Dual, time-dependent deleterious and protective effect of anandamide on the course of cerulein-induced acute pancreatitis. Role of sensory nerves.",https://www.ncbi.nlm.nih.gov/pubmed/18593574,Positive,,Animal Study,2008,Anandamide (AEA),Digestive System; Endocrine System,Pancreatitis
2005065,"The cannabinoid 1 receptor antagonist, AM251, prolongs the survival of rats with severe acute pancreatitis.",https://pubmed.ncbi.nlm.nih.gov/16141678/,Positive,,Animal Study,2005,AM-x Synthetic Cannabinoids; Anandamide (AEA),Digestive System; Endocrine System,Pancreatitis
2016264,Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease.,https://www.ncbi.nlm.nih.gov/pubmed/25863279,Positive,,Animal Study,2016,HU-x Synthetic Cannabinoids,,Parkinson's Disease
2016265,Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908199/,Positive,,Meta-analysis,2016,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Other Related Compounds; WIN-x Synthetic Cannabinoids,Nervous System,Chorea; Neurodegenerative Issues; Dystonia; Parkinson's Disease
2016266,Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease.,https://www.ncbi.nlm.nih.gov/pubmed/27318096,Positive,,Animal Study,2016,Fatty Acid Amide Hydrolase (FAAH); Other Related Compounds,,Parkinson's Disease
2016267,Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969295/,Positive,,Animal Study,2016,AM-x Synthetic Cannabinoids,,Neurodegenerative Issues; Oxidative Stress; Parkinson's Disease
2017248,Effect of medical cannabis on thermal quantitative measurements of pain in patients with Parkinson's disease.,https://www.ncbi.nlm.nih.gov/pubmed/27723182,Positive,,Clinical Trial,2017,,Nervous System,Parkinson's Disease
2016268,Targeting the cannabinoid CB2 receptor to attenuate the progression of motor deficits in LRRK2-transgenic mice.,https://www.ncbi.nlm.nih.gov/pubmed/27063942,Positive,,Animal Study,2016,,,Parkinson's Disease
2015203,Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604184/,Positive,,Meta-analysis,2015,,,Huntington's Disease; Multiple Sclerosis; Parkinson's Disease
2015204,Identification of CB₂ receptors in human nigral neurons that degenerate in Parkinson's disease.,https://www.ncbi.nlm.nih.gov/pubmed/25481767,Positive,,Laboratory Study,2015,,,Parkinson's Disease
2014173,Effects of cannabidiol in the treatment of patients with Parkinson's disease: an exploratory double-blind trial,https://www.ncbi.nlm.nih.gov/pubmed/25237116,Positive,,Clinical Trial,2014,,Nervous System,Parkinson's Disease
2014174,Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series.,https://www.ncbi.nlm.nih.gov/pubmed/24845114,Positive,,Meta-analysis,2014,,,REM Sleep Behavior Disorder; Insomnia and Sleep Disorders; Parkinson's Disease
2014175,Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson´s disease.,https://www.ncbi.nlm.nih.gov/pubmed/24140894,Positive,,Animal Study,2014,Oleoylethanolamide (OEA),Nervous System,Parkinson's Disease
2012155,Δ⁹-tetrahydrocannabinol (Δ⁹-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease.,https://www.ncbi.nlm.nih.gov/pubmed/22236282,Positive,,Laboratory Study,2012,AM-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Nervous System,Parkinson's Disease
2009104,Cannabidiol: a promising drug for neurodegenerative disorders?,https://www.ncbi.nlm.nih.gov/pubmed/19228180,Positive,,Meta-analysis,2009,,Nervous System,Neurodegenerative Issues; Parkinson's Disease
2009105,Treatment of a hyperkinetic movement disorder during pregnancy with dronabinol.,https://www.ncbi.nlm.nih.gov/pubmed/18692426,Positive,,Meta-analysis,2009,Pharma THC; Tetrahydrocannabinol (THC),Reproductive System,Pregnancy; Parkinson's Disease
2009106,"WIN55,212-2, a Cannabinoid Receptor Agonist, Protects Against Nigrostriatal Cell Loss in the MPTP Mouse Model of Parkinson’s Disease.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2755595/,Positive,,Animal Study,2009,WIN-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,Nervous System,Parkinson's Disease
2007081,Cannabinoids and neuroprotection in basal ganglia disorders.,https://www.ncbi.nlm.nih.gov/pubmed/17952653/,Positive,,Meta-analysis,2007,,,Neurodegenerative Issues; Cardiovascular Diseases (CVD); Chorea; Huntington's Disease; Inflammation; Oxidative Stress; Parkinson's Disease; Reperfusion Injury
2004056,Survey on cannabis use in Parkinson's disease: Subjective improvement of motor symptoms.,https://www.researchgate.net/publication/227621685_Survey_on_Cannabis_use_in_Parkinson%27s_disease_Subjective_improvement_of_motor_symptoms,Positive,,Meta-analysis,2004,,,Parkinson's Disease
2009107,Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats.,https://www.ncbi.nlm.nih.gov/pubmed/19070683,Positive,,Animal Study,2009,,Digestive System,Periodontal Disease; Pain - Dental - Acute
1996014,"A novel nonpsychotropic cannabinoid, HU-211, in the treatment of experimental pneumococcal meningitis.",https://www.ncbi.nlm.nih.gov/pubmed/8627042,Positive,,Animal Study,1996,HU-x Synthetic Cannabinoids,Nervous System,Bacterial Meningitis
2018321,Psychobiological Responses to Aerobic Exercise in Individuals With Posttraumatic Stress Disorder.,https://www.ncbi.nlm.nih.gov/pubmed/29388710,Positive,,Clinical Trial,2018,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Other Related Compounds,Mental/Emotional System,PTSD
2018322,Cannabinoids prevent depressive-like symptoms and alterations in BDNF expression in a rat model of PTSD.,https://www.ncbi.nlm.nih.gov/pubmed/29458190,Positive,,Animal Study,2018,Other Related Compounds; WIN-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,PTSD
2018323,Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder.,https://www.ncbi.nlm.nih.gov/pubmed/28745306,Positive,,Meta-analysis,2018,Endocannabinoid (unspecified),Mental/Emotional System,PTSD
2016269,Endocannabinoid concentrations in hair are associated with PTSD symptom severity.,https://www.ncbi.nlm.nih.gov/pubmed/26923850,Positive,,Clinical Trial,2016,Endocannabinoid (unspecified); Other Related Compounds,Mental/Emotional System,PTSD
2017249,Medical cannabis and mental health: A guided systematic review.,https://www.ncbi.nlm.nih.gov/pubmed/27816801,Positive,,Meta-analysis,2017,,,PTSD
2016270,Bidirectional Effects of Cannabidiol on Contextual Fear Memory Extinction.,https://www.frontiersin.org/articles/10.3389/fphar.2016.00493/full,Positive,,Animal Study,2016,,Mental/Emotional System,PTSD; Anxiety
2015205,"The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study.",https://www.ncbi.nlm.nih.gov/pubmed/25467221,Positive,,Double Blind Clinical Trial,2015,,Mental/Emotional System; Nervous System,PTSD
2013139,The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD).,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3739026/,Positive,,Meta-analysis,2013,Endocannabinoid (unspecified); Other Related Compounds; Synthetic Cannabinoid (unspecified),Mental/Emotional System,PTSD; Anxiety
2013140,Reductions in Circulating Endocannabinoid Levels in Individuals with Post-Traumatic Stress Disorder Following Exposure to the World Trade Center Attacks,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870889/,Positive,,Clinical Trial,2013,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Other Related Compounds,Mental/Emotional System,PTSD; Anxiety
2012156,Mitigation of post-traumatic stress symptoms by Cannabis resin: a review of the clinical and neurobiological evidence.,https://www.ncbi.nlm.nih.gov/pubmed/22736575,Positive,,Meta-analysis,2012,,Mental/Emotional System; Nervous System,PTSD
2009108,Cannabinoid Receptor Activation in the Basolateral Amygdala Blocks the Effects of Stress on the Conditioning and Extinction of Inhibitory Avoidance.,https://www.researchgate.net/publication/26799511_Cannabinoid_Receptor_Activation_in_the_Basolateral_Amygdala_Blocks_the_Effects_of_Stress_on_the_Conditioning_and_Extinction_of_Inhibitory_Avoidance,Positive,,Animal Study,2009,AM-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Mental/Emotional System,PTSD
2009109,The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD).,https://onlinelibrary.wiley.com/doi/full/10.1111/j.1755-5949.2008.00071.x,Positive,,Clinical Trial,2009,Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System,PTSD
2007082,Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2234438/#SD8,Positive,,Animal Study,2007,WIN-x Synthetic Cannabinoids; 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Other Related Compounds,,Pain; Pain - Neuropathy - Inflammatory Polyneuropathy
2017250,Cannabinoids in treatment-resistant epilepsy: A review.,https://www.ncbi.nlm.nih.gov/pubmed/28188044,Positive,,Meta-analysis,2017,,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy
2018324,"Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial",https://www.ncbi.nlm.nih.gov/pubmed/29395273,Positive,,Double Blind Clinical Trial,2018,,Nervous System,Epilepsy - Lennox-Gastaut; Epilepsy
2018325,"Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes.",https://www.epilepsybehavior.com/article/S1525-5050(18)30191-4/fulltext,Positive,,Clinical Trial,2018,,Nervous System,Epilepsy
2016271,Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.,https://www.ncbi.nlm.nih.gov/pubmed/26724101,Positive,,Clinical Trial,2016,,,Epilepsy
2016272,The Pharmacological Basis of Cannabis Therapy for Epilepsy.,https://www.ncbi.nlm.nih.gov/pubmed/26787773,Positive,,Meta-analysis,2016,,,Epilepsy
2017251,Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases.,https://pubmed.ncbi.nlm.nih.gov/27655472/,Positive,,Clinical Trial,2017,Pharma CBD,Immune System; Nervous System,Epilepsy - FIRES; Epilepsy
2016273,CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience,https://www.seizure-journal.com/article/S1059-1311(16)00005-4/fulltext,Positive,,Meta-analysis,2016,,,Epilepsy
1998020,Cannabidiol and Delta9-tetrahydrocannabinol are neuroprotective antioxidants.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC20965/,Positive,,Laboratory Study,1998,Tetrahydrocannabinol (THC),,Neurodegenerative Issues; Oxidative Stress
2015206,Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404240/,Positive,,Meta-analysis,2015,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); CP-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); Other Related Compounds; WIN-x Synthetic Cannabinoids,,Neurodegenerative Issues; Parkinson's Disease
2011151,Prospects for cannabinoid therapies in basal ganglia disorders.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165947/,Positive,,Meta-analysis,2011,,,Huntington's Disease; Inflammation; Neurodegenerative Issues; Parkinson's Disease
2015207,"The neuroprotection of cannabidiol against MPP(+)-induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins, neuritogenesis, and might be relevant to Parkinson's disease.",https://www.researchgate.net/publication/283717163_The_neuroprotection_of_cannabidiol_against_MPP-induced_toxicity_in_PC12_cells_involves_trkA_receptors_upregulation_of_axonal_and_synaptic_proteins_neuritogenesis_and_might_be_relevant_to_Parkinson%27s_d,Positive,,Laboratory Study,2015,,,Neurodegenerative Issues; Parkinson's Disease; Labor and Delivery Issues; Oxidative Stress
2004057,"Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1575333/,Positive,,Animal Study,2004,SR-x Synthetic Cannabinoids,,Pain; Pain - Neuropathy - Inflammatory Polyneuropathy
2010120,Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866040/,Positive,,Animal Study,2010,Cannabichromene (CBC); Tetrahydrocannabinol (THC); Cannabigerol (CBG); Cannabinol (CBN),Mental/Emotional System; Nervous System,Depression
1990002,Therapeutic effects of borneol-walnut oil in the treatment of purulent otitis media.,https://pubmed.ncbi.nlm.nih.gov/2364470/,Positive,,Clinical Trial,1990,,,Middle Ear Infection
2014176,The effect of a minor constituent of essential oil from Citrus aurantium: the role of β-myrcene in preventing peptic ulcer disease.,https://www.ncbi.nlm.nih.gov/pubmed/?term=The+effect+of+a+minor+constituent+of+essential+oil+from+Citrus+aurantium%3A+The+role+of+%CE%B2-myrcene+in+preventing+peptic+ulcer+disease.,Positive,,Animal Study,2014,,Digestive System,Stomach Ulcers
2015208,Anticancer activity of Cinnamon tamala leaf constituents towards human ovarian cancer cells.,https://pubmed.ncbi.nlm.nih.gov/26004731/,Positive,,Laboratory Study,2015,,Reproductive System,Cancer - Ovarian; Cancer
2006053,Anticonflict effects of lavender oil and identification of its active constituents.,https://pubmed.ncbi.nlm.nih.gov/17173962/,Positive,,Animal Study,2006,,Mental/Emotional System,Anxiety
1995009,Effects of Linalool on glutamatergic system in the rat cerebral cortex.,https://www.ncbi.nlm.nih.gov/pubmed/7651584,Positive,,Animal Study,1995,,Mental/Emotional System,Anxiety; Epilepsy
2003048,Antileishmanial Activity of a Linalool-Rich Essential Oil from Croton cajucara.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC155815/,Positive,,Laboratory Study,2003,,Integumentary System,Leishmaniasis
2006054,Olfactory stimulation with scent of lavender oil affects autonomic neurotransmission and blood pressure in rats.,https://www.ncbi.nlm.nih.gov/pubmed/16442729,Positive,,Animal Study,2006,,,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2007083,Treatment with lavender aromatherapy in the post-anesthesia care unit reduces opioid requirements of morbidly obese patients undergoing laparoscopic adjustable gastric banding.,https://pubmed.ncbi.nlm.nih.gov/17894152/,Positive,,Double Blind Clinical Trial,2007,,Nervous System,Pain; Pain - Acute; Addiction - Opioid
2016274,Linalool reverses neuropathological and behavioral impairments in old triple transgenic Alzheimer’s mice.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698173/,Positive,,Animal Study,2016,,Nervous System,Alzheimer's Disease
2015209,Linalool inhibits cigarette smoke-induced lung inflammation by inhibiting NF-κB activation.,https://pubmed.ncbi.nlm.nih.gov/26432179/,Positive,,Animal Study,2015,,Nervous System,Inflammation; Addiction - Nicotine; Pain; Pain - Neuropathy - Inflammatory Polyneuropathy
1993011,Fragrance compounds and essential oils with sedative effects upon inhalation.,https://www.ncbi.nlm.nih.gov/pubmed/8331544,Positive,,Animal Study,1993,,Mental/Emotional System,Anxiety
1991010,Myrcene mimics the peripheral analgesic activity of lemongrass tea.,https://pubmed.ncbi.nlm.nih.gov/1753786/,Positive,,Animal Study,1991,,Nervous System,Pain; Pain - Neuropathy - Peripheral
1990003,Effect of myrcene on nociception in mice.,https://pubmed.ncbi.nlm.nih.gov/1983154/,Positive,,Animal Study,1990,,Nervous System,Pain
2012157,Biological activities of α-pinene and β-pinene enantiomers.,https://www.ncbi.nlm.nih.gov/pubmed/23442885,Positive,,Laboratory Study,2012,,Digestive System; Immune System; Integumentary System,Fungal Infections; Staph Infection
2000018,In-vitro inhibition of human erythrocyte acetylcholinesterase by salvia lavandulaefolia essential oil and constituent terpenes.,https://pubmed.ncbi.nlm.nih.gov/10933142/,Positive,,Laboratory Study,2000,,,Cognitive Dysfunction; Alzheimer's Disease; Multiple Sclerosis; Parkinson's Disease
1991011,Terpenes and the lipid-protein-partitioning theory of skin penetration enhancement.,https://pubmed.ncbi.nlm.nih.gov/2014203/,Positive,,Laboratory Study,1991,,Integumentary System,Skin Diseases
2013141,The sedative effect of inhaled terpinolene in mice and its structure-activity relationships.,https://www.ncbi.nlm.nih.gov/pubmed/23339024,Positive,,Animal Study,2013,,,Anxiety
2012158,"Terpinolene, a component of herbal sage, downregulates AKT1 expression in K562 cells.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362481/,Positive,,Laboratory Study,2012,,,Cancer
1999016,Use of caryophyllene oxide as an antifungal agent in an in vitro experimental model of onychomycosis.,https://link.springer.com/article/10.1023%2FA%3A1007178924408,Positive,,Laboratory Study,1999,,Integumentary System,Foot Nail Fungus
2014177,"Phytol, a Diterpene Alcohol from Chlorophyll, as a Drug against Neglected Tropical Disease Schistosomiasis Mansoni.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879229/,Positive,,Animal Study,2014,,Integumentary System,Snail Fever
2009110,Endocannabinoids anandamide and its cannabinoid receptors in liver fibrosis after murine schistosomiasis.,https://link.springer.com/article/10.1007/s11596-009-0209-y#/page-1,Positive,,Animal Study,2009,Anandamide (AEA),Digestive System; Integumentary System,Fibrosis - Liver (Cirrhosis); Fibrosis; Snail Fever
2008110,Pharmacokinetics and tissue distribution of the sesquiterpene alpha-humulene in mice.,https://www.ncbi.nlm.nih.gov/pubmed/18951339,Positive,,Animal Study,2008,,Nervous System,Pain; Pain - Neuropathy - Inflammatory Polyneuropathy
2003049,"Sensitization of Staphylococcus aureus and Escherichia coli to Antibiotics by the Sesquiterpenoids Nerolidol, Farnesol, Bisabolol, and Apritone.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC201169/,Positive,,Laboratory Study,2003,,Immune System,Staph Infection
1999017,Antimalarial use of volatile oil from leaves of Virola surinamensis (Rol.) Warb. by Waiãpi Amazon Indians.,https://pubmed.ncbi.nlm.nih.gov/10617066/,Positive,,Laboratory Study,1999,,Immune System,Malaria
2002038,"Phytol, SSADH inhibitory diterpenoid of Lactuca sativa.",https://www.ncbi.nlm.nih.gov/pubmed/12433198,Positive,,Laboratory Study,2002,,,Anxiety
2005066,"Biphasic Effects of Geranylgeraniol, Teprenone, and Phytol on the Growth of Staphylococcus aureus.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1087616/,Positive,,Laboratory Study,2005,,Immune System,Staph Infection
2014178,"Phytol, a diterpene alcohol, inhibits the inflammatory response by reducing cytokine production and oxidative stress.",https://www.researchgate.net/publication/267033198_Phytol_a_diterpene_alcohol_inhibits_the_inflammatory_response_by_reducing_cytokine_production_and_oxidative_stress,Positive,,Animal Study,2014,,Nervous System,Oxidative Stress; Pain; Pain - Neuropathy - Inflammatory Polyneuropathy
2013142,Antinociceptive and Antioxidant Activities of Phytol In Vivo and In Vitro Models.,https://www.researchgate.net/publication/258400982_Antinociceptive_and_Antioxidant_Activities_of_Phytol_In_Vivo_and_In_Vitro_Models,Positive,,Animal Study,2013,,Nervous System,Pain; Oxidative Stress; Pain - Neuropathy - Inflammatory Polyneuropathy
2011152,"Camphene, a Plant-Derived Monoterpene, Reduces Plasma Cholesterol and Triglycerides in Hyperlipidemic Rats Independently of HMG-CoA Reductase Activity.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207810/,Positive,,Animal Study,2011,,Cardiovascular System,Atherosclerosis; Cardiovascular Diseases (CVD)
2013143,"Antinociceptive Activity and Redox Profile of the Monoterpenes (+)-Camphene, p-Cymene, and Geranyl Acetate in Experimental Models.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658412/,Positive,,Animal Study,2013,,Nervous System,Pain; Pain - Neuropathy - Inflammatory Polyneuropathy
2005067,"Impaired thermosensation in mice lacking TRPV3, a heat and camphor sensor in the skin.",https://www.ncbi.nlm.nih.gov/pubmed/15746429,Positive,,Animal Study,2005,,Nervous System,Pain; Pain - Neuropathy - Inflammatory Polyneuropathy
2017252,A clinical and mechanistic study of topical borneol‐induced analgesia.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452010/,Positive,,Double Blind Clinical Trial,2017,,Nervous System,Pain; Pain - Acute
1990004,Antianxiety effect of cannabidiol in the elevated plus-maze.,https://www.ncbi.nlm.nih.gov/pubmed/1969666/,Positive,,Animal Study,1990,,Mental/Emotional System,Anxiety
1993012,Characterization of cannabidiol-mediated cytochrome P450 inactivation.,https://www.ncbi.nlm.nih.gov/pubmed/8466552,Positive,,Animal Study,1993,,,Addiction - Stimulant
1995010,Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain.,https://www.ncbi.nlm.nih.gov/pubmed/7493549/,Positive,,Animal Study,1995,Tetrahydrocannabinol (THC),Mental/Emotional System,Cannabis Adverse Effects
1972002,A metabolic interaction in vivo between cannabidiol and Δ1-tetrahydrocannabinol.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1666148/,Positive,,Animal Study,1972,,,Cannabis Adverse Effects
2018326,Cannabidiol attenuates delta 9-tetrahydrocannabinol-like discriminative stimulus effects of cannabinol.,https://www.ncbi.nlm.nih.gov/pubmed/3017729/,Positive,,Animal Study,2018,Cannabinol (CBN),,Cannabis Adverse Effects
2008111,Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Δ9-tetrahydrocannabinol.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2279017/,Positive,,Animal Study,2008,Tetrahydrocannabinol (THC),,Addiction - Cannabis; Cannabis Adverse Effects
2010121,Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906701/,Positive,,Clinical Trial,2010,Tetrahydrocannabinol (THC),Mental/Emotional System,Cannabis Adverse Effects; Addiction - Alcohol; Addiction - Cannabis; Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid; Addiction - Stimulant
2011153,Spontaneous regression of septum pellucidum/forniceal pilocytic astrocytomas--possible role of Cannabis inhalation.,https://pubmed.ncbi.nlm.nih.gov/21336992/,Positive,,Meta-analysis,2011,,,Cancer - Brain; Cancer
2012159,Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657999/,Positive,,Animal Study,2012,2-Arachidonoyl Glycerol (2-AG); Monoacylglycerol Lipase (MAGL),,Fragile X Syndrome
2016275,Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex.,https://onlinelibrary.wiley.com/doi/10.1111/epi.13499,Positive,,Clinical Trial,2016,,,Epilepsy
1960001,Cannabis as a medicament.,https://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1960-01-01_3_page003.html,Positive,,Laboratory Study,1960,,Respiratory System,Tuberculosis
2016276,Cannabidiol: a potential treatment for post Ebola Syndrome?,https://www.researchgate.net/publication/308738700_Cannabidiol_a_potential_treatment_for_post_Ebola_Syndrome,Positive,,Meta-analysis,2016,,Immune System,Ebola Virus Disease
2013144,Cannabinoids: Well-Suited Candidates for the Treatment of Perinatal Brain Injury.,https://www.mdpi.com/2076-3425/3/3/1043,Positive,,Meta-analysis,2013,WIN-x Synthetic Cannabinoids,Nervous System; Reproductive System,Labor and Delivery Issues; Neonatal Cerebral Issues; Neurodegenerative Issues; Oxidative Stress; Stroke
2010122,"Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress and cell death in nephropathy.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869084/?tool=pubmed,Positive,,Animal Study,2010,HU-x Synthetic Cannabinoids,Nervous System; Urinary System,Drug-Induced Nephropathy; Oxidative Stress
2018327,Reduced Incidence and Better Liver Disease Outcomes among Chronic HCV Infected Patients Who Consume Cannabis.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174743/,Positive,,Meta-analysis,2018,,Digestive System,Fibrosis - Liver (Cirrhosis); Fibrosis
2015210,Emerging Therapeutic Targets of Sepsis-Associated Acute Kidney Injury.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369320/,Positive,,Meta-analysis,2015,Anandamide (AEA),Urinary System,Kidney Failure
2018328,Proximal Tubular Cannabinoid-1 Receptor Regulates Obesity-Induced CKD.,https://www.ncbi.nlm.nih.gov/pubmed/28860163,Positive,,Animal Study,2018,Endocannabinoid (unspecified),,Chronic Kidney Disease
2018329,Biphasic effects of THC in memory and cognition.,https://www.ncbi.nlm.nih.gov/pubmed/29574698,Positive,,Meta-analysis,2018,Tetrahydrocannabinol (THC),Nervous System,Alzheimer's Disease; Cognitive Dysfunction; Neurodegenerative Issues; Encephalitis and Myelitis
2018330,"Investigating the Relationships Between Alcohol Consumption, Cannabis Use, and Circulating Cytokines: A Preliminary Analysis.",https://www.ncbi.nlm.nih.gov/pubmed/29286537,Positive,,Clinical Trial,2018,,Mental/Emotional System,Addiction - Alcohol; Addiction
2015211,Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9-Tetrahydrocannabinol.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669115/,Positive,,Animal Study,2015,,Digestive System; Endocrine System,Microbiome Imbalance; Obesity
2008112,Biological activities of Korean Citrus obovoides and Citrus natsudaidai essential oils against acne-inducing bacteria.,https://pubmed.ncbi.nlm.nih.gov/18838824/,Positive,,Laboratory Study,2008,,Integumentary System,Acne
2012160,Evaluation of acute toxicity of a natural compound (+)-limonene epoxide and its anxiolytic-like action,https://pubmed.ncbi.nlm.nih.gov/22364736/,Positive,,Animal Study,2012,,Mental/Emotional System; Nervous System,Anxiety; Addiction - Benzodiazepine
1995011,Effects of citrus fragrance on immune function and depressive states.,https://pubmed.ncbi.nlm.nih.gov/8646568/,Positive,,Clinical Trial,1995,,Mental/Emotional System,Depression; Injury Immunodeficiency
2013145,Oral administration of d-limonene controls inflammation in rat colitis and displays anti-inflammatory properties as diet supplementation in humans.,https://pubmed.ncbi.nlm.nih.gov/23665426/,Positive,,Animal Study,2013,,,Acne; IBD - Inflammatory Bowel Disease; Pain; Pain - Neuropathy - Inflammatory Polyneuropathy
2011154,"Limonene, a natural cyclic terpene, is an agonistic ligand for adenosine A(2A) receptors.",https://pubmed.ncbi.nlm.nih.gov/21134357/,Positive,,Laboratory Study,2011,,,Acne; Pain; Pain - Neuropathy - Inflammatory Polyneuropathy
2011155,Efficacy of monoterpene perillyl alcohol upon survival rate of patients with recurrent glioblastoma.,https://pubmed.ncbi.nlm.nih.gov/20401670/,Positive,,Clinical Trial,2011,,Nervous System,Cancer - Brain; Cancer
2008113,Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas.,https://www.ncbi.nlm.nih.gov/pubmed/18295834,Positive,,Clinical Trial,2008,,Nervous System,Cancer - Brain; Cancer
2015212,Preclinical development and clinical use of perillyl alcohol for chemoprevention and cancer therapy.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497427/,Positive,,Meta-analysis,2015,,,Cancer - Brain; Cancer
2008114,Antiproliferative effects of essential oils and their major constituents in human renal adenocarcinoma and amelanotic melanoma cells.,https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-2184.2008.00561.x,Positive,,Laboratory Study,2008,,Integumentary System; Nervous System; Urinary System,Cancer - Kidney; Cancer - Melanoma; Cancer
2015213,β-Caryophyllene potently inhibits solid tumor growth and lymph node metastasis of B16F10 melanoma cells in high-fat diet-induced obese C57BL/6N mice.,https://pubmed.ncbi.nlm.nih.gov/26025912/,Positive,,Animal Study,2015,,Immune System; Integumentary System; Nervous System,Cancer - Lymphoma; Cancer - Melanoma; Cancer
2006055,Antiproliferative activity of essential oils derived from plants belonging to the Magnoliophyta division.,https://pubmed.ncbi.nlm.nih.gov/16964395/,Positive,,Laboratory Study,2006,,Immune System; Nervous System,Cancer - Leukemia; Cancer
2010123,Alpha terpineol: a potential anticancer agent which acts through suppressing NF-kappaB signalling.,https://pubmed.ncbi.nlm.nih.gov/20651334/,Positive,,Laboratory Study,2010,,Nervous System,Cancer; Cancer - Lung
2015214,Anti-tumor effect of α-pinene on human hepatoma cell lines through inducing G2/M cell cycle arrest.,https://pubmed.ncbi.nlm.nih.gov/25837931/,Positive,,Laboratory Study,2015,,Digestive System; Nervous System,Cancer - Liver; Cancer
2003050,Antileukemic activity of selected natural products in Taiwan.,https://www.ncbi.nlm.nih.gov/pubmed/12723753,Positive,,Laboratory Study,2003,,Immune System,Cancer - Leukemia; Cancer - Lymphoma; Cancer
2008115,"Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells.",https://www.ncbi.nlm.nih.gov/pubmed/18695915,Positive,,Laboratory Study,2008,,Nervous System; Reproductive System,Cancer - Breast; Cancer
2013146,Human breast tissue disposition and bioactivity of limonene in women with early stage breast cancer.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692564/,Positive,,Clinical Trial,2013,,Nervous System; Reproductive System,Cancer - Breast; Cancer
2002039,"Specific induction of apoptosis by 1,8-cineole in two human leukemia cell lines, but not a in human stomach cancer cell line.",https://www.ncbi.nlm.nih.gov/pubmed/12066204,Positive,,Laboratory Study,2002,,Immune System; Nervous System,Cancer - Leukemia; Cancer
1990005,"Uptake, distribution and elimination of alpha-pinene in man after exposure by inhalation.",https://www.researchgate.net/publication/20899950_Uptake_distribution_and_elimination_of_-pinene_in_man_after_exposure_by_inhalation,Positive,,Clinical Trial,1990,,Respiratory System,Asthma; Cough
1998021,Inhibition of cytokine production and arachidonic acid metabolism by eucalyptol (1.8-cineole) in human blood monocytes in vitro.,https://pubmed.ncbi.nlm.nih.gov/9810029/,Positive,,Laboratory Study,1998,,Respiratory System,Asthma; Cough; COVID-19
2004058,"Therapy for acute nonpurulent rhinosinusitis with cineole: results of a double-blind, randomized, placebo-controlled trial.",https://pubmed.ncbi.nlm.nih.gov/15064633/,Positive,,Double Blind Clinical Trial,2004,,,Cough
2017253,Targeting fatty acid amide hydrolase as a therapeutic strategy for antitussive therapy.,https://pubmed.ncbi.nlm.nih.gov/28931663/,Positive,,Animal Study,2017,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Endocannabinoid (unspecified); Other Related Compounds,Respiratory System,Cough
2009111,Marijuana and chronic obstructive lung disease: a population-based study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2665947/,Inconclusive,,Meta-analysis,2009,,Respiratory System,COPD; Cough
2009112,Effects of Marijuana Smoking on Pulmonary Function and Respiratory Complications: A Systematic Review.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720277/,Positive,,Meta-analysis,2009,,Respiratory System,Asthma; Cough; Bronchitis
2005068,Novel treatment for cough,http://www.freepatentsonline.com/y2006/0013777.html,Positive,,Meta-analysis,2005,Anandamide (AEA); Synthetic Cannabinoid (unspecified),Respiratory System,Cough
2003051,Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea-pigs by cannabinoid (CB2) receptor activation.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574031/,Positive,,Animal Study,2003,JWH-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Respiratory System,Cough
2015215,"The Effect of Phytocannabinoids on Airway Hyper-Responsiveness, Airway Inflammation, and Cough.",http://jpet.aspetjournals.org/content/353/1/169,Positive,,Animal Study,2015,Tetrahydrocannabinol (THC); AM-x Synthetic Cannabinoids; Cannabichromene (CBC); Cannabidiolic Acid (CBD-a); Cannabigerol (CBG); CP-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,Respiratory System,Cough
2016277,Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013116/,Positive,,Meta-analysis,2016,Pharma THC:CBD; Tetrahydrocannabinol (THC),,Multiple Sclerosis
2016278,Tetrahydrocannabinol:Cannabidiol Oromucosal Spray for Multiple Sclerosis-Related Resistant Spasticity in Daily Practice,https://www.ncbi.nlm.nih.gov/pubmed/27732980,Positive,,Clinical Trial,2016,Pharma THC:CBD,Nervous System,Multiple Sclerosis; Quality of Life
2017254,Potent immunomodulatory activity of a highly selective cannabinoid CB2 agonist on immune cells from healthy subjects and patients with multiple sclerosis.,https://www.ncbi.nlm.nih.gov/pubmed/28041663,Positive,,Laboratory Study,2017,Synthetic Cannabinoid (unspecified),Nervous System,Multiple Sclerosis
2017255,Cannabinoids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: a systematic review and meta-analysis.,https://www.ncbi.nlm.nih.gov/pubmed/28058780,Positive,,Meta-analysis,2017,,Nervous System,Multiple Sclerosis
2017256,Delta-9-Tetrahydrocannabinol/Cannabidiol Oromucosal Spray (Sativex®): A Review in Multiple Sclerosis-Related Spasticity,https://www.ncbi.nlm.nih.gov/pubmed/28293911,Positive,,Meta-analysis,2017,Pharma THC:CBD,,Multiple Sclerosis
2017257,Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538735/,Positive,,Meta-analysis,2017,Pharma THC:CBD,Nervous System,Multiple Sclerosis
2018331,Cannabinoids for spasticity due to multiple sclerosis or paraplegia: A systematic review and meta-analysis of randomized clinical trials.,https://www.ncbi.nlm.nih.gov/pubmed/28917371,Positive,,Clinical Meta-analysis,2018,,Nervous System,Multiple Sclerosis
2018332,THC/CBD oromucosal spray in patients with multiple sclerosis overactive bladder: a pilot prospective study,https://www.ncbi.nlm.nih.gov/pubmed/29052091,Positive,,Clinical Trial,2018,Pharma THC:CBD; Tetrahydrocannabinol (THC),Nervous System,Multiple Sclerosis
2018333,Sativex in the management of multiple sclerosis-related spasticity: An overview of the last decade of clinical evaluation,https://www.ncbi.nlm.nih.gov/pubmed/29055461,Positive,,Clinical Meta-analysis,2018,Pharma THC:CBD; Tetrahydrocannabinol (THC),Nervous System,Multiple Sclerosis
2018334,The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews.,https://www.ncbi.nlm.nih.gov/pubmed/29442178,Positive,,Meta-analysis,2018,Pharma THC:CBD; Pharma THC; Tetrahydrocannabinol (THC),,Multiple Sclerosis
2018335,"Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831753/,Positive,,Animal Study,2018,Synthetic Cannabinoid (unspecified),,Multiple Sclerosis
2018336,Clinical response to Nabiximols correlates with the downregulation of immune pathways in multiple sclerosis.,https://www.ncbi.nlm.nih.gov/pubmed/29528549,Positive,,Clinical Trial,2018,Pharma THC:CBD,Nervous System,Multiple Sclerosis
2018337,Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients With Multiple Sclerosis: A Pilot Study on the Plasma Concentration-Effect Relationship,https://www.ncbi.nlm.nih.gov/pubmed/30024443,Positive,,Clinical Trial,2018,Pharma THC:CBD; Tetrahydrocannabinol (THC),Nervous System,Multiple Sclerosis
2018338,Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164967/,Positive,,Meta-analysis,2018,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); JWH-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); O-x Synthetic Cannabinoids; Other Related Compounds; Pharma THC:CBD; Pharma THC; Synthetic Cannabinoid (unspecified); Tetrahydrocannabinol (THC); WIN-x Synthetic Cannabinoids,,Multiple Sclerosis
2018339,Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085417/,Positive,,Animal Study,2018,,Nervous System,Multiple Sclerosis
2019739,"Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis.",https://www.ncbi.nlm.nih.gov/pubmed/19690824/,Positive,,Animal Study,2019,,Digestive System,IBD - Inflammatory Bowel Disease; IBD - Crohn's Disease; Irritable Bowel Syndrome; Oxidative Stress
2013147,Cannabidiol in inflammatory bowel diseases: a brief overview.,https://www.ncbi.nlm.nih.gov/pubmed/22815234,Positive,,Meta-analysis,2013,,,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Irritable Bowel Syndrome
2013148,Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study,https://www.cghjournal.org/article/S1542-3565(13)00604-6/fulltext,Positive,,Double Blind Clinical Trial,2013,,Digestive System,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Irritable Bowel Syndrome
2018340,Cannabis and pediatric inflammatory bowel disease: change blossoms a mile high.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5250561/,Positive,,Meta-analysis,2018,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Irritable Bowel Syndrome; Microbiome Imbalance
2018341,"The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information: Commissioned by the Crohn's and Colitis Foundation.",https://www.ncbi.nlm.nih.gov/pubmed/30358848,Positive,,Meta-analysis,2018,,Digestive System,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Irritable Bowel Syndrome
2014179,Cannabis for inflammatory bowel disease.,https://www.ncbi.nlm.nih.gov/pubmed/24969296,Positive,,Meta-analysis,2014,,,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Irritable Bowel Syndrome
2016279,The gastrointestinal tract – a central organ of cannabinoid signaling in health and disease.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130148/,Positive,,Meta-analysis,2016,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); JWH-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); Other Related Compounds; Pharma THC; SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,,Cancer - Colon; Cancer; IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Irritable Bowel Syndrome; Microbiome Imbalance
2016280,An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047908/,Positive,,Animal Study,2016,Cannabichromene (CBC); Tetrahydrocannabinol (THC),,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Irritable Bowel Syndrome
2016281,Therapeutic Use of Cannabis in Inflammatory Bowel Disease.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193087/,Positive,,Meta-analysis,2016,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Irritable Bowel Syndrome
2017258,Manipulation of the Endocannabinoid System in Colitis: A Comprehensive Review.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038810/,Positive,,Meta-analysis,2017,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); O-x Synthetic Cannabinoids; Other Related Compounds; SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); WIN-x Synthetic Cannabinoids,Digestive System,IBD - Inflammatory Bowel Disease; IBD - Crohn's Disease; Irritable Bowel Syndrome
2017259,Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388177/,Positive,,Meta-analysis,2017,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Endocannabinoid (unspecified); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Pharma THC:CBD; Pharma THC; Synthetic Cannabinoid (unspecified),,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Irritable Bowel Syndrome
2017260,"Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial",https://www.ncbi.nlm.nih.gov/pubmed/28349233,Inconclusive,,Double Blind Clinical Trial,2017,,Digestive System,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease; Irritable Bowel Syndrome
2017261,Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon.,https://www.ncbi.nlm.nih.gov/pubmed/28954820,Positive,,Laboratory Study,2017,Palmitoylethanolamide (PEA); AM-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Digestive System,IBD - Inflammatory Bowel Disease
2017262,Anti-Inflammatory Activity in Colon Models Is Derived from Δ9-Tetrahydrocannabinolic Acid That Interacts with Additional Compounds in Cannabis Extracts.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627671/,Positive,,Laboratory Study,2017,Tetrahydrocannabinolic Acid (THC-a),Digestive System,IBD - Crohn's Disease; IBD - Inflammatory Bowel Disease
2016282,"Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study.",https://www.ncbi.nlm.nih.gov/pubmed/27573936,Positive,,Double Blind Clinical Trial,2016,Tetrahydrocannabivarin (THCV),Endocrine System,Diabetes; Fatty Liver Disease
2016283,Marijuana Use and Type 2 Diabetes Mellitus: a Review.,https://www.ncbi.nlm.nih.gov/pubmed/27747490,Positive,,Meta-analysis,2016,,Endocrine System,Diabetes
2017263,Dual therapy targeting the endocannabinoid system prevents experimental diabetic nephropathy.,https://www.ncbi.nlm.nih.gov/pubmed/28387811,Positive,,Animal Study,2017,AM-x Synthetic Cannabinoids,Endocrine System; Urinary System,Diabetic Kidney Disease
2018342,Endocannabinoid system acts as a regulator of immune homeostasis in the gut.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441729/,Positive,,Animal Study,2018,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Digestive System,Microbiome Imbalance; Diabetes
2018343,The Inhibitory Effects of Cobalt Protoporphyrin IX and Cannabinoid 2 Receptor Agonists in Type 2 Diabetic Mice.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713238/,Positive,,Animal Study,2018,JWH-x Synthetic Cannabinoids; AM-x Synthetic Cannabinoids,Endocrine System; Nervous System,Diabetes; Pain; Pain - Neuropathy - Diabetic
2018344,Δ9-Tetrahydrocannabinol Prevents Cardiovascular Dysfunction in STZ-Diabetic Wistar-Kyoto Rats.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664274/,Positive,,Animal Study,2018,,Cardiovascular System; Endocrine System,Cardiovascular Diseases (CVD); Diabetes; Neurodegenerative Issues; Oxidative Stress
2018345,LH-21 and abnormal cannabidiol improve β-cell function in isolated human and mouse islets through GPR55-dependent and -independent signalling.,https://www.ncbi.nlm.nih.gov/pubmed/29205751,Positive,,Animal Study,2018,Abnormal Cannabidiol (Abn-CBD); Synthetic Cannabinoid (unspecified),,Diabetes
2018346,Cannabis Therapeutics and the Future of Neurology,https://www.frontiersin.org/articles/10.3389/fnint.2018.00051/full,Positive,,Meta-analysis,2018,Cannabidiolic Acid (CBD-a); Tetrahydrocannabinol (THC); Tetrahydrocannabinolic Acid (THC-a),,Alzheimer's Disease; Cancer - Brain; Cancer; Epilepsy - Dravet Syndrome; Epilepsy - Lennox-Gastaut; Epilepsy; Multiple Sclerosis; Neurodegenerative Issues; Obesity; Parkinson's Disease; Traumatic Brain Injury
2006056,Cannabinoid Derivatives Induce Cell Death In Pancreatic MIA PaCa-2 Cells Via A Receptor-independent Mechanism,https://www.sciencedirect.com/science/article/pii/S0014579306002110,Positive,,Laboratory Study,2006,Synthetic Cannabinoid (unspecified); AM-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Endocrine System,Cancer - Pancreatic; Cancer
2006057,Cannabinoids Induce Apoptosis Of Pancreatic Tumor Cells Via Endoplasmic Reticulum Stress-related Genes,https://www.ncbi.nlm.nih.gov/pubmed/16818650,Positive,,Laboratory Study,2006,Tetrahydrocannabinol (THC),Endocrine System; Nervous System,Cancer - Pancreatic; Cancer
2008116,Cannabinoids in pancreatic cancer: Correlation with survival and pain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225529/,Positive,,Laboratory Study,2008,Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Endocrine System; Nervous System,Cancer - Pancreatic; Cancer
2008117,Inhaled linalool-induced sedation in mice.,https://www.ncbi.nlm.nih.gov/pubmed/18824339,Positive,,Animal Study,2008,,,Anxiety; Epilepsy; Insomnia and Sleep Disorders
2018347,Linalool Odor-Induced Anxiolytic Effects in Mice.,https://www.frontiersin.org/articles/10.3389/fnbeh.2018.00241/full,Positive,,Animal Study,2018,,Mental/Emotional System; Nervous System,Anxiety
2018348,A prospective open-label trial of a CBD/THC cannabis oil in Dravet Syndrome.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144444/,Positive,,Clinical Trial,2018,Tetrahydrocannabinol (THC),Nervous System,Epilepsy - Dravet Syndrome; Epilepsy; Quality of Life
2016284,β‐caryophyllene and β‐caryophyllene oxide—natural compounds of anticancer and analgesic properties.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083753/,Positive,,Meta-analysis,2016,,Nervous System,"Cancer; Pain; Pain - Cancer; ADD and ADHD; Autism; Cancer - Colon; Cancer - Breast; Cancer - Cervical; Cancer - Leukemia; Cancer - Lung; Cancer - Metastatic; Cancer - Myeloma; Cancer - Pancreatic; Cancer - Prostate; Cancer - Stomach; Epstein-Barr, Mono; Inflammation; Neurodegenerative Issues; Obesity; Osteoporosis"
2017264,"β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412277/,Positive,,Animal Study,2017,AM-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,Nervous System,Multiple Sclerosis; Neurodegenerative Issues; Encephalitis and Myelitis
2017265,Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520783/,Positive,,Meta-analysis,2017,Pharma THC; Tetrahydrocannabinol (THC); CP-x Synthetic Cannabinoids; HU-x Synthetic Cannabinoids; Pharma THC:CBD; WIN-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction; Pain; Pain - Acute; Pain - Cancer; Pain - Central Pain Syndrome; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral
2017266,Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson’s Disease. Induced by MPTP.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620604/,Positive,,Animal Study,2017,AM-x Synthetic Cannabinoids,,Parkinson's Disease
2017267,Neuroprotective Effect of β-Caryophyllene on Cerebral Ischemia-Reperfusion Injury via Regulation of Necroptotic Neuronal Death and Inflammation: In Vivo and in Vitro,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662640/,Positive,,Animal Study,2017,,Cardiovascular System; Nervous System,Cardiovascular Diseases (CVD); Neurodegenerative Issues; Reperfusion Injury; Stroke
2013149,β-caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312970/,Positive,,Animal Study,2013,,Urinary System,Drug-Induced Nephropathy
1999018,Side effects of pharmaceuticals not elicited by comparable herbal medicines: the case of tetrahydrocannabinol and marijuana.,https://www.ncbi.nlm.nih.gov/pubmed/10394675,Positive,,Meta-analysis,1999,,,Addiction - Cannabis
2018349,Endocannabinoid signalling: has it got rhythm?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931554/,Positive,,Meta-analysis,2018,Anandamide (AEA),,Insomnia and Sleep Disorders
2018350,Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test.,https://www.researchgate.net/publication/328338223_Cannabidiol_presents_an_inverted_U-shaped_dose-response_curve_in_a_simulated_public_speaking_test,Positive,,Double Blind Clinical Trial,2018,,Mental/Emotional System,Anxiety
2011156,Dramatic improvement of refractory Isaacs' syndrome after treatment with dronabinol.,https://www.ncbi.nlm.nih.gov/pubmed/21144646%20%20,Positive,,Meta-analysis,2011,Pharma THC,Muscular System,Muscular Dystrophy & Myotonic Disorders
2010124,Cannabinoids Inhibit Cellular Respiration Of Human Oral Cancer Cells,https://www.ncbi.nlm.nih.gov/pubmed/20516734,Positive,,Laboratory Study,2010,Tetrahydrocannabinol (THC),Digestive System; Nervous System,Cancer - Oral; Cancer
2015216,Exploiting Cannabinoid-induced Cytotoxic Autophagy To Drive Melanoma Cell Death,https://www.ncbi.nlm.nih.gov/pubmed/25674907,Positive,,Animal Study,2015,,Integumentary System; Nervous System,Cancer - Melanoma; Cancer; Cancer - Metastatic
2017268,"Cannabidiol, A Novel Inverse Agonist For GPR12",https://www.ncbi.nlm.nih.gov/pubmed/28888984,Positive,,Laboratory Study,2017,,Nervous System,Cancer - Metastatic; Cancer
2000019,Anandamide Induces Apoptosis In Human Cells Via Vanilloid Receptors: Evidence For A Protective Role Of Cannabinoid Receptors,http://www.jbc.org/content/275/41/31938.full,Positive,,Laboratory Study,2000,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); SR-x Synthetic Cannabinoids,Immune System; Nervous System,Cancer - Lymphoma; Cancer; Kaposi's Sarcoma
2006058,"Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma.",https://www.ncbi.nlm.nih.gov/pubmed/16936228,Positive,,Laboratory Study,2006,WIN-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Immune System; Nervous System,Cancer - Lymphoma; Cancer
2008118,Expression Of Cannabinoid Receptors Type 1 And Type 2 In Non-Hodgkin Lymphoma: Growth Inhibition By Receptor Activation,https://www.ncbi.nlm.nih.gov/pubmed/18546271,Positive,,Laboratory Study,2008,Other Related Compounds,Immune System; Nervous System,Cancer - Lymphoma; Cancer
2009113,Potentiation of cannabinoid-induced cytotoxicity in mantle cell lymphoma through modulation of ceramide metabolism.,https://www.ncbi.nlm.nih.gov/pubmed/19609004,Positive,,Laboratory Study,2009,Other Related Compounds; SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Immune System; Nervous System,Cancer - Lymphoma; Cancer
2014180,"Beta caryophyllene and caryophyllene oxide, isolated from Aegle marmelos, as the potent anti-inflammatory agents against lymphoma and neuroblastoma cells.",https://www.ncbi.nlm.nih.gov/pubmed/24484210,Positive,,Laboratory Study,2014,,Immune System; Nervous System,Cancer - Lymphoma; Cancer - Neuroblastoma; Cancer
1975007,Antineoplastic Activity Of Cannabinoids,https://academic.oup.com/jnci/article-abstract/55/3/597/912322?redirectedFrom=fulltext,Positive,,Laboratory Study,1975,Cannabinol (CBN); Tetrahydrocannabinol (THC),Respiratory System,Cancer - Lung; Cancer - Leukemia; Cancer
2006059,Marijuana Use And The Risk Of Lung And Upper Aerodigestive Tract Cancers: Results Of A Population-based Case-control Study,https://www.ncbi.nlm.nih.gov/pubmed/17035389,Inconclusive,,Meta-analysis,2006,,Nervous System; Respiratory System,Cancer - Lung; Cancer
2008119,Delta9-Tetrahydrocannabinol Inhibits Epithelial Growth Factor-induced Lung Cancer Cell Migration In Vitro As Well As Its Growth And Metastasis In Vivo,https://www.ncbi.nlm.nih.gov/pubmed/17621270,Positive,,Laboratory Study,2008,Tetrahydrocannabinol (THC),Nervous System; Respiratory System,Cancer - Lung; Cancer
2013150,COX-2 And PPAR-γ Confer Cannabidiol-induced Apoptosis Of Human Lung Cancer Cells,https://www.ncbi.nlm.nih.gov/pubmed/23220503,Positive,,Laboratory Study,2013,,Nervous System; Respiratory System,Cancer - Lung; Cancer
2014181,Cannabinoids Increase Lung Cancer Cell Lysis By Lymphokine-activated Killer Cells Via Upregulation Of ICAM-1,https://www.ncbi.nlm.nih.gov/pubmed/25069049,Positive,,Laboratory Study,2014,Tetrahydrocannabinol (THC); Other Related Compounds,Nervous System; Respiratory System,Cancer - Lung; Cancer - Metastatic; Cancer
2006060,Overexpression Of Cannabinoid Receptors CB1 And CB2 Correlates With Improved Prognosis Of Patients With Hepatocellular Carcinoma,https://www.ncbi.nlm.nih.gov/pubmed/17074588,Positive,,Laboratory Study,2006,,Digestive System; Nervous System,Cancer - Liver; Cancer
2009114,Cannabidiol Ameliorates Cognitive And Motor Impairments In Mice With Bile Duct Ligation,https://www.ncbi.nlm.nih.gov/pubmed/19596476,Positive,,Animal Study,2009,,Nervous System,Cognitive Dysfunction; Cancer - Liver; Cancer; Fatty Liver Disease; Fibrosis - Liver (Cirrhosis); Fibrosis
2009115,Apoptosis Induced In HepG2 Cells By The Synthetic Cannabinoid WIN: Involvement Of The Transcription Factor PPARgamma,https://www.ncbi.nlm.nih.gov/pubmed/19059457,Positive,,Laboratory Study,2009,WIN-x Synthetic Cannabinoids,Digestive System; Nervous System,Cancer - Liver; Cancer
2011157,Anti-tumoral Action Of Cannabinoids On Hepatocellular Carcinoma: Role Of AMPK-dependent Activation Of Autophagy,https://www.ncbi.nlm.nih.gov/pubmed/21475304,Positive,,Laboratory Study,2011,JWH-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC),Digestive System; Nervous System,Cancer - Liver; Cancer
2005069,Cannabis-induced Cytotoxicity In Leukemic Cell Lines: The Role Of The Cannabinoid Receptors And The MAPK Pathway,https://www.ncbi.nlm.nih.gov/pubmed/15454482,Positive,,Laboratory Study,2005,Tetrahydrocannabinol (THC),Immune System; Nervous System,Cancer - Leukemia; Cancer
2006061,Cannabidiol-induced Apoptosis In Human Leukemia Cells: A Novel Role Of Cannabidiol In The Regulation Of P22phox And Nox4 Expression,http://molpharm.aspetjournals.org/content/70/3/897.full,Positive,,Laboratory Study,2006,,Immune System; Nervous System,Cancer - Leukemia; Cancer
2008120,Enhancing The In Vitro Cytotoxic Activity Of Delta9-tetrahydrocannabinol In Leukemic Cells Through A Combinatorial Approach,https://www.ncbi.nlm.nih.gov/pubmed/18608861,Positive,,Laboratory Study,2008,Tetrahydrocannabinol (THC),Immune System; Nervous System,Cancer - Leukemia; Cancer
2013151,Cannabis Extract Treatment for Terminal Acute Lymphoblastic Leukemia with a Philadelphia Chromosome Mutation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901602/,Positive,,Meta-analysis,2013,,Immune System; Nervous System,Cancer - Leukemia; Cancer
2017269,Anticancer Effects Of Phytocannabinoids Used With Chemotherapy In Leukaemia Cells Can Be Improved By Altering The Sequence Of Their Administration,https://www.spandidos-publications.com/ijo/51/1/369,Positive,,Laboratory Study,2017,Cannabigerol (CBG); Tetrahydrocannabinol (THC),Immune System; Nervous System,Cancer - Leukemia; Cancer
2017270,Cannabidiol Reduces Leukemic Cell Size – But Is It Important?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364234/,Positive,,Laboratory Study,2017,,Immune System,Cancer - Leukemia; Cancer
2010125,Cannabinoid CB1 Receptor Is Downregulated In Clear Cell Renal Cell Carcinoma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2989249/,Positive,,Laboratory Study,2010,,Nervous System; Urinary System,Cancer - Kidney; Cancer
2016285,The Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory.,https://www.researchgate.net/publication/286976859_The_Therapeutic_Aspects_of_the_Endocannabinoid_System_ECS_for_Cancer_and_their_Development_From_Nature_to_Laboratory,Positive,,Meta-analysis,2016,,Nervous System; Urinary System,Cancer - Kidney; Cancer
2004059,Delta-9 tetrahydrocannabinol (THC) inhibits lytic replication of gamma oncogenic herpesviruses in vitro,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC521080/,Positive,,Laboratory Study,2004,,Immune System; Integumentary System,"Epstein-Barr, Mono; Herpes; Kaposi's Sarcoma; Shingles (Herpes Zoster)"
2007084,Cannabinoid modulation of Kaposi's sarcoma-associated herpesvirus infection and transformation.,https://www.ncbi.nlm.nih.gov/pubmed/17671191,Negative,,Laboratory Study,2007,,Integumentary System,Kaposi's Sarcoma
2009116,Recreational Drug Use And Risk Of Kaposi's Sarcoma In HIV- And HHV-8-coinfected Homosexual Men,https://www.ncbi.nlm.nih.gov/pubmed/19108691,Inconclusive,,Meta-analysis,2009,,,Kaposi's Sarcoma
2009117,"The CB(1)/CB(2) receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro",https://www.researchgate.net/publication/26304421_The_CB1CB2_receptor_agonist_WIN-55212-2_reduces_viability_of_human_Kaposi%27s_sarcoma_cells_in_vitro,Positive,,Laboratory Study,2009,WIN-x Synthetic Cannabinoids,Integumentary System,Kaposi's Sarcoma
2016286,Comparing the effects of endogenous and synthetic cannabinoid receptor agonists on survival of gastric cancer cells.,https://www.ncbi.nlm.nih.gov/pubmed/27640887,Positive,,Laboratory Study,2016,Anandamide (AEA); CP-x Synthetic Cannabinoids; Other Related Compounds,Digestive System; Nervous System,Cancer - Stomach; Cancer
2018351,Cannabinoid-induced Cell Death In Endometrial Cancer Cells: Involvement Of TRPV1 Receptors In Apoptosis,https://www.ncbi.nlm.nih.gov/pubmed/29441458,Positive,,Laboratory Study,2018,Anandamide (AEA); 2-Arachidonoyl Glycerol (2-AG),Nervous System; Reproductive System,Cancer - Uterine; Cancer
2005070,"The Endogenous Cannabinoid, Anandamide, Induces Cell Death In Colorectal Carcinoma Cells: A Possible Role For Cyclooxygenase 2",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774787/,Positive,,Laboratory Study,2005,Anandamide (AEA),Digestive System,Cancer - Colon; Cancer
2008121,Loss of Cannabinoid Receptor 1 Accelerates Intestinal Tumor Growth,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2561258/,Positive,,Animal Study,2008,,Digestive System; Nervous System,Cancer - Colon; Cancer
2011158,Evaluation Of The Cyclooxygenase Inhibiting Effects Of Six Major Cannabinoids Isolated From Cannabis Sativa,https://www.researchgate.net/publication/51088411_Evaluation_of_the_Cyclooxygenase_Inhibiting_Effects_of_Six_Major_Cannabinoids_Isolated_from_Cannabis_sativa,Positive,,Laboratory Study,2011,Cannabidiolic Acid (CBD-a); Cannabigerol (CBG); Cannabigerolic Acid (CBG-a); Tetrahydrocannabinol (THC); Tetrahydrocannabinolic Acid (THC-a),,Cancer - Colon; Cancer
2012161,Anti-tumor activity of the novel hexahydrocannabinol analog LYR-8 in Human colorectal tumor xenograft is mediated through the inhibition of Akt and hypoxia-inducible factor-1α activation.,https://www.ncbi.nlm.nih.gov/pubmed/22687485,Positive,,Laboratory Study,2012,,Digestive System; Nervous System,Cancer - Colon; Cancer
2012162,Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer.,https://www.ncbi.nlm.nih.gov/pubmed/22231745,Positive,,Animal Study,2012,,Digestive System; Nervous System,Cancer - Colon; Cancer
2013152,Composition and in vitro anticancer activities of the leaf essential oil of Neolitsea variabillima from Taiwan.,https://www.ncbi.nlm.nih.gov/pubmed/23738472,Positive,,Laboratory Study,2013,,,Cancer - Colon; Cancer - Leukemia; Cancer - Liver; Cancer - Lung; Cancer - Melanoma; Cancer - Oral; Cancer
2015217,"The Anticancer, Antioxidant And Antimicrobial Properties Of The Sesquiterpene β-Caryophyllene From The Essential Oil Of Aquilaria Crassna",https://www.ncbi.nlm.nih.gov/pubmed/26132906,Positive,,Laboratory Study,2015,,Digestive System; Immune System; Nervous System,Cancer - Colon; Cancer; Oxidative Stress; Staph Infection
2016287,GPR55 Promotes Migration And Adhesion Of Colon Cancer Cells Indicating A Role In Metastasis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688947/,Positive,,Animal Study,2016,,Digestive System,Cancer - Colon; Cancer
2018352,Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis,https://www.frontiersin.org/articles/10.3389/fneur.2018.00759/full,Positive,,Meta-analysis,2018,,Nervous System,Epilepsy - Lennox-Gastaut; Epilepsy; Epilepsy - Dravet Syndrome
2018353,Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer's disease and Less Well-Known Diseases.,https://www.ncbi.nlm.nih.gov/pubmed/29484980,Positive,,Meta-analysis,2018,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),Nervous System,Alzheimer's Disease; Autism; Cardiovascular Diseases (CVD); Fragile X Syndrome; Multiple Sclerosis
2012163,"Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures.",https://www.ncbi.nlm.nih.gov/pubmed/22571976,Positive,,Laboratory Study,2012,Tetrahydrocannabinolic Acid (THC-a),Nervous System,Neurodegenerative Issues; Oxidative Stress
2011159,Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165957/,Positive,,Laboratory Study,2011,Cannabichromene (CBC); Cannabidiolic Acid (CBD-a); Cannabigerol (CBG); Cannabigerolic Acid (CBG-a); Cannabinol (CBN); Monoacylglycerol Lipase (MAGL); Tetrahydrocannabinolic Acid (THC-a); Anandamide (AEA); Cannabichromenic Acid (CBC-a); Fatty Acid Amide Hydrolase (FAAH); Other Related Compounds,,Pain; Pain - Neuropathy - Inflammatory Polyneuropathy
2013153,Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792001/,Positive,,Animal Study,2013,Tetrahydrocannabinolic Acid (THC-a); Cannabidiolic Acid (CBD-a); SR-x Synthetic Cannabinoids,Digestive System,Nausea and Vomiting; Chemotherapy-induced Nausea & Vomiting; Morning sickness; Motion Sickness
2013154,Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596650/,Positive,,Animal Study,2013,Cannabidiolic Acid (CBD-a); CP-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Digestive System,Nausea and Vomiting; Chemotherapy-induced Nausea & Vomiting; Morning sickness; Motion Sickness
2012164,"Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009504/,Positive,,Laboratory Study,2012,Cannabidiolic Acid (CBD-a),Nervous System; Reproductive System,Cancer - Breast; Cancer
2018354,Acute oral Cannabidiolic Acid Methyl Ester reduces depression-like behavior in two genetic animal models of depression.,https://www.sciencedirect.com/science/article/pii/S0166432818304832,Positive,,Animal Study,2018,HU-x Synthetic Cannabinoids; Cannabidiolic Acid (CBD-a),Mental/Emotional System,Depression; Anxiety
2018355,Genetic deletion of CB1 cannabinoid receptors exacerbates the Alzheimer-like symptoms in a transgenic animal model.,https://www.ncbi.nlm.nih.gov/pubmed/30096288,Positive,,Animal Study,2018,,,Alzheimer's Disease
2018356,Cannabis use is associated with reduced prevalence of progressive stages of alcoholic liver disease.,https://www.ncbi.nlm.nih.gov/pubmed/29341392,Positive,,Meta-analysis,2018,,Digestive System,Alcoholic Liver Disease; Cancer - Liver; Cancer; Fibrosis - Liver (Cirrhosis); Fibrosis; Toxic Liver Disease
2018357,Beneficial Effect of Medical Cannabis in the Treatment of a Pharmacoresistant Nausea Associated with a Somatoform Disorder in a Patient with Post-Polio Syndrome.,https://www.ncbi.nlm.nih.gov/pubmed/29506301,Positive,,Meta-analysis,2018,,Muscular System,Post-Polio Syndrome
2016288,Psychosocial Determinants of Cannabis Dependence: A Systematic Review of the Literature.,https://www.karger.com/Article/FullText/441777,Inconclusive,,Meta-analysis,2016,,Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2017271,Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674070/,Positive,,Animal Study,2017,Tetrahydrocannabinol (THC),,Arthritis - Rheumatoid; Arthritis; Diabetes; Multiple Sclerosis
2016289,Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715874/,Positive,,Laboratory Study,2016,Pharma THC,Immune System,Cancer - Leukemia; Cancer
2015218,Effect of Non-psychotropic Plant-derived Cannabinoids on Bladder Contractility: Focus on Cannabigerol,https://www.researchgate.net/publication/280391642_Effect_of_Non-psychotropic_Plant-derived_Cannabinoids_on_Bladder_Contractility_Focus_on_Cannabigerol,Positive,,Laboratory Study,2015,Cannabigerol (CBG); Cannabichromene (CBC),,Cystitis
2017272,Cannabis and Pain: A Clinical Review,https://www.researchgate.net/publication/317143762_Cannabis_and_Pain_A_Clinical_Review,Positive,,Meta-analysis,2017,,,Pain; Pain - Chronic; Addiction - Opioid
2017273,"Schizophrenia and depression, two poles of endocannabinoid system deregulation.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802629/,Positive,,Laboratory Study,2017,Anandamide (AEA); Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,Depression; Schizophrenia
2018358,Medical Cannabis for Neuropathic Pain.,https://www.ncbi.nlm.nih.gov/pubmed/29388063,Positive,,Meta-analysis,2018,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),,Pain; Pain - Neuropathy - Peripheral
2018359,The Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2.,https://www.ncbi.nlm.nih.gov/pubmed/29412125,Positive,,Meta-analysis,2018,Endocannabinoid (unspecified),Cardiovascular System,Atherosclerosis; Cardiovascular Diseases (CVD); Reperfusion Injury
2018360,Plasma anandamide concentrations are lower in children with autism spectrum disorder.,https://www.researchgate.net/publication/323714387_Plasma_anandamide_concentrations_are_lower_in_children_with_autism_spectrum_disorder,Positive,,Meta-analysis,2018,Anandamide (AEA),Mental/Emotional System,Autism
2015219,Endocannabinoid Levels in Newborns in Relation to the Mode of Delivery.,https://www.ncbi.nlm.nih.gov/pubmed/25915139/,Positive,,Clinical Trial,2015,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Other Related Compounds,Reproductive System,Labor and Delivery Issues; Pregnancy
2018361,Relation of Cannabis Use and Atrial Fibrillation Among Patients Hospitalized for Heart Failure.,https://www.ncbi.nlm.nih.gov/pubmed/29685570,Positive,,Meta-analysis,2018,,Cardiovascular System,Atrial Fibrillation; Cardiovascular Diseases (CVD)
2018362,Maternal and paternal cannabis use during pregnancy and risk of psychotic symptoms in the offspring.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888492/,Negative,,Meta-analysis,2018,,Mental/Emotional System,Psychosis; Schizophrenia
2018363,Dronabinol oral solution in the management of anorexia and weight loss in AIDS and cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896684/,Positive,,Meta-analysis,2018,Pharma THC; Tetrahydrocannabinol (THC),Digestive System; Immune System; Muscular System; Nervous System,Anorexia; Cachexia; Cancer; HIV/AIDS; Loss of Appetite; Nausea and Vomiting; Psychosis
2018364,Will Widespread Synthetic Opioid Consumption Induce Epigenetic Consequences in Future Generations?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037745/,Inconclusive,,Meta-analysis,2018,,,Addiction - Opioid
2016290,Maternal Marijuana Use and Adverse Neonatal Outcomes: A Systematic Review and Meta-analysis.,https://www.ncbi.nlm.nih.gov/pubmed/27607879,Inconclusive,,Meta-analysis,2016,,Reproductive System,Pregnancy
2007085,Nonpsychoactive Cannabidiol Prevents Prion Accumulation and Protects Neurons against Prion Toxicity.,http://www.jneurosci.org/content/27/36/9537.long,Positive,,Animal Study,2007,Anandamide (AEA); Synthetic Cannabinoid (unspecified),,Prion Disease
2017274,Cannabinoids: Possible agents for treatment of psoriasis via suppression of angiogenesis and inflammation.,https://www.ncbi.nlm.nih.gov/pubmed/28110689,Positive,,Laboratory Study,2017,JWH-x Synthetic Cannabinoids,Integumentary System,Psoriasis
2018365,The Risks and Benefits of Cannabis in the Dermatology Clinic.,https://www.ncbi.nlm.nih.gov/pubmed/29056081,Positive,,Meta-analysis,2018,,,Acne; Allergic Contact Dermatitis; Cancer - Melanoma; Cancer - Skin (Non-melanoma); Cancer; Lupus; Multiple Sclerosis; Pruritis; Psoriasis
2016291,Selective Cannabinoid Receptor-1 Agonists Regulate Mast Cell Activation in an Oxazolone-Induced Atopic Dermatitis Model.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737832/,Positive,,Animal Study,2016,Anandamide (AEA); HU-x Synthetic Cannabinoids; Other Related Compounds,Integumentary System,Allergic Contact Dermatitis; Psoriasis
2006062,Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis.,https://www.theroc.us/researchlibrary/Cannabinoids%20inhibit%20human%20keratinocyte%20proliferation%20through%20a%20non-CB1-CB2%20mechanism%20and%20have%20a%20potential%20therapeutic%20value%20in%20the%20treatment%20of%20psoriasis.pdf,Positive,,Laboratory Study,2006,AM-x Synthetic Cannabinoids; Cannabigerol (CBG); Cannabinol (CBN); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Integumentary System,Psoriasis
2018366,Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099309/,Positive,,Double Blind Clinical Trial,2018,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System,Addiction - Nicotine; Addiction
2016292,Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4988731/,Negative,,Meta-analysis,2016,,Mental/Emotional System,Psychosis; Schizophrenia
2016293,Cannabis and Psychosis: a Critical Overview of the Relationship.,https://www.ncbi.nlm.nih.gov/pubmed/26781550,Positive,,Meta-analysis,2016,,Mental/Emotional System,Psychosis; Schizophrenia
2018367,Effects of cannabinoid receptor type 2 in respiratory syncytial virus infection in human subjects and mice.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955186/,Positive,,Meta-analysis,2018,AM-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,Respiratory System,Respiratory Syncytial Virus
2018368,The Role of Cannabinoid Receptor 1 in the Immunopathology of Respiratory Syncytial Virus.,https://www.ncbi.nlm.nih.gov/pubmed/29461930,Positive,,Animal Study,2018,AM-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Respiratory System,Respiratory Syncytial Virus
2016294,The Endocannabinoid System in the Retina: From Physiology to Practical and Therapeutic Applications.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736597/,Positive,,Meta-analysis,2016,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Tetrahydrocannabinol (THC),,Macular Degeneration; Retinal Disorders
2016295,Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736800/,Positive,,Meta-analysis,2016,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); AM-x Synthetic Cannabinoids; CP-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); Other Related Compounds; WIN-x Synthetic Cannabinoids,,Glaucoma; Retinal Disorders
2008122,Mediation of Cannabidiol anti-inflammation in the Retina by Equilibrative Nucleoside Transporter and A2A Adenosine Receptor.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2588644/,Positive,,Animal Study,2008,,Nervous System,Retinal Disorders
2017275,"Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges.",https://www.frontiersin.org/articles/10.3389/fimmu.2017.01487/full,Positive,,Meta-analysis,2017,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Cannabigerol (CBG); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Pharma THC:CBD; SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); Tetrahydrocannabinol (THC); WIN-x Synthetic Cannabinoids,,Arthritis - Rheumatoid; Arthritis; Celiac Disease; Chagas Disease; Ebola Virus Disease; Hyperthyroidism and Graves' Disease; IBD - Crohn's Disease; Hepatitis; HIV/AIDS; Lupus; Malaria; Multiple Sclerosis; Myasthenia Gravis; Organ Transplant Failure; Sepsis
2015220,Effects of Cannabinoids on T-cell Function and Resistance to Infection.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470840/,Positive,,Meta-analysis,2015,Tetrahydrocannabinol (THC); AM-x Synthetic Cannabinoids; Anandamide (AEA); JWH-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),,Arthritis - Rheumatoid; Arthritis; Irritable Bowel Syndrome; Organ Transplant Failure; Systemic Sclerosis
2011160,Cannabidiol as an Emergent Therapeutic Strategy for Lessening the Impact of Inflammation on Oxidative Stress.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085542/,Positive,,Meta-analysis,2011,Fatty Acid Amide Hydrolase (FAAH),Nervous System,Oxidative Stress; Alzheimer's Disease; Arthritis - Rheumatoid; Arthritis; Atherosclerosis; Cardiovascular Diseases (CVD); Depression; Diabetes; Hypertension (High Blood Pressure); Metabolic Syndrome; Pain; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral; Parkinson's Disease
2018369,"GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine.",https://www.researchgate.net/publication/326690771_GPR55_signalling_promotes_proliferation_of_pancreatic_cancer_cells_and_tumour_growth_in_mice_and_its_inhibition_increases_effects_of_gemcitabine,Positive,,Animal Study,2018,,Endocrine System; Nervous System,Cancer - Pancreatic; Cancer
2009118,"Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664885/,Positive,,Meta-analysis,2009,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Cannabichromene (CBC); CP-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Other Related Compounds; SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,,Arthritis - Rheumatoid; Arthritis; Fibromyalgia; Hemorrhoids; Pain; Pain - Acute; Pain - Chronic; Pain - Neuropathy - Peripheral
2008123,Suppression of human macrophage interleukin-6 by a nonpsychoactive cannabinoid acid.,https://pubmed.ncbi.nlm.nih.gov/18040689/,Positive,,Laboratory Study,2008,,,Inflammation; Arthritis - Rheumatoid; Arthritis; Lupus
2006063,The cannabinergic system as a target for anti-inflammatory therapies.,https://www.ncbi.nlm.nih.gov/pubmed/16918457,Positive,,Meta-analysis,2006,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),,Arthritis - Rheumatoid; Arthritis; Asthma; Atherosclerosis; Cardiovascular Diseases (CVD); Diabetes; Irritable Bowel Syndrome; Multiple Sclerosis
2006064,"Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis",https://academic.oup.com/rheumatology/article/45/1/50/1788693,Positive,,Double Blind Clinical Trial,2006,Pharma THC:CBD; Tetrahydrocannabinol (THC),Nervous System; Skeletal System,Arthritis - Rheumatoid; Arthritis; Pain; Pain - Chronic; Ehlers-Danlos Syndrome; Inflammation
2004060,Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1.,https://www.ncbi.nlm.nih.gov/pubmed/15047233,Positive,,Laboratory Study,2004,Other Related Compounds,Reproductive System,Cancer - Cervical; Cancer
2008124,Inhibition Of Cancer Cell Invasion By Cannabinoids Via Increased Expression Of Tissue Inhibitor Of Matrix Metalloproteinases-1,https://academic.oup.com/jnci/article/100/1/59/2567700,Positive,,Laboratory Study,2008,Tetrahydrocannabinol (THC); Anandamide (AEA); Other Related Compounds,Nervous System,Cancer; Cancer - Cervical; Cancer - Lung
2010126,Cannabidiol Inhibits Cancer Cell Invasion Via Upregulation Of Tissue Inhibitor Of Matrix Metalloproteinases-1,https://www.ncbi.nlm.nih.gov/pubmed/19914218,Positive,,Animal Study,2010,,Nervous System; Reproductive System,Cancer - Cervical; Cancer - Metastatic; Cancer; Cancer - Lung
2016296,Cannabidiol Rather Than Cannabis Sativa Extracts Inhibit Cell Growth And Induce Apoptosis In Cervical Cancer Cells,https://www.ncbi.nlm.nih.gov/pubmed/27586579,Positive,,Laboratory Study,2016,,Nervous System; Reproductive System,Cancer - Cervical; Cancer
1998022,The Endogenous Cannabinoid Anandamide Inhibits Human Breast Cancer Cell Proliferation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC20983/,Positive,,Laboratory Study,1998,Anandamide (AEA); HU-x Synthetic Cannabinoids,Reproductive System,Cancer - Breast; Cancer
2000020,Suppression Of Nerve Growth Factor Trk Receptors And Prolactin Receptors By Endocannabinoids Leads To Inhibition Of Human Breast And Prostate Cancer Cell Proliferation,https://academic.oup.com/endo/article/141/1/118/2988024,Positive,,Laboratory Study,2000,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); HU-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Nervous System; Reproductive System,Cancer - Breast; Cancer - Prostate; Cancer
2006065,Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma,https://www.ncbi.nlm.nih.gov/pubmed/16728591,Positive,,Animal Study,2006,Cannabichromene (CBC); Cannabigerol (CBG); Cannabichromenic Acid (CBC-a); Tetrahydrocannabinol (THC),Reproductive System,Cancer - Breast; Cancer; Cancer - Lung; Cancer - Thyroid
2006066,Δ9-Tetrahydrocannabinol Inhibits Cell Cycle Progression In Human Breast Cancer Cells Through Cdc2 Regulation,https://www.ncbi.nlm.nih.gov/pubmed/16818634,Positive,,Laboratory Study,2006,Tetrahydrocannabinol (THC),Nervous System; Reproductive System,Cancer - Breast; Cancer
2007086,"Potentiating Effect Of Beta-caryophyllene On Anticancer Activity Of Alpha-humulene, Isocaryophyllene And Paclitaxel",https://www.ncbi.nlm.nih.gov/pubmed/18053325,Positive,,Laboratory Study,2007,,Nervous System; Reproductive System,Cancer - Breast; Cancer
2007087,Cannabidiol As A Novel Inhibitor Of Id-1 Gene Expression In Aggressive Breast Cancer Cells,https://www.ncbi.nlm.nih.gov/pubmed/18025276,Positive,,Laboratory Study,2007,,Nervous System; Reproductive System,Cancer - Breast; Cancer
2008125,JunD Is Involved In The Antiproliferative Effect Of Δ9-tetrahydrocannabinol On Human Breast Cancer Cells,http://www.nature.com/articles/onc2008145,Positive,,Laboratory Study,2008,,Nervous System; Reproductive System,Cancer - Breast; Cancer
2010127,Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition,https://molecular-cancer.biomedcentral.com/articles/10.1186/1476-4598-9-196,Positive,,Animal Study,2010,JWH-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC),Nervous System; Reproductive System,Cancer - Breast; Cancer
2011161,"Pathways Mediating The Effects Of Cannabidiol On The Reduction Of Breast Cancer Cell Proliferation, Invasion, And Metastasis",https://www.ncbi.nlm.nih.gov/pubmed/20859676,Positive,,Animal Study,2011,,Reproductive System,Cancer - Breast; Cancer; Cancer - Lung
2011162,b-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation.,https://pubmed.ncbi.nlm.nih.gov/21924548/,Positive,,Laboratory Study,2011,,,Cancer - Breast; Cancer - Prostate; Cancer
2014182,Targeting Multiple Cannabinoid Anti-tumour Pathways With A Resorcinol Derivative Leads To Inhibition Of Advanced Stages Of Breast Cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209152/,Positive,,Animal Study,2014,O-x Synthetic Cannabinoids,Nervous System; Reproductive System,Cancer - Breast; Cancer - Metastatic; Cancer
2015221,"Selective, nontoxic CB(2) cannabinoid o-quinone with in vivo activity against triple-negative breast cancer.",https://www.ncbi.nlm.nih.gov/pubmed/25671648,Positive,,Animal Study,2015,,Nervous System; Reproductive System,Cancer - Breast; Cancer
2015222,Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway; novel anti-tumor mechanisms of Cannabidiol in breast cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387115/,Positive,,Animal Study,2015,,Nervous System; Reproductive System,Cancer - Breast; Cancer
2016297,"Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas.",https://www.ncbi.nlm.nih.gov/pubmed/27633508,Positive,,Meta-analysis,2016,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),Nervous System; Reproductive System,Cancer - Breast; Cancer - Prostate; Cancer
2017276,Cannabidiolic Acid-mediated Selective Down-regulation Of C-fos In Highly Aggressive Breast Cancer MDA-MB-231 Cells: Possible Involvement Of Its Down-regulation In The Abrogation Of Aggressiveness,https://www.ncbi.nlm.nih.gov/pubmed/27530354,Positive,,Laboratory Study,2017,Cannabidiolic Acid (CBD-a),Nervous System; Reproductive System,Cancer - Breast; Cancer
2016298,Simultaneous Activation Of Induced Heterodimerization Between CXCR4 Chemokine Receptor And Cannabinoid Receptor 2 (CB2) Reveal A Mechanism For Regulation Of Tumor Progression,https://www.ncbi.nlm.nih.gov/pubmed/26841863,Positive,,Laboratory Study,2016,AM-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,,Cancer - Metastatic; Cancer; Cancer - Breast; Cancer - Prostate; HIV/AIDS; Pain; Pain - Cancer
2008126,Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum.,http://www.nature.com/articles/npp2008138,Positive,,Double Blind Clinical Trial,2008,Tetrahydrocannabinol (THC),,Schizophrenia
2017277,Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688117/,Positive,,Animal Study,2017,Microbiome; SR-x Synthetic Cannabinoids,Digestive System; Endocrine System; Nervous System,Inflammation; Microbiome Imbalance; Obesity; Diabetes; Metabolic Syndrome
2013155,The Gastric CB1 Receptor Modulates Ghrelin Production through the mTOR Pathway to Regulate Food Intake.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841176/,Positive,,Animal Study,2013,SR-x Synthetic Cannabinoids,,Anorexia; Obesity
2018370,Effects of repeated long‐term psychosocial stress and acute cannabinoid exposure on mouse corticostriatal circuitries: Implications for neuropsychiatric disorders.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969305/,Positive,,Animal Study,2018,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Monoacylglycerol Lipase (MAGL); Other Related Compounds; SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); WIN-x Synthetic Cannabinoids,Mental/Emotional System,
2018371,Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113576/,Positive,,Animal Study,2018,,Mental/Emotional System; Nervous System,Schizophrenia
2018372,Antiapoptotic effects of cannabidiol in an experimental model of cognitive decline induced by brain iron overload.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120904/,Positive,,Animal Study,2018,,,Cognitive Dysfunction
2018373,Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125482/,Negative,,Double Blind Clinical Trial,2018,Tetrahydrocannabinol (THC),,Cognitive Dysfunction; Psychosis
2017278,"Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection (poly I:C) Rat Model.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436124/,Positive,,Animal Study,2017,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2018374,Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial.,https://www.ncbi.nlm.nih.gov/pubmed/29241357,Positive,,Double Blind Clinical Trial,2018,,Mental/Emotional System,Schizophrenia
2016299,"Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315552/,Positive,,Laboratory Study,2016,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2012165,Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316151/,Positive,,Double Blind Clinical Trial,2012,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Other Related Compounds,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2010128,The endocannabinoid system and psychiatric disorders.,https://www.ncbi.nlm.nih.gov/pubmed/20353783,Positive,,Meta-analysis,2010,SR-x Synthetic Cannabinoids; 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System; Nervous System,Psychosis; Schizophrenia; Anxiety; Depression
2009119,Antipsychotic effects of cannabidiol.,https://www.sciencedirect.com/science/article/pii/S0924933809704407,Positive,,Double Blind Clinical Trial,2009,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia
2004061,Cerebrospinal Anandamide Levels are Elevated in Acute Schizophrenia and are Inversely Correlated with Psychotic Symptoms.,http://files.iowamedicalmarijuana.org/science/psych/Giuffrida%202004.pdf,Positive,,Meta-analysis,2004,Anandamide (AEA),Mental/Emotional System,Psychosis; Schizophrenia
2018375,"Anti-Inflammatory, Antioxidative, and Hepatoprotective Effects of Trans Δ9-Tetrahydrocannabinol/Sesame Oil on Adjuvant-Induced Arthritis in Rats.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036806/,Positive,,Animal Study,2018,Pharma THC; Tetrahydrocannabinol (THC),Skeletal System,Arthritis - Rheumatoid; Arthritis; Neurodegenerative Issues
2018376,Palmitoylethanolamide Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053486/,Positive,,Animal Study,2018,Palmitoylethanolamide (PEA),Digestive System,Fibrosis - Liver (Cirrhosis); Fibrosis
2018377,Cannabinoid Hyperemesis Syndrome Masquerading as Uremia: An Educational Case Report.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109838/,Inconclusive,,Meta-analysis,2018,,,Cannabis Hyperemesis Syndrome
2018378,Cannabinoids for the treatment of rheumatic diseases - where do we stand?,https://www.ncbi.nlm.nih.gov/pubmed/29884803,Positive,,Meta-analysis,2018,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),Skeletal System,Arthritis - Rheumatoid; Arthritis
2018379,Cannabinoids in dermatology: a scoping review.,https://www.ncbi.nlm.nih.gov/pubmed/30142706,Positive,,Meta-analysis,2018,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),Integumentary System,Eczema; Acne Inversa; Acne; Allergic Contact Dermatitis; Cancer - Melanoma; Cancer - Skin (Non-melanoma); Cancer; Kaposi's Sarcoma; Pruritis; Psoriasis; Systemic Sclerosis
2009120,Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts.,https://www.ncbi.nlm.nih.gov/pubmed/19589890,Positive,,Laboratory Study,2009,WIN-x Synthetic Cannabinoids,Integumentary System,Systemic Sclerosis
2012166,Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system.,https://www.ncbi.nlm.nih.gov/pubmed/22033526,Positive,,Laboratory Study,2012,WIN-x Synthetic Cannabinoids,Integumentary System,Systemic Sclerosis
2012167,Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis.,https://www.ncbi.nlm.nih.gov/pubmed/22492781,Positive,,Animal Study,2012,,Integumentary System,Systemic Sclerosis
2018380,The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders.,https://www.ncbi.nlm.nih.gov/pubmed/30138623,Positive,,Meta-analysis,2018,,Integumentary System,Cancer - Skin (Non-melanoma); Eczema; Skin Diseases; Allergic Contact Dermatitis; Cancer - Melanoma; Cancer; Psoriasis
1998023,Δ9-Tetrahydrocannabinol induces apoptosis in C6 glioma cells,https://www.sciencedirect.com/science/article/pii/S0014579398010850,Positive,,Laboratory Study,1998,SR-x Synthetic Cannabinoids,Nervous System,Cancer - Brain; Cancer
2001031,Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor,https://www.ncbi.nlm.nih.gov/pubmed/11479216,Positive,,Animal Study,2001,JWH-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,,Cancer - Brain; Cancer
2006067,The Non-psychoactive Cannabidiol Triggers Caspase Activation And Oxidative Stress In Human Glioma Cells,https://www.ncbi.nlm.nih.gov/pubmed/16909207,Positive,,Laboratory Study,2006,,Nervous System,Cancer - Brain; Cancer
2004062,"Antitumor Effects Of Cannabidiol, A Nonpsychoactive Cannabinoid, On Human Glioma Cell Lines",http://jpet.aspetjournals.org/content/308/3/838.full,Positive,,Animal Study,2004,,Nervous System,Cancer - Brain; Cancer
2004063,Cannabinoids Inhibit The Vascular Endothelial Growth Factor Pathway In Gliomas,http://cancerres.aacrjournals.org/content/64/16/5617.full,Positive,,Clinical Trial,2004,Anandamide (AEA); JWH-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC); WIN-x Synthetic Cannabinoids,,Cancer - Brain; Cancer
2005071,Cannabidiol Inhibits Human Glioma Cell Migration Through A Cannabinoid Receptor-independent Mechanism,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1576089/,Positive,,Laboratory Study,2005,SR-x Synthetic Cannabinoids,Nervous System,Cancer - Brain; Cancer
2005072,Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells.,https://www.ncbi.nlm.nih.gov/pubmed/16078104?dopt=Abstract,Positive,,Laboratory Study,2005,Tetrahydrocannabinol (THC); WIN-x Synthetic Cannabinoids,,Cancer - Brain; Cancer
2006068,A Pilot Clinical Study Of Delta9-tetrahydrocannabinol In Patients With Recurrent Glioblastoma Multiforme,https://www.ncbi.nlm.nih.gov/pubmed/16804518,Positive,,Clinical Trial,2006,,Nervous System,Cancer - Brain; Cancer
2008127,Delta 9-tetrahydrocannabinol Inhibits Cell Cycle Progression By Downregulation Of E2F1 In Human Glioblastoma Multiforme Cells,https://www.ncbi.nlm.nih.gov/pubmed/17934890,Positive,,Laboratory Study,2008,,Nervous System,Cancer - Brain; Cancer
2007088,Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?,http://www.bbm1.ucm.es/cannabis/archivos/publicaciones/Neuropharmacology08_54_235_243.pdf,Positive,,Animal Study,2007,JWH-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC),,Cancer - Brain; Cancer
2010129,Opposite Changes In Cannabinoid CB1 And CB2 Receptor Expression In Human Gliomas,https://www.ncbi.nlm.nih.gov/pubmed/20307616,Positive,,Laboratory Study,2010,WIN-x Synthetic Cannabinoids,,Cancer - Brain; Cancer
2010130,Cannabidiol Enhances The Inhibitory Effects Of Delta9-tetrahydrocannabinol On Human Glioblastoma Cell Proliferation And Survival,https://www.ncbi.nlm.nih.gov/pubmed/20053780,Positive,,Animal Study,2010,Tetrahydrocannabinol (THC),Nervous System,Cancer - Brain; Cancer
2011163,A Combined Preclinical Therapy Of Cannabinoids And Temozolomide Against Glioma,http://mct.aacrjournals.org/content/10/1/90,Positive,,Animal Study,2011,Tetrahydrocannabinol (THC); SR-x Synthetic Cannabinoids,Nervous System,Cancer - Brain; Cancer
2012168,Cannabidiol As Potential Anticancer Drug,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579246/,Positive,,Meta-analysis,2012,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); SR-x Synthetic Cannabinoids,Nervous System,Cancer; Cancer - Colon; Cancer - Brain; Cancer - Breast; Cancer - Leukemia; Cancer - Lung; Cancer - Lymphoma
2013156,Critical Appraisal Of The Potential Use Of Cannabinoids In Cancer Management,https://www.ncbi.nlm.nih.gov/pubmed/24039449,Positive,,Meta-analysis,2013,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),Nervous System,Cancer; Cancer - Brain; Cancer - Breast; Cancer - Liver; Cancer - Lung; Cancer - Prostate
2013157,Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents.,https://www.ncbi.nlm.nih.gov/pubmed/23079154,Positive,,Laboratory Study,2013,,Nervous System,Cancer - Brain; Cancer
2014183,Cannabinoid Signaling In Glioma Cells,https://www.ncbi.nlm.nih.gov/pubmed/22879071,Positive,,Meta-analysis,2014,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),Nervous System,Cancer - Brain; Cancer
2014184,Systematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas.,https://www.ncbi.nlm.nih.gov/pubmed/24142199,Positive,,Meta-analysis,2014,,,Cancer - Brain; Cancer
2015223,Inhibiting Heat Shock Proteins Can Potentiate the Cytotoxic Effect of Cannabidiol in Human Glioma Cells.,https://www.ncbi.nlm.nih.gov/pubmed/26504004,Positive,,Laboratory Study,2015,,,Cancer - Brain; Cancer
2015224,The Antitumor Action Of Cannabinoids On Glioma Tumorigenesis,https://www.ncbi.nlm.nih.gov/pubmed/25472761,Positive,,Meta-analysis,2015,Endocannabinoid (unspecified),,Cancer - Brain; Cancer
2016300,The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757881/,Positive,,Animal Study,2016,AM-x Synthetic Cannabinoids,Integumentary System,Systemic Sclerosis; Dupuytren's Contracture
2014185,Experimental Cannabinoid 2 Receptor-Mediated Immune Modulation in Sepsis.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997158/,Positive,,Animal Study,2014,AM-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL),Immune System,Sepsis
2015225,On The Effects Of CP 55-940 And Other Cannabinoid Receptor Agonists In C6 And U373 Cell Lines,https://www.ncbi.nlm.nih.gov/pubmed/26255146,Positive,,Laboratory Study,2015,CP-x Synthetic Cannabinoids; Anandamide (AEA); WIN-x Synthetic Cannabinoids,Nervous System,Cancer - Brain; Cancer
2015226,Cannabidiol Stimulates Aml-1a-dependent Glial Differentiation And Inhibits Glioma Stem-like Cells Proliferation By Inducing Autophagy In A TRPV2-dependent Manner,https://www.ncbi.nlm.nih.gov/pubmed/25903924,Positive,,Laboratory Study,2015,,,Cancer - Brain; Cancer
2013158,Targeting the Endocannabinoid System to Treat Sepsis.,https://www.researchgate.net/publication/263845266_Targeting_the_Endocannabinoid_System_to_Treat_Sepsis,Positive,,Meta-analysis,2013,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Synthetic Cannabinoid (unspecified),Immune System,Sepsis
2013159,Inhibition of endocannabinoid degradation in experimental endotoxemia reduces leukocyte adhesion and improves capillary perfusion in the gut.,https://www.ncbi.nlm.nih.gov/pubmed/23382309,Positive,,Animal Study,2013,Fatty Acid Amide Hydrolase (FAAH); AM-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Immune System,Sepsis
2009121,CB2 Cannabinoid Receptors Contribute to Bacterial Invasion and Mortality in Polymicrobial Sepsis.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2712683/,Positive,,Animal Study,2009,,Immune System,Sepsis
2008128,Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB receptors and fatty acid amide hydrolase.,https://www.ncbi.nlm.nih.gov/pubmed/18373655,Positive,,Animal Study,2008,AM-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH),Immune System,Sepsis
2006069,Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus.,https://www.ncbi.nlm.nih.gov/pubmed/16874533,Positive,,Clinical Trial,2006,Other Related Compounds,Integumentary System,Pruritis
2002040,Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease.,https://www.ncbi.nlm.nih.gov/pubmed/12190187,Positive,,Clinical Trial,2002,Pharma THC; Tetrahydrocannabinol (THC),Integumentary System,Pruritis
2016301,Cannabinoid receptor-specific mechanisms to alleviate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004356/,Positive,,Animal Study,2016,Anandamide (AEA); CP-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,Cardiovascular System,Sickle Cell Disorders
2006070,The prevalence of marijuana smoking in young adults with sickle cell disease: a longitudinal study.,https://www.ncbi.nlm.nih.gov/pubmed/17249310/,Inconclusive,,Meta-analysis,2006,,,Sickle Cell Disorders
2017279,The Use of Cannabis by Patients with Sickle Cell Disease Increased the Frequency of Hospitalization due to Vaso-Occlusive Crises.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627667/,Negative,,Meta-analysis,2017,,Cardiovascular System,Sickle Cell Disorders
2010131,Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2913454/,Positive,,Animal Study,2010,CP-x Synthetic Cannabinoids,Cardiovascular System,Sickle Cell Disorders
2005073,Cannabis use in sickle cell disease: a questionnaire study.,https://www.ncbi.nlm.nih.gov/pubmed/16173972,Positive,,Meta-analysis,2005,,Cardiovascular System,Sickle Cell Disorders
2007089,Inhibition of human hair follicle growth by endo- and exocannabinoids.,https://www.ncbi.nlm.nih.gov/pubmed/?term=Inhibition+of+human+hair+follicle+growth+by+endo-+and+exocannabinoids,Positive,,Laboratory Study,2007,Anandamide (AEA),Integumentary System,Abnormal Hair Growth; Hair Loss
2018381,"No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895650/,Inconclusive,,Double Blind Clinical Trial,2018,,,Sleep Apnea
2018382,"Pharmacotherapy of Apnea by Cannabimimetic Enhancement, the PACE Clinical Trial: Effects of Dronabinol in Obstructive Sleep Apnea.",https://academic.oup.com/sleep/article/41/1/zsx184/4600041,Positive,,Double Blind Clinical Trial,2018,Pharma THC; Tetrahydrocannabinol (THC),,Sleep Apnea
2014186,Intranodose ganglion injections of dronabinol attenuate serotonin-induced apnea in Sprague-Dawley rat.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880550/,Positive,,Animal Study,2014,Pharma THC,Nervous System,Sleep Apnea
2013160,Proof of Concept Trial of Dronabinol in Obstructive Sleep Apnea.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3550518/,Positive,,Clinical Trial,2013,Tetrahydrocannabinol (THC),Nervous System,Sleep Apnea
2002041,Functional role for cannabinoids in respiratory stability during sleep.,https://www.ncbi.nlm.nih.gov/pubmed/12071539,Positive,,Animal Study,2002,Tetrahydrocannabinol (THC); Other Related Compounds,Nervous System,Sleep Apnea
2016302,Effective treatment of spasticity using dronabinol in pediatric palliative care.,https://www.ncbi.nlm.nih.gov/pubmed/27506815,Positive,,Clinical Trial,2016,Pharma THC; Tetrahydrocannabinol (THC),Nervous System,Cerebral Palsy; Palliative Care
2018383,Delta-9-tetrahydrocannabinol-cannabidiol in the treatment of spasticity in chronic spinal cord injury: a clinical experience.,https://www.ncbi.nlm.nih.gov/pubmed/28929471#%5BDelta-9-tetrahydrocannabinol-cannabidiol%20in%20the%20treatment%20of%20spasticity%20in%20chronic%20spinal%20cord%20injury:%20a%20clinical%20experience%5D,Positive,,Clinical Trial,2018,Pharma THC:CBD; Tetrahydrocannabinol (THC),Skeletal System,Spinal Cord Injuries
2016303,An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007175/,Positive,,Double Blind Clinical Trial,2016,,Skeletal System,Pain; Pain - Central Pain Syndrome; Pain - Neuropathy - Peripheral; Spinal Cord Injuries
2012169,Cannabidiol-treated rats exhibited higher motor score after cryogenic spinal cord injury.,https://pubmed.ncbi.nlm.nih.gov/20381618/,Positive,,Animal Study,2012,,Nervous System; Skeletal System,Neurodegenerative Issues; Spinal Cord Injuries
2006071,The treatment of spasticity with Δ9-tetrahydrocannabinol in persons with spinal cord injury.,https://www.nature.com/articles/3101982,Positive,,Double Blind Clinical Trial,2006,Pharma THC,Skeletal System,Spinal Cord Injuries
2016304,Spontaneous Involution Of Pediatric Low-grade Gliomas: High Expression Of Cannabinoid Receptor 1 (CNR1) At The Time Of Diagnosis May Indicate Involvement Of The Endocannabinoid System,https://www.ncbi.nlm.nih.gov/pubmed/27613640/,Positive,,Laboratory Study,2016,Endocannabinoid (unspecified),,Cancer - Brain; Cancer
2017280,Quantitative Analyses Of Synergistic Responses Between Cannabidiol And DNA-damaging Agents On The Proliferation And Viability Of Glioblastoma And Neural Progenitor Cells In Culture,https://www.ncbi.nlm.nih.gov/pubmed/27821713,Positive,,Laboratory Study,2017,,Nervous System,Cancer - Brain; Cancer
2016305,Dihydroceramide Accumulation Mediates Cytotoxic Autophagy Of Cancer Cells Via Autolysosome Destabilization,https://www.ncbi.nlm.nih.gov/pubmed/27635674,Positive,,Animal Study,2016,Tetrahydrocannabinol (THC),,Cancer - Brain; Cancer
2017281,"Regulation Of Human Glioblastoma Cell Death By Combined Treatment Of Cannabidiol, γ-radiation And Small Molecule Inhibitors Of Cell Signaling Pathways",https://www.ncbi.nlm.nih.gov/pubmed/29088769,Positive,,Laboratory Study,2017,,Nervous System,Cancer - Brain; Cancer; Radiation sickness
1995012,"Treatment of Spasticity in Spinal Cord Injury with Dronabinol, a Tetrahydrocannabinol Derivative.",https://www.ncbi.nlm.nih.gov/pubmed/11854790,Inconclusive,,Clinical Trial,1995,Pharma THC; Tetrahydrocannabinol (THC),Skeletal System,Spinal Cord Injuries
1990006,Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single double-blind trial.,https://www.ncbi.nlm.nih.gov/pubmed/2175265,Positive,,Double Blind Clinical Trial,1990,,Skeletal System,Spinal Cord Injuries
1982006,Cannabis effect on spasticity in spinal cord injury.,https://www.ncbi.nlm.nih.gov/pubmed/6978699,Positive,,Meta-analysis,1982,,Skeletal System,Spinal Cord Injuries
1974002,The Perceived Effects Of Marijuana On Spinal Cord Injured Males.,https://www.researchgate.net/publication/18713436_The_perceived_effects_of_marijuana_on_spinal_cord_injured_males,Positive,,Meta-analysis,1974,,Skeletal System,Spinal Cord Injuries
2018384,"Preliminary evaluation of the efficacy, safety, and costs associated with the treatment of chronic pain with medical cannabis",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007634/,Positive,,Clinical Trial,2018,,Nervous System,Pain - Chronic; Cancer; Ehlers-Danlos Syndrome; IBD - Inflammatory Bowel Disease; Pain; Pain - Cancer; Pain - Neuropathy - Peripheral; Parkinson's Disease; Quality of Life; Spinal Cord Injuries
2018385,"Cannabinoids, the Heart of the Matter.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064852/,Positive,,Meta-analysis,2018,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Cannabichromene (CBC); Cannabigerol (CBG); Cannabinol (CBN); CP-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Cardiovascular System,Cardiovascular Diseases (CVD)
2018386,"Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065210/,Positive,,Animal Study -,2018,Cannabichromene (CBC); Cannabidiolic Acid (CBD-a); Cannabigerol (CBG); Tetrahydrocannabinol (THC),,Veterinary Applications
2008129,Role Of Cannabinoid Receptors In Bone Disorders: Alternatives For Treatment,https://www.ncbi.nlm.nih.gov/pubmed/19221634,Positive,,Meta-analysis,2008,,Skeletal System,Cancer - Bone; Cancer; Osteoporosis; Arthritis - Rheumatoid; Arthritis
2008130,A decrease in anandamide signaling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer pain,https://www.ncbi.nlm.nih.gov/pubmed/18971457,Positive,,Animal Study,2008,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Nervous System; Skeletal System,Cancer - Bone; Cancer
2010132,A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871326/,Positive,,Animal Study,2010,AM-x Synthetic Cannabinoids,Nervous System; Skeletal System,Cancer - Bone; Cancer
2015227,Association Between Cannabis Use And The Risk Of Bladder Cancer: Results From The California Men's Health,https://www.ncbi.nlm.nih.gov/pubmed/25623697,Positive,,Meta-analysis,2015,,Nervous System; Urinary System,Cancer - Bladder; Cancer
2017282,Blunted stress reactivity in chronic cannabis users.,https://www.ncbi.nlm.nih.gov/pubmed/28567696,Positive,,Clinical Trial,2017,,Mental/Emotional System,
2016306,Endocannabinoids and Stress Resilience: Is Deficiency Sufficient to Promote Vulnerability?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086031/,Positive,,Meta-analysis,2016,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); SR-x Synthetic Cannabinoids,Mental/Emotional System,
2016307,Reductions in circulating endocannabinoid 2-arachidonoylglycerol levels in healthy human subjects exposed to chronic stressors.,https://www.ncbi.nlm.nih.gov/pubmed/26780604,Positive,,Clinical Trial,2016,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Mental/Emotional System,
2016308,"Anxiety, Stress, and Fear Response in Mice With Reduced Endocannabinoid Levels.",https://www.ncbi.nlm.nih.gov/pubmed/25981172,Positive,,Animal Study,2016,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Mind-Body Medicine,Mental/Emotional System; Nervous System,Anxiety
2016309,Neurobiological Interactions Between Stress and the Endocannabinoid System.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677118/,Positive,,Meta-analysis,2016,Mind-Body Medicine; 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Mental/Emotional System,
2016310,Variants in the CNR1 gene predispose to headache with nausea in the presence of life stress.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347942/,Positive,,Meta-analysis,2016,Anandamide (AEA),Nervous System,Migraine
2015228,Endocannabinoid Regulation of Neuroendocrine Systems.,https://www.ncbi.nlm.nih.gov/pubmed/26638767,Positive,,Meta-analysis,2015,Endocannabinoid (unspecified),,
2018387,Chronic Stress Induces Anxiety via an Amygdalar Intracellular Cascade that Impairs Endocannabinoid Signaling.,https://www.cell.com/neuron/fulltext/S0896-6273(15)00130-0?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0896627315001300%3Fshowall%3Dtrue,Positive,,Animal Study,2018,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); HU-x Synthetic Cannabinoids,Mental/Emotional System,Anxiety
2014187,Role of the basolateral amygdala in mediating the effects of the fatty acid amide hydrolase inhibitor URB597 on HPA axis response to stress.,https://www.ncbi.nlm.nih.gov/pubmed/25106694,Positive,,Animal Study,2014,Fatty Acid Amide Hydrolase (FAAH); AM-x Synthetic Cannabinoids,Mental/Emotional System,
2014188,Endocannabinoid Signaling in Hypothalamic-Pituitary-Adrenocortical Axis Recovery Following Stress: Effects of Indirect Agonists and Comparison of Male and Female Mice.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929302/,Positive,,Animal Study,2014,Palmitoylethanolamide (PEA); 2-Arachidonoyl Glycerol (2-AG); Monoacylglycerol Lipase (MAGL); SR-x Synthetic Cannabinoids,Mental/Emotional System,
2014189,Anti-stress effects of d-limonene and its metabolite perillyl alcohol.,https://www.ncbi.nlm.nih.gov/pubmed/24125633,Positive,,Animal Study,2014,,Mental/Emotional System,
2014190,"Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549323/,Positive,,Animal Study,2014,Anandamide (AEA); AM-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System; Nervous System,PTSD; Behavioral Disorders; Anxiety; Cognitive Dysfunction
2012170,Role of the endocannabinoid system in extinction of fear memories: lessons from animal studies,https://www.researchgate.net/publication/272736884_Role_of_the_endocannabinoid_system_in_extinction_of_fear_memories_lessons_from_animal_studies,Positive,,Meta-analysis,2012,AM-x Synthetic Cannabinoids; Endocannabinoid (unspecified); SR-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,PTSD; Anxiety
2012171,Neuronal populations mediating the effects of endocannabinoids on stress and emotionality.,https://www.ncbi.nlm.nih.gov/pubmed/22233782,Positive,,Meta-analysis,2012,Endocannabinoid (unspecified),Mental/Emotional System,
2012172,"Endocannabinoid Signaling, Glucocorticoid-Mediated Negative Feedback and Regulation of the HPA Axis.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3288468/,Positive,,Meta-analysis,2012,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System,
2012173,Stress-induced sensitization of cortical adrenergic receptors following a history of cannabinoid exposure,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905974/,Positive,,Animal Study,2012,WIN-x Synthetic Cannabinoids,Mental/Emotional System,
2011164,Endocannabinoids and stress,https://www.researchgate.net/publication/51209960_Endocannabinoids_and_stress,Positive,,Meta-analysis,2011,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),,Anxiety; Depression
2011165,Alterations in Corticolimbic Dendritic Morphology and Emotional Behavior in Cannabinoid CB1 Receptor–Deficient Mice Parallel the Effects of Chronic Stress.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155602/,Positive,,Animal Study,2011,,,Anxiety; Depression
2011166,Involvement of the Endocannabinoid System in the Neurobehavioral Effects of Stress and Glucocorticoids.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945244/,Positive,,Meta-analysis,2011,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Mental/Emotional System,
2010133,Depression-like phenotype following chronic CB1 receptor antagonism.,https://pubmed.ncbi.nlm.nih.gov/20381618/,Negative,,Animal Study,2010,SR-x Synthetic Cannabinoids; Mind-Body Medicine,Mental/Emotional System; Nervous System,Depression; Inflammation; Obesity
2009122,5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697769/,Positive,,Animal Study,2009,,Mental/Emotional System,Cardiovascular Diseases (CVD)
2008131,Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders.,https://www.ncbi.nlm.nih.gov/pubmed/18433869/,Positive,,Meta-analysis,2008,Endocannabinoid (unspecified),Mental/Emotional System,Depression
2008132,Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis.,https://www.ncbi.nlm.nih.gov/pubmed/18655899,Positive,,Meta-analysis,2008,Endocannabinoid (unspecified),,
2005074,Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus.,https://www.ncbi.nlm.nih.gov/pubmed/15949823,Positive,,Animal Study,2005,AM-x Synthetic Cannabinoids; Anandamide (AEA); CP-x Synthetic Cannabinoids,,Anorexia
1996015,Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1909901/,Positive,,Animal Study,1996,Anandamide (AEA); Tetrahydrocannabinol (THC); SR-x Synthetic Cannabinoids,Mental/Emotional System,Cardiovascular Diseases (CVD)
2017283,Stimulated CB1 Cannabinoid Receptor Inducing Ischemic Tolerance and Protecting Neuron from Cerebral Ischemia.,https://www.ncbi.nlm.nih.gov/pubmed/27142423,Positive,,Meta-analysis,2017,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Nervous System,Stroke
2016311,Signs and symptoms associated with synthetic cannabinoid toxicity: systematic review,https://www.ncbi.nlm.nih.gov/pubmed/27558216,Negative,,Meta-analysis,2016,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis
2016312,Repeated Thrombosis After Synthetic Cannabinoid Use.,https://www.ncbi.nlm.nih.gov/pubmed/27595371,Negative,,Meta-analysis,2016,Synthetic Cannabinoid (unspecified),,Poisoning by Synthetic Cannabis; Bleeding Disorders
2017284,Ischemic stroke associated with the use of a synthetic cannabinoid (spice).,https://www.ncbi.nlm.nih.gov/pubmed/28262132,Negative,,Meta-analysis,2017,Synthetic Cannabinoid (unspecified),Nervous System,Poisoning by Synthetic Cannabis
2017285,Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP),https://www.ncbi.nlm.nih.gov/pubmed/28478594,Positive,,Animal Study,2017,,Nervous System,Epilepsy
2017286,Role of cannabis in cardiovascular disorders.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542986/,Inconclusive,,Meta-analysis,2017,Synthetic Cannabinoid (unspecified),Cardiovascular System,Cardiovascular Diseases (CVD); Stroke
2017287,Intra-cerebral cannabidiol infusion-induced neuroprotection is partly associated with the TNF-α/TNFR1/NF-кB pathway in transient focal cerebral ischaemia.,https://www.ncbi.nlm.nih.gov/pubmed/28872345,Positive,,Animal Study,2017,,Nervous System,Stroke
2018388,Cardiovascular Complications of Marijuana and Related Substances: A Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986667/,Negative,,Meta-analysis,2018,Synthetic Cannabinoid (unspecified),Cardiovascular System,Cardiovascular Diseases (CVD)
2018389,Long-term depression induced by endogenous cannabinoids produces neuroprotection via astroglial CB1R after stroke in rodents.,https://www.ncbi.nlm.nih.gov/pubmed/29432698,Positive,,Animal Study,2018,AM-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Nervous System,Stroke
2017288,Anti-excitotoxic effects of cannabidiol are partly mediated by enhancement of NCX2 and NCX3 expression in animal model of cerebral ischemia.,https://www.ncbi.nlm.nih.gov/pubmed/27856160,Positive,,Animal Study,2017,,Nervous System,Stroke
2017289,Cannabidiol attenuates OGD/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neuron.,https://www.sciencedirect.com/science/article/pii/S221323171630338X,Positive,,Laboratory Study,2017,,Cardiovascular System; Nervous System,Cardiovascular Diseases (CVD); Reperfusion Injury; Stroke; Neurodegenerative Issues
2016313,Prior Cannabis Use Is Associated with Outcome after Intracerebral Hemorrhage.,https://www.ncbi.nlm.nih.gov/pubmed/26820826,Positive,,Meta-analysis,2016,,,Stroke
2011167,Consequences Of Cannabinoid And Monoaminergic System Disruption In A Mouse Model Of Autism Spectrum Disorders,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137184/,Positive,,Animal Study,2011,Tetrahydrocannabinol (THC),Mental/Emotional System,Autism; Schizophrenia
2016314,Recreational marijuana use and acute ischemic stroke: A population-based analysis of hospitalized patients in the United States.,https://www.ncbi.nlm.nih.gov/pubmed/26874461,Negative,,Meta-analysis,2016,,,Stroke
2012174,Would some cannabinoids ameliorate symptoms of autism?,https://www.researchgate.net/publication/221847393_Would_some_cannabinoids_ameliorate_symptoms_of_autism,Positive,,Meta-analysis,2012,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Autism
2015229,Endocannabinoid Signaling Mediates Oxytocin-driven Social Reward,http://www.pnas.org/content/112/45/14084,Positive,,Animal Study,2015,Anandamide (AEA),,Autism
2016315,Expression of the Endocannabinoid Receptor 1 in Human Stroke: An Autoptic Study.,https://www.ncbi.nlm.nih.gov/pubmed/27425766,Inconclusive,,Meta-analysis,2016,,Nervous System,Stroke
2017290,Cannabidiol Attenuates Seizures And Social Deficits In A Mouse Model Of Dravet Syndrome,https://www.ncbi.nlm.nih.gov/pubmed/28973916,Positive,,Animal Study,2017,,Nervous System,Epilepsy - Dravet Syndrome; Epilepsy; Autism
2018390,Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia.,https://www.ncbi.nlm.nih.gov/pubmed/27889412,Positive,,Animal Study,2018,,Nervous System,Stroke
2017291,Marijuana use and inpatient outcomes among hospitalized patients: analysis of the nationwide inpatient sample database.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5269570/,Positive,,Meta-analysis,2017,,,Cardiovascular Diseases (CVD)
2018391,Marijuana use and inpatient outcomes among hospitalized patients: analysis of the nationwide inpatient sample database.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5269570/,Negative,,Meta-analysis,2018,,,Stroke
2017292,Role of Endocannabinoids on Neuroinflammation in Autism Spectrum Disorder Prevention.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535348/,Positive,,Meta-analysis,2017,Endocannabinoid (unspecified),Mental/Emotional System,Autism
2017293,Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome After Stroke.,https://www.ncbi.nlm.nih.gov/pubmed/27899748,Positive,,Animal Study,2017,JWH-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Nervous System,Stroke
2017294,Cannabidiol reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke.,https://www.ncbi.nlm.nih.gov/pubmed/28012949,Positive,,Animal Study,2017,,Nervous System,Neurodegenerative Issues; Stroke
2017295,Endocannabinod Signal Dysregulation In Autism Spectrum Disorders: A Correlation Link Between Inflammatory State And Neuro-Immune Alterations,http://www.mdpi.com/1422-0067/18/7/1425/htm,Positive,,Meta-analysis,2017,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),Mental/Emotional System; Nervous System,Autism
2006072,Concurrent cannabis use during treatment for comorbid ADHD and cocaine dependence: effects on outcome.,https://pubmed.ncbi.nlm.nih.gov/17127551/,Positive,,Clinical Trial,2006,,Mental/Emotional System; Nervous System,ADD and ADHD
2009123,Bidirectional Regulation Of Novelty-induced Behavioral Inhibition By The Endocannabinoid System,https://www.ncbi.nlm.nih.gov/pubmed/19607846,Positive,,Animal Study,2009,AM-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Behavioral Disorders; ADD and ADHD; Intermittent Explosive Disorder
2011168,Loss Of Striatal Cannabinoid CB1 Receptor Function In Attention-deficit / hyperactivity Disorder Mice With Point-mutation Of The Dopamine Transporter,https://www.ncbi.nlm.nih.gov/pubmed/22034972,Positive,,Animal Study,2011,,Mental/Emotional System; Nervous System,ADD and ADHD
2012175,Cannabidiol And Clozapine Reverse MK-801-induced Deficits In Social Interaction And Hyperactivity In Sprague-Dawley Rats,http://journals.sagepub.com/doi/abs/10.1177/0269881112441865,Positive,,Animal Study,2012,,Mental/Emotional System; Nervous System,ADD and ADHD
2013161,Marijuana Use Is Associated With Inattention In Men And Sleep Quality In Women With Attention-Deficit/Hyperactivity Disorder: A Preliminary Study,https://www.ncbi.nlm.nih.gov/pubmed/23993465,Positive,,Meta-analysis,2013,,Mental/Emotional System; Nervous System,ADD and ADHD
2014191,Subtypes Of Attention Deficit-hyperactivity Disorder (ADHD) And Cannabis Use,https://www.ncbi.nlm.nih.gov/pubmed/24093525,Positive,,Meta-analysis,2014,,Mental/Emotional System; Nervous System,ADD and ADHD
2017296,Cannabinoids In Attention-deficit/hyperactivity Disorder: A Randomised-controlled Trial,https://www.europeanneuropsychopharmacology.com/article/S0924-977X(17)30237-7/fulltext,Positive,,Double Blind Clinical Trial,2017,Pharma THC:CBD; Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,ADD and ADHD
2014192,Inhibition of the cannabinoid 2 receptor in CNS-injury induced immunodeficiency syndrome.,https://www.ncbi.nlm.nih.gov/pubmed/24702836,Positive,,Meta-analysis,2014,,Immune System; Nervous System,Injury Immunodeficiency; Stroke
2008133,Beta-caryophyllene Is A Dietary Cannabinoid,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2449371/,Positive,,Animal Study,2008,,,Atherosclerosis; Cardiovascular Diseases (CVD); Pain; Osteoporosis; Pain - Chronic
2014193,Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice.,https://www.ncbi.nlm.nih.gov/pubmed/24532152,Positive,,Animal Study,2014,,Nervous System,Stroke
2009124,"Cannabidiol-2',6'-dimethyl Ether, A Cannabidiol Derivative, Is A Highly Potent And Selective 15-lipoxygenase Inhibitor",http://dmd.aspetjournals.org/content/dmd/37/8/1733.full.pdf,Positive,,Laboratory Study,2009,,Cardiovascular System,Atherosclerosis; Cardiovascular Diseases (CVD)
2013162,Activation of cannabinoid CB2 receptor-mediated AMPK/CREB pathway reduces cerebral ischemic injury.,https://pubmed.ncbi.nlm.nih.gov/23414569/,Positive,,Animal Study,2013,AM-x Synthetic Cannabinoids,Nervous System,Stroke
2010134,Activation Of Cannabinoid CB2 Receptor Ameliorates Atherosclerosis Associated With Suppression Of Adhesion Molecules,https://www.ncbi.nlm.nih.gov/pubmed/20075743,Positive,,Animal Study,2010,WIN-x Synthetic Cannabinoids,Cardiovascular System,Atherosclerosis; Cardiovascular Diseases (CVD)
2007090,Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor‐independent myeloperoxidase‐inhibiting mechanism.,https://onlinelibrary.wiley.com/doi/full/10.1111/j.1471-4159.2007.04565.x,Positive,,Animal Study,2007,Tetrahydrocannabinol (THC); AM-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,,Neurodegenerative Issues; Stroke
2015230,"Activation Of GPR55 Receptors Exacerbates OxLDL-Induced Lipid Accumulation And Inflammatory Responses, While Reducing Cholesterol Efflux From Human Macrophages",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430319/,Positive,,Laboratory Study,2015,,,Atherosclerosis; Cardiovascular Diseases (CVD)
2017297,Inhibitory Effect Of Trans-caryophyllene (TC) On Leukocyte-endothelial Attachment,https://www.sciencedirect.com/science/article/pii/S0041008X17302727,Positive,,Laboratory Study,2017,,Cardiovascular System,Atherosclerosis; Cardiovascular Diseases (CVD)
2007091,Delta9-tetrahydrocannabinol (Delta9-THC) prevents cerebral infarction via hypothalamic-independent hypothermia.,https://www.ncbi.nlm.nih.gov/pubmed/17289082,Positive,,Animal Study,2007,SR-x Synthetic Cannabinoids,Immune System,Stroke; Epilepsy - FIRES
1974003,Acute Effects of Smoked Marijuana and Oral Δ9-Tetrahydrocannabinol on Specific Airway Conductance in Asthmatic Subjects,https://www.atsjournals.org/doi/abs/10.1164/arrd.1974.109.4.420#.VqFY3DbAZuY,Positive,,Double Blind Clinical Trial,1974,Tetrahydrocannabinol (THC),Respiratory System,Asthma
1975008,Effects Of Smoked Marijuana In Experimentally Induced Asthma,https://www.atsjournals.org/doi/abs/10.1164/arrd.1975.112.3.377#.VqFYXzbAZuY,Positive,,Double Blind Clinical Trial,1975,Tetrahydrocannabinol (THC),Respiratory System,Asthma
1999019,Cannabinoids as antioxidants and neuroprotectants.,https://patents.google.com/patent/US6630507,Positive,,Meta-analysis,1999,HU-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); Tetrahydrocannabinol (THC),,Alzheimer's Disease; Cognitive Dysfunction; Pain; Neurodegenerative Issues; Pain - Acute; Parkinson's Disease; Stroke
1976007,Bronchodilator Effect Of Delta1-tetrahydrocannabinol Administered By Aerosol Of Asthmatic Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC470501/,Positive,,Double Blind Clinical Trial,1976,,Respiratory System,Asthma
1977008,Bronchial Effects Of Aerosolized Delta 9-tetrahydrocannabinol In Healthy And Asthmatic Subjects,https://www.ncbi.nlm.nih.gov/pubmed/319717,Positive,,Double Blind Clinical Trial,1977,Tetrahydrocannabinol (THC),Respiratory System,Asthma; Urinary Incontinence
1978003,Bronchodilator Effect Of Delta1-tetrahydrocannabinol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1429361/,Positive,,Clinical Trial,1978,,Respiratory System,Asthma
1998024,Cannabidiol and Delta9-tetrahydrocannabinol are neuroprotective antioxidants.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC20965/,Positive,,Laboratory Study,1998,Tetrahydrocannabinol (THC); HU-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids,Nervous System,Neurodegenerative Issues; Stroke
1983008,Comparison Of Bronchial Effects Of Nabilone And Terbutaline In Healthy And Asthmatic Subjects,https://www.ncbi.nlm.nih.gov/pubmed/6306060,Inconclusive,,Double Blind Clinical Trial,1983,Pharma THC,Respiratory System,Asthma
2015231,Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458548/,Positive,,Animal Study,2015,,Respiratory System,Asthma
2016316,Δ9-Tetrahydrocannabinol Reverses TNFα-induced Increase In Airway Epithelial Cell Permeability Through CB2 Receptors,https://www.ncbi.nlm.nih.gov/pubmed/27641813,Positive,,Laboratory Study,2016,AM-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,Respiratory System,Asthma; Cough
2016317,The Effect Of Cannabinoids On Dinitrofluorobenzene-induced Experimental Asthma In Mice,https://www.ncbi.nlm.nih.gov/pubmed/27216000,Positive,,Animal Study,2016,Synthetic Cannabinoid (unspecified),Respiratory System,Asthma
2000021,The Nonpsychoactive Cannabis Constituent Cannabidiol Is An Oral Anti-arthritic Therapeutic In Murine Collagen-induced Arthritis,http://www.pnas.org/content/97/17/9561.full,Positive,,Animal Study,2000,,Skeletal System,Arthritis; Inflammation
2005075,Survey of Australians using cannabis for medical purposes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1262744/,Positive,,Meta-analysis,2005,,,Arthritis - Osteoarthritis; Arthritis; Depression; Insomnia and Sleep Disorders; Pain; Nausea and Vomiting; Pain - Chronic
2005076,"Ajulemic Acid (IP-751): Synthesis, Proof Of Principle, Toxicity Studies, And Clinical Trials",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751505/,Positive,,Animal Study,2005,Synthetic Cannabinoid (unspecified),Skeletal System,Arthritis - Osteoarthritis; Arthritis
2011169,Local Application Of The Endocannabinoid Hydrolysis Inhibitor URB597 Reduces Nociception In Spontaneous And Chemically Induced Models Of Osteoarthritis,https://www.ncbi.nlm.nih.gov/pubmed/21185649,Positive,,Animal Study,2011,AM-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH),Skeletal System,Arthritis
2017298,"Comparative In Silico Analyses Of Cannabis Sativa, Prunella Vulgaris And Withania Somnifera Compounds Elucidating The Medicinal Properties Against Rheumatoid Arthritis",https://www.ncbi.nlm.nih.gov/pubmed/28472734,Positive,,Laboratory Study,2017,,Skeletal System,Arthritis - Rheumatoid; Arthritis; Arthritis - Osteoarthritis
2017299,Endocannabinoids In Arthritis: Current Views And Perspective,https://www.ncbi.nlm.nih.gov/pubmed/28736968,Positive,,Meta-analysis,2017,Endocannabinoid (unspecified),Skeletal System,Arthritis - Osteoarthritis; Arthritis
2015232,Physicochemical characterization and analgesic effect of inclusion complexes of essential oil from Hyptis pectinata L. Poit leaves with β-cyclodextrin.,https://www.researchgate.net/profile/Lucindo_Quintans-Junior/publication/273960680_Physicochemical_Characterization_and_Analgesic_Effect_of_Inclusion_Complexes_of_Essential_Oil_from_Hyptis_pectinata_L_Poit_Leaves_with_-Cyclodextrin/links/5517437e0cf2f7d80a39ee4f/Physicochemical-Characterization-and-Analgesic-Effect-of-Inclusion-Complexes-of-Essential-Oil-from-Hyptis-pectinata-L-Poit-Leaves-with-Cyclodextrin.pdf,Positive,,Animal Study,2015,,,Pain; Pain - Neuropathy - Inflammatory Polyneuropathy; Pain - Neuropathy - Peripheral
2018392,Medical marijuana for urologic chronic pelvic pain.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040614/,Positive,,Meta-analysis,2018,Cannabichromene (CBC); Tetrahydrocannabinol (THC),Urinary System,Cystitis
2018393,Cannabidiol as a Therapeutic Alternative for Post-traumatic Stress Disorder: From Bench Research to Confirmation in Human Trials.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066583/,Positive,,Meta-analysis,2018,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System; Nervous System,PTSD; Anxiety
2018394,Protective effects of elevated anandamide on stress and fear-related behaviors: translational evidence from humans and mice.,https://pubmed.ncbi.nlm.nih.gov/30120421/,Positive,,Animal Study,2018,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System; Nervous System,PTSD; Anxiety
2005077,Cannabimimetic effects of osteopathic manipulative treatment.,https://www.ncbi.nlm.nih.gov/pubmed/16118355/,Positive,,Clinical Trial,2005,Anandamide (AEA); 2-Arachidonoyl Glycerol (2-AG); Other Related Compounds,,Anxiety; Pain; Pain - Chronic
2005078,A Role For Cannabinoid CB1 Receptors In Mood And Anxiety Disorders,https://www.ncbi.nlm.nih.gov/pubmed/16148437,Positive,,Meta-analysis,2005,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Anxiety
2005079,Cannabinoids Promote Embryonic And Adult Hippocampus Neurogenesis And Produce Anxiolytic- And Antidepressant-like Effects,https://www.jci.org/articles/view/25509,Positive,,Animal Study,2005,HU-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Anxiety; Depression; Cognitive Dysfunction; Longevity; Neurodegenerative Issues
2009125,The endocannabinoid system and the treatment of mood and anxiety disorders.,https://www.ncbi.nlm.nih.gov/pubmed/19839936,Positive,,Meta-analysis,2009,,Mental/Emotional System; Nervous System,Anxiety; Bipolar Disorder; Depression; PTSD
2009126,Marijuana Effectiveness As An HIV Self-care Strategy,https://www.ncbi.nlm.nih.gov/pubmed/19377043,Positive,,Meta-analysis,2009,,Immune System,HIV/AIDS; Anxiety; Depression; Nausea and Vomiting
2013163,Trans-β-Caryophyllene: An Effective Antileishmanial Compound Found in Commercial Copaiba Oil (Copaifera spp.),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705974/,Positive,,Laboratory Study,2013,,Integumentary System,Leishmaniasis
2010135,Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055598/,Positive,,Double Blind Clinical Trial,2010,Tetrahydrocannabinol (THC),Mental/Emotional System,Anxiety
2010136,Therapeutical Use Of The Cannabinoids In Psychiatry  (Uso Terapêutico Dos Canabinoides Em Psiquiatria) ,http://www.scielo.br/pdf/rbp/v32s1/en_a09v32s1.pdf,Positive,,Meta-analysis,2010,,,Anxiety
2011170,Neural Basis Of Anxiolytic Effects Of Cannabidiol (CBD) In Generalized Social Anxiety Disorder: A Preliminary Report,https://www.ncbi.nlm.nih.gov/pubmed/20829306,Positive,,Double Blind Clinical Trial,2011,,Mental/Emotional System; Nervous System,Anxiety
2011171,Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079847/,Positive,,Double Blind Clinical Trial,2011,,Mental/Emotional System; Nervous System,Anxiety
2012176,Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders,http://rstb.royalsocietypublishing.org/content/367/1607/3364,Positive,,Meta-analysis,2012,,,Anxiety; Depression; Psychosis
2013164,Cannabidiol Enhances Consolidation Of Explicit Fear Extinction In Humans,https://www.ncbi.nlm.nih.gov/pubmed/23307069,Positive,,Double Blind Clinical Trial,2013,,,Anxiety; Hemorrhoids
2014194,Multiple Mechanistically Distinct Modes of Endocannabinoid Mobilization at Central Amygdala Glutamatergic Synapses,https://www.cell.com/neuron/fulltext/S0896-6273(14)00017-8?_returnURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0896627314000178%3Fshowall%3Dtrue,Positive,,Animal Study,2014,2-Arachidonoyl Glycerol (2-AG); CP-x Synthetic Cannabinoids,,Anxiety; PTSD
2014195,"β-Caryophyllene, A CB2 Receptor Agonist Produces Multiple Behavioral Changes Relevant To Anxiety And Depression In Mice",https://www.sciencedirect.com/science/article/abs/pii/S0031938414003400?via%3Dihub,Positive,,Animal Study,2014,AM-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Anxiety; Depression; OCD
2015233,FAAH genetic variation enhances fronto-amygdala function in mouse and human,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351757/,Positive,,Clinical Trial,2015,Fatty Acid Amide Hydrolase (FAAH),,Anxiety; PTSD
2015234,Cannabidiol as a Potential Treatment for Anxiety Disorders.,https://www.ncbi.nlm.nih.gov/pubmed/26341731,Positive,,Meta-analysis,2015,,Mental/Emotional System; Nervous System,Anxiety; OCD; PTSD
2016318,Effectiveness Of Cannabidiol Oil For Pediatric Anxiety And Insomnia As Part Of Posttraumatic Stress Disorder: A Case Report,https://www.ncbi.nlm.nih.gov/pubmed/27768570,Positive,,Meta-analysis,2016,,Mental/Emotional System; Nervous System,Anxiety; Insomnia and Sleep Disorders; PTSD
2016319,"Cannabidiol, neuroprotection and neuropsychiatric disorders.",https://www.ncbi.nlm.nih.gov/pubmed/26845349,Positive,,Meta-analysis,2016,,Nervous System,Neurodegenerative Issues; Anxiety; Cardiovascular Diseases (CVD); Cognitive Dysfunction; Depression; Inflammation; Oxidative Stress; Parkinson's Disease; Psychosis; Reperfusion Injury; Stroke; Traumatic Brain Injury
2017300,Cannabidiol Does Not Dampen Responses To Emotional Stimuli In Healthy Adults,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569582/,Inconclusive,,Double Blind Clinical Trial,2017,,,Anxiety
2017301,Plastic And Neuroprotective Mechanisms Involved In The Therapeutic Effects Of Cannabidiol In Psychiatric Disorders,https://www.frontiersin.org/articles/10.3389/fphar.2017.00269/full,Positive,,Meta-analysis,2017,,Nervous System,Neurodegenerative Issues; Anxiety; Depression; Psychosis; Schizophrenia
2017302,Cannabis as a substitute for prescription drugs - a cross-sectional study.,https://pubmed.ncbi.nlm.nih.gov/28496355/,Positive,,Meta-analysis,2017,,,Anxiety; Depression; Pain; Pain - Acute; Pain - Chronic
2017303,"Substitution Of Medical Cannabis For Pharmaceutical Agents For Pain, Anxiety, And Sleep",https://www.ncbi.nlm.nih.gov/pubmed/28372506,Positive,,Meta-analysis,2017,,Mental/Emotional System; Nervous System,Anxiety; Insomnia and Sleep Disorders; Pain
2017304,Endocannabinoid signalling modulates susceptibility to traumatic stress exposure,http://www.nature.com/articles/ncomms14782,Positive,,Animal Study,2017,2-Arachidonoyl Glycerol (2-AG),Mental/Emotional System; Nervous System,PTSD; Anxiety; Bipolar Disorder; Depression; OCD
2017305,Cannabidiol Regulation Of Emotion And Emotional Memory Processing: Relevance For Treating Anxiety-related And Substance Abuse Disorders,https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bph.13724,Positive,,Meta-analysis,2017,,Mental/Emotional System; Nervous System,Anxiety; PTSD
2017306,Cannabidiol Treatment for Refractory Seizures in Sturge-Weber Syndrome,https://www.researchgate.net/publication/314253356_Cannabidiol_Treatment_for_Refractory_Seizures_in_Sturge-Weber_Syndrome,Positive,,Clinical Trial,2017,,Nervous System,Sturge-Weber Syndrome
2010137,Targeting the Cannabinoid Pathway Limits the Development of Fibrosis and Autoimmunity in a Mouse Model of Systemic Sclerosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893662/,Positive,,Animal Study,2010,JWH-x Synthetic Cannabinoids; WIN-x Synthetic Cannabinoids,Integumentary System,Systemic Sclerosis
2016320,Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome.,https://www.ncbi.nlm.nih.gov/pubmed/26883879,Inconclusive,,Meta-analysis,2016,Tetrahydrocannabinol (THC),Digestive System; Muscular System,Cachexia
1991012,Recent clinical experience with dronabinol.,https://www.ncbi.nlm.nih.gov/pubmed/1666930,Positive,,Clinical Meta-analysis,1991,Pharma THC; Tetrahydrocannabinol (THC),,Anorexia
1994005,A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia.,https://www.ncbi.nlm.nih.gov/pubmed/8035251,Positive,,Clinical Trial,1994,Tetrahydrocannabinol (THC),Digestive System; Mental/Emotional System; Nervous System,Anorexia; Cancer; Loss of Appetite; Cachexia
1995013,Dronabinol As A Treatment For Anorexia Associated With Weight Loss In Patients With AIDS,https://www.ncbi.nlm.nih.gov/pubmed/7730690,Positive,,Double Blind Clinical Trial,1995,Pharma THC; Tetrahydrocannabinol (THC),Digestive System; Immune System,Anorexia; HIV/AIDS; Cachexia
2002042,A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.,https://www.ncbi.nlm.nih.gov/pubmed/12417686,Positive,,Animal Study,2002,Anandamide (AEA); Endocannabinoid (unspecified),,Anorexia
2005080,Endocannabinoids In The Regulation Of Appetite And Body Weight,https://www.ncbi.nlm.nih.gov/pubmed/16148436,Positive,,Laboratory Study,2005,Endocannabinoid (unspecified),Digestive System,Anorexia; Anorexia Nervosa; Cachexia; Metabolic Syndrome
2005081,Integration Of Endocannabinoid And Leptin Signaling In An Appetite-related Neural Circuit,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2280039/,Positive,,Animal Study,2005,Anandamide (AEA),,Anorexia
2006073,"Comparison Of Orally Administered Cannabis Extract And Delta-9-tetrahydrocannabinol In Treating Patients With Cancer-related Anorexia-cachexia Syndrome: A Multicenter, Phase III, Randomized, Double-blind, Placebo-controlled Clinical Trial From The Cannabis-In-Cachexia-Study-Group",https://ascopubs.org/doi/10.1200/JCO.2005.05.1847,Inconclusive,,Double Blind Clinical Trial,2006,Tetrahydrocannabinol (THC),Digestive System; Muscular System; Nervous System,Anorexia; Cachexia; Cancer; Chemotherapy-induced Nausea & Vomiting; Quality of Life
2007092,Use of Dronabinol Improves Appetite and Reverses Weight Loss in HIV/AIDS-Infected Patients.,https://www.ncbi.nlm.nih.gov/pubmed/17538000,Positive,,Clinical Trial,2007,Pharma THC,Digestive System; Immune System; Muscular System,Anorexia; Cachexia; HIV/AIDS; Nausea and Vomiting
2007093,Anorexia of aging in long term care: is dronabinol an effective appetite stimulant?--a pilot study.,https://www.ncbi.nlm.nih.gov/pubmed/17435963,Positive,,Meta-analysis,2007,Pharma THC; Tetrahydrocannabinol (THC),Digestive System,Anorexia; Cachexia; Geriatric Conditions; Longevity
2008134,"Evaluation of oral cannabinoid-containing medications for the management of interferon and ribavirin-induced anorexia, nausea and weight loss in patients treated for chronic hepatitis C virus.",https://www.ncbi.nlm.nih.gov/pubmed/18414712,Positive,,Meta-analysis,2008,,Digestive System,Anorexia; Hepatitis; Nausea and Vomiting
2016321,"Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021742/,Positive,,Animal Study,2016,Cannabigerol (CBG),,Anorexia Nervosa; Anorexia; Cachexia
2017307,"A Cannabigerol-rich Cannabis Sativa Extract, Devoid Of Delta 9-tetrahydrocannabinol, Elicits Hyperphagia In Rats",https://www.ncbi.nlm.nih.gov/pubmed/28125508,Positive,,Animal Study,2017,Cannabigerol (CBG),,Anorexia Nervosa; Anorexia; Cachexia
2018395,Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922297/,Positive,,Meta-analysis,2018,Pharma THC:CBD; Tetrahydrocannabinol (THC); Pharma THC,Nervous System,Pain; Pain - Cancer; Pain - Chronic; Arthritis - Rheumatoid; Arthritis; Pain - Neuropathy - Peripheral
2018396,Anandamide and endocannabinoid system: an attractive therapeutic approach for cardiovascular disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009078/,Positive,,Meta-analysis,2018,Anandamide (AEA); AM-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH); HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; Other Related Compounds; WIN-x Synthetic Cannabinoids,,
2018397,The Role of Cannabinoids in the Setting of Cirrhosis.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023500/,Positive,,Meta-analysis,2018,Anandamide (AEA); 2-Arachidonoyl Glycerol (2-AG),Digestive System,Fibrosis - Liver (Cirrhosis); Fibrosis
2018398,Cannabis and cannabinoids for the treatment of people with chronic non-cancer pain conditions: a systematic review and meta-analysis of controlled and observational studies.,https://www.ncbi.nlm.nih.gov/pubmed/29847469,Positive,,Meta-analysis,2018,,,Pain; Pain - Chronic
2018399,Potential of Endocannabinoids to Control Bladder Pain.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5962905/,Positive,,Meta-analysis,2018,Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); 2-Arachidonoyl Glycerol (2-AG),Urinary System,Cystitis
2018400,Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023518/,Positive,,Meta-analysis,2018,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); JWH-x Synthetic Cannabinoids,Digestive System,Fatty Liver Disease
2018401,A Cross-Sectional Study of Cannabidiol Users,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043845/,Positive,,Meta-analysis,2018,,,Anxiety; Depression; Insomnia and Sleep Disorders; Pain; Pain - Chronic
2018402,Marijuana Use in Adults Living with Sickle Cell Disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044416/,Positive,,Meta-analysis,2018,,Cardiovascular System,Sickle Cell Disorders
2018403,"Involvement of the CB2 cannabinoid receptor in cell growth inhibition and G0/G1 cell cycle arrest via the cannabinoid agonist WIN 55,212–2 in renal cell carcinoma.",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966919/,Positive,,Laboratory Study,2018,WIN-x Synthetic Cannabinoids; AM-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids; SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),Urinary System,Cancer - Kidney; Cancer
2018404,Acute myocardial infarction triggered by use of synthetic cannabis.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5914480/,Negative,,Meta-analysis,2018,Synthetic Cannabinoid (unspecified),,Poisoning by Synthetic Cannabis
2018405,Ethnopharmacology of Love.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041438/,Positive,,Meta-analysis,2018,,Mental/Emotional System,Grief and Bereavement
2018406,Inhibitory effects of β-caryophyllene on Streptococcus mutans biofilm.,https://www.ncbi.nlm.nih.gov/pubmed/29407750,Positive,,Laboratory Study,2018,,Integumentary System,Cavities
2018407,"Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis.",https://www.ncbi.nlm.nih.gov/pubmed/29632236,Positive,,Laboratory Study,2018,2-Arachidonoyl Glycerol (2-AG); AM-x Synthetic Cannabinoids; Anandamide (AEA); Cannabichromene (CBC); Cannabidiolic Acid (CBD-a); Cannabigerol (CBG); Cannabigerolic Acid (CBG-a); Other Related Compounds,Integumentary System,Allergic Contact Dermatitis
2018408,Acute administration of beta-caryophyllene prevents endocannabinoid system activation during transient common carotid artery occlusion and reperfusion.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799897/,Positive,,Animal Study,2018,,Cardiovascular System,Cardiovascular Diseases (CVD); Reperfusion Injury
2018409,"Pharmacological characterization of the cannabinoid receptor 2 agonist, β-caryophyllene on seizure models in mice.",https://www.ncbi.nlm.nih.gov/pubmed/29547827,Positive,,Animal Study,2018,,,Epilepsy
2018410,Cannabis Essential Oil: A Preliminary Study for the Evaluation of the Brain Effects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822802/,Positive,,Double Blind Clinical Trial,2018,,,Cognitive Dysfunction; Anxiety; Depression; Oxidative Stress
2018411,Monoamine Involvement in the Antidepressant-Like Effect of β-Caryophyllene.,https://www.ncbi.nlm.nih.gov/pubmed/29676236,Positive,,Animal Study,2018,,Mental/Emotional System,Depression
2018412,Hypocholesterolemic effect of β-caryophyllene in rats fed cholesterol and fat enriched diet.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990408/,Positive,,Animal Study,2018,,Cardiovascular System,Atherosclerosis; Cardiovascular Diseases (CVD); Fatty Liver Disease
2018413,"Induction of programmed cell death in Trypanosoma cruzi by Lippia alba essential oils and their major and synergistic terpenes (citral, limonene and caryophyllene oxide).",https://www.ncbi.nlm.nih.gov/pubmed/30053848,Positive,,Laboratory Study,2018,,Cardiovascular System,Chagas Disease
2018414,A new cause of ischaemic priapism: Synthetic cannabinoids.,https://www.ncbi.nlm.nih.gov/pubmed/29607523,Negative,,Meta-analysis,2018,Synthetic Cannabinoid (unspecified),,Poisoning by Synthetic Cannabis
2018415,Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?,https://www.frontiersin.org/articles/10.3389/fphar.2018.00482/full,Positive,,Meta-analysis,2018,Pharma THC:CBD; Tetrahydrocannabinol (THC),,Huntington's Disease; Multiple Sclerosis; Parkinson's Disease
2018416,Cannabinoids for Treatment of Dystonia in Huntington's Disease.,https://www.ncbi.nlm.nih.gov/pubmed/29562549,Positive,,Clinical Trial,2018,Pharma THC:CBD; Pharma THC; Tetrahydrocannabinol (THC),Nervous System,Dystonia; Huntington's Disease; Chorea
2018417,The Use of Cannabinoids in Colitis: A Systematic Review and Meta-Analysis.,https://www.ncbi.nlm.nih.gov/pubmed/29562280,Positive,,Meta-analysis,2018,AM-x Synthetic Cannabinoids; Anandamide (AEA); Cannabigerol (CBG); Synthetic Cannabinoid (unspecified); WIN-x Synthetic Cannabinoids,Digestive System,IBD - Inflammatory Bowel Disease; Irritable Bowel Syndrome
2011172,Cognitive Reserve in Aging.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135666/,Positive,,Meta-analysis,2011,,,Alzheimer's Disease
2018418,β-Caryophyllene (BCP) ameliorates MPP+ induced cytotoxicity.,https://www.ncbi.nlm.nih.gov/pubmed/29710667,Positive,,Laboratory Study,2018,Capsaicin (CAPS),Nervous System,Neurodegenerative Issues; Oxidative Stress; Parkinson's Disease
2018419,Marijuana use and short-term outcomes in patients hospitalized for acute myocardial infarction,http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0199705,Positive,,Meta-analysis,2018,,Cardiovascular System,Cardiovascular Diseases (CVD)
2013165,Marijuana use and long-term mortality among survivors of acute myocardial infarction,https://www.sciencedirect.com/science/article/pii/S0002870312008356,Positive,,Meta-analysis,2013,,Cardiovascular System,Cardiovascular Diseases (CVD); Heart Attack
2001032,Marijuana In The Management Of Amyotrophic Lateral Sclerosis,https://www.researchgate.net/publication/11875440_Marijuana_in_the_management_of_amyotrophic_lateral_sclerosis,Positive,,Meta-analysis,2001,,,Amyotrophic Lateral Sclerosis (ALS)
2004064,Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid.,https://www.ncbi.nlm.nih.gov/pubmed/15204022,Positive,,Animal Study,2004,,,Amyotrophic Lateral Sclerosis (ALS)
2004065,Survey Of Cannabis Use In Patients With Amyotrophic Lateral Sclerosis,https://www.ncbi.nlm.nih.gov/pubmed/15055508,Positive,,Meta-analysis,2004,,Nervous System,Amyotrophic Lateral Sclerosis (ALS)
2005082,Cannabinol Delays Symptom Onset In SOD1 (G93A) Transgenic Mice Without Affecting Survival,https://www.tandfonline.com/doi/abs/10.1080/14660820510030149?journalCode=iafd19,Positive,,Animal Study,2005,Cannabinol (CBN),Nervous System,Neurodegenerative Issues; Amyotrophic Lateral Sclerosis (ALS)
2006074,Increasing Cannabinoid Levels By Pharmacological And Genetic Manipulation Delay Disease Progression In SOD1 Mice,https://pubmed.ncbi.nlm.nih.gov/16571781/,Positive,,Animal Study,2006,WIN-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH),,Neurodegenerative Issues; Amyotrophic Lateral Sclerosis (ALS)
2010138,The Endocannabinoid System In The Inflammatory And Neurodegenerative Processes Of Multiple Sclerosis And Of Amyotrophic Lateral Sclerosis,https://www.ncbi.nlm.nih.gov/pubmed/20353778,Positive,,Meta-analysis,2010,Endocannabinoid (unspecified),,Amyotrophic Lateral Sclerosis (ALS); Multiple Sclerosis
2010139,"Cannabis And Amyotrophic Lateral Sclerosis: Hypothetical And Practical Applications, And A Call For Clinical Trials",https://www.ncbi.nlm.nih.gov/pubmed/20439484,Positive,,Animal Study,2010,,Nervous System,Amyotrophic Lateral Sclerosis (ALS)
2010140,"Tetrahydrocannabinol (THC) For Cramps In Amyotrophic Lateral Sclerosis: A Randomised, Double-blind Crossover Trial",https://www.ncbi.nlm.nih.gov/pubmed/20498181,Inconclusive,,Double Blind Clinical Trial,2010,Tetrahydrocannabinol (THC),Nervous System,Amyotrophic Lateral Sclerosis (ALS); Pain
2017308,Gingival Stromal Cells As An In Vitro Model: Cannabidiol Modulates Genes Linked With Amyotrophic Lateral Sclerosis,https://www.ncbi.nlm.nih.gov/pubmed/27714895,Positive,,Laboratory Study,2017,,,Amyotrophic Lateral Sclerosis (ALS)
2017309,Co-medication with Cannabidiol May Slow Down the Progression of Motor Neuron Disease: A Case Report.,https://www.omicsonline.org/open-access/comedication-with-cannabidiol-may-slow-down-the-progression-of-motorneuron-disease-a-case-report-2329-9126-1000316.pdf,Positive,,Meta-analysis,2017,,,Amyotrophic Lateral Sclerosis (ALS)
2017310,"Up-regulation Of CB2 Receptors In Reactive Astrocytes In Canine Degenerative Myelopathy, A Disease Model Of Amyotrophic Lateral Sclerosis",https://www.ncbi.nlm.nih.gov/pubmed/28069688,Positive,,Animal Study,2017,,,Amyotrophic Lateral Sclerosis (ALS)
1997016,Effects Of Dronabinol On Anorexia And Disturbed Behavior In Patients With Alzheimer's Disease,https://pubmed.ncbi.nlm.nih.gov/9309469/,Positive,,Double Blind Clinical Trial,1997,Pharma THC; Tetrahydrocannabinol (THC),Digestive System; Nervous System,Alzheimer's Disease; Anorexia
2002043,Anandamide And Noladin Ether Prevent Neurotoxicity Of The Human Amyloid-beta Peptide,https://www.ncbi.nlm.nih.gov/pubmed/12384227,Positive,,Laboratory Study,2002,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); AM-x Synthetic Cannabinoids,,Alzheimer's Disease
2003052,Cannabinoid CB2 Receptors And Fatty Acid Amide Hydrolase Are Selectively Overexpressed In Neuritic Plaque-associated Glia In Alzheimer's Disease Brains,https://www.ncbi.nlm.nih.gov/pubmed/14657172,Positive,,Laboratory Study,2003,Fatty Acid Amide Hydrolase (FAAH),,Alzheimer's Disease
2004066,"Neuroprotective Effect Of Cannabidiol, A Non-psychoactive Component From Cannabis Sativa, On Beta-amyloid-induced Toxicity In PC12 Cells",https://www.ncbi.nlm.nih.gov/pubmed/15030397,Positive,,Laboratory Study,2004,,,Alzheimer's Disease; Oxidative Stress
2004067,Role of the endocannabinoid system in Alzheimer's disease: new perspectives.,https://www.ncbi.nlm.nih.gov/pubmed/15306158,Positive,,Laboratory Study,2004,,,Alzheimer's Disease
2005083,Prevention Of Alzheimer's Disease Pathology By Cannabinoids: Neuroprotection Mediated By Blockade Of Microglial Activation,http://www.jneurosci.org/content/jneuro/25/8/1904.full.pdf,Positive,,Animal Study,2005,WIN-x Synthetic Cannabinoids; HU-x Synthetic Cannabinoids; JWH-x Synthetic Cannabinoids,,Alzheimer's Disease
2006075,A Molecular Link Between The Active Component Of Marijuana And Alzheimer's Disease Pathology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2562334/#!po=68.7500,Positive,,Laboratory Study,2006,,,Alzheimer's Disease
2007094,Alzheimer's disease; taking the edge off with cannabinoids?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190031/,Positive,,Meta-analysis,2007,,,Alzheimer's Disease
2008135,The Cannabinoid Receptor Agonist Nabilone For The Treatment Of Dementia-related Agitation,https://www.researchgate.net/publication/5767638_The_cannabinoid_receptor_agonist_nabilone_for_the_treatment_of_dementia-related_agitation,Positive,,Meta-analysis,2008,Pharma THC,,Alzheimer's Disease
2008136,The Role Of The Endocannabinoid System In Alzheimer's Disease: Facts And Hypotheses,https://www.ncbi.nlm.nih.gov/pubmed/18781980,Positive,,Meta-analysis,2008,,,Alzheimer's Disease
2009127,The Activation Of Cannabinoid CB2 Receptors Stimulates In Situ And In Vitro Beta-amyloid Removal By Human Macrophages,https://www.ncbi.nlm.nih.gov/pubmed/19505450,Positive,,Laboratory Study,2009,JWH-x Synthetic Cannabinoids,Nervous System,Alzheimer's Disease; Dementia
2010141,Therapeutic Potential Of Non-Psychotropic Cannabidiol In Ischemic Stroke,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036658/,Positive,,Meta-analysis,2010,,Nervous System,Stroke; Alzheimer's Disease; Arthritis - Rheumatoid; Arthritis; Cognitive Dysfunction; Parkinson's Disease
2010142,Cannabinoid Receptors and Endocannabinoids: Role in Neuroinflammatory and Neurodegenerative Disorders,https://www.researchgate.net/publication/45198554_Cannabinoid_Receptors_and_Endocannabinoids_Role_in_Neuroinflammatory_and_Neurodegenerative_Disorders,Positive,,Meta-analysis,2010,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),,Alzheimer's Disease; Amyotrophic Lateral Sclerosis (ALS); Huntington's Disease; Multiple Sclerosis; Parkinson's Disease
2014196,β-Caryophyllene ameliorates the Alzheimer-like phenotype in APP/PS1 Mice through CB2 receptor activation and the PPARγ pathway.,https://www.ncbi.nlm.nih.gov/pubmed/25171128,Positive,,Animal Study,2014,AM-x Synthetic Cannabinoids,Nervous System,Alzheimer's Disease
2014197,The Influence Of Cannabinoids On Generic Traits Of Neurodegeneration,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954477/,Positive,,Meta-analysis,2014,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); SR-x Synthetic Cannabinoids,,Alzheimer's Disease; Geriatric Conditions; Huntington's Disease; Parkinson's Disease
2015235,Cannabinoids In Neurodegenerative Disorders And Stroke/Brain Trauma: From Preclinical Models To Clinical Applications,https://www.ncbi.nlm.nih.gov/pubmed/26260390,Positive,,Meta-analysis,2015,,,Neurodegenerative Issues; Alzheimer's Disease; Amyotrophic Lateral Sclerosis (ALS); Huntington's Disease; Neonatal Cerebral Issues; Parkinson's Disease; Stroke
2015236,Cannabinoids In Late-onset Alzheimer's Disease,https://www.ncbi.nlm.nih.gov/pubmed/25788394,Positive,,Meta-analysis,2015,,,Alzheimer's Disease; Cognitive Dysfunction
2016322,Endocannabionoid System In Neurological Disorders,https://www.ncbi.nlm.nih.gov/pubmed/27364363,Positive,,Meta-analysis,2016,,,Alzheimer's Disease; Huntington's Disease; Multiple Sclerosis; Parkinson's Disease
2016323,Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model,https://www.ncbi.nlm.nih.gov/pubmed/27567873,Positive,,Animal Study,2016,,Nervous System,Alzheimer's Disease; Dementia
2016324,"Activity Of Muscarinic, Galanin And Cannabinoid Receptors In The Prodromal And Advanced Stages In The Triple Transgenic Mice Model Of Alzheimer's Disease",https://www.ncbi.nlm.nih.gov/pubmed/27223629,Positive,,Animal Study,2016,,Nervous System,Alzheimer's Disease
2016325,"Safety And Efficacy Of Medical Cannabis Oil For Behavioral And Psychological Symptoms Of Dementia: An-Open Label, Add-On, Pilot Study",https://www.ncbi.nlm.nih.gov/pubmed/26757043,Positive,,Meta-analysis,2016,,Nervous System,Alzheimer's Disease; Dementia; Cognitive Dysfunction
2017311,"GPR3 And GPR6, Novel Molecular Targets For Cannabidiol",https://www.sciencedirect.com/science/article/pii/S0006291X17310744,Positive,,Laboratory Study,2017,,,Alzheimer's Disease; Parkinson's Disease
2017312,Neurological Aspects Of Medical Use Of Cannabidiol,https://www.ncbi.nlm.nih.gov/pubmed/28412918,Positive,,Meta-analysis,2017,,,Alzheimer's Disease; Amyotrophic Lateral Sclerosis (ALS); Cognitive Dysfunction; Epilepsy - Dravet Syndrome; Epilepsy; Huntington's Disease; Multiple Sclerosis; Parkinson's Disease
2017313,Cannabinoid Receptor 2 Signaling In Neurodegenerative Disorders: From Pathogenesis To A Promising Therapeutic Target,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288380/,Positive,,Meta-analysis,2017,,,Cognitive Dysfunction; Neurodegenerative Issues; Alzheimer's Disease; Parkinson's Disease
2017314,Beta-caryophyllene Protects Against Alcoholic Steatohepatitis By Attenuating Inflammation And Metabolic Dysregulation In Mice,https://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/bph.13722,Positive,,Animal Study,2017,,Digestive System; Nervous System,Alcoholic Liver Disease; Fatty Liver Disease; Oxidative Stress
2004068,Cannabis As A Substitute For Alcohol: A Harm-reduction Approach,http://hams.cc/mikuriya.pdf,Positive,,Meta-analysis,2004,,Mental/Emotional System,Addiction - Alcohol; Addiction
2005084,Ethanol Self-administration And Ethanol Conditioned Place Preference Are Reduced In Mice Lacking Cannabinoid CB1 Receptors,https://www.ncbi.nlm.nih.gov/pubmed/16140402,Positive,,Animal Study,2005,SR-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction
2008137,Genetic And Pharmacological Manipulations Of The CB(1) Receptor Alter Ethanol Preference And Dependence In Ethanol Preferring And Nonpreferring Mice,https://onlinelibrary.wiley.com/doi/abs/10.1002/syn.20533,Positive,,Animal Study,2008,SR-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction
2009128,Cannabis As A Substitute For Alcohol And Other Drugs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795734/,Positive,,Meta-analysis,2009,,Mental/Emotional System,Addiction - Alcohol; Addiction
2016326,FAAH Gene Variation Moderates Stress Response And Symptom Severity In Patients With Posttraumatic Stress Disorder And Comorbid Alcohol Dependence,https://www.ncbi.nlm.nih.gov/pubmed/27716956,Positive,,Clinical Trial,2016,Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction; PTSD
2016327,"Involvement Of Endocannabinoids In Alcohol ""Binge"" Drinking: Studies Of Mice With Human Fatty Acid Amide Hydrolase Genetic Variation And After CB1 Receptor Antagonists",https://www.ncbi.nlm.nih.gov/pubmed/26857901,Positive,,Animal Study,2016,AM-x Synthetic Cannabinoids; Fatty Acid Amide Hydrolase (FAAH); Anandamide (AEA),Mental/Emotional System; Nervous System,Addiction - Alcohol; Addiction
2017315,Helping Settle the Marijuana and Alcohol Debate: Evidence from Scanner Data,https://www.researchgate.net/publication/320735052_Helping_Settle_the_Marijuana_and_Alcohol_Debate_Evidence_from_Scanner_Data,Positive,,Meta-analysis,2017,,Mental/Emotional System,Addiction - Alcohol; Addiction
2017316,"Cannabidiol reduces ethanol consumption, motivation and relapse in mice.",https://onlinelibrary.wiley.com/doi/abs/10.1111/adb.12495,Positive,,Animal Study,2017,,Mental/Emotional System,Addiction - Alcohol; Addiction
2006076,The Endocannabinoid System in Ageing: A New Target for Drug Development,https://www.researchgate.net/publication/6696220_The_Endocannabinoid_System_in_Ageing_A_New_Target_for_Drug_Development,Positive,,Meta-analysis,2006,Endocannabinoid (unspecified),Muscular System; Nervous System; Skeletal System,Geriatric Conditions; Cognitive Dysfunction; Longevity; Sarcopenia
2009129,Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis,https://pubmed.ncbi.nlm.nih.gov/19385063/,Positive,,Animal Study,2009,WIN-x Synthetic Cannabinoids,Muscular System; Nervous System; Skeletal System,Geriatric Conditions; Neurodegenerative Issues; Cognitive Dysfunction; Sarcopenia
2012177,The Endocannabinoid System In Normal And Pathological Brain Aging,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481530/,Positive,,Meta-analysis,2012,Endocannabinoid (unspecified),Muscular System; Nervous System; Skeletal System,Geriatric Conditions; Cognitive Dysfunction; Longevity
2016328,Amyloid Proteotoxicity Initiates An Inflammatory Response Blocked By Cannabinoids,http://www.nature.com/articles/npjamd201612#abstract,Positive,,Laboratory Study,2016,Anandamide (AEA); Tetrahydrocannabinol (THC); AM-x Synthetic Cannabinoids,,Alzheimer's Disease; Geriatric Conditions; Huntington's Disease; Parkinson's Disease
2017317,A Chronic Low Dose Of Δ9-tetrahydrocannabinol (THC) Restores Cognitive Function In Old Mice,https://www.nature.com/articles/nm.4311,Positive,,Animal Study,2017,Tetrahydrocannabinol (THC),Muscular System; Nervous System; Skeletal System,Cognitive Dysfunction; Geriatric Conditions; Neurodegenerative Issues
2006077,Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration.,https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1016%2Fj.plefa.2006.08.002,Inconclusive,,Laboratory Study,2006,Anandamide (AEA); 2-Arachidonoyl Glycerol (2-AG); Other Related Compounds,Nervous System,Macular Degeneration
2009130,Presence And Regulation Of Cannabinoid Receptors In Human Retinal Pigment Epithelial Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697670/,Positive,,Laboratory Study,2009,Fatty Acid Amide Hydrolase (FAAH),Nervous System,Macular Degeneration
2014198,Neuroprotective effects of the cannabinoid agonist HU210 on retinal degeneration,https://www.sciencedirect.com/science/article/pii/S0014483514000347,Positive,,Animal Study,2014,HU-x Synthetic Cannabinoids,Nervous System,Macular Degeneration; Retinal Disorders
2000022,"Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndrome.",https://www.ncbi.nlm.nih.gov/pubmed/10834304/,Positive,,Animal Study,2000,SR-x Synthetic Cannabinoids,Mental/Emotional System,Addiction - Opioid; Addiction
2001033,Reduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572728/,Positive,,Animal Study,2001,SR-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC),Mental/Emotional System,Addiction - Opioid; Addiction
2007095,Synergy Between Delta9-tetrahydrocannabinol And Morphine In The Arthritic Rat,https://www.sciencedirect.com/science/article/abs/pii/S0014299907004700?via%3Dihub,Positive,,Animal Study,2007,,Skeletal System,Arthritis; Pain; Pain - Chronic; Addiction - Opioid; Inflammation
2011173,Cannabinoid-opioid Interaction In Chronic Pain,https://www.ncbi.nlm.nih.gov/pubmed/22048225,Positive,,Clinical Trial,2011,,Mental/Emotional System,Addiction - Opioid; Addiction
2012178,Prescribing Cannabis For Harm Reduction,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295721/,Positive,,Meta-analysis,2012,,,Addiction - Opioid; Pain; Pain - Neuropathy - Peripheral
2014199,"Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392651/,Positive,,Meta-analysis,2014,,,Addiction - Opioid
2015237,Safety And Pharmacokinetics Of Oral Cannabidiol When Administered Concomitantly With Intravenous Fentanyl In Humans,https://www.ncbi.nlm.nih.gov/pubmed/25748562,Positive,,Clinical Trial,2015,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction; Pain; Pain - Chronic
2015238,Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage.,https://www.ncbi.nlm.nih.gov/pubmed/26269227,Positive,,Meta-analysis,2015,,Mental/Emotional System,Addiction - Opioid; Addiction
2016329,Splendor In The Grass? A Pilot Study Assessing The Impact Of Medical Marijuana On Executive Function,https://www.frontiersin.org/articles/10.3389/fphar.2016.00355/full,Positive,,Meta-analysis,2016,,,Addiction - Opioid; Depression; Geriatric Conditions; Insomnia and Sleep Disorders
2016330,Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D,https://www.healthaffairs.org/doi/abs/10.1377/hlthaff.2015.1661,Positive,,Meta-analysis,2016,,,Addiction - Opioid
2018420,Effects Of Cannabidiol On Morphine Conditioned Place Preference In Mice,https://www.ncbi.nlm.nih.gov/pubmed/28793355,Positive,,Animal Study,2018,,Mental/Emotional System,Addiction - Opioid; Addiction
2017318,Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report,https://www.liebertpub.com/doi/full/10.1089/can.2017.0012,Positive,,Meta-analysis,2017,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction; Pain; Pain - Chronic
2018421,"Epidemiological Characteristics, Safety And Efficacy Of Medical Cannabis In The Elderly",https://www.ncbi.nlm.nih.gov/pubmed/29398248?dopt=Abstract,Positive,,Meta-analysis,2018,,Muscular System; Nervous System; Skeletal System,Geriatric Conditions; Addiction - Opioid; Cognitive Dysfunction; Pain; Pain - Chronic; Sarcopenia
2018422,The Grass Might Be Greener: Medical Marijuana Patients Exhibit Altered Brain Activity And Improved Executive Function After 3 Months Of Treatment,https://www.ncbi.nlm.nih.gov/pubmed/29387010,Positive,,Clinical Trial,2018,,,Cognitive Dysfunction; Addiction - Opioid
1994006,Inhalation Of Vapor From Black Pepper Extract Reduces Smoking Withdrawal Symptoms,https://www.ncbi.nlm.nih.gov/pubmed/8033760,Positive,,Double Blind Clinical Trial,1994,,Mental/Emotional System,Addiction - Nicotine; Addiction
2005085,CB1 receptor antagonists for the treatment of nicotine addiction.,https://www.ncbi.nlm.nih.gov/pubmed/15935455/,Positive,,Animal Study,2005,SR-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Addiction - Nicotine; Addiction
2002044,"SR141716, A Central Cannabinoid (CB(1)) Receptor Antagonist, Blocks The Motivational And Dopamine-releasing Effects Of Nicotine In Rats",https://www.ncbi.nlm.nih.gov/pubmed/12394421/,Positive,,Animal Study,2002,SR-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Addiction - Nicotine; Addiction; Addiction - Alcohol
2007096,Damage To The Insula Disrupts Addiction To Cigarette Smoking,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698854/,Positive,,Meta-analysis,2007,,Mental/Emotional System,Addiction - Nicotine; Addiction
2008138,The Cannabinoid Antagonist AM251 Attenuates Nicotine Self-administration And Nicotine-seeking Behaviour In Rats,https://www.ncbi.nlm.nih.gov/pubmed/18054052/,Positive,,Animal Study,2008,AM-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Addiction - Nicotine; Addiction
2009131,Blocking Cannabinoid CB1 Receptors For The Treatment Of Nicotine Dependence: Insights From Pre-clinical And Clinical Studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752688/,Positive,,Animal Study,2009,SR-x Synthetic Cannabinoids; AM-x Synthetic Cannabinoids,Mental/Emotional System; Nervous System,Addiction - Nicotine; Addiction
2009132,Inhibition Of Fatty Acid Amide Hydrolase Reduces Reinstatement Of Nicotine Seeking But Not Break Point For Nicotine Self-administration--comparison With CB(1) Receptor Blockade,https://www.ncbi.nlm.nih.gov/pubmed/19484221/,Positive,,Animal Study,2009,Fatty Acid Amide Hydrolase (FAAH),Mental/Emotional System; Nervous System,Addiction - Nicotine; Addiction
2013166,Cannabidiol Reduces Cigarette Consumption In Tobacco Smokers: Preliminary Findings,https://www.ncbi.nlm.nih.gov/pubmed/23685330#,Positive,,Double Blind Clinical Trial,2013,,Mental/Emotional System; Nervous System,Addiction - Nicotine; Addiction
2013167,The Volitional Nature Of Nicotine Exposure Alters Anandamide And Oleoylethanolamide Levels In The Ventral Tegmental Area,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572454/,Positive,,Animal Study,2013,2-Arachidonoyl Glycerol (2-AG),Mental/Emotional System; Nervous System,Addiction - Nicotine; Addiction
2015239,Neuroscience of nicotine for addiction medicine: novel targets for smoking cessation medications,https://pubmed.ncbi.nlm.nih.gov/26806777/,Positive,,Meta-analysis,2015,Anandamide (AEA),Mental/Emotional System; Nervous System,Addiction - Nicotine; Addiction
2016331,CB1 Cannabinoid Receptors Mediate Cognitive Deficits And Structural Plasticity Changes During Nicotine Withdrawal,https://www.ncbi.nlm.nih.gov/pubmed/27737762,Positive,,Animal Study,2016,Anandamide (AEA); 2-Arachidonoyl Glycerol (2-AG),Mental/Emotional System,Addiction - Nicotine; Addiction
2016332,Inhibition of monoacylglycerol lipase (MAGL) enhances cue-induced reinstatement of nicotine-seeking behavior in mice.,https://www.ncbi.nlm.nih.gov/pubmed/26490035,Positive,,Animal Study,2016,2-Arachidonoyl Glycerol (2-AG); Monoacylglycerol Lipase (MAGL); Anandamide (AEA),Mental/Emotional System,Addiction - Nicotine; Addiction
2016333,Attenuation Of Cue-induced Reinstatement Of Nicotine Seeking By URB597 Through Cannabinoid CB1 Receptor In Rats,https://www.ncbi.nlm.nih.gov/pubmed/26864774,Positive,,Animal Study,2016,AM-x Synthetic Cannabinoids,Mental/Emotional System,Addiction - Nicotine; Addiction
1976008,Correlation Between The In Vivo And An In Vitro Expression Of Opiate Withdrawal Precipitated By Naloxone: Their Antagonism By L-(-)-delta9-tetrahydrocannabinol,https://www.ncbi.nlm.nih.gov/pubmed/988178/,Positive,,Animal Study,1976,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
1995014,Anandamide Decreases Naloxone-precipitated Withdrawal Signs In Mice Chronically Treated With Morphine,https://www.ncbi.nlm.nih.gov/pubmed/7566503/,Positive,,Animal Study,1995,Anandamide (AEA),Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
2001034,"Endogenous Cannabinoid, 2-arachidonoylglycerol, Attenuates Naloxone-precipitated Withdrawal Signs In Morphine-dependent Mice",https://www.ncbi.nlm.nih.gov/pubmed/11478928/,Positive,,Animal Study,2001,2-Arachidonoyl Glycerol (2-AG); HU-x Synthetic Cannabinoids; Tetrahydrocannabinol (THC),Mental/Emotional System,Addiction - Opioid; Addiction
2001035,Opioid And Cannabinoid Modulation Of Precipitated Withdrawal In Delta(9)-tetrahydrocannabinol And Morphine-dependent Mice,https://www.ncbi.nlm.nih.gov/pubmed/11504797/,Positive,,Animal Study,2001,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
2001036,Delta9-tetrahydrocannabinol Releases And Facilitates The Effects Of Endogenous Enkephalins: Reduction In Morphine Withdrawal Syndrome Without Change In Rewarding Effect,https://www.ncbi.nlm.nih.gov/pubmed/11359533/,Positive,,Animal Study,2001,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
2002045,Attenuation Of Spontaneous Opiate Withdrawal In Mice By The Anandamide Transport Inhibitor AM404,https://www.ncbi.nlm.nih.gov/pubmed/12409011/,Positive,,Animal Study,2002,Anandamide (AEA),Mental/Emotional System,Addiction - Opioid; Addiction
2017319,Speechlessness in Gilles de la Tourette Syndrome: Cannabis-Based Medicines Improve Severe Vocal Blocking Tics in Two Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578129/,Positive,,Meta-analysis,2017,Pharma THC,Nervous System,Tics and Tourettes
2017320,Medical Cannabinoids in Children and Adolescents: A Systematic Review.,https://www.ncbi.nlm.nih.gov/pubmed/29061872,Positive,,Meta-analysis,2017,,,Epilepsy; Tics and Tourettes; Pain; Nausea and Vomiting; Pain - Neuropathy - Peripheral; PTSD
2018423,"A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678490/,Positive,,Meta-analysis,2018,Pharma THC:CBD; Pharma THC,,Alzheimer's Disease; Anorexia; Anxiety; Cognitive Dysfunction; Huntington's Disease; Tics and Tourettes; Parkinson's Disease; Psychosis; PTSD
2018424,"The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report.",https://www.ncbi.nlm.nih.gov/pubmed/29325791,Positive,,Meta-analysis,2018,,,Anorexia; Anxiety; Epilepsy; Insomnia and Sleep Disorders; Tics and Tourettes; Irritable Bowel Syndrome; Pain; Multiple Sclerosis; Nausea and Vomiting; Pain - Chronic; PTSD
2018425,Medical use of cannabis: Italian and European legislation.,https://www.europeanreview.org/wp/wp-content/uploads/1161-1167-1.pdf,Positive,,Meta-analysis,2018,Other Related Compounds; Pharma THC:CBD; Pharma THC,,Anorexia; Anxiety; Arthritis - Rheumatoid; Arthritis; HIV/AIDS; Pain; Multiple Sclerosis; Nausea and Vomiting; Pain - Cancer; Pain - Neuropathy - Diabetic; Pain - Neuropathy - Peripheral; Spinal Cord Injuries
2004069,Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade.,https://www.ncbi.nlm.nih.gov/pubmed/15085091,Positive,,Animal Study,2004,SR-x Synthetic Cannabinoids,Mental/Emotional System,Addiction - Stimulant; Addiction
2004070,Neurocognitive Performance Of Methamphetamine Users Discordant For History Of Marijuana Exposure,https://www.ncbi.nlm.nih.gov/pubmed/15488342,Inconclusive,,Meta-analysis,2004,,Mental/Emotional System,Addiction - Stimulant; Addiction
2014200,Δ9-tetrahydrocannabinol Prevents Methamphetamine-induced Neurotoxicity,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4028295/,Positive,,Animal Study,2014,Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Stimulant; Addiction
2016334,Cannabidiol Counteracts Amphetamine-Induced Neuronal And Behavioral Sensitization Of The Mesolimbic Dopamine Pathway Through A Novel MTOR/p70S6 Kinase Signaling Pathway,https://www.ncbi.nlm.nih.gov/pubmed/27147666,Positive,,Animal Study,2016,,Mental/Emotional System; Nervous System,Psychosis; Schizophrenia; Addiction - Stimulant
2003053,Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.,https://www.ncbi.nlm.nih.gov/pubmed/12606610/,Positive,,Animal Study,2003,,Mental/Emotional System,Addiction - Opioid; Addiction
2008139,Neural Basis Of Delta-9-tetrahydrocannabinol And Cannabidiol: Effects During Response Inhibition,https://www.ncbi.nlm.nih.gov/pubmed/18589404/,Positive,,Double Blind Clinical Trial,2008,,,Addiction - Nicotine
2009133,"Cannabidiol, A Nonpsychotropic Component Of Cannabis, Inhibits Cue-induced Heroin Seeking And Normalizes Discrete Mesolimbic Neuronal Disturbances",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829756/,Positive,,Animal Study,2009,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
2013168,Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742578/,Positive,,Meta-analysis,2013,Endocannabinoid (unspecified),Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
2015240,The Effects Of Dronabinol During Detoxification And The Initiation Of Treatment With Extended Release Naltrexone.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536087/,Positive,,Double Blind Clinical Trial,2015,Pharma THC,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
2017321,The endocannabinoid system as a target for addiction treatment: Trials and tribulations,https://www.sciencedirect.com/science/article/pii/S0028390817302563,Positive,,Meta-analysis,2017,,,Addiction - Alcohol; Addiction - Nicotine; Addiction - Opioid
2017322,Cannabidiol: Swinging The Marijuana Pendulum From 'Weed' To Medication To Treat The Opioid Epidemic,https://ncbiinsights.ncbi.nlm.nih.gov/2018/06/15/pubmed-journals-shut-down/,Positive,,Meta-analysis,2017,,Mental/Emotional System; Nervous System,Addiction - Opioid; Addiction
2018426,Impact Of Co-administration Of Oxycodone And Smoked Cannabis On Analgesia And Abuse Liability,https://www.ncbi.nlm.nih.gov/pubmed/29463913,Positive,,Double Blind Clinical Trial,2018,,Mental/Emotional System,Addiction - Opioid; Addiction; Pain
1999020,Therapeutic use of cannabis by crack addicts in Brazil,https://www.ncbi.nlm.nih.gov/pubmed/10681113/,Positive,,Clinical Trial,1999,,Mental/Emotional System; Nervous System,Addiction - Cocaine; Addiction
2002046,Crack Heads and Roots Daughters: The Therapeutic Use of Cannabis in Jamaica,https://www.cannabis-med.org/data/pdf/2002-03-04-7.pdf,Positive,,Meta-analysis,2002,,Mental/Emotional System; Nervous System,Addiction - Cocaine; Addiction
2004071,Effect Of Low Doses Of Delta9-tetrahydrocannabinol And Cannabidiol On The Extinction Of Cocaine-induced And Amphetamine-induced Conditioned Place Preference Learning In Rats,https://www.ncbi.nlm.nih.gov/pubmed/15138755/,Positive,,Animal Study,2004,Tetrahydrocannabinol (THC); SR-x Synthetic Cannabinoids,Mental/Emotional System,Addiction - Cocaine; Addiction - Stimulant; Addiction
2011174,Brain Cannabinoid CB₂ Receptors Modulate Cocaine's Actions In Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164946/,Positive,,Animal Study,2011,,Mental/Emotional System; Nervous System,Addiction - Cocaine; Addiction
2015241,The dark side of emotion: the addiction perspective,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4380644/,Positive,,Meta-analysis,2015,Endocannabinoid (unspecified),,Addiction - Cocaine; Addiction - Nicotine; Addiction - Opioid
2017323,Intentional Cannabis Use To Reduce Crack Cocaine Use In A Canadian Setting: A Longitudinal Analysis,https://www.ncbi.nlm.nih.gov/pubmed/28399488,Positive,,Meta-analysis,2017,,Mental/Emotional System; Nervous System,Addiction - Cocaine; Addiction
2017324,Preliminary Evidence On Cannabis Effectiveness And Tolerability For Adults With Tourette Syndrome,https://pubmed.ncbi.nlm.nih.gov/28464701/,Positive,,Meta-analysis,2017,,Nervous System,Tics and Tourettes
2016335,Endocannabinoid System: A Multi-Facet Therapeutic Target.,https://www.ncbi.nlm.nih.gov/pubmed/27086601,Positive,,Meta-analysis,2016,Pharma THC:CBD; Pharma THC; SR-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified); Tetrahydrocannabinol (THC),,Alzheimer's Disease; Anorexia; Cardiovascular Diseases (CVD); Epilepsy; Glaucoma; Huntington's Disease; Tics and Tourettes; Multiple Sclerosis; Nausea and Vomiting; Obesity; Parkinson's Disease; Schizophrenia
2018427,Severe motor and vocal tics controlled with Sativex®.,https://www.ncbi.nlm.nih.gov/pubmed/27558217,Positive,,Meta-analysis,2018,Tetrahydrocannabinol (THC),,Tics and Tourettes
2010143,Oral Delta 9-tetrahydrocannabinol Improved Refractory Gilles De La Tourette Syndrome In An Adolescent By Increasing Intracortical Inhibition: A Case Report,https://www.ncbi.nlm.nih.gov/pubmed/20520294,Positive,,Meta-analysis,2010,Tetrahydrocannabinol (THC),,Tics and Tourettes
2009134,Cannabinoids for Tourette's Syndrome.,https://www.ncbi.nlm.nih.gov/pubmed/19821373,Positive,,Clinical Meta-analysis,2009,,Nervous System,Tics and Tourettes
2001037,Treatment of Tourette-Syndrome with ∆9-Tetrahydrocannabinol (THC): a randomized crossover trial,https://www.ncbi.nlm.nih.gov/pubmed/11951146,Positive,,Double Blind Clinical Trial,2001,,,Tics and Tourettes
2001038,Influence Of Treatment Of Tourette Syndrome With Delta9-tetrahydrocannabinol (delta9-THC) On Neuropsychological Performance,https://www.ncbi.nlm.nih.gov/pubmed/11229617,Positive,,Double Blind Clinical Trial,2001,Tetrahydrocannabinol (THC),,Tics and Tourettes
2000023,The importance of the endogenous cannabinoid system in various neuropsychiatric disorders,https://www.ncbi.nlm.nih.gov/pubmed/11103679,Positive,,Meta-analysis,2000,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA),,Addiction - Opioid; Tics and Tourettes; Stroke
1999021,Cannabis In Movement Disorders,https://www.karger.com/Article/Abstract/57153,Positive,,Meta-analysis,1999,,,Dystonia; Huntington's Disease; Tics and Tourettes; Parkinson's Disease
2018428,Cannabinoids: possible role in patho-physiology and therapy of Gilles de la Tourette syndrome.,https://www.ncbi.nlm.nih.gov/pubmed/9879795,Positive,,Meta-analysis,2018,,,Tics and Tourettes
2018429,Nicotine and cannabinoids as adjuncts to neuroleptics in the treatment of Tourette syndrome,https://www.ncbi.nlm.nih.gov/pubmed/2567480,Positive,,Meta-analysis,2018,,,Tics and Tourettes
2018430,Betacaryophyllene – A phytocannabinoid as potential therapeutic modality for human sepsis?,https://www.sciencedirect.com/science/article/pii/S0306987717308617#!,Positive,,Meta-analysis,2018,,Immune System,Sepsis
2017325,How Does Marijuana Effect Outcomes After Trauma In ICU Patients? A Propensity Matched Analysis,https://www.ncbi.nlm.nih.gov/pubmed/28787375,Positive,,Meta-analysis,2017,,,Pain; Pain - Acute
2017326,Endocannabinoids: A Promising Impact for Traumatic Brain Injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314139/,Positive,,Meta-analysis,2017,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL); Synthetic Cannabinoid (unspecified),Nervous System,Traumatic Brain Injury
2009135,2-Arachidonoylglycerol Elicits Neuroprotective Effects On Excitotoxically Lesioned Dentate Gyrus Granule Cells Via Abnormal-cannabidiol-sensitive Receptors On Microglial Cells,https://www.ncbi.nlm.nih.gov/pubmed/18837048,Positive,,Laboratory Study,2009,2-Arachidonoyl Glycerol (2-AG); Abnormal Cannabidiol (Abn-CBD); AM-x Synthetic Cannabinoids,Nervous System,Traumatic Brain Injury
2007097,Endocannabinoids And Traumatic Brain Injury,https://www.ncbi.nlm.nih.gov/pubmed/17952651,Positive,,Animal Study,2007,2-Arachidonoyl Glycerol (2-AG); SR-x Synthetic Cannabinoids,,Traumatic Brain Injury
2006078,"Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial",https://pubmed.ncbi.nlm.nih.gov/16361021/,Inconclusive,,Double Blind Clinical Trial,2006,Synthetic Cannabinoid (unspecified),Nervous System,Traumatic Brain Injury
2011175,"Dronabinol, a cannabinoid agonist, reduces hair pulling in trichotillomania: a pilot study.",https://pubmed.ncbi.nlm.nih.gov/21590520/,Positive,,Clinical Trial,2011,Pharma THC,Integumentary System,Compulsive hair pulling
2016336,The cannabinoid 2 receptor agonist β-caryophyllene modulates the inflammatory reaction induced by Mycobacterium bovis BCG by inhibiting neutrophil migration.,https://www.ncbi.nlm.nih.gov/pubmed/27379721,Positive,,Animal Study -,2016,,,Tuberculosis; Veterinary Applications
2006079,"The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS).",https://www.researchgate.net/publication/7225749_The_effect_of_cannabis_on_urge_incontinence_in_patients_with_multiple_sclerosis_A_multicentre_randomised_placebo-controlled_trial_CAMS-LUTS,Positive,,Double Blind Clinical Trial,2006,,Nervous System; Urinary System,Multiple Sclerosis; Urinary Tract Infection
2004072,An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis,https://journals.sagepub.com/doi/10.1191/1352458504ms1063oa,Positive,,Clinical Trial,2004,Tetrahydrocannabinol (THC),Urinary System,Multiple Sclerosis; Urinary Incontinence; Pain
2003054,A Preliminary Controlled Study To Determine Whether Whole-plant Cannabis Extracts Can Improve Intractable Neurogenic Symptoms,https://pubmed.ncbi.nlm.nih.gov/12617376/,Positive,,Double Blind Clinical Trial,2003,,Urinary System,Pain; Pain - Chronic; Urinary Incontinence; Multiple Sclerosis; Spinal Cord Injuries
2018431,Nabiximols Combined With Motivational Enhancement/cognitive Behavioral Therapy For The Treatment Of Cannabis Dependence: A Pilot Randomized Clinical Trial,https://www.ncbi.nlm.nih.gov/pubmed/29385147,Positive,,Double Blind Clinical Trial,2018,Pharma THC:CBD; Tetrahydrocannabinol (THC),Mental/Emotional System; Nervous System,Addiction - Cannabis; Addiction
2018432,Synthetic Cannabinoid Induced acute Tubulointerstitial Nephritis and Uveitis Syndrome: A Case Report and Review of Literature,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948465/,Negative,,Meta-analysis,2018,Synthetic Cannabinoid (unspecified),,Poisoning by Synthetic Cannabis
2018433,Turning Down the Thermostat: Modulating the Endocannabinoid System in Ocular Inflammation and Pain,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024674/,Positive,,Meta-analysis,2018,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),Immune System,Pain; Pain - Eye; Uveitis
2014201,Anti-inflammatory effects of cannabinoid CB2 receptor activation in endotoxin-induced uveitis.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954484/,Positive,,Animal Study,2014,HU-x Synthetic Cannabinoids; AM-x Synthetic Cannabinoids,Immune System; Nervous System,Uveitis
2018434,Endocannabinoids affect innate immunity of Muller glia during HIV-1 Tat cytotoxicity.,https://pubmed.ncbi.nlm.nih.gov/24418364/,Positive,,Laboratory Study,2018,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); AM-x Synthetic Cannabinoids; Other Related Compounds,Immune System; Nervous System,Uveitis
2007098,Anti‐inflammatory property of the cannabinoid receptor‐2‐selective agonist JWH‐133 in a rodent model of autoimmune uveoretinitis,https://jlb.onlinelibrary.wiley.com/doi/10.1189/jlb.0307159,Positive,,Animal Study,2007,JWH-x Synthetic Cannabinoids,Immune System,Uveitis
2018435,Marijuana use differentially affects cannabinoid receptor expression in early gestational human endometrium and placenta.,https://www.ncbi.nlm.nih.gov/pubmed/29884300,Inconclusive,,Laboratory Study,2018,Endocannabinoid (unspecified),Reproductive System,Pregnancy
2018436,Chronic cannabidiol exposure promotes functional impairment in sexual behavior and fertility of male mice.,https://www.ncbi.nlm.nih.gov/pubmed/29936126,Negative,,Animal Study,2018,,Endocrine System; Reproductive System,Libido; Erectile Dysfunction
1994007,"Comparative Epidemiology Of Dependence On Tobacco, Alcohol, Controlled Substances, And Inhalants: Basic Findings From The National Comorbidity Survey",https://pdfs.semanticscholar.org/60cd/d49b5ed6a84423762a366727ae4880c6f255.pdf,Positive,,Meta-analysis,1994,,Mental/Emotional System,Addiction - Cannabis; Addiction
2018437,Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure.,https://www.ncbi.nlm.nih.gov/pubmed/29786643,Positive,,Animal Study,2018,AM-x Synthetic Cannabinoids; Monoacylglycerol Lipase (MAGL); 2-Arachidonoyl Glycerol (2-AG); Tetrahydrocannabinol (THC),,Glaucoma
2018438,Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain.,https://www.ncbi.nlm.nih.gov/pubmed/29781960,Positive,,Animal Study,2018,SR-x Synthetic Cannabinoids,,Pain; Pain - Cancer
2018439,Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome,https://www.nejm.org/doi/10.1056/NEJMoa1714631,Positive,,Double Blind Clinical Trial,2018,,Nervous System,Epilepsy - Lennox-Gastaut; Epilepsy
2018440,Cannabinoid signalling in embryonic and adult neurogenesis: possible implications for psychiatric and neurological disorders.,https://www.ncbi.nlm.nih.gov/pubmed/29764526,Positive,,Meta-analysis,2018,Endocannabinoid (unspecified); Synthetic Cannabinoid (unspecified),,Alzheimer's Disease; Anxiety; Depression; Schizophrenia; Stroke
2018441,Enhancing the Therapeutic Efficacy of Cancer Treatment With Cannabinoids,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928848/,Positive,,Animal Study,2018,,Nervous System,Cancer; Cancer - Lung; Cancer - Pancreatic
2018442,Emerging Role of (Endo)Cannabinoids in Migraine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928495/,Positive,,Meta-analysis,2018,2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); Fatty Acid Amide Hydrolase (FAAH); Monoacylglycerol Lipase (MAGL),,Migraine
2018443,Cannabis and joints: scientific evidence for the alleviation of osteoarthritis pain by cannabinoids.,https://www.ncbi.nlm.nih.gov/pubmed/29635215,Positive,,Meta-analysis,2018,,Skeletal System,Arthritis - Osteoarthritis; Arthritis
2018444,The Endocannabinoid System Affects Myocardial Glucose Metabolism in the DOCA-Salt Model of Hypertension.,https://www.karger.com/Article/FullText/488730,Positive,,Animal Study,2018,Fatty Acid Amide Hydrolase (FAAH),Cardiovascular System,Cardiovascular Diseases (CVD); Hypertension (High Blood Pressure)
2018445,The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial.,https://www.ncbi.nlm.nih.gov/pubmed/29619533,Inconclusive,,Double Blind Clinical Trial,2018,,Mental/Emotional System,Schizophrenia
2018446,Medical Cannabis and the Treatment of Obstructive Sleep Apnea: An American Academy of Sleep Medicine Position Statement,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886446/,Negative,,Meta-analysis,2018,Pharma THC; Tetrahydrocannabinol (THC),,Sleep Apnea
2018447,Profiles of Patients Who Use Marijuana for Inflammatory Bowel Disease.,https://www.ncbi.nlm.nih.gov/pubmed/29594968,Inconclusive,,Meta-analysis,2018,,Digestive System,IBD - Inflammatory Bowel Disease
2018448,Antiepileptogenic Effect of Subchronic Palmitoylethanolamide Treatment in a Mouse Model of Acute Epilepsy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861196/,Positive,,Animal Study,2018,Palmitoylethanolamide (PEA); Other Related Compounds,Nervous System,Epilepsy
2018449,Joint problems arising from lack of repair mechanisms: can cannabinoids help?,https://www.ncbi.nlm.nih.gov/pubmed/29574720,Positive,,Meta-analysis,2018,,Skeletal System,Arthritis - Osteoarthritis; Arthritis
2018450,Paeoniflorin exerts neuroprotective effects by modulating the M1/M2 subset polarization of microglia/macrophages in the hippocampal CA1 region of vascular dementia rats via cannabinoid receptor 2.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859430/,Positive,,Animal Study,2018,AM-x Synthetic Cannabinoids; Synthetic Cannabinoid (unspecified),,Dementia; Alzheimer's Disease
2018451,Cannabis and psychosis: what do we know and what should we do?,https://pubmed.ncbi.nlm.nih.gov/29557759/,Negative,,Meta-analysis,2018,Synthetic Cannabinoid (unspecified),Mental/Emotional System; Nervous System,Psychosis
2018452,Anti-invasion Effects of Cannabinoids Agonist and Antagonist on Human Breast Cancer Stem Cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843309/,Positive,,Laboratory Study,2018,AM-x Synthetic Cannabinoids,Nervous System; Reproductive System,Cancer - Breast; Cancer
2009136,The Endocannabinoid System Of The Skin In Health And Disease: Novel Perspectives And Therapeutic Opportunities,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757311/,Positive,,Meta-analysis,2009,,,Abnormal Hair Growth; Acne; Allergic Contact Dermatitis; Cancer - Skin (Non-melanoma); Cancer; Compulsive hair pulling; Hair Loss; Pruritis; Psoriasis; Seborrhea; Systemic Sclerosis
2014202,"TRP Channel Cannabinoid Receptors In Skin Sensation, Homeostasis, And Inflammation",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240254/,Positive,,Meta-analysis,2014,Cannabichromene (CBC); Cannabigerol (CBG),,Acne; Seborrhea
2006080,Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia.,https://pubmed.ncbi.nlm.nih.gov/16521031/,Positive,,Clinical Trial,2006,Pharma THC; Tetrahydrocannabinol (THC),Muscular System; Nervous System; Skeletal System,Cognitive Dysfunction; Dementia; Geriatric Conditions; Alzheimer's Disease
2014203,Cannabidiol Exerts Sebostatic And Antiinflammatory Effects On Human Sebocytes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151231/,Positive,,Laboratory Study,2014,,Integumentary System,Acne
2005086,Cannabis sativa and dystonia secondary to Wilson's disease.,https://www.ncbi.nlm.nih.gov/pubmed/15390041?dopt=Abstract,Positive,,Meta-analysis,2005,Cannabichromene (CBC); Tetrahydrocannabinol (THC),Digestive System; Urinary System,Wilson's Disease
2016337,Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrhoeic skin and acne treatment.,https://www.ncbi.nlm.nih.gov/pubmed/27094344,Positive,,Laboratory Study,2016,Anandamide (AEA),Integumentary System,Acne
2008140,Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling.,https://www.ncbi.nlm.nih.gov/pubmed/18596221,Positive,,Laboratory Study,2008,Endocannabinoid (unspecified); 2-Arachidonoyl Glycerol (2-AG); Anandamide (AEA); JWH-x Synthetic Cannabinoids,Integumentary System,Acne; Seborrhea
